Drug1_ID,Drug1_Name,Drug2_ID,Drug2_Name,Prediction_Score,Predicted_Type_Index,Predicted_Type_Name,Interaction_Translation,True_Type_Index,True_Type_Name,Match
DB00177,Valsartan,DB00266,Dicoumarol,0.8351441025733948,47,Type_47,The metabolism of Dicoumarol can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00270,Isradipine,DB00426,Famciclovir,0.9812881946563721,47,Type_47,The metabolism of Famciclovir can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00218,Moxifloxacin,DB01075,Diphenhydramine,0.9988512992858887,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Diphenhydramine.,20,Type_20,Yes
DB00655,Estrone,DB01250,Olsalazine,0.9648227691650391,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Olsalazine.,49,Type_49,Yes
DB01590,Everolimus,DB08933,Luliconazole,0.992202877998352,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00762,Irinotecan,DB08896,Regorafenib,0.4803900718688965,47,Type_47,The metabolism of Regorafenib can be decreased when combined with Irinotecan.,77,Type_77,No
DB01626,Pargyline,DB06826,Unoprostone,0.9999998807907104,60,Type_60,Pargyline may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00191,Phentermine,DB01142,Doxepin,0.42233020067214966,76,Type_76,Phentermine may decrease the sedative activities of Doxepin.,76,Type_76,Yes
DB00344,Protriptyline,DB06701,Dexmethylphenidate,0.6070095300674438,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Dexmethylphenidate.,49,Type_49,Yes
DB00679,Thioridazine,DB09242,Moxonidine,0.38952746987342834,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Moxonidine.,49,Type_49,Yes
DB01045,Rifampicin,DB01181,Ifosfamide,0.7227182388305664,4,Type_4,The metabolism of Ifosfamide can be increased when combined with Rifampicin.,77,Type_77,No
DB00807,Proparacaine,DB06716,Fospropofol,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Fospropofol.,49,Type_49,Yes
DB00243,Ranolazine,DB04794,Bifonazole,0.7691794037818909,73,Type_73,The serum concentration of Bifonazole can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00872,Conivaptan,DB05109,Trabectedin,0.9856514930725098,73,Type_73,The serum concentration of Trabectedin can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00334,Olanzapine,DB01081,Diphenoxylate,0.9911262392997742,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Diphenoxylate.,49,Type_49,Yes
DB00701,Amprenavir,DB06616,Bosutinib,0.8719561696052551,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Amprenavir.,73,Type_73,Yes
DB01168,Procarbazine,DB04840,Debrisoquine,0.9935345649719238,60,Type_60,Procarbazine may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00298,Dapiprazole,DB01154,Thiamylal,0.9827553629875183,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Thiamylal.,49,Type_49,Yes
DB00244,Mesalazine,DB08439,Parecoxib,0.924095094203949,57,Type_57,Mesalazine may increase the nephrotoxic activities of Parecoxib.,57,Type_57,Yes
DB00404,Alprazolam,DB00623,Fluphenazine,0.9960689544677734,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Fluphenazine.,49,Type_49,Yes
DB00524,Metolazone,DB00914,Phenformin,0.998582124710083,70,Type_70,The therapeutic efficacy of Phenformin can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00541,Vincristine,DB13179,Troleandomycin,0.4993850886821747,73,Type_73,The serum concentration of Troleandomycin can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB06154,Pentaerythritol tetranitrate,DB09030,Vorapaxar,0.8448987007141113,6,Type_6,Pentaerythritol tetranitrate may increase the anticoagulant activities of Vorapaxar.,49,Type_49,No
DB00163,Vitamin E,DB00974,Edetic acid,0.9746606349945068,6,Type_6,Vitamin E may increase the anticoagulant activities of Edetic acid.,6,Type_6,Yes
DB01072,Atazanavir,DB06770,Benzyl alcohol,0.7804217338562012,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00210,Adapalene,DB01088,Iloprost,0.9907614588737488,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00399,Zoledronic acid,DB01177,Idarubicin,0.9995750784873962,24,Type_24,Zoledronic acid may increase the hypocalcemic activities of Idarubicin.,24,Type_24,Yes
DB00847,Cysteamine,DB09281,Magnesium trisilicate,0.8680422306060791,70,Type_70,The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Cysteamine.,70,Type_70,Yes
DB00371,Meprobamate,DB09280,Lumacaftor,0.46178555488586426,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Meprobamate.,75,Type_75,Yes
DB00700,Eplerenone,DB01210,Levobunolol,0.9946122169494629,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Levobunolol.,49,Type_49,Yes
DB00695,Furosemide,DB06696,Arbekacin,0.9355039596557617,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Arbekacin.,49,Type_49,Yes
DB00656,Trazodone,DB09034,Suvorexant,0.951946496963501,16,Type_16,Trazodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00334,Olanzapine,DB01416,Cefpodoxime,0.3838789761066437,75,Type_75,The serum concentration of Cefpodoxime can be decreased when it is combined with Olanzapine.,67,Type_67,No
DB00297,Bupivacaine,DB08987,Etidocaine,0.9970851540565491,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Etidocaine.,49,Type_49,Yes
DB01242,Clomipramine,DB09198,Lobeglitazone,0.9978703260421753,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Clomipramine.,47,Type_47,Yes
DB01018,Guanfacine,DB01171,Moclobemide,0.4840031564235687,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Moclobemide.,47,Type_47,No
DB00850,Perphenazine,DB01214,Metipranolol,0.9782886505126953,60,Type_60,Perphenazine may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00203,Sildenafil,DB00541,Vincristine,0.5261486172676086,47,Type_47,The metabolism of Vincristine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00486,Nabilone,DB01355,Hexobarbital,0.970085620880127,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.,16,Type_16,Yes
DB00273,Topiramate,DB09286,Pipamperone,0.9830096364021301,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Pipamperone.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB01348,Spirapril,0.9410267472267151,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB01247,Isocarboxazid,DB04871,Lorcaserin,0.9657140970230103,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lorcaserin.,49,Type_49,Yes
DB09026,Aliskiren,DB09238,Manidipine,0.932965874671936,60,Type_60,Aliskiren may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00623,Fluphenazine,DB01026,Ketoconazole,0.6288486123085022,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Fluphenazine.,47,Type_47,Yes
DB00899,Remifentanil,DB01002,Levobupivacaine,0.9950834512710571,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Levobupivacaine.,49,Type_49,Yes
DB00331,Metformin,DB04576,Fleroxacin,0.9965303540229797,9,Type_9,Metformin may increase the hypoglycemic activities of Fleroxacin.,9,Type_9,Yes
DB00554,Piroxicam,DB08816,Ticagrelor,0.8505228161811829,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Piroxicam.,47,Type_47,Yes
DB00933,Mesoridazine,DB01351,Amobarbital,0.9351522922515869,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Amobarbital.,49,Type_49,Yes
DB00326,Calcium glucoheptonate,DB00630,Alendronic acid,0.9172778725624084,75,Type_75,The serum concentration of Alendronic acid can be decreased when it is combined with Calcium glucoheptonate.,75,Type_75,Yes
DB00328,Indomethacin,DB09288,Propacetamol,0.9931157231330872,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Propacetamol.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB07615,Tranilast,0.993897020816803,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Tranilast.,49,Type_49,Yes
DB00519,Trandolapril,DB01626,Pargyline,0.996988832950592,60,Type_60,Trandolapril may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00633,Dexmedetomidine,DB00794,Primidone,0.7349085807800293,4,Type_4,The metabolism of Primidone can be increased when combined with Dexmedetomidine.,49,Type_49,No
DB00273,Topiramate,DB00921,Buprenorphine,0.9994514584541321,16,Type_16,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB01209,Dezocine,DB01595,Nitrazepam,0.9938561320304871,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Nitrazepam.,49,Type_49,Yes
DB00768,Olopatadine,DB00818,Propofol,0.500393807888031,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Propofol.,49,Type_49,Yes
DB00391,Sulpiride,DB00831,Trifluoperazine,0.726237416267395,36,Type_36,Sulpiride may increase the antipsychotic activities of Trifluoperazine.,36,Type_36,Yes
DB01319,Fosamprenavir,DB08881,Vemurafenib,0.6452019214630127,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Fosamprenavir.,75,Type_75,No
DB00699,Nicergoline,DB01127,Econazole,0.9974066615104675,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Econazole.,49,Type_49,Yes
DB01072,Atazanavir,DB05541,Brivaracetam,0.7890391945838928,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00501,Cimetidine,DB01254,Dasatinib,0.7157022953033447,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Cimetidine.,67,Type_67,No
DB06616,Bosutinib,DB11613,Velpatasvir,0.8136611580848694,73,Type_73,The serum concentration of Velpatasvir can be increased when it is combined with Bosutinib.,73,Type_73,Yes
DB00696,Ergotamine,DB08864,Rilpivirine,0.9014358520507812,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Ergotamine.,73,Type_73,Yes
DB00905,Bimatoprost,DB01037,Selegiline,0.9999682903289795,60,Type_60,Bimatoprost may increase the hypotensive activities of Selegiline.,60,Type_60,Yes
DB01396,Digitoxin,DB11363,Alectinib,0.9899235367774963,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Alectinib.,58,Type_58,Yes
DB00651,Dyphylline,DB01032,Probenecid,0.49464496970176697,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Dyphylline.,73,Type_73,Yes
DB00288,Amcinonide,DB01401,Choline magnesium trisalicylate,0.9997298121452332,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB01223,Aminophylline,DB01264,Darunavir,0.5175769925117493,47,Type_47,The metabolism of Darunavir can be decreased when combined with Aminophylline.,47,Type_47,Yes
DB00608,Chloroquine,DB04786,Suramin,0.601468563079834,73,Type_73,The serum concentration of Suramin can be increased when it is combined with Chloroquine.,75,Type_75,No
DB00399,Zoledronic acid,DB00653,Magnesium sulfate,0.9117752909660339,75,Type_75,The serum concentration of Magnesium sulfate can be decreased when it is combined with Zoledronic acid.,75,Type_75,Yes
DB00498,Phenindione,DB00795,Sulfasalazine,0.9993765950202942,6,Type_6,Phenindione may increase the anticoagulant activities of Sulfasalazine.,6,Type_6,Yes
DB01263,Posaconazole,DB05541,Brivaracetam,0.872044563293457,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB01242,Clomipramine,DB09017,Brotizolam,0.9997710585594177,49,Type_49,The risk or severity of adverse effects can be increased when Clomipramine is combined with Brotizolam.,49,Type_49,Yes
DB09017,Brotizolam,DB11304,Phenoxyethanol,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Brotizolam is combined with Phenoxyethanol.,49,Type_49,Yes
DB00549,Zafirlukast,DB00850,Perphenazine,0.8781791925430298,47,Type_47,The metabolism of Perphenazine can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00188,Bortezomib,DB01144,Diclofenamide,0.9940134882926941,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Diclofenamide.,49,Type_49,Yes
DB01041,Thalidomide,DB08864,Rilpivirine,0.5343469977378845,75,Type_75,The serum concentration of Rilpivirine can be decreased when it is combined with Thalidomide.,75,Type_75,Yes
DB00363,Clozapine,DB02703,Fusidic acid,0.995421826839447,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Clozapine.,73,Type_73,Yes
DB01168,Procarbazine,DB01452,Diamorphine,0.9903733730316162,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Diamorphine.,49,Type_49,Yes
DB00850,Perphenazine,DB08910,Pomalidomide,0.9955018162727356,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Pomalidomide.,49,Type_49,Yes
DB00468,Quinine,DB00477,Chlorpromazine,0.6999901533126831,20,Type_20,Quinine may increase the QTc-prolonging activities of Chlorpromazine.,73,Type_73,No
DB00243,Ranolazine,DB00539,Toremifene,0.54067063331604,20,Type_20,Ranolazine may increase the QTc-prolonging activities of Toremifene.,73,Type_73,No
DB00212,Remikiren,DB06826,Unoprostone,0.9998883008956909,60,Type_60,Remikiren may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00324,Fluorometholone,DB00337,Pimecrolimus,0.9990168809890747,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Pimecrolimus.,49,Type_49,Yes
DB04868,Nilotinib,DB06290,Simeprevir,0.8893396258354187,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Nilotinib.,73,Type_73,Yes
DB00248,Cabergoline,DB01110,Miconazole,0.9674209952354431,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Miconazole.,49,Type_49,Yes
DB00696,Ergotamine,DB04876,Vildagliptin,0.41538792848587036,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Vildagliptin.,73,Type_73,No
DB00541,Vincristine,DB00584,Enalapril,0.6593503355979919,73,Type_73,The serum concentration of Enalapril can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00852,Pseudoephedrine,DB06603,Panobinostat,0.9161386489868164,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Pseudoephedrine.,73,Type_73,Yes
DB00268,Ropinirole,DB01178,Chlormezanone,0.9992007613182068,32,Type_32,Ropinirole may increase the sedative activities of Chlormezanone.,32,Type_32,Yes
DB00603,Medroxyprogesterone acetate,DB00615,Rifabutin,0.5505642890930176,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Medroxyprogesterone acetate.,4,Type_4,No
DB00408,Loxapine,DB01075,Diphenhydramine,0.786167323589325,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Diphenhydramine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00757,Dolasetron,0.9114593863487244,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00196,Fluconazole,DB00277,Theophylline,0.8453414440155029,47,Type_47,The metabolism of Theophylline can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01180,Rescinnamine,DB01401,Choline magnesium trisalicylate,0.9871470928192139,49,Type_49,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00615,Rifabutin,DB00813,Fentanyl,0.9431841373443604,75,Type_75,The serum concentration of Fentanyl can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00490,Buspirone,DB01263,Posaconazole,0.8065455555915833,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Buspirone.,47,Type_47,Yes
DB04865,Omacetaxine mepesuccinate,DB09075,Edoxaban,0.6800709366798401,66,Type_66,The risk or severity of bleeding can be increased when Omacetaxine mepesuccinate is combined with Edoxaban.,66,Type_66,Yes
DB08882,Linagliptin,DB09128,Brexpiprazole,0.9782100319862366,70,Type_70,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Linagliptin.,70,Type_70,Yes
DB00546,Adinazolam,DB01319,Fosamprenavir,0.9065641760826111,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00176,Fluvoxamine,DB00309,Vindesine,0.6540272235870361,73,Type_73,The serum concentration of Vindesine can be increased when it is combined with Fluvoxamine.,73,Type_73,Yes
DB00715,Paroxetine,DB01239,Chlorprothixene,0.7150243520736694,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Chlorprothixene.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00401,Nisoldipine,0.8386181592941284,47,Type_47,The metabolism of Nisoldipine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB01393,Bezafibrate,DB04855,Dronedarone,0.9464377164840698,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Bezafibrate.,47,Type_47,Yes
DB00627,Niacin,DB00839,Tolazamide,0.9416462779045105,70,Type_70,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Niacin.,70,Type_70,Yes
DB00307,Bexarotene,DB01232,Saquinavir,0.7701290249824524,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00181,Baclofen,DB01580,Oxprenolol,0.8412726521492004,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Oxprenolol.,49,Type_49,Yes
DB00690,Flurazepam,DB12332,Rucaparib,0.9654873609542847,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Flurazepam.,47,Type_47,Yes
DB01452,Diamorphine,DB09338,Mersalyl,0.9995108842849731,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Mersalyl.,49,Type_49,Yes
DB00255,Diethylstilbestrol,DB09119,Eslicarbazepine acetate,0.47335803508758545,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Diethylstilbestrol.,75,Type_75,No
DB00476,Duloxetine,DB00653,Magnesium sulfate,0.8913814425468445,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Magnesium sulfate.,49,Type_49,Yes
DB00844,Nalbuphine,DB01227,Levacetylmethadol,0.9300006031990051,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Levacetylmethadol.,49,Type_49,Yes
DB00612,Bisoprolol,DB00794,Primidone,0.7879684567451477,60,Type_60,Bisoprolol may increase the hypotensive activities of Primidone.,4,Type_4,No
DB00455,Loratadine,DB06335,Saxagliptin,0.4838241636753082,73,Type_73,The serum concentration of Saxagliptin can be increased when it is combined with Loratadine.,75,Type_75,No
DB06737,Zaltoprofen,DB09279,Fimasartan,0.9989809393882751,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Fimasartan.,49,Type_49,Yes
DB00814,Meloxicam,DB09091,Tixocortol,0.999555766582489,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Tixocortol.,49,Type_49,Yes
DB00612,Bisoprolol,DB01014,Balsalazide,0.9985668063163757,37,Type_37,Bisoprolol may decrease the antihypertensive activities of Balsalazide.,37,Type_37,Yes
DB00974,Edetic acid,DB08991,Epirizole,0.9972726702690125,6,Type_6,Edetic acid may increase the anticoagulant activities of Epirizole.,6,Type_6,Yes
DB00317,Gefitinib,DB00541,Vincristine,0.8130016326904297,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Gefitinib.,73,Type_73,Yes
DB00196,Fluconazole,DB09080,Olodaterol,0.5861455798149109,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Olodaterol.,47,Type_47,No
DB00404,Alprazolam,DB00584,Enalapril,0.28952986001968384,73,Type_73,The serum concentration of Enalapril can be increased when it is combined with Alprazolam.,73,Type_73,Yes
DB00243,Ranolazine,DB01218,Halofantrine,0.5691064596176147,73,Type_73,The serum concentration of Halofantrine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB06144,Sertindole,DB06716,Fospropofol,0.9999877214431763,49,Type_49,The risk or severity of adverse effects can be increased when Sertindole is combined with Fospropofol.,49,Type_49,Yes
DB00375,Colestipol,DB08991,Epirizole,0.9926854372024536,67,Type_67,Colestipol can cause a decrease in the absorption of Epirizole resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00435,Nitric Oxide,DB01210,Levobunolol,0.9991015195846558,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Levobunolol.,49,Type_49,Yes
DB01029,Irbesartan,DB08941,Isoxsuprine,0.8806101679801941,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Isoxsuprine.,49,Type_49,Yes
DB06708,Lumefantrine,DB09280,Lumacaftor,0.7063891291618347,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Lumefantrine.,4,Type_4,No
DB00223,Diflorasone,DB00783,Estradiol,0.972305417060852,73,Type_73,The serum concentration of Estradiol can be increased when it is combined with Diflorasone.,73,Type_73,Yes
DB04946,Iloperidone,DB09039,Eliglustat,0.4899516999721527,20,Type_20,Iloperidone may increase the QTc-prolonging activities of Eliglustat.,47,Type_47,No
DB09038,Empagliflozin,DB09232,Cilnidipine,0.9995797276496887,49,Type_49,The risk or severity of adverse effects can be increased when Empagliflozin is combined with Cilnidipine.,49,Type_49,Yes
DB01338,Pipecuronium,DB06810,Plicamycin,0.9621604084968567,40,Type_40,Pipecuronium may increase the respiratory depressant activities of Plicamycin.,40,Type_40,Yes
DB00748,Carbinoxamine,DB06702,Fesoterodine,0.9822015166282654,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Carbinoxamine.,77,Type_77,Yes
DB01026,Ketoconazole,DB05294,Vandetanib,0.5927709937095642,73,Type_73,The serum concentration of Vandetanib can be increased when it is combined with Ketoconazole.,47,Type_47,No
DB01151,Desipramine,DB08933,Luliconazole,0.9859470129013062,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00363,Clozapine,DB01267,Paliperidone,0.7454303503036499,20,Type_20,Clozapine may increase the QTc-prolonging activities of Paliperidone.,49,Type_49,No
DB00320,Dihydroergotamine,DB00343,Diltiazem,0.9491733312606812,47,Type_47,The metabolism of Diltiazem can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00697,Tizanidine,DB01113,Papaverine,0.9924732446670532,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Papaverine.,49,Type_49,Yes
DB00726,Trimipramine,DB05265,Ecabet,0.4659937918186188,73,Type_73,The serum concentration of Ecabet can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00228,Enflurane,DB00312,Pentobarbital,0.8811323046684265,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Pentobarbital.,49,Type_49,Yes
DB01251,Gliquidone,DB01590,Everolimus,0.3625134527683258,70,Type_70,The therapeutic efficacy of Everolimus can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB00351,Megestrol acetate,DB01078,Deslanoside,0.9982238411903381,58,Type_58,Megestrol acetate may decrease the cardiotoxic activities of Deslanoside.,58,Type_58,Yes
DB00834,Mifepristone,DB01626,Pargyline,0.9140316843986511,9,Type_9,Mifepristone may increase the hypoglycemic activities of Pargyline.,9,Type_9,Yes
DB00384,Triamterene,DB05812,Abiraterone,0.7398535013198853,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Triamterene.,73,Type_73,Yes
DB00243,Ranolazine,DB01087,Primaquine,0.5618733763694763,73,Type_73,The serum concentration of Primaquine can be increased when it is combined with Ranolazine.,20,Type_20,No
DB00182,Amphetamine,DB01348,Spirapril,0.9992765784263611,60,Type_60,Amphetamine may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00722,Lisinopril,DB01088,Iloprost,0.7097111344337463,60,Type_60,Lisinopril may increase the hypotensive activities of Iloprost.,60,Type_60,Yes
DB00503,Ritonavir,DB00731,Nateglinide,0.9466434717178345,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00252,Phenytoin,DB01583,Liotrix,0.8063186407089233,75,Type_75,The serum concentration of Liotrix can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00395,Carisoprodol,DB00475,Chlordiazepoxide,0.9884640574455261,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Chlordiazepoxide.,49,Type_49,Yes
DB00628,Clorazepic acid,DB08987,Etidocaine,0.9984784722328186,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Etidocaine.,49,Type_49,Yes
DB00321,Amitriptyline,DB09352,Hydroxyamphetamine,0.7937361001968384,23,Type_23,Amitriptyline may increase the stimulatory activities of Hydroxyamphetamine.,23,Type_23,Yes
DB00751,Epinastine,DB06207,Silodosin,0.7619932293891907,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Epinastine.,5,Type_5,No
DB00695,Furosemide,DB09242,Moxonidine,0.7086069583892822,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Moxonidine.,49,Type_49,Yes
DB00865,Benzphetamine,DB01609,Deferasirox,0.9913553595542908,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Benzphetamine.,75,Type_75,Yes
DB00705,Delavirdine,DB00863,Ranitidine,0.8568779230117798,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Delavirdine.,67,Type_67,No
DB01098,Rosuvastatin,DB04839,Cyproterone acetate,0.5660195350646973,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00517,Anisotropine methylbromide,DB00774,Hydroflumethiazide,0.9990826845169067,73,Type_73,The serum concentration of Hydroflumethiazide can be increased when it is combined with Anisotropine methylbromide.,73,Type_73,Yes
DB00754,Ethotoin,DB06204,Tapentadol,0.9970362186431885,16,Type_16,Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00370,Mirtazapine,DB00898,Ethanol,0.9999992847442627,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00528,Lercanidipine,DB00606,Cyclothiazide,0.9648739099502563,60,Type_60,Lercanidipine may increase the hypotensive activities of Cyclothiazide.,60,Type_60,Yes
DB01104,Sertraline,DB01618,Molindone,0.9692413806915283,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Molindone.,49,Type_49,Yes
DB00794,Primidone,DB04846,Celiprolol,0.6065785884857178,4,Type_4,The metabolism of Celiprolol can be increased when combined with Primidone.,4,Type_4,Yes
DB00845,Clofazimine,DB01098,Rosuvastatin,0.6802939772605896,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Clofazimine.,73,Type_73,Yes
DB00854,Levorphanol,DB01626,Pargyline,0.9273631572723389,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Pargyline.,49,Type_49,Yes
DB00222,Glimepiride,DB00752,Tranylcypromine,0.6620664596557617,9,Type_9,Glimepiride may increase the hypoglycemic activities of Tranylcypromine.,9,Type_9,Yes
DB00446,Chloramphenicol,DB01544,Flunitrazepam,0.9918723702430725,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00353,Methylergometrine,DB01128,Bicalutamide,0.8976249694824219,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Bicalutamide.,49,Type_49,Yes
DB00794,Primidone,DB09038,Empagliflozin,0.9638747572898865,60,Type_60,Primidone may increase the hypotensive activities of Empagliflozin.,60,Type_60,Yes
DB00289,Atomoxetine,DB00495,Zidovudine,0.9149156212806702,47,Type_47,The metabolism of Zidovudine can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00284,Acarbose,DB04839,Cyproterone acetate,0.9850951433181763,70,Type_70,The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00390,Digoxin,DB06410,Doxercalciferol,0.6422343254089355,82,Type_82,Digoxin may increase the arrhythmogenic activities of Doxercalciferol.,82,Type_82,Yes
DB00543,Amoxapine,DB06204,Tapentadol,0.9902716279029846,16,Type_16,Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00841,Dobutamine,DB06698,Betahistine,0.9977880716323853,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Dobutamine.,70,Type_70,Yes
DB00373,Timolol,DB12332,Rucaparib,0.9747007489204407,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Timolol.,47,Type_47,Yes
DB06786,Halcinonide,DB09215,Droxicam,0.9994125366210938,49,Type_49,The risk or severity of adverse effects can be increased when Halcinonide is combined with Droxicam.,49,Type_49,Yes
DB00402,Eszopiclone,DB00980,Ramelteon,0.9971749782562256,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ramelteon.,49,Type_49,Yes
DB00351,Megestrol acetate,DB00914,Phenformin,0.8814892768859863,70,Type_70,The therapeutic efficacy of Phenformin can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00987,Cytarabine,DB01254,Dasatinib,0.8592509031295776,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Cytarabine.,73,Type_73,Yes
DB00273,Topiramate,DB00732,Atracurium besylate,0.7414680123329163,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Atracurium besylate.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00234,Reboxetine,0.9858006834983826,47,Type_47,The metabolism of Reboxetine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00333,Methadone,DB05109,Trabectedin,0.9116688370704651,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Methadone.,47,Type_47,Yes
DB01044,Gatifloxacin,DB09095,Difluocortolone,0.9244270920753479,49,Type_49,The risk or severity of adverse effects can be increased when Gatifloxacin is combined with Difluocortolone.,49,Type_49,Yes
DB00361,Vinorelbine,DB00951,Isoniazid,0.402056485414505,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB00726,Trimipramine,DB08987,Etidocaine,0.9997648596763611,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Etidocaine.,49,Type_49,Yes
DB01338,Pipecuronium,DB08893,Mirabegron,0.9935204386711121,49,Type_49,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Mirabegron.,49,Type_49,Yes
DB06717,Fosaprepitant,DB09095,Difluocortolone,0.5078885555267334,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB01149,Nefazodone,DB09280,Lumacaftor,0.5147524476051331,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Nefazodone.,4,Type_4,No
DB01037,Selegiline,DB08899,Enzalutamide,0.8943672180175781,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Selegiline.,75,Type_75,Yes
DB00932,Tipranavir,DB01395,Drospirenone,0.5715634226799011,73,Type_73,The serum concentration of Drospirenone can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB00996,Gabapentin,DB06288,Amisulpride,0.9985389709472656,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Amisulpride.,49,Type_49,Yes
DB06403,Ambrisentan,DB09220,Nicorandil,0.9999979734420776,60,Type_60,Ambrisentan may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00625,Efavirenz,DB01068,Clonazepam,0.8996624946594238,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Clonazepam.,49,Type_49,Yes
DB01115,Nifedipine,DB09054,Idelalisib,0.8023226261138916,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Nifedipine.,47,Type_47,Yes
DB09068,Vortioxetine,DB09198,Lobeglitazone,0.9987474679946899,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Vortioxetine.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB00404,Alprazolam,0.9959681034088135,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Alprazolam.,49,Type_49,Yes
DB11268,Protocatechualdehyde,DB11362,Selexipag,0.9955266118049622,6,Type_6,Protocatechualdehyde may increase the anticoagulant activities of Selexipag.,6,Type_6,Yes
DB00541,Vincristine,DB01142,Doxepin,0.5425182580947876,47,Type_47,The metabolism of Doxepin can be decreased when combined with Vincristine.,73,Type_73,No
DB00673,Aprepitant,DB01395,Drospirenone,0.9793045520782471,73,Type_73,The serum concentration of Drospirenone can be increased when it is combined with Aprepitant.,75,Type_75,No
DB00220,Nelfinavir,DB00285,Venlafaxine,0.5836117267608643,47,Type_47,The metabolism of Venlafaxine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00695,Furosemide,DB00860,Prednisolone,0.9981168508529663,83,Type_83,Furosemide may increase the hypokalemic activities of Prednisolone.,83,Type_83,Yes
DB00208,Ticlopidine,DB01107,Methyprylon,0.9996466636657715,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00398,Sorafenib,DB09049,Naloxegol,0.9998867511749268,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Sorafenib.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB00818,Propofol,0.7962372899055481,47,Type_47,The metabolism of Propofol can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00720,Clodronic acid,DB00812,Phenylbutazone,0.9954364895820618,49,Type_49,The risk or severity of adverse effects can be increased when Clodronic acid is combined with Phenylbutazone.,49,Type_49,Yes
DB01263,Posaconazole,DB06203,Alogliptin,0.48231440782546997,73,Type_73,The serum concentration of Alogliptin can be increased when it is combined with Posaconazole.,47,Type_47,No
DB00169,Cholecalciferol,DB00549,Zafirlukast,0.9334189295768738,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00757,Dolasetron,DB05521,Telaprevir,0.7515931129455566,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Dolasetron.,47,Type_47,Yes
DB01202,Levetiracetam,DB09117,Paraldehyde,0.9999942779541016,16,Type_16,Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00918,Almotriptan,DB01267,Paliperidone,0.9357630014419556,49,Type_49,The risk or severity of adverse effects can be increased when Almotriptan is combined with Paliperidone.,49,Type_49,Yes
DB01137,Levofloxacin,DB01250,Olsalazine,0.9603134393692017,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Olsalazine.,27,Type_27,Yes
DB00623,Fluphenazine,DB09281,Magnesium trisilicate,0.9917563199996948,67,Type_67,Fluphenazine can cause a decrease in the absorption of Magnesium trisilicate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00230,Pregabalin,DB01167,Itraconazole,0.5528309941291809,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Itraconazole.,49,Type_49,Yes
DB00266,Dicoumarol,DB00622,Nicardipine,0.6318846940994263,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Dicoumarol.,47,Type_47,Yes
DB01065,Melatonin,DB01176,Cyclizine,0.9999977350234985,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Cyclizine.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00727,Nitroglycerin,0.9999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Nitroglycerin.,49,Type_49,Yes
DB01142,Doxepin,DB09082,Vilanterol,0.5661442279815674,20,Type_20,Doxepin may increase the QTc-prolonging activities of Vilanterol.,49,Type_49,No
DB00233,Aminosalicylic acid,DB00945,Acetylsalicylic acid,0.924545168876648,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB00467,Enoxacin,DB01401,Choline magnesium trisalicylate,0.9981367588043213,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Choline magnesium trisalicylate.,27,Type_27,Yes
DB00615,Rifabutin,DB06176,Romidepsin,0.4853314161300659,75,Type_75,The serum concentration of Romidepsin can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00929,Misoprostol,DB00936,Salicylic acid,0.7551267743110657,49,Type_49,The risk or severity of adverse effects can be increased when Misoprostol is combined with Salicylic acid.,70,Type_70,No
DB09449,"Sodium phosphate, monobasic",DB11106,Pamabrom,0.6408365964889526,49,Type_49,"The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Pamabrom.",57,Type_57,No
DB00660,Metaxalone,DB01161,Chloroprocaine,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Chloroprocaine.,49,Type_49,Yes
DB00188,Bortezomib,DB01275,Hydralazine,0.9546095728874207,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydralazine.,49,Type_49,Yes
DB00750,Prilocaine,DB01614,Acepromazine,0.9999953508377075,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Acepromazine.,49,Type_49,Yes
DB00486,Nabilone,DB01144,Diclofenamide,0.9914736747741699,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Diclofenamide.,49,Type_49,Yes
DB00788,Naproxen,DB05676,Apremilast,0.999398946762085,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Apremilast.,49,Type_49,Yes
DB01181,Ifosfamide,DB01200,Bromocriptine,0.5413011908531189,49,Type_49,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Bromocriptine.,49,Type_49,Yes
DB00593,Ethosuximide,DB09017,Brotizolam,0.9989092350006104,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Brotizolam.,49,Type_49,Yes
DB01069,Promethazine,DB09065,Cobicistat,0.8381173014640808,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Promethazine.,73,Type_73,Yes
DB00953,Rizatriptan,DB01614,Acepromazine,0.9940701127052307,49,Type_49,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Acepromazine.,49,Type_49,Yes
DB01232,Saquinavir,DB09091,Tixocortol,0.9918124675750732,73,Type_73,The serum concentration of Tixocortol can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00949,Felbamate,DB01189,Desflurane,0.9784201979637146,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Desflurane.,49,Type_49,Yes
DB01088,Iloprost,DB06737,Zaltoprofen,0.9306398630142212,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Iloprost.,70,Type_70,Yes
DB01065,Melatonin,DB01236,Sevoflurane,0.9953787326812744,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Sevoflurane.,49,Type_49,Yes
DB00794,Primidone,DB06212,Tolvaptan,0.8964384198188782,75,Type_75,The serum concentration of Tolvaptan can be decreased when it is combined with Primidone.,75,Type_75,Yes
DB00835,Brompheniramine,DB09120,Zucapsaicin,0.9978713989257812,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB00426,Famciclovir,DB06717,Fosaprepitant,0.8844557404518127,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Famciclovir.,73,Type_73,Yes
DB00655,Estrone,DB00843,Donepezil,0.8376668095588684,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Donepezil.,49,Type_49,Yes
DB01220,Rifaximin,DB01253,Ergometrine,0.4290081262588501,73,Type_73,The serum concentration of Ergometrine can be increased when it is combined with Rifaximin.,73,Type_73,Yes
DB00933,Mesoridazine,DB09275,Bismuth subcitrate potassium,0.9599246978759766,67,Type_67,Mesoridazine can cause a decrease in the absorption of Bismuth subcitrate potassium resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00313,Valproic acid,DB00909,Zonisamide,0.9370677471160889,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Zonisamide.,49,Type_49,Yes
DB00921,Buprenorphine,DB01029,Irbesartan,0.8539041876792908,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Buprenorphine.,47,Type_47,Yes
DB00866,Alprenolol,DB01069,Promethazine,0.8441070914268494,60,Type_60,Alprenolol may increase the hypotensive activities of Promethazine.,60,Type_60,Yes
DB00712,Flurbiprofen,DB01418,Acenocoumarol,0.9978936314582825,6,Type_6,Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01143,Amifostine,DB01229,Paclitaxel,0.9999686479568481,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Paclitaxel.,49,Type_49,Yes
DB00091,Cyclosporine,DB00588,Fluticasone propionate,0.8661773204803467,47,Type_47,The metabolism of Fluticasone propionate can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00487,Pefloxacin,DB00814,Meloxicam,0.9994090795516968,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Meloxicam.,27,Type_27,Yes
DB00850,Perphenazine,DB01142,Doxepin,0.9765915870666504,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Doxepin.,49,Type_49,Yes
DB04846,Celiprolol,DB06707,Levonordefrin,0.9925300478935242,25,Type_25,Celiprolol may increase the atrioventricular blocking (AV block) activities of Levonordefrin.,25,Type_25,Yes
DB00373,Timolol,DB01242,Clomipramine,0.8882521390914917,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Timolol.,49,Type_49,No
DB00187,Esmolol,DB00217,Bethanidine,0.997252881526947,25,Type_25,Esmolol may increase the atrioventricular blocking (AV block) activities of Bethanidine.,25,Type_25,Yes
DB00281,Lidocaine,DB00589,Lisuride,0.6905137300491333,47,Type_47,The metabolism of Lisuride can be decreased when combined with Lidocaine.,49,Type_49,No
DB00332,Ipratropium,DB06717,Fosaprepitant,0.8348392248153687,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Ipratropium.,73,Type_73,Yes
DB00204,Dofetilide,DB00674,Galantamine,0.9899418950080872,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Galantamine.,20,Type_20,Yes
DB00470,Dronabinol,DB06290,Simeprevir,0.9880422353744507,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB01197,Captopril,DB03585,Oxyphenbutazone,0.9724880456924438,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00568,Cinnarizine,DB06603,Panobinostat,0.9248278737068176,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Cinnarizine.,73,Type_73,Yes
DB00455,Loratadine,DB00850,Perphenazine,0.980886697769165,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Perphenazine.,49,Type_49,Yes
DB00625,Efavirenz,DB00801,Halazepam,0.9961434006690979,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Halazepam.,49,Type_49,Yes
DB01226,Mivacurium,DB06694,Xylometazoline,0.996129035949707,21,Type_21,Mivacurium may increase the neuromuscular blocking activities of Xylometazoline.,21,Type_21,Yes
DB01367,Rasagiline,DB09352,Hydroxyamphetamine,0.8020524382591248,71,Type_71,Rasagiline may increase the hypertensive activities of Hydroxyamphetamine.,71,Type_71,Yes
DB00647,Dextropropoxyphene,DB00752,Tranylcypromine,0.6341845989227295,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Tranylcypromine.,49,Type_49,Yes
DB00714,Apomorphine,DB01247,Isocarboxazid,0.5097048282623291,60,Type_60,Apomorphine may increase the hypotensive activities of Isocarboxazid.,49,Type_49,No
DB01168,Procarbazine,DB04946,Iloperidone,0.8993582129478455,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Iloperidone.,49,Type_49,Yes
DB07615,Tranilast,DB08880,Teriflunomide,0.752433717250824,49,Type_49,The risk or severity of adverse effects can be increased when Tranilast is combined with Teriflunomide.,49,Type_49,Yes
DB00254,Doxycycline,DB00674,Galantamine,0.9560544490814209,47,Type_47,The metabolism of Galantamine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00744,Zileuton,DB00817,Rosoxacin,0.86786949634552,27,Type_27,Zileuton may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB00903,Etacrynic acid,DB00972,Azelastine,0.9998478889465332,29,Type_29,Etacrynic acid may decrease the diuretic activities of Azelastine.,29,Type_29,Yes
DB00381,Amlodipine,DB01392,Yohimbine,0.9974133372306824,37,Type_37,Amlodipine may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00715,Paroxetine,DB00768,Olopatadine,0.5375601649284363,47,Type_47,The metabolism of Olopatadine can be decreased when combined with Paroxetine.,49,Type_49,No
DB00436,Bendroflumethiazide,DB00964,Apraclonidine,0.963744580745697,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Apraclonidine.,49,Type_49,Yes
DB01173,Orphenadrine,DB09009,Articaine,0.9573249816894531,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Articaine.,16,Type_16,Yes
DB00405,Dexbrompheniramine,DB00690,Flurazepam,0.9996650218963623,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Flurazepam.,49,Type_49,Yes
DB00250,Dapsone,DB00619,Imatinib,0.9325096607208252,47,Type_47,The metabolism of Imatinib can be decreased when combined with Dapsone.,47,Type_47,Yes
DB00182,Amphetamine,DB00501,Cimetidine,0.4568818211555481,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB01026,Ketoconazole,DB01124,Tolbutamide,0.6593992710113525,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB01169,Arsenic trioxide,DB08907,Canagliflozin,0.9440517425537109,49,Type_49,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Canagliflozin.,49,Type_49,Yes
DB00196,Fluconazole,DB00628,Clorazepic acid,0.8668420314788818,47,Type_47,The metabolism of Clorazepic acid can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00539,Toremifene,DB00927,Famotidine,0.9704139828681946,20,Type_20,Toremifene may increase the QTc-prolonging activities of Famotidine.,20,Type_20,Yes
DB00169,Cholecalciferol,DB11614,Rupatadine,0.9242535829544067,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00277,Theophylline,DB01155,Gemifloxacin,0.5490080714225769,47,Type_47,The metabolism of Gemifloxacin can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00188,Bortezomib,DB00637,Astemizole,0.33724507689476013,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB00181,Baclofen,DB01353,Butobarbital,0.999984860420227,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Butobarbital.,49,Type_49,Yes
DB00418,Secobarbital,DB00514,Dextromethorphan,0.5714128613471985,4,Type_4,The metabolism of Dextromethorphan can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00963,Bromfenac,DB04743,Nimesulide,0.9984809756278992,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Nimesulide.,49,Type_49,Yes
DB00209,Trospium,DB01325,Quinethazone,0.9999648332595825,73,Type_73,The serum concentration of Quinethazone can be increased when it is combined with Trospium.,73,Type_73,Yes
DB00623,Fluphenazine,DB00807,Proparacaine,0.9999020099639893,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Proparacaine.,49,Type_49,Yes
DB00508,Triflupromazine,DB01353,Butobarbital,0.9999827146530151,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Butobarbital.,49,Type_49,Yes
DB04855,Dronedarone,DB06155,Rimonabant,0.9385988712310791,47,Type_47,The metabolism of Rimonabant can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00575,Clonidine,DB09068,Vortioxetine,0.9625328779220581,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Vortioxetine.,49,Type_49,Yes
DB00648,Mitotane,DB00850,Perphenazine,0.9877274036407471,75,Type_75,The serum concentration of Perphenazine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01078,Deslanoside,DB05109,Trabectedin,0.9861118793487549,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Trabectedin.,58,Type_58,Yes
DB01118,Amiodarone,DB06237,Avanafil,0.5118710398674011,73,Type_73,The serum concentration of Avanafil can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00601,Linezolid,DB01037,Selegiline,0.9741268754005432,49,Type_49,The risk or severity of adverse effects can be increased when Linezolid is combined with Selegiline.,49,Type_49,Yes
DB00989,Rivastigmine,DB01200,Bromocriptine,0.6333085894584656,54,Type_54,Rivastigmine may increase the bradycardic activities of Bromocriptine.,49,Type_49,No
DB00934,Maprotiline,DB09068,Vortioxetine,0.9943641424179077,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Vortioxetine.,49,Type_49,Yes
DB00170,Menadione,DB00184,Nicotine,0.9756720662117004,47,Type_47,The metabolism of Nicotine can be decreased when combined with Menadione.,47,Type_47,Yes
DB00224,Indinavir,DB00836,Loperamide,0.8143547773361206,47,Type_47,The metabolism of Loperamide can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00468,Quinine,DB00699,Nicergoline,0.743132472038269,49,Type_49,The risk or severity of adverse effects can be increased when Quinine is combined with Nicergoline.,47,Type_47,No
DB00264,Metoprolol,DB00843,Donepezil,0.6009702086448669,54,Type_54,Metoprolol may increase the bradycardic activities of Donepezil.,54,Type_54,Yes
DB08906,Fluticasone furoate,DB09063,Ceritinib,0.9106985330581665,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Fluticasone furoate.,73,Type_73,Yes
DB00759,Tetracycline,DB09320,Procaine benzylpenicillin,0.9776504039764404,70,Type_70,The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Tetracycline.,70,Type_70,Yes
DB00408,Loxapine,DB13323,Trichloroethylene,0.9997957348823547,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Trichloroethylene.,49,Type_49,Yes
DB00420,Promazine,DB00575,Clonidine,0.44378209114074707,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Clonidine.,47,Type_47,No
DB00696,Ergotamine,DB01587,Ketazolam,0.969667375087738,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Ketazolam.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01297,Practolol,0.9997053742408752,37,Type_37,Mycophenolic acid may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB01211,Clarithromycin,DB01216,Finasteride,0.8502854108810425,47,Type_47,The metabolism of Finasteride can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00514,Dextromethorphan,DB00601,Linezolid,0.9726921319961548,64,Type_64,Dextromethorphan may increase the serotonergic activities of Linezolid.,49,Type_49,No
DB00985,Dimenhydrinate,DB08815,Lurasidone,0.9975510239601135,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lurasidone.,49,Type_49,Yes
DB00495,Zidovudine,DB01118,Amiodarone,0.6213935017585754,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB00393,Nimodipine,DB01018,Guanfacine,0.8068684935569763,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Guanfacine.,49,Type_49,Yes
DB00188,Bortezomib,DB00321,Amitriptyline,0.4740275740623474,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Amitriptyline.,47,Type_47,No
DB00482,Celecoxib,DB00568,Cinnarizine,0.7835150361061096,47,Type_47,The metabolism of Cinnarizine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00162,Vitamin A,DB01083,Orlistat,0.9554545283317566,75,Type_75,The serum concentration of Orlistat can be decreased when it is combined with Vitamin A.,75,Type_75,Yes
DB00972,Azelastine,DB01224,Quetiapine,0.9466970562934875,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,16,Type_16,Yes
DB00633,Dexmedetomidine,DB00690,Flurazepam,0.9751940965652466,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Flurazepam.,49,Type_49,Yes
DB01418,Acenocoumarol,DB09289,Tianeptine,0.950660765171051,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Tianeptine.,6,Type_6,Yes
DB00564,Carbamazepine,DB00633,Dexmedetomidine,0.5877218246459961,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dexmedetomidine.,49,Type_49,Yes
DB00476,Duloxetine,DB09204,Arotinolol,0.9740267992019653,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Arotinolol.,30,Type_30,Yes
DB00814,Meloxicam,DB01580,Oxprenolol,0.9803535342216492,37,Type_37,Meloxicam may decrease the antihypertensive activities of Oxprenolol.,37,Type_37,Yes
DB00349,Clobazam,DB00647,Dextropropoxyphene,0.5931856036186218,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Clobazam.,49,Type_49,No
DB00946,Phenprocoumon,DB01101,Capecitabine,0.8094984292984009,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Phenprocoumon.,73,Type_73,No
DB00404,Alprazolam,DB01463,Fencamfamin,0.9995744824409485,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Fencamfamin.,49,Type_49,Yes
DB00675,Tamoxifen,DB05528,Mipomersen,0.9799694418907166,80,Type_80,Tamoxifen may increase the hepatotoxic activities of Mipomersen.,80,Type_80,Yes
DB06603,Panobinostat,DB08893,Mirabegron,0.5746510624885559,20,Type_20,Panobinostat may increase the QTc-prolonging activities of Mirabegron.,73,Type_73,No
DB00495,Zidovudine,DB00625,Efavirenz,0.5071682929992676,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB00835,Brompheniramine,DB01178,Chlormezanone,0.9999722242355347,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Chlormezanone.,49,Type_49,Yes
DB00624,Testosterone,DB01384,Paramethasone,0.9991914629936218,74,Type_74,Testosterone may increase the fluid retaining activities of Paramethasone.,74,Type_74,Yes
DB01275,Hydralazine,DB06712,Nilvadipine,0.8818788528442383,60,Type_60,Hydralazine may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00589,Lisuride,DB00615,Rifabutin,0.8348871469497681,4,Type_4,The metabolism of Rifabutin can be increased when combined with Lisuride.,4,Type_4,Yes
DB06144,Sertindole,DB06282,Levocetirizine,0.9973465204238892,49,Type_49,The risk or severity of adverse effects can be increased when Sertindole is combined with Levocetirizine.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB09117,Paraldehyde,0.9938231706619263,16,Type_16,Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00169,Cholecalciferol,DB01198,Zopiclone,0.9745814204216003,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00208,Ticlopidine,DB06403,Ambrisentan,0.9948315620422363,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01067,Glipizide,DB01367,Rasagiline,0.99698406457901,9,Type_9,Glipizide may increase the hypoglycemic activities of Rasagiline.,9,Type_9,Yes
DB00771,Clidinium,DB06144,Sertindole,0.99977046251297,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Sertindole.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB01259,Lapatinib,0.7968072891235352,20,Type_20,Arsenic trioxide may increase the QTc-prolonging activities of Lapatinib.,20,Type_20,Yes
DB00230,Pregabalin,DB00829,Diazepam,0.7885779142379761,70,Type_70,The therapeutic efficacy of Diazepam can be decreased when used in combination with Pregabalin.,70,Type_70,Yes
DB00944,Demecarium,DB09095,Difluocortolone,0.9998457431793213,49,Type_49,The risk or severity of adverse effects can be increased when Demecarium is combined with Difluocortolone.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01193,Acebutolol,0.9939583539962769,37,Type_37,Mycophenolic acid may decrease the antihypertensive activities of Acebutolol.,37,Type_37,Yes
DB00425,Zolpidem,DB00540,Nortriptyline,0.9682231545448303,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.,16,Type_16,Yes
DB00412,Rosiglitazone,DB01174,Phenobarbital,0.9361824989318848,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Rosiglitazone.,4,Type_4,Yes
DB00774,Hydroflumethiazide,DB01116,Trimethaphan,0.9558451771736145,73,Type_73,The serum concentration of Trimethaphan can be increased when it is combined with Hydroflumethiazide.,73,Type_73,Yes
DB00794,Primidone,DB01220,Rifaximin,0.5730748176574707,4,Type_4,The metabolism of Rifaximin can be increased when combined with Primidone.,4,Type_4,Yes
DB01319,Fosamprenavir,DB06717,Fosaprepitant,0.9502608180046082,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Fosamprenavir.,73,Type_73,Yes
DB00547,Desoximetasone,DB01155,Gemifloxacin,0.9931574463844299,49,Type_49,The risk or severity of adverse effects can be increased when Desoximetasone is combined with Gemifloxacin.,49,Type_49,Yes
DB00343,Diltiazem,DB00903,Etacrynic acid,0.9403784275054932,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Etacrynic acid.,49,Type_49,Yes
DB01551,Dihydrocodeine,DB01622,Thioproperazine,0.5596725940704346,60,Type_60,Dihydrocodeine may increase the hypotensive activities of Thioproperazine.,60,Type_60,Yes
DB00321,Amitriptyline,DB00661,Verapamil,0.6914240717887878,47,Type_47,The metabolism of Verapamil can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB06695,Dabigatran etexilate,DB08797,Salicylamide,0.9886317849159241,6,Type_6,Dabigatran etexilate may increase the anticoagulant activities of Salicylamide.,6,Type_6,Yes
DB00288,Amcinonide,DB01226,Mivacurium,0.9835594296455383,22,Type_22,Amcinonide may increase the adverse neuromuscular activities of Mivacurium.,22,Type_22,Yes
DB01002,Levobupivacaine,DB01263,Posaconazole,0.8526359796524048,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Levobupivacaine.,73,Type_73,No
DB00721,Procaine,DB01028,Methoxyflurane,0.9998811483383179,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Methoxyflurane.,49,Type_49,Yes
DB00933,Mesoridazine,DB04846,Celiprolol,0.9182678461074829,60,Type_60,Mesoridazine may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB00996,Gabapentin,DB01351,Amobarbital,0.9023710489273071,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Amobarbital.,49,Type_49,Yes
DB00904,Ondansetron,DB01589,Quazepam,0.6560141444206238,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Quazepam.,49,Type_49,Yes
DB00722,Lisinopril,DB01154,Thiamylal,0.8137181997299194,60,Type_60,Lisinopril may increase the hypotensive activities of Thiamylal.,60,Type_60,Yes
DB01100,Pimozide,DB09072,Sodium oxybate,0.9999996423721313,16,Type_16,Pimozide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01153,Sertaconazole,DB01268,Sunitinib,0.4493236243724823,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Sertaconazole.,47,Type_47,No
DB00758,Clopidogrel,DB06176,Romidepsin,0.6944702863693237,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Clopidogrel.,47,Type_47,Yes
DB00861,Diflunisal,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Diflunisal.,70,Type_70,Yes
DB00448,Lansoprazole,DB00625,Efavirenz,0.6457180976867676,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Lansoprazole.,47,Type_47,Yes
DB00257,Clotrimazole,DB04868,Nilotinib,0.5362611413002014,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00721,Procaine,DB01104,Sertraline,0.9942434430122375,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Sertraline.,49,Type_49,Yes
DB08820,Ivacaftor,DB08877,Ruxolitinib,0.9925001263618469,73,Type_73,The serum concentration of Ruxolitinib can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB00335,Atenolol,DB01403,Methotrimeprazine,0.31085118651390076,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Atenolol.,60,Type_60,No
DB00359,Sulfadiazine,DB00435,Nitric Oxide,0.9135910868644714,47,Type_47,The metabolism of Nitric Oxide can be decreased when combined with Sulfadiazine.,49,Type_49,No
DB00343,Diltiazem,DB00361,Vinorelbine,0.7487371563911438,47,Type_47,The metabolism of Vinorelbine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01589,Quazepam,DB01618,Molindone,0.9901089668273926,49,Type_49,The risk or severity of adverse effects can be increased when Quazepam is combined with Molindone.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00469,Tenoxicam,0.9842818379402161,70,Type_70,The therapeutic efficacy of Tenoxicam can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB00343,Diltiazem,DB08932,Macitentan,0.9442543983459473,60,Type_60,Diltiazem may increase the hypotensive activities of Macitentan.,47,Type_47,No
DB00838,Clocortolone,DB01226,Mivacurium,0.9846910834312439,22,Type_22,Clocortolone may increase the adverse neuromuscular activities of Mivacurium.,22,Type_22,Yes
DB00784,Mefenamic acid,DB08971,Fluocortolone,0.9998353719711304,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Fluocortolone.,49,Type_49,Yes
DB01110,Miconazole,DB09238,Manidipine,0.7492668032646179,47,Type_47,The metabolism of Manidipine can be decreased when combined with Miconazole.,49,Type_49,No
DB09084,Benzydamine,DB09211,Limaprost,0.983024001121521,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Benzydamine.,70,Type_70,Yes
DB00944,Demecarium,DB06781,Difluprednate,0.9998624324798584,49,Type_49,The risk or severity of adverse effects can be increased when Demecarium is combined with Difluprednate.,49,Type_49,Yes
DB00697,Tizanidine,DB01106,Levocabastine,0.9703989624977112,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Levocabastine.,49,Type_49,Yes
DB01062,Oxybutynin,DB09280,Lumacaftor,0.5452590584754944,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Oxybutynin.,4,Type_4,No
DB00544,Fluorouracil,DB04898,Ximelagatran,0.5240755081176758,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Fluorouracil.,47,Type_47,No
DB00872,Conivaptan,DB08931,Riociguat,0.7358598113059998,73,Type_73,The serum concentration of Riociguat can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00763,Methimazole,DB08864,Rilpivirine,0.7463685274124146,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Methimazole.,73,Type_73,Yes
DB00169,Cholecalciferol,DB01016,Glyburide,0.8291016221046448,47,Type_47,The metabolism of Glyburide can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00201,Caffeine,DB09039,Eliglustat,0.8978926539421082,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00847,Cysteamine,DB06216,Asenapine,0.9007601141929626,49,Type_49,The risk or severity of adverse effects can be increased when Cysteamine is combined with Asenapine.,70,Type_70,No
DB00571,Propranolol,DB01041,Thalidomide,0.6834399700164795,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Thalidomide.,49,Type_49,Yes
DB04844,Tetrabenazine,DB11609,Normethadone,0.9960565567016602,49,Type_49,The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Normethadone.,49,Type_49,Yes
DB00335,Atenolol,DB06292,Dapagliflozin,0.99793541431427,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Dapagliflozin.,49,Type_49,Yes
DB00835,Brompheniramine,DB09017,Brotizolam,0.9999942779541016,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Brotizolam.,49,Type_49,Yes
DB00524,Metolazone,DB09244,Pirlindole,0.99078768491745,60,Type_60,Metolazone may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB01118,Amiodarone,DB08912,Dabrafenib,0.9194058179855347,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Amiodarone.,75,Type_75,Yes
DB00904,Ondansetron,DB01001,Salbutamol,0.8949838876724243,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Salbutamol.,20,Type_20,Yes
DB00900,Didanosine,DB09040,Efinaconazole,0.9042283892631531,67,Type_67,Didanosine can cause a decrease in the absorption of Efinaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01614,Acepromazine,DB09224,Melperone,0.9900432825088501,49,Type_49,The risk or severity of adverse effects can be increased when Acepromazine is combined with Melperone.,49,Type_49,Yes
DB00470,Dronabinol,DB01351,Amobarbital,0.9994325041770935,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.,16,Type_16,Yes
DB00808,Indapamide,DB00936,Salicylic acid,0.9238911271095276,70,Type_70,The therapeutic efficacy of Salicylic acid can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00188,Bortezomib,DB00402,Eszopiclone,0.8927657008171082,47,Type_47,The metabolism of Eszopiclone can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00657,Mecamylamine,DB09300,Butylscopolamine,0.9899536371231079,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Butylscopolamine.,49,Type_49,Yes
DB00006,Bivalirudin,DB01283,Lumiracoxib,0.9509987831115723,6,Type_6,Bivalirudin may increase the anticoagulant activities of Lumiracoxib.,6,Type_6,Yes
DB00529,Foscarnet,DB00604,Cisapride,0.9948554039001465,20,Type_20,Foscarnet may increase the QTc-prolonging activities of Cisapride.,20,Type_20,Yes
DB00195,Betaxolol,DB01201,Rifapentine,0.5526576638221741,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Betaxolol.,75,Type_75,Yes
DB00169,Cholecalciferol,DB00571,Propranolol,0.951047956943512,47,Type_47,The metabolism of Propranolol can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00344,Protriptyline,DB00413,Pramipexole,0.9989920258522034,32,Type_32,Protriptyline may increase the sedative activities of Pramipexole.,32,Type_32,Yes
DB00486,Nabilone,DB01090,Pentolinium,0.5968285202980042,85,Type_85,Nabilone may increase the tachycardic activities of Pentolinium.,85,Type_85,Yes
DB00196,Fluconazole,DB01296,Glucosamine,0.9716563820838928,47,Type_47,The metabolism of Glucosamine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00956,Hydrocodone,DB05271,Rotigotine,0.9847952723503113,32,Type_32,Hydrocodone may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00502,Haloperidol,DB01198,Zopiclone,0.8415429592132568,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Zopiclone.,49,Type_49,Yes
DB04840,Debrisoquine,DB04846,Celiprolol,0.9989117383956909,60,Type_60,Debrisoquine may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB00425,Zolpidem,DB01124,Tolbutamide,0.5185195803642273,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB00820,Tadalafil,DB06403,Ambrisentan,0.9403990507125854,10,Type_10,Tadalafil may increase the antihypertensive activities of Ambrisentan.,10,Type_10,Yes
DB08867,Ulipristal,DB09118,Stiripentol,0.9096688032150269,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ulipristal.,73,Type_73,Yes
DB00243,Ranolazine,DB00440,Trimethoprim,0.5672501921653748,47,Type_47,The metabolism of Trimethoprim can be decreased when combined with Ranolazine.,73,Type_73,No
DB09073,Palbociclib,DB11817,Baricitinib,0.8419581055641174,73,Type_73,The serum concentration of Baricitinib can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB00433,Prochlorperazine,DB00455,Loratadine,0.9382218718528748,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Loratadine.,49,Type_49,Yes
DB00182,Amphetamine,DB01197,Captopril,0.9951798915863037,60,Type_60,Amphetamine may increase the hypotensive activities of Captopril.,60,Type_60,Yes
DB00243,Ranolazine,DB00528,Lercanidipine,0.4642869830131531,73,Type_73,The serum concentration of Lercanidipine can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00722,Lisinopril,DB01283,Lumiracoxib,0.9394051432609558,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Lumiracoxib.,49,Type_49,Yes
DB00224,Indinavir,DB01219,Dantrolene,0.8430370092391968,47,Type_47,The metabolism of Dantrolene can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00834,Mifepristone,DB01263,Posaconazole,0.6823698878288269,73,Type_73,The serum concentration of Posaconazole can be increased when it is combined with Mifepristone.,20,Type_20,No
DB00266,Dicoumarol,DB01044,Gatifloxacin,0.9781092405319214,6,Type_6,Dicoumarol may increase the anticoagulant activities of Gatifloxacin.,6,Type_6,Yes
DB00220,Nelfinavir,DB00556,Perflutren,0.9999563694000244,20,Type_20,Nelfinavir may increase the QTc-prolonging activities of Perflutren.,20,Type_20,Yes
DB06595,Midostaurin,DB09074,Olaparib,0.7794977426528931,47,Type_47,The metabolism of Olaparib can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00231,Temazepam,DB09119,Eslicarbazepine acetate,0.9422239065170288,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00939,Meclofenamic acid,DB01155,Gemifloxacin,0.9873214364051819,27,Type_27,Meclofenamic acid may increase the neuroexcitatory activities of Gemifloxacin.,27,Type_27,Yes
DB00921,Buprenorphine,DB09076,Umeclidinium,0.97066330909729,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Umeclidinium.,49,Type_49,Yes
DB00246,Ziprasidone,DB01410,Ciclesonide,0.8511644601821899,47,Type_47,The metabolism of Ciclesonide can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00313,Valproic acid,DB09053,Ibrutinib,0.418425053358078,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Valproic acid.,73,Type_73,Yes
DB05676,Apremilast,DB13783,Acemetacin,0.936872661113739,49,Type_49,The risk or severity of adverse effects can be increased when Apremilast is combined with Acemetacin.,49,Type_49,Yes
DB00457,Prazosin,DB01367,Rasagiline,0.807026743888855,60,Type_60,Prazosin may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB01054,Nitrendipine,DB01188,Ciclopirox,0.9647497534751892,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Ciclopirox.,49,Type_49,Yes
DB00333,Methadone,DB11609,Normethadone,0.9703501462936401,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Normethadone.,49,Type_49,Yes
DB00528,Lercanidipine,DB08864,Rilpivirine,0.8211768269538879,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Lercanidipine.,73,Type_73,Yes
DB00220,Nelfinavir,DB00367,Levonorgestrel,0.6203880310058594,47,Type_47,The metabolism of Levonorgestrel can be decreased when combined with Nelfinavir.,75,Type_75,No
DB04743,Nimesulide,DB08943,Isoconazole,0.8062426447868347,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Isoconazole.,49,Type_49,Yes
DB01224,Quetiapine,DB04948,Lofexidine,0.7699281573295593,60,Type_60,Quetiapine may increase the hypotensive activities of Lofexidine.,49,Type_49,No
DB01032,Probenecid,DB02709,Resveratrol,0.924492359161377,73,Type_73,The serum concentration of Resveratrol can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00208,Ticlopidine,DB00794,Primidone,0.5229794979095459,4,Type_4,The metabolism of Primidone can be increased when combined with Ticlopidine.,4,Type_4,Yes
DB00014,Goserelin,DB00912,Repaglinide,0.9998086094856262,70,Type_70,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Goserelin.,70,Type_70,Yes
DB00571,Propranolol,DB06403,Ambrisentan,0.9976356029510498,60,Type_60,Propranolol may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00708,Sufentanil,DB00880,Chlorothiazide,0.9996001124382019,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Chlorothiazide.,49,Type_49,Yes
DB00409,Remoxipride,DB01012,Cinacalcet,0.8733739256858826,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Remoxipride.,47,Type_47,Yes
DB00366,Doxylamine,DB00395,Carisoprodol,0.9999978542327881,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Carisoprodol.,16,Type_16,Yes
DB00771,Clidinium,DB01320,Fosphenytoin,0.9301592707633972,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Fosphenytoin.,49,Type_49,Yes
DB00572,Atropine,DB01122,Ambenonium,0.9986827969551086,70,Type_70,The therapeutic efficacy of Ambenonium can be decreased when used in combination with Atropine.,70,Type_70,Yes
DB01169,Arsenic trioxide,DB01195,Flecainide,0.7127771973609924,20,Type_20,Arsenic trioxide may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00531,Cyclophosphamide,DB04898,Ximelagatran,0.5030000805854797,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Cyclophosphamide.,49,Type_49,No
DB00975,Dipyridamole,DB08994,Ditazole,0.8919369578361511,6,Type_6,Dipyridamole may increase the anticoagulant activities of Ditazole.,6,Type_6,Yes
DB01151,Desipramine,DB06684,Vilazodone,0.890743613243103,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Vilazodone.,49,Type_49,Yes
DB09162,Ferric Citrate,DB09281,Magnesium trisilicate,0.9868886470794678,67,Type_67,Ferric Citrate can cause a decrease in the absorption of Magnesium trisilicate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00490,Buspirone,DB01233,Metoclopramide,0.45725348591804504,64,Type_64,Buspirone may increase the serotonergic activities of Metoclopramide.,49,Type_49,No
DB00196,Fluconazole,DB09128,Brexpiprazole,0.8182170987129211,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Fluconazole.,73,Type_73,Yes
DB00469,Tenoxicam,DB00598,Labetalol,0.9996644258499146,37,Type_37,Tenoxicam may decrease the antihypertensive activities of Labetalol.,37,Type_37,Yes
DB00370,Mirtazapine,DB00818,Propofol,0.9889037013053894,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Propofol.,16,Type_16,Yes
DB00477,Chlorpromazine,DB09080,Olodaterol,0.7666692137718201,20,Type_20,Chlorpromazine may increase the QTc-prolonging activities of Olodaterol.,20,Type_20,Yes
DB00206,Reserpine,DB09236,Lacidipine,0.9503346681594849,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Lacidipine.,60,Type_60,No
DB00497,Oxycodone,DB00656,Trazodone,0.9527656435966492,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Trazodone.,49,Type_49,Yes
DB01170,Guanethidine,DB01244,Bepridil,0.9995076656341553,60,Type_60,Guanethidine may increase the hypotensive activities of Bepridil.,60,Type_60,Yes
DB00768,Olopatadine,DB00796,Candesartan cilexetil,0.706004798412323,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Candesartan cilexetil.,49,Type_49,Yes
DB00764,Mometasone,DB09084,Benzydamine,0.9997662901878357,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Benzydamine.,49,Type_49,Yes
DB00273,Topiramate,DB00625,Efavirenz,0.7099930047988892,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Efavirenz.,49,Type_49,Yes
DB00564,Carbamazepine,DB00596,Ulobetasol,0.9835972189903259,75,Type_75,The serum concentration of Ulobetasol can be decreased when it is combined with Carbamazepine.,75,Type_75,Yes
DB00880,Chlorothiazide,DB09236,Lacidipine,0.7720212936401367,60,Type_60,Chlorothiazide may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00983,Formoterol,DB01200,Bromocriptine,0.5279620289802551,71,Type_71,Formoterol may increase the hypertensive activities of Bromocriptine.,71,Type_71,Yes
DB00557,Hydroxyzine,DB04946,Iloperidone,0.9257819056510925,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.,16,Type_16,Yes
DB00700,Eplerenone,DB01143,Amifostine,0.98329758644104,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Amifostine.,49,Type_49,Yes
DB00178,Ramipril,DB00390,Digoxin,0.35750651359558105,73,Type_73,The serum concentration of Digoxin can be increased when it is combined with Ramipril.,73,Type_73,Yes
DB00390,Digoxin,DB00919,Spectinomycin,0.7616796493530273,75,Type_75,The serum concentration of Spectinomycin can be decreased when it is combined with Digoxin.,75,Type_75,Yes
DB00748,Carbinoxamine,DB00835,Brompheniramine,0.9823295474052429,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Brompheniramine.,49,Type_49,Yes
DB00598,Labetalol,DB01113,Papaverine,0.9997952580451965,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Papaverine.,49,Type_49,Yes
DB00972,Azelastine,DB09198,Lobeglitazone,0.9995349645614624,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Azelastine.,47,Type_47,Yes
DB00182,Amphetamine,DB00468,Quinine,0.6468024253845215,47,Type_47,The metabolism of Quinine can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB00006,Bivalirudin,DB04865,Omacetaxine mepesuccinate,0.9836210012435913,66,Type_66,The risk or severity of bleeding can be increased when Bivalirudin is combined with Omacetaxine mepesuccinate.,66,Type_66,Yes
DB00986,Glycopyrronium,DB11315,Methscopolamine,0.9893682599067688,2,Type_2,Glycopyrronium may increase the anticholinergic activities of Methscopolamine.,2,Type_2,Yes
DB02701,Nicotinamide,DB06616,Bosutinib,0.9836499691009521,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Nicotinamide.,73,Type_73,Yes
DB01218,Halofantrine,DB06636,Isavuconazonium,0.7827867269515991,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Halofantrine.,73,Type_73,No
DB00653,Magnesium sulfate,DB09270,Ubidecarenone,0.8323022723197937,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Magnesium sulfate.,49,Type_49,No
DB00358,Mefloquine,DB00838,Clocortolone,0.9498586058616638,49,Type_49,The risk or severity of adverse effects can be increased when Mefloquine is combined with Clocortolone.,49,Type_49,Yes
DB00268,Ropinirole,DB09065,Cobicistat,0.6330602765083313,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB01440,gamma-Hydroxybutyric acid,DB11304,Phenoxyethanol,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Phenoxyethanol.,49,Type_49,Yes
DB00606,Cyclothiazide,DB00905,Bimatoprost,0.9999998807907104,60,Type_60,Cyclothiazide may increase the hypotensive activities of Bimatoprost.,60,Type_60,Yes
DB00321,Amitriptyline,DB00737,Meclizine,0.9983319640159607,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Meclizine.,49,Type_49,Yes
DB01174,Phenobarbital,DB04743,Nimesulide,0.6590670347213745,4,Type_4,The metabolism of Nimesulide can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00872,Conivaptan,DB09083,Ivabradine,0.720453143119812,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00476,Duloxetine,DB00797,Tolazoline,0.9982519745826721,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Tolazoline.,30,Type_30,Yes
DB00582,Voriconazole,DB04938,Ospemifene,0.8744807839393616,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Voriconazole.,73,Type_73,No
DB00537,Ciprofloxacin,DB00743,Gadobenic acid,0.9999957084655762,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB00381,Amlodipine,DB00564,Carbamazepine,0.5406140685081482,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Amlodipine.,4,Type_4,Yes
DB00371,Meprobamate,DB00734,Risperidone,0.986375629901886,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Risperidone.,49,Type_49,Yes
DB00575,Clonidine,DB00903,Etacrynic acid,0.9751210808753967,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Etacrynic acid.,49,Type_49,Yes
DB06690,Nitrous oxide,DB09286,Pipamperone,0.9998276233673096,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Pipamperone.,49,Type_49,Yes
DB00284,Acarbose,DB06825,Triptorelin,0.9999276399612427,70,Type_70,The therapeutic efficacy of Triptorelin can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00588,Fluticasone propionate,DB05271,Rotigotine,0.8351230621337891,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Rotigotine.,32,Type_32,No
DB00501,Cimetidine,DB09090,Pinaverium,0.695412278175354,49,Type_49,The risk or severity of adverse effects can be increased when Cimetidine is combined with Pinaverium.,73,Type_73,No
DB00358,Mefloquine,DB00940,Methantheline,0.9159696698188782,70,Type_70,The therapeutic efficacy of Methantheline can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB01068,Clonazepam,DB06690,Nitrous oxide,0.9957414865493774,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Nitrous oxide.,49,Type_49,Yes
DB00963,Bromfenac,DB06786,Halcinonide,0.999788224697113,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Halcinonide.,49,Type_49,Yes
DB00571,Propranolol,DB00843,Donepezil,0.9276553392410278,54,Type_54,Propranolol may increase the bradycardic activities of Donepezil.,54,Type_54,Yes
DB01118,Amiodarone,DB12483,Copanlisib,0.9313831925392151,47,Type_47,The metabolism of Copanlisib can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB01356,Lithium cation,DB08880,Teriflunomide,0.8713054060935974,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Lithium cation.,73,Type_73,Yes
DB00169,Cholecalciferol,DB01058,Praziquantel,0.8677057027816772,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00584,Enalapril,DB01048,Abacavir,0.8549790382385254,75,Type_75,The serum concentration of Abacavir can be decreased when it is combined with Enalapril.,75,Type_75,Yes
DB00866,Alprenolol,DB01090,Pentolinium,0.9973487854003906,60,Type_60,Alprenolol may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB06605,Apixaban,DB06717,Fosaprepitant,0.31945401430130005,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Apixaban.,73,Type_73,Yes
DB00333,Methadone,DB00980,Ramelteon,0.3897899091243744,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Ramelteon.,49,Type_49,Yes
DB00764,Mometasone,DB08797,Salicylamide,0.9997389912605286,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Salicylamide.,49,Type_49,Yes
DB00327,Hydromorphone,DB05812,Abiraterone,0.5575997829437256,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Hydromorphone.,73,Type_73,Yes
DB00180,Flunisolide,DB09073,Palbociclib,0.9840223789215088,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Flunisolide.,73,Type_73,Yes
DB01130,Prednicarbate,DB06802,Nepafenac,0.9997153878211975,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Nepafenac.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB08893,Mirabegron,0.9976698756217957,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Mirabegron.,49,Type_49,Yes
DB06684,Vilazodone,DB08933,Luliconazole,0.9778814315795898,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Vilazodone.,73,Type_73,Yes
DB00254,Doxycycline,DB09297,Paritaprevir,0.9737343192100525,47,Type_47,The metabolism of Paritaprevir can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00468,Quinine,DB09076,Umeclidinium,0.955451250076294,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Quinine.,47,Type_47,Yes
DB06148,Mianserin,DB06707,Levonordefrin,0.9415484070777893,70,Type_70,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Mianserin.,70,Type_70,Yes
DB06335,Saxagliptin,DB09054,Idelalisib,0.4767022132873535,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Saxagliptin.,73,Type_73,No
DB00264,Metoprolol,DB01289,Glisoxepide,0.7408612370491028,9,Type_9,Metoprolol may increase the hypoglycemic activities of Glisoxepide.,9,Type_9,Yes
DB00685,Trovafloxacin,DB00860,Prednisolone,0.967409610748291,49,Type_49,The risk or severity of adverse effects can be increased when Trovafloxacin is combined with Prednisolone.,49,Type_49,Yes
DB00935,Oxymetazoline,DB01577,Metamfetamine,0.9851556420326233,49,Type_49,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Metamfetamine.,49,Type_49,Yes
DB01143,Amifostine,DB01144,Diclofenamide,0.9977654218673706,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Diclofenamide.,49,Type_49,Yes
DB09054,Idelalisib,DB09270,Ubidecarenone,0.9028974175453186,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Idelalisib.,73,Type_73,Yes
DB01337,Pancuronium,DB11609,Normethadone,0.9993670582771301,49,Type_49,The risk or severity of adverse effects can be increased when Pancuronium is combined with Normethadone.,49,Type_49,Yes
DB00950,Fexofenadine,DB06770,Benzyl alcohol,0.9980518817901611,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Benzyl alcohol.,49,Type_49,Yes
DB00656,Trazodone,DB09054,Idelalisib,0.6438037753105164,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Trazodone.,47,Type_47,Yes
DB00768,Olopatadine,DB06802,Nepafenac,0.9994528889656067,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Nepafenac.,49,Type_49,Yes
DB01289,Glisoxepide,DB04861,Nebivolol,0.8497044444084167,9,Type_9,Glisoxepide may increase the hypoglycemic activities of Nebivolol.,9,Type_9,Yes
DB01176,Cyclizine,DB01452,Diamorphine,0.9985482096672058,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Diamorphine.,49,Type_49,Yes
DB00315,Zolmitriptan,DB01200,Bromocriptine,0.9103606343269348,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromocriptine.,49,Type_49,Yes
DB00282,Pamidronic acid,DB08984,Etofenamate,0.9816552400588989,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Etofenamate.,49,Type_49,Yes
DB00976,Telithromycin,DB01126,Dutasteride,0.9530659317970276,47,Type_47,The metabolism of Dutasteride can be decreased when combined with Telithromycin.,73,Type_73,No
DB00511,Acetyldigitoxin,DB06771,Besifloxacin,0.9990341663360596,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Besifloxacin.,58,Type_58,Yes
DB00199,Erythromycin,DB00906,Tiagabine,0.9330590963363647,47,Type_47,The metabolism of Tiagabine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01221,Ketamine,DB09286,Pipamperone,0.996535062789917,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Pipamperone.,49,Type_49,Yes
DB00621,Oxandrolone,DB00764,Mometasone,1.0,74,Type_74,Oxandrolone may increase the fluid retaining activities of Mometasone.,74,Type_74,Yes
DB01558,Bromazepam,DB08820,Ivacaftor,0.9967139959335327,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Bromazepam.,73,Type_73,Yes
DB00446,Chloramphenicol,DB01211,Clarithromycin,0.927428662776947,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00315,Zolmitriptan,DB08881,Vemurafenib,0.40757909417152405,33,Type_33,The risk or severity of QTc prolongation can be increased when Zolmitriptan is combined with Vemurafenib.,73,Type_73,No
DB00275,Olmesartan,DB00528,Lercanidipine,0.6570873260498047,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Lercanidipine.,60,Type_60,No
DB00546,Adinazolam,DB01263,Posaconazole,0.9362300634384155,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00683,Midazolam,DB00801,Halazepam,0.9999825954437256,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Halazepam.,49,Type_49,Yes
DB00289,Atomoxetine,DB08912,Dabrafenib,0.8513619303703308,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Atomoxetine.,75,Type_75,Yes
DB00564,Carbamazepine,DB01189,Desflurane,0.9737815260887146,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desflurane.,49,Type_49,Yes
DB01032,Probenecid,DB08976,Floctafenine,0.9713575839996338,73,Type_73,The serum concentration of Floctafenine can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00283,Clemastine,DB05812,Abiraterone,0.5777696967124939,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00849,Methylphenobarbital,DB00854,Levorphanol,0.9754898548126221,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Levorphanol.,49,Type_49,Yes
DB01082,Streptomycin,DB01250,Olsalazine,0.9999140501022339,72,Type_72,Streptomycin may decrease the excretion rate of Olsalazine which could result in a higher serum level.,72,Type_72,Yes
DB00641,Simvastatin,DB01029,Irbesartan,0.3580513894557953,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Simvastatin.,47,Type_47,Yes
DB00773,Etoposide,DB00864,Tacrolimus,0.7282299399375916,49,Type_49,The risk or severity of adverse effects can be increased when Etoposide is combined with Tacrolimus.,49,Type_49,Yes
DB00313,Valproic acid,DB00356,Chlorzoxazone,0.8289409279823303,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Chlorzoxazone.,49,Type_49,Yes
DB00264,Metoprolol,DB01074,Perhexiline,0.7534536719322205,60,Type_60,Metoprolol may increase the hypotensive activities of Perhexiline.,73,Type_73,No
DB01041,Thalidomide,DB01236,Sevoflurane,0.8968781232833862,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.,16,Type_16,Yes
DB00699,Nicergoline,DB06290,Simeprevir,0.8327562212944031,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Simeprevir.,49,Type_49,Yes
DB00842,Oxazepam,DB01466,Ethylmorphine,0.9931989312171936,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Ethylmorphine.,49,Type_49,Yes
DB00622,Nicardipine,DB01624,Zuclopenthixol,0.4888342022895813,20,Type_20,Nicardipine may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB00268,Ropinirole,DB01282,Carbetocin,0.9770772457122803,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Carbetocin.,49,Type_49,Yes
DB00091,Cyclosporine,DB00246,Ziprasidone,0.9056107401847839,47,Type_47,The metabolism of Ziprasidone can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01149,Nefazodone,DB09262,Imidafenacin,0.9478535056114197,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Nefazodone.,73,Type_73,No
DB00295,Morphine,DB00975,Dipyridamole,0.8740873336791992,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Dipyridamole.,49,Type_49,Yes
DB00325,Nitroprusside,DB01367,Rasagiline,0.9759698510169983,60,Type_60,Nitroprusside may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00227,Lovastatin,DB00688,Mycophenolate mofetil,0.803250789642334,47,Type_47,The metabolism of Mycophenolate mofetil can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00227,Lovastatin,DB06148,Mianserin,0.82415771484375,47,Type_47,The metabolism of Mianserin can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00455,Loratadine,DB00472,Fluoxetine,0.8325594663619995,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Loratadine.,47,Type_47,Yes
DB00292,Etomidate,DB01002,Levobupivacaine,0.974025547504425,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Levobupivacaine.,49,Type_49,Yes
DB06700,Desvenlafaxine,DB09072,Sodium oxybate,0.9205839037895203,49,Type_49,The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Sodium oxybate.,49,Type_49,Yes
DB06717,Fosaprepitant,DB09262,Imidafenacin,0.7724791169166565,73,Type_73,The serum concentration of Imidafenacin can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB00524,Metolazone,DB08941,Isoxsuprine,0.9955006241798401,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Isoxsuprine.,49,Type_49,Yes
DB01098,Rosuvastatin,DB06287,Temsirolimus,0.8171945810317993,73,Type_73,The serum concentration of Temsirolimus can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB01010,Edrophonium,DB01226,Mivacurium,0.9725416898727417,17,Type_17,Edrophonium may decrease the neuromuscular blocking activities of Mivacurium.,17,Type_17,Yes
DB01197,Captopril,DB09026,Aliskiren,0.47893819212913513,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Aliskiren.,68,Type_68,No
DB00176,Fluvoxamine,DB09143,Sonidegib,0.8006596565246582,73,Type_73,The serum concentration of Sonidegib can be increased when it is combined with Fluvoxamine.,73,Type_73,Yes
DB00755,Tretinoin,DB01136,Carvedilol,0.9518358111381531,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Carvedilol.,49,Type_49,Yes
DB01242,Clomipramine,DB09242,Moxonidine,0.439333438873291,70,Type_70,The therapeutic efficacy of Moxonidine can be decreased when used in combination with Clomipramine.,70,Type_70,Yes
DB00232,Methyclothiazide,DB00368,Norepinephrine,0.9221192002296448,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Norepinephrine.,83,Type_83,Yes
DB00582,Voriconazole,DB06268,Sitaxentan,0.8952580094337463,47,Type_47,The metabolism of Sitaxentan can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB06826,Unoprostone,DB11362,Selexipag,0.9999923706054688,60,Type_60,Unoprostone may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00233,Aminosalicylic acid,DB01418,Acenocoumarol,0.9935818910598755,6,Type_6,Aminosalicylic acid may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01104,Sertraline,DB01551,Dihydrocodeine,0.5626201033592224,64,Type_64,Sertraline may increase the serotonergic activities of Dihydrocodeine.,47,Type_47,No
DB00780,Phenelzine,DB06335,Saxagliptin,0.9884647130966187,9,Type_9,Phenelzine may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00312,Pentobarbital,DB00484,Brimonidine,0.5058914422988892,16,Type_16,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,16,Type_16,Yes
DB00390,Digoxin,DB06626,Axitinib,0.9786267280578613,58,Type_58,Digoxin may decrease the cardiotoxic activities of Axitinib.,58,Type_58,Yes
DB01589,Quazepam,DB04871,Lorcaserin,0.8365226984024048,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Quazepam.,73,Type_73,No
DB09065,Cobicistat,DB11915,Valbenazine,0.5447817444801331,47,Type_47,The metabolism of Valbenazine can be decreased when combined with Cobicistat.,73,Type_73,No
DB00176,Fluvoxamine,DB00911,Tinidazole,0.9890729784965515,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00613,Amodiaquine,DB01103,Quinacrine,0.8110987544059753,47,Type_47,The metabolism of Quinacrine can be decreased when combined with Amodiaquine.,75,Type_75,No
DB00663,Flumethasone,DB13783,Acemetacin,0.9687134623527527,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Acemetacin.,49,Type_49,Yes
DB01433,Methadyl acetate,DB01545,Ethyl loflazepate,0.9997143149375916,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00543,Amoxapine,DB00807,Proparacaine,0.9979792237281799,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Proparacaine.,49,Type_49,Yes
DB00467,Enoxacin,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Enoxacin.,70,Type_70,Yes
DB00327,Hydromorphone,DB00633,Dexmedetomidine,0.991236686706543,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dexmedetomidine.,49,Type_49,Yes
DB00238,Nevirapine,DB00924,Cyclobenzaprine,0.8504826426506042,4,Type_4,The metabolism of Cyclobenzaprine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00897,Triazolam,DB09065,Cobicistat,0.6305960416793823,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Triazolam.,73,Type_73,Yes
DB00495,Zidovudine,DB00678,Losartan,0.5034512281417847,47,Type_47,The metabolism of Losartan can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB00203,Sildenafil,DB00347,Trimethadione,0.9256227612495422,47,Type_47,The metabolism of Trimethadione can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00753,Isoflurane,DB00780,Phenelzine,0.7932428121566772,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Phenelzine.,49,Type_49,Yes
DB00435,Nitric Oxide,DB00790,Perindopril,0.998862624168396,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Perindopril.,49,Type_49,Yes
DB06414,Etravirine,DB09118,Stiripentol,0.916605532169342,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Etravirine.,73,Type_73,Yes
DB00821,Carprofen,DB06725,Lornoxicam,0.9984652996063232,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Lornoxicam.,49,Type_49,Yes
DB00605,Sulindac,DB09285,Morniflumate,0.999661922454834,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Morniflumate.,49,Type_49,Yes
DB01014,Balsalazide,DB01207,Ridogrel,0.9659347534179688,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Ridogrel.,49,Type_49,Yes
DB00586,Diclofenac,DB00974,Edetic acid,0.9946146607398987,6,Type_6,Diclofenac may increase the anticoagulant activities of Edetic acid.,6,Type_6,Yes
DB01403,Methotrimeprazine,DB09166,Etizolam,0.9068102836608887,16,Type_16,Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Etizolam.,16,Type_16,Yes
DB00297,Bupivacaine,DB09112,Nitrous acid,0.9411919116973877,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nitrous acid.,49,Type_49,Yes
DB00333,Methadone,DB01199,Tubocurarine,0.9344334602355957,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Tubocurarine.,49,Type_49,Yes
DB00726,Trimipramine,DB01366,Procaterol,0.9874833822250366,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Procaterol.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB11586,Asunaprevir,0.5375104546546936,73,Type_73,The serum concentration of Asunaprevir can be increased when it is combined with Cyclobenzaprine.,73,Type_73,Yes
DB00242,Cladribine,DB00337,Pimecrolimus,0.8077189326286316,49,Type_49,The risk or severity of adverse effects can be increased when Cladribine is combined with Pimecrolimus.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00946,Phenprocoumon,0.7638146877288818,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00335,Atenolol,DB00887,Bumetanide,0.996283233165741,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Bumetanide.,49,Type_49,Yes
DB04855,Dronedarone,DB08910,Pomalidomide,0.9247499108314514,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00014,Goserelin,DB05039,Indacaterol,0.999991774559021,20,Type_20,Goserelin may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00189,Ethchlorvynol,DB01563,Chloral hydrate,0.9999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Chloral hydrate.,49,Type_49,Yes
DB00175,Pravastatin,DB09227,Barnidipine,0.9161526560783386,49,Type_49,The risk or severity of adverse effects can be increased when Pravastatin is combined with Barnidipine.,49,Type_49,Yes
DB01365,Mephentermine,DB01623,Thiothixene,0.9999533891677856,61,Type_61,Mephentermine may decrease the stimulatory activities of Thiothixene.,61,Type_61,Yes
DB00238,Nevirapine,DB01223,Aminophylline,0.3788515627384186,4,Type_4,The metabolism of Aminophylline can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00896,Rimexolone,DB04743,Nimesulide,0.9900193214416504,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Nimesulide.,49,Type_49,Yes
DB00215,Citalopram,DB06708,Lumefantrine,0.4551653265953064,20,Type_20,Citalopram may increase the QTc-prolonging activities of Lumefantrine.,47,Type_47,No
DB00653,Magnesium sulfate,DB01100,Pimozide,0.8845794200897217,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pimozide.,16,Type_16,Yes
DB01016,Glyburide,DB08933,Luliconazole,0.9352562427520752,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB00908,Quinidine,DB09048,Netupitant,0.9765035510063171,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00458,Imipramine,DB01118,Amiodarone,0.5933830142021179,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Imipramine.,47,Type_47,Yes
DB01222,Budesonide,DB01233,Metoclopramide,0.9980953335762024,49,Type_49,The risk or severity of adverse effects can be increased when Budesonide is combined with Metoclopramide.,49,Type_49,Yes
DB00813,Fentanyl,DB01151,Desipramine,0.8675445318222046,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Desipramine.,49,Type_49,Yes
DB08822,Azilsartan medoxomil,DB09449,"Sodium phosphate, monobasic",0.8706300258636475,57,Type_57,"Azilsartan medoxomil may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00503,Ritonavir,DB09555,Dexchlorpheniramine maleate,0.9648265242576599,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00343,Diltiazem,DB11126,Calcium gluconate,0.7138911485671997,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Diltiazem.,70,Type_70,Yes
DB00503,Ritonavir,DB09167,Dosulepin,0.7183065414428711,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00765,Metyrosine,DB00806,Pentoxifylline,0.9759924411773682,60,Type_60,Metyrosine may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00238,Nevirapine,DB00896,Rimexolone,0.8812236785888672,75,Type_75,The serum concentration of Rimexolone can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00904,Ondansetron,DB08820,Ivacaftor,0.9953676462173462,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Ondansetron.,73,Type_73,Yes
DB00501,Cimetidine,DB01224,Quetiapine,0.7439998984336853,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00678,Losartan,DB00805,Minaprine,0.6945877075195312,60,Type_60,Losartan may increase the hypotensive activities of Minaprine.,60,Type_60,Yes
DB01377,Magnesium oxide,DB09146,Iron sucrose,0.8520070314407349,67,Type_67,Magnesium oxide can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00278,Argatroban,DB00705,Delavirdine,0.7535884976387024,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Argatroban.,75,Type_75,No
DB00772,Malathion,DB00810,Biperiden,0.9737299084663391,70,Type_70,The therapeutic efficacy of Biperiden can be decreased when used in combination with Malathion.,70,Type_70,Yes
DB00983,Formoterol,DB08933,Luliconazole,0.9892946481704712,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Formoterol.,73,Type_73,Yes
DB00555,Lamotrigine,DB08987,Etidocaine,0.9998563528060913,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Etidocaine.,49,Type_49,Yes
DB00690,Flurazepam,DB06770,Benzyl alcohol,0.9945828318595886,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Benzyl alcohol.,49,Type_49,Yes
DB00762,Irinotecan,DB05521,Telaprevir,0.6856713891029358,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Irinotecan.,73,Type_73,No
DB00648,Mitotane,DB09555,Dexchlorpheniramine maleate,0.9835194945335388,75,Type_75,The serum concentration of Dexchlorpheniramine maleate can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00996,Gabapentin,DB09342,Propoxycaine,0.9981726408004761,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Propoxycaine.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB08918,Levomilnacipran,0.9895825386047363,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levomilnacipran.,49,Type_49,Yes
DB00501,Cimetidine,DB00619,Imatinib,0.8548769354820251,47,Type_47,The metabolism of Imatinib can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00876,Eprosartan,DB01014,Balsalazide,0.5288682579994202,37,Type_37,Eprosartan may decrease the antihypertensive activities of Balsalazide.,49,Type_49,No
DB00356,Chlorzoxazone,DB00557,Hydroxyzine,0.9993317723274231,16,Type_16,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB00623,Fluphenazine,DB09068,Vortioxetine,0.9962813258171082,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vortioxetine.,49,Type_49,Yes
DB00765,Metyrosine,DB01119,Diazoxide,0.999413013458252,60,Type_60,Metyrosine may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00227,Lovastatin,DB00683,Midazolam,0.6830005645751953,47,Type_47,The metabolism of Midazolam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01029,Irbesartan,DB01612,Amyl Nitrite,0.9770994782447815,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Amyl Nitrite.,49,Type_49,Yes
DB01396,Digitoxin,DB09063,Ceritinib,0.6859450340270996,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Ceritinib.,73,Type_73,No
DB00318,Codeine,DB00850,Perphenazine,0.9879213571548462,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Perphenazine.,49,Type_49,Yes
DB01080,Vigabatrin,DB01452,Diamorphine,0.9997479319572449,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Diamorphine.,49,Type_49,Yes
DB01116,Trimethaphan,DB01338,Pipecuronium,0.9995524287223816,49,Type_49,The risk or severity of adverse effects can be increased when Trimethaphan is combined with Pipecuronium.,49,Type_49,Yes
DB00214,Torasemide,DB06826,Unoprostone,0.9999991655349731,60,Type_60,Torasemide may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00212,Remikiren,DB13783,Acemetacin,0.9592576026916504,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Remikiren.,70,Type_70,Yes
DB00732,Atracurium besylate,DB01222,Budesonide,0.9980186223983765,22,Type_22,Atracurium besylate may increase the adverse neuromuscular activities of Budesonide.,22,Type_22,Yes
DB00248,Cabergoline,DB00763,Methimazole,0.7681928873062134,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Methimazole.,49,Type_49,Yes
DB01037,Selegiline,DB09232,Cilnidipine,0.8728955984115601,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Cilnidipine.,49,Type_49,Yes
DB06410,Doxercalciferol,DB11348,Calcium Phosphate,0.9720540642738342,49,Type_49,The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcium Phosphate.,49,Type_49,Yes
DB00500,Tolmetin,DB06737,Zaltoprofen,0.999352753162384,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Zaltoprofen.,49,Type_49,Yes
DB00559,Bosentan,DB00582,Voriconazole,0.6646765470504761,75,Type_75,The serum concentration of Voriconazole can be decreased when it is combined with Bosentan.,73,Type_73,No
DB00338,Omeprazole,DB01075,Diphenhydramine,0.9788299798965454,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00623,Fluphenazine,DB05246,Methsuximide,0.9944936633110046,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methsuximide.,49,Type_49,Yes
DB00622,Nicardipine,DB01072,Atazanavir,0.842246949672699,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB00983,Formoterol,0.9959640502929688,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Formoterol.,83,Type_83,Yes
DB01348,Spirapril,DB04876,Vildagliptin,0.5938434600830078,49,Type_49,The risk or severity of adverse effects can be increased when Spirapril is combined with Vildagliptin.,49,Type_49,Yes
DB00422,Methylphenidate,DB00876,Eprosartan,0.9999263286590576,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Eprosartan.,37,Type_37,Yes
DB00927,Famotidine,DB01100,Pimozide,0.7276133894920349,20,Type_20,Famotidine may increase the QTc-prolonging activities of Pimozide.,20,Type_20,Yes
DB00216,Eletriptan,DB00270,Isradipine,0.5273348689079285,47,Type_47,The metabolism of Isradipine can be decreased when combined with Eletriptan.,73,Type_73,No
DB00417,Phenoxymethylpenicillin,DB13783,Acemetacin,0.3733757734298706,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Phenoxymethylpenicillin.,72,Type_72,No
DB01010,Edrophonium,DB01019,Bethanechol,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Edrophonium is combined with Bethanechol.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB06770,Benzyl alcohol,0.9998071789741516,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Benzyl alcohol.,49,Type_49,Yes
DB00980,Ramelteon,DB01205,Flumazenil,0.9853870868682861,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Flumazenil.,76,Type_76,No
DB00806,Pentoxifylline,DB08814,Triflusal,0.854505181312561,53,Type_53,Pentoxifylline may increase the antiplatelet activities of Triflusal.,53,Type_53,Yes
DB04840,Debrisoquine,DB04871,Lorcaserin,0.9873002171516418,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Debrisoquine.,47,Type_47,Yes
DB00254,Doxycycline,DB00549,Zafirlukast,0.920937716960907,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00215,Citalopram,DB06704,Iobenguane,0.8172516226768494,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Citalopram.,70,Type_70,Yes
DB00521,Carteolol,DB01118,Amiodarone,0.44555148482322693,54,Type_54,Carteolol may increase the bradycardic activities of Amiodarone.,54,Type_54,Yes
DB00247,Methysergide,DB01016,Glyburide,0.9984411597251892,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Glyburide.,49,Type_49,Yes
DB00185,Cevimeline,DB00312,Pentobarbital,0.6141825914382935,4,Type_4,The metabolism of Pentobarbital can be increased when combined with Cevimeline.,4,Type_4,Yes
DB00497,Oxycodone,DB09117,Paraldehyde,0.9993048906326294,16,Type_16,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01234,Dexamethasone,DB01264,Darunavir,0.6306967735290527,47,Type_47,The metabolism of Darunavir can be decreased when combined with Dexamethasone.,47,Type_47,Yes
DB00451,Levothyroxine,DB01083,Orlistat,0.5164899230003357,67,Type_67,Levothyroxine can cause a decrease in the absorption of Orlistat resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB01118,Amiodarone,DB08820,Ivacaftor,0.998769223690033,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00599,Thiopental,DB00957,Norgestimate,0.7153688073158264,70,Type_70,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Thiopental.,70,Type_70,Yes
DB00705,Delavirdine,DB00757,Dolasetron,0.9035886526107788,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00264,Metoprolol,DB00500,Tolmetin,0.9937425255775452,37,Type_37,Metoprolol may decrease the antihypertensive activities of Tolmetin.,37,Type_37,Yes
DB00529,Foscarnet,DB08881,Vemurafenib,0.9150286316871643,20,Type_20,Foscarnet may increase the QTc-prolonging activities of Vemurafenib.,20,Type_20,Yes
DB00188,Bortezomib,DB09279,Fimasartan,0.9162744283676147,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Fimasartan.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB00940,Methantheline,0.9735822677612305,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Methantheline.,49,Type_49,Yes
DB00327,Hydromorphone,DB01116,Trimethaphan,0.9772587418556213,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trimethaphan.,49,Type_49,Yes
DB06826,Unoprostone,DB09236,Lacidipine,0.99998939037323,60,Type_60,Unoprostone may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00731,Nateglinide,DB00877,Sirolimus,0.7245439887046814,70,Type_70,The therapeutic efficacy of Sirolimus can be decreased when used in combination with Nateglinide.,70,Type_70,Yes
DB00575,Clonidine,DB04868,Nilotinib,0.5612995624542236,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Clonidine.,47,Type_47,Yes
DB05039,Indacaterol,DB09289,Tianeptine,0.8861089944839478,49,Type_49,The risk or severity of adverse effects can be increased when Indacaterol is combined with Tianeptine.,49,Type_49,Yes
DB00384,Triamterene,DB00573,Fenoprofen,0.9975711703300476,37,Type_37,Triamterene may decrease the antihypertensive activities of Fenoprofen.,37,Type_37,Yes
DB01384,Paramethasone,DB04951,Pirfenidone,0.9988508224487305,49,Type_49,The risk or severity of adverse effects can be increased when Paramethasone is combined with Pirfenidone.,49,Type_49,Yes
DB06207,Silodosin,DB06717,Fosaprepitant,0.9976785778999329,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Silodosin.,73,Type_73,Yes
DB00428,Streptozocin,DB01338,Pipecuronium,0.9998123049736023,40,Type_40,Streptozocin may increase the respiratory depressant activities of Pipecuronium.,40,Type_40,Yes
DB08881,Vemurafenib,DB09389,Norgestrel,0.707744836807251,73,Type_73,The serum concentration of Norgestrel can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB00898,Ethanol,DB01069,Promethazine,0.9715564846992493,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Promethazine.,16,Type_16,Yes
DB00185,Cevimeline,DB00843,Donepezil,0.3125832676887512,75,Type_75,The serum concentration of Donepezil can be decreased when it is combined with Cevimeline.,49,Type_49,No
DB00325,Nitroprusside,DB01197,Captopril,0.6701897382736206,60,Type_60,Nitroprusside may increase the hypotensive activities of Captopril.,49,Type_49,No
DB01200,Bromocriptine,DB09038,Empagliflozin,0.6207529902458191,9,Type_9,Bromocriptine may increase the hypoglycemic activities of Empagliflozin.,49,Type_49,No
DB01111,Colistimethate,DB01172,Kanamycin,0.9718174934387207,57,Type_57,Colistimethate may increase the nephrotoxic activities of Kanamycin.,57,Type_57,Yes
DB00371,Meprobamate,DB00802,Alfentanil,0.9983168840408325,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Alfentanil.,49,Type_49,Yes
DB00599,Thiopental,DB09279,Fimasartan,0.930336594581604,60,Type_60,Thiopental may increase the hypotensive activities of Fimasartan.,60,Type_60,Yes
DB00370,Mirtazapine,DB09085,Tetracaine,0.9929186701774597,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.,16,Type_16,Yes
DB00622,Nicardipine,DB01067,Glipizide,0.8827135562896729,47,Type_47,The metabolism of Glipizide can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00999,Hydrochlorothiazide,DB01159,Halothane,0.9954857230186462,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Halothane.,49,Type_49,Yes
DB00468,Quinine,DB00794,Primidone,0.5802564024925232,4,Type_4,The metabolism of Primidone can be increased when combined with Quinine.,4,Type_4,Yes
DB00764,Mometasone,DB01118,Amiodarone,0.8157616257667542,73,Type_73,The serum concentration of Amiodarone can be increased when it is combined with Mometasone.,73,Type_73,Yes
DB00325,Nitroprusside,DB00975,Dipyridamole,0.9645631313323975,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Dipyridamole.,49,Type_49,Yes
DB00210,Adapalene,DB00784,Mefenamic acid,0.9997479319572449,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Mefenamic acid.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00925,Phenoxybenzamine,0.5440390706062317,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB05521,Telaprevir,DB08875,Cabozantinib,0.7602547407150269,47,Type_47,The metabolism of Cabozantinib can be decreased when combined with Telaprevir.,73,Type_73,No
DB00625,Efavirenz,DB00869,Dorzolamide,0.7195701599121094,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00614,Furazolidone,DB01171,Moclobemide,0.4323519170284271,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Moclobemide.,49,Type_49,Yes
DB00402,Eszopiclone,DB01551,Dihydrocodeine,0.9969898462295532,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dihydrocodeine.,49,Type_49,Yes
DB00683,Midazolam,DB01614,Acepromazine,0.9990321397781372,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Acepromazine.,49,Type_49,Yes
DB00508,Triflupromazine,DB06770,Benzyl alcohol,0.9974691867828369,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Benzyl alcohol.,49,Type_49,Yes
DB00976,Telithromycin,DB01211,Clarithromycin,0.5486666560173035,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Telithromycin.,20,Type_20,No
DB01087,Primaquine,DB06290,Simeprevir,0.9820926189422607,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Primaquine.,73,Type_73,Yes
DB00498,Phenindione,DB01583,Liotrix,0.8121582269668579,6,Type_6,Phenindione may increase the anticoagulant activities of Liotrix.,6,Type_6,Yes
DB00768,Olopatadine,DB01340,Cilazapril,0.7351464033126831,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Cilazapril.,49,Type_49,Yes
DB00906,Tiagabine,DB01353,Butobarbital,0.9987506866455078,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Butobarbital.,49,Type_49,Yes
DB00619,Imatinib,DB01098,Rosuvastatin,0.4808599054813385,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB00802,Alfentanil,0.5423226356506348,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alfentanil.,47,Type_47,No
DB01074,Perhexiline,DB06636,Isavuconazonium,0.9363266825675964,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Perhexiline.,47,Type_47,Yes
DB00940,Methantheline,DB01122,Ambenonium,0.9757798910140991,70,Type_70,The therapeutic efficacy of Ambenonium can be decreased when used in combination with Methantheline.,70,Type_70,Yes
DB00396,Progesterone,DB00569,Fondaparinux,0.4270540475845337,75,Type_75,The serum concentration of Fondaparinux can be decreased when it is combined with Progesterone.,70,Type_70,No
DB00556,Perflutren,DB01238,Aripiprazole,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Aripiprazole.,20,Type_20,Yes
DB01410,Ciclesonide,DB08938,Magaldrate,0.9966893196105957,3,Type_3,The bioavailability of Magaldrate can be decreased when combined with Ciclesonide.,3,Type_3,Yes
DB00593,Ethosuximide,DB01118,Amiodarone,0.8838255405426025,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Ethosuximide.,47,Type_47,Yes
DB09079,Nintedanib,DB11268,Protocatechualdehyde,0.7872005105018616,12,Type_12,Nintedanib may decrease the anticoagulant activities of Protocatechualdehyde.,49,Type_49,No
DB01101,Capecitabine,DB01154,Thiamylal,0.8957831859588623,47,Type_47,The metabolism of Thiamylal can be decreased when combined with Capecitabine.,47,Type_47,Yes
DB00564,Carbamazepine,DB00985,Dimenhydrinate,0.9878451228141785,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimenhydrinate.,49,Type_49,Yes
DB00396,Progesterone,DB08934,Sofosbuvir,0.6295047402381897,73,Type_73,The serum concentration of Sofosbuvir can be increased when it is combined with Progesterone.,75,Type_75,No
DB00368,Norepinephrine,DB00841,Dobutamine,0.9613355398178101,49,Type_49,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Dobutamine.,49,Type_49,Yes
DB06589,Pazopanib,DB08880,Teriflunomide,0.584963321685791,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Pazopanib.,75,Type_75,Yes
DB06148,Mianserin,DB09291,Rolapitant,0.8784497976303101,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Mianserin.,47,Type_47,Yes
DB06209,Prasugrel,DB09543,Methyl salicylate,0.8638432621955872,6,Type_6,Prasugrel may increase the anticoagulant activities of Methyl salicylate.,49,Type_49,No
DB00475,Chlordiazepoxide,DB00768,Olopatadine,0.9867672324180603,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Olopatadine.,49,Type_49,Yes
DB00996,Gabapentin,DB01551,Dihydrocodeine,0.9963474869728088,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Dihydrocodeine.,49,Type_49,Yes
DB00919,Spectinomycin,DB08797,Salicylamide,0.999991774559021,72,Type_72,Spectinomycin may decrease the excretion rate of Salicylamide which could result in a higher serum level.,72,Type_72,Yes
DB00393,Nimodipine,DB01088,Iloprost,0.5383358001708984,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Iloprost.,60,Type_60,No
DB00298,Dapiprazole,DB00508,Triflupromazine,0.9761531352996826,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Triflupromazine.,49,Type_49,Yes
DB00368,Norepinephrine,DB00780,Phenelzine,0.970797061920166,71,Type_71,Norepinephrine may increase the hypertensive activities of Phenelzine.,71,Type_71,Yes
DB00169,Cholecalciferol,DB00471,Montelukast,0.9149484634399414,47,Type_47,The metabolism of Montelukast can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB09267,Strontium ranelate,DB11126,Calcium gluconate,0.9977072477340698,75,Type_75,The serum concentration of Calcium gluconate can be decreased when it is combined with Strontium ranelate.,75,Type_75,Yes
DB00238,Nevirapine,DB00726,Trimipramine,0.9299407005310059,4,Type_4,The metabolism of Trimipramine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00281,Lidocaine,DB09128,Brexpiprazole,0.913689374923706,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Brexpiprazole.,49,Type_49,Yes
DB01397,Magnesium salicylate,DB06813,Pralatrexate,0.8571165204048157,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Magnesium salicylate.,73,Type_73,Yes
DB00220,Nelfinavir,DB01194,Brinzolamide,0.7901333570480347,47,Type_47,The metabolism of Brinzolamide can be decreased when combined with Nelfinavir.,73,Type_73,No
DB00658,Sevelamer,DB01137,Levofloxacin,0.8671290278434753,67,Type_67,Sevelamer can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00436,Bendroflumethiazide,DB00805,Minaprine,0.9404456615447998,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Minaprine.,60,Type_60,Yes
DB00751,Epinastine,DB01167,Itraconazole,0.886639416217804,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Epinastine.,75,Type_75,No
DB00413,Pramipexole,DB13025,Tiapride,0.9999905824661255,32,Type_32,Pramipexole may increase the sedative activities of Tiapride.,32,Type_32,Yes
DB00889,Granisetron,DB00916,Metronidazole,0.9448310732841492,20,Type_20,Granisetron may increase the QTc-prolonging activities of Metronidazole.,20,Type_20,Yes
DB01173,Orphenadrine,DB08918,Levomilnacipran,0.9327667355537415,49,Type_49,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Levomilnacipran.,49,Type_49,Yes
DB00187,Esmolol,DB00629,Guanabenz,0.9682537913322449,25,Type_25,Esmolol may increase the atrioventricular blocking (AV block) activities of Guanabenz.,25,Type_25,Yes
DB01168,Procarbazine,DB01274,Arformoterol,0.9575203657150269,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Arformoterol.,49,Type_49,Yes
DB01580,Oxprenolol,DB01614,Acepromazine,0.7530196905136108,60,Type_60,Oxprenolol may increase the hypotensive activities of Acepromazine.,49,Type_49,No
DB00280,Disopyramide,DB06791,Lanreotide,0.8579525351524353,9,Type_9,Disopyramide may increase the hypoglycemic activities of Lanreotide.,9,Type_9,Yes
DB01065,Melatonin,DB05812,Abiraterone,0.5694859623908997,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Melatonin.,73,Type_73,Yes
DB00270,Isradipine,DB08901,Ponatinib,0.9506028294563293,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB00753,Isoflurane,0.9989803433418274,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Isoflurane.,49,Type_49,Yes
DB01217,Anastrozole,DB01357,Mestranol,0.9788020849227905,70,Type_70,The therapeutic efficacy of Mestranol can be decreased when used in combination with Anastrozole.,70,Type_70,Yes
DB00281,Lidocaine,DB01115,Nifedipine,0.8740116953849792,47,Type_47,The metabolism of Nifedipine can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00476,Duloxetine,DB00908,Quinidine,0.6559556126594543,47,Type_47,The metabolism of Quinidine can be decreased when combined with Duloxetine.,73,Type_73,No
DB00695,Furosemide,DB00997,Doxorubicin,0.6596451997756958,57,Type_57,Furosemide may increase the nephrotoxic activities of Doxorubicin.,49,Type_49,No
DB00997,Doxorubicin,DB01244,Bepridil,0.6117552518844604,47,Type_47,The metabolism of Bepridil can be decreased when combined with Doxorubicin.,73,Type_73,No
DB00423,Methocarbamol,DB01224,Quetiapine,0.9954125285148621,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Quetiapine.,49,Type_49,Yes
DB00761,Potassium chloride,DB01036,Tolterodine,0.9999990463256836,59,Type_59,Potassium chloride may increase the ulcerogenic activities of Tolterodine.,59,Type_59,Yes
DB00312,Pentobarbital,DB01198,Zopiclone,0.9411377310752869,4,Type_4,The metabolism of Zopiclone can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00997,Doxorubicin,DB08899,Enzalutamide,0.6779438257217407,73,Type_73,The serum concentration of Enzalutamide can be increased when it is combined with Doxorubicin.,73,Type_73,Yes
DB00988,Dopamine,DB04846,Celiprolol,0.6759750843048096,49,Type_49,The risk or severity of adverse effects can be increased when Dopamine is combined with Celiprolol.,49,Type_49,Yes
DB00420,Promazine,DB09128,Brexpiprazole,0.6612494587898254,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Brexpiprazole.,73,Type_73,No
DB01044,Gatifloxacin,DB03754,Tromethamine,0.9635629057884216,67,Type_67,Gatifloxacin can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00201,Caffeine,DB06717,Fosaprepitant,0.817441999912262,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Caffeine.,73,Type_73,Yes
DB00486,Nabilone,DB01017,Minocycline,0.9999977350234985,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00880,Chlorothiazide,DB01238,Aripiprazole,0.9377126097679138,60,Type_60,Chlorothiazide may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00540,Nortriptyline,DB09330,Osimertinib,0.8952842950820923,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Nortriptyline.,73,Type_73,Yes
DB01074,Perhexiline,DB01095,Fluvastatin,0.46300050616264343,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Perhexiline.,49,Type_49,No
DB00213,Pantoprazole,DB08820,Ivacaftor,0.9978073239326477,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Pantoprazole.,73,Type_73,Yes
DB00289,Atomoxetine,DB01229,Paclitaxel,0.8482614159584045,47,Type_47,The metabolism of Paclitaxel can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00526,Oxaliplatin,DB08880,Teriflunomide,0.3631505072116852,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Oxaliplatin.,75,Type_75,Yes
DB00409,Remoxipride,DB00434,Cyproheptadine,0.9866064786911011,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Cyproheptadine.,49,Type_49,Yes
DB00754,Ethotoin,DB06216,Asenapine,0.9914736747741699,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Asenapine.,49,Type_49,Yes
DB01400,Neostigmine,DB08906,Fluticasone furoate,0.995644211769104,49,Type_49,The risk or severity of adverse effects can be increased when Neostigmine is combined with Fluticasone furoate.,49,Type_49,Yes
DB00180,Flunisolide,DB00254,Doxycycline,0.7733332514762878,47,Type_47,The metabolism of Doxycycline can be decreased when combined with Flunisolide.,47,Type_47,Yes
DB00221,Isoetharine,DB01247,Isocarboxazid,0.9864066243171692,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Isocarboxazid.,49,Type_49,Yes
DB00528,Lercanidipine,DB01162,Terazosin,0.9780514240264893,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Terazosin.,60,Type_60,No
DB00248,Cabergoline,DB02709,Resveratrol,0.9965717792510986,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Resveratrol.,49,Type_49,Yes
DB01059,Norfloxacin,DB01267,Paliperidone,0.955657958984375,20,Type_20,Norfloxacin may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00394,Beclomethasone dipropionate,DB06718,Stanozolol,1.0,74,Type_74,Beclomethasone dipropionate may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB01143,Amifostine,DB08907,Canagliflozin,0.9920172691345215,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Canagliflozin.,49,Type_49,Yes
DB01246,Alimemazine,DB09068,Vortioxetine,0.7930498719215393,49,Type_49,The risk or severity of adverse effects can be increased when Alimemazine is combined with Vortioxetine.,49,Type_49,Yes
DB00471,Montelukast,DB05521,Telaprevir,0.947696328163147,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Montelukast.,47,Type_47,Yes
DB00673,Aprepitant,DB09078,Lenvatinib,0.9758244156837463,73,Type_73,The serum concentration of Lenvatinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01202,Levetiracetam,DB01580,Oxprenolol,0.9853379726409912,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Oxprenolol.,49,Type_49,Yes
DB01207,Ridogrel,DB08994,Ditazole,0.9970706701278687,6,Type_6,Ridogrel may increase the anticoagulant activities of Ditazole.,6,Type_6,Yes
DB00682,Warfarin,DB06725,Lornoxicam,0.9996294975280762,6,Type_6,Warfarin may increase the anticoagulant activities of Lornoxicam.,6,Type_6,Yes
DB00379,Mexiletine,DB06636,Isavuconazonium,0.9598929286003113,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01149,Nefazodone,DB06153,Pizotifen,0.9843012690544128,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Pizotifen.,49,Type_49,Yes
DB01370,Aluminium,DB01410,Ciclesonide,0.9959490299224854,3,Type_3,The bioavailability of Ciclesonide can be decreased when combined with Aluminium.,3,Type_3,Yes
DB01006,Letrozole,DB06717,Fosaprepitant,0.8892897367477417,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Letrozole.,73,Type_73,Yes
DB00674,Galantamine,DB12332,Rucaparib,0.9293830990791321,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Galantamine.,47,Type_47,Yes
DB00476,Duloxetine,DB01171,Moclobemide,0.6492632031440735,64,Type_64,Duloxetine may increase the serotonergic activities of Moclobemide.,49,Type_49,No
DB01167,Itraconazole,DB01392,Yohimbine,0.9719271659851074,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00362,Anidulafungin,DB09232,Cilnidipine,0.9997194409370422,49,Type_49,The risk or severity of adverse effects can be increased when Anidulafungin is combined with Cilnidipine.,49,Type_49,Yes
DB00734,Risperidone,DB01588,Prazepam,0.9913203120231628,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Prazepam.,49,Type_49,Yes
DB00660,Metaxalone,DB06700,Desvenlafaxine,0.994803249835968,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Desvenlafaxine.,49,Type_49,Yes
DB00980,Ramelteon,DB01595,Nitrazepam,0.98886638879776,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Nitrazepam.,49,Type_49,Yes
DB05521,Telaprevir,DB06777,Chenodeoxycholic acid,0.8420516848564148,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Telaprevir.,47,Type_47,Yes
DB09212,Loxoprofen,DB13783,Acemetacin,0.943483829498291,49,Type_49,The risk or severity of adverse effects can be increased when Loxoprofen is combined with Acemetacin.,49,Type_49,Yes
DB00323,Tolcapone,DB01626,Pargyline,0.9788203835487366,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Pargyline.,49,Type_49,Yes
DB00261,Anagrelide,DB00775,Tirofiban,0.7933948040008545,6,Type_6,Anagrelide may increase the anticoagulant activities of Tirofiban.,6,Type_6,Yes
DB00625,Efavirenz,DB09072,Sodium oxybate,1.0,16,Type_16,Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00976,Telithromycin,DB01039,Fenofibrate,0.8216416835784912,47,Type_47,The metabolism of Fenofibrate can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00280,Disopyramide,DB11730,Ribociclib,0.9938485026359558,33,Type_33,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Ribociclib.,33,Type_33,Yes
DB01168,Procarbazine,DB13025,Tiapride,0.9527471661567688,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Tiapride.,49,Type_49,Yes
DB04743,Nimesulide,DB06810,Plicamycin,0.9984272718429565,72,Type_72,Nimesulide may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00268,Ropinirole,DB01162,Terazosin,0.9367878437042236,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Terazosin.,49,Type_49,Yes
DB00599,Thiopental,DB00660,Metaxalone,0.999984860420227,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Metaxalone.,49,Type_49,Yes
DB01174,Phenobarbital,DB06144,Sertindole,0.8491409420967102,4,Type_4,The metabolism of Sertindole can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB06718,Stanozolol,DB11921,Deflazacort,0.9999998807907104,74,Type_74,Stanozolol may increase the fluid retaining activities of Deflazacort.,74,Type_74,Yes
DB00801,Halazepam,DB09118,Stiripentol,0.9588204622268677,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Stiripentol.,49,Type_49,Yes
DB00599,Thiopental,DB01074,Perhexiline,0.9114606380462646,4,Type_4,The metabolism of Perhexiline can be increased when combined with Thiopental.,4,Type_4,Yes
DB00244,Mesalazine,DB00452,Framycetin,0.9993768334388733,72,Type_72,Mesalazine may decrease the excretion rate of Framycetin which could result in a higher serum level.,72,Type_72,Yes
DB00240,Alclometasone,DB01174,Phenobarbital,0.7084154486656189,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Alclometasone.,4,Type_4,Yes
DB00512,Vancomycin,DB08439,Parecoxib,0.8911473751068115,73,Type_73,The serum concentration of Parecoxib can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00206,Reserpine,DB08822,Azilsartan medoxomil,0.9835034608840942,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB01544,Flunitrazepam,DB06413,Armodafinil,0.9635999798774719,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Flunitrazepam.,47,Type_47,Yes
DB00819,Acetazolamide,DB01081,Diphenoxylate,0.9710246324539185,49,Type_49,The risk or severity of adverse effects can be increased when Acetazolamide is combined with Diphenoxylate.,49,Type_49,Yes
DB00731,Nateglinide,DB01319,Fosamprenavir,0.848150908946991,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00310,Chlorthalidone,DB08882,Linagliptin,0.9419870972633362,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB01023,Felodipine,DB08899,Enzalutamide,0.9047241806983948,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Felodipine.,75,Type_75,Yes
DB09449,"Sodium phosphate, monobasic",DB13231,Calcium lactate,0.6791783571243286,67,Type_67,"Sodium phosphate, monobasic can cause a decrease in the absorption of Calcium lactate resulting in a reduced serum concentration and potentially a decrease in efficacy.",67,Type_67,Yes
DB01035,Procainamide,DB06663,Pasireotide,0.9958292841911316,20,Type_20,Procainamide may increase the QTc-prolonging activities of Pasireotide.,20,Type_20,Yes
DB01623,Thiothixene,DB08987,Etidocaine,0.9998973608016968,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Etidocaine.,49,Type_49,Yes
DB00889,Granisetron,DB01075,Diphenhydramine,0.7254958152770996,20,Type_20,Granisetron may increase the QTc-prolonging activities of Diphenhydramine.,20,Type_20,Yes
DB01394,Colchicine,DB11730,Ribociclib,0.9817860722541809,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Colchicine.,73,Type_73,Yes
DB00543,Amoxapine,DB00575,Clonidine,0.7656977772712708,37,Type_37,Amoxapine may decrease the antihypertensive activities of Clonidine.,37,Type_37,Yes
DB00396,Progesterone,DB01067,Glipizide,0.7836425304412842,70,Type_70,The therapeutic efficacy of Glipizide can be decreased when used in combination with Progesterone.,70,Type_70,Yes
DB04868,Nilotinib,DB08815,Lurasidone,0.8325971961021423,20,Type_20,Nilotinib may increase the QTc-prolonging activities of Lurasidone.,73,Type_73,No
DB00624,Testosterone,DB09120,Zucapsaicin,0.997092604637146,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00203,Sildenafil,DB00588,Fluticasone propionate,0.9459366798400879,47,Type_47,The metabolism of Fluticasone propionate can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00214,Torasemide,DB01384,Paramethasone,0.9995571970939636,83,Type_83,Torasemide may increase the hypokalemic activities of Paramethasone.,83,Type_83,Yes
DB00809,Tropicamide,DB01409,Tiotropium,0.9907132387161255,2,Type_2,Tropicamide may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB00451,Levothyroxine,DB08918,Levomilnacipran,0.4389066994190216,70,Type_70,The therapeutic efficacy of Levomilnacipran can be decreased when used in combination with Levothyroxine.,70,Type_70,Yes
DB00844,Nalbuphine,DB01437,Glutethimide,0.9956914782524109,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Glutethimide.,49,Type_49,Yes
DB00598,Labetalol,DB08957,Hexoprenaline,0.998927652835846,5,Type_5,Labetalol may decrease the vasoconstricting activities of Hexoprenaline.,5,Type_5,Yes
DB00320,Dihydroergotamine,DB01407,Clenbuterol,0.7924395799636841,71,Type_71,Dihydroergotamine may increase the hypertensive activities of Clenbuterol.,71,Type_71,Yes
DB04920,Clevidipine,DB09270,Ubidecarenone,0.6418455243110657,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Clevidipine.,49,Type_49,No
DB00212,Remikiren,DB09026,Aliskiren,0.9700722694396973,60,Type_60,Remikiren may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB00175,Pravastatin,DB00448,Lansoprazole,0.4093947112560272,73,Type_73,The serum concentration of Lansoprazole can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00203,Sildenafil,DB00622,Nicardipine,0.7846483588218689,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00512,Vancomycin,DB06263,Amrubicin,0.9997962117195129,57,Type_57,Vancomycin may increase the nephrotoxic activities of Amrubicin.,57,Type_57,Yes
DB00224,Indinavir,DB01357,Mestranol,0.3807452321052551,47,Type_47,The metabolism of Mestranol can be decreased when combined with Indinavir.,75,Type_75,No
DB00458,Imipramine,DB09042,Tedizolid phosphate,0.7744569778442383,64,Type_64,Imipramine may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB04855,Dronedarone,DB09291,Rolapitant,0.9127486348152161,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00845,Clofazimine,DB01263,Posaconazole,0.7214776277542114,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Clofazimine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB01136,Carvedilol,0.9667515754699707,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carvedilol.,49,Type_49,Yes
DB00227,Lovastatin,DB06212,Tolvaptan,0.9447871446609497,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB01159,Halothane,DB09063,Ceritinib,0.9546548128128052,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Halothane.,73,Type_73,Yes
DB00499,Flutamide,DB00976,Telithromycin,0.8962383270263672,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Flutamide.,47,Type_47,Yes
DB00850,Perphenazine,DB01233,Metoclopramide,0.9034420251846313,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Metoclopramide.,49,Type_49,Yes
DB00831,Trifluoperazine,DB00918,Almotriptan,0.875160813331604,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Almotriptan.,49,Type_49,Yes
DB01075,Diphenhydramine,DB13323,Trichloroethylene,0.9998024106025696,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Trichloroethylene.,49,Type_49,Yes
DB00717,Norethisterone,DB08820,Ivacaftor,0.99830162525177,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Norethisterone.,73,Type_73,Yes
DB00246,Ziprasidone,DB06770,Benzyl alcohol,0.7125687003135681,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01297,Practolol,DB09212,Loxoprofen,0.9985106587409973,37,Type_37,Practolol may decrease the antihypertensive activities of Loxoprofen.,37,Type_37,Yes
DB00230,Pregabalin,DB00391,Sulpiride,0.8995664119720459,8,Type_8,The therapeutic efficacy of Sulpiride can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB01018,Guanfacine,DB01176,Cyclizine,0.9983038902282715,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Cyclizine.,49,Type_49,Yes
DB00929,Misoprostol,DB01283,Lumiracoxib,0.7436419129371643,70,Type_70,The therapeutic efficacy of Lumiracoxib can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB00999,Hydrochlorothiazide,DB01339,Vecuronium,0.9892228841781616,73,Type_73,The serum concentration of Vecuronium can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB00912,Repaglinide,DB08881,Vemurafenib,0.7669098377227783,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Repaglinide.,75,Type_75,No
DB00611,Butorphanol,DB09085,Tetracaine,0.9997581839561462,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Tetracaine.,49,Type_49,Yes
DB00477,Chlorpromazine,DB01171,Moclobemide,0.7682616710662842,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00645,Dyclonine,DB00771,Clidinium,0.999998927116394,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Clidinium.,49,Type_49,Yes
DB00344,Protriptyline,DB11609,Normethadone,0.9537440538406372,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Normethadone.,49,Type_49,Yes
DB00818,Propofol,DB01186,Pergolide,0.6397716999053955,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Pergolide.,49,Type_49,Yes
DB00818,Propofol,DB01320,Fosphenytoin,0.7843523025512695,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Propofol.,4,Type_4,Yes
DB01118,Amiodarone,DB05351,Dexlansoprazole,0.936559796333313,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00747,Scopolamine,DB00794,Primidone,0.6660401821136475,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Primidone.,49,Type_49,Yes
DB01159,Halothane,DB01254,Dasatinib,0.7263621687889099,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Halothane.,73,Type_73,Yes
DB00195,Betaxolol,DB00270,Isradipine,0.8914524912834167,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Isradipine.,49,Type_49,Yes
DB00628,Clorazepic acid,DB00850,Perphenazine,0.9959008097648621,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Perphenazine.,49,Type_49,Yes
DB00370,Mirtazapine,DB01168,Procarbazine,0.9260254502296448,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Procarbazine.,49,Type_49,Yes
DB00288,Amcinonide,DB03754,Tromethamine,0.9978905320167542,3,Type_3,The bioavailability of Tromethamine can be decreased when combined with Amcinonide.,3,Type_3,Yes
DB00366,Doxylamine,DB01171,Moclobemide,0.9424855709075928,2,Type_2,Doxylamine may increase the anticholinergic activities of Moclobemide.,2,Type_2,Yes
DB00346,Alfuzosin,DB00673,Aprepitant,0.9765710830688477,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Alfuzosin.,73,Type_73,Yes
DB01242,Clomipramine,DB09204,Arotinolol,0.5698564052581787,73,Type_73,The serum concentration of Arotinolol can be increased when it is combined with Clomipramine.,49,Type_49,No
DB00648,Mitotane,DB00921,Buprenorphine,0.8177463412284851,75,Type_75,The serum concentration of Buprenorphine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00195,Betaxolol,DB00836,Loperamide,0.807619571685791,47,Type_47,The metabolism of Loperamide can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00673,Aprepitant,DB01074,Perhexiline,0.9171819686889648,73,Type_73,The serum concentration of Perhexiline can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01248,Docetaxel,DB09124,Medrogestone,0.999808132648468,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Medrogestone.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01321,Josamycin,0.853201150894165,47,Type_47,The metabolism of Josamycin can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB00208,Ticlopidine,DB06441,Cangrelor,0.6291697025299072,26,Type_26,Ticlopidine may decrease the antiplatelet activities of Cangrelor.,6,Type_6,No
DB00571,Propranolol,DB09039,Eliglustat,0.8434842824935913,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Propranolol.,47,Type_47,Yes
DB00645,Dyclonine,DB00794,Primidone,0.9371293187141418,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Primidone.,49,Type_49,Yes
DB00765,Metyrosine,DB00985,Dimenhydrinate,0.9999901056289673,32,Type_32,Metyrosine may increase the sedative activities of Dimenhydrinate.,32,Type_32,Yes
DB00531,Cyclophosphamide,DB01015,Sulfamethoxazole,0.7323788404464722,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sulfamethoxazole.,47,Type_47,No
DB04835,Maraviroc,DB06717,Fosaprepitant,0.9651309847831726,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Maraviroc.,73,Type_73,Yes
DB00300,Tenofovir disoproxil,DB06263,Amrubicin,0.5336029529571533,57,Type_57,Tenofovir disoproxil may increase the nephrotoxic activities of Amrubicin.,73,Type_73,No
DB00250,Dapsone,DB00359,Sulfadiazine,0.9767757654190063,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Dapsone.,49,Type_49,No
DB00849,Methylphenobarbital,DB09099,Somatostatin,0.7907119989395142,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Somatostatin.,49,Type_49,Yes
DB00575,Clonidine,DB00608,Chloroquine,0.6513572335243225,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Clonidine.,47,Type_47,Yes
DB08865,Crizotinib,DB09054,Idelalisib,0.7684672474861145,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Crizotinib.,73,Type_73,No
DB01151,Desipramine,DB01501,Difenoxin,0.9994997978210449,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Difenoxin.,49,Type_49,Yes
DB00559,Bosentan,DB09128,Brexpiprazole,0.9108178615570068,75,Type_75,The serum concentration of Brexpiprazole can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB09097,Quinagolide,DB09286,Pipamperone,0.9589866399765015,70,Type_70,The therapeutic efficacy of Pipamperone can be decreased when used in combination with Quinagolide.,70,Type_70,Yes
DB00264,Metoprolol,DB09112,Nitrous acid,0.9966208934783936,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Nitrous acid.,49,Type_49,Yes
DB00421,Spironolactone,DB01041,Thalidomide,0.9979192614555359,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Thalidomide.,49,Type_49,Yes
DB00958,Carboplatin,DB01092,Ouabain,0.9445040225982666,58,Type_58,Carboplatin may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00409,Remoxipride,DB01142,Doxepin,0.983944833278656,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Doxepin.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB01551,Dihydrocodeine,0.9845811724662781,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Dihydrocodeine.,49,Type_49,Yes
DB00281,Lidocaine,DB00934,Maprotiline,0.7032049894332886,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Maprotiline.,47,Type_47,No
DB00320,Dihydroergotamine,DB01008,Busulfan,0.8840389251708984,47,Type_47,The metabolism of Busulfan can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00846,Flurandrenolide,DB13167,Alclofenac,0.9996563196182251,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Alclofenac.,49,Type_49,Yes
DB00211,Midodrine,DB01247,Isocarboxazid,0.9209933280944824,71,Type_71,Midodrine may increase the hypertensive activities of Isocarboxazid.,71,Type_71,Yes
DB00296,Ropivacaine,DB01403,Methotrimeprazine,0.9870570302009583,16,Type_16,Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB01224,Quetiapine,DB09120,Zucapsaicin,0.9914126396179199,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Quetiapine.,47,Type_47,Yes
DB01103,Quinacrine,DB02703,Fusidic acid,0.9995641112327576,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Quinacrine.,73,Type_73,Yes
DB00178,Ramipril,DB00744,Zileuton,0.9755305647850037,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Zileuton.,49,Type_49,Yes
DB00720,Clodronic acid,DB00798,Gentamicin,0.9997668862342834,24,Type_24,Clodronic acid may increase the hypocalcemic activities of Gentamicin.,24,Type_24,Yes
DB00742,Mannitol,DB13783,Acemetacin,0.8274381756782532,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Mannitol.,70,Type_70,Yes
DB00582,Voriconazole,DB06287,Temsirolimus,0.7545484900474548,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB01235,Levodopa,DB09242,Moxonidine,0.8235134482383728,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Moxonidine.,30,Type_30,No
DB00512,Vancomycin,DB00963,Bromfenac,0.9527857899665833,73,Type_73,The serum concentration of Bromfenac can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB01424,Aminophenazone,DB06603,Panobinostat,0.865489661693573,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Aminophenazone.,73,Type_73,Yes
DB00700,Eplerenone,DB01242,Clomipramine,0.41841182112693787,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Clomipramine.,49,Type_49,Yes
DB00806,Pentoxifylline,DB00925,Phenoxybenzamine,0.9785798788070679,60,Type_60,Pentoxifylline may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB00373,Timolol,DB01023,Felodipine,0.5006288886070251,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Felodipine.,49,Type_49,Yes
DB00903,Etacrynic acid,DB05676,Apremilast,0.9999712705612183,29,Type_29,Etacrynic acid may decrease the diuretic activities of Apremilast.,29,Type_29,Yes
DB00404,Alprazolam,DB01618,Molindone,0.9999215602874756,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Molindone.,49,Type_49,Yes
DB00490,Buspirone,DB01392,Yohimbine,0.9026296734809875,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Buspirone.,70,Type_70,No
DB00253,Medrysone,DB01320,Fosphenytoin,0.9599401354789734,75,Type_75,The serum concentration of Fosphenytoin can be decreased when it is combined with Medrysone.,75,Type_75,Yes
DB00696,Ergotamine,DB09000,Cyamemazine,0.9309470057487488,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Cyamemazine.,49,Type_49,Yes
DB00747,Scopolamine,DB00768,Olopatadine,0.8563451170921326,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Olopatadine.,49,Type_49,Yes
DB00831,Trifluoperazine,DB06595,Midostaurin,0.685545802116394,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Trifluoperazine.,47,Type_47,Yes
DB00292,Etomidate,DB00962,Zaleplon,0.9951451420783997,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Zaleplon.,49,Type_49,Yes
DB00307,Bexarotene,DB01685,Topiroxostat,0.989176332950592,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00487,Pefloxacin,DB00972,Azelastine,0.8403621912002563,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Azelastine.,27,Type_27,Yes
DB00285,Venlafaxine,DB01264,Darunavir,0.7638682723045349,47,Type_47,The metabolism of Darunavir can be decreased when combined with Venlafaxine.,73,Type_73,No
DB08918,Levomilnacipran,DB08922,Perospirone,0.988585889339447,49,Type_49,The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Perospirone.,49,Type_49,Yes
DB04574,Estrone sulfate,DB08804,Nandrolone decanoate,0.9998441934585571,74,Type_74,Estrone sulfate may increase the fluid retaining activities of Nandrolone decanoate.,74,Type_74,Yes
DB00722,Lisinopril,DB00806,Pentoxifylline,0.8844673037528992,60,Type_60,Lisinopril may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00956,Hydrocodone,DB06702,Fesoterodine,0.9294672012329102,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Fesoterodine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00575,Clonidine,0.8934349417686462,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Clonidine.,49,Type_49,Yes
DB00213,Pantoprazole,DB01181,Ifosfamide,0.9831033945083618,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00176,Fluvoxamine,DB00318,Codeine,0.6420162320137024,47,Type_47,The metabolism of Codeine can be decreased when combined with Fluvoxamine.,70,Type_70,No
DB00312,Pentobarbital,DB00604,Cisapride,0.9640316367149353,4,Type_4,The metabolism of Cisapride can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00203,Sildenafil,DB04835,Maraviroc,0.7486777901649475,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00343,Diltiazem,DB02703,Fusidic acid,0.9972912669181824,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB01623,Thiothixene,DB09068,Vortioxetine,0.9931250810623169,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Vortioxetine.,49,Type_49,Yes
DB01100,Pimozide,DB01173,Orphenadrine,0.999860405921936,16,Type_16,Pimozide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB01356,Lithium cation,DB09118,Stiripentol,0.6716307997703552,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Lithium cation.,49,Type_49,No
DB00604,Cisapride,DB01127,Econazole,0.7048542499542236,73,Type_73,The serum concentration of Econazole can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00186,Lorazepam,DB13025,Tiapride,0.994599461555481,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Tiapride.,49,Type_49,Yes
DB00636,Clofibrate,DB08820,Ivacaftor,0.9776899218559265,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Clofibrate.,73,Type_73,Yes
DB05219,Crisaborole,DB06589,Pazopanib,0.7160565853118896,47,Type_47,The metabolism of Pazopanib can be decreased when combined with Crisaborole.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB00966,Telmisartan,0.8918682932853699,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Telmisartan.,60,Type_60,No
DB00732,Atracurium besylate,DB01092,Ouabain,0.9175963401794434,82,Type_82,Atracurium besylate may increase the arrhythmogenic activities of Ouabain.,82,Type_82,Yes
DB00625,Efavirenz,DB08922,Perospirone,0.7656524181365967,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Perospirone.,49,Type_49,Yes
DB08893,Mirabegron,DB09053,Ibrutinib,0.7729737758636475,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Mirabegron.,47,Type_47,No
DB00485,Dicloxacillin,DB00498,Phenindione,0.9647577404975891,12,Type_12,Dicloxacillin may decrease the anticoagulant activities of Phenindione.,12,Type_12,Yes
DB00246,Ziprasidone,DB00529,Foscarnet,0.9526634812355042,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Foscarnet.,20,Type_20,Yes
DB00972,Azelastine,DB01250,Olsalazine,0.7226650714874268,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Olsalazine.,57,Type_57,No
DB01614,Acepromazine,DB09104,Magnesium hydroxide,0.9828431010246277,67,Type_67,Acepromazine can cause a decrease in the absorption of Magnesium hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00199,Erythromycin,DB00270,Isradipine,0.5358715057373047,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Isradipine.,47,Type_47,No
DB00241,Butalbital,DB00476,Duloxetine,0.9932557344436646,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Duloxetine.,49,Type_49,Yes
DB00726,Trimipramine,DB09117,Paraldehyde,0.9537362456321716,16,Type_16,Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00203,Sildenafil,DB01118,Amiodarone,0.8502922058105469,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Sildenafil.,73,Type_73,No
DB00678,Losartan,DB06802,Nepafenac,0.962231457233429,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Nepafenac.,49,Type_49,Yes
DB00780,Phenelzine,DB00887,Bumetanide,0.9915524125099182,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Bumetanide.,49,Type_49,Yes
DB00450,Droperidol,DB06699,Degarelix,0.999932050704956,20,Type_20,Droperidol may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00598,Labetalol,DB12598,Nafamostat,0.8910439014434814,37,Type_37,Labetalol may decrease the antihypertensive activities of Nafamostat.,37,Type_37,Yes
DB00726,Trimipramine,DB09071,Tasimelteon,0.9966576099395752,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Tasimelteon.,49,Type_49,Yes
DB09288,Propacetamol,DB09295,Talniflumate,0.9998264908790588,49,Type_49,The risk or severity of adverse effects can be increased when Propacetamol is combined with Talniflumate.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB01047,Fluocinonide,0.9954981803894043,73,Type_73,The serum concentration of Fluocinonide can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00593,Ethosuximide,DB12532,Oxetacaine,0.9719973206520081,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Oxetacaine.,49,Type_49,Yes
DB00294,Etonogestrel,DB01320,Fosphenytoin,0.7025914192199707,70,Type_70,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00568,Cinnarizine,DB00997,Doxorubicin,0.49698272347450256,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Cinnarizine.,47,Type_47,No
DB01236,Sevoflurane,DB09235,Efonidipine,0.9730805158615112,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Efonidipine.,49,Type_49,Yes
DB00611,Butorphanol,DB00844,Nalbuphine,0.9966121315956116,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Nalbuphine.,49,Type_49,Yes
DB01060,Amoxicillin,DB06810,Plicamycin,0.9968210458755493,75,Type_75,The serum concentration of Plicamycin can be decreased when it is combined with Amoxicillin.,75,Type_75,Yes
DB01244,Bepridil,DB09038,Empagliflozin,0.9561891555786133,49,Type_49,The risk or severity of adverse effects can be increased when Bepridil is combined with Empagliflozin.,49,Type_49,Yes
DB00316,Acetaminophen,DB06414,Etravirine,0.8855071067810059,47,Type_47,The metabolism of Etravirine can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB01254,Dasatinib,DB06144,Sertindole,0.9428907632827759,73,Type_73,The serum concentration of Sertindole can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB04835,Maraviroc,DB09063,Ceritinib,0.9992536902427673,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Maraviroc.,73,Type_73,Yes
DB00321,Amitriptyline,DB01545,Ethyl loflazepate,0.9995496869087219,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00268,Ropinirole,DB01144,Diclofenamide,0.9917814135551453,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Diclofenamide.,49,Type_49,Yes
DB00474,Methohexital,DB01463,Fencamfamin,0.9958798885345459,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Fencamfamin.,49,Type_49,Yes
DB00321,Amitriptyline,DB00683,Midazolam,0.9032897353172302,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Midazolam.,49,Type_49,Yes
DB01609,Deferasirox,DB04552,Niflumic acid,0.44659456610679626,49,Type_49,The risk or severity of adverse effects can be increased when Deferasirox is combined with Niflumic acid.,49,Type_49,Yes
DB00875,Flupentixol,DB01320,Fosphenytoin,0.33660057187080383,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Fosphenytoin.,49,Type_49,Yes
DB01149,Nefazodone,DB09225,Zotepine,0.8082498908042908,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Zotepine.,49,Type_49,Yes
DB00378,Dydrogesterone,DB11268,Protocatechualdehyde,0.9999958276748657,70,Type_70,The therapeutic efficacy of Protocatechualdehyde can be decreased when used in combination with Dydrogesterone.,70,Type_70,Yes
DB01020,Isosorbide mononitrate,DB01088,Iloprost,0.9573703408241272,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Iloprost.,49,Type_49,Yes
DB01260,Desonide,DB01435,Antipyrine,0.9993357062339783,49,Type_49,The risk or severity of adverse effects can be increased when Desonide is combined with Antipyrine.,49,Type_49,Yes
DB00972,Azelastine,DB08971,Fluocortolone,0.9963202476501465,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Fluocortolone.,49,Type_49,Yes
DB00794,Primidone,DB13323,Trichloroethylene,0.9986360669136047,49,Type_49,The risk or severity of adverse effects can be increased when Primidone is combined with Trichloroethylene.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB01623,Thiothixene,0.7145192623138428,33,Type_33,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Thiothixene.,20,Type_20,No
DB01137,Levofloxacin,DB01229,Paclitaxel,0.7711350321769714,49,Type_49,The risk or severity of adverse effects can be increased when Levofloxacin is combined with Paclitaxel.,49,Type_49,Yes
DB00270,Isradipine,DB09570,Ixazomib,0.9006295800209045,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00335,Atenolol,DB00869,Dorzolamide,0.9445513486862183,60,Type_60,Atenolol may increase the hypotensive activities of Dorzolamide.,60,Type_60,Yes
DB00544,Fluorouracil,DB08868,Fingolimod,0.8004308938980103,34,Type_34,Fluorouracil may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB01154,Thiamylal,DB01614,Acepromazine,0.9879817366600037,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Acepromazine.,49,Type_49,Yes
DB00714,Apomorphine,DB09220,Nicorandil,0.9999315738677979,60,Type_60,Apomorphine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00701,Amprenavir,DB06480,Prucalopride,0.9265913963317871,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Amprenavir.,73,Type_73,Yes
DB01160,Dinoprost tromethamine,DB13167,Alclofenac,0.8274580836296082,70,Type_70,The therapeutic efficacy of Alclofenac can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB00433,Prochlorperazine,DB01221,Ketamine,0.987270712852478,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ketamine.,49,Type_49,Yes
DB01544,Flunitrazepam,DB01623,Thiothixene,0.9855672121047974,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Thiothixene.,49,Type_49,Yes
DB00519,Trandolapril,DB01023,Felodipine,0.5709521770477295,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Felodipine.,49,Type_49,Yes
DB00821,Carprofen,DB00997,Doxorubicin,0.9979547262191772,72,Type_72,Carprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,72,Type_72,Yes
DB00238,Nevirapine,DB09073,Palbociclib,0.9215278625488281,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Nevirapine.,73,Type_73,Yes
DB00524,Metolazone,DB01070,Dihydrotachysterol,0.9799931645393372,51,Type_51,Metolazone may increase the hypercalcemic activities of Dihydrotachysterol.,51,Type_51,Yes
DB01090,Pentolinium,DB01580,Oxprenolol,0.7541828155517578,10,Type_10,Pentolinium may increase the antihypertensive activities of Oxprenolol.,60,Type_60,No
DB00289,Atomoxetine,DB00308,Ibutilide,0.9088869094848633,20,Type_20,Atomoxetine may increase the QTc-prolonging activities of Ibutilide.,20,Type_20,Yes
DB00492,Fosinopril,DB00612,Bisoprolol,0.8133491277694702,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Bisoprolol.,49,Type_49,Yes
DB00371,Meprobamate,DB08872,Gabapentin enacarbil,0.9971170425415039,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB01111,Colistimethate,DB01338,Pipecuronium,0.9994673132896423,21,Type_21,Colistimethate may increase the neuromuscular blocking activities of Pipecuronium.,21,Type_21,Yes
DB00794,Primidone,DB11148,Butamben,0.9924610257148743,49,Type_49,The risk or severity of adverse effects can be increased when Primidone is combined with Butamben.,49,Type_49,Yes
DB00449,Dipivefrin,DB00780,Phenelzine,0.8219855427742004,49,Type_49,The risk or severity of adverse effects can be increased when Dipivefrin is combined with Phenelzine.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00617,Paramethadione,0.9458485841751099,47,Type_47,The metabolism of Paramethadione can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB05812,Abiraterone,DB06594,Agomelatine,0.8986105918884277,73,Type_73,The serum concentration of Agomelatine can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00554,Piroxicam,DB11268,Protocatechualdehyde,0.9940987825393677,6,Type_6,Piroxicam may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB01209,Dezocine,DB09009,Articaine,0.9988466501235962,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Articaine.,49,Type_49,Yes
DB01621,Pipotiazine,DB09085,Tetracaine,0.9999953508377075,49,Type_49,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Tetracaine.,49,Type_49,Yes
DB00691,Moexipril,DB01359,Penbutolol,0.5122716426849365,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Penbutolol.,49,Type_49,Yes
DB00991,Oxaprozin,DB05219,Crisaborole,0.9998354911804199,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Oxaprozin.,47,Type_47,Yes
DB00321,Amitriptyline,DB06697,Artemether,0.4504290223121643,47,Type_47,The metabolism of Artemether can be decreased when combined with Amitriptyline.,20,Type_20,No
DB00498,Phenindione,DB01196,Estramustine,0.6902869939804077,12,Type_12,Phenindione may decrease the anticoagulant activities of Estramustine.,12,Type_12,Yes
DB00246,Ziprasidone,DB00961,Mepivacaine,0.9950783252716064,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Mepivacaine.,49,Type_49,Yes
DB00489,Sotalol,DB01072,Atazanavir,0.4540463387966156,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Sotalol.,20,Type_20,No
DB00906,Tiagabine,DB06636,Isavuconazonium,0.8481147289276123,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Tiagabine.,47,Type_47,Yes
DB00310,Chlorthalidone,DB08918,Levomilnacipran,0.9933233857154846,55,Type_55,Chlorthalidone may increase the hyponatremic activities of Levomilnacipran.,55,Type_55,Yes
DB06603,Panobinostat,DB12332,Rucaparib,0.6946969032287598,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Panobinostat.,73,Type_73,Yes
DB00253,Medrysone,DB09070,Tibolone,0.948470413684845,73,Type_73,The serum concentration of Tibolone can be increased when it is combined with Medrysone.,73,Type_73,Yes
DB00091,Cyclosporine,DB01274,Arformoterol,0.7790650129318237,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00186,Lorazepam,DB00726,Trimipramine,0.9955319166183472,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Trimipramine.,49,Type_49,Yes
DB00390,Digoxin,DB01006,Letrozole,0.8813409209251404,58,Type_58,Digoxin may decrease the cardiotoxic activities of Letrozole.,58,Type_58,Yes
DB00288,Amcinonide,DB01021,Trichlormethiazide,0.9999403953552246,83,Type_83,Amcinonide may increase the hypokalemic activities of Trichlormethiazide.,83,Type_83,Yes
DB01607,Ticarcillin,DB06263,Amrubicin,0.9985622763633728,75,Type_75,The serum concentration of Amrubicin can be decreased when it is combined with Ticarcillin.,75,Type_75,Yes
DB00865,Benzphetamine,DB09280,Lumacaftor,0.8047024607658386,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Benzphetamine.,75,Type_75,Yes
DB00285,Venlafaxine,DB00857,Terbinafine,0.9392065405845642,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01175,Escitalopram,DB01545,Ethyl loflazepate,0.9442325234413147,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00652,Pentazocine,DB01198,Zopiclone,0.997641921043396,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Zopiclone.,49,Type_49,Yes
DB00762,Irinotecan,DB09280,Lumacaftor,0.5104542374610901,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Irinotecan.,75,Type_75,Yes
DB00295,Morphine,DB00906,Tiagabine,0.968761682510376,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Tiagabine.,49,Type_49,Yes
DB02638,Terlipressin,DB09026,Aliskiren,0.9986817240715027,60,Type_60,Terlipressin may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB00706,Tamsulosin,DB01012,Cinacalcet,0.5263782739639282,73,Type_73,The serum concentration of Cinacalcet can be increased when it is combined with Tamsulosin.,73,Type_73,Yes
DB00991,Oxaprozin,DB09212,Loxoprofen,0.9964409470558167,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Loxoprofen.,49,Type_49,Yes
DB00222,Glimepiride,DB00614,Furazolidone,0.9981843829154968,9,Type_9,Glimepiride may increase the hypoglycemic activities of Furazolidone.,9,Type_9,Yes
DB00904,Ondansetron,DB04871,Lorcaserin,0.7263872027397156,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Ondansetron.,64,Type_64,No
DB00434,Cyproheptadine,DB00737,Meclizine,0.9992877840995789,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Meclizine.,49,Type_49,Yes
DB00802,Alfentanil,DB01168,Procarbazine,0.872334897518158,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Procarbazine.,49,Type_49,Yes
DB00153,Ergocalciferol,DB08820,Ivacaftor,0.9972042441368103,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Ergocalciferol.,73,Type_73,Yes
DB00273,Topiramate,DB01424,Aminophenazone,0.9301280379295349,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Topiramate.,47,Type_47,Yes
DB00419,Miglustat,DB01319,Fosamprenavir,0.6759069561958313,70,Type_70,The therapeutic efficacy of Fosamprenavir can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00747,Scopolamine,DB00807,Proparacaine,0.9998148083686829,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Proparacaine.,49,Type_49,Yes
DB00312,Pentobarbital,DB01162,Terazosin,0.9281650185585022,60,Type_60,Pentobarbital may increase the hypotensive activities of Terazosin.,60,Type_60,Yes
DB00956,Hydrocodone,DB01065,Melatonin,0.9199965000152588,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Melatonin.,16,Type_16,Yes
DB00244,Mesalazine,DB04743,Nimesulide,0.8536547422409058,57,Type_57,Mesalazine may increase the nephrotoxic activities of Nimesulide.,49,Type_49,No
DB00495,Zidovudine,DB00722,Lisinopril,0.8041651248931885,49,Type_49,The risk or severity of adverse effects can be increased when Zidovudine is combined with Lisinopril.,75,Type_75,No
DB00980,Ramelteon,DB01624,Zuclopenthixol,0.9640186429023743,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Zuclopenthixol.,49,Type_49,Yes
DB01239,Chlorprothixene,DB06282,Levocetirizine,0.9961860775947571,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Levocetirizine.,49,Type_49,Yes
DB00179,Masoprocol,DB00374,Treprostinil,0.8247705698013306,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Treprostinil.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB06153,Pizotifen,0.9941708445549011,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Pizotifen.,49,Type_49,Yes
DB00678,Losartan,DB01015,Sulfamethoxazole,0.961844801902771,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Losartan.,47,Type_47,Yes
DB00394,Beclomethasone dipropionate,DB03585,Oxyphenbutazone,0.9997346997261047,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00484,Brimonidine,DB04953,Ezogabine,0.9934484362602234,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.,16,Type_16,Yes
DB00434,Cyproheptadine,DB00802,Alfentanil,0.999890923500061,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Alfentanil.,49,Type_49,Yes
DB00604,Cisapride,DB08864,Rilpivirine,0.8210110068321228,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00559,Bosentan,DB00814,Meloxicam,0.6776841878890991,75,Type_75,The serum concentration of Meloxicam can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00678,Losartan,DB00701,Amprenavir,0.6248375773429871,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Losartan.,47,Type_47,Yes
DB04865,Omacetaxine mepesuccinate,DB06725,Lornoxicam,0.975406289100647,49,Type_49,The risk or severity of adverse effects can be increased when Omacetaxine mepesuccinate is combined with Lornoxicam.,49,Type_49,Yes
DB01234,Dexamethasone,DB04876,Vildagliptin,0.9914420247077942,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Dexamethasone.,70,Type_70,Yes
DB01162,Terazosin,DB09216,Tolfenamic acid,0.5646525025367737,60,Type_60,Terazosin may increase the hypotensive activities of Tolfenamic acid.,60,Type_60,Yes
DB01227,Levacetylmethadol,DB01263,Posaconazole,0.6656906604766846,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Levacetylmethadol.,47,Type_47,Yes
DB00681,Amphotericin B,DB09220,Nicorandil,0.862956166267395,60,Type_60,Amphotericin B may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00976,Telithromycin,DB01001,Salbutamol,0.9565302729606628,20,Type_20,Telithromycin may increase the QTc-prolonging activities of Salbutamol.,20,Type_20,Yes
DB04841,Flunarizine,DB06716,Fospropofol,0.9995017051696777,49,Type_49,The risk or severity of adverse effects can be increased when Flunarizine is combined with Fospropofol.,49,Type_49,Yes
DB00752,Tranylcypromine,DB06698,Betahistine,0.7839959263801575,73,Type_73,The serum concentration of Betahistine can be increased when it is combined with Tranylcypromine.,73,Type_73,Yes
DB00897,Triazolam,DB04842,Fluspirilene,0.9993195533752441,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Fluspirilene.,49,Type_49,Yes
DB06739,Seratrodast,DB08905,Formestane,0.9989681243896484,49,Type_49,The risk or severity of adverse effects can be increased when Seratrodast is combined with Formestane.,49,Type_49,Yes
DB00458,Imipramine,DB00801,Halazepam,0.9990192651748657,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Halazepam.,49,Type_49,Yes
DB00313,Valproic acid,DB01601,Lopinavir,0.7019838094711304,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Valproic acid.,75,Type_75,No
DB00951,Isoniazid,DB12332,Rucaparib,0.7962278127670288,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB01283,Lumiracoxib,DB04839,Cyproterone acetate,0.6105292439460754,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Lumiracoxib.,75,Type_75,Yes
DB00950,Fexofenadine,DB01433,Methadyl acetate,0.9989222288131714,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Methadyl acetate.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB06737,Zaltoprofen,0.5307126641273499,47,Type_47,The metabolism of Zaltoprofen can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00189,Ethchlorvynol,DB00765,Metyrosine,0.9980186223983765,32,Type_32,Ethchlorvynol may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00854,Levorphanol,DB00979,Cyclopentolate,0.9998712539672852,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Cyclopentolate.,49,Type_49,Yes
DB00393,Nimodipine,DB00571,Propranolol,0.4981444478034973,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Propranolol.,49,Type_49,Yes
DB00909,Zonisamide,DB08872,Gabapentin enacarbil,0.999687910079956,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00316,Acetaminophen,DB00502,Haloperidol,0.9556246399879456,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00708,Sufentanil,DB00722,Lisinopril,0.9813631772994995,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Lisinopril.,49,Type_49,Yes
DB00694,Daunorubicin,DB01254,Dasatinib,0.7469225525856018,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Daunorubicin.,73,Type_73,Yes
DB01626,Pargyline,DB04844,Tetrabenazine,0.9365742206573486,49,Type_49,The risk or severity of adverse effects can be increased when Pargyline is combined with Tetrabenazine.,49,Type_49,Yes
DB08881,Vemurafenib,DB08903,Bedaquiline,0.7734763026237488,73,Type_73,The serum concentration of Bedaquiline can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB00244,Mesalazine,DB00596,Ulobetasol,0.9981295466423035,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Ulobetasol.,49,Type_49,Yes
DB00323,Tolcapone,DB01367,Rasagiline,0.9940833449363708,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Rasagiline.,49,Type_49,Yes
DB06282,Levocetirizine,DB06636,Isavuconazonium,0.8623897433280945,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Levocetirizine.,47,Type_47,Yes
DB00370,Mirtazapine,DB06695,Dabigatran etexilate,0.8367676138877869,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Mirtazapine.,73,Type_73,No
DB00620,Triamcinolone,DB01122,Ambenonium,0.9966272115707397,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ambenonium.,49,Type_49,Yes
DB00295,Morphine,DB00979,Cyclopentolate,0.9998639822006226,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Cyclopentolate.,49,Type_49,Yes
DB00628,Clorazepic acid,DB04953,Ezogabine,0.9840283989906311,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Ezogabine.,49,Type_49,Yes
DB00434,Cyproheptadine,DB04841,Flunarizine,0.9970638155937195,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Flunarizine.,49,Type_49,Yes
DB01267,Paliperidone,DB13323,Trichloroethylene,0.9978978633880615,49,Type_49,The risk or severity of adverse effects can be increased when Paliperidone is combined with Trichloroethylene.,49,Type_49,Yes
DB00512,Vancomycin,DB08981,Fenbufen,0.9495036005973816,73,Type_73,The serum concentration of Fenbufen can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00615,Rifabutin,DB09227,Barnidipine,0.32454490661621094,4,Type_4,The metabolism of Barnidipine can be increased when combined with Rifabutin.,75,Type_75,No
DB00454,Meperidine,DB12532,Oxetacaine,0.9647295475006104,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Oxetacaine.,49,Type_49,Yes
DB00240,Alclometasone,DB01628,Etoricoxib,0.9982290863990784,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Etoricoxib.,49,Type_49,Yes
DB01580,Oxprenolol,DB06594,Agomelatine,0.9651926159858704,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Agomelatine.,49,Type_49,Yes
DB01236,Sevoflurane,DB06636,Isavuconazonium,0.7324806451797485,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Sevoflurane.,47,Type_47,Yes
DB00344,Protriptyline,DB01366,Procaterol,0.9858132004737854,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Procaterol.,49,Type_49,Yes
DB00359,Sulfadiazine,DB05381,Histamine,0.9820735454559326,47,Type_47,The metabolism of Histamine can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00419,Miglustat,DB00887,Bumetanide,0.9998747110366821,70,Type_70,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00921,Buprenorphine,DB09015,Canrenoic acid,0.9988158941268921,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Canrenoic acid.,49,Type_49,Yes
DB00091,Cyclosporine,DB00474,Methohexital,0.46503746509552,47,Type_47,The metabolism of Methohexital can be decreased when combined with Cyclosporine.,4,Type_4,No
DB00027,Gramicidin D,DB09027,Ledipasvir,0.9921545386314392,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Gramicidin D.,73,Type_73,Yes
DB00301,Flucloxacillin,DB00445,Epirubicin,0.9946449995040894,75,Type_75,The serum concentration of Epirubicin can be decreased when it is combined with Flucloxacillin.,75,Type_75,Yes
DB00482,Celecoxib,DB06204,Tapentadol,0.9862035512924194,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00309,Vindesine,DB06772,Cabazitaxel,0.9952320456504822,49,Type_49,The risk or severity of adverse effects can be increased when Vindesine is combined with Cabazitaxel.,49,Type_49,Yes
DB01252,Mitiglinide,DB01590,Everolimus,0.992176353931427,70,Type_70,The therapeutic efficacy of Everolimus can be decreased when used in combination with Mitiglinide.,70,Type_70,Yes
DB00468,Quinine,DB01012,Cinacalcet,0.9808962345123291,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Quinine.,47,Type_47,Yes
DB00239,Oxiconazole,DB01115,Nifedipine,0.8087663650512695,49,Type_49,The risk or severity of adverse effects can be increased when Oxiconazole is combined with Nifedipine.,49,Type_49,Yes
DB00324,Fluorometholone,DB00500,Tolmetin,0.9994192123413086,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Tolmetin.,49,Type_49,Yes
DB01173,Orphenadrine,DB01588,Prazepam,0.9801484942436218,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Prazepam.,16,Type_16,Yes
DB00653,Magnesium sulfate,DB09034,Suvorexant,0.9999973773956299,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00458,Imipramine,DB06292,Dapagliflozin,0.41091030836105347,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Imipramine.,49,Type_49,No
DB00203,Sildenafil,DB01095,Fluvastatin,0.5768049955368042,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00289,Atomoxetine,DB00377,Palonosetron,0.9477437734603882,47,Type_47,The metabolism of Palonosetron can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00485,Dicloxacillin,DB01418,Acenocoumarol,0.9775508046150208,12,Type_12,Dicloxacillin may decrease the anticoagulant activities of Acenocoumarol.,12,Type_12,Yes
DB00203,Sildenafil,DB06176,Romidepsin,0.8834863305091858,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01246,Alimemazine,DB01359,Penbutolol,0.9915643930435181,60,Type_60,Alimemazine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB06723,Aluminum hydroxide,DB08860,Pitavastatin,0.9776154160499573,75,Type_75,The serum concentration of Pitavastatin can be decreased when it is combined with Aluminum hydroxide.,75,Type_75,Yes
DB00282,Pamidronic acid,DB00945,Acetylsalicylic acid,0.9956158399581909,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB00199,Erythromycin,DB01551,Dihydrocodeine,0.9318962693214417,47,Type_47,The metabolism of Dihydrocodeine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00182,Amphetamine,DB00427,Triprolidine,0.8848915100097656,76,Type_76,Amphetamine may decrease the sedative activities of Triprolidine.,76,Type_76,Yes
DB08880,Teriflunomide,DB08881,Vemurafenib,0.7124775052070618,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Teriflunomide.,73,Type_73,No
DB00563,Methotrexate,DB06196,Icatibant,0.6930226683616638,73,Type_73,The serum concentration of Icatibant can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00699,Nicergoline,DB01559,Clotiazepam,0.9899163842201233,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Clotiazepam.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB00465,Ketorolac,0.9599587321281433,49,Type_49,The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Ketorolac.,49,Type_49,Yes
DB00283,Clemastine,DB01131,Proguanil,0.980201780796051,47,Type_47,The metabolism of Proguanil can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00661,Verapamil,DB01320,Fosphenytoin,0.8832594156265259,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Verapamil.,73,Type_73,No
DB00254,Doxycycline,DB00948,Mezlocillin,0.2905817925930023,70,Type_70,The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Doxycycline.,70,Type_70,Yes
DB01587,Ketazolam,DB09063,Ceritinib,0.9871413707733154,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Ketazolam.,73,Type_73,Yes
DB01587,Ketazolam,DB09166,Etizolam,0.9966505169868469,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Etizolam.,49,Type_49,Yes
DB00231,Temazepam,DB00289,Atomoxetine,0.9663006067276001,47,Type_47,The metabolism of Atomoxetine can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00976,Telithromycin,DB06267,Udenafil,0.7376490235328674,47,Type_47,The metabolism of Udenafil can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00547,Desoximetasone,DB01044,Gatifloxacin,0.9858733415603638,49,Type_49,The risk or severity of adverse effects can be increased when Desoximetasone is combined with Gatifloxacin.,49,Type_49,Yes
DB01397,Magnesium salicylate,DB01580,Oxprenolol,0.35966062545776367,70,Type_70,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Magnesium salicylate.,37,Type_37,No
DB00371,Meprobamate,DB00904,Ondansetron,0.944407045841217,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Ondansetron.,49,Type_49,Yes
DB00297,Bupivacaine,DB01203,Nadolol,0.7288660407066345,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nadolol.,73,Type_73,No
DB00448,Lansoprazole,DB00468,Quinine,0.9029896855354309,47,Type_47,The metabolism of Quinine can be decreased when combined with Lansoprazole.,47,Type_47,Yes
DB00977,Ethinylestradiol,DB06636,Isavuconazonium,0.6251235008239746,75,Type_75,The serum concentration of Isavuconazonium can be decreased when it is combined with Ethinylestradiol.,47,Type_47,No
DB01211,Clarithromycin,DB09262,Imidafenacin,0.8515518307685852,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Clarithromycin.,73,Type_73,No
DB00521,Carteolol,DB03128,Acetylcholine,0.4448844790458679,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Acetylcholine.,49,Type_49,Yes
DB01184,Domperidone,DB01201,Rifapentine,0.8445602059364319,4,Type_4,The metabolism of Rifapentine can be increased when combined with Domperidone.,4,Type_4,Yes
DB00765,Metyrosine,DB00898,Ethanol,0.9999504089355469,32,Type_32,Metyrosine may increase the sedative activities of Ethanol.,32,Type_32,Yes
DB00999,Hydrochlorothiazide,DB09286,Pipamperone,0.9913039207458496,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Pipamperone.,49,Type_49,Yes
DB05541,Brivaracetam,DB09120,Zucapsaicin,0.9981415271759033,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Brivaracetam.,47,Type_47,Yes
DB00814,Meloxicam,DB00905,Bimatoprost,0.9979633092880249,70,Type_70,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB00341,Cetirizine,DB00409,Remoxipride,0.9992638230323792,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Remoxipride.,49,Type_49,Yes
DB00450,Droperidol,DB01466,Ethylmorphine,0.9971292614936829,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.,16,Type_16,Yes
DB06710,Methyltestosterone,DB09048,Netupitant,0.9744206666946411,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Methyltestosterone.,73,Type_73,Yes
DB01174,Phenobarbital,DB09289,Tianeptine,0.9699786305427551,4,Type_4,The metabolism of Tianeptine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB06228,Rivaroxaban,DB09167,Dosulepin,0.7316913604736328,73,Type_73,The serum concentration of Dosulepin can be increased when it is combined with Rivaroxaban.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB00705,Delavirdine,0.9749128222465515,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00282,Pamidronic acid,DB00448,Lansoprazole,0.7655970454216003,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Lansoprazole.,70,Type_70,No
DB01220,Rifaximin,DB09268,Picosulfuric acid,0.9999997615814209,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Rifaximin.,70,Type_70,Yes
DB00413,Pramipexole,DB01551,Dihydrocodeine,0.9999972581863403,32,Type_32,Pramipexole may increase the sedative activities of Dihydrocodeine.,32,Type_32,Yes
DB00412,Rosiglitazone,DB00918,Almotriptan,0.7731464505195618,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00943,Zalcitabine,DB01319,Fosamprenavir,0.7500941753387451,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Zalcitabine.,47,Type_47,Yes
DB00420,Promazine,DB01685,Topiroxostat,0.9962856769561768,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Promazine.,47,Type_47,Yes
DB01076,Atorvastatin,DB04898,Ximelagatran,0.6766684055328369,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Atorvastatin.,73,Type_73,Yes
DB00296,Ropivacaine,DB00734,Risperidone,0.8076420426368713,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Risperidone.,60,Type_60,No
DB00315,Zolmitriptan,DB00601,Linezolid,0.8638381361961365,64,Type_64,Zolmitriptan may increase the serotonergic activities of Linezolid.,49,Type_49,No
DB00818,Propofol,DB09242,Moxonidine,0.922391951084137,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Moxonidine.,49,Type_49,Yes
DB00333,Methadone,DB01356,Lithium cation,0.6155080795288086,35,Type_35,Methadone may increase the neurotoxic activities of Lithium cation.,49,Type_49,No
DB01195,Flecainide,DB08864,Rilpivirine,0.8099534511566162,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Flecainide.,20,Type_20,No
DB00752,Tranylcypromine,DB06335,Saxagliptin,0.6250689029693604,9,Type_9,Tranylcypromine may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00921,Buprenorphine,DB01615,Aceprometazine,0.9999517202377319,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine.,16,Type_16,Yes
DB00188,Bortezomib,DB05294,Vandetanib,0.4336971342563629,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB01320,Fosphenytoin,DB08881,Vemurafenib,0.9435880184173584,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Fosphenytoin.,73,Type_73,No
DB00486,Nabilone,DB00715,Paroxetine,0.8963503837585449,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Paroxetine.,49,Type_49,Yes
DB00614,Furazolidone,DB11362,Selexipag,0.9930521249771118,60,Type_60,Furazolidone may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB06292,Dapagliflozin,DB09543,Methyl salicylate,0.6954806447029114,49,Type_49,The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Methyl salicylate.,9,Type_9,No
DB00321,Amitriptyline,DB00682,Warfarin,0.9860742092132568,6,Type_6,Amitriptyline may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00146,Calcifediol,DB13231,Calcium lactate,0.9733362793922424,49,Type_49,The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium lactate.,49,Type_49,Yes
DB01232,Saquinavir,DB08906,Fluticasone furoate,0.9171068072319031,47,Type_47,The metabolism of Fluticasone furoate can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00295,Morphine,DB09065,Cobicistat,0.6284775733947754,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Morphine.,73,Type_73,No
DB00604,Cisapride,DB06589,Pazopanib,0.500416100025177,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Cisapride.,20,Type_20,No
DB00831,Trifluoperazine,DB01200,Bromocriptine,0.7785047292709351,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Bromocriptine.,70,Type_70,No
DB00199,Erythromycin,DB09102,Daclatasvir,0.7031599879264832,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00277,Theophylline,DB01095,Fluvastatin,0.44010382890701294,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Theophylline.,47,Type_47,No
DB00014,Goserelin,DB01238,Aripiprazole,0.9999785423278809,20,Type_20,Goserelin may increase the QTc-prolonging activities of Aripiprazole.,20,Type_20,Yes
DB01558,Bromazepam,DB09074,Olaparib,0.9132527112960815,47,Type_47,The metabolism of Olaparib can be decreased when combined with Bromazepam.,47,Type_47,Yes
DB01215,Estazolam,DB09071,Tasimelteon,0.99972003698349,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Tasimelteon.,49,Type_49,Yes
DB00755,Tretinoin,DB00960,Pindolol,0.9311243295669556,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Pindolol.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01623,Thiothixene,0.9588690996170044,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Thiothixene.,49,Type_49,Yes
DB01214,Metipranolol,DB06694,Xylometazoline,0.7303367257118225,60,Type_60,Metipranolol may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00196,Fluconazole,DB00470,Dronabinol,0.8175389170646667,73,Type_73,The serum concentration of Dronabinol can be increased when it is combined with Fluconazole.,73,Type_73,Yes
DB00679,Thioridazine,DB00967,Desloratadine,0.996065080165863,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Desloratadine.,73,Type_73,No
DB00359,Sulfadiazine,DB01149,Nefazodone,0.9925274848937988,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB01609,Deferasirox,DB04868,Nilotinib,0.6958982944488525,75,Type_75,The serum concentration of Nilotinib can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB01072,Atazanavir,DB04930,Permethrin,0.8399110436439514,47,Type_47,The metabolism of Permethrin can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB01236,Sevoflurane,DB04842,Fluspirilene,0.9851587414741516,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Fluspirilene.,49,Type_49,Yes
DB00612,Bisoprolol,DB00629,Guanabenz,0.6675622463226318,25,Type_25,Bisoprolol may increase the atrioventricular blocking (AV block) activities of Guanabenz.,25,Type_25,Yes
DB01227,Levacetylmethadol,DB08883,Perampanel,0.9986060261726379,16,Type_16,Levacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00358,Mefloquine,DB00541,Vincristine,0.5938134789466858,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB00696,Ergotamine,DB06616,Bosutinib,0.652441143989563,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ergotamine.,73,Type_73,Yes
DB01136,Carvedilol,DB06262,Droxidopa,0.9881852865219116,25,Type_25,Carvedilol may increase the atrioventricular blocking (AV block) activities of Droxidopa.,25,Type_25,Yes
DB00169,Cholecalciferol,DB04841,Flunarizine,0.9216756820678711,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01544,Flunitrazepam,DB04946,Iloperidone,0.9351735711097717,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Iloperidone.,49,Type_49,Yes
DB00425,Zolpidem,DB01202,Levetiracetam,0.9989941716194153,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.,16,Type_16,Yes
DB09118,Stiripentol,DB09227,Barnidipine,0.8053998351097107,73,Type_73,The serum concentration of Barnidipine can be increased when it is combined with Stiripentol.,73,Type_73,Yes
DB00203,Sildenafil,DB00448,Lansoprazole,0.8963516354560852,47,Type_47,The metabolism of Lansoprazole can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB09065,Cobicistat,DB09570,Ixazomib,0.48590484261512756,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00695,Furosemide,DB06738,Ketobemidone,0.9952107071876526,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Ketobemidone.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB00655,Estrone,0.9942692518234253,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Estrone.,49,Type_49,Yes
DB00343,Diltiazem,DB01210,Levobunolol,0.7934213876724243,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Levobunolol.,49,Type_49,Yes
DB00873,Loteprednol,DB01010,Edrophonium,0.9998433589935303,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Edrophonium.,49,Type_49,Yes
DB00379,Mexiletine,DB00682,Warfarin,0.8662042021751404,47,Type_47,The metabolism of Warfarin can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00461,Nabumetone,DB06810,Plicamycin,0.9998177886009216,72,Type_72,Nabumetone may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00461,Nabumetone,DB01283,Lumiracoxib,0.9899376630783081,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Lumiracoxib.,49,Type_49,Yes
DB00714,Apomorphine,DB00738,Pentamidine,0.9006195068359375,20,Type_20,Apomorphine may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00519,Trandolapril,DB01240,Epoprostenol,0.6766717433929443,60,Type_60,Trandolapril may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB00619,Imatinib,DB01012,Cinacalcet,0.8808714747428894,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Imatinib.,47,Type_47,Yes
DB08808,Bupranolol,DB13783,Acemetacin,0.7333272099494934,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Bupranolol.,70,Type_70,Yes
DB01058,Praziquantel,DB01104,Sertraline,0.9059141278266907,47,Type_47,The metabolism of Sertraline can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00813,Fentanyl,DB00849,Methylphenobarbital,0.5136333107948303,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Methylphenobarbital.,49,Type_49,Yes
DB00907,Cocaine,DB09063,Ceritinib,0.9644569158554077,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Cocaine.,73,Type_73,Yes
DB01132,Pioglitazone,DB01184,Domperidone,0.7439706921577454,47,Type_47,The metabolism of Domperidone can be decreased when combined with Pioglitazone.,47,Type_47,Yes
DB00296,Ropivacaine,DB00571,Propranolol,0.5408950448036194,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Propranolol.,49,Type_49,Yes
DB00892,Oxybuprocaine,DB01151,Desipramine,0.9988118410110474,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Desipramine.,49,Type_49,Yes
DB06636,Isavuconazonium,DB08903,Bedaquiline,0.5379421710968018,73,Type_73,The serum concentration of Bedaquiline can be increased when it is combined with Isavuconazonium.,47,Type_47,No
DB00409,Remoxipride,DB00852,Pseudoephedrine,0.9904009699821472,61,Type_61,Remoxipride may decrease the stimulatory activities of Pseudoephedrine.,61,Type_61,Yes
DB00474,Methohexital,DB00977,Ethinylestradiol,0.5343112349510193,70,Type_70,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Methohexital.,70,Type_70,Yes
DB00524,Metolazone,DB00820,Tadalafil,0.9997768998146057,10,Type_10,Metolazone may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00331,Metformin,DB01124,Tolbutamide,0.9814726114273071,9,Type_9,Metformin may increase the hypoglycemic activities of Tolbutamide.,9,Type_9,Yes
DB00305,Mitomycin,DB00337,Pimecrolimus,0.8478963971138,49,Type_49,The risk or severity of adverse effects can be increased when Mitomycin is combined with Pimecrolimus.,49,Type_49,Yes
DB00859,Penicillamine,DB09275,Bismuth subcitrate potassium,0.8376750946044922,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Penicillamine.,75,Type_75,Yes
DB00482,Celecoxib,DB04841,Flunarizine,0.5905816555023193,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01156,Bupropion,DB09068,Vortioxetine,0.5570424795150757,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Bupropion.,49,Type_49,No
DB00810,Biperiden,DB01400,Neostigmine,0.9989633560180664,70,Type_70,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Biperiden.,70,Type_70,Yes
DB00322,Floxuridine,DB08860,Pitavastatin,0.5124831199645996,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Floxuridine.,47,Type_47,No
DB01199,Tubocurarine,DB04861,Nebivolol,0.811346709728241,54,Type_54,Tubocurarine may increase the bradycardic activities of Nebivolol.,54,Type_54,Yes
DB00418,Secobarbital,DB00921,Buprenorphine,0.9996373653411865,16,Type_16,Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00834,Mifepristone,DB01216,Finasteride,0.8845423460006714,73,Type_73,The serum concentration of Finasteride can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00230,Pregabalin,DB01463,Fencamfamin,0.9922155737876892,8,Type_8,The therapeutic efficacy of Fencamfamin can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00246,Ziprasidone,DB00842,Oxazepam,0.7213343977928162,47,Type_47,The metabolism of Oxazepam can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00726,Trimipramine,DB01577,Metamfetamine,0.871167004108429,37,Type_37,Trimipramine may decrease the antihypertensive activities of Metamfetamine.,37,Type_37,Yes
DB00588,Fluticasone propionate,DB01017,Minocycline,0.4896775782108307,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Minocycline.,16,Type_16,No
DB00277,Theophylline,DB08865,Crizotinib,0.9927269220352173,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Theophylline.,47,Type_47,Yes
DB06207,Silodosin,DB06712,Nilvadipine,0.9732581973075867,60,Type_60,Silodosin may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00268,Ropinirole,DB00696,Ergotamine,0.36428430676460266,19,Type_19,Ropinirole may increase the vasoconstricting activities of Ergotamine.,47,Type_47,No
DB02638,Terlipressin,DB09238,Manidipine,0.9974578022956848,60,Type_60,Terlipressin may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00252,Phenytoin,DB01002,Levobupivacaine,0.8039410710334778,4,Type_4,The metabolism of Levobupivacaine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00512,Vancomycin,DB00795,Sulfasalazine,0.9169455766677856,73,Type_73,The serum concentration of Sulfasalazine can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00542,Benazepril,DB09477,Enalaprilat,0.5207936763763428,60,Type_60,Benazepril may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00325,Nitroprusside,DB01193,Acebutolol,0.9305513501167297,60,Type_60,Nitroprusside may increase the hypotensive activities of Acebutolol.,49,Type_49,No
DB01162,Terazosin,DB01197,Captopril,0.7713736891746521,49,Type_49,The risk or severity of adverse effects can be increased when Terazosin is combined with Captopril.,49,Type_49,Yes
DB00401,Nisoldipine,DB01240,Epoprostenol,0.9137840270996094,60,Type_60,Nisoldipine may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB01435,Antipyrine,DB09214,Dexketoprofen,0.8667770624160767,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Dexketoprofen.,49,Type_49,Yes
DB00691,Moexipril,DB13167,Alclofenac,0.9792779088020325,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Alclofenac.,49,Type_49,Yes
DB00691,Moexipril,DB00708,Sufentanil,0.9424955248832703,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Sufentanil.,49,Type_49,Yes
DB00614,Furazolidone,DB09241,Methylene blue,0.6556554436683655,64,Type_64,Furazolidone may increase the serotonergic activities of Methylene blue.,64,Type_64,Yes
DB00549,Zafirlukast,DB01120,Gliclazide,0.9529498815536499,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00353,Methylergometrine,DB09238,Manidipine,0.8763917684555054,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Manidipine.,49,Type_49,Yes
DB00215,Citalopram,DB01623,Thiothixene,0.3761482834815979,20,Type_20,Citalopram may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00228,Enflurane,DB00996,Gabapentin,0.9989838004112244,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Gabapentin.,49,Type_49,Yes
DB00857,Terbinafine,DB08992,Eperisone,0.8625617623329163,49,Type_49,The risk or severity of adverse effects can be increased when Terbinafine is combined with Eperisone.,49,Type_49,Yes
DB03585,Oxyphenbutazone,DB06826,Unoprostone,0.9999076128005981,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Oxyphenbutazone.,70,Type_70,Yes
DB00757,Dolasetron,DB00998,Frovatriptan,0.9330816268920898,64,Type_64,Dolasetron may increase the serotonergic activities of Frovatriptan.,64,Type_64,Yes
DB00653,Magnesium sulfate,DB01595,Nitrazepam,0.8692551851272583,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.,16,Type_16,Yes
DB00397,Phenylpropanolamine,DB06152,Nylidrin,0.9998495578765869,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Nylidrin.,49,Type_49,Yes
DB00652,Pentazocine,DB01320,Fosphenytoin,0.7217506766319275,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Fosphenytoin.,49,Type_49,Yes
DB00214,Torasemide,DB01132,Pioglitazone,0.9438523650169373,70,Type_70,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Torasemide.,70,Type_70,Yes
DB01067,Glipizide,DB06717,Fosaprepitant,0.6897540092468262,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Glipizide.,73,Type_73,Yes
DB00220,Nelfinavir,DB00615,Rifabutin,0.32533296942710876,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Nelfinavir.,77,Type_77,No
DB00335,Atenolol,DB01615,Aceprometazine,0.9288769960403442,60,Type_60,Atenolol may increase the hypotensive activities of Aceprometazine.,60,Type_60,Yes
DB09231,Benidipine,DB09270,Ubidecarenone,0.8618625402450562,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Benidipine.,49,Type_49,No
DB01072,Atazanavir,DB09053,Ibrutinib,0.8794536590576172,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00655,Estrone,DB04938,Ospemifene,0.8161861896514893,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Estrone.,49,Type_49,No
DB00861,Diflunisal,DB00975,Dipyridamole,0.4914630055427551,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Dipyridamole.,49,Type_49,Yes
DB00554,Piroxicam,DB01214,Metipranolol,0.9999024868011475,37,Type_37,Piroxicam may decrease the antihypertensive activities of Metipranolol.,37,Type_37,Yes
DB00508,Triflupromazine,DB00599,Thiopental,0.9702432751655579,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Thiopental.,49,Type_49,Yes
DB00461,Nabumetone,DB01088,Iloprost,0.66972815990448,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Nabumetone.,70,Type_70,Yes
DB00201,Caffeine,DB06290,Simeprevir,0.9218283891677856,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Caffeine.,73,Type_73,Yes
DB00523,Alitretinoin,DB01092,Ouabain,0.9932374954223633,58,Type_58,Alitretinoin may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00909,Zonisamide,DB01142,Doxepin,0.993239164352417,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Doxepin.,49,Type_49,Yes
DB00972,Azelastine,DB01418,Acenocoumarol,0.997684121131897,6,Type_6,Azelastine may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01211,Clarithromycin,DB11730,Ribociclib,0.9108580946922302,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB00261,Anagrelide,DB08893,Mirabegron,0.9453448057174683,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Mirabegron.,20,Type_20,Yes
DB00556,Perflutren,DB00976,Telithromycin,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Telithromycin.,20,Type_20,Yes
DB00482,Celecoxib,DB09068,Vortioxetine,0.5537301898002625,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01157,Trimetrexate,DB09236,Lacidipine,0.9967834949493408,49,Type_49,The risk or severity of adverse effects can be increased when Trimetrexate is combined with Lacidipine.,49,Type_49,Yes
DB00695,Furosemide,DB00800,Fenoldopam,0.5065202713012695,60,Type_60,Furosemide may increase the hypotensive activities of Fenoldopam.,49,Type_49,No
DB00925,Phenoxybenzamine,DB06403,Ambrisentan,0.996476948261261,60,Type_60,Phenoxybenzamine may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00726,Trimipramine,DB06216,Asenapine,0.4840426445007324,20,Type_20,Trimipramine may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB01092,Ouabain,DB01297,Practolol,0.9966081380844116,54,Type_54,Ouabain may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB00829,Diazepam,DB06148,Mianserin,0.455835223197937,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Diazepam.,70,Type_70,Yes
DB00244,Mesalazine,DB01193,Acebutolol,0.6341331601142883,37,Type_37,Mesalazine may decrease the antihypertensive activities of Acebutolol.,37,Type_37,Yes
DB01618,Molindone,DB08910,Pomalidomide,0.9978888630867004,49,Type_49,The risk or severity of adverse effects can be increased when Molindone is combined with Pomalidomide.,49,Type_49,Yes
DB00412,Rosiglitazone,DB08931,Riociguat,0.8619123697280884,47,Type_47,The metabolism of Riociguat can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00219,Oxyphenonium,DB00677,Isoflurophate,0.9983978867530823,70,Type_70,The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Oxyphenonium.,70,Type_70,Yes
DB00239,Oxiconazole,DB08912,Dabrafenib,0.9695186614990234,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Oxiconazole.,75,Type_75,Yes
DB01009,Ketoprofen,DB08906,Fluticasone furoate,0.9994072914123535,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluticasone furoate.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB06702,Fesoterodine,0.9859998822212219,73,Type_73,The serum concentration of Fesoterodine can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB00564,Carbamazepine,DB01319,Fosamprenavir,0.4622901380062103,4,Type_4,The metabolism of Fosamprenavir can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB08899,Enzalutamide,DB11574,Elbasvir,0.8975820541381836,75,Type_75,The serum concentration of Elbasvir can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB00188,Bortezomib,DB04845,Ixabepilone,0.7412468194961548,47,Type_47,The metabolism of Ixabepilone can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00979,Cyclopentolate,DB01324,Polythiazide,0.9999042749404907,73,Type_73,The serum concentration of Polythiazide can be increased when it is combined with Cyclopentolate.,73,Type_73,Yes
DB01026,Ketoconazole,DB08827,Lomitapide,0.9267786145210266,73,Type_73,The serum concentration of Lomitapide can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00854,Levorphanol,DB01623,Thiothixene,0.9939951300621033,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Thiothixene.,49,Type_49,Yes
DB00490,Buspirone,DB08824,Ioflupane I-123,0.9999295473098755,45,Type_45,Buspirone may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.,45,Type_45,Yes
DB00997,Doxorubicin,DB01037,Selegiline,0.5038278102874756,47,Type_47,The metabolism of Selegiline can be decreased when combined with Doxorubicin.,47,Type_47,Yes
DB00243,Ranolazine,DB00757,Dolasetron,0.457979291677475,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Ranolazine.,20,Type_20,No
DB00206,Reserpine,DB01156,Bupropion,0.6885762810707092,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Bupropion.,73,Type_73,No
DB00864,Tacrolimus,DB01024,Mycophenolic acid,0.8893284201622009,57,Type_57,Tacrolimus may increase the nephrotoxic activities of Mycophenolic acid.,57,Type_57,Yes
DB00521,Carteolol,DB06292,Dapagliflozin,0.9931682348251343,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Dapagliflozin.,49,Type_49,Yes
DB00927,Famotidine,DB01035,Procainamide,0.8514954447746277,20,Type_20,Famotidine may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB01234,Dexamethasone,DB09070,Tibolone,0.9359269142150879,81,Type_81,Dexamethasone may increase the thrombogenic activities of Tibolone.,73,Type_73,No
DB00734,Risperidone,DB00796,Candesartan cilexetil,0.4033242166042328,73,Type_73,The serum concentration of Candesartan cilexetil can be increased when it is combined with Risperidone.,60,Type_60,No
DB01028,Methoxyflurane,DB01065,Melatonin,0.9992566704750061,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Melatonin.,49,Type_49,Yes
DB00428,Streptozocin,DB01606,Tazobactam,0.9585319757461548,75,Type_75,The serum concentration of Tazobactam can be decreased when it is combined with Streptozocin.,75,Type_75,Yes
DB00790,Perindopril,DB05271,Rotigotine,0.7737302780151367,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Rotigotine.,49,Type_49,Yes
DB00006,Bivalirudin,DB08816,Ticagrelor,0.6107602119445801,6,Type_6,Bivalirudin may increase the anticoagulant activities of Ticagrelor.,6,Type_6,Yes
DB00655,Estrone,DB04574,Estrone sulfate,0.9751741290092468,73,Type_73,The serum concentration of Estrone sulfate can be increased when it is combined with Estrone.,73,Type_73,Yes
DB00390,Digoxin,DB00444,Teniposide,0.907561182975769,58,Type_58,Digoxin may decrease the cardiotoxic activities of Teniposide.,58,Type_58,Yes
DB00582,Voriconazole,DB00675,Tamoxifen,0.6311690807342529,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00615,Rifabutin,DB06287,Temsirolimus,0.612971842288971,4,Type_4,The metabolism of Temsirolimus can be increased when combined with Rifabutin.,75,Type_75,No
DB01433,Methadyl acetate,DB08872,Gabapentin enacarbil,0.9963272213935852,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01426,Ajmaline,0.7425423860549927,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB03754,Tromethamine,DB06824,Triethylenetetramine,0.8862859606742859,67,Type_67,Tromethamine can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00474,Methohexital,DB01618,Molindone,0.9982399940490723,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Molindone.,49,Type_49,Yes
DB00285,Venlafaxine,DB00541,Vincristine,0.5877787470817566,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Venlafaxine.,47,Type_47,No
DB00554,Piroxicam,DB00700,Eplerenone,0.8813533782958984,37,Type_37,Piroxicam may decrease the antihypertensive activities of Eplerenone.,37,Type_37,Yes
DB00884,Risedronic acid,DB06810,Plicamycin,0.9987026453018188,24,Type_24,Risedronic acid may increase the hypocalcemic activities of Plicamycin.,24,Type_24,Yes
DB01106,Levocabastine,DB01151,Desipramine,0.9975166320800781,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Desipramine.,49,Type_49,Yes
DB00648,Mitotane,DB00976,Telithromycin,0.9840100407600403,75,Type_75,The serum concentration of Telithromycin can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01138,Sulfinpyrazone,DB01264,Darunavir,0.8415534496307373,47,Type_47,The metabolism of Darunavir can be decreased when combined with Sulfinpyrazone.,47,Type_47,Yes
DB00834,Mifepristone,DB05294,Vandetanib,0.7202146649360657,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Vandetanib.,73,Type_73,No
DB00575,Clonidine,DB00857,Terbinafine,0.49949148297309875,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Clonidine.,47,Type_47,Yes
DB00177,Valsartan,DB01181,Ifosfamide,0.9415624737739563,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Valsartan.,47,Type_47,Yes
DB09070,Tibolone,DB12598,Nafamostat,0.7401909232139587,6,Type_6,Tibolone may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB00679,Thioridazine,DB00802,Alfentanil,0.8498822450637817,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Alfentanil.,49,Type_49,Yes
DB00363,Clozapine,DB01005,Hydroxyurea,0.8565525412559509,73,Type_73,The serum concentration of Hydroxyurea can be increased when it is combined with Clozapine.,49,Type_49,No
DB01166,Cilostazol,DB09048,Netupitant,0.98515784740448,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB06209,Prasugrel,DB09063,Ceritinib,0.9945698380470276,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Prasugrel.,73,Type_73,Yes
DB00244,Mesalazine,DB04865,Omacetaxine mepesuccinate,0.9727250933647156,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00502,Haloperidol,DB00721,Procaine,0.9997952580451965,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Procaine.,49,Type_49,Yes
DB01107,Methyprylon,DB06603,Panobinostat,0.7554842829704285,47,Type_47,The metabolism of Panobinostat can be decreased when combined with Methyprylon.,73,Type_73,No
DB01149,Nefazodone,DB09286,Pipamperone,0.6781895160675049,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Pipamperone.,49,Type_49,Yes
DB01129,Rabeprazole,DB01198,Zopiclone,0.9688998460769653,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Rabeprazole.,47,Type_47,Yes
DB00607,Nafcillin,DB03615,Ribostamycin,0.999996542930603,75,Type_75,The serum concentration of Ribostamycin can be decreased when it is combined with Nafcillin.,75,Type_75,Yes
DB00633,Dexmedetomidine,DB08868,Fingolimod,0.9796976447105408,54,Type_54,Dexmedetomidine may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB01201,Rifapentine,DB08867,Ulipristal,0.893508791923523,75,Type_75,The serum concentration of Ulipristal can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00645,Dyclonine,DB01086,Benzocaine,0.9999885559082031,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Benzocaine.,49,Type_49,Yes
DB00361,Vinorelbine,DB00496,Darifenacin,0.6010231971740723,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB00296,Ropivacaine,DB00907,Cocaine,0.42535361647605896,47,Type_47,The metabolism of Cocaine can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00158,Folic acid,DB01283,Lumiracoxib,0.9007033705711365,70,Type_70,The therapeutic efficacy of Lumiracoxib can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00263,Sulfisoxazole,DB06789,Hydroxyprogesterone caproate,0.9575456380844116,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00906,Tiagabine,DB01018,Guanfacine,0.9895271062850952,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Guanfacine.,49,Type_49,Yes
DB01167,Itraconazole,DB05541,Brivaracetam,0.8324258923530579,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00921,Buprenorphine,DB01563,Chloral hydrate,0.9999170303344727,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.,16,Type_16,Yes
DB01215,Estazolam,DB09074,Olaparib,0.9075599908828735,47,Type_47,The metabolism of Olaparib can be decreased when combined with Estazolam.,47,Type_47,Yes
DB00470,Dronabinol,DB00921,Buprenorphine,0.9999995231628418,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB01263,Posaconazole,DB06770,Benzyl alcohol,0.7361221313476562,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00388,Phenylephrine,DB00706,Tamsulosin,0.9992185831069946,5,Type_5,Phenylephrine may decrease the vasoconstricting activities of Tamsulosin.,5,Type_5,Yes
DB00999,Hydrochlorothiazide,DB11315,Methscopolamine,0.998884379863739,73,Type_73,The serum concentration of Methscopolamine can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB00742,Mannitol,DB01351,Amobarbital,0.7808229923248291,60,Type_60,Mannitol may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB01200,Bromocriptine,DB04948,Lofexidine,0.7769351601600647,25,Type_25,Bromocriptine may increase the atrioventricular blocking (AV block) activities of Lofexidine.,49,Type_49,No
DB00715,Paroxetine,DB06739,Seratrodast,0.7190313935279846,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00563,Methotrexate,DB08981,Fenbufen,0.7662701606750488,73,Type_73,The serum concentration of Fenbufen can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00215,Citalopram,DB00521,Carteolol,0.489381343126297,47,Type_47,The metabolism of Carteolol can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00238,Nevirapine,DB01039,Fenofibrate,0.9601777195930481,4,Type_4,The metabolism of Fenofibrate can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00215,Citalopram,DB00629,Guanabenz,0.5934739112854004,47,Type_47,The metabolism of Guanabenz can be decreased when combined with Citalopram.,47,Type_47,Yes
DB09214,Dexketoprofen,DB11079,Trolamine salicylate,0.99415522813797,49,Type_49,The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Trolamine salicylate.,49,Type_49,Yes
DB00866,Alprenolol,DB08808,Bupranolol,0.7535189986228943,54,Type_54,Alprenolol may increase the bradycardic activities of Bupranolol.,60,Type_60,No
DB00423,Methocarbamol,DB04841,Flunarizine,0.9969469904899597,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Flunarizine.,49,Type_49,Yes
DB00373,Timolol,DB00696,Ergotamine,0.9163535237312317,25,Type_25,Timolol may increase the atrioventricular blocking (AV block) activities of Ergotamine.,25,Type_25,Yes
DB00726,Trimipramine,DB06144,Sertindole,0.9792485237121582,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Sertindole.,49,Type_49,Yes
DB01097,Leflunomide,DB08860,Pitavastatin,0.3847010135650635,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Leflunomide.,47,Type_47,No
DB00540,Nortriptyline,DB01466,Ethylmorphine,0.9287959337234497,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethylmorphine.,49,Type_49,Yes
DB00737,Meclizine,DB01567,Fludiazepam,0.9988908171653748,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Fludiazepam.,49,Type_49,Yes
DB00735,Naftifine,DB01268,Sunitinib,0.4214975833892822,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Naftifine.,47,Type_47,No
DB01068,Clonazepam,DB01356,Lithium cation,0.9397628307342529,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Lithium cation.,49,Type_49,Yes
DB01224,Quetiapine,DB01259,Lapatinib,0.42910826206207275,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Quetiapine.,20,Type_20,No
DB01421,Paromomycin,DB09324,Sulbactam,0.9915870428085327,75,Type_75,The serum concentration of Sulbactam can be decreased when it is combined with Paromomycin.,75,Type_75,Yes
DB01015,Sulfamethoxazole,DB06700,Desvenlafaxine,0.9670332074165344,9,Type_9,Sulfamethoxazole may increase the hypoglycemic activities of Desvenlafaxine.,9,Type_9,Yes
DB01595,Nitrazepam,DB01621,Pipotiazine,0.9768889546394348,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Pipotiazine.,49,Type_49,Yes
DB00379,Mexiletine,DB01184,Domperidone,0.95790034532547,47,Type_47,The metabolism of Domperidone can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00582,Voriconazole,DB01068,Clonazepam,0.8151130676269531,47,Type_47,The metabolism of Clonazepam can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00565,Cisatracurium,DB01111,Colistimethate,1.0,21,Type_21,Cisatracurium may increase the neuromuscular blocking activities of Colistimethate.,21,Type_21,Yes
DB00790,Perindopril,DB01592,Iron,0.44532570242881775,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Iron.,49,Type_49,Yes
DB00619,Imatinib,DB01114,Chlorpheniramine,0.9237764477729797,47,Type_47,The metabolism of Chlorpheniramine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00805,Minaprine,DB01197,Captopril,0.9847584962844849,60,Type_60,Minaprine may increase the hypotensive activities of Captopril.,60,Type_60,Yes
DB00363,Clozapine,DB01182,Propafenone,0.6942503452301025,20,Type_20,Clozapine may increase the QTc-prolonging activities of Propafenone.,73,Type_73,No
DB06737,Zaltoprofen,DB08964,Gemeprost,1.0,70,Type_70,The therapeutic efficacy of Gemeprost can be decreased when used in combination with Zaltoprofen.,70,Type_70,Yes
DB00335,Atenolol,DB09049,Naloxegol,0.9992283582687378,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Atenolol.,73,Type_73,Yes
DB00238,Nevirapine,DB00281,Lidocaine,0.7098752856254578,4,Type_4,The metabolism of Lidocaine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00726,Trimipramine,DB00918,Almotriptan,0.9301722645759583,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Almotriptan.,49,Type_49,Yes
DB00512,Vancomycin,DB06196,Icatibant,0.9267221093177795,73,Type_73,The serum concentration of Icatibant can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00469,Tenoxicam,DB00939,Meclofenamic acid,0.9992799162864685,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Meclofenamic acid.,49,Type_49,Yes
DB00656,Trazodone,DB06708,Lumefantrine,0.8147491216659546,20,Type_20,Trazodone may increase the QTc-prolonging activities of Lumefantrine.,20,Type_20,Yes
DB00333,Methadone,DB00675,Tamoxifen,0.5441423058509827,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Methadone.,11,Type_11,No
DB00333,Methadone,DB00599,Thiopental,0.7581415176391602,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Thiopental.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB00834,Mifepristone,0.8054768443107605,9,Type_9,Aminosalicylic acid may increase the hypoglycemic activities of Mifepristone.,9,Type_9,Yes
DB00300,Tenofovir disoproxil,DB09118,Stiripentol,0.7045530080795288,47,Type_47,The metabolism of Stiripentol can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00261,Anagrelide,DB00489,Sotalol,0.7818735837936401,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Sotalol.,33,Type_33,No
DB01070,Dihydrotachysterol,DB13142,Calcium glubionate anhydrous,0.9266942739486694,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium glubionate anhydrous.,49,Type_49,Yes
DB00759,Tetracycline,DB12332,Rucaparib,0.9609820246696472,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Tetracycline.,47,Type_47,Yes
DB00844,Nalbuphine,DB01624,Zuclopenthixol,0.9904554486274719,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zuclopenthixol.,49,Type_49,Yes
DB00363,Clozapine,DB00457,Prazosin,0.9291031956672668,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Prazosin.,49,Type_49,Yes
DB00568,Cinnarizine,DB08880,Teriflunomide,0.409292995929718,70,Type_70,The therapeutic efficacy of Teriflunomide can be decreased when used in combination with Cinnarizine.,75,Type_75,No
DB00189,Ethchlorvynol,DB01452,Diamorphine,0.9994140863418579,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Diamorphine.,49,Type_49,Yes
DB01621,Pipotiazine,DB02703,Fusidic acid,0.998704195022583,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Pipotiazine.,73,Type_73,Yes
DB00814,Meloxicam,DB00946,Phenprocoumon,0.9997004270553589,6,Type_6,Meloxicam may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00679,Thioridazine,DB01365,Mephentermine,0.9305448532104492,61,Type_61,Thioridazine may decrease the stimulatory activities of Mephentermine.,61,Type_61,Yes
DB00227,Lovastatin,DB01274,Arformoterol,0.8866297602653503,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01142,Doxepin,DB06413,Armodafinil,0.8739334940910339,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Doxepin.,47,Type_47,Yes
DB00313,Valproic acid,DB01580,Oxprenolol,0.3240407109260559,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Oxprenolol.,49,Type_49,Yes
DB06335,Saxagliptin,DB08804,Nandrolone decanoate,0.9998894929885864,9,Type_9,Saxagliptin may increase the hypoglycemic activities of Nandrolone decanoate.,9,Type_9,Yes
DB00755,Tretinoin,DB01201,Rifapentine,0.9526178240776062,4,Type_4,The metabolism of Rifapentine can be increased when combined with Tretinoin.,4,Type_4,Yes
DB00324,Fluorometholone,DB00624,Testosterone,0.9982948899269104,74,Type_74,Fluorometholone may increase the fluid retaining activities of Testosterone.,74,Type_74,Yes
DB00213,Pantoprazole,DB00541,Vincristine,0.49660518765449524,47,Type_47,The metabolism of Vincristine can be decreased when combined with Pantoprazole.,73,Type_73,No
DB01567,Fludiazepam,DB08872,Gabapentin enacarbil,0.9969360828399658,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00206,Reserpine,DB01075,Diphenhydramine,0.912869930267334,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Diphenhydramine.,49,Type_49,Yes
DB00661,Verapamil,DB09104,Magnesium hydroxide,0.5313695669174194,75,Type_75,The serum concentration of Magnesium hydroxide can be decreased when it is combined with Verapamil.,49,Type_49,No
DB00862,Vardenafil,DB05294,Vandetanib,0.9166128635406494,20,Type_20,Vardenafil may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00381,Amlodipine,DB00742,Mannitol,0.9830440878868103,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Mannitol.,49,Type_49,Yes
DB01076,Atorvastatin,DB01244,Bepridil,0.7961134314537048,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Bepridil.,49,Type_49,Yes
DB00619,Imatinib,DB06413,Armodafinil,0.9116727113723755,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00395,Carisoprodol,DB00484,Brimonidine,0.9833374619483948,16,Type_16,Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,16,Type_16,Yes
DB01164,Calcium chloride,DB01244,Bepridil,0.7471297383308411,70,Type_70,The therapeutic efficacy of Bepridil can be decreased when used in combination with Calcium chloride.,70,Type_70,Yes
DB00246,Ziprasidone,DB01054,Nitrendipine,0.8131287693977356,47,Type_47,The metabolism of Nitrendipine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00757,Dolasetron,DB01184,Domperidone,0.951199471950531,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Domperidone.,20,Type_20,Yes
DB00203,Sildenafil,DB08881,Vemurafenib,0.5885108113288879,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Sildenafil.,75,Type_75,Yes
DB00281,Lidocaine,DB00904,Ondansetron,0.6233891248703003,47,Type_47,The metabolism of Ondansetron can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00717,Norethisterone,DB01254,Dasatinib,0.7581861019134521,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Norethisterone.,73,Type_73,Yes
DB00206,Reserpine,DB00334,Olanzapine,0.9091058373451233,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Olanzapine.,49,Type_49,Yes
DB00257,Clotrimazole,DB09076,Umeclidinium,0.9824169874191284,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01201,Rifapentine,DB09030,Vorapaxar,0.9274975657463074,75,Type_75,The serum concentration of Vorapaxar can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00091,Cyclosporine,DB06626,Axitinib,0.44368648529052734,47,Type_47,The metabolism of Axitinib can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB01209,Dezocine,0.9979133009910583,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Dezocine.,49,Type_49,Yes
DB01174,Phenobarbital,DB01190,Clindamycin,0.7680153846740723,4,Type_4,The metabolism of Clindamycin can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00474,Methohexital,DB00584,Enalapril,0.891883373260498,60,Type_60,Methohexital may increase the hypotensive activities of Enalapril.,60,Type_60,Yes
DB00385,Valrubicin,DB09084,Benzydamine,0.9999527931213379,72,Type_72,Valrubicin may decrease the excretion rate of Benzydamine which could result in a higher serum level.,72,Type_72,Yes
DB00870,Suprofen,DB06595,Midostaurin,0.9492325186729431,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Suprofen.,47,Type_47,Yes
DB00472,Fluoxetine,DB09118,Stiripentol,0.7147901058197021,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00757,Dolasetron,DB00934,Maprotiline,0.8604457974433899,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Maprotiline.,20,Type_20,Yes
DB00297,Bupivacaine,DB00934,Maprotiline,0.9932530522346497,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Maprotiline.,49,Type_49,Yes
DB00384,Triamterene,DB03585,Oxyphenbutazone,0.9969717264175415,37,Type_37,Triamterene may decrease the antihypertensive activities of Oxyphenbutazone.,37,Type_37,Yes
DB00873,Loteprednol,DB13783,Acemetacin,0.9686790108680725,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Acemetacin.,49,Type_49,Yes
DB00328,Indomethacin,DB08797,Salicylamide,0.997307300567627,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Salicylamide.,49,Type_49,Yes
DB00433,Prochlorperazine,DB08881,Vemurafenib,0.4660683274269104,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Prochlorperazine.,33,Type_33,No
DB00590,Doxazosin,DB08992,Eperisone,0.978335440158844,60,Type_60,Doxazosin may increase the hypotensive activities of Eperisone.,60,Type_60,Yes
DB01076,Atorvastatin,DB01190,Clindamycin,0.6174159049987793,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Clindamycin.,49,Type_49,Yes
DB00916,Metronidazole,DB08816,Ticagrelor,0.5469086766242981,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Metronidazole.,47,Type_47,Yes
DB00273,Topiramate,DB06201,Rufinamide,0.9984834790229797,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Rufinamide.,49,Type_49,Yes
DB04272,Citric acid,DB09123,Dienogest,0.7244964241981506,12,Type_12,Citric acid may decrease the anticoagulant activities of Dienogest.,70,Type_70,No
DB00343,Diltiazem,DB00945,Acetylsalicylic acid,0.8171901702880859,47,Type_47,The metabolism of Acetylsalicylic acid can be decreased when combined with Diltiazem.,6,Type_6,No
DB01232,Saquinavir,DB05109,Trabectedin,0.5942919254302979,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Saquinavir.,73,Type_73,No
DB00285,Venlafaxine,DB01100,Pimozide,0.44213104248046875,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Pimozide.,73,Type_73,No
DB00489,Sotalol,DB08881,Vemurafenib,0.6783537268638611,33,Type_33,The risk or severity of QTc prolongation can be increased when Sotalol is combined with Vemurafenib.,33,Type_33,Yes
DB00588,Fluticasone propionate,DB00633,Dexmedetomidine,0.9738478064537048,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dexmedetomidine.,49,Type_49,Yes
DB00795,Sulfasalazine,DB01359,Penbutolol,0.9999241828918457,37,Type_37,Sulfasalazine may decrease the antihypertensive activities of Penbutolol.,37,Type_37,Yes
DB00188,Bortezomib,DB05219,Crisaborole,0.9971484541893005,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00573,Fenoprofen,DB01044,Gatifloxacin,0.9967381358146667,27,Type_27,Fenoprofen may increase the neuroexcitatory activities of Gatifloxacin.,27,Type_27,Yes
DB00615,Rifabutin,DB04572,Thiotepa,0.7410677075386047,4,Type_4,The metabolism of Thiotepa can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00771,Clidinium,DB06201,Rufinamide,0.9799177050590515,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Rufinamide.,49,Type_49,Yes
DB01238,Aripiprazole,DB01587,Ketazolam,0.9524228572845459,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ketazolam.,49,Type_49,Yes
DB00136,Calcitriol,DB01211,Clarithromycin,0.9053555727005005,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Calcitriol.,47,Type_47,Yes
DB00243,Ranolazine,DB12161,Deutetrabenazine,0.819920539855957,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00921,Buprenorphine,DB01338,Pipecuronium,0.9995189905166626,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Pipecuronium.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB00888,Mechlorethamine,0.9999809265136719,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Mechlorethamine.,58,Type_58,Yes
DB06210,Eltrombopag,DB11613,Velpatasvir,0.48241809010505676,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Eltrombopag.,73,Type_73,No
DB01563,Chloral hydrate,DB13025,Tiapride,0.9999889135360718,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Tiapride.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB04861,Nebivolol,0.9520370364189148,25,Type_25,Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Nebivolol.,25,Type_25,Yes
DB01030,Topotecan,DB01054,Nitrendipine,0.9111448526382446,73,Type_73,The serum concentration of Nitrendipine can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB01320,Fosphenytoin,DB09225,Zotepine,0.8488549590110779,49,Type_49,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Zotepine.,49,Type_49,Yes
DB00337,Pimecrolimus,DB09138,Technetium Tc-99m medronate,0.9999746084213257,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Technetium Tc-99m medronate.,49,Type_49,Yes
DB00687,Fludrocortisone,DB01377,Magnesium oxide,0.9995154142379761,3,Type_3,The bioavailability of Magnesium oxide can be decreased when combined with Fludrocortisone.,3,Type_3,Yes
DB00252,Phenytoin,DB01023,Felodipine,0.593971848487854,4,Type_4,The metabolism of Felodipine can be increased when combined with Phenytoin.,73,Type_73,No
DB00353,Methylergometrine,DB13874,Enasidenib,0.857327401638031,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Enasidenib.,49,Type_49,Yes
DB00805,Minaprine,DB01026,Ketoconazole,0.9716131687164307,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Minaprine.,47,Type_47,Yes
DB00331,Metformin,DB01037,Selegiline,0.9984906911849976,9,Type_9,Metformin may increase the hypoglycemic activities of Selegiline.,9,Type_9,Yes
DB01192,Oxymorphone,DB04908,Flibanserin,0.9921183586120605,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Flibanserin.,49,Type_49,Yes
DB00450,Droperidol,DB01015,Sulfamethoxazole,0.9948451519012451,20,Type_20,Droperidol may increase the QTc-prolonging activities of Sulfamethoxazole.,20,Type_20,Yes
DB00340,Metixene,DB00436,Bendroflumethiazide,0.9941748976707458,73,Type_73,The serum concentration of Bendroflumethiazide can be increased when it is combined with Metixene.,73,Type_73,Yes
DB01452,Diamorphine,DB09224,Melperone,0.9997541308403015,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Melperone.,49,Type_49,Yes
DB00690,Flurazepam,DB01239,Chlorprothixene,0.9954042434692383,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Chlorprothixene.,49,Type_49,Yes
DB00899,Remifentanil,DB00979,Cyclopentolate,0.9999901056289673,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclopentolate.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB01628,Etoricoxib,0.9960001111030579,70,Type_70,The therapeutic efficacy of Etoricoxib can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00247,Methysergide,DB00705,Delavirdine,0.996095597743988,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Delavirdine.,49,Type_49,Yes
DB00468,Quinine,DB08816,Ticagrelor,0.7337163090705872,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Quinine.,47,Type_47,Yes
DB00188,Bortezomib,DB00426,Famciclovir,0.9666078090667725,47,Type_47,The metabolism of Famciclovir can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01072,Atazanavir,DB09570,Ixazomib,0.6657162308692932,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB06595,Midostaurin,DB08828,Vismodegib,0.8660667538642883,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00261,Anagrelide,DB00946,Phenprocoumon,0.9750213623046875,6,Type_6,Anagrelide may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00688,Mycophenolate mofetil,DB00905,Bimatoprost,0.9949475526809692,70,Type_70,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mycophenolate mofetil.,70,Type_70,Yes
DB00255,Diethylstilbestrol,DB00555,Lamotrigine,0.4229879081249237,70,Type_70,The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Diethylstilbestrol.,75,Type_75,No
DB00238,Nevirapine,DB01426,Ajmaline,0.3685155212879181,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Nevirapine.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB06770,Benzyl alcohol,0.9948397278785706,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Benzyl alcohol.,49,Type_49,Yes
DB00457,Prazosin,DB00862,Vardenafil,0.779666543006897,60,Type_60,Prazosin may increase the hypotensive activities of Vardenafil.,60,Type_60,Yes
DB00961,Mepivacaine,DB04908,Flibanserin,0.9999785423278809,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Flibanserin.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB00797,Tolazoline,0.8035827875137329,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Tolazoline.,60,Type_60,Yes
DB00604,Cisapride,DB01153,Sertaconazole,0.6992917656898499,73,Type_73,The serum concentration of Sertaconazole can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00193,Tramadol,DB08893,Mirabegron,0.4034745991230011,64,Type_64,Tramadol may increase the serotonergic activities of Mirabegron.,70,Type_70,No
DB00312,Pentobarbital,DB00750,Prilocaine,0.9999176263809204,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Prilocaine.,49,Type_49,Yes
DB00960,Pindolol,DB01019,Bethanechol,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Pindolol is combined with Bethanechol.,49,Type_49,Yes
DB01396,Digitoxin,DB11641,Vinflunine,0.9984190464019775,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Vinflunine.,58,Type_58,Yes
DB01238,Aripiprazole,DB01242,Clomipramine,0.36665478348731995,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Clomipramine.,73,Type_73,No
DB00359,Sulfadiazine,DB06663,Pasireotide,0.628434419631958,47,Type_47,The metabolism of Pasireotide can be decreased when combined with Sulfadiazine.,9,Type_9,No
DB00455,Loratadine,DB01220,Rifaximin,0.7323242425918579,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Loratadine.,73,Type_73,Yes
DB00783,Estradiol,DB01355,Hexobarbital,0.6398519277572632,70,Type_70,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Estradiol.,70,Type_70,Yes
DB00615,Rifabutin,DB00842,Oxazepam,0.8926356434822083,4,Type_4,The metabolism of Oxazepam can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00246,Ziprasidone,DB11609,Normethadone,0.9118736982345581,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Normethadone.,49,Type_49,Yes
DB01069,Promethazine,DB06702,Fesoterodine,0.9926155805587769,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Promethazine.,77,Type_77,Yes
DB00436,Bendroflumethiazide,DB00812,Phenylbutazone,0.9656210541725159,70,Type_70,The therapeutic efficacy of Phenylbutazone can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00312,Pentobarbital,DB08893,Mirabegron,0.893951952457428,4,Type_4,The metabolism of Mirabegron can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00391,Sulpiride,DB01075,Diphenhydramine,0.6408069729804993,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Diphenhydramine.,49,Type_49,Yes
DB01588,Prazepam,DB06288,Amisulpride,0.9924557209014893,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Amisulpride.,49,Type_49,Yes
DB00705,Delavirdine,DB09082,Vilanterol,0.8996850848197937,47,Type_47,The metabolism of Vilanterol can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01018,Guanfacine,DB01254,Dasatinib,0.9074668288230896,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Guanfacine.,73,Type_73,Yes
DB00455,Loratadine,DB09075,Edoxaban,0.9858059287071228,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Loratadine.,73,Type_73,Yes
DB00750,Prilocaine,DB01209,Dezocine,0.9980157613754272,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Dezocine.,49,Type_49,Yes
DB00683,Midazolam,DB11148,Butamben,0.9999831914901733,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Butamben.,49,Type_49,Yes
DB01236,Sevoflurane,DB09073,Palbociclib,0.9948728680610657,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Sevoflurane.,73,Type_73,Yes
DB01588,Prazepam,DB08922,Perospirone,0.9975252747535706,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Perospirone.,49,Type_49,Yes
DB01151,Desipramine,DB01191,Dexfenfluramine,0.8979257941246033,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Desipramine.,47,Type_47,Yes
DB00275,Olmesartan,DB00559,Bosentan,0.8544771671295166,60,Type_60,Olmesartan may increase the hypotensive activities of Bosentan.,60,Type_60,Yes
DB00224,Indinavir,DB00762,Irinotecan,0.663837730884552,47,Type_47,The metabolism of Irinotecan can be decreased when combined with Indinavir.,73,Type_73,No
DB00275,Olmesartan,DB07615,Tranilast,0.8700793981552124,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Tranilast.,49,Type_49,Yes
DB00199,Erythromycin,DB00862,Vardenafil,0.6194190979003906,47,Type_47,The metabolism of Vardenafil can be decreased when combined with Erythromycin.,73,Type_73,No
DB00263,Sulfisoxazole,DB01233,Metoclopramide,0.8964158892631531,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00735,Naftifine,DB09227,Barnidipine,0.9579070806503296,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Barnidipine.,49,Type_49,Yes
DB00989,Rivastigmine,DB01203,Nadolol,0.9928147792816162,54,Type_54,Rivastigmine may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB05351,Dexlansoprazole,DB08931,Riociguat,0.7006120681762695,47,Type_47,The metabolism of Riociguat can be decreased when combined with Dexlansoprazole.,75,Type_75,No
DB00179,Masoprocol,DB00655,Estrone,0.8793341517448425,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Estrone.,49,Type_49,Yes
DB00398,Sorafenib,DB00472,Fluoxetine,0.6793524026870728,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Sorafenib.,20,Type_20,No
DB00187,Esmolol,DB01407,Clenbuterol,0.9779695272445679,14,Type_14,Esmolol may decrease the bronchodilatory activities of Clenbuterol.,14,Type_14,Yes
DB00323,Tolcapone,DB00904,Ondansetron,0.9987038373947144,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Ondansetron.,49,Type_49,Yes
DB00393,Nimodipine,DB00418,Secobarbital,0.8195142149925232,60,Type_60,Nimodipine may increase the hypotensive activities of Secobarbital.,60,Type_60,Yes
DB00312,Pentobarbital,DB00347,Trimethadione,0.9791192412376404,4,Type_4,The metabolism of Trimethadione can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00287,Travoprost,DB01014,Balsalazide,0.9516657590866089,70,Type_70,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB00656,Trazodone,DB01155,Gemifloxacin,0.9874184131622314,20,Type_20,Trazodone may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB01097,Leflunomide,DB08797,Salicylamide,0.8748355507850647,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Salicylamide.,49,Type_49,Yes
DB00780,Phenelzine,DB01203,Nadolol,0.9484660029411316,60,Type_60,Phenelzine may increase the hypotensive activities of Nadolol.,60,Type_60,Yes
DB00297,Bupivacaine,DB04839,Cyproterone acetate,0.8478149771690369,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Bupivacaine.,75,Type_75,Yes
DB00320,Dihydroergotamine,DB01264,Darunavir,0.9465967416763306,47,Type_47,The metabolism of Darunavir can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB09049,Naloxegol,DB09462,Glycerin,0.9997848868370056,73,Type_73,The serum concentration of Glycerin can be increased when it is combined with Naloxegol.,73,Type_73,Yes
DB00349,Clobazam,DB01319,Fosamprenavir,0.8013811111450195,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Clobazam.,47,Type_47,Yes
DB08806,Roxatidine acetate,DB09352,Hydroxyamphetamine,0.9917033314704895,76,Type_76,Roxatidine acetate may decrease the sedative activities of Hydroxyamphetamine.,76,Type_76,Yes
DB00238,Nevirapine,DB00637,Astemizole,0.7240040898323059,4,Type_4,The metabolism of Astemizole can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00688,Mycophenolate mofetil,DB01197,Captopril,0.8594883680343628,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Captopril.,49,Type_49,Yes
DB00281,Lidocaine,DB09071,Tasimelteon,0.9597747325897217,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Tasimelteon.,49,Type_49,Yes
DB00266,Dicoumarol,DB00586,Diclofenac,0.9986302852630615,6,Type_6,Dicoumarol may increase the anticoagulant activities of Diclofenac.,6,Type_6,Yes
DB00983,Formoterol,DB04871,Lorcaserin,0.7130187749862671,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Formoterol.,47,Type_47,Yes
DB06268,Sitaxentan,DB09241,Methylene blue,0.9957303404808044,60,Type_60,Sitaxentan may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB01071,Mequitazine,DB01253,Ergometrine,0.5381267070770264,49,Type_49,The risk or severity of adverse effects can be increased when Mequitazine is combined with Ergometrine.,49,Type_49,Yes
DB00540,Nortriptyline,DB04839,Cyproterone acetate,0.5540781617164612,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB00641,Simvastatin,DB08873,Boceprevir,0.7171622514724731,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB01020,Isosorbide mononitrate,DB01200,Bromocriptine,0.9794787764549255,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Bromocriptine.,49,Type_49,Yes
DB00440,Trimethoprim,DB00966,Telmisartan,0.7406215667724609,68,Type_68,Trimethoprim may increase the hyperkalemic activities of Telmisartan.,68,Type_68,Yes
DB00591,Fluocinolone acetonide,DB06725,Lornoxicam,0.9996498823165894,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Lornoxicam.,49,Type_49,Yes
DB06717,Fosaprepitant,DB11574,Elbasvir,0.563771665096283,73,Type_73,The serum concentration of Elbasvir can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB01159,Halothane,DB04861,Nebivolol,0.9503911137580872,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Nebivolol.,49,Type_49,Yes
DB01095,Fluvastatin,DB01319,Fosamprenavir,0.5602547526359558,73,Type_73,The serum concentration of Fosamprenavir can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00835,Brompheniramine,DB01029,Irbesartan,0.93129962682724,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB00248,Cabergoline,DB09477,Enalaprilat,0.6085858941078186,73,Type_73,The serum concentration of Enalaprilat can be increased when it is combined with Cabergoline.,73,Type_73,Yes
DB00246,Ziprasidone,DB00726,Trimipramine,0.5157885551452637,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Ziprasidone.,20,Type_20,No
DB01155,Gemifloxacin,DB08880,Teriflunomide,0.8223273158073425,27,Type_27,Gemifloxacin may increase the neuroexcitatory activities of Teriflunomide.,27,Type_27,Yes
DB00582,Voriconazole,DB08798,Sulfamoxole,0.9341365694999695,47,Type_47,The metabolism of Sulfamoxole can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00233,Aminosalicylic acid,DB00912,Repaglinide,0.9912874102592468,9,Type_9,Aminosalicylic acid may increase the hypoglycemic activities of Repaglinide.,9,Type_9,Yes
DB00817,Rosoxacin,DB08971,Fluocortolone,0.9970098733901978,49,Type_49,The risk or severity of adverse effects can be increased when Rosoxacin is combined with Fluocortolone.,49,Type_49,Yes
DB00232,Methyclothiazide,DB08882,Linagliptin,0.9044563174247742,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB00458,Imipramine,DB06335,Saxagliptin,0.6948801279067993,73,Type_73,The serum concentration of Saxagliptin can be increased when it is combined with Imipramine.,73,Type_73,Yes
DB00328,Indomethacin,DB00524,Metolazone,0.9904696941375732,70,Type_70,The therapeutic efficacy of Metolazone can be decreased when used in combination with Indomethacin.,70,Type_70,Yes
DB00645,Dyclonine,DB00950,Fexofenadine,0.9998739957809448,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Fexofenadine.,49,Type_49,Yes
DB00461,Nabumetone,DB00788,Naproxen,0.9910914301872253,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Naproxen.,49,Type_49,Yes
DB01054,Nitrendipine,DB01394,Colchicine,0.9553155899047852,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Nitrendipine.,73,Type_73,Yes
DB00235,Milrinone,DB01014,Balsalazide,0.5476818680763245,49,Type_49,The risk or severity of adverse effects can be increased when Milrinone is combined with Balsalazide.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09275,Bismuth subcitrate potassium,0.9755073189735413,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Rosuvastatin.,75,Type_75,Yes
DB00450,Droperidol,DB01624,Zuclopenthixol,0.96864914894104,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,16,Type_16,Yes
DB00967,Desloratadine,DB06738,Ketobemidone,0.9962750673294067,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Ketobemidone.,49,Type_49,Yes
DB00696,Ergotamine,DB04871,Lorcaserin,0.8657209277153015,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Lorcaserin.,49,Type_49,Yes
DB00684,Tobramycin,DB00784,Mefenamic acid,0.9999581575393677,72,Type_72,Tobramycin may decrease the excretion rate of Mefenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB00487,Pefloxacin,DB01250,Olsalazine,0.9990804195404053,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Olsalazine.,27,Type_27,Yes
DB00187,Esmolol,DB00373,Timolol,0.5418474674224854,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Timolol.,49,Type_49,Yes
DB00899,Remifentanil,DB11148,Butamben,0.9997426867485046,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Butamben.,49,Type_49,Yes
DB00844,Nalbuphine,DB00849,Methylphenobarbital,0.9882676005363464,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methylphenobarbital.,49,Type_49,Yes
DB00961,Mepivacaine,DB01178,Chlormezanone,0.9999990463256836,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Chlormezanone.,49,Type_49,Yes
DB00772,Malathion,DB00960,Pindolol,0.9857856631278992,54,Type_54,Malathion may increase the bradycardic activities of Pindolol.,54,Type_54,Yes
DB00446,Chloramphenicol,DB09120,Zucapsaicin,0.9993317723274231,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00420,Promazine,DB01029,Irbesartan,0.8475419282913208,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Promazine.,47,Type_47,Yes
DB00497,Oxycodone,DB00924,Cyclobenzaprine,0.897845983505249,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00810,Biperiden,DB06695,Dabigatran etexilate,0.9931575655937195,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Biperiden.,77,Type_77,Yes
DB01078,Deslanoside,DB13142,Calcium glubionate anhydrous,0.9979367256164551,82,Type_82,Deslanoside may increase the arrhythmogenic activities of Calcium glubionate anhydrous.,82,Type_82,Yes
DB01708,Prasterone,DB08804,Nandrolone decanoate,1.0,74,Type_74,Prasterone may increase the fluid retaining activities of Nandrolone decanoate.,74,Type_74,Yes
DB00705,Delavirdine,DB00860,Prednisolone,0.9333875775337219,47,Type_47,The metabolism of Prednisolone can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00222,Glimepiride,DB06700,Desvenlafaxine,0.9670010209083557,9,Type_9,Glimepiride may increase the hypoglycemic activities of Desvenlafaxine.,9,Type_9,Yes
DB00310,Chlorthalidone,DB00871,Terbutaline,0.9999055862426758,83,Type_83,Chlorthalidone may increase the hypokalemic activities of Terbutaline.,83,Type_83,Yes
DB00604,Cisapride,DB06717,Fosaprepitant,0.8960238695144653,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00691,Moexipril,DB00744,Zileuton,0.9543429613113403,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Zileuton.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB08808,Bupranolol,0.7777305841445923,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00655,Estrone,DB00817,Rosoxacin,0.6892789006233215,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Rosoxacin.,49,Type_49,Yes
DB01026,Ketoconazole,DB08860,Pitavastatin,0.7783432006835938,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Ketoconazole.,47,Type_47,No
DB00905,Bimatoprost,DB07615,Tranilast,0.9135554432868958,70,Type_70,The therapeutic efficacy of Tranilast can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00892,Oxybuprocaine,DB01545,Ethyl loflazepate,0.9999982118606567,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00205,Pyrimethamine,DB00531,Cyclophosphamide,0.4239148795604706,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00651,Dyphylline,DB01337,Pancuronium,0.9409293532371521,49,Type_49,The risk or severity of adverse effects can be increased when Dyphylline is combined with Pancuronium.,49,Type_49,Yes
DB00418,Secobarbital,DB00844,Nalbuphine,0.9803445339202881,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Nalbuphine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01275,Hydralazine,0.8602739572525024,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Hydralazine.,49,Type_49,Yes
DB00328,Indomethacin,DB00564,Carbamazepine,0.8910715579986572,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Indomethacin.,4,Type_4,Yes
DB00624,Testosterone,DB01095,Fluvastatin,0.6927664875984192,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00489,Sotalol,DB01158,Bretylium,0.792219340801239,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Bretylium.,54,Type_54,No
DB00682,Warfarin,DB01604,Pivampicillin,0.9940289258956909,6,Type_6,Warfarin may increase the anticoagulant activities of Pivampicillin.,6,Type_6,Yes
DB00695,Furosemide,DB00722,Lisinopril,0.903934121131897,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Lisinopril.,49,Type_49,Yes
DB01186,Pergolide,DB09073,Palbociclib,0.9903523325920105,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Pergolide.,73,Type_73,Yes
DB00977,Ethinylestradiol,DB09073,Palbociclib,0.7548726201057434,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB01017,Minocycline,DB01588,Prazepam,0.9851927757263184,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Prazepam.,16,Type_16,Yes
DB00758,Clopidogrel,DB08873,Boceprevir,0.5512771010398865,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Clopidogrel.,47,Type_47,Yes
DB00498,Phenindione,DB00540,Nortriptyline,0.8385325074195862,6,Type_6,Phenindione may increase the anticoagulant activities of Nortriptyline.,6,Type_6,Yes
DB00193,Tramadol,DB00494,Entacapone,0.9895512461662292,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Entacapone.,49,Type_49,Yes
DB00418,Secobarbital,DB00808,Indapamide,0.9029135704040527,30,Type_30,Secobarbital may increase the orthostatic hypotensive activities of Indapamide.,30,Type_30,Yes
DB04896,Milnacipran,DB04953,Ezogabine,0.7692028880119324,49,Type_49,The risk or severity of adverse effects can be increased when Milnacipran is combined with Ezogabine.,49,Type_49,Yes
DB01325,Quinethazone,DB08984,Etofenamate,0.9973822236061096,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB04855,Dronedarone,DB11614,Rupatadine,0.9350035786628723,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00503,Ritonavir,DB08912,Dabrafenib,0.9672572612762451,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Ritonavir.,75,Type_75,Yes
DB00450,Droperidol,DB00683,Midazolam,0.9957705140113831,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.,16,Type_16,Yes
DB00241,Butalbital,DB01159,Halothane,0.995890736579895,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Halothane.,49,Type_49,Yes
DB00457,Prazosin,DB00584,Enalapril,0.8529036045074463,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Enalapril.,49,Type_49,Yes
DB00341,Cetirizine,DB04842,Fluspirilene,0.995705783367157,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Fluspirilene.,49,Type_49,Yes
DB00367,Levonorgestrel,DB09343,Tipiracil,0.9970396161079407,70,Type_70,The therapeutic efficacy of Tipiracil can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB01202,Levetiracetam,DB04908,Flibanserin,0.9884395599365234,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Flibanserin.,49,Type_49,Yes
DB00708,Sufentanil,DB00925,Phenoxybenzamine,0.861348032951355,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Phenoxybenzamine.,49,Type_49,Yes
DB00264,Metoprolol,DB00349,Clobazam,0.7422276735305786,47,Type_47,The metabolism of Clobazam can be decreased when combined with Metoprolol.,73,Type_73,No
DB00320,Dihydroergotamine,DB00661,Verapamil,0.9624221324920654,47,Type_47,The metabolism of Verapamil can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00720,Clodronic acid,DB09275,Bismuth subcitrate potassium,0.9932093024253845,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Clodronic acid.,75,Type_75,Yes
DB00289,Atomoxetine,DB00553,Methoxsalen,0.9841317534446716,47,Type_47,The metabolism of Methoxsalen can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00241,Butalbital,DB00734,Risperidone,0.9969246983528137,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Risperidone.,49,Type_49,Yes
DB00227,Lovastatin,DB06708,Lumefantrine,0.45412299036979675,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00474,Methohexital,DB00748,Carbinoxamine,0.8887302279472351,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Carbinoxamine.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB06772,Cabazitaxel,0.7210075259208679,47,Type_47,The metabolism of Cabazitaxel can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00429,Carboprost tromethamine,DB06725,Lornoxicam,0.5800096392631531,70,Type_70,The therapeutic efficacy of Lornoxicam can be decreased when used in combination with Carboprost tromethamine.,70,Type_70,Yes
DB00285,Venlafaxine,DB13025,Tiapride,0.8973321318626404,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tiapride.,49,Type_49,Yes
DB08873,Boceprevir,DB09280,Lumacaftor,0.4769924283027649,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Boceprevir.,75,Type_75,Yes
DB00839,Tolazamide,DB01251,Gliquidone,0.9954793453216553,9,Type_9,Tolazamide may increase the hypoglycemic activities of Gliquidone.,9,Type_9,Yes
DB00234,Reboxetine,DB08820,Ivacaftor,0.9991449117660522,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Reboxetine.,73,Type_73,Yes
DB00998,Frovatriptan,DB06288,Amisulpride,0.9987478256225586,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Amisulpride.,49,Type_49,Yes
DB01183,Naloxone,DB09330,Osimertinib,0.8906399607658386,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Naloxone.,73,Type_73,Yes
DB00363,Clozapine,DB00423,Methocarbamol,0.9866654276847839,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Methocarbamol.,49,Type_49,Yes
DB01403,Methotrimeprazine,DB09183,Dasabuvir,0.8465549945831299,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Methotrimeprazine.,47,Type_47,Yes
DB08933,Luliconazole,DB09270,Ubidecarenone,0.9966741800308228,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Luliconazole.,73,Type_73,Yes
DB00822,Disulfiram,DB01174,Phenobarbital,0.9725720286369324,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Disulfiram.,4,Type_4,Yes
DB00648,Mitotane,DB08896,Regorafenib,0.9857429265975952,75,Type_75,The serum concentration of Regorafenib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01182,Propafenone,DB01193,Acebutolol,0.8940533995628357,54,Type_54,Propafenone may increase the bradycardic activities of Acebutolol.,73,Type_73,No
DB00335,Atenolol,DB01067,Glipizide,0.8510705828666687,9,Type_9,Atenolol may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00497,Oxycodone,DB01118,Amiodarone,0.808580219745636,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Oxycodone.,49,Type_49,No
DB00445,Epirubicin,DB11156,Pyrantel,0.9999704360961914,40,Type_40,Epirubicin may increase the respiratory depressant activities of Pyrantel.,40,Type_40,Yes
DB00421,Spironolactone,DB01242,Clomipramine,0.7650565505027771,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Clomipramine.,49,Type_49,Yes
DB01355,Hexobarbital,DB08992,Eperisone,0.9620201587677002,4,Type_4,The metabolism of Eperisone can be increased when combined with Hexobarbital.,4,Type_4,Yes
DB00925,Phenoxybenzamine,DB13783,Acemetacin,0.9845207333564758,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Phenoxybenzamine.,70,Type_70,Yes
DB00193,Tramadol,DB01440,gamma-Hydroxybutyric acid,0.9876790642738342,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00455,Loratadine,DB11148,Butamben,0.999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Butamben.,49,Type_49,Yes
DB00608,Chloroquine,DB08903,Bedaquiline,0.913455605506897,20,Type_20,Chloroquine may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB05521,Telaprevir,DB09289,Tianeptine,0.8125776648521423,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Telaprevir.,73,Type_73,No
DB00630,Alendronic acid,DB00870,Suprofen,0.9959039092063904,49,Type_49,The risk or severity of adverse effects can be increased when Alendronic acid is combined with Suprofen.,49,Type_49,Yes
DB01234,Dexamethasone,DB02709,Resveratrol,0.9926395416259766,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Resveratrol.,49,Type_49,Yes
DB00834,Mifepristone,DB12026,Voxilaprevir,0.8302445411682129,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00687,Fludrocortisone,DB08873,Boceprevir,0.8078073859214783,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Fludrocortisone.,73,Type_73,Yes
DB00594,Amiloride,DB09232,Cilnidipine,0.9665440917015076,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Cilnidipine.,49,Type_49,Yes
DB01236,Sevoflurane,DB01587,Ketazolam,0.9765465259552002,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Ketazolam.,49,Type_49,Yes
DB01236,Sevoflurane,DB06695,Dabigatran etexilate,0.946429431438446,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Sevoflurane.,6,Type_6,No
DB00528,Lercanidipine,DB00866,Alprenolol,0.8153901100158691,60,Type_60,Lercanidipine may increase the hypotensive activities of Alprenolol.,60,Type_60,Yes
DB00252,Phenytoin,DB05294,Vandetanib,0.7324174046516418,75,Type_75,The serum concentration of Vandetanib can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00524,Metolazone,DB02300,Calcipotriol,0.9907981157302856,51,Type_51,Metolazone may increase the hypercalcemic activities of Calcipotriol.,51,Type_51,Yes
DB00620,Triamcinolone,DB00681,Amphotericin B,0.9600496888160706,83,Type_83,Triamcinolone may increase the hypokalemic activities of Amphotericin B.,83,Type_83,Yes
DB00939,Meclofenamic acid,DB01628,Etoricoxib,0.9997453093528748,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etoricoxib.,49,Type_49,Yes
DB01107,Methyprylon,DB01601,Lopinavir,0.984067976474762,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Methyprylon.,47,Type_47,Yes
DB01104,Sertraline,DB08883,Perampanel,0.6118679046630859,47,Type_47,The metabolism of Perampanel can be decreased when combined with Sertraline.,49,Type_49,No
DB00872,Conivaptan,DB01167,Itraconazole,0.9199647903442383,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00661,Verapamil,DB09112,Nitrous acid,0.9997503161430359,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Nitrous acid.,49,Type_49,Yes
DB01053,Benzylpenicillin,DB03615,Ribostamycin,0.9997442364692688,75,Type_75,The serum concentration of Ribostamycin can be decreased when it is combined with Benzylpenicillin.,75,Type_75,Yes
DB01403,Methotrimeprazine,DB09167,Dosulepin,0.6239060759544373,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Methotrimeprazine.,47,Type_47,Yes
DB09079,Nintedanib,DB13874,Enasidenib,0.8685701489448547,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Nintedanib.,73,Type_73,Yes
DB00541,Vincristine,DB00624,Testosterone,0.731370210647583,73,Type_73,The serum concentration of Testosterone can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00915,Amantadine,DB06708,Lumefantrine,0.9124770760536194,20,Type_20,Amantadine may increase the QTc-prolonging activities of Lumefantrine.,20,Type_20,Yes
DB00960,Pindolol,DB01251,Gliquidone,0.9847742915153503,9,Type_9,Pindolol may increase the hypoglycemic activities of Gliquidone.,9,Type_9,Yes
DB00813,Fentanyl,DB01065,Melatonin,0.9987707734107971,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Melatonin.,49,Type_49,Yes
DB08439,Parecoxib,DB09084,Benzydamine,0.9934194684028625,49,Type_49,The risk or severity of adverse effects can be increased when Parecoxib is combined with Benzydamine.,49,Type_49,Yes
DB00663,Flumethasone,DB06710,Methyltestosterone,0.995851993560791,74,Type_74,Flumethasone may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB06716,Fospropofol,DB09117,Paraldehyde,0.9999909400939941,16,Type_16,Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00797,Tolazoline,DB00820,Tadalafil,0.9942321181297302,10,Type_10,Tolazoline may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00590,Doxazosin,DB01151,Desipramine,0.5696126818656921,47,Type_47,The metabolism of Desipramine can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00755,Tretinoin,DB00783,Estradiol,0.5858711004257202,47,Type_47,The metabolism of Estradiol can be decreased when combined with Tretinoin.,70,Type_70,No
DB08865,Crizotinib,DB08893,Mirabegron,0.6840901970863342,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Crizotinib.,20,Type_20,No
DB01095,Fluvastatin,DB01217,Anastrozole,0.8258190751075745,73,Type_73,The serum concentration of Anastrozole can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00481,Raloxifene,DB01211,Clarithromycin,0.895658552646637,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB01380,Cortisone acetate,DB09038,Empagliflozin,0.7895961403846741,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Cortisone acetate.,70,Type_70,Yes
DB00898,Ethanol,DB08881,Vemurafenib,0.5285829305648804,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Ethanol.,73,Type_73,No
DB09049,Naloxegol,DB12026,Voxilaprevir,0.9947478175163269,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Naloxegol.,73,Type_73,Yes
DB01224,Quetiapine,DB11730,Ribociclib,0.941294252872467,33,Type_33,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ribociclib.,73,Type_73,No
DB00320,Dihydroergotamine,DB13025,Tiapride,0.9071986079216003,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tiapride.,49,Type_49,Yes
DB06288,Amisulpride,DB06738,Ketobemidone,0.9805387258529663,49,Type_49,The risk or severity of adverse effects can be increased when Amisulpride is combined with Ketobemidone.,49,Type_49,Yes
DB00187,Esmolol,DB01288,Fenoterol,0.9594314098358154,14,Type_14,Esmolol may decrease the bronchodilatory activities of Fenoterol.,14,Type_14,Yes
DB00472,Fluoxetine,DB05812,Abiraterone,0.6761852502822876,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00470,Dronabinol,DB04908,Flibanserin,0.9999402761459351,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,16,Type_16,Yes
DB00598,Labetalol,DB01021,Trichlormethiazide,0.9764391183853149,60,Type_60,Labetalol may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB00177,Valsartan,DB00465,Ketorolac,0.9739236831665039,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Ketorolac.,49,Type_49,Yes
DB00315,Zolmitriptan,DB09241,Methylene blue,0.6109936237335205,47,Type_47,The metabolism of Methylene blue can be decreased when combined with Zolmitriptan.,47,Type_47,Yes
DB00243,Ranolazine,DB09026,Aliskiren,0.6648150086402893,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00405,Dexbrompheniramine,DB00921,Buprenorphine,0.9992942810058594,16,Type_16,Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00907,Cocaine,DB01209,Dezocine,0.9920680522918701,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Dezocine.,49,Type_49,Yes
DB00421,Spironolactone,DB01024,Mycophenolic acid,0.5154507160186768,37,Type_37,Spironolactone may decrease the antihypertensive activities of Mycophenolic acid.,37,Type_37,Yes
DB08880,Teriflunomide,DB13874,Enasidenib,0.6401940584182739,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Teriflunomide.,75,Type_75,No
DB00176,Fluvoxamine,DB01028,Methoxyflurane,0.6715164184570312,47,Type_47,The metabolism of Methoxyflurane can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00726,Trimipramine,DB09074,Olaparib,0.84324711561203,47,Type_47,The metabolism of Olaparib can be decreased when combined with Trimipramine.,47,Type_47,Yes
DB01576,Dextroamphetamine,DB04855,Dronedarone,0.9783016443252563,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Dextroamphetamine.,47,Type_47,Yes
DB00575,Clonidine,DB01045,Rifampicin,0.9623607397079468,4,Type_4,The metabolism of Rifampicin can be increased when combined with Clonidine.,4,Type_4,Yes
DB00694,Daunorubicin,DB00744,Zileuton,0.9866786599159241,72,Type_72,Daunorubicin may decrease the excretion rate of Zileuton which could result in a higher serum level.,72,Type_72,Yes
DB00880,Chlorothiazide,DB09070,Tibolone,0.9690028429031372,60,Type_60,Chlorothiazide may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00774,Hydroflumethiazide,DB01282,Carbetocin,0.8975940346717834,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Carbetocin.,49,Type_49,Yes
DB00975,Dipyridamole,DB06605,Apixaban,0.5292165875434875,6,Type_6,Dipyridamole may increase the anticoagulant activities of Apixaban.,49,Type_49,No
DB00252,Phenytoin,DB06016,Cariprazine,0.6034554243087769,4,Type_4,The metabolism of Cariprazine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00904,Ondansetron,DB01169,Arsenic trioxide,0.8826810717582703,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB01168,Procarbazine,DB09244,Pirlindole,0.5077111124992371,71,Type_71,Procarbazine may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB00537,Ciprofloxacin,DB08916,Afatinib,0.8200806975364685,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Ciprofloxacin.,73,Type_73,Yes
DB00919,Spectinomycin,DB04743,Nimesulide,0.9993146657943726,72,Type_72,Spectinomycin may decrease the excretion rate of Nimesulide which could result in a higher serum level.,72,Type_72,Yes
DB00500,Tolmetin,DB04272,Citric acid,0.9996902942657471,6,Type_6,Tolmetin may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00363,Clozapine,DB09117,Paraldehyde,0.9912691116333008,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00692,Phentolamine,DB00808,Indapamide,0.6972525715827942,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Indapamide.,60,Type_60,No
DB00254,Doxycycline,DB00949,Felbamate,0.8985180854797363,47,Type_47,The metabolism of Felbamate can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00875,Flupentixol,DB09080,Olodaterol,0.9172223210334778,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Olodaterol.,20,Type_20,Yes
DB00998,Frovatriptan,DB01238,Aripiprazole,0.9096912741661072,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aripiprazole.,49,Type_49,Yes
DB01018,Guanfacine,DB12532,Oxetacaine,0.9987596273422241,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Oxetacaine.,49,Type_49,Yes
DB01223,Aminophylline,DB01355,Hexobarbital,0.7614522576332092,70,Type_70,The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Aminophylline.,75,Type_75,No
DB01091,Butenafine,DB01268,Sunitinib,0.6817463040351868,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Butenafine.,47,Type_47,No
DB00961,Mepivacaine,DB08918,Levomilnacipran,0.996403694152832,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Levomilnacipran.,49,Type_49,Yes
DB01182,Propafenone,DB01238,Aripiprazole,0.4664185345172882,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Propafenone.,20,Type_20,No
DB00400,Griseofulvin,DB00898,Ethanol,0.5638788342475891,73,Type_73,The serum concentration of Ethanol can be increased when it is combined with Griseofulvin.,49,Type_49,No
DB00976,Telithromycin,DB06212,Tolvaptan,0.9756660461425781,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Telithromycin.,73,Type_73,Yes
DB00334,Olanzapine,DB00818,Propofol,0.495217502117157,20,Type_20,Olanzapine may increase the QTc-prolonging activities of Propofol.,49,Type_49,No
DB00246,Ziprasidone,DB00683,Midazolam,0.70607590675354,47,Type_47,The metabolism of Midazolam can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01015,Sulfamethoxazole,DB06739,Seratrodast,0.7376764416694641,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB01567,Fludiazepam,DB06716,Fospropofol,0.9968061447143555,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Fospropofol.,49,Type_49,Yes
DB00358,Mefloquine,DB04841,Flunarizine,0.6397783756256104,70,Type_70,The therapeutic efficacy of Flunarizine can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00628,Clorazepic acid,DB04841,Flunarizine,0.9945090413093567,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Flunarizine.,49,Type_49,Yes
DB00726,Trimipramine,DB01155,Gemifloxacin,0.9007201790809631,20,Type_20,Trimipramine may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00675,Tamoxifen,DB06738,Ketobemidone,0.8802732825279236,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB00323,Tolcapone,DB01275,Hydralazine,0.9389391541481018,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Hydralazine.,49,Type_49,Yes
DB04743,Nimesulide,DB06154,Pentaerythritol tetranitrate,0.9999241828918457,6,Type_6,Nimesulide may increase the anticoagulant activities of Pentaerythritol tetranitrate.,6,Type_6,Yes
DB00196,Fluconazole,DB00589,Lisuride,0.9605681300163269,47,Type_47,The metabolism of Lisuride can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01601,Lopinavir,DB09272,Eluxadoline,0.8328396081924438,73,Type_73,The serum concentration of Eluxadoline can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00494,Entacapone,DB00557,Hydroxyzine,0.9994271993637085,16,Type_16,Entacapone may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB00880,Chlorothiazide,DB13158,Clobetasone,0.9999550580978394,83,Type_83,Chlorothiazide may increase the hypokalemic activities of Clobetasone.,83,Type_83,Yes
DB00721,Procaine,DB01017,Minocycline,0.998396098613739,16,Type_16,Procaine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00934,Maprotiline,DB09118,Stiripentol,0.7830407023429871,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Maprotiline.,47,Type_47,No
DB00334,Olanzapine,DB00601,Linezolid,0.7657181620597839,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Linezolid.,49,Type_49,Yes
DB01105,Sibutramine,DB09073,Palbociclib,0.9944548010826111,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Sibutramine.,73,Type_73,Yes
DB00915,Amantadine,DB01211,Clarithromycin,0.5160056352615356,20,Type_20,Amantadine may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB01433,Methadyl acetate,DB04946,Iloperidone,0.9836961030960083,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Iloperidone.,49,Type_49,Yes
DB00206,Reserpine,DB09280,Lumacaftor,0.4279833137989044,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Reserpine.,75,Type_75,Yes
DB01193,Acebutolol,DB06702,Fesoterodine,0.8586389422416687,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Acebutolol.,77,Type_77,Yes
DB00907,Cocaine,DB06153,Pizotifen,0.9995449185371399,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Pizotifen.,49,Type_49,Yes
DB00421,Spironolactone,DB00881,Quinapril,0.9714081883430481,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.,49,Type_49,Yes
DB00938,Salmeterol,DB01253,Ergometrine,0.9006064534187317,71,Type_71,Salmeterol may increase the hypertensive activities of Ergometrine.,71,Type_71,Yes
DB00770,Alprostadil,DB08984,Etofenamate,0.8938827514648438,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00245,Benzatropine,DB06204,Tapentadol,0.9524641633033752,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Tapentadol.,49,Type_49,Yes
DB00838,Clocortolone,DB08909,Glycerol phenylbutyrate,0.9633587598800659,70,Type_70,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Clocortolone.,70,Type_70,Yes
DB00232,Methyclothiazide,DB06739,Seratrodast,0.9733601808547974,70,Type_70,The therapeutic efficacy of Seratrodast can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB00470,Dronabinol,DB00816,Orciprenaline,0.9871184825897217,85,Type_85,Dronabinol may increase the tachycardic activities of Orciprenaline.,85,Type_85,Yes
DB00395,Carisoprodol,DB06716,Fospropofol,0.9999948740005493,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fospropofol.,49,Type_49,Yes
DB00220,Nelfinavir,DB01319,Fosamprenavir,0.46701106429100037,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB04868,Nilotinib,DB09262,Imidafenacin,0.9759474396705627,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB00655,Estrone,DB00805,Minaprine,0.6061572432518005,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Minaprine.,49,Type_49,Yes
DB01223,Aminophylline,DB01348,Spirapril,0.9678499102592468,75,Type_75,The serum concentration of Spirapril can be decreased when it is combined with Aminophylline.,75,Type_75,Yes
DB01023,Felodipine,DB01072,Atazanavir,0.7707042694091797,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Felodipine.,47,Type_47,Yes
DB00457,Prazosin,DB01169,Arsenic trioxide,0.9550836682319641,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Arsenic trioxide.,49,Type_49,Yes
DB00683,Midazolam,DB01254,Dasatinib,0.7260658740997314,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Midazolam.,73,Type_73,Yes
DB00270,Isradipine,DB00656,Trazodone,0.8988853096961975,20,Type_20,Isradipine may increase the QTc-prolonging activities of Trazodone.,47,Type_47,No
DB00331,Metformin,DB00783,Estradiol,0.9088081121444702,70,Type_70,The therapeutic efficacy of Estradiol can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00674,Galantamine,DB00757,Dolasetron,0.9305532574653625,20,Type_20,Galantamine may increase the QTc-prolonging activities of Dolasetron.,20,Type_20,Yes
DB00592,Piperazine,DB06335,Saxagliptin,0.9374167919158936,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Piperazine.,70,Type_70,Yes
DB00814,Meloxicam,DB04574,Estrone sulfate,0.8614701628684998,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Estrone sulfate.,49,Type_49,Yes
DB01197,Captopril,DB01348,Spirapril,0.9250946044921875,60,Type_60,Captopril may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00604,Cisapride,DB00862,Vardenafil,0.9373295903205872,20,Type_20,Cisapride may increase the QTc-prolonging activities of Vardenafil.,20,Type_20,Yes
DB00573,Fenoprofen,DB04951,Pirfenidone,0.9797898530960083,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Pirfenidone.,49,Type_49,Yes
DB00283,Clemastine,DB00660,Metaxalone,0.9837396740913391,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Metaxalone.,49,Type_49,Yes
DB00782,Propantheline,DB01122,Ambenonium,0.998808741569519,70,Type_70,The therapeutic efficacy of Ambenonium can be decreased when used in combination with Propantheline.,70,Type_70,Yes
DB00422,Methylphenidate,DB00678,Losartan,0.9570757150650024,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Losartan.,37,Type_37,Yes
DB01080,Vigabatrin,DB06144,Sertindole,0.9999454021453857,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Sertindole.,49,Type_49,Yes
DB00741,Hydrocortisone,DB09053,Ibrutinib,0.72756427526474,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Hydrocortisone.,73,Type_73,Yes
DB00401,Nisoldipine,DB09292,Sacubitril,0.9982692003250122,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Sacubitril.,49,Type_49,Yes
DB01248,Docetaxel,DB09280,Lumacaftor,0.6332454681396484,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Docetaxel.,75,Type_75,Yes
DB00281,Lidocaine,DB00842,Oxazepam,0.7705807089805603,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Oxazepam.,49,Type_49,Yes
DB01026,Ketoconazole,DB06402,Telavancin,0.9999896287918091,20,Type_20,Ketoconazole may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00316,Acetaminophen,DB01011,Metyrapone,0.8813723921775818,73,Type_73,The serum concentration of Metyrapone can be increased when it is combined with Acetaminophen.,73,Type_73,Yes
DB00899,Remifentanil,DB00999,Hydrochlorothiazide,0.9998127818107605,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00805,Minaprine,DB06203,Alogliptin,0.9993958473205566,9,Type_9,Minaprine may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00475,Chlordiazepoxide,DB00496,Darifenacin,0.9134148359298706,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00751,Epinastine,DB01320,Fosphenytoin,0.9003424048423767,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Epinastine.,4,Type_4,Yes
DB00248,Cabergoline,DB00390,Digoxin,0.32621070742607117,25,Type_25,Cabergoline may increase the atrioventricular blocking (AV block) activities of Digoxin.,58,Type_58,No
DB00890,Dienestrol,DB13158,Clobetasone,0.9988345503807068,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Dienestrol.,73,Type_73,Yes
DB00820,Tadalafil,DB08873,Boceprevir,0.6864179968833923,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Tadalafil.,73,Type_73,Yes
DB00470,Dronabinol,DB06413,Armodafinil,0.5583969354629517,73,Type_73,The serum concentration of Armodafinil can be increased when it is combined with Dronabinol.,47,Type_47,No
DB04855,Dronedarone,DB05381,Histamine,0.8063775897026062,47,Type_47,The metabolism of Histamine can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00633,Dexmedetomidine,DB00985,Dimenhydrinate,0.9910399317741394,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Dimenhydrinate.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00542,Benazepril,0.5269318222999573,73,Type_73,The serum concentration of Benazepril can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB00521,Carteolol,DB01250,Olsalazine,0.9947563409805298,37,Type_37,Carteolol may decrease the antihypertensive activities of Olsalazine.,37,Type_37,Yes
DB00611,Butorphanol,DB06594,Agomelatine,0.9999620914459229,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Agomelatine.,49,Type_49,Yes
DB00257,Clotrimazole,DB06605,Apixaban,0.6499519348144531,47,Type_47,The metabolism of Apixaban can be decreased when combined with Clotrimazole.,73,Type_73,No
DB00508,Triflupromazine,DB01466,Ethylmorphine,0.9918770790100098,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Ethylmorphine.,49,Type_49,Yes
DB00681,Amphotericin B,DB00925,Phenoxybenzamine,0.9902922511100769,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phenoxybenzamine.,49,Type_49,Yes
DB01045,Rifampicin,DB01295,Bevantolol,0.8070536851882935,75,Type_75,The serum concentration of Bevantolol can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00831,Trifluoperazine,DB00854,Levorphanol,0.9943853616714478,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levorphanol.,49,Type_49,Yes
DB06145,Spiramycin,DB09065,Cobicistat,0.5972626805305481,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Spiramycin.,47,Type_47,Yes
DB00312,Pentobarbital,DB00379,Mexiletine,0.6510992646217346,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Pentobarbital.,4,Type_4,No
DB01218,Halofantrine,DB09241,Methylene blue,0.3302984833717346,47,Type_47,The metabolism of Methylene blue can be decreased when combined with Halofantrine.,73,Type_73,No
DB00905,Bimatoprost,DB00945,Acetylsalicylic acid,0.8751459121704102,70,Type_70,The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00457,Prazosin,DB09245,Toloxatone,0.9687281250953674,60,Type_60,Prazosin may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00454,Meperidine,DB00708,Sufentanil,0.8852326273918152,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Sufentanil.,49,Type_49,Yes
DB00498,Phenindione,DB00861,Diflunisal,0.9998475313186646,6,Type_6,Phenindione may increase the anticoagulant activities of Diflunisal.,6,Type_6,Yes
DB00654,Latanoprost,DB04861,Nebivolol,0.9999845027923584,60,Type_60,Latanoprost may increase the hypotensive activities of Nebivolol.,60,Type_60,Yes
DB00887,Bumetanide,DB06781,Difluprednate,0.9996121525764465,83,Type_83,Bumetanide may increase the hypokalemic activities of Difluprednate.,83,Type_83,Yes
DB01021,Trichlormethiazide,DB09288,Propacetamol,0.9957516193389893,70,Type_70,The therapeutic efficacy of Propacetamol can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB00932,Tipranavir,DB06203,Alogliptin,0.4190502464771271,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Tipranavir.,75,Type_75,No
DB01463,Fencamfamin,DB06738,Ketobemidone,0.9898555278778076,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Ketobemidone.,49,Type_49,Yes
DB00820,Tadalafil,DB09280,Lumacaftor,0.5615825653076172,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Tadalafil.,75,Type_75,No
DB00604,Cisapride,DB00934,Maprotiline,0.9623599648475647,20,Type_20,Cisapride may increase the QTc-prolonging activities of Maprotiline.,20,Type_20,Yes
DB00014,Goserelin,DB09039,Eliglustat,0.9950397610664368,20,Type_20,Goserelin may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB06207,Silodosin,DB08807,Bopindolol,0.9953967928886414,30,Type_30,Silodosin may increase the orthostatic hypotensive activities of Bopindolol.,30,Type_30,Yes
DB00317,Gefitinib,DB01394,Colchicine,0.5740669369697571,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Gefitinib.,73,Type_73,Yes
DB00381,Amlodipine,DB00486,Nabilone,0.977168083190918,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Nabilone.,49,Type_49,Yes
DB06694,Xylometazoline,DB08943,Isoconazole,0.9624983072280884,49,Type_49,The risk or severity of adverse effects can be increased when Xylometazoline is combined with Isoconazole.,49,Type_49,Yes
DB00273,Topiramate,DB01267,Paliperidone,0.980423092842102,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Paliperidone.,49,Type_49,Yes
DB00747,Scopolamine,DB09009,Articaine,0.999815046787262,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Articaine.,49,Type_49,Yes
DB00703,Methazolamide,DB01224,Quetiapine,0.9788661599159241,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Quetiapine.,49,Type_49,Yes
DB09054,Idelalisib,DB09082,Vilanterol,0.901692271232605,47,Type_47,The metabolism of Vilanterol can be decreased when combined with Idelalisib.,47,Type_47,Yes
DB00682,Warfarin,DB01138,Sulfinpyrazone,0.9335777759552002,6,Type_6,Warfarin may increase the anticoagulant activities of Sulfinpyrazone.,47,Type_47,No
DB00204,Dofetilide,DB00555,Lamotrigine,0.4801100194454193,82,Type_82,Dofetilide may increase the arrhythmogenic activities of Lamotrigine.,73,Type_73,No
DB00503,Ritonavir,DB01261,Sitagliptin,0.41078490018844604,47,Type_47,The metabolism of Sitagliptin can be decreased when combined with Ritonavir.,70,Type_70,No
DB00243,Ranolazine,DB09041,Tavaborole,0.8190399408340454,73,Type_73,The serum concentration of Tavaborole can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01437,Glutethimide,DB06738,Ketobemidone,0.9477642178535461,49,Type_49,The risk or severity of adverse effects can be increased when Glutethimide is combined with Ketobemidone.,49,Type_49,Yes
DB01101,Capecitabine,DB06209,Prasugrel,0.8745717406272888,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Capecitabine.,47,Type_47,Yes
DB00712,Flurbiprofen,DB06414,Etravirine,0.9413721561431885,47,Type_47,The metabolism of Etravirine can be decreased when combined with Flurbiprofen.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB01142,Doxepin,0.9753639698028564,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Doxepin.,49,Type_49,Yes
DB00458,Imipramine,DB01614,Acepromazine,0.9285434484481812,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Acepromazine.,49,Type_49,Yes
DB00175,Pravastatin,DB01241,Gemfibrozil,0.45393869280815125,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Pravastatin.,48,Type_48,No
DB01320,Fosphenytoin,DB09063,Ceritinib,0.6217772364616394,75,Type_75,The serum concentration of Ceritinib can be decreased when it is combined with Fosphenytoin.,73,Type_73,No
DB00776,Oxcarbazepine,DB00898,Ethanol,0.9635218381881714,16,Type_16,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00320,Dihydroergotamine,DB00977,Ethinylestradiol,0.9205750823020935,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00332,Ipratropium,DB09074,Olaparib,0.9772111177444458,47,Type_47,The metabolism of Olaparib can be decreased when combined with Ipratropium.,47,Type_47,Yes
DB00622,Nicardipine,DB00774,Hydroflumethiazide,0.6804336905479431,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Hydroflumethiazide.,60,Type_60,No
DB00467,Enoxacin,DB01435,Antipyrine,0.9996384382247925,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Antipyrine.,27,Type_27,Yes
DB00444,Teniposide,DB09063,Ceritinib,0.9953261613845825,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Teniposide.,73,Type_73,Yes
DB06717,Fosaprepitant,DB08893,Mirabegron,0.7347983121871948,73,Type_73,The serum concentration of Mirabegron can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB00402,Eszopiclone,DB12532,Oxetacaine,0.9813830256462097,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxetacaine.,49,Type_49,Yes
DB00246,Ziprasidone,DB00602,Ivermectin,0.9884315729141235,47,Type_47,The metabolism of Ivermectin can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00158,Folic acid,DB00735,Naftifine,0.9073501229286194,70,Type_70,The therapeutic efficacy of Naftifine can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00542,Benazepril,DB06736,Aceclofenac,0.97109454870224,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Aceclofenac.,49,Type_49,Yes
DB00705,Delavirdine,DB00898,Ethanol,0.4537239074707031,47,Type_47,The metabolism of Ethanol can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00196,Fluconazole,DB00996,Gabapentin,0.6080944538116455,47,Type_47,The metabolism of Gabapentin can be decreased when combined with Fluconazole.,73,Type_73,No
DB00684,Tobramycin,DB01606,Tazobactam,0.9902365803718567,75,Type_75,The serum concentration of Tazobactam can be decreased when it is combined with Tobramycin.,75,Type_75,Yes
DB00252,Phenytoin,DB01047,Fluocinonide,0.9585914611816406,75,Type_75,The serum concentration of Fluocinonide can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00328,Indomethacin,DB00685,Trovafloxacin,0.9916703701019287,27,Type_27,Indomethacin may increase the neuroexcitatory activities of Trovafloxacin.,27,Type_27,Yes
DB00312,Pentobarbital,DB01340,Cilazapril,0.7827202081680298,60,Type_60,Pentobarbital may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB01421,Paromomycin,DB04743,Nimesulide,0.9995506405830383,72,Type_72,Paromomycin may decrease the excretion rate of Nimesulide which could result in a higher serum level.,72,Type_72,Yes
DB00405,Dexbrompheniramine,DB06282,Levocetirizine,0.9999294281005859,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levocetirizine.,49,Type_49,Yes
DB00991,Oxaprozin,DB01421,Paromomycin,0.9999661445617676,72,Type_72,Oxaprozin may decrease the excretion rate of Paromomycin which could result in a higher serum level.,72,Type_72,Yes
DB00413,Pramipexole,DB00708,Sufentanil,0.999430239200592,32,Type_32,Pramipexole may increase the sedative activities of Sufentanil.,32,Type_32,Yes
DB00210,Adapalene,DB01160,Dinoprost tromethamine,0.9977407455444336,70,Type_70,The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00208,Ticlopidine,DB00683,Midazolam,0.9635273814201355,47,Type_47,The metabolism of Midazolam can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00207,Azithromycin,DB00924,Cyclobenzaprine,0.7605948448181152,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Cyclobenzaprine.,47,Type_47,No
DB00373,Timolol,DB01236,Sevoflurane,0.423560231924057,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Timolol.,49,Type_49,No
DB01149,Nefazodone,DB09117,Paraldehyde,0.9987389445304871,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Paraldehyde.,49,Type_49,Yes
DB00706,Tamsulosin,DB09477,Enalaprilat,0.7800731062889099,60,Type_60,Tamsulosin may increase the hypotensive activities of Enalaprilat.,49,Type_49,No
DB00870,Suprofen,DB04865,Omacetaxine mepesuccinate,0.8487287759780884,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00484,Brimonidine,DB00611,Butorphanol,0.9438492059707642,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.,16,Type_16,Yes
DB00246,Ziprasidone,DB00946,Phenprocoumon,0.41061779856681824,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01255,Lisdexamfetamine,DB09275,Bismuth subcitrate potassium,0.9964343309402466,72,Type_72,Lisdexamfetamine may decrease the excretion rate of Bismuth subcitrate potassium which could result in a higher serum level.,72,Type_72,Yes
DB00343,Diltiazem,DB09555,Dexchlorpheniramine maleate,0.9847877025604248,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00341,Cetirizine,DB00420,Promazine,0.9628276228904724,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Promazine.,49,Type_49,Yes
DB01154,Thiamylal,DB09289,Tianeptine,0.2704486548900604,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Thiamylal.,4,Type_4,No
DB00956,Hydrocodone,DB08893,Mirabegron,0.5548468828201294,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Hydrocodone.,47,Type_47,Yes
DB00364,Sucralfate,DB00682,Warfarin,0.8655247688293457,6,Type_6,Sucralfate may increase the anticoagulant activities of Warfarin.,12,Type_12,No
DB00524,Metolazone,DB08822,Azilsartan medoxomil,0.999552309513092,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00399,Zoledronic acid,DB00870,Suprofen,0.9932571649551392,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Suprofen.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB01156,Bupropion,0.9016453623771667,47,Type_47,The metabolism of Bupropion can be decreased when combined with Pseudoephedrine.,47,Type_47,Yes
DB00184,Nicotine,DB00246,Ziprasidone,0.9276091456413269,47,Type_47,The metabolism of Ziprasidone can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00252,Phenytoin,DB00588,Fluticasone propionate,0.6739270687103271,4,Type_4,The metabolism of Fluticasone propionate can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00182,Amphetamine,DB06697,Artemether,0.9621320366859436,47,Type_47,The metabolism of Artemether can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB00752,Tranylcypromine,DB01214,Metipranolol,0.8546551465988159,60,Type_60,Tranylcypromine may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00559,Bosentan,DB01138,Sulfinpyrazone,0.8529129028320312,75,Type_75,The serum concentration of Sulfinpyrazone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00393,Nimodipine,DB00489,Sotalol,0.9830595254898071,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Sotalol.,49,Type_49,Yes
DB00699,Nicergoline,DB01054,Nitrendipine,0.9958141446113586,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Nitrendipine.,49,Type_49,Yes
DB00916,Metronidazole,DB00932,Tipranavir,0.5842004418373108,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Metronidazole.,49,Type_49,No
DB00264,Metoprolol,DB06691,Mepyramine,0.653358519077301,73,Type_73,The serum concentration of Mepyramine can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB08918,Levomilnacipran,DB09054,Idelalisib,0.8182986974716187,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Levomilnacipran.,73,Type_73,No
DB00384,Triamterene,DB00870,Suprofen,0.9952430129051208,37,Type_37,Triamterene may decrease the antihypertensive activities of Suprofen.,37,Type_37,Yes
DB01136,Carvedilol,DB08933,Luliconazole,0.9947159886360168,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Carvedilol.,73,Type_73,Yes
DB01234,Dexamethasone,DB09281,Magnesium trisilicate,0.9882726073265076,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Dexamethasone.,3,Type_3,Yes
DB00857,Terbinafine,DB01429,Aprindine,0.9990605711936951,47,Type_47,The metabolism of Aprindine can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00257,Clotrimazole,DB00312,Pentobarbital,0.4025762379169464,47,Type_47,The metabolism of Pentobarbital can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00875,Flupentixol,DB09075,Edoxaban,0.9740216135978699,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Flupentixol.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB00280,Disopyramide,0.5606263875961304,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Disopyramide.,9,Type_9,No
DB00571,Propranolol,DB02638,Terlipressin,0.9972000122070312,60,Type_60,Propranolol may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00842,Oxazepam,DB01018,Guanfacine,0.915226399898529,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Guanfacine.,49,Type_49,Yes
DB01075,Diphenhydramine,DB12532,Oxetacaine,0.9997841715812683,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Oxetacaine.,49,Type_49,Yes
DB01324,Polythiazide,DB09091,Tixocortol,0.9999933242797852,83,Type_83,Polythiazide may increase the hypokalemic activities of Tixocortol.,83,Type_83,Yes
DB00346,Alfuzosin,DB04844,Tetrabenazine,0.9825164079666138,20,Type_20,Alfuzosin may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00277,Theophylline,DB00599,Thiopental,0.6308693289756775,70,Type_70,The therapeutic efficacy of Thiopental can be decreased when used in combination with Theophylline.,75,Type_75,No
DB00734,Risperidone,DB00743,Gadobenic acid,0.9998846054077148,20,Type_20,Risperidone may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB00273,Topiramate,DB09118,Stiripentol,0.49079543352127075,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Topiramate.,49,Type_49,No
DB00394,Beclomethasone dipropionate,DB01324,Polythiazide,0.9999868869781494,83,Type_83,Beclomethasone dipropionate may increase the hypokalemic activities of Polythiazide.,83,Type_83,Yes
DB00238,Nevirapine,DB13158,Clobetasone,0.9493915438652039,75,Type_75,The serum concentration of Clobetasone can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00748,Carbinoxamine,DB00813,Fentanyl,0.9993625283241272,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Fentanyl.,49,Type_49,Yes
DB00598,Labetalol,DB09038,Empagliflozin,0.7733128070831299,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Empagliflozin.,49,Type_49,Yes
DB06636,Isavuconazonium,DB06700,Desvenlafaxine,0.9341781735420227,47,Type_47,The metabolism of Desvenlafaxine can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00465,Ketorolac,DB00686,Pentosan polysulfate,0.9880591034889221,6,Type_6,Ketorolac may increase the anticoagulant activities of Pentosan polysulfate.,6,Type_6,Yes
DB01161,Chloroprocaine,DB09034,Suvorexant,0.9999388456344604,16,Type_16,Chloroprocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB08918,Levomilnacipran,DB09166,Etizolam,0.9859123826026917,49,Type_49,The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Etizolam.,49,Type_49,Yes
DB08912,Dabrafenib,DB11817,Baricitinib,0.8176466822624207,75,Type_75,The serum concentration of Baricitinib can be decreased when it is combined with Dabrafenib.,75,Type_75,Yes
DB00470,Dronabinol,DB08922,Perospirone,0.9969887137413025,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Perospirone.,16,Type_16,Yes
DB01028,Methoxyflurane,DB01045,Rifampicin,0.9177536368370056,4,Type_4,The metabolism of Rifampicin can be increased when combined with Methoxyflurane.,4,Type_4,Yes
DB00375,Colestipol,DB04574,Estrone sulfate,0.8417252898216248,75,Type_75,The serum concentration of Estrone sulfate can be decreased when it is combined with Colestipol.,75,Type_75,Yes
DB01246,Alimemazine,DB09204,Arotinolol,0.9894620776176453,60,Type_60,Alimemazine may increase the hypotensive activities of Arotinolol.,60,Type_60,Yes
DB00204,Dofetilide,DB00227,Lovastatin,0.8954213261604309,73,Type_73,The serum concentration of Lovastatin can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB00270,Isradipine,DB01263,Posaconazole,0.7782875895500183,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00176,Fluvoxamine,DB01142,Doxepin,0.5505127906799316,47,Type_47,The metabolism of Doxepin can be decreased when combined with Fluvoxamine.,49,Type_49,No
DB00528,Lercanidipine,DB00700,Eplerenone,0.9731609225273132,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Eplerenone.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB00794,Primidone,0.8820362091064453,4,Type_4,The metabolism of Primidone can be increased when combined with Mycophenolate mofetil.,4,Type_4,Yes
DB00300,Tenofovir disoproxil,DB09027,Ledipasvir,0.917801022529602,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Tenofovir disoproxil.,73,Type_73,Yes
DB00924,Cyclobenzaprine,DB01355,Hexobarbital,0.6348457336425781,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Cyclobenzaprine.,4,Type_4,Yes
DB00774,Hydroflumethiazide,DB01384,Paramethasone,0.9996993541717529,83,Type_83,Hydroflumethiazide may increase the hypokalemic activities of Paramethasone.,83,Type_83,Yes
DB00313,Valproic acid,DB05541,Brivaracetam,0.591973066329956,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB00554,Piroxicam,DB00779,Nalidixic acid,0.9996752738952637,27,Type_27,Piroxicam may increase the neuroexcitatory activities of Nalidixic acid.,27,Type_27,Yes
DB00784,Mefenamic acid,DB06695,Dabigatran etexilate,0.905724287033081,6,Type_6,Mefenamic acid may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00244,Mesalazine,DB00870,Suprofen,0.9219833016395569,57,Type_57,Mesalazine may increase the nephrotoxic activities of Suprofen.,57,Type_57,Yes
DB00344,Protriptyline,DB00425,Zolpidem,0.9713810682296753,16,Type_16,Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB01244,Bepridil,DB09040,Efinaconazole,0.940153181552887,49,Type_49,The risk or severity of adverse effects can be increased when Bepridil is combined with Efinaconazole.,49,Type_49,Yes
DB00932,Tipranavir,DB06701,Dexmethylphenidate,0.6769691705703735,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB09054,Idelalisib,DB09396,Dextropropoxyphene napsylate,0.86557537317276,47,Type_47,The metabolism of Dextropropoxyphene napsylate can be decreased when combined with Idelalisib.,47,Type_47,Yes
DB00363,Clozapine,DB00876,Eprosartan,0.8356626629829407,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Eprosartan.,49,Type_49,Yes
DB00465,Ketorolac,DB01133,Tiludronic acid,0.9941270351409912,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Tiludronic acid.,49,Type_49,Yes
DB00169,Cholecalciferol,DB01124,Tolbutamide,0.8321527242660522,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00252,Phenytoin,DB00916,Metronidazole,0.5688205361366272,4,Type_4,The metabolism of Metronidazole can be increased when combined with Phenytoin.,75,Type_75,No
DB01077,Etidronic acid,DB04552,Niflumic acid,0.9976444840431213,49,Type_49,The risk or severity of adverse effects can be increased when Etidronic acid is combined with Niflumic acid.,49,Type_49,Yes
DB00399,Zoledronic acid,DB00821,Carprofen,0.9942947030067444,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Carprofen.,49,Type_49,Yes
DB01016,Glyburide,DB04339,Carbocisteine,0.9998782873153687,49,Type_49,The risk or severity of adverse effects can be increased when Glyburide is combined with Carbocisteine.,49,Type_49,Yes
DB00503,Ritonavir,DB09039,Eliglustat,0.3534206449985504,73,Type_73,The serum concentration of Eliglustat can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB00289,Atomoxetine,DB00924,Cyclobenzaprine,0.6620069742202759,47,Type_47,The metabolism of Cyclobenzaprine can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00813,Fentanyl,DB00829,Diazepam,0.9314644932746887,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Diazepam.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB00768,Olopatadine,0.5657458901405334,47,Type_47,The metabolism of Olopatadine can be decreased when combined with Tenofovir disoproxil.,49,Type_49,No
DB00771,Clidinium,DB00875,Flupentixol,0.9994126558303833,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Flupentixol.,49,Type_49,Yes
DB00333,Methadone,DB01041,Thalidomide,0.9974699020385742,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00883,Isosorbide dinitrate,DB01355,Hexobarbital,0.6959357261657715,60,Type_60,Isosorbide dinitrate may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00335,Atenolol,DB00668,Epinephrine,0.7714130282402039,25,Type_25,Atenolol may increase the atrioventricular blocking (AV block) activities of Epinephrine.,25,Type_25,Yes
DB01466,Ethylmorphine,DB06212,Tolvaptan,0.7331517934799194,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Ethylmorphine.,49,Type_49,No
DB00661,Verapamil,DB04855,Dronedarone,0.9055021405220032,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Verapamil.,25,Type_25,No
DB00375,Colestipol,DB08976,Floctafenine,0.9920055270195007,67,Type_67,Colestipol can cause a decrease in the absorption of Floctafenine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00212,Remikiren,DB00571,Propranolol,0.991479218006134,60,Type_60,Remikiren may increase the hypotensive activities of Propranolol.,60,Type_60,Yes
DB00688,Mycophenolate mofetil,DB09211,Limaprost,0.9313498139381409,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Mycophenolate mofetil.,70,Type_70,Yes
DB01215,Estazolam,DB13872,Lormetazepam,0.9999245405197144,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Lormetazepam.,49,Type_49,Yes
DB00897,Triazolam,DB01065,Melatonin,0.9986258745193481,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Melatonin.,49,Type_49,Yes
DB01238,Aripiprazole,DB06335,Saxagliptin,0.5139952301979065,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Aripiprazole.,70,Type_70,Yes
DB09215,Droxicam,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Droxicam.,70,Type_70,Yes
DB00601,Linezolid,DB01239,Chlorprothixene,0.9794493913650513,49,Type_49,The risk or severity of adverse effects can be increased when Linezolid is combined with Chlorprothixene.,49,Type_49,Yes
DB00243,Ranolazine,DB00647,Dextropropoxyphene,0.7222979068756104,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00747,Scopolamine,DB01227,Levacetylmethadol,0.9987653493881226,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Levacetylmethadol.,49,Type_49,Yes
DB06701,Dexmethylphenidate,DB09275,Bismuth subcitrate potassium,0.9978922009468079,18,Type_18,Dexmethylphenidate can cause an increase in the absorption of Bismuth subcitrate potassium resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB00303,Ertapenem,DB00313,Valproic acid,0.6618868708610535,75,Type_75,The serum concentration of Valproic acid can be decreased when it is combined with Ertapenem.,75,Type_75,Yes
DB00831,Trifluoperazine,DB09085,Tetracaine,0.9999895095825195,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tetracaine.,49,Type_49,Yes
DB00906,Tiagabine,DB13025,Tiapride,0.9996868371963501,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Tiapride.,49,Type_49,Yes
DB00521,Carteolol,DB01024,Mycophenolic acid,0.9261256456375122,37,Type_37,Carteolol may decrease the antihypertensive activities of Mycophenolic acid.,37,Type_37,Yes
DB00333,Methadone,DB01403,Methotrimeprazine,0.9939017295837402,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00193,Tramadol,DB01104,Sertraline,0.49843114614486694,27,Type_27,Tramadol may increase the neuroexcitatory activities of Sertraline.,27,Type_27,Yes
DB01588,Prazepam,DB08910,Pomalidomide,0.9974066615104675,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Pomalidomide.,49,Type_49,Yes
DB00768,Olopatadine,DB06739,Seratrodast,0.9718989133834839,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Seratrodast.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB00818,Propofol,0.9993189573287964,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Propofol.,49,Type_49,Yes
DB06724,Calcium carbonate,DB09561,Sodium glycerophosphate,0.9941127896308899,67,Type_67,Calcium carbonate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00762,Irinotecan,DB08881,Vemurafenib,0.627228856086731,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Irinotecan.,73,Type_73,Yes
DB00490,Buspirone,DB04953,Ezogabine,0.9989733695983887,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Ezogabine.,49,Type_49,Yes
DB01578,Metrizamide,DB13450,Cisatracurium besylate,0.9999973773956299,40,Type_40,Metrizamide may increase the respiratory depressant activities of Cisatracurium besylate.,40,Type_40,Yes
DB00169,Cholecalciferol,DB00446,Chloramphenicol,0.9863290190696716,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00976,Telithromycin,DB01169,Arsenic trioxide,0.7931438088417053,20,Type_20,Telithromycin may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB00929,Misoprostol,DB08976,Floctafenine,0.8758921027183533,70,Type_70,The therapeutic efficacy of Floctafenine can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB00211,Midodrine,DB00816,Orciprenaline,0.997079610824585,49,Type_49,The risk or severity of adverse effects can be increased when Midodrine is combined with Orciprenaline.,49,Type_49,Yes
DB00691,Moexipril,DB01170,Guanethidine,0.9999650716781616,60,Type_60,Moexipril may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB00802,Alfentanil,DB01242,Clomipramine,0.7759939432144165,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Clomipramine.,49,Type_49,Yes
DB00282,Pamidronic acid,DB06723,Aluminum hydroxide,0.9864516258239746,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Pamidronic acid.,75,Type_75,Yes
DB00091,Cyclosporine,DB01259,Lapatinib,0.7974340319633484,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01232,Saquinavir,DB09280,Lumacaftor,0.5860232710838318,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Saquinavir.,75,Type_75,Yes
DB00795,Sulfasalazine,DB01250,Olsalazine,0.8423683643341064,57,Type_57,Sulfasalazine may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB00182,Amphetamine,DB00924,Cyclobenzaprine,0.49668991565704346,23,Type_23,Amphetamine may increase the stimulatory activities of Cyclobenzaprine.,64,Type_64,No
DB00381,Amlodipine,DB05521,Telaprevir,0.8032865524291992,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Amlodipine.,47,Type_47,Yes
DB00397,Phenylpropanolamine,DB00924,Cyclobenzaprine,0.8946366310119629,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00091,Cyclosporine,DB01120,Gliclazide,0.8960394859313965,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00765,Metyrosine,DB01203,Nadolol,0.9957731366157532,60,Type_60,Metyrosine may increase the hypotensive activities of Nadolol.,60,Type_60,Yes
DB01215,Estazolam,DB08987,Etidocaine,0.9998623132705688,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Etidocaine.,49,Type_49,Yes
DB00220,Nelfinavir,DB00603,Medroxyprogesterone acetate,0.661291241645813,47,Type_47,The metabolism of Medroxyprogesterone acetate can be decreased when combined with Nelfinavir.,75,Type_75,No
DB08932,Macitentan,DB09242,Moxonidine,0.9999855756759644,60,Type_60,Macitentan may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00177,Valsartan,DB08912,Dabrafenib,0.8698439598083496,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Valsartan.,75,Type_75,Yes
DB01211,Clarithromycin,DB06786,Halcinonide,0.9466398358345032,73,Type_73,The serum concentration of Halcinonide can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB09235,Efonidipine,DB11093,Calcium citrate,0.7975962162017822,70,Type_70,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Efonidipine.,70,Type_70,Yes
DB00182,Amphetamine,DB00918,Almotriptan,0.4976554214954376,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Almotriptan.,73,Type_73,No
DB00318,Codeine,DB00420,Promazine,0.6419708132743835,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Promazine.,70,Type_70,No
DB00883,Isosorbide dinitrate,DB01174,Phenobarbital,0.7998055815696716,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Isosorbide dinitrate.,4,Type_4,Yes
DB00496,Darifenacin,DB01026,Ketoconazole,0.9546969532966614,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00762,Irinotecan,DB01320,Fosphenytoin,0.5662279725074768,75,Type_75,The serum concentration of Fosphenytoin can be decreased when it is combined with Irinotecan.,75,Type_75,Yes
DB00283,Clemastine,DB00530,Erlotinib,0.9802354574203491,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00409,Remoxipride,DB09342,Propoxycaine,0.9999961853027344,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Propoxycaine.,49,Type_49,Yes
DB00831,Trifluoperazine,DB01018,Guanfacine,0.9315651059150696,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Guanfacine.,49,Type_49,Yes
DB00238,Nevirapine,DB06789,Hydroxyprogesterone caproate,0.5688305497169495,4,Type_4,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00588,Fluticasone propionate,DB01137,Levofloxacin,0.8812047243118286,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levofloxacin.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00611,Butorphanol,0.9944489002227783,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Butorphanol.,49,Type_49,Yes
DB01113,Papaverine,DB09242,Moxonidine,0.988335907459259,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Moxonidine.,49,Type_49,Yes
DB00682,Warfarin,DB09079,Nintedanib,0.48455139994621277,49,Type_49,The risk or severity of adverse effects can be increased when Warfarin is combined with Nintedanib.,49,Type_49,Yes
DB00732,Atracurium besylate,DB09290,Ramosetron,0.9999991655349731,39,Type_39,Atracurium besylate may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB00631,Clofarabine,DB01018,Guanfacine,0.7017483711242676,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Guanfacine.,49,Type_49,Yes
DB00731,Nateglinide,DB09065,Cobicistat,0.6993199586868286,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Nateglinide.,73,Type_73,No
DB00921,Buprenorphine,DB01588,Prazepam,0.9991976618766785,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Prazepam.,16,Type_16,Yes
DB00448,Lansoprazole,DB01015,Sulfamethoxazole,0.9631229043006897,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Lansoprazole.,47,Type_47,Yes
DB00213,Pantoprazole,DB09118,Stiripentol,0.6609137654304504,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Pantoprazole.,73,Type_73,Yes
DB00393,Nimodipine,DB01264,Darunavir,0.45421671867370605,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Nimodipine.,73,Type_73,Yes
DB00230,Pregabalin,DB05271,Rotigotine,0.5271504521369934,32,Type_32,Pregabalin may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00422,Methylphenidate,DB00496,Darifenacin,0.49860474467277527,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Darifenacin.,47,Type_47,No
DB00284,Acarbose,DB06700,Desvenlafaxine,0.9618510603904724,9,Type_9,Acarbose may increase the hypoglycemic activities of Desvenlafaxine.,9,Type_9,Yes
DB00872,Conivaptan,DB06144,Sertindole,0.9714294672012329,73,Type_73,The serum concentration of Sertindole can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB01253,Ergometrine,DB01394,Colchicine,0.8451492786407471,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00661,Verapamil,DB00972,Azelastine,0.9007334113121033,47,Type_47,The metabolism of Azelastine can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00582,Voriconazole,DB00622,Nicardipine,0.7201927304267883,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00240,Alclometasone,DB00621,Oxandrolone,1.0,74,Type_74,Alclometasone may increase the fluid retaining activities of Oxandrolone.,74,Type_74,Yes
DB01045,Rifampicin,DB08905,Formestane,0.959967315196991,75,Type_75,The serum concentration of Formestane can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00224,Indinavir,DB01235,Levodopa,0.6344567537307739,47,Type_47,The metabolism of Levodopa can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00625,Efavirenz,DB01076,Atorvastatin,0.3803768754005432,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Efavirenz.,75,Type_75,No
DB00468,Quinine,DB01054,Nitrendipine,0.6417465806007385,47,Type_47,The metabolism of Nitrendipine can be decreased when combined with Quinine.,60,Type_60,No
DB00993,Azathioprine,DB09477,Enalaprilat,0.7552996277809143,63,Type_63,Azathioprine may increase the myelosuppressive activities of Enalaprilat.,63,Type_63,Yes
DB00497,Oxycodone,DB00703,Methazolamide,0.9729631543159485,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Methazolamide.,49,Type_49,Yes
DB00669,Sumatriptan,DB01069,Promethazine,0.8161007165908813,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Promethazine.,49,Type_49,Yes
DB00946,Phenprocoumon,DB09198,Lobeglitazone,0.9983231425285339,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB04574,Estrone sulfate,DB08909,Glycerol phenylbutyrate,0.6444929838180542,70,Type_70,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Estrone sulfate.,70,Type_70,Yes
DB08981,Fenbufen,DB09204,Arotinolol,0.9999206066131592,37,Type_37,Fenbufen may decrease the antihypertensive activities of Arotinolol.,37,Type_37,Yes
DB00912,Repaglinide,DB00999,Hydrochlorothiazide,0.9982007741928101,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Repaglinide.,70,Type_70,Yes
DB00318,Codeine,DB00771,Clidinium,0.9997890591621399,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Clidinium.,49,Type_49,Yes
DB01156,Bupropion,DB01589,Quazepam,0.8585288524627686,47,Type_47,The metabolism of Quazepam can be decreased when combined with Bupropion.,73,Type_73,No
DB01295,Bevantolol,DB01600,Tiaprofenic acid,0.9987302422523499,37,Type_37,Bevantolol may decrease the antihypertensive activities of Tiaprofenic acid.,37,Type_37,Yes
DB00669,Sumatriptan,DB00933,Mesoridazine,0.9803050756454468,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Mesoridazine.,49,Type_49,Yes
DB00224,Indinavir,DB00409,Remoxipride,0.7397576570510864,47,Type_47,The metabolism of Remoxipride can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01197,Captopril,DB01592,Iron,0.48159557580947876,75,Type_75,The serum concentration of Iron can be decreased when it is combined with Captopril.,49,Type_49,No
DB00735,Naftifine,DB01115,Nifedipine,0.9137207269668579,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Nifedipine.,49,Type_49,Yes
DB00153,Ergocalciferol,DB01118,Amiodarone,0.8824615478515625,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Ergocalciferol.,47,Type_47,Yes
DB01028,Methoxyflurane,DB06204,Tapentadol,0.9938259124755859,16,Type_16,Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00494,Entacapone,DB00934,Maprotiline,0.9989532232284546,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Maprotiline.,49,Type_49,Yes
DB00681,Amphotericin B,DB01113,Papaverine,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Papaverine.,49,Type_49,Yes
DB01151,Desipramine,DB06335,Saxagliptin,0.7504945397377014,73,Type_73,The serum concentration of Saxagliptin can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00588,Fluticasone propionate,DB09330,Osimertinib,0.8752984404563904,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Fluticasone propionate.,73,Type_73,Yes
DB00472,Fluoxetine,DB01452,Diamorphine,0.8928753733634949,64,Type_64,Fluoxetine may increase the serotonergic activities of Diamorphine.,64,Type_64,Yes
DB01149,Nefazodone,DB05381,Histamine,0.8976680040359497,47,Type_47,The metabolism of Histamine can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB09167,Dosulepin,DB12332,Rucaparib,0.880243718624115,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Dosulepin.,47,Type_47,Yes
DB00467,Enoxacin,DB00846,Flurandrenolide,0.9285986423492432,49,Type_49,The risk or severity of adverse effects can be increased when Enoxacin is combined with Flurandrenolide.,49,Type_49,Yes
DB00327,Hydromorphone,DB00344,Protriptyline,0.921836793422699,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Protriptyline.,49,Type_49,Yes
DB01384,Paramethasone,DB13783,Acemetacin,0.9498793482780457,49,Type_49,The risk or severity of adverse effects can be increased when Paramethasone is combined with Acemetacin.,49,Type_49,Yes
DB00823,Ethynodiol diacetate,DB08882,Linagliptin,0.5034579038619995,75,Type_75,The serum concentration of Linagliptin can be decreased when it is combined with Ethynodiol diacetate.,70,Type_70,No
DB00333,Methadone,DB01159,Halothane,0.5881428718566895,47,Type_47,The metabolism of Halothane can be decreased when combined with Methadone.,47,Type_47,Yes
DB00187,Esmolol,DB00477,Chlorpromazine,0.4801151156425476,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Chlorpromazine.,60,Type_60,No
DB01239,Chlorprothixene,DB01356,Lithium cation,0.9633311033248901,35,Type_35,Chlorprothixene may increase the neurotoxic activities of Lithium cation.,35,Type_35,Yes
DB00397,Phenylpropanolamine,DB01142,Doxepin,0.8584339618682861,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Doxepin.,49,Type_49,Yes
DB00288,Amcinonide,DB00963,Bromfenac,0.999725878238678,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Bromfenac.,49,Type_49,Yes
DB00890,Dienestrol,DB01260,Desonide,0.9988521337509155,73,Type_73,The serum concentration of Desonide can be increased when it is combined with Dienestrol.,73,Type_73,Yes
DB00476,Duloxetine,DB00964,Apraclonidine,0.9593575596809387,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Apraclonidine.,30,Type_30,Yes
DB00349,Clobazam,DB01151,Desipramine,0.8310686945915222,47,Type_47,The metabolism of Desipramine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01177,Idarubicin,DB09324,Sulbactam,0.9207640290260315,75,Type_75,The serum concentration of Sulbactam can be decreased when it is combined with Idarubicin.,75,Type_75,Yes
DB01118,Amiodarone,DB01558,Bromazepam,0.65253746509552,47,Type_47,The metabolism of Bromazepam can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00959,Methylprednisolone,DB08860,Pitavastatin,0.8701728582382202,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Methylprednisolone.,73,Type_73,Yes
DB00523,Alitretinoin,DB01229,Paclitaxel,0.8804149031639099,49,Type_49,The risk or severity of adverse effects can be increased when Alitretinoin is combined with Paclitaxel.,49,Type_49,Yes
DB00196,Fluconazole,DB07615,Tranilast,0.8186806440353394,47,Type_47,The metabolism of Tranilast can be decreased when combined with Fluconazole.,73,Type_73,No
DB00592,Piperazine,DB00715,Paroxetine,0.4574154019355774,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Piperazine.,47,Type_47,Yes
DB01264,Darunavir,DB09102,Daclatasvir,0.5215888023376465,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Darunavir.,73,Type_73,No
DB01577,Metamfetamine,DB06144,Sertindole,0.9592752456665039,61,Type_61,Metamfetamine may decrease the stimulatory activities of Sertindole.,61,Type_61,Yes
DB00844,Nalbuphine,DB01199,Tubocurarine,0.9878519773483276,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tubocurarine.,49,Type_49,Yes
DB00670,Pirenzepine,DB00809,Tropicamide,0.9981613755226135,49,Type_49,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Tropicamide.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB13142,Calcium glubionate anhydrous,0.9524835348129272,72,Type_72,Bendroflumethiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level.,72,Type_72,Yes
DB00844,Nalbuphine,DB09015,Canrenoic acid,0.9997144341468811,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Canrenoic acid.,49,Type_49,Yes
DB00771,Clidinium,DB01437,Glutethimide,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Glutethimide.,49,Type_49,Yes
DB00564,Carbamazepine,DB06287,Temsirolimus,0.7271618843078613,4,Type_4,The metabolism of Temsirolimus can be increased when combined with Carbamazepine.,75,Type_75,No
DB01100,Pimozide,DB09224,Melperone,0.9947499632835388,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Melperone.,49,Type_49,Yes
DB04868,Nilotinib,DB11921,Deflazacort,0.910474956035614,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB01203,Nadolol,DB09245,Toloxatone,0.9939682483673096,60,Type_60,Nadolol may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB01043,Memantine,DB13595,Almasilate,0.6097196936607361,73,Type_73,The serum concentration of Almasilate can be increased when it is combined with Memantine.,73,Type_73,Yes
DB01154,Thiamylal,DB09242,Moxonidine,0.5202459096908569,60,Type_60,Thiamylal may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00465,Ketorolac,DB00784,Mefenamic acid,0.9996100068092346,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Mefenamic acid.,49,Type_49,Yes
DB00540,Nortriptyline,DB00604,Cisapride,0.7973632216453552,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Cisapride.,20,Type_20,Yes
DB01136,Carvedilol,DB01626,Pargyline,0.9768497347831726,60,Type_60,Carvedilol may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00158,Folic acid,DB00244,Mesalazine,0.9241241216659546,70,Type_70,The therapeutic efficacy of Mesalazine can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB01155,Gemifloxacin,DB11348,Calcium Phosphate,0.9641522765159607,67,Type_67,Gemifloxacin can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00317,Gefitinib,DB00496,Darifenacin,0.6784635782241821,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB00619,Imatinib,DB00762,Irinotecan,0.7733250856399536,47,Type_47,The metabolism of Irinotecan can be decreased when combined with Imatinib.,47,Type_47,Yes
DB06216,Asenapine,DB09286,Pipamperone,0.8265997767448425,49,Type_49,The risk or severity of adverse effects can be increased when Asenapine is combined with Pipamperone.,49,Type_49,Yes
DB09063,Ceritinib,DB09074,Olaparib,0.9955219030380249,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Ceritinib.,73,Type_73,Yes
DB00206,Reserpine,DB06267,Udenafil,0.7754728198051453,10,Type_10,Reserpine may increase the antihypertensive activities of Udenafil.,10,Type_10,Yes
DB00395,Carisoprodol,DB00501,Cimetidine,0.9548260569572449,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Carisoprodol.,47,Type_47,Yes
DB00316,Acetaminophen,DB08899,Enzalutamide,0.9509685635566711,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Acetaminophen.,75,Type_75,Yes
DB00227,Lovastatin,DB00677,Isoflurophate,0.7769170999526978,47,Type_47,The metabolism of Isoflurophate can be decreased when combined with Lovastatin.,73,Type_73,No
DB00358,Mefloquine,DB01624,Zuclopenthixol,0.8175733089447021,20,Type_20,Mefloquine may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB00519,Trandolapril,DB01151,Desipramine,0.6742565035820007,73,Type_73,The serum concentration of Desipramine can be increased when it is combined with Trandolapril.,73,Type_73,Yes
DB00737,Meclizine,DB01618,Molindone,0.9991703033447266,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Molindone.,49,Type_49,Yes
DB00413,Pramipexole,DB00800,Fenoldopam,0.8739703893661499,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Fenoldopam.,49,Type_49,Yes
DB00338,Omeprazole,DB06803,Niclosamide,0.9359232187271118,47,Type_47,The metabolism of Niclosamide can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00313,Valproic acid,DB00347,Trimethadione,0.558637797832489,47,Type_47,The metabolism of Trimethadione can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB02703,Fusidic acid,DB12161,Deutetrabenazine,0.9925186634063721,73,Type_73,The serum concentration of Deutetrabenazine can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00850,Perphenazine,DB01095,Fluvastatin,0.693130373954773,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Perphenazine.,47,Type_47,No
DB00358,Mefloquine,DB01203,Nadolol,0.9968234300613403,54,Type_54,Mefloquine may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB00822,Disulfiram,DB01201,Rifapentine,0.9818183779716492,4,Type_4,The metabolism of Rifapentine can be increased when combined with Disulfiram.,4,Type_4,Yes
DB00328,Indomethacin,DB00997,Doxorubicin,0.9764049053192139,72,Type_72,Indomethacin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,72,Type_72,Yes
DB00887,Bumetanide,DB09091,Tixocortol,0.9996542930603027,83,Type_83,Bumetanide may increase the hypokalemic activities of Tixocortol.,83,Type_83,Yes
DB00921,Buprenorphine,DB06700,Desvenlafaxine,0.6714893579483032,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Desvenlafaxine.,64,Type_64,No
DB00503,Ritonavir,DB00637,Astemizole,0.45133644342422485,47,Type_47,The metabolism of Astemizole can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB08991,Epirizole,DB09084,Benzydamine,0.9991703033447266,49,Type_49,The risk or severity of adverse effects can be increased when Epirizole is combined with Benzydamine.,49,Type_49,Yes
DB00682,Warfarin,DB01017,Minocycline,0.9643864035606384,6,Type_6,Warfarin may increase the anticoagulant activities of Minocycline.,6,Type_6,Yes
DB00196,Fluconazole,DB09396,Dextropropoxyphene napsylate,0.8984244465827942,47,Type_47,The metabolism of Dextropropoxyphene napsylate can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01618,Molindone,DB09225,Zotepine,0.993012011051178,49,Type_49,The risk or severity of adverse effects can be increased when Molindone is combined with Zotepine.,49,Type_49,Yes
DB01036,Tolterodine,DB01192,Oxymorphone,0.979852020740509,49,Type_49,The risk or severity of adverse effects can be increased when Tolterodine is combined with Oxymorphone.,49,Type_49,Yes
DB00904,Ondansetron,DB09078,Lenvatinib,0.9322932958602905,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB01283,Lumiracoxib,DB09238,Manidipine,0.8791593313217163,47,Type_47,The metabolism of Manidipine can be decreased when combined with Lumiracoxib.,47,Type_47,Yes
DB00243,Ranolazine,DB00656,Trazodone,0.4239474833011627,73,Type_73,The serum concentration of Trazodone can be increased when it is combined with Ranolazine.,47,Type_47,No
DB01089,Deserpidine,DB04861,Nebivolol,0.9999850988388062,60,Type_60,Deserpidine may increase the hypotensive activities of Nebivolol.,60,Type_60,Yes
DB01036,Tolterodine,DB01087,Primaquine,0.9580691456794739,20,Type_20,Tolterodine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB01238,Aripiprazole,DB01255,Lisdexamfetamine,0.9558413624763489,61,Type_61,Aripiprazole may decrease the stimulatory activities of Lisdexamfetamine.,61,Type_61,Yes
DB00653,Magnesium sulfate,DB01104,Sertraline,0.6227985620498657,47,Type_47,The metabolism of Sertraline can be decreased when combined with Magnesium sulfate.,49,Type_49,No
DB00091,Cyclosporine,DB00705,Delavirdine,0.866111159324646,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00497,Oxycodone,DB01232,Saquinavir,0.7857639789581299,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Oxycodone.,49,Type_49,No
DB00091,Cyclosporine,DB00582,Voriconazole,0.9195983409881592,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB06605,Apixaban,DB08881,Vemurafenib,0.8541543483734131,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Apixaban.,73,Type_73,No
DB00445,Epirubicin,DB08439,Parecoxib,0.9907060265541077,72,Type_72,Epirubicin may decrease the excretion rate of Parecoxib which could result in a higher serum level.,72,Type_72,Yes
DB00220,Nelfinavir,DB09095,Difluocortolone,0.9722597002983093,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Nelfinavir.,73,Type_73,Yes
DB00334,Olanzapine,DB09117,Paraldehyde,0.996673583984375,16,Type_16,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00619,Imatinib,DB08916,Afatinib,0.7624568343162537,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Imatinib.,73,Type_73,Yes
DB00625,Efavirenz,DB06144,Sertindole,0.8047329783439636,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Sertindole.,49,Type_49,Yes
DB01577,Metamfetamine,DB12332,Rucaparib,0.9951812624931335,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Metamfetamine.,47,Type_47,Yes
DB01545,Ethyl loflazepate,DB06216,Asenapine,0.9963853359222412,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Asenapine.,49,Type_49,Yes
DB00253,Medrysone,DB06725,Lornoxicam,0.9996500015258789,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Lornoxicam.,49,Type_49,Yes
DB00735,Naftifine,DB00919,Spectinomycin,0.999729335308075,72,Type_72,Naftifine may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB00708,Sufentanil,DB00753,Isoflurane,0.9951430559158325,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Isoflurane.,49,Type_49,Yes
DB00220,Nelfinavir,DB00736,Esomeprazole,0.868918240070343,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Nelfinavir.,11,Type_11,No
DB00706,Tamsulosin,DB01365,Mephentermine,0.9804314970970154,5,Type_5,Tamsulosin may decrease the vasoconstricting activities of Mephentermine.,5,Type_5,Yes
DB01210,Levobunolol,DB04920,Clevidipine,0.8696873188018799,49,Type_49,The risk or severity of adverse effects can be increased when Levobunolol is combined with Clevidipine.,49,Type_49,Yes
DB01609,Deferasirox,DB04920,Clevidipine,0.9086157083511353,75,Type_75,The serum concentration of Clevidipine can be decreased when it is combined with Deferasirox.,73,Type_73,No
DB00289,Atomoxetine,DB13139,Levosalbutamol,0.6564411520957947,85,Type_85,Atomoxetine may increase the tachycardic activities of Levosalbutamol.,85,Type_85,Yes
DB00614,Furazolidone,DB01037,Selegiline,0.3698229193687439,71,Type_71,Furazolidone may increase the hypertensive activities of Selegiline.,71,Type_71,Yes
DB00697,Tizanidine,DB08910,Pomalidomide,0.8366937041282654,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Pomalidomide.,49,Type_49,Yes
DB00178,Ramipril,DB04574,Estrone sulfate,0.6998815536499023,75,Type_75,The serum concentration of Estrone sulfate can be decreased when it is combined with Ramipril.,75,Type_75,Yes
DB00338,Omeprazole,DB00541,Vincristine,0.48370635509490967,47,Type_47,The metabolism of Vincristine can be decreased when combined with Omeprazole.,73,Type_73,No
DB06702,Fesoterodine,DB09120,Zucapsaicin,0.9793727993965149,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Fesoterodine.,77,Type_77,No
DB00910,Paricalcitol,DB11348,Calcium Phosphate,0.729236364364624,49,Type_49,The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium Phosphate.,49,Type_49,Yes
DB00435,Nitric Oxide,DB06712,Nilvadipine,0.9822688102722168,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nilvadipine.,49,Type_49,Yes
DB00295,Morphine,DB01412,Theobromine,0.6948811411857605,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Theobromine.,49,Type_49,Yes
DB00564,Carbamazepine,DB01190,Clindamycin,0.7974825501441956,4,Type_4,The metabolism of Clindamycin can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01118,Amiodarone,DB03756,Doconexent,0.9334835410118103,47,Type_47,The metabolism of Doconexent can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00476,Duloxetine,DB04946,Iloperidone,0.623376190662384,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Iloperidone.,47,Type_47,No
DB00752,Tranylcypromine,DB09071,Tasimelteon,0.9592321515083313,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Tasimelteon.,49,Type_49,Yes
DB00751,Epinastine,DB00975,Dipyridamole,0.9873372912406921,53,Type_53,Epinastine may increase the antiplatelet activities of Dipyridamole.,6,Type_6,No
DB00263,Sulfisoxazole,DB00454,Meperidine,0.9857158064842224,47,Type_47,The metabolism of Meperidine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00850,Perphenazine,DB00872,Conivaptan,0.9254714846611023,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Perphenazine.,73,Type_73,Yes
DB01221,Ketamine,DB09072,Sodium oxybate,1.0,16,Type_16,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00215,Citalopram,DB00661,Verapamil,0.9087183475494385,47,Type_47,The metabolism of Verapamil can be decreased when combined with Citalopram.,47,Type_47,Yes
DB01037,Selegiline,DB01626,Pargyline,0.4263564646244049,60,Type_60,Selegiline may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB01045,Rifampicin,DB05219,Crisaborole,0.9392164349555969,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Rifampicin.,47,Type_47,Yes
DB01396,Digitoxin,DB01609,Deferasirox,0.7159062623977661,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Digitoxin.,75,Type_75,Yes
DB00328,Indomethacin,DB00712,Flurbiprofen,0.9929870963096619,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Flurbiprofen.,49,Type_49,Yes
DB00568,Cinnarizine,DB01157,Trimetrexate,0.605372428894043,49,Type_49,The risk or severity of adverse effects can be increased when Cinnarizine is combined with Trimetrexate.,49,Type_49,Yes
DB00813,Fentanyl,DB09280,Lumacaftor,0.6665352582931519,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Fentanyl.,75,Type_75,Yes
DB00537,Ciprofloxacin,DB00641,Simvastatin,0.9487320184707642,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Ciprofloxacin.,73,Type_73,Yes
DB00361,Vinorelbine,DB00363,Clozapine,0.5374632477760315,47,Type_47,The metabolism of Clozapine can be decreased when combined with Vinorelbine.,49,Type_49,No
DB00184,Nicotine,DB00472,Fluoxetine,0.9748862981796265,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01708,Prasterone,DB09220,Nicorandil,0.9638433456420898,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Nicorandil.,49,Type_49,Yes
DB00492,Fosinopril,DB01600,Tiaprofenic acid,0.943760871887207,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Tiaprofenic acid.,49,Type_49,Yes
DB00903,Etacrynic acid,DB01275,Hydralazine,0.9755958318710327,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hydralazine.,49,Type_49,Yes
DB00861,Diflunisal,DB01130,Prednicarbate,0.9990181922912598,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Prednicarbate.,49,Type_49,Yes
DB00199,Erythromycin,DB06403,Ambrisentan,0.9736247658729553,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00497,Oxycodone,DB01591,Solifenacin,0.9936226010322571,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Solifenacin.,49,Type_49,Yes
DB01609,Deferasirox,DB05109,Trabectedin,0.6944323778152466,75,Type_75,The serum concentration of Trabectedin can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00444,Teniposide,DB00736,Esomeprazole,0.6497802734375,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Teniposide.,47,Type_47,Yes
DB00629,Guanabenz,DB09238,Manidipine,0.7674818634986877,60,Type_60,Guanabenz may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00973,Ezetimibe,DB01039,Fenofibrate,0.819190263748169,49,Type_49,The risk or severity of adverse effects can be increased when Ezetimibe is combined with Fenofibrate.,49,Type_49,Yes
DB01264,Darunavir,DB01357,Mestranol,0.45394736528396606,75,Type_75,The serum concentration of Mestranol can be decreased when it is combined with Darunavir.,75,Type_75,Yes
DB00248,Cabergoline,DB01254,Dasatinib,0.6793532371520996,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Cabergoline.,73,Type_73,Yes
DB00539,Toremifene,DB09063,Ceritinib,0.8246140480041504,20,Type_20,Toremifene may increase the QTc-prolonging activities of Ceritinib.,73,Type_73,No
DB04272,Citric acid,DB08816,Ticagrelor,0.9530325531959534,6,Type_6,Citric acid may increase the anticoagulant activities of Ticagrelor.,6,Type_6,Yes
DB01628,Etoricoxib,DB08865,Crizotinib,0.9880951642990112,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Etoricoxib.,47,Type_47,Yes
DB00440,Trimethoprim,DB01104,Sertraline,0.8492926359176636,47,Type_47,The metabolism of Sertraline can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB09212,Loxoprofen,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Loxoprofen.,70,Type_70,Yes
DB00537,Ciprofloxacin,DB01137,Levofloxacin,0.9760252237319946,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB06737,Zaltoprofen,DB08906,Fluticasone furoate,0.9994113445281982,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Fluticasone furoate.,49,Type_49,Yes
DB00346,Alfuzosin,DB00871,Terbutaline,0.9826381802558899,5,Type_5,Alfuzosin may decrease the vasoconstricting activities of Terbutaline.,5,Type_5,Yes
DB01227,Levacetylmethadol,DB13025,Tiapride,0.986329972743988,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Tiapride.,49,Type_49,Yes
DB00571,Propranolol,DB04896,Milnacipran,0.74770587682724,73,Type_73,The serum concentration of Milnacipran can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00185,Cevimeline,DB00619,Imatinib,0.9507803916931152,47,Type_47,The metabolism of Imatinib can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00963,Bromfenac,DB08981,Fenbufen,0.9994530081748962,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Fenbufen.,49,Type_49,Yes
DB00252,Phenytoin,DB01235,Levodopa,0.4387918710708618,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Levodopa.,70,Type_70,No
DB00214,Torasemide,DB04743,Nimesulide,0.9998718500137329,29,Type_29,Torasemide may decrease the diuretic activities of Nimesulide.,29,Type_29,Yes
DB00486,Nabilone,DB00657,Mecamylamine,0.9931286573410034,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Mecamylamine.,85,Type_85,No
DB06155,Rimonabant,DB08912,Dabrafenib,0.990564227104187,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Rimonabant.,75,Type_75,Yes
DB06716,Fospropofol,DB06770,Benzyl alcohol,0.9999924898147583,49,Type_49,The risk or severity of adverse effects can be increased when Fospropofol is combined with Benzyl alcohol.,49,Type_49,Yes
DB00379,Mexiletine,DB00924,Cyclobenzaprine,0.9436490535736084,47,Type_47,The metabolism of Cyclobenzaprine can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01233,Metoclopramide,DB04868,Nilotinib,0.8671547770500183,20,Type_20,Metoclopramide may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB00223,Diflorasone,DB00732,Atracurium besylate,0.9990490078926086,22,Type_22,Diflorasone may increase the adverse neuromuscular activities of Atracurium besylate.,22,Type_22,Yes
DB01016,Glyburide,DB01201,Rifapentine,0.9754653573036194,4,Type_4,The metabolism of Rifapentine can be increased when combined with Glyburide.,4,Type_4,Yes
DB00933,Mesoridazine,DB01100,Pimozide,0.859917402267456,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pimozide.,49,Type_49,Yes
DB00685,Trovafloxacin,DB01628,Etoricoxib,0.9973656535148621,27,Type_27,Trovafloxacin may increase the neuroexcitatory activities of Etoricoxib.,27,Type_27,Yes
DB00808,Indapamide,DB09280,Lumacaftor,0.8263485431671143,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Indapamide.,4,Type_4,Yes
DB00169,Cholecalciferol,DB11560,Lesinurad,0.9273496270179749,47,Type_47,The metabolism of Lesinurad can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00528,Lercanidipine,DB04948,Lofexidine,0.957114040851593,60,Type_60,Lercanidipine may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00215,Citalopram,DB00332,Ipratropium,0.8175650238990784,47,Type_47,The metabolism of Ipratropium can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00422,Methylphenidate,DB00915,Amantadine,0.7417556047439575,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Amantadine.,49,Type_49,Yes
DB00312,Pentobarbital,DB05521,Telaprevir,0.5081737041473389,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Pentobarbital.,75,Type_75,No
DB00633,Dexmedetomidine,DB00653,Magnesium sulfate,0.8271511793136597,16,Type_16,Dexmedetomidine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00176,Fluvoxamine,DB00865,Benzphetamine,0.9407034516334534,47,Type_47,The metabolism of Benzphetamine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB01006,Letrozole,DB01320,Fosphenytoin,0.6482749581336975,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Letrozole.,4,Type_4,Yes
DB00762,Irinotecan,DB01241,Gemfibrozil,0.7428547739982605,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Irinotecan.,77,Type_77,No
DB00838,Clocortolone,DB01122,Ambenonium,0.9995318651199341,49,Type_49,The risk or severity of adverse effects can be increased when Clocortolone is combined with Ambenonium.,49,Type_49,Yes
DB00788,Naproxen,DB01324,Polythiazide,0.9981935620307922,70,Type_70,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Naproxen.,70,Type_70,Yes
DB01071,Mequitazine,DB01224,Quetiapine,0.9939794540405273,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Quetiapine.,82,Type_82,Yes
DB00261,Anagrelide,DB00834,Mifepristone,0.9636915326118469,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Mifepristone.,20,Type_20,Yes
DB01224,Quetiapine,DB08864,Rilpivirine,0.5135117769241333,20,Type_20,Quetiapine may increase the QTc-prolonging activities of Rilpivirine.,20,Type_20,Yes
DB00227,Lovastatin,DB00471,Montelukast,0.8501976728439331,47,Type_47,The metabolism of Montelukast can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00661,Verapamil,DB00774,Hydroflumethiazide,0.9901395440101624,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Hydroflumethiazide.,49,Type_49,Yes
DB00721,Procaine,DB00921,Buprenorphine,0.999593198299408,16,Type_16,Procaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB05521,Telaprevir,DB06589,Pazopanib,0.8537960648536682,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Telaprevir.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB00834,Mifepristone,0.8727121949195862,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB01106,Levocabastine,DB06288,Amisulpride,0.9967972636222839,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Amisulpride.,49,Type_49,Yes
DB00202,Succinylcholine,DB01433,Methadyl acetate,0.9648783802986145,54,Type_54,Succinylcholine may increase the bradycardic activities of Methadyl acetate.,54,Type_54,Yes
DB01100,Pimozide,DB01167,Itraconazole,0.6103132963180542,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Pimozide.,73,Type_73,No
DB00936,Salicylic acid,DB09477,Enalaprilat,0.5932674407958984,37,Type_37,Salicylic acid may decrease the antihypertensive activities of Enalaprilat.,37,Type_37,Yes
DB00443,Betamethasone,DB00564,Carbamazepine,0.8893282413482666,75,Type_75,The serum concentration of Carbamazepine can be decreased when it is combined with Betamethasone.,75,Type_75,Yes
DB00294,Etonogestrel,DB00498,Phenindione,0.5284001231193542,70,Type_70,The therapeutic efficacy of Phenindione can be decreased when used in combination with Etonogestrel.,12,Type_12,No
DB00674,Galantamine,DB00875,Flupentixol,0.9198637008666992,20,Type_20,Galantamine may increase the QTc-prolonging activities of Flupentixol.,20,Type_20,Yes
DB00571,Propranolol,DB05676,Apremilast,0.9775840640068054,37,Type_37,Propranolol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB00794,Primidone,DB09034,Suvorexant,0.9717833995819092,16,Type_16,Primidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00408,Loxapine,DB01238,Aripiprazole,0.9619725942611694,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Aripiprazole.,49,Type_49,Yes
DB00228,Enflurane,DB01142,Doxepin,0.9963181018829346,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Doxepin.,49,Type_49,Yes
DB01095,Fluvastatin,DB01156,Bupropion,0.755029559135437,47,Type_47,The metabolism of Bupropion can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00396,Progesterone,DB01095,Fluvastatin,0.6469656825065613,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Progesterone.,47,Type_47,No
DB00179,Masoprocol,DB00796,Candesartan cilexetil,0.4828696846961975,37,Type_37,Masoprocol may decrease the antihypertensive activities of Candesartan cilexetil.,49,Type_49,No
DB00455,Loratadine,DB00690,Flurazepam,0.942376971244812,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Flurazepam.,49,Type_49,Yes
DB01295,Bevantolol,DB02709,Resveratrol,0.9996354579925537,37,Type_37,Bevantolol may decrease the antihypertensive activities of Resveratrol.,37,Type_37,Yes
DB00408,Loxapine,DB06690,Nitrous oxide,0.9997534155845642,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Nitrous oxide.,49,Type_49,Yes
DB01217,Anastrozole,DB08860,Pitavastatin,0.8651551008224487,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Anastrozole.,73,Type_73,Yes
DB00375,Colestipol,DB00591,Fluocinolone acetonide,0.9520552158355713,67,Type_67,Colestipol can cause a decrease in the absorption of Fluocinolone acetonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00296,Ropivacaine,DB00703,Methazolamide,0.8231986165046692,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Methazolamide.,49,Type_49,Yes
DB00498,Phenindione,DB00608,Chloroquine,0.9944801330566406,6,Type_6,Phenindione may increase the anticoagulant activities of Chloroquine.,6,Type_6,Yes
DB00905,Bimatoprost,DB06737,Zaltoprofen,0.9572596549987793,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00708,Sufentanil,DB09118,Stiripentol,0.5842101573944092,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Sufentanil.,73,Type_73,Yes
DB00408,Loxapine,DB09009,Articaine,0.9999970197677612,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Articaine.,49,Type_49,Yes
DB06292,Dapagliflozin,DB06414,Etravirine,0.5676279664039612,47,Type_47,The metabolism of Etravirine can be decreased when combined with Dapagliflozin.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB00475,Chlordiazepoxide,0.9812160134315491,47,Type_47,The metabolism of Chlordiazepoxide can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00989,Rivastigmine,DB01098,Rosuvastatin,0.6327472925186157,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Rivastigmine.,73,Type_73,Yes
DB00695,Furosemide,DB00780,Phenelzine,0.7941884994506836,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Phenelzine.,49,Type_49,Yes
DB00363,Clozapine,DB00700,Eplerenone,0.9644940495491028,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Eplerenone.,49,Type_49,Yes
DB00798,Gentamicin,DB09288,Propacetamol,0.9999314546585083,72,Type_72,Gentamicin may decrease the excretion rate of Propacetamol which could result in a higher serum level.,72,Type_72,Yes
DB01551,Dihydrocodeine,DB11148,Butamben,0.9979938268661499,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Butamben.,49,Type_49,Yes
DB00737,Meclizine,DB00906,Tiagabine,0.9994363188743591,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Tiagabine.,49,Type_49,Yes
DB00869,Dorzolamide,DB06237,Avanafil,0.898478627204895,10,Type_10,Dorzolamide may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00691,Moexipril,DB08932,Macitentan,0.9998985528945923,60,Type_60,Moexipril may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00206,Reserpine,DB01078,Deslanoside,0.4685095250606537,25,Type_25,Reserpine may increase the atrioventricular blocking (AV block) activities of Deslanoside.,49,Type_49,No
DB05039,Indacaterol,DB08873,Boceprevir,0.7081403136253357,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Indacaterol.,47,Type_47,Yes
DB00245,Benzatropine,DB08893,Mirabegron,0.5076847076416016,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Benzatropine.,49,Type_49,No
DB01232,Saquinavir,DB01623,Thiothixene,0.600825309753418,73,Type_73,The serum concentration of Thiothixene can be increased when it is combined with Saquinavir.,20,Type_20,No
DB00253,Medrysone,DB01399,Salsalate,0.9996662139892578,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Salsalate.,49,Type_49,Yes
DB02709,Resveratrol,DB06781,Difluprednate,0.999771773815155,49,Type_49,The risk or severity of adverse effects can be increased when Resveratrol is combined with Difluprednate.,49,Type_49,Yes
DB01126,Dutasteride,DB09073,Palbociclib,0.9957139492034912,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Dutasteride.,73,Type_73,Yes
DB00228,Enflurane,DB00697,Tizanidine,0.9591482281684875,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Tizanidine.,49,Type_49,Yes
DB00797,Tolazoline,DB13783,Acemetacin,0.9994158744812012,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Tolazoline.,70,Type_70,Yes
DB01161,Chloroprocaine,DB11609,Normethadone,0.9999450445175171,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Normethadone.,49,Type_49,Yes
DB00806,Pentoxifylline,DB06595,Midostaurin,0.5933802127838135,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Pentoxifylline.,73,Type_73,No
DB00508,Triflupromazine,DB06594,Agomelatine,0.9998619556427002,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Agomelatine.,49,Type_49,Yes
DB00196,Fluconazole,DB00312,Pentobarbital,0.5638051629066467,47,Type_47,The metabolism of Pentobarbital can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01364,Ephedrine,DB01577,Metamfetamine,0.999953031539917,49,Type_49,The risk or severity of adverse effects can be increased when Ephedrine is combined with Metamfetamine.,49,Type_49,Yes
DB01246,Alimemazine,DB09274,Artesunate,0.6828629970550537,73,Type_73,The serum concentration of Artesunate can be increased when it is combined with Alimemazine.,73,Type_73,Yes
DB00179,Masoprocol,DB00798,Gentamicin,0.999936580657959,72,Type_72,Masoprocol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,72,Type_72,Yes
DB08828,Vismodegib,DB09063,Ceritinib,0.9930375218391418,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Vismodegib.,73,Type_73,Yes
DB00705,Delavirdine,DB00738,Pentamidine,0.6216934323310852,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00857,Terbinafine,DB01319,Fosamprenavir,0.7810302972793579,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00191,Phentermine,DB01114,Chlorpheniramine,0.8878152966499329,76,Type_76,Phentermine may decrease the sedative activities of Chlorpheniramine.,76,Type_76,Yes
DB00808,Indapamide,DB01282,Carbetocin,0.7669315934181213,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Carbetocin.,49,Type_49,Yes
DB00518,Albendazole,DB09280,Lumacaftor,0.46582654118537903,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Albendazole.,4,Type_4,No
DB00701,Amprenavir,DB09079,Nintedanib,0.9153388142585754,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Amprenavir.,73,Type_73,Yes
DB00604,Cisapride,DB01244,Bepridil,0.9025310277938843,20,Type_20,Cisapride may increase the QTc-prolonging activities of Bepridil.,20,Type_20,Yes
DB00557,Hydroxyzine,DB01017,Minocycline,1.0,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00270,Isradipine,DB00530,Erlotinib,0.9533746242523193,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00734,Risperidone,DB09034,Suvorexant,0.9906172156333923,16,Type_16,Risperidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00238,Nevirapine,DB00296,Ropivacaine,0.9795275330543518,4,Type_4,The metabolism of Ropivacaine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00264,Metoprolol,DB00870,Suprofen,0.9954960346221924,37,Type_37,Metoprolol may decrease the antihypertensive activities of Suprofen.,37,Type_37,Yes
DB00834,Mifepristone,DB01236,Sevoflurane,0.8552393317222595,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Sevoflurane.,20,Type_20,Yes
DB00732,Atracurium besylate,DB00944,Demecarium,0.7701812982559204,70,Type_70,The therapeutic efficacy of Demecarium can be decreased when used in combination with Atracurium besylate.,70,Type_70,Yes
DB00863,Ranitidine,DB00908,Quinidine,0.9063926935195923,47,Type_47,The metabolism of Quinidine can be decreased when combined with Ranitidine.,47,Type_47,Yes
DB00206,Reserpine,DB00750,Prilocaine,0.9996254444122314,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Prilocaine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01050,Ibuprofen,0.9819066524505615,70,Type_70,The therapeutic efficacy of Ibuprofen can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB06268,Sitaxentan,DB09238,Manidipine,0.975019633769989,60,Type_60,Sitaxentan may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB01264,Darunavir,DB08875,Cabozantinib,0.7669808864593506,47,Type_47,The metabolism of Cabozantinib can be decreased when combined with Darunavir.,73,Type_73,No
DB00857,Terbinafine,DB01191,Dexfenfluramine,0.9215565919876099,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00189,Ethchlorvynol,DB01081,Diphenoxylate,0.9993384480476379,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Diphenoxylate.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB01355,Hexobarbital,0.9703494310379028,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01074,Perhexiline,DB06820,Sulconazole,0.8768680095672607,49,Type_49,The risk or severity of adverse effects can be increased when Perhexiline is combined with Sulconazole.,49,Type_49,Yes
DB00251,Terconazole,DB01054,Nitrendipine,0.9758424162864685,49,Type_49,The risk or severity of adverse effects can be increased when Terconazole is combined with Nitrendipine.,49,Type_49,Yes
DB00851,Dacarbazine,DB09120,Zucapsaicin,0.988085150718689,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Dacarbazine.,47,Type_47,Yes
DB00091,Cyclosporine,DB00163,Vitamin E,0.4404396414756775,49,Type_49,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Vitamin E.,75,Type_75,No
DB00486,Nabilone,DB00623,Fluphenazine,0.9994999170303345,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.,16,Type_16,Yes
DB00237,Butabarbital,DB01595,Nitrazepam,0.997931957244873,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Nitrazepam.,49,Type_49,Yes
DB01239,Chlorprothixene,DB08881,Vemurafenib,0.6846096515655518,33,Type_33,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vemurafenib.,33,Type_33,Yes
DB00695,Furosemide,DB05676,Apremilast,0.9997459053993225,29,Type_29,Furosemide may decrease the diuretic activities of Apremilast.,29,Type_29,Yes
DB00518,Albendazole,DB01078,Deslanoside,0.9464344382286072,58,Type_58,Albendazole may decrease the cardiotoxic activities of Deslanoside.,58,Type_58,Yes
DB00433,Prochlorperazine,DB00844,Nalbuphine,0.9865263104438782,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Nalbuphine.,49,Type_49,Yes
DB00327,Hydromorphone,DB06767,Ammonium chloride,0.9950007796287537,65,Type_65,Hydromorphone may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,65,Type_65,Yes
DB01017,Minocycline,DB08795,Azidocillin,0.6316018104553223,70,Type_70,The therapeutic efficacy of Azidocillin can be decreased when used in combination with Minocycline.,70,Type_70,Yes
DB01580,Oxprenolol,DB11609,Normethadone,0.988997220993042,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Normethadone.,49,Type_49,Yes
DB00622,Nicardipine,DB01254,Dasatinib,0.6758916974067688,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB00727,Nitroglycerin,DB00790,Perindopril,0.9979578256607056,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Perindopril.,49,Type_49,Yes
DB00998,Frovatriptan,DB01100,Pimozide,0.9544029235839844,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pimozide.,49,Type_49,Yes
DB00498,Phenindione,DB01026,Ketoconazole,0.5319757461547852,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Phenindione.,73,Type_73,No
DB00363,Clozapine,DB05039,Indacaterol,0.6231470704078674,20,Type_20,Clozapine may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00827,Cinoxacin,DB09216,Tolfenamic acid,0.9410282373428345,27,Type_27,Cinoxacin may increase the neuroexcitatory activities of Tolfenamic acid.,27,Type_27,Yes
DB00495,Zidovudine,DB01132,Pioglitazone,0.46838700771331787,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB06595,Midostaurin,0.9702404737472534,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01685,Topiroxostat,DB06210,Eltrombopag,0.9931789636611938,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00421,Spironolactone,DB00486,Nabilone,0.9617093801498413,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Nabilone.,49,Type_49,Yes
DB00918,Almotriptan,DB06595,Midostaurin,0.8089956641197205,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Almotriptan.,47,Type_47,Yes
DB00158,Folic acid,DB08881,Vemurafenib,0.6727020740509033,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Folic acid.,75,Type_75,No
DB00404,Alprazolam,DB08865,Crizotinib,0.8746433258056641,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Alprazolam.,47,Type_47,Yes
DB00251,Terconazole,DB09230,Azelnidipine,0.9997288584709167,49,Type_49,The risk or severity of adverse effects can be increased when Terconazole is combined with Azelnidipine.,49,Type_49,Yes
DB00338,Omeprazole,DB00514,Dextromethorphan,0.9818259477615356,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00323,Tolcapone,DB00457,Prazosin,0.9760931730270386,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Prazosin.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB08905,Formestane,0.9948915243148804,73,Type_73,The serum concentration of Formestane can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00398,Sorafenib,DB01232,Saquinavir,0.5432912707328796,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Sorafenib.,73,Type_73,No
DB01118,Amiodarone,DB01411,Pranlukast,0.9786179065704346,73,Type_73,The serum concentration of Pranlukast can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00203,Sildenafil,DB00773,Etoposide,0.8884684443473816,47,Type_47,The metabolism of Etoposide can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB08918,Levomilnacipran,DB09280,Lumacaftor,0.4699109196662903,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Levomilnacipran.,73,Type_73,Yes
DB00283,Clemastine,DB00937,Diethylpropion,0.6495341062545776,47,Type_47,The metabolism of Diethylpropion can be decreased when combined with Clemastine.,76,Type_76,No
DB00398,Sorafenib,DB01151,Desipramine,0.63670414686203,47,Type_47,The metabolism of Desipramine can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00243,Ranolazine,DB00655,Estrone,0.6879634261131287,47,Type_47,The metabolism of Estrone can be decreased when combined with Ranolazine.,73,Type_73,No
DB00308,Ibutilide,DB00753,Isoflurane,0.9936829805374146,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Isoflurane.,20,Type_20,Yes
DB00223,Diflorasone,DB01283,Lumiracoxib,0.9989935755729675,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Lumiracoxib.,49,Type_49,Yes
DB01171,Moclobemide,DB05039,Indacaterol,0.8742258548736572,49,Type_49,The risk or severity of adverse effects can be increased when Moclobemide is combined with Indacaterol.,49,Type_49,Yes
DB01013,Clobetasol propionate,DB06718,Stanozolol,1.0,74,Type_74,Clobetasol propionate may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB00321,Amitriptyline,DB08820,Ivacaftor,0.9982069730758667,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Amitriptyline.,73,Type_73,Yes
DB00673,Aprepitant,DB06148,Mianserin,0.5182311534881592,73,Type_73,The serum concentration of Mianserin can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00424,Hyoscyamine,DB00486,Nabilone,0.8728907108306885,85,Type_85,Hyoscyamine may increase the tachycardic activities of Nabilone.,85,Type_85,Yes
DB01012,Cinacalcet,DB09076,Umeclidinium,0.936581552028656,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00818,Propofol,DB01159,Halothane,0.8012571334838867,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Halothane.,49,Type_49,Yes
DB00734,Risperidone,DB04841,Flunarizine,0.9679659605026245,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Flunarizine.,49,Type_49,Yes
DB01416,Cefpodoxime,DB01418,Acenocoumarol,0.9981582760810852,6,Type_6,Cefpodoxime may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00614,Furazolidone,DB04896,Milnacipran,0.9849984049797058,64,Type_64,Furazolidone may increase the serotonergic activities of Milnacipran.,64,Type_64,Yes
DB00678,Losartan,DB00696,Ergotamine,0.46033838391304016,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Ergotamine.,49,Type_49,Yes
DB00462,Methscopolamine bromide,DB01043,Memantine,0.9981454610824585,70,Type_70,The therapeutic efficacy of Memantine can be decreased when used in combination with Methscopolamine bromide.,70,Type_70,Yes
DB00176,Fluvoxamine,DB01274,Arformoterol,0.8870516419410706,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00321,Amitriptyline,DB00679,Thioridazine,0.5210062265396118,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Thioridazine.,73,Type_73,No
DB00594,Amiloride,DB00972,Azelastine,0.989260196685791,37,Type_37,Amiloride may decrease the antihypertensive activities of Azelastine.,37,Type_37,Yes
DB00203,Sildenafil,DB00321,Amitriptyline,0.8374581336975098,47,Type_47,The metabolism of Amitriptyline can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00907,Cocaine,DB01320,Fosphenytoin,0.7515702843666077,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Cocaine.,4,Type_4,Yes
DB08899,Enzalutamide,DB09061,Cannabidiol,0.9999706745147705,75,Type_75,The serum concentration of Cannabidiol can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB01050,Ibuprofen,DB02187,Equilin,0.9997389912605286,49,Type_49,The risk or severity of adverse effects can be increased when Ibuprofen is combined with Equilin.,49,Type_49,Yes
DB01171,Moclobemide,DB08932,Macitentan,0.9546529650688171,60,Type_60,Moclobemide may increase the hypotensive activities of Macitentan.,47,Type_47,No
DB01021,Trichlormethiazide,DB09215,Droxicam,0.994111955165863,70,Type_70,The therapeutic efficacy of Droxicam can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB00604,Cisapride,DB01104,Sertraline,0.5226325392723083,20,Type_20,Cisapride may increase the QTc-prolonging activities of Sertraline.,20,Type_20,Yes
DB01115,Nifedipine,DB01174,Phenobarbital,0.6728739738464355,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Nifedipine.,4,Type_4,Yes
DB00227,Lovastatin,DB00790,Perindopril,0.525286853313446,47,Type_47,The metabolism of Perindopril can be decreased when combined with Lovastatin.,73,Type_73,No
DB00238,Nevirapine,DB00932,Tipranavir,0.3147284686565399,4,Type_4,The metabolism of Tipranavir can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00338,Omeprazole,DB01238,Aripiprazole,0.4414334297180176,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Omeprazole.,75,Type_75,Yes
DB04878,Voglibose,DB06663,Pasireotide,0.8670058250427246,9,Type_9,Voglibose may increase the hypoglycemic activities of Pasireotide.,70,Type_70,No
DB00873,Loteprednol,DB04576,Fleroxacin,0.9918796420097351,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Fleroxacin.,49,Type_49,Yes
DB00490,Buspirone,DB09073,Palbociclib,0.9967547059059143,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Buspirone.,73,Type_73,Yes
DB01086,Benzocaine,DB06288,Amisulpride,0.9993662238121033,49,Type_49,The risk or severity of adverse effects can be increased when Benzocaine is combined with Amisulpride.,49,Type_49,Yes
DB00508,Triflupromazine,DB01576,Dextroamphetamine,0.9377017617225647,61,Type_61,Triflupromazine may decrease the stimulatory activities of Dextroamphetamine.,61,Type_61,Yes
DB00715,Paroxetine,DB01071,Mequitazine,0.5915908217430115,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Paroxetine.,73,Type_73,No
DB00384,Triamterene,DB01349,Tasosartan,0.563603937625885,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Tasosartan.,68,Type_68,No
DB00202,Succinylcholine,DB00479,Amikacin,0.9999980926513672,40,Type_40,Succinylcholine may increase the respiratory depressant activities of Amikacin.,40,Type_40,Yes
DB00814,Meloxicam,DB06636,Isavuconazonium,0.985431969165802,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Meloxicam.,47,Type_47,Yes
DB00450,Droperidol,DB00834,Mifepristone,0.9953061938285828,20,Type_20,Droperidol may increase the QTc-prolonging activities of Mifepristone.,20,Type_20,Yes
DB01151,Desipramine,DB01253,Ergometrine,0.9821068644523621,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Ergometrine.,49,Type_49,Yes
DB00343,Diltiazem,DB00741,Hydrocortisone,0.8504382371902466,47,Type_47,The metabolism of Hydrocortisone can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00337,Pimecrolimus,DB00385,Valrubicin,0.9084368944168091,72,Type_72,Pimecrolimus may decrease the excretion rate of Valrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00887,Bumetanide,DB01260,Desonide,0.9996035695075989,83,Type_83,Bumetanide may increase the hypokalemic activities of Desonide.,83,Type_83,Yes
DB00849,Methylphenobarbital,DB00968,Methyldopa,0.5384382605552673,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Methyldopa.,60,Type_60,No
DB01192,Oxymorphone,DB01320,Fosphenytoin,0.6657947897911072,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Oxymorphone.,4,Type_4,Yes
DB00489,Sotalol,DB00715,Paroxetine,0.5495901703834534,20,Type_20,Sotalol may increase the QTc-prolonging activities of Paroxetine.,20,Type_20,Yes
DB00641,Simvastatin,DB04946,Iloperidone,0.7243458032608032,73,Type_73,The serum concentration of Iloperidone can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00588,Fluticasone propionate,DB09009,Articaine,0.9971345663070679,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Articaine.,49,Type_49,Yes
DB00735,Naftifine,DB01260,Desonide,0.9997212290763855,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Desonide.,49,Type_49,Yes
DB01319,Fosamprenavir,DB04868,Nilotinib,0.49165692925453186,73,Type_73,The serum concentration of Nilotinib can be increased when it is combined with Fosamprenavir.,47,Type_47,No
DB00737,Meclizine,DB00972,Azelastine,0.9457148313522339,16,Type_16,Meclizine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB01466,Ethylmorphine,DB08897,Aclidinium,0.9972760081291199,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Aclidinium.,49,Type_49,Yes
DB00296,Ropivacaine,DB00661,Verapamil,0.7598584890365601,47,Type_47,The metabolism of Verapamil can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB01201,Rifapentine,DB01256,Retapamulin,0.8127868175506592,4,Type_4,The metabolism of Retapamulin can be increased when combined with Rifapentine.,4,Type_4,Yes
DB04953,Ezogabine,DB08883,Perampanel,0.989395797252655,16,Type_16,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00175,Pravastatin,DB04855,Dronedarone,0.6457415223121643,73,Type_73,The serum concentration of Dronedarone can be increased when it is combined with Pravastatin.,47,Type_47,No
DB01024,Mycophenolic acid,DB06723,Aluminum hydroxide,0.6201595664024353,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Mycophenolic acid.,67,Type_67,No
DB00554,Piroxicam,DB06263,Amrubicin,0.9996077418327332,72,Type_72,Piroxicam may decrease the excretion rate of Amrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00744,Zileuton,DB09214,Dexketoprofen,0.8803713917732239,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Dexketoprofen.,49,Type_49,Yes
DB00679,Thioridazine,DB09042,Tedizolid phosphate,0.9611030220985413,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Tedizolid phosphate.,49,Type_49,Yes
DB00873,Loteprednol,DB01357,Mestranol,0.9971141815185547,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Loteprednol.,73,Type_73,Yes
DB00708,Sufentanil,DB01143,Amifostine,0.9953165054321289,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Amifostine.,49,Type_49,Yes
DB00661,Verapamil,DB01144,Diclofenamide,0.9951993823051453,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Diclofenamide.,49,Type_49,Yes
DB00604,Cisapride,DB01224,Quetiapine,0.8873726725578308,20,Type_20,Cisapride may increase the QTc-prolonging activities of Quetiapine.,33,Type_33,No
DB00936,Salicylic acid,DB01118,Amiodarone,0.9578436613082886,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Salicylic acid.,47,Type_47,Yes
DB01236,Sevoflurane,DB01601,Lopinavir,0.6227449774742126,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Sevoflurane.,47,Type_47,Yes
DB01324,Polythiazide,DB13231,Calcium lactate,0.9993321299552917,72,Type_72,Polythiazide may decrease the excretion rate of Calcium lactate which could result in a higher serum level.,72,Type_72,Yes
DB00398,Sorafenib,DB00420,Promazine,0.5642710328102112,47,Type_47,The metabolism of Promazine can be decreased when combined with Sorafenib.,20,Type_20,No
DB00201,Caffeine,DB09273,Doxofylline,0.605324923992157,49,Type_49,The risk or severity of adverse effects can be increased when Caffeine is combined with Doxofylline.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB01295,Bevantolol,0.9921360015869141,54,Type_54,Gallamine triethiodide may increase the bradycardic activities of Bevantolol.,54,Type_54,Yes
DB00436,Bendroflumethiazide,DB01144,Diclofenamide,0.9955205917358398,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Diclofenamide.,49,Type_49,Yes
DB00443,Betamethasone,DB01250,Olsalazine,0.998410701751709,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Olsalazine.,49,Type_49,Yes
DB00731,Nateglinide,DB06414,Etravirine,0.8456749320030212,47,Type_47,The metabolism of Etravirine can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00474,Methohexital,DB07615,Tranilast,0.8366508483886719,4,Type_4,The metabolism of Tranilast can be increased when combined with Methohexital.,4,Type_4,Yes
DB00248,Cabergoline,DB00619,Imatinib,0.5010902881622314,47,Type_47,The metabolism of Imatinib can be decreased when combined with Cabergoline.,47,Type_47,Yes
DB00875,Flupentixol,DB01118,Amiodarone,0.5222125053405762,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Amiodarone.,33,Type_33,No
DB08881,Vemurafenib,DB09083,Ivabradine,0.7458289861679077,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB00831,Trifluoperazine,DB01403,Methotrimeprazine,0.9903653264045715,16,Type_16,Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB01189,Desflurane,DB04842,Fluspirilene,0.9780433177947998,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Fluspirilene.,49,Type_49,Yes
DB00270,Isradipine,DB00422,Methylphenidate,0.8864781260490417,47,Type_47,The metabolism of Methylphenidate can be decreased when combined with Isradipine.,37,Type_37,No
DB00655,Estrone,DB09118,Stiripentol,0.5273149609565735,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Estrone.,73,Type_73,Yes
DB00492,Fosinopril,DB02638,Terlipressin,0.9999550580978394,60,Type_60,Fosinopril may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00927,Famotidine,DB01072,Atazanavir,0.4029664695262909,20,Type_20,Famotidine may increase the QTc-prolonging activities of Atazanavir.,75,Type_75,No
DB00418,Secobarbital,DB08883,Perampanel,0.9851170778274536,16,Type_16,Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00409,Remoxipride,DB00490,Buspirone,0.9501746892929077,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Buspirone.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00863,Ranitidine,0.9318864345550537,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00584,Enalapril,DB00712,Flurbiprofen,0.9544828534126282,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Flurbiprofen.,49,Type_49,Yes
DB00726,Trimipramine,DB08872,Gabapentin enacarbil,0.9997748732566833,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB08991,Epirizole,DB09095,Difluocortolone,0.9998618364334106,49,Type_49,The risk or severity of adverse effects can be increased when Epirizole is combined with Difluocortolone.,49,Type_49,Yes
DB00241,Butalbital,DB05271,Rotigotine,0.9174994826316833,32,Type_32,Butalbital may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB01397,Magnesium salicylate,DB13450,Cisatracurium besylate,0.9916995763778687,21,Type_21,Magnesium salicylate may increase the neuromuscular blocking activities of Cisatracurium besylate.,21,Type_21,Yes
DB01137,Levofloxacin,DB06335,Saxagliptin,0.9579769968986511,9,Type_9,Levofloxacin may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00379,Mexiletine,DB00998,Frovatriptan,0.9300757646560669,47,Type_47,The metabolism of Frovatriptan can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00210,Adapalene,DB01133,Tiludronic acid,0.9965721368789673,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Tiludronic acid.,49,Type_49,Yes
DB09236,Lacidipine,DB11348,Calcium Phosphate,0.7519937753677368,70,Type_70,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lacidipine.,70,Type_70,Yes
DB00588,Fluticasone propionate,DB01175,Escitalopram,0.9655283689498901,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Escitalopram.,49,Type_49,Yes
DB00636,Clofibrate,DB00682,Warfarin,0.864194393157959,6,Type_6,Clofibrate may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00598,Labetalol,DB01019,Bethanechol,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Bethanechol.,49,Type_49,Yes
DB00268,Ropinirole,DB00980,Ramelteon,0.9974971413612366,32,Type_32,Ropinirole may increase the sedative activities of Ramelteon.,32,Type_32,Yes
DB00366,Doxylamine,DB01080,Vigabatrin,0.9999998807907104,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,16,Type_16,Yes
DB01087,Primaquine,DB08864,Rilpivirine,0.8713526725769043,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Primaquine.,73,Type_73,Yes
DB02709,Resveratrol,DB06209,Prasugrel,0.5858569145202637,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Resveratrol.,6,Type_6,No
DB00257,Clotrimazole,DB06603,Panobinostat,0.8072136640548706,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00308,Ibutilide,DB01059,Norfloxacin,0.7984901666641235,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Norfloxacin.,20,Type_20,Yes
DB00608,Chloroquine,DB00711,Diethylcarbamazine,0.9564298391342163,75,Type_75,The serum concentration of Diethylcarbamazine can be decreased when it is combined with Chloroquine.,75,Type_75,Yes
DB00771,Clidinium,DB01175,Escitalopram,0.9909062385559082,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Escitalopram.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB09080,Olodaterol,0.9862005710601807,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Olodaterol.,83,Type_83,Yes
DB00705,Delavirdine,DB06803,Niclosamide,0.8892616629600525,47,Type_47,The metabolism of Niclosamide can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00519,Trandolapril,DB01397,Magnesium salicylate,0.8895817399024963,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Magnesium salicylate.,49,Type_49,Yes
DB01406,Danazol,DB02187,Equilin,0.9999920129776001,74,Type_74,Danazol may increase the fluid retaining activities of Equilin.,74,Type_74,Yes
DB00465,Ketorolac,DB00876,Eprosartan,0.9275054931640625,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Eprosartan.,49,Type_49,Yes
DB00918,Almotriptan,DB08912,Dabrafenib,0.6855707168579102,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Almotriptan.,75,Type_75,Yes
DB00275,Olmesartan,DB00606,Cyclothiazide,0.8431681990623474,60,Type_60,Olmesartan may increase the hypotensive activities of Cyclothiazide.,60,Type_60,Yes
DB08880,Teriflunomide,DB08899,Enzalutamide,0.9502585530281067,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Teriflunomide.,47,Type_47,No
DB00779,Nalidixic acid,DB09095,Difluocortolone,0.926756739616394,49,Type_49,The risk or severity of adverse effects can be increased when Nalidixic acid is combined with Difluocortolone.,49,Type_49,Yes
DB00764,Mometasone,DB01149,Nefazodone,0.8464909791946411,73,Type_73,The serum concentration of Nefazodone can be increased when it is combined with Mometasone.,73,Type_73,Yes
DB00425,Zolpidem,DB04841,Flunarizine,0.9983699917793274,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.,16,Type_16,Yes
DB09280,Lumacaftor,DB11560,Lesinurad,0.644087016582489,75,Type_75,The serum concentration of Lesinurad can be decreased when it is combined with Lumacaftor.,75,Type_75,Yes
DB01359,Penbutolol,DB01396,Digitoxin,0.9801392555236816,54,Type_54,Penbutolol may increase the bradycardic activities of Digitoxin.,54,Type_54,Yes
DB00755,Tretinoin,DB00968,Methyldopa,0.9705288410186768,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Methyldopa.,49,Type_49,Yes
DB00344,Protriptyline,DB09063,Ceritinib,0.9011393785476685,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Protriptyline.,20,Type_20,No
DB00405,Dexbrompheniramine,DB00807,Proparacaine,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Proparacaine.,49,Type_49,Yes
DB00350,Minoxidil,DB01355,Hexobarbital,0.8668103218078613,60,Type_60,Minoxidil may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00564,Carbamazepine,DB01590,Everolimus,0.7878267168998718,75,Type_75,The serum concentration of Everolimus can be decreased when it is combined with Carbamazepine.,73,Type_73,No
DB00645,Dyclonine,DB01227,Levacetylmethadol,0.9873889684677124,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Levacetylmethadol.,49,Type_49,Yes
DB00694,Daunorubicin,DB01199,Tubocurarine,0.9839041233062744,40,Type_40,Daunorubicin may increase the respiratory depressant activities of Tubocurarine.,40,Type_40,Yes
DB00280,Disopyramide,DB00624,Testosterone,0.5437207818031311,9,Type_9,Disopyramide may increase the hypoglycemic activities of Testosterone.,9,Type_9,Yes
DB00292,Etomidate,DB00475,Chlordiazepoxide,0.993477463722229,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Chlordiazepoxide.,49,Type_49,Yes
DB00452,Framycetin,DB00483,Gallamine triethiodide,0.9999827146530151,40,Type_40,Framycetin may increase the respiratory depressant activities of Gallamine triethiodide.,40,Type_40,Yes
DB00212,Remikiren,DB00876,Eprosartan,0.9732417464256287,60,Type_60,Remikiren may increase the hypotensive activities of Eprosartan.,60,Type_60,Yes
DB00247,Methysergide,DB01301,Rolitetracycline,0.9999619722366333,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Rolitetracycline.,49,Type_49,Yes
DB00673,Aprepitant,DB01131,Proguanil,0.9453974366188049,73,Type_73,The serum concentration of Proguanil can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00699,Nicergoline,DB09054,Idelalisib,0.6352805495262146,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Idelalisib.,49,Type_49,Yes
DB00794,Primidone,DB06209,Prasugrel,0.9449462294578552,4,Type_4,The metabolism of Prasugrel can be increased when combined with Primidone.,4,Type_4,Yes
DB06267,Udenafil,DB08808,Bupranolol,0.7212595343589783,10,Type_10,Udenafil may increase the antihypertensive activities of Bupranolol.,10,Type_10,Yes
DB00768,Olopatadine,DB04953,Ezogabine,0.8353381156921387,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Ezogabine.,49,Type_49,Yes
DB00390,Digoxin,DB09048,Netupitant,0.9504495859146118,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00440,Trimethoprim,DB09080,Olodaterol,0.5582004189491272,20,Type_20,Trimethoprim may increase the QTc-prolonging activities of Olodaterol.,47,Type_47,No
DB00834,Mifepristone,DB01128,Bicalutamide,0.7760677337646484,73,Type_73,The serum concentration of Bicalutamide can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00324,Fluorometholone,DB01026,Ketoconazole,0.9315487742424011,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Fluorometholone.,47,Type_47,Yes
DB00091,Cyclosporine,DB01104,Sertraline,0.9717009663581848,47,Type_47,The metabolism of Sertraline can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00421,Spironolactone,DB01144,Diclofenamide,0.9954687356948853,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Diclofenamide.,49,Type_49,Yes
DB01204,Mitoxantrone,DB08860,Pitavastatin,0.8238312602043152,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Mitoxantrone.,73,Type_73,Yes
DB00424,Hyoscyamine,DB01390,Sodium bicarbonate,0.3365892171859741,73,Type_73,The serum concentration of Sodium bicarbonate can be increased when it is combined with Hyoscyamine.,75,Type_75,No
DB00883,Isosorbide dinitrate,DB01144,Diclofenamide,0.9986787438392639,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Diclofenamide.,49,Type_49,Yes
DB04868,Nilotinib,DB09074,Olaparib,0.7278643250465393,47,Type_47,The metabolism of Olaparib can be decreased when combined with Nilotinib.,73,Type_73,No
DB00617,Paramethadione,DB06290,Simeprevir,0.8908034563064575,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Paramethadione.,73,Type_73,Yes
DB00798,Gentamicin,DB03585,Oxyphenbutazone,0.9999934434890747,72,Type_72,Gentamicin may decrease the excretion rate of Oxyphenbutazone which could result in a higher serum level.,72,Type_72,Yes
DB00997,Doxorubicin,DB08868,Fingolimod,0.984377384185791,34,Type_34,Doxorubicin may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00750,Prilocaine,DB00961,Mepivacaine,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Mepivacaine.,49,Type_49,Yes
DB00933,Mesoridazine,DB01452,Diamorphine,0.9954954385757446,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Diamorphine.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB06802,Nepafenac,0.995731770992279,70,Type_70,The therapeutic efficacy of Nepafenac can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00967,Desloratadine,DB01615,Aceprometazine,0.9514266848564148,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Aceprometazine.,49,Type_49,Yes
DB06791,Lanreotide,DB08868,Fingolimod,0.9969444870948792,54,Type_54,Lanreotide may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB00353,Methylergometrine,DB00820,Tadalafil,0.8181635737419128,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Tadalafil.,49,Type_49,Yes
DB00227,Lovastatin,DB00918,Almotriptan,0.6403683423995972,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00808,Indapamide,DB01144,Diclofenamide,0.9948668479919434,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Diclofenamide.,49,Type_49,Yes
DB00742,Mannitol,DB01115,Nifedipine,0.9848568439483643,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Nifedipine.,49,Type_49,Yes
DB00469,Tenoxicam,DB08816,Ticagrelor,0.8320598602294922,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Tenoxicam.,47,Type_47,Yes
DB00423,Methocarbamol,DB00527,Cinchocaine,0.9999969005584717,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Cinchocaine.,49,Type_49,Yes
DB00932,Tipranavir,DB09198,Lobeglitazone,0.9974567294120789,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00508,Triflupromazine,DB01017,Minocycline,0.9998515844345093,16,Type_16,Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00285,Venlafaxine,DB00947,Fulvestrant,0.9197213053703308,47,Type_47,The metabolism of Fulvestrant can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00631,Clofarabine,DB00633,Dexmedetomidine,0.6245549917221069,30,Type_30,Clofarabine may increase the orthostatic hypotensive activities of Dexmedetomidine.,49,Type_49,No
DB00091,Cyclosporine,DB00280,Disopyramide,0.7721954584121704,47,Type_47,The metabolism of Disopyramide can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00624,Testosterone,DB01030,Topotecan,0.9876854419708252,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Testosterone.,73,Type_73,Yes
DB00988,Dopamine,DB08941,Isoxsuprine,0.9867821931838989,49,Type_49,The risk or severity of adverse effects can be increased when Dopamine is combined with Isoxsuprine.,49,Type_49,Yes
DB01283,Lumiracoxib,DB01340,Cilazapril,0.851100742816925,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Cilazapril.,49,Type_49,Yes
DB00921,Buprenorphine,DB09274,Artesunate,0.9231507182121277,65,Type_65,Buprenorphine may increase the excretion rate of Artesunate which could result in a lower serum level and potentially a reduction in efficacy.,11,Type_11,No
DB01437,Glutethimide,DB09166,Etizolam,0.9999884366989136,49,Type_49,The risk or severity of adverse effects can be increased when Glutethimide is combined with Etizolam.,49,Type_49,Yes
DB00408,Loxapine,DB01558,Bromazepam,0.9975728392601013,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Bromazepam.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB01037,Selegiline,0.8941344022750854,60,Type_60,Hydrochlorothiazide may increase the hypotensive activities of Selegiline.,60,Type_60,Yes
DB00227,Lovastatin,DB08883,Perampanel,0.4012632966041565,47,Type_47,The metabolism of Perampanel can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00409,Remoxipride,DB00907,Cocaine,0.7734974026679993,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Cocaine.,47,Type_47,No
DB00937,Diethylpropion,DB00950,Fexofenadine,0.9537121653556824,76,Type_76,Diethylpropion may decrease the sedative activities of Fexofenadine.,76,Type_76,Yes
DB00870,Suprofen,DB00880,Chlorothiazide,0.9965289235115051,70,Type_70,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Suprofen.,70,Type_70,Yes
DB00313,Valproic acid,DB13025,Tiapride,0.9976523518562317,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Tiapride.,49,Type_49,Yes
DB00193,Tramadol,DB00810,Biperiden,0.9992017149925232,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Biperiden.,49,Type_49,Yes
DB01180,Rescinnamine,DB05676,Apremilast,0.9583574533462524,49,Type_49,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Apremilast.,49,Type_49,Yes
DB00679,Thioridazine,DB09227,Barnidipine,0.9898888468742371,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Barnidipine.,49,Type_49,Yes
DB06616,Bosutinib,DB08874,Fidaxomicin,0.9560338258743286,73,Type_73,The serum concentration of Fidaxomicin can be increased when it is combined with Bosutinib.,73,Type_73,Yes
DB00445,Epirubicin,DB00821,Carprofen,0.9974972605705261,72,Type_72,Epirubicin may decrease the excretion rate of Carprofen which could result in a higher serum level.,72,Type_72,Yes
DB00590,Doxazosin,DB01197,Captopril,0.8687795996665955,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Captopril.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB01320,Fosphenytoin,0.7466739416122437,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Cyclobenzaprine.,4,Type_4,Yes
DB00227,Lovastatin,DB09280,Lumacaftor,0.4504672884941101,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Lovastatin.,4,Type_4,No
DB01240,Epoprostenol,DB09075,Edoxaban,0.819366455078125,6,Type_6,Epoprostenol may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB01010,Edrophonium,DB01297,Practolol,0.9996650218963623,54,Type_54,Edrophonium may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB00266,Dicoumarol,DB06701,Dexmethylphenidate,0.43661922216415405,73,Type_73,The serum concentration of Dexmethylphenidate can be increased when it is combined with Dicoumarol.,73,Type_73,Yes
DB00907,Cocaine,DB01353,Butobarbital,0.9999148845672607,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Butobarbital.,49,Type_49,Yes
DB01403,Methotrimeprazine,DB06292,Dapagliflozin,0.6628733277320862,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Methotrimeprazine.,47,Type_47,Yes
DB00175,Pravastatin,DB01220,Rifaximin,0.8665711283683777,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00564,Carbamazepine,DB09063,Ceritinib,0.669291615486145,75,Type_75,The serum concentration of Ceritinib can be decreased when it is combined with Carbamazepine.,73,Type_73,No
DB00177,Valsartan,DB00178,Ramipril,0.8167806267738342,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Ramipril.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB01435,Antipyrine,0.9875591397285461,70,Type_70,The therapeutic efficacy of Antipyrine can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB00402,Eszopiclone,DB06595,Midostaurin,0.9148756265640259,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Eszopiclone.,47,Type_47,Yes
DB00750,Prilocaine,DB01149,Nefazodone,0.9955514073371887,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Nefazodone.,49,Type_49,Yes
DB01215,Estazolam,DB01452,Diamorphine,0.9992140531539917,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Diamorphine.,49,Type_49,Yes
DB00347,Trimethadione,DB01201,Rifapentine,0.9629692435264587,4,Type_4,The metabolism of Rifapentine can be increased when combined with Trimethadione.,4,Type_4,Yes
DB00210,Adapalene,DB00288,Amcinonide,0.9999544620513916,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Amcinonide.,49,Type_49,Yes
DB00323,Tolcapone,DB00683,Midazolam,0.9995598196983337,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Midazolam.,49,Type_49,Yes
DB00313,Valproic acid,DB00624,Testosterone,0.7799555063247681,47,Type_47,The metabolism of Testosterone can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB01401,Choline magnesium trisalicylate,DB08981,Fenbufen,0.9997846484184265,49,Type_49,The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fenbufen.,49,Type_49,Yes
DB00472,Fluoxetine,DB01072,Atazanavir,0.7502734661102295,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00296,Ropivacaine,DB01567,Fludiazepam,0.9964002370834351,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fludiazepam.,49,Type_49,Yes
DB01580,Oxprenolol,DB01623,Thiothixene,0.3502064049243927,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Thiothixene.,49,Type_49,Yes
DB00319,Piperacillin,DB01024,Mycophenolic acid,0.5841708183288574,49,Type_49,The risk or severity of adverse effects can be increased when Piperacillin is combined with Mycophenolic acid.,11,Type_11,No
DB00441,Gemcitabine,DB00511,Acetyldigitoxin,0.9954000115394592,58,Type_58,Gemcitabine may decrease the cardiotoxic activities of Acetyldigitoxin.,58,Type_58,Yes
DB00313,Valproic acid,DB00656,Trazodone,0.6726095080375671,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Trazodone.,49,Type_49,Yes
DB00268,Ropinirole,DB01219,Dantrolene,0.9998440742492676,32,Type_32,Ropinirole may increase the sedative activities of Dantrolene.,32,Type_32,Yes
DB00989,Rivastigmine,DB06709,Methacholine,0.9846018552780151,49,Type_49,The risk or severity of adverse effects can be increased when Rivastigmine is combined with Methacholine.,49,Type_49,Yes
DB00817,Rosoxacin,DB08991,Epirizole,0.9747865200042725,27,Type_27,Rosoxacin may increase the neuroexcitatory activities of Epirizole.,27,Type_27,Yes
DB00933,Mesoridazine,DB01224,Quetiapine,0.9362182021141052,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Quetiapine.,49,Type_49,Yes
DB00682,Warfarin,DB00846,Flurandrenolide,0.9441097974777222,6,Type_6,Warfarin may increase the anticoagulant activities of Flurandrenolide.,6,Type_6,Yes
DB00735,Naftifine,DB08991,Epirizole,0.9996896982192993,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Epirizole.,49,Type_49,Yes
DB00454,Meperidine,DB00542,Benazepril,0.9038132429122925,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Benazepril.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00796,Candesartan cilexetil,0.7962225079536438,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Candesartan cilexetil.,56,Type_56,No
DB00180,Flunisolide,DB01211,Clarithromycin,0.852400004863739,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Flunisolide.,47,Type_47,Yes
DB00966,Telmisartan,DB01119,Diazoxide,0.9918756484985352,60,Type_60,Telmisartan may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00904,Ondansetron,DB01355,Hexobarbital,0.9470391869544983,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexobarbital.,49,Type_49,Yes
DB00136,Calcitriol,DB08899,Enzalutamide,0.9261283874511719,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Calcitriol.,75,Type_75,Yes
DB00208,Ticlopidine,DB05246,Methsuximide,0.9550968408584595,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00498,Phenindione,DB01406,Danazol,0.9982366561889648,6,Type_6,Phenindione may increase the anticoagulant activities of Danazol.,6,Type_6,Yes
DB00694,Daunorubicin,DB04552,Niflumic acid,0.99154132604599,72,Type_72,Daunorubicin may decrease the excretion rate of Niflumic acid which could result in a higher serum level.,72,Type_72,Yes
DB00737,Meclizine,DB09017,Brotizolam,0.9999986886978149,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Brotizolam.,49,Type_49,Yes
DB00715,Paroxetine,DB01021,Trichlormethiazide,0.9928271174430847,55,Type_55,Paroxetine may increase the hyponatremic activities of Trichlormethiazide.,55,Type_55,Yes
DB00446,Chloramphenicol,DB00951,Isoniazid,0.9436843991279602,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00244,Mesalazine,DB00686,Pentosan polysulfate,0.936725914478302,6,Type_6,Mesalazine may increase the anticoagulant activities of Pentosan polysulfate.,6,Type_6,Yes
DB00203,Sildenafil,DB00363,Clozapine,0.7286987900733948,47,Type_47,The metabolism of Clozapine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00755,Tretinoin,DB01115,Nifedipine,0.9872668385505676,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Nifedipine.,49,Type_49,Yes
DB01192,Oxymorphone,DB09300,Butylscopolamine,0.9997853636741638,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Butylscopolamine.,49,Type_49,Yes
DB00178,Ramipril,DB00435,Nitric Oxide,0.9996545314788818,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Nitric Oxide.,49,Type_49,Yes
DB00195,Betaxolol,DB00332,Ipratropium,0.7945228219032288,47,Type_47,The metabolism of Ipratropium can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB09048,Netupitant,DB11362,Selexipag,0.9360553622245789,73,Type_73,The serum concentration of Selexipag can be increased when it is combined with Netupitant.,73,Type_73,Yes
DB00300,Tenofovir disoproxil,DB06216,Asenapine,0.8076200485229492,47,Type_47,The metabolism of Asenapine can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00500,Tolmetin,DB01324,Polythiazide,0.9997491240501404,70,Type_70,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Tolmetin.,70,Type_70,Yes
DB01396,Digitoxin,DB08905,Formestane,0.5930708646774292,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Formestane.,58,Type_58,Yes
DB00243,Ranolazine,DB09078,Lenvatinib,0.5566007494926453,20,Type_20,Ranolazine may increase the QTc-prolonging activities of Lenvatinib.,73,Type_73,No
DB00278,Argatroban,DB00370,Mirtazapine,0.7825269103050232,73,Type_73,The serum concentration of Mirtazapine can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00818,Propofol,DB09073,Palbociclib,0.9842288494110107,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Propofol.,73,Type_73,Yes
DB00708,Sufentanil,DB01577,Metamfetamine,0.9929245710372925,69,Type_69,Sufentanil may increase the analgesic activities of Metamfetamine.,69,Type_69,Yes
DB00288,Amcinonide,DB01174,Phenobarbital,0.8834289908409119,75,Type_75,The serum concentration of Phenobarbital can be decreased when it is combined with Amcinonide.,75,Type_75,Yes
DB00344,Protriptyline,DB06228,Rivaroxaban,0.544318675994873,73,Type_73,The serum concentration of Rivaroxaban can be increased when it is combined with Protriptyline.,73,Type_73,Yes
DB00737,Meclizine,DB01587,Ketazolam,0.9992985725402832,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Ketazolam.,49,Type_49,Yes
DB00188,Bortezomib,DB00635,Prednisone,0.8935737609863281,47,Type_47,The metabolism of Prednisone can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00169,Cholecalciferol,DB06697,Artemether,0.8778720498085022,47,Type_47,The metabolism of Artemether can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00293,Raltitrexed,DB06772,Cabazitaxel,0.9959717392921448,49,Type_49,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Cabazitaxel.,49,Type_49,Yes
DB01133,Tiludronic acid,DB06263,Amrubicin,0.9848566651344299,24,Type_24,Tiludronic acid may increase the hypocalcemic activities of Amrubicin.,24,Type_24,Yes
DB00936,Salicylic acid,DB06786,Halcinonide,0.9957064986228943,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Halcinonide.,49,Type_49,Yes
DB00502,Haloperidol,DB06201,Rufinamide,0.9731966853141785,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Rufinamide.,49,Type_49,Yes
DB01016,Glyburide,DB06788,Histrelin,0.9592363238334656,70,Type_70,The therapeutic efficacy of Histrelin can be decreased when used in combination with Glyburide.,70,Type_70,Yes
DB01254,Dasatinib,DB08820,Ivacaftor,0.9992945194244385,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB01264,Darunavir,DB06595,Midostaurin,0.7067576050758362,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Darunavir.,47,Type_47,Yes
DB00720,Clodronic acid,DB09216,Tolfenamic acid,0.9966031312942505,49,Type_49,The risk or severity of adverse effects can be increased when Clodronic acid is combined with Tolfenamic acid.,49,Type_49,Yes
DB00321,Amitriptyline,DB00549,Zafirlukast,0.7204623222351074,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00323,Tolcapone,DB09072,Sodium oxybate,0.9968616962432861,16,Type_16,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00736,Esomeprazole,DB05521,Telaprevir,0.7797618508338928,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB01206,Lomustine,DB01403,Methotrimeprazine,0.88968425989151,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Lomustine.,47,Type_47,Yes
DB00334,Olanzapine,DB09038,Empagliflozin,0.7380654811859131,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Olanzapine.,70,Type_70,Yes
DB00869,Dorzolamide,DB05219,Crisaborole,0.9995055198669434,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Dorzolamide.,47,Type_47,Yes
DB00496,Darifenacin,DB08881,Vemurafenib,0.5326903462409973,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Darifenacin.,75,Type_75,No
DB01608,Periciazine,DB04844,Tetrabenazine,0.5222463011741638,20,Type_20,Periciazine may increase the QTc-prolonging activities of Tetrabenazine.,49,Type_49,No
DB00564,Carbamazepine,DB00957,Norgestimate,0.6821350455284119,70,Type_70,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Carbamazepine.,70,Type_70,Yes
DB00744,Zileuton,DB01021,Trichlormethiazide,0.9954445362091064,70,Type_70,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Zileuton.,70,Type_70,Yes
DB00246,Ziprasidone,DB06288,Amisulpride,0.8708553314208984,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Amisulpride.,36,Type_36,No
DB00881,Quinapril,DB01628,Etoricoxib,0.9461396932601929,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Etoricoxib.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB00475,Chlordiazepoxide,0.9997978806495667,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Chlordiazepoxide.,49,Type_49,Yes
DB01026,Ketoconazole,DB01232,Saquinavir,0.4261433184146881,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00323,Tolcapone,DB00425,Zolpidem,0.999562680721283,16,Type_16,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB01325,Quinethazone,DB06262,Droxidopa,0.9987248778343201,83,Type_83,Quinethazone may increase the hypokalemic activities of Droxidopa.,83,Type_83,Yes
DB00860,Prednisolone,DB01057,Echothiophate,0.9863948822021484,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Echothiophate.,49,Type_49,Yes
DB00297,Bupivacaine,DB01192,Oxymorphone,0.9829844236373901,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Oxymorphone.,49,Type_49,Yes
DB00605,Sulindac,DB01130,Prednicarbate,0.9999420642852783,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Prednicarbate.,49,Type_49,Yes
DB01044,Gatifloxacin,DB03585,Oxyphenbutazone,0.99899822473526,27,Type_27,Gatifloxacin may increase the neuroexcitatory activities of Oxyphenbutazone.,27,Type_27,Yes
DB00610,Metaraminol,DB01367,Rasagiline,0.9914031624794006,71,Type_71,Metaraminol may increase the hypertensive activities of Rasagiline.,71,Type_71,Yes
DB00765,Metyrosine,DB00768,Olopatadine,0.9869901537895203,32,Type_32,Metyrosine may increase the sedative activities of Olopatadine.,32,Type_32,Yes
DB00246,Ziprasidone,DB01256,Retapamulin,0.966892659664154,47,Type_47,The metabolism of Retapamulin can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00549,Zafirlukast,DB01142,Doxepin,0.9002363681793213,47,Type_47,The metabolism of Doxepin can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00425,Zolpidem,DB00835,Brompheniramine,0.9915408492088318,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.,16,Type_16,Yes
DB00252,Phenytoin,DB03793,Benzoic acid,0.8703399300575256,73,Type_73,The serum concentration of Benzoic acid can be increased when it is combined with Phenytoin.,73,Type_73,Yes
DB00887,Bumetanide,DB01064,Isoprenaline,0.997961163520813,83,Type_83,Bumetanide may increase the hypokalemic activities of Isoprenaline.,83,Type_83,Yes
DB06196,Icatibant,DB09211,Limaprost,0.9749879240989685,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Icatibant.,70,Type_70,Yes
DB01149,Nefazodone,DB06789,Hydroxyprogesterone caproate,0.7255654335021973,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00341,Cetirizine,DB01151,Desipramine,0.9944218993186951,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Desipramine.,49,Type_49,Yes
DB00150,Tryptophan,DB00514,Dextromethorphan,0.8866982460021973,64,Type_64,Tryptophan may increase the serotonergic activities of Dextromethorphan.,64,Type_64,Yes
DB00568,Cinnarizine,DB09040,Efinaconazole,0.8529723882675171,49,Type_49,The risk or severity of adverse effects can be increased when Cinnarizine is combined with Efinaconazole.,49,Type_49,Yes
DB00284,Acarbose,DB00614,Furazolidone,0.9980352520942688,9,Type_9,Acarbose may increase the hypoglycemic activities of Furazolidone.,9,Type_9,Yes
DB00700,Eplerenone,DB01192,Oxymorphone,0.993556559085846,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Oxymorphone.,49,Type_49,Yes
DB01544,Flunitrazepam,DB09120,Zucapsaicin,0.9982630610466003,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Flunitrazepam.,47,Type_47,Yes
DB00860,Prednisolone,DB01092,Ouabain,0.9999549388885498,58,Type_58,Prednisolone may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB01132,Pioglitazone,DB06739,Seratrodast,0.7539972066879272,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Pioglitazone.,47,Type_47,Yes
DB01167,Itraconazole,DB01559,Clotiazepam,0.6722288727760315,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00224,Indinavir,DB00381,Amlodipine,0.8868187069892883,47,Type_47,The metabolism of Amlodipine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00925,Phenoxybenzamine,DB01115,Nifedipine,0.8671524524688721,49,Type_49,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Nifedipine.,49,Type_49,Yes
DB01215,Estazolam,DB06636,Isavuconazonium,0.8422375917434692,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Estazolam.,47,Type_47,Yes
DB00202,Succinylcholine,DB00677,Isoflurophate,0.9978262782096863,73,Type_73,The serum concentration of Isoflurophate can be increased when it is combined with Succinylcholine.,73,Type_73,Yes
DB00224,Indinavir,DB01098,Rosuvastatin,0.48990586400032043,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00243,Ranolazine,DB01208,Sparfloxacin,0.45307159423828125,73,Type_73,The serum concentration of Sparfloxacin can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00474,Methohexital,DB00598,Labetalol,0.9076119661331177,60,Type_60,Methohexital may increase the hypotensive activities of Labetalol.,60,Type_60,Yes
DB00253,Medrysone,DB00545,Pyridostigmine,0.9998847246170044,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Pyridostigmine.,49,Type_49,Yes
DB00091,Cyclosporine,DB00482,Celecoxib,0.700590193271637,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Celecoxib.,57,Type_57,Yes
DB00503,Ritonavir,DB04876,Vildagliptin,0.45045650005340576,47,Type_47,The metabolism of Vildagliptin can be decreased when combined with Ritonavir.,70,Type_70,No
DB00413,Pramipexole,DB00697,Tizanidine,0.999270498752594,32,Type_32,Pramipexole may increase the sedative activities of Tizanidine.,32,Type_32,Yes
DB00774,Hydroflumethiazide,DB01054,Nitrendipine,0.7830722332000732,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB00482,Celecoxib,DB00554,Piroxicam,0.7813906669616699,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Piroxicam.,47,Type_47,No
DB00240,Alclometasone,DB00608,Chloroquine,0.6506125330924988,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Chloroquine.,49,Type_49,Yes
DB00780,Phenelzine,DB09026,Aliskiren,0.9747406244277954,60,Type_60,Phenelzine may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB01165,Ofloxacin,DB01263,Posaconazole,0.9997534155845642,20,Type_20,Ofloxacin may increase the QTc-prolonging activities of Posaconazole.,20,Type_20,Yes
DB03585,Oxyphenbutazone,DB08991,Epirizole,0.9993916749954224,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Epirizole.,49,Type_49,Yes
DB00195,Betaxolol,DB00790,Perindopril,0.855806291103363,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Perindopril.,49,Type_49,Yes
DB00939,Meclofenamic acid,DB01014,Balsalazide,0.6385917067527771,57,Type_57,Meclofenamic acid may increase the nephrotoxic activities of Balsalazide.,57,Type_57,Yes
DB00216,Eletriptan,DB01623,Thiothixene,0.971038818359375,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Thiothixene.,49,Type_49,Yes
DB01154,Thiamylal,DB01282,Carbetocin,0.7146180868148804,60,Type_60,Thiamylal may increase the hypotensive activities of Carbetocin.,60,Type_60,Yes
DB01002,Levobupivacaine,DB09048,Netupitant,0.9066538214683533,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Levobupivacaine.,73,Type_73,Yes
DB00335,Atenolol,DB01396,Digitoxin,0.9497712850570679,54,Type_54,Atenolol may increase the bradycardic activities of Digitoxin.,54,Type_54,Yes
DB01159,Halothane,DB04948,Lofexidine,0.8942357301712036,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Lofexidine.,49,Type_49,Yes
DB00246,Ziprasidone,DB11613,Velpatasvir,0.9577573537826538,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00334,Olanzapine,DB01273,Varenicline,0.7011374831199646,73,Type_73,The serum concentration of Varenicline can be increased when it is combined with Olanzapine.,73,Type_73,Yes
DB00245,Benzatropine,DB01241,Gemfibrozil,0.9106625318527222,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB00614,Furazolidone,DB01104,Sertraline,0.8804338574409485,64,Type_64,Furazolidone may increase the serotonergic activities of Sertraline.,64,Type_64,Yes
DB06723,Aluminum hydroxide,DB09154,Sodium citrate,0.8852661848068237,18,Type_18,Aluminum hydroxide can cause an increase in the absorption of Sodium citrate resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB01224,Quetiapine,DB09048,Netupitant,0.9584716558456421,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Quetiapine.,73,Type_73,Yes
DB06216,Asenapine,DB09074,Olaparib,0.7160626649856567,47,Type_47,The metabolism of Olaparib can be decreased when combined with Asenapine.,47,Type_47,Yes
DB00497,Oxycodone,DB09244,Pirlindole,0.8843633532524109,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Pirlindole.,49,Type_49,Yes
DB00641,Simvastatin,DB00734,Risperidone,0.7457664608955383,73,Type_73,The serum concentration of Risperidone can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00310,Chlorthalidone,DB08984,Etofenamate,0.9905750155448914,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB04839,Cyproterone acetate,DB04946,Iloperidone,0.6324743628501892,73,Type_73,The serum concentration of Iloperidone can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB01263,Posaconazole,DB09102,Daclatasvir,0.6561810970306396,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Posaconazole.,73,Type_73,No
DB00179,Masoprocol,DB00487,Pefloxacin,0.9995384216308594,27,Type_27,Masoprocol may increase the neuroexcitatory activities of Pefloxacin.,27,Type_27,Yes
DB00673,Aprepitant,DB00764,Mometasone,0.923927366733551,73,Type_73,The serum concentration of Mometasone can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00440,Trimethoprim,DB00549,Zafirlukast,0.8802872896194458,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB09236,Lacidipine,0.7192132472991943,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00850,Perphenazine,DB01101,Capecitabine,0.9124664664268494,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Perphenazine.,47,Type_47,Yes
DB00912,Repaglinide,DB01252,Mitiglinide,0.9916602969169617,9,Type_9,Repaglinide may increase the hypoglycemic activities of Mitiglinide.,9,Type_9,Yes
DB00794,Primidone,DB01072,Atazanavir,0.7061430215835571,4,Type_4,The metabolism of Atazanavir can be increased when combined with Primidone.,4,Type_4,Yes
DB06725,Lornoxicam,DB08976,Floctafenine,0.9978728294372559,49,Type_49,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Floctafenine.,49,Type_49,Yes
DB00482,Celecoxib,DB01201,Rifapentine,0.8188919425010681,4,Type_4,The metabolism of Rifapentine can be increased when combined with Celecoxib.,4,Type_4,Yes
DB00446,Chloramphenicol,DB00679,Thioridazine,0.8301873207092285,47,Type_47,The metabolism of Thioridazine can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00370,Mirtazapine,DB04908,Flibanserin,0.9998113512992859,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,16,Type_16,Yes
DB01563,Chloral hydrate,DB09117,Paraldehyde,0.9998231530189514,16,Type_16,Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00503,Ritonavir,DB08820,Ivacaftor,0.9988722205162048,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB01132,Pioglitazone,DB06414,Etravirine,0.5481086373329163,47,Type_47,The metabolism of Etravirine can be decreased when combined with Pioglitazone.,47,Type_47,Yes
DB00601,Linezolid,DB01193,Acebutolol,0.5961780548095703,71,Type_71,Linezolid may increase the hypertensive activities of Acebutolol.,71,Type_71,Yes
DB05812,Abiraterone,DB08820,Ivacaftor,0.9984622001647949,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB01002,Levobupivacaine,DB08881,Vemurafenib,0.822553813457489,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Levobupivacaine.,73,Type_73,No
DB06210,Eltrombopag,DB09054,Idelalisib,0.7136873006820679,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Eltrombopag.,73,Type_73,No
DB01065,Melatonin,DB01189,Desflurane,0.9923110008239746,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Desflurane.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB01359,Penbutolol,0.49637261033058167,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Penbutolol.,49,Type_49,Yes
DB01418,Acenocoumarol,DB01420,Testosterone propionate,0.9327038526535034,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Testosterone propionate.,6,Type_6,Yes
DB00177,Valsartan,DB03585,Oxyphenbutazone,0.9742547273635864,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00353,Methylergometrine,DB00542,Benazepril,0.7297360301017761,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Benazepril.,73,Type_73,No
DB00754,Ethotoin,DB08987,Etidocaine,0.9858038425445557,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Etidocaine.,49,Type_49,Yes
DB00184,Nicotine,DB00277,Theophylline,0.795671284198761,47,Type_47,The metabolism of Theophylline can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00472,Fluoxetine,DB00906,Tiagabine,0.7997288703918457,47,Type_47,The metabolism of Tiagabine can be decreased when combined with Fluoxetine.,49,Type_49,No
DB00363,Clozapine,DB01340,Cilazapril,0.7830395102500916,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Cilazapril.,49,Type_49,Yes
DB01221,Ketamine,DB09280,Lumacaftor,0.43833550810813904,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Ketamine.,73,Type_73,No
DB00945,Acetylsalicylic acid,DB01210,Levobunolol,0.9993917942047119,37,Type_37,Acetylsalicylic acid may decrease the antihypertensive activities of Levobunolol.,37,Type_37,Yes
DB00358,Mefloquine,DB00394,Beclomethasone dipropionate,0.9497106671333313,49,Type_49,The risk or severity of adverse effects can be increased when Mefloquine is combined with Beclomethasone dipropionate.,49,Type_49,Yes
DB00214,Torasemide,DB00381,Amlodipine,0.970066249370575,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Amlodipine.,49,Type_49,Yes
DB00313,Valproic acid,DB00907,Cocaine,0.577921986579895,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Cocaine.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB00849,Methylphenobarbital,0.9270114302635193,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Methylphenobarbital.,49,Type_49,Yes
DB00543,Amoxapine,DB01087,Primaquine,0.8805524110794067,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB06636,Isavuconazonium,DB08895,Tofacitinib,0.6278288960456848,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00544,Fluorouracil,DB00748,Carbinoxamine,0.8945019245147705,47,Type_47,The metabolism of Carbinoxamine can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00687,Fludrocortisone,DB01656,Roflumilast,0.45706555247306824,34,Type_34,Fludrocortisone may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00821,Carprofen,DB09091,Tixocortol,0.9996719360351562,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Tixocortol.,49,Type_49,Yes
DB00559,Bosentan,DB01090,Pentolinium,0.989170253276825,60,Type_60,Bosentan may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB01222,Budesonide,DB06290,Simeprevir,0.9653160572052002,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Budesonide.,73,Type_73,Yes
DB00637,Astemizole,DB09048,Netupitant,0.9797690510749817,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Astemizole.,73,Type_73,Yes
DB00715,Paroxetine,DB09204,Arotinolol,0.5126619935035706,73,Type_73,The serum concentration of Arotinolol can be increased when it is combined with Paroxetine.,73,Type_73,Yes
DB00335,Atenolol,DB00944,Demecarium,0.9817525148391724,54,Type_54,Atenolol may increase the bradycardic activities of Demecarium.,54,Type_54,Yes
DB01211,Clarithromycin,DB12483,Copanlisib,0.8461613059043884,47,Type_47,The metabolism of Copanlisib can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00409,Remoxipride,DB06204,Tapentadol,0.9894654750823975,16,Type_16,Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00966,Telmisartan,DB09112,Nitrous acid,0.9924132227897644,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Nitrous acid.,49,Type_49,Yes
DB01029,Irbesartan,DB09204,Arotinolol,0.9603985548019409,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Arotinolol.,49,Type_49,Yes
DB00648,Mitotane,DB08439,Parecoxib,0.9954378008842468,75,Type_75,The serum concentration of Parecoxib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00818,Propofol,DB09225,Zotepine,0.9969428181648254,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Zotepine.,49,Type_49,Yes
DB00589,Lisuride,DB04871,Lorcaserin,0.6098150014877319,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Lorcaserin.,47,Type_47,No
DB00641,Simvastatin,DB01076,Atorvastatin,0.40033435821533203,49,Type_49,The risk or severity of adverse effects can be increased when Simvastatin is combined with Atorvastatin.,49,Type_49,Yes
DB01165,Ofloxacin,DB09082,Vilanterol,0.999971866607666,20,Type_20,Ofloxacin may increase the QTc-prolonging activities of Vilanterol.,20,Type_20,Yes
DB00313,Valproic acid,DB01100,Pimozide,0.6455651521682739,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Pimozide.,49,Type_49,Yes
DB00952,Naratriptan,DB09128,Brexpiprazole,0.9966193437576294,49,Type_49,The risk or severity of adverse effects can be increased when Naratriptan is combined with Brexpiprazole.,49,Type_49,Yes
DB00277,Theophylline,DB08880,Teriflunomide,0.6930520534515381,18,Type_18,Theophylline can cause an increase in the absorption of Teriflunomide resulting in an increased serum concentration and potentially a worsening of adverse effects.,75,Type_75,No
DB00598,Labetalol,DB00744,Zileuton,0.9947526454925537,37,Type_37,Labetalol may decrease the antihypertensive activities of Zileuton.,37,Type_37,Yes
DB00738,Pentamidine,DB01248,Docetaxel,0.6425105333328247,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Pentamidine.,47,Type_47,Yes
DB01255,Lisdexamfetamine,DB09128,Brexpiprazole,0.9999459981918335,61,Type_61,Lisdexamfetamine may decrease the stimulatory activities of Brexpiprazole.,61,Type_61,Yes
DB00320,Dihydroergotamine,DB00584,Enalapril,0.46680691838264465,47,Type_47,The metabolism of Enalapril can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00663,Flumethasone,DB09070,Tibolone,0.9493574500083923,73,Type_73,The serum concentration of Tibolone can be increased when it is combined with Flumethasone.,73,Type_73,Yes
DB01192,Oxymorphone,DB05271,Rotigotine,0.9773653745651245,32,Type_32,Oxymorphone may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00678,Losartan,DB04855,Dronedarone,0.884088933467865,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Losartan.,47,Type_47,Yes
DB00734,Risperidone,DB09074,Olaparib,0.8831685781478882,47,Type_47,The metabolism of Olaparib can be decreased when combined with Risperidone.,47,Type_47,Yes
DB00450,Droperidol,DB09085,Tetracaine,0.9994761347770691,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.,16,Type_16,Yes
DB01397,Magnesium salicylate,DB06736,Aceclofenac,0.9961936473846436,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Aceclofenac.,49,Type_49,Yes
DB00543,Amoxapine,DB00708,Sufentanil,0.8942664861679077,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Sufentanil.,49,Type_49,Yes
DB00705,Delavirdine,DB09123,Dienogest,0.2861885726451874,75,Type_75,The serum concentration of Dienogest can be decreased when it is combined with Delavirdine.,47,Type_47,No
DB00237,Butabarbital,DB00557,Hydroxyzine,0.9998010993003845,16,Type_16,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB01325,Quinethazone,DB06786,Halcinonide,0.9999977350234985,83,Type_83,Quinethazone may increase the hypokalemic activities of Halcinonide.,83,Type_83,Yes
DB00937,Diethylpropion,DB09286,Pipamperone,0.9989297986030579,61,Type_61,Diethylpropion may decrease the stimulatory activities of Pipamperone.,61,Type_61,Yes
DB00486,Nabilone,DB00703,Methazolamide,0.9830923676490784,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Methazolamide.,49,Type_49,Yes
DB00846,Flurandrenolide,DB09543,Methyl salicylate,0.9958820343017578,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Methyl salicylate.,49,Type_49,Yes
DB00909,Zonisamide,DB01154,Thiamylal,0.9929986000061035,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Thiamylal.,49,Type_49,Yes
DB01256,Retapamulin,DB01263,Posaconazole,0.9492108225822449,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Retapamulin.,73,Type_73,No
DB01158,Bretylium,DB01180,Rescinnamine,0.9431068301200867,60,Type_60,Bretylium may increase the hypotensive activities of Rescinnamine.,60,Type_60,Yes
DB01018,Guanfacine,DB06663,Pasireotide,0.6976873874664307,54,Type_54,Guanfacine may increase the bradycardic activities of Pasireotide.,54,Type_54,Yes
DB00280,Disopyramide,DB01201,Rifapentine,0.9402459263801575,4,Type_4,The metabolism of Rifapentine can be increased when combined with Disopyramide.,4,Type_4,Yes
DB00359,Sulfadiazine,DB00685,Trovafloxacin,0.9872949719429016,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Trovafloxacin.,9,Type_9,Yes
DB04855,Dronedarone,DB09048,Netupitant,0.9634960293769836,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Dronedarone.,73,Type_73,Yes
DB00182,Amphetamine,DB00243,Ranolazine,0.6964397430419922,73,Type_73,The serum concentration of Ranolazine can be increased when it is combined with Amphetamine.,47,Type_47,No
DB00252,Phenytoin,DB01103,Quinacrine,0.5437145233154297,75,Type_75,The serum concentration of Quinacrine can be decreased when it is combined with Phenytoin.,4,Type_4,No
DB01104,Sertraline,DB01615,Aceprometazine,0.9007488489151001,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Aceprometazine.,49,Type_49,Yes
DB01340,Cilazapril,DB01351,Amobarbital,0.8514510989189148,60,Type_60,Cilazapril may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00742,Mannitol,DB01002,Levobupivacaine,0.743815004825592,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Levobupivacaine.,49,Type_49,Yes
DB00193,Tramadol,DB00732,Atracurium besylate,0.9893686175346375,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Atracurium besylate.,49,Type_49,Yes
DB01589,Quazepam,DB08910,Pomalidomide,0.966884434223175,49,Type_49,The risk or severity of adverse effects can be increased when Quazepam is combined with Pomalidomide.,49,Type_49,Yes
DB00646,Nystatin,DB09235,Efonidipine,0.9989725351333618,49,Type_49,The risk or severity of adverse effects can be increased when Nystatin is combined with Efonidipine.,49,Type_49,Yes
DB00498,Phenindione,DB09218,Clonixin,0.9998106360435486,6,Type_6,Phenindione may increase the anticoagulant activities of Clonixin.,6,Type_6,Yes
DB01367,Rasagiline,DB01463,Fencamfamin,0.9787715077400208,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Fencamfamin.,49,Type_49,Yes
DB00257,Clotrimazole,DB06210,Eltrombopag,0.8448559641838074,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00213,Pantoprazole,DB01050,Ibuprofen,0.9688257575035095,47,Type_47,The metabolism of Ibuprofen can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00276,Amsacrine,DB04868,Nilotinib,0.8804535865783691,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Amsacrine.,47,Type_47,Yes
DB00184,Nicotine,DB01203,Nadolol,0.884009063243866,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Nadolol.,49,Type_49,Yes
DB01239,Chlorprothixene,DB08918,Levomilnacipran,0.9782516956329346,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Levomilnacipran.,49,Type_49,Yes
DB00622,Nicardipine,DB01544,Flunitrazepam,0.9419524073600769,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB09039,Eliglustat,DB09083,Ivabradine,0.850701093673706,20,Type_20,Eliglustat may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB00748,Carbinoxamine,DB05219,Crisaborole,0.9984431862831116,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB00275,Olmesartan,0.985170304775238,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Olmesartan.,49,Type_49,Yes
DB00714,Apomorphine,DB00899,Remifentanil,0.9802859425544739,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Remifentanil.,49,Type_49,Yes
DB00697,Tizanidine,DB01198,Zopiclone,0.8732486367225647,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Zopiclone.,49,Type_49,Yes
DB00246,Ziprasidone,DB00374,Treprostinil,0.8235349655151367,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Treprostinil.,20,Type_20,Yes
DB00244,Mesalazine,DB00374,Treprostinil,0.8102607131004333,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Treprostinil.,49,Type_49,Yes
DB00696,Ergotamine,DB01203,Nadolol,0.6503716707229614,25,Type_25,Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.,25,Type_25,Yes
DB01227,Levacetylmethadol,DB01624,Zuclopenthixol,0.8686090111732483,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Zuclopenthixol.,49,Type_49,Yes
DB00450,Droperidol,DB04844,Tetrabenazine,0.9961650371551514,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetrabenazine.,16,Type_16,Yes
DB00758,Clopidogrel,DB06739,Seratrodast,0.5109430551528931,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Clopidogrel.,47,Type_47,Yes
DB00657,Mecamylamine,DB00999,Hydrochlorothiazide,0.620595395565033,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00572,Atropine,DB01337,Pancuronium,0.9993334412574768,49,Type_49,The risk or severity of adverse effects can be increased when Atropine is combined with Pancuronium.,49,Type_49,Yes
DB00734,Risperidone,DB00907,Cocaine,0.6525272727012634,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Cocaine.,47,Type_47,No
DB00322,Floxuridine,DB00359,Sulfadiazine,0.970544159412384,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00177,Valsartan,DB00252,Phenytoin,0.8954097032546997,4,Type_4,The metabolism of Phenytoin can be increased when combined with Valsartan.,4,Type_4,Yes
DB00227,Lovastatin,DB00675,Tamoxifen,0.5930415987968445,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01101,Capecitabine,DB05109,Trabectedin,0.7658165097236633,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Capecitabine.,47,Type_47,Yes
DB00035,Desmopressin,DB06212,Tolvaptan,0.9981429576873779,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Tolvaptan.,70,Type_70,No
DB00104,Octreotide,DB00468,Quinine,0.9450782537460327,20,Type_20,Octreotide may increase the QTc-prolonging activities of Quinine.,20,Type_20,Yes
DB00921,Buprenorphine,DB01097,Leflunomide,0.9015827178955078,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Buprenorphine.,47,Type_47,Yes
DB00404,Alprazolam,DB09034,Suvorexant,0.9962133765220642,16,Type_16,Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00220,Nelfinavir,DB00231,Temazepam,0.8758636116981506,47,Type_47,The metabolism of Temazepam can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01235,Levodopa,DB01621,Pipotiazine,0.9835655093193054,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Pipotiazine.,49,Type_49,Yes
DB00889,Granisetron,DB06603,Panobinostat,0.523746907711029,20,Type_20,Granisetron may increase the QTc-prolonging activities of Panobinostat.,82,Type_82,No
DB00542,Benazepril,DB08873,Boceprevir,0.4509127140045166,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Benazepril.,75,Type_75,No
DB00897,Triazolam,DB00972,Azelastine,0.9453078508377075,16,Type_16,Triazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00608,Chloroquine,DB09026,Aliskiren,0.5954902768135071,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Chloroquine.,37,Type_37,No
DB00208,Ticlopidine,DB11614,Rupatadine,0.9729477763175964,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00796,Candesartan cilexetil,DB01392,Yohimbine,0.999504566192627,37,Type_37,Candesartan cilexetil may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00904,Ondansetron,DB08933,Luliconazole,0.9718833565711975,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Ondansetron.,73,Type_73,Yes
DB00608,Chloroquine,DB01118,Amiodarone,0.6449756622314453,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00648,Mitotane,DB08882,Linagliptin,0.994346559047699,75,Type_75,The serum concentration of Linagliptin can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01708,Prasterone,DB09084,Benzydamine,0.9995824694633484,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Benzydamine.,49,Type_49,Yes
DB00788,Naproxen,DB09285,Morniflumate,0.9998225569725037,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Morniflumate.,49,Type_49,Yes
DB00681,Amphotericin B,DB01340,Cilazapril,0.9971674084663391,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Cilazapril.,49,Type_49,Yes
DB00502,Haloperidol,DB13872,Lormetazepam,0.9949343800544739,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Lormetazepam.,49,Type_49,Yes
DB00625,Efavirenz,DB06594,Agomelatine,0.9965774416923523,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Agomelatine.,49,Type_49,Yes
DB00195,Betaxolol,DB00839,Tolazamide,0.979826033115387,9,Type_9,Betaxolol may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00795,Sulfasalazine,DB01580,Oxprenolol,0.9952027797698975,37,Type_37,Sulfasalazine may decrease the antihypertensive activities of Oxprenolol.,37,Type_37,Yes
DB00297,Bupivacaine,DB08899,Enzalutamide,0.9234845042228699,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Bupivacaine.,75,Type_75,Yes
DB00633,Dexmedetomidine,DB09112,Nitrous acid,0.8859599232673645,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Nitrous acid.,49,Type_49,Yes
DB01222,Budesonide,DB06710,Methyltestosterone,0.9987428784370422,74,Type_74,Budesonide may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB00191,Phentermine,DB00933,Mesoridazine,0.9911594986915588,61,Type_61,Phentermine may decrease the stimulatory activities of Mesoridazine.,61,Type_61,Yes
DB00699,Nicergoline,DB01259,Lapatinib,0.8362036943435669,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Lapatinib.,49,Type_49,Yes
DB00882,Clomifene,DB01076,Atorvastatin,0.6175950169563293,49,Type_49,The risk or severity of adverse effects can be increased when Clomifene is combined with Atorvastatin.,49,Type_49,Yes
DB00873,Loteprednol,DB02709,Resveratrol,0.9994841814041138,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Resveratrol.,49,Type_49,Yes
DB00196,Fluconazole,DB09123,Dienogest,0.6827883124351501,47,Type_47,The metabolism of Dienogest can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00750,Prilocaine,DB06690,Nitrous oxide,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Nitrous oxide.,49,Type_49,Yes
DB01151,Desipramine,DB11699,Tropisetron,0.9984911680221558,64,Type_64,Desipramine may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00332,Ipratropium,DB06708,Lumefantrine,0.9707943797111511,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Ipratropium.,47,Type_47,Yes
DB00584,Enalapril,DB00752,Tranylcypromine,0.9123478531837463,60,Type_60,Enalapril may increase the hypotensive activities of Tranylcypromine.,60,Type_60,Yes
DB00341,Cetirizine,DB06288,Amisulpride,0.9873636364936829,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Amisulpride.,49,Type_49,Yes
DB06480,Prucalopride,DB09054,Idelalisib,0.9227526783943176,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Prucalopride.,73,Type_73,Yes
DB00582,Voriconazole,DB09091,Tixocortol,0.9855086207389832,73,Type_73,The serum concentration of Tixocortol can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB04839,Cyproterone acetate,DB06203,Alogliptin,0.4075746536254883,75,Type_75,The serum concentration of Alogliptin can be decreased when it is combined with Cyproterone acetate.,70,Type_70,No
DB06403,Ambrisentan,DB08933,Luliconazole,0.8944013118743896,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Ambrisentan.,73,Type_73,Yes
DB00745,Modafinil,DB08912,Dabrafenib,0.9413183927536011,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Modafinil.,75,Type_75,Yes
DB00586,Diclofenac,DB00663,Flumethasone,0.9992341995239258,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Flumethasone.,49,Type_49,Yes
DB01069,Promethazine,DB09291,Rolapitant,0.7276928424835205,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Promethazine.,47,Type_47,Yes
DB00903,Etacrynic acid,DB06739,Seratrodast,0.9999929666519165,29,Type_29,Etacrynic acid may decrease the diuretic activities of Seratrodast.,29,Type_29,Yes
DB01248,Docetaxel,DB04894,Vapreotide,0.9332711696624756,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vapreotide.,49,Type_49,Yes
DB04855,Dronedarone,DB06287,Temsirolimus,0.7618623375892639,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB01136,Carvedilol,DB01245,Decamethonium,0.9721983671188354,54,Type_54,Carvedilol may increase the bradycardic activities of Decamethonium.,54,Type_54,Yes
DB00829,Diazepam,DB00934,Maprotiline,0.9709105491638184,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Maprotiline.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00773,Etoposide,0.8045362234115601,47,Type_47,The metabolism of Etoposide can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00199,Erythromycin,DB04930,Permethrin,0.9653137922286987,47,Type_47,The metabolism of Permethrin can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00350,Minoxidil,DB00421,Spironolactone,0.9956591129302979,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Spironolactone.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01589,Quazepam,0.7891038060188293,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Quazepam.,49,Type_49,Yes
DB01018,Guanfacine,DB01601,Lopinavir,0.5846373438835144,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Guanfacine.,73,Type_73,No
DB00652,Pentazocine,DB00802,Alfentanil,0.9987658262252808,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Alfentanil.,49,Type_49,Yes
DB00484,Brimonidine,DB00950,Fexofenadine,0.9946962594985962,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fexofenadine.,16,Type_16,Yes
DB00518,Albendazole,DB00608,Chloroquine,0.9361971020698547,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Albendazole.,75,Type_75,No
DB00613,Amodiaquine,DB01076,Atorvastatin,0.44264525175094604,47,Type_47,The metabolism of Atorvastatin can be decreased when combined with Amodiaquine.,73,Type_73,No
DB00619,Imatinib,DB01588,Prazepam,0.820866584777832,47,Type_47,The metabolism of Prazepam can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00976,Telithromycin,DB09166,Etizolam,0.7617858052253723,47,Type_47,The metabolism of Etizolam can be decreased when combined with Telithromycin.,73,Type_73,No
DB00436,Bendroflumethiazide,DB00492,Fosinopril,0.8608460426330566,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Fosinopril.,49,Type_49,Yes
DB00964,Apraclonidine,DB01189,Desflurane,0.9770828485488892,49,Type_49,The risk or severity of adverse effects can be increased when Apraclonidine is combined with Desflurane.,49,Type_49,Yes
DB02703,Fusidic acid,DB11737,Icotinib,0.9924783706665039,73,Type_73,The serum concentration of Icotinib can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00220,Nelfinavir,DB01110,Miconazole,0.7538313865661621,47,Type_47,The metabolism of Miconazole can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00486,Nabilone,DB01002,Levobupivacaine,0.9916419982910156,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,16,Type_16,Yes
DB00320,Dihydroergotamine,DB00635,Prednisone,0.8415610194206238,47,Type_47,The metabolism of Prednisone can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00440,Trimethoprim,DB08880,Teriflunomide,0.45963868498802185,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Trimethoprim.,47,Type_47,No
DB00999,Hydrochlorothiazide,DB01104,Sertraline,0.9788497090339661,55,Type_55,Hydrochlorothiazide may increase the hyponatremic activities of Sertraline.,55,Type_55,Yes
DB00337,Pimecrolimus,DB01118,Amiodarone,0.7500806450843811,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Pimecrolimus.,47,Type_47,Yes
DB00699,Nicergoline,DB09167,Dosulepin,0.5635900497436523,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Dosulepin.,47,Type_47,No
DB01200,Bromocriptine,DB09235,Efonidipine,0.9744580984115601,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Efonidipine.,49,Type_49,Yes
DB00295,Morphine,DB00933,Mesoridazine,0.9475568532943726,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Mesoridazine.,49,Type_49,Yes
DB00379,Mexiletine,DB01424,Aminophenazone,0.9673418998718262,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00694,Daunorubicin,DB01320,Fosphenytoin,0.7938631176948547,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Daunorubicin.,4,Type_4,Yes
DB00823,Ethynodiol diacetate,DB06717,Fosaprepitant,0.7950544953346252,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Ethynodiol diacetate.,75,Type_75,Yes
DB01081,Diphenoxylate,DB01116,Trimethaphan,0.9965605139732361,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Trimethaphan.,49,Type_49,Yes
DB01179,Podofilox,DB02703,Fusidic acid,0.9995672106742859,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Podofilox.,73,Type_73,Yes
DB00896,Rimexolone,DB01628,Etoricoxib,0.9994156360626221,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Etoricoxib.,49,Type_49,Yes
DB01202,Levetiracetam,DB01544,Flunitrazepam,0.9992226362228394,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Flunitrazepam.,49,Type_49,Yes
DB01071,Mequitazine,DB06708,Lumefantrine,0.47686952352523804,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Lumefantrine.,47,Type_47,No
DB01021,Trichlormethiazide,DB01199,Tubocurarine,0.986492931842804,73,Type_73,The serum concentration of Tubocurarine can be increased when it is combined with Trichlormethiazide.,73,Type_73,Yes
DB00250,Dapsone,DB01615,Aceprometazine,0.5899505615234375,70,Type_70,The therapeutic efficacy of Aceprometazine can be decreased when used in combination with Dapsone.,73,Type_73,No
DB00692,Phentolamine,DB00697,Tizanidine,0.9578796625137329,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Tizanidine.,49,Type_49,Yes
DB00178,Ramipril,DB00323,Tolcapone,0.8866912126541138,60,Type_60,Ramipril may increase the hypotensive activities of Tolcapone.,49,Type_49,No
DB00714,Apomorphine,DB01162,Terazosin,0.9949353337287903,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Terazosin.,49,Type_49,Yes
DB00623,Fluphenazine,DB05812,Abiraterone,0.8313375115394592,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Fluphenazine.,73,Type_73,Yes
DB01242,Clomipramine,DB06702,Fesoterodine,0.9608777761459351,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Clomipramine.,77,Type_77,Yes
DB00780,Phenelzine,DB01622,Thioproperazine,0.9158506989479065,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Thioproperazine.,49,Type_49,Yes
DB00738,Pentamidine,DB00976,Telithromycin,0.899334192276001,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Telithromycin.,20,Type_20,Yes
DB04844,Tetrabenazine,DB08871,Eribulin,0.9995899796485901,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Eribulin.,20,Type_20,Yes
DB00328,Indomethacin,DB01044,Gatifloxacin,0.9989373087882996,27,Type_27,Indomethacin may increase the neuroexcitatory activities of Gatifloxacin.,27,Type_27,Yes
DB00972,Azelastine,DB01567,Fludiazepam,0.7783333659172058,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Fludiazepam.,16,Type_16,Yes
DB04876,Vildagliptin,DB09289,Tianeptine,0.34571465849876404,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Vildagliptin.,73,Type_73,No
DB08896,Regorafenib,DB12332,Rucaparib,0.7453839778900146,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Regorafenib.,47,Type_47,Yes
DB00636,Clofibrate,DB00834,Mifepristone,0.5975779294967651,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Clofibrate.,73,Type_73,Yes
DB00343,Diltiazem,DB00774,Hydroflumethiazide,0.6408652067184448,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Hydroflumethiazide.,60,Type_60,No
DB09118,Stiripentol,DB13874,Enasidenib,0.6449955701828003,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Stiripentol.,73,Type_73,Yes
DB01337,Pancuronium,DB01627,Lincomycin,0.9932131767272949,21,Type_21,Pancuronium may increase the neuromuscular blocking activities of Lincomycin.,21,Type_21,Yes
DB00359,Sulfadiazine,DB00794,Primidone,0.9619330167770386,4,Type_4,The metabolism of Primidone can be increased when combined with Sulfadiazine.,4,Type_4,Yes
DB00206,Reserpine,DB00408,Loxapine,0.9668342471122742,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Loxapine.,49,Type_49,Yes
DB01211,Clarithromycin,DB02546,Vorinostat,0.9836660623550415,20,Type_20,Clarithromycin may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB00227,Lovastatin,DB08815,Lurasidone,0.8160868287086487,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00188,Bortezomib,DB01320,Fosphenytoin,0.49303343892097473,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Bortezomib.,75,Type_75,No
DB00179,Masoprocol,DB08976,Floctafenine,0.9996507167816162,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Floctafenine.,49,Type_49,Yes
DB01209,Dezocine,DB01403,Methotrimeprazine,0.9454947113990784,16,Type_16,Dezocine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB01030,Topotecan,DB09054,Idelalisib,0.9181577563285828,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB01092,Ouabain,DB08871,Eribulin,0.9942675232887268,58,Type_58,Ouabain may decrease the cardiotoxic activities of Eribulin.,58,Type_58,Yes
DB00944,Demecarium,DB01036,Tolterodine,0.9835648536682129,70,Type_70,The therapeutic efficacy of Tolterodine can be decreased when used in combination with Demecarium.,70,Type_70,Yes
DB00337,Pimecrolimus,DB08877,Ruxolitinib,0.8075616359710693,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ruxolitinib.,49,Type_49,Yes
DB00620,Triamcinolone,DB01233,Metoclopramide,0.997259259223938,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Metoclopramide.,49,Type_49,Yes
DB01224,Quetiapine,DB01233,Metoclopramide,0.5017832517623901,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Metoclopramide.,20,Type_20,No
DB00418,Secobarbital,DB00423,Methocarbamol,0.9993832111358643,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Methocarbamol.,49,Type_49,Yes
DB01153,Sertaconazole,DB09238,Manidipine,0.8569344282150269,49,Type_49,The risk or severity of adverse effects can be increased when Sertaconazole is combined with Manidipine.,49,Type_49,Yes
DB00193,Tramadol,DB08873,Boceprevir,0.5429472327232361,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Tramadol.,73,Type_73,No
DB00940,Methantheline,DB09162,Ferric Citrate,0.9963470101356506,67,Type_67,Methantheline can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01236,Sevoflurane,DB01267,Paliperidone,0.4657887816429138,20,Type_20,Sevoflurane may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00977,Ethinylestradiol,DB06781,Difluprednate,0.9955137372016907,73,Type_73,The serum concentration of Difluprednate can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00206,Reserpine,DB01041,Thalidomide,0.8400869965553284,16,Type_16,Reserpine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00289,Atomoxetine,DB01173,Orphenadrine,0.8631353378295898,47,Type_47,The metabolism of Orphenadrine can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00177,Valsartan,DB00731,Nateglinide,0.953606367111206,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Valsartan.,47,Type_47,Yes
DB04841,Flunarizine,DB09040,Efinaconazole,0.8676737546920776,49,Type_49,The risk or severity of adverse effects can be increased when Flunarizine is combined with Efinaconazole.,49,Type_49,Yes
DB00294,Etonogestrel,DB08867,Ulipristal,0.6874644756317139,70,Type_70,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00573,Fenoprofen,DB08984,Etofenamate,0.9991631507873535,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Etofenamate.,49,Type_49,Yes
DB00584,Enalapril,DB01041,Thalidomide,0.8801775574684143,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Thalidomide.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09198,Lobeglitazone,0.9533286690711975,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Rosuvastatin.,47,Type_47,Yes
DB00805,Minaprine,DB01102,Arbutamine,0.9891219735145569,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Arbutamine.,49,Type_49,Yes
DB00741,Hydrocortisone,DB06737,Zaltoprofen,0.9995349645614624,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Zaltoprofen.,49,Type_49,Yes
DB00245,Benzatropine,DB01173,Orphenadrine,0.918398916721344,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Orphenadrine.,49,Type_49,Yes
DB00193,Tramadol,DB00376,Trihexyphenidyl,0.999357283115387,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Trihexyphenidyl.,49,Type_49,Yes
DB00347,Trimethadione,DB09198,Lobeglitazone,0.999560534954071,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Trimethadione.,47,Type_47,Yes
DB00257,Clotrimazole,DB01065,Melatonin,0.9564967751502991,47,Type_47,The metabolism of Melatonin can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01021,Trichlormethiazide,DB08906,Fluticasone furoate,0.9998965263366699,83,Type_83,Trichlormethiazide may increase the hypokalemic activities of Fluticasone furoate.,83,Type_83,Yes
DB09091,Tixocortol,DB11079,Trolamine salicylate,0.9957296252250671,49,Type_49,The risk or severity of adverse effects can be increased when Tixocortol is combined with Trolamine salicylate.,49,Type_49,Yes
DB00182,Amphetamine,DB08801,Dimetindene,0.9933047890663147,76,Type_76,Amphetamine may decrease the sedative activities of Dimetindene.,76,Type_76,Yes
DB00184,Nicotine,DB06637,Dalfampridine,0.6126936078071594,47,Type_47,The metabolism of Dalfampridine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01173,Orphenadrine,DB01624,Zuclopenthixol,0.944499135017395,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,16,Type_16,Yes
DB00446,Chloramphenicol,DB04339,Carbocisteine,0.999909520149231,49,Type_49,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Carbocisteine.,49,Type_49,Yes
DB02703,Fusidic acid,DB06414,Etravirine,0.9711514115333557,73,Type_73,The serum concentration of Etravirine can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00243,Ranolazine,DB00495,Zidovudine,0.589787483215332,73,Type_73,The serum concentration of Zidovudine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00440,Trimethoprim,DB00582,Voriconazole,0.7569735646247864,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB00940,Methantheline,0.972865879535675,73,Type_73,The serum concentration of Methantheline can be increased when it is combined with Bendroflumethiazide.,73,Type_73,Yes
DB01357,Mestranol,DB01708,Prasterone,0.99648118019104,73,Type_73,The serum concentration of Prasterone can be increased when it is combined with Mestranol.,49,Type_49,No
DB00468,Quinine,DB00976,Telithromycin,0.6566677093505859,20,Type_20,Quinine may increase the QTc-prolonging activities of Telithromycin.,73,Type_73,No
DB00500,Tolmetin,DB00688,Mycophenolate mofetil,0.994830310344696,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00321,Amitriptyline,DB00953,Rizatriptan,0.9522340893745422,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rizatriptan.,49,Type_49,Yes
DB01186,Pergolide,DB08899,Enzalutamide,0.8479824066162109,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Pergolide.,75,Type_75,Yes
DB00933,Mesoridazine,DB01065,Melatonin,0.9990646243095398,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Melatonin.,49,Type_49,Yes
DB00277,Theophylline,DB00849,Methylphenobarbital,0.5534289479255676,70,Type_70,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Theophylline.,75,Type_75,No
DB00697,Tizanidine,DB01171,Moclobemide,0.9527848958969116,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Moclobemide.,73,Type_73,No
DB00598,Labetalol,DB00843,Donepezil,0.9914110898971558,54,Type_54,Labetalol may increase the bradycardic activities of Donepezil.,54,Type_54,Yes
DB00972,Azelastine,DB01155,Gemifloxacin,0.8763658404350281,27,Type_27,Azelastine may increase the neuroexcitatory activities of Gemifloxacin.,27,Type_27,Yes
DB00752,Tranylcypromine,DB01067,Glipizide,0.8455123901367188,9,Type_9,Tranylcypromine may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00469,Tenoxicam,DB09280,Lumacaftor,0.4592595100402832,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Tenoxicam.,75,Type_75,Yes
DB00246,Ziprasidone,DB00943,Zalcitabine,0.9238771796226501,47,Type_47,The metabolism of Zalcitabine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00465,Ketorolac,DB09216,Tolfenamic acid,0.9980553388595581,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Tolfenamic acid.,49,Type_49,Yes
DB00724,Imiquimod,DB06772,Cabazitaxel,0.982130229473114,49,Type_49,The risk or severity of adverse effects can be increased when Imiquimod is combined with Cabazitaxel.,49,Type_49,Yes
DB00884,Risedronic acid,DB02709,Resveratrol,0.9156768321990967,49,Type_49,The risk or severity of adverse effects can be increased when Risedronic acid is combined with Resveratrol.,49,Type_49,Yes
DB01248,Docetaxel,DB02546,Vorinostat,0.6656239032745361,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vorinostat.,49,Type_49,Yes
DB00177,Valsartan,DB00714,Apomorphine,0.9860820770263672,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Apomorphine.,49,Type_49,Yes
DB01229,Paclitaxel,DB08911,Trametinib,0.9343549609184265,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Trametinib.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB00744,Zileuton,0.9892846941947937,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Zileuton.,49,Type_49,Yes
DB00967,Desloratadine,DB01233,Metoclopramide,0.8551216125488281,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Desloratadine.,70,Type_70,Yes
DB00346,Alfuzosin,DB09220,Nicorandil,0.9998819828033447,60,Type_60,Alfuzosin may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00295,Morphine,DB01325,Quinethazone,0.9884653091430664,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Quinethazone.,49,Type_49,Yes
DB00281,Lidocaine,DB01295,Bevantolol,0.7272768020629883,73,Type_73,The serum concentration of Bevantolol can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB09038,Empagliflozin,DB09236,Lacidipine,0.9516309499740601,49,Type_49,The risk or severity of adverse effects can be increased when Empagliflozin is combined with Lacidipine.,49,Type_49,Yes
DB00350,Minoxidil,DB00486,Nabilone,0.8852930068969727,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Nabilone.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB01009,Ketoprofen,0.9887219667434692,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Ketoprofen.,49,Type_49,Yes
DB00690,Flurazepam,DB06594,Agomelatine,0.9998202919960022,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Agomelatine.,49,Type_49,Yes
DB01041,Thalidomide,DB01124,Tolbutamide,0.47035688161849976,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Thalidomide.,47,Type_47,No
DB00568,Cinnarizine,DB01101,Capecitabine,0.8003330826759338,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Cinnarizine.,47,Type_47,Yes
DB01026,Ketoconazole,DB09216,Tolfenamic acid,0.38171079754829407,47,Type_47,The metabolism of Tolfenamic acid can be decreased when combined with Ketoconazole.,49,Type_49,No
DB00647,Dextropropoxyphene,DB00732,Atracurium besylate,0.9848328232765198,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Atracurium besylate.,49,Type_49,Yes
DB00899,Remifentanil,DB01282,Carbetocin,0.9998453855514526,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Carbetocin.,49,Type_49,Yes
DB00964,Apraclonidine,DB01136,Carvedilol,0.8890022039413452,49,Type_49,The risk or severity of adverse effects can be increased when Apraclonidine is combined with Carvedilol.,49,Type_49,Yes
DB00296,Ropivacaine,DB00433,Prochlorperazine,0.9478588700294495,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Prochlorperazine.,49,Type_49,Yes
DB00270,Isradipine,DB00758,Clopidogrel,0.9114665985107422,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Isradipine.,70,Type_70,No
DB06595,Midostaurin,DB06737,Zaltoprofen,0.9075237512588501,47,Type_47,The metabolism of Zaltoprofen can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00476,Duloxetine,DB01026,Ketoconazole,0.9483974575996399,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB01380,Cortisone acetate,DB01628,Etoricoxib,0.9975038170814514,49,Type_49,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Etoricoxib.,49,Type_49,Yes
DB00420,Promazine,DB09097,Quinagolide,0.9999027252197266,70,Type_70,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Promazine.,70,Type_70,Yes
DB00326,Calcium glucoheptonate,DB01396,Digitoxin,0.9283465147018433,82,Type_82,Calcium glucoheptonate may increase the arrhythmogenic activities of Digitoxin.,82,Type_82,Yes
DB00203,Sildenafil,DB00377,Palonosetron,0.9943811297416687,47,Type_47,The metabolism of Palonosetron can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00472,Fluoxetine,DB01021,Trichlormethiazide,0.9881888628005981,55,Type_55,Fluoxetine may increase the hyponatremic activities of Trichlormethiazide.,55,Type_55,Yes
DB00318,Codeine,DB00508,Triflupromazine,0.9917889833450317,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Triflupromazine.,49,Type_49,Yes
DB00472,Fluoxetine,DB00559,Bosentan,0.5832993984222412,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Fluoxetine.,75,Type_75,Yes
DB01174,Phenobarbital,DB09352,Hydroxyamphetamine,0.9891200065612793,75,Type_75,The serum concentration of Hydroxyamphetamine can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00292,Etomidate,DB00813,Fentanyl,0.9999709129333496,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Fentanyl.,49,Type_49,Yes
DB00866,Alprenolol,DB01580,Oxprenolol,0.7297557592391968,25,Type_25,Alprenolol may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,60,Type_60,No
DB00564,Carbamazepine,DB00568,Cinnarizine,0.7350430488586426,4,Type_4,The metabolism of Cinnarizine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00604,Cisapride,DB06699,Degarelix,0.9910536408424377,20,Type_20,Cisapride may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00559,Bosentan,DB08868,Fingolimod,0.634912371635437,75,Type_75,The serum concentration of Fingolimod can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00214,Torasemide,DB04846,Celiprolol,0.831805408000946,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Celiprolol.,83,Type_83,No
DB01032,Probenecid,DB06207,Silodosin,0.9958617687225342,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00956,Hydrocodone,DB01622,Thioproperazine,0.6406393647193909,60,Type_60,Hydrocodone may increase the hypotensive activities of Thioproperazine.,60,Type_60,Yes
DB00220,Nelfinavir,DB08820,Ivacaftor,0.9990944862365723,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Nelfinavir.,73,Type_73,Yes
DB00213,Pantoprazole,DB00546,Adinazolam,0.9702436327934265,47,Type_47,The metabolism of Adinazolam can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00185,Cevimeline,DB01043,Memantine,0.9872370958328247,49,Type_49,The risk or severity of adverse effects can be increased when Cevimeline is combined with Memantine.,49,Type_49,Yes
DB00802,Alfentanil,DB01246,Alimemazine,0.41352686285972595,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Alimemazine.,60,Type_60,No
DB00608,Chloroquine,DB01622,Thioproperazine,0.3033123016357422,27,Type_27,Chloroquine may increase the neuroexcitatory activities of Thioproperazine.,73,Type_73,No
DB00219,Oxyphenonium,DB00940,Methantheline,0.9928070306777954,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methantheline.,49,Type_49,Yes
DB00844,Nalbuphine,DB00907,Cocaine,0.9553636908531189,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cocaine.,49,Type_49,Yes
DB01068,Clonazepam,DB05521,Telaprevir,0.6148387789726257,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Clonazepam.,47,Type_47,Yes
DB06154,Pentaerythritol tetranitrate,DB08976,Floctafenine,0.999824583530426,6,Type_6,Pentaerythritol tetranitrate may increase the anticoagulant activities of Floctafenine.,6,Type_6,Yes
DB00503,Ritonavir,DB00822,Disulfiram,0.8103864192962646,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Ritonavir.,49,Type_49,No
DB00489,Sotalol,DB00714,Apomorphine,0.8062351942062378,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Apomorphine.,25,Type_25,No
DB01182,Propafenone,DB09039,Eliglustat,0.40745773911476135,20,Type_20,Propafenone may increase the QTc-prolonging activities of Eliglustat.,73,Type_73,No
DB00322,Floxuridine,DB01240,Epoprostenol,0.7563266754150391,47,Type_47,The metabolism of Epoprostenol can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00479,Amikacin,DB00887,Bumetanide,0.9172715544700623,49,Type_49,The risk or severity of adverse effects can be increased when Amikacin is combined with Bumetanide.,49,Type_49,Yes
DB09286,Pipamperone,DB09477,Enalaprilat,0.6868346929550171,49,Type_49,The risk or severity of adverse effects can be increased when Pipamperone is combined with Enalaprilat.,49,Type_49,Yes
DB00734,Risperidone,DB06636,Isavuconazonium,0.7861535549163818,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Risperidone.,47,Type_47,Yes
DB00223,Diflorasone,DB01609,Deferasirox,0.8286964893341064,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Deferasirox.,49,Type_49,Yes
DB00227,Lovastatin,DB06616,Bosutinib,0.9540170431137085,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB01037,Selegiline,DB01275,Hydralazine,0.9282692670822144,60,Type_60,Selegiline may increase the hypotensive activities of Hydralazine.,60,Type_60,Yes
DB00588,Fluticasone propionate,DB01267,Paliperidone,0.9960495829582214,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Paliperidone.,49,Type_49,Yes
DB00231,Temazepam,DB00409,Remoxipride,0.9992696642875671,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Remoxipride.,49,Type_49,Yes
DB01045,Rifampicin,DB08958,Hexetidine,0.907585620880127,73,Type_73,The serum concentration of Hexetidine can be increased when it is combined with Rifampicin.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB00426,Famciclovir,0.9743358492851257,47,Type_47,The metabolism of Famciclovir can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01154,Thiamylal,DB01223,Aminophylline,0.4581928253173828,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Thiamylal.,75,Type_75,Yes
DB00203,Sildenafil,DB01090,Pentolinium,0.7158179879188538,10,Type_10,Sildenafil may increase the antihypertensive activities of Pentolinium.,10,Type_10,Yes
DB00243,Ranolazine,DB00289,Atomoxetine,0.5165439248085022,47,Type_47,The metabolism of Atomoxetine can be decreased when combined with Ranolazine.,73,Type_73,No
DB00294,Etonogestrel,DB04898,Ximelagatran,0.6147693991661072,75,Type_75,The serum concentration of Ximelagatran can be decreased when it is combined with Etonogestrel.,70,Type_70,No
DB00413,Pramipexole,DB00962,Zaleplon,0.9999978542327881,32,Type_32,Pramipexole may increase the sedative activities of Zaleplon.,32,Type_32,Yes
DB00625,Efavirenz,DB00961,Mepivacaine,0.9427192211151123,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Mepivacaine.,49,Type_49,Yes
DB00847,Cysteamine,DB01370,Aluminium,0.9631993174552917,70,Type_70,The therapeutic efficacy of Aluminium can be decreased when used in combination with Cysteamine.,70,Type_70,Yes
DB00248,Cabergoline,DB00263,Sulfisoxazole,0.6337811946868896,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Cabergoline.,47,Type_47,Yes
DB01095,Fluvastatin,DB01110,Miconazole,0.4670283794403076,73,Type_73,The serum concentration of Miconazole can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00471,Montelukast,DB09280,Lumacaftor,0.7364906668663025,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Montelukast.,75,Type_75,No
DB00196,Fluconazole,DB00991,Oxaprozin,0.952548086643219,47,Type_47,The metabolism of Oxaprozin can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00283,Clemastine,DB01431,Allylestrenol,0.9803805947303772,47,Type_47,The metabolism of Allylestrenol can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00180,Flunisolide,DB01377,Magnesium oxide,0.9954074025154114,3,Type_3,The bioavailability of Magnesium oxide can be decreased when combined with Flunisolide.,3,Type_3,Yes
DB00863,Ranitidine,DB01045,Rifampicin,0.7638254761695862,4,Type_4,The metabolism of Rifampicin can be increased when combined with Ranitidine.,4,Type_4,Yes
DB00540,Nortriptyline,DB00953,Rizatriptan,0.9567110538482666,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Rizatriptan.,49,Type_49,Yes
DB00672,Chlorpropamide,DB01220,Rifaximin,0.342388778924942,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Chlorpropamide.,73,Type_73,Yes
DB00643,Mebendazole,DB08899,Enzalutamide,0.9598032236099243,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Mebendazole.,75,Type_75,Yes
DB05271,Rotigotine,DB05316,Pimavanserin,0.9999266862869263,70,Type_70,The therapeutic efficacy of Pimavanserin can be decreased when used in combination with Rotigotine.,70,Type_70,Yes
DB00231,Temazepam,DB01624,Zuclopenthixol,0.9790192246437073,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Zuclopenthixol.,49,Type_49,Yes
DB00427,Triprolidine,DB01081,Diphenoxylate,0.9991722106933594,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Diphenoxylate.,49,Type_49,Yes
DB08439,Parecoxib,DB09091,Tixocortol,0.9971467852592468,49,Type_49,The risk or severity of adverse effects can be increased when Parecoxib is combined with Tixocortol.,49,Type_49,Yes
DB00476,Duloxetine,DB01067,Glipizide,0.9209432601928711,9,Type_9,Duloxetine may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00622,Nicardipine,DB00880,Chlorothiazide,0.6130455732345581,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Chlorothiazide.,49,Type_49,Yes
DB00195,Betaxolol,DB01200,Bromocriptine,0.7836360335350037,25,Type_25,Betaxolol may increase the atrioventricular blocking (AV block) activities of Bromocriptine.,25,Type_25,Yes
DB01154,Thiamylal,DB09071,Tasimelteon,0.9987694621086121,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Tasimelteon.,49,Type_49,Yes
DB00775,Tirofiban,DB08887,Icosapent ethyl,0.5895147919654846,6,Type_6,Tirofiban may increase the anticoagulant activities of Icosapent ethyl.,6,Type_6,Yes
DB00205,Pyrimethamine,DB01174,Phenobarbital,0.8040780425071716,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Pyrimethamine.,47,Type_47,No
DB00289,Atomoxetine,DB01058,Praziquantel,0.7934731245040894,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00353,Methylergometrine,DB04846,Celiprolol,0.979597270488739,19,Type_19,Methylergometrine may increase the vasoconstricting activities of Celiprolol.,19,Type_19,Yes
DB06605,Apixaban,DB09084,Benzydamine,0.9483186602592468,6,Type_6,Apixaban may increase the anticoagulant activities of Benzydamine.,6,Type_6,Yes
DB01161,Chloroprocaine,DB06738,Ketobemidone,0.9936134219169617,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Ketobemidone.,49,Type_49,Yes
DB00476,Duloxetine,DB00695,Furosemide,0.59052973985672,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Furosemide.,30,Type_30,No
DB08815,Lurasidone,DB09342,Propoxycaine,0.9999819993972778,49,Type_49,The risk or severity of adverse effects can be increased when Lurasidone is combined with Propoxycaine.,49,Type_49,Yes
DB00297,Bupivacaine,DB00521,Carteolol,0.663418173789978,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Carteolol.,73,Type_73,No
DB00297,Bupivacaine,DB01118,Amiodarone,0.8695868849754333,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB00458,Imipramine,DB05521,Telaprevir,0.6653182506561279,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Imipramine.,47,Type_47,Yes
DB01595,Nitrazepam,DB09009,Articaine,0.9994004964828491,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Articaine.,49,Type_49,Yes
DB00620,Triamcinolone,DB00887,Bumetanide,0.9998358488082886,83,Type_83,Triamcinolone may increase the hypokalemic activities of Bumetanide.,83,Type_83,Yes
DB00836,Loperamide,DB05521,Telaprevir,0.6214700937271118,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Loperamide.,47,Type_47,Yes
DB00193,Tramadol,DB01045,Rifampicin,0.9614869356155396,4,Type_4,The metabolism of Rifampicin can be increased when combined with Tramadol.,4,Type_4,Yes
DB00321,Amitriptyline,DB09128,Brexpiprazole,0.9876048564910889,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brexpiprazole.,49,Type_49,Yes
DB00387,Procyclidine,DB01062,Oxybutynin,0.99849534034729,49,Type_49,The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxybutynin.,49,Type_49,Yes
DB00413,Pramipexole,DB13323,Trichloroethylene,0.9998834133148193,32,Type_32,Pramipexole may increase the sedative activities of Trichloroethylene.,32,Type_32,Yes
DB00866,Alprenolol,DB01435,Antipyrine,0.9975605010986328,37,Type_37,Alprenolol may decrease the antihypertensive activities of Antipyrine.,37,Type_37,Yes
DB00603,Medroxyprogesterone acetate,DB01072,Atazanavir,0.47788020968437195,75,Type_75,The serum concentration of Atazanavir can be decreased when it is combined with Medroxyprogesterone acetate.,73,Type_73,No
DB00298,Dapiprazole,DB00697,Tizanidine,0.9551327228546143,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Tizanidine.,49,Type_49,Yes
DB00750,Prilocaine,DB01178,Chlormezanone,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Chlormezanone.,49,Type_49,Yes
DB00542,Benazepril,DB09167,Dosulepin,0.8752705454826355,73,Type_73,The serum concentration of Dosulepin can be increased when it is combined with Benazepril.,73,Type_73,Yes
DB01195,Flecainide,DB09083,Ivabradine,0.970158576965332,20,Type_20,Flecainide may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB00297,Bupivacaine,DB08910,Pomalidomide,0.8293734192848206,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Pomalidomide.,49,Type_49,Yes
DB00353,Methylergometrine,DB00759,Tetracycline,0.890659511089325,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Tetracycline.,49,Type_49,Yes
DB00297,Bupivacaine,DB00598,Labetalol,0.4960795044898987,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Labetalol.,73,Type_73,No
DB00213,Pantoprazole,DB01024,Mycophenolic acid,0.40305301547050476,47,Type_47,The metabolism of Mycophenolic acid can be decreased when combined with Pantoprazole.,75,Type_75,No
DB00594,Amiloride,DB01214,Metipranolol,0.9623778462409973,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Metipranolol.,49,Type_49,Yes
DB00254,Doxycycline,DB01020,Isosorbide mononitrate,0.7963233590126038,47,Type_47,The metabolism of Isosorbide mononitrate can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01590,Everolimus,DB08873,Boceprevir,0.8243951201438904,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00370,Mirtazapine,DB01236,Sevoflurane,0.8503550291061401,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.,16,Type_16,Yes
DB09118,Stiripentol,DB09389,Norgestrel,0.5051208734512329,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Stiripentol.,73,Type_73,No
DB01090,Pentolinium,DB06204,Tapentadol,0.997079610824585,49,Type_49,The risk or severity of adverse effects can be increased when Pentolinium is combined with Tapentadol.,49,Type_49,Yes
DB00602,Ivermectin,DB00834,Mifepristone,0.8113892078399658,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Ivermectin.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB01392,Yohimbine,0.9256647229194641,37,Type_37,Dihydroergotamine may decrease the antihypertensive activities of Yohimbine.,47,Type_47,No
DB00653,Magnesium sulfate,DB04920,Clevidipine,0.9038269519805908,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Clevidipine.,49,Type_49,Yes
DB00860,Prednisolone,DB01010,Edrophonium,0.9895763397216797,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Edrophonium.,49,Type_49,Yes
DB00586,Diclofenac,DB04898,Ximelagatran,0.92525315284729,6,Type_6,Diclofenac may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB01013,Clobetasol propionate,DB09281,Magnesium trisilicate,0.9991674423217773,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Clobetasol propionate.,3,Type_3,Yes
DB00907,Cocaine,DB01159,Halothane,0.6917764544487,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Halothane.,47,Type_47,No
DB00768,Olopatadine,DB00821,Carprofen,0.9995718598365784,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Carprofen.,49,Type_49,Yes
DB01177,Idarubicin,DB08912,Dabrafenib,0.8664800524711609,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Idarubicin.,75,Type_75,Yes
DB00903,Etacrynic acid,DB09236,Lacidipine,0.7567741274833679,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Lacidipine.,49,Type_49,Yes
DB00677,Isoflurophate,DB01295,Bevantolol,0.9914621710777283,54,Type_54,Isoflurophate may increase the bradycardic activities of Bevantolol.,54,Type_54,Yes
DB00312,Pentobarbital,DB00883,Isosorbide dinitrate,0.9084577560424805,4,Type_4,The metabolism of Isosorbide dinitrate can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00006,Bivalirudin,DB00814,Meloxicam,0.8780745267868042,6,Type_6,Bivalirudin may increase the anticoagulant activities of Meloxicam.,6,Type_6,Yes
DB00708,Sufentanil,DB01198,Zopiclone,0.9955278038978577,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Zopiclone.,49,Type_49,Yes
DB00486,Nabilone,DB01365,Mephentermine,0.9992166757583618,85,Type_85,Nabilone may increase the tachycardic activities of Mephentermine.,85,Type_85,Yes
DB00521,Carteolol,DB00623,Fluphenazine,0.5307227969169617,60,Type_60,Carteolol may increase the hypotensive activities of Fluphenazine.,60,Type_60,Yes
DB00614,Furazolidone,DB00924,Cyclobenzaprine,0.8540562391281128,64,Type_64,Furazolidone may increase the serotonergic activities of Cyclobenzaprine.,64,Type_64,Yes
DB00812,Phenylbutazone,DB05812,Abiraterone,0.48884737491607666,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Phenylbutazone.,47,Type_47,No
DB00981,Physostigmine,DB01339,Vecuronium,0.9997041821479797,70,Type_70,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Physostigmine.,70,Type_70,Yes
DB00363,Clozapine,DB00450,Droperidol,0.9857404828071594,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Droperidol.,16,Type_16,Yes
DB00903,Etacrynic acid,DB06738,Ketobemidone,0.9978213310241699,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Ketobemidone.,49,Type_49,Yes
DB01080,Vigabatrin,DB01621,Pipotiazine,0.9998712539672852,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Pipotiazine.,49,Type_49,Yes
DB00872,Conivaptan,DB01254,Dasatinib,0.9930362105369568,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00461,Nabumetone,DB01032,Probenecid,0.8017790913581848,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Nabumetone.,73,Type_73,Yes
DB00461,Nabumetone,DB00864,Tacrolimus,0.9143694043159485,57,Type_57,Nabumetone may increase the nephrotoxic activities of Tacrolimus.,57,Type_57,Yes
DB00228,Enflurane,DB00476,Duloxetine,0.9822538495063782,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Duloxetine.,49,Type_49,Yes
DB00612,Bisoprolol,DB01200,Bromocriptine,0.5856011509895325,25,Type_25,Bisoprolol may increase the atrioventricular blocking (AV block) activities of Bromocriptine.,25,Type_25,Yes
DB08932,Macitentan,DB09048,Netupitant,0.8816272020339966,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Macitentan.,73,Type_73,Yes
DB00748,Carbinoxamine,DB01624,Zuclopenthixol,0.9497315883636475,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Zuclopenthixol.,49,Type_49,Yes
DB00482,Celecoxib,DB01357,Mestranol,0.4461929500102997,47,Type_47,The metabolism of Mestranol can be decreased when combined with Celecoxib.,81,Type_81,No
DB00358,Mefloquine,DB09074,Olaparib,0.9700367450714111,47,Type_47,The metabolism of Olaparib can be decreased when combined with Mefloquine.,47,Type_47,Yes
DB00571,Propranolol,DB04861,Nebivolol,0.5888102054595947,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Nebivolol.,49,Type_49,Yes
DB00950,Fexofenadine,DB01100,Pimozide,0.9811251163482666,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Pimozide.,49,Type_49,Yes
DB00643,Mebendazole,DB08912,Dabrafenib,0.9542262554168701,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Mebendazole.,75,Type_75,Yes
DB00469,Tenoxicam,DB11921,Deflazacort,0.9997314810752869,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Deflazacort.,49,Type_49,Yes
DB00472,Fluoxetine,DB06589,Pazopanib,0.4723139703273773,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00820,Tadalafil,DB01601,Lopinavir,0.5638756155967712,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Tadalafil.,73,Type_73,Yes
DB00252,Phenytoin,DB00277,Theophylline,0.4698883891105652,4,Type_4,The metabolism of Theophylline can be increased when combined with Phenytoin.,75,Type_75,No
DB00227,Lovastatin,DB09281,Magnesium trisilicate,0.9356311559677124,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Lovastatin.,75,Type_75,Yes
DB00433,Prochlorperazine,DB00559,Bosentan,0.6859915852546692,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Prochlorperazine.,75,Type_75,Yes
DB01118,Amiodarone,DB01297,Practolol,0.4802285432815552,54,Type_54,Amiodarone may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB00584,Enalapril,DB06826,Unoprostone,0.9999914169311523,60,Type_60,Enalapril may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00283,Clemastine,DB06144,Sertindole,0.7087526321411133,47,Type_47,The metabolism of Sertindole can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00333,Methadone,DB01116,Trimethaphan,0.9684492945671082,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Trimethaphan.,49,Type_49,Yes
DB01211,Clarithromycin,DB09091,Tixocortol,0.9862974882125854,73,Type_73,The serum concentration of Tixocortol can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB00892,Oxybuprocaine,DB00904,Ondansetron,0.9996534585952759,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ondansetron.,49,Type_49,Yes
DB01189,Desflurane,DB09039,Eliglustat,0.9978954792022705,20,Type_20,Desflurane may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00854,Levorphanol,DB00908,Quinidine,0.7684879302978516,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Quinidine.,49,Type_49,Yes
DB00175,Pravastatin,DB00370,Mirtazapine,0.6543150544166565,47,Type_47,The metabolism of Mirtazapine can be decreased when combined with Pravastatin.,73,Type_73,No
DB00687,Fludrocortisone,DB06196,Icatibant,0.9998811483383179,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Icatibant.,49,Type_49,Yes
DB00328,Indomethacin,DB00398,Sorafenib,0.695911169052124,47,Type_47,The metabolism of Sorafenib can be decreased when combined with Indomethacin.,47,Type_47,Yes
DB00873,Loteprednol,DB01420,Testosterone propionate,0.999901294708252,74,Type_74,Loteprednol may increase the fluid retaining activities of Testosterone propionate.,74,Type_74,Yes
DB00653,Magnesium sulfate,DB09041,Tavaborole,0.8643432855606079,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Tavaborole.,49,Type_49,Yes
DB00465,Ketorolac,DB00827,Cinoxacin,0.9973945617675781,27,Type_27,Ketorolac may increase the neuroexcitatory activities of Cinoxacin.,27,Type_27,Yes
DB00502,Haloperidol,DB01351,Amobarbital,0.7182042002677917,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Amobarbital.,49,Type_49,Yes
DB08822,Azilsartan medoxomil,DB09477,Enalaprilat,0.9300053119659424,49,Type_49,The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Enalaprilat.,49,Type_49,Yes
DB00967,Desloratadine,DB01202,Levetiracetam,0.7952476739883423,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Levetiracetam.,49,Type_49,Yes
DB01420,Testosterone propionate,DB02187,Equilin,0.9998735189437866,74,Type_74,Testosterone propionate may increase the fluid retaining activities of Equilin.,74,Type_74,Yes
DB00645,Dyclonine,DB01219,Dantrolene,0.9997872710227966,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Dantrolene.,49,Type_49,Yes
DB00997,Doxorubicin,DB09330,Osimertinib,0.9916852712631226,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Doxorubicin.,73,Type_73,Yes
DB00234,Reboxetine,DB09065,Cobicistat,0.5890766382217407,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Reboxetine.,47,Type_47,Yes
DB00091,Cyclosporine,DB04574,Estrone sulfate,0.4123770594596863,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01211,Clarithromycin,DB01435,Antipyrine,0.8722288012504578,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00469,Tenoxicam,DB00959,Methylprednisolone,0.9996778964996338,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Methylprednisolone.,49,Type_49,Yes
DB01200,Bromocriptine,DB08860,Pitavastatin,0.829188883304596,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Bromocriptine.,73,Type_73,Yes
DB00599,Thiopental,DB09232,Cilnidipine,0.8873597383499146,4,Type_4,The metabolism of Cilnidipine can be increased when combined with Thiopental.,4,Type_4,Yes
DB00896,Rimexolone,DB01233,Metoclopramide,0.9928190112113953,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Metoclopramide.,49,Type_49,Yes
DB08820,Ivacaftor,DB09026,Aliskiren,0.9700710773468018,73,Type_73,The serum concentration of Aliskiren can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB01253,Ergometrine,DB09068,Vortioxetine,0.9911728501319885,49,Type_49,The risk or severity of adverse effects can be increased when Ergometrine is combined with Vortioxetine.,49,Type_49,Yes
DB03793,Benzoic acid,DB06786,Halcinonide,0.7964920401573181,70,Type_70,The therapeutic efficacy of Halcinonide can be decreased when used in combination with Benzoic acid.,70,Type_70,Yes
DB00690,Flurazepam,DB01223,Aminophylline,0.6441100835800171,47,Type_47,The metabolism of Aminophylline can be decreased when combined with Flurazepam.,70,Type_70,No
DB01095,Fluvastatin,DB13874,Enasidenib,0.7052814960479736,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00641,Simvastatin,DB09227,Barnidipine,0.8374038934707642,49,Type_49,The risk or severity of adverse effects can be increased when Simvastatin is combined with Barnidipine.,49,Type_49,Yes
DB00935,Oxymetazoline,DB08808,Bupranolol,0.9988420605659485,25,Type_25,Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Bupranolol.,25,Type_25,Yes
DB00214,Torasemide,DB00275,Olmesartan,0.949650764465332,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Olmesartan.,49,Type_49,Yes
DB00379,Mexiletine,DB00806,Pentoxifylline,0.9169421792030334,47,Type_47,The metabolism of Pentoxifylline can be decreased when combined with Mexiletine.,73,Type_73,No
DB00231,Temazepam,DB00263,Sulfisoxazole,0.9787105917930603,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00530,Erlotinib,DB00564,Carbamazepine,0.6979372501373291,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Erlotinib.,75,Type_75,No
DB00630,Alendronic acid,DB01377,Magnesium oxide,0.9744192957878113,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Alendronic acid.,75,Type_75,Yes
DB00690,Flurazepam,DB01201,Rifapentine,0.945836067199707,4,Type_4,The metabolism of Rifapentine can be increased when combined with Flurazepam.,4,Type_4,Yes
DB00690,Flurazepam,DB01351,Amobarbital,0.9337533116340637,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Amobarbital.,49,Type_49,Yes
DB00296,Ropivacaine,DB01113,Papaverine,0.969707190990448,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Papaverine.,49,Type_49,Yes
DB01086,Benzocaine,DB01267,Paliperidone,0.997776448726654,49,Type_49,The risk or severity of adverse effects can be increased when Benzocaine is combined with Paliperidone.,49,Type_49,Yes
DB00598,Labetalol,DB01274,Arformoterol,0.7830382585525513,5,Type_5,Labetalol may decrease the vasoconstricting activities of Arformoterol.,5,Type_5,Yes
DB01192,Oxymorphone,DB08815,Lurasidone,0.9269593954086304,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Lurasidone.,49,Type_49,Yes
DB00827,Cinoxacin,DB01032,Probenecid,0.7136237025260925,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Cinoxacin.,73,Type_73,Yes
DB01609,Deferasirox,DB11614,Rupatadine,0.907071590423584,75,Type_75,The serum concentration of Rupatadine can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB06589,Pazopanib,DB09281,Magnesium trisilicate,0.8475003838539124,67,Type_67,Pazopanib can cause a decrease in the absorption of Magnesium trisilicate resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00898,Ethanol,DB01239,Chlorprothixene,0.9765656590461731,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.,16,Type_16,Yes
DB00904,Ondansetron,DB01623,Thiothixene,0.5407444834709167,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiothixene.,20,Type_20,No
DB00215,Citalopram,DB04868,Nilotinib,0.47795259952545166,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00861,Diflunisal,DB01029,Irbesartan,0.8831784129142761,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Irbesartan.,49,Type_49,Yes
DB00419,Miglustat,DB01232,Saquinavir,0.9464241862297058,70,Type_70,The therapeutic efficacy of Saquinavir can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00991,Oxaprozin,DB09280,Lumacaftor,0.49449247121810913,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Oxaprozin.,75,Type_75,Yes
DB00602,Ivermectin,DB08912,Dabrafenib,0.9639116525650024,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Ivermectin.,75,Type_75,Yes
DB00288,Amcinonide,DB01357,Mestranol,0.9971031546592712,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Amcinonide.,73,Type_73,Yes
DB00252,Phenytoin,DB00826,Natamycin,0.9427054524421692,73,Type_73,The serum concentration of Natamycin can be increased when it is combined with Phenytoin.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB06699,Degarelix,0.9929312467575073,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Degarelix.,58,Type_58,Yes
DB01168,Procarbazine,DB01267,Paliperidone,0.8591358661651611,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Paliperidone.,49,Type_49,Yes
DB01210,Levobunolol,DB01403,Methotrimeprazine,0.5348498225212097,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Levobunolol.,60,Type_60,No
DB00408,Loxapine,DB01209,Dezocine,0.9973639845848083,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Dezocine.,49,Type_49,Yes
DB01609,Deferasirox,DB08816,Ticagrelor,0.49691030383110046,75,Type_75,The serum concentration of Ticagrelor can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB01227,Levacetylmethadol,DB06201,Rufinamide,0.9986870884895325,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Rufinamide.,49,Type_49,Yes
DB00182,Amphetamine,DB00656,Trazodone,0.4303867518901825,47,Type_47,The metabolism of Trazodone can be decreased when combined with Amphetamine.,64,Type_64,No
DB00937,Diethylpropion,DB01106,Levocabastine,0.9616756439208984,76,Type_76,Diethylpropion may decrease the sedative activities of Levocabastine.,76,Type_76,Yes
DB00188,Bortezomib,DB01403,Methotrimeprazine,0.36578717827796936,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Bortezomib.,47,Type_47,No
DB00184,Nicotine,DB08912,Dabrafenib,0.9881607294082642,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Nicotine.,75,Type_75,Yes
DB00904,Ondansetron,DB00927,Famotidine,0.6717705130577087,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Famotidine.,20,Type_20,Yes
DB00963,Bromfenac,DB01283,Lumiracoxib,0.9991061091423035,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Lumiracoxib.,49,Type_49,Yes
DB00903,Etacrynic acid,DB00945,Acetylsalicylic acid,0.9999961853027344,29,Type_29,Etacrynic acid may decrease the diuretic activities of Acetylsalicylic acid.,29,Type_29,Yes
DB00322,Floxuridine,DB01104,Sertraline,0.9356734156608582,47,Type_47,The metabolism of Sertraline can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00424,Hyoscyamine,DB00470,Dronabinol,0.5914981365203857,85,Type_85,Hyoscyamine may increase the tachycardic activities of Dronabinol.,85,Type_85,Yes
DB00477,Chlorpromazine,DB04896,Milnacipran,0.885661244392395,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Milnacipran.,49,Type_49,Yes
DB01075,Diphenhydramine,DB01435,Antipyrine,0.9696211814880371,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Diphenhydramine.,47,Type_47,Yes
DB01173,Orphenadrine,DB01215,Estazolam,0.9456212520599365,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.,16,Type_16,Yes
DB00230,Pregabalin,DB00854,Levorphanol,0.9980946183204651,8,Type_8,The therapeutic efficacy of Levorphanol can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00461,Nabumetone,DB00710,Ibandronate,0.47699785232543945,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Ibandronate.,49,Type_49,Yes
DB00252,Phenytoin,DB00396,Progesterone,0.43731027841567993,75,Type_75,The serum concentration of Progesterone can be decreased when it is combined with Phenytoin.,4,Type_4,No
DB00745,Modafinil,DB06616,Bosutinib,0.9529065489768982,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Modafinil.,73,Type_73,Yes
DB01264,Darunavir,DB05541,Brivaracetam,0.8062983751296997,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Darunavir.,47,Type_47,Yes
DB01353,Butobarbital,DB09225,Zotepine,0.9999592304229736,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Zotepine.,49,Type_49,Yes
DB00933,Mesoridazine,DB01198,Zopiclone,0.9964753985404968,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zopiclone.,49,Type_49,Yes
DB00951,Isoniazid,DB01181,Ifosfamide,0.8861082792282104,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB00821,Carprofen,DB00896,Rimexolone,0.999901294708252,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Rimexolone.,49,Type_49,Yes
DB00986,Glycopyrronium,DB01245,Decamethonium,0.9961695075035095,70,Type_70,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Glycopyrronium.,70,Type_70,Yes
DB00344,Protriptyline,DB09238,Manidipine,0.743443489074707,47,Type_47,The metabolism of Manidipine can be decreased when combined with Protriptyline.,47,Type_47,Yes
DB00368,Norepinephrine,DB01325,Quinethazone,0.9804177284240723,83,Type_83,Norepinephrine may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB00368,Norepinephrine,DB06207,Silodosin,0.9997878670692444,5,Type_5,Norepinephrine may decrease the vasoconstricting activities of Silodosin.,5,Type_5,Yes
DB00651,Dyphylline,DB00866,Alprenolol,0.9993835687637329,14,Type_14,Dyphylline may decrease the bronchodilatory activities of Alprenolol.,14,Type_14,Yes
DB00613,Amodiaquine,DB00938,Salmeterol,0.9598938226699829,47,Type_47,The metabolism of Salmeterol can be decreased when combined with Amodiaquine.,73,Type_73,No
DB06738,Ketobemidone,DB13872,Lormetazepam,0.9990488886833191,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Lormetazepam.,49,Type_49,Yes
DB06210,Eltrombopag,DB06626,Axitinib,0.6402700543403625,73,Type_73,The serum concentration of Axitinib can be increased when it is combined with Eltrombopag.,73,Type_73,Yes
DB00542,Benazepril,DB00654,Latanoprost,0.9999959468841553,60,Type_60,Benazepril may increase the hypotensive activities of Latanoprost.,60,Type_60,Yes
DB00568,Cinnarizine,DB00678,Losartan,0.6255677938461304,60,Type_60,Cinnarizine may increase the hypotensive activities of Losartan.,47,Type_47,No
DB00248,Cabergoline,DB00254,Doxycycline,0.7339245676994324,47,Type_47,The metabolism of Doxycycline can be decreased when combined with Cabergoline.,47,Type_47,Yes
DB01254,Dasatinib,DB09123,Dienogest,0.6652242541313171,73,Type_73,The serum concentration of Dienogest can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00224,Indinavir,DB00734,Risperidone,0.7802734375,47,Type_47,The metabolism of Risperidone can be decreased when combined with Indinavir.,47,Type_47,Yes
DB06791,Lanreotide,DB08865,Crizotinib,0.519157350063324,54,Type_54,Lanreotide may increase the bradycardic activities of Crizotinib.,54,Type_54,Yes
DB00703,Methazolamide,DB01169,Arsenic trioxide,0.9937667846679688,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Arsenic trioxide.,49,Type_49,Yes
DB00433,Prochlorperazine,DB08815,Lurasidone,0.9802591800689697,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Lurasidone.,49,Type_49,Yes
DB00476,Duloxetine,DB00960,Pindolol,0.8773385882377625,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Pindolol.,30,Type_30,Yes
DB00231,Temazepam,DB00708,Sufentanil,0.9959188103675842,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Sufentanil.,49,Type_49,Yes
DB00425,Zolpidem,DB00622,Nicardipine,0.6304478645324707,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB00618,Demeclocycline,DB01338,Pipecuronium,0.9995916485786438,21,Type_21,Demeclocycline may increase the neuromuscular blocking activities of Pipecuronium.,21,Type_21,Yes
DB00631,Clofarabine,DB00790,Perindopril,0.9949760437011719,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Perindopril.,49,Type_49,Yes
DB01142,Doxepin,DB01227,Levacetylmethadol,0.8482952117919922,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Levacetylmethadol.,49,Type_49,Yes
DB00835,Brompheniramine,DB01201,Rifapentine,0.9309989809989929,4,Type_4,The metabolism of Rifapentine can be increased when combined with Brompheniramine.,4,Type_4,Yes
DB00248,Cabergoline,DB01054,Nitrendipine,0.8327212929725647,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Nitrendipine.,49,Type_49,Yes
DB00327,Hydromorphone,DB00496,Darifenacin,0.4432528614997864,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Darifenacin.,47,Type_47,No
DB00284,Acarbose,DB04868,Nilotinib,0.983235239982605,70,Type_70,The therapeutic efficacy of Nilotinib can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00530,Erlotinib,DB12332,Rucaparib,0.9018484354019165,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Erlotinib.,47,Type_47,Yes
DB00502,Haloperidol,DB01202,Levetiracetam,0.9936476349830627,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Levetiracetam.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB08815,Lurasidone,0.9976716637611389,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Lurasidone.,49,Type_49,Yes
DB01248,Docetaxel,DB01262,Decitabine,0.9983422756195068,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Decitabine.,49,Type_49,Yes
DB00228,Enflurane,DB01567,Fludiazepam,0.9989166259765625,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Fludiazepam.,49,Type_49,Yes
DB00960,Pindolol,DB01238,Aripiprazole,0.9954304695129395,60,Type_60,Pindolol may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB01395,Drospirenone,DB01601,Lopinavir,0.4521012604236603,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Drospirenone.,75,Type_75,No
DB00556,Perflutren,DB09078,Lenvatinib,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00252,Phenytoin,DB05219,Crisaborole,0.912578821182251,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Phenytoin.,47,Type_47,Yes
DB00752,Tranylcypromine,DB00875,Flupentixol,0.7857362031936646,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Flupentixol.,49,Type_49,Yes
DB00783,Estradiol,DB01223,Aminophylline,0.48782241344451904,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Estradiol.,73,Type_73,No
DB00289,Atomoxetine,DB00537,Ciprofloxacin,0.5992409586906433,20,Type_20,Atomoxetine may increase the QTc-prolonging activities of Ciprofloxacin.,20,Type_20,Yes
DB00374,Treprostinil,DB00875,Flupentixol,0.8955392241477966,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Flupentixol.,20,Type_20,Yes
DB01545,Ethyl loflazepate,DB01595,Nitrazepam,0.9990140199661255,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Nitrazepam.,49,Type_49,Yes
DB00295,Morphine,DB01394,Colchicine,0.9592041969299316,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Morphine.,73,Type_73,Yes
DB00298,Dapiprazole,DB00813,Fentanyl,0.9985452890396118,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Fentanyl.,49,Type_49,Yes
DB00963,Bromfenac,DB01172,Kanamycin,0.9999889135360718,72,Type_72,Bromfenac may decrease the excretion rate of Kanamycin which could result in a higher serum level.,72,Type_72,Yes
DB01081,Diphenoxylate,DB01174,Phenobarbital,0.8573331832885742,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Phenobarbital.,49,Type_49,Yes
DB00221,Isoetharine,DB00321,Amitriptyline,0.9710546731948853,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Amitriptyline.,49,Type_49,Yes
DB01577,Metamfetamine,DB06723,Aluminum hydroxide,0.9967681169509888,72,Type_72,Metamfetamine may decrease the excretion rate of Aluminum hydroxide which could result in a higher serum level.,72,Type_72,Yes
DB00864,Tacrolimus,DB06212,Tolvaptan,0.7522692680358887,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Tacrolimus.,73,Type_73,Yes
DB00715,Paroxetine,DB05541,Brivaracetam,0.9206269979476929,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00582,Voriconazole,DB00653,Magnesium sulfate,0.49315041303634644,47,Type_47,The metabolism of Magnesium sulfate can be decreased when combined with Voriconazole.,49,Type_49,No
DB00327,Hydromorphone,DB00418,Secobarbital,0.9682596921920776,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Secobarbital.,4,Type_4,No
DB00296,Ropivacaine,DB00887,Bumetanide,0.8890721201896667,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bumetanide.,49,Type_49,Yes
DB00615,Rifabutin,DB01601,Lopinavir,0.5872505307197571,75,Type_75,The serum concentration of Lopinavir can be decreased when it is combined with Rifabutin.,77,Type_77,No
DB00696,Ergotamine,DB04842,Fluspirilene,0.9658949375152588,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluspirilene.,49,Type_49,Yes
DB09083,Ivabradine,DB09330,Osimertinib,0.8965377807617188,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Ivabradine.,73,Type_73,Yes
DB01589,Quazepam,DB08816,Ticagrelor,0.5455467104911804,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Quazepam.,47,Type_47,Yes
DB00221,Isoetharine,DB00774,Hydroflumethiazide,0.999790608882904,83,Type_83,Isoetharine may increase the hypokalemic activities of Hydroflumethiazide.,83,Type_83,Yes
DB00734,Risperidone,DB00899,Remifentanil,0.9723790287971497,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Remifentanil.,60,Type_60,No
DB00227,Lovastatin,DB00656,Trazodone,0.5971765518188477,47,Type_47,The metabolism of Trazodone can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01181,Ifosfamide,DB06717,Fosaprepitant,0.9109461307525635,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Ifosfamide.,73,Type_73,Yes
DB00694,Daunorubicin,DB06636,Isavuconazonium,0.9665256142616272,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB00467,Enoxacin,DB00768,Olopatadine,0.9913323521614075,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Olopatadine.,27,Type_27,Yes
DB00876,Eprosartan,DB09477,Enalaprilat,0.5413144826889038,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Enalaprilat.,49,Type_49,Yes
DB00798,Gentamicin,DB00814,Meloxicam,0.9998997449874878,72,Type_72,Gentamicin may decrease the excretion rate of Meloxicam which could result in a higher serum level.,72,Type_72,Yes
DB00549,Zafirlukast,DB00731,Nateglinide,0.9629657864570618,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00474,Methohexital,DB00492,Fosinopril,0.9127354025840759,60,Type_60,Methohexital may increase the hypotensive activities of Fosinopril.,60,Type_60,Yes
DB00187,Esmolol,DB00849,Methylphenobarbital,0.595665454864502,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Methylphenobarbital.,60,Type_60,No
DB00722,Lisinopril,DB00752,Tranylcypromine,0.9697574973106384,60,Type_60,Lisinopril may increase the hypotensive activities of Tranylcypromine.,60,Type_60,Yes
DB00237,Butabarbital,DB11304,Phenoxyethanol,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Phenoxyethanol.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB06724,Calcium carbonate,0.9986591339111328,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Fluocinolone acetonide.,3,Type_3,Yes
DB00332,Ipratropium,DB01156,Bupropion,0.9526969194412231,47,Type_47,The metabolism of Bupropion can be decreased when combined with Ipratropium.,47,Type_47,Yes
DB00312,Pentobarbital,DB00350,Minoxidil,0.8896937370300293,60,Type_60,Pentobarbital may increase the hypotensive activities of Minoxidil.,60,Type_60,Yes
DB00590,Doxazosin,DB00876,Eprosartan,0.8778668642044067,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Eprosartan.,49,Type_49,Yes
DB00244,Mesalazine,DB00790,Perindopril,0.5440196394920349,37,Type_37,Mesalazine may decrease the antihypertensive activities of Perindopril.,37,Type_37,Yes
DB01054,Nitrendipine,DB09112,Nitrous acid,0.8117715120315552,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Nitrous acid.,49,Type_49,Yes
DB00182,Amphetamine,DB06767,Ammonium chloride,0.8629490733146667,73,Type_73,The serum concentration of Ammonium chloride can be increased when it is combined with Amphetamine.,75,Type_75,No
DB01240,Epoprostenol,DB01282,Carbetocin,0.9838418960571289,60,Type_60,Epoprostenol may increase the hypotensive activities of Carbetocin.,49,Type_49,No
DB01136,Carvedilol,DB09075,Edoxaban,0.9883600473403931,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Carvedilol.,73,Type_73,Yes
DB06154,Pentaerythritol tetranitrate,DB06209,Prasugrel,0.9881995916366577,6,Type_6,Pentaerythritol tetranitrate may increase the anticoagulant activities of Prasugrel.,6,Type_6,Yes
DB00999,Hydrochlorothiazide,DB09282,Molsidomine,1.0,60,Type_60,Hydrochlorothiazide may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00866,Alprenolol,DB04861,Nebivolol,0.5624933242797852,54,Type_54,Alprenolol may increase the bradycardic activities of Nebivolol.,60,Type_60,No
DB00679,Thioridazine,DB00742,Mannitol,0.8799871802330017,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Mannitol.,49,Type_49,Yes
DB00629,Guanabenz,DB06704,Iobenguane,0.9999022483825684,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Guanabenz.,70,Type_70,Yes
DB00006,Bivalirudin,DB00370,Mirtazapine,0.7320401668548584,73,Type_73,The serum concentration of Mirtazapine can be increased when it is combined with Bivalirudin.,73,Type_73,Yes
DB00691,Moexipril,DB00755,Tretinoin,0.8976796269416809,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Tretinoin.,49,Type_49,Yes
DB00440,Trimethoprim,DB00448,Lansoprazole,0.9092323780059814,47,Type_47,The metabolism of Lansoprazole can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00402,Eszopiclone,DB04896,Milnacipran,0.9707961678504944,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Milnacipran.,49,Type_49,Yes
DB00691,Moexipril,DB08981,Fenbufen,0.975996732711792,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Fenbufen.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00851,Dacarbazine,0.7955781817436218,47,Type_47,The metabolism of Dacarbazine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00182,Amphetamine,DB01174,Phenobarbital,0.7713649868965149,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Amphetamine.,75,Type_75,No
DB00177,Valsartan,DB01142,Doxepin,0.9004850387573242,47,Type_47,The metabolism of Doxepin can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00542,Benazepril,DB04743,Nimesulide,0.8783553242683411,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Nimesulide.,49,Type_49,Yes
DB00418,Secobarbital,DB08808,Bupranolol,0.7854322195053101,60,Type_60,Secobarbital may increase the hypotensive activities of Bupranolol.,75,Type_75,No
DB00627,Niacin,DB00679,Thioridazine,0.2986955940723419,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Niacin.,73,Type_73,Yes
DB00498,Phenindione,DB00624,Testosterone,0.7977819442749023,6,Type_6,Phenindione may increase the anticoagulant activities of Testosterone.,6,Type_6,Yes
DB00991,Oxaprozin,DB08822,Azilsartan medoxomil,0.9962738752365112,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB01045,Rifampicin,DB06717,Fosaprepitant,0.4756101965904236,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00683,Midazolam,DB09054,Idelalisib,0.8511092662811279,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Midazolam.,73,Type_73,No
DB06237,Avanafil,DB09118,Stiripentol,0.9648422002792358,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Avanafil.,73,Type_73,Yes
DB01321,Josamycin,DB04743,Nimesulide,0.3425407111644745,49,Type_49,The risk or severity of adverse effects can be increased when Josamycin is combined with Nimesulide.,47,Type_47,No
DB00104,Octreotide,DB00373,Timolol,0.9937818646430969,54,Type_54,Octreotide may increase the bradycardic activities of Timolol.,54,Type_54,Yes
DB01078,Deslanoside,DB01421,Paromomycin,0.7404727339744568,75,Type_75,The serum concentration of Paromomycin can be decreased when it is combined with Deslanoside.,75,Type_75,Yes
DB00706,Tamsulosin,DB00871,Terbutaline,0.9986860156059265,5,Type_5,Tamsulosin may decrease the vasoconstricting activities of Terbutaline.,5,Type_5,Yes
DB01122,Ambenonium,DB01199,Tubocurarine,0.9787719249725342,70,Type_70,The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Ambenonium.,70,Type_70,Yes
DB01114,Chlorpheniramine,DB09128,Brexpiprazole,0.9924365878105164,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Brexpiprazole.,49,Type_49,Yes
DB01176,Cyclizine,DB01189,Desflurane,0.9995163679122925,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Desflurane.,49,Type_49,Yes
DB00361,Vinorelbine,DB00390,Digoxin,0.964723527431488,58,Type_58,Vinorelbine may decrease the cardiotoxic activities of Digoxin.,58,Type_58,Yes
DB00688,Mycophenolate mofetil,DB00955,Netilmicin,0.9991921782493591,72,Type_72,Mycophenolate mofetil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB00865,Benzphetamine,DB01433,Methadyl acetate,0.99972003698349,69,Type_69,Benzphetamine may increase the analgesic activities of Methadyl acetate.,69,Type_69,Yes
DB00257,Clotrimazole,DB05109,Trabectedin,0.8147996664047241,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB06724,Calcium carbonate,0.9815836548805237,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Fluticasone propionate.,3,Type_3,Yes
DB00263,Sulfisoxazole,DB00835,Brompheniramine,0.9812551736831665,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00321,Amitriptyline,DB01097,Leflunomide,0.5185345411300659,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00712,Flurbiprofen,DB01380,Cortisone acetate,0.9994589686393738,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Cortisone acetate.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00477,Chlorpromazine,0.5691819190979004,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Chlorpromazine.,47,Type_47,No
DB01151,Desipramine,DB06144,Sertindole,0.8737290501594543,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Sertindole.,47,Type_47,No
DB06724,Calcium carbonate,DB08912,Dabrafenib,0.9873878359794617,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Calcium carbonate.,75,Type_75,Yes
DB01263,Posaconazole,DB04946,Iloperidone,0.44057130813598633,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Posaconazole.,77,Type_77,No
DB01013,Clobetasol propionate,DB01390,Sodium bicarbonate,0.9952768087387085,3,Type_3,The bioavailability of Sodium bicarbonate can be decreased when combined with Clobetasol propionate.,3,Type_3,Yes
DB01242,Clomipramine,DB01319,Fosamprenavir,0.8115975260734558,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Clomipramine.,73,Type_73,No
DB00872,Conivaptan,DB01558,Bromazepam,0.9817097783088684,73,Type_73,The serum concentration of Bromazepam can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00829,Diazepam,DB13323,Trichloroethylene,0.988134503364563,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Trichloroethylene.,49,Type_49,Yes
DB00844,Nalbuphine,DB06201,Rufinamide,0.9997376799583435,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rufinamide.,49,Type_49,Yes
DB00367,Levonorgestrel,DB06335,Saxagliptin,0.8307557702064514,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00688,Mycophenolate mofetil,DB01708,Prasterone,0.998703122138977,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Prasterone.,49,Type_49,Yes
DB00881,Quinapril,DB08439,Parecoxib,0.9040448665618896,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Parecoxib.,49,Type_49,Yes
DB00277,Theophylline,DB04854,Febuxostat,0.9763115048408508,73,Type_73,The serum concentration of Febuxostat can be increased when it is combined with Theophylline.,77,Type_77,No
DB00653,Magnesium sulfate,DB09236,Lacidipine,0.775078296661377,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Lacidipine.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00615,Rifabutin,0.772203803062439,4,Type_4,The metabolism of Rifabutin can be increased when combined with Prochlorperazine.,4,Type_4,Yes
DB00959,Methylprednisolone,DB09275,Bismuth subcitrate potassium,0.9994082450866699,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Methylprednisolone.,3,Type_3,Yes
DB01118,Amiodarone,DB08880,Teriflunomide,0.5395486354827881,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Amiodarone.,75,Type_75,Yes
DB01545,Ethyl loflazepate,DB06201,Rufinamide,0.9530138373374939,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Rufinamide.,49,Type_49,Yes
DB00226,Guanadrel,DB00275,Olmesartan,0.9999878406524658,60,Type_60,Guanadrel may increase the hypotensive activities of Olmesartan.,60,Type_60,Yes
DB00876,Eprosartan,DB09244,Pirlindole,0.9988723397254944,60,Type_60,Eprosartan may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00556,Perflutren,DB04844,Tetrabenazine,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00418,Secobarbital,DB01183,Naloxone,0.974378764629364,4,Type_4,The metabolism of Naloxone can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01219,Dantrolene,DB08933,Luliconazole,0.9824796915054321,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Dantrolene.,73,Type_73,Yes
DB00963,Bromfenac,DB09279,Fimasartan,0.999488353729248,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Fimasartan.,49,Type_49,Yes
DB00458,Imipramine,DB01626,Pargyline,0.5271347761154175,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Pargyline.,64,Type_64,No
DB00521,Carteolol,DB09118,Stiripentol,0.8325936794281006,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Carteolol.,47,Type_47,No
DB01260,Desonide,DB06737,Zaltoprofen,0.9996604919433594,49,Type_49,The risk or severity of adverse effects can be increased when Desonide is combined with Zaltoprofen.,49,Type_49,Yes
DB00679,Thioridazine,DB00997,Doxorubicin,0.526996374130249,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Thioridazine.,73,Type_73,No
DB01149,Nefazodone,DB06148,Mianserin,0.8261772990226746,47,Type_47,The metabolism of Mianserin can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB09054,Idelalisib,DB12001,Abemaciclib,0.773313581943512,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Idelalisib.,49,Type_49,No
DB00333,Methadone,DB09245,Toloxatone,0.3999807834625244,64,Type_64,Methadone may increase the serotonergic activities of Toloxatone.,49,Type_49,No
DB00947,Fulvestrant,DB01201,Rifapentine,0.8796737790107727,4,Type_4,The metabolism of Rifapentine can be increased when combined with Fulvestrant.,4,Type_4,Yes
DB01545,Ethyl loflazepate,DB05271,Rotigotine,0.7794014811515808,32,Type_32,Ethyl loflazepate may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB01065,Melatonin,DB01097,Leflunomide,0.7557277679443359,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Melatonin.,47,Type_47,Yes
DB00316,Acetaminophen,DB08873,Boceprevir,0.8570216298103333,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB01263,Posaconazole,DB04574,Estrone sulfate,0.5164204239845276,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00652,Pentazocine,DB00842,Oxazepam,0.9988279938697815,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Oxazepam.,49,Type_49,Yes
DB00857,Terbinafine,DB01427,Amrinone,0.9091551303863525,49,Type_49,The risk or severity of adverse effects can be increased when Terbinafine is combined with Amrinone.,49,Type_49,Yes
DB01011,Metyrapone,DB09288,Propacetamol,0.8910049200057983,73,Type_73,The serum concentration of Propacetamol can be increased when it is combined with Metyrapone.,77,Type_77,No
DB00596,Ulobetasol,DB00945,Acetylsalicylic acid,0.9990543723106384,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB01588,Prazepam,DB09048,Netupitant,0.9722530245780945,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Prazepam.,73,Type_73,Yes
DB00228,Enflurane,DB00623,Fluphenazine,0.9982534050941467,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Fluphenazine.,49,Type_49,Yes
DB00180,Flunisolide,DB05039,Indacaterol,0.9912673830986023,83,Type_83,Flunisolide may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00892,Oxybuprocaine,DB01106,Levocabastine,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levocabastine.,49,Type_49,Yes
DB00695,Furosemide,DB00966,Telmisartan,0.9640668630599976,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Telmisartan.,49,Type_49,Yes
DB00956,Hydrocodone,DB04844,Tetrabenazine,0.9883885979652405,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Tetrabenazine.,16,Type_16,Yes
DB00257,Clotrimazole,DB00653,Magnesium sulfate,0.6002405881881714,47,Type_47,The metabolism of Magnesium sulfate can be decreased when combined with Clotrimazole.,49,Type_49,No
DB00203,Sildenafil,DB01222,Budesonide,0.5848901271820068,47,Type_47,The metabolism of Budesonide can be decreased when combined with Sildenafil.,73,Type_73,No
DB01267,Paliperidone,DB06594,Agomelatine,0.9980127811431885,49,Type_49,The risk or severity of adverse effects can be increased when Paliperidone is combined with Agomelatine.,49,Type_49,Yes
DB01247,Isocarboxazid,DB06700,Desvenlafaxine,0.8297831416130066,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Desvenlafaxine.,49,Type_49,Yes
DB01614,Acepromazine,DB08987,Etidocaine,0.9999829530715942,49,Type_49,The risk or severity of adverse effects can be increased when Acepromazine is combined with Etidocaine.,49,Type_49,Yes
DB00956,Hydrocodone,DB01319,Fosamprenavir,0.6152318120002747,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Hydrocodone.,73,Type_73,No
DB00890,Dienestrol,DB01597,Cilastatin,0.7728075981140137,75,Type_75,The serum concentration of Cilastatin can be decreased when it is combined with Dienestrol.,75,Type_75,Yes
DB00559,Bosentan,DB01192,Oxymorphone,0.5963783860206604,75,Type_75,The serum concentration of Oxymorphone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB04868,Nilotinib,DB09330,Osimertinib,0.9293527007102966,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Nilotinib.,73,Type_73,Yes
DB00169,Cholecalciferol,DB05246,Methsuximide,0.9594576358795166,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00747,Scopolamine,DB01151,Desipramine,0.9973526000976562,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Desipramine.,49,Type_49,Yes
DB08860,Pitavastatin,DB09227,Barnidipine,0.9181945323944092,49,Type_49,The risk or severity of adverse effects can be increased when Pitavastatin is combined with Barnidipine.,49,Type_49,Yes
DB00280,Disopyramide,DB00839,Tolazamide,0.999724805355072,9,Type_9,Disopyramide may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00622,Nicardipine,DB08932,Macitentan,0.9597711563110352,60,Type_60,Nicardipine may increase the hypotensive activities of Macitentan.,47,Type_47,No
DB04743,Nimesulide,DB05266,Ibudilast,0.8565236926078796,53,Type_53,Nimesulide may increase the antiplatelet activities of Ibudilast.,53,Type_53,Yes
DB00968,Methyldopa,DB01143,Amifostine,0.5217278599739075,49,Type_49,The risk or severity of adverse effects can be increased when Methyldopa is combined with Amifostine.,60,Type_60,No
DB00367,Levonorgestrel,DB01174,Phenobarbital,0.5557612180709839,70,Type_70,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Levonorgestrel.,4,Type_4,No
DB00327,Hydromorphone,DB06738,Ketobemidone,0.9773364663124084,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ketobemidone.,49,Type_49,Yes
DB06153,Pizotifen,DB08815,Lurasidone,0.9997243285179138,49,Type_49,The risk or severity of adverse effects can be increased when Pizotifen is combined with Lurasidone.,49,Type_49,Yes
DB02187,Equilin,DB13783,Acemetacin,0.9677672982215881,49,Type_49,The risk or severity of adverse effects can be increased when Equilin is combined with Acemetacin.,49,Type_49,Yes
DB00346,Alfuzosin,DB01026,Ketoconazole,0.6955476403236389,73,Type_73,The serum concentration of Ketoconazole can be increased when it is combined with Alfuzosin.,73,Type_73,Yes
DB00850,Perphenazine,DB01241,Gemfibrozil,0.8835461735725403,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Perphenazine.,47,Type_47,Yes
DB00682,Warfarin,DB11362,Selexipag,0.9966171383857727,6,Type_6,Warfarin may increase the anticoagulant activities of Selexipag.,6,Type_6,Yes
DB00939,Meclofenamic acid,DB01208,Sparfloxacin,0.996253252029419,27,Type_27,Meclofenamic acid may increase the neuroexcitatory activities of Sparfloxacin.,27,Type_27,Yes
DB00699,Nicergoline,DB00908,Quinidine,0.6133626699447632,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Quinidine.,47,Type_47,No
DB00253,Medrysone,DB06723,Aluminum hydroxide,0.9983258843421936,3,Type_3,The bioavailability of Aluminum hydroxide can be decreased when combined with Medrysone.,3,Type_3,Yes
DB00554,Piroxicam,DB00613,Amodiaquine,0.9576306343078613,47,Type_47,The metabolism of Amodiaquine can be decreased when combined with Piroxicam.,73,Type_73,No
DB00188,Bortezomib,DB00436,Bendroflumethiazide,0.8950480818748474,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Bendroflumethiazide.,49,Type_49,Yes
DB00710,Ibandronate,DB03754,Tromethamine,0.9482112526893616,75,Type_75,The serum concentration of Tromethamine can be decreased when it is combined with Ibandronate.,75,Type_75,Yes
DB00368,Norepinephrine,DB01159,Halothane,0.6934870481491089,82,Type_82,Norepinephrine may increase the arrhythmogenic activities of Halothane.,82,Type_82,Yes
DB00554,Piroxicam,DB09280,Lumacaftor,0.46506550908088684,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Piroxicam.,73,Type_73,No
DB00682,Warfarin,DB01333,Cefradine,0.9988166093826294,6,Type_6,Warfarin may increase the anticoagulant activities of Cefradine.,6,Type_6,Yes
DB00547,Desoximetasone,DB01370,Aluminium,0.9940284490585327,3,Type_3,The bioavailability of Aluminium can be decreased when combined with Desoximetasone.,3,Type_3,Yes
DB00239,Oxiconazole,DB00490,Buspirone,0.9058893918991089,47,Type_47,The metabolism of Buspirone can be decreased when combined with Oxiconazole.,47,Type_47,Yes
DB01167,Itraconazole,DB01248,Docetaxel,0.7769986391067505,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB04743,Nimesulide,DB08807,Bopindolol,0.9963382482528687,37,Type_37,Nimesulide may decrease the antihypertensive activities of Bopindolol.,37,Type_37,Yes
DB06595,Midostaurin,DB06717,Fosaprepitant,0.9188215136528015,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Midostaurin.,73,Type_73,Yes
DB00976,Telithromycin,DB00996,Gabapentin,0.675834059715271,47,Type_47,The metabolism of Gabapentin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB01173,Orphenadrine,DB01551,Dihydrocodeine,0.5639557838439941,49,Type_49,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Dihydrocodeine.,16,Type_16,No
DB02703,Fusidic acid,DB04868,Nilotinib,0.9990342855453491,73,Type_73,The serum concentration of Nilotinib can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB01035,Procainamide,DB06825,Triptorelin,0.9979097247123718,20,Type_20,Procainamide may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00575,Clonidine,DB00692,Phentolamine,0.618297815322876,60,Type_60,Clonidine may increase the hypotensive activities of Phentolamine.,60,Type_60,Yes
DB00317,Gefitinib,DB09048,Netupitant,0.9864718914031982,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Gefitinib.,73,Type_73,Yes
DB00452,Framycetin,DB01607,Ticarcillin,0.9914210438728333,75,Type_75,The serum concentration of Ticarcillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB00468,Quinine,DB00784,Mefenamic acid,0.9192029237747192,47,Type_47,The metabolism of Mefenamic acid can be decreased when combined with Quinine.,47,Type_47,Yes
DB00220,Nelfinavir,DB11915,Valbenazine,0.9410189390182495,47,Type_47,The metabolism of Valbenazine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01159,Halothane,DB04920,Clevidipine,0.9971582889556885,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Clevidipine.,49,Type_49,Yes
DB00224,Indinavir,DB00263,Sulfisoxazole,0.9769286513328552,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00852,Pseudoephedrine,DB04855,Dronedarone,0.8792923092842102,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Pseudoephedrine.,47,Type_47,Yes
DB01208,Sparfloxacin,DB13231,Calcium lactate,0.9238280653953552,67,Type_67,Sparfloxacin can cause a decrease in the absorption of Calcium lactate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00195,Betaxolol,DB00264,Metoprolol,0.6008860468864441,30,Type_30,Betaxolol may increase the orthostatic hypotensive activities of Metoprolol.,73,Type_73,No
DB00706,Tamsulosin,DB00872,Conivaptan,0.776462733745575,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Tamsulosin.,73,Type_73,Yes
DB00448,Lansoprazole,DB01026,Ketoconazole,0.8202694654464722,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Lansoprazole.,75,Type_75,No
DB01551,Dihydrocodeine,DB06204,Tapentadol,0.989284098148346,16,Type_16,Dihydrocodeine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00428,Streptozocin,DB08934,Sofosbuvir,0.71928870677948,73,Type_73,The serum concentration of Sofosbuvir can be increased when it is combined with Streptozocin.,75,Type_75,No
DB00203,Sildenafil,DB09034,Suvorexant,0.6401023864746094,73,Type_73,The serum concentration of Suvorexant can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB01242,Clomipramine,DB01408,Bambuterol,0.9810721278190613,49,Type_49,The risk or severity of adverse effects can be increased when Clomipramine is combined with Bambuterol.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01180,Rescinnamine,0.9873358607292175,60,Type_60,Tranylcypromine may increase the hypotensive activities of Rescinnamine.,60,Type_60,Yes
DB00199,Erythromycin,DB04743,Nimesulide,0.8293585181236267,47,Type_47,The metabolism of Nimesulide can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB09030,Vorapaxar,DB09065,Cobicistat,0.7505341172218323,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Vorapaxar.,73,Type_73,Yes
DB00575,Clonidine,DB06403,Ambrisentan,0.8713421821594238,60,Type_60,Clonidine may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00976,Telithromycin,DB01045,Rifampicin,0.6863727569580078,4,Type_4,The metabolism of Rifampicin can be increased when combined with Telithromycin.,4,Type_4,Yes
DB00252,Phenytoin,DB01242,Clomipramine,0.9589059352874756,4,Type_4,The metabolism of Clomipramine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01576,Dextroamphetamine,DB09245,Toloxatone,0.9930896162986755,71,Type_71,Dextroamphetamine may increase the hypertensive activities of Toloxatone.,71,Type_71,Yes
DB00966,Telmisartan,DB01324,Polythiazide,0.8536025285720825,60,Type_60,Telmisartan may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00688,Mycophenolate mofetil,DB00976,Telithromycin,0.9649882316589355,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Mycophenolate mofetil.,47,Type_47,Yes
DB00695,Furosemide,DB06725,Lornoxicam,0.9999685287475586,29,Type_29,Furosemide may decrease the diuretic activities of Lornoxicam.,29,Type_29,Yes
DB00457,Prazosin,DB01238,Aripiprazole,0.9979956150054932,60,Type_60,Prazosin may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00814,Meloxicam,DB01201,Rifapentine,0.9193639159202576,4,Type_4,The metabolism of Rifapentine can be increased when combined with Meloxicam.,4,Type_4,Yes
DB00409,Remoxipride,DB01198,Zopiclone,0.9978684186935425,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Zopiclone.,49,Type_49,Yes
DB00482,Celecoxib,DB00549,Zafirlukast,0.9857085943222046,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00296,Ropivacaine,DB00850,Perphenazine,0.9224771857261658,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Perphenazine.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB00552,Pentostatin,0.9999803304672241,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Pentostatin.,58,Type_58,Yes
DB00747,Scopolamine,DB01116,Trimethaphan,0.9872382879257202,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Trimethaphan.,49,Type_49,Yes
DB00331,Metformin,DB01380,Cortisone acetate,0.9788203835487366,70,Type_70,The therapeutic efficacy of Cortisone acetate can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00250,Dapsone,DB08899,Enzalutamide,0.9307435154914856,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Dapsone.,75,Type_75,Yes
DB00294,Etonogestrel,DB01067,Glipizide,0.9317759871482849,70,Type_70,The therapeutic efficacy of Glipizide can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00685,Trovafloxacin,DB09267,Strontium ranelate,0.8664692044258118,75,Type_75,The serum concentration of Strontium ranelate can be decreased when it is combined with Trovafloxacin.,75,Type_75,Yes
DB00495,Zidovudine,DB08899,Enzalutamide,0.9487419128417969,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Zidovudine.,75,Type_75,Yes
DB00541,Vincristine,DB01229,Paclitaxel,0.9053010940551758,49,Type_49,The risk or severity of adverse effects can be increased when Vincristine is combined with Paclitaxel.,49,Type_49,Yes
DB00458,Imipramine,DB01264,Darunavir,0.6737101078033447,47,Type_47,The metabolism of Darunavir can be decreased when combined with Imipramine.,73,Type_73,No
DB00487,Pefloxacin,DB00651,Dyphylline,0.3772796392440796,47,Type_47,The metabolism of Dyphylline can be decreased when combined with Pefloxacin.,47,Type_47,Yes
DB00794,Primidone,DB00850,Perphenazine,0.638765811920166,4,Type_4,The metabolism of Perphenazine can be increased when combined with Primidone.,4,Type_4,Yes
DB00341,Cetirizine,DB01068,Clonazepam,0.9973195195198059,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Clonazepam.,49,Type_49,Yes
DB00179,Masoprocol,DB01283,Lumiracoxib,0.9991395473480225,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Lumiracoxib.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00883,Isosorbide dinitrate,0.9930741786956787,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00186,Lorazepam,DB09342,Propoxycaine,0.5045393109321594,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Propoxycaine.,49,Type_49,No
DB01264,Darunavir,DB01595,Nitrazepam,0.64283686876297,47,Type_47,The metabolism of Nitrazepam can be decreased when combined with Darunavir.,47,Type_47,Yes
DB00511,Acetyldigitoxin,DB04845,Ixabepilone,0.9995558857917786,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Ixabepilone.,58,Type_58,Yes
DB00881,Quinapril,DB04576,Fleroxacin,0.8189033269882202,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Fleroxacin.,75,Type_75,No
DB00677,Isoflurophate,DB01116,Trimethaphan,0.9541769027709961,70,Type_70,The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Isoflurophate.,70,Type_70,Yes
DB01248,Docetaxel,DB09041,Tavaborole,0.6909031867980957,47,Type_47,The metabolism of Tavaborole can be decreased when combined with Docetaxel.,47,Type_47,Yes
DB00674,Galantamine,DB00838,Clocortolone,0.891186535358429,49,Type_49,The risk or severity of adverse effects can be increased when Galantamine is combined with Clocortolone.,49,Type_49,Yes
DB00681,Amphotericin B,DB01018,Guanfacine,0.9825025796890259,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Guanfacine.,49,Type_49,Yes
DB00217,Bethanidine,DB01340,Cilazapril,0.99986732006073,60,Type_60,Bethanidine may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB00205,Pyrimethamine,DB00682,Warfarin,0.9124333262443542,47,Type_47,The metabolism of Warfarin can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00470,Dronabinol,DB11304,Phenoxyethanol,0.9999198913574219,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Phenoxyethanol.,16,Type_16,Yes
DB00524,Metolazone,DB01064,Isoprenaline,0.9968299269676208,83,Type_83,Metolazone may increase the hypokalemic activities of Isoprenaline.,83,Type_83,Yes
DB00413,Pramipexole,DB00450,Droperidol,0.9994041919708252,32,Type_32,Pramipexole may increase the sedative activities of Droperidol.,32,Type_32,Yes
DB00672,Chlorpropamide,DB00827,Cinoxacin,0.9972139000892639,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Cinoxacin.,9,Type_9,Yes
DB00278,Argatroban,DB00784,Mefenamic acid,0.9469290971755981,6,Type_6,Argatroban may increase the anticoagulant activities of Mefenamic acid.,6,Type_6,Yes
DB00661,Verapamil,DB00909,Zonisamide,0.9238751530647278,47,Type_47,The metabolism of Zonisamide can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00238,Nevirapine,DB01107,Methyprylon,0.997658371925354,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Nevirapine.,47,Type_47,Yes
DB01601,Lopinavir,DB04572,Thiotepa,0.8406848907470703,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB00313,Valproic acid,DB01274,Arformoterol,0.5977262258529663,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB00492,Fosinopril,DB00977,Ethinylestradiol,0.8116008043289185,75,Type_75,The serum concentration of Ethinylestradiol can be decreased when it is combined with Fosinopril.,75,Type_75,Yes
DB00176,Fluvoxamine,DB00990,Exemestane,0.860257089138031,47,Type_47,The metabolism of Exemestane can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00598,Labetalol,DB00820,Tadalafil,0.7248969674110413,10,Type_10,Labetalol may increase the antihypertensive activities of Tadalafil.,60,Type_60,No
DB01088,Iloprost,DB06695,Dabigatran etexilate,0.9959439635276794,6,Type_6,Iloprost may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00390,Digoxin,DB00633,Dexmedetomidine,0.38835448026657104,25,Type_25,Digoxin may increase the atrioventricular blocking (AV block) activities of Dexmedetomidine.,54,Type_54,No
DB00390,Digoxin,DB08868,Fingolimod,0.9875520467758179,54,Type_54,Digoxin may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB00224,Indinavir,DB01047,Fluocinonide,0.8945627212524414,73,Type_73,The serum concentration of Fluocinonide can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB01092,Ouabain,DB01137,Levofloxacin,0.9281304478645325,58,Type_58,Ouabain may decrease the cardiotoxic activities of Levofloxacin.,58,Type_58,Yes
DB00475,Chlordiazepoxide,DB00708,Sufentanil,0.9780148863792419,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Sufentanil.,49,Type_49,Yes
DB00206,Reserpine,DB06684,Vilazodone,0.8655401468276978,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Vilazodone.,49,Type_49,Yes
DB00413,Pramipexole,DB00854,Levorphanol,0.9999892711639404,32,Type_32,Pramipexole may increase the sedative activities of Levorphanol.,32,Type_32,Yes
DB00489,Sotalol,DB01370,Aluminium,0.46036359667778015,82,Type_82,Sotalol may increase the arrhythmogenic activities of Aluminium.,75,Type_75,No
DB01174,Phenobarbital,DB01263,Posaconazole,0.593423068523407,4,Type_4,The metabolism of Posaconazole can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00300,Tenofovir disoproxil,DB00315,Zolmitriptan,0.8303353190422058,47,Type_47,The metabolism of Zolmitriptan can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00487,Pefloxacin,DB06786,Halcinonide,0.9334903955459595,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Halcinonide.,49,Type_49,Yes
DB00325,Nitroprusside,DB01324,Polythiazide,0.9570891857147217,60,Type_60,Nitroprusside may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00392,Profenamine,DB01576,Dextroamphetamine,0.8671596050262451,76,Type_76,Profenamine may decrease the sedative activities of Dextroamphetamine.,76,Type_76,Yes
DB00544,Fluorouracil,DB09080,Olodaterol,0.8406066298484802,47,Type_47,The metabolism of Olodaterol can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00590,Doxazosin,DB09198,Lobeglitazone,0.9979656934738159,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00206,Reserpine,DB01359,Penbutolol,0.8375830054283142,60,Type_60,Reserpine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00723,Methoxamine,DB06700,Desvenlafaxine,0.9923229217529297,85,Type_85,Methoxamine may increase the tachycardic activities of Desvenlafaxine.,85,Type_85,Yes
DB00158,Folic acid,DB06739,Seratrodast,0.729751706123352,70,Type_70,The therapeutic efficacy of Seratrodast can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00661,Verapamil,DB01595,Nitrazepam,0.8756241202354431,47,Type_47,The metabolism of Nitrazepam can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00703,Methazolamide,DB09053,Ibrutinib,0.916347086429596,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Methazolamide.,73,Type_73,Yes
DB00443,Betamethasone,DB00903,Etacrynic acid,0.9999616146087646,83,Type_83,Betamethasone may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB00962,Zaleplon,DB01215,Estazolam,0.987097442150116,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Estazolam.,49,Type_49,Yes
DB01628,Etoricoxib,DB05812,Abiraterone,0.5900402665138245,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Etoricoxib.,73,Type_73,No
DB00405,Dexbrompheniramine,DB09034,Suvorexant,0.9996305704116821,16,Type_16,Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB06710,Methyltestosterone,DB08899,Enzalutamide,0.9768508672714233,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Methyltestosterone.,75,Type_75,Yes
DB00648,Mitotane,DB00969,Alosetron,0.8882527351379395,75,Type_75,The serum concentration of Alosetron can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB04896,Milnacipran,DB09224,Melperone,0.9762091040611267,49,Type_49,The risk or severity of adverse effects can be increased when Milnacipran is combined with Melperone.,49,Type_49,Yes
DB00731,Nateglinide,DB01045,Rifampicin,0.7390182614326477,4,Type_4,The metabolism of Rifampicin can be increased when combined with Nateglinide.,4,Type_4,Yes
DB00468,Quinine,DB00758,Clopidogrel,0.7817050218582153,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Quinine.,47,Type_47,Yes
DB00257,Clotrimazole,DB09073,Palbociclib,0.9915532469749451,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00731,Nateglinide,DB00805,Minaprine,0.9986048340797424,9,Type_9,Nateglinide may increase the hypoglycemic activities of Minaprine.,9,Type_9,Yes
DB00593,Ethosuximide,DB09073,Palbociclib,0.9852286577224731,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Ethosuximide.,73,Type_73,Yes
DB00831,Trifluoperazine,DB05812,Abiraterone,0.832476019859314,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Trifluoperazine.,73,Type_73,Yes
DB00296,Ropivacaine,DB00575,Clonidine,0.9538812041282654,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Clonidine.,49,Type_49,Yes
DB00706,Tamsulosin,DB01075,Diphenhydramine,0.6396908164024353,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Tamsulosin.,47,Type_47,Yes
DB00374,Treprostinil,DB00770,Alprostadil,0.9940032362937927,53,Type_53,Treprostinil may increase the antiplatelet activities of Alprostadil.,53,Type_53,Yes
DB00921,Buprenorphine,DB01558,Bromazepam,0.9988804459571838,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.,16,Type_16,Yes
DB05039,Indacaterol,DB05521,Telaprevir,0.8215151429176331,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Indacaterol.,47,Type_47,Yes
DB00373,Timolol,DB00446,Chloramphenicol,0.9933876991271973,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Timolol.,47,Type_47,Yes
DB00230,Pregabalin,DB09071,Tasimelteon,0.9991338849067688,8,Type_8,The therapeutic efficacy of Tasimelteon can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00296,Ropivacaine,DB00715,Paroxetine,0.46217572689056396,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Paroxetine.,47,Type_47,No
DB00604,Cisapride,DB01171,Moclobemide,0.5078657865524292,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Cisapride.,47,Type_47,Yes
DB00246,Ziprasidone,DB00373,Timolol,0.8170743584632874,47,Type_47,The metabolism of Timolol can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00295,Morphine,DB08933,Luliconazole,0.8936898112297058,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Morphine.,73,Type_73,Yes
DB00675,Tamoxifen,DB01253,Ergometrine,0.4982224404811859,49,Type_49,The risk or severity of adverse effects can be increased when Tamoxifen is combined with Ergometrine.,49,Type_49,Yes
DB00422,Methylphenidate,DB00705,Delavirdine,0.8502070903778076,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00790,Perindopril,DB01261,Sitagliptin,0.66605144739151,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Sitagliptin.,49,Type_49,Yes
DB01058,Praziquantel,DB01601,Lopinavir,0.607850968837738,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00703,Methazolamide,DB01154,Thiamylal,0.6474852561950684,60,Type_60,Methazolamide may increase the hypotensive activities of Thiamylal.,60,Type_60,Yes
DB01002,Levobupivacaine,DB01587,Ketazolam,0.9897365570068359,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ketazolam.,49,Type_49,Yes
DB00203,Sildenafil,DB06654,Safinamide,0.9913060069084167,47,Type_47,The metabolism of Safinamide can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00178,Ramipril,DB09276,Sodium aurothiomalate,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Sodium aurothiomalate.,49,Type_49,Yes
DB00193,Tramadol,DB00402,Eszopiclone,0.8360516428947449,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Eszopiclone.,49,Type_49,Yes
DB00542,Benazepril,DB00876,Eprosartan,0.8791351914405823,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Eprosartan.,49,Type_49,Yes
DB00363,Clozapine,DB01176,Cyclizine,0.9986129999160767,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Cyclizine.,49,Type_49,Yes
DB01338,Pipecuronium,DB06263,Amrubicin,0.9573977589607239,40,Type_40,Pipecuronium may increase the respiratory depressant activities of Amrubicin.,40,Type_40,Yes
DB01151,Desipramine,DB01320,Fosphenytoin,0.701991856098175,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Desipramine.,4,Type_4,Yes
DB00422,Methylphenidate,DB00622,Nicardipine,0.5921130180358887,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Methylphenidate.,37,Type_37,No
DB00228,Enflurane,DB01209,Dezocine,0.9986132383346558,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Dezocine.,49,Type_49,Yes
DB00207,Azithromycin,DB01356,Lithium cation,0.7529746890068054,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Lithium cation.,20,Type_20,Yes
DB06699,Degarelix,DB06708,Lumefantrine,0.8940169811248779,20,Type_20,Degarelix may increase the QTc-prolonging activities of Lumefantrine.,20,Type_20,Yes
DB00035,Desmopressin,DB00476,Duloxetine,0.9475964307785034,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Duloxetine.,49,Type_49,Yes
DB01028,Methoxyflurane,DB01440,gamma-Hydroxybutyric acid,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB01254,Dasatinib,DB09291,Rolapitant,0.6656563878059387,73,Type_73,The serum concentration of Rolapitant can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00227,Lovastatin,DB00726,Trimipramine,0.7005028128623962,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01626,Pargyline,DB09082,Vilanterol,0.9383223056793213,49,Type_49,The risk or severity of adverse effects can be increased when Pargyline is combined with Vilanterol.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01421,Paromomycin,0.9974039196968079,72,Type_72,Mycophenolic acid may decrease the excretion rate of Paromomycin which could result in a higher serum level.,72,Type_72,Yes
DB00419,Miglustat,DB08815,Lurasidone,0.9656044840812683,70,Type_70,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00559,Bosentan,DB06144,Sertindole,0.8946863412857056,75,Type_75,The serum concentration of Sertindole can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00695,Furosemide,DB00991,Oxaprozin,0.9999884366989136,29,Type_29,Furosemide may decrease the diuretic activities of Oxaprozin.,29,Type_29,Yes
DB01169,Arsenic trioxide,DB09286,Pipamperone,0.4361136257648468,49,Type_49,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pipamperone.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01239,Chlorprothixene,0.9817719459533691,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Chlorprothixene.,49,Type_49,Yes
DB00283,Clemastine,DB08883,Perampanel,0.9925147891044617,16,Type_16,Clemastine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01119,Diazoxide,DB09235,Efonidipine,0.9941555261611938,60,Type_60,Diazoxide may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00448,Lansoprazole,DB08864,Rilpivirine,0.6493927836418152,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Lansoprazole.,73,Type_73,Yes
DB00257,Clotrimazole,DB00883,Isosorbide dinitrate,0.8771422505378723,47,Type_47,The metabolism of Isosorbide dinitrate can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00622,Nicardipine,DB09041,Tavaborole,0.9362602233886719,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Tavaborole.,49,Type_49,Yes
DB00700,Eplerenone,DB01244,Bepridil,0.9785229563713074,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Bepridil.,49,Type_49,Yes
DB00199,Erythromycin,DB01424,Aminophenazone,0.9651223421096802,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00317,Gefitinib,DB09054,Idelalisib,0.6440535187721252,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB06403,Ambrisentan,DB09236,Lacidipine,0.9995266199111938,60,Type_60,Ambrisentan may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00808,Indapamide,DB06725,Lornoxicam,0.9137238264083862,70,Type_70,The therapeutic efficacy of Lornoxicam can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00657,Mecamylamine,DB08893,Mirabegron,0.5935007333755493,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Mirabegron.,49,Type_49,Yes
DB02546,Vorinostat,DB06772,Cabazitaxel,0.7780014872550964,49,Type_49,The risk or severity of adverse effects can be increased when Vorinostat is combined with Cabazitaxel.,49,Type_49,Yes
DB00772,Malathion,DB05812,Abiraterone,0.4543974697589874,75,Type_75,The serum concentration of Abiraterone can be decreased when it is combined with Malathion.,73,Type_73,No
DB00327,Hydromorphone,DB00660,Metaxalone,0.9995108842849731,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Metaxalone.,49,Type_49,Yes
DB00238,Nevirapine,DB05812,Abiraterone,0.5496208667755127,75,Type_75,The serum concentration of Abiraterone can be decreased when it is combined with Nevirapine.,73,Type_73,No
DB00334,Olanzapine,DB09072,Sodium oxybate,0.9999998807907104,16,Type_16,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00263,Sulfisoxazole,DB01020,Isosorbide mononitrate,0.9775226712226868,47,Type_47,The metabolism of Isosorbide mononitrate can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01166,Cilostazol,DB01628,Etoricoxib,0.8241526484489441,53,Type_53,Cilostazol may increase the antiplatelet activities of Etoricoxib.,73,Type_73,No
DB00860,Prednisolone,DB00936,Salicylic acid,0.9735609292984009,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Salicylic acid.,49,Type_49,Yes
DB01138,Sulfinpyrazone,DB01253,Ergometrine,0.9400069713592529,49,Type_49,The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Ergometrine.,49,Type_49,Yes
DB09027,Ledipasvir,DB12026,Voxilaprevir,0.6290894150733948,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Ledipasvir.,73,Type_73,Yes
DB00695,Furosemide,DB01240,Epoprostenol,0.9101377725601196,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Epoprostenol.,49,Type_49,Yes
DB01036,Tolterodine,DB09119,Eslicarbazepine acetate,0.9249936938285828,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Tolterodine.,47,Type_47,Yes
DB00425,Zolpidem,DB00737,Meclizine,0.9900240302085876,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Meclizine.,16,Type_16,Yes
DB00027,Gramicidin D,DB06695,Dabigatran etexilate,0.9826167225837708,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Gramicidin D.,77,Type_77,Yes
DB00706,Tamsulosin,DB01366,Procaterol,0.998536229133606,5,Type_5,Tamsulosin may decrease the vasoconstricting activities of Procaterol.,5,Type_5,Yes
DB01082,Streptomycin,DB01135,Doxacurium,0.9999946355819702,40,Type_40,Streptomycin may increase the respiratory depressant activities of Doxacurium.,40,Type_40,Yes
DB00622,Nicardipine,DB04868,Nilotinib,0.6495193243026733,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Nicardipine.,20,Type_20,No
DB00793,Haloprogin,DB01045,Rifampicin,0.5796420574188232,73,Type_73,The serum concentration of Rifampicin can be increased when it is combined with Haloprogin.,73,Type_73,Yes
DB01178,Chlormezanone,DB01192,Oxymorphone,0.9965853691101074,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Oxymorphone.,49,Type_49,Yes
DB00745,Modafinil,DB09053,Ibrutinib,0.7442290782928467,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Modafinil.,73,Type_73,Yes
DB00939,Meclofenamic acid,DB01097,Leflunomide,0.7984296083450317,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Leflunomide.,49,Type_49,Yes
DB00736,Esomeprazole,DB01263,Posaconazole,0.8991824388504028,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Esomeprazole.,75,Type_75,No
DB00399,Zoledronic acid,DB04552,Niflumic acid,0.9936328530311584,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Niflumic acid.,49,Type_49,Yes
DB00880,Chlorothiazide,DB09477,Enalaprilat,0.8259198069572449,60,Type_60,Chlorothiazide may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00468,Quinine,DB01626,Pargyline,0.6599188446998596,9,Type_9,Quinine may increase the hypoglycemic activities of Pargyline.,60,Type_60,No
DB06739,Seratrodast,DB08964,Gemeprost,1.0,70,Type_70,The therapeutic efficacy of Gemeprost can be decreased when used in combination with Seratrodast.,70,Type_70,Yes
DB00559,Bosentan,DB05351,Dexlansoprazole,0.8752612471580505,75,Type_75,The serum concentration of Dexlansoprazole can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00333,Methadone,DB11148,Butamben,0.8933800458908081,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Butamben.,49,Type_49,Yes
DB00821,Carprofen,DB04865,Omacetaxine mepesuccinate,0.9283847808837891,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00753,Isoflurane,DB00794,Primidone,0.7314083576202393,4,Type_4,The metabolism of Primidone can be increased when combined with Isoflurane.,4,Type_4,Yes
DB00684,Tobramycin,DB09268,Picosulfuric acid,0.9883990287780762,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Tobramycin.,70,Type_70,Yes
DB00487,Pefloxacin,DB04951,Pirfenidone,0.9995319843292236,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Pirfenidone.,27,Type_27,Yes
DB00752,Tranylcypromine,DB01268,Sunitinib,0.7679834961891174,9,Type_9,Tranylcypromine may increase the hypoglycemic activities of Sunitinib.,9,Type_9,Yes
DB01214,Metipranolol,DB01359,Penbutolol,0.6772677898406982,49,Type_49,The risk or severity of adverse effects can be increased when Metipranolol is combined with Penbutolol.,49,Type_49,Yes
DB01047,Fluocinonide,DB09288,Propacetamol,0.999222993850708,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Propacetamol.,49,Type_49,Yes
DB01283,Lumiracoxib,DB01401,Choline magnesium trisalicylate,0.996738851070404,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00477,Chlorpromazine,DB00754,Ethotoin,0.987675666809082,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ethotoin.,49,Type_49,Yes
DB06616,Bosutinib,DB13878,Pibrentasvir,0.7677619457244873,73,Type_73,The serum concentration of Pibrentasvir can be increased when it is combined with Bosutinib.,73,Type_73,Yes
DB01078,Deslanoside,DB08905,Formestane,0.7929543256759644,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Formestane.,58,Type_58,Yes
DB00166,Lipoic acid,DB00222,Glimepiride,0.9920921325683594,9,Type_9,Lipoic acid may increase the hypoglycemic activities of Glimepiride.,9,Type_9,Yes
DB00991,Oxaprozin,DB01082,Streptomycin,0.9998689889907837,72,Type_72,Oxaprozin may decrease the excretion rate of Streptomycin which could result in a higher serum level.,72,Type_72,Yes
DB00458,Imipramine,DB00599,Thiopental,0.6144225597381592,4,Type_4,The metabolism of Thiopental can be increased when combined with Imipramine.,4,Type_4,Yes
DB00385,Valrubicin,DB06725,Lornoxicam,0.9997685551643372,72,Type_72,Valrubicin may decrease the excretion rate of Lornoxicam which could result in a higher serum level.,72,Type_72,Yes
DB00336,Nitrofural,DB00476,Duloxetine,0.99604731798172,47,Type_47,The metabolism of Duloxetine can be decreased when combined with Nitrofural.,47,Type_47,Yes
DB00866,Alprenolol,DB01201,Rifapentine,0.7532455325126648,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Alprenolol.,75,Type_75,Yes
DB00246,Ziprasidone,DB00818,Propofol,0.5703648328781128,47,Type_47,The metabolism of Propofol can be decreased when combined with Ziprasidone.,20,Type_20,No
DB00496,Darifenacin,DB09054,Idelalisib,0.9040236473083496,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Darifenacin.,73,Type_73,No
DB01100,Pimozide,DB09071,Tasimelteon,0.9910071492195129,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Tasimelteon.,49,Type_49,Yes
DB00283,Clemastine,DB01129,Rabeprazole,0.9795989990234375,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01072,Atazanavir,DB01357,Mestranol,0.4161347448825836,75,Type_75,The serum concentration of Mestranol can be decreased when it is combined with Atazanavir.,75,Type_75,Yes
DB05676,Apremilast,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Apremilast.,70,Type_70,Yes
DB00313,Valproic acid,DB08815,Lurasidone,0.9676578044891357,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Lurasidone.,49,Type_49,Yes
DB00651,Dyphylline,DB00779,Nalidixic acid,0.509067952632904,47,Type_47,The metabolism of Nalidixic acid can be decreased when combined with Dyphylline.,47,Type_47,Yes
DB00691,Moexipril,DB01113,Papaverine,0.9969245791435242,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Papaverine.,49,Type_49,Yes
DB00322,Floxuridine,DB01424,Aminophenazone,0.943577229976654,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00593,Ethosuximide,DB00909,Zonisamide,0.9990230798721313,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Zonisamide.,49,Type_49,Yes
DB01132,Pioglitazone,DB06287,Temsirolimus,0.4887862801551819,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Pioglitazone.,70,Type_70,No
DB01063,Acetophenazine,DB04844,Tetrabenazine,0.5553885102272034,49,Type_49,The risk or severity of adverse effects can be increased when Acetophenazine is combined with Tetrabenazine.,49,Type_49,Yes
DB00648,Mitotane,DB00943,Zalcitabine,0.9941074848175049,75,Type_75,The serum concentration of Zalcitabine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB06605,Apixaban,DB09054,Idelalisib,0.4357745945453644,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Apixaban.,73,Type_73,No
DB01095,Fluvastatin,DB08860,Pitavastatin,0.7194456458091736,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00268,Ropinirole,DB09118,Stiripentol,0.5200502872467041,32,Type_32,Ropinirole may increase the sedative activities of Stiripentol.,73,Type_73,No
DB01229,Paclitaxel,DB06695,Dabigatran etexilate,0.41798362135887146,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Dabigatran etexilate.,77,Type_77,No
DB00363,Clozapine,DB00528,Lercanidipine,0.8789055943489075,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Lercanidipine.,49,Type_49,Yes
DB00918,Almotriptan,DB01320,Fosphenytoin,0.9481000304222107,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Almotriptan.,4,Type_4,Yes
DB00477,Chlorpromazine,DB09281,Magnesium trisilicate,0.9695332050323486,67,Type_67,Chlorpromazine can cause a decrease in the absorption of Magnesium trisilicate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00296,Ropivacaine,DB00962,Zaleplon,0.9929463267326355,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zaleplon.,49,Type_49,Yes
DB00401,Nisoldipine,DB01110,Miconazole,0.9594281911849976,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Miconazole.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB01551,Dihydrocodeine,0.945927083492279,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Dihydrocodeine.,49,Type_49,Yes
DB00813,Fentanyl,DB01210,Levobunolol,0.9427549242973328,54,Type_54,Fentanyl may increase the bradycardic activities of Levobunolol.,54,Type_54,Yes
DB00613,Amodiaquine,DB08974,Flubendazole,0.9928498268127441,75,Type_75,The serum concentration of Flubendazole can be decreased when it is combined with Amodiaquine.,75,Type_75,Yes
DB00312,Pentobarbital,DB12161,Deutetrabenazine,0.9631338715553284,4,Type_4,The metabolism of Deutetrabenazine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01393,Bezafibrate,DB09063,Ceritinib,0.9840001463890076,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Bezafibrate.,73,Type_73,Yes
DB00805,Minaprine,DB01626,Pargyline,0.4559210538864136,71,Type_71,Minaprine may increase the hypertensive activities of Pargyline.,60,Type_60,No
DB00296,Ropivacaine,DB09291,Rolapitant,0.902209997177124,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB01708,Prasterone,DB08797,Salicylamide,0.9994774460792542,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Salicylamide.,49,Type_49,Yes
DB00392,Profenamine,DB09076,Umeclidinium,0.9854719042778015,2,Type_2,Profenamine may increase the anticholinergic activities of Umeclidinium.,2,Type_2,Yes
DB05219,Crisaborole,DB06738,Ketobemidone,0.9955319166183472,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Crisaborole.,47,Type_47,Yes
DB00924,Cyclobenzaprine,DB01069,Promethazine,0.8732227087020874,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Promethazine.,49,Type_49,Yes
DB00641,Simvastatin,DB01104,Sertraline,0.4981054663658142,73,Type_73,The serum concentration of Sertraline can be increased when it is combined with Simvastatin.,47,Type_47,No
DB00584,Enalapril,DB08933,Luliconazole,0.9848713278770447,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Enalapril.,73,Type_73,Yes
DB01623,Thiothixene,DB09039,Eliglustat,0.31646692752838135,20,Type_20,Thiothixene may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00572,Atropine,DB08897,Aclidinium,0.8979642987251282,2,Type_2,Atropine may increase the anticholinergic activities of Aclidinium.,2,Type_2,Yes
DB00559,Bosentan,DB09198,Lobeglitazone,0.4788157045841217,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Bosentan.,73,Type_73,No
DB00384,Triamterene,DB09279,Fimasartan,0.5601769089698792,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Fimasartan.,49,Type_49,Yes
DB00254,Doxycycline,DB09039,Eliglustat,0.7314525246620178,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Doxycycline.,73,Type_73,No
DB00199,Erythromycin,DB00643,Mebendazole,0.8756935000419617,47,Type_47,The metabolism of Mebendazole can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00804,Dicyclomine,DB01245,Decamethonium,0.9990842342376709,70,Type_70,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Dicyclomine.,70,Type_70,Yes
DB01041,Thalidomide,DB01143,Amifostine,0.9988640546798706,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Amifostine.,49,Type_49,Yes
DB00656,Trazodone,DB00721,Procaine,0.9999804496765137,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Procaine.,49,Type_49,Yes
DB00297,Bupivacaine,DB01023,Felodipine,0.5907825827598572,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Felodipine.,49,Type_49,Yes
DB00465,Ketorolac,DB00955,Netilmicin,0.9999690055847168,72,Type_72,Ketorolac may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB01203,Nadolol,DB09216,Tolfenamic acid,0.9860824346542358,37,Type_37,Nadolol may decrease the antihypertensive activities of Tolfenamic acid.,37,Type_37,Yes
DB00182,Amphetamine,DB08922,Perospirone,0.9177713394165039,61,Type_61,Amphetamine may decrease the stimulatory activities of Perospirone.,61,Type_61,Yes
DB00338,Omeprazole,DB05521,Telaprevir,0.892985999584198,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00264,Metoprolol,DB08896,Regorafenib,0.9421588182449341,54,Type_54,Metoprolol may increase the bradycardic activities of Regorafenib.,54,Type_54,Yes
DB00660,Metaxalone,DB01189,Desflurane,0.9996998310089111,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Desflurane.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB01390,Sodium bicarbonate,0.9952734112739563,3,Type_3,The bioavailability of Sodium bicarbonate can be decreased when combined with Fluocinolone acetonide.,3,Type_3,Yes
DB00477,Chlorpromazine,DB00748,Carbinoxamine,0.48707661032676697,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Carbinoxamine.,49,Type_49,Yes
DB00762,Irinotecan,DB08820,Ivacaftor,0.9988024234771729,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Irinotecan.,73,Type_73,Yes
DB00239,Oxiconazole,DB01098,Rosuvastatin,0.50044846534729,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Oxiconazole.,49,Type_49,No
DB01142,Doxepin,DB01215,Estazolam,0.9019811749458313,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Estazolam.,49,Type_49,Yes
DB01260,Desonide,DB06723,Aluminum hydroxide,0.9983731508255005,3,Type_3,The bioavailability of Aluminum hydroxide can be decreased when combined with Desonide.,3,Type_3,Yes
DB00919,Spectinomycin,DB01283,Lumiracoxib,0.9998267292976379,72,Type_72,Spectinomycin may decrease the excretion rate of Lumiracoxib which could result in a higher serum level.,72,Type_72,Yes
DB00935,Oxymetazoline,DB01365,Mephentermine,0.9998388290405273,49,Type_49,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Mephentermine.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01544,Flunitrazepam,0.7563211917877197,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Flunitrazepam.,49,Type_49,Yes
DB00589,Lisuride,DB00860,Prednisolone,0.9964106678962708,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Prednisolone.,49,Type_49,Yes
DB00955,Netilmicin,DB13450,Cisatracurium besylate,0.9999934434890747,40,Type_40,Netilmicin may increase the respiratory depressant activities of Cisatracurium besylate.,40,Type_40,Yes
DB00570,Vinblastine,DB01095,Fluvastatin,0.6974708437919617,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Vinblastine.,73,Type_73,Yes
DB00829,Diazepam,DB01198,Zopiclone,0.9749735593795776,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Zopiclone.,49,Type_49,Yes
DB00951,Isoniazid,DB01224,Quetiapine,0.4625525176525116,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB00623,Fluphenazine,DB01159,Halothane,0.9638059139251709,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Halothane.,49,Type_49,Yes
DB00590,Doxazosin,DB00951,Isoniazid,0.3449559509754181,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00227,Lovastatin,DB00540,Nortriptyline,0.6773614287376404,47,Type_47,The metabolism of Nortriptyline can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00451,Levothyroxine,DB09330,Osimertinib,0.583075225353241,75,Type_75,The serum concentration of Osimertinib can be decreased when it is combined with Levothyroxine.,73,Type_73,No
DB00264,Metoprolol,DB00622,Nicardipine,0.45448383688926697,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Nicardipine.,73,Type_73,No
DB00219,Oxyphenonium,DB00999,Hydrochlorothiazide,0.9987890124320984,73,Type_73,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphenonium.,73,Type_73,Yes
DB00734,Risperidone,DB00802,Alfentanil,0.9954825639724731,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Alfentanil.,49,Type_49,Yes
DB00297,Bupivacaine,DB08881,Vemurafenib,0.817847490310669,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Bupivacaine.,73,Type_73,No
DB00475,Chlordiazepoxide,DB00482,Celecoxib,0.592919647693634,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00584,Enalapril,DB09279,Fimasartan,0.9805957078933716,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Fimasartan.,49,Type_49,Yes
DB00224,Indinavir,DB00278,Argatroban,0.704860270023346,47,Type_47,The metabolism of Argatroban can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00472,Fluoxetine,DB00839,Tolazamide,0.9900784492492676,9,Type_9,Fluoxetine may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00312,Pentobarbital,DB09099,Somatostatin,0.40384820103645325,4,Type_4,The metabolism of Somatostatin can be increased when combined with Pentobarbital.,49,Type_49,No
DB00273,Topiramate,DB08932,Macitentan,0.7692269086837769,47,Type_47,The metabolism of Macitentan can be decreased when combined with Topiramate.,47,Type_47,Yes
DB00307,Bexarotene,DB01601,Lopinavir,0.8484761714935303,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00678,Losartan,DB01612,Amyl Nitrite,0.9951051473617554,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Amyl Nitrite.,49,Type_49,Yes
DB01320,Fosphenytoin,DB09017,Brotizolam,0.9949840307235718,49,Type_49,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Brotizolam.,49,Type_49,Yes
DB00700,Eplerenone,DB06212,Tolvaptan,0.9775902628898621,68,Type_68,Eplerenone may increase the hyperkalemic activities of Tolvaptan.,68,Type_68,Yes
DB06684,Vilazodone,DB09063,Ceritinib,0.9892162084579468,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Vilazodone.,73,Type_73,Yes
DB00476,Duloxetine,DB01228,Encainide,0.9995790123939514,47,Type_47,The metabolism of Encainide can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB01018,Guanfacine,DB09068,Vortioxetine,0.9653847217559814,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Vortioxetine.,49,Type_49,Yes
DB01183,Naloxone,DB01264,Darunavir,0.8697323799133301,47,Type_47,The metabolism of Darunavir can be decreased when combined with Naloxone.,47,Type_47,Yes
DB01069,Promethazine,DB01390,Sodium bicarbonate,0.8207621574401855,67,Type_67,Promethazine can cause a decrease in the absorption of Sodium bicarbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00436,Bendroflumethiazide,DB09282,Molsidomine,1.0,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00508,Triflupromazine,DB00921,Buprenorphine,0.9999384880065918,16,Type_16,Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00610,Metaraminol,DB00723,Methoxamine,0.9652488231658936,49,Type_49,The risk or severity of adverse effects can be increased when Metaraminol is combined with Methoxamine.,49,Type_49,Yes
DB00347,Trimethadione,DB09063,Ceritinib,0.9932722449302673,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Trimethadione.,73,Type_73,Yes
DB00744,Zileuton,DB04552,Niflumic acid,0.9969367980957031,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Niflumic acid.,49,Type_49,Yes
DB00209,Trospium,DB00462,Methscopolamine bromide,0.9982057809829712,49,Type_49,The risk or severity of adverse effects can be increased when Trospium is combined with Methscopolamine bromide.,49,Type_49,Yes
DB00275,Olmesartan,DB06237,Avanafil,0.9666978120803833,10,Type_10,Olmesartan may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00356,Chlorzoxazone,DB09085,Tetracaine,0.999996542930603,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Tetracaine.,49,Type_49,Yes
DB01232,Saquinavir,DB09026,Aliskiren,0.884936511516571,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00214,Torasemide,DB08984,Etofenamate,0.9996715784072876,29,Type_29,Torasemide may decrease the diuretic activities of Etofenamate.,29,Type_29,Yes
DB00465,Ketorolac,DB08984,Etofenamate,0.9993693232536316,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Etofenamate.,49,Type_49,Yes
DB00622,Nicardipine,DB01409,Tiotropium,0.9865154027938843,47,Type_47,The metabolism of Tiotropium can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB06696,Arbekacin,DB08439,Parecoxib,0.9994593262672424,72,Type_72,Arbekacin may decrease the excretion rate of Parecoxib which could result in a higher serum level.,72,Type_72,Yes
DB00738,Pentamidine,DB00834,Mifepristone,0.9329002499580383,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Mifepristone.,20,Type_20,Yes
DB01588,Prazepam,DB09068,Vortioxetine,0.9990198612213135,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Vortioxetine.,49,Type_49,Yes
DB00199,Erythromycin,DB00361,Vinorelbine,0.6290057301521301,47,Type_47,The metabolism of Vinorelbine can be decreased when combined with Erythromycin.,73,Type_73,No
DB00353,Methylergometrine,DB01115,Nifedipine,0.9856439828872681,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Nifedipine.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB01245,Decamethonium,0.9999442100524902,21,Type_21,Magnesium sulfate may increase the neuromuscular blocking activities of Decamethonium.,21,Type_21,Yes
DB00395,Carisoprodol,DB00420,Promazine,0.559505045413971,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Promazine.,49,Type_49,Yes
DB01092,Ouabain,DB02709,Resveratrol,0.9374341368675232,58,Type_58,Ouabain may decrease the cardiotoxic activities of Resveratrol.,58,Type_58,Yes
DB00196,Fluconazole,DB00433,Prochlorperazine,0.5073028802871704,47,Type_47,The metabolism of Prochlorperazine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB09048,Netupitant,0.9146687984466553,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Dextropropoxyphene.,73,Type_73,Yes
DB00807,Proparacaine,DB01440,gamma-Hydroxybutyric acid,0.9999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00203,Sildenafil,DB00836,Loperamide,0.8567924499511719,47,Type_47,The metabolism of Loperamide can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01016,Glyburide,DB01395,Drospirenone,0.8897450566291809,70,Type_70,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Glyburide.,70,Type_70,Yes
DB00584,Enalapril,DB00765,Metyrosine,0.9998772144317627,60,Type_60,Enalapril may increase the hypotensive activities of Metyrosine.,60,Type_60,Yes
DB00176,Fluvoxamine,DB00934,Maprotiline,0.8066262602806091,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Maprotiline.,47,Type_47,No
DB00591,Fluocinolone acetonide,DB01097,Leflunomide,0.9885588884353638,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Leflunomide.,49,Type_49,Yes
DB00735,Naftifine,DB06712,Nilvadipine,0.8823313117027283,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Nilvadipine.,49,Type_49,Yes
DB00996,Gabapentin,DB01356,Lithium cation,0.785590410232544,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Lithium cation.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00322,Floxuridine,0.9543273448944092,47,Type_47,The metabolism of Floxuridine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00179,Masoprocol,DB00700,Eplerenone,0.9444382190704346,37,Type_37,Masoprocol may decrease the antihypertensive activities of Eplerenone.,37,Type_37,Yes
DB00433,Prochlorperazine,DB01359,Penbutolol,0.9044669270515442,60,Type_60,Prochlorperazine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00744,Zileuton,DB09074,Olaparib,0.9754936099052429,47,Type_47,The metabolism of Olaparib can be decreased when combined with Zileuton.,47,Type_47,Yes
DB00224,Indinavir,DB01418,Acenocoumarol,0.4957606792449951,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Indinavir.,47,Type_47,No
DB00834,Mifepristone,DB01035,Procainamide,0.8353587985038757,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00743,Gadobenic acid,DB00915,Amantadine,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Amantadine.,20,Type_20,Yes
DB00812,Phenylbutazone,DB09292,Sacubitril,0.9986850619316101,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Sacubitril.,49,Type_49,Yes
DB00421,Spironolactone,DB01238,Aripiprazole,0.981238603591919,60,Type_60,Spironolactone may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00801,Halazepam,DB00950,Fexofenadine,0.999954342842102,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Fexofenadine.,49,Type_49,Yes
DB00673,Aprepitant,DB01002,Levobupivacaine,0.6214787364006042,4,Type_4,The metabolism of Levobupivacaine can be increased when combined with Aprepitant.,73,Type_73,No
DB00695,Furosemide,DB01229,Paclitaxel,0.9920324087142944,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Paclitaxel.,49,Type_49,Yes
DB00220,Nelfinavir,DB00674,Galantamine,0.7492268085479736,47,Type_47,The metabolism of Galantamine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00540,Nortriptyline,DB01192,Oxymorphone,0.9498131275177002,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Oxymorphone.,49,Type_49,Yes
DB00385,Valrubicin,DB00821,Carprofen,0.9999384880065918,72,Type_72,Valrubicin may decrease the excretion rate of Carprofen which could result in a higher serum level.,72,Type_72,Yes
DB00816,Orciprenaline,DB01247,Isocarboxazid,0.986555814743042,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Isocarboxazid.,49,Type_49,Yes
DB01355,Hexobarbital,DB09166,Etizolam,0.9892295002937317,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Etizolam.,49,Type_49,Yes
DB00758,Clopidogrel,DB06697,Artemether,0.6773512363433838,47,Type_47,The metabolism of Artemether can be decreased when combined with Clopidogrel.,47,Type_47,Yes
DB01209,Dezocine,DB09125,Potassium citrate,0.9997281432151794,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Potassium citrate.,49,Type_49,Yes
DB00325,Nitroprusside,DB00458,Imipramine,0.931442141532898,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Imipramine.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB09167,Dosulepin,0.524950385093689,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Candesartan cilexetil.,47,Type_47,Yes
DB00465,Ketorolac,DB00687,Fludrocortisone,0.999950647354126,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Fludrocortisone.,49,Type_49,Yes
DB00517,Anisotropine methylbromide,DB06738,Ketobemidone,0.9999772310256958,49,Type_49,The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Ketobemidone.,49,Type_49,Yes
DB00451,Levothyroxine,DB01223,Aminophylline,0.7208893299102783,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Levothyroxine.,4,Type_4,No
DB00252,Phenytoin,DB05381,Histamine,0.8927203416824341,4,Type_4,The metabolism of Histamine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00363,Clozapine,DB00794,Primidone,0.6157233715057373,4,Type_4,The metabolism of Primidone can be increased when combined with Clozapine.,75,Type_75,No
DB00318,Codeine,DB01167,Itraconazole,0.7539543509483337,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Codeine.,47,Type_47,Yes
DB01095,Fluvastatin,DB06292,Dapagliflozin,0.4605029821395874,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00680,Moricizine,DB00854,Levorphanol,0.953559398651123,60,Type_60,Moricizine may increase the hypotensive activities of Levorphanol.,60,Type_60,Yes
DB00279,Liothyronine,DB08918,Levomilnacipran,0.36516261100769043,70,Type_70,The therapeutic efficacy of Levomilnacipran can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00203,Sildenafil,DB00212,Remikiren,0.8847044110298157,10,Type_10,Sildenafil may increase the antihypertensive activities of Remikiren.,73,Type_73,No
DB00285,Venlafaxine,DB00959,Methylprednisolone,0.7946102023124695,47,Type_47,The metabolism of Methylprednisolone can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01263,Posaconazole,DB09068,Vortioxetine,0.7501669526100159,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00418,Secobarbital,DB04574,Estrone sulfate,0.8176460862159729,4,Type_4,The metabolism of Estrone sulfate can be increased when combined with Secobarbital.,70,Type_70,No
DB00620,Triamcinolone,DB09216,Tolfenamic acid,0.9940072298049927,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tolfenamic acid.,49,Type_49,Yes
DB00268,Ropinirole,DB01412,Theobromine,0.3825560212135315,73,Type_73,The serum concentration of Theobromine can be increased when it is combined with Ropinirole.,47,Type_47,No
DB00875,Flupentixol,DB06825,Triptorelin,0.9966292977333069,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00223,Diflorasone,DB06819,Phenylbutyric acid,0.9523376226425171,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Diflorasone.,70,Type_70,Yes
DB00404,Alprazolam,DB01076,Atorvastatin,0.586756706237793,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Alprazolam.,49,Type_49,No
DB00489,Sotalol,DB00814,Meloxicam,0.9612342715263367,37,Type_37,Sotalol may decrease the antihypertensive activities of Meloxicam.,37,Type_37,Yes
DB06708,Lumefantrine,DB09241,Methylene blue,0.7251501083374023,47,Type_47,The metabolism of Methylene blue can be decreased when combined with Lumefantrine.,73,Type_73,No
DB01157,Trimetrexate,DB09238,Manidipine,0.689376950263977,49,Type_49,The risk or severity of adverse effects can be increased when Trimetrexate is combined with Manidipine.,49,Type_49,Yes
DB00754,Ethotoin,DB01151,Desipramine,0.9929162263870239,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Desipramine.,49,Type_49,Yes
DB00339,Pyrazinamide,DB01045,Rifampicin,0.8209107518196106,4,Type_4,The metabolism of Rifampicin can be increased when combined with Pyrazinamide.,80,Type_80,No
DB00322,Floxuridine,DB01274,Arformoterol,0.9137586951255798,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB01421,Paromomycin,DB04552,Niflumic acid,0.9999983310699463,72,Type_72,Paromomycin may decrease the excretion rate of Niflumic acid which could result in a higher serum level.,72,Type_72,Yes
DB00353,Methylergometrine,DB00358,Mefloquine,0.6206385493278503,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Mefloquine.,49,Type_49,Yes
DB00492,Fosinopril,DB01240,Epoprostenol,0.6113551259040833,60,Type_60,Fosinopril may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB00688,Mycophenolate mofetil,DB01078,Deslanoside,0.9494476318359375,58,Type_58,Mycophenolate mofetil may decrease the cardiotoxic activities of Deslanoside.,58,Type_58,Yes
DB01095,Fluvastatin,DB01138,Sulfinpyrazone,0.538931667804718,73,Type_73,The serum concentration of Sulfinpyrazone can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00381,Amlodipine,DB01002,Levobupivacaine,0.5194752812385559,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Levobupivacaine.,49,Type_49,Yes
DB00521,Carteolol,DB00907,Cocaine,0.8070129156112671,47,Type_47,The metabolism of Cocaine can be decreased when combined with Carteolol.,47,Type_47,Yes
DB00232,Methyclothiazide,DB00804,Dicyclomine,0.9844521284103394,73,Type_73,The serum concentration of Dicyclomine can be increased when it is combined with Methyclothiazide.,73,Type_73,Yes
DB06207,Silodosin,DB13879,Glecaprevir,0.9772341251373291,73,Type_73,The serum concentration of Glecaprevir can be increased when it is combined with Silodosin.,73,Type_73,Yes
DB00924,Cyclobenzaprine,DB01452,Diamorphine,0.9714912176132202,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Diamorphine.,49,Type_49,Yes
DB00655,Estrone,DB09054,Idelalisib,0.655891478061676,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Estrone.,47,Type_47,Yes
DB00338,Omeprazole,DB01058,Praziquantel,0.8288459181785583,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00292,Etomidate,DB00349,Clobazam,0.9528231024742126,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Clobazam.,49,Type_49,Yes
DB01233,Metoclopramide,DB09076,Umeclidinium,0.9843732118606567,70,Type_70,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Metoclopramide.,70,Type_70,Yes
DB00474,Methohexital,DB00765,Metyrosine,0.996639609336853,32,Type_32,Methohexital may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00320,Dihydroergotamine,DB09120,Zucapsaicin,0.9955413937568665,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB00605,Sulindac,DB12364,Betrixaban,0.9994503855705261,66,Type_66,The risk or severity of bleeding can be increased when Sulindac is combined with Betrixaban.,66,Type_66,Yes
DB01020,Isosorbide mononitrate,DB09227,Barnidipine,0.9703221917152405,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Barnidipine.,49,Type_49,Yes
DB00374,Treprostinil,DB05219,Crisaborole,0.9962438344955444,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Treprostinil.,47,Type_47,Yes
DB00285,Venlafaxine,DB01087,Primaquine,0.62837153673172,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00474,Methohexital,DB09204,Arotinolol,0.8105239272117615,60,Type_60,Methohexital may increase the hypotensive activities of Arotinolol.,75,Type_75,No
DB00353,Methylergometrine,DB01263,Posaconazole,0.8911609053611755,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Posaconazole.,73,Type_73,No
DB00177,Valsartan,DB00477,Chlorpromazine,0.7899491786956787,47,Type_47,The metabolism of Chlorpromazine can be decreased when combined with Valsartan.,49,Type_49,No
DB00774,Hydroflumethiazide,DB09241,Methylene blue,0.9992363452911377,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00468,Quinine,DB00732,Atracurium besylate,0.9999402761459351,21,Type_21,Quinine may increase the neuromuscular blocking activities of Atracurium besylate.,21,Type_21,Yes
DB00549,Zafirlukast,DB06414,Etravirine,0.8639968633651733,47,Type_47,The metabolism of Etravirine can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00722,Lisinopril,DB06737,Zaltoprofen,0.9700337052345276,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Zaltoprofen.,49,Type_49,Yes
DB00208,Ticlopidine,DB00805,Minaprine,0.9836294054985046,47,Type_47,The metabolism of Minaprine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00860,Prednisolone,DB01320,Fosphenytoin,0.5267869830131531,75,Type_75,The serum concentration of Fosphenytoin can be decreased when it is combined with Prednisolone.,75,Type_75,Yes
DB00210,Adapalene,DB01384,Paramethasone,0.999234676361084,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Paramethasone.,49,Type_49,Yes
DB00312,Pentobarbital,DB06777,Chenodeoxycholic acid,0.9734879732131958,4,Type_4,The metabolism of Chenodeoxycholic acid can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01180,Rescinnamine,DB07615,Tranilast,0.7418279051780701,49,Type_49,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Tranilast.,49,Type_49,Yes
DB04896,Milnacipran,DB09071,Tasimelteon,0.9991098046302795,49,Type_49,The risk or severity of adverse effects can be increased when Milnacipran is combined with Tasimelteon.,49,Type_49,Yes
DB00179,Masoprocol,DB00266,Dicoumarol,0.9998103976249695,6,Type_6,Masoprocol may increase the anticoagulant activities of Dicoumarol.,6,Type_6,Yes
DB00547,Desoximetasone,DB00939,Meclofenamic acid,0.9997301697731018,49,Type_49,The risk or severity of adverse effects can be increased when Desoximetasone is combined with Meclofenamic acid.,49,Type_49,Yes
DB00619,Imatinib,DB01171,Moclobemide,0.9763584136962891,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00252,Phenytoin,DB00697,Tizanidine,0.43700167536735535,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Tizanidine.,49,Type_49,Yes
DB01420,Testosterone propionate,DB09244,Pirlindole,0.3893924653530121,9,Type_9,Testosterone propionate may increase the hypoglycemic activities of Pirlindole.,49,Type_49,No
DB00255,Diethylstilbestrol,DB01586,Ursodeoxycholic acid,0.8033477663993835,75,Type_75,The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Diethylstilbestrol.,70,Type_70,No
DB00936,Salicylic acid,DB01177,Idarubicin,0.9413328766822815,72,Type_72,Salicylic acid may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB00313,Valproic acid,DB01215,Estazolam,0.8874801397323608,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Estazolam.,49,Type_49,Yes
DB00933,Mesoridazine,DB04871,Lorcaserin,0.41629502177238464,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Mesoridazine.,47,Type_47,Yes
DB00327,Hydromorphone,DB00721,Procaine,0.9995400905609131,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Procaine.,49,Type_49,Yes
DB00721,Procaine,DB01100,Pimozide,0.9992772936820984,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Pimozide.,49,Type_49,Yes
DB00764,Mometasone,DB01155,Gemifloxacin,0.9932920932769775,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Gemifloxacin.,49,Type_49,Yes
DB00571,Propranolol,DB09330,Osimertinib,0.917902410030365,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00910,Paricalcitol,DB01026,Ketoconazole,0.9562410116195679,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Paricalcitol.,73,Type_73,No
DB00575,Clonidine,DB00968,Methyldopa,0.9733296036720276,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Methyldopa.,49,Type_49,Yes
DB00834,Mifepristone,DB01155,Gemifloxacin,0.5864124894142151,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00367,Levonorgestrel,DB09280,Lumacaftor,0.9377851486206055,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Levonorgestrel.,75,Type_75,Yes
DB00233,Aminosalicylic acid,DB00498,Phenindione,0.9968538880348206,6,Type_6,Aminosalicylic acid may increase the anticoagulant activities of Phenindione.,6,Type_6,Yes
DB00575,Clonidine,DB00714,Apomorphine,0.5903540253639221,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Apomorphine.,49,Type_49,Yes
DB00468,Quinine,DB00529,Foscarnet,0.9173587560653687,20,Type_20,Quinine may increase the QTc-prolonging activities of Foscarnet.,20,Type_20,Yes
DB01232,Saquinavir,DB06825,Triptorelin,0.9994779229164124,20,Type_20,Saquinavir may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00622,Nicardipine,DB11362,Selexipag,0.9472103714942932,60,Type_60,Nicardipine may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00408,Loxapine,DB01065,Melatonin,0.9995935559272766,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Melatonin.,49,Type_49,Yes
DB00313,Valproic acid,DB00985,Dimenhydrinate,0.9961052536964417,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Dimenhydrinate.,49,Type_49,Yes
DB00679,Thioridazine,DB09085,Tetracaine,0.9996994733810425,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Tetracaine.,49,Type_49,Yes
DB00396,Progesterone,DB00582,Voriconazole,0.7504338026046753,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Progesterone.,13,Type_13,No
DB00834,Mifepristone,DB06791,Lanreotide,0.4552812874317169,73,Type_73,The serum concentration of Lanreotide can be increased when it is combined with Mifepristone.,9,Type_9,No
DB00588,Fluticasone propionate,DB00802,Alfentanil,0.9995985627174377,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Alfentanil.,49,Type_49,Yes
DB00508,Triflupromazine,DB01215,Estazolam,0.9952176809310913,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Estazolam.,49,Type_49,Yes
DB00598,Labetalol,DB00999,Hydrochlorothiazide,0.596494197845459,60,Type_60,Labetalol may increase the hypotensive activities of Hydrochlorothiazide.,49,Type_49,No
DB01615,Aceprometazine,DB08910,Pomalidomide,0.9954885840415955,49,Type_49,The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pomalidomide.,49,Type_49,Yes
DB00457,Prazosin,DB07615,Tranilast,0.8745846748352051,37,Type_37,Prazosin may decrease the antihypertensive activities of Tranilast.,60,Type_60,No
DB01012,Cinacalcet,DB09128,Brexpiprazole,0.6986902356147766,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Cinacalcet.,73,Type_73,Yes
DB01339,Vecuronium,DB09104,Magnesium hydroxide,0.6204798221588135,21,Type_21,Vecuronium may increase the neuromuscular blocking activities of Magnesium hydroxide.,21,Type_21,Yes
DB00854,Levorphanol,DB00980,Ramelteon,0.995604395866394,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Ramelteon.,49,Type_49,Yes
DB00325,Nitroprusside,DB02638,Terlipressin,0.9999810457229614,60,Type_60,Nitroprusside may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00182,Amphetamine,DB06794,Lodoxamide,0.9816909432411194,76,Type_76,Amphetamine may decrease the sedative activities of Lodoxamide.,76,Type_76,Yes
DB00278,Argatroban,DB04575,Quinestrol,0.873952329158783,12,Type_12,Argatroban may decrease the anticoagulant activities of Quinestrol.,12,Type_12,Yes
DB00218,Moxifloxacin,DB01182,Propafenone,0.9965260624885559,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Propafenone.,20,Type_20,Yes
DB00730,Thiabendazole,DB01611,Hydroxychloroquine,0.6216574907302856,47,Type_47,The metabolism of Hydroxychloroquine can be decreased when combined with Thiabendazole.,75,Type_75,No
DB00283,Clemastine,DB00834,Mifepristone,0.8091130256652832,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Clemastine.,47,Type_47,No
DB01222,Budesonide,DB12332,Rucaparib,0.5542630553245544,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Budesonide.,73,Type_73,No
DB00612,Bisoprolol,DB01088,Iloprost,0.9521580934524536,60,Type_60,Bisoprolol may increase the hypotensive activities of Iloprost.,60,Type_60,Yes
DB00934,Maprotiline,DB06589,Pazopanib,0.5829974412918091,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Maprotiline.,73,Type_73,Yes
DB01072,Atazanavir,DB01198,Zopiclone,0.8158144354820251,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Atazanavir.,73,Type_73,No
DB01118,Amiodarone,DB01609,Deferasirox,0.8153977394104004,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Amiodarone.,75,Type_75,Yes
DB00519,Trandolapril,DB01612,Amyl Nitrite,0.9759839177131653,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Amyl Nitrite.,49,Type_49,Yes
DB00371,Meprobamate,DB13323,Trichloroethylene,0.9984544515609741,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Trichloroethylene.,49,Type_49,Yes
DB01041,Thalidomide,DB08941,Isoxsuprine,0.998198926448822,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Isoxsuprine.,49,Type_49,Yes
DB00240,Alclometasone,DB01399,Salsalate,0.999483585357666,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Salsalate.,49,Type_49,Yes
DB00540,Nortriptyline,DB01182,Propafenone,0.626106858253479,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Propafenone.,20,Type_20,Yes
DB01100,Pimozide,DB01589,Quazepam,0.5285768508911133,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Quazepam.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01078,Deslanoside,0.9821953177452087,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Deslanoside.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00540,Nortriptyline,0.9507229328155518,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Nortriptyline.,49,Type_49,Yes
DB00384,Triamterene,DB09120,Zucapsaicin,0.7910125851631165,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Triamterene.,47,Type_47,Yes
DB00813,Fentanyl,DB04844,Tetrabenazine,0.9960854053497314,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Tetrabenazine.,49,Type_49,Yes
DB00443,Betamethasone,DB00861,Diflunisal,0.9991208910942078,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Diflunisal.,49,Type_49,Yes
DB00451,Levothyroxine,DB11126,Calcium gluconate,0.6219950318336487,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Levothyroxine.,70,Type_70,Yes
DB00648,Mitotane,DB04574,Estrone sulfate,0.9999005794525146,75,Type_75,The serum concentration of Estrone sulfate can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01628,Etoricoxib,DB06702,Fesoterodine,0.6112872362136841,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Etoricoxib.,77,Type_77,Yes
DB00519,Trandolapril,DB00742,Mannitol,0.9319350123405457,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Mannitol.,49,Type_49,Yes
DB00862,Vardenafil,DB01201,Rifapentine,0.930941104888916,4,Type_4,The metabolism of Rifapentine can be increased when combined with Vardenafil.,4,Type_4,Yes
DB00243,Ranolazine,DB09068,Vortioxetine,0.7012072205543518,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00608,Chloroquine,DB01685,Topiroxostat,0.9988614320755005,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00285,Venlafaxine,DB01576,Dextroamphetamine,0.9176997542381287,47,Type_47,The metabolism of Dextroamphetamine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB00503,Ritonavir,0.9249124526977539,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Chlorzoxazone.,47,Type_47,Yes
DB00749,Etodolac,DB01418,Acenocoumarol,0.9994803071022034,6,Type_6,Etodolac may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00594,Amiloride,DB01078,Deslanoside,0.4394001364707947,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Deslanoside.,70,Type_70,No
DB02187,Equilin,DB09084,Benzydamine,0.9997668862342834,49,Type_49,The risk or severity of adverse effects can be increased when Equilin is combined with Benzydamine.,49,Type_49,Yes
DB01118,Amiodarone,DB01580,Oxprenolol,0.5013096928596497,54,Type_54,Amiodarone may increase the bradycardic activities of Oxprenolol.,54,Type_54,Yes
DB00470,Dronabinol,DB01587,Ketazolam,0.9997518658638,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,16,Type_16,Yes
DB00404,Alprazolam,DB00933,Mesoridazine,0.998933732509613,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Mesoridazine.,49,Type_49,Yes
DB00199,Erythromycin,DB08906,Fluticasone furoate,0.9561770558357239,47,Type_47,The metabolism of Fluticasone furoate can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB01070,Dihydrotachysterol,0.9664557576179504,51,Type_51,Bendroflumethiazide may increase the hypercalcemic activities of Dihydrotachysterol.,51,Type_51,Yes
DB00335,Atenolol,DB00435,Nitric Oxide,0.9998206496238708,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Nitric Oxide.,49,Type_49,Yes
DB00246,Ziprasidone,DB00356,Chlorzoxazone,0.7323083281517029,47,Type_47,The metabolism of Chlorzoxazone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00625,Efavirenz,DB08883,Perampanel,0.9747933149337769,16,Type_16,Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00401,Nisoldipine,DB00691,Moexipril,0.608025848865509,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Moexipril.,49,Type_49,Yes
DB00651,Dyphylline,DB00817,Rosoxacin,0.45620158314704895,47,Type_47,The metabolism of Rosoxacin can be decreased when combined with Dyphylline.,47,Type_47,Yes
DB00708,Sufentanil,DB09112,Nitrous acid,0.9994446635246277,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Nitrous acid.,49,Type_49,Yes
DB00264,Metoprolol,DB01251,Gliquidone,0.9074904918670654,9,Type_9,Metoprolol may increase the hypoglycemic activities of Gliquidone.,9,Type_9,Yes
DB00784,Mefenamic acid,DB01609,Deferasirox,0.530265212059021,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Mefenamic acid.,73,Type_73,No
DB00523,Alitretinoin,DB06713,Norelgestromin,0.9860500693321228,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Alitretinoin.,70,Type_70,Yes
DB00203,Sildenafil,DB00783,Estradiol,0.8329483866691589,47,Type_47,The metabolism of Estradiol can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00418,Secobarbital,DB00918,Almotriptan,0.8114611506462097,4,Type_4,The metabolism of Almotriptan can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00622,Nicardipine,DB01104,Sertraline,0.8850077390670776,47,Type_47,The metabolism of Sertraline can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB01623,Thiothixene,DB06282,Levocetirizine,0.9854448437690735,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Levocetirizine.,49,Type_49,Yes
DB00675,Tamoxifen,DB01156,Bupropion,0.8549692034721375,47,Type_47,The metabolism of Bupropion can be decreased when combined with Tamoxifen.,73,Type_73,No
DB00455,Loratadine,DB08883,Perampanel,0.9775384068489075,16,Type_16,Loratadine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00484,Brimonidine,DB05271,Rotigotine,0.7114543914794922,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.,32,Type_32,No
DB00349,Clobazam,DB00593,Ethosuximide,0.5955365896224976,47,Type_47,The metabolism of Ethosuximide can be decreased when combined with Clobazam.,49,Type_49,No
DB00472,Fluoxetine,DB12161,Deutetrabenazine,0.9751603007316589,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00631,Clofarabine,DB09291,Rolapitant,0.4723672866821289,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Clofarabine.,73,Type_73,No
DB01587,Ketazolam,DB04842,Fluspirilene,0.998604953289032,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Fluspirilene.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01589,Quazepam,0.8740035891532898,47,Type_47,The metabolism of Quazepam can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00684,Tobramycin,DB00945,Acetylsalicylic acid,0.9999330043792725,72,Type_72,Tobramycin may decrease the excretion rate of Acetylsalicylic acid which could result in a higher serum level.,72,Type_72,Yes
DB00801,Halazepam,DB00967,Desloratadine,0.9989743232727051,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Desloratadine.,49,Type_49,Yes
DB00305,Mitomycin,DB00541,Vincristine,0.8895739912986755,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Mitomycin.,49,Type_49,No
DB00224,Indinavir,DB01048,Abacavir,0.8821008801460266,75,Type_75,The serum concentration of Abacavir can be decreased when it is combined with Indinavir.,75,Type_75,Yes
DB00489,Sotalol,DB08871,Eribulin,0.9960422515869141,20,Type_20,Sotalol may increase the QTc-prolonging activities of Eribulin.,20,Type_20,Yes
DB00454,Meperidine,DB13025,Tiapride,0.9939117431640625,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Tiapride.,49,Type_49,Yes
DB00590,Doxazosin,DB09039,Eliglustat,0.7705564498901367,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB01437,Glutethimide,DB08815,Lurasidone,0.9999643564224243,49,Type_49,The risk or severity of adverse effects can be increased when Glutethimide is combined with Lurasidone.,49,Type_49,Yes
DB01590,Everolimus,DB08864,Rilpivirine,0.950012743473053,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00349,Clobazam,DB00611,Butorphanol,0.993683934211731,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Butorphanol.,49,Type_49,Yes
DB00257,Clotrimazole,DB00759,Tetracycline,0.8901985287666321,47,Type_47,The metabolism of Tetracycline can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00502,Haloperidol,DB00998,Frovatriptan,0.8872482180595398,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Frovatriptan.,49,Type_49,Yes
DB00199,Erythromycin,DB00898,Ethanol,0.5914183259010315,47,Type_47,The metabolism of Ethanol can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB08881,Vemurafenib,0.5589467287063599,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Chlorzoxazone.,73,Type_73,Yes
DB01166,Cilostazol,DB11730,Ribociclib,0.9470536112785339,33,Type_33,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ribociclib.,33,Type_33,Yes
DB00586,Diclofenac,DB00686,Pentosan polysulfate,0.9872786998748779,6,Type_6,Diclofenac may increase the anticoagulant activities of Pentosan polysulfate.,6,Type_6,Yes
DB00423,Methocarbamol,DB01086,Benzocaine,0.9999752044677734,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Benzocaine.,49,Type_49,Yes
DB01544,Flunitrazepam,DB09330,Osimertinib,0.8909228444099426,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Flunitrazepam.,73,Type_73,Yes
DB00203,Sildenafil,DB01158,Bretylium,0.950089156627655,10,Type_10,Sildenafil may increase the antihypertensive activities of Bretylium.,10,Type_10,Yes
DB00681,Amphotericin B,DB09236,Lacidipine,0.9719001054763794,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lacidipine.,49,Type_49,Yes
DB00877,Sirolimus,DB06717,Fosaprepitant,0.9013068675994873,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Sirolimus.,73,Type_73,Yes
DB00313,Valproic acid,DB00854,Levorphanol,0.9570671916007996,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Levorphanol.,49,Type_49,Yes
DB00281,Lidocaine,DB00283,Clemastine,0.44127964973449707,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Clemastine.,47,Type_47,No
DB00731,Nateglinide,DB01095,Fluvastatin,0.6882754564285278,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00206,Reserpine,DB00226,Guanadrel,0.9997649788856506,60,Type_60,Reserpine may increase the hypotensive activities of Guanadrel.,60,Type_60,Yes
DB00834,Mifepristone,DB04855,Dronedarone,0.6525068283081055,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Dronedarone.,73,Type_73,No
DB01014,Balsalazide,DB06696,Arbekacin,0.9995310306549072,72,Type_72,Balsalazide may decrease the excretion rate of Arbekacin which could result in a higher serum level.,72,Type_72,Yes
DB00373,Timolol,DB00999,Hydrochlorothiazide,0.6410555839538574,60,Type_60,Timolol may increase the hypotensive activities of Hydrochlorothiazide.,49,Type_49,No
DB01072,Atazanavir,DB01149,Nefazodone,0.4706474840641022,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Atazanavir.,73,Type_73,No
DB01110,Miconazole,DB05521,Telaprevir,0.902916669845581,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Miconazole.,47,Type_47,Yes
DB00564,Carbamazepine,DB04876,Vildagliptin,0.906842827796936,4,Type_4,The metabolism of Vildagliptin can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00771,Clidinium,DB01227,Levacetylmethadol,0.9774230122566223,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Levacetylmethadol.,49,Type_49,Yes
DB00889,Granisetron,DB01012,Cinacalcet,0.9628010392189026,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Granisetron.,47,Type_47,Yes
DB04953,Ezogabine,DB06204,Tapentadol,0.9998629093170166,16,Type_16,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00750,Prilocaine,DB09112,Nitrous acid,0.7220213413238525,32,Type_32,Prilocaine may increase the sedative activities of Nitrous acid.,49,Type_49,No
DB06414,Etravirine,DB09074,Olaparib,0.6148250699043274,47,Type_47,The metabolism of Olaparib can be decreased when combined with Etravirine.,47,Type_47,Yes
DB00569,Fondaparinux,DB00861,Diflunisal,0.9718356132507324,6,Type_6,Fondaparinux may increase the anticoagulant activities of Diflunisal.,6,Type_6,Yes
DB00692,Phentolamine,DB01021,Trichlormethiazide,0.9787111878395081,60,Type_60,Phentolamine may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB00220,Nelfinavir,DB05294,Vandetanib,0.6454903483390808,73,Type_73,The serum concentration of Vandetanib can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00394,Beclomethasone dipropionate,DB08873,Boceprevir,0.7487104535102844,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Beclomethasone dipropionate.,73,Type_73,Yes
DB00449,Dipivefrin,DB08918,Levomilnacipran,0.9962368011474609,85,Type_85,Dipivefrin may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00655,Estrone,DB09280,Lumacaftor,0.9287028908729553,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Estrone.,75,Type_75,Yes
DB00393,Nimodipine,DB00774,Hydroflumethiazide,0.9649724960327148,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Hydroflumethiazide.,60,Type_60,No
DB00434,Cyproheptadine,DB00924,Cyclobenzaprine,0.9978519678115845,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00471,Montelukast,DB00794,Primidone,0.9755566716194153,4,Type_4,The metabolism of Primidone can be increased when combined with Montelukast.,4,Type_4,Yes
DB00959,Methylprednisolone,DB08933,Luliconazole,0.9777102470397949,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Methylprednisolone.,73,Type_73,Yes
DB00321,Amitriptyline,DB00349,Clobazam,0.6288545727729797,47,Type_47,The metabolism of Clobazam can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00296,Ropivacaine,DB01065,Melatonin,0.9681274890899658,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Melatonin.,49,Type_49,Yes
DB01393,Bezafibrate,DB06290,Simeprevir,0.8475146293640137,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Bezafibrate.,73,Type_73,Yes
DB06708,Lumefantrine,DB09073,Palbociclib,0.9949414134025574,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Lumefantrine.,73,Type_73,Yes
DB00829,Diazepam,DB06700,Desvenlafaxine,0.9406179785728455,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Desvenlafaxine.,49,Type_49,Yes
DB01184,Domperidone,DB09280,Lumacaftor,0.5988038778305054,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Domperidone.,73,Type_73,No
DB01395,Drospirenone,DB01399,Salsalate,0.981103777885437,68,Type_68,Drospirenone may increase the hyperkalemic activities of Salsalate.,68,Type_68,Yes
DB00182,Amphetamine,DB00885,Pemirolast,0.9998154044151306,76,Type_76,Amphetamine may decrease the sedative activities of Pemirolast.,76,Type_76,Yes
DB00295,Morphine,DB00721,Procaine,0.999516487121582,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Procaine.,49,Type_49,Yes
DB00312,Pentobarbital,DB04844,Tetrabenazine,0.5847475528717041,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Tetrabenazine.,49,Type_49,Yes
DB04868,Nilotinib,DB08880,Teriflunomide,0.43326523900032043,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Nilotinib.,73,Type_73,No
DB00910,Paricalcitol,DB01092,Ouabain,0.7388288974761963,82,Type_82,Paricalcitol may increase the arrhythmogenic activities of Ouabain.,82,Type_82,Yes
DB00564,Carbamazepine,DB00772,Malathion,0.9365754127502441,4,Type_4,The metabolism of Malathion can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01624,Zuclopenthixol,DB09345,Pramocaine,0.9999873638153076,49,Type_49,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pramocaine.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB09027,Ledipasvir,0.9349115490913391,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Ciprofloxacin.,73,Type_73,Yes
DB01104,Sertraline,DB01228,Encainide,0.9987074136734009,47,Type_47,The metabolism of Encainide can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00575,Clonidine,DB01161,Chloroprocaine,0.9998136162757874,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Chloroprocaine.,49,Type_49,Yes
DB00908,Quinidine,DB06589,Pazopanib,0.436591237783432,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00273,Topiramate,DB01224,Quetiapine,0.9629029035568237,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Quetiapine.,49,Type_49,Yes
DB09054,Idelalisib,DB11921,Deflazacort,0.9346067905426025,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Idelalisib.,47,Type_47,Yes
DB08877,Ruxolitinib,DB09048,Netupitant,0.952014148235321,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Ruxolitinib.,73,Type_73,Yes
DB01060,Amoxicillin,DB01578,Metrizamide,0.997080385684967,75,Type_75,The serum concentration of Metrizamide can be decreased when it is combined with Amoxicillin.,75,Type_75,Yes
DB00673,Aprepitant,DB01159,Halothane,0.7685929536819458,73,Type_73,The serum concentration of Halothane can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00675,Tamoxifen,DB01198,Zopiclone,0.8073222637176514,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB00697,Tizanidine,DB00750,Prilocaine,0.996832549571991,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Prilocaine.,49,Type_49,Yes
DB00427,Triprolidine,DB00477,Chlorpromazine,0.9440169334411621,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Chlorpromazine.,49,Type_49,Yes
DB06290,Simeprevir,DB08931,Riociguat,0.7458066940307617,73,Type_73,The serum concentration of Riociguat can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00240,Alclometasone,DB00794,Primidone,0.7728277444839478,4,Type_4,The metabolism of Primidone can be increased when combined with Alclometasone.,4,Type_4,Yes
DB00498,Phenindione,DB01174,Phenobarbital,0.9846019744873047,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Phenindione.,4,Type_4,Yes
DB06605,Apixaban,DB08933,Luliconazole,0.49598434567451477,77,Type_77,The serum concentration of the active metabolites of Luliconazole can be increased when Luliconazole is used in combination with Apixaban.,73,Type_73,No
DB00294,Etonogestrel,DB00755,Tretinoin,0.7156192064285278,70,Type_70,The therapeutic efficacy of Tretinoin can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB06210,Eltrombopag,DB06605,Apixaban,0.44073018431663513,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Eltrombopag.,73,Type_73,No
DB00661,Verapamil,DB01156,Bupropion,0.9748972654342651,47,Type_47,The metabolism of Bupropion can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00451,Levothyroxine,DB01211,Clarithromycin,0.9066175818443298,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Levothyroxine.,47,Type_47,Yes
DB01151,Desipramine,DB06616,Bosutinib,0.7951505780220032,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00300,Tenofovir disoproxil,DB08880,Teriflunomide,0.5409464240074158,57,Type_57,Tenofovir disoproxil may increase the nephrotoxic activities of Teriflunomide.,49,Type_49,No
DB06800,Methylnaltrexone,DB09272,Eluxadoline,0.8627874255180359,73,Type_73,The serum concentration of Eluxadoline can be increased when it is combined with Methylnaltrexone.,49,Type_49,No
DB00224,Indinavir,DB00983,Formoterol,0.889882504940033,47,Type_47,The metabolism of Formoterol can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00705,Delavirdine,DB00749,Etodolac,0.9103947877883911,47,Type_47,The metabolism of Etodolac can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00176,Fluvoxamine,DB08987,Etidocaine,0.9999489784240723,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Etidocaine.,49,Type_49,Yes
DB00612,Bisoprolol,DB00795,Sulfasalazine,0.9995096921920776,37,Type_37,Bisoprolol may decrease the antihypertensive activities of Sulfasalazine.,37,Type_37,Yes
DB00831,Trifluoperazine,DB01320,Fosphenytoin,0.6770009398460388,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fosphenytoin.,49,Type_49,Yes
DB00586,Diclofenac,DB01009,Ketoprofen,0.9862982034683228,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Ketoprofen.,49,Type_49,Yes
DB01259,Lapatinib,DB09073,Palbociclib,0.9985756874084473,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Lapatinib.,73,Type_73,Yes
DB01685,Topiroxostat,DB05109,Trabectedin,0.9823141098022461,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00972,Azelastine,DB01177,Idarubicin,0.8730827569961548,72,Type_72,Azelastine may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB01016,Glyburide,DB08808,Bupranolol,0.7559723854064941,9,Type_9,Glyburide may increase the hypoglycemic activities of Bupranolol.,9,Type_9,Yes
DB00193,Tramadol,DB00572,Atropine,0.9977446794509888,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Atropine.,49,Type_49,Yes
DB00741,Hydrocortisone,DB06695,Dabigatran etexilate,0.5721989274024963,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Hydrocortisone.,77,Type_77,Yes
DB00575,Clonidine,DB04839,Cyproterone acetate,0.503882884979248,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Clonidine.,75,Type_75,No
DB00289,Atomoxetine,DB00822,Disulfiram,0.9108384251594543,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00695,Furosemide,DB00849,Methylphenobarbital,0.6856721639633179,60,Type_60,Furosemide may increase the hypotensive activities of Methylphenobarbital.,60,Type_60,Yes
DB00862,Vardenafil,DB01359,Penbutolol,0.9016912579536438,10,Type_10,Vardenafil may increase the antihypertensive activities of Penbutolol.,10,Type_10,Yes
DB00764,Mometasone,DB02709,Resveratrol,0.9994847774505615,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Resveratrol.,49,Type_49,Yes
DB00592,Piperazine,DB01075,Diphenhydramine,0.6135441064834595,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Piperazine.,47,Type_47,Yes
DB00854,Levorphanol,DB06201,Rufinamide,0.9997277855873108,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Rufinamide.,49,Type_49,Yes
DB00608,Chloroquine,DB01380,Cortisone acetate,0.5816801190376282,47,Type_47,The metabolism of Cortisone acetate can be decreased when combined with Chloroquine.,49,Type_49,No
DB00014,Goserelin,DB08882,Linagliptin,0.9988405108451843,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Goserelin.,70,Type_70,Yes
DB01041,Thalidomide,DB01356,Lithium cation,0.6094438433647156,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Lithium cation.,16,Type_16,Yes
DB00673,Aprepitant,DB08828,Vismodegib,0.9745215177536011,73,Type_73,The serum concentration of Vismodegib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00325,Nitroprusside,DB00805,Minaprine,0.98372882604599,60,Type_60,Nitroprusside may increase the hypotensive activities of Minaprine.,60,Type_60,Yes
DB00412,Rosiglitazone,DB06412,Oxymetholone,0.9994760155677795,9,Type_9,Rosiglitazone may increase the hypoglycemic activities of Oxymetholone.,9,Type_9,Yes
DB01143,Amifostine,DB09112,Nitrous acid,0.9999983310699463,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Nitrous acid.,49,Type_49,Yes
DB00246,Ziprasidone,DB00481,Raloxifene,0.9692334532737732,47,Type_47,The metabolism of Raloxifene can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00420,Promazine,DB00433,Prochlorperazine,0.6714020371437073,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Prochlorperazine.,47,Type_47,No
DB00297,Bupivacaine,DB00904,Ondansetron,0.9586204886436462,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Ondansetron.,49,Type_49,Yes
DB00686,Pentosan polysulfate,DB09075,Edoxaban,0.988006055355072,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB00673,Aprepitant,DB00842,Oxazepam,0.9149057269096375,73,Type_73,The serum concentration of Oxazepam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00501,Cimetidine,DB09048,Netupitant,0.9285484552383423,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Cimetidine.,47,Type_47,No
DB00333,Methadone,DB01151,Desipramine,0.4610776901245117,47,Type_47,The metabolism of Desipramine can be decreased when combined with Methadone.,49,Type_49,No
DB01229,Paclitaxel,DB09074,Olaparib,0.5945479869842529,47,Type_47,The metabolism of Olaparib can be decreased when combined with Paclitaxel.,49,Type_49,No
DB00980,Ramelteon,DB01351,Amobarbital,0.9645166993141174,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Amobarbital.,49,Type_49,Yes
DB01176,Cyclizine,DB01320,Fosphenytoin,0.9505808353424072,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Fosphenytoin.,49,Type_49,Yes
DB00734,Risperidone,DB00918,Almotriptan,0.8468617796897888,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Almotriptan.,49,Type_49,Yes
DB00564,Carbamazepine,DB08875,Cabozantinib,0.7700698971748352,4,Type_4,The metabolism of Cabozantinib can be increased when combined with Carbamazepine.,75,Type_75,No
DB00908,Quinidine,DB09183,Dasabuvir,0.907736599445343,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Quinidine.,73,Type_73,No
DB00615,Rifabutin,DB01175,Escitalopram,0.8667539954185486,4,Type_4,The metabolism of Escitalopram can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00298,Dapiprazole,DB08881,Vemurafenib,0.8983176350593567,33,Type_33,The risk or severity of QTc prolongation can be increased when Dapiprazole is combined with Vemurafenib.,33,Type_33,Yes
DB00788,Naproxen,DB01395,Drospirenone,0.9909077882766724,68,Type_68,Naproxen may increase the hyperkalemic activities of Drospirenone.,68,Type_68,Yes
DB00462,Methscopolamine bromide,DB06148,Mianserin,0.9671328663825989,2,Type_2,Methscopolamine bromide may increase the anticholinergic activities of Mianserin.,2,Type_2,Yes
DB00176,Fluvoxamine,DB05246,Methsuximide,0.9451261758804321,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Methsuximide.,47,Type_47,No
DB06736,Aceclofenac,DB08816,Ticagrelor,0.8450838327407837,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Aceclofenac.,47,Type_47,Yes
DB00555,Lamotrigine,DB09071,Tasimelteon,0.9996819496154785,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Tasimelteon.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB01222,Budesonide,0.9989902377128601,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Budesonide.,49,Type_49,Yes
DB00392,Profenamine,DB01337,Pancuronium,0.9993471503257751,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Pancuronium.,49,Type_49,Yes
DB01182,Propafenone,DB09075,Edoxaban,0.9926889538764954,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Propafenone.,73,Type_73,Yes
DB00801,Halazepam,DB01433,Methadyl acetate,0.9988963603973389,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Methadyl acetate.,49,Type_49,Yes
DB00490,Buspirone,DB08943,Isoconazole,0.6550133228302002,47,Type_47,The metabolism of Isoconazole can be decreased when combined with Buspirone.,47,Type_47,Yes
DB00876,Eprosartan,DB01367,Rasagiline,0.9745083451271057,60,Type_60,Eprosartan may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00315,Zolmitriptan,DB00409,Remoxipride,0.9983991980552673,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remoxipride.,49,Type_49,Yes
DB06287,Temsirolimus,DB08916,Afatinib,0.5863751769065857,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Temsirolimus.,73,Type_73,Yes
DB00999,Hydrochlorothiazide,DB02187,Equilin,0.9997370839118958,83,Type_83,Hydrochlorothiazide may increase the hypokalemic activities of Equilin.,83,Type_83,Yes
DB00350,Minoxidil,DB09279,Fimasartan,0.9998148083686829,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Fimasartan.,49,Type_49,Yes
DB00425,Zolpidem,DB09068,Vortioxetine,0.8804709911346436,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,16,Type_16,Yes
DB09000,Cyamemazine,DB09042,Tedizolid phosphate,0.9716055393218994,49,Type_49,The risk or severity of adverse effects can be increased when Cyamemazine is combined with Tedizolid phosphate.,49,Type_49,Yes
DB00408,Loxapine,DB00726,Trimipramine,0.9865877032279968,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Trimipramine.,49,Type_49,Yes
DB00655,Estrone,DB01101,Capecitabine,0.9011175632476807,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Estrone.,47,Type_47,Yes
DB00880,Chlorothiazide,DB01054,Nitrendipine,0.8115310072898865,60,Type_60,Chlorothiazide may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB00498,Phenindione,DB03585,Oxyphenbutazone,0.9998362064361572,6,Type_6,Phenindione may increase the anticoagulant activities of Oxyphenbutazone.,6,Type_6,Yes
DB00831,Trifluoperazine,DB09330,Osimertinib,0.9221231937408447,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Trifluoperazine.,75,Type_75,No
DB00391,Sulpiride,DB01235,Levodopa,0.9874330163002014,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Levodopa.,70,Type_70,No
DB00780,Phenelzine,DB01174,Phenobarbital,0.9534006118774414,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Phenobarbital.,60,Type_60,No
DB00624,Testosterone,DB09198,Lobeglitazone,0.9988611936569214,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00985,Dimenhydrinate,DB09068,Vortioxetine,0.999808132648468,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Vortioxetine.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01192,Oxymorphone,0.9980272650718689,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Oxymorphone.,49,Type_49,Yes
DB01045,Rifampicin,DB01173,Orphenadrine,0.9642360806465149,4,Type_4,The metabolism of Orphenadrine can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00584,Enalapril,DB06237,Avanafil,0.9830471873283386,10,Type_10,Enalapril may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00648,Mitotane,DB01466,Ethylmorphine,0.93265700340271,75,Type_75,The serum concentration of Ethylmorphine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00543,Amoxapine,DB01161,Chloroprocaine,0.9981131553649902,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Chloroprocaine.,49,Type_49,Yes
DB00582,Voriconazole,DB06414,Etravirine,0.6052306890487671,47,Type_47,The metabolism of Etravirine can be decreased when combined with Voriconazole.,75,Type_75,No
DB00524,Metolazone,DB09292,Sacubitril,0.999552309513092,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Sacubitril.,49,Type_49,Yes
DB01348,Spirapril,DB09235,Efonidipine,0.9860515594482422,60,Type_60,Spirapril may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00572,Atropine,DB00979,Cyclopentolate,0.9239190220832825,49,Type_49,The risk or severity of adverse effects can be increased when Atropine is combined with Cyclopentolate.,49,Type_49,Yes
DB00508,Triflupromazine,DB01563,Chloral hydrate,0.9999414682388306,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Chloral hydrate.,49,Type_49,Yes
DB06699,Degarelix,DB09039,Eliglustat,0.9423159956932068,20,Type_20,Degarelix may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00611,Butorphanol,DB00752,Tranylcypromine,0.9258062243461609,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Tranylcypromine.,49,Type_49,Yes
DB00641,Simvastatin,DB00691,Moexipril,0.8166791200637817,73,Type_73,The serum concentration of Moexipril can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB01367,Rasagiline,DB08822,Azilsartan medoxomil,0.9895961880683899,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00238,Nevirapine,DB09030,Vorapaxar,0.5112236738204956,73,Type_73,The serum concentration of Vorapaxar can be increased when it is combined with Nevirapine.,75,Type_75,No
DB00257,Clotrimazole,DB06697,Artemether,0.5479695200920105,47,Type_47,The metabolism of Artemether can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00409,Remoxipride,DB00425,Zolpidem,0.9965662956237793,16,Type_16,Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB00273,Topiramate,DB00752,Tranylcypromine,0.6804502606391907,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Topiramate.,49,Type_49,No
DB00208,Ticlopidine,DB06725,Lornoxicam,0.9623948335647583,47,Type_47,The metabolism of Lornoxicam can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01133,Tiludronic acid,DB06725,Lornoxicam,0.9970667958259583,49,Type_49,The risk or severity of adverse effects can be increased when Tiludronic acid is combined with Lornoxicam.,49,Type_49,Yes
DB00318,Codeine,DB06770,Benzyl alcohol,0.9931286573410034,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Benzyl alcohol.,49,Type_49,Yes
DB01032,Probenecid,DB01166,Cilostazol,0.8928883075714111,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00420,Promazine,DB00484,Brimonidine,0.986920952796936,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,16,Type_16,Yes
DB05219,Crisaborole,DB12026,Voxilaprevir,0.9844813346862793,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Crisaborole.,47,Type_47,Yes
DB00238,Nevirapine,DB08905,Formestane,0.758564829826355,75,Type_75,The serum concentration of Formestane can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00196,Fluconazole,DB01241,Gemfibrozil,0.9356708526611328,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01325,Quinethazone,DB08439,Parecoxib,0.9512099027633667,70,Type_70,The therapeutic efficacy of Parecoxib can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB00180,Flunisolide,DB06636,Isavuconazonium,0.9274115562438965,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Flunisolide.,47,Type_47,Yes
DB00808,Indapamide,DB01174,Phenobarbital,0.7912930250167847,60,Type_60,Indapamide may increase the hypotensive activities of Phenobarbital.,4,Type_4,No
DB00307,Bexarotene,DB00705,Delavirdine,0.7431966662406921,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00938,Salmeterol,DB02703,Fusidic acid,0.9993698000907898,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Salmeterol.,73,Type_73,Yes
DB00243,Ranolazine,DB09297,Paritaprevir,0.816480278968811,47,Type_47,The metabolism of Paritaprevir can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB01409,Tiotropium,DB06717,Fosaprepitant,0.5658240914344788,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Tiotropium.,73,Type_73,No
DB00321,Amitriptyline,DB00359,Sulfadiazine,0.8563818335533142,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00257,Clotrimazole,DB04855,Dronedarone,0.6356267333030701,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00175,Pravastatin,DB06723,Aluminum hydroxide,0.9416608810424805,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Pravastatin.,75,Type_75,Yes
DB01238,Aripiprazole,DB09054,Idelalisib,0.796904444694519,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Aripiprazole.,73,Type_73,Yes
DB00611,Butorphanol,DB01621,Pipotiazine,0.9971790313720703,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Pipotiazine.,49,Type_49,Yes
DB01081,Diphenoxylate,DB09235,Efonidipine,0.9819886684417725,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Efonidipine.,49,Type_49,Yes
DB00373,Timolol,DB00374,Treprostinil,0.997672975063324,60,Type_60,Timolol may increase the hypotensive activities of Treprostinil.,60,Type_60,Yes
DB00312,Pentobarbital,DB01236,Sevoflurane,0.9036110639572144,4,Type_4,The metabolism of Sevoflurane can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00182,Amphetamine,DB00608,Chloroquine,0.9441785216331482,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB09112,Nitrous acid,DB09204,Arotinolol,0.9565396904945374,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous acid is combined with Arotinolol.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB09027,Ledipasvir,0.8897776007652283,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB00765,Metyrosine,DB09477,Enalaprilat,0.9980002045631409,60,Type_60,Metyrosine may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB02187,Equilin,DB11079,Trolamine salicylate,0.9958434700965881,49,Type_49,The risk or severity of adverse effects can be increased when Equilin is combined with Trolamine salicylate.,49,Type_49,Yes
DB01008,Busulfan,DB04868,Nilotinib,0.8102895021438599,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Busulfan.,47,Type_47,Yes
DB00381,Amlodipine,DB00936,Salicylic acid,0.6900022029876709,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Salicylic acid.,49,Type_49,Yes
DB04842,Fluspirilene,DB11304,Phenoxyethanol,0.9999874830245972,49,Type_49,The risk or severity of adverse effects can be increased when Fluspirilene is combined with Phenoxyethanol.,49,Type_49,Yes
DB00240,Alclometasone,DB01264,Darunavir,0.7248844504356384,47,Type_47,The metabolism of Darunavir can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB01202,Levetiracetam,DB09225,Zotepine,0.998715877532959,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Zotepine.,49,Type_49,Yes
DB00946,Phenprocoumon,DB12598,Nafamostat,0.9992122650146484,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB00531,Cyclophosphamide,DB11231,Lycopene,0.9999204874038696,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Lycopene.,15,Type_15,Yes
DB00817,Rosoxacin,DB00821,Carprofen,0.9820607900619507,27,Type_27,Rosoxacin may increase the neuroexcitatory activities of Carprofen.,27,Type_27,Yes
DB00027,Gramicidin D,DB00243,Ranolazine,0.9616552591323853,73,Type_73,The serum concentration of Ranolazine can be increased when it is combined with Gramicidin D.,73,Type_73,Yes
DB01222,Budesonide,DB06636,Isavuconazonium,0.8156319260597229,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Budesonide.,73,Type_73,No
DB01590,Everolimus,DB12001,Abemaciclib,0.9495183229446411,73,Type_73,The serum concentration of Abemaciclib can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00687,Fludrocortisone,DB04951,Pirfenidone,0.9996461868286133,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pirfenidone.,49,Type_49,Yes
DB00243,Ranolazine,DB00758,Clopidogrel,0.4624336361885071,11,Type_11,The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Ranolazine resulting in a loss in efficacy.,73,Type_73,No
DB00318,Codeine,DB01219,Dantrolene,0.994343638420105,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Dantrolene.,49,Type_49,Yes
DB00275,Olmesartan,DB01116,Trimethaphan,0.9996154308319092,60,Type_60,Olmesartan may increase the hypotensive activities of Trimethaphan.,60,Type_60,Yes
DB00751,Epinastine,DB00884,Risedronic acid,0.5090003609657288,18,Type_18,Epinastine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB00520,Caspofungin,DB09227,Barnidipine,0.9988860487937927,49,Type_49,The risk or severity of adverse effects can be increased when Caspofungin is combined with Barnidipine.,49,Type_49,Yes
DB00937,Diethylpropion,DB00967,Desloratadine,0.9994698166847229,76,Type_76,Diethylpropion may decrease the sedative activities of Desloratadine.,76,Type_76,Yes
DB00228,Enflurane,DB06282,Levocetirizine,0.9989761114120483,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Levocetirizine.,49,Type_49,Yes
DB01403,Methotrimeprazine,DB08918,Levomilnacipran,0.4870721697807312,49,Type_49,The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Levomilnacipran.,47,Type_47,No
DB00503,Ritonavir,DB00661,Verapamil,0.8648889660835266,47,Type_47,The metabolism of Verapamil can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00309,Vindesine,DB08912,Dabrafenib,0.9340114593505859,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Vindesine.,75,Type_75,Yes
DB00327,Hydromorphone,DB00494,Entacapone,0.9988386034965515,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Entacapone.,49,Type_49,Yes
DB00327,Hydromorphone,DB00705,Delavirdine,0.850257396697998,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB00333,Methadone,DB01048,Abacavir,0.6093062162399292,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Abacavir.,70,Type_70,No
DB00281,Lidocaine,DB04844,Tetrabenazine,0.6153362989425659,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Tetrabenazine.,49,Type_49,Yes
DB00494,Entacapone,DB08883,Perampanel,0.995594322681427,16,Type_16,Entacapone may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01177,Idarubicin,DB01338,Pipecuronium,0.9988948702812195,40,Type_40,Idarubicin may increase the respiratory depressant activities of Pipecuronium.,40,Type_40,Yes
DB00182,Amphetamine,DB00796,Candesartan cilexetil,0.7897161245346069,60,Type_60,Amphetamine may increase the hypotensive activities of Candesartan cilexetil.,60,Type_60,Yes
DB01156,Bupropion,DB06016,Cariprazine,0.912109911441803,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Bupropion.,47,Type_47,Yes
DB00802,Alfentanil,DB02703,Fusidic acid,0.9981359243392944,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Alfentanil.,73,Type_73,Yes
DB00349,Clobazam,DB01175,Escitalopram,0.9254270792007446,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00240,Alclometasone,DB01149,Nefazodone,0.8157742023468018,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB00434,Cyproheptadine,DB00842,Oxazepam,0.9967066645622253,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Oxazepam.,49,Type_49,Yes
DB00860,Prednisolone,DB09212,Loxoprofen,0.9997538924217224,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Loxoprofen.,49,Type_49,Yes
DB00246,Ziprasidone,DB01558,Bromazepam,0.6575766205787659,47,Type_47,The metabolism of Bromazepam can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00872,Conivaptan,DB01072,Atazanavir,0.9132696390151978,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB01018,Guanfacine,DB09128,Brexpiprazole,0.9564486145973206,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Brexpiprazole.,49,Type_49,Yes
DB00936,Salicylic acid,DB01050,Ibuprofen,0.8724945783615112,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ibuprofen.,49,Type_49,Yes
DB04846,Celiprolol,DB09245,Toloxatone,0.9888933300971985,60,Type_60,Celiprolol may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00844,Nalbuphine,DB01161,Chloroprocaine,0.9987289309501648,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chloroprocaine.,49,Type_49,Yes
DB08887,Icosapent ethyl,DB11362,Selexipag,0.8821644186973572,6,Type_6,Icosapent ethyl may increase the anticoagulant activities of Selexipag.,6,Type_6,Yes
DB00605,Sulindac,DB00688,Mycophenolate mofetil,0.9955050945281982,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00415,Ampicillin,DB00684,Tobramycin,0.9848987460136414,75,Type_75,The serum concentration of Tobramycin can be decreased when it is combined with Ampicillin.,75,Type_75,Yes
DB00472,Fluoxetine,DB00835,Brompheniramine,0.8259011507034302,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00501,Cimetidine,DB09256,Tegafur,0.6144221425056458,47,Type_47,The metabolism of Tegafur can be decreased when combined with Cimetidine.,77,Type_77,No
DB04272,Citric acid,DB08994,Ditazole,0.9993284940719604,6,Type_6,Citric acid may increase the anticoagulant activities of Ditazole.,6,Type_6,Yes
DB01202,Levetiracetam,DB06148,Mianserin,0.8093131184577942,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Mianserin.,70,Type_70,No
DB00284,Acarbose,DB01264,Darunavir,0.8641186356544495,70,Type_70,The therapeutic efficacy of Darunavir can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB01167,Itraconazole,DB06218,Lacosamide,0.8997970223426819,73,Type_73,The serum concentration of Lacosamide can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00547,Desoximetasone,DB01377,Magnesium oxide,0.99692302942276,3,Type_3,The bioavailability of Magnesium oxide can be decreased when combined with Desoximetasone.,3,Type_3,Yes
DB00243,Ranolazine,DB05676,Apremilast,0.6156960725784302,47,Type_47,The metabolism of Apremilast can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00524,Metolazone,DB01234,Dexamethasone,0.9998356103897095,83,Type_83,Metolazone may increase the hypokalemic activities of Dexamethasone.,83,Type_83,Yes
DB00955,Netilmicin,DB01199,Tubocurarine,0.9993541836738586,40,Type_40,Netilmicin may increase the respiratory depressant activities of Tubocurarine.,40,Type_40,Yes
DB08880,Teriflunomide,DB08905,Formestane,0.9941750168800354,49,Type_49,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Formestane.,49,Type_49,Yes
DB01221,Ketamine,DB09342,Propoxycaine,0.9999221563339233,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Propoxycaine.,49,Type_49,Yes
DB00427,Triprolidine,DB01356,Lithium cation,0.586863100528717,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Lithium cation.,49,Type_49,Yes
DB00337,Pimecrolimus,DB09288,Propacetamol,0.9978283047676086,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Propacetamol.,49,Type_49,Yes
DB06196,Icatibant,DB08981,Fenbufen,0.9992328882217407,49,Type_49,The risk or severity of adverse effects can be increased when Icatibant is combined with Fenbufen.,49,Type_49,Yes
DB00863,Ranitidine,DB06698,Betahistine,0.8353832960128784,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Ranitidine.,70,Type_70,Yes
DB00239,Oxiconazole,DB09232,Cilnidipine,0.9910928606987,49,Type_49,The risk or severity of adverse effects can be increased when Oxiconazole is combined with Cilnidipine.,49,Type_49,Yes
DB00494,Entacapone,DB01114,Chlorpheniramine,0.9971204996109009,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Chlorpheniramine.,49,Type_49,Yes
DB00470,Dronabinol,DB09330,Osimertinib,0.96306973695755,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00188,Bortezomib,DB00263,Sulfisoxazole,0.7630765438079834,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00544,Fluorouracil,DB01124,Tolbutamide,0.8100134134292603,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00950,Fexofenadine,DB08938,Magaldrate,0.8689699172973633,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Fexofenadine.,75,Type_75,Yes
DB00732,Atracurium besylate,DB04574,Estrone sulfate,0.784031867980957,73,Type_73,The serum concentration of Estrone sulfate can be increased when it is combined with Atracurium besylate.,22,Type_22,No
DB00623,Fluphenazine,DB00664,Sulfametopyrazine,0.6828784942626953,73,Type_73,The serum concentration of Sulfametopyrazine can be increased when it is combined with Fluphenazine.,73,Type_73,Yes
DB01120,Gliclazide,DB01324,Polythiazide,0.9892268180847168,70,Type_70,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Gliclazide.,70,Type_70,Yes
DB00215,Citalopram,DB00598,Labetalol,0.48433351516723633,73,Type_73,The serum concentration of Labetalol can be increased when it is combined with Citalopram.,47,Type_47,No
DB01208,Sparfloxacin,DB01397,Magnesium salicylate,0.43401485681533813,49,Type_49,The risk or severity of adverse effects can be increased when Sparfloxacin is combined with Magnesium salicylate.,75,Type_75,No
DB00850,Perphenazine,DB11304,Phenoxyethanol,0.9999725818634033,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Phenoxyethanol.,49,Type_49,Yes
DB00461,Nabumetone,DB08905,Formestane,0.9995354413986206,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Formestane.,49,Type_49,Yes
DB00490,Buspirone,DB00950,Fexofenadine,0.9828038215637207,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Fexofenadine.,49,Type_49,Yes
DB00334,Olanzapine,DB00366,Doxylamine,0.9999998807907104,16,Type_16,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00615,Rifabutin,DB05239,Cobimetinib,0.8791707754135132,75,Type_75,The serum concentration of Cobimetinib can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00264,Metoprolol,DB09235,Efonidipine,0.5029802918434143,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Efonidipine.,60,Type_60,No
DB00320,Dihydroergotamine,DB01110,Miconazole,0.5070517659187317,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Miconazole.,47,Type_47,No
DB00502,Haloperidol,DB00568,Cinnarizine,0.824680745601654,47,Type_47,The metabolism of Cinnarizine can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00361,Vinorelbine,DB08864,Rilpivirine,0.9219644665718079,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB00182,Amphetamine,DB00956,Hydrocodone,0.9299479126930237,69,Type_69,Amphetamine may increase the analgesic activities of Hydrocodone.,49,Type_49,No
DB00752,Tranylcypromine,DB06209,Prasugrel,0.9195809960365295,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Tranylcypromine.,47,Type_47,Yes
DB00398,Sorafenib,DB00738,Pentamidine,0.3587149381637573,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00490,Buspirone,DB01161,Chloroprocaine,0.9999862909317017,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Chloroprocaine.,49,Type_49,Yes
DB00467,Enoxacin,DB01410,Ciclesonide,0.8942818641662598,49,Type_49,The risk or severity of adverse effects can be increased when Enoxacin is combined with Ciclesonide.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB00985,Dimenhydrinate,0.9987799525260925,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Dimenhydrinate.,49,Type_49,Yes
DB00494,Entacapone,DB06690,Nitrous oxide,0.9999692440032959,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Nitrous oxide.,49,Type_49,Yes
DB00775,Tirofiban,DB01418,Acenocoumarol,0.9997183680534363,6,Type_6,Tirofiban may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00872,Conivaptan,DB09074,Olaparib,0.8795614242553711,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00244,Mesalazine,DB13158,Clobetasone,0.9949213862419128,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Clobetasone.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00949,Felbamate,0.7031652927398682,47,Type_47,The metabolism of Felbamate can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB00829,Diazepam,0.9982061386108398,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Diazepam.,49,Type_49,Yes
DB00908,Quinidine,DB01576,Dextroamphetamine,0.5151254534721375,76,Type_76,Quinidine may decrease the sedative activities of Dextroamphetamine.,47,Type_47,No
DB00468,Quinine,DB08932,Macitentan,0.6810950636863708,60,Type_60,Quinine may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00496,Darifenacin,DB01319,Fosamprenavir,0.8927708864212036,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00688,Mycophenolate mofetil,DB00846,Flurandrenolide,0.9997926354408264,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Flurandrenolide.,49,Type_49,Yes
DB00571,Propranolol,DB01151,Desipramine,0.729746401309967,47,Type_47,The metabolism of Desipramine can be decreased when combined with Propranolol.,47,Type_47,Yes
DB00166,Lipoic acid,DB01397,Magnesium salicylate,0.9941805601119995,70,Type_70,The therapeutic efficacy of Magnesium salicylate can be decreased when used in combination with Lipoic acid.,67,Type_67,No
DB00449,Dipivefrin,DB00960,Pindolol,0.9971676468849182,25,Type_25,Dipivefrin may increase the atrioventricular blocking (AV block) activities of Pindolol.,25,Type_25,Yes
DB00277,Theophylline,DB00673,Aprepitant,0.7573555707931519,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Theophylline.,73,Type_73,Yes
DB01320,Fosphenytoin,DB05676,Apremilast,0.6850452423095703,4,Type_4,The metabolism of Apremilast can be increased when combined with Fosphenytoin.,75,Type_75,No
DB00542,Benazepril,DB00584,Enalapril,0.9437704086303711,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Enalapril.,49,Type_49,Yes
DB00452,Framycetin,DB00630,Alendronic acid,0.9993929862976074,24,Type_24,Framycetin may increase the hypocalcemic activities of Alendronic acid.,24,Type_24,Yes
DB00177,Valsartan,DB00975,Dipyridamole,0.9904788732528687,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Dipyridamole.,49,Type_49,Yes
DB00752,Tranylcypromine,DB04846,Celiprolol,0.8302950859069824,60,Type_60,Tranylcypromine may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB01032,Probenecid,DB08439,Parecoxib,0.8126290440559387,73,Type_73,The serum concentration of Parecoxib can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00440,Trimethoprim,DB01015,Sulfamethoxazole,0.7398344278335571,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00390,Digoxin,DB09102,Daclatasvir,0.7651928663253784,73,Type_73,The serum concentration of Daclatasvir can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB01203,Nadolol,DB01224,Quetiapine,0.5338175296783447,49,Type_49,The risk or severity of adverse effects can be increased when Nadolol is combined with Quetiapine.,49,Type_49,Yes
DB00872,Conivaptan,DB01551,Dihydrocodeine,0.6915280818939209,73,Type_73,The serum concentration of Dihydrocodeine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00521,Carteolol,DB05676,Apremilast,0.986869752407074,37,Type_37,Carteolol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB00904,Ondansetron,DB06717,Fosaprepitant,0.8271342515945435,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Ondansetron.,73,Type_73,Yes
DB00313,Valproic acid,DB06201,Rufinamide,0.9712601900100708,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Rufinamide.,73,Type_73,No
DB00244,Mesalazine,DB01166,Cilostazol,0.31851857900619507,9,Type_9,Mesalazine may increase the hypoglycemic activities of Cilostazol.,49,Type_49,No
DB00489,Sotalol,DB00661,Verapamil,0.5267789363861084,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Verapamil.,49,Type_49,Yes
DB01440,gamma-Hydroxybutyric acid,DB04953,Ezogabine,0.9807525277137756,49,Type_49,The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ezogabine.,49,Type_49,Yes
DB00491,Miglitol,DB09244,Pirlindole,0.9992825388908386,9,Type_9,Miglitol may increase the hypoglycemic activities of Pirlindole.,9,Type_9,Yes
DB00703,Methazolamide,DB09026,Aliskiren,0.8980712890625,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Aliskiren.,49,Type_49,Yes
DB01176,Cyclizine,DB08883,Perampanel,0.9988142251968384,16,Type_16,Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00187,Esmolol,DB00211,Midodrine,0.3117651343345642,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Midodrine.,54,Type_54,No
DB00445,Epirubicin,DB00939,Meclofenamic acid,0.9982914328575134,72,Type_72,Epirubicin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB06414,Etravirine,DB06736,Aceclofenac,0.7910051345825195,47,Type_47,The metabolism of Aceclofenac can be decreased when combined with Etravirine.,47,Type_47,Yes
DB01324,Polythiazide,DB08984,Etofenamate,0.9973015189170837,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Polythiazide.,70,Type_70,Yes
DB00266,Dicoumarol,DB01395,Drospirenone,0.7427029013633728,12,Type_12,Dicoumarol may decrease the anticoagulant activities of Drospirenone.,12,Type_12,Yes
DB00320,Dihydroergotamine,DB01259,Lapatinib,0.9342601895332336,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01149,Nefazodone,DB09342,Propoxycaine,0.9985467791557312,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Propoxycaine.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB01176,Cyclizine,0.9999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Cyclizine.,49,Type_49,Yes
DB00213,Pantoprazole,DB08916,Afatinib,0.5998791456222534,75,Type_75,The serum concentration of Afatinib can be decreased when it is combined with Pantoprazole.,73,Type_73,No
DB00521,Carteolol,DB00674,Galantamine,0.9837943911552429,54,Type_54,Carteolol may increase the bradycardic activities of Galantamine.,54,Type_54,Yes
DB01089,Deserpidine,DB06694,Xylometazoline,0.9999842643737793,60,Type_60,Deserpidine may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB01327,Cefazolin,DB08880,Teriflunomide,0.5980912446975708,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Cefazolin.,73,Type_73,Yes
DB00755,Tretinoin,DB05812,Abiraterone,0.4949549734592438,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Tretinoin.,73,Type_73,No
DB00471,Montelukast,DB00549,Zafirlukast,0.9131413698196411,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Montelukast.,47,Type_47,Yes
DB00298,Dapiprazole,DB01002,Levobupivacaine,0.9901145696640015,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Levobupivacaine.,49,Type_49,Yes
DB06335,Saxagliptin,DB08815,Lurasidone,0.980707049369812,70,Type_70,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Saxagliptin.,70,Type_70,Yes
DB01118,Amiodarone,DB01282,Carbetocin,0.8717415928840637,49,Type_49,The risk or severity of adverse effects can be increased when Amiodarone is combined with Carbetocin.,49,Type_49,Yes
DB00255,Diethylstilbestrol,DB00635,Prednisone,0.7007494568824768,73,Type_73,The serum concentration of Prednisone can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00656,Trazodone,DB01624,Zuclopenthixol,0.831575870513916,20,Type_20,Trazodone may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB00686,Pentosan polysulfate,DB13783,Acemetacin,0.9767147302627563,66,Type_66,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Acemetacin.,66,Type_66,Yes
DB00865,Benzphetamine,DB08807,Bopindolol,0.9947772026062012,25,Type_25,Benzphetamine may increase the atrioventricular blocking (AV block) activities of Bopindolol.,25,Type_25,Yes
DB06287,Temsirolimus,DB06335,Saxagliptin,0.40171462297439575,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Temsirolimus.,49,Type_49,No
DB00520,Caspofungin,DB09027,Ledipasvir,0.9132854342460632,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Caspofungin.,73,Type_73,Yes
DB00179,Masoprocol,DB01088,Iloprost,0.981080949306488,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Masoprocol.,70,Type_70,Yes
DB00278,Argatroban,DB00890,Dienestrol,0.33552905917167664,12,Type_12,Argatroban may decrease the anticoagulant activities of Dienestrol.,75,Type_75,No
DB00248,Cabergoline,DB09225,Zotepine,0.9963194131851196,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Zotepine.,49,Type_49,Yes
DB00934,Maprotiline,DB09042,Tedizolid phosphate,0.8913605809211731,64,Type_64,Maprotiline may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB00289,Atomoxetine,DB00598,Labetalol,0.5062982439994812,47,Type_47,The metabolism of Labetalol can be decreased when combined with Atomoxetine.,71,Type_71,No
DB00240,Alclometasone,DB00712,Flurbiprofen,0.9983516931533813,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Flurbiprofen.,49,Type_49,Yes
DB00370,Mirtazapine,DB00904,Ondansetron,0.718051552772522,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,16,Type_16,Yes
DB00454,Meperidine,DB00588,Fluticasone propionate,0.9764777421951294,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Fluticasone propionate.,49,Type_49,Yes
DB00624,Testosterone,DB01129,Rabeprazole,0.7900306582450867,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Testosterone.,47,Type_47,Yes
DB01201,Rifapentine,DB09090,Pinaverium,0.5792136192321777,75,Type_75,The serum concentration of Pinaverium can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00328,Indomethacin,DB00752,Tranylcypromine,0.9822151064872742,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Indomethacin.,47,Type_47,Yes
DB00808,Indapamide,DB06738,Ketobemidone,0.9868262410163879,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Ketobemidone.,49,Type_49,Yes
DB00458,Imipramine,DB09449,"Sodium phosphate, monobasic",0.603662371635437,49,Type_49,"The risk or severity of adverse effects can be increased when Imipramine is combined with Sodium phosphate, monobasic.",49,Type_49,Yes
DB00685,Trovafloxacin,DB01380,Cortisone acetate,0.9414390325546265,49,Type_49,The risk or severity of adverse effects can be increased when Trovafloxacin is combined with Cortisone acetate.,49,Type_49,Yes
DB00749,Etodolac,DB01101,Capecitabine,0.9658793210983276,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Etodolac.,47,Type_47,Yes
DB00524,Metolazone,DB01600,Tiaprofenic acid,0.9894328713417053,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00191,Phentermine,DB00703,Methazolamide,0.9964689016342163,72,Type_72,Phentermine may decrease the excretion rate of Methazolamide which could result in a higher serum level.,72,Type_72,Yes
DB04946,Iloperidone,DB09009,Articaine,0.9999904632568359,49,Type_49,The risk or severity of adverse effects can be increased when Iloperidone is combined with Articaine.,49,Type_49,Yes
DB00418,Secobarbital,DB00907,Cocaine,0.5183826684951782,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Cocaine.,49,Type_49,Yes
DB00608,Chloroquine,DB01410,Ciclesonide,0.8852460980415344,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Ciclesonide.,49,Type_49,Yes
DB01209,Dezocine,DB06274,Alvimopan,0.999991774559021,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Alvimopan.,49,Type_49,Yes
DB00628,Clorazepic acid,DB01081,Diphenoxylate,0.9988827109336853,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Diphenoxylate.,49,Type_49,Yes
DB00296,Ropivacaine,DB06288,Amisulpride,0.993650496006012,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Amisulpride.,49,Type_49,Yes
DB00347,Trimethadione,DB00678,Losartan,0.9464089274406433,47,Type_47,The metabolism of Losartan can be decreased when combined with Trimethadione.,47,Type_47,Yes
DB06196,Icatibant,DB09075,Edoxaban,0.9842079281806946,6,Type_6,Icatibant may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB00428,Streptozocin,DB09215,Droxicam,0.9974387884140015,72,Type_72,Streptozocin may decrease the excretion rate of Droxicam which could result in a higher serum level.,72,Type_72,Yes
DB01320,Fosphenytoin,DB11581,Venetoclax,0.53592848777771,4,Type_4,The metabolism of Venetoclax can be increased when combined with Fosphenytoin.,4,Type_4,Yes
DB00270,Isradipine,DB09041,Tavaborole,0.9577829837799072,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Tavaborole.,49,Type_49,Yes
DB00268,Ropinirole,DB00425,Zolpidem,0.9811814427375793,32,Type_32,Ropinirole may increase the sedative activities of Zolpidem.,32,Type_32,Yes
DB00487,Pefloxacin,DB00846,Flurandrenolide,0.9376428723335266,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Flurandrenolide.,49,Type_49,Yes
DB00203,Sildenafil,DB00797,Tolazoline,0.9190416932106018,10,Type_10,Sildenafil may increase the antihypertensive activities of Tolazoline.,10,Type_10,Yes
DB00956,Hydrocodone,DB01045,Rifampicin,0.8910360336303711,4,Type_4,The metabolism of Rifampicin can be increased when combined with Hydrocodone.,75,Type_75,No
DB00588,Fluticasone propionate,DB01435,Antipyrine,0.9972611665725708,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Antipyrine.,49,Type_49,Yes
DB01325,Quinethazone,DB06335,Saxagliptin,0.6646533608436584,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB01044,Gatifloxacin,DB01396,Digitoxin,0.9913088083267212,58,Type_58,Gatifloxacin may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00283,Clemastine,DB08896,Regorafenib,0.7218802571296692,47,Type_47,The metabolism of Regorafenib can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB01236,Sevoflurane,0.699465274810791,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00337,Pimecrolimus,DB03585,Oxyphenbutazone,0.9990247488021851,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00599,Thiopental,DB09225,Zotepine,0.9991974234580994,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Zotepine.,49,Type_49,Yes
DB01026,Ketoconazole,DB01233,Metoclopramide,0.5017129778862,47,Type_47,The metabolism of Metoclopramide can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00546,Adinazolam,DB06636,Isavuconazonium,0.9548964500427246,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00206,Reserpine,DB04946,Iloperidone,0.9397663474082947,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Iloperidone.,49,Type_49,Yes
DB00764,Mometasone,DB01122,Ambenonium,0.9995331764221191,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Ambenonium.,49,Type_49,Yes
DB04839,Cyproterone acetate,DB06702,Fesoterodine,0.8886376619338989,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Cyproterone acetate.,77,Type_77,Yes
DB00446,Chloramphenicol,DB00783,Estradiol,0.9028447866439819,47,Type_47,The metabolism of Estradiol can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00591,Fluocinolone acetonide,DB00991,Oxaprozin,0.9996088147163391,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Oxaprozin.,49,Type_49,Yes
DB00238,Nevirapine,DB00688,Mycophenolate mofetil,0.734053909778595,4,Type_4,The metabolism of Mycophenolate mofetil can be increased when combined with Nevirapine.,4,Type_4,Yes
DB01058,Praziquantel,DB08899,Enzalutamide,0.9275116324424744,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Praziquantel.,75,Type_75,Yes
DB00715,Paroxetine,DB01221,Ketamine,0.7072531580924988,47,Type_47,The metabolism of Ketamine can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00553,Methoxsalen,DB00619,Imatinib,0.8977494835853577,47,Type_47,The metabolism of Imatinib can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB01200,Bromocriptine,DB09053,Ibrutinib,0.9435399770736694,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Bromocriptine.,73,Type_73,Yes
DB00652,Pentazocine,DB01588,Prazepam,0.9992497563362122,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Prazepam.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01656,Roflumilast,0.7259821891784668,73,Type_73,The serum concentration of Roflumilast can be increased when it is combined with Fluvoxamine.,77,Type_77,No
DB00418,Secobarbital,DB01356,Lithium cation,0.9363287091255188,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Lithium cation.,49,Type_49,Yes
DB00783,Estradiol,DB13158,Clobetasone,0.9889442920684814,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB01078,Deslanoside,DB05015,Belinostat,0.9996606111526489,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Belinostat.,58,Type_58,Yes
DB00582,Voriconazole,DB01624,Zuclopenthixol,0.3918531537055969,73,Type_73,The serum concentration of Zuclopenthixol can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00997,Doxorubicin,DB06207,Silodosin,0.9889292120933533,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Doxorubicin.,73,Type_73,Yes
DB00318,Codeine,DB00780,Phenelzine,0.8132184743881226,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Phenelzine.,49,Type_49,Yes
DB01356,Lithium cation,DB09345,Pramocaine,0.9998719692230225,49,Type_49,The risk or severity of adverse effects can be increased when Lithium cation is combined with Pramocaine.,49,Type_49,Yes
DB00794,Primidone,DB00910,Paricalcitol,0.9778681993484497,4,Type_4,The metabolism of Paricalcitol can be increased when combined with Primidone.,4,Type_4,Yes
DB00790,Perindopril,DB01119,Diazoxide,0.9947256445884705,60,Type_60,Perindopril may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB01100,Pimozide,DB13323,Trichloroethylene,0.9997398257255554,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Trichloroethylene.,49,Type_49,Yes
DB00252,Phenytoin,DB00765,Metyrosine,0.7869114279747009,32,Type_32,Phenytoin may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00555,Lamotrigine,DB00783,Estradiol,0.5035043954849243,70,Type_70,The therapeutic efficacy of Estradiol can be decreased when used in combination with Lamotrigine.,75,Type_75,No
DB00641,Simvastatin,DB00819,Acetazolamide,0.7783011198043823,73,Type_73,The serum concentration of Acetazolamide can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00907,Cocaine,DB01244,Bepridil,0.4198947250843048,47,Type_47,The metabolism of Bepridil can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00633,Dexmedetomidine,DB09225,Zotepine,0.9973412156105042,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Zotepine.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB01580,Oxprenolol,0.7312899231910706,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Oxprenolol.,49,Type_49,Yes
DB00834,Mifepristone,DB01087,Primaquine,0.8636579513549805,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00292,Etomidate,DB13872,Lormetazepam,0.9988045692443848,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Lormetazepam.,49,Type_49,Yes
DB00720,Clodronic acid,DB09104,Magnesium hydroxide,0.9533299803733826,75,Type_75,The serum concentration of Magnesium hydroxide can be decreased when it is combined with Clodronic acid.,75,Type_75,Yes
DB00624,Testosterone,DB01076,Atorvastatin,0.6621185541152954,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Testosterone.,49,Type_49,No
DB00897,Triazolam,DB01075,Diphenhydramine,0.502833902835846,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Triazolam.,49,Type_49,No
DB00381,Amlodipine,DB01201,Rifapentine,0.9471616148948669,4,Type_4,The metabolism of Rifapentine can be increased when combined with Amlodipine.,4,Type_4,Yes
DB00779,Nalidixic acid,DB01124,Tolbutamide,0.9953069090843201,9,Type_9,Nalidixic acid may increase the hypoglycemic activities of Tolbutamide.,9,Type_9,Yes
DB00672,Chlorpropamide,DB01171,Moclobemide,0.9852132201194763,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Moclobemide.,9,Type_9,Yes
DB00327,Hydromorphone,DB00934,Maprotiline,0.9969043135643005,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Maprotiline.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB04841,Flunarizine,0.9181210994720459,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Flunarizine.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB01132,Pioglitazone,0.9143263697624207,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00208,Ticlopidine,DB00849,Methylphenobarbital,0.9292258024215698,47,Type_47,The metabolism of Methylphenobarbital can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00353,Methylergometrine,DB04946,Iloperidone,0.9514034390449524,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Iloperidone.,49,Type_49,Yes
DB00203,Sildenafil,DB08868,Fingolimod,0.6786458492279053,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00809,Tropicamide,DB00854,Levorphanol,0.9999918937683105,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Levorphanol.,49,Type_49,Yes
DB00264,Metoprolol,DB09477,Enalaprilat,0.6013165712356567,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Enalaprilat.,60,Type_60,No
DB01264,Darunavir,DB06589,Pazopanib,0.800399661064148,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB00839,Tolazamide,DB01367,Rasagiline,0.998771607875824,9,Type_9,Tolazamide may increase the hypoglycemic activities of Rasagiline.,9,Type_9,Yes
DB00827,Cinoxacin,DB08984,Etofenamate,0.9959350824356079,27,Type_27,Cinoxacin may increase the neuroexcitatory activities of Etofenamate.,27,Type_27,Yes
DB06700,Desvenlafaxine,DB09245,Toloxatone,0.9893611073493958,64,Type_64,Desvenlafaxine may increase the serotonergic activities of Toloxatone.,64,Type_64,Yes
DB01355,Hexobarbital,DB09279,Fimasartan,0.6368763446807861,60,Type_60,Hexobarbital may increase the hypotensive activities of Fimasartan.,60,Type_60,Yes
DB00687,Fludrocortisone,DB01185,Fluoxymesterone,1.0,74,Type_74,Fludrocortisone may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB00215,Citalopram,DB00914,Phenformin,0.9856385588645935,9,Type_9,Citalopram may increase the hypoglycemic activities of Phenformin.,47,Type_47,No
DB00472,Fluoxetine,DB00653,Magnesium sulfate,0.5624741315841675,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Magnesium sulfate.,49,Type_49,Yes
DB01115,Nifedipine,DB09074,Olaparib,0.9207788109779358,47,Type_47,The metabolism of Olaparib can be decreased when combined with Nifedipine.,47,Type_47,Yes
DB00764,Mometasone,DB01185,Fluoxymesterone,1.0,74,Type_74,Mometasone may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB01082,Streptomycin,DB09218,Clonixin,0.9999802112579346,72,Type_72,Streptomycin may decrease the excretion rate of Clonixin which could result in a higher serum level.,72,Type_72,Yes
DB00180,Flunisolide,DB01024,Mycophenolic acid,0.9613714218139648,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Mycophenolic acid.,49,Type_49,Yes
DB00207,Azithromycin,DB06717,Fosaprepitant,0.9226572513580322,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00695,Furosemide,DB00876,Eprosartan,0.9568120837211609,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Eprosartan.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01028,Methoxyflurane,0.6946479678153992,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Methoxyflurane.,47,Type_47,No
DB00321,Amitriptyline,DB00972,Azelastine,0.881609320640564,16,Type_16,Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00450,Droperidol,DB00768,Olopatadine,0.6326795220375061,49,Type_49,The risk or severity of adverse effects can be increased when Droperidol is combined with Olopatadine.,16,Type_16,No
DB00343,Diltiazem,DB00390,Digoxin,0.42858272790908813,25,Type_25,Diltiazem may increase the atrioventricular blocking (AV block) activities of Digoxin.,47,Type_47,No
DB00884,Risedronic acid,DB04552,Niflumic acid,0.9614855051040649,49,Type_49,The risk or severity of adverse effects can be increased when Risedronic acid is combined with Niflumic acid.,49,Type_49,Yes
DB00203,Sildenafil,DB01180,Rescinnamine,0.48995113372802734,73,Type_73,The serum concentration of Rescinnamine can be increased when it is combined with Sildenafil.,10,Type_10,No
DB01558,Bromazepam,DB06201,Rufinamide,0.9922010898590088,49,Type_49,The risk or severity of adverse effects can be increased when Bromazepam is combined with Rufinamide.,49,Type_49,Yes
DB06196,Icatibant,DB06802,Nepafenac,0.9989994168281555,49,Type_49,The risk or severity of adverse effects can be increased when Icatibant is combined with Nepafenac.,49,Type_49,Yes
DB00496,Darifenacin,DB01043,Memantine,0.9600345492362976,70,Type_70,The therapeutic efficacy of Memantine can be decreased when used in combination with Darifenacin.,70,Type_70,Yes
DB01324,Polythiazide,DB08970,Fluprednidene,0.999982476234436,83,Type_83,Polythiazide may increase the hypokalemic activities of Fluprednidene.,83,Type_83,Yes
DB00224,Indinavir,DB00636,Clofibrate,0.9531370997428894,47,Type_47,The metabolism of Clofibrate can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00346,Alfuzosin,DB09216,Tolfenamic acid,0.8522082567214966,60,Type_60,Alfuzosin may increase the hypotensive activities of Tolfenamic acid.,60,Type_60,Yes
DB00484,Brimonidine,DB08883,Perampanel,0.9999889135360718,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00700,Eplerenone,DB01236,Sevoflurane,0.9937083721160889,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Sevoflurane.,49,Type_49,Yes
DB00261,Anagrelide,DB00682,Warfarin,0.9849885702133179,6,Type_6,Anagrelide may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB01319,Fosamprenavir,DB09074,Olaparib,0.5854454040527344,47,Type_47,The metabolism of Olaparib can be decreased when combined with Fosamprenavir.,73,Type_73,No
DB00482,Celecoxib,DB00598,Labetalol,0.49911436438560486,47,Type_47,The metabolism of Labetalol can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00489,Sotalol,DB01195,Flecainide,0.70915287733078,20,Type_20,Sotalol may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00320,Dihydroergotamine,DB00570,Vinblastine,0.8225402235984802,47,Type_47,The metabolism of Vinblastine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00252,Phenytoin,DB09123,Dienogest,0.9248408675193787,70,Type_70,The therapeutic efficacy of Dienogest can be decreased when used in combination with Phenytoin.,70,Type_70,Yes
DB00425,Zolpidem,DB00446,Chloramphenicol,0.9593541622161865,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB00404,Alprazolam,DB00645,Dyclonine,0.9999796152114868,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Dyclonine.,49,Type_49,Yes
DB00373,Timolol,DB00991,Oxaprozin,0.9856082201004028,37,Type_37,Timolol may decrease the antihypertensive activities of Oxaprozin.,37,Type_37,Yes
DB00292,Etomidate,DB00599,Thiopental,0.9634057283401489,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Thiopental.,49,Type_49,Yes
DB01628,Etoricoxib,DB09026,Aliskiren,0.6238035559654236,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Aliskiren.,37,Type_37,No
DB00196,Fluconazole,DB00455,Loratadine,0.7728097438812256,47,Type_47,The metabolism of Loratadine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00243,Ranolazine,DB00312,Pentobarbital,0.5959201455116272,4,Type_4,The metabolism of Pentobarbital can be increased when combined with Ranolazine.,4,Type_4,Yes
DB00091,Cyclosporine,DB01393,Bezafibrate,0.937741219997406,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Bezafibrate.,57,Type_57,Yes
DB00629,Guanabenz,DB00925,Phenoxybenzamine,0.7641546130180359,60,Type_60,Guanabenz may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB00747,Scopolamine,DB06204,Tapentadol,0.695904552936554,16,Type_16,Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00196,Fluconazole,DB00906,Tiagabine,0.8747972846031189,47,Type_47,The metabolism of Tiagabine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00477,Chlorpromazine,DB01113,Papaverine,0.9433603286743164,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Papaverine.,49,Type_49,Yes
DB00289,Atomoxetine,DB06654,Safinamide,0.9871723055839539,47,Type_47,The metabolism of Safinamide can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00556,Perflutren,DB06699,Degarelix,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB01452,Diamorphine,DB01624,Zuclopenthixol,0.9923778772354126,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Zuclopenthixol.,49,Type_49,Yes
DB00492,Fosinopril,DB05676,Apremilast,0.9795946478843689,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Apremilast.,49,Type_49,Yes
DB00865,Benzphetamine,DB01072,Atazanavir,0.946750819683075,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Benzphetamine.,47,Type_47,Yes
DB00514,Dextromethorphan,DB13025,Tiapride,0.9857239127159119,49,Type_49,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Tiapride.,49,Type_49,Yes
DB00508,Triflupromazine,DB00608,Chloroquine,0.5231912732124329,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Triflupromazine.,73,Type_73,No
DB00185,Cevimeline,DB00608,Chloroquine,0.9840190410614014,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00601,Linezolid,DB00852,Pseudoephedrine,0.9785588979721069,71,Type_71,Linezolid may increase the hypertensive activities of Pseudoephedrine.,71,Type_71,Yes
DB00282,Pamidronic acid,DB00390,Digoxin,0.9986454844474792,58,Type_58,Pamidronic acid may decrease the cardiotoxic activities of Digoxin.,58,Type_58,Yes
DB00486,Nabilone,DB00697,Tizanidine,0.9992532134056091,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tizanidine.,16,Type_16,Yes
DB00398,Sorafenib,DB04898,Ximelagatran,0.4864218831062317,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Sorafenib.,47,Type_47,No
DB00224,Indinavir,DB12161,Deutetrabenazine,0.905570387840271,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00678,Losartan,DB01394,Colchicine,0.9619200229644775,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Losartan.,73,Type_73,Yes
DB00744,Zileuton,DB00779,Nalidixic acid,0.999159574508667,27,Type_27,Zileuton may increase the neuroexcitatory activities of Nalidixic acid.,27,Type_27,Yes
DB01247,Isocarboxazid,DB01324,Polythiazide,0.8927514553070068,60,Type_60,Isocarboxazid may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB01320,Fosphenytoin,DB09085,Tetracaine,0.995973527431488,49,Type_49,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Tetracaine.,49,Type_49,Yes
DB00966,Telmisartan,DB01171,Moclobemide,0.9005758166313171,60,Type_60,Telmisartan may increase the hypotensive activities of Moclobemide.,60,Type_60,Yes
DB00436,Bendroflumethiazide,DB00881,Quinapril,0.875497043132782,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Quinapril.,49,Type_49,Yes
DB00420,Promazine,DB00710,Ibandronate,0.7881379723548889,20,Type_20,Promazine may increase the QTc-prolonging activities of Ibandronate.,20,Type_20,Yes
DB00657,Mecamylamine,DB09026,Aliskiren,0.7915710806846619,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Aliskiren.,49,Type_49,Yes
DB00421,Spironolactone,DB00887,Bumetanide,0.9998225569725037,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Bumetanide.,49,Type_49,Yes
DB00622,Nicardipine,DB04839,Cyproterone acetate,0.4960002303123474,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Nicardipine.,75,Type_75,No
DB01320,Fosphenytoin,DB01466,Ethylmorphine,0.8466256856918335,4,Type_4,The metabolism of Ethylmorphine can be increased when combined with Fosphenytoin.,4,Type_4,Yes
DB00774,Hydroflumethiazide,DB09286,Pipamperone,0.9948681592941284,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Pipamperone.,49,Type_49,Yes
DB00420,Promazine,DB00539,Toremifene,0.874054491519928,20,Type_20,Promazine may increase the QTc-prolonging activities of Toremifene.,20,Type_20,Yes
DB00608,Chloroquine,DB01184,Domperidone,0.6889563202857971,20,Type_20,Chloroquine may increase the QTc-prolonging activities of Domperidone.,47,Type_47,No
DB00363,Clozapine,DB00642,Pemetrexed,0.9384486675262451,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Pemetrexed.,49,Type_49,Yes
DB00289,Atomoxetine,DB09083,Ivabradine,0.7743670344352722,20,Type_20,Atomoxetine may increase the QTc-prolonging activities of Ivabradine.,73,Type_73,No
DB01075,Diphenhydramine,DB01095,Fluvastatin,0.7396448254585266,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Diphenhydramine.,47,Type_47,Yes
DB00701,Amprenavir,DB00977,Ethinylestradiol,0.6628829836845398,70,Type_70,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Amprenavir.,75,Type_75,No
DB00014,Goserelin,DB08881,Vemurafenib,0.9928540587425232,20,Type_20,Goserelin may increase the QTc-prolonging activities of Vemurafenib.,20,Type_20,Yes
DB00584,Enalapril,DB01253,Ergometrine,0.6103397011756897,73,Type_73,The serum concentration of Ergometrine can be increased when it is combined with Enalapril.,73,Type_73,Yes
DB00563,Methotrexate,DB06802,Nepafenac,0.7833498120307922,73,Type_73,The serum concentration of Nepafenac can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00588,Fluticasone propionate,DB09048,Netupitant,0.9942235350608826,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Fluticasone propionate.,73,Type_73,Yes
DB00582,Voriconazole,DB09291,Rolapitant,0.8582976460456848,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00486,Nabilone,DB04953,Ezogabine,0.9978532195091248,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.,16,Type_16,Yes
DB00850,Perphenazine,DB01103,Quinacrine,0.5643999576568604,47,Type_47,The metabolism of Quinacrine can be decreased when combined with Perphenazine.,73,Type_73,No
DB00908,Quinidine,DB09063,Ceritinib,0.9069167375564575,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00870,Suprofen,DB01384,Paramethasone,0.9993330836296082,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Paramethasone.,49,Type_49,Yes
DB00288,Amcinonide,DB00582,Voriconazole,0.8229594230651855,73,Type_73,The serum concentration of Voriconazole can be increased when it is combined with Amcinonide.,73,Type_73,Yes
DB00310,Chlorthalidone,DB08880,Teriflunomide,0.996207594871521,70,Type_70,The therapeutic efficacy of Teriflunomide can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00540,Nortriptyline,DB01169,Arsenic trioxide,0.8339625000953674,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB01142,Doxepin,DB09009,Articaine,0.9974008798599243,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Articaine.,49,Type_49,Yes
DB00835,Brompheniramine,DB01211,Clarithromycin,0.8191320896148682,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB00238,Nevirapine,DB01253,Ergometrine,0.8665308356285095,4,Type_4,The metabolism of Ergometrine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00705,Delavirdine,DB00834,Mifepristone,0.9238094091415405,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Delavirdine.,73,Type_73,Yes
DB00734,Risperidone,DB00904,Ondansetron,0.6459399461746216,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Ondansetron.,20,Type_20,No
DB00918,Almotriptan,DB04839,Cyproterone acetate,0.6414983868598938,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Almotriptan.,75,Type_75,Yes
DB01098,Rosuvastatin,DB09055,Acipimox,0.994124710559845,48,Type_48,Rosuvastatin may increase the myopathic rhabdomyolysis activities of Acipimox.,48,Type_48,Yes
DB08873,Boceprevir,DB11737,Icotinib,0.8150237798690796,47,Type_47,The metabolism of Icotinib can be decreased when combined with Boceprevir.,47,Type_47,Yes
DB00688,Mycophenolate mofetil,DB01214,Metipranolol,0.9998637437820435,37,Type_37,Mycophenolate mofetil may decrease the antihypertensive activities of Metipranolol.,37,Type_37,Yes
DB01232,Saquinavir,DB12267,Brigatinib,0.890268862247467,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Saquinavir.,75,Type_75,No
DB00748,Carbinoxamine,DB09166,Etizolam,0.994524359703064,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Etizolam.,49,Type_49,Yes
DB01194,Brinzolamide,DB01356,Lithium cation,0.4453910291194916,49,Type_49,The risk or severity of adverse effects can be increased when Brinzolamide is combined with Lithium cation.,75,Type_75,No
DB00651,Dyphylline,DB01595,Nitrazepam,0.9425957202911377,70,Type_70,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Dyphylline.,70,Type_70,Yes
DB00334,Olanzapine,DB06290,Simeprevir,0.9828255772590637,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Olanzapine.,47,Type_47,No
DB00809,Tropicamide,DB01233,Metoclopramide,0.9862686991691589,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Tropicamide.,70,Type_70,Yes
DB00375,Colestipol,DB01418,Acenocoumarol,0.3572511374950409,75,Type_75,The serum concentration of Acenocoumarol can be decreased when it is combined with Colestipol.,67,Type_67,No
DB00866,Alprenolol,DB01408,Bambuterol,0.9932355284690857,14,Type_14,Alprenolol may decrease the bronchodilatory activities of Bambuterol.,14,Type_14,Yes
DB00726,Trimipramine,DB00934,Maprotiline,0.954678475856781,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Maprotiline.,49,Type_49,Yes
DB00661,Verapamil,DB05676,Apremilast,0.6190215349197388,47,Type_47,The metabolism of Apremilast can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00542,Benazepril,DB01154,Thiamylal,0.80581134557724,60,Type_60,Benazepril may increase the hypotensive activities of Thiamylal.,60,Type_60,Yes
DB00230,Pregabalin,DB01239,Chlorprothixene,0.9937928915023804,8,Type_8,The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00889,Granisetron,DB09054,Idelalisib,0.8838319182395935,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Granisetron.,47,Type_47,Yes
DB00501,Cimetidine,DB01218,Halofantrine,0.9059569835662842,47,Type_47,The metabolism of Halofantrine can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB01142,Doxepin,0.6213944554328918,47,Type_47,The metabolism of Doxepin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00804,Dicyclomine,DB01090,Pentolinium,0.9955287575721741,49,Type_49,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Pentolinium.,49,Type_49,Yes
DB00455,Loratadine,DB08820,Ivacaftor,0.9980669617652893,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Loratadine.,73,Type_73,Yes
DB04839,Cyproterone acetate,DB06689,Ethanolamine oleate,0.7769208550453186,75,Type_75,The serum concentration of Ethanolamine oleate can be decreased when it is combined with Cyproterone acetate.,75,Type_75,Yes
DB00943,Zalcitabine,DB06414,Etravirine,0.7032102942466736,47,Type_47,The metabolism of Etravirine can be decreased when combined with Zalcitabine.,47,Type_47,Yes
DB01263,Posaconazole,DB09270,Ubidecarenone,0.9227323532104492,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Posaconazole.,73,Type_73,Yes
DB00708,Sufentanil,DB06594,Agomelatine,0.9996374845504761,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Agomelatine.,49,Type_49,Yes
DB00635,Prednisone,DB00784,Mefenamic acid,0.9927646517753601,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Mefenamic acid.,49,Type_49,Yes
DB00503,Ritonavir,DB06701,Dexmethylphenidate,0.927444577217102,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00635,Prednisone,DB08976,Floctafenine,0.9994134902954102,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Floctafenine.,49,Type_49,Yes
DB01463,Fencamfamin,DB06204,Tapentadol,0.9887083768844604,16,Type_16,Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00295,Morphine,DB00648,Mitotane,0.960296094417572,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Morphine.,75,Type_75,Yes
DB01068,Clonazepam,DB08820,Ivacaftor,0.9945570230484009,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Clonazepam.,73,Type_73,Yes
DB00346,Alfuzosin,DB00489,Sotalol,0.4968074560165405,30,Type_30,Alfuzosin may increase the orthostatic hypotensive activities of Sotalol.,20,Type_20,No
DB00280,Disopyramide,DB00608,Chloroquine,0.7714762091636658,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Chloroquine.,20,Type_20,Yes
DB00989,Rivastigmine,DB09076,Umeclidinium,0.999646782875061,70,Type_70,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Rivastigmine.,70,Type_70,Yes
DB00939,Meclofenamic acid,DB01283,Lumiracoxib,0.9989437460899353,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Lumiracoxib.,49,Type_49,Yes
DB01098,Rosuvastatin,DB08899,Enzalutamide,0.8804675340652466,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Rosuvastatin.,75,Type_75,Yes
DB08910,Pomalidomide,DB08912,Dabrafenib,0.7715741991996765,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Pomalidomide.,75,Type_75,Yes
DB00908,Quinidine,DB00967,Desloratadine,0.9606755375862122,49,Type_49,The risk or severity of adverse effects can be increased when Quinidine is combined with Desloratadine.,49,Type_49,Yes
DB01047,Fluocinonide,DB13783,Acemetacin,0.9681270718574524,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Acemetacin.,49,Type_49,Yes
DB00434,Cyproheptadine,DB01452,Diamorphine,0.9998953342437744,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Diamorphine.,49,Type_49,Yes
DB00255,Diethylstilbestrol,DB01076,Atorvastatin,0.5460959672927856,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Diethylstilbestrol.,49,Type_49,No
DB01236,Sevoflurane,DB01615,Aceprometazine,0.9207618236541748,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Aceprometazine.,49,Type_49,Yes
DB00177,Valsartan,DB01132,Pioglitazone,0.937140703201294,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00454,Meperidine,DB00875,Flupentixol,0.9652430415153503,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Flupentixol.,49,Type_49,Yes
DB01095,Fluvastatin,DB01242,Clomipramine,0.6784955859184265,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB08815,Lurasidone,0.875375509262085,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Lurasidone.,73,Type_73,No
DB01267,Paliperidone,DB08865,Crizotinib,0.8520382642745972,20,Type_20,Paliperidone may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB00503,Ritonavir,DB00843,Donepezil,0.9333738684654236,47,Type_47,The metabolism of Donepezil can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00468,Quinine,DB09296,Ombitasvir,0.9869215488433838,47,Type_47,The metabolism of Ombitasvir can be decreased when combined with Quinine.,47,Type_47,Yes
DB01227,Levacetylmethadol,DB01365,Mephentermine,0.9999756813049316,69,Type_69,Levacetylmethadol may increase the analgesic activities of Mephentermine.,69,Type_69,Yes
DB00275,Olmesartan,DB09026,Aliskiren,0.5594192147254944,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Aliskiren.,68,Type_68,No
DB00207,Azithromycin,DB00511,Acetyldigitoxin,0.7549344301223755,58,Type_58,Azithromycin may decrease the cardiotoxic activities of Acetyldigitoxin.,73,Type_73,No
DB01201,Rifapentine,DB06212,Tolvaptan,0.8875652551651001,75,Type_75,The serum concentration of Tolvaptan can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB01544,Flunitrazepam,DB09286,Pipamperone,0.9964120984077454,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Pipamperone.,49,Type_49,Yes
DB01124,Tolbutamide,DB01203,Nadolol,0.9965992569923401,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Nadolol.,9,Type_9,Yes
DB01222,Budesonide,DB06723,Aluminum hydroxide,0.9991119503974915,3,Type_3,The bioavailability of Aluminum hydroxide can be decreased when combined with Budesonide.,3,Type_3,Yes
DB00188,Bortezomib,DB00910,Paricalcitol,0.5230380296707153,47,Type_47,The metabolism of Paricalcitol can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00221,Isoetharine,DB09289,Tianeptine,0.9213401675224304,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Tianeptine.,49,Type_49,Yes
DB01296,Glucosamine,DB02709,Resveratrol,0.5684723854064941,53,Type_53,Glucosamine may increase the antiplatelet activities of Resveratrol.,53,Type_53,Yes
DB00691,Moexipril,DB06603,Panobinostat,0.6992816925048828,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Moexipril.,20,Type_20,No
DB01260,Desonide,DB09543,Methyl salicylate,0.9958771467208862,49,Type_49,The risk or severity of adverse effects can be increased when Desonide is combined with Methyl salicylate.,49,Type_49,Yes
DB00470,Dronabinol,DB00830,Phenmetrazine,0.9853125214576721,85,Type_85,Dronabinol may increase the tachycardic activities of Phenmetrazine.,85,Type_85,Yes
DB00502,Haloperidol,DB01189,Desflurane,0.822450578212738,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Desflurane.,20,Type_20,No
DB00468,Quinine,DB09242,Moxonidine,0.9116525053977966,60,Type_60,Quinine may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00907,Cocaine,DB01161,Chloroprocaine,0.999913215637207,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Chloroprocaine.,49,Type_49,Yes
DB00312,Pentobarbital,DB11737,Icotinib,0.964884340763092,4,Type_4,The metabolism of Icotinib can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB08881,Vemurafenib,DB09297,Paritaprevir,0.5575186014175415,73,Type_73,The serum concentration of Paritaprevir can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB01208,Sparfloxacin,DB01234,Dexamethasone,0.8946098685264587,49,Type_49,The risk or severity of adverse effects can be increased when Sparfloxacin is combined with Dexamethasone.,49,Type_49,Yes
DB09097,Quinagolide,DB09128,Brexpiprazole,0.9995715022087097,70,Type_70,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Quinagolide.,70,Type_70,Yes
DB00244,Mesalazine,DB00880,Chlorothiazide,0.9942717552185059,70,Type_70,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Mesalazine.,70,Type_70,Yes
DB01433,Methadyl acetate,DB06770,Benzyl alcohol,0.9959553480148315,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Benzyl alcohol.,49,Type_49,Yes
DB00661,Verapamil,DB01128,Bicalutamide,0.9287355542182922,47,Type_47,The metabolism of Bicalutamide can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00206,Reserpine,DB00721,Procaine,0.9990070462226868,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Procaine.,49,Type_49,Yes
DB00835,Brompheniramine,DB01440,gamma-Hydroxybutyric acid,0.999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00539,Toremifene,DB01100,Pimozide,0.7839961051940918,20,Type_20,Toremifene may increase the QTc-prolonging activities of Pimozide.,33,Type_33,No
DB00790,Perindopril,DB08981,Fenbufen,0.9686375856399536,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Fenbufen.,49,Type_49,Yes
DB01239,Chlorprothixene,DB04841,Flunarizine,0.9862787127494812,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Flunarizine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01355,Hexobarbital,0.8784194588661194,30,Type_30,Chlorothiazide may increase the orthostatic hypotensive activities of Hexobarbital.,30,Type_30,Yes
DB00873,Loteprednol,DB09275,Bismuth subcitrate potassium,0.9987956285476685,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Loteprednol.,3,Type_3,Yes
DB00320,Dihydroergotamine,DB00625,Efavirenz,0.8453890681266785,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01229,Paclitaxel,DB13145,Nedaplatin,0.6452261805534363,63,Type_63,Paclitaxel may increase the myelosuppressive activities of Nedaplatin.,63,Type_63,Yes
DB00187,Esmolol,DB06196,Icatibant,0.9845549464225769,37,Type_37,Esmolol may decrease the antihypertensive activities of Icatibant.,37,Type_37,Yes
DB00472,Fluoxetine,DB00665,Nilutamide,0.9003903269767761,47,Type_47,The metabolism of Nilutamide can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00839,Tolazamide,DB08918,Levomilnacipran,0.9017024040222168,9,Type_9,Tolazamide may increase the hypoglycemic activities of Levomilnacipran.,9,Type_9,Yes
DB00476,Duloxetine,DB06594,Agomelatine,0.9817718267440796,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Agomelatine.,49,Type_49,Yes
DB01068,Clonazepam,DB01284,Tetracosactide,0.996702253818512,80,Type_80,Clonazepam may increase the hepatotoxic activities of Tetracosactide.,80,Type_80,Yes
DB06684,Vilazodone,DB11699,Tropisetron,1.0,64,Type_64,Vilazodone may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00827,Cinoxacin,DB08971,Fluocortolone,0.9900155663490295,49,Type_49,The risk or severity of adverse effects can be increased when Cinoxacin is combined with Fluocortolone.,49,Type_49,Yes
DB01197,Captopril,DB09292,Sacubitril,0.9833784699440002,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Sacubitril.,49,Type_49,Yes
DB00564,Carbamazepine,DB01256,Retapamulin,0.9405798316001892,4,Type_4,The metabolism of Retapamulin can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01590,Everolimus,DB05521,Telaprevir,0.914979875087738,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00408,Loxapine,DB01236,Sevoflurane,0.978873610496521,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Sevoflurane.,49,Type_49,Yes
DB01340,Cilazapril,DB09216,Tolfenamic acid,0.8895612359046936,49,Type_49,The risk or severity of adverse effects can be increased when Cilazapril is combined with Tolfenamic acid.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00850,Perphenazine,0.9847249388694763,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Perphenazine.,49,Type_49,Yes
DB00346,Alfuzosin,DB00697,Tizanidine,0.48596829175949097,20,Type_20,Alfuzosin may increase the QTc-prolonging activities of Tizanidine.,5,Type_5,No
DB00860,Prednisolone,DB06737,Zaltoprofen,0.9982646107673645,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Zaltoprofen.,49,Type_49,Yes
DB01173,Orphenadrine,DB06216,Asenapine,0.9728373289108276,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,16,Type_16,Yes
DB00486,Nabilone,DB01113,Papaverine,0.9274464249610901,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Papaverine.,49,Type_49,Yes
DB00227,Lovastatin,DB11362,Selexipag,0.88627690076828,47,Type_47,The metabolism of Selexipag can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01012,Cinacalcet,DB09068,Vortioxetine,0.9527463912963867,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Cinacalcet.,73,Type_73,No
DB00263,Sulfisoxazole,DB06799,Methenamine,0.6590836048126221,73,Type_73,The serum concentration of Methenamine can be increased when it is combined with Sulfisoxazole.,49,Type_49,No
DB00316,Acetaminophen,DB01220,Rifaximin,0.5396853685379028,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Acetaminophen.,73,Type_73,Yes
DB00230,Pregabalin,DB00921,Buprenorphine,0.9292019009590149,16,Type_16,Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB01067,Glipizide,DB01263,Posaconazole,0.7013683915138245,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Glipizide.,9,Type_9,No
DB00250,Dapsone,DB01171,Moclobemide,0.957062840461731,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Dapsone.,47,Type_47,Yes
DB00231,Temazepam,DB06594,Agomelatine,0.9999866485595703,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Agomelatine.,49,Type_49,Yes
DB00477,Chlorpromazine,DB01227,Levacetylmethadol,0.4411328434944153,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Levacetylmethadol.,49,Type_49,Yes
DB00264,Metoprolol,DB01612,Amyl Nitrite,0.9998335838317871,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Amyl Nitrite.,49,Type_49,Yes
DB00270,Isradipine,DB06694,Xylometazoline,0.820102334022522,60,Type_60,Isradipine may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00446,Chloramphenicol,DB01058,Praziquantel,0.9451160430908203,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00423,Methocarbamol,DB11609,Normethadone,0.9997395873069763,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Normethadone.,49,Type_49,Yes
DB01355,Hexobarbital,DB09236,Lacidipine,0.5083925127983093,4,Type_4,The metabolism of Lacidipine can be increased when combined with Hexobarbital.,4,Type_4,Yes
DB00465,Ketorolac,DB00790,Perindopril,0.9263636469841003,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Perindopril.,49,Type_49,Yes
DB00195,Betaxolol,DB00468,Quinine,0.9415061473846436,47,Type_47,The metabolism of Quinine can be decreased when combined with Betaxolol.,60,Type_60,No
DB01023,Felodipine,DB01034,Cerulenin,0.9359704256057739,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Cerulenin.,49,Type_49,Yes
DB00896,Rimexolone,DB09070,Tibolone,0.9500989317893982,73,Type_73,The serum concentration of Tibolone can be increased when it is combined with Rimexolone.,73,Type_73,Yes
DB00211,Midodrine,DB09245,Toloxatone,0.9988505840301514,71,Type_71,Midodrine may increase the hypertensive activities of Toloxatone.,71,Type_71,Yes
DB00285,Venlafaxine,DB01191,Dexfenfluramine,0.9213660955429077,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00246,Ziprasidone,DB00645,Dyclonine,0.9896356463432312,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dyclonine.,49,Type_49,Yes
DB00921,Buprenorphine,DB01437,Glutethimide,0.9996589422225952,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,16,Type_16,Yes
DB06262,Droxidopa,DB06698,Betahistine,0.9999213218688965,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Droxidopa.,70,Type_70,Yes
DB01009,Ketoprofen,DB09204,Arotinolol,0.99996018409729,37,Type_37,Ketoprofen may decrease the antihypertensive activities of Arotinolol.,37,Type_37,Yes
DB00482,Celecoxib,DB01075,Diphenhydramine,0.9958134293556213,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01018,Guanfacine,DB08883,Perampanel,0.780816912651062,16,Type_16,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB05812,Abiraterone,DB08918,Levomilnacipran,0.657143235206604,73,Type_73,The serum concentration of Levomilnacipran can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00554,Piroxicam,DB05676,Apremilast,0.9996477365493774,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Apremilast.,49,Type_49,Yes
DB00270,Isradipine,DB00678,Losartan,0.4875442385673523,47,Type_47,The metabolism of Losartan can be decreased when combined with Isradipine.,49,Type_49,No
DB00849,Methylphenobarbital,DB01545,Ethyl loflazepate,0.7684749364852905,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00238,Nevirapine,DB09570,Ixazomib,0.5735926032066345,4,Type_4,The metabolism of Ixazomib can be increased when combined with Nevirapine.,75,Type_75,No
DB01154,Thiamylal,DB06716,Fospropofol,0.9993973970413208,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Fospropofol.,49,Type_49,Yes
DB00705,Delavirdine,DB08931,Riociguat,0.8526831269264221,47,Type_47,The metabolism of Riociguat can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00285,Venlafaxine,DB00952,Naratriptan,0.7496356964111328,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.,49,Type_49,Yes
DB00289,Atomoxetine,DB00420,Promazine,0.5729849338531494,47,Type_47,The metabolism of Promazine can be decreased when combined with Atomoxetine.,20,Type_20,No
DB00298,Dapiprazole,DB00967,Desloratadine,0.9873406291007996,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Desloratadine.,49,Type_49,Yes
DB00389,Carbimazole,DB09293,Iodide I-131,1.0,70,Type_70,The therapeutic efficacy of Iodide I-131 can be decreased when used in combination with Carbimazole.,70,Type_70,Yes
DB00359,Sulfadiazine,DB00951,Isoniazid,0.9160274863243103,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00255,Diethylstilbestrol,DB06717,Fosaprepitant,0.794029712677002,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB00320,Dihydroergotamine,DB00333,Methadone,0.9280974864959717,47,Type_47,The metabolism of Methadone can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB00699,Nicergoline,DB01169,Arsenic trioxide,0.9992828965187073,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Arsenic trioxide.,49,Type_49,Yes
DB00321,Amitriptyline,DB09286,Pipamperone,0.9382675290107727,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pipamperone.,49,Type_49,Yes
DB00325,Nitroprusside,DB00521,Carteolol,0.9072213768959045,60,Type_60,Nitroprusside may increase the hypotensive activities of Carteolol.,49,Type_49,No
DB00241,Butalbital,DB00842,Oxazepam,0.9996764659881592,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Oxazepam.,49,Type_49,Yes
DB00521,Carteolol,DB00905,Bimatoprost,0.999839186668396,60,Type_60,Carteolol may increase the hypotensive activities of Bimatoprost.,60,Type_60,Yes
DB01559,Clotiazepam,DB01601,Lopinavir,0.9331035017967224,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Clotiazepam.,47,Type_47,Yes
DB00201,Caffeine,DB08881,Vemurafenib,0.6759347319602966,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Caffeine.,73,Type_73,No
DB00695,Furosemide,DB08906,Fluticasone furoate,0.9993112087249756,83,Type_83,Furosemide may increase the hypokalemic activities of Fluticasone furoate.,83,Type_83,Yes
DB00280,Disopyramide,DB01403,Methotrimeprazine,0.8641576170921326,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Methotrimeprazine.,20,Type_20,Yes
DB00694,Daunorubicin,DB01077,Etidronic acid,0.9998406171798706,24,Type_24,Daunorubicin may increase the hypocalcemic activities of Etidronic acid.,24,Type_24,Yes
DB00476,Duloxetine,DB08987,Etidocaine,0.9898059964179993,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Etidocaine.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01250,Olsalazine,0.9859389066696167,57,Type_57,Mycophenolic acid may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB00461,Nabumetone,DB01421,Paromomycin,0.9999195337295532,72,Type_72,Nabumetone may decrease the excretion rate of Paromomycin which could result in a higher serum level.,72,Type_72,Yes
DB00215,Citalopram,DB09183,Dasabuvir,0.9704588055610657,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00178,Ramipril,DB04951,Pirfenidone,0.9640458226203918,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Pirfenidone.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB01620,Pheniramine,0.9996832609176636,76,Type_76,Pseudoephedrine may decrease the sedative activities of Pheniramine.,76,Type_76,Yes
DB00458,Imipramine,DB08910,Pomalidomide,0.8740149736404419,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Pomalidomide.,49,Type_49,Yes
DB00467,Enoxacin,DB00741,Hydrocortisone,0.9478181600570679,49,Type_49,The risk or severity of adverse effects can be increased when Enoxacin is combined with Hydrocortisone.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01181,Ifosfamide,0.9297654628753662,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Tranylcypromine.,47,Type_47,Yes
DB00346,Alfuzosin,DB06203,Alogliptin,0.4908507466316223,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Alfuzosin.,73,Type_73,No
DB01227,Levacetylmethadol,DB06738,Ketobemidone,0.819952130317688,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Ketobemidone.,49,Type_49,Yes
DB00208,Ticlopidine,DB06712,Nilvadipine,0.962831974029541,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00458,Imipramine,DB00589,Lisuride,0.805086612701416,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Lisuride.,47,Type_47,No
DB00643,Mebendazole,DB06636,Isavuconazonium,0.9023591876029968,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Mebendazole.,47,Type_47,Yes
DB00829,Diazepam,DB00898,Ethanol,0.9994544386863708,16,Type_16,Diazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00996,Gabapentin,DB01544,Flunitrazepam,0.9894033670425415,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Flunitrazepam.,49,Type_49,Yes
DB00318,Codeine,DB01238,Aripiprazole,0.5433907508850098,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Aripiprazole.,49,Type_49,Yes
DB01384,Paramethasone,DB06290,Simeprevir,0.9631261229515076,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Paramethasone.,73,Type_73,Yes
DB00794,Primidone,DB01009,Ketoprofen,0.9861560463905334,4,Type_4,The metabolism of Ketoprofen can be increased when combined with Primidone.,4,Type_4,Yes
DB00395,Carisoprodol,DB01192,Oxymorphone,0.9929832220077515,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxymorphone.,49,Type_49,Yes
DB00497,Oxycodone,DB09300,Butylscopolamine,0.9998250603675842,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Butylscopolamine.,49,Type_49,Yes
DB01067,Glipizide,DB06414,Etravirine,0.690272331237793,47,Type_47,The metabolism of Etravirine can be decreased when combined with Glipizide.,47,Type_47,Yes
DB00881,Quinapril,DB01282,Carbetocin,0.902050793170929,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Carbetocin.,49,Type_49,Yes
DB01078,Deslanoside,DB01177,Idarubicin,0.8459100127220154,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Idarubicin.,58,Type_58,Yes
DB00474,Methohexital,DB01353,Butobarbital,0.9999064207077026,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Butobarbital.,49,Type_49,Yes
DB01149,Nefazodone,DB06654,Safinamide,0.9748015403747559,47,Type_47,The metabolism of Safinamide can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00242,Cladribine,DB01156,Bupropion,0.914151132106781,73,Type_73,The serum concentration of Bupropion can be increased when it is combined with Cladribine.,73,Type_73,Yes
DB00344,Protriptyline,DB01200,Bromocriptine,0.640728771686554,37,Type_37,Protriptyline may decrease the antihypertensive activities of Bromocriptine.,37,Type_37,Yes
DB01026,Ketoconazole,DB01589,Quazepam,0.6733039617538452,47,Type_47,The metabolism of Quazepam can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00813,Fentanyl,DB09338,Mersalyl,0.9987419247627258,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Mersalyl.,49,Type_49,Yes
DB00440,Trimethoprim,DB00997,Doxorubicin,0.5976238250732422,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Trimethoprim.,73,Type_73,No
DB00865,Benzphetamine,DB02703,Fusidic acid,0.9914265871047974,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Benzphetamine.,73,Type_73,Yes
DB00628,Clorazepic acid,DB00752,Tranylcypromine,0.8631635308265686,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Tranylcypromine.,49,Type_49,Yes
DB00909,Zonisamide,DB09225,Zotepine,0.9999021291732788,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Zotepine.,49,Type_49,Yes
DB00742,Mannitol,DB01029,Irbesartan,0.982698380947113,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Irbesartan.,49,Type_49,Yes
DB00797,Tolazoline,DB01348,Spirapril,0.9893836379051208,60,Type_60,Tolazoline may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB01029,Irbesartan,DB08828,Vismodegib,0.807371199131012,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB01600,Tiaprofenic acid,DB08808,Bupranolol,0.9998878240585327,37,Type_37,Tiaprofenic acid may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB00216,Eletriptan,DB01241,Gemfibrozil,0.7234728336334229,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB00596,Ulobetasol,DB01199,Tubocurarine,0.9992115497589111,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Tubocurarine.,49,Type_49,Yes
DB00571,Propranolol,DB01021,Trichlormethiazide,0.9855339527130127,60,Type_60,Propranolol may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB01685,Topiroxostat,DB08899,Enzalutamide,0.6100510954856873,47,Type_47,The metabolism of Enzalutamide can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00091,Cyclosporine,DB00203,Sildenafil,0.8925955891609192,47,Type_47,The metabolism of Sildenafil can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00230,Pregabalin,DB00656,Trazodone,0.9601913690567017,8,Type_8,The therapeutic efficacy of Trazodone can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00963,Bromfenac,DB06810,Plicamycin,0.9999674558639526,72,Type_72,Bromfenac may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00502,Haloperidol,DB00921,Buprenorphine,0.999550998210907,16,Type_16,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00408,Loxapine,DB00780,Phenelzine,0.9437755942344666,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Phenelzine.,49,Type_49,Yes
DB00705,Delavirdine,DB01075,Diphenhydramine,0.8926860094070435,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01036,Tolterodine,DB01057,Echothiophate,0.998099148273468,70,Type_70,The therapeutic efficacy of Echothiophate can be decreased when used in combination with Tolterodine.,70,Type_70,Yes
DB00280,Disopyramide,DB05039,Indacaterol,0.9501043558120728,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00519,Trandolapril,DB01024,Mycophenolic acid,0.9246838688850403,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Mycophenolic acid.,49,Type_49,Yes
DB00266,Dicoumarol,DB08814,Triflusal,0.9980595707893372,6,Type_6,Dicoumarol may increase the anticoagulant activities of Triflusal.,6,Type_6,Yes
DB00976,Telithromycin,DB09262,Imidafenacin,0.9529995322227478,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Telithromycin.,73,Type_73,No
DB00556,Perflutren,DB04855,Dronedarone,0.9999996423721313,20,Type_20,Perflutren may increase the QTc-prolonging activities of Dronedarone.,20,Type_20,Yes
DB00275,Olmesartan,DB04948,Lofexidine,0.965000331401825,60,Type_60,Olmesartan may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00215,Citalopram,DB09034,Suvorexant,0.7692753076553345,49,Type_49,The risk or severity of adverse effects can be increased when Citalopram is combined with Suvorexant.,49,Type_49,Yes
DB00484,Brimonidine,DB00590,Doxazosin,0.9058772325515747,10,Type_10,Brimonidine may increase the antihypertensive activities of Doxazosin.,10,Type_10,Yes
DB00228,Enflurane,DB00230,Pregabalin,0.5006839632987976,8,Type_8,The therapeutic efficacy of Pregabalin can be increased when used in combination with Enflurane.,8,Type_8,Yes
DB00270,Isradipine,DB00283,Clemastine,0.8688715100288391,47,Type_47,The metabolism of Clemastine can be decreased when combined with Isradipine.,47,Type_47,Yes
DB01036,Tolterodine,DB06290,Simeprevir,0.9218859672546387,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Tolterodine.,73,Type_73,Yes
DB00246,Ziprasidone,DB00499,Flutamide,0.9063889384269714,47,Type_47,The metabolism of Flutamide can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00281,Lidocaine,DB01076,Atorvastatin,0.5453649163246155,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Lidocaine.,49,Type_49,No
DB00612,Bisoprolol,DB00899,Remifentanil,0.7155410647392273,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Remifentanil.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00528,Lercanidipine,0.7926247119903564,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Lercanidipine.,49,Type_49,Yes
DB01177,Idarubicin,DB01601,Lopinavir,0.8855358958244324,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Idarubicin.,47,Type_47,Yes
DB00405,Dexbrompheniramine,DB01041,Thalidomide,0.9978528022766113,16,Type_16,Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00690,Flurazepam,DB08883,Perampanel,0.9919782876968384,16,Type_16,Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00427,Triprolidine,DB00660,Metaxalone,0.9999957084655762,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Metaxalone.,49,Type_49,Yes
DB00254,Doxycycline,DB01211,Clarithromycin,0.7783109545707703,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB09291,Rolapitant,DB09570,Ixazomib,0.8867595791816711,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Rolapitant.,47,Type_47,Yes
DB01048,Abacavir,DB01261,Sitagliptin,0.9073322415351868,75,Type_75,The serum concentration of Sitagliptin can be decreased when it is combined with Abacavir.,75,Type_75,Yes
DB00175,Pravastatin,DB08992,Eperisone,0.7048825025558472,49,Type_49,The risk or severity of adverse effects can be increased when Pravastatin is combined with Eperisone.,49,Type_49,Yes
DB00889,Granisetron,DB09078,Lenvatinib,0.9836839437484741,20,Type_20,Granisetron may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00454,Meperidine,DB01002,Levobupivacaine,0.949855625629425,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Levobupivacaine.,49,Type_49,Yes
DB00490,Buspirone,DB01437,Glutethimide,0.9999792575836182,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Glutethimide.,49,Type_49,Yes
DB00231,Temazepam,DB08873,Boceprevir,0.7007219195365906,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00240,Alclometasone,DB01254,Dasatinib,0.8654102683067322,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Alclometasone.,73,Type_73,Yes
DB00925,Phenoxybenzamine,DB01244,Bepridil,0.5275142192840576,60,Type_60,Phenoxybenzamine may increase the hypotensive activities of Bepridil.,60,Type_60,Yes
DB01012,Cinacalcet,DB02703,Fusidic acid,0.9993749260902405,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Cinacalcet.,73,Type_73,Yes
DB00945,Acetylsalicylic acid,DB08822,Azilsartan medoxomil,0.9892470240592957,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00976,Telithromycin,DB09071,Tasimelteon,0.6264600157737732,73,Type_73,The serum concentration of Tasimelteon can be increased when it is combined with Telithromycin.,73,Type_73,Yes
DB00735,Naftifine,DB00774,Hydroflumethiazide,0.9996432065963745,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Naftifine.,70,Type_70,Yes
DB00462,Methscopolamine bromide,DB00517,Anisotropine methylbromide,0.9997547268867493,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Anisotropine methylbromide.,49,Type_49,Yes
DB00980,Ramelteon,DB01227,Levacetylmethadol,0.9788283705711365,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Levacetylmethadol.,49,Type_49,Yes
DB00390,Digoxin,DB01044,Gatifloxacin,0.9006572365760803,58,Type_58,Digoxin may decrease the cardiotoxic activities of Gatifloxacin.,58,Type_58,Yes
DB00363,Clozapine,DB00584,Enalapril,0.693440318107605,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Enalapril.,49,Type_49,Yes
DB00294,Etonogestrel,DB01254,Dasatinib,0.4117869734764099,47,Type_47,The metabolism of Dasatinib can be decreased when combined with Etonogestrel.,73,Type_73,No
DB00861,Diflunisal,DB06605,Apixaban,0.945700466632843,6,Type_6,Diflunisal may increase the anticoagulant activities of Apixaban.,6,Type_6,Yes
DB00402,Eszopiclone,DB00543,Amoxapine,0.9888356328010559,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amoxapine.,49,Type_49,Yes
DB00281,Lidocaine,DB01161,Chloroprocaine,0.9987103939056396,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Chloroprocaine.,49,Type_49,Yes
DB04946,Iloperidone,DB13872,Lormetazepam,0.9986818432807922,49,Type_49,The risk or severity of adverse effects can be increased when Iloperidone is combined with Lormetazepam.,49,Type_49,Yes
DB01197,Captopril,DB09084,Benzydamine,0.9722210168838501,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Benzydamine.,49,Type_49,Yes
DB01274,Arformoterol,DB08881,Vemurafenib,0.34577423334121704,33,Type_33,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Vemurafenib.,33,Type_33,Yes
DB00216,Eletriptan,DB00224,Indinavir,0.8596301674842834,47,Type_47,The metabolism of Indinavir can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB01167,Itraconazole,DB06414,Etravirine,0.4809521734714508,73,Type_73,The serum concentration of Etravirine can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00706,Tamsulosin,DB09227,Barnidipine,0.5870884656906128,60,Type_60,Tamsulosin may increase the hypotensive activities of Barnidipine.,60,Type_60,Yes
DB00630,Alendronic acid,DB01129,Rabeprazole,0.8158514499664307,70,Type_70,The therapeutic efficacy of Rabeprazole can be decreased when used in combination with Alendronic acid.,70,Type_70,Yes
DB00829,Diazepam,DB09073,Palbociclib,0.9754568338394165,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB00402,Eszopiclone,DB06770,Benzyl alcohol,0.9977828860282898,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Benzyl alcohol.,49,Type_49,Yes
DB00705,Delavirdine,DB04920,Clevidipine,0.8542018532752991,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01437,Glutethimide,DB01614,Acepromazine,0.9999713897705078,49,Type_49,The risk or severity of adverse effects can be increased when Glutethimide is combined with Acepromazine.,49,Type_49,Yes
DB00257,Clotrimazole,DB00637,Astemizole,0.6819753050804138,47,Type_47,The metabolism of Astemizole can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00869,Dorzolamide,DB09054,Idelalisib,0.9742263555526733,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Dorzolamide.,47,Type_47,Yes
DB00975,Dipyridamole,DB01122,Ambenonium,0.6935287714004517,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Ambenonium.,70,Type_70,No
DB00240,Alclometasone,DB01118,Amiodarone,0.6559571027755737,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB01621,Pipotiazine,DB08881,Vemurafenib,0.49889588356018066,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Pipotiazine.,73,Type_73,Yes
DB00881,Quinapril,DB09279,Fimasartan,0.9847095608711243,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Fimasartan.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01113,Papaverine,0.9999798536300659,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Papaverine.,49,Type_49,Yes
DB01115,Nifedipine,DB06335,Saxagliptin,0.35159146785736084,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Nifedipine.,75,Type_75,No
DB00925,Phenoxybenzamine,DB01072,Atazanavir,0.7619438171386719,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Phenoxybenzamine.,47,Type_47,Yes
DB00452,Framycetin,DB01401,Choline magnesium trisalicylate,0.9999963045120239,72,Type_72,Framycetin may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level.,72,Type_72,Yes
DB01435,Antipyrine,DB09026,Aliskiren,0.795490026473999,37,Type_37,Antipyrine may decrease the antihypertensive activities of Aliskiren.,37,Type_37,Yes
DB00186,Lorazepam,DB00950,Fexofenadine,0.9842276573181152,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Fexofenadine.,49,Type_49,Yes
DB08964,Gemeprost,DB09215,Droxicam,0.9999512434005737,70,Type_70,The therapeutic efficacy of Droxicam can be decreased when used in combination with Gemeprost.,70,Type_70,Yes
DB08922,Perospirone,DB09085,Tetracaine,0.9999922513961792,49,Type_49,The risk or severity of adverse effects can be increased when Perospirone is combined with Tetracaine.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB01149,Nefazodone,0.9046460390090942,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Nefazodone.,49,Type_49,Yes
DB01067,Glipizide,DB01076,Atorvastatin,0.8186063766479492,9,Type_9,Glipizide may increase the hypoglycemic activities of Atorvastatin.,9,Type_9,Yes
DB00232,Methyclothiazide,DB00333,Methadone,0.9657002091407776,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Methadone.,49,Type_49,Yes
DB00808,Indapamide,DB01124,Tolbutamide,0.9629647135734558,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00765,Metyrosine,DB04846,Celiprolol,0.9622316956520081,60,Type_60,Metyrosine may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB01452,Diamorphine,DB09290,Ramosetron,0.9999954700469971,39,Type_39,Diamorphine may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB00184,Nicotine,DB00989,Rivastigmine,0.3552706837654114,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Rivastigmine.,49,Type_49,Yes
DB00732,Atracurium besylate,DB00805,Minaprine,0.6175593137741089,70,Type_70,The therapeutic efficacy of Minaprine can be decreased when used in combination with Atracurium besylate.,70,Type_70,Yes
DB00275,Olmesartan,DB01626,Pargyline,0.9981375932693481,60,Type_60,Olmesartan may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00501,Cimetidine,DB08895,Tofacitinib,0.8019424080848694,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00710,Ibandronate,DB01211,Clarithromycin,0.8486599326133728,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00273,Topiramate,DB00514,Dextromethorphan,0.699851393699646,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Topiramate.,47,Type_47,Yes
DB00199,Erythromycin,DB00962,Zaleplon,0.7871322631835938,47,Type_47,The metabolism of Zaleplon can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00207,Azithromycin,DB06480,Prucalopride,0.9487419128417969,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00854,Levorphanol,DB01151,Desipramine,0.8914046287536621,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Desipramine.,49,Type_49,Yes
DB00672,Chlorpropamide,DB01026,Ketoconazole,0.8504217863082886,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Chlorpropamide.,47,Type_47,Yes
DB00564,Carbamazepine,DB06742,Ambroxol,0.9931938052177429,4,Type_4,The metabolism of Ambroxol can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00618,Demeclocycline,DB00653,Magnesium sulfate,0.6209865212440491,49,Type_49,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Magnesium sulfate.,67,Type_67,No
DB00454,Meperidine,DB01409,Tiotropium,0.9961494207382202,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Tiotropium.,49,Type_49,Yes
DB00857,Terbinafine,DB09118,Stiripentol,0.9051684737205505,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Terbinafine.,73,Type_73,Yes
DB00669,Sumatriptan,DB01590,Everolimus,0.964691162109375,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Sumatriptan.,73,Type_73,Yes
DB00166,Lipoic acid,DB00412,Rosiglitazone,0.9942307472229004,9,Type_9,Lipoic acid may increase the hypoglycemic activities of Rosiglitazone.,9,Type_9,Yes
DB00246,Ziprasidone,DB01255,Lisdexamfetamine,0.9433944821357727,61,Type_61,Ziprasidone may decrease the stimulatory activities of Lisdexamfetamine.,61,Type_61,Yes
DB00176,Fluvoxamine,DB05351,Dexlansoprazole,0.9895457625389099,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00393,Nimodipine,DB01090,Pentolinium,0.9993556141853333,60,Type_60,Nimodipine may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00589,Lisuride,DB01072,Atazanavir,0.7709430456161499,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Lisuride.,47,Type_47,Yes
DB00842,Oxazepam,DB01017,Minocycline,0.9983452558517456,16,Type_16,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00603,Medroxyprogesterone acetate,DB06605,Apixaban,0.5423151254653931,70,Type_70,The therapeutic efficacy of Apixaban can be decreased when used in combination with Medroxyprogesterone acetate.,70,Type_70,Yes
DB00933,Mesoridazine,DB01178,Chlormezanone,0.9999405145645142,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chlormezanone.,49,Type_49,Yes
DB00870,Suprofen,DB06263,Amrubicin,0.999415397644043,72,Type_72,Suprofen may decrease the excretion rate of Amrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00091,Cyclosporine,DB09216,Tolfenamic acid,0.9356428384780884,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Tolfenamic acid.,57,Type_57,Yes
DB00559,Bosentan,DB00802,Alfentanil,0.90089350938797,75,Type_75,The serum concentration of Alfentanil can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00275,Olmesartan,DB01355,Hexobarbital,0.6995202302932739,60,Type_60,Olmesartan may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00270,Isradipine,DB01422,Nitroxoline,0.9291880130767822,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Nitroxoline.,49,Type_49,Yes
DB00820,Tadalafil,DB01197,Captopril,0.8419042229652405,10,Type_10,Tadalafil may increase the antihypertensive activities of Captopril.,10,Type_10,Yes
DB01149,Nefazodone,DB01544,Flunitrazepam,0.8524627089500427,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00655,Estrone,DB09067,Corticorelin ovine triflutate,0.9997134804725647,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Estrone.,70,Type_70,Yes
DB00892,Oxybuprocaine,DB09286,Pipamperone,0.9997891783714294,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pipamperone.,49,Type_49,Yes
DB00710,Ibandronate,DB04743,Nimesulide,0.9975752234458923,49,Type_49,The risk or severity of adverse effects can be increased when Ibandronate is combined with Nimesulide.,49,Type_49,Yes
DB08873,Boceprevir,DB11817,Baricitinib,0.8181441426277161,47,Type_47,The metabolism of Baricitinib can be decreased when combined with Boceprevir.,47,Type_47,Yes
DB00441,Gemcitabine,DB00864,Tacrolimus,0.7010621428489685,49,Type_49,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tacrolimus.,49,Type_49,Yes
DB00222,Glimepiride,DB06203,Alogliptin,0.9414480328559875,9,Type_9,Glimepiride may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00228,Enflurane,DB00423,Methocarbamol,0.9998853206634521,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Methocarbamol.,49,Type_49,Yes
DB00358,Mefloquine,DB01409,Tiotropium,0.9988069534301758,70,Type_70,The therapeutic efficacy of Tiotropium can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB01129,Rabeprazole,DB01263,Posaconazole,0.9054346084594727,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Rabeprazole.,75,Type_75,No
DB00312,Pentobarbital,DB08875,Cabozantinib,0.837993323802948,4,Type_4,The metabolism of Cabozantinib can be increased when combined with Pentobarbital.,75,Type_75,No
DB00337,Pimecrolimus,DB04574,Estrone sulfate,0.9227548241615295,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Estrone sulfate.,49,Type_49,Yes
DB01577,Metamfetamine,DB06764,Tetryzoline,0.989984393119812,49,Type_49,The risk or severity of adverse effects can be increased when Metamfetamine is combined with Tetryzoline.,49,Type_49,Yes
DB00949,Felbamate,DB01267,Paliperidone,0.5987285375595093,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Paliperidone.,20,Type_20,No
DB00784,Mefenamic acid,DB01240,Epoprostenol,0.527799129486084,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Epoprostenol.,70,Type_70,No
DB00818,Propofol,DB08922,Perospirone,0.8385794758796692,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Perospirone.,49,Type_49,Yes
DB00252,Phenytoin,DB00484,Brimonidine,0.9605050086975098,16,Type_16,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,16,Type_16,Yes
DB00275,Olmesartan,DB00765,Metyrosine,0.9998725652694702,60,Type_60,Olmesartan may increase the hypotensive activities of Metyrosine.,60,Type_60,Yes
DB00594,Amiloride,DB00945,Acetylsalicylic acid,0.9992073178291321,37,Type_37,Amiloride may decrease the antihypertensive activities of Acetylsalicylic acid.,37,Type_37,Yes
DB00338,Omeprazole,DB00936,Salicylic acid,0.9303461909294128,47,Type_47,The metabolism of Salicylic acid can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00502,Haloperidol,DB13025,Tiapride,0.9875446557998657,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Tiapride.,49,Type_49,Yes
DB00773,Etoposide,DB08933,Luliconazole,0.9680920839309692,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Etoposide.,73,Type_73,Yes
DB01012,Cinacalcet,DB08901,Ponatinib,0.9535315632820129,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB01001,Salbutamol,DB01155,Gemifloxacin,0.9908825755119324,20,Type_20,Salbutamol may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00283,Clemastine,DB01035,Procainamide,0.7970377802848816,47,Type_47,The metabolism of Procainamide can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00178,Ramipril,DB00812,Phenylbutazone,0.9668014049530029,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Phenylbutazone.,49,Type_49,Yes
DB00387,Procyclidine,DB01409,Tiotropium,0.9561842083930969,2,Type_2,Procyclidine may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB01253,Ergometrine,DB01580,Oxprenolol,0.6363336443901062,19,Type_19,Ergometrine may increase the vasoconstricting activities of Oxprenolol.,19,Type_19,Yes
DB00321,Amitriptyline,DB00844,Nalbuphine,0.97920161485672,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nalbuphine.,49,Type_49,Yes
DB00296,Ropivacaine,DB01221,Ketamine,0.9184964895248413,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ketamine.,49,Type_49,Yes
DB00238,Nevirapine,DB00745,Modafinil,0.48761677742004395,47,Type_47,The metabolism of Modafinil can be decreased when combined with Nevirapine.,4,Type_4,No
DB00696,Ergotamine,DB00820,Tadalafil,0.8289806842803955,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Tadalafil.,49,Type_49,Yes
DB00208,Ticlopidine,DB01242,Clomipramine,0.9663024544715881,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00334,Olanzapine,DB01066,Cefditoren,0.38558200001716614,67,Type_67,Olanzapine can cause a decrease in the absorption of Cefditoren resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00417,Phenoxymethylpenicillin,DB01177,Idarubicin,0.8784529566764832,75,Type_75,The serum concentration of Idarubicin can be decreased when it is combined with Phenoxymethylpenicillin.,75,Type_75,Yes
DB00371,Meprobamate,DB01437,Glutethimide,0.9968529343605042,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Glutethimide.,49,Type_49,Yes
DB00726,Trimipramine,DB05812,Abiraterone,0.8442419767379761,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00490,Buspirone,DB01463,Fencamfamin,0.9977045655250549,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Fencamfamin.,49,Type_49,Yes
DB01018,Guanfacine,DB01392,Yohimbine,0.9987491369247437,37,Type_37,Guanfacine may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00188,Bortezomib,DB00521,Carteolol,0.6096163392066956,47,Type_47,The metabolism of Carteolol can be decreased when combined with Bortezomib.,49,Type_49,No
DB00184,Nicotine,DB00228,Enflurane,0.8334861397743225,47,Type_47,The metabolism of Enflurane can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00692,Phentolamine,DB01324,Polythiazide,0.945033848285675,60,Type_60,Phentolamine may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00924,Cyclobenzaprine,DB04855,Dronedarone,0.6049171090126038,20,Type_20,Cyclobenzaprine may increase the QTc-prolonging activities of Dronedarone.,47,Type_47,No
DB00227,Lovastatin,DB00234,Reboxetine,0.7771433591842651,47,Type_47,The metabolism of Reboxetine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00679,Thioridazine,DB09119,Eslicarbazepine acetate,0.5486696362495422,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Thioridazine.,47,Type_47,Yes
DB04552,Niflumic acid,DB12364,Betrixaban,0.9968926906585693,66,Type_66,The risk or severity of bleeding can be increased when Niflumic acid is combined with Betrixaban.,66,Type_66,Yes
DB01624,Zuclopenthixol,DB09034,Suvorexant,0.9993359446525574,16,Type_16,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00273,Topiramate,DB11609,Normethadone,0.9964243769645691,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Normethadone.,49,Type_49,Yes
DB00283,Clemastine,DB00518,Albendazole,0.9914661645889282,47,Type_47,The metabolism of Albendazole can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00401,Nisoldipine,DB00525,Tolnaftate,0.989513635635376,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Tolnaftate.,49,Type_49,Yes
DB01359,Penbutolol,DB09082,Vilanterol,0.739057183265686,14,Type_14,Penbutolol may decrease the bronchodilatory activities of Vilanterol.,14,Type_14,Yes
DB00708,Sufentanil,DB06690,Nitrous oxide,0.9986382126808167,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Nitrous oxide.,49,Type_49,Yes
DB01082,Streptomycin,DB08976,Floctafenine,0.9999769926071167,72,Type_72,Streptomycin may decrease the excretion rate of Floctafenine which could result in a higher serum level.,72,Type_72,Yes
DB00737,Meclizine,DB01576,Dextroamphetamine,0.9985771179199219,76,Type_76,Meclizine may decrease the sedative activities of Dextroamphetamine.,76,Type_76,Yes
DB01563,Chloral hydrate,DB06716,Fospropofol,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Fospropofol.,49,Type_49,Yes
DB00656,Trazodone,DB00708,Sufentanil,0.9760896563529968,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Sufentanil.,49,Type_49,Yes
DB00207,Azithromycin,DB08916,Afatinib,0.807701587677002,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00180,Flunisolide,DB09288,Propacetamol,0.9977989792823792,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Propacetamol.,49,Type_49,Yes
DB00501,Cimetidine,DB01159,Halothane,0.9755423665046692,47,Type_47,The metabolism of Halothane can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00696,Ergotamine,DB08808,Bupranolol,0.9702872633934021,25,Type_25,Ergotamine may increase the atrioventricular blocking (AV block) activities of Bupranolol.,25,Type_25,Yes
DB00210,Adapalene,DB00461,Nabumetone,0.9994818568229675,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Nabumetone.,49,Type_49,Yes
DB00318,Codeine,DB00333,Methadone,0.7601875066757202,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Methadone.,70,Type_70,No
DB00752,Tranylcypromine,DB01244,Bepridil,0.5149818658828735,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Bepridil.,47,Type_47,No
DB00227,Lovastatin,DB00956,Hydrocodone,0.774231493473053,47,Type_47,The metabolism of Hydrocodone can be decreased when combined with Lovastatin.,73,Type_73,No
DB00206,Reserpine,DB00768,Olopatadine,0.9786796569824219,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Olopatadine.,49,Type_49,Yes
DB00427,Triprolidine,DB00599,Thiopental,0.9947916269302368,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Thiopental.,49,Type_49,Yes
DB00907,Cocaine,DB01100,Pimozide,0.4328433871269226,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Pimozide.,73,Type_73,No
DB00996,Gabapentin,DB01080,Vigabatrin,0.9995468258857727,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Vigabatrin.,49,Type_49,Yes
DB00678,Losartan,DB08439,Parecoxib,0.48284581303596497,47,Type_47,The metabolism of Parecoxib can be decreased when combined with Losartan.,47,Type_47,Yes
DB00813,Fentanyl,DB01036,Tolterodine,0.9288366436958313,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Tolterodine.,49,Type_49,Yes
DB00353,Methylergometrine,DB06589,Pazopanib,0.504362940788269,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Pazopanib.,49,Type_49,Yes
DB01137,Levofloxacin,DB08916,Afatinib,0.8292522430419922,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Levofloxacin.,73,Type_73,Yes
DB01174,Phenobarbital,DB01367,Rasagiline,0.6425786018371582,49,Type_49,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Rasagiline.,60,Type_60,No
DB00177,Valsartan,DB01029,Irbesartan,0.5200321674346924,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Irbesartan.,49,Type_49,Yes
DB00648,Mitotane,DB01259,Lapatinib,0.990343451499939,75,Type_75,The serum concentration of Lapatinib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00670,Pirenzepine,DB00854,Levorphanol,0.9952746629714966,49,Type_49,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Levorphanol.,49,Type_49,Yes
DB01236,Sevoflurane,DB09026,Aliskiren,0.5747736692428589,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Aliskiren.,49,Type_49,Yes
DB01142,Doxepin,DB01367,Rasagiline,0.8626095652580261,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Rasagiline.,49,Type_49,Yes
DB00322,Floxuridine,DB01016,Glyburide,0.9237461686134338,47,Type_47,The metabolism of Glyburide can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00244,Mesalazine,DB00598,Labetalol,0.8944357633590698,37,Type_37,Mesalazine may decrease the antihypertensive activities of Labetalol.,37,Type_37,Yes
DB00245,Benzatropine,DB09119,Eslicarbazepine acetate,0.9025726914405823,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB00278,Argatroban,DB00726,Trimipramine,0.7913315296173096,73,Type_73,The serum concentration of Trimipramine can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00801,Halazepam,DB00899,Remifentanil,0.9996973276138306,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Remifentanil.,49,Type_49,Yes
DB00612,Bisoprolol,DB00755,Tretinoin,0.655878484249115,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Tretinoin.,49,Type_49,Yes
DB00705,Delavirdine,DB01418,Acenocoumarol,0.49268120527267456,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Delavirdine.,47,Type_47,No
DB01395,Drospirenone,DB09026,Aliskiren,0.6008857488632202,68,Type_68,Drospirenone may increase the hyperkalemic activities of Aliskiren.,68,Type_68,Yes
DB00500,Tolmetin,DB00929,Misoprostol,0.9974212646484375,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Tolmetin.,70,Type_70,Yes
DB00807,Proparacaine,DB00906,Tiagabine,0.9993601441383362,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Tiagabine.,49,Type_49,Yes
DB06603,Panobinostat,DB06701,Dexmethylphenidate,0.9067897796630859,73,Type_73,The serum concentration of Dexmethylphenidate can be increased when it is combined with Panobinostat.,73,Type_73,Yes
DB01007,Tioconazole,DB01244,Bepridil,0.9795233011245728,49,Type_49,The risk or severity of adverse effects can be increased when Tioconazole is combined with Bepridil.,49,Type_49,Yes
DB00927,Famotidine,DB01104,Sertraline,0.7261842489242554,47,Type_47,The metabolism of Sertraline can be decreased when combined with Famotidine.,47,Type_47,Yes
DB00788,Naproxen,DB01172,Kanamycin,0.9999523162841797,72,Type_72,Naproxen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,72,Type_72,Yes
DB00735,Naftifine,DB00959,Methylprednisolone,0.999370276927948,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Methylprednisolone.,49,Type_49,Yes
DB00445,Epirubicin,DB09215,Droxicam,0.9984138011932373,72,Type_72,Epirubicin may decrease the excretion rate of Droxicam which could result in a higher serum level.,72,Type_72,Yes
DB01591,Solifenacin,DB04868,Nilotinib,0.6789440512657166,20,Type_20,Solifenacin may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB00849,Methylphenobarbital,DB00980,Ramelteon,0.9878843426704407,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Ramelteon.,49,Type_49,Yes
DB00277,Theophylline,DB09273,Doxofylline,0.5345270037651062,49,Type_49,The risk or severity of adverse effects can be increased when Theophylline is combined with Doxofylline.,49,Type_49,Yes
DB00270,Isradipine,DB00683,Midazolam,0.8772820830345154,47,Type_47,The metabolism of Midazolam can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00614,Furazolidone,DB06700,Desvenlafaxine,0.8474212884902954,64,Type_64,Furazolidone may increase the serotonergic activities of Desvenlafaxine.,64,Type_64,Yes
DB00811,Ribavirin,DB00943,Zalcitabine,0.9895601272583008,4,Type_4,The metabolism of Zalcitabine can be increased when combined with Ribavirin.,80,Type_80,No
DB00996,Gabapentin,DB01422,Nitroxoline,0.9742831587791443,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Nitroxoline.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB06700,Desvenlafaxine,0.8523673415184021,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Desvenlafaxine.,49,Type_49,Yes
DB06594,Agomelatine,DB09118,Stiripentol,0.674928605556488,49,Type_49,The risk or severity of adverse effects can be increased when Agomelatine is combined with Stiripentol.,49,Type_49,Yes
DB00490,Buspirone,DB00496,Darifenacin,0.9275912046432495,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Buspirone.,47,Type_47,Yes
DB00227,Lovastatin,DB00773,Etoposide,0.5362325310707092,47,Type_47,The metabolism of Etoposide can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01196,Estramustine,DB01394,Colchicine,0.9851049780845642,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Estramustine.,73,Type_73,Yes
DB00158,Folic acid,DB00257,Clotrimazole,0.7925782799720764,47,Type_47,The metabolism of Clotrimazole can be decreased when combined with Folic acid.,47,Type_47,Yes
DB00472,Fluoxetine,DB08872,Gabapentin enacarbil,0.9946080446243286,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00594,Amiloride,DB01244,Bepridil,0.9708604216575623,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Bepridil.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB01174,Phenobarbital,0.9804702401161194,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.,16,Type_16,Yes
DB00231,Temazepam,DB13872,Lormetazepam,0.9999854564666748,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Lormetazepam.,49,Type_49,Yes
DB00501,Cimetidine,DB06148,Mianserin,0.89439857006073,47,Type_47,The metabolism of Mianserin can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00976,Telithromycin,DB01002,Levobupivacaine,0.8917872309684753,47,Type_47,The metabolism of Levobupivacaine can be decreased when combined with Telithromycin.,73,Type_73,No
DB00359,Sulfadiazine,DB00396,Progesterone,0.9741904735565186,47,Type_47,The metabolism of Progesterone can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00275,Olmesartan,DB00492,Fosinopril,0.9394245147705078,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Fosinopril.,49,Type_49,Yes
DB00258,Calcium acetate,DB09238,Manidipine,0.5570144653320312,70,Type_70,The therapeutic efficacy of Manidipine can be decreased when used in combination with Calcium acetate.,70,Type_70,Yes
DB00252,Phenytoin,DB01511,Delorazepam,0.48583173751831055,75,Type_75,The serum concentration of Delorazepam can be decreased when it is combined with Phenytoin.,73,Type_73,No
DB00428,Streptozocin,DB12598,Nafamostat,0.8293783664703369,72,Type_72,Streptozocin may decrease the excretion rate of Nafamostat which could result in a higher serum level.,72,Type_72,Yes
DB00790,Perindopril,DB04951,Pirfenidone,0.9491379261016846,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Pirfenidone.,49,Type_49,Yes
DB00328,Indomethacin,DB09215,Droxicam,0.9938738346099854,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Droxicam.,49,Type_49,Yes
DB00222,Glimepiride,DB09244,Pirlindole,0.9977620840072632,9,Type_9,Glimepiride may increase the hypoglycemic activities of Pirlindole.,9,Type_9,Yes
DB00660,Metaxalone,DB04908,Flibanserin,0.9999721050262451,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Flibanserin.,49,Type_49,Yes
DB00462,Methscopolamine bromide,DB00677,Isoflurophate,0.9990070462226868,70,Type_70,The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Methscopolamine bromide.,70,Type_70,Yes
DB00334,Olanzapine,DB00454,Meperidine,0.8300287127494812,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Meperidine.,49,Type_49,Yes
DB01029,Irbesartan,DB01154,Thiamylal,0.5563946962356567,60,Type_60,Irbesartan may increase the hypotensive activities of Thiamylal.,47,Type_47,No
DB00531,Cyclophosphamide,DB08880,Teriflunomide,0.5431577563285828,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Teriflunomide.,47,Type_47,No
DB01076,Atorvastatin,DB01319,Fosamprenavir,0.6777871251106262,73,Type_73,The serum concentration of Fosamprenavir can be increased when it is combined with Atorvastatin.,73,Type_73,Yes
DB00831,Trifluoperazine,DB09224,Melperone,0.9985038042068481,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Melperone.,49,Type_49,Yes
DB01250,Olsalazine,DB04865,Omacetaxine mepesuccinate,0.9748165011405945,49,Type_49,The risk or severity of adverse effects can be increased when Olsalazine is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00377,Palonosetron,DB09120,Zucapsaicin,0.9995546936988831,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Palonosetron.,47,Type_47,Yes
DB00673,Aprepitant,DB11613,Velpatasvir,0.8932929039001465,73,Type_73,The serum concentration of Velpatasvir can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00870,Suprofen,DB08439,Parecoxib,0.9944576025009155,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Parecoxib.,49,Type_49,Yes
DB04855,Dronedarone,DB09101,Elvitegravir,0.9011090397834778,47,Type_47,The metabolism of Elvitegravir can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00370,Mirtazapine,DB00608,Chloroquine,0.5283984541893005,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Mirtazapine.,20,Type_20,No
DB00435,Nitric Oxide,DB01041,Thalidomide,0.9930899739265442,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Thalidomide.,49,Type_49,Yes
DB00714,Apomorphine,DB00849,Methylphenobarbital,0.7056488990783691,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Methylphenobarbital.,60,Type_60,No
DB00810,Biperiden,DB01116,Trimethaphan,0.9757456183433533,49,Type_49,The risk or severity of adverse effects can be increased when Biperiden is combined with Trimethaphan.,49,Type_49,Yes
DB00216,Eletriptan,DB01463,Fencamfamin,0.9979386925697327,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Fencamfamin.,49,Type_49,Yes
DB00203,Sildenafil,DB00820,Tadalafil,0.6066194176673889,10,Type_10,Sildenafil may increase the antihypertensive activities of Tadalafil.,47,Type_47,No
DB00214,Torasemide,DB01054,Nitrendipine,0.5159099102020264,60,Type_60,Torasemide may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB00663,Flumethasone,DB00673,Aprepitant,0.9964097142219543,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Flumethasone.,73,Type_73,Yes
DB00283,Clemastine,DB00623,Fluphenazine,0.5000343918800354,47,Type_47,The metabolism of Fluphenazine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00547,Desoximetasone,DB01167,Itraconazole,0.9217297434806824,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Desoximetasone.,73,Type_73,Yes
DB00802,Alfentanil,DB09345,Pramocaine,0.9999933242797852,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Pramocaine.,49,Type_49,Yes
DB01009,Ketoprofen,DB01136,Carvedilol,0.9995501637458801,37,Type_37,Ketoprofen may decrease the antihypertensive activities of Carvedilol.,37,Type_37,Yes
DB00726,Trimipramine,DB06717,Fosaprepitant,0.945493221282959,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00755,Tretinoin,DB01101,Capecitabine,0.9083207249641418,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Tretinoin.,47,Type_47,Yes
DB00614,Furazolidone,DB00854,Levorphanol,0.8876752853393555,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Levorphanol.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB01297,Practolol,0.9999436140060425,37,Type_37,Mycophenolate mofetil may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00318,Codeine,DB06282,Levocetirizine,0.9960691928863525,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Levocetirizine.,49,Type_49,Yes
DB00253,Medrysone,DB05676,Apremilast,0.9996968507766724,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Apremilast.,49,Type_49,Yes
DB00377,Palonosetron,DB01356,Lithium cation,0.9802244305610657,64,Type_64,Palonosetron may increase the serotonergic activities of Lithium cation.,64,Type_64,Yes
DB08887,Icosapent ethyl,DB09075,Edoxaban,0.9488345384597778,6,Type_6,Icosapent ethyl may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB00270,Isradipine,DB00877,Sirolimus,0.4982134997844696,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Sirolimus.,49,Type_49,Yes
DB00408,Loxapine,DB00502,Haloperidol,0.9131465554237366,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Haloperidol.,49,Type_49,Yes
DB01074,Perhexiline,DB09238,Manidipine,0.8698397278785706,60,Type_60,Perhexiline may increase the hypotensive activities of Manidipine.,47,Type_47,No
DB01254,Dasatinib,DB11737,Icotinib,0.7476630806922913,73,Type_73,The serum concentration of Icotinib can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00387,Procyclidine,DB01199,Tubocurarine,0.9978421926498413,49,Type_49,The risk or severity of adverse effects can be increased when Procyclidine is combined with Tubocurarine.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB01254,Dasatinib,0.8252308964729309,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Mycophenolate mofetil.,73,Type_73,Yes
DB01243,Chloroxine,DB04743,Nimesulide,0.9945053458213806,49,Type_49,The risk or severity of adverse effects can be increased when Chloroxine is combined with Nimesulide.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB00722,Lisinopril,0.8781207203865051,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Lisinopril.,49,Type_49,Yes
DB00443,Betamethasone,DB08873,Boceprevir,0.8064669370651245,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Betamethasone.,73,Type_73,Yes
DB01171,Moclobemide,DB01340,Cilazapril,0.7526936531066895,60,Type_60,Moclobemide may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB00471,Montelukast,DB04868,Nilotinib,0.955189049243927,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Montelukast.,47,Type_47,Yes
DB00285,Venlafaxine,DB01431,Allylestrenol,0.9802852869033813,47,Type_47,The metabolism of Allylestrenol can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB04946,Iloperidone,DB09118,Stiripentol,0.744925856590271,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Iloperidone.,73,Type_73,Yes
DB01416,Cefpodoxime,DB13595,Almasilate,0.8843569159507751,75,Type_75,The serum concentration of Almasilate can be decreased when it is combined with Cefpodoxime.,75,Type_75,Yes
DB00554,Piroxicam,DB00860,Prednisolone,0.9996414184570312,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Prednisolone.,49,Type_49,Yes
DB00443,Betamethasone,DB01252,Mitiglinide,0.99998939037323,70,Type_70,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Betamethasone.,70,Type_70,Yes
DB01100,Pimozide,DB09078,Lenvatinib,0.9111242294311523,20,Type_20,Pimozide may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB01072,Atazanavir,DB06702,Fesoterodine,0.8492749333381653,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atazanavir.,77,Type_77,Yes
DB00494,Entacapone,DB00683,Midazolam,0.9970133304595947,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Midazolam.,49,Type_49,Yes
DB00834,Mifepristone,DB01435,Antipyrine,0.8871874809265137,73,Type_73,The serum concentration of Antipyrine can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00310,Chlorthalidone,DB00363,Clozapine,0.965248167514801,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Clozapine.,49,Type_49,Yes
DB00518,Albendazole,DB00872,Conivaptan,0.9196023344993591,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Albendazole.,73,Type_73,Yes
DB00668,Epinephrine,DB08918,Levomilnacipran,0.9891083240509033,85,Type_85,Epinephrine may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00559,Bosentan,DB00700,Eplerenone,0.5983082056045532,60,Type_60,Bosentan may increase the hypotensive activities of Eplerenone.,75,Type_75,No
DB00546,Adinazolam,DB06413,Armodafinil,0.9814336895942688,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00215,Citalopram,DB01114,Chlorpheniramine,0.5790729522705078,47,Type_47,The metabolism of Chlorpheniramine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00091,Cyclosporine,DB06708,Lumefantrine,0.8504245281219482,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01118,Amiodarone,DB01544,Flunitrazepam,0.8214235901832581,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00475,Chlordiazepoxide,DB06717,Fosaprepitant,0.8729829788208008,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Chlordiazepoxide.,73,Type_73,Yes
DB00316,Acetaminophen,DB00699,Nicergoline,0.7738217711448669,49,Type_49,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Nicergoline.,49,Type_49,Yes
DB01131,Proguanil,DB06708,Lumefantrine,0.8011197447776794,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Proguanil.,33,Type_33,No
DB00176,Fluvoxamine,DB01239,Chlorprothixene,0.9140791893005371,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Chlorprothixene.,49,Type_49,Yes
DB00199,Erythromycin,DB09166,Etizolam,0.854508101940155,47,Type_47,The metabolism of Etizolam can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01198,Zopiclone,DB01215,Estazolam,0.9965644478797913,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Estazolam.,49,Type_49,Yes
DB00501,Cimetidine,DB00908,Quinidine,0.9510505199432373,47,Type_47,The metabolism of Quinidine can be decreased when combined with Cimetidine.,73,Type_73,No
DB00798,Gentamicin,DB00939,Meclofenamic acid,0.9999935626983643,72,Type_72,Gentamicin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB01142,Doxepin,DB09074,Olaparib,0.809082567691803,47,Type_47,The metabolism of Olaparib can be decreased when combined with Doxepin.,47,Type_47,Yes
DB00327,Hydromorphone,DB00540,Nortriptyline,0.9198230504989624,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nortriptyline.,49,Type_49,Yes
DB00794,Primidone,DB08896,Regorafenib,0.7348622679710388,75,Type_75,The serum concentration of Regorafenib can be decreased when it is combined with Primidone.,75,Type_75,Yes
DB00736,Esomeprazole,DB01319,Fosamprenavir,0.7724229097366333,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB00169,Cholecalciferol,DB09073,Palbociclib,0.9823739528656006,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Cholecalciferol.,73,Type_73,Yes
DB00831,Trifluoperazine,DB00898,Ethanol,0.9980119466781616,16,Type_16,Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00252,Phenytoin,DB01396,Digitoxin,0.7080307602882385,4,Type_4,The metabolism of Digitoxin can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00571,Propranolol,DB00831,Trifluoperazine,0.9046777486801147,60,Type_60,Propranolol may increase the hypotensive activities of Trifluoperazine.,60,Type_60,Yes
DB00333,Methadone,DB00899,Remifentanil,0.9798473119735718,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Remifentanil.,49,Type_49,Yes
DB00469,Tenoxicam,DB06802,Nepafenac,0.9990863800048828,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Nepafenac.,49,Type_49,Yes
DB00917,Dinoprostone,DB01628,Etoricoxib,0.8084637522697449,70,Type_70,The therapeutic efficacy of Etoricoxib can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00975,Dipyridamole,DB01020,Isosorbide mononitrate,0.9980360865592957,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Isosorbide mononitrate.,49,Type_49,Yes
DB00524,Metolazone,DB01359,Penbutolol,0.708139181137085,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Penbutolol.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB06268,Sitaxentan,0.9370861649513245,60,Type_60,Candesartan cilexetil may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00363,Clozapine,DB01621,Pipotiazine,0.6103551983833313,47,Type_47,The metabolism of Pipotiazine can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00884,Risedronic acid,DB01162,Terazosin,0.9906644821166992,49,Type_49,The risk or severity of adverse effects can be increased when Risedronic acid is combined with Terazosin.,60,Type_60,No
DB00283,Clemastine,DB01087,Primaquine,0.8727014660835266,47,Type_47,The metabolism of Primaquine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00206,Reserpine,DB01590,Everolimus,0.7514894008636475,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Reserpine.,73,Type_73,Yes
DB01054,Nitrendipine,DB01076,Atorvastatin,0.8301417231559753,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Atorvastatin.,49,Type_49,Yes
DB04576,Fleroxacin,DB06335,Saxagliptin,0.9960978031158447,9,Type_9,Fleroxacin may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00363,Clozapine,DB06700,Desvenlafaxine,0.7619584798812866,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Desvenlafaxine.,73,Type_73,No
DB00224,Indinavir,DB01411,Pranlukast,0.9725077748298645,73,Type_73,The serum concentration of Pranlukast can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00184,Nicotine,DB09120,Zucapsaicin,0.995183527469635,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01168,Procarbazine,DB06016,Cariprazine,0.9659451842308044,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Cariprazine.,49,Type_49,Yes
DB08808,Bupranolol,DB09238,Manidipine,0.991306722164154,60,Type_60,Bupranolol may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00685,Trovafloxacin,DB01016,Glyburide,0.9980966448783875,9,Type_9,Trovafloxacin may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00215,Citalopram,DB12026,Voxilaprevir,0.947001039981842,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Citalopram.,47,Type_47,Yes
DB01296,Glucosamine,DB05266,Ibudilast,0.9483670592308044,53,Type_53,Glucosamine may increase the antiplatelet activities of Ibudilast.,53,Type_53,Yes
DB00619,Imatinib,DB01621,Pipotiazine,0.9171927571296692,47,Type_47,The metabolism of Pipotiazine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00697,Tizanidine,DB01155,Gemifloxacin,0.9958230257034302,20,Type_20,Tizanidine may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00674,Galantamine,DB01130,Prednicarbate,0.8937068581581116,49,Type_49,The risk or severity of adverse effects can be increased when Galantamine is combined with Prednicarbate.,49,Type_49,Yes
DB00216,Eletriptan,DB01101,Capecitabine,0.6756830215454102,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB00158,Folic acid,DB06736,Aceclofenac,0.801158607006073,70,Type_70,The therapeutic efficacy of Aceclofenac can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00813,Fentanyl,DB01614,Acepromazine,0.9971981048583984,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Acepromazine.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB05676,Apremilast,0.9935265779495239,70,Type_70,The therapeutic efficacy of Apremilast can be decreased when used in combination with Hydrochlorothiazide.,70,Type_70,Yes
DB00491,Miglitol,DB00717,Norethisterone,0.9898892045021057,70,Type_70,The therapeutic efficacy of Norethisterone can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00222,Glimepiride,DB00603,Medroxyprogesterone acetate,0.9806581735610962,70,Type_70,The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Glimepiride.,70,Type_70,Yes
DB00428,Streptozocin,DB00821,Carprofen,0.9971837401390076,72,Type_72,Streptozocin may decrease the excretion rate of Carprofen which could result in a higher serum level.,72,Type_72,Yes
DB00433,Prochlorperazine,DB00748,Carbinoxamine,0.9780421853065491,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Carbinoxamine.,49,Type_49,Yes
DB00744,Zileuton,DB00917,Dinoprostone,0.30627015233039856,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Dinoprostone.,70,Type_70,No
DB01024,Mycophenolic acid,DB06739,Seratrodast,0.5808243155479431,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Seratrodast.,49,Type_49,Yes
DB01130,Prednicarbate,DB09084,Benzydamine,0.9997667670249939,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Benzydamine.,49,Type_49,Yes
DB01544,Flunitrazepam,DB08865,Crizotinib,0.9463185667991638,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Flunitrazepam.,47,Type_47,Yes
DB00802,Alfentanil,DB06153,Pizotifen,0.9975632429122925,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Pizotifen.,49,Type_49,Yes
DB09091,Tixocortol,DB09216,Tolfenamic acid,0.9913081526756287,49,Type_49,The risk or severity of adverse effects can be increased when Tixocortol is combined with Tolfenamic acid.,49,Type_49,Yes
DB00182,Amphetamine,DB04946,Iloperidone,0.8820638656616211,61,Type_61,Amphetamine may decrease the stimulatory activities of Iloperidone.,61,Type_61,Yes
DB03585,Oxyphenbutazone,DB04865,Omacetaxine mepesuccinate,0.8934547305107117,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB04743,Nimesulide,DB08816,Ticagrelor,0.36220717430114746,6,Type_6,Nimesulide may increase the anticoagulant activities of Ticagrelor.,6,Type_6,Yes
DB08964,Gemeprost,DB08976,Floctafenine,0.9999665021896362,70,Type_70,The therapeutic efficacy of Floctafenine can be decreased when used in combination with Gemeprost.,70,Type_70,Yes
DB00571,Propranolol,DB00839,Tolazamide,0.9813706278800964,9,Type_9,Propranolol may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00599,Thiopental,DB06713,Norelgestromin,0.7168172597885132,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Thiopental.,70,Type_70,Yes
DB00321,Amitriptyline,DB09073,Palbociclib,0.9946929812431335,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Amitriptyline.,73,Type_73,Yes
DB01131,Proguanil,DB01608,Periciazine,0.6051649451255798,73,Type_73,The serum concentration of Periciazine can be increased when it is combined with Proguanil.,73,Type_73,Yes
DB00793,Haloprogin,DB00884,Risedronic acid,0.9970448613166809,49,Type_49,The risk or severity of adverse effects can be increased when Haloprogin is combined with Risedronic acid.,49,Type_49,Yes
DB00270,Isradipine,DB01186,Pergolide,0.3398345708847046,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Pergolide.,47,Type_47,No
DB00220,Nelfinavir,DB00448,Lansoprazole,0.7733362317085266,47,Type_47,The metabolism of Lansoprazole can be decreased when combined with Nelfinavir.,11,Type_11,No
DB00765,Metyrosine,DB01239,Chlorprothixene,0.9959549903869629,32,Type_32,Metyrosine may increase the sedative activities of Chlorprothixene.,32,Type_32,Yes
DB00243,Ranolazine,DB09296,Ombitasvir,0.8187493085861206,47,Type_47,The metabolism of Ombitasvir can be decreased when combined with Ranolazine.,73,Type_73,No
DB01275,Hydralazine,DB13167,Alclofenac,0.880283772945404,37,Type_37,Hydralazine may decrease the antihypertensive activities of Alclofenac.,37,Type_37,Yes
DB00932,Tipranavir,DB00997,Doxorubicin,0.834661602973938,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00292,Etomidate,DB00472,Fluoxetine,0.7714037299156189,37,Type_37,Etomidate may decrease the antihypertensive activities of Fluoxetine.,49,Type_49,No
DB00487,Pefloxacin,DB11093,Calcium citrate,0.9070597887039185,67,Type_67,Pefloxacin can cause a decrease in the absorption of Calcium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB04953,Ezogabine,DB09342,Propoxycaine,0.596439003944397,16,Type_16,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Propoxycaine.,49,Type_49,No
DB00244,Mesalazine,DB00927,Famotidine,0.405149906873703,57,Type_57,Mesalazine may increase the nephrotoxic activities of Famotidine.,70,Type_70,No
DB00185,Cevimeline,DB06603,Panobinostat,0.8689699769020081,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Cevimeline.,73,Type_73,Yes
DB00617,Paramethadione,DB00705,Delavirdine,0.9197985529899597,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Paramethadione.,47,Type_47,Yes
DB00283,Clemastine,DB00320,Dihydroergotamine,0.9396480917930603,47,Type_47,The metabolism of Dihydroergotamine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00257,Clotrimazole,DB00962,Zaleplon,0.7322795987129211,47,Type_47,The metabolism of Zaleplon can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00710,Ibandronate,DB04868,Nilotinib,0.9595326781272888,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB01009,Ketoprofen,DB01578,Metrizamide,0.9999277591705322,72,Type_72,Ketoprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level.,72,Type_72,Yes
DB00916,Metronidazole,DB01015,Sulfamethoxazole,0.5840560793876648,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Metronidazole.,47,Type_47,Yes
DB00502,Haloperidol,DB00683,Midazolam,0.6765882968902588,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Midazolam.,49,Type_49,Yes
DB00182,Amphetamine,DB00540,Nortriptyline,0.5609269738197327,23,Type_23,Amphetamine may increase the stimulatory activities of Nortriptyline.,23,Type_23,Yes
DB00379,Mexiletine,DB00604,Cisapride,0.8665919899940491,47,Type_47,The metabolism of Cisapride can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB06616,Bosutinib,DB08899,Enzalutamide,0.7850171327590942,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Bosutinib.,75,Type_75,Yes
DB00814,Meloxicam,DB01356,Lithium cation,0.7946950197219849,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Meloxicam.,73,Type_73,Yes
DB00582,Voriconazole,DB01151,Desipramine,0.5919908285140991,47,Type_47,The metabolism of Desipramine can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB01001,Salbutamol,DB01211,Clarithromycin,0.9175934195518494,20,Type_20,Salbutamol may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00569,Fondaparinux,DB00775,Tirofiban,0.7910341024398804,6,Type_6,Fondaparinux may increase the anticoagulant activities of Tirofiban.,6,Type_6,Yes
DB01427,Amrinone,DB09031,Miltefosine,0.8716352581977844,49,Type_49,The risk or severity of adverse effects can be increased when Amrinone is combined with Miltefosine.,49,Type_49,Yes
DB00912,Repaglinide,DB01067,Glipizide,0.9897701740264893,9,Type_9,Repaglinide may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00253,Medrysone,DB13783,Acemetacin,0.9687511324882507,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Acemetacin.,49,Type_49,Yes
DB00578,Carbenicillin,DB06263,Amrubicin,0.9985567927360535,75,Type_75,The serum concentration of Amrubicin can be decreased when it is combined with Carbenicillin.,75,Type_75,Yes
DB00679,Thioridazine,DB01100,Pimozide,0.7194811701774597,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Pimozide.,73,Type_73,No
DB01211,Clarithromycin,DB05039,Indacaterol,0.8637511730194092,47,Type_47,The metabolism of Indacaterol can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00861,Diflunisal,DB11079,Trolamine salicylate,0.9968063831329346,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Trolamine salicylate.,6,Type_6,No
DB00641,Simvastatin,DB00675,Tamoxifen,0.6263072490692139,73,Type_73,The serum concentration of Tamoxifen can be increased when it is combined with Simvastatin.,47,Type_47,No
DB00418,Secobarbital,DB01175,Escitalopram,0.5473467111587524,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Escitalopram.,49,Type_49,Yes
DB01124,Tolbutamide,DB01359,Penbutolol,0.9878643155097961,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Penbutolol.,9,Type_9,Yes
DB00310,Chlorthalidone,DB01251,Gliquidone,0.9983108043670654,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00214,Torasemide,DB00310,Chlorthalidone,0.9151492714881897,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Chlorthalidone.,49,Type_49,Yes
DB00277,Theophylline,DB08808,Bupranolol,0.9630018472671509,14,Type_14,Theophylline may decrease the bronchodilatory activities of Bupranolol.,14,Type_14,Yes
DB00865,Benzphetamine,DB09330,Osimertinib,0.6085582375526428,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Benzphetamine.,73,Type_73,Yes
DB00736,Esomeprazole,DB01166,Cilostazol,0.542048990726471,47,Type_47,The metabolism of Cilostazol can be decreased when combined with Esomeprazole.,73,Type_73,No
DB00959,Methylprednisolone,DB01208,Sparfloxacin,0.9663028120994568,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Sparfloxacin.,49,Type_49,Yes
DB00283,Clemastine,DB01154,Thiamylal,0.6316730976104736,47,Type_47,The metabolism of Thiamylal can be decreased when combined with Clemastine.,49,Type_49,No
DB00392,Profenamine,DB00647,Dextropropoxyphene,0.999954104423523,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00492,Fosinopril,DB03585,Oxyphenbutazone,0.9684080481529236,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Oxyphenbutazone.,49,Type_49,Yes
DB01061,Azlocillin,DB01082,Streptomycin,0.9989306330680847,75,Type_75,The serum concentration of Streptomycin can be decreased when it is combined with Azlocillin.,75,Type_75,Yes
DB00215,Citalopram,DB00245,Benzatropine,0.786998987197876,47,Type_47,The metabolism of Benzatropine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00298,Dapiprazole,DB00679,Thioridazine,0.9245120286941528,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Thioridazine.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01242,Clomipramine,0.6101579070091248,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Clomipramine.,49,Type_49,Yes
DB06772,Cabazitaxel,DB08820,Ivacaftor,0.9969737529754639,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Cabazitaxel.,73,Type_73,Yes
DB00593,Ethosuximide,DB01351,Amobarbital,0.9923345446586609,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Amobarbital.,49,Type_49,Yes
DB05812,Abiraterone,DB09073,Palbociclib,0.9951247572898865,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00294,Etonogestrel,DB12598,Nafamostat,0.6131055951118469,75,Type_75,The serum concentration of Nafamostat can be decreased when it is combined with Etonogestrel.,70,Type_70,No
DB00237,Butabarbital,DB00844,Nalbuphine,0.9980119466781616,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Nalbuphine.,49,Type_49,Yes
DB00818,Propofol,DB01227,Levacetylmethadol,0.6734116077423096,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Levacetylmethadol.,49,Type_49,Yes
DB00834,Mifepristone,DB01120,Gliclazide,0.5321857929229736,73,Type_73,The serum concentration of Gliclazide can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00794,Primidone,DB06605,Apixaban,0.943855345249176,4,Type_4,The metabolism of Apixaban can be increased when combined with Primidone.,75,Type_75,No
DB00618,Demeclocycline,DB13595,Almasilate,0.8839012980461121,67,Type_67,Demeclocycline can cause a decrease in the absorption of Almasilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB04839,Cyproterone acetate,DB09570,Ixazomib,0.693609893321991,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB04865,Omacetaxine mepesuccinate,DB08976,Floctafenine,0.9972947239875793,49,Type_49,The risk or severity of adverse effects can be increased when Omacetaxine mepesuccinate is combined with Floctafenine.,49,Type_49,Yes
DB00715,Paroxetine,DB00794,Primidone,0.39377593994140625,4,Type_4,The metabolism of Primidone can be increased when combined with Paroxetine.,49,Type_49,No
DB00465,Ketorolac,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Ketorolac.,70,Type_70,Yes
DB01013,Clobetasol propionate,DB08797,Salicylamide,0.9997425675392151,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Salicylamide.,49,Type_49,Yes
DB00695,Furosemide,DB09449,"Sodium phosphate, monobasic",0.9995288848876953,57,Type_57,"Furosemide may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB09073,Palbociclib,DB09280,Lumacaftor,0.753463625907898,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Palbociclib.,75,Type_75,No
DB00615,Rifabutin,DB00977,Ethinylestradiol,0.47698721289634705,75,Type_75,The serum concentration of Ethinylestradiol can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00808,Indapamide,DB01100,Pimozide,0.4987153708934784,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Pimozide.,20,Type_20,No
DB01320,Fosphenytoin,DB01353,Butobarbital,0.9832248687744141,49,Type_49,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Butobarbital.,49,Type_49,Yes
DB00278,Argatroban,DB04573,Estriol,0.7542474865913391,12,Type_12,Argatroban may decrease the anticoagulant activities of Estriol.,12,Type_12,Yes
DB00686,Pentosan polysulfate,DB01435,Antipyrine,0.9811131954193115,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Antipyrine.,6,Type_6,Yes
DB00887,Bumetanide,DB09227,Barnidipine,0.9873660802841187,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Barnidipine.,49,Type_49,Yes
DB01016,Glyburide,DB06717,Fosaprepitant,0.8395837545394897,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB00818,Propofol,DB00887,Bumetanide,0.9348524808883667,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Bumetanide.,49,Type_49,Yes
DB00972,Azelastine,DB01142,Doxepin,0.7220884561538696,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Doxepin.,16,Type_16,Yes
DB00247,Methysergide,DB00281,Lidocaine,0.9926124811172485,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Lidocaine.,49,Type_49,Yes
DB00708,Sufentanil,DB09054,Idelalisib,0.770340621471405,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Sufentanil.,47,Type_47,Yes
DB00708,Sufentanil,DB00754,Ethotoin,0.9952061772346497,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Ethotoin.,49,Type_49,Yes
DB00091,Cyclosporine,DB01129,Rabeprazole,0.8496118783950806,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00409,Remoxipride,DB01621,Pipotiazine,0.9937564134597778,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Pipotiazine.,49,Type_49,Yes
DB00315,Zolmitriptan,DB00656,Trazodone,0.706400454044342,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trazodone.,49,Type_49,Yes
DB00820,Tadalafil,DB01072,Atazanavir,0.6759525537490845,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Tadalafil.,73,Type_73,Yes
DB00865,Benzphetamine,DB04896,Milnacipran,0.7976898550987244,37,Type_37,Benzphetamine may decrease the antihypertensive activities of Milnacipran.,37,Type_37,Yes
DB00264,Metoprolol,DB00608,Chloroquine,0.5669381022453308,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Metoprolol.,73,Type_73,No
DB01016,Glyburide,DB01110,Miconazole,0.3781884014606476,49,Type_49,The risk or severity of adverse effects can be increased when Glyburide is combined with Miconazole.,9,Type_9,No
DB00788,Naproxen,DB01197,Captopril,0.8219044208526611,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Captopril.,49,Type_49,Yes
DB00222,Glimepiride,DB00304,Desogestrel,0.9968110918998718,70,Type_70,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Glimepiride.,70,Type_70,Yes
DB00252,Phenytoin,DB00637,Astemizole,0.5819448232650757,4,Type_4,The metabolism of Astemizole can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00708,Sufentanil,DB09166,Etizolam,0.9933958649635315,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Etizolam.,49,Type_49,Yes
DB01072,Atazanavir,DB09238,Manidipine,0.8359229564666748,47,Type_47,The metabolism of Manidipine can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB04865,Omacetaxine mepesuccinate,DB13783,Acemetacin,0.9616317749023438,66,Type_66,The risk or severity of bleeding can be increased when Omacetaxine mepesuccinate is combined with Acemetacin.,49,Type_49,No
DB00213,Pantoprazole,DB00682,Warfarin,0.5251277089118958,47,Type_47,The metabolism of Warfarin can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB01397,Magnesium salicylate,DB01708,Prasterone,0.9972602128982544,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Prasterone.,49,Type_49,Yes
DB00195,Betaxolol,DB00679,Thioridazine,0.579054594039917,47,Type_47,The metabolism of Thioridazine can be decreased when combined with Betaxolol.,73,Type_73,No
DB00215,Citalopram,DB01018,Guanfacine,0.4964402914047241,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00498,Phenindione,DB11636,Nomegestrol,1.0,70,Type_70,The therapeutic efficacy of Nomegestrol can be decreased when used in combination with Phenindione.,70,Type_70,Yes
DB00705,Delavirdine,DB06626,Axitinib,0.4752742052078247,47,Type_47,The metabolism of Axitinib can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01015,Sulfamethoxazole,DB06770,Benzyl alcohol,0.9536120891571045,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB04878,Voglibose,DB08912,Dabrafenib,0.9706101417541504,70,Type_70,The therapeutic efficacy of Dabrafenib can be decreased when used in combination with Voglibose.,70,Type_70,Yes
DB00629,Guanabenz,DB01324,Polythiazide,0.9177342653274536,60,Type_60,Guanabenz may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00323,Tolcapone,DB01210,Levobunolol,0.6854163408279419,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Levobunolol.,49,Type_49,Yes
DB04920,Clevidipine,DB09220,Nicorandil,0.5216049551963806,68,Type_68,Clevidipine may increase the hyperkalemic activities of Nicorandil.,60,Type_60,No
DB01261,Sitagliptin,DB01367,Rasagiline,0.9959332346916199,9,Type_9,Sitagliptin may increase the hypoglycemic activities of Rasagiline.,9,Type_9,Yes
DB00275,Olmesartan,DB01600,Tiaprofenic acid,0.9216672778129578,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Tiaprofenic acid.,49,Type_49,Yes
DB01431,Allylestrenol,DB09063,Ceritinib,0.9946540594100952,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Allylestrenol.,73,Type_73,Yes
DB09183,Dasabuvir,DB09280,Lumacaftor,0.6854499578475952,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Dasabuvir.,73,Type_73,No
DB01014,Balsalazide,DB09216,Tolfenamic acid,0.5428640246391296,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Tolfenamic acid.,57,Type_57,No
DB00582,Voriconazole,DB01002,Levobupivacaine,0.7963244318962097,47,Type_47,The metabolism of Levobupivacaine can be decreased when combined with Voriconazole.,73,Type_73,No
DB00175,Pravastatin,DB00481,Raloxifene,0.4957036077976227,73,Type_73,The serum concentration of Raloxifene can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00390,Digoxin,DB01076,Atorvastatin,0.7365812063217163,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00500,Tolmetin,DB01013,Clobetasol propionate,0.9999264478683472,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Clobetasol propionate.,49,Type_49,Yes
DB00363,Clozapine,DB06738,Ketobemidone,0.5795571208000183,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Clozapine.,49,Type_49,No
DB00593,Ethosuximide,DB01219,Dantrolene,0.9985584616661072,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Dantrolene.,49,Type_49,Yes
DB08439,Parecoxib,DB08899,Enzalutamide,0.9794418811798096,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Parecoxib.,75,Type_75,Yes
DB00169,Cholecalciferol,DB01071,Mequitazine,0.7025346159934998,70,Type_70,The therapeutic efficacy of Mequitazine can be decreased when used in combination with Cholecalciferol.,47,Type_47,No
DB00912,Repaglinide,DB08882,Linagliptin,0.855624794960022,9,Type_9,Repaglinide may increase the hypoglycemic activities of Linagliptin.,9,Type_9,Yes
DB00608,Chloroquine,DB13167,Alclofenac,0.9293071031570435,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Alclofenac.,49,Type_49,Yes
DB00245,Benzatropine,DB06698,Betahistine,0.8654647469520569,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzatropine.,70,Type_70,Yes
DB00797,Tolazoline,DB04861,Nebivolol,0.8560137152671814,60,Type_60,Tolazoline may increase the hypotensive activities of Nebivolol.,60,Type_60,Yes
DB00413,Pramipexole,DB00748,Carbinoxamine,0.999981164932251,32,Type_32,Pramipexole may increase the sedative activities of Carbinoxamine.,32,Type_32,Yes
DB02703,Fusidic acid,DB09128,Brexpiprazole,0.9978129863739014,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00474,Methohexital,DB09009,Articaine,0.999875545501709,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Articaine.,49,Type_49,Yes
DB01252,Mitiglinide,DB09063,Ceritinib,0.9971988201141357,70,Type_70,The therapeutic efficacy of Ceritinib can be decreased when used in combination with Mitiglinide.,70,Type_70,Yes
DB01050,Ibuprofen,DB01172,Kanamycin,0.9999337196350098,72,Type_72,Ibuprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,72,Type_72,Yes
DB00333,Methadone,DB01609,Deferasirox,0.950676441192627,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Methadone.,75,Type_75,Yes
DB00474,Methohexital,DB01240,Epoprostenol,0.7564422488212585,4,Type_4,The metabolism of Epoprostenol can be increased when combined with Methohexital.,60,Type_60,No
DB01427,Amrinone,DB11126,Calcium gluconate,0.9495996832847595,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Amrinone.,70,Type_70,Yes
DB00946,Phenprocoumon,DB01132,Pioglitazone,0.2938627302646637,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB00196,Fluconazole,DB06725,Lornoxicam,0.941670298576355,47,Type_47,The metabolism of Lornoxicam can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00654,Latanoprost,DB01283,Lumiracoxib,0.9720583558082581,70,Type_70,The therapeutic efficacy of Lumiracoxib can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB00285,Venlafaxine,DB00869,Dorzolamide,0.9515296220779419,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00822,Disulfiram,DB09330,Osimertinib,0.9324316382408142,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Disulfiram.,73,Type_73,Yes
DB00956,Hydrocodone,DB01345,Potassium cation,0.9993334412574768,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Potassium cation.,49,Type_49,Yes
DB00349,Clobazam,DB12161,Deutetrabenazine,0.9692810773849487,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00784,Mefenamic acid,DB09167,Dosulepin,0.8523494005203247,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Mefenamic acid.,47,Type_47,Yes
DB00860,Prednisolone,DB01609,Deferasirox,0.7274735569953918,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Prednisolone.,75,Type_75,Yes
DB00295,Morphine,DB00540,Nortriptyline,0.5195832848548889,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Nortriptyline.,49,Type_49,Yes
DB00831,Trifluoperazine,DB06201,Rufinamide,0.9845358729362488,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Rufinamide.,49,Type_49,Yes
DB01615,Aceprometazine,DB08987,Etidocaine,0.9999814033508301,49,Type_49,The risk or severity of adverse effects can be increased when Aceprometazine is combined with Etidocaine.,49,Type_49,Yes
DB00573,Fenoprofen,DB00963,Bromfenac,0.9991593360900879,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Bromfenac.,49,Type_49,Yes
DB00240,Alclometasone,DB01226,Mivacurium,0.998561441898346,22,Type_22,Alclometasone may increase the adverse neuromuscular activities of Mivacurium.,22,Type_22,Yes
DB01239,Chlorprothixene,DB01394,Colchicine,0.9520634412765503,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Chlorprothixene.,73,Type_73,Yes
DB00294,Etonogestrel,DB01124,Tolbutamide,0.8950390219688416,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00870,Suprofen,DB01349,Tasosartan,0.5843335390090942,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Suprofen.,49,Type_49,No
DB00188,Bortezomib,DB00492,Fosinopril,0.5427687168121338,47,Type_47,The metabolism of Fosinopril can be decreased when combined with Bortezomib.,49,Type_49,No
DB00705,Delavirdine,DB01029,Irbesartan,0.9254565238952637,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00541,Vincristine,DB00655,Estrone,0.49247416853904724,73,Type_73,The serum concentration of Estrone can be increased when it is combined with Vincristine.,75,Type_75,No
DB00243,Ranolazine,DB00623,Fluphenazine,0.7138088941574097,73,Type_73,The serum concentration of Fluphenazine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01463,Fencamfamin,DB01623,Thiothixene,0.8106565475463867,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Thiothixene.,49,Type_49,Yes
DB00373,Timolol,DB00545,Pyridostigmine,0.9664748311042786,54,Type_54,Timolol may increase the bradycardic activities of Pyridostigmine.,54,Type_54,Yes
DB00619,Imatinib,DB00956,Hydrocodone,0.9529725909233093,47,Type_47,The metabolism of Hydrocodone can be decreased when combined with Imatinib.,73,Type_73,No
DB01070,Dihydrotachysterol,DB01324,Polythiazide,0.9991233944892883,51,Type_51,Dihydrotachysterol may increase the hypercalcemic activities of Polythiazide.,51,Type_51,Yes
DB01059,Norfloxacin,DB01175,Escitalopram,0.759502649307251,20,Type_20,Norfloxacin may increase the QTc-prolonging activities of Escitalopram.,20,Type_20,Yes
DB01591,Solifenacin,DB09078,Lenvatinib,0.9570099711418152,20,Type_20,Solifenacin may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB01590,Everolimus,DB01609,Deferasirox,0.5992717742919922,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Everolimus.,75,Type_75,Yes
DB00690,Flurazepam,DB01595,Nitrazepam,0.9822425842285156,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Nitrazepam.,49,Type_49,Yes
DB00322,Floxuridine,DB01544,Flunitrazepam,0.9699429869651794,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB00780,Phenelzine,0.7915374040603638,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenelzine.,49,Type_49,Yes
DB01295,Bevantolol,DB08797,Salicylamide,0.9987677335739136,37,Type_37,Bevantolol may decrease the antihypertensive activities of Salicylamide.,37,Type_37,Yes
DB00287,Travoprost,DB00945,Acetylsalicylic acid,0.9016596078872681,70,Type_70,The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB01071,Mequitazine,DB09167,Dosulepin,0.8657507300376892,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Mequitazine.,73,Type_73,No
DB01104,Sertraline,DB01195,Flecainide,0.3874147832393646,20,Type_20,Sertraline may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00422,Methylphenidate,DB01069,Promethazine,0.8829582929611206,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Promethazine.,18,Type_18,No
DB00476,Duloxetine,DB01063,Acetophenazine,0.9866107702255249,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Acetophenazine.,49,Type_49,Yes
DB08954,Ifenprodil,DB11268,Protocatechualdehyde,0.9990695118904114,6,Type_6,Ifenprodil may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB01234,Dexamethasone,DB09038,Empagliflozin,0.9491741061210632,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Dexamethasone.,70,Type_70,Yes
DB00331,Metformin,DB00695,Furosemide,0.6997884511947632,70,Type_70,The therapeutic efficacy of Furosemide can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00695,Furosemide,DB01016,Glyburide,0.719123363494873,70,Type_70,The therapeutic efficacy of Glyburide can be decreased when used in combination with Furosemide.,70,Type_70,Yes
DB00996,Gabapentin,DB01220,Rifaximin,0.6274399757385254,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Gabapentin.,75,Type_75,No
DB00678,Losartan,DB00997,Doxorubicin,0.6464316248893738,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Losartan.,73,Type_73,Yes
DB00593,Ethosuximide,DB00705,Delavirdine,0.8333990573883057,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Ethosuximide.,47,Type_47,Yes
DB08907,Canagliflozin,DB09123,Dienogest,0.6983606219291687,70,Type_70,The therapeutic efficacy of Dienogest can be decreased when used in combination with Canagliflozin.,70,Type_70,Yes
DB00391,Sulpiride,DB00842,Oxazepam,0.9751877784729004,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Oxazepam.,49,Type_49,Yes
DB00285,Venlafaxine,DB00373,Timolol,0.8260959386825562,47,Type_47,The metabolism of Timolol can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00768,Olopatadine,DB01106,Levocabastine,0.98997563123703,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Levocabastine.,49,Type_49,Yes
DB00909,Zonisamide,DB01588,Prazepam,0.9990070462226868,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Prazepam.,49,Type_49,Yes
DB05381,Histamine,DB06702,Fesoterodine,0.7740247249603271,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Histamine.,77,Type_77,Yes
DB00368,Norepinephrine,DB01021,Trichlormethiazide,0.9781578183174133,83,Type_83,Norepinephrine may increase the hypokalemic activities of Trichlormethiazide.,83,Type_83,Yes
DB00613,Amodiaquine,DB09054,Idelalisib,0.7737776041030884,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Amodiaquine.,73,Type_73,No
DB00715,Paroxetine,DB09072,Sodium oxybate,0.9644604325294495,16,Type_16,Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,49,Type_49,No
DB04868,Nilotinib,DB06789,Hydroxyprogesterone caproate,0.9235824942588806,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB00573,Fenoprofen,DB01133,Tiludronic acid,0.9939972162246704,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Tiludronic acid.,49,Type_49,Yes
DB00471,Montelukast,DB01319,Fosamprenavir,0.9382384419441223,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Montelukast.,47,Type_47,Yes
DB01026,Ketoconazole,DB01392,Yohimbine,0.9809695482254028,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00206,Reserpine,DB01069,Promethazine,0.9354451298713684,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Promethazine.,49,Type_49,Yes
DB00829,Diazepam,DB08860,Pitavastatin,0.600311279296875,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB00208,Ticlopidine,DB00987,Cytarabine,0.8754411339759827,47,Type_47,The metabolism of Cytarabine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00402,Eszopiclone,DB01095,Fluvastatin,0.4918714463710785,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Eszopiclone.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB01104,Sertraline,0.9009348750114441,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Sertraline.,49,Type_49,Yes
DB00213,Pantoprazole,DB01075,Diphenhydramine,0.9801115393638611,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00496,Darifenacin,DB00598,Labetalol,0.7481201887130737,47,Type_47,The metabolism of Labetalol can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB06702,Fesoterodine,DB09330,Osimertinib,0.4816668629646301,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Fesoterodine.,73,Type_73,Yes
DB01544,Flunitrazepam,DB09167,Dosulepin,0.885928750038147,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Flunitrazepam.,47,Type_47,Yes
DB00633,Dexmedetomidine,DB00678,Losartan,0.5777390599250793,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Losartan.,49,Type_49,Yes
DB01069,Promethazine,DB06723,Aluminum hydroxide,0.7589461803436279,67,Type_67,Promethazine can cause a decrease in the absorption of Aluminum hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00918,Almotriptan,DB01253,Ergometrine,0.9759959578514099,49,Type_49,The risk or severity of adverse effects can be increased when Almotriptan is combined with Ergometrine.,49,Type_49,Yes
DB00679,Thioridazine,DB03754,Tromethamine,0.9650389552116394,67,Type_67,Thioridazine can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00180,Flunisolide,DB01324,Polythiazide,0.9996116757392883,83,Type_83,Flunisolide may increase the hypokalemic activities of Polythiazide.,83,Type_83,Yes
DB09053,Ibrutinib,DB13878,Pibrentasvir,0.6349141001701355,75,Type_75,The serum concentration of Pibrentasvir can be decreased when it is combined with Ibrutinib.,73,Type_73,No
DB01149,Nefazodone,DB04908,Flibanserin,0.557456910610199,49,Type_49,The risk or severity of adverse effects can be increased when Nefazodone is combined with Flibanserin.,73,Type_73,No
DB00232,Methyclothiazide,DB00678,Losartan,0.9654417037963867,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Losartan.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00328,Indomethacin,0.9725443124771118,70,Type_70,The therapeutic efficacy of Indomethacin can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00691,Moexipril,DB00805,Minaprine,0.9820610284805298,60,Type_60,Moexipril may increase the hypotensive activities of Minaprine.,60,Type_60,Yes
DB00809,Tropicamide,DB12278,Propiverine,0.864008903503418,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Propiverine.,49,Type_49,Yes
DB00215,Citalopram,DB01209,Dezocine,0.7758844494819641,64,Type_64,Citalopram may increase the serotonergic activities of Dezocine.,64,Type_64,Yes
DB00188,Bortezomib,DB00863,Ranitidine,0.8723337054252625,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01068,Clonazepam,DB04842,Fluspirilene,0.9960435628890991,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Fluspirilene.,49,Type_49,Yes
DB00327,Hydromorphone,DB01201,Rifapentine,0.9308518767356873,4,Type_4,The metabolism of Rifapentine can be increased when combined with Hydromorphone.,4,Type_4,Yes
DB00240,Alclometasone,DB01167,Itraconazole,0.9481083750724792,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB00288,Amcinonide,DB00682,Warfarin,0.897771954536438,6,Type_6,Amcinonide may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB01090,Pentolinium,DB01466,Ethylmorphine,0.9943298101425171,49,Type_49,The risk or severity of adverse effects can be increased when Pentolinium is combined with Ethylmorphine.,49,Type_49,Yes
DB00484,Brimonidine,DB00933,Mesoridazine,0.9986405968666077,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.,16,Type_16,Yes
DB00321,Amitriptyline,DB00701,Amprenavir,0.44561222195625305,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Amitriptyline.,73,Type_73,No
DB01182,Propafenone,DB04868,Nilotinib,0.43018263578414917,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Propafenone.,73,Type_73,No
DB00523,Alitretinoin,DB09093,Chlortetracycline,0.7114884257316589,70,Type_70,The therapeutic efficacy of Chlortetracycline can be decreased when used in combination with Alitretinoin.,49,Type_49,No
DB01054,Nitrendipine,DB09204,Arotinolol,0.8968374729156494,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Arotinolol.,49,Type_49,Yes
DB00621,Oxandrolone,DB00672,Chlorpropamide,0.9999843835830688,9,Type_9,Oxandrolone may increase the hypoglycemic activities of Chlorpropamide.,9,Type_9,Yes
DB00295,Morphine,DB00966,Telmisartan,0.8905622363090515,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Telmisartan.,49,Type_49,Yes
DB00469,Tenoxicam,DB00489,Sotalol,0.9926626682281494,37,Type_37,Tenoxicam may decrease the antihypertensive activities of Sotalol.,37,Type_37,Yes
DB00254,Doxycycline,DB01115,Nifedipine,0.9069161415100098,47,Type_47,The metabolism of Nifedipine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00392,Profenamine,DB00524,Metolazone,0.999622106552124,73,Type_73,The serum concentration of Metolazone can be increased when it is combined with Profenamine.,73,Type_73,Yes
DB00228,Enflurane,DB00972,Azelastine,0.7557839751243591,16,Type_16,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB06636,Isavuconazonium,DB08932,Macitentan,0.8539231419563293,47,Type_47,The metabolism of Macitentan can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00208,Ticlopidine,DB01036,Tolterodine,0.9488716721534729,47,Type_47,The metabolism of Tolterodine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00590,Doxazosin,DB06708,Lumefantrine,0.8246113657951355,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB01074,Perhexiline,DB06603,Panobinostat,0.9090395569801331,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Perhexiline.,73,Type_73,Yes
DB00195,Betaxolol,DB01409,Tiotropium,0.8515956401824951,47,Type_47,The metabolism of Tiotropium can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00975,Dipyridamole,DB08931,Riociguat,0.9513024687767029,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Riociguat.,60,Type_60,No
DB00491,Miglitol,DB01367,Rasagiline,0.9992433786392212,9,Type_9,Miglitol may increase the hypoglycemic activities of Rasagiline.,9,Type_9,Yes
DB01242,Clomipramine,DB06711,Naphazoline,0.998711347579956,37,Type_37,Clomipramine may decrease the antihypertensive activities of Naphazoline.,37,Type_37,Yes
DB00794,Primidone,DB00932,Tipranavir,0.5928608179092407,4,Type_4,The metabolism of Tipranavir can be increased when combined with Primidone.,4,Type_4,Yes
DB00608,Chloroquine,DB01160,Dinoprost tromethamine,0.8797995448112488,70,Type_70,The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Chloroquine.,70,Type_70,Yes
DB00370,Mirtazapine,DB01288,Fenoterol,0.9214769005775452,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Fenoterol.,49,Type_49,Yes
DB00238,Nevirapine,DB02187,Equilin,0.8803998231887817,75,Type_75,The serum concentration of Equilin can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00753,Isoflurane,DB01184,Domperidone,0.8784545660018921,20,Type_20,Isoflurane may increase the QTc-prolonging activities of Domperidone.,20,Type_20,Yes
DB00264,Metoprolol,DB09215,Droxicam,0.9968293309211731,37,Type_37,Metoprolol may decrease the antihypertensive activities of Droxicam.,37,Type_37,Yes
DB00802,Alfentanil,DB00903,Etacrynic acid,0.9981216788291931,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Etacrynic acid.,49,Type_49,Yes
DB00657,Mecamylamine,DB00677,Isoflurophate,0.8617644309997559,70,Type_70,The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Mecamylamine.,70,Type_70,Yes
DB00014,Goserelin,DB04946,Iloperidone,0.9992701411247253,20,Type_20,Goserelin may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB01242,Clomipramine,DB06402,Telavancin,0.9999951124191284,20,Type_20,Clomipramine may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00266,Dicoumarol,DB00788,Naproxen,0.9994727969169617,6,Type_6,Dicoumarol may increase the anticoagulant activities of Naproxen.,6,Type_6,Yes
DB00224,Indinavir,DB00977,Ethinylestradiol,0.3853393793106079,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00807,Proparacaine,DB06153,Pizotifen,0.9595286250114441,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Pizotifen.,49,Type_49,Yes
DB00237,Butabarbital,DB01149,Nefazodone,0.8488196730613708,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Nefazodone.,49,Type_49,Yes
DB01026,Ketoconazole,DB01171,Moclobemide,0.8879909515380859,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00241,Butalbital,DB01173,Orphenadrine,0.996466875076294,16,Type_16,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB01142,Doxepin,DB01197,Captopril,0.8306708931922913,73,Type_73,The serum concentration of Captopril can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB00209,Trospium,DB00802,Alfentanil,0.9994872808456421,49,Type_49,The risk or severity of adverse effects can be increased when Trospium is combined with Alfentanil.,49,Type_49,Yes
DB00188,Bortezomib,DB01158,Bretylium,0.9815831780433655,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Bretylium.,49,Type_49,Yes
DB01340,Cilazapril,DB06480,Prucalopride,0.9044304490089417,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Cilazapril.,73,Type_73,Yes
DB00243,Ranolazine,DB00915,Amantadine,0.6929339170455933,73,Type_73,The serum concentration of Amantadine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00489,Sotalol,DB00734,Risperidone,0.6675530076026917,25,Type_25,Sotalol may increase the atrioventricular blocking (AV block) activities of Risperidone.,60,Type_60,No
DB00292,Etomidate,DB09286,Pipamperone,0.9886125922203064,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Pipamperone.,49,Type_49,Yes
DB09075,Edoxaban,DB09291,Rolapitant,0.8525180816650391,73,Type_73,The serum concentration of Rolapitant can be increased when it is combined with Edoxaban.,73,Type_73,Yes
DB00622,Nicardipine,DB06603,Panobinostat,0.6627381443977356,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB00285,Venlafaxine,DB01440,gamma-Hydroxybutyric acid,0.9896552562713623,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB09216,Tolfenamic acid,DB11126,Calcium gluconate,0.9012166857719421,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Tolfenamic acid.,70,Type_70,Yes
DB00035,Desmopressin,DB00749,Etodolac,0.7553490996360779,70,Type_70,The therapeutic efficacy of Etodolac can be decreased when used in combination with Desmopressin.,49,Type_49,No
DB00744,Zileuton,DB01297,Practolol,0.999980092048645,37,Type_37,Zileuton may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00904,Ondansetron,DB01264,Darunavir,0.7472743988037109,47,Type_47,The metabolism of Darunavir can be decreased when combined with Ondansetron.,73,Type_73,No
DB00312,Pentobarbital,DB00647,Dextropropoxyphene,0.9637212753295898,4,Type_4,The metabolism of Dextropropoxyphene can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00370,Mirtazapine,DB01291,Pirbuterol,0.9232227802276611,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Pirbuterol.,49,Type_49,Yes
DB00489,Sotalol,DB00939,Meclofenamic acid,0.9295738935470581,37,Type_37,Sotalol may decrease the antihypertensive activities of Meclofenamic acid.,37,Type_37,Yes
DB00613,Amodiaquine,DB00850,Perphenazine,0.8629920482635498,47,Type_47,The metabolism of Perphenazine can be decreased when combined with Amodiaquine.,73,Type_73,No
DB01628,Etoricoxib,DB02703,Fusidic acid,0.9980712532997131,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Etoricoxib.,73,Type_73,Yes
DB00474,Methohexital,DB00807,Proparacaine,0.9999265670776367,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Proparacaine.,49,Type_49,Yes
DB00323,Tolcapone,DB09227,Barnidipine,0.9685643315315247,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Barnidipine.,49,Type_49,Yes
DB00722,Lisinopril,DB09220,Nicorandil,0.9905187487602234,60,Type_60,Lisinopril may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB01192,Oxymorphone,DB09244,Pirlindole,0.8850091695785522,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Pirlindole.,49,Type_49,Yes
DB01013,Clobetasol propionate,DB06717,Fosaprepitant,0.8777465224266052,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Clobetasol propionate.,73,Type_73,Yes
DB00408,Loxapine,DB00660,Metaxalone,0.9999804496765137,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Metaxalone.,49,Type_49,Yes
DB00328,Indomethacin,DB01349,Tasosartan,0.8346573114395142,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Indomethacin.,49,Type_49,No
DB00203,Sildenafil,DB09262,Imidafenacin,0.9383265972137451,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01113,Papaverine,DB01197,Captopril,0.995919942855835,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Captopril.,49,Type_49,Yes
DB00313,Valproic acid,DB01018,Guanfacine,0.484772264957428,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Guanfacine.,73,Type_73,No
DB00091,Cyclosporine,DB00658,Sevelamer,0.9297213554382324,75,Type_75,The serum concentration of Sevelamer can be decreased when it is combined with Cyclosporine.,75,Type_75,Yes
DB01041,Thalidomide,DB01248,Docetaxel,0.8071944713592529,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Docetaxel.,49,Type_49,Yes
DB01200,Bromocriptine,DB09027,Ledipasvir,0.9311016798019409,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Bromocriptine.,73,Type_73,Yes
DB00391,Sulpiride,DB09166,Etizolam,0.9153095483779907,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Etizolam.,49,Type_49,Yes
DB00795,Sulfasalazine,DB06810,Plicamycin,0.9996631145477295,72,Type_72,Sulfasalazine may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00475,Chlordiazepoxide,DB09225,Zotepine,0.9994964599609375,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zotepine.,49,Type_49,Yes
DB00328,Indomethacin,DB06696,Arbekacin,0.9998199343681335,72,Type_72,Indomethacin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,72,Type_72,Yes
DB00169,Cholecalciferol,DB08922,Perospirone,0.8718936443328857,47,Type_47,The metabolism of Perospirone can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00204,Dofetilide,DB01034,Cerulenin,0.9575812220573425,73,Type_73,The serum concentration of Cerulenin can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB00391,Sulpiride,DB09104,Magnesium hydroxide,0.8281782269477844,67,Type_67,Sulpiride can cause a decrease in the absorption of Magnesium hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00289,Atomoxetine,DB00393,Nimodipine,0.8846949934959412,47,Type_47,The metabolism of Nimodipine can be decreased when combined with Atomoxetine.,73,Type_73,No
DB00368,Norepinephrine,DB00695,Furosemide,0.9942785501480103,83,Type_83,Norepinephrine may increase the hypokalemic activities of Furosemide.,83,Type_83,Yes
DB06216,Asenapine,DB08872,Gabapentin enacarbil,0.9999129772186279,49,Type_49,The risk or severity of adverse effects can be increased when Asenapine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00619,Imatinib,DB11575,Grazoprevir,0.9418787956237793,47,Type_47,The metabolism of Grazoprevir can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00254,Doxycycline,DB00987,Cytarabine,0.8894047141075134,47,Type_47,The metabolism of Cytarabine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB04794,Bifonazole,DB09270,Ubidecarenone,0.5063737630844116,49,Type_49,The risk or severity of adverse effects can be increased when Bifonazole is combined with Ubidecarenone.,73,Type_73,No
DB01208,Sparfloxacin,DB06781,Difluprednate,0.9372128248214722,49,Type_49,The risk or severity of adverse effects can be increased when Sparfloxacin is combined with Difluprednate.,49,Type_49,Yes
DB00706,Tamsulosin,DB09236,Lacidipine,0.9748719334602356,60,Type_60,Tamsulosin may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB08873,Boceprevir,DB11586,Asunaprevir,0.6604083180427551,47,Type_47,The metabolism of Asunaprevir can be decreased when combined with Boceprevir.,75,Type_75,No
DB08896,Regorafenib,DB09270,Ubidecarenone,0.9690017104148865,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Regorafenib.,73,Type_73,Yes
DB00285,Venlafaxine,DB00334,Olanzapine,0.6693090200424194,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Olanzapine.,64,Type_64,No
DB00852,Pseudoephedrine,DB00908,Quinidine,0.901081383228302,47,Type_47,The metabolism of Quinidine can be decreased when combined with Pseudoephedrine.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB06702,Fesoterodine,0.9890639185905457,73,Type_73,The serum concentration of Fesoterodine can be increased when it is combined with Hydroflumethiazide.,73,Type_73,Yes
DB00573,Fenoprofen,DB01324,Polythiazide,0.9996352195739746,70,Type_70,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Fenoprofen.,70,Type_70,Yes
DB00681,Amphotericin B,DB00936,Salicylic acid,0.9019249081611633,70,Type_70,The therapeutic efficacy of Salicylic acid can be decreased when used in combination with Amphotericin B.,70,Type_70,Yes
DB06700,Desvenlafaxine,DB09166,Etizolam,0.9915860891342163,49,Type_49,The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Etizolam.,49,Type_49,Yes
DB00208,Ticlopidine,DB00404,Alprazolam,0.962462306022644,47,Type_47,The metabolism of Alprazolam can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00405,Dexbrompheniramine,DB12532,Oxetacaine,0.9999970197677612,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Oxetacaine.,49,Type_49,Yes
DB00246,Ziprasidone,DB09078,Lenvatinib,0.7665687203407288,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Lenvatinib.,47,Type_47,No
DB00193,Tramadol,DB00257,Clotrimazole,0.8391003608703613,47,Type_47,The metabolism of Clotrimazole can be decreased when combined with Tramadol.,70,Type_70,No
DB00695,Furosemide,DB01244,Bepridil,0.9538024663925171,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Bepridil.,49,Type_49,Yes
DB00706,Tamsulosin,DB09204,Arotinolol,0.8513904809951782,49,Type_49,The risk or severity of adverse effects can be increased when Tamsulosin is combined with Arotinolol.,30,Type_30,No
DB00839,Tolazamide,DB04339,Carbocisteine,0.9973652958869934,49,Type_49,The risk or severity of adverse effects can be increased when Tolazamide is combined with Carbocisteine.,49,Type_49,Yes
DB00887,Bumetanide,DB01143,Amifostine,0.7452158331871033,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Amifostine.,49,Type_49,Yes
DB00223,Diflorasone,DB06802,Nepafenac,0.9997103810310364,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Nepafenac.,49,Type_49,Yes
DB00956,Hydrocodone,DB09241,Methylene blue,0.7787651419639587,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Methylene blue.,49,Type_49,Yes
DB01174,Phenobarbital,DB01295,Bevantolol,0.6655961275100708,75,Type_75,The serum concentration of Bevantolol can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00471,Montelukast,DB01263,Posaconazole,0.9643213152885437,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Montelukast.,47,Type_47,Yes
DB01168,Procarbazine,DB01229,Paclitaxel,0.9993358254432678,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Paclitaxel.,49,Type_49,Yes
DB00285,Venlafaxine,DB00949,Felbamate,0.4544563591480255,47,Type_47,The metabolism of Felbamate can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00310,Chlorthalidone,DB00972,Azelastine,0.9946860074996948,70,Type_70,The therapeutic efficacy of Azelastine can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00218,Moxifloxacin,DB00537,Ciprofloxacin,0.9993422627449036,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Ciprofloxacin.,20,Type_20,Yes
DB00323,Tolcapone,DB00652,Pentazocine,0.9984506368637085,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Pentazocine.,49,Type_49,Yes
DB00909,Zonisamide,DB06201,Rufinamide,0.9982137680053711,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Rufinamide.,49,Type_49,Yes
DB01092,Ouabain,DB09123,Dienogest,0.9639275074005127,58,Type_58,Ouabain may decrease the cardiotoxic activities of Dienogest.,58,Type_58,Yes
DB08877,Ruxolitinib,DB08933,Luliconazole,0.9542937874794006,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Ruxolitinib.,73,Type_73,Yes
DB00246,Ziprasidone,DB01168,Procarbazine,0.558814525604248,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Procarbazine.,49,Type_49,Yes
DB01377,Magnesium oxide,DB09090,Pinaverium,0.9070081114768982,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Pinaverium.,49,Type_49,Yes
DB01394,Colchicine,DB08873,Boceprevir,0.9386191368103027,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Colchicine.,73,Type_73,Yes
DB01102,Arbutamine,DB09289,Tianeptine,0.890042245388031,49,Type_49,The risk or severity of adverse effects can be increased when Arbutamine is combined with Tianeptine.,49,Type_49,Yes
DB04552,Niflumic acid,DB06826,Unoprostone,0.9998606443405151,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Niflumic acid.,70,Type_70,Yes
DB01184,Domperidone,DB05219,Crisaborole,0.9917678833007812,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Domperidone.,47,Type_47,Yes
DB00338,Omeprazole,DB00454,Meperidine,0.9502105712890625,47,Type_47,The metabolism of Meperidine can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00254,Doxycycline,DB00726,Trimipramine,0.887641191482544,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00474,Methohexital,DB09166,Etizolam,0.9302131533622742,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Etizolam.,49,Type_49,Yes
DB00722,Lisinopril,DB00924,Cyclobenzaprine,0.7691885232925415,73,Type_73,The serum concentration of Cyclobenzaprine can be increased when it is combined with Lisinopril.,73,Type_73,Yes
DB00805,Minaprine,DB01291,Pirbuterol,0.9393421411514282,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Pirbuterol.,49,Type_49,Yes
DB00295,Morphine,DB00872,Conivaptan,0.6126584410667419,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Conivaptan.,73,Type_73,No
DB00502,Haloperidol,DB08873,Boceprevir,0.6332858800888062,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00268,Ropinirole,DB04839,Cyproterone acetate,0.4932258129119873,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Ropinirole.,75,Type_75,No
DB00257,Clotrimazole,DB00755,Tretinoin,0.891237199306488,47,Type_47,The metabolism of Tretinoin can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00800,Fenoldopam,DB01275,Hydralazine,0.5685137510299683,60,Type_60,Fenoldopam may increase the hypotensive activities of Hydralazine.,60,Type_60,Yes
DB01264,Darunavir,DB01591,Solifenacin,0.7246250510215759,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Darunavir.,47,Type_47,Yes
DB06636,Isavuconazonium,DB09049,Naloxegol,0.9997264742851257,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Isavuconazonium.,73,Type_73,Yes
DB01198,Zopiclone,DB08815,Lurasidone,0.9986820816993713,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Lurasidone.,49,Type_49,Yes
DB00220,Nelfinavir,DB00916,Metronidazole,0.37367695569992065,73,Type_73,The serum concentration of Metronidazole can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00705,Delavirdine,DB00734,Risperidone,0.8268826603889465,47,Type_47,The metabolism of Risperidone can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00653,Magnesium sulfate,DB01153,Sertaconazole,0.640216052532196,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Sertaconazole.,49,Type_49,Yes
DB00295,Morphine,DB00865,Benzphetamine,0.990145742893219,69,Type_69,Morphine may increase the analgesic activities of Benzphetamine.,69,Type_69,Yes
DB00694,Daunorubicin,DB00939,Meclofenamic acid,0.9911077618598938,72,Type_72,Daunorubicin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB01380,Cortisone acetate,DB06725,Lornoxicam,0.9988355040550232,49,Type_49,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Lornoxicam.,49,Type_49,Yes
DB00280,Disopyramide,DB06710,Methyltestosterone,0.9632279872894287,9,Type_9,Disopyramide may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB00412,Rosiglitazone,DB00668,Epinephrine,0.5063167810440063,73,Type_73,The serum concentration of Epinephrine can be increased when it is combined with Rosiglitazone.,70,Type_70,No
DB00524,Metolazone,DB01260,Desonide,0.9995110034942627,83,Type_83,Metolazone may increase the hypokalemic activities of Desonide.,83,Type_83,Yes
DB00860,Prednisolone,DB01095,Fluvastatin,0.804242730140686,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Prednisolone.,73,Type_73,Yes
DB01621,Pipotiazine,DB06716,Fospropofol,0.9999947547912598,49,Type_49,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Fospropofol.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB06268,Sitaxentan,0.5914698243141174,47,Type_47,The metabolism of Sitaxentan can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00611,Butorphanol,DB01075,Diphenhydramine,0.9604317545890808,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Diphenhydramine.,49,Type_49,Yes
DB00802,Alfentanil,DB01030,Topotecan,0.9801044464111328,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Alfentanil.,73,Type_73,Yes
DB00681,Amphotericin B,DB01141,Micafungin,0.97074294090271,70,Type_70,The therapeutic efficacy of Micafungin can be decreased when used in combination with Amphotericin B.,70,Type_70,Yes
DB08933,Luliconazole,DB11921,Deflazacort,0.9549112319946289,73,Type_73,The serum concentration of Deflazacort can be increased when it is combined with Luliconazole.,73,Type_73,Yes
DB00622,Nicardipine,DB01169,Arsenic trioxide,0.8237175941467285,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Arsenic trioxide.,20,Type_20,No
DB00835,Brompheniramine,DB01452,Diamorphine,0.9990880489349365,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Diamorphine.,49,Type_49,Yes
DB00379,Mexiletine,DB06148,Mianserin,0.9934930205345154,47,Type_47,The metabolism of Mianserin can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01118,Amiodarone,DB09078,Lenvatinib,0.4084011912345886,20,Type_20,Amiodarone may increase the QTc-prolonging activities of Lenvatinib.,47,Type_47,No
DB04871,Lorcaserin,DB13025,Tiapride,0.9719799757003784,49,Type_49,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tiapride.,49,Type_49,Yes
DB00193,Tramadol,DB01173,Orphenadrine,0.9633422493934631,16,Type_16,Tramadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00880,Chlorothiazide,DB08932,Macitentan,0.9998849630355835,60,Type_60,Chlorothiazide may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00215,Citalopram,DB00614,Furazolidone,0.891867995262146,64,Type_64,Citalopram may increase the serotonergic activities of Furazolidone.,64,Type_64,Yes
DB01115,Nifedipine,DB06697,Artemether,0.7140527367591858,47,Type_47,The metabolism of Artemether can be decreased when combined with Nifedipine.,49,Type_49,No
DB00721,Procaine,DB09286,Pipamperone,0.999690055847168,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Pipamperone.,49,Type_49,Yes
DB00854,Levorphanol,DB06288,Amisulpride,0.9971305727958679,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Amisulpride.,49,Type_49,Yes
DB00349,Clobazam,DB08873,Boceprevir,0.6279180645942688,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01181,Ifosfamide,DB08820,Ivacaftor,0.9979269504547119,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Ifosfamide.,73,Type_73,Yes
DB00328,Indomethacin,DB00929,Misoprostol,0.963405430316925,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Indomethacin.,70,Type_70,Yes
DB00210,Adapalene,DB06713,Norelgestromin,0.9013749361038208,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00559,Bosentan,DB00850,Perphenazine,0.8995350003242493,75,Type_75,The serum concentration of Perphenazine can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB01440,gamma-Hydroxybutyric acid,DB04842,Fluspirilene,0.999927282333374,49,Type_49,The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Fluspirilene.,49,Type_49,Yes
DB00206,Reserpine,DB00611,Butorphanol,0.9858194589614868,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Butorphanol.,49,Type_49,Yes
DB00327,Hydromorphone,DB01118,Amiodarone,0.7927575707435608,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB01219,Dantrolene,DB09280,Lumacaftor,0.45876064896583557,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Dantrolene.,4,Type_4,No
DB01232,Saquinavir,DB09095,Difluocortolone,0.9905149936676025,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00768,Olopatadine,DB00917,Dinoprostone,0.4736883044242859,73,Type_73,The serum concentration of Dinoprostone can be increased when it is combined with Olopatadine.,70,Type_70,No
DB00255,Diethylstilbestrol,DB00776,Oxcarbazepine,0.5443256497383118,73,Type_73,The serum concentration of Oxcarbazepine can be increased when it is combined with Diethylstilbestrol.,75,Type_75,No
DB04846,Celiprolol,DB06268,Sitaxentan,0.99643874168396,60,Type_60,Celiprolol may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB01175,Escitalopram,DB04908,Flibanserin,0.9754078388214111,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Flibanserin.,49,Type_49,Yes
DB00227,Lovastatin,DB01215,Estazolam,0.797561526298523,47,Type_47,The metabolism of Estazolam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00182,Amphetamine,DB00433,Prochlorperazine,0.9018678069114685,61,Type_61,Amphetamine may decrease the stimulatory activities of Prochlorperazine.,61,Type_61,Yes
DB00615,Rifabutin,DB00759,Tetracycline,0.8662355542182922,4,Type_4,The metabolism of Tetracycline can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00829,Diazepam,DB08820,Ivacaftor,0.9947511553764343,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB00204,Dofetilide,DB08930,Dolutegravir,0.7744815349578857,75,Type_75,The serum concentration of Dolutegravir can be decreased when it is combined with Dofetilide.,73,Type_73,No
DB00468,Quinine,DB00543,Amoxapine,0.7598324418067932,20,Type_20,Quinine may increase the QTc-prolonging activities of Amoxapine.,20,Type_20,Yes
DB00177,Valsartan,DB09286,Pipamperone,0.9433135390281677,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Pipamperone.,49,Type_49,Yes
DB01236,Sevoflurane,DB05294,Vandetanib,0.5638095736503601,33,Type_33,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vandetanib.,20,Type_20,No
DB00896,Rimexolone,DB11079,Trolamine salicylate,0.9959024786949158,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Trolamine salicylate.,49,Type_49,Yes
DB00784,Mefenamic acid,DB01580,Oxprenolol,0.9620538353919983,37,Type_37,Mefenamic acid may decrease the antihypertensive activities of Oxprenolol.,37,Type_37,Yes
DB00327,Hydromorphone,DB00940,Methantheline,0.982821524143219,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methantheline.,49,Type_49,Yes
DB01203,Nadolol,DB01229,Paclitaxel,0.9952740669250488,49,Type_49,The risk or severity of adverse effects can be increased when Nadolol is combined with Paclitaxel.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB01045,Rifampicin,0.9640274047851562,4,Type_4,The metabolism of Rifampicin can be increased when combined with Chlorzoxazone.,4,Type_4,Yes
DB00429,Carboprost tromethamine,DB06737,Zaltoprofen,0.5537473559379578,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Carboprost tromethamine.,70,Type_70,Yes
DB00790,Perindopril,DB00880,Chlorothiazide,0.5498355627059937,60,Type_60,Perindopril may increase the hypotensive activities of Chlorothiazide.,49,Type_49,No
DB00571,Propranolol,DB01182,Propafenone,0.6346087455749512,73,Type_73,The serum concentration of Propafenone can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00181,Baclofen,DB01198,Zopiclone,0.9997438788414001,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Zopiclone.,49,Type_49,Yes
DB00519,Trandolapril,DB00749,Etodolac,0.8938552141189575,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Etodolac.,49,Type_49,Yes
DB00967,Desloratadine,DB11315,Methscopolamine,0.5897670984268188,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Methscopolamine.,49,Type_49,Yes
DB06697,Artemether,DB09198,Lobeglitazone,0.9957048296928406,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Artemether.,47,Type_47,Yes
DB00838,Clocortolone,DB06710,Methyltestosterone,0.9957342743873596,74,Type_74,Clocortolone may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB00614,Furazolidone,DB00629,Guanabenz,0.8085068464279175,60,Type_60,Furazolidone may increase the hypotensive activities of Guanabenz.,60,Type_60,Yes
DB00610,Metaraminol,DB01626,Pargyline,0.9934796094894409,71,Type_71,Metaraminol may increase the hypertensive activities of Pargyline.,71,Type_71,Yes
DB00517,Anisotropine methylbromide,DB09290,Ramosetron,0.9999452829360962,39,Type_39,Anisotropine methylbromide may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB00687,Fludrocortisone,DB13595,Almasilate,0.9999125003814697,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Fludrocortisone.,3,Type_3,Yes
DB00483,Gallamine triethiodide,DB00782,Propantheline,0.982069730758667,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Propantheline.,49,Type_49,Yes
DB01197,Captopril,DB06826,Unoprostone,0.9999942779541016,60,Type_60,Captopril may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00821,Carprofen,DB06263,Amrubicin,0.9998173117637634,72,Type_72,Carprofen may decrease the excretion rate of Amrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00880,Chlorothiazide,DB09212,Loxoprofen,0.9953910112380981,70,Type_70,The therapeutic efficacy of Loxoprofen can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00247,Methysergide,DB09048,Netupitant,0.9714800715446472,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Netupitant.,49,Type_49,Yes
DB01623,Thiothixene,DB13323,Trichloroethylene,0.9995092153549194,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Trichloroethylene.,49,Type_49,Yes
DB00201,Caffeine,DB00752,Tranylcypromine,0.954644501209259,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00708,Sufentanil,DB06716,Fospropofol,0.999833345413208,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Fospropofol.,49,Type_49,Yes
DB00476,Duloxetine,DB00491,Miglitol,0.9080101251602173,9,Type_9,Duloxetine may increase the hypoglycemic activities of Miglitol.,9,Type_9,Yes
DB00678,Losartan,DB00800,Fenoldopam,0.7341389060020447,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Fenoldopam.,60,Type_60,No
DB00515,Cisplatin,DB00531,Cyclophosphamide,0.9127787351608276,49,Type_49,The risk or severity of adverse effects can be increased when Cisplatin is combined with Cyclophosphamide.,15,Type_15,No
DB01151,Desipramine,DB12161,Deutetrabenazine,0.9142130613327026,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Desipramine.,47,Type_47,Yes
DB04951,Pirfenidone,DB08970,Fluprednidene,0.9997302889823914,49,Type_49,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluprednidene.,49,Type_49,Yes
DB08865,Crizotinib,DB09026,Aliskiren,0.904295027256012,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Crizotinib.,47,Type_47,Yes
DB01149,Nefazodone,DB02703,Fusidic acid,0.9998180270195007,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00817,Rosoxacin,DB11348,Calcium Phosphate,0.6198025345802307,67,Type_67,Rosoxacin can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00327,Hydromorphone,DB00872,Conivaptan,0.5241702795028687,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Hydromorphone.,73,Type_73,Yes
DB00338,Omeprazole,DB13874,Enasidenib,0.9361345171928406,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB01380,Cortisone acetate,DB09084,Benzydamine,0.9997056126594543,49,Type_49,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Benzydamine.,49,Type_49,Yes
DB00472,Fluoxetine,DB01394,Colchicine,0.9458068609237671,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00268,Ropinirole,DB01192,Oxymorphone,0.9997056126594543,32,Type_32,Ropinirole may increase the sedative activities of Oxymorphone.,32,Type_32,Yes
DB00700,Eplerenone,DB01250,Olsalazine,0.9832847714424133,37,Type_37,Eplerenone may decrease the antihypertensive activities of Olsalazine.,37,Type_37,Yes
DB00273,Topiramate,DB00490,Buspirone,0.8874486088752747,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Buspirone.,49,Type_49,Yes
DB00343,Diltiazem,DB00379,Mexiletine,0.9905129671096802,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00808,Indapamide,DB07615,Tranilast,0.888237476348877,70,Type_70,The therapeutic efficacy of Tranilast can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00966,Telmisartan,DB09235,Efonidipine,0.8133653998374939,60,Type_60,Telmisartan may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00754,Ethotoin,DB01544,Flunitrazepam,0.9954094290733337,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Flunitrazepam.,49,Type_49,Yes
DB00181,Baclofen,DB00230,Pregabalin,0.769484281539917,8,Type_8,The therapeutic efficacy of Pregabalin can be increased when used in combination with Baclofen.,8,Type_8,Yes
DB00991,Oxaprozin,DB09063,Ceritinib,0.9918899536132812,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Oxaprozin.,73,Type_73,Yes
DB00215,Citalopram,DB04920,Clevidipine,0.6362879872322083,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00418,Secobarbital,DB00790,Perindopril,0.8739084005355835,60,Type_60,Secobarbital may increase the hypotensive activities of Perindopril.,60,Type_60,Yes
DB00401,Nisoldipine,DB01099,Flucytosine,0.9558744430541992,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Flucytosine.,49,Type_49,Yes
DB00196,Fluconazole,DB08798,Sulfamoxole,0.9402156472206116,47,Type_47,The metabolism of Sulfamoxole can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB06710,Methyltestosterone,DB08865,Crizotinib,0.9852588176727295,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Methyltestosterone.,47,Type_47,Yes
DB05109,Trabectedin,DB09073,Palbociclib,0.997564435005188,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Trabectedin.,73,Type_73,Yes
DB00619,Imatinib,DB00850,Perphenazine,0.8622380495071411,47,Type_47,The metabolism of Perphenazine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00370,Mirtazapine,DB00871,Terbutaline,0.9587839841842651,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Terbutaline.,49,Type_49,Yes
DB00281,Lidocaine,DB00660,Metaxalone,0.9976592063903809,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Metaxalone.,49,Type_49,Yes
DB00363,Clozapine,DB00703,Methazolamide,0.9577876925468445,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Methazolamide.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB09224,Melperone,0.9997021555900574,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Melperone.,49,Type_49,Yes
DB01181,Ifosfamide,DB09118,Stiripentol,0.8031242489814758,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ifosfamide.,73,Type_73,Yes
DB00191,Phentermine,DB01433,Methadyl acetate,0.9997588992118835,69,Type_69,Phentermine may increase the analgesic activities of Methadyl acetate.,69,Type_69,Yes
DB00495,Zidovudine,DB00564,Carbamazepine,0.9092122912406921,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Zidovudine.,4,Type_4,Yes
DB00322,Floxuridine,DB00921,Buprenorphine,0.9731844663619995,47,Type_47,The metabolism of Buprenorphine can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00181,Baclofen,DB09017,Brotizolam,0.999985933303833,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Brotizolam.,49,Type_49,Yes
DB00413,Pramipexole,DB00645,Dyclonine,0.9999943971633911,32,Type_32,Pramipexole may increase the sedative activities of Dyclonine.,32,Type_32,Yes
DB00691,Moexipril,DB08991,Epirizole,0.9760786294937134,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Epirizole.,49,Type_49,Yes
DB00575,Clonidine,DB09034,Suvorexant,0.9948307871818542,16,Type_16,Clonidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00839,Tolazamide,DB00912,Repaglinide,0.999583899974823,9,Type_9,Tolazamide may increase the hypoglycemic activities of Repaglinide.,9,Type_9,Yes
DB00604,Cisapride,DB00673,Aprepitant,0.9702366590499878,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00872,Conivaptan,DB06742,Ambroxol,0.9826679825782776,73,Type_73,The serum concentration of Ambroxol can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00252,Phenytoin,DB01544,Flunitrazepam,0.9276886582374573,4,Type_4,The metabolism of Flunitrazepam can be increased when combined with Phenytoin.,73,Type_73,No
DB00208,Ticlopidine,DB00665,Nilutamide,0.8884182572364807,47,Type_47,The metabolism of Nilutamide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00628,Clorazepic acid,DB01065,Melatonin,0.9994012117385864,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Melatonin.,49,Type_49,Yes
DB00866,Alprenolol,DB08797,Salicylamide,0.9878138303756714,37,Type_37,Alprenolol may decrease the antihypertensive activities of Salicylamide.,37,Type_37,Yes
DB00231,Temazepam,DB01452,Diamorphine,0.9994099140167236,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Diamorphine.,49,Type_49,Yes
DB00619,Imatinib,DB01349,Tasosartan,0.990644097328186,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Imatinib.,47,Type_47,Yes
DB01201,Rifapentine,DB06694,Xylometazoline,0.5826022028923035,4,Type_4,The metabolism of Xylometazoline can be increased when combined with Rifapentine.,75,Type_75,No
DB00949,Felbamate,DB01254,Dasatinib,0.5651839971542358,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Felbamate.,73,Type_73,Yes
DB00422,Methylphenidate,DB12332,Rucaparib,0.8843750953674316,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00951,Isoniazid,DB01098,Rosuvastatin,0.5886409878730774,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Isoniazid.,47,Type_47,No
DB00366,Doxylamine,DB01002,Levobupivacaine,0.9999994039535522,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,16,Type_16,Yes
DB00455,Loratadine,DB01104,Sertraline,0.7216723561286926,47,Type_47,The metabolism of Sertraline can be decreased when combined with Loratadine.,47,Type_47,Yes
DB00476,Duloxetine,DB06262,Droxidopa,0.9870010614395142,85,Type_85,Duloxetine may increase the tachycardic activities of Droxidopa.,85,Type_85,Yes
DB00568,Cinnarizine,DB04855,Dronedarone,0.7598703503608704,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Cinnarizine.,47,Type_47,Yes
DB00472,Fluoxetine,DB01239,Chlorprothixene,0.7083868384361267,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Chlorprothixene.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00633,Dexmedetomidine,0.9572533965110779,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Dexmedetomidine.,49,Type_49,Yes
DB00661,Verapamil,DB01192,Oxymorphone,0.9319401979446411,47,Type_47,The metabolism of Oxymorphone can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00668,Epinephrine,DB06704,Iobenguane,0.9996727705001831,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Epinephrine.,70,Type_70,Yes
DB00765,Metyrosine,DB09166,Etizolam,0.9994940757751465,32,Type_32,Metyrosine may increase the sedative activities of Etizolam.,32,Type_32,Yes
DB01136,Carvedilol,DB02638,Terlipressin,0.9959490299224854,60,Type_60,Carvedilol may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00292,Etomidate,DB00434,Cyproheptadine,0.8699190020561218,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Cyproheptadine.,49,Type_49,Yes
DB00199,Erythromycin,DB01195,Flecainide,0.41962191462516785,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00320,Dihydroergotamine,DB00752,Tranylcypromine,0.5752160549163818,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB01175,Escitalopram,DB01601,Lopinavir,0.8193826079368591,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Escitalopram.,47,Type_47,Yes
DB08873,Boceprevir,DB09049,Naloxegol,0.9996932744979858,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Boceprevir.,73,Type_73,Yes
DB00210,Adapalene,DB00929,Misoprostol,0.997256338596344,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00280,Disopyramide,DB00539,Toremifene,0.7967632412910461,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Toremifene.,33,Type_33,No
DB00169,Cholecalciferol,DB08828,Vismodegib,0.9353339672088623,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01202,Levetiracetam,DB08881,Vemurafenib,0.5597130060195923,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Levetiracetam.,73,Type_73,Yes
DB00319,Piperacillin,DB00946,Phenprocoumon,0.46346813440322876,6,Type_6,Piperacillin may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00624,Testosterone,DB01708,Prasterone,0.9992732405662537,74,Type_74,Testosterone may increase the fluid retaining activities of Prasterone.,49,Type_49,No
DB00205,Pyrimethamine,DB00469,Tenoxicam,0.9026327133178711,47,Type_47,The metabolism of Tenoxicam can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB01234,Dexamethasone,DB01390,Sodium bicarbonate,0.9593855142593384,3,Type_3,The bioavailability of Sodium bicarbonate can be decreased when combined with Dexamethasone.,3,Type_3,Yes
DB00226,Guanadrel,DB01214,Metipranolol,0.9999940395355225,60,Type_60,Guanadrel may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB01256,Retapamulin,DB06717,Fosaprepitant,0.7639510631561279,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Retapamulin.,73,Type_73,Yes
DB00445,Epirubicin,DB00573,Fenoprofen,0.9984191656112671,72,Type_72,Epirubicin may decrease the excretion rate of Fenoprofen which could result in a higher serum level.,72,Type_72,Yes
DB01192,Oxymorphone,DB01247,Isocarboxazid,0.9449605941772461,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Isocarboxazid.,49,Type_49,Yes
DB00210,Adapalene,DB06826,Unoprostone,0.9999362230300903,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00169,Cholecalciferol,DB00908,Quinidine,0.9606819152832031,47,Type_47,The metabolism of Quinidine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00035,Desmopressin,DB00899,Remifentanil,0.9999756813049316,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Remifentanil.,49,Type_49,Yes
DB00297,Bupivacaine,DB00615,Rifabutin,0.9858707785606384,4,Type_4,The metabolism of Rifabutin can be increased when combined with Bupivacaine.,4,Type_4,Yes
DB00890,Dienestrol,DB01174,Phenobarbital,0.5543174147605896,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Dienestrol.,70,Type_70,No
DB00324,Fluorometholone,DB00685,Trovafloxacin,0.9505913853645325,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Trovafloxacin.,49,Type_49,Yes
DB00243,Ranolazine,DB01197,Captopril,0.5774262547492981,73,Type_73,The serum concentration of Captopril can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00472,Fluoxetine,DB01440,gamma-Hydroxybutyric acid,0.9907246232032776,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00844,Nalbuphine,DB08922,Perospirone,0.9965271353721619,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Perospirone.,49,Type_49,Yes
DB01087,Primaquine,DB05521,Telaprevir,0.5060006380081177,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Primaquine.,47,Type_47,Yes
DB06288,Amisulpride,DB11148,Butamben,0.9999862909317017,49,Type_49,The risk or severity of adverse effects can be increased when Amisulpride is combined with Butamben.,49,Type_49,Yes
DB00754,Ethotoin,DB11609,Normethadone,0.9949476718902588,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Normethadone.,49,Type_49,Yes
DB00614,Furazolidone,DB09038,Empagliflozin,0.909266471862793,9,Type_9,Furazolidone may increase the hypoglycemic activities of Empagliflozin.,9,Type_9,Yes
DB00843,Donepezil,DB00872,Conivaptan,0.7458622455596924,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Donepezil.,73,Type_73,Yes
DB00795,Sulfasalazine,DB09449,"Sodium phosphate, monobasic",0.9877716302871704,57,Type_57,"Sulfasalazine may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00573,Fenoprofen,DB01240,Epoprostenol,0.8473773002624512,70,Type_70,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Fenoprofen.,70,Type_70,Yes
DB00227,Lovastatin,DB00404,Alprazolam,0.7180474996566772,47,Type_47,The metabolism of Alprazolam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00683,Midazolam,DB01545,Ethyl loflazepate,0.9999874830245972,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00268,Ropinirole,DB08901,Ponatinib,0.9449623823165894,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00497,Oxycodone,DB00937,Diethylpropion,0.9992474317550659,69,Type_69,Oxycodone may increase the analgesic activities of Diethylpropion.,69,Type_69,Yes
DB06697,Artemether,DB11614,Rupatadine,0.9627412557601929,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Artemether.,47,Type_47,Yes
DB00370,Mirtazapine,DB01408,Bambuterol,0.8886256217956543,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Bambuterol.,49,Type_49,Yes
DB00899,Remifentanil,DB01088,Iloprost,0.9370580911636353,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Iloprost.,49,Type_49,Yes
DB00807,Proparacaine,DB06738,Ketobemidone,0.9957309365272522,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Ketobemidone.,49,Type_49,Yes
DB00163,Vitamin E,DB01166,Cilostazol,0.6507593393325806,6,Type_6,Vitamin E may increase the anticoagulant activities of Cilostazol.,53,Type_53,No
DB00189,Ethchlorvynol,DB00455,Loratadine,0.9990645051002502,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Loratadine.,49,Type_49,Yes
DB00673,Aprepitant,DB01054,Nitrendipine,0.8340842723846436,73,Type_73,The serum concentration of Nitrendipine can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00373,Timolol,DB01067,Glipizide,0.9300732612609863,9,Type_9,Timolol may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB01124,Tolbutamide,DB01544,Flunitrazepam,0.822861909866333,70,Type_70,The therapeutic efficacy of Flunitrazepam can be decreased when used in combination with Tolbutamide.,47,Type_47,No
DB00628,Clorazepic acid,DB08933,Luliconazole,0.9586150050163269,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Clorazepic acid.,73,Type_73,Yes
DB00376,Trihexyphenidyl,DB00813,Fentanyl,0.9999427795410156,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Fentanyl.,49,Type_49,Yes
DB00243,Ranolazine,DB01132,Pioglitazone,0.7714915871620178,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00857,Terbinafine,DB06589,Pazopanib,0.6619642376899719,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Terbinafine.,47,Type_47,No
DB00857,Terbinafine,DB00997,Doxorubicin,0.8876975774765015,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00371,Meprobamate,DB00737,Meclizine,0.9980746507644653,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Meclizine.,49,Type_49,Yes
DB00158,Folic acid,DB01401,Choline magnesium trisalicylate,0.9230626821517944,70,Type_70,The therapeutic efficacy of Choline magnesium trisalicylate can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB01169,Arsenic trioxide,DB01214,Metipranolol,0.9271103143692017,49,Type_49,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Metipranolol.,49,Type_49,Yes
DB00661,Verapamil,DB01295,Bevantolol,0.8229489922523499,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Bevantolol.,60,Type_60,No
DB00844,Nalbuphine,DB01036,Tolterodine,0.9949852228164673,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tolterodine.,49,Type_49,Yes
DB00227,Lovastatin,DB00780,Phenelzine,0.4458082616329193,73,Type_73,The serum concentration of Phenelzine can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB01050,Ibuprofen,DB06695,Dabigatran etexilate,0.909071683883667,6,Type_6,Ibuprofen may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB01089,Deserpidine,DB01247,Isocarboxazid,0.9999865293502808,60,Type_60,Deserpidine may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB01104,Sertraline,DB01206,Lomustine,0.8821046352386475,47,Type_47,The metabolism of Lomustine can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00975,Dipyridamole,DB06616,Bosutinib,0.7893887162208557,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Dipyridamole.,73,Type_73,Yes
DB00384,Triamterene,DB01224,Quetiapine,0.9624907970428467,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Quetiapine.,49,Type_49,Yes
DB00188,Bortezomib,DB06145,Spiramycin,0.795958936214447,47,Type_47,The metabolism of Spiramycin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB04861,Nebivolol,DB05812,Abiraterone,0.8825839161872864,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Nebivolol.,73,Type_73,Yes
DB00206,Reserpine,DB06153,Pizotifen,0.924839437007904,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Pizotifen.,49,Type_49,Yes
DB00887,Bumetanide,DB00966,Telmisartan,0.9613402485847473,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Telmisartan.,49,Type_49,Yes
DB06723,Aluminum hydroxide,DB09138,Technetium Tc-99m medronate,0.9997405409812927,75,Type_75,The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Aluminum hydroxide.,75,Type_75,Yes
DB09204,Arotinolol,DB13167,Alclofenac,0.9978775978088379,37,Type_37,Arotinolol may decrease the antihypertensive activities of Alclofenac.,37,Type_37,Yes
DB00622,Nicardipine,DB09241,Methylene blue,0.929104745388031,60,Type_60,Nicardipine may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB01002,Levobupivacaine,DB01236,Sevoflurane,0.8660801649093628,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Sevoflurane.,49,Type_49,Yes
DB00006,Bivalirudin,DB00975,Dipyridamole,0.5508430004119873,73,Type_73,The serum concentration of Dipyridamole can be increased when it is combined with Bivalirudin.,6,Type_6,No
DB00224,Indinavir,DB08916,Afatinib,0.5103716850280762,75,Type_75,The serum concentration of Afatinib can be decreased when it is combined with Indinavir.,75,Type_75,Yes
DB01078,Deslanoside,DB01203,Nadolol,0.9553471207618713,54,Type_54,Deslanoside may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB00520,Caspofungin,DB01186,Pergolide,0.7875949144363403,49,Type_49,The risk or severity of adverse effects can be increased when Caspofungin is combined with Pergolide.,49,Type_49,Yes
DB00317,Gefitinib,DB12332,Rucaparib,0.8462191224098206,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB00312,Pentobarbital,DB01012,Cinacalcet,0.762704610824585,4,Type_4,The metabolism of Cinacalcet can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00318,Codeine,DB00844,Nalbuphine,0.986099362373352,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Nalbuphine.,49,Type_49,Yes
DB00866,Alprenolol,DB01193,Acebutolol,0.47576236724853516,14,Type_14,Alprenolol may decrease the bronchodilatory activities of Acebutolol.,60,Type_60,No
DB01356,Lithium cation,DB01577,Metamfetamine,0.8745833039283752,61,Type_61,Lithium cation may decrease the stimulatory activities of Metamfetamine.,61,Type_61,Yes
DB09027,Ledipasvir,DB11363,Alectinib,0.9439288377761841,73,Type_73,The serum concentration of Alectinib can be increased when it is combined with Ledipasvir.,73,Type_73,Yes
DB00715,Paroxetine,DB08901,Ponatinib,0.9273446798324585,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00338,Omeprazole,DB00363,Clozapine,0.8904191851615906,47,Type_47,The metabolism of Clozapine can be decreased when combined with Omeprazole.,75,Type_75,No
DB00425,Zolpidem,DB00559,Bosentan,0.5503047108650208,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Zolpidem.,75,Type_75,No
DB00780,Phenelzine,DB00912,Repaglinide,0.9992175102233887,9,Type_9,Phenelzine may increase the hypoglycemic activities of Repaglinide.,9,Type_9,Yes
DB00582,Voriconazole,DB00673,Aprepitant,0.9196469187736511,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB08865,Crizotinib,0.6177156567573547,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Sulfisoxazole.,20,Type_20,No
DB00741,Hydrocortisone,DB09220,Nicorandil,0.9857069849967957,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Nicorandil.,49,Type_49,Yes
DB00328,Indomethacin,DB08964,Gemeprost,1.0,70,Type_70,The therapeutic efficacy of Gemeprost can be decreased when used in combination with Indomethacin.,70,Type_70,Yes
DB09009,Articaine,DB09286,Pipamperone,0.9999618530273438,49,Type_49,The risk or severity of adverse effects can be increased when Articaine is combined with Pipamperone.,49,Type_49,Yes
DB06737,Zaltoprofen,DB09215,Droxicam,0.9975041747093201,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Droxicam.,49,Type_49,Yes
DB06738,Ketobemidone,DB09068,Vortioxetine,0.9987062215805054,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Vortioxetine.,49,Type_49,Yes
DB00884,Risedronic acid,DB07615,Tranilast,0.9762344360351562,49,Type_49,The risk or severity of adverse effects can be increased when Risedronic acid is combined with Tranilast.,49,Type_49,Yes
DB00336,Nitrofural,DB00907,Cocaine,0.9940677881240845,47,Type_47,The metabolism of Cocaine can be decreased when combined with Nitrofural.,47,Type_47,Yes
DB00376,Trihexyphenidyl,DB01337,Pancuronium,0.9985859394073486,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Pancuronium.,49,Type_49,Yes
DB01077,Etidronic acid,DB05676,Apremilast,0.9974151849746704,49,Type_49,The risk or severity of adverse effects can be increased when Etidronic acid is combined with Apremilast.,49,Type_49,Yes
DB01143,Amifostine,DB01193,Acebutolol,0.821507453918457,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Acebutolol.,60,Type_60,No
DB01120,Gliclazide,DB08907,Canagliflozin,0.9113002419471741,9,Type_9,Gliclazide may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB00263,Sulfisoxazole,DB09570,Ixazomib,0.9604330658912659,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00685,Trovafloxacin,DB01014,Balsalazide,0.9965729713439941,27,Type_27,Trovafloxacin may increase the neuroexcitatory activities of Balsalazide.,27,Type_27,Yes
DB00295,Morphine,DB00527,Cinchocaine,0.9995124340057373,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Cinchocaine.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00443,Betamethasone,0.9998925924301147,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Betamethasone.,49,Type_49,Yes
DB00285,Venlafaxine,DB00697,Tizanidine,0.5008226037025452,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Tizanidine.,85,Type_85,No
DB00318,Codeine,DB01227,Levacetylmethadol,0.9257132411003113,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Levacetylmethadol.,49,Type_49,Yes
DB00297,Bupivacaine,DB06636,Isavuconazonium,0.8588724136352539,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB04574,Estrone sulfate,DB06718,Stanozolol,0.999841570854187,74,Type_74,Estrone sulfate may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB00477,Chlorpromazine,DB08880,Teriflunomide,0.5263176560401917,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Chlorpromazine.,75,Type_75,Yes
DB01009,Ketoprofen,DB12598,Nafamostat,0.8740230202674866,6,Type_6,Ketoprofen may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB01355,Hexobarbital,DB06770,Benzyl alcohol,0.9906186461448669,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Benzyl alcohol.,49,Type_49,Yes
DB00235,Milrinone,DB00806,Pentoxifylline,0.9425538778305054,53,Type_53,Milrinone may increase the antiplatelet activities of Pentoxifylline.,53,Type_53,Yes
DB00829,Diazepam,DB01017,Minocycline,0.9999972581863403,16,Type_16,Diazepam may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB04920,Clevidipine,DB09238,Manidipine,0.6031655669212341,60,Type_60,Clevidipine may increase the hypotensive activities of Manidipine.,47,Type_47,No
DB01466,Ethylmorphine,DB04855,Dronedarone,0.7310017347335815,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Ethylmorphine.,47,Type_47,Yes
DB01267,Paliperidone,DB09345,Pramocaine,0.9999678134918213,49,Type_49,The risk or severity of adverse effects can be increased when Paliperidone is combined with Pramocaine.,49,Type_49,Yes
DB01167,Itraconazole,DB09078,Lenvatinib,0.4009895622730255,47,Type_47,The metabolism of Lenvatinib can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00452,Framycetin,DB00485,Dicloxacillin,0.9962564706802368,75,Type_75,The serum concentration of Dicloxacillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB01403,Methotrimeprazine,DB01577,Metamfetamine,0.6974205374717712,76,Type_76,Methotrimeprazine may decrease the sedative activities of Metamfetamine.,47,Type_47,No
DB00280,Disopyramide,DB00672,Chlorpropamide,0.9980781078338623,9,Type_9,Disopyramide may increase the hypoglycemic activities of Chlorpropamide.,9,Type_9,Yes
DB01319,Fosamprenavir,DB01392,Yohimbine,0.9677800536155701,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00346,Alfuzosin,DB00678,Losartan,0.46320605278015137,60,Type_60,Alfuzosin may increase the hypotensive activities of Losartan.,60,Type_60,Yes
DB00288,Amcinonide,DB00358,Mefloquine,0.988492488861084,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Mefloquine.,49,Type_49,Yes
DB01018,Guanfacine,DB09009,Articaine,0.9991884827613831,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Articaine.,49,Type_49,Yes
DB00889,Granisetron,DB06697,Artemether,0.6597065329551697,20,Type_20,Granisetron may increase the QTc-prolonging activities of Artemether.,47,Type_47,No
DB00287,Travoprost,DB00881,Quinapril,0.9999910593032837,60,Type_60,Travoprost may increase the hypotensive activities of Quinapril.,60,Type_60,Yes
DB00418,Secobarbital,DB00887,Bumetanide,0.7003735303878784,60,Type_60,Secobarbital may increase the hypotensive activities of Bumetanide.,60,Type_60,Yes
DB01551,Dihydrocodeine,DB01591,Solifenacin,0.9912577867507935,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Solifenacin.,49,Type_49,Yes
DB00399,Zoledronic acid,DB06723,Aluminum hydroxide,0.9975405931472778,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Zoledronic acid.,75,Type_75,Yes
DB01193,Acebutolol,DB05039,Indacaterol,0.9991742968559265,14,Type_14,Acebutolol may decrease the bronchodilatory activities of Indacaterol.,14,Type_14,Yes
DB00343,Diltiazem,DB01037,Selegiline,0.3870936334133148,47,Type_47,The metabolism of Selegiline can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01254,Dasatinib,DB06210,Eltrombopag,0.7614657878875732,73,Type_73,The serum concentration of Eltrombopag can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00490,Buspirone,DB00831,Trifluoperazine,0.9881751537322998,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Trifluoperazine.,49,Type_49,Yes
DB01200,Bromocriptine,DB01242,Clomipramine,0.49975329637527466,37,Type_37,Bromocriptine may decrease the antihypertensive activities of Clomipramine.,37,Type_37,Yes
DB01168,Procarbazine,DB04846,Celiprolol,0.88318932056427,60,Type_60,Procarbazine may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB00653,Magnesium sulfate,DB09238,Manidipine,0.27120718359947205,47,Type_47,The metabolism of Manidipine can be decreased when combined with Magnesium sulfate.,49,Type_49,No
DB01032,Probenecid,DB09075,Edoxaban,0.9897119998931885,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00191,Phentermine,DB06766,Alcaftadine,0.9999988079071045,76,Type_76,Phentermine may decrease the sedative activities of Alcaftadine.,76,Type_76,Yes
DB01171,Moclobemide,DB08816,Ticagrelor,0.8824427127838135,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Moclobemide.,47,Type_47,Yes
DB00434,Cyproheptadine,DB01621,Pipotiazine,0.9720051884651184,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Pipotiazine.,49,Type_49,Yes
DB00492,Fosinopril,DB00586,Diclofenac,0.960911214351654,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Diclofenac.,49,Type_49,Yes
DB00226,Guanadrel,DB01170,Guanethidine,0.9999922513961792,60,Type_60,Guanadrel may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB00344,Protriptyline,DB00542,Benazepril,0.7838670611381531,73,Type_73,The serum concentration of Benazepril can be increased when it is combined with Protriptyline.,73,Type_73,Yes
DB00985,Dimenhydrinate,DB01239,Chlorprothixene,0.9988349080085754,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlorprothixene.,49,Type_49,Yes
DB00182,Amphetamine,DB00436,Bendroflumethiazide,0.9741230607032776,60,Type_60,Amphetamine may increase the hypotensive activities of Bendroflumethiazide.,60,Type_60,Yes
DB00480,Lenalidomide,DB00783,Estradiol,0.6376688480377197,75,Type_75,The serum concentration of Estradiol can be decreased when it is combined with Lenalidomide.,81,Type_81,No
DB00846,Flurandrenolide,DB06819,Phenylbutyric acid,0.9517901539802551,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Flurandrenolide.,70,Type_70,Yes
DB01259,Lapatinib,DB09570,Ixazomib,0.7253124117851257,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Lapatinib.,47,Type_47,Yes
DB00254,Doxycycline,DB09073,Palbociclib,0.9838773608207703,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Doxycycline.,47,Type_47,No
DB00575,Clonidine,DB04840,Debrisoquine,0.9861531257629395,60,Type_60,Clonidine may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB01247,Isocarboxazid,DB06153,Pizotifen,0.7216048836708069,2,Type_2,Isocarboxazid may increase the anticholinergic activities of Pizotifen.,2,Type_2,Yes
DB00367,Levonorgestrel,DB01154,Thiamylal,0.4142844080924988,70,Type_70,The therapeutic efficacy of Thiamylal can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00233,Aminosalicylic acid,DB02187,Equilin,0.9991891980171204,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Equilin.,49,Type_49,Yes
DB01588,Prazepam,DB05246,Methsuximide,0.9992716908454895,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Methsuximide.,49,Type_49,Yes
DB00215,Citalopram,DB11148,Butamben,0.9929279685020447,49,Type_49,The risk or severity of adverse effects can be increased when Citalopram is combined with Butamben.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB08860,Pitavastatin,0.9535323977470398,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Ciprofloxacin.,73,Type_73,Yes
DB00323,Tolcapone,DB06700,Desvenlafaxine,0.8608933687210083,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Desvenlafaxine.,49,Type_49,Yes
DB00922,Levosimendan,DB01136,Carvedilol,0.9104138612747192,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Carvedilol.,49,Type_49,Yes
DB00323,Tolcapone,DB08907,Canagliflozin,0.5814873576164246,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Canagliflozin.,49,Type_49,Yes
DB00318,Codeine,DB00433,Prochlorperazine,0.9827899932861328,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Prochlorperazine.,49,Type_49,Yes
DB00476,Duloxetine,DB06216,Asenapine,0.785167932510376,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Asenapine.,49,Type_49,Yes
DB01233,Metoclopramide,DB01356,Lithium cation,0.5898160338401794,20,Type_20,Metoclopramide may increase the QTc-prolonging activities of Lithium cation.,49,Type_49,No
DB00710,Ibandronate,DB06216,Asenapine,0.9808989763259888,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00814,Meloxicam,DB01088,Iloprost,0.9389176964759827,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB01081,Diphenoxylate,DB09290,Ramosetron,0.9999951124191284,39,Type_39,Diphenoxylate may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB01282,Carbetocin,DB01359,Penbutolol,0.9531906843185425,49,Type_49,The risk or severity of adverse effects can be increased when Carbetocin is combined with Penbutolol.,49,Type_49,Yes
DB00604,Cisapride,DB01100,Pimozide,0.8925653100013733,20,Type_20,Cisapride may increase the QTc-prolonging activities of Pimozide.,33,Type_33,No
DB00224,Indinavir,DB01008,Busulfan,0.8762421607971191,47,Type_47,The metabolism of Busulfan can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00482,Celecoxib,DB00880,Chlorothiazide,0.9949693083763123,70,Type_70,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Celecoxib.,70,Type_70,Yes
DB00899,Remifentanil,DB01591,Solifenacin,0.9981353282928467,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Solifenacin.,49,Type_49,Yes
DB00215,Citalopram,DB00341,Cetirizine,0.9188111424446106,49,Type_49,The risk or severity of adverse effects can be increased when Citalopram is combined with Cetirizine.,49,Type_49,Yes
DB00209,Trospium,DB00940,Methantheline,0.8453422784805298,49,Type_49,The risk or severity of adverse effects can be increased when Trospium is combined with Methantheline.,49,Type_49,Yes
DB00928,Azacitidine,DB01656,Roflumilast,0.999994158744812,34,Type_34,Azacitidine may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00715,Paroxetine,DB09075,Edoxaban,0.660233736038208,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Paroxetine.,73,Type_73,Yes
DB00645,Dyclonine,DB01623,Thiothixene,0.9969316720962524,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Thiothixene.,49,Type_49,Yes
DB00784,Mefenamic acid,DB01435,Antipyrine,0.9954670667648315,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Antipyrine.,49,Type_49,Yes
DB00203,Sildenafil,DB05676,Apremilast,0.9609948992729187,47,Type_47,The metabolism of Apremilast can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00727,Nitroglycerin,DB00755,Tretinoin,0.9955423474311829,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Tretinoin.,49,Type_49,Yes
DB00472,Fluoxetine,DB00731,Nateglinide,0.5637124180793762,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00231,Temazepam,DB01118,Amiodarone,0.9263606667518616,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Temazepam.,47,Type_47,Yes
DB01041,Thalidomide,DB01247,Isocarboxazid,0.9199584722518921,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Isocarboxazid.,49,Type_49,Yes
DB00476,Duloxetine,DB01609,Deferasirox,0.5100035071372986,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Duloxetine.,73,Type_73,No
DB00199,Erythromycin,DB04938,Ospemifene,0.9139506220817566,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00289,Atomoxetine,DB01137,Levofloxacin,0.7728334069252014,20,Type_20,Atomoxetine may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB00625,Efavirenz,DB00734,Risperidone,0.7166846990585327,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Risperidone.,49,Type_49,Yes
DB00184,Nicotine,DB00471,Montelukast,0.6816229820251465,47,Type_47,The metabolism of Montelukast can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01224,Quetiapine,DB01267,Paliperidone,0.5034375190734863,20,Type_20,Quetiapine may increase the QTc-prolonging activities of Paliperidone.,49,Type_49,No
DB01181,Ifosfamide,DB01241,Gemfibrozil,0.9289525747299194,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Ifosfamide.,47,Type_47,Yes
DB00744,Zileuton,DB01072,Atazanavir,0.8602116107940674,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Zileuton.,47,Type_47,Yes
DB00244,Mesalazine,DB08907,Canagliflozin,0.9973664879798889,9,Type_9,Mesalazine may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB00564,Carbamazepine,DB00691,Moexipril,0.34022611379623413,75,Type_75,The serum concentration of Moexipril can be decreased when it is combined with Carbamazepine.,4,Type_4,No
DB00206,Reserpine,DB01161,Chloroprocaine,0.9982655644416809,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Chloroprocaine.,49,Type_49,Yes
DB00283,Clemastine,DB11581,Venetoclax,0.9801198840141296,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00433,Prochlorperazine,DB00780,Phenelzine,0.615830659866333,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Phenelzine.,49,Type_49,Yes
DB00370,Mirtazapine,DB11699,Tropisetron,0.9712773561477661,64,Type_64,Mirtazapine may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00277,Theophylline,DB01100,Pimozide,0.9131129384040833,47,Type_47,The metabolism of Pimozide can be decreased when combined with Theophylline.,47,Type_47,Yes
DB01196,Estramustine,DB09073,Palbociclib,0.9897991418838501,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Estramustine.,73,Type_73,Yes
DB00976,Telithromycin,DB05676,Apremilast,0.667469322681427,47,Type_47,The metabolism of Apremilast can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00091,Cyclosporine,DB00736,Esomeprazole,0.8446330428123474,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB01577,Metamfetamine,0.998525083065033,76,Type_76,Cyproheptadine may decrease the sedative activities of Metamfetamine.,76,Type_76,Yes
DB01197,Captopril,DB06723,Aluminum hydroxide,0.9090656638145447,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Captopril.,75,Type_75,Yes
DB00358,Mefloquine,DB09300,Butylscopolamine,0.9955161213874817,70,Type_70,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00401,Nisoldipine,DB00528,Lercanidipine,0.5274864435195923,60,Type_60,Nisoldipine may increase the hypotensive activities of Lercanidipine.,60,Type_60,Yes
DB01254,Dasatinib,DB01390,Sodium bicarbonate,0.9236131906509399,67,Type_67,Dasatinib can cause a decrease in the absorption of Sodium bicarbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00323,Tolcapone,DB00933,Mesoridazine,0.9975207448005676,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Mesoridazine.,49,Type_49,Yes
DB00321,Amitriptyline,DB00932,Tipranavir,0.704999566078186,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00253,Medrysone,DB00461,Nabumetone,0.999024510383606,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Nabumetone.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00814,Meloxicam,0.9963700771331787,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Meloxicam.,49,Type_49,Yes
DB00661,Verapamil,DB01105,Sibutramine,0.9798458218574524,47,Type_47,The metabolism of Sibutramine can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00353,Methylergometrine,DB00998,Frovatriptan,0.6250950694084167,19,Type_19,Methylergometrine may increase the vasoconstricting activities of Frovatriptan.,19,Type_19,Yes
DB00946,Phenprocoumon,DB13873,Fenofibric acid,0.9999125003814697,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Fenofibric acid.,6,Type_6,Yes
DB00612,Bisoprolol,DB00615,Rifabutin,0.6157318949699402,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Bisoprolol.,4,Type_4,No
DB00592,Piperazine,DB00914,Phenformin,0.9801408648490906,70,Type_70,The therapeutic efficacy of Phenformin can be decreased when used in combination with Piperazine.,70,Type_70,Yes
DB00179,Masoprocol,DB01399,Salsalate,0.9996273517608643,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Salsalate.,49,Type_49,Yes
DB00298,Dapiprazole,DB01558,Bromazepam,0.997645914554596,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Bromazepam.,49,Type_49,Yes
DB00872,Conivaptan,DB01221,Ketamine,0.932033360004425,73,Type_73,The serum concentration of Ketamine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00514,Dextromethorphan,DB06603,Panobinostat,0.8793334364891052,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Dextromethorphan.,73,Type_73,Yes
DB00224,Indinavir,DB01006,Letrozole,0.9231380224227905,47,Type_47,The metabolism of Letrozole can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01023,Felodipine,DB01141,Micafungin,0.9313238263130188,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Micafungin.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB06770,Benzyl alcohol,0.9803808331489563,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Benzyl alcohol.,49,Type_49,Yes
DB01149,Nefazodone,DB06287,Temsirolimus,0.7466016411781311,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB01355,Hexobarbital,DB04743,Nimesulide,0.540008544921875,4,Type_4,The metabolism of Nimesulide can be increased when combined with Hexobarbital.,4,Type_4,Yes
DB00881,Quinapril,DB08981,Fenbufen,0.9830743670463562,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Fenbufen.,49,Type_49,Yes
DB01263,Posaconazole,DB09128,Brexpiprazole,0.8533869981765747,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Posaconazole.,73,Type_73,Yes
DB00683,Midazolam,DB01219,Dantrolene,0.9951654672622681,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Dantrolene.,49,Type_49,Yes
DB00615,Rifabutin,DB04908,Flibanserin,0.7160490155220032,75,Type_75,The serum concentration of Flibanserin can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00450,Droperidol,DB08881,Vemurafenib,0.9375928044319153,20,Type_20,Droperidol may increase the QTc-prolonging activities of Vemurafenib.,33,Type_33,No
DB01015,Sulfamethoxazole,DB01218,Halofantrine,0.5984907746315002,20,Type_20,Sulfamethoxazole may increase the QTc-prolonging activities of Halofantrine.,47,Type_47,No
DB00349,Clobazam,DB00427,Triprolidine,0.9512524008750916,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Triprolidine.,49,Type_49,Yes
DB00695,Furosemide,DB09220,Nicorandil,0.99904865026474,60,Type_60,Furosemide may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB08984,Etofenamate,DB09292,Sacubitril,0.9994630217552185,49,Type_49,The risk or severity of adverse effects can be increased when Etofenamate is combined with Sacubitril.,49,Type_49,Yes
DB00325,Nitroprusside,DB09238,Manidipine,0.9964513778686523,60,Type_60,Nitroprusside may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00361,Vinorelbine,DB01072,Atazanavir,0.4570200741291046,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Vinorelbine.,47,Type_47,No
DB00215,Citalopram,DB02709,Resveratrol,0.6569721102714539,53,Type_53,Citalopram may increase the antiplatelet activities of Resveratrol.,47,Type_47,No
DB00960,Pindolol,DB01283,Lumiracoxib,0.9958294034004211,37,Type_37,Pindolol may decrease the antihypertensive activities of Lumiracoxib.,37,Type_37,Yes
DB00324,Fluorometholone,DB00674,Galantamine,0.9897637367248535,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Galantamine.,49,Type_49,Yes
DB01114,Chlorpheniramine,DB01624,Zuclopenthixol,0.8590088486671448,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Zuclopenthixol.,49,Type_49,Yes
DB00738,Pentamidine,DB01165,Ofloxacin,0.9988625049591064,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00625,Efavirenz,DB01186,Pergolide,0.8501999378204346,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Pergolide.,49,Type_49,Yes
DB05271,Rotigotine,DB06708,Lumefantrine,0.9342644214630127,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Rotigotine.,47,Type_47,Yes
DB05812,Abiraterone,DB08899,Enzalutamide,0.955669641494751,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Abiraterone.,75,Type_75,Yes
DB01396,Digitoxin,DB08873,Boceprevir,0.8811203837394714,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Digitoxin.,47,Type_47,No
DB00455,Loratadine,DB01615,Aceprometazine,0.9974296689033508,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Aceprometazine.,49,Type_49,Yes
DB00780,Phenelzine,DB08932,Macitentan,0.9988310933113098,60,Type_60,Phenelzine may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00612,Bisoprolol,DB01154,Thiamylal,0.8849165439605713,60,Type_60,Bisoprolol may increase the hypotensive activities of Thiamylal.,60,Type_60,Yes
DB00474,Methohexital,DB09072,Sodium oxybate,0.9999988079071045,16,Type_16,Methohexital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00273,Topiramate,DB00908,Quinidine,0.8924857974052429,47,Type_47,The metabolism of Quinidine can be decreased when combined with Topiramate.,49,Type_49,No
DB00976,Telithromycin,DB08906,Fluticasone furoate,0.8199228644371033,47,Type_47,The metabolism of Fluticasone furoate can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00952,Naratriptan,DB01239,Chlorprothixene,0.997132420539856,49,Type_49,The risk or severity of adverse effects can be increased when Naratriptan is combined with Chlorprothixene.,49,Type_49,Yes
DB00184,Nicotine,DB01012,Cinacalcet,0.9317247867584229,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00363,Clozapine,DB01115,Nifedipine,0.7025411128997803,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Nifedipine.,49,Type_49,Yes
DB00203,Sildenafil,DB01216,Finasteride,0.9378703832626343,47,Type_47,The metabolism of Finasteride can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00343,Diltiazem,DB01250,Olsalazine,0.36814549565315247,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Olsalazine.,6,Type_6,No
DB00654,Latanoprost,DB00788,Naproxen,0.9152601957321167,70,Type_70,The therapeutic efficacy of Naproxen can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB04861,Nebivolol,DB06237,Avanafil,0.7745981812477112,10,Type_10,Nebivolol may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00268,Ropinirole,DB01274,Arformoterol,0.8583347797393799,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00569,Fondaparinux,DB00814,Meloxicam,0.9973202347755432,6,Type_6,Fondaparinux may increase the anticoagulant activities of Meloxicam.,6,Type_6,Yes
DB00620,Triamcinolone,DB01201,Rifapentine,0.7961328029632568,4,Type_4,The metabolism of Rifapentine can be increased when combined with Triamcinolone.,4,Type_4,Yes
DB00512,Vancomycin,DB04951,Pirfenidone,0.9086775779724121,73,Type_73,The serum concentration of Pirfenidone can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00445,Epirubicin,DB00630,Alendronic acid,0.9999730587005615,24,Type_24,Epirubicin may increase the hypocalcemic activities of Alendronic acid.,24,Type_24,Yes
DB01232,Saquinavir,DB01587,Ketazolam,0.8486762642860413,47,Type_47,The metabolism of Ketazolam can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00241,Butalbital,DB09112,Nitrous acid,0.9611058831214905,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Nitrous acid.,49,Type_49,Yes
DB00540,Nortriptyline,DB00952,Naratriptan,0.9263899922370911,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Naratriptan.,49,Type_49,Yes
DB00344,Protriptyline,DB13025,Tiapride,0.9977244734764099,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Tiapride.,49,Type_49,Yes
DB00593,Ethosuximide,DB06144,Sertindole,0.9978848099708557,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Sertindole.,49,Type_49,Yes
DB00208,Ticlopidine,DB00499,Flutamide,0.8950868248939514,47,Type_47,The metabolism of Flutamide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00695,Furosemide,DB01222,Budesonide,0.9994176626205444,83,Type_83,Furosemide may increase the hypokalemic activities of Budesonide.,83,Type_83,Yes
DB00296,Ropivacaine,DB01614,Acepromazine,0.9776934385299683,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Acepromazine.,49,Type_49,Yes
DB00261,Anagrelide,DB00344,Protriptyline,0.8082544803619385,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Protriptyline.,20,Type_20,Yes
DB00177,Valsartan,DB01090,Pentolinium,0.9958102703094482,60,Type_60,Valsartan may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00373,Timolol,DB09204,Arotinolol,0.9133644104003906,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Arotinolol.,49,Type_49,Yes
DB00268,Ropinirole,DB00851,Dacarbazine,0.780211329460144,47,Type_47,The metabolism of Dacarbazine can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00690,Flurazepam,DB00802,Alfentanil,0.9951509237289429,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Alfentanil.,49,Type_49,Yes
DB00484,Brimonidine,DB00862,Vardenafil,0.9964125752449036,10,Type_10,Brimonidine may increase the antihypertensive activities of Vardenafil.,10,Type_10,Yes
DB00586,Diclofenac,DB09026,Aliskiren,0.8062258958816528,37,Type_37,Diclofenac may decrease the antihypertensive activities of Aliskiren.,37,Type_37,Yes
DB00751,Epinastine,DB01072,Atazanavir,0.46455392241477966,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Epinastine.,75,Type_75,No
DB00826,Natamycin,DB09268,Picosulfuric acid,0.9999480247497559,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Natamycin.,70,Type_70,Yes
DB00472,Fluoxetine,DB01171,Moclobemide,0.41628700494766235,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.,47,Type_47,No
DB00622,Nicardipine,DB06739,Seratrodast,0.8804916143417358,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB01014,Balsalazide,DB01380,Cortisone acetate,0.9995177984237671,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Cortisone acetate.,49,Type_49,Yes
DB00708,Sufentanil,DB08807,Bopindolol,0.7672085165977478,54,Type_54,Sufentanil may increase the bradycardic activities of Bopindolol.,54,Type_54,Yes
DB00521,Carteolol,DB01069,Promethazine,0.5967686772346497,60,Type_60,Carteolol may increase the hypotensive activities of Promethazine.,60,Type_60,Yes
DB00734,Risperidone,DB01167,Itraconazole,0.6665254235267639,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Risperidone.,47,Type_47,Yes
DB00397,Phenylpropanolamine,DB00867,Ritodrine,0.9999563694000244,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Ritodrine.,49,Type_49,Yes
DB00768,Olopatadine,DB03615,Ribostamycin,0.9989991784095764,72,Type_72,Olopatadine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,72,Type_72,Yes
DB00451,Levothyroxine,DB00648,Mitotane,0.9951409101486206,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Levothyroxine.,75,Type_75,Yes
DB00585,Nizatidine,DB00705,Delavirdine,0.8273986577987671,75,Type_75,The serum concentration of Delavirdine can be decreased when it is combined with Nizatidine.,67,Type_67,No
DB01080,Vigabatrin,DB01567,Fludiazepam,0.9895233511924744,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fludiazepam.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB09245,Toloxatone,0.9981968998908997,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00445,Epirubicin,DB01336,Metocurine,0.9998809099197388,40,Type_40,Epirubicin may increase the respiratory depressant activities of Metocurine.,40,Type_40,Yes
DB01175,Escitalopram,DB06203,Alogliptin,0.990406334400177,9,Type_9,Escitalopram may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00503,Ritonavir,DB00588,Fluticasone propionate,0.9371729493141174,47,Type_47,The metabolism of Fluticasone propionate can be decreased when combined with Ritonavir.,73,Type_73,No
DB00390,Digoxin,DB06263,Amrubicin,0.6526234149932861,75,Type_75,The serum concentration of Amrubicin can be decreased when it is combined with Digoxin.,58,Type_58,No
DB01076,Atorvastatin,DB01587,Ketazolam,0.7019217610359192,73,Type_73,The serum concentration of Ketazolam can be increased when it is combined with Atorvastatin.,49,Type_49,No
DB00363,Clozapine,DB00425,Zolpidem,0.9910663962364197,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB08976,Floctafenine,DB09218,Clonixin,0.9996477365493774,49,Type_49,The risk or severity of adverse effects can be increased when Floctafenine is combined with Clonixin.,49,Type_49,Yes
DB01254,Dasatinib,DB09082,Vilanterol,0.4282183051109314,20,Type_20,Dasatinib may increase the QTc-prolonging activities of Vilanterol.,73,Type_73,No
DB01229,Paclitaxel,DB08912,Dabrafenib,0.9808440804481506,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Paclitaxel.,75,Type_75,Yes
DB09026,Aliskiren,DB09227,Barnidipine,0.935106635093689,49,Type_49,The risk or severity of adverse effects can be increased when Aliskiren is combined with Barnidipine.,49,Type_49,Yes
DB01047,Fluocinonide,DB09543,Methyl salicylate,0.9957872033119202,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Methyl salicylate.,49,Type_49,Yes
DB00549,Zafirlukast,DB08828,Vismodegib,0.8087103962898254,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00312,Pentobarbital,DB08881,Vemurafenib,0.9371384978294373,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Pentobarbital.,4,Type_4,No
DB00384,Triamterene,DB00519,Trandolapril,0.5803791880607605,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Trandolapril.,49,Type_49,Yes
DB00997,Doxorubicin,DB01397,Magnesium salicylate,0.7371333837509155,72,Type_72,Doxorubicin may decrease the excretion rate of Magnesium salicylate which could result in a higher serum level.,72,Type_72,Yes
DB00615,Rifabutin,DB06710,Methyltestosterone,0.8875047564506531,4,Type_4,The metabolism of Methyltestosterone can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00661,Verapamil,DB00794,Primidone,0.9541289210319519,4,Type_4,The metabolism of Primidone can be increased when combined with Verapamil.,4,Type_4,Yes
DB00921,Buprenorphine,DB01238,Aripiprazole,0.9995856881141663,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.,16,Type_16,Yes
DB00972,Azelastine,DB01587,Ketazolam,0.9025532603263855,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,16,Type_16,Yes
DB00334,Olanzapine,DB00813,Fentanyl,0.9957664012908936,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Fentanyl.,49,Type_49,Yes
DB00578,Carbenicillin,DB01024,Mycophenolic acid,0.4775785505771637,75,Type_75,The serum concentration of Mycophenolic acid can be decreased when it is combined with Carbenicillin.,11,Type_11,No
DB00476,Duloxetine,DB00641,Simvastatin,0.4142782688140869,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Duloxetine.,47,Type_47,No
DB00794,Primidone,DB06153,Pizotifen,0.9975236058235168,49,Type_49,The risk or severity of adverse effects can be increased when Primidone is combined with Pizotifen.,49,Type_49,Yes
DB00907,Cocaine,DB00983,Formoterol,0.7273008227348328,47,Type_47,The metabolism of Formoterol can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00820,Tadalafil,DB01119,Diazoxide,0.9671981334686279,10,Type_10,Tadalafil may increase the antihypertensive activities of Diazoxide.,10,Type_10,Yes
DB00175,Pravastatin,DB01001,Salbutamol,0.6737276315689087,73,Type_73,The serum concentration of Salbutamol can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00808,Indapamide,DB01013,Clobetasol propionate,0.9913120865821838,83,Type_83,Indapamide may increase the hypokalemic activities of Clobetasol propionate.,83,Type_83,Yes
DB00661,Verapamil,DB01085,Pilocarpine,0.9589117765426636,47,Type_47,The metabolism of Pilocarpine can be decreased when combined with Verapamil.,47,Type_47,Yes
DB01012,Cinacalcet,DB01184,Domperidone,0.7926740050315857,47,Type_47,The metabolism of Domperidone can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB05812,Abiraterone,DB06736,Aceclofenac,0.7057347893714905,73,Type_73,The serum concentration of Aceclofenac can be increased when it is combined with Abiraterone.,47,Type_47,No
DB00309,Vindesine,DB00320,Dihydroergotamine,0.8884012699127197,73,Type_73,The serum concentration of Dihydroergotamine can be increased when it is combined with Vindesine.,73,Type_73,Yes
DB00946,Phenprocoumon,DB06710,Methyltestosterone,0.7315239906311035,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Methyltestosterone.,6,Type_6,Yes
DB00537,Ciprofloxacin,DB06216,Asenapine,0.9139247536659241,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB08932,Macitentan,DB09241,Methylene blue,0.9800644516944885,60,Type_60,Macitentan may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00487,Pefloxacin,DB01261,Sitagliptin,0.9953646659851074,9,Type_9,Pefloxacin may increase the hypoglycemic activities of Sitagliptin.,9,Type_9,Yes
DB00374,Treprostinil,DB01136,Carvedilol,0.966123640537262,60,Type_60,Treprostinil may increase the hypotensive activities of Carvedilol.,60,Type_60,Yes
DB00312,Pentobarbital,DB00349,Clobazam,0.6389909386634827,4,Type_4,The metabolism of Clobazam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01384,Paramethasone,DB04576,Fleroxacin,0.9558682441711426,49,Type_49,The risk or severity of adverse effects can be increased when Paramethasone is combined with Fleroxacin.,49,Type_49,Yes
DB00679,Thioridazine,DB04938,Ospemifene,0.6660208106040955,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Thioridazine.,73,Type_73,No
DB01259,Lapatinib,DB01394,Colchicine,0.9944637417793274,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Lapatinib.,73,Type_73,Yes
DB00502,Haloperidol,DB06282,Levocetirizine,0.8984938263893127,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Levocetirizine.,49,Type_49,Yes
DB00214,Torasemide,DB01399,Salsalate,0.9991486072540283,29,Type_29,Torasemide may decrease the diuretic activities of Salsalate.,29,Type_29,Yes
DB00320,Dihydroergotamine,DB01131,Proguanil,0.9399836659431458,47,Type_47,The metabolism of Proguanil can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00494,Entacapone,DB01198,Zopiclone,0.9991262555122375,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Zopiclone.,49,Type_49,Yes
DB00297,Bupivacaine,DB00661,Verapamil,0.6945889592170715,47,Type_47,The metabolism of Verapamil can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB01085,Pilocarpine,DB08865,Crizotinib,0.9708566069602966,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Pilocarpine.,47,Type_47,Yes
DB01242,Clomipramine,DB05271,Rotigotine,0.9382042288780212,32,Type_32,Clomipramine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00196,Fluconazole,DB01238,Aripiprazole,0.6607942581176758,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Fluconazole.,73,Type_73,Yes
DB00377,Palonosetron,DB04868,Nilotinib,0.9172077775001526,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Palonosetron.,47,Type_47,Yes
DB00690,Flurazepam,DB00924,Cyclobenzaprine,0.9594843983650208,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Cyclobenzaprine.,49,Type_49,Yes
DB06702,Fesoterodine,DB09238,Manidipine,0.4112319052219391,77,Type_77,The serum concentration of the active metabolites of Manidipine can be increased when Manidipine is used in combination with Fesoterodine.,77,Type_77,Yes
DB01010,Edrophonium,DB01085,Pilocarpine,0.6227328181266785,49,Type_49,The risk or severity of adverse effects can be increased when Edrophonium is combined with Pilocarpine.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB09063,Ceritinib,0.9822928309440613,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Acetylsalicylic acid.,73,Type_73,Yes
DB00484,Brimonidine,DB01295,Bevantolol,0.7012342214584351,25,Type_25,Brimonidine may increase the atrioventricular blocking (AV block) activities of Bevantolol.,25,Type_25,Yes
DB00927,Famotidine,DB01319,Fosamprenavir,0.6372573375701904,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Famotidine.,75,Type_75,No
DB00959,Methylprednisolone,DB01155,Gemifloxacin,0.9681554436683655,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Gemifloxacin.,49,Type_49,Yes
DB01199,Tubocurarine,DB01338,Pipecuronium,0.8595018982887268,49,Type_49,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pipecuronium.,49,Type_49,Yes
DB05039,Indacaterol,DB06786,Halcinonide,0.996887743473053,83,Type_83,Indacaterol may increase the hypokalemic activities of Halcinonide.,83,Type_83,Yes
DB00598,Labetalol,DB09227,Barnidipine,0.7643008232116699,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Barnidipine.,60,Type_60,No
DB01029,Irbesartan,DB06292,Dapagliflozin,0.9099819660186768,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Dapagliflozin.,49,Type_49,Yes
DB00370,Mirtazapine,DB01101,Capecitabine,0.6813134551048279,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00207,Azithromycin,DB00498,Phenindione,0.4111441671848297,73,Type_73,The serum concentration of Phenindione can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00850,Perphenazine,DB09097,Quinagolide,0.9998761415481567,70,Type_70,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Perphenazine.,70,Type_70,Yes
DB00934,Maprotiline,DB06402,Telavancin,0.9999995231628418,20,Type_20,Maprotiline may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00393,Nimodipine,DB00908,Quinidine,0.3891838788986206,47,Type_47,The metabolism of Quinidine can be decreased when combined with Nimodipine.,75,Type_75,No
DB00682,Warfarin,DB08918,Levomilnacipran,0.8493329286575317,49,Type_49,The risk or severity of adverse effects can be increased when Warfarin is combined with Levomilnacipran.,49,Type_49,Yes
DB00419,Miglustat,DB01621,Pipotiazine,0.9792638421058655,70,Type_70,The therapeutic efficacy of Pipotiazine can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB06290,Simeprevir,DB09396,Dextropropoxyphene napsylate,0.886388897895813,73,Type_73,The serum concentration of Dextropropoxyphene napsylate can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB01251,Gliquidone,DB08808,Bupranolol,0.928341805934906,9,Type_9,Gliquidone may increase the hypoglycemic activities of Bupranolol.,9,Type_9,Yes
DB00398,Sorafenib,DB00559,Bosentan,0.7038752436637878,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Sorafenib.,73,Type_73,No
DB00615,Rifabutin,DB00655,Estrone,0.6312179565429688,4,Type_4,The metabolism of Estrone can be increased when combined with Rifabutin.,4,Type_4,Yes
DB01032,Probenecid,DB01223,Aminophylline,0.5379005074501038,73,Type_73,The serum concentration of Aminophylline can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00744,Zileuton,DB01250,Olsalazine,0.8184241652488708,57,Type_57,Zileuton may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB00818,Propofol,DB09167,Dosulepin,0.767837405204773,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Propofol.,47,Type_47,Yes
DB00404,Alprazolam,DB06282,Levocetirizine,0.9981056451797485,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Levocetirizine.,49,Type_49,Yes
DB00501,Cimetidine,DB01175,Escitalopram,0.9644977450370789,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Cimetidine.,73,Type_73,No
DB00358,Mefloquine,DB09049,Naloxegol,0.9987200498580933,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB00529,Foscarnet,DB01137,Levofloxacin,0.9985455274581909,20,Type_20,Foscarnet may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB01340,Cilazapril,DB09215,Droxicam,0.9638278484344482,49,Type_49,The risk or severity of adverse effects can be increased when Cilazapril is combined with Droxicam.,49,Type_49,Yes
DB00481,Raloxifene,DB02703,Fusidic acid,0.9979045391082764,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Raloxifene.,73,Type_73,Yes
DB01229,Paclitaxel,DB06717,Fosaprepitant,0.8687711358070374,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Paclitaxel.,73,Type_73,Yes
DB00672,Chlorpropamide,DB09167,Dosulepin,0.8275301456451416,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Chlorpropamide.,47,Type_47,Yes
DB00248,Cabergoline,DB01435,Antipyrine,0.9893540143966675,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Antipyrine.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB06203,Alogliptin,0.9701520800590515,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00359,Sulfadiazine,DB04898,Ximelagatran,0.9150707125663757,47,Type_47,The metabolism of Ximelagatran can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00187,Esmolol,DB01229,Paclitaxel,0.9990792274475098,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Paclitaxel.,49,Type_49,Yes
DB06203,Alogliptin,DB09073,Palbociclib,0.9857546091079712,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Alogliptin.,73,Type_73,Yes
DB01158,Bretylium,DB09279,Fimasartan,0.9999078512191772,49,Type_49,The risk or severity of adverse effects can be increased when Bretylium is combined with Fimasartan.,49,Type_49,Yes
DB04743,Nimesulide,DB09211,Limaprost,0.567040205001831,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Nimesulide.,53,Type_53,No
DB00686,Pentosan polysulfate,DB00783,Estradiol,0.5541121363639832,70,Type_70,The therapeutic efficacy of Estradiol can be decreased when used in combination with Pentosan polysulfate.,12,Type_12,No
DB00248,Cabergoline,DB06144,Sertindole,0.9952542781829834,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Sertindole.,49,Type_49,Yes
DB00773,Etoposide,DB06207,Silodosin,0.9029069542884827,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Etoposide.,73,Type_73,Yes
DB00398,Sorafenib,DB01624,Zuclopenthixol,0.48674556612968445,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB00214,Torasemide,DB00390,Digoxin,0.48130372166633606,70,Type_70,The therapeutic efficacy of Digoxin can be decreased when used in combination with Torasemide.,49,Type_49,No
DB01149,Nefazodone,DB01614,Acepromazine,0.6668282747268677,73,Type_73,The serum concentration of Acepromazine can be increased when it is combined with Nefazodone.,49,Type_49,No
DB09166,Etizolam,DB11148,Butamben,0.9999974966049194,49,Type_49,The risk or severity of adverse effects can be increased when Etizolam is combined with Butamben.,49,Type_49,Yes
DB00477,Chlorpromazine,DB00961,Mepivacaine,0.9980827569961548,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Mepivacaine.,49,Type_49,Yes
DB00908,Quinidine,DB00936,Salicylic acid,0.7818193435668945,47,Type_47,The metabolism of Salicylic acid can be decreased when combined with Quinidine.,73,Type_73,No
DB00461,Nabumetone,DB01348,Spirapril,0.9572784304618835,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Spirapril.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB00754,Ethotoin,0.9978500604629517,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ethotoin.,49,Type_49,Yes
DB00673,Aprepitant,DB00683,Midazolam,0.8142581582069397,73,Type_73,The serum concentration of Midazolam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00398,Sorafenib,DB00972,Azelastine,0.6257047057151794,47,Type_47,The metabolism of Azelastine can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00178,Ramipril,DB01395,Drospirenone,0.9077498316764832,68,Type_68,Ramipril may increase the hyperkalemic activities of Drospirenone.,68,Type_68,Yes
DB00685,Trovafloxacin,DB09104,Magnesium hydroxide,0.8720787167549133,67,Type_67,Trovafloxacin can cause a decrease in the absorption of Magnesium hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00352,Tioguanine,DB00864,Tacrolimus,0.8628871440887451,49,Type_49,The risk or severity of adverse effects can be increased when Tioguanine is combined with Tacrolimus.,49,Type_49,Yes
DB01141,Micafungin,DB01591,Solifenacin,0.4908239245414734,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Micafungin.,47,Type_47,Yes
DB00683,Midazolam,DB01618,Molindone,0.9998297691345215,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Molindone.,49,Type_49,Yes
DB00800,Fenoldopam,DB01180,Rescinnamine,0.9870456457138062,60,Type_60,Fenoldopam may increase the hypotensive activities of Rescinnamine.,60,Type_60,Yes
DB00287,Travoprost,DB01392,Yohimbine,0.8372690081596375,37,Type_37,Travoprost may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00188,Bortezomib,DB06789,Hydroxyprogesterone caproate,0.8398435115814209,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00292,Etomidate,DB00924,Cyclobenzaprine,0.9298104643821716,37,Type_37,Etomidate may decrease the antihypertensive activities of Cyclobenzaprine.,37,Type_37,Yes
DB01159,Halothane,DB09112,Nitrous acid,0.9993928670883179,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Nitrous acid.,49,Type_49,Yes
DB09048,Netupitant,DB09053,Ibrutinib,0.9951085448265076,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Netupitant.,73,Type_73,Yes
DB01545,Ethyl loflazepate,DB08918,Levomilnacipran,0.9892270565032959,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Levomilnacipran.,49,Type_49,Yes
DB00887,Bumetanide,DB13450,Cisatracurium besylate,0.9998782873153687,17,Type_17,Bumetanide may decrease the neuromuscular blocking activities of Cisatracurium besylate.,17,Type_17,Yes
DB04855,Dronedarone,DB05676,Apremilast,0.626327633857727,47,Type_47,The metabolism of Apremilast can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00818,Propofol,DB01161,Chloroprocaine,0.9997715353965759,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Chloroprocaine.,49,Type_49,Yes
DB00742,Mannitol,DB01240,Epoprostenol,0.7380031943321228,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Epoprostenol.,49,Type_49,Yes
DB09167,Dosulepin,DB09242,Moxonidine,0.9442159533500671,37,Type_37,Dosulepin may decrease the antihypertensive activities of Moxonidine.,70,Type_70,No
DB01151,Desipramine,DB06207,Silodosin,0.9806405305862427,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00222,Glimepiride,DB09204,Arotinolol,0.9993717074394226,9,Type_9,Glimepiride may increase the hypoglycemic activities of Arotinolol.,9,Type_9,Yes
DB00187,Esmolol,DB00939,Meclofenamic acid,0.9966525435447693,37,Type_37,Esmolol may decrease the antihypertensive activities of Meclofenamic acid.,37,Type_37,Yes
DB01263,Posaconazole,DB04846,Celiprolol,0.8264114260673523,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00527,Cinchocaine,DB08883,Perampanel,0.9607248306274414,16,Type_16,Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00091,Cyclosporine,DB01181,Ifosfamide,0.7994945049285889,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Cyclosporine.,11,Type_11,No
DB00254,Doxycycline,DB08795,Azidocillin,0.2946270704269409,70,Type_70,The therapeutic efficacy of Azidocillin can be decreased when used in combination with Doxycycline.,70,Type_70,Yes
DB00213,Pantoprazole,DB09075,Edoxaban,0.9441285729408264,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Pantoprazole.,73,Type_73,Yes
DB00186,Lorazepam,DB09072,Sodium oxybate,1.0,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01626,Pargyline,DB04948,Lofexidine,0.9730917811393738,60,Type_60,Pargyline may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00899,Remifentanil,DB06700,Desvenlafaxine,0.8483062386512756,64,Type_64,Remifentanil may increase the serotonergic activities of Desvenlafaxine.,64,Type_64,Yes
DB00476,Duloxetine,DB00755,Tretinoin,0.7904568314552307,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Tretinoin.,30,Type_30,Yes
DB00399,Zoledronic acid,DB09162,Ferric Citrate,0.984279215335846,75,Type_75,The serum concentration of Ferric Citrate can be decreased when it is combined with Zoledronic acid.,75,Type_75,Yes
DB00204,Dofetilide,DB02703,Fusidic acid,0.9987012147903442,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB00845,Clofazimine,DB01609,Deferasirox,0.9278231859207153,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Clofazimine.,75,Type_75,Yes
DB01006,Letrozole,DB04868,Nilotinib,0.7790850400924683,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Letrozole.,47,Type_47,Yes
DB00381,Amlodipine,DB09241,Methylene blue,0.9895890951156616,60,Type_60,Amlodipine may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB01197,Captopril,DB13783,Acemetacin,0.7088599801063538,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Captopril.,70,Type_70,Yes
DB00445,Epirubicin,DB01602,Bacampicillin,0.9751161336898804,75,Type_75,The serum concentration of Bacampicillin can be decreased when it is combined with Epirubicin.,75,Type_75,Yes
DB00399,Zoledronic acid,DB00784,Mefenamic acid,0.9936709403991699,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Mefenamic acid.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00778,Roxithromycin,0.9648907780647278,47,Type_47,The metabolism of Roxithromycin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01263,Posaconazole,DB01395,Drospirenone,0.9069631099700928,73,Type_73,The serum concentration of Drospirenone can be increased when it is combined with Posaconazole.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB01587,Ketazolam,0.6603655815124512,47,Type_47,The metabolism of Ketazolam can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00444,Teniposide,DB01241,Gemfibrozil,0.6159909963607788,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Teniposide.,47,Type_47,Yes
DB00273,Topiramate,DB00682,Warfarin,0.4851406514644623,6,Type_6,Topiramate may increase the anticoagulant activities of Warfarin.,47,Type_47,No
DB00434,Cyproheptadine,DB09224,Melperone,0.9993289709091187,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Melperone.,49,Type_49,Yes
DB00393,Nimodipine,DB00575,Clonidine,0.8699936866760254,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Clonidine.,49,Type_49,Yes
DB01267,Paliperidone,DB08864,Rilpivirine,0.853839099407196,20,Type_20,Paliperidone may increase the QTc-prolonging activities of Rilpivirine.,20,Type_20,Yes
DB01615,Aceprometazine,DB01621,Pipotiazine,0.9855790138244629,49,Type_49,The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pipotiazine.,49,Type_49,Yes
DB00834,Mifepristone,DB01260,Desonide,0.6500592827796936,70,Type_70,The therapeutic efficacy of Desonide can be decreased when used in combination with Mifepristone.,70,Type_70,Yes
DB00268,Ropinirole,DB01195,Flecainide,0.6261009573936462,47,Type_47,The metabolism of Flecainide can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00361,Vinorelbine,DB01253,Ergometrine,0.87138432264328,49,Type_49,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ergometrine.,49,Type_49,Yes
DB08899,Enzalutamide,DB09143,Sonidegib,0.682151734828949,75,Type_75,The serum concentration of Sonidegib can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB00181,Baclofen,DB00413,Pramipexole,0.9999197721481323,32,Type_32,Baclofen may increase the sedative activities of Pramipexole.,32,Type_32,Yes
DB09039,Eliglustat,DB09128,Brexpiprazole,0.7143830060958862,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Eliglustat.,73,Type_73,Yes
DB00469,Tenoxicam,DB00821,Carprofen,0.999091625213623,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Carprofen.,49,Type_49,Yes
DB01234,Dexamethasone,DB04868,Nilotinib,0.42733708024024963,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Dexamethasone.,75,Type_75,No
DB00280,Disopyramide,DB08871,Eribulin,0.894091784954071,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Eribulin.,20,Type_20,Yes
DB01009,Ketoprofen,DB01297,Practolol,0.9999836683273315,37,Type_37,Ketoprofen may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00393,Nimodipine,DB00899,Remifentanil,0.9956257343292236,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Remifentanil.,49,Type_49,Yes
DB00559,Bosentan,DB01393,Bezafibrate,0.9019204378128052,75,Type_75,The serum concentration of Bezafibrate can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB01132,Pioglitazone,DB06605,Apixaban,0.6006054282188416,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Pioglitazone.,47,Type_47,No
DB00322,Floxuridine,DB00327,Hydromorphone,0.910481333732605,47,Type_47,The metabolism of Hydromorphone can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB01090,Pentolinium,DB06237,Avanafil,0.9808006882667542,10,Type_10,Pentolinium may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00230,Pregabalin,DB01127,Econazole,0.9273098111152649,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Econazole.,49,Type_49,Yes
DB00944,Demecarium,DB01410,Ciclesonide,0.9998093247413635,49,Type_49,The risk or severity of adverse effects can be increased when Demecarium is combined with Ciclesonide.,49,Type_49,Yes
DB00573,Fenoprofen,DB00795,Sulfasalazine,0.9995211362838745,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Sulfasalazine.,49,Type_49,Yes
DB00230,Pregabalin,DB00835,Brompheniramine,0.9801560640335083,8,Type_8,The therapeutic efficacy of Brompheniramine can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00215,Citalopram,DB00611,Butorphanol,0.8855530023574829,64,Type_64,Citalopram may increase the serotonergic activities of Butorphanol.,64,Type_64,Yes
DB00691,Moexipril,DB00788,Naproxen,0.9253680109977722,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Naproxen.,49,Type_49,Yes
DB01173,Orphenadrine,DB01245,Decamethonium,0.9846171140670776,70,Type_70,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Orphenadrine.,70,Type_70,Yes
DB00661,Verapamil,DB06414,Etravirine,0.9023790955543518,47,Type_47,The metabolism of Etravirine can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00323,Tolcapone,DB01065,Melatonin,0.9995934367179871,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Melatonin.,49,Type_49,Yes
DB00646,Nystatin,DB00900,Didanosine,0.8495061993598938,67,Type_67,Nystatin can cause a decrease in the absorption of Didanosine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00390,Digoxin,DB00642,Pemetrexed,0.9990252256393433,58,Type_58,Digoxin may decrease the cardiotoxic activities of Pemetrexed.,58,Type_58,Yes
DB01384,Paramethasone,DB06819,Phenylbutyric acid,0.9678065180778503,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Paramethasone.,70,Type_70,Yes
DB00477,Chlorpromazine,DB13872,Lormetazepam,0.9943934679031372,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Lormetazepam.,49,Type_49,Yes
DB00264,Metoprolol,DB00887,Bumetanide,0.98451828956604,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Bumetanide.,49,Type_49,Yes
DB00343,Diltiazem,DB08899,Enzalutamide,0.9006989002227783,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Diltiazem.,75,Type_75,Yes
DB09124,Medrogestone,DB11268,Protocatechualdehyde,0.9967040419578552,70,Type_70,The therapeutic efficacy of Protocatechualdehyde can be decreased when used in combination with Medrogestone.,70,Type_70,Yes
DB00312,Pentobarbital,DB09072,Sodium oxybate,1.0,16,Type_16,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00191,Phentermine,DB09104,Magnesium hydroxide,0.9978495836257935,72,Type_72,Phentermine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,72,Type_72,Yes
DB08880,Teriflunomide,DB12364,Betrixaban,0.999966025352478,66,Type_66,The risk or severity of bleeding can be increased when Teriflunomide is combined with Betrixaban.,66,Type_66,Yes
DB00227,Lovastatin,DB00945,Acetylsalicylic acid,0.7876979112625122,47,Type_47,The metabolism of Acetylsalicylic acid can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00499,Flutamide,DB06595,Midostaurin,0.8603757619857788,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Flutamide.,47,Type_47,Yes
DB08883,Perampanel,DB09128,Brexpiprazole,0.617908239364624,16,Type_16,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.,16,Type_16,Yes
DB00215,Citalopram,DB00852,Pseudoephedrine,0.7328565716743469,47,Type_47,The metabolism of Pseudoephedrine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00393,Nimodipine,DB00883,Isosorbide dinitrate,0.9849495887756348,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00266,Dicoumarol,DB00328,Indomethacin,0.9981677532196045,6,Type_6,Dicoumarol may increase the anticoagulant activities of Indomethacin.,6,Type_6,Yes
DB00420,Promazine,DB09352,Hydroxyamphetamine,0.98661208152771,61,Type_61,Promazine may decrease the stimulatory activities of Hydroxyamphetamine.,61,Type_61,Yes
DB00651,Dyphylline,DB01357,Mestranol,0.5722171068191528,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Dyphylline.,73,Type_73,Yes
DB00735,Naftifine,DB01297,Practolol,0.9997509121894836,37,Type_37,Naftifine may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB01370,Aluminium,DB09095,Difluocortolone,0.9947123527526855,3,Type_3,The bioavailability of Difluocortolone can be decreased when combined with Aluminium.,3,Type_3,Yes
DB00699,Nicergoline,DB08864,Rilpivirine,0.8755598068237305,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Rilpivirine.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB01261,Sitagliptin,0.9751948714256287,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00607,Nafcillin,DB06335,Saxagliptin,0.7993801236152649,75,Type_75,The serum concentration of Saxagliptin can be decreased when it is combined with Nafcillin.,75,Type_75,Yes
DB00497,Oxycodone,DB01463,Fencamfamin,0.998979389667511,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Fencamfamin.,49,Type_49,Yes
DB01656,Roflumilast,DB08910,Pomalidomide,0.27808138728141785,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Roflumilast.,34,Type_34,No
DB00477,Chlorpromazine,DB06770,Benzyl alcohol,0.7927936911582947,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzyl alcohol.,47,Type_47,No
DB00203,Sildenafil,DB00281,Lidocaine,0.651435375213623,47,Type_47,The metabolism of Lidocaine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01158,Bretylium,DB01242,Clomipramine,0.6924455165863037,49,Type_49,The risk or severity of adverse effects can be increased when Bretylium is combined with Clomipramine.,49,Type_49,Yes
DB00395,Carisoprodol,DB00490,Buspirone,0.8953912258148193,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Buspirone.,49,Type_49,Yes
DB01001,Salbutamol,DB01168,Procarbazine,0.9990045428276062,49,Type_49,The risk or severity of adverse effects can be increased when Salbutamol is combined with Procarbazine.,49,Type_49,Yes
DB00280,Disopyramide,DB01087,Primaquine,0.9619694948196411,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB01609,Deferasirox,DB08932,Macitentan,0.9091536402702332,75,Type_75,The serum concentration of Macitentan can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00461,Nabumetone,DB09288,Propacetamol,0.9949101805686951,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Propacetamol.,49,Type_49,Yes
DB00794,Primidone,DB00843,Donepezil,0.9783564209938049,4,Type_4,The metabolism of Donepezil can be increased when combined with Primidone.,4,Type_4,Yes
DB00328,Indomethacin,DB09292,Sacubitril,0.9963034391403198,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Sacubitril.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB01403,Methotrimeprazine,0.9857774376869202,16,Type_16,Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00214,Torasemide,DB00749,Etodolac,0.9999022483825684,29,Type_29,Torasemide may decrease the diuretic activities of Etodolac.,29,Type_29,Yes
DB08826,Deferiprone,DB08938,Magaldrate,0.9999984502792358,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Deferiprone.,75,Type_75,Yes
DB00927,Famotidine,DB09146,Iron sucrose,0.8835200071334839,67,Type_67,Famotidine can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00201,Caffeine,DB00320,Dihydroergotamine,0.92219078540802,47,Type_47,The metabolism of Dihydroergotamine can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00683,Midazolam,DB01587,Ketazolam,0.9925641417503357,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Ketazolam.,49,Type_49,Yes
DB00289,Atomoxetine,DB00907,Cocaine,0.8754712343215942,47,Type_47,The metabolism of Cocaine can be decreased when combined with Atomoxetine.,73,Type_73,No
DB00745,Modafinil,DB01179,Podofilox,0.9031991958618164,47,Type_47,The metabolism of Podofilox can be decreased when combined with Modafinil.,47,Type_47,Yes
DB01097,Leflunomide,DB01628,Etoricoxib,0.6766473650932312,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Leflunomide.,47,Type_47,Yes
DB00490,Buspirone,DB00708,Sufentanil,0.9643157720565796,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Sufentanil.,49,Type_49,Yes
DB00909,Zonisamide,DB02703,Fusidic acid,0.997071385383606,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Zonisamide.,73,Type_73,Yes
DB00215,Citalopram,DB06605,Apixaban,0.4382563531398773,47,Type_47,The metabolism of Apixaban can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00203,Sildenafil,DB01006,Letrozole,0.9691224694252014,47,Type_47,The metabolism of Letrozole can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00104,Octreotide,DB01211,Clarithromycin,0.7519188523292542,20,Type_20,Octreotide may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00699,Nicergoline,DB00959,Methylprednisolone,0.996892511844635,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Methylprednisolone.,49,Type_49,Yes
DB00784,Mefenamic acid,DB04846,Celiprolol,0.9997084736824036,37,Type_37,Mefenamic acid may decrease the antihypertensive activities of Celiprolol.,37,Type_37,Yes
DB00715,Paroxetine,DB06695,Dabigatran etexilate,0.9021055102348328,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Paroxetine.,77,Type_77,Yes
DB04842,Fluspirilene,DB06288,Amisulpride,0.7782843708992004,36,Type_36,Fluspirilene may increase the antipsychotic activities of Amisulpride.,36,Type_36,Yes
DB00830,Phenmetrazine,DB01577,Metamfetamine,0.9983783960342407,49,Type_49,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Metamfetamine.,49,Type_49,Yes
DB01071,Mequitazine,DB09224,Melperone,0.9481995105743408,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Melperone.,82,Type_82,Yes
DB00959,Methylprednisolone,DB03754,Tromethamine,0.9988131523132324,3,Type_3,The bioavailability of Tromethamine can be decreased when combined with Methylprednisolone.,3,Type_3,Yes
DB06690,Nitrous oxide,DB09117,Paraldehyde,0.9999877214431763,16,Type_16,Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00559,Bosentan,DB01089,Deserpidine,0.9947724938392639,60,Type_60,Bosentan may increase the hypotensive activities of Deserpidine.,60,Type_60,Yes
DB00477,Chlorpromazine,DB00637,Astemizole,0.44893258810043335,20,Type_20,Chlorpromazine may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB01353,Butobarbital,DB01589,Quazepam,0.9991831183433533,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Quazepam.,49,Type_49,Yes
DB00312,Pentobarbital,DB00489,Sotalol,0.7924212217330933,60,Type_60,Pentobarbital may increase the hypotensive activities of Sotalol.,60,Type_60,Yes
DB00181,Baclofen,DB00363,Clozapine,0.9672636985778809,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Clozapine.,49,Type_49,Yes
DB00783,Estradiol,DB01174,Phenobarbital,0.6519855856895447,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Estradiol.,4,Type_4,Yes
DB00344,Protriptyline,DB09244,Pirlindole,0.9531350135803223,64,Type_64,Protriptyline may increase the serotonergic activities of Pirlindole.,64,Type_64,Yes
DB00204,Dofetilide,DB00648,Mitotane,0.9941642880439758,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Dofetilide.,75,Type_75,Yes
DB05521,Telaprevir,DB09102,Daclatasvir,0.5121592283248901,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Telaprevir.,73,Type_73,No
DB00749,Etodolac,DB01421,Paromomycin,0.9998351335525513,72,Type_72,Etodolac may decrease the excretion rate of Paromomycin which could result in a higher serum level.,72,Type_72,Yes
DB00375,Colestipol,DB09389,Norgestrel,0.8771746754646301,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Colestipol.,75,Type_75,Yes
DB00619,Imatinib,DB01394,Colchicine,0.9190165996551514,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Imatinib.,73,Type_73,Yes
DB01115,Nifedipine,DB09112,Nitrous acid,0.997330904006958,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Nitrous acid.,49,Type_49,Yes
DB00635,Prednisone,DB06335,Saxagliptin,0.8188877105712891,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Prednisone.,75,Type_75,No
DB00950,Fexofenadine,DB09075,Edoxaban,0.9830965995788574,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Fexofenadine.,73,Type_73,Yes
DB00543,Amoxapine,DB01367,Rasagiline,0.9422382712364197,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Rasagiline.,49,Type_49,Yes
DB01356,Lithium cation,DB01589,Quazepam,0.6515506505966187,73,Type_73,The serum concentration of Quazepam can be increased when it is combined with Lithium cation.,49,Type_49,No
DB00295,Morphine,DB01320,Fosphenytoin,0.9670537114143372,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Morphine.,4,Type_4,Yes
DB06725,Lornoxicam,DB06781,Difluprednate,0.999742329120636,49,Type_49,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Difluprednate.,49,Type_49,Yes
DB00727,Nitroglycerin,DB08931,Riociguat,0.995261549949646,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Riociguat.,60,Type_60,No
DB00748,Carbinoxamine,DB04896,Milnacipran,0.9575291872024536,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Milnacipran.,49,Type_49,Yes
DB00731,Nateglinide,DB01167,Itraconazole,0.9276773929595947,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00790,Perindopril,DB00812,Phenylbutazone,0.9553385376930237,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Phenylbutazone.,49,Type_49,Yes
DB00808,Indapamide,DB08984,Etofenamate,0.8849290609359741,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00962,Zaleplon,DB13323,Trichloroethylene,0.885801374912262,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Trichloroethylene.,49,Type_49,Yes
DB00818,Propofol,DB01095,Fluvastatin,0.607189953327179,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Propofol.,47,Type_47,Yes
DB00656,Trazodone,DB08899,Enzalutamide,0.9246512651443481,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Trazodone.,75,Type_75,Yes
DB00808,Indapamide,DB00820,Tadalafil,0.9998468160629272,10,Type_10,Indapamide may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00710,Ibandronate,DB08865,Crizotinib,0.9912223815917969,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB00434,Cyproheptadine,DB09342,Propoxycaine,0.9922673106193542,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Propoxycaine.,49,Type_49,Yes
DB00683,Midazolam,DB01041,Thalidomide,0.9880191683769226,16,Type_16,Midazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00849,Methylphenobarbital,DB08872,Gabapentin enacarbil,0.950524628162384,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00468,Quinine,DB00501,Cimetidine,0.9557234048843384,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Quinine.,73,Type_73,No
DB00395,Carisoprodol,DB01142,Doxepin,0.9746165871620178,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Doxepin.,49,Type_49,Yes
DB00308,Ibutilide,DB00976,Telithromycin,0.9907591342926025,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Telithromycin.,20,Type_20,Yes
DB00814,Meloxicam,DB01124,Tolbutamide,0.8183049559593201,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Meloxicam.,47,Type_47,Yes
DB01255,Lisdexamfetamine,DB01367,Rasagiline,0.632329523563385,49,Type_49,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Rasagiline.,71,Type_71,No
DB00400,Griseofulvin,DB01201,Rifapentine,0.7779250144958496,4,Type_4,The metabolism of Rifapentine can be increased when combined with Griseofulvin.,73,Type_73,No
DB01155,Gemifloxacin,DB08903,Bedaquiline,0.995144248008728,20,Type_20,Gemifloxacin may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00596,Ulobetasol,DB08439,Parecoxib,0.9977321624755859,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Parecoxib.,49,Type_49,Yes
DB09082,Vilanterol,DB09118,Stiripentol,0.9080137610435486,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Vilanterol.,73,Type_73,Yes
DB08964,Gemeprost,DB08984,Etofenamate,0.9999511241912842,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Gemeprost.,70,Type_70,Yes
DB00956,Hydrocodone,DB01595,Nitrazepam,0.9323852062225342,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.,16,Type_16,Yes
DB00804,Dicyclomine,DB01466,Ethylmorphine,0.9999291896820068,49,Type_49,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Ethylmorphine.,49,Type_49,Yes
DB06724,Calcium carbonate,DB09147,Ferric pyrophosphate,0.9953376054763794,67,Type_67,Calcium carbonate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00645,Dyclonine,DB09286,Pipamperone,0.9989252686500549,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Pipamperone.,49,Type_49,Yes
DB00608,Chloroquine,DB08868,Fingolimod,0.7250914573669434,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Chloroquine.,20,Type_20,No
DB01028,Methoxyflurane,DB06153,Pizotifen,0.999338686466217,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Pizotifen.,49,Type_49,Yes
DB00880,Chlorothiazide,DB13231,Calcium lactate,0.9918466806411743,72,Type_72,Chlorothiazide may decrease the excretion rate of Calcium lactate which could result in a higher serum level.,72,Type_72,Yes
DB00865,Benzphetamine,DB08912,Dabrafenib,0.978457510471344,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Benzphetamine.,75,Type_75,Yes
DB08896,Regorafenib,DB09048,Netupitant,0.9927420616149902,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Regorafenib.,73,Type_73,Yes
DB00322,Floxuridine,DB01072,Atazanavir,0.823045551776886,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00807,Proparacaine,DB06204,Tapentadol,0.9949641227722168,16,Type_16,Proparacaine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00193,Tramadol,DB00897,Triazolam,0.8705080151557922,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Triazolam.,49,Type_49,Yes
DB00195,Betaxolol,DB06739,Seratrodast,0.9498326182365417,37,Type_37,Betaxolol may decrease the antihypertensive activities of Seratrodast.,37,Type_37,Yes
DB00770,Alprostadil,DB06736,Aceclofenac,0.938691258430481,70,Type_70,The therapeutic efficacy of Aceclofenac can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00563,Methotrexate,DB00744,Zileuton,0.6900391578674316,73,Type_73,The serum concentration of Zileuton can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00252,Phenytoin,DB00670,Pirenzepine,0.7112089991569519,16,Type_16,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.,73,Type_73,No
DB00700,Eplerenone,DB09236,Lacidipine,0.9162968397140503,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Lacidipine.,49,Type_49,Yes
DB00612,Bisoprolol,DB08822,Azilsartan medoxomil,0.9980511665344238,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00806,Pentoxifylline,DB08816,Ticagrelor,0.8036292195320129,53,Type_53,Pentoxifylline may increase the antiplatelet activities of Ticagrelor.,53,Type_53,Yes
DB00563,Methotrexate,DB09320,Procaine benzylpenicillin,0.41366907954216003,70,Type_70,The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Methotrexate.,73,Type_73,No
DB00708,Sufentanil,DB00737,Meclizine,0.9995684027671814,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Meclizine.,49,Type_49,Yes
DB00474,Methohexital,DB01115,Nifedipine,0.6030521392822266,4,Type_4,The metabolism of Nifedipine can be increased when combined with Methohexital.,60,Type_60,No
DB00318,Codeine,DB01154,Thiamylal,0.9769993424415588,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Thiamylal.,49,Type_49,Yes
DB01009,Ketoprofen,DB01708,Prasterone,0.9993972778320312,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prasterone.,49,Type_49,Yes
DB00240,Alclometasone,DB04576,Fleroxacin,0.9464144706726074,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Fleroxacin.,49,Type_49,Yes
DB00834,Mifepristone,DB01192,Oxymorphone,0.8069860339164734,73,Type_73,The serum concentration of Oxymorphone can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00199,Erythromycin,DB00647,Dextropropoxyphene,0.9124352931976318,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01054,Nitrendipine,DB09070,Tibolone,0.9949002861976624,60,Type_60,Nitrendipine may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00877,Sirolimus,DB09268,Picosulfuric acid,0.9999991655349731,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Sirolimus.,70,Type_70,Yes
DB01319,Fosamprenavir,DB09054,Idelalisib,0.4758906960487366,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00188,Bortezomib,DB09238,Manidipine,0.9224042296409607,47,Type_47,The metabolism of Manidipine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01367,Rasagiline,DB11362,Selexipag,0.9700361490249634,60,Type_60,Rasagiline may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB01059,Norfloxacin,DB08984,Etofenamate,0.9956193566322327,27,Type_27,Norfloxacin may increase the neuroexcitatory activities of Etofenamate.,27,Type_27,Yes
DB06263,Amrubicin,DB08880,Teriflunomide,0.9842494130134583,72,Type_72,Amrubicin may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,72,Type_72,Yes
DB00188,Bortezomib,DB06176,Romidepsin,0.8318496942520142,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00408,Loxapine,DB09068,Vortioxetine,0.9986007809638977,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Vortioxetine.,49,Type_49,Yes
DB00344,Protriptyline,DB00750,Prilocaine,0.9998206496238708,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Prilocaine.,49,Type_49,Yes
DB00695,Furosemide,DB01050,Ibuprofen,0.999963641166687,29,Type_29,Furosemide may decrease the diuretic activities of Ibuprofen.,29,Type_29,Yes
DB00952,Naratriptan,DB09245,Toloxatone,0.7459899187088013,47,Type_47,The metabolism of Toloxatone can be decreased when combined with Naratriptan.,47,Type_47,Yes
DB01260,Desonide,DB09067,Corticorelin ovine triflutate,0.9999995231628418,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Desonide.,70,Type_70,Yes
DB00374,Treprostinil,DB00925,Phenoxybenzamine,0.9747251272201538,60,Type_60,Treprostinil may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB00263,Sulfisoxazole,DB01247,Isocarboxazid,0.7215160131454468,9,Type_9,Sulfisoxazole may increase the hypoglycemic activities of Isocarboxazid.,9,Type_9,Yes
DB00491,Miglitol,DB01420,Testosterone propionate,0.9954237341880798,9,Type_9,Miglitol may increase the hypoglycemic activities of Testosterone propionate.,9,Type_9,Yes
DB00401,Nisoldipine,DB00960,Pindolol,0.5685014128684998,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Pindolol.,49,Type_49,Yes
DB01028,Methoxyflurane,DB01319,Fosamprenavir,0.8147544264793396,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00474,Methohexital,DB00653,Magnesium sulfate,0.715337336063385,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Magnesium sulfate.,16,Type_16,No
DB00843,Donepezil,DB01214,Metipranolol,0.9924008846282959,54,Type_54,Donepezil may increase the bradycardic activities of Metipranolol.,54,Type_54,Yes
DB00419,Miglustat,DB02546,Vorinostat,0.9852995872497559,70,Type_70,The therapeutic efficacy of Vorinostat can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00177,Valsartan,DB06414,Etravirine,0.7728267908096313,47,Type_47,The metabolism of Etravirine can be decreased when combined with Valsartan.,47,Type_47,Yes
DB05521,Telaprevir,DB08864,Rilpivirine,0.9017234444618225,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Telaprevir.,73,Type_73,Yes
DB01357,Mestranol,DB09570,Ixazomib,0.5421015024185181,70,Type_70,The therapeutic efficacy of Ixazomib can be decreased when used in combination with Mestranol.,75,Type_75,No
DB00264,Metoprolol,DB00435,Nitric Oxide,0.9961515069007874,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Nitric Oxide.,49,Type_49,Yes
DB00236,Pipobroman,DB01092,Ouabain,0.999951958656311,58,Type_58,Pipobroman may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00770,Alprostadil,DB04898,Ximelagatran,0.9211955070495605,6,Type_6,Alprostadil may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00373,Timolol,DB01580,Oxprenolol,0.7106858491897583,25,Type_25,Timolol may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,60,Type_60,No
DB00338,Omeprazole,DB00458,Imipramine,0.9381441473960876,47,Type_47,The metabolism of Imipramine can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00625,Efavirenz,DB06210,Eltrombopag,0.46533751487731934,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00683,Midazolam,DB01433,Methadyl acetate,0.9977937936782837,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Methadyl acetate.,49,Type_49,Yes
DB00465,Ketorolac,DB01222,Budesonide,0.9994692206382751,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Budesonide.,49,Type_49,Yes
DB01078,Deslanoside,DB11231,Lycopene,0.9999929666519165,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Lycopene.,58,Type_58,Yes
DB00869,Dorzolamide,DB01197,Captopril,0.93882155418396,60,Type_60,Dorzolamide may increase the hypotensive activities of Captopril.,60,Type_60,Yes
DB00703,Methazolamide,DB08864,Rilpivirine,0.9927398562431335,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Methazolamide.,73,Type_73,Yes
DB00661,Verapamil,DB00976,Telithromycin,0.9386012554168701,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Verapamil.,54,Type_54,No
DB00477,Chlorpromazine,DB01174,Phenobarbital,0.703251838684082,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Chlorpromazine.,4,Type_4,Yes
DB00804,Dicyclomine,DB00981,Physostigmine,0.998871386051178,70,Type_70,The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dicyclomine.,70,Type_70,Yes
DB00614,Furazolidone,DB00839,Tolazamide,0.999247670173645,9,Type_9,Furazolidone may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00623,Fluphenazine,DB08883,Perampanel,0.9936671853065491,16,Type_16,Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00620,Triamcinolone,DB01325,Quinethazone,0.9999493360519409,83,Type_83,Triamcinolone may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB01118,Amiodarone,DB01601,Lopinavir,0.4990207552909851,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Amiodarone.,20,Type_20,No
DB01149,Nefazodone,DB01583,Liotrix,0.8126280307769775,73,Type_73,The serum concentration of Liotrix can be increased when it is combined with Nefazodone.,70,Type_70,No
DB00755,Tretinoin,DB00903,Etacrynic acid,0.8232651352882385,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Etacrynic acid.,49,Type_49,Yes
DB04840,Debrisoquine,DB09282,Molsidomine,0.9999982118606567,60,Type_60,Debrisoquine may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB01106,Levocabastine,DB09117,Paraldehyde,0.9998661279678345,16,Type_16,Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01116,Trimethaphan,DB09238,Manidipine,0.9940599203109741,60,Type_60,Trimethaphan may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00801,Halazepam,DB00875,Flupentixol,0.9946738481521606,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Flupentixol.,49,Type_49,Yes
DB01102,Arbutamine,DB06700,Desvenlafaxine,0.9928043484687805,85,Type_85,Arbutamine may increase the tachycardic activities of Desvenlafaxine.,85,Type_85,Yes
DB00683,Midazolam,DB01069,Promethazine,0.9753105640411377,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Promethazine.,49,Type_49,Yes
DB00187,Esmolol,DB01069,Promethazine,0.6496347188949585,60,Type_60,Esmolol may increase the hypotensive activities of Promethazine.,60,Type_60,Yes
DB00461,Nabumetone,DB00687,Fludrocortisone,0.9996908903121948,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Fludrocortisone.,49,Type_49,Yes
DB00500,Tolmetin,DB09216,Tolfenamic acid,0.9982811212539673,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Tolfenamic acid.,49,Type_49,Yes
DB00295,Morphine,DB00625,Efavirenz,0.32908153533935547,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Morphine.,49,Type_49,No
DB00805,Minaprine,DB01264,Darunavir,0.8699367642402649,47,Type_47,The metabolism of Darunavir can be decreased when combined with Minaprine.,73,Type_73,No
DB00214,Torasemide,DB09220,Nicorandil,0.9999637603759766,60,Type_60,Torasemide may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00549,Zafirlukast,DB08933,Luliconazole,0.9755222797393799,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Zafirlukast.,73,Type_73,Yes
DB01142,Doxepin,DB09570,Ixazomib,0.45929601788520813,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB01118,Amiodarone,DB06414,Etravirine,0.8157470226287842,47,Type_47,The metabolism of Etravirine can be decreased when combined with Amiodarone.,75,Type_75,No
DB01210,Levobunolol,DB06196,Icatibant,0.9933075308799744,37,Type_37,Levobunolol may decrease the antihypertensive activities of Icatibant.,37,Type_37,Yes
DB01320,Fosphenytoin,DB09061,Cannabidiol,0.9558717608451843,75,Type_75,The serum concentration of Cannabidiol can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB00333,Methadone,DB00529,Foscarnet,0.8665343523025513,20,Type_20,Methadone may increase the QTc-prolonging activities of Foscarnet.,20,Type_20,Yes
DB00471,Montelukast,DB01211,Clarithromycin,0.9348855018615723,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Montelukast.,47,Type_47,Yes
DB01197,Captopril,DB01261,Sitagliptin,0.7802194356918335,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Sitagliptin.,49,Type_49,Yes
DB00752,Tranylcypromine,DB09070,Tibolone,0.9447048902511597,60,Type_60,Tranylcypromine may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00224,Indinavir,DB06144,Sertindole,0.8032256960868835,47,Type_47,The metabolism of Sertindole can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00182,Amphetamine,DB00335,Atenolol,0.7347865700721741,60,Type_60,Amphetamine may increase the hypotensive activities of Atenolol.,60,Type_60,Yes
DB00531,Cyclophosphamide,DB08896,Regorafenib,0.844382107257843,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Regorafenib.,15,Type_15,Yes
DB08865,Crizotinib,DB08907,Canagliflozin,0.7363595366477966,47,Type_47,The metabolism of Canagliflozin can be decreased when combined with Crizotinib.,47,Type_47,Yes
DB00788,Naproxen,DB01045,Rifampicin,0.9356018304824829,4,Type_4,The metabolism of Rifampicin can be increased when combined with Naproxen.,4,Type_4,Yes
DB08976,Floctafenine,DB12364,Betrixaban,0.9916090369224548,66,Type_66,The risk or severity of bleeding can be increased when Floctafenine is combined with Betrixaban.,66,Type_66,Yes
DB00397,Phenylpropanolamine,DB00903,Etacrynic acid,0.9738083481788635,83,Type_83,Phenylpropanolamine may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB00178,Ramipril,DB00350,Minoxidil,0.7137948274612427,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Minoxidil.,49,Type_49,Yes
DB05294,Vandetanib,DB09083,Ivabradine,0.9857625961303711,20,Type_20,Vandetanib may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB00179,Masoprocol,DB01180,Rescinnamine,0.9912484884262085,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Rescinnamine.,49,Type_49,Yes
DB00598,Labetalol,DB08941,Isoxsuprine,0.9939578771591187,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Isoxsuprine.,49,Type_49,Yes
DB00224,Indinavir,DB00912,Repaglinide,0.9151546955108643,47,Type_47,The metabolism of Repaglinide can be decreased when combined with Indinavir.,73,Type_73,No
DB01019,Bethanechol,DB04846,Celiprolol,0.9983861446380615,49,Type_49,The risk or severity of adverse effects can be increased when Bethanechol is combined with Celiprolol.,49,Type_49,Yes
DB00854,Levorphanol,DB09345,Pramocaine,0.9873579740524292,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Pramocaine.,49,Type_49,Yes
DB00175,Pravastatin,DB06774,Capsaicin,0.8020167946815491,73,Type_73,The serum concentration of Capsaicin can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01294,Bismuth subsalicylate,DB09093,Chlortetracycline,0.9931806325912476,75,Type_75,The serum concentration of Chlortetracycline can be decreased when it is combined with Bismuth subsalicylate.,75,Type_75,Yes
DB00247,Methysergide,DB01054,Nitrendipine,0.9999486207962036,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Nitrendipine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00184,Nicotine,0.9575076699256897,47,Type_47,The metabolism of Nicotine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00345,Aminohippuric acid,DB00541,Vincristine,0.9893733859062195,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Aminohippuric acid.,73,Type_73,Yes
DB00231,Temazepam,DB06738,Ketobemidone,0.9962583780288696,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Ketobemidone.,49,Type_49,Yes
DB00903,Etacrynic acid,DB01396,Digitoxin,0.6496496796607971,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Digitoxin.,49,Type_49,Yes
DB00877,Sirolimus,DB09477,Enalaprilat,0.917011022567749,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Enalaprilat.,49,Type_49,Yes
DB00628,Clorazepic acid,DB00897,Triazolam,0.99444580078125,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Triazolam.,49,Type_49,Yes
DB00673,Aprepitant,DB01355,Hexobarbital,0.4892357289791107,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Aprepitant.,73,Type_73,No
DB00757,Dolasetron,DB01232,Saquinavir,0.6852030158042908,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Saquinavir.,20,Type_20,Yes
DB00641,Simvastatin,DB00845,Clofazimine,0.8487862348556519,73,Type_73,The serum concentration of Clofazimine can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00768,Olopatadine,DB01255,Lisdexamfetamine,0.9996591806411743,76,Type_76,Olopatadine may decrease the sedative activities of Lisdexamfetamine.,76,Type_76,Yes
DB01037,Selegiline,DB06204,Tapentadol,0.8826593160629272,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Tapentadol.,49,Type_49,Yes
DB00911,Tinidazole,DB04855,Dronedarone,0.9060216546058655,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Tinidazole.,47,Type_47,Yes
DB00862,Vardenafil,DB01624,Zuclopenthixol,0.910161018371582,20,Type_20,Vardenafil may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB01367,Rasagiline,DB09235,Efonidipine,0.7839787602424622,60,Type_60,Rasagiline may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00647,Dextropropoxyphene,DB09300,Butylscopolamine,0.9997374415397644,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Butylscopolamine.,49,Type_49,Yes
DB00575,Clonidine,DB01193,Acebutolol,0.9782060384750366,25,Type_25,Clonidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.,25,Type_25,Yes
DB09053,Ibrutinib,DB09063,Ceritinib,0.9901482462882996,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Ibrutinib.,73,Type_73,Yes
DB00557,Hydroxyzine,DB01242,Clomipramine,0.746792197227478,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.,16,Type_16,Yes
DB00483,Gallamine triethiodide,DB00843,Donepezil,0.9557268023490906,70,Type_70,The therapeutic efficacy of Donepezil can be decreased when used in combination with Gallamine triethiodide.,70,Type_70,Yes
DB00497,Oxycodone,DB09073,Palbociclib,0.9751402735710144,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Oxycodone.,73,Type_73,Yes
DB00796,Candesartan cilexetil,DB01174,Phenobarbital,0.7858566045761108,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Candesartan cilexetil.,4,Type_4,Yes
DB01551,Dihydrocodeine,DB08865,Crizotinib,0.7483071684837341,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Dihydrocodeine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB09068,Vortioxetine,0.9998283386230469,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Vortioxetine.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB01623,Thiothixene,0.6380807757377625,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00283,Clemastine,DB09068,Vortioxetine,0.6249538660049438,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB06154,Pentaerythritol tetranitrate,DB06267,Udenafil,0.9798924922943115,38,Type_38,Pentaerythritol tetranitrate may increase the vasodilatory activities of Udenafil.,38,Type_38,Yes
DB01199,Tubocurarine,DB04846,Celiprolol,0.8428565859794617,54,Type_54,Tubocurarine may increase the bradycardic activities of Celiprolol.,54,Type_54,Yes
DB00875,Flupentixol,DB05294,Vandetanib,0.7149887681007385,33,Type_33,The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Vandetanib.,33,Type_33,Yes
DB00175,Pravastatin,DB00333,Methadone,0.5946932435035706,47,Type_47,The metabolism of Methadone can be decreased when combined with Pravastatin.,73,Type_73,No
DB01339,Vecuronium,DB12278,Propiverine,0.8928481936454773,49,Type_49,The risk or severity of adverse effects can be increased when Vecuronium is combined with Propiverine.,49,Type_49,Yes
DB00599,Thiopental,DB00603,Medroxyprogesterone acetate,0.68425452709198,70,Type_70,The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Thiopental.,70,Type_70,Yes
DB00475,Chlordiazepoxide,DB00748,Carbinoxamine,0.9906291365623474,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Carbinoxamine.,49,Type_49,Yes
DB01095,Fluvastatin,DB04938,Ospemifene,0.7062383890151978,73,Type_73,The serum concentration of Ospemifene can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00883,Isosorbide dinitrate,DB06717,Fosaprepitant,0.96125727891922,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Isosorbide dinitrate.,73,Type_73,Yes
DB00678,Losartan,DB00699,Nicergoline,0.9451117515563965,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Nicergoline.,49,Type_49,Yes
DB00808,Indapamide,DB01120,Gliclazide,0.9632047414779663,70,Type_70,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00257,Clotrimazole,DB01114,Chlorpheniramine,0.8783966302871704,47,Type_47,The metabolism of Chlorpheniramine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01110,Miconazole,DB01186,Pergolide,0.9016388654708862,49,Type_49,The risk or severity of adverse effects can be increased when Miconazole is combined with Pergolide.,49,Type_49,Yes
DB00919,Spectinomycin,DB01628,Etoricoxib,0.9997453093528748,72,Type_72,Spectinomycin may decrease the excretion rate of Etoricoxib which could result in a higher serum level.,72,Type_72,Yes
DB06603,Panobinostat,DB09076,Umeclidinium,0.6907021403312683,73,Type_73,The serum concentration of Umeclidinium can be increased when it is combined with Panobinostat.,73,Type_73,Yes
DB00219,Oxyphenonium,DB00524,Metolazone,0.9961481094360352,73,Type_73,The serum concentration of Metolazone can be increased when it is combined with Oxyphenonium.,73,Type_73,Yes
DB01567,Fludiazepam,DB09345,Pramocaine,0.9816412925720215,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Pramocaine.,49,Type_49,Yes
DB00476,Duloxetine,DB04841,Flunarizine,0.8809237480163574,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Flunarizine.,47,Type_47,No
DB01128,Bicalutamide,DB09065,Cobicistat,0.5029844045639038,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Bicalutamide.,47,Type_47,No
DB00400,Griseofulvin,DB01244,Bepridil,0.9741111397743225,49,Type_49,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Bepridil.,49,Type_49,Yes
DB06684,Vilazodone,DB08820,Ivacaftor,0.9983667731285095,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Vilazodone.,73,Type_73,Yes
DB00457,Prazosin,DB09216,Tolfenamic acid,0.6605202555656433,37,Type_37,Prazosin may decrease the antihypertensive activities of Tolfenamic acid.,60,Type_60,No
DB00175,Pravastatin,DB00647,Dextropropoxyphene,0.49493926763534546,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Pravastatin.,73,Type_73,No
DB00685,Trovafloxacin,DB06739,Seratrodast,0.9966705441474915,27,Type_27,Trovafloxacin may increase the neuroexcitatory activities of Seratrodast.,27,Type_27,Yes
DB00214,Torasemide,DB09282,Molsidomine,1.0,60,Type_60,Torasemide may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB01559,Clotiazepam,DB01609,Deferasirox,0.9528033137321472,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Clotiazepam.,75,Type_75,Yes
DB00318,Codeine,DB01551,Dihydrocodeine,0.9845649003982544,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Dihydrocodeine.,49,Type_49,Yes
DB00178,Ramipril,DB01250,Olsalazine,0.6888391375541687,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Olsalazine.,49,Type_49,Yes
DB00734,Risperidone,DB06690,Nitrous oxide,0.9982091188430786,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Nitrous oxide.,49,Type_49,Yes
DB00491,Miglitol,DB00731,Nateglinide,0.9998052716255188,9,Type_9,Miglitol may increase the hypoglycemic activities of Nateglinide.,9,Type_9,Yes
DB00176,Fluvoxamine,DB00559,Bosentan,0.48933520913124084,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Fluvoxamine.,73,Type_73,Yes
DB00959,Methylprednisolone,DB12598,Nafamostat,0.9458361864089966,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Nafamostat.,49,Type_49,Yes
DB01624,Zuclopenthixol,DB09166,Etizolam,0.9678703546524048,49,Type_49,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Etizolam.,49,Type_49,Yes
DB00708,Sufentanil,DB00985,Dimenhydrinate,0.9993417859077454,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Dimenhydrinate.,49,Type_49,Yes
DB05521,Telaprevir,DB08896,Regorafenib,0.5661425590515137,73,Type_73,The serum concentration of Regorafenib can be increased when it is combined with Telaprevir.,47,Type_47,No
DB01072,Atazanavir,DB09073,Palbociclib,0.9935734868049622,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00203,Sildenafil,DB01149,Nefazodone,0.8441696166992188,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Sildenafil.,73,Type_73,No
DB00264,Metoprolol,DB00748,Carbinoxamine,0.5286514759063721,47,Type_47,The metabolism of Carbinoxamine can be decreased when combined with Metoprolol.,73,Type_73,No
DB00213,Pantoprazole,DB00559,Bosentan,0.6008089184761047,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Pantoprazole.,75,Type_75,Yes
DB00341,Cetirizine,DB06153,Pizotifen,0.9528824090957642,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Pizotifen.,49,Type_49,Yes
DB00298,Dapiprazole,DB01247,Isocarboxazid,0.9742740988731384,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Isocarboxazid.,49,Type_49,Yes
DB01162,Terazosin,DB04920,Clevidipine,0.8571702241897583,49,Type_49,The risk or severity of adverse effects can be increased when Terazosin is combined with Clevidipine.,49,Type_49,Yes
DB00476,Duloxetine,DB08893,Mirabegron,0.524678111076355,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Duloxetine.,85,Type_85,No
DB01104,Sertraline,DB01295,Bevantolol,0.465379923582077,73,Type_73,The serum concentration of Bevantolol can be increased when it is combined with Sertraline.,73,Type_73,Yes
DB00204,Dofetilide,DB00735,Naftifine,0.9728248119354248,73,Type_73,The serum concentration of Naftifine can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB05246,Methsuximide,DB09128,Brexpiprazole,0.9991233944892883,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Brexpiprazole.,49,Type_49,Yes
DB04898,Ximelagatran,DB09167,Dosulepin,0.6392748355865479,73,Type_73,The serum concentration of Dosulepin can be increased when it is combined with Ximelagatran.,47,Type_47,No
DB00310,Chlorthalidone,DB00796,Candesartan cilexetil,0.6115890741348267,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Candesartan cilexetil.,56,Type_56,No
DB00091,Cyclosporine,DB00240,Alclometasone,0.8660492300987244,47,Type_47,The metabolism of Alclometasone can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00547,Desoximetasone,DB06710,Methyltestosterone,0.995798647403717,74,Type_74,Desoximetasone may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB01282,Carbetocin,DB06712,Nilvadipine,0.5906286835670471,60,Type_60,Carbetocin may increase the hypotensive activities of Nilvadipine.,49,Type_49,No
DB00508,Triflupromazine,DB01002,Levobupivacaine,0.9659630060195923,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Levobupivacaine.,49,Type_49,Yes
DB00921,Buprenorphine,DB06274,Alvimopan,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Alvimopan.,49,Type_49,Yes
DB01088,Iloprost,DB08981,Fenbufen,0.9577693939208984,70,Type_70,The therapeutic efficacy of Fenbufen can be decreased when used in combination with Iloprost.,70,Type_70,Yes
DB00214,Torasemide,DB01001,Salbutamol,0.999427080154419,83,Type_83,Torasemide may increase the hypokalemic activities of Salbutamol.,83,Type_83,Yes
DB01288,Fenoterol,DB04896,Milnacipran,0.980705201625824,85,Type_85,Fenoterol may increase the tachycardic activities of Milnacipran.,85,Type_85,Yes
DB00736,Esomeprazole,DB09120,Zucapsaicin,0.999068558216095,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB00842,Oxazepam,DB04908,Flibanserin,0.9997105002403259,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Flibanserin.,49,Type_49,Yes
DB00486,Nabilone,DB00765,Metyrosine,0.9861306548118591,32,Type_32,Nabilone may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00673,Aprepitant,DB00945,Acetylsalicylic acid,0.8866153359413147,73,Type_73,The serum concentration of Acetylsalicylic acid can be increased when it is combined with Aprepitant.,4,Type_4,No
DB00599,Thiopental,DB00690,Flurazepam,0.9679825305938721,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Flurazepam.,49,Type_49,Yes
DB00884,Risedronic acid,DB13142,Calcium glubionate anhydrous,0.86152184009552,75,Type_75,The serum concentration of Calcium glubionate anhydrous can be decreased when it is combined with Risedronic acid.,75,Type_75,Yes
DB00625,Efavirenz,DB00823,Ethynodiol diacetate,0.7099695801734924,75,Type_75,The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Efavirenz.,75,Type_75,Yes
DB00503,Ritonavir,DB00582,Voriconazole,0.5303295850753784,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Ritonavir.,75,Type_75,No
DB00427,Triprolidine,DB00633,Dexmedetomidine,0.8855593800544739,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Dexmedetomidine.,49,Type_49,Yes
DB00162,Vitamin A,DB00755,Tretinoin,0.8509476780891418,49,Type_49,The risk or severity of adverse effects can be increased when Vitamin A is combined with Tretinoin.,49,Type_49,Yes
DB09230,Azelnidipine,DB13231,Calcium lactate,0.8692906498908997,70,Type_70,The therapeutic efficacy of Calcium lactate can be decreased when used in combination with Azelnidipine.,70,Type_70,Yes
DB09065,Cobicistat,DB11737,Icotinib,0.5373729467391968,47,Type_47,The metabolism of Icotinib can be decreased when combined with Cobicistat.,47,Type_47,Yes
DB01288,Fenoterol,DB01364,Ephedrine,0.999496340751648,49,Type_49,The risk or severity of adverse effects can be increased when Fenoterol is combined with Ephedrine.,49,Type_49,Yes
DB01028,Methoxyflurane,DB01068,Clonazepam,0.9936389327049255,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Clonazepam.,49,Type_49,Yes
DB00997,Doxorubicin,DB07615,Tranilast,0.9663600325584412,72,Type_72,Doxorubicin may decrease the excretion rate of Tranilast which could result in a higher serum level.,72,Type_72,Yes
DB00559,Bosentan,DB09082,Vilanterol,0.7803900241851807,75,Type_75,The serum concentration of Vilanterol can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB06690,Nitrous oxide,DB09071,Tasimelteon,0.9999717473983765,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Tasimelteon.,49,Type_49,Yes
DB00323,Tolcapone,DB00962,Zaleplon,0.9234843850135803,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Zaleplon.,49,Type_49,Yes
DB00327,Hydromorphone,DB00782,Propantheline,0.9998345375061035,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Propantheline.,49,Type_49,Yes
DB01166,Cilostazol,DB01601,Lopinavir,0.4584724009037018,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB00208,Ticlopidine,DB00959,Methylprednisolone,0.7754400968551636,47,Type_47,The metabolism of Methylprednisolone can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00458,Imipramine,DB09204,Arotinolol,0.49883946776390076,73,Type_73,The serum concentration of Arotinolol can be increased when it is combined with Imipramine.,49,Type_49,No
DB00337,Pimecrolimus,DB09214,Dexketoprofen,0.8598247170448303,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexketoprofen.,49,Type_49,Yes
DB00681,Amphotericin B,DB00960,Pindolol,0.9944168329238892,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Pindolol.,49,Type_49,Yes
DB00412,Rosiglitazone,DB04743,Nimesulide,0.6551789045333862,70,Type_70,The therapeutic efficacy of Nimesulide can be decreased when used in combination with Rosiglitazone.,6,Type_6,No
DB00976,Telithromycin,DB09183,Dasabuvir,0.9518159627914429,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00604,Cisapride,DB00679,Thioridazine,0.6958520412445068,20,Type_20,Cisapride may increase the QTc-prolonging activities of Thioridazine.,73,Type_73,No
DB00679,Thioridazine,DB09166,Etizolam,0.795202910900116,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Etizolam.,49,Type_49,Yes
DB00472,Fluoxetine,DB01295,Bevantolol,0.32829174399375916,73,Type_73,The serum concentration of Bevantolol can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB01184,Domperidone,DB01356,Lithium cation,0.7438735365867615,20,Type_20,Domperidone may increase the QTc-prolonging activities of Lithium cation.,20,Type_20,Yes
DB00313,Valproic acid,DB00752,Tranylcypromine,0.4600810408592224,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Tranylcypromine.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB00682,Warfarin,0.8130480647087097,12,Type_12,Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.,12,Type_12,Yes
DB01072,Atazanavir,DB01229,Paclitaxel,0.6096765398979187,73,Type_73,The serum concentration of Paclitaxel can be increased when it is combined with Atazanavir.,47,Type_47,No
DB00244,Mesalazine,DB01172,Kanamycin,0.9992274045944214,72,Type_72,Mesalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,72,Type_72,Yes
DB00283,Clemastine,DB00976,Telithromycin,0.8058271408081055,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01601,Lopinavir,DB12332,Rucaparib,0.635834813117981,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB06663,Pasireotide,DB09039,Eliglustat,0.9517013430595398,20,Type_20,Pasireotide may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00370,Mirtazapine,DB00474,Methohexital,0.9984534978866577,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.,16,Type_16,Yes
DB00356,Chlorzoxazone,DB00765,Metyrosine,0.9957131147384644,32,Type_32,Chlorzoxazone may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00696,Ergotamine,DB00818,Propofol,0.8443776965141296,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Propofol.,49,Type_49,Yes
DB04855,Dronedarone,DB09074,Olaparib,0.517130434513092,47,Type_47,The metabolism of Olaparib can be decreased when combined with Dronedarone.,73,Type_73,No
DB01247,Isocarboxazid,DB01612,Amyl Nitrite,0.9987805485725403,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Amyl Nitrite.,49,Type_49,Yes
DB00906,Tiagabine,DB01433,Methadyl acetate,0.9968969821929932,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Methadyl acetate.,49,Type_49,Yes
DB00220,Nelfinavir,DB11730,Ribociclib,0.8879955410957336,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Nelfinavir.,73,Type_73,Yes
DB00502,Haloperidol,DB08909,Glycerol phenylbutyrate,0.4326418936252594,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Glycerol phenylbutyrate.,70,Type_70,No
DB00778,Roxithromycin,DB00794,Primidone,0.9188245534896851,4,Type_4,The metabolism of Primidone can be increased when combined with Roxithromycin.,4,Type_4,Yes
DB01032,Probenecid,DB01250,Olsalazine,0.8686600923538208,73,Type_73,The serum concentration of Olsalazine can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00661,Verapamil,DB01348,Spirapril,0.4500771462917328,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Spirapril.,47,Type_47,No
DB01463,Fencamfamin,DB06282,Levocetirizine,0.9969688057899475,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Levocetirizine.,49,Type_49,Yes
DB00187,Esmolol,DB00925,Phenoxybenzamine,0.8232503533363342,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Phenoxybenzamine.,49,Type_49,Yes
DB01355,Hexobarbital,DB01356,Lithium cation,0.903247058391571,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Lithium cation.,49,Type_49,Yes
DB08912,Dabrafenib,DB11560,Lesinurad,0.8166051506996155,75,Type_75,The serum concentration of Lesinurad can be decreased when it is combined with Dabrafenib.,75,Type_75,Yes
DB06267,Udenafil,DB09048,Netupitant,0.9840680956840515,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Udenafil.,73,Type_73,Yes
DB01242,Clomipramine,DB06480,Prucalopride,0.907288670539856,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Clomipramine.,73,Type_73,Yes
DB00734,Risperidone,DB01198,Zopiclone,0.990105926990509,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Zopiclone.,49,Type_49,Yes
DB00396,Progesterone,DB09048,Netupitant,0.9680615663528442,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00444,Teniposide,DB00625,Efavirenz,0.5611844062805176,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Teniposide.,47,Type_47,Yes
DB00220,Nelfinavir,DB00957,Norgestimate,0.7455799579620361,75,Type_75,The serum concentration of Norgestimate can be decreased when it is combined with Nelfinavir.,75,Type_75,Yes
DB01238,Aripiprazole,DB06589,Pazopanib,0.5120199918746948,20,Type_20,Aripiprazole may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB00631,Clofarabine,DB00691,Moexipril,0.997765064239502,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Moexipril.,49,Type_49,Yes
DB00655,Estrone,DB06724,Calcium carbonate,0.924592137336731,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Estrone.,3,Type_3,Yes
DB00391,Sulpiride,DB12532,Oxetacaine,0.9999909400939941,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Oxetacaine.,49,Type_49,Yes
DB00622,Nicardipine,DB05541,Brivaracetam,0.9634413719177246,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00691,Moexipril,DB01612,Amyl Nitrite,0.9894557595252991,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Amyl Nitrite.,49,Type_49,Yes
DB00288,Amcinonide,DB00695,Furosemide,0.9996795654296875,83,Type_83,Amcinonide may increase the hypokalemic activities of Furosemide.,83,Type_83,Yes
DB00715,Paroxetine,DB09048,Netupitant,0.9506588578224182,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Paroxetine.,47,Type_47,No
DB00188,Bortezomib,DB00998,Frovatriptan,0.7930892109870911,47,Type_47,The metabolism of Frovatriptan can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB01320,Fosphenytoin,0.8911224603652954,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Chlorzoxazone.,4,Type_4,Yes
DB00454,Meperidine,DB00619,Imatinib,0.8513281345367432,47,Type_47,The metabolism of Imatinib can be decreased when combined with Meperidine.,47,Type_47,Yes
DB00328,Indomethacin,DB01021,Trichlormethiazide,0.9956120252609253,70,Type_70,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Indomethacin.,70,Type_70,Yes
DB00918,Almotriptan,DB13025,Tiapride,0.9970813393592834,49,Type_49,The risk or severity of adverse effects can be increased when Almotriptan is combined with Tiapride.,49,Type_49,Yes
DB00296,Ropivacaine,DB00482,Celecoxib,0.6288777589797974,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00284,Acarbose,DB00738,Pentamidine,0.5016080737113953,70,Type_70,The therapeutic efficacy of Pentamidine can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00754,Ethotoin,DB00967,Desloratadine,0.9987486600875854,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Desloratadine.,49,Type_49,Yes
DB00812,Phenylbutazone,DB01050,Ibuprofen,0.9978992938995361,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Ibuprofen.,49,Type_49,Yes
DB00481,Raloxifene,DB09054,Idelalisib,0.9047682881355286,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00321,Amitriptyline,DB00451,Levothyroxine,0.5270048975944519,47,Type_47,The metabolism of Levothyroxine can be decreased when combined with Amitriptyline.,82,Type_82,No
DB00612,Bisoprolol,DB01037,Selegiline,0.6942919492721558,60,Type_60,Bisoprolol may increase the hypotensive activities of Selegiline.,60,Type_60,Yes
DB00324,Fluorometholone,DB06412,Oxymetholone,0.9930853843688965,74,Type_74,Fluorometholone may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB00996,Gabapentin,DB01353,Butobarbital,0.9999748468399048,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Butobarbital.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01191,Dexfenfluramine,0.9476761221885681,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00333,Methadone,DB09118,Stiripentol,0.5588127970695496,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Methadone.,73,Type_73,Yes
DB01046,Lubiprostone,DB02709,Resveratrol,0.99993896484375,70,Type_70,The therapeutic efficacy of Resveratrol can be decreased when used in combination with Lubiprostone.,70,Type_70,Yes
DB00470,Dronabinol,DB00628,Clorazepic acid,0.9999356269836426,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Clorazepic acid.,16,Type_16,Yes
DB00277,Theophylline,DB08912,Dabrafenib,0.983807384967804,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Theophylline.,75,Type_75,Yes
DB00471,Montelukast,DB00661,Verapamil,0.9848797917366028,47,Type_47,The metabolism of Verapamil can be decreased when combined with Montelukast.,47,Type_47,Yes
DB00425,Zolpidem,DB00854,Levorphanol,0.9805066585540771,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.,16,Type_16,Yes
DB00421,Spironolactone,DB00571,Propranolol,0.9445315003395081,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Propranolol.,49,Type_49,Yes
DB00620,Triamcinolone,DB06710,Methyltestosterone,0.9970211386680603,74,Type_74,Triamcinolone may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB00196,Fluconazole,DB09102,Daclatasvir,0.6417465806007385,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01007,Tioconazole,DB08860,Pitavastatin,0.7196540832519531,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Tioconazole.,73,Type_73,Yes
DB00349,Clobazam,DB01083,Orlistat,0.9917150139808655,75,Type_75,The serum concentration of Orlistat can be decreased when it is combined with Clobazam.,75,Type_75,Yes
DB00091,Cyclosporine,DB01357,Mestranol,0.7468925714492798,47,Type_47,The metabolism of Mestranol can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00575,Clonidine,DB00690,Flurazepam,0.9714143872261047,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Flurazepam.,49,Type_49,Yes
DB00821,Carprofen,DB01297,Practolol,0.9999604225158691,37,Type_37,Carprofen may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00219,Oxyphenonium,DB00813,Fentanyl,0.9999889135360718,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fentanyl.,49,Type_49,Yes
DB00179,Masoprocol,DB00768,Olopatadine,0.9997950196266174,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Olopatadine.,49,Type_49,Yes
DB01037,Selegiline,DB01136,Carvedilol,0.5231961607933044,60,Type_60,Selegiline may increase the hypotensive activities of Carvedilol.,60,Type_60,Yes
DB00457,Prazosin,DB00841,Dobutamine,0.9965212345123291,5,Type_5,Prazosin may decrease the vasoconstricting activities of Dobutamine.,5,Type_5,Yes
DB00921,Buprenorphine,DB01614,Acepromazine,0.9999403953552246,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.,16,Type_16,Yes
DB00371,Meprobamate,DB00768,Olopatadine,0.8389502167701721,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Olopatadine.,49,Type_49,Yes
DB01166,Cilostazol,DB02709,Resveratrol,0.7086882591247559,53,Type_53,Cilostazol may increase the antiplatelet activities of Resveratrol.,6,Type_6,No
DB00867,Ritodrine,DB00999,Hydrochlorothiazide,0.9998031258583069,83,Type_83,Ritodrine may increase the hypokalemic activities of Hydrochlorothiazide.,83,Type_83,Yes
DB00248,Cabergoline,DB00514,Dextromethorphan,0.8543862700462341,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Dextromethorphan.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB08808,Bupranolol,0.967593252658844,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00214,Torasemide,DB00663,Flumethasone,0.997309684753418,83,Type_83,Torasemide may increase the hypokalemic activities of Flumethasone.,83,Type_83,Yes
DB00318,Codeine,DB06204,Tapentadol,0.995022177696228,16,Type_16,Codeine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00248,Cabergoline,DB00489,Sotalol,0.6756427884101868,19,Type_19,Cabergoline may increase the vasoconstricting activities of Sotalol.,19,Type_19,Yes
DB00678,Losartan,DB09245,Toloxatone,0.876192569732666,60,Type_60,Losartan may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB01106,Levocabastine,DB09224,Melperone,0.9999700784683228,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Melperone.,49,Type_49,Yes
DB00231,Temazepam,DB00933,Mesoridazine,0.9993932247161865,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Mesoridazine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00599,Thiopental,0.5926655530929565,47,Type_47,The metabolism of Thiopental can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB00963,Bromfenac,DB00997,Doxorubicin,0.9981585144996643,72,Type_72,Bromfenac may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,72,Type_72,Yes
DB00180,Flunisolide,DB00744,Zileuton,0.9986072182655334,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Zileuton.,49,Type_49,Yes
DB00593,Ethosuximide,DB06201,Rufinamide,0.9976277947425842,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Rufinamide.,49,Type_49,Yes
DB01580,Oxprenolol,DB06738,Ketobemidone,0.8857090473175049,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Ketobemidone.,49,Type_49,Yes
DB00327,Hydromorphone,DB00752,Tranylcypromine,0.7405174374580383,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tranylcypromine.,47,Type_47,No
DB00252,Phenytoin,DB00962,Zaleplon,0.7555935978889465,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Zaleplon.,75,Type_75,No
DB00253,Medrysone,DB06739,Seratrodast,0.998519241809845,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Seratrodast.,49,Type_49,Yes
DB00091,Cyclosporine,DB00741,Hydrocortisone,0.5962277054786682,47,Type_47,The metabolism of Hydrocortisone can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00208,Ticlopidine,DB00947,Fulvestrant,0.9404140710830688,47,Type_47,The metabolism of Fulvestrant can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00222,Glimepiride,DB01104,Sertraline,0.9317052364349365,9,Type_9,Glimepiride may increase the hypoglycemic activities of Sertraline.,9,Type_9,Yes
DB00263,Sulfisoxazole,DB06725,Lornoxicam,0.7250718474388123,47,Type_47,The metabolism of Lornoxicam can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01298,Sulfacytine,DB09214,Dexketoprofen,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Sulfacytine is combined with Dexketoprofen.,49,Type_49,Yes
DB00987,Cytarabine,DB01097,Leflunomide,0.4637736678123474,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Cytarabine.,49,Type_49,No
DB00180,Flunisolide,DB01045,Rifampicin,0.8605508208274841,4,Type_4,The metabolism of Rifampicin can be increased when combined with Flunisolide.,4,Type_4,Yes
DB01339,Vecuronium,DB08893,Mirabegron,0.991582453250885,49,Type_49,The risk or severity of adverse effects can be increased when Vecuronium is combined with Mirabegron.,49,Type_49,Yes
DB00203,Sildenafil,DB01227,Levacetylmethadol,0.89308762550354,47,Type_47,The metabolism of Levacetylmethadol can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00752,Tranylcypromine,DB06684,Vilazodone,0.7954806685447693,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Vilazodone.,49,Type_49,Yes
DB00514,Dextromethorphan,DB09039,Eliglustat,0.7167093753814697,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB00368,Norepinephrine,DB01028,Methoxyflurane,0.5089344382286072,37,Type_37,Norepinephrine may decrease the antihypertensive activities of Methoxyflurane.,82,Type_82,No
DB00176,Fluvoxamine,DB00724,Imiquimod,0.9480613470077515,47,Type_47,The metabolism of Imiquimod can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00999,Hydrochlorothiazide,DB02638,Terlipressin,0.999893069267273,60,Type_60,Hydrochlorothiazide may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00586,Diclofenac,DB00744,Zileuton,0.9873217940330505,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Zileuton.,49,Type_49,Yes
DB00309,Vindesine,DB00661,Verapamil,0.6003532409667969,49,Type_49,The risk or severity of adverse effects can be increased when Vindesine is combined with Verapamil.,73,Type_73,No
DB00972,Azelastine,DB06697,Artemether,0.8646298050880432,47,Type_47,The metabolism of Artemether can be decreased when combined with Azelastine.,47,Type_47,Yes
DB00234,Reboxetine,DB04855,Dronedarone,0.8955020904541016,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Reboxetine.,47,Type_47,Yes
DB00324,Fluorometholone,DB06819,Phenylbutyric acid,0.9672994017601013,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluorometholone.,70,Type_70,Yes
DB06335,Saxagliptin,DB08864,Rilpivirine,0.8386831879615784,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Saxagliptin.,75,Type_75,No
DB00916,Metronidazole,DB01098,Rosuvastatin,0.7676740288734436,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Metronidazole.,73,Type_73,Yes
DB01247,Isocarboxazid,DB08907,Canagliflozin,0.9317002296447754,9,Type_9,Isocarboxazid may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB00482,Celecoxib,DB01576,Dextroamphetamine,0.6485165953636169,76,Type_76,Celecoxib may decrease the sedative activities of Dextroamphetamine.,47,Type_47,No
DB00373,Timolol,DB09082,Vilanterol,0.863063633441925,14,Type_14,Timolol may decrease the bronchodilatory activities of Vilanterol.,14,Type_14,Yes
DB01032,Probenecid,DB01251,Gliquidone,0.820768415927887,43,Type_43,The protein binding of Gliquidone can be decreased when combined with Probenecid.,43,Type_43,Yes
DB01324,Polythiazide,DB06262,Droxidopa,0.9973419308662415,83,Type_83,Polythiazide may increase the hypokalemic activities of Droxidopa.,83,Type_83,Yes
DB00672,Chlorpropamide,DB01418,Acenocoumarol,0.9374297857284546,6,Type_6,Chlorpropamide may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00483,Gallamine triethiodide,DB11315,Methscopolamine,0.5552513003349304,2,Type_2,Gallamine triethiodide may increase the anticholinergic activities of Methscopolamine.,49,Type_49,No
DB01577,Metamfetamine,DB06204,Tapentadol,0.9990090131759644,69,Type_69,Metamfetamine may increase the analgesic activities of Tapentadol.,69,Type_69,Yes
DB01029,Irbesartan,DB01072,Atazanavir,0.8539047837257385,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00280,Disopyramide,DB06697,Artemether,0.5705472826957703,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Artemether.,33,Type_33,No
DB00363,Clozapine,DB01262,Decitabine,0.9364990592002869,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Decitabine.,49,Type_49,Yes
DB00663,Flumethasone,DB04575,Quinestrol,0.999259889125824,73,Type_73,The serum concentration of Quinestrol can be increased when it is combined with Flumethasone.,73,Type_73,Yes
DB01041,Thalidomide,DB01240,Epoprostenol,0.5348344445228577,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Epoprostenol.,49,Type_49,Yes
DB00962,Zaleplon,DB01595,Nitrazepam,0.9886335134506226,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Nitrazepam.,49,Type_49,Yes
DB00904,Ondansetron,DB01437,Glutethimide,0.99997878074646,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Glutethimide.,49,Type_49,Yes
DB01088,Iloprost,DB01418,Acenocoumarol,0.9997158646583557,6,Type_6,Iloprost may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00497,Oxycodone,DB09241,Methylene blue,0.6180006265640259,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Methylene blue.,49,Type_49,Yes
DB00661,Verapamil,DB00834,Mifepristone,0.8134435415267944,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Verapamil.,73,Type_73,Yes
DB00727,Nitroglycerin,DB01214,Metipranolol,0.9999767541885376,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Metipranolol.,49,Type_49,Yes
DB01065,Melatonin,DB01219,Dantrolene,0.9990160465240479,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Dantrolene.,49,Type_49,Yes
DB04839,Cyproterone acetate,DB12332,Rucaparib,0.7730447053909302,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB01283,Lumiracoxib,DB04575,Quinestrol,0.9721606373786926,81,Type_81,Lumiracoxib may increase the thrombogenic activities of Quinestrol.,81,Type_81,Yes
DB00511,Acetyldigitoxin,DB01101,Capecitabine,0.9936127066612244,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Capecitabine.,58,Type_58,Yes
DB00482,Celecoxib,DB01132,Pioglitazone,0.9621815085411072,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00872,Conivaptan,DB09280,Lumacaftor,0.8206762671470642,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Conivaptan.,4,Type_4,No
DB00932,Tipranavir,DB01348,Spirapril,0.776982843875885,75,Type_75,The serum concentration of Spirapril can be decreased when it is combined with Tipranavir.,75,Type_75,Yes
DB00490,Buspirone,DB04841,Flunarizine,0.9487093091011047,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Flunarizine.,49,Type_49,Yes
DB00575,Clonidine,DB06290,Simeprevir,0.9814848899841309,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Clonidine.,73,Type_73,Yes
DB00353,Methylergometrine,DB00697,Tizanidine,0.9509634375572205,71,Type_71,Methylergometrine may increase the hypertensive activities of Tizanidine.,71,Type_71,Yes
DB00946,Phenprocoumon,DB01053,Benzylpenicillin,0.9874277114868164,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Benzylpenicillin.,6,Type_6,Yes
DB00737,Meclizine,DB01018,Guanfacine,0.8745235204696655,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Guanfacine.,49,Type_49,Yes
DB01209,Dezocine,DB09068,Vortioxetine,0.9996956586837769,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Vortioxetine.,49,Type_49,Yes
DB00502,Haloperidol,DB00708,Sufentanil,0.6188799142837524,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Sufentanil.,49,Type_49,Yes
DB00514,Dextromethorphan,DB09198,Lobeglitazone,0.9992882609367371,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB00227,Lovastatin,DB08877,Ruxolitinib,0.7678396701812744,47,Type_47,The metabolism of Ruxolitinib can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00695,Furosemide,DB01367,Rasagiline,0.8077311515808105,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Rasagiline.,49,Type_49,Yes
DB00751,Epinastine,DB00972,Azelastine,0.3621937334537506,76,Type_76,Epinastine may decrease the sedative activities of Azelastine.,53,Type_53,No
DB00712,Flurbiprofen,DB06810,Plicamycin,0.9998626708984375,72,Type_72,Flurbiprofen may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB08827,Lomitapide,DB08916,Afatinib,0.836512565612793,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Lomitapide.,73,Type_73,Yes
DB00206,Reserpine,DB01295,Bevantolol,0.6469339728355408,60,Type_60,Reserpine may increase the hypotensive activities of Bevantolol.,60,Type_60,Yes
DB00708,Sufentanil,DB09272,Eluxadoline,0.9984361529350281,39,Type_39,Sufentanil may increase the constipating activities of Eluxadoline.,39,Type_39,Yes
DB00564,Carbamazepine,DB00651,Dyphylline,0.30339157581329346,70,Type_70,The therapeutic efficacy of Dyphylline can be decreased when used in combination with Carbamazepine.,75,Type_75,No
DB00312,Pentobarbital,DB00361,Vinorelbine,0.845496416091919,4,Type_4,The metabolism of Vinorelbine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB09291,Rolapitant,DB13878,Pibrentasvir,0.663537859916687,75,Type_75,The serum concentration of Pibrentasvir can be decreased when it is combined with Rolapitant.,73,Type_73,No
DB00199,Erythromycin,DB08815,Lurasidone,0.6277864575386047,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Lurasidone.,73,Type_73,No
DB01359,Penbutolol,DB13167,Alclofenac,0.9929860234260559,37,Type_37,Penbutolol may decrease the antihypertensive activities of Alclofenac.,37,Type_37,Yes
DB00569,Fondaparinux,DB00605,Sulindac,0.9954873919487,6,Type_6,Fondaparinux may increase the anticoagulant activities of Sulindac.,6,Type_6,Yes
DB00589,Lisuride,DB09167,Dosulepin,0.5122699737548828,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Lisuride.,47,Type_47,Yes
DB00919,Spectinomycin,DB01053,Benzylpenicillin,0.9527250528335571,75,Type_75,The serum concentration of Benzylpenicillin can be decreased when it is combined with Spectinomycin.,75,Type_75,Yes
DB00582,Voriconazole,DB01129,Rabeprazole,0.8095610737800598,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Voriconazole.,73,Type_73,No
DB00865,Benzphetamine,DB01192,Oxymorphone,0.9987614154815674,69,Type_69,Benzphetamine may increase the analgesic activities of Oxymorphone.,69,Type_69,Yes
DB00243,Ranolazine,DB00283,Clemastine,0.44686099886894226,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00477,Chlorpromazine,DB06697,Artemether,0.5059803128242493,47,Type_47,The metabolism of Artemether can be decreased when combined with Chlorpromazine.,73,Type_73,No
DB01144,Diclofenamide,DB04920,Clevidipine,0.9985817670822144,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenamide is combined with Clevidipine.,49,Type_49,Yes
DB08941,Isoxsuprine,DB09242,Moxonidine,0.9962974190711975,49,Type_49,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Moxonidine.,49,Type_49,Yes
DB00264,Metoprolol,DB09232,Cilnidipine,0.9084470272064209,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Cilnidipine.,49,Type_49,Yes
DB01181,Ifosfamide,DB09073,Palbociclib,0.9976598024368286,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Ifosfamide.,73,Type_73,Yes
DB00405,Dexbrompheniramine,DB00477,Chlorpromazine,0.9918079972267151,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Chlorpromazine.,49,Type_49,Yes
DB00502,Haloperidol,DB08987,Etidocaine,0.999836802482605,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Etidocaine.,49,Type_49,Yes
DB09048,Netupitant,DB09280,Lumacaftor,0.6756764650344849,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Netupitant.,75,Type_75,No
DB00346,Alfuzosin,DB06290,Simeprevir,0.9885009527206421,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Alfuzosin.,73,Type_73,Yes
DB00486,Nabilone,DB08941,Isoxsuprine,0.9656326174736023,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Isoxsuprine.,85,Type_85,No
DB00104,Octreotide,DB00195,Betaxolol,0.9934319853782654,54,Type_54,Octreotide may increase the bradycardic activities of Betaxolol.,54,Type_54,Yes
DB08877,Ruxolitinib,DB12332,Rucaparib,0.9211032390594482,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Ruxolitinib.,47,Type_47,Yes
DB00234,Reboxetine,DB09280,Lumacaftor,0.6989078521728516,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Reboxetine.,4,Type_4,Yes
DB00967,Desloratadine,DB01215,Estazolam,0.9812512397766113,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Estazolam.,49,Type_49,Yes
DB00752,Tranylcypromine,DB08918,Levomilnacipran,0.7216581106185913,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Levomilnacipran.,49,Type_49,Yes
DB00252,Phenytoin,DB01075,Diphenhydramine,0.9436333775520325,4,Type_4,The metabolism of Diphenhydramine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01115,Nifedipine,DB01189,Desflurane,0.9993267059326172,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Desflurane.,49,Type_49,Yes
DB00593,Ethosuximide,DB00949,Felbamate,0.9924705028533936,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Felbamate.,49,Type_49,Yes
DB01002,Levobupivacaine,DB01200,Bromocriptine,0.5799211263656616,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bromocriptine.,49,Type_49,Yes
DB00696,Ergotamine,DB01403,Methotrimeprazine,0.7157238721847534,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Methotrimeprazine.,49,Type_49,Yes
DB01229,Paclitaxel,DB01268,Sunitinib,0.9807258248329163,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Sunitinib.,49,Type_49,Yes
DB00490,Buspirone,DB12532,Oxetacaine,0.9999734163284302,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Oxetacaine.,49,Type_49,Yes
DB01088,Iloprost,DB02638,Terlipressin,0.999915361404419,60,Type_60,Iloprost may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00298,Dapiprazole,DB00458,Imipramine,0.9523136615753174,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Imipramine.,49,Type_49,Yes
DB00353,Methylergometrine,DB00845,Clofazimine,0.9283992648124695,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Clofazimine.,49,Type_49,Yes
DB00285,Venlafaxine,DB01559,Clotiazepam,0.9204714298248291,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00178,Ramipril,DB01024,Mycophenolic acid,0.9125377535820007,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Mycophenolic acid.,49,Type_49,Yes
DB00285,Venlafaxine,DB09085,Tetracaine,0.991330623626709,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tetracaine.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB01359,Penbutolol,0.7372164130210876,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB01601,Lopinavir,DB06589,Pazopanib,0.7988225221633911,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00214,Torasemide,DB01113,Papaverine,0.9999598264694214,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Papaverine.,49,Type_49,Yes
DB00232,Methyclothiazide,DB13167,Alclofenac,0.9877272844314575,70,Type_70,The therapeutic efficacy of Alclofenac can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB01418,Acenocoumarol,DB06715,Potassium Iodide,0.988456130027771,12,Type_12,Acenocoumarol may decrease the anticoagulant activities of Potassium Iodide.,12,Type_12,Yes
DB00673,Aprepitant,DB12001,Abemaciclib,0.9866136908531189,73,Type_73,The serum concentration of Abemaciclib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01044,Gatifloxacin,DB01223,Aminophylline,0.32244259119033813,70,Type_70,The therapeutic efficacy of Aminophylline can be decreased when used in combination with Gatifloxacin.,47,Type_47,No
DB00641,Simvastatin,DB09055,Acipimox,0.9960101842880249,48,Type_48,Simvastatin may increase the myopathic rhabdomyolysis activities of Acipimox.,48,Type_48,Yes
DB00938,Salmeterol,DB09244,Pirlindole,0.9426258206367493,49,Type_49,The risk or severity of adverse effects can be increased when Salmeterol is combined with Pirlindole.,49,Type_49,Yes
DB00273,Topiramate,DB00294,Etonogestrel,0.5385084748268127,70,Type_70,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Topiramate.,75,Type_75,No
DB01098,Rosuvastatin,DB01559,Clotiazepam,0.8899381756782532,73,Type_73,The serum concentration of Clotiazepam can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB01030,Topotecan,DB01129,Rabeprazole,0.8795670866966248,73,Type_73,The serum concentration of Rabeprazole can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB00412,Rosiglitazone,DB01238,Aripiprazole,0.833183765411377,70,Type_70,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Rosiglitazone.,70,Type_70,Yes
DB00409,Remoxipride,DB00752,Tranylcypromine,0.7392818927764893,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Tranylcypromine.,47,Type_47,No
DB00257,Clotrimazole,DB01320,Fosphenytoin,0.4342668652534485,73,Type_73,The serum concentration of Fosphenytoin can be increased when it is combined with Clotrimazole.,75,Type_75,No
DB00246,Ziprasidone,DB00549,Zafirlukast,0.9321987628936768,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00321,Amitriptyline,DB06694,Xylometazoline,0.6828147768974304,37,Type_37,Amitriptyline may decrease the antihypertensive activities of Xylometazoline.,37,Type_37,Yes
DB00476,Duloxetine,DB00841,Dobutamine,0.903204619884491,85,Type_85,Duloxetine may increase the tachycardic activities of Dobutamine.,85,Type_85,Yes
DB01203,Nadolol,DB08941,Isoxsuprine,0.9986773133277893,49,Type_49,The risk or severity of adverse effects can be increased when Nadolol is combined with Isoxsuprine.,49,Type_49,Yes
DB00418,Secobarbital,DB06201,Rufinamide,0.9870001673698425,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Rufinamide.,49,Type_49,Yes
DB00908,Quinidine,DB01189,Desflurane,0.7438510656356812,20,Type_20,Quinidine may increase the QTc-prolonging activities of Desflurane.,20,Type_20,Yes
DB00549,Zafirlukast,DB00757,Dolasetron,0.9788697361946106,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00736,Esomeprazole,DB06290,Simeprevir,0.8776258230209351,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Esomeprazole.,73,Type_73,Yes
DB00091,Cyclosporine,DB09074,Olaparib,0.9141063690185547,47,Type_47,The metabolism of Olaparib can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00363,Clozapine,DB00568,Cinnarizine,0.4790937006473541,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Cinnarizine.,47,Type_47,No
DB00196,Fluconazole,DB00947,Fulvestrant,0.9151807427406311,47,Type_47,The metabolism of Fulvestrant can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01115,Nifedipine,DB09118,Stiripentol,0.8001016974449158,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Nifedipine.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB00855,Aminolevulinic acid,0.9997583031654358,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Aminolevulinic acid.,58,Type_58,Yes
DB00695,Furosemide,DB05039,Indacaterol,0.9999502897262573,83,Type_83,Furosemide may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00753,Isoflurane,DB09477,Enalaprilat,0.9550109505653381,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Enalaprilat.,49,Type_49,Yes
DB00508,Triflupromazine,DB01136,Carvedilol,0.939460813999176,60,Type_60,Triflupromazine may increase the hypotensive activities of Carvedilol.,60,Type_60,Yes
DB00916,Metronidazole,DB00976,Telithromycin,0.49516260623931885,20,Type_20,Metronidazole may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB00315,Zolmitriptan,DB00904,Ondansetron,0.922258198261261,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ondansetron.,64,Type_64,No
DB00398,Sorafenib,DB01169,Arsenic trioxide,0.9201923608779907,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB00253,Medrysone,DB00808,Indapamide,0.9999798536300659,83,Type_83,Medrysone may increase the hypokalemic activities of Indapamide.,83,Type_83,Yes
DB00808,Indapamide,DB01227,Levacetylmethadol,0.9944531321525574,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Levacetylmethadol.,49,Type_49,Yes
DB00187,Esmolol,DB00681,Amphotericin B,0.9997934699058533,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Amphotericin B.,49,Type_49,Yes
DB00497,Oxycodone,DB09125,Potassium citrate,0.9986249208450317,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Potassium citrate.,49,Type_49,Yes
DB00575,Clonidine,DB09282,Molsidomine,0.9999942779541016,60,Type_60,Clonidine may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00436,Bendroflumethiazide,DB00896,Rimexolone,0.9984596967697144,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Rimexolone.,83,Type_83,Yes
DB00823,Ethynodiol diacetate,DB01320,Fosphenytoin,0.8837268948554993,70,Type_70,The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Ethynodiol diacetate.,70,Type_70,Yes
DB00191,Phentermine,DB00585,Nizatidine,0.9996210336685181,76,Type_76,Phentermine may decrease the sedative activities of Nizatidine.,76,Type_76,Yes
DB00750,Prilocaine,DB08922,Perospirone,0.9999885559082031,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Perospirone.,49,Type_49,Yes
DB00486,Nabilone,DB01162,Terazosin,0.6598700284957886,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Terazosin.,49,Type_49,Yes
DB00472,Fluoxetine,DB09079,Nintedanib,0.9162707328796387,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00210,Adapalene,DB01295,Bevantolol,0.9998422861099243,37,Type_37,Adapalene may decrease the antihypertensive activities of Bevantolol.,37,Type_37,Yes
DB00233,Aminosalicylic acid,DB00903,Etacrynic acid,0.8525805473327637,29,Type_29,Aminosalicylic acid may decrease the diuretic activities of Etacrynic acid.,29,Type_29,Yes
DB00765,Metyrosine,DB01028,Methoxyflurane,0.9086509346961975,32,Type_32,Metyrosine may increase the sedative activities of Methoxyflurane.,32,Type_32,Yes
DB00268,Ropinirole,DB00796,Candesartan cilexetil,0.6557546854019165,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Candesartan cilexetil.,49,Type_49,Yes
DB01319,Fosamprenavir,DB11581,Venetoclax,0.7384698390960693,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00571,Propranolol,DB00575,Clonidine,0.9752019047737122,25,Type_25,Propranolol may increase the atrioventricular blocking (AV block) activities of Clonidine.,25,Type_25,Yes
DB00376,Trihexyphenidyl,DB00483,Gallamine triethiodide,0.9925448298454285,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Gallamine triethiodide.,49,Type_49,Yes
DB00582,Voriconazole,DB01118,Amiodarone,0.5506017208099365,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00554,Piroxicam,DB01320,Fosphenytoin,0.865653932094574,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Piroxicam.,4,Type_4,Yes
DB00150,Tryptophan,DB00193,Tramadol,0.9941461086273193,64,Type_64,Tryptophan may increase the serotonergic activities of Tramadol.,64,Type_64,Yes
DB00585,Nizatidine,DB09280,Lumacaftor,0.9876388311386108,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Nizatidine.,75,Type_75,Yes
DB00248,Cabergoline,DB00683,Midazolam,0.9885045886039734,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Midazolam.,49,Type_49,Yes
DB00645,Dyclonine,DB01151,Desipramine,0.9978450536727905,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Desipramine.,49,Type_49,Yes
DB00226,Guanadrel,DB08931,Riociguat,0.9999492168426514,60,Type_60,Guanadrel may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00257,Clotrimazole,DB01595,Nitrazepam,0.7854616045951843,47,Type_47,The metabolism of Nitrazepam can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00996,Gabapentin,DB06216,Asenapine,0.9718191623687744,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Asenapine.,49,Type_49,Yes
DB00689,Cephaloglycin,DB00946,Phenprocoumon,0.9886583685874939,6,Type_6,Cephaloglycin may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00905,Bimatoprost,DB09477,Enalaprilat,0.9999985694885254,60,Type_60,Bimatoprost may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00295,Morphine,DB08815,Lurasidone,0.721990704536438,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Lurasidone.,49,Type_49,Yes
DB01047,Fluocinonide,DB01325,Quinethazone,0.9999785423278809,83,Type_83,Fluocinonide may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB00648,Mitotane,DB01254,Dasatinib,0.9889083504676819,75,Type_75,The serum concentration of Dasatinib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01628,Etoricoxib,DB08976,Floctafenine,0.9994155168533325,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Floctafenine.,49,Type_49,Yes
DB00188,Bortezomib,DB00227,Lovastatin,0.7000685334205627,47,Type_47,The metabolism of Lovastatin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00153,Ergocalciferol,DB00188,Bortezomib,0.7728832364082336,47,Type_47,The metabolism of Bortezomib can be decreased when combined with Ergocalciferol.,47,Type_47,Yes
DB00184,Nicotine,DB00619,Imatinib,0.8409757614135742,47,Type_47,The metabolism of Imatinib can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00720,Clodronic acid,DB00919,Spectinomycin,0.9997645020484924,24,Type_24,Clodronic acid may increase the hypocalcemic activities of Spectinomycin.,24,Type_24,Yes
DB00924,Cyclobenzaprine,DB01114,Chlorpheniramine,0.9705206751823425,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Chlorpheniramine.,49,Type_49,Yes
DB00515,Cisplatin,DB09280,Lumacaftor,0.5416727662086487,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Cisplatin.,75,Type_75,Yes
DB00481,Raloxifene,DB08865,Crizotinib,0.9657164216041565,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00153,Ergocalciferol,DB01070,Dihydrotachysterol,0.8044053912162781,51,Type_51,Ergocalciferol may increase the hypercalcemic activities of Dihydrotachysterol.,49,Type_49,No
DB01407,Clenbuterol,DB08880,Teriflunomide,0.46232765913009644,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Clenbuterol.,75,Type_75,Yes
DB01160,Dinoprost tromethamine,DB06737,Zaltoprofen,0.5750066041946411,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB01356,Lithium cation,DB08991,Epirizole,0.9041382074356079,73,Type_73,The serum concentration of Epirizole can be increased when it is combined with Lithium cation.,73,Type_73,Yes
DB00203,Sildenafil,DB01424,Aminophenazone,0.9378364086151123,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00596,Ulobetasol,DB00795,Sulfasalazine,0.997863233089447,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Sulfasalazine.,49,Type_49,Yes
DB00611,Butorphanol,DB00961,Mepivacaine,0.9996657371520996,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Mepivacaine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00325,Nitroprusside,0.6343583464622498,60,Type_60,Chlorthalidone may increase the hypotensive activities of Nitroprusside.,49,Type_49,No
DB01006,Letrozole,DB01319,Fosamprenavir,0.8595678806304932,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Letrozole.,47,Type_47,Yes
DB00726,Trimipramine,DB06282,Levocetirizine,0.985469400882721,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Levocetirizine.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB01209,Dezocine,0.9929057359695435,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Dezocine.,49,Type_49,Yes
DB00266,Dicoumarol,DB00476,Duloxetine,0.7382170557975769,6,Type_6,Dicoumarol may increase the anticoagulant activities of Duloxetine.,6,Type_6,Yes
DB00345,Aminohippuric acid,DB06589,Pazopanib,0.9967252612113953,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Aminohippuric acid.,73,Type_73,Yes
DB00255,Diethylstilbestrol,DB01384,Paramethasone,0.9587196707725525,73,Type_73,The serum concentration of Paramethasone can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00647,Dextropropoxyphene,DB01037,Selegiline,0.8302162289619446,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Selegiline.,49,Type_49,Yes
DB00518,Albendazole,DB01319,Fosamprenavir,0.889223575592041,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Albendazole.,47,Type_47,Yes
DB01173,Orphenadrine,DB08912,Dabrafenib,0.8944090604782104,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Orphenadrine.,75,Type_75,Yes
DB00679,Thioridazine,DB13025,Tiapride,0.9775574207305908,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Tiapride.,49,Type_49,Yes
DB01029,Irbesartan,DB01282,Carbetocin,0.823296070098877,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Carbetocin.,49,Type_49,Yes
DB00295,Morphine,DB01240,Epoprostenol,0.5174195170402527,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Epoprostenol.,49,Type_49,Yes
DB00182,Amphetamine,DB01102,Arbutamine,0.9990648627281189,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Arbutamine.,49,Type_49,Yes
DB01013,Clobetasol propionate,DB09067,Corticorelin ovine triflutate,0.9999995231628418,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Clobetasol propionate.,70,Type_70,Yes
DB00834,Mifepristone,DB06237,Avanafil,0.9965600371360779,73,Type_73,The serum concentration of Avanafil can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB00636,Clofibrate,0.988734245300293,47,Type_47,The metabolism of Clofibrate can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00590,Doxazosin,DB06712,Nilvadipine,0.9140772819519043,60,Type_60,Doxazosin may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB08895,Tofacitinib,DB11921,Deflazacort,0.43271633982658386,34,Type_34,Tofacitinib may increase the immunosuppressive activities of Deflazacort.,34,Type_34,Yes
DB06589,Pazopanib,DB09074,Olaparib,0.5677839517593384,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Pazopanib.,47,Type_47,No
DB00377,Palonosetron,DB00540,Nortriptyline,0.9609442353248596,64,Type_64,Palonosetron may increase the serotonergic activities of Nortriptyline.,64,Type_64,Yes
DB00187,Esmolol,DB00584,Enalapril,0.985299825668335,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Enalapril.,49,Type_49,Yes
DB00319,Piperacillin,DB01418,Acenocoumarol,0.5600295066833496,70,Type_70,The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Piperacillin.,6,Type_6,No
DB00722,Lisinopril,DB05676,Apremilast,0.9778974652290344,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Apremilast.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB01069,Promethazine,0.5643844604492188,61,Type_61,Pseudoephedrine may decrease the stimulatory activities of Promethazine.,76,Type_76,No
DB00310,Chlorthalidone,DB00528,Lercanidipine,0.6777434349060059,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Lercanidipine.,60,Type_60,No
DB00215,Citalopram,DB00674,Galantamine,0.5577113032341003,20,Type_20,Citalopram may increase the QTc-prolonging activities of Galantamine.,47,Type_47,No
DB05541,Brivaracetam,DB06636,Isavuconazonium,0.9539960026741028,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Brivaracetam.,47,Type_47,Yes
DB00474,Methohexital,DB01229,Paclitaxel,0.4202863574028015,60,Type_60,Methohexital may increase the hypotensive activities of Paclitaxel.,60,Type_60,Yes
DB00312,Pentobarbital,DB01656,Roflumilast,0.4260731339454651,4,Type_4,The metabolism of Roflumilast can be increased when combined with Pentobarbital.,75,Type_75,No
DB00412,Rosiglitazone,DB09570,Ixazomib,0.6395097970962524,70,Type_70,The therapeutic efficacy of Ixazomib can be decreased when used in combination with Rosiglitazone.,47,Type_47,No
DB01162,Terazosin,DB09080,Olodaterol,0.9999806880950928,5,Type_5,Terazosin may decrease the vasoconstricting activities of Olodaterol.,5,Type_5,Yes
DB01175,Escitalopram,DB06690,Nitrous oxide,0.9310814142227173,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Nitrous oxide.,49,Type_49,Yes
DB00501,Cimetidine,DB00665,Nilutamide,0.8799805045127869,47,Type_47,The metabolism of Nilutamide can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00865,Benzphetamine,DB09104,Magnesium hydroxide,0.9978771209716797,72,Type_72,Benzphetamine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,72,Type_72,Yes
DB00515,Cisplatin,DB09343,Tipiracil,0.9810832142829895,73,Type_73,The serum concentration of Tipiracil can be increased when it is combined with Cisplatin.,73,Type_73,Yes
DB00744,Zileuton,DB06636,Isavuconazonium,0.9817588329315186,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Zileuton.,47,Type_47,Yes
DB00531,Cyclophosphamide,DB00997,Doxorubicin,0.9435566067695618,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Doxorubicin.,15,Type_15,Yes
DB00714,Apomorphine,DB00999,Hydrochlorothiazide,0.975937008857727,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00205,Pyrimethamine,DB00231,Temazepam,0.9146633148193359,47,Type_47,The metabolism of Temazepam can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00524,Metolazone,DB09300,Butylscopolamine,0.9979698061943054,73,Type_73,The serum concentration of Butylscopolamine can be increased when it is combined with Metolazone.,73,Type_73,Yes
DB00433,Prochlorperazine,DB01156,Bupropion,0.7142428159713745,47,Type_47,The metabolism of Bupropion can be decreased when combined with Prochlorperazine.,47,Type_47,Yes
DB01224,Quetiapine,DB01236,Sevoflurane,0.6977471709251404,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Sevoflurane.,20,Type_20,No
DB00255,Diethylstilbestrol,DB08860,Pitavastatin,0.7174124717712402,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00765,Metyrosine,DB06712,Nilvadipine,0.9444706439971924,60,Type_60,Metyrosine may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00227,Lovastatin,DB12001,Abemaciclib,0.49276912212371826,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00433,Prochlorperazine,DB06282,Levocetirizine,0.9922806024551392,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Levocetirizine.,49,Type_49,Yes
DB00402,Eszopiclone,DB06690,Nitrous oxide,0.99831223487854,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nitrous oxide.,49,Type_49,Yes
DB00188,Bortezomib,DB01227,Levacetylmethadol,0.8010075092315674,47,Type_47,The metabolism of Levacetylmethadol can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00323,Tolcapone,DB00418,Secobarbital,0.9506753087043762,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Secobarbital.,49,Type_49,Yes
DB01045,Rifampicin,DB01261,Sitagliptin,0.7704513669013977,4,Type_4,The metabolism of Sitagliptin can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00374,Treprostinil,DB05266,Ibudilast,0.9102159142494202,53,Type_53,Treprostinil may increase the antiplatelet activities of Ibudilast.,53,Type_53,Yes
DB00731,Nateglinide,DB08820,Ivacaftor,0.931034505367279,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Nateglinide.,73,Type_73,Yes
DB00546,Adinazolam,DB00976,Telithromycin,0.953670084476471,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00909,Zonisamide,DB08918,Levomilnacipran,0.9861984252929688,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Levomilnacipran.,49,Type_49,Yes
DB00814,Meloxicam,DB06813,Pralatrexate,0.8361735939979553,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Meloxicam.,73,Type_73,Yes
DB00783,Estradiol,DB06717,Fosaprepitant,0.5176217555999756,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Estradiol.,75,Type_75,Yes
DB01319,Fosamprenavir,DB06237,Avanafil,0.9655386209487915,73,Type_73,The serum concentration of Avanafil can be increased when it is combined with Fosamprenavir.,73,Type_73,Yes
DB06694,Xylometazoline,DB09220,Nicorandil,0.9964622855186462,60,Type_60,Xylometazoline may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00208,Ticlopidine,DB01006,Letrozole,0.9381358623504639,47,Type_47,The metabolism of Letrozole can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00421,Spironolactone,DB00647,Dextropropoxyphene,0.9965403079986572,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Dextropropoxyphene.,49,Type_49,Yes
DB01605,Pivmecillinam,DB06810,Plicamycin,0.9984036087989807,75,Type_75,The serum concentration of Plicamycin can be decreased when it is combined with Pivmecillinam.,75,Type_75,Yes
DB00292,Etomidate,DB00628,Clorazepic acid,0.9965091347694397,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Clorazepic acid.,49,Type_49,Yes
DB00521,Carteolol,DB01351,Amobarbital,0.8473796844482422,60,Type_60,Carteolol may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00184,Nicotine,DB01263,Posaconazole,0.8880259990692139,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00780,Phenelzine,DB01621,Pipotiazine,0.9346954822540283,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Pipotiazine.,49,Type_49,Yes
DB00218,Moxifloxacin,DB00289,Atomoxetine,0.9971315860748291,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Atomoxetine.,20,Type_20,Yes
DB00834,Mifepristone,DB01076,Atorvastatin,0.8687867522239685,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00373,Timolol,DB00871,Terbutaline,0.9964492321014404,14,Type_14,Timolol may decrease the bronchodilatory activities of Terbutaline.,14,Type_14,Yes
DB00691,Moexipril,DB00703,Methazolamide,0.8838124871253967,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Methazolamide.,49,Type_49,Yes
DB00443,Betamethasone,DB06819,Phenylbutyric acid,0.9699130058288574,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Betamethasone.,70,Type_70,Yes
DB00220,Nelfinavir,DB00451,Levothyroxine,0.8300396203994751,47,Type_47,The metabolism of Levothyroxine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01614,Acepromazine,DB09118,Stiripentol,0.554423451423645,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Acepromazine.,49,Type_49,No
DB01016,Glyburide,DB09053,Ibrutinib,0.6600348353385925,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB00270,Isradipine,DB00614,Furazolidone,0.9191502332687378,60,Type_60,Isradipine may increase the hypotensive activities of Furazolidone.,60,Type_60,Yes
DB00695,Furosemide,DB01408,Bambuterol,0.6110357642173767,83,Type_83,Furosemide may increase the hypokalemic activities of Bambuterol.,83,Type_83,Yes
DB00182,Amphetamine,DB13595,Almasilate,0.8762850761413574,72,Type_72,Amphetamine may decrease the excretion rate of Almasilate which could result in a higher serum level.,72,Type_72,Yes
DB00715,Paroxetine,DB09085,Tetracaine,0.9935203194618225,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Tetracaine.,49,Type_49,Yes
DB00284,Acarbose,DB00503,Ritonavir,0.9896581768989563,70,Type_70,The therapeutic efficacy of Ritonavir can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00353,Methylergometrine,DB09120,Zucapsaicin,0.8523539304733276,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Zucapsaicin.,49,Type_49,Yes
DB00240,Alclometasone,DB00554,Piroxicam,0.998621940612793,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Piroxicam.,49,Type_49,Yes
DB00284,Acarbose,DB01119,Diazoxide,0.9997530579566956,70,Type_70,The therapeutic efficacy of Diazoxide can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00722,Lisinopril,DB08880,Teriflunomide,0.7994904518127441,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Teriflunomide.,49,Type_49,Yes
DB00280,Disopyramide,DB01015,Sulfamethoxazole,0.4335392415523529,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Sulfamethoxazole.,20,Type_20,Yes
DB00213,Pantoprazole,DB01394,Colchicine,0.9645130038261414,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Pantoprazole.,73,Type_73,Yes
DB01174,Phenobarbital,DB01244,Bepridil,0.822170078754425,4,Type_4,The metabolism of Bepridil can be increased when combined with Phenobarbital.,60,Type_60,No
DB00375,Colestipol,DB06802,Nepafenac,0.9918741583824158,67,Type_67,Colestipol can cause a decrease in the absorption of Nepafenac resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00455,Loratadine,DB08899,Enzalutamide,0.9326714873313904,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Loratadine.,75,Type_75,Yes
DB00768,Olopatadine,DB09072,Sodium oxybate,0.9999994039535522,16,Type_16,Olopatadine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01200,Bromocriptine,DB01234,Dexamethasone,0.4581923186779022,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Dexamethasone.,49,Type_49,Yes
DB00694,Daunorubicin,DB08991,Epirizole,0.9915721416473389,72,Type_72,Daunorubicin may decrease the excretion rate of Epirizole which could result in a higher serum level.,72,Type_72,Yes
DB00794,Primidone,DB01021,Trichlormethiazide,0.6461420059204102,60,Type_60,Primidone may increase the hypotensive activities of Trichlormethiazide.,30,Type_30,No
DB00476,Duloxetine,DB00800,Fenoldopam,0.9982573390007019,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Fenoldopam.,30,Type_30,Yes
DB01595,Nitrazepam,DB09345,Pramocaine,0.9979426264762878,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Pramocaine.,49,Type_49,Yes
DB01182,Propafenone,DB09238,Manidipine,0.6181996464729309,47,Type_47,The metabolism of Manidipine can be decreased when combined with Propafenone.,73,Type_73,No
DB01131,Proguanil,DB01263,Posaconazole,0.882043182849884,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Proguanil.,47,Type_47,Yes
DB01209,Dezocine,DB08883,Perampanel,0.9976254105567932,16,Type_16,Dezocine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00334,Olanzapine,DB00934,Maprotiline,0.8079521656036377,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Maprotiline.,49,Type_49,Yes
DB00210,Adapalene,DB09095,Difluocortolone,0.9999198913574219,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Difluocortolone.,49,Type_49,Yes
DB00184,Nicotine,DB04846,Celiprolol,0.46517619490623474,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Celiprolol.,49,Type_49,Yes
DB01124,Tolbutamide,DB01420,Testosterone propionate,0.9638396501541138,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Testosterone propionate.,9,Type_9,Yes
DB00547,Desoximetasone,DB09275,Bismuth subcitrate potassium,0.9987585544586182,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Desoximetasone.,3,Type_3,Yes
DB01039,Fenofibrate,DB08865,Crizotinib,0.984089732170105,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Fenofibrate.,47,Type_47,Yes
DB00433,Prochlorperazine,DB09280,Lumacaftor,0.6887160539627075,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Prochlorperazine.,4,Type_4,No
DB00244,Mesalazine,DB04898,Ximelagatran,0.8856621980667114,6,Type_6,Mesalazine may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00338,Omeprazole,DB00991,Oxaprozin,0.9385574460029602,47,Type_47,The metabolism of Oxaprozin can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00237,Butabarbital,DB00349,Clobazam,0.9879355430603027,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Clobazam.,49,Type_49,Yes
DB00220,Nelfinavir,DB00863,Ranitidine,0.8394941687583923,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Nelfinavir.,75,Type_75,No
DB00327,Hydromorphone,DB01028,Methoxyflurane,0.9910354614257812,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methoxyflurane.,49,Type_49,Yes
DB00951,Isoniazid,DB08970,Fluprednidene,0.8471558094024658,75,Type_75,The serum concentration of Fluprednidene can be decreased when it is combined with Isoniazid.,75,Type_75,Yes
DB00180,Flunisolide,DB06723,Aluminum hydroxide,0.9973892569541931,3,Type_3,The bioavailability of Aluminum hydroxide can be decreased when combined with Flunisolide.,3,Type_3,Yes
DB01254,Dasatinib,DB08816,Ticagrelor,0.809073805809021,73,Type_73,The serum concentration of Ticagrelor can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00318,Codeine,DB00588,Fluticasone propionate,0.9929565191268921,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Fluticasone propionate.,49,Type_49,Yes
DB00324,Fluorometholone,DB00375,Colestipol,0.6664790511131287,75,Type_75,The serum concentration of Colestipol can be decreased when it is combined with Fluorometholone.,67,Type_67,No
DB00898,Ethanol,DB00915,Amantadine,0.6247597932815552,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Amantadine.,16,Type_16,No
DB06696,Arbekacin,DB08991,Epirizole,0.9999971389770508,72,Type_72,Arbekacin may decrease the excretion rate of Epirizole which could result in a higher serum level.,72,Type_72,Yes
DB01050,Ibuprofen,DB01136,Carvedilol,0.9994816184043884,37,Type_37,Ibuprofen may decrease the antihypertensive activities of Carvedilol.,37,Type_37,Yes
DB00947,Fulvestrant,DB08933,Luliconazole,0.9688020348548889,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Fulvestrant.,73,Type_73,Yes
DB01153,Sertaconazole,DB09216,Tolfenamic acid,0.989858090877533,49,Type_49,The risk or severity of adverse effects can be increased when Sertaconazole is combined with Tolfenamic acid.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB01124,Tolbutamide,0.9806045293807983,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Hydrochlorothiazide.,70,Type_70,Yes
DB00872,Conivaptan,DB09291,Rolapitant,0.9428852796554565,73,Type_73,The serum concentration of Rolapitant can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB01255,Lisdexamfetamine,DB09488,Acrivastine,0.9998761415481567,76,Type_76,Lisdexamfetamine may decrease the sedative activities of Acrivastine.,76,Type_76,Yes
DB00314,Capreomycin,DB09268,Picosulfuric acid,0.9981339573860168,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Capreomycin.,70,Type_70,Yes
DB00908,Quinidine,DB09080,Olodaterol,0.6501604318618774,20,Type_20,Quinidine may increase the QTc-prolonging activities of Olodaterol.,20,Type_20,Yes
DB04840,Debrisoquine,DB13783,Acemetacin,0.8922070264816284,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Debrisoquine.,70,Type_70,Yes
DB00610,Metaraminol,DB06152,Nylidrin,0.9997664093971252,49,Type_49,The risk or severity of adverse effects can be increased when Metaraminol is combined with Nylidrin.,49,Type_49,Yes
DB00349,Clobazam,DB00921,Buprenorphine,0.9687891602516174,16,Type_16,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00625,Efavirenz,DB04896,Milnacipran,0.9091129302978516,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Milnacipran.,49,Type_49,Yes
DB00691,Moexipril,DB07615,Tranilast,0.6479799747467041,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Tranilast.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB08918,Levomilnacipran,0.7972250580787659,85,Type_85,Pseudoephedrine may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00393,Nimodipine,DB01143,Amifostine,0.8616890907287598,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Amifostine.,60,Type_60,No
DB00921,Buprenorphine,DB04855,Dronedarone,0.5901290774345398,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Buprenorphine.,47,Type_47,Yes
DB00881,Quinapril,DB05676,Apremilast,0.9879278540611267,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Apremilast.,49,Type_49,Yes
DB01325,Quinethazone,DB01356,Lithium cation,0.9834848046302795,72,Type_72,Quinethazone may decrease the excretion rate of Lithium cation which could result in a higher serum level.,72,Type_72,Yes
DB06786,Halcinonide,DB08439,Parecoxib,0.9941611886024475,49,Type_49,The risk or severity of adverse effects can be increased when Halcinonide is combined with Parecoxib.,49,Type_49,Yes
DB00333,Methadone,DB01100,Pimozide,0.5751608610153198,20,Type_20,Methadone may increase the QTc-prolonging activities of Pimozide.,49,Type_49,No
DB01242,Clomipramine,DB08880,Teriflunomide,0.48837515711784363,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Clomipramine.,75,Type_75,Yes
DB00602,Ivermectin,DB00661,Verapamil,0.9837039113044739,47,Type_47,The metabolism of Verapamil can be decreased when combined with Ivermectin.,47,Type_47,Yes
DB01609,Deferasirox,DB06777,Chenodeoxycholic acid,0.8899727463722229,75,Type_75,The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00820,Tadalafil,DB00869,Dorzolamide,0.9511842727661133,10,Type_10,Tadalafil may increase the antihypertensive activities of Dorzolamide.,10,Type_10,Yes
DB00422,Methylphenidate,DB01197,Captopril,0.9958747029304504,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Captopril.,37,Type_37,Yes
DB00298,Dapiprazole,DB04844,Tetrabenazine,0.9887683391571045,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Tetrabenazine.,49,Type_49,Yes
DB00104,Octreotide,DB01015,Sulfamethoxazole,0.8547030687332153,20,Type_20,Octreotide may increase the QTc-prolonging activities of Sulfamethoxazole.,9,Type_9,No
DB00187,Esmolol,DB01001,Salbutamol,0.8956344127655029,14,Type_14,Esmolol may decrease the bronchodilatory activities of Salbutamol.,14,Type_14,Yes
DB00450,Droperidol,DB00715,Paroxetine,0.9294629693031311,20,Type_20,Droperidol may increase the QTc-prolonging activities of Paroxetine.,20,Type_20,Yes
DB01021,Trichlormethiazide,DB08907,Canagliflozin,0.8467757701873779,49,Type_49,The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Canagliflozin.,70,Type_70,No
DB00907,Cocaine,DB09073,Palbociclib,0.9917776584625244,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Cocaine.,73,Type_73,Yes
DB00398,Sorafenib,DB00945,Acetylsalicylic acid,0.6088257431983948,47,Type_47,The metabolism of Acetylsalicylic acid can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB01045,Rifampicin,DB01229,Paclitaxel,0.9210565090179443,4,Type_4,The metabolism of Paclitaxel can be increased when combined with Rifampicin.,4,Type_4,Yes
DB01320,Fosphenytoin,DB09078,Lenvatinib,0.661357581615448,75,Type_75,The serum concentration of Lenvatinib can be decreased when it is combined with Fosphenytoin.,4,Type_4,No
DB00391,Sulpiride,DB09118,Stiripentol,0.694555938243866,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Stiripentol.,49,Type_49,Yes
DB00959,Methylprednisolone,DB01043,Memantine,0.9932979941368103,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Memantine.,49,Type_49,Yes
DB04743,Nimesulide,DB09543,Methyl salicylate,0.9485902190208435,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Methyl salicylate.,49,Type_49,Yes
DB00715,Paroxetine,DB01608,Periciazine,0.5362769365310669,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Periciazine.,49,Type_49,Yes
DB01319,Fosamprenavir,DB13179,Troleandomycin,0.7720372676849365,47,Type_47,The metabolism of Troleandomycin can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB01321,Josamycin,DB09053,Ibrutinib,0.699193000793457,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Josamycin.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB01018,Guanfacine,0.45288681983947754,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB08931,Riociguat,DB09112,Nitrous acid,0.8957685232162476,49,Type_49,The risk or severity of adverse effects can be increased when Riociguat is combined with Nitrous acid.,49,Type_49,Yes
DB00363,Clozapine,DB09065,Cobicistat,0.5483320951461792,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Clozapine.,73,Type_73,Yes
DB01106,Levocabastine,DB01576,Dextroamphetamine,0.9936221241950989,76,Type_76,Levocabastine may decrease the sedative activities of Dextroamphetamine.,76,Type_76,Yes
DB00309,Vindesine,DB02703,Fusidic acid,0.9993583559989929,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Vindesine.,73,Type_73,Yes
DB00257,Clotrimazole,DB00773,Etoposide,0.772538423538208,47,Type_47,The metabolism of Etoposide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00211,Midodrine,DB01193,Acebutolol,0.9592126607894897,54,Type_54,Midodrine may increase the bradycardic activities of Acebutolol.,54,Type_54,Yes
DB01114,Chlorpheniramine,DB06290,Simeprevir,0.9527106881141663,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Chlorpheniramine.,73,Type_73,Yes
DB00246,Ziprasidone,DB00977,Ethinylestradiol,0.7523143291473389,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00527,Cinchocaine,DB00844,Nalbuphine,0.9968401193618774,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Nalbuphine.,49,Type_49,Yes
DB00641,Simvastatin,DB00864,Tacrolimus,0.35464709997177124,48,Type_48,Simvastatin may increase the myopathic rhabdomyolysis activities of Tacrolimus.,73,Type_73,No
DB00280,Disopyramide,DB01100,Pimozide,0.8807988166809082,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Pimozide.,33,Type_33,No
DB00719,Azatadine,DB09352,Hydroxyamphetamine,0.9997789263725281,76,Type_76,Azatadine may decrease the sedative activities of Hydroxyamphetamine.,76,Type_76,Yes
DB00224,Indinavir,DB09054,Idelalisib,0.6609963178634644,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Indinavir.,73,Type_73,No
DB00521,Carteolol,DB09244,Pirlindole,0.9610952138900757,60,Type_60,Carteolol may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00401,Nisoldipine,DB00486,Nabilone,0.9944427609443665,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Nabilone.,49,Type_49,Yes
DB06290,Simeprevir,DB09555,Dexchlorpheniramine maleate,0.8184601068496704,73,Type_73,The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00486,Nabilone,DB00683,Midazolam,0.999731719493866,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Midazolam.,16,Type_16,Yes
DB00540,Nortriptyline,DB00601,Linezolid,0.9157078266143799,64,Type_64,Nortriptyline may increase the serotonergic activities of Linezolid.,64,Type_64,Yes
DB00834,Mifepristone,DB01015,Sulfamethoxazole,0.7411858439445496,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Sulfamethoxazole.,73,Type_73,No
DB00976,Telithromycin,DB06697,Artemether,0.4262714982032776,73,Type_73,The serum concentration of Artemether can be increased when it is combined with Telithromycin.,47,Type_47,No
DB00554,Piroxicam,DB00663,Flumethasone,0.9997968077659607,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Flumethasone.,49,Type_49,Yes
DB00316,Acetaminophen,DB01104,Sertraline,0.9671851992607117,47,Type_47,The metabolism of Sertraline can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB06772,Cabazitaxel,DB06810,Plicamycin,0.967909038066864,49,Type_49,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Plicamycin.,49,Type_49,Yes
DB00501,Cimetidine,DB04868,Nilotinib,0.9009462594985962,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Cimetidine.,75,Type_75,No
DB00758,Clopidogrel,DB00770,Alprostadil,0.5977280139923096,53,Type_53,Clopidogrel may increase the antiplatelet activities of Alprostadil.,6,Type_6,No
DB00243,Ranolazine,DB04946,Iloperidone,0.5562107563018799,73,Type_73,The serum concentration of Iloperidone can be increased when it is combined with Ranolazine.,20,Type_20,No
DB00591,Fluocinolone acetonide,DB00749,Etodolac,0.9984766840934753,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Etodolac.,49,Type_49,Yes
DB01339,Vecuronium,DB01377,Magnesium oxide,0.5827689170837402,21,Type_21,Vecuronium may increase the neuromuscular blocking activities of Magnesium oxide.,21,Type_21,Yes
DB01224,Quetiapine,DB01263,Posaconazole,0.5783514380455017,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Quetiapine.,73,Type_73,No
DB00875,Flupentixol,DB06153,Pizotifen,0.9825610518455505,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Pizotifen.,49,Type_49,Yes
DB00835,Brompheniramine,DB00980,Ramelteon,0.9945090413093567,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Ramelteon.,49,Type_49,Yes
DB00338,Omeprazole,DB00980,Ramelteon,0.9754505157470703,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB01244,Bepridil,DB09075,Edoxaban,0.9629898071289062,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Bepridil.,73,Type_73,Yes
DB00570,Vinblastine,DB01072,Atazanavir,0.5520974397659302,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB01074,Perhexiline,DB01403,Methotrimeprazine,0.47145143151283264,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Perhexiline.,47,Type_47,No
DB00395,Carisoprodol,DB01028,Methoxyflurane,0.9924163818359375,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Methoxyflurane.,49,Type_49,Yes
DB01198,Zopiclone,DB01205,Flumazenil,0.9821401238441467,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Flumazenil.,76,Type_76,No
DB00712,Flurbiprofen,DB00770,Alprostadil,0.9298239946365356,70,Type_70,The therapeutic efficacy of Alprostadil can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB00960,Pindolol,DB01089,Deserpidine,0.9998642206192017,60,Type_60,Pindolol may increase the hypotensive activities of Deserpidine.,60,Type_60,Yes
DB00660,Metaxalone,DB01320,Fosphenytoin,0.943715512752533,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Fosphenytoin.,49,Type_49,Yes
DB06820,Sulconazole,DB08992,Eperisone,0.9984982013702393,49,Type_49,The risk or severity of adverse effects can be increased when Sulconazole is combined with Eperisone.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00327,Hydromorphone,0.9946731925010681,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Hydromorphone.,49,Type_49,Yes
DB00178,Ramipril,DB00454,Meperidine,0.39160382747650146,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Meperidine.,49,Type_49,Yes
DB00368,Norepinephrine,DB09273,Doxofylline,0.6854177117347717,49,Type_49,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Doxofylline.,49,Type_49,Yes
DB00801,Halazepam,DB01623,Thiothixene,0.9948369264602661,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Thiothixene.,49,Type_49,Yes
DB00326,Calcium glucoheptonate,DB08826,Deferiprone,0.9965158700942993,75,Type_75,The serum concentration of Deferiprone can be decreased when it is combined with Calcium glucoheptonate.,75,Type_75,Yes
DB00722,Lisinopril,DB01435,Antipyrine,0.9510245323181152,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Antipyrine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00571,Propranolol,0.9057996869087219,47,Type_47,The metabolism of Propranolol can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00715,Paroxetine,DB09068,Vortioxetine,0.6151759028434753,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Vortioxetine.,73,Type_73,No
DB00268,Ropinirole,DB01355,Hexobarbital,0.9991851449012756,32,Type_32,Ropinirole may increase the sedative activities of Hexobarbital.,32,Type_32,Yes
DB00091,Cyclosporine,DB00546,Adinazolam,0.860141396522522,47,Type_47,The metabolism of Adinazolam can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00215,Citalopram,DB00765,Metyrosine,0.5128477215766907,70,Type_70,The therapeutic efficacy of Metyrosine can be decreased when used in combination with Citalopram.,49,Type_49,No
DB00402,Eszopiclone,DB06201,Rufinamide,0.9988526105880737,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Rufinamide.,49,Type_49,Yes
DB01092,Ouabain,DB06772,Cabazitaxel,0.9547401666641235,58,Type_58,Ouabain may decrease the cardiotoxic activities of Cabazitaxel.,58,Type_58,Yes
DB00677,Isoflurophate,DB00975,Dipyridamole,0.5927473306655884,70,Type_70,The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Isoflurophate.,70,Type_70,Yes
DB00496,Darifenacin,DB00502,Haloperidol,0.9822127819061279,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00318,Codeine,DB00582,Voriconazole,0.8561140894889832,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Codeine.,47,Type_47,Yes
DB00285,Venlafaxine,DB11148,Butamben,0.995394229888916,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Butamben.,49,Type_49,Yes
DB00248,Cabergoline,DB00255,Diethylstilbestrol,0.7043161988258362,47,Type_47,The metabolism of Diethylstilbestrol can be decreased when combined with Cabergoline.,49,Type_49,No
DB01214,Metipranolol,DB01397,Magnesium salicylate,0.9385142922401428,37,Type_37,Metipranolol may decrease the antihypertensive activities of Magnesium salicylate.,37,Type_37,Yes
DB00179,Masoprocol,DB00876,Eprosartan,0.8931922316551208,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Eprosartan.,49,Type_49,Yes
DB01628,Etoricoxib,DB13783,Acemetacin,0.915355920791626,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Acemetacin.,49,Type_49,Yes
DB00207,Azithromycin,DB01155,Gemifloxacin,0.9800887703895569,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00557,Hydroxyzine,DB09072,Sodium oxybate,1.0,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00208,Ticlopidine,DB09054,Idelalisib,0.7353432774543762,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00881,Quinapril,DB00890,Dienestrol,0.8966307044029236,75,Type_75,The serum concentration of Dienestrol can be decreased when it is combined with Quinapril.,75,Type_75,Yes
DB06589,Pazopanib,DB06788,Histrelin,0.9999970197677612,20,Type_20,Pazopanib may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB00246,Ziprasidone,DB09270,Ubidecarenone,0.8142056465148926,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Ziprasidone.,73,Type_73,Yes
DB00834,Mifepristone,DB01250,Olsalazine,0.837456464767456,9,Type_9,Mifepristone may increase the hypoglycemic activities of Olsalazine.,9,Type_9,Yes
DB00956,Hydrocodone,DB06700,Desvenlafaxine,0.6333073377609253,64,Type_64,Hydrocodone may increase the serotonergic activities of Desvenlafaxine.,64,Type_64,Yes
DB00390,Digoxin,DB01336,Metocurine,0.9947472214698792,82,Type_82,Digoxin may increase the arrhythmogenic activities of Metocurine.,82,Type_82,Yes
DB01114,Chlorpheniramine,DB09071,Tasimelteon,0.9993395209312439,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Tasimelteon.,49,Type_49,Yes
DB00974,Edetic acid,DB09079,Nintedanib,0.9800251722335815,49,Type_49,The risk or severity of adverse effects can be increased when Edetic acid is combined with Nintedanib.,49,Type_49,Yes
DB00091,Cyclosporine,DB01154,Thiamylal,0.5604491829872131,47,Type_47,The metabolism of Thiamylal can be decreased when combined with Cyclosporine.,4,Type_4,No
DB00686,Pentosan polysulfate,DB06695,Dabigatran etexilate,0.9931227564811707,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00528,Lercanidipine,DB03793,Benzoic acid,0.9785011410713196,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Benzoic acid.,49,Type_49,Yes
DB01580,Oxprenolol,DB09118,Stiripentol,0.8448127508163452,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Oxprenolol.,49,Type_49,No
DB00186,Lorazepam,DB00477,Chlorpromazine,0.9405180215835571,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Chlorpromazine.,49,Type_49,Yes
DB00243,Ranolazine,DB00320,Dihydroergotamine,0.7067176103591919,47,Type_47,The metabolism of Dihydroergotamine can be decreased when combined with Ranolazine.,73,Type_73,No
DB00243,Ranolazine,DB01020,Isosorbide mononitrate,0.5383659601211548,47,Type_47,The metabolism of Isosorbide mononitrate can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00312,Pentobarbital,DB01068,Clonazepam,0.4897468388080597,4,Type_4,The metabolism of Clonazepam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB08816,Ticagrelor,DB11079,Trolamine salicylate,0.8417542576789856,6,Type_6,Ticagrelor may increase the anticoagulant activities of Trolamine salicylate.,49,Type_49,No
DB00502,Haloperidol,DB00768,Olopatadine,0.5848850011825562,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Olopatadine.,49,Type_49,Yes
DB00446,Chloramphenicol,DB06204,Tapentadol,0.9857546091079712,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00428,Streptozocin,DB09212,Loxoprofen,0.9975591897964478,72,Type_72,Streptozocin may decrease the excretion rate of Loxoprofen which could result in a higher serum level.,72,Type_72,Yes
DB00857,Terbinafine,DB01248,Docetaxel,0.9481098055839539,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00219,Oxyphenonium,DB01433,Methadyl acetate,0.9999896287918091,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methadyl acetate.,49,Type_49,Yes
DB00177,Valsartan,DB00287,Travoprost,0.9999783039093018,60,Type_60,Valsartan may increase the hypotensive activities of Travoprost.,60,Type_60,Yes
DB00268,Ropinirole,DB01045,Rifampicin,0.955491304397583,4,Type_4,The metabolism of Rifampicin can be increased when combined with Ropinirole.,4,Type_4,Yes
DB00790,Perindopril,DB09038,Empagliflozin,0.9661545753479004,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Empagliflozin.,49,Type_49,Yes
DB08938,Magaldrate,DB09561,Sodium glycerophosphate,0.9908209443092346,67,Type_67,Magaldrate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00289,Atomoxetine,DB01587,Ketazolam,0.9595115184783936,47,Type_47,The metabolism of Ketazolam can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB00734,Risperidone,0.46128779649734497,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Risperidone.,47,Type_47,No
DB03615,Ribostamycin,DB09320,Procaine benzylpenicillin,0.9505898952484131,75,Type_75,The serum concentration of Procaine benzylpenicillin can be decreased when it is combined with Ribostamycin.,75,Type_75,Yes
DB01159,Halothane,DB01210,Levobunolol,0.9694468379020691,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Levobunolol.,49,Type_49,Yes
DB00204,Dofetilide,DB00346,Alfuzosin,0.9688200950622559,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Alfuzosin.,20,Type_20,Yes
DB00237,Butabarbital,DB00909,Zonisamide,0.9994953870773315,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Zonisamide.,49,Type_49,Yes
DB00240,Alclometasone,DB13167,Alclofenac,0.9989820122718811,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Alclofenac.,49,Type_49,Yes
DB00949,Felbamate,DB01028,Methoxyflurane,0.8976733088493347,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Methoxyflurane.,49,Type_49,Yes
DB00543,Amoxapine,DB05271,Rotigotine,0.9781612157821655,32,Type_32,Amoxapine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00564,Carbamazepine,DB00843,Donepezil,0.952985942363739,4,Type_4,The metabolism of Donepezil can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00257,Clotrimazole,DB00741,Hydrocortisone,0.9431234002113342,47,Type_47,The metabolism of Hydrocortisone can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01261,Sitagliptin,DB11079,Trolamine salicylate,0.9848651885986328,9,Type_9,Sitagliptin may increase the hypoglycemic activities of Trolamine salicylate.,9,Type_9,Yes
DB00961,Mepivacaine,DB01104,Sertraline,0.9905070066452026,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Sertraline.,49,Type_49,Yes
DB00337,Pimecrolimus,DB09048,Netupitant,0.9419868588447571,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Pimecrolimus.,73,Type_73,Yes
DB00668,Epinephrine,DB01365,Mephentermine,0.9998505115509033,49,Type_49,The risk or severity of adverse effects can be increased when Epinephrine is combined with Mephentermine.,49,Type_49,Yes
DB00590,Doxazosin,DB01367,Rasagiline,0.9485753774642944,60,Type_60,Doxazosin may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00738,Pentamidine,DB08918,Levomilnacipran,0.37130507826805115,49,Type_49,The risk or severity of adverse effects can be increased when Pentamidine is combined with Levomilnacipran.,9,Type_9,No
DB01069,Promethazine,DB01236,Sevoflurane,0.7924927473068237,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Sevoflurane.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB08893,Mirabegron,0.9979616403579712,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Mirabegron.,47,Type_47,No
DB00695,Furosemide,DB01410,Ciclesonide,0.9993423819541931,83,Type_83,Furosemide may increase the hypokalemic activities of Ciclesonide.,83,Type_83,Yes
DB01044,Gatifloxacin,DB06739,Seratrodast,0.9993780851364136,27,Type_27,Gatifloxacin may increase the neuroexcitatory activities of Seratrodast.,27,Type_27,Yes
DB00091,Cyclosporine,DB00850,Perphenazine,0.9066635370254517,47,Type_47,The metabolism of Perphenazine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00158,Folic acid,DB00608,Chloroquine,0.6686192154884338,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Folic acid.,70,Type_70,No
DB09030,Vorapaxar,DB09054,Idelalisib,0.5228553414344788,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Vorapaxar.,73,Type_73,Yes
DB08873,Boceprevir,DB13874,Enasidenib,0.7711681127548218,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Boceprevir.,47,Type_47,Yes
DB00188,Bortezomib,DB04846,Celiprolol,0.785538375377655,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00838,Clocortolone,DB01021,Trichlormethiazide,0.9999397993087769,83,Type_83,Clocortolone may increase the hypokalemic activities of Trichlormethiazide.,83,Type_83,Yes
DB00419,Miglustat,DB00627,Niacin,0.9979581832885742,70,Type_70,The therapeutic efficacy of Niacin can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00873,Loteprednol,DB09070,Tibolone,0.9490877389907837,73,Type_73,The serum concentration of Tibolone can be increased when it is combined with Loteprednol.,73,Type_73,Yes
DB00976,Telithromycin,DB04574,Estrone sulfate,0.8320615291595459,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00829,Diazepam,DB00962,Zaleplon,0.9003357291221619,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Zaleplon.,49,Type_49,Yes
DB00857,Terbinafine,DB08912,Dabrafenib,0.9708356261253357,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Terbinafine.,75,Type_75,Yes
DB00420,Promazine,DB08918,Levomilnacipran,0.6579188108444214,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Levomilnacipran.,47,Type_47,No
DB00484,Brimonidine,DB00502,Haloperidol,0.9884494543075562,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.,16,Type_16,Yes
DB00281,Lidocaine,DB00740,Riluzole,0.5653677582740784,47,Type_47,The metabolism of Riluzole can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00500,Tolmetin,DB00884,Risedronic acid,0.9044497609138489,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Risedronic acid.,49,Type_49,Yes
DB04844,Tetrabenazine,DB06595,Midostaurin,0.9166297912597656,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Tetrabenazine.,73,Type_73,No
DB06268,Sitaxentan,DB06712,Nilvadipine,0.9934919476509094,60,Type_60,Sitaxentan may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB09039,Eliglustat,DB09082,Vilanterol,0.6535949110984802,20,Type_20,Eliglustat may increase the QTc-prolonging activities of Vilanterol.,20,Type_20,Yes
DB00511,Acetyldigitoxin,DB09516,Mequinol,0.999992847442627,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Mequinol.,58,Type_58,Yes
DB00177,Valsartan,DB09241,Methylene blue,0.8191552758216858,60,Type_60,Valsartan may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00472,Fluoxetine,DB00593,Ethosuximide,0.8226660490036011,47,Type_47,The metabolism of Ethosuximide can be decreased when combined with Fluoxetine.,49,Type_49,No
DB00547,Desoximetasone,DB01026,Ketoconazole,0.8244215250015259,73,Type_73,The serum concentration of Ketoconazole can be increased when it is combined with Desoximetasone.,73,Type_73,Yes
DB00998,Frovatriptan,DB09224,Melperone,0.9985929131507874,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Melperone.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB01260,Desonide,0.9995208978652954,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desonide.,49,Type_49,Yes
DB01236,Sevoflurane,DB01282,Carbetocin,0.9634696245193481,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Carbetocin.,49,Type_49,Yes
DB00215,Citalopram,DB00316,Acetaminophen,0.9365358948707581,47,Type_47,The metabolism of Acetaminophen can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00322,Floxuridine,DB00870,Suprofen,0.7945706248283386,47,Type_47,The metabolism of Suprofen can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB01232,Saquinavir,DB12001,Abemaciclib,0.516335666179657,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Saquinavir.,49,Type_49,No
DB00193,Tramadol,DB01409,Tiotropium,0.9838873744010925,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Tiotropium.,49,Type_49,Yes
DB00843,Donepezil,DB01264,Darunavir,0.7049483060836792,47,Type_47,The metabolism of Darunavir can be decreased when combined with Donepezil.,73,Type_73,No
DB01238,Aripiprazole,DB08922,Perospirone,0.7148481011390686,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Perospirone.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB00530,Erlotinib,0.9979573488235474,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Erlotinib.,58,Type_58,Yes
DB01563,Chloral hydrate,DB09017,Brotizolam,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Brotizolam.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB09015,Canrenoic acid,0.852220356464386,56,Type_56,The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Canrenoic acid.,56,Type_56,Yes
DB00283,Clemastine,DB06603,Panobinostat,0.44905391335487366,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Clemastine.,47,Type_47,No
DB01081,Diphenoxylate,DB13323,Trichloroethylene,0.9977265000343323,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Trichloroethylene.,49,Type_49,Yes
DB00559,Bosentan,DB01132,Pioglitazone,0.9843783974647522,75,Type_75,The serum concentration of Pioglitazone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB01224,Quetiapine,DB04876,Vildagliptin,0.9433161020278931,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Quetiapine.,70,Type_70,Yes
DB00990,Exemestane,DB04855,Dronedarone,0.7753252983093262,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Exemestane.,47,Type_47,Yes
DB00921,Buprenorphine,DB01501,Difenoxin,0.9998722076416016,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.,16,Type_16,Yes
DB00283,Clemastine,DB00934,Maprotiline,0.48366719484329224,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Maprotiline.,47,Type_47,No
DB00263,Sulfisoxazole,DB00554,Piroxicam,0.7255260348320007,47,Type_47,The metabolism of Piroxicam can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01239,Chlorprothixene,DB08922,Perospirone,0.9900063872337341,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Perospirone.,49,Type_49,Yes
DB02709,Resveratrol,DB08976,Floctafenine,0.9952358603477478,49,Type_49,The risk or severity of adverse effects can be increased when Resveratrol is combined with Floctafenine.,49,Type_49,Yes
DB00308,Ibutilide,DB01356,Lithium cation,0.9757413864135742,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Lithium cation.,20,Type_20,Yes
DB00180,Flunisolide,DB01609,Deferasirox,0.8724774718284607,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Flunisolide.,75,Type_75,Yes
DB00531,Cyclophosphamide,DB11363,Alectinib,0.9935762286186218,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Alectinib.,15,Type_15,Yes
DB01399,Salsalate,DB04865,Omacetaxine mepesuccinate,0.981745183467865,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00726,Trimipramine,DB01466,Ethylmorphine,0.9097594618797302,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Ethylmorphine.,49,Type_49,Yes
DB01037,Selegiline,DB08932,Macitentan,0.9916136264801025,60,Type_60,Selegiline may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00743,Gadobenic acid,DB00927,Famotidine,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Famotidine.,20,Type_20,Yes
DB01115,Nifedipine,DB09031,Miltefosine,0.9615972638130188,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Miltefosine.,49,Type_49,Yes
DB01181,Ifosfamide,DB06413,Armodafinil,0.9714034795761108,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Ifosfamide.,47,Type_47,Yes
DB01029,Irbesartan,DB01283,Lumiracoxib,0.587205171585083,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00468,Quinine,DB01261,Sitagliptin,0.47972261905670166,9,Type_9,Quinine may increase the hypoglycemic activities of Sitagliptin.,47,Type_47,No
DB00705,Delavirdine,DB01215,Estazolam,0.8993223309516907,47,Type_47,The metabolism of Estazolam can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01106,Levocabastine,DB01403,Methotrimeprazine,0.9888548254966736,16,Type_16,Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00821,Carprofen,DB04846,Celiprolol,0.9979578256607056,37,Type_37,Carprofen may decrease the antihypertensive activities of Celiprolol.,37,Type_37,Yes
DB00264,Metoprolol,DB00446,Chloramphenicol,0.9486683011054993,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Metoprolol.,47,Type_47,Yes
DB00591,Fluocinolone acetonide,DB01399,Salsalate,0.9996610879898071,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Salsalate.,49,Type_49,Yes
DB00734,Risperidone,DB06595,Midostaurin,0.8751201629638672,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Risperidone.,47,Type_47,Yes
DB00959,Methylprednisolone,DB01122,Ambenonium,0.9949126243591309,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ambenonium.,49,Type_49,Yes
DB00387,Procyclidine,DB01400,Neostigmine,0.9990241527557373,70,Type_70,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Procyclidine.,70,Type_70,Yes
DB00690,Flurazepam,DB00752,Tranylcypromine,0.567461371421814,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Tranylcypromine.,49,Type_49,Yes
DB00468,Quinine,DB01028,Methoxyflurane,0.929965615272522,47,Type_47,The metabolism of Methoxyflurane can be decreased when combined with Quinine.,47,Type_47,Yes
DB00790,Perindopril,DB01356,Lithium cation,0.6638829112052917,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Perindopril.,73,Type_73,Yes
DB00498,Phenindione,DB00544,Fluorouracil,0.5181195139884949,47,Type_47,The metabolism of Fluorouracil can be decreased when combined with Phenindione.,73,Type_73,No
DB00780,Phenelzine,DB01200,Bromocriptine,0.8893418908119202,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Bromocriptine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00418,Secobarbital,0.9381786584854126,47,Type_47,The metabolism of Secobarbital can be decreased when combined with Sulfisoxazole.,4,Type_4,No
DB00857,Terbinafine,DB05219,Crisaborole,0.9980373978614807,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00778,Roxithromycin,DB01211,Clarithromycin,0.8223174214363098,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Roxithromycin.,47,Type_47,Yes
DB00559,Bosentan,DB01214,Metipranolol,0.7032330632209778,60,Type_60,Bosentan may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB01115,Nifedipine,DB02703,Fusidic acid,0.9940084218978882,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Nifedipine.,73,Type_73,Yes
DB02187,Equilin,DB08984,Etofenamate,0.9997370839118958,49,Type_49,The risk or severity of adverse effects can be increased when Equilin is combined with Etofenamate.,49,Type_49,Yes
DB00136,Calcitriol,DB01026,Ketoconazole,0.944593071937561,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Calcitriol.,47,Type_47,Yes
DB01397,Magnesium salicylate,DB08971,Fluocortolone,0.9986880421638489,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fluocortolone.,49,Type_49,Yes
DB00247,Methysergide,DB09118,Stiripentol,0.9604400396347046,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Stiripentol.,49,Type_49,Yes
DB08865,Crizotinib,DB09280,Lumacaftor,0.49149996042251587,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Crizotinib.,75,Type_75,No
DB00433,Prochlorperazine,DB00647,Dextropropoxyphene,0.9773842096328735,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Dextropropoxyphene.,49,Type_49,Yes
DB01544,Flunitrazepam,DB04855,Dronedarone,0.837370753288269,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Flunitrazepam.,47,Type_47,Yes
DB00908,Quinidine,DB11315,Methscopolamine,0.41212141513824463,2,Type_2,Quinidine may increase the anticholinergic activities of Methscopolamine.,49,Type_49,No
DB00592,Piperazine,DB00912,Repaglinide,0.9961850047111511,70,Type_70,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Piperazine.,70,Type_70,Yes
DB00586,Diclofenac,DB04272,Citric acid,0.9978930354118347,6,Type_6,Diclofenac may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB01351,Amobarbital,DB01427,Amrinone,0.9677800536155701,4,Type_4,The metabolism of Amrinone can be increased when combined with Amobarbital.,4,Type_4,Yes
DB01026,Ketoconazole,DB08881,Vemurafenib,0.6613332033157349,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB01435,Antipyrine,DB01589,Quazepam,0.4965810775756836,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Quazepam.,73,Type_73,No
DB00477,Chlorpromazine,DB00726,Trimipramine,0.32252684235572815,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Chlorpromazine.,20,Type_20,No
DB01058,Praziquantel,DB09198,Lobeglitazone,0.9965915679931641,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00807,Proparacaine,DB08922,Perospirone,0.999612033367157,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Perospirone.,49,Type_49,Yes
DB01017,Minocycline,DB11348,Calcium Phosphate,0.8044652938842773,75,Type_75,The serum concentration of Calcium Phosphate can be decreased when it is combined with Minocycline.,75,Type_75,Yes
DB00297,Bupivacaine,DB01106,Levocabastine,0.9993903636932373,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Levocabastine.,49,Type_49,Yes
DB01392,Yohimbine,DB09065,Cobicistat,0.9610651135444641,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Yohimbine.,73,Type_73,No
DB00877,Sirolimus,DB06712,Nilvadipine,0.9619433879852295,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Nilvadipine.,49,Type_49,Yes
DB00327,Hydromorphone,DB01236,Sevoflurane,0.9729592800140381,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Sevoflurane.,49,Type_49,Yes
DB00224,Indinavir,DB13179,Troleandomycin,0.8730052709579468,47,Type_47,The metabolism of Troleandomycin can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00652,Pentazocine,DB01090,Pentolinium,0.9968932867050171,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Pentolinium.,49,Type_49,Yes
DB00252,Phenytoin,DB06218,Lacosamide,0.7782570719718933,4,Type_4,The metabolism of Lacosamide can be increased when combined with Phenytoin.,75,Type_75,No
DB06810,Plicamycin,DB11156,Pyrantel,0.9999990463256836,40,Type_40,Plicamycin may increase the respiratory depressant activities of Pyrantel.,40,Type_40,Yes
DB00648,Mitotane,DB08931,Riociguat,0.9911982417106628,75,Type_75,The serum concentration of Riociguat can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01176,Cyclizine,DB01351,Amobarbital,0.9988117218017578,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Amobarbital.,49,Type_49,Yes
DB00440,Trimethoprim,DB06770,Benzyl alcohol,0.9189233779907227,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00278,Argatroban,DB06695,Dabigatran etexilate,0.9541876316070557,6,Type_6,Argatroban may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00624,Testosterone,DB01101,Capecitabine,0.9750064015388489,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Testosterone.,47,Type_47,Yes
DB04844,Tetrabenazine,DB05271,Rotigotine,0.9780617952346802,32,Type_32,Tetrabenazine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00465,Ketorolac,DB00817,Rosoxacin,0.9508332014083862,27,Type_27,Ketorolac may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB00199,Erythromycin,DB01403,Methotrimeprazine,0.4422667622566223,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Methotrimeprazine.,20,Type_20,Yes
DB00343,Diltiazem,DB01268,Sunitinib,0.33795735239982605,47,Type_47,The metabolism of Sunitinib can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00742,Mannitol,DB00968,Methyldopa,0.9841383099555969,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Methyldopa.,49,Type_49,Yes
DB00349,Clobazam,DB00745,Modafinil,0.9759833216667175,47,Type_47,The metabolism of Modafinil can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00465,Ketorolac,DB00584,Enalapril,0.9249071478843689,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Enalapril.,49,Type_49,Yes
DB00246,Ziprasidone,DB06654,Safinamide,0.9844299554824829,47,Type_47,The metabolism of Safinamide can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00959,Methylprednisolone,DB01167,Itraconazole,0.8169369101524353,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Methylprednisolone.,73,Type_73,No
DB00327,Hydromorphone,DB01558,Bromazepam,0.9969828724861145,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bromazepam.,49,Type_49,Yes
DB06176,Romidepsin,DB09120,Zucapsaicin,0.990826427936554,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Romidepsin.,47,Type_47,Yes
DB00705,Delavirdine,DB01110,Miconazole,0.8836511373519897,47,Type_47,The metabolism of Miconazole can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00343,Diltiazem,DB00701,Amprenavir,0.8980531096458435,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01026,Ketoconazole,DB04920,Clevidipine,0.7172092199325562,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Ketoconazole.,49,Type_49,No
DB06292,Dapagliflozin,DB09291,Rolapitant,0.9397945404052734,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Dapagliflozin.,47,Type_47,Yes
DB01072,Atazanavir,DB09065,Cobicistat,0.8041306138038635,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Atazanavir.,47,Type_47,No
DB00645,Dyclonine,DB06770,Benzyl alcohol,0.9998672008514404,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Benzyl alcohol.,49,Type_49,Yes
DB00215,Citalopram,DB00697,Tizanidine,0.7317189574241638,20,Type_20,Citalopram may increase the QTc-prolonging activities of Tizanidine.,73,Type_73,No
DB04861,Nebivolol,DB05676,Apremilast,0.9909482598304749,37,Type_37,Nebivolol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB01393,Bezafibrate,DB09073,Palbociclib,0.9719957113265991,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Bezafibrate.,73,Type_73,Yes
DB00213,Pantoprazole,DB01274,Arformoterol,0.9483064413070679,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00404,Alprazolam,DB00737,Meclizine,0.9999562501907349,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Meclizine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB01045,Rifampicin,0.8930478096008301,4,Type_4,The metabolism of Rifampicin can be increased when combined with Sulfisoxazole.,4,Type_4,Yes
DB00465,Ketorolac,DB00594,Amiloride,0.9309909343719482,37,Type_37,Ketorolac may decrease the antihypertensive activities of Amiloride.,37,Type_37,Yes
DB00458,Imipramine,DB00727,Nitroglycerin,0.9979749321937561,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Nitroglycerin.,49,Type_49,Yes
DB05541,Brivaracetam,DB06414,Etravirine,0.8346034288406372,47,Type_47,The metabolism of Etravirine can be decreased when combined with Brivaracetam.,47,Type_47,Yes
DB00544,Fluorouracil,DB00701,Amprenavir,0.5559679865837097,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00091,Cyclosporine,DB00264,Metoprolol,0.4962811768054962,47,Type_47,The metabolism of Metoprolol can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00844,Nalbuphine,DB01608,Periciazine,0.8534467816352844,60,Type_60,Nalbuphine may increase the hypotensive activities of Periciazine.,60,Type_60,Yes
DB00988,Dopamine,DB09167,Dosulepin,0.9050681591033936,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Dopamine.,47,Type_47,Yes
DB00498,Phenindione,DB01609,Deferasirox,0.4582441747188568,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Phenindione.,49,Type_49,No
DB00887,Bumetanide,DB01359,Penbutolol,0.9064707159996033,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Penbutolol.,49,Type_49,Yes
DB01624,Zuclopenthixol,DB11609,Normethadone,0.9859877228736877,49,Type_49,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Normethadone.,49,Type_49,Yes
DB00091,Cyclosporine,DB00865,Benzphetamine,0.9222228527069092,47,Type_47,The metabolism of Benzphetamine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00343,Diltiazem,DB09026,Aliskiren,0.5202178359031677,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Diltiazem.,49,Type_49,No
DB00590,Doxazosin,DB00697,Tizanidine,0.35851263999938965,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Tizanidine.,49,Type_49,Yes
DB00674,Galantamine,DB02703,Fusidic acid,0.9975394010543823,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Galantamine.,73,Type_73,Yes
DB01600,Tiaprofenic acid,DB09295,Talniflumate,0.9995391368865967,49,Type_49,The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Talniflumate.,49,Type_49,Yes
DB00701,Amprenavir,DB09198,Lobeglitazone,0.9993734955787659,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Amprenavir.,47,Type_47,Yes
DB01261,Sitagliptin,DB09128,Brexpiprazole,0.9888773560523987,70,Type_70,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Sitagliptin.,70,Type_70,Yes
DB00682,Warfarin,DB01072,Atazanavir,0.4213685393333435,6,Type_6,Warfarin may increase the anticoagulant activities of Atazanavir.,73,Type_73,No
DB00806,Pentoxifylline,DB06228,Rivaroxaban,0.9869150519371033,6,Type_6,Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.,6,Type_6,Yes
DB01113,Papaverine,DB09220,Nicorandil,0.9492620825767517,60,Type_60,Papaverine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00273,Topiramate,DB00425,Zolpidem,0.9937984347343445,16,Type_16,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB00215,Citalopram,DB00863,Ranitidine,0.9571983814239502,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00603,Medroxyprogesterone acetate,DB00849,Methylphenobarbital,0.9717511534690857,70,Type_70,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Medroxyprogesterone acetate.,70,Type_70,Yes
DB01609,Deferasirox,DB09053,Ibrutinib,0.4973165988922119,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Deferasirox.,75,Type_75,No
DB00710,Ibandronate,DB01628,Etoricoxib,0.9907258749008179,49,Type_49,The risk or severity of adverse effects can be increased when Ibandronate is combined with Etoricoxib.,49,Type_49,Yes
DB00508,Triflupromazine,DB01065,Melatonin,0.9990277290344238,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Melatonin.,49,Type_49,Yes
DB00673,Aprepitant,DB00916,Metronidazole,0.9722653031349182,73,Type_73,The serum concentration of Metronidazole can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00433,Prochlorperazine,DB06716,Fospropofol,0.999980092048645,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fospropofol.,49,Type_49,Yes
DB08864,Rilpivirine,DB11943,Delafloxacin,0.5988284349441528,73,Type_73,The serum concentration of Delafloxacin can be increased when it is combined with Rilpivirine.,75,Type_75,No
DB00492,Fosinopril,DB01325,Quinethazone,0.9010705351829529,60,Type_60,Fosinopril may increase the hypotensive activities of Quinethazone.,60,Type_60,Yes
DB01104,Sertraline,DB06216,Asenapine,0.41604137420654297,20,Type_20,Sertraline may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00911,Tinidazole,DB08933,Luliconazole,0.9659743309020996,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Tinidazole.,73,Type_73,Yes
DB00569,Fondaparinux,DB09030,Vorapaxar,0.7735906839370728,49,Type_49,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Vorapaxar.,49,Type_49,Yes
DB06204,Tapentadol,DB06697,Artemether,0.7462049722671509,47,Type_47,The metabolism of Artemether can be decreased when combined with Tapentadol.,47,Type_47,Yes
DB00270,Isradipine,DB00559,Bosentan,0.37373054027557373,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Isradipine.,73,Type_73,Yes
DB00850,Perphenazine,DB01440,gamma-Hydroxybutyric acid,0.9999823570251465,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB05246,Methsuximide,DB08922,Perospirone,0.9989715814590454,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Perospirone.,49,Type_49,Yes
DB01563,Chloral hydrate,DB06690,Nitrous oxide,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Nitrous oxide.,49,Type_49,Yes
DB00243,Ranolazine,DB00518,Albendazole,0.8027926683425903,47,Type_47,The metabolism of Albendazole can be decreased when combined with Ranolazine.,73,Type_73,No
DB00206,Reserpine,DB13323,Trichloroethylene,0.9796725511550903,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Trichloroethylene.,49,Type_49,Yes
DB00866,Alprenolol,DB04552,Niflumic acid,0.9878761768341064,37,Type_37,Alprenolol may decrease the antihypertensive activities of Niflumic acid.,37,Type_37,Yes
DB00608,Chloroquine,DB00641,Simvastatin,0.6294765472412109,47,Type_47,The metabolism of Simvastatin can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB01129,Rabeprazole,DB11613,Velpatasvir,0.870937168598175,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Rabeprazole.,47,Type_47,Yes
DB00794,Primidone,DB00808,Indapamide,0.4135405123233795,60,Type_60,Primidone may increase the hypotensive activities of Indapamide.,4,Type_4,No
DB00924,Cyclobenzaprine,DB01118,Amiodarone,0.3786441683769226,20,Type_20,Cyclobenzaprine may increase the QTc-prolonging activities of Amiodarone.,47,Type_47,No
DB09244,Pirlindole,DB09289,Tianeptine,0.44777989387512207,49,Type_49,The risk or severity of adverse effects can be increased when Pirlindole is combined with Tianeptine.,49,Type_49,Yes
DB01154,Thiamylal,DB01466,Ethylmorphine,0.9931041598320007,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Ethylmorphine.,49,Type_49,Yes
DB00524,Metolazone,DB04574,Estrone sulfate,0.9992400407791138,83,Type_83,Metolazone may increase the hypokalemic activities of Estrone sulfate.,83,Type_83,Yes
DB00814,Meloxicam,DB00945,Acetylsalicylic acid,0.9115776419639587,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB09224,Melperone,DB11148,Butamben,0.9999991655349731,49,Type_49,The risk or severity of adverse effects can be increased when Melperone is combined with Butamben.,49,Type_49,Yes
DB00420,Promazine,DB01264,Darunavir,0.4960116147994995,47,Type_47,The metabolism of Darunavir can be decreased when combined with Promazine.,47,Type_47,Yes
DB00254,Doxycycline,DB00603,Medroxyprogesterone acetate,0.8514827489852905,47,Type_47,The metabolism of Medroxyprogesterone acetate can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00744,Zileuton,DB04272,Citric acid,0.997599184513092,6,Type_6,Zileuton may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB01053,Benzylpenicillin,DB01082,Streptomycin,0.9998273253440857,75,Type_75,The serum concentration of Streptomycin can be decreased when it is combined with Benzylpenicillin.,75,Type_75,Yes
DB00253,Medrysone,DB00788,Naproxen,0.9996334314346313,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Naproxen.,49,Type_49,Yes
DB00091,Cyclosporine,DB00932,Tipranavir,0.7452465891838074,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Cyclosporine.,73,Type_73,No
DB01124,Tolbutamide,DB01380,Cortisone acetate,0.968619167804718,70,Type_70,The therapeutic efficacy of Cortisone acetate can be decreased when used in combination with Tolbutamide.,70,Type_70,Yes
DB00606,Cyclothiazide,DB00765,Metyrosine,0.9999985694885254,60,Type_60,Cyclothiazide may increase the hypotensive activities of Metyrosine.,60,Type_60,Yes
DB00278,Argatroban,DB00682,Warfarin,0.993541955947876,6,Type_6,Argatroban may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00477,Chlorpromazine,DB00660,Metaxalone,0.9996469020843506,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Metaxalone.,49,Type_49,Yes
DB01054,Nitrendipine,DB01232,Saquinavir,0.8747453689575195,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Nitrendipine.,47,Type_47,Yes
DB00543,Amoxapine,DB00794,Primidone,0.8280454277992249,4,Type_4,The metabolism of Primidone can be increased when combined with Amoxapine.,4,Type_4,Yes
DB00618,Demeclocycline,DB01397,Magnesium salicylate,0.9369943737983704,49,Type_49,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Magnesium salicylate.,67,Type_67,No
DB00440,Trimethoprim,DB00641,Simvastatin,0.640779435634613,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Trimethoprim.,47,Type_47,No
DB01130,Prednicarbate,DB06724,Calcium carbonate,0.9986617565155029,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Prednicarbate.,3,Type_3,Yes
DB00176,Fluvoxamine,DB04841,Flunarizine,0.5569614768028259,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00683,Midazolam,DB00950,Fexofenadine,0.9973180890083313,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Fexofenadine.,49,Type_49,Yes
DB01002,Levobupivacaine,DB09034,Suvorexant,0.9997997879981995,16,Type_16,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00472,Fluoxetine,DB09049,Naloxegol,0.9995676875114441,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB01170,Guanethidine,DB08931,Riociguat,0.9997785687446594,60,Type_60,Guanethidine may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00176,Fluvoxamine,DB01367,Rasagiline,0.7249330878257751,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Rasagiline.,73,Type_73,No
DB01154,Thiamylal,DB06201,Rufinamide,0.99808669090271,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Rufinamide.,49,Type_49,Yes
DB00420,Promazine,DB01263,Posaconazole,0.5799607634544373,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Promazine.,47,Type_47,Yes
DB00906,Tiagabine,DB01151,Desipramine,0.8861201405525208,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Desipramine.,49,Type_49,Yes
DB01255,Lisdexamfetamine,DB06148,Mianserin,0.9955018162727356,76,Type_76,Lisdexamfetamine may decrease the sedative activities of Mianserin.,76,Type_76,Yes
DB00310,Chlorthalidone,DB00678,Losartan,0.9193153977394104,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Losartan.,49,Type_49,Yes
DB00240,Alclometasone,DB09067,Corticorelin ovine triflutate,0.9999874830245972,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Alclometasone.,70,Type_70,Yes
DB00320,Dihydroergotamine,DB01058,Praziquantel,0.922471284866333,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00215,Citalopram,DB09224,Melperone,0.9250199198722839,49,Type_49,The risk or severity of adverse effects can be increased when Citalopram is combined with Melperone.,49,Type_49,Yes
DB00623,Fluphenazine,DB04841,Flunarizine,0.9842585325241089,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunarizine.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB01227,Levacetylmethadol,0.9736334681510925,69,Type_69,Pseudoephedrine may increase the analgesic activities of Levacetylmethadol.,69,Type_69,Yes
DB00675,Tamoxifen,DB09118,Stiripentol,0.9418906569480896,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Tamoxifen.,73,Type_73,Yes
DB09101,Elvitegravir,DB12332,Rucaparib,0.9341242909431458,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Elvitegravir.,47,Type_47,Yes
DB00354,Buclizine,DB06698,Betahistine,0.9619207382202148,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Buclizine.,70,Type_70,Yes
DB02703,Fusidic acid,DB11581,Venetoclax,0.9987624883651733,73,Type_73,The serum concentration of Venetoclax can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00898,Ethanol,DB01254,Dasatinib,0.79759681224823,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Ethanol.,73,Type_73,Yes
DB00199,Erythromycin,DB00932,Tipranavir,0.8102359771728516,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00703,Methazolamide,DB09227,Barnidipine,0.9888152480125427,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Barnidipine.,49,Type_49,Yes
DB00714,Apomorphine,DB00866,Alprenolol,0.7822221517562866,25,Type_25,Apomorphine may increase the atrioventricular blocking (AV block) activities of Alprenolol.,25,Type_25,Yes
DB06813,Pralatrexate,DB13783,Acemetacin,0.7997668981552124,49,Type_49,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Acemetacin.,73,Type_73,No
DB08970,Fluprednidene,DB13167,Alclofenac,0.999653697013855,49,Type_49,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Alclofenac.,49,Type_49,Yes
DB08881,Vemurafenib,DB09039,Eliglustat,0.9485560059547424,33,Type_33,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Eliglustat.,75,Type_75,No
DB01601,Lopinavir,DB06209,Prasugrel,0.5449510812759399,11,Type_11,The serum concentration of the active metabolites of Prasugrel can be reduced when Prasugrel is used in combination with Lopinavir resulting in a loss in efficacy.,11,Type_11,Yes
DB00604,Cisapride,DB09120,Zucapsaicin,0.9873615503311157,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Cisapride.,47,Type_47,Yes
DB00366,Doxylamine,DB00425,Zolpidem,1.0,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,16,Type_16,Yes
DB00938,Salmeterol,DB01609,Deferasirox,0.9318148493766785,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Salmeterol.,75,Type_75,Yes
DB00179,Masoprocol,DB01208,Sparfloxacin,0.9995253086090088,27,Type_27,Masoprocol may increase the neuroexcitatory activities of Sparfloxacin.,27,Type_27,Yes
DB00812,Phenylbutazone,DB01384,Paramethasone,0.9993565678596497,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Paramethasone.,49,Type_49,Yes
DB00929,Misoprostol,DB08981,Fenbufen,0.7838348746299744,70,Type_70,The therapeutic efficacy of Fenbufen can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB00422,Methylphenidate,DB01463,Fencamfamin,0.9836815595626831,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Fencamfamin.,49,Type_49,Yes
DB00564,Carbamazepine,DB01060,Amoxicillin,0.9356497526168823,4,Type_4,The metabolism of Amoxicillin can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01190,Clindamycin,DB06212,Tolvaptan,0.6258451342582703,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Clindamycin.,73,Type_73,Yes
DB00772,Malathion,DB01210,Levobunolol,0.9904905557632446,54,Type_54,Malathion may increase the bradycardic activities of Levobunolol.,54,Type_54,Yes
DB00501,Cimetidine,DB06712,Nilvadipine,0.8508719801902771,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Cimetidine.,73,Type_73,No
DB00663,Flumethasone,DB00682,Warfarin,0.8967562913894653,6,Type_6,Flumethasone may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB01159,Halothane,DB08910,Pomalidomide,0.9592491388320923,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Pomalidomide.,49,Type_49,Yes
DB01268,Sunitinib,DB06290,Simeprevir,0.9848513007164001,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Sunitinib.,73,Type_73,Yes
DB00700,Eplerenone,DB00966,Telmisartan,0.6939340829849243,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Telmisartan.,68,Type_68,No
DB00333,Methadone,DB01253,Ergometrine,0.7674878835678101,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Ergometrine.,49,Type_49,Yes
DB00250,Dapsone,DB01601,Lopinavir,0.9341551065444946,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Dapsone.,47,Type_47,Yes
DB00324,Fluorometholone,DB00615,Rifabutin,0.8517343401908875,4,Type_4,The metabolism of Rifabutin can be increased when combined with Fluorometholone.,4,Type_4,Yes
DB00433,Prochlorperazine,DB00496,Darifenacin,0.7521170377731323,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Prochlorperazine.,47,Type_47,Yes
DB00866,Alprenolol,DB01242,Clomipramine,0.8248602151870728,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Alprenolol.,47,Type_47,Yes
DB01107,Methyprylon,DB09167,Dosulepin,0.9933642148971558,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Methyprylon.,47,Type_47,Yes
DB00469,Tenoxicam,DB00544,Fluorouracil,0.7444252371788025,47,Type_47,The metabolism of Fluorouracil can be decreased when combined with Tenoxicam.,47,Type_47,Yes
DB00808,Indapamide,DB01244,Bepridil,0.5217376351356506,60,Type_60,Indapamide may increase the hypotensive activities of Bepridil.,60,Type_60,Yes
DB00796,Candesartan cilexetil,DB08931,Riociguat,0.7763389348983765,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Riociguat.,49,Type_49,Yes
DB00933,Mesoridazine,DB01621,Pipotiazine,0.989522397518158,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pipotiazine.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB04946,Iloperidone,0.9276235103607178,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Iloperidone.,49,Type_49,Yes
DB01186,Pergolide,DB01263,Posaconazole,0.46183034777641296,49,Type_49,The risk or severity of adverse effects can be increased when Pergolide is combined with Posaconazole.,47,Type_47,No
DB00604,Cisapride,DB01184,Domperidone,0.8323684334754944,20,Type_20,Cisapride may increase the QTc-prolonging activities of Domperidone.,33,Type_33,No
DB01366,Procaterol,DB01367,Rasagiline,0.9911079406738281,49,Type_49,The risk or severity of adverse effects can be increased when Procaterol is combined with Rasagiline.,49,Type_49,Yes
DB01037,Selegiline,DB01267,Paliperidone,0.6894469261169434,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Paliperidone.,49,Type_49,Yes
DB01058,Praziquantel,DB04855,Dronedarone,0.5942502021789551,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00625,Efavirenz,DB00843,Donepezil,0.49396881461143494,47,Type_47,The metabolism of Donepezil can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00765,Metyrosine,DB09235,Efonidipine,0.9918066263198853,60,Type_60,Metyrosine may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00829,Diazepam,DB08881,Vemurafenib,0.533501148223877,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB01029,Irbesartan,DB12332,Rucaparib,0.961168646812439,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00876,Eprosartan,DB08932,Macitentan,0.9997860789299011,60,Type_60,Eprosartan may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00142,Glutamic acid,DB01577,Metamfetamine,0.9996758699417114,75,Type_75,The serum concentration of Metamfetamine can be decreased when it is combined with Glutamic acid.,75,Type_75,Yes
DB00217,Bethanidine,DB09070,Tibolone,0.999994158744812,60,Type_60,Bethanidine may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00300,Tenofovir disoproxil,DB00898,Ethanol,0.8889156579971313,47,Type_47,The metabolism of Ethanol can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00350,Minoxidil,DB00614,Furazolidone,0.9924299120903015,60,Type_60,Minoxidil may increase the hypotensive activities of Furazolidone.,60,Type_60,Yes
DB00458,Imipramine,DB09053,Ibrutinib,0.8372066617012024,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Imipramine.,47,Type_47,No
DB00282,Pamidronic acid,DB01370,Aluminium,0.9822404980659485,75,Type_75,The serum concentration of Aluminium can be decreased when it is combined with Pamidronic acid.,75,Type_75,Yes
DB00381,Amlodipine,DB00908,Quinidine,0.9361948370933533,47,Type_47,The metabolism of Quinidine can be decreased when combined with Amlodipine.,75,Type_75,No
DB00433,Prochlorperazine,DB01242,Clomipramine,0.5461956858634949,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Clomipramine.,47,Type_47,No
DB00234,Reboxetine,DB08865,Crizotinib,0.9643798470497131,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Reboxetine.,47,Type_47,Yes
DB00806,Pentoxifylline,DB11268,Protocatechualdehyde,0.9960032105445862,6,Type_6,Pentoxifylline may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00949,Felbamate,DB04868,Nilotinib,0.44165998697280884,20,Type_20,Felbamate may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB01201,Rifapentine,DB06781,Difluprednate,0.9969896078109741,75,Type_75,The serum concentration of Difluprednate can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00331,Metformin,DB01626,Pargyline,0.9989602565765381,9,Type_9,Metformin may increase the hypoglycemic activities of Pargyline.,9,Type_9,Yes
DB00961,Mepivacaine,DB08922,Perospirone,0.9995013475418091,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Perospirone.,49,Type_49,Yes
DB00220,Nelfinavir,DB00726,Trimipramine,0.6284348964691162,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00335,Atenolol,DB00814,Meloxicam,0.9858762621879578,37,Type_37,Atenolol may decrease the antihypertensive activities of Meloxicam.,37,Type_37,Yes
DB00230,Pregabalin,DB00502,Haloperidol,0.9809697866439819,8,Type_8,The therapeutic efficacy of Haloperidol can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00622,Nicardipine,DB09167,Dosulepin,0.8104428648948669,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB04861,Nebivolol,DB06711,Naphazoline,0.9877495169639587,25,Type_25,Nebivolol may increase the atrioventricular blocking (AV block) activities of Naphazoline.,25,Type_25,Yes
DB08987,Etidocaine,DB09224,Melperone,0.9999833106994629,49,Type_49,The risk or severity of adverse effects can be increased when Etidocaine is combined with Melperone.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB01222,Budesonide,0.9998072981834412,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Budesonide.,49,Type_49,Yes
DB00257,Clotrimazole,DB05239,Cobimetinib,0.9467054009437561,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Clotrimazole.,73,Type_73,Yes
DB00341,Cetirizine,DB00962,Zaleplon,0.990069568157196,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Zaleplon.,49,Type_49,Yes
DB00363,Clozapine,DB00366,Doxylamine,0.9999998807907104,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00257,Clotrimazole,DB01071,Mequitazine,0.8780166506767273,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00285,Venlafaxine,DB01424,Aminophenazone,0.9661824703216553,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00695,Furosemide,DB06712,Nilvadipine,0.9281797409057617,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Nilvadipine.,49,Type_49,Yes
DB01247,Isocarboxazid,DB08918,Levomilnacipran,0.8295609354972839,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levomilnacipran.,49,Type_49,Yes
DB00544,Fluorouracil,DB01075,Diphenhydramine,0.9620148539543152,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00227,Lovastatin,DB00788,Naproxen,0.8187280893325806,47,Type_47,The metabolism of Naproxen can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00905,Bimatoprost,DB12598,Nafamostat,0.9775872826576233,70,Type_70,The therapeutic efficacy of Nafamostat can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00338,Omeprazole,DB00582,Voriconazole,0.9360812902450562,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Omeprazole.,73,Type_73,No
DB00176,Fluvoxamine,DB00812,Phenylbutazone,0.9348528981208801,47,Type_47,The metabolism of Phenylbutazone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00333,Methadone,DB09166,Etizolam,0.5296095013618469,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Etizolam.,16,Type_16,No
DB01232,Saquinavir,DB09027,Ledipasvir,0.8985805511474609,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00673,Aprepitant,DB04845,Ixabepilone,0.9885114431381226,73,Type_73,The serum concentration of Ixabepilone can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00353,Methylergometrine,DB00727,Nitroglycerin,0.9759640097618103,62,Type_62,The bioavailability of Nitroglycerin can be increased when combined with Methylergometrine.,62,Type_62,Yes
DB00370,Mirtazapine,DB04846,Celiprolol,0.8261823058128357,37,Type_37,Mirtazapine may decrease the antihypertensive activities of Celiprolol.,49,Type_49,No
DB00371,Meprobamate,DB01238,Aripiprazole,0.9736210703849792,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Aripiprazole.,49,Type_49,Yes
DB00448,Lansoprazole,DB01253,Ergometrine,0.6050163507461548,49,Type_49,The risk or severity of adverse effects can be increased when Lansoprazole is combined with Ergometrine.,49,Type_49,Yes
DB00454,Meperidine,DB00476,Duloxetine,0.6004272103309631,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Duloxetine.,49,Type_49,Yes
DB00969,Alosetron,DB04839,Cyproterone acetate,0.6617494225502014,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Alosetron.,75,Type_75,Yes
DB00549,Zafirlukast,DB01211,Clarithromycin,0.8067312836647034,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00950,Fexofenadine,DB01618,Molindone,0.9999034404754639,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Molindone.,49,Type_49,Yes
DB00343,Diltiazem,DB00697,Tizanidine,0.5048478841781616,73,Type_73,The serum concentration of Tizanidine can be increased when it is combined with Diltiazem.,49,Type_49,No
DB00635,Prednisone,DB06290,Simeprevir,0.9712755680084229,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Prednisone.,73,Type_73,Yes
DB00270,Isradipine,DB03793,Benzoic acid,0.8665437698364258,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Benzoic acid.,49,Type_49,Yes
DB00393,Nimodipine,DB08933,Luliconazole,0.9870774745941162,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Nimodipine.,73,Type_73,Yes
DB00620,Triamcinolone,DB00963,Bromfenac,0.9996985197067261,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Bromfenac.,49,Type_49,Yes
DB00845,Clofazimine,DB09053,Ibrutinib,0.6797673106193542,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Clofazimine.,73,Type_73,Yes
DB08883,Perampanel,DB09054,Idelalisib,0.4278528094291687,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Perampanel.,47,Type_47,Yes
DB00737,Meclizine,DB09068,Vortioxetine,0.9996832609176636,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Vortioxetine.,49,Type_49,Yes
DB00569,Fondaparinux,DB00717,Norethisterone,0.9726355075836182,70,Type_70,The therapeutic efficacy of Norethisterone can be decreased when used in combination with Fondaparinux.,70,Type_70,Yes
DB01114,Chlorpheniramine,DB09117,Paraldehyde,0.9851124882698059,16,Type_16,Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01168,Procarbazine,DB09236,Lacidipine,0.790388286113739,60,Type_60,Procarbazine may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00333,Methadone,DB01433,Methadyl acetate,0.9069995284080505,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Methadyl acetate.,49,Type_49,Yes
DB00549,Zafirlukast,DB00648,Mitotane,0.9446173310279846,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Zafirlukast.,75,Type_75,Yes
DB00261,Anagrelide,DB12598,Nafamostat,0.9816808104515076,6,Type_6,Anagrelide may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB00679,Thioridazine,DB06148,Mianserin,0.28801095485687256,47,Type_47,The metabolism of Mianserin can be decreased when combined with Thioridazine.,73,Type_73,No
DB01036,Tolterodine,DB05812,Abiraterone,0.6998614072799683,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Tolterodine.,73,Type_73,Yes
DB00881,Quinapril,DB01137,Levofloxacin,0.4703393280506134,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Levofloxacin.,75,Type_75,No
DB00227,Lovastatin,DB00455,Loratadine,0.7687881588935852,47,Type_47,The metabolism of Loratadine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00413,Pramipexole,DB00903,Etacrynic acid,0.9948391318321228,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Etacrynic acid.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00918,Almotriptan,0.6202440857887268,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB01263,Posaconazole,DB12483,Copanlisib,0.8799540400505066,47,Type_47,The metabolism of Copanlisib can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00951,Isoniazid,DB01095,Fluvastatin,0.518497109413147,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Isoniazid.,47,Type_47,No
DB00881,Quinapril,DB01275,Hydralazine,0.5328695774078369,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Hydralazine.,49,Type_49,Yes
DB00461,Nabumetone,DB09095,Difluocortolone,0.9996190071105957,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Difluocortolone.,49,Type_49,Yes
DB00477,Chlorpromazine,DB08865,Crizotinib,0.5098432302474976,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Chlorpromazine.,20,Type_20,No
DB00277,Theophylline,DB00316,Acetaminophen,0.6937677264213562,47,Type_47,The metabolism of Acetaminophen can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00175,Pravastatin,DB01275,Hydralazine,0.5988088846206665,73,Type_73,The serum concentration of Hydralazine can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01023,Felodipine,DB09070,Tibolone,0.9956231713294983,60,Type_60,Felodipine may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB01059,Norfloxacin,DB01370,Aluminium,0.7480149865150452,67,Type_67,Norfloxacin can cause a decrease in the absorption of Aluminium resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00413,Pramipexole,DB00899,Remifentanil,0.9998670816421509,32,Type_32,Pramipexole may increase the sedative activities of Remifentanil.,32,Type_32,Yes
DB01254,Dasatinib,DB11921,Deflazacort,0.6332129240036011,73,Type_73,The serum concentration of Deflazacort can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00708,Sufentanil,DB04855,Dronedarone,0.5647153258323669,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Sufentanil.,47,Type_47,Yes
DB00498,Phenindione,DB09256,Tegafur,0.4671919047832489,70,Type_70,The therapeutic efficacy of Tegafur can be decreased when used in combination with Phenindione.,73,Type_73,No
DB01016,Glyburide,DB01169,Arsenic trioxide,0.8606048226356506,70,Type_70,The therapeutic efficacy of Arsenic trioxide can be decreased when used in combination with Glyburide.,70,Type_70,Yes
DB01078,Deslanoside,DB01611,Hydroxychloroquine,0.5107674598693848,73,Type_73,The serum concentration of Hydroxychloroquine can be increased when it is combined with Deslanoside.,73,Type_73,Yes
DB00599,Thiopental,DB01224,Quetiapine,0.901918888092041,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Quetiapine.,49,Type_49,Yes
DB00741,Hydrocortisone,DB01252,Mitiglinide,0.9999954700469971,70,Type_70,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydrocortisone.,70,Type_70,Yes
DB00615,Rifabutin,DB01229,Paclitaxel,0.9018563628196716,4,Type_4,The metabolism of Paclitaxel can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00297,Bupivacaine,DB00313,Valproic acid,0.5805093050003052,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Valproic acid.,49,Type_49,Yes
DB00313,Valproic acid,DB00996,Gabapentin,0.9582576155662537,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin.,49,Type_49,Yes
DB00742,Mannitol,DB08907,Canagliflozin,0.9916238188743591,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Canagliflozin.,49,Type_49,Yes
DB00625,Efavirenz,DB09270,Ubidecarenone,0.4744206964969635,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Efavirenz.,73,Type_73,Yes
DB00273,Topiramate,DB06335,Saxagliptin,0.4544481337070465,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Topiramate.,75,Type_75,No
DB06636,Isavuconazonium,DB12332,Rucaparib,0.6719928979873657,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00554,Piroxicam,DB06154,Pentaerythritol tetranitrate,0.9997532963752747,6,Type_6,Piroxicam may increase the anticoagulant activities of Pentaerythritol tetranitrate.,6,Type_6,Yes
DB00489,Sotalol,DB00889,Granisetron,0.9532685875892639,20,Type_20,Sotalol may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00615,Rifabutin,DB00653,Magnesium sulfate,0.651938796043396,75,Type_75,The serum concentration of Magnesium sulfate can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00542,Benazepril,DB01021,Trichlormethiazide,0.9470629096031189,60,Type_60,Benazepril may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB00266,Dicoumarol,DB00440,Trimethoprim,0.48112842440605164,47,Type_47,The metabolism of Trimethoprim can be decreased when combined with Dicoumarol.,47,Type_47,Yes
DB00405,Dexbrompheniramine,DB01106,Levocabastine,0.9999985694885254,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levocabastine.,49,Type_49,Yes
DB01433,Methadyl acetate,DB06282,Levocetirizine,0.9956710338592529,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Levocetirizine.,49,Type_49,Yes
DB00246,Ziprasidone,DB01120,Gliclazide,0.8434247970581055,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Ziprasidone.,70,Type_70,No
DB00540,Nortriptyline,DB01124,Tolbutamide,0.4236929714679718,73,Type_73,The serum concentration of Tolbutamide can be increased when it is combined with Nortriptyline.,47,Type_47,No
DB00422,Methylphenidate,DB01075,Diphenhydramine,0.7414696216583252,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00445,Epirubicin,DB00695,Furosemide,0.6634358167648315,49,Type_49,The risk or severity of adverse effects can be increased when Epirubicin is combined with Furosemide.,49,Type_49,Yes
DB00468,Quinine,DB01016,Glyburide,0.5976559519767761,9,Type_9,Quinine may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00752,Tranylcypromine,DB09048,Netupitant,0.8817482590675354,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Tranylcypromine.,47,Type_47,No
DB00950,Fexofenadine,DB01178,Chlormezanone,0.9999939203262329,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Chlormezanone.,49,Type_49,Yes
DB01068,Clonazepam,DB01267,Paliperidone,0.9939655661582947,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Paliperidone.,49,Type_49,Yes
DB08916,Afatinib,DB12332,Rucaparib,0.5515303611755371,75,Type_75,The serum concentration of Rucaparib can be decreased when it is combined with Afatinib.,73,Type_73,No
DB00205,Pyrimethamine,DB00726,Trimipramine,0.8128304481506348,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00244,Mesalazine,DB00974,Edetic acid,0.9735533595085144,6,Type_6,Mesalazine may increase the anticoagulant activities of Edetic acid.,6,Type_6,Yes
DB00831,Trifluoperazine,DB08938,Magaldrate,0.8436557054519653,67,Type_67,Trifluoperazine can cause a decrease in the absorption of Magaldrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01199,Tubocurarine,DB01209,Dezocine,0.9962930083274841,49,Type_49,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dezocine.,49,Type_49,Yes
DB01177,Idarubicin,DB09039,Eliglustat,0.9361086487770081,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Idarubicin.,47,Type_47,Yes
DB01026,Ketoconazole,DB01259,Lapatinib,0.5093317627906799,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Ketoconazole.,73,Type_73,No
DB00489,Sotalol,DB00755,Tretinoin,0.9163531064987183,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Tretinoin.,49,Type_49,Yes
DB09080,Olodaterol,DB09241,Methylene blue,0.9514737129211426,49,Type_49,The risk or severity of adverse effects can be increased when Olodaterol is combined with Methylene blue.,49,Type_49,Yes
DB00748,Carbinoxamine,DB00976,Telithromycin,0.8890875577926636,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB00738,Pentamidine,DB01274,Arformoterol,0.9394143223762512,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Arformoterol.,20,Type_20,Yes
DB00231,Temazepam,DB00318,Codeine,0.9939863681793213,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Codeine.,49,Type_49,Yes
DB08992,Eperisone,DB11093,Calcium citrate,0.9542180299758911,70,Type_70,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Eperisone.,70,Type_70,Yes
DB00653,Magnesium sulfate,DB01208,Sparfloxacin,0.4934200644493103,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Sparfloxacin.,75,Type_75,No
DB00283,Clemastine,DB00845,Clofazimine,0.9436243176460266,47,Type_47,The metabolism of Clofazimine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00238,Nevirapine,DB01384,Paramethasone,0.9437211751937866,4,Type_4,The metabolism of Paramethasone can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00720,Clodronic acid,DB06736,Aceclofenac,0.9959508180618286,49,Type_49,The risk or severity of adverse effects can be increased when Clodronic acid is combined with Aceclofenac.,49,Type_49,Yes
DB00482,Celecoxib,DB08922,Perospirone,0.6057640910148621,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Perospirone.,47,Type_47,No
DB00373,Timolol,DB09227,Barnidipine,0.7348735928535461,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Barnidipine.,49,Type_49,Yes
DB00349,Clobazam,DB00366,Doxylamine,0.9999985694885254,16,Type_16,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00465,Ketorolac,DB01088,Iloprost,0.9893984794616699,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Ketorolac.,70,Type_70,Yes
DB00908,Quinidine,DB01253,Ergometrine,0.6640833616256714,49,Type_49,The risk or severity of adverse effects can be increased when Quinidine is combined with Ergometrine.,49,Type_49,Yes
DB00333,Methadone,DB01156,Bupropion,0.8484022617340088,47,Type_47,The metabolism of Bupropion can be decreased when combined with Methadone.,47,Type_47,Yes
DB00310,Chlorthalidone,DB08907,Canagliflozin,0.6884994506835938,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Canagliflozin.,49,Type_49,Yes
DB00212,Remikiren,DB00654,Latanoprost,0.9998903274536133,60,Type_60,Remikiren may increase the hypotensive activities of Latanoprost.,60,Type_60,Yes
DB00836,Loperamide,DB08820,Ivacaftor,0.9982454776763916,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Loperamide.,73,Type_73,Yes
DB00475,Chlordiazepoxide,DB09085,Tetracaine,0.999996542930603,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Tetracaine.,49,Type_49,Yes
DB00620,Triamcinolone,DB00912,Repaglinide,0.9779485464096069,70,Type_70,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Triamcinolone.,70,Type_70,Yes
DB06212,Tolvaptan,DB06636,Isavuconazonium,0.9466292262077332,73,Type_73,The serum concentration of Isavuconazonium can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB00333,Methadone,DB00641,Simvastatin,0.4414398968219757,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Methadone.,47,Type_47,No
DB01184,Domperidone,DB01319,Fosamprenavir,0.7469742894172668,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Domperidone.,73,Type_73,No
DB08932,Macitentan,DB09063,Ceritinib,0.9867123365402222,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Macitentan.,73,Type_73,Yes
DB00175,Pravastatin,DB09075,Edoxaban,0.9429600238800049,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00294,Etonogestrel,DB08883,Perampanel,0.8077930212020874,70,Type_70,The therapeutic efficacy of Perampanel can be decreased when used in combination with Etonogestrel.,75,Type_75,No
DB00277,Theophylline,DB00608,Chloroquine,0.9655792713165283,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Theophylline.,47,Type_47,Yes
DB01200,Bromocriptine,DB01621,Pipotiazine,0.5418106317520142,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Pipotiazine.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00582,Voriconazole,0.7825066447257996,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Pimecrolimus.,47,Type_47,Yes
DB00477,Chlorpromazine,DB00743,Gadobenic acid,0.9999959468841553,20,Type_20,Chlorpromazine may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB00648,Mitotane,DB11915,Valbenazine,0.9637784361839294,75,Type_75,The serum concentration of Valbenazine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01410,Ciclesonide,DB06290,Simeprevir,0.9630374312400818,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Ciclesonide.,73,Type_73,Yes
DB01377,Magnesium oxide,DB06589,Pazopanib,0.644616961479187,75,Type_75,The serum concentration of Pazopanib can be decreased when it is combined with Magnesium oxide.,75,Type_75,Yes
DB00694,Daunorubicin,DB06595,Midostaurin,0.755462646484375,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB00224,Indinavir,DB04855,Dronedarone,0.6328920722007751,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Indinavir.,73,Type_73,No
DB00203,Sildenafil,DB01263,Posaconazole,0.83889240026474,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Sildenafil.,73,Type_73,No
DB00201,Caffeine,DB00568,Cinnarizine,0.6372714042663574,47,Type_47,The metabolism of Cinnarizine can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB01023,Felodipine,0.48749497532844543,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Felodipine.,49,Type_49,Yes
DB00433,Prochlorperazine,DB09275,Bismuth subcitrate potassium,0.8401785492897034,67,Type_67,Prochlorperazine can cause a decrease in the absorption of Bismuth subcitrate potassium resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00476,Duloxetine,DB00753,Isoflurane,0.4642266035079956,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Isoflurane.,30,Type_30,Yes
DB01029,Irbesartan,DB01036,Tolterodine,0.9032121300697327,47,Type_47,The metabolism of Tolterodine can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00492,Fosinopril,DB08931,Riociguat,0.7045972347259521,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Riociguat.,73,Type_73,No
DB00343,Diltiazem,DB08941,Isoxsuprine,0.8480863571166992,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Isoxsuprine.,49,Type_49,Yes
DB00838,Clocortolone,DB01045,Rifampicin,0.9444664120674133,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Clocortolone.,75,Type_75,Yes
DB00475,Chlordiazepoxide,DB00715,Paroxetine,0.5642761588096619,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00601,Linezolid,DB01366,Procaterol,0.9828542470932007,71,Type_71,Linezolid may increase the hypertensive activities of Procaterol.,71,Type_71,Yes
DB00397,Phenylpropanolamine,DB00805,Minaprine,0.9930893778800964,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Minaprine.,49,Type_49,Yes
DB00687,Fludrocortisone,DB08984,Etofenamate,0.9998458623886108,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Etofenamate.,49,Type_49,Yes
DB00726,Trimipramine,DB00871,Terbutaline,0.9251183867454529,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Terbutaline.,49,Type_49,Yes
DB05294,Vandetanib,DB09078,Lenvatinib,0.6663246154785156,20,Type_20,Vandetanib may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00582,Voriconazole,DB02187,Equilin,0.9764087796211243,73,Type_73,The serum concentration of Equilin can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00481,Raloxifene,DB00615,Rifabutin,0.8227471113204956,4,Type_4,The metabolism of Rifabutin can be increased when combined with Raloxifene.,4,Type_4,Yes
DB00474,Methohexital,DB06713,Norelgestromin,0.6652361154556274,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Methohexital.,70,Type_70,Yes
DB00266,Dicoumarol,DB06700,Desvenlafaxine,0.746030330657959,49,Type_49,The risk or severity of adverse effects can be increased when Dicoumarol is combined with Desvenlafaxine.,49,Type_49,Yes
DB01609,Deferasirox,DB09555,Dexchlorpheniramine maleate,0.8254721164703369,75,Type_75,The serum concentration of Dexchlorpheniramine maleate can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00975,Dipyridamole,DB11362,Selexipag,0.9912039041519165,60,Type_60,Dipyridamole may increase the hypotensive activities of Selexipag.,6,Type_6,No
DB01239,Chlorprothixene,DB01544,Flunitrazepam,0.9923391342163086,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Flunitrazepam.,49,Type_49,Yes
DB00678,Losartan,DB00788,Naproxen,0.5385280847549438,47,Type_47,The metabolism of Naproxen can be decreased when combined with Losartan.,47,Type_47,Yes
DB00594,Amiloride,DB01247,Isocarboxazid,0.8182523846626282,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Isocarboxazid.,49,Type_49,Yes
DB00705,Delavirdine,DB01396,Digitoxin,0.6150842905044556,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Delavirdine.,47,Type_47,No
DB00670,Pirenzepine,DB09272,Eluxadoline,0.9992419481277466,39,Type_39,Pirenzepine may increase the constipating activities of Eluxadoline.,39,Type_39,Yes
DB00964,Apraclonidine,DB01193,Acebutolol,0.5547928810119629,49,Type_49,The risk or severity of adverse effects can be increased when Apraclonidine is combined with Acebutolol.,49,Type_49,Yes
DB01392,Yohimbine,DB01580,Oxprenolol,0.9851199984550476,37,Type_37,Yohimbine may decrease the antihypertensive activities of Oxprenolol.,70,Type_70,No
DB00307,Bexarotene,DB01196,Estramustine,0.34019920229911804,75,Type_75,The serum concentration of Estramustine can be decreased when it is combined with Bexarotene.,75,Type_75,Yes
DB00401,Nisoldipine,DB00727,Nitroglycerin,0.9993929862976074,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Nitroglycerin.,49,Type_49,Yes
DB01227,Levacetylmethadol,DB01626,Pargyline,0.9287384152412415,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Pargyline.,49,Type_49,Yes
DB00313,Valproic acid,DB01232,Saquinavir,0.6141512989997864,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Valproic acid.,75,Type_75,No
DB01214,Metipranolol,DB09227,Barnidipine,0.8439299464225769,49,Type_49,The risk or severity of adverse effects can be increased when Metipranolol is combined with Barnidipine.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB00701,Amprenavir,0.3974050283432007,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Cyclophosphamide.,49,Type_49,No
DB05521,Telaprevir,DB09063,Ceritinib,0.998437225818634,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Telaprevir.,73,Type_73,Yes
DB00199,Erythromycin,DB00248,Cabergoline,0.8785140514373779,47,Type_47,The metabolism of Cabergoline can be decreased when combined with Erythromycin.,73,Type_73,No
DB01086,Benzocaine,DB01589,Quazepam,0.9937373399734497,49,Type_49,The risk or severity of adverse effects can be increased when Benzocaine is combined with Quazepam.,49,Type_49,Yes
DB00541,Vincristine,DB00950,Fexofenadine,0.7191774845123291,73,Type_73,The serum concentration of Fexofenadine can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB01576,Dextroamphetamine,DB09244,Pirlindole,0.9942985773086548,71,Type_71,Dextroamphetamine may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB01137,Levofloxacin,DB04953,Ezogabine,0.9979733824729919,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Ezogabine.,20,Type_20,Yes
DB00967,Desloratadine,DB01591,Solifenacin,0.7823877930641174,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Solifenacin.,49,Type_49,Yes
DB01018,Guanfacine,DB08895,Tofacitinib,0.9906348586082458,54,Type_54,Guanfacine may increase the bradycardic activities of Tofacitinib.,54,Type_54,Yes
DB00629,Guanabenz,DB00880,Chlorothiazide,0.7697993516921997,60,Type_60,Guanabenz may increase the hypotensive activities of Chlorothiazide.,60,Type_60,Yes
DB00795,Sulfasalazine,DB01050,Ibuprofen,0.9773873686790466,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibuprofen.,49,Type_49,Yes
DB00521,Carteolol,DB00820,Tadalafil,0.9442395567893982,10,Type_10,Carteolol may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00476,Duloxetine,DB01501,Difenoxin,0.9924435019493103,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Difenoxin.,49,Type_49,Yes
DB00238,Nevirapine,DB00367,Levonorgestrel,0.4009552597999573,4,Type_4,The metabolism of Levonorgestrel can be increased when combined with Nevirapine.,75,Type_75,No
DB00446,Chloramphenicol,DB11614,Rupatadine,0.9899343848228455,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00363,Clozapine,DB01247,Isocarboxazid,0.7373266220092773,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Isocarboxazid.,49,Type_49,Yes
DB00514,Dextromethorphan,DB01247,Isocarboxazid,0.8521338105201721,49,Type_49,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Isocarboxazid.,64,Type_64,No
DB00559,Bosentan,DB01015,Sulfamethoxazole,0.7795636653900146,75,Type_75,The serum concentration of Sulfamethoxazole can be decreased when it is combined with Bosentan.,73,Type_73,No
DB00421,Spironolactone,DB01037,Selegiline,0.9463019371032715,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Selegiline.,49,Type_49,Yes
DB00494,Entacapone,DB01367,Rasagiline,0.965189516544342,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Rasagiline.,49,Type_49,Yes
DB00203,Sildenafil,DB04841,Flunarizine,0.7869442701339722,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00611,Butorphanol,DB00872,Conivaptan,0.9135308861732483,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Conivaptan.,49,Type_49,Yes
DB00188,Bortezomib,DB00943,Zalcitabine,0.8908177614212036,47,Type_47,The metabolism of Zalcitabine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00835,Brompheniramine,DB06603,Panobinostat,0.832671046257019,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Brompheniramine.,73,Type_73,Yes
DB00244,Mesalazine,DB00586,Diclofenac,0.9511968493461609,57,Type_57,Mesalazine may increase the nephrotoxic activities of Diclofenac.,49,Type_49,No
DB00195,Betaxolol,DB04868,Nilotinib,0.926534116268158,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00175,Pravastatin,DB01390,Sodium bicarbonate,0.8216471076011658,75,Type_75,The serum concentration of Sodium bicarbonate can be decreased when it is combined with Pravastatin.,75,Type_75,Yes
DB00555,Lamotrigine,DB00645,Dyclonine,0.9999074935913086,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Dyclonine.,49,Type_49,Yes
DB00882,Clomifene,DB09274,Artesunate,0.5603031516075134,73,Type_73,The serum concentration of Artesunate can be increased when it is combined with Clomifene.,11,Type_11,No
DB00470,Dronabinol,DB01220,Rifaximin,0.9521268606185913,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00564,Carbamazepine,DB01009,Ketoprofen,0.9793936014175415,4,Type_4,The metabolism of Ketoprofen can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00248,Cabergoline,DB06016,Cariprazine,0.8987395763397217,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Cariprazine.,49,Type_49,Yes
DB09112,Nitrous acid,DB09292,Sacubitril,0.999990701675415,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous acid is combined with Sacubitril.,49,Type_49,Yes
DB00252,Phenytoin,DB08881,Vemurafenib,0.9301171898841858,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB01264,Darunavir,DB01274,Arformoterol,0.8079422116279602,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Darunavir.,73,Type_73,No
DB00136,Calcitriol,DB00208,Ticlopidine,0.9720007181167603,47,Type_47,The metabolism of Ticlopidine can be decreased when combined with Calcitriol.,47,Type_47,Yes
DB00237,Butabarbital,DB08987,Etidocaine,0.9999932050704956,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Etidocaine.,49,Type_49,Yes
DB04855,Dronedarone,DB11575,Grazoprevir,0.9372396469116211,47,Type_47,The metabolism of Grazoprevir can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00612,Bisoprolol,DB06725,Lornoxicam,0.9863866567611694,37,Type_37,Bisoprolol may decrease the antihypertensive activities of Lornoxicam.,37,Type_37,Yes
DB00492,Fosinopril,DB01119,Diazoxide,0.9943008422851562,60,Type_60,Fosinopril may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00268,Ropinirole,DB11915,Valbenazine,0.9419649839401245,47,Type_47,The metabolism of Valbenazine can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00709,Lamivudine,DB00811,Ribavirin,0.4394475817680359,73,Type_73,The serum concentration of Ribavirin can be increased when it is combined with Lamivudine.,80,Type_80,No
DB00732,Atracurium besylate,DB01173,Orphenadrine,0.6985465288162231,49,Type_49,The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Orphenadrine.,49,Type_49,Yes
DB04839,Cyproterone acetate,DB06210,Eltrombopag,0.5035704970359802,75,Type_75,The serum concentration of Eltrombopag can be decreased when it is combined with Cyproterone acetate.,75,Type_75,Yes
DB00327,Hydromorphone,DB01595,Nitrazepam,0.9912641048431396,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nitrazepam.,49,Type_49,Yes
DB01009,Ketoprofen,DB01250,Olsalazine,0.6184589266777039,57,Type_57,Ketoprofen may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB00208,Ticlopidine,DB00539,Toremifene,0.5701000690460205,47,Type_47,The metabolism of Toremifene can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00875,Flupentixol,DB01161,Chloroprocaine,0.9998925924301147,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Chloroprocaine.,49,Type_49,Yes
DB00652,Pentazocine,DB01036,Tolterodine,0.9841126799583435,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Tolterodine.,49,Type_49,Yes
DB00343,Diltiazem,DB01196,Estramustine,0.834394633769989,47,Type_47,The metabolism of Estramustine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00700,Eplerenone,DB01081,Diphenoxylate,0.9879158735275269,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Diphenoxylate.,49,Type_49,Yes
DB00467,Enoxacin,DB00749,Etodolac,0.9995219707489014,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Etodolac.,27,Type_27,Yes
DB00491,Miglitol,DB06825,Triptorelin,0.9999493360519409,70,Type_70,The therapeutic efficacy of Triptorelin can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00866,Alprenolol,DB01021,Trichlormethiazide,0.9703431725502014,60,Type_60,Alprenolol may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB01685,Topiroxostat,DB03756,Doconexent,0.9970065951347351,47,Type_47,The metabolism of Doconexent can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00568,Cinnarizine,DB01241,Gemfibrozil,0.8770071864128113,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Cinnarizine.,47,Type_47,Yes
DB00712,Flurbiprofen,DB00999,Hydrochlorothiazide,0.9964460730552673,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB01007,Tioconazole,DB06414,Etravirine,0.5685464143753052,47,Type_47,The metabolism of Etravirine can be decreased when combined with Tioconazole.,73,Type_73,No
DB01069,Promethazine,DB01416,Cefpodoxime,0.6169920563697815,75,Type_75,The serum concentration of Cefpodoxime can be decreased when it is combined with Promethazine.,67,Type_67,No
DB00774,Hydroflumethiazide,DB01162,Terazosin,0.9768062829971313,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Terazosin.,49,Type_49,Yes
DB00264,Metoprolol,DB00420,Promazine,0.5085405707359314,47,Type_47,The metabolism of Promazine can be decreased when combined with Metoprolol.,73,Type_73,No
DB01101,Capecitabine,DB01424,Aminophenazone,0.9576249718666077,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Capecitabine.,47,Type_47,Yes
DB00790,Perindopril,DB04876,Vildagliptin,0.8125128149986267,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Vildagliptin.,49,Type_49,Yes
DB00794,Primidone,DB01215,Estazolam,0.8163991570472717,4,Type_4,The metabolism of Estazolam can be increased when combined with Primidone.,4,Type_4,Yes
DB00136,Calcitriol,DB04855,Dronedarone,0.9317794442176819,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Calcitriol.,47,Type_47,Yes
DB00512,Vancomycin,DB01283,Lumiracoxib,0.863884449005127,73,Type_73,The serum concentration of Lumiracoxib can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00961,Mepivacaine,DB01018,Guanfacine,0.9824337959289551,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Guanfacine.,49,Type_49,Yes
DB00252,Phenytoin,DB00400,Griseofulvin,0.40946075320243835,73,Type_73,The serum concentration of Griseofulvin can be increased when it is combined with Phenytoin.,73,Type_73,Yes
DB00375,Colestipol,DB00605,Sulindac,0.9986414313316345,67,Type_67,Colestipol can cause a decrease in the absorption of Sulindac resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00844,Nalbuphine,DB01324,Polythiazide,0.9985419511795044,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Polythiazide.,49,Type_49,Yes
DB01580,Oxprenolol,DB06694,Xylometazoline,0.954595685005188,60,Type_60,Oxprenolol may increase the hypotensive activities of Xylometazoline.,25,Type_25,No
DB00976,Telithromycin,DB05351,Dexlansoprazole,0.965452253818512,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00207,Azithromycin,DB01233,Metoclopramide,0.9589700698852539,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00203,Sildenafil,DB05812,Abiraterone,0.5400329828262329,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB00252,Phenytoin,DB00918,Almotriptan,0.9316501617431641,4,Type_4,The metabolism of Almotriptan can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00449,Dipivefrin,DB00457,Prazosin,0.8419030904769897,5,Type_5,Dipivefrin may decrease the vasoconstricting activities of Prazosin.,5,Type_5,Yes
DB00705,Delavirdine,DB06287,Temsirolimus,0.7471476793289185,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00408,Loxapine,DB01154,Thiamylal,0.9764883518218994,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Thiamylal.,49,Type_49,Yes
DB08881,Vemurafenib,DB11614,Rupatadine,0.5621573328971863,73,Type_73,The serum concentration of Rupatadine can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB00768,Olopatadine,DB04908,Flibanserin,0.9529643654823303,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Flibanserin.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00184,Nicotine,0.8730133175849915,47,Type_47,The metabolism of Nicotine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00604,Cisapride,DB00691,Moexipril,0.8844537734985352,20,Type_20,Cisapride may increase the QTc-prolonging activities of Moexipril.,20,Type_20,Yes
DB00880,Chlorothiazide,DB09286,Pipamperone,0.9936144351959229,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Pipamperone.,49,Type_49,Yes
DB00816,Orciprenaline,DB00871,Terbutaline,0.9999324083328247,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Terbutaline.,49,Type_49,Yes
DB08827,Lomitapide,DB09270,Ubidecarenone,0.6023469567298889,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Lomitapide.,73,Type_73,Yes
DB00275,Olmesartan,DB00350,Minoxidil,0.8378111124038696,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Minoxidil.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB06288,Amisulpride,0.9979459643363953,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Amisulpride.,49,Type_49,Yes
DB00344,Protriptyline,DB09345,Pramocaine,0.999394416809082,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Pramocaine.,49,Type_49,Yes
DB00836,Loperamide,DB09049,Naloxegol,0.9994182586669922,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Loperamide.,73,Type_73,Yes
DB00254,Doxycycline,DB08903,Bedaquiline,0.6444207429885864,47,Type_47,The metabolism of Bedaquiline can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00818,Propofol,DB01437,Glutethimide,0.9993515610694885,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Glutethimide.,49,Type_49,Yes
DB00349,Clobazam,DB06203,Alogliptin,0.586707592010498,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00904,Ondansetron,DB01224,Quetiapine,0.4707193076610565,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Quetiapine.,49,Type_49,No
DB00774,Hydroflumethiazide,DB01409,Tiotropium,0.9922515749931335,73,Type_73,The serum concentration of Tiotropium can be increased when it is combined with Hydroflumethiazide.,73,Type_73,Yes
DB00219,Oxyphenonium,DB00333,Methadone,0.9996204376220703,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methadone.,49,Type_49,Yes
DB00911,Tinidazole,DB01026,Ketoconazole,0.9623562097549438,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Tinidazole.,47,Type_47,Yes
DB00831,Trifluoperazine,DB06724,Calcium carbonate,0.9421226382255554,67,Type_67,Trifluoperazine can cause a decrease in the absorption of Calcium carbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00962,Zaleplon,DB09072,Sodium oxybate,1.0,16,Type_16,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00623,Fluphenazine,DB00998,Frovatriptan,0.9569529294967651,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Frovatriptan.,49,Type_49,Yes
DB00381,Amlodipine,DB09232,Cilnidipine,0.9671711325645447,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Cilnidipine.,49,Type_49,Yes
DB09543,Methyl salicylate,DB11079,Trolamine salicylate,0.9910079836845398,49,Type_49,The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Trolamine salicylate.,6,Type_6,No
DB01026,Ketoconazole,DB06228,Rivaroxaban,0.6466289162635803,73,Type_73,The serum concentration of Rivaroxaban can be increased when it is combined with Ketoconazole.,47,Type_47,No
DB01045,Rifampicin,DB09083,Ivabradine,0.9456331729888916,75,Type_75,The serum concentration of Ivabradine can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB01141,Micafungin,DB01248,Docetaxel,0.7211302518844604,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Micafungin.,47,Type_47,Yes
DB00905,Bimatoprost,DB01359,Penbutolol,0.999985933303833,60,Type_60,Bimatoprost may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB02187,Equilin,DB08873,Boceprevir,0.7464163303375244,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Equilin.,73,Type_73,Yes
DB00682,Warfarin,DB00763,Methimazole,0.3394901752471924,12,Type_12,Warfarin may decrease the anticoagulant activities of Methimazole.,12,Type_12,Yes
DB00503,Ritonavir,DB00738,Pentamidine,0.6409181356430054,20,Type_20,Ritonavir may increase the QTc-prolonging activities of Pentamidine.,47,Type_47,No
DB00246,Ziprasidone,DB09198,Lobeglitazone,0.997161865234375,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01166,Cilostazol,DB08860,Pitavastatin,0.751065194606781,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB06210,Eltrombopag,DB12026,Voxilaprevir,0.4978052079677582,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Eltrombopag.,73,Type_73,No
DB00443,Betamethasone,DB00887,Bumetanide,0.9999614953994751,83,Type_83,Betamethasone may increase the hypokalemic activities of Bumetanide.,83,Type_83,Yes
DB01260,Desonide,DB01400,Neostigmine,0.997787594795227,49,Type_49,The risk or severity of adverse effects can be increased when Desonide is combined with Neostigmine.,49,Type_49,Yes
DB00178,Ramipril,DB11362,Selexipag,0.9977856874465942,60,Type_60,Ramipril may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00839,Tolazamide,DB06789,Hydroxyprogesterone caproate,0.9137759208679199,70,Type_70,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Tolazamide.,70,Type_70,Yes
DB00370,Mirtazapine,DB01348,Spirapril,0.9176734685897827,73,Type_73,The serum concentration of Spirapril can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB00738,Pentamidine,DB01023,Felodipine,0.6230325698852539,47,Type_47,The metabolism of Felodipine can be decreased when combined with Pentamidine.,49,Type_49,No
DB00333,Methadone,DB04844,Tetrabenazine,0.4843218922615051,20,Type_20,Methadone may increase the QTc-prolonging activities of Tetrabenazine.,47,Type_47,No
DB00196,Fluconazole,DB00784,Mefenamic acid,0.9583816528320312,47,Type_47,The metabolism of Mefenamic acid can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00216,Eletriptan,DB00850,Perphenazine,0.9527681469917297,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Perphenazine.,49,Type_49,Yes
DB00846,Flurandrenolide,DB08899,Enzalutamide,0.9829146265983582,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Flurandrenolide.,75,Type_75,Yes
DB01045,Rifampicin,DB06290,Simeprevir,0.6811997890472412,75,Type_75,The serum concentration of Simeprevir can be decreased when it is combined with Rifampicin.,73,Type_73,No
DB00477,Chlorpromazine,DB01162,Terazosin,0.737389862537384,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Terazosin.,49,Type_49,Yes
DB00535,Cefdinir,DB01592,Iron,0.9745364189147949,75,Type_75,The serum concentration of Iron can be decreased when it is combined with Cefdinir.,75,Type_75,Yes
DB00285,Venlafaxine,DB06711,Naphazoline,0.9256213307380676,85,Type_85,Venlafaxine may increase the tachycardic activities of Naphazoline.,85,Type_85,Yes
DB00932,Tipranavir,DB01167,Itraconazole,0.7549023628234863,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Tipranavir.,73,Type_73,No
DB00679,Thioridazine,DB00881,Quinapril,0.6326091885566711,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Quinapril.,49,Type_49,Yes
DB00474,Methohexital,DB00975,Dipyridamole,0.9067128300666809,60,Type_60,Methohexital may increase the hypotensive activities of Dipyridamole.,60,Type_60,Yes
DB00524,Metolazone,DB04876,Vildagliptin,0.9916002750396729,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00646,Nystatin,DB00908,Quinidine,0.5340622663497925,73,Type_73,The serum concentration of Quinidine can be increased when it is combined with Nystatin.,73,Type_73,Yes
DB00333,Methadone,DB00880,Chlorothiazide,0.7905101776123047,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Chlorothiazide.,49,Type_49,Yes
DB00744,Zileuton,DB00963,Bromfenac,0.9963215589523315,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Bromfenac.,49,Type_49,Yes
DB00136,Calcitriol,DB06786,Halcinonide,0.9640706181526184,70,Type_70,The therapeutic efficacy of Halcinonide can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB01167,Itraconazole,DB04908,Flibanserin,0.8029834032058716,73,Type_73,The serum concentration of Flibanserin can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB01588,Prazepam,DB02703,Fusidic acid,0.9994947910308838,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Prazepam.,73,Type_73,Yes
DB01095,Fluvastatin,DB05541,Brivaracetam,0.4435805082321167,73,Type_73,The serum concentration of Brivaracetam can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00391,Sulpiride,DB01563,Chloral hydrate,0.999792754650116,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Chloral hydrate.,49,Type_49,Yes
DB00422,Methylphenidate,DB09236,Lacidipine,0.9999500513076782,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Lacidipine.,37,Type_37,Yes
DB01174,Phenobarbital,DB09030,Vorapaxar,0.8966697454452515,75,Type_75,The serum concentration of Vorapaxar can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00625,Efavirenz,DB00747,Scopolamine,0.9991338849067688,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Scopolamine.,49,Type_49,Yes
DB00946,Phenprocoumon,DB06802,Nepafenac,0.9999408721923828,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Nepafenac.,6,Type_6,Yes
DB00975,Dipyridamole,DB01115,Nifedipine,0.994841992855072,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Nifedipine.,49,Type_49,Yes
DB00807,Proparacaine,DB01595,Nitrazepam,0.9987096786499023,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Nitrazepam.,49,Type_49,Yes
DB00218,Moxifloxacin,DB00862,Vardenafil,0.9984756112098694,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Vardenafil.,20,Type_20,Yes
DB00358,Mefloquine,DB06709,Methacholine,0.9874562621116638,49,Type_49,The risk or severity of adverse effects can be increased when Mefloquine is combined with Methacholine.,49,Type_49,Yes
DB01136,Carvedilol,DB01224,Quetiapine,0.4645697772502899,49,Type_49,The risk or severity of adverse effects can be increased when Carvedilol is combined with Quetiapine.,49,Type_49,Yes
DB01210,Levobunolol,DB09083,Ivabradine,0.9151971936225891,54,Type_54,Levobunolol may increase the bradycardic activities of Ivabradine.,54,Type_54,Yes
DB00450,Droperidol,DB06663,Pasireotide,0.9337520599365234,20,Type_20,Droperidol may increase the QTc-prolonging activities of Pasireotide.,20,Type_20,Yes
DB01106,Levocabastine,DB01452,Diamorphine,0.9994243383407593,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Diamorphine.,49,Type_49,Yes
DB00656,Trazodone,DB00933,Mesoridazine,0.9681494235992432,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Mesoridazine.,49,Type_49,Yes
DB04743,Nimesulide,DB09292,Sacubitril,0.9853644967079163,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Sacubitril.,49,Type_49,Yes
DB00498,Phenindione,DB08976,Floctafenine,0.9998249411582947,6,Type_6,Phenindione may increase the anticoagulant activities of Floctafenine.,6,Type_6,Yes
DB00747,Scopolamine,DB08922,Perospirone,0.9975528120994568,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Perospirone.,49,Type_49,Yes
DB01159,Halothane,DB06594,Agomelatine,0.9998887777328491,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Agomelatine.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB00589,Lisuride,0.6416279673576355,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Lisuride.,49,Type_49,Yes
DB00199,Erythromycin,DB01196,Estramustine,0.7775264978408813,47,Type_47,The metabolism of Estramustine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01580,Oxprenolol,DB06196,Icatibant,0.9231081008911133,37,Type_37,Oxprenolol may decrease the antihypertensive activities of Icatibant.,37,Type_37,Yes
DB08991,Epirizole,DB13167,Alclofenac,0.9970312118530273,49,Type_49,The risk or severity of adverse effects can be increased when Epirizole is combined with Alclofenac.,49,Type_49,Yes
DB00656,Trazodone,DB12532,Oxetacaine,0.999966025352478,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Oxetacaine.,49,Type_49,Yes
DB00264,Metoprolol,DB00672,Chlorpropamide,0.7250970602035522,9,Type_9,Metoprolol may increase the hypoglycemic activities of Chlorpropamide.,9,Type_9,Yes
DB00686,Pentosan polysulfate,DB04951,Pirfenidone,0.8824055790901184,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Pirfenidone.,6,Type_6,Yes
DB00264,Metoprolol,DB01264,Darunavir,0.6776526570320129,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00541,Vincristine,DB08882,Linagliptin,0.8142620921134949,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Vincristine.,75,Type_75,No
DB00932,Tipranavir,DB06212,Tolvaptan,0.9561920762062073,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB00404,Alprazolam,DB00834,Mifepristone,0.8987761735916138,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Alprazolam.,73,Type_73,Yes
DB00295,Morphine,DB00883,Isosorbide dinitrate,0.9755256175994873,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00553,Methoxsalen,DB01319,Fosamprenavir,0.8989807963371277,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB00238,Nevirapine,DB01211,Clarithromycin,0.31637850403785706,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Nevirapine.,77,Type_77,No
DB00672,Chlorpropamide,DB00794,Primidone,0.9455912709236145,4,Type_4,The metabolism of Primidone can be increased when combined with Chlorpropamide.,4,Type_4,Yes
DB01097,Leflunomide,DB01168,Procarbazine,0.5120347738265991,47,Type_47,The metabolism of Procarbazine can be decreased when combined with Leflunomide.,49,Type_49,No
DB00288,Amcinonide,DB00976,Telithromycin,0.889784038066864,73,Type_73,The serum concentration of Telithromycin can be increased when it is combined with Amcinonide.,73,Type_73,Yes
DB00678,Losartan,DB00903,Etacrynic acid,0.5192009806632996,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Etacrynic acid.,49,Type_49,Yes
DB00674,Galantamine,DB08918,Levomilnacipran,0.6181456446647644,49,Type_49,The risk or severity of adverse effects can be increased when Galantamine is combined with Levomilnacipran.,47,Type_47,No
DB00408,Loxapine,DB01544,Flunitrazepam,0.9950003027915955,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Flunitrazepam.,49,Type_49,Yes
DB00423,Methocarbamol,DB01002,Levobupivacaine,0.997948944568634,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Levobupivacaine.,49,Type_49,Yes
DB01072,Atazanavir,DB08938,Magaldrate,0.7055099010467529,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Atazanavir.,67,Type_67,No
DB00873,Loteprednol,DB00880,Chlorothiazide,0.9999902248382568,83,Type_83,Loteprednol may increase the hypokalemic activities of Chlorothiazide.,83,Type_83,Yes
DB00836,Loperamide,DB02703,Fusidic acid,0.9995803236961365,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Loperamide.,73,Type_73,Yes
DB00622,Nicardipine,DB06212,Tolvaptan,0.8942630887031555,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB01002,Levobupivacaine,DB06700,Desvenlafaxine,0.9333394765853882,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Desvenlafaxine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00471,Montelukast,0.9878938794136047,47,Type_47,The metabolism of Montelukast can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00903,Etacrynic acid,DB01135,Doxacurium,0.999652624130249,17,Type_17,Etacrynic acid may decrease the neuromuscular blocking activities of Doxacurium.,17,Type_17,Yes
DB00196,Fluconazole,DB01267,Paliperidone,0.8583831787109375,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00313,Valproic acid,DB01624,Zuclopenthixol,0.6839228868484497,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Zuclopenthixol.,49,Type_49,Yes
DB00748,Carbinoxamine,DB01015,Sulfamethoxazole,0.9682458639144897,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB00700,Eplerenone,DB01088,Iloprost,0.8929963111877441,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Iloprost.,49,Type_49,Yes
DB00726,Trimipramine,DB05521,Telaprevir,0.5760031342506409,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Trimipramine.,47,Type_47,Yes
DB00896,Rimexolone,DB01201,Rifapentine,0.9823954701423645,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Rimexolone.,75,Type_75,Yes
DB01016,Glyburide,DB01097,Leflunomide,0.8907831907272339,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Glyburide.,47,Type_47,Yes
DB00748,Carbinoxamine,DB09063,Ceritinib,0.9809664487838745,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Carbinoxamine.,73,Type_73,Yes
DB00820,Tadalafil,DB01359,Penbutolol,0.9572538733482361,10,Type_10,Tadalafil may increase the antihypertensive activities of Penbutolol.,10,Type_10,Yes
DB01174,Phenobarbital,DB09279,Fimasartan,0.788435697555542,60,Type_60,Phenobarbital may increase the hypotensive activities of Fimasartan.,60,Type_60,Yes
DB00298,Dapiprazole,DB01209,Dezocine,0.9985528588294983,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Dezocine.,49,Type_49,Yes
DB00975,Dipyridamole,DB04272,Citric acid,0.8675083518028259,6,Type_6,Dipyridamole may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00700,Eplerenone,DB06767,Ammonium chloride,0.7612103819847107,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Ammonium chloride.,49,Type_49,Yes
DB00503,Ritonavir,DB01403,Methotrimeprazine,0.3978908956050873,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Ritonavir.,47,Type_47,No
DB01012,Cinacalcet,DB01392,Yohimbine,0.9926756024360657,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00323,Tolcapone,DB00391,Sulpiride,0.9973418116569519,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Sulpiride.,49,Type_49,Yes
DB00608,Chloroquine,DB03128,Acetylcholine,0.9677465558052063,47,Type_47,The metabolism of Acetylcholine can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00795,Sulfasalazine,DB04574,Estrone sulfate,0.8140103816986084,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Estrone sulfate.,49,Type_49,Yes
DB00443,Betamethasone,DB09104,Magnesium hydroxide,0.9992832541465759,3,Type_3,The bioavailability of Magnesium hydroxide can be decreased when combined with Betamethasone.,3,Type_3,Yes
DB00570,Vinblastine,DB00582,Voriconazole,0.8940005302429199,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Vinblastine.,49,Type_49,No
DB00757,Dolasetron,DB00818,Propofol,0.9287208318710327,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Propofol.,20,Type_20,Yes
DB00203,Sildenafil,DB00794,Primidone,0.890379011631012,4,Type_4,The metabolism of Primidone can be increased when combined with Sildenafil.,4,Type_4,Yes
DB01203,Nadolol,DB08808,Bupranolol,0.5327011346817017,60,Type_60,Nadolol may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00539,Toremifene,DB08868,Fingolimod,0.6802389621734619,34,Type_34,Toremifene may increase the immunosuppressive activities of Fingolimod.,20,Type_20,No
DB00324,Fluorometholone,DB09281,Magnesium trisilicate,0.997643768787384,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Fluorometholone.,3,Type_3,Yes
DB00344,Protriptyline,DB01026,Ketoconazole,0.5933420658111572,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Protriptyline.,47,Type_47,Yes
DB00524,Metolazone,DB01251,Gliquidone,0.9974761605262756,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00582,Voriconazole,DB01229,Paclitaxel,0.7806525826454163,47,Type_47,The metabolism of Paclitaxel can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00752,Tranylcypromine,DB00918,Almotriptan,0.6688510179519653,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Almotriptan.,49,Type_49,Yes
DB00349,Clobazam,DB08922,Perospirone,0.5441049337387085,47,Type_47,The metabolism of Perospirone can be decreased when combined with Clobazam.,49,Type_49,No
DB00263,Sulfisoxazole,DB06712,Nilvadipine,0.9063820838928223,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01196,Estramustine,DB13231,Calcium lactate,0.4220813810825348,72,Type_72,Estramustine may decrease the excretion rate of Calcium lactate which could result in a higher serum level.,67,Type_67,No
DB00696,Ergotamine,DB01259,Lapatinib,0.523171603679657,73,Type_73,The serum concentration of Lapatinib can be increased when it is combined with Ergotamine.,49,Type_49,No
DB00189,Ethchlorvynol,DB01028,Methoxyflurane,0.9998559951782227,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Methoxyflurane.,49,Type_49,Yes
DB00968,Methyldopa,DB00989,Rivastigmine,0.955454409122467,54,Type_54,Methyldopa may increase the bradycardic activities of Rivastigmine.,54,Type_54,Yes
DB01017,Minocycline,DB01226,Mivacurium,0.9997835755348206,21,Type_21,Minocycline may increase the neuromuscular blocking activities of Mivacurium.,21,Type_21,Yes
DB00519,Trandolapril,DB04876,Vildagliptin,0.7936127781867981,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Vildagliptin.,49,Type_49,Yes
DB00564,Carbamazepine,DB09280,Lumacaftor,0.49752476811408997,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Carbamazepine.,73,Type_73,No
DB00214,Torasemide,DB01226,Mivacurium,0.999954342842102,17,Type_17,Torasemide may decrease the neuromuscular blocking activities of Mivacurium.,17,Type_17,Yes
DB00248,Cabergoline,DB01045,Rifampicin,0.7816757559776306,4,Type_4,The metabolism of Rifampicin can be increased when combined with Cabergoline.,4,Type_4,Yes
DB00252,Phenytoin,DB00304,Desogestrel,0.8108636736869812,70,Type_70,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Phenytoin.,70,Type_70,Yes
DB00313,Valproic acid,DB00753,Isoflurane,0.5798224806785583,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Isoflurane.,49,Type_49,Yes
DB00683,Midazolam,DB00715,Paroxetine,0.5563346147537231,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Midazolam.,47,Type_47,Yes
DB00214,Torasemide,DB00586,Diclofenac,0.9996273517608643,29,Type_29,Torasemide may decrease the diuretic activities of Diclofenac.,29,Type_29,Yes
DB00208,Ticlopidine,DB00904,Ondansetron,0.9766677618026733,47,Type_47,The metabolism of Ondansetron can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB08976,Floctafenine,0.9939008951187134,70,Type_70,The therapeutic efficacy of Floctafenine can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB00679,Thioridazine,DB01115,Nifedipine,0.5565966367721558,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Nifedipine.,73,Type_73,No
DB00540,Nortriptyline,DB06144,Sertindole,0.9737778306007385,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sertindole.,49,Type_49,Yes
DB00420,Promazine,DB09117,Paraldehyde,0.9947015643119812,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00402,Eszopiclone,DB01356,Lithium cation,0.9537337422370911,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lithium cation.,49,Type_49,Yes
DB00523,Alitretinoin,DB00563,Methotrexate,0.7578203678131104,73,Type_73,The serum concentration of Methotrexate can be increased when it is combined with Alitretinoin.,80,Type_80,No
DB06441,Cangrelor,DB11362,Selexipag,0.9562152624130249,6,Type_6,Cangrelor may increase the anticoagulant activities of Selexipag.,6,Type_6,Yes
DB01197,Captopril,DB01403,Methotrimeprazine,0.8642096519470215,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Captopril.,47,Type_47,No
DB00752,Tranylcypromine,DB00857,Terbinafine,0.7440860867500305,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Tranylcypromine.,47,Type_47,Yes
DB00946,Phenprocoumon,DB01104,Sertraline,0.9001883864402771,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Sertraline.,6,Type_6,Yes
DB00420,Promazine,DB04946,Iloperidone,0.7652618885040283,20,Type_20,Promazine may increase the QTc-prolonging activities of Iloperidone.,47,Type_47,No
DB01095,Fluvastatin,DB06204,Tapentadol,0.6287096738815308,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00691,Moexipril,DB00876,Eprosartan,0.6335375308990479,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Eprosartan.,49,Type_49,Yes
DB00418,Secobarbital,DB00530,Erlotinib,0.4881499409675598,4,Type_4,The metabolism of Erlotinib can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00475,Chlordiazepoxide,DB01544,Flunitrazepam,0.9926503300666809,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Flunitrazepam.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00678,Losartan,0.9434033632278442,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Losartan.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00959,Methylprednisolone,0.7420681118965149,47,Type_47,The metabolism of Methylprednisolone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00627,Niacin,DB00898,Ethanol,0.48737767338752747,75,Type_75,The serum concentration of Ethanol can be decreased when it is combined with Niacin.,49,Type_49,No
DB00810,Biperiden,DB08893,Mirabegron,0.8470478653907776,49,Type_49,The risk or severity of adverse effects can be increased when Biperiden is combined with Mirabegron.,49,Type_49,Yes
DB00684,Tobramycin,DB01397,Magnesium salicylate,0.9991918206214905,72,Type_72,Tobramycin may decrease the excretion rate of Magnesium salicylate which could result in a higher serum level.,72,Type_72,Yes
DB00337,Pimecrolimus,DB00461,Nabumetone,0.9964888095855713,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nabumetone.,49,Type_49,Yes
DB00622,Nicardipine,DB06480,Prucalopride,0.9268646240234375,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB08906,Fluticasone furoate,DB09212,Loxoprofen,0.9995155334472656,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Loxoprofen.,49,Type_49,Yes
DB01029,Irbesartan,DB06595,Midostaurin,0.9403467774391174,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB01229,Paclitaxel,DB04865,Omacetaxine mepesuccinate,0.9821627736091614,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00246,Ziprasidone,DB00863,Ranitidine,0.9644565582275391,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00394,Beclomethasone dipropionate,DB01390,Sodium bicarbonate,0.9952325224876404,3,Type_3,The bioavailability of Sodium bicarbonate can be decreased when combined with Beclomethasone dipropionate.,3,Type_3,Yes
DB00661,Verapamil,DB06742,Ambroxol,0.957443118095398,47,Type_47,The metabolism of Ambroxol can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00641,Simvastatin,DB06695,Dabigatran etexilate,0.9002928137779236,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Simvastatin.,77,Type_77,Yes
DB00208,Ticlopidine,DB06695,Dabigatran etexilate,0.5061430335044861,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Ticlopidine.,6,Type_6,No
DB00768,Olopatadine,DB13167,Alclofenac,0.9986953139305115,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Alclofenac.,49,Type_49,Yes
DB00967,Desloratadine,DB01409,Tiotropium,0.9990713596343994,2,Type_2,Desloratadine may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB00241,Butalbital,DB00268,Ropinirole,0.9896285533905029,32,Type_32,Butalbital may increase the sedative activities of Ropinirole.,32,Type_32,Yes
DB00366,Doxylamine,DB13323,Trichloroethylene,0.9999990463256836,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.,16,Type_16,Yes
DB00899,Remifentanil,DB04844,Tetrabenazine,0.9955251812934875,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Tetrabenazine.,49,Type_49,Yes
DB00866,Alprenolol,DB09080,Olodaterol,0.9966697096824646,14,Type_14,Alprenolol may decrease the bronchodilatory activities of Olodaterol.,14,Type_14,Yes
DB06216,Asenapine,DB09167,Dosulepin,0.6171939969062805,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Asenapine.,47,Type_47,Yes
DB00688,Mycophenolate mofetil,DB01047,Fluocinonide,0.9997901320457458,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Fluocinonide.,49,Type_49,Yes
DB00953,Rizatriptan,DB09330,Osimertinib,0.9195727109909058,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Rizatriptan.,75,Type_75,No
DB00220,Nelfinavir,DB00243,Ranolazine,0.6669538617134094,73,Type_73,The serum concentration of Ranolazine can be increased when it is combined with Nelfinavir.,73,Type_73,Yes
DB00907,Cocaine,DB09065,Cobicistat,0.5493003726005554,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00296,Ropivacaine,DB09068,Vortioxetine,0.9638685584068298,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Vortioxetine.,49,Type_49,Yes
DB00764,Mometasone,DB06736,Aceclofenac,0.9996612071990967,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Aceclofenac.,49,Type_49,Yes
DB00502,Haloperidol,DB05039,Indacaterol,0.9007144570350647,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00368,Norepinephrine,DB00723,Methoxamine,0.9669614434242249,49,Type_49,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Methoxamine.,49,Type_49,Yes
DB00968,Methyldopa,DB08808,Bupranolol,0.39494529366493225,25,Type_25,Methyldopa may increase the atrioventricular blocking (AV block) activities of Bupranolol.,60,Type_60,No
DB00343,Diltiazem,DB00745,Modafinil,0.9500391483306885,47,Type_47,The metabolism of Modafinil can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00572,Atropine,DB11609,Normethadone,0.8152950406074524,49,Type_49,The risk or severity of adverse effects can be increased when Atropine is combined with Normethadone.,49,Type_49,Yes
DB00813,Fentanyl,DB01365,Mephentermine,0.9953652620315552,69,Type_69,Fentanyl may increase the analgesic activities of Mephentermine.,75,Type_75,No
DB00175,Pravastatin,DB00973,Ezetimibe,0.788804292678833,73,Type_73,The serum concentration of Ezetimibe can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00287,Travoprost,DB09477,Enalaprilat,0.9999985694885254,60,Type_60,Travoprost may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB01396,Digitoxin,DB09123,Dienogest,0.9292511940002441,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Dienogest.,58,Type_58,Yes
DB00768,Olopatadine,DB00774,Hydroflumethiazide,0.9866456985473633,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Olopatadine.,70,Type_70,Yes
DB04855,Dronedarone,DB04920,Clevidipine,0.7844120264053345,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00572,Atropine,DB00944,Demecarium,0.9986751675605774,70,Type_70,The therapeutic efficacy of Demecarium can be decreased when used in combination with Atropine.,70,Type_70,Yes
DB00270,Isradipine,DB01396,Digitoxin,0.48347151279449463,47,Type_47,The metabolism of Digitoxin can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00788,Naproxen,DB00903,Etacrynic acid,0.9999548196792603,29,Type_29,Naproxen may decrease the diuretic activities of Etacrynic acid.,29,Type_29,Yes
DB00950,Fexofenadine,DB00967,Desloratadine,0.9998502731323242,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Desloratadine.,49,Type_49,Yes
DB09040,Efinaconazole,DB09270,Ubidecarenone,0.5499407649040222,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Efinaconazole.,49,Type_49,No
DB00906,Tiagabine,DB01209,Dezocine,0.9986191987991333,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Dezocine.,49,Type_49,Yes
DB00203,Sildenafil,DB01039,Fenofibrate,0.873563826084137,47,Type_47,The metabolism of Fenofibrate can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00565,Cisatracurium,DB01017,Minocycline,0.999992847442627,21,Type_21,Cisatracurium may increase the neuromuscular blocking activities of Minocycline.,21,Type_21,Yes
DB00559,Bosentan,DB00820,Tadalafil,0.8213232755661011,60,Type_60,Bosentan may increase the hypotensive activities of Tadalafil.,75,Type_75,No
DB00459,Acitretin,DB01395,Drospirenone,0.498473197221756,70,Type_70,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Acitretin.,70,Type_70,Yes
DB00253,Medrysone,DB00890,Dienestrol,0.9951356053352356,73,Type_73,The serum concentration of Dienestrol can be increased when it is combined with Medrysone.,73,Type_73,Yes
DB00835,Brompheniramine,DB01189,Desflurane,0.9978278279304504,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Desflurane.,49,Type_49,Yes
DB00240,Alclometasone,DB06636,Isavuconazonium,0.9274774789810181,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB00396,Progesterone,DB06636,Isavuconazonium,0.9100043773651123,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Progesterone.,47,Type_47,Yes
DB00743,Gadobenic acid,DB05294,Vandetanib,0.9999982118606567,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00353,Methylergometrine,DB01359,Penbutolol,0.9582322835922241,19,Type_19,Methylergometrine may increase the vasoconstricting activities of Penbutolol.,19,Type_19,Yes
DB00241,Butalbital,DB00907,Cocaine,0.993235170841217,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Cocaine.,49,Type_49,Yes
DB00489,Sotalol,DB04946,Iloperidone,0.6955462098121643,20,Type_20,Sotalol may increase the QTc-prolonging activities of Iloperidone.,33,Type_33,No
DB00352,Tioguanine,DB06772,Cabazitaxel,0.9906772375106812,49,Type_49,The risk or severity of adverse effects can be increased when Tioguanine is combined with Cabazitaxel.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01242,Clomipramine,0.9038865566253662,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Clomipramine.,49,Type_49,Yes
DB01166,Cilostazol,DB01241,Gemfibrozil,0.47305309772491455,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Cilostazol.,73,Type_73,No
DB00765,Metyrosine,DB01081,Diphenoxylate,0.9996788501739502,32,Type_32,Metyrosine may increase the sedative activities of Diphenoxylate.,32,Type_32,Yes
DB00186,Lorazepam,DB00268,Ropinirole,0.9865540862083435,32,Type_32,Lorazepam may increase the sedative activities of Ropinirole.,32,Type_32,Yes
DB00448,Lansoprazole,DB08912,Dabrafenib,0.9912192225456238,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Lansoprazole.,75,Type_75,Yes
DB01069,Promethazine,DB01159,Halothane,0.96773362159729,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Halothane.,49,Type_49,Yes
DB00409,Remoxipride,DB00647,Dextropropoxyphene,0.9867335557937622,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00652,Pentazocine,DB00700,Eplerenone,0.975354790687561,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Eplerenone.,49,Type_49,Yes
DB00675,Tamoxifen,DB09049,Naloxegol,0.9998102784156799,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Tamoxifen.,73,Type_73,Yes
DB06810,Plicamycin,DB09212,Loxoprofen,0.9999901056289673,72,Type_72,Plicamycin may decrease the excretion rate of Loxoprofen which could result in a higher serum level.,72,Type_72,Yes
DB00207,Azithromycin,DB00575,Clonidine,0.5416284203529358,47,Type_47,The metabolism of Clonidine can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00935,Oxymetazoline,DB01193,Acebutolol,0.9836907982826233,25,Type_25,Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Acebutolol.,25,Type_25,Yes
DB01167,Itraconazole,DB06700,Desvenlafaxine,0.8895513415336609,47,Type_47,The metabolism of Desvenlafaxine can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00435,Nitric Oxide,DB04861,Nebivolol,0.9922522902488708,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nebivolol.,49,Type_49,Yes
DB00892,Oxybuprocaine,DB01142,Doxepin,0.9940339922904968,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Doxepin.,49,Type_49,Yes
DB00196,Fluconazole,DB05541,Brivaracetam,0.9326812624931335,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01159,Halothane,DB01229,Paclitaxel,0.9811151623725891,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Paclitaxel.,49,Type_49,Yes
DB00401,Nisoldipine,DB09279,Fimasartan,0.9982607960700989,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Fimasartan.,49,Type_49,Yes
DB00875,Flupentixol,DB06201,Rufinamide,0.9324526786804199,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Rufinamide.,49,Type_49,Yes
DB06144,Sertindole,DB06684,Vilazodone,0.9394810795783997,49,Type_49,The risk or severity of adverse effects can be increased when Sertindole is combined with Vilazodone.,49,Type_49,Yes
DB00395,Carisoprodol,DB01353,Butobarbital,0.9999961853027344,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Butobarbital.,49,Type_49,Yes
DB00323,Tolcapone,DB01159,Halothane,0.9911044836044312,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Halothane.,49,Type_49,Yes
DB05246,Methsuximide,DB06148,Mianserin,0.676531195640564,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Mianserin.,70,Type_70,No
DB00758,Clopidogrel,DB02703,Fusidic acid,0.9938269257545471,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Clopidogrel.,73,Type_73,Yes
DB00337,Pimecrolimus,DB00374,Treprostinil,0.9700397849082947,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Treprostinil.,49,Type_49,Yes
DB01264,Darunavir,DB13158,Clobetasone,0.5856330990791321,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB00539,Toremifene,0.9972890615463257,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Toremifene.,15,Type_15,Yes
DB00481,Raloxifene,DB06636,Isavuconazonium,0.9689890742301941,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00768,Olopatadine,DB08922,Perospirone,0.9587581157684326,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Perospirone.,49,Type_49,Yes
DB00731,Nateglinide,DB00912,Repaglinide,0.9755731225013733,9,Type_9,Nateglinide may increase the hypoglycemic activities of Repaglinide.,9,Type_9,Yes
DB01180,Rescinnamine,DB01359,Penbutolol,0.6122040152549744,60,Type_60,Rescinnamine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00731,Nateglinide,DB06718,Stanozolol,0.9999654293060303,9,Type_9,Nateglinide may increase the hypoglycemic activities of Stanozolol.,9,Type_9,Yes
DB00864,Tacrolimus,DB06605,Apixaban,0.5317394733428955,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Tacrolimus.,47,Type_47,No
DB00281,Lidocaine,DB00918,Almotriptan,0.8057575225830078,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00681,Amphotericin B,DB08931,Riociguat,0.9908196330070496,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat.,49,Type_49,Yes
DB00421,Spironolactone,DB00612,Bisoprolol,0.924389660358429,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Bisoprolol.,49,Type_49,Yes
DB00673,Aprepitant,DB01006,Letrozole,0.9456581473350525,73,Type_73,The serum concentration of Letrozole can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01065,Melatonin,DB09128,Brexpiprazole,0.9995284080505371,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Brexpiprazole.,49,Type_49,Yes
DB00949,Felbamate,DB06730,Gestodene,0.6768283247947693,70,Type_70,The therapeutic efficacy of Gestodene can be decreased when used in combination with Felbamate.,75,Type_75,No
DB01098,Rosuvastatin,DB09216,Tolfenamic acid,0.7352439761161804,49,Type_49,The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Tolfenamic acid.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB01626,Pargyline,0.9793193936347961,60,Type_60,Candesartan cilexetil may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00631,Clofarabine,DB00708,Sufentanil,0.5762479901313782,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Sufentanil.,49,Type_49,Yes
DB04844,Tetrabenazine,DB06788,Histrelin,0.9999994039535522,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB00465,Ketorolac,DB00917,Dinoprostone,0.5494279861450195,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Dinoprostone.,70,Type_70,No
DB00571,Propranolol,DB09063,Ceritinib,0.5171931982040405,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00544,Fluorouracil,DB09167,Dosulepin,0.9028114676475525,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00220,Nelfinavir,DB01012,Cinacalcet,0.8424389958381653,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00195,Betaxolol,DB01102,Arbutamine,0.9793540239334106,14,Type_14,Betaxolol may decrease the bronchodilatory activities of Arbutamine.,14,Type_14,Yes
DB00957,Norgestimate,DB00982,Isotretinoin,0.9877790808677673,70,Type_70,The therapeutic efficacy of Isotretinoin can be decreased when used in combination with Norgestimate.,70,Type_70,Yes
DB00528,Lercanidipine,DB02638,Terlipressin,0.9993649125099182,60,Type_60,Lercanidipine may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB01193,Acebutolol,DB06700,Desvenlafaxine,0.7929285168647766,73,Type_73,The serum concentration of Desvenlafaxine can be increased when it is combined with Acebutolol.,73,Type_73,Yes
DB00831,Trifluoperazine,DB01377,Magnesium oxide,0.919903576374054,67,Type_67,Trifluoperazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB04946,Iloperidone,DB11609,Normethadone,0.9908115863800049,49,Type_49,The risk or severity of adverse effects can be increased when Iloperidone is combined with Normethadone.,49,Type_49,Yes
DB01167,Itraconazole,DB08881,Vemurafenib,0.7972274422645569,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00596,Ulobetasol,DB00861,Diflunisal,0.9987891316413879,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Diflunisal.,49,Type_49,Yes
DB01026,Ketoconazole,DB02703,Fusidic acid,0.9994974136352539,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00903,Etacrynic acid,DB00938,Salmeterol,0.9989172220230103,83,Type_83,Etacrynic acid may increase the hypokalemic activities of Salmeterol.,83,Type_83,Yes
DB01075,Diphenhydramine,DB01355,Hexobarbital,0.7537568807601929,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Hexobarbital.,49,Type_49,Yes
DB01198,Zopiclone,DB09068,Vortioxetine,0.9975433945655823,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Vortioxetine.,49,Type_49,Yes
DB00363,Clozapine,DB01275,Hydralazine,0.8719084858894348,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Hydralazine.,49,Type_49,Yes
DB00384,Triamterene,DB01023,Felodipine,0.9074565172195435,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Felodipine.,49,Type_49,Yes
DB00594,Amiloride,DB00755,Tretinoin,0.9640024900436401,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Tretinoin.,49,Type_49,Yes
DB00471,Montelukast,DB01149,Nefazodone,0.9793805480003357,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Montelukast.,47,Type_47,Yes
DB00206,Reserpine,DB01149,Nefazodone,0.7073431611061096,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Nefazodone.,49,Type_49,Yes
DB01406,Danazol,DB08907,Canagliflozin,0.28333625197410583,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Danazol.,70,Type_70,Yes
DB00678,Losartan,DB01240,Epoprostenol,0.48564863204956055,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Epoprostenol.,47,Type_47,No
DB00722,Lisinopril,DB08797,Salicylamide,0.9685844779014587,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Salicylamide.,49,Type_49,Yes
DB00203,Sildenafil,DB01173,Orphenadrine,0.6760895848274231,47,Type_47,The metabolism of Orphenadrine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01173,Orphenadrine,DB01587,Ketazolam,0.972935140132904,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,16,Type_16,Yes
DB01209,Dezocine,DB09128,Brexpiprazole,0.9984787106513977,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Brexpiprazole.,49,Type_49,Yes
DB00270,Isradipine,DB01179,Podofilox,0.966140627861023,47,Type_47,The metabolism of Podofilox can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00502,Haloperidol,DB00932,Tipranavir,0.9191791415214539,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00648,Mitotane,DB08912,Dabrafenib,0.9997757077217102,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00446,Chloramphenicol,DB01129,Rabeprazole,0.9770498275756836,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00273,Topiramate,DB01196,Estramustine,0.7187796235084534,47,Type_47,The metabolism of Estramustine can be decreased when combined with Topiramate.,75,Type_75,No
DB00334,Olanzapine,DB09097,Quinagolide,0.9999891519546509,70,Type_70,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Olanzapine.,70,Type_70,Yes
DB00359,Sulfadiazine,DB01198,Zopiclone,0.9942418932914734,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00319,Piperacillin,DB00452,Framycetin,0.9048947691917419,75,Type_75,The serum concentration of Framycetin can be decreased when it is combined with Piperacillin.,75,Type_75,Yes
DB00655,Estrone,DB00686,Pentosan polysulfate,0.8247844576835632,12,Type_12,Estrone may decrease the anticoagulant activities of Pentosan polysulfate.,12,Type_12,Yes
DB01102,Arbutamine,DB01200,Bromocriptine,0.6005477905273438,71,Type_71,Arbutamine may increase the hypertensive activities of Bromocriptine.,71,Type_71,Yes
DB00470,Dronabinol,DB06282,Levocetirizine,0.9997193217277527,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.,16,Type_16,Yes
DB00780,Phenelzine,DB04871,Lorcaserin,0.9144282341003418,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Lorcaserin.,49,Type_49,Yes
DB01220,Rifaximin,DB09065,Cobicistat,0.8472964763641357,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Rifaximin.,73,Type_73,Yes
DB01424,Aminophenazone,DB08912,Dabrafenib,0.9904999136924744,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Aminophenazone.,75,Type_75,Yes
DB01137,Levofloxacin,DB06402,Telavancin,0.9999949932098389,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB01151,Desipramine,DB04844,Tetrabenazine,0.5775886178016663,20,Type_20,Desipramine may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00187,Esmolol,DB00232,Methyclothiazide,0.9923811554908752,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Methyclothiazide.,49,Type_49,Yes
DB00648,Mitotane,DB01115,Nifedipine,0.9930704236030579,75,Type_75,The serum concentration of Nifedipine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00472,Fluoxetine,DB08907,Canagliflozin,0.6515160202980042,9,Type_9,Fluoxetine may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB00648,Mitotane,DB09123,Dienogest,0.9731683731079102,75,Type_75,The serum concentration of Dienogest can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB06595,Midostaurin,DB09570,Ixazomib,0.821533203125,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00176,Fluvoxamine,DB09225,Zotepine,0.9960447549819946,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Zotepine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01324,Polythiazide,0.7924823760986328,60,Type_60,Chlorothiazide may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB01059,Norfloxacin,DB03585,Oxyphenbutazone,0.9962014555931091,27,Type_27,Norfloxacin may increase the neuroexcitatory activities of Oxyphenbutazone.,27,Type_27,Yes
DB00472,Fluoxetine,DB01068,Clonazepam,0.7455840110778809,47,Type_47,The metabolism of Clonazepam can be decreased when combined with Fluoxetine.,49,Type_49,No
DB00468,Quinine,DB01228,Encainide,0.9991493225097656,47,Type_47,The metabolism of Encainide can be decreased when combined with Quinine.,47,Type_47,Yes
DB06153,Pizotifen,DB06738,Ketobemidone,0.9997151494026184,49,Type_49,The risk or severity of adverse effects can be increased when Pizotifen is combined with Ketobemidone.,49,Type_49,Yes
DB00384,Triamterene,DB01088,Iloprost,0.7921330332756042,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Iloprost.,49,Type_49,Yes
DB01263,Posaconazole,DB08971,Fluocortolone,0.8306434154510498,73,Type_73,The serum concentration of Fluocortolone can be increased when it is combined with Posaconazole.,73,Type_73,Yes
DB01224,Quetiapine,DB06825,Triptorelin,0.9984330534934998,20,Type_20,Quetiapine may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00321,Amitriptyline,DB00514,Dextromethorphan,0.5739036798477173,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromethorphan.,49,Type_49,Yes
DB00435,Nitric Oxide,DB01174,Phenobarbital,0.7009561657905579,60,Type_60,Nitric Oxide may increase the hypotensive activities of Phenobarbital.,49,Type_49,No
DB00768,Olopatadine,DB00875,Flupentixol,0.8176964521408081,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Flupentixol.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00554,Piroxicam,0.9125632643699646,47,Type_47,The metabolism of Piroxicam can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00207,Azithromycin,DB00983,Formoterol,0.9246030449867249,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Formoterol.,20,Type_20,Yes
DB00421,Spironolactone,DB04861,Nebivolol,0.9490470886230469,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Nebivolol.,5,Type_5,No
DB00366,Doxylamine,DB09245,Toloxatone,0.9997972846031189,2,Type_2,Doxylamine may increase the anticholinergic activities of Toloxatone.,2,Type_2,Yes
DB01197,Captopril,DB01220,Rifaximin,0.4424229860305786,75,Type_75,The serum concentration of Rifaximin can be decreased when it is combined with Captopril.,73,Type_73,No
DB00890,Dienestrol,DB06605,Apixaban,0.8771968483924866,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Dienestrol.,75,Type_75,Yes
DB00185,Cevimeline,DB00289,Atomoxetine,0.9913185834884644,47,Type_47,The metabolism of Atomoxetine can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00295,Morphine,DB06201,Rufinamide,0.9959184527397156,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Rufinamide.,49,Type_49,Yes
DB00645,Dyclonine,DB00768,Olopatadine,0.9940219521522522,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Olopatadine.,49,Type_49,Yes
DB06414,Etravirine,DB08933,Luliconazole,0.9766476154327393,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Etravirine.,73,Type_73,Yes
DB01021,Trichlormethiazide,DB09242,Moxonidine,0.975990355014801,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00540,Nortriptyline,DB00559,Bosentan,0.5033720135688782,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB00188,Bortezomib,DB06769,Bendamustine,0.7413695454597473,47,Type_47,The metabolism of Bendamustine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00615,Rifabutin,DB01085,Pilocarpine,0.9533387422561646,4,Type_4,The metabolism of Pilocarpine can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00411,Carbamoylcholine,DB01214,Metipranolol,0.9985777139663696,49,Type_49,The risk or severity of adverse effects can be increased when Carbamoylcholine is combined with Metipranolol.,49,Type_49,Yes
DB01069,Promethazine,DB01359,Penbutolol,0.5235249400138855,60,Type_60,Promethazine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB01028,Methoxyflurane,DB01104,Sertraline,0.49795040488243103,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Sertraline.,47,Type_47,No
DB06243,Eflornithine,DB06772,Cabazitaxel,0.997177243232727,49,Type_49,The risk or severity of adverse effects can be increased when Eflornithine is combined with Cabazitaxel.,49,Type_49,Yes
DB00768,Olopatadine,DB00834,Mifepristone,0.8751022815704346,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Olopatadine.,73,Type_73,Yes
DB00482,Celecoxib,DB07615,Tranilast,0.7640759944915771,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Tranilast.,49,Type_49,Yes
DB01151,Desipramine,DB01200,Bromocriptine,0.6745424866676331,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Bromocriptine.,37,Type_37,No
DB00934,Maprotiline,DB04844,Tetrabenazine,0.9249579310417175,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Tetrabenazine.,20,Type_20,No
DB00498,Phenindione,DB00936,Salicylic acid,0.996843695640564,6,Type_6,Phenindione may increase the anticoagulant activities of Salicylic acid.,6,Type_6,Yes
DB00875,Flupentixol,DB08868,Fingolimod,0.9112467765808105,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Fingolimod.,20,Type_20,Yes
DB04841,Flunarizine,DB09198,Lobeglitazone,0.9911468625068665,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Flunarizine.,47,Type_47,Yes
DB00349,Clobazam,DB01196,Estramustine,0.7727991938591003,47,Type_47,The metabolism of Estramustine can be decreased when combined with Clobazam.,75,Type_75,No
DB00795,Sulfasalazine,DB01030,Topotecan,0.8970363140106201,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Sulfasalazine.,73,Type_73,Yes
DB00335,Atenolol,DB00661,Verapamil,0.44676101207733154,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Verapamil.,49,Type_49,Yes
DB00308,Ibutilide,DB01623,Thiothixene,0.5999536514282227,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00796,Candesartan cilexetil,DB01095,Fluvastatin,0.43227729201316833,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Candesartan cilexetil.,47,Type_47,No
DB00247,Methysergide,DB09074,Olaparib,0.9889606833457947,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Olaparib.,49,Type_49,Yes
DB00559,Bosentan,DB00705,Delavirdine,0.7609801888465881,75,Type_75,The serum concentration of Delavirdine can be decreased when it is combined with Bosentan.,73,Type_73,No
DB00335,Atenolol,DB01113,Papaverine,0.9999768733978271,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Papaverine.,49,Type_49,Yes
DB00335,Atenolol,DB06589,Pazopanib,0.8093209266662598,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Atenolol.,73,Type_73,Yes
DB01178,Chlormezanone,DB06216,Asenapine,0.9986312985420227,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Asenapine.,49,Type_49,Yes
DB00744,Zileuton,DB04576,Fleroxacin,0.9927722811698914,27,Type_27,Zileuton may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00834,Mifepristone,DB08916,Afatinib,0.9273833632469177,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Mifepristone.,75,Type_75,No
DB00989,Rivastigmine,DB06786,Halcinonide,0.998879611492157,49,Type_49,The risk or severity of adverse effects can be increased when Rivastigmine is combined with Halcinonide.,49,Type_49,Yes
DB01159,Halothane,DB06712,Nilvadipine,0.9906365275382996,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Nilvadipine.,49,Type_49,Yes
DB01071,Mequitazine,DB01168,Procarbazine,0.9072386622428894,2,Type_2,Mequitazine may increase the anticholinergic activities of Procarbazine.,2,Type_2,Yes
DB00819,Acetazolamide,DB01194,Brinzolamide,0.4949164390563965,49,Type_49,The risk or severity of adverse effects can be increased when Acetazolamide is combined with Brinzolamide.,49,Type_49,Yes
DB01295,Bevantolol,DB06709,Methacholine,0.9991540908813477,46,Type_46,Bevantolol may increase the bronchoconstrictory activities of Methacholine.,46,Type_46,Yes
DB00622,Nicardipine,DB00624,Testosterone,0.9575574994087219,47,Type_47,The metabolism of Testosterone can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00870,Suprofen,DB01174,Phenobarbital,0.9519322514533997,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Suprofen.,4,Type_4,Yes
DB01045,Rifampicin,DB08896,Regorafenib,0.722356915473938,75,Type_75,The serum concentration of Regorafenib can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00757,Dolasetron,DB00951,Isoniazid,0.8365278840065002,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Dolasetron.,47,Type_47,Yes
DB00648,Mitotane,DB04871,Lorcaserin,0.9628768563270569,75,Type_75,The serum concentration of Lorcaserin can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00635,Prednisone,DB00712,Flurbiprofen,0.9926469326019287,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Flurbiprofen.,49,Type_49,Yes
DB00224,Indinavir,DB00598,Labetalol,0.7361759543418884,47,Type_47,The metabolism of Labetalol can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00300,Tenofovir disoproxil,DB00554,Piroxicam,0.7500113248825073,49,Type_49,The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Piroxicam.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB09235,Efonidipine,0.6443663835525513,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB01072,Atazanavir,DB01349,Tasosartan,0.9766754508018494,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00461,Nabumetone,DB01401,Choline magnesium trisalicylate,0.9972366094589233,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00214,Torasemide,DB06696,Arbekacin,0.9897195100784302,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Arbekacin.,49,Type_49,Yes
DB00619,Imatinib,DB09049,Naloxegol,0.9997641444206238,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Imatinib.,73,Type_73,Yes
DB00243,Ranolazine,DB08864,Rilpivirine,0.9543929100036621,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00346,Alfuzosin,DB00657,Mecamylamine,0.9171623587608337,60,Type_60,Alfuzosin may increase the hypotensive activities of Mecamylamine.,60,Type_60,Yes
DB09065,Cobicistat,DB09102,Daclatasvir,0.6234134435653687,73,Type_73,The serum concentration of Daclatasvir can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00593,Ethosuximide,DB01255,Lisdexamfetamine,0.8123540878295898,76,Type_76,Ethosuximide may decrease the sedative activities of Lisdexamfetamine.,70,Type_70,No
DB00186,Lorazepam,DB01017,Minocycline,0.9999725818634033,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB01182,Propafenone,DB01295,Bevantolol,0.5802757143974304,54,Type_54,Propafenone may increase the bradycardic activities of Bevantolol.,73,Type_73,No
DB00705,Delavirdine,DB01175,Escitalopram,0.8995280265808105,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00246,Ziprasidone,DB01563,Chloral hydrate,0.9962819218635559,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Chloral hydrate.,49,Type_49,Yes
DB00772,Malathion,DB13158,Clobetasone,0.9967054724693298,49,Type_49,The risk or severity of adverse effects can be increased when Malathion is combined with Clobetasone.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB00737,Meclizine,0.9830644726753235,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Meclizine.,16,Type_16,Yes
DB00353,Methylergometrine,DB04948,Lofexidine,0.8331881165504456,71,Type_71,Methylergometrine may increase the hypertensive activities of Lofexidine.,71,Type_71,Yes
DB01392,Yohimbine,DB04855,Dronedarone,0.9941092729568481,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Yohimbine.,47,Type_47,Yes
DB01104,Sertraline,DB08881,Vemurafenib,0.6530334949493408,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Sertraline.,73,Type_73,Yes
DB06716,Fospropofol,DB11304,Phenoxyethanol,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Fospropofol is combined with Phenoxyethanol.,49,Type_49,Yes
DB00818,Propofol,DB01340,Cilazapril,0.7449917793273926,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Cilazapril.,49,Type_49,Yes
DB00297,Bupivacaine,DB01210,Levobunolol,0.8075122237205505,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Levobunolol.,73,Type_73,No
DB00178,Ramipril,DB00461,Nabumetone,0.8960592150688171,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Nabumetone.,49,Type_49,Yes
DB00227,Lovastatin,DB00759,Tetracycline,0.5294393301010132,47,Type_47,The metabolism of Tetracycline can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00834,Mifepristone,DB01174,Phenobarbital,0.4216444194316864,75,Type_75,The serum concentration of Phenobarbital can be decreased when it is combined with Mifepristone.,73,Type_73,No
DB04839,Cyproterone acetate,DB06770,Benzyl alcohol,0.7270398736000061,73,Type_73,The serum concentration of Benzyl alcohol can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB00384,Triamterene,DB00966,Telmisartan,0.6087162494659424,68,Type_68,Triamterene may increase the hyperkalemic activities of Telmisartan.,49,Type_49,No
DB00465,Ketorolac,DB00873,Loteprednol,0.9999103546142578,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Loteprednol.,49,Type_49,Yes
DB00252,Phenytoin,DB09095,Difluocortolone,0.9660710096359253,75,Type_75,The serum concentration of Difluocortolone can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB04846,Celiprolol,DB06694,Xylometazoline,0.852742612361908,60,Type_60,Celiprolol may increase the hypotensive activities of Xylometazoline.,25,Type_25,No
DB00227,Lovastatin,DB00738,Pentamidine,0.3957933187484741,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00304,Desogestrel,DB01174,Phenobarbital,0.558525025844574,75,Type_75,The serum concentration of Phenobarbital can be decreased when it is combined with Desogestrel.,70,Type_70,No
DB00844,Nalbuphine,DB08987,Etidocaine,0.9980396628379822,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etidocaine.,49,Type_49,Yes
DB00014,Goserelin,DB08907,Canagliflozin,0.9988294243812561,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Goserelin.,70,Type_70,Yes
DB01395,Drospirenone,DB08976,Floctafenine,0.9905683398246765,68,Type_68,Drospirenone may increase the hyperkalemic activities of Floctafenine.,68,Type_68,Yes
DB00285,Venlafaxine,DB00555,Lamotrigine,0.466433048248291,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lamotrigine.,49,Type_49,Yes
DB00743,Gadobenic acid,DB05039,Indacaterol,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB01241,Gemfibrozil,DB09063,Ceritinib,0.9953030347824097,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Gemfibrozil.,73,Type_73,Yes
DB00221,Isoetharine,DB00696,Ergotamine,0.9988229870796204,71,Type_71,Isoetharine may increase the hypertensive activities of Ergotamine.,71,Type_71,Yes
DB00660,Metaxalone,DB05271,Rotigotine,0.6872321963310242,32,Type_32,Metaxalone may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00909,Zonisamide,DB04841,Flunarizine,0.9971742630004883,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Flunarizine.,49,Type_49,Yes
DB00618,Demeclocycline,DB00755,Tretinoin,0.5854257941246033,49,Type_49,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Tretinoin.,49,Type_49,Yes
DB00800,Fenoldopam,DB00818,Propofol,0.850712776184082,49,Type_49,The risk or severity of adverse effects can be increased when Fenoldopam is combined with Propofol.,49,Type_49,Yes
DB00661,Verapamil,DB01158,Bretylium,0.94368577003479,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Bretylium.,54,Type_54,No
DB00559,Bosentan,DB11915,Valbenazine,0.8229410648345947,75,Type_75,The serum concentration of Valbenazine can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB01097,Leflunomide,DB09288,Propacetamol,0.8626193404197693,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Propacetamol.,49,Type_49,Yes
DB00557,Hydroxyzine,DB00831,Trifluoperazine,0.998292863368988,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.,16,Type_16,Yes
DB00268,Ropinirole,DB00790,Perindopril,0.7643270492553711,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Perindopril.,49,Type_49,Yes
DB00835,Brompheniramine,DB09198,Lobeglitazone,0.9988479614257812,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB01626,Pargyline,DB06237,Avanafil,0.5969557762145996,10,Type_10,Pargyline may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB08916,Afatinib,DB09075,Edoxaban,0.5233817100524902,75,Type_75,The serum concentration of Edoxaban can be decreased when it is combined with Afatinib.,73,Type_73,No
DB00668,Epinephrine,DB06698,Betahistine,0.9890589118003845,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Epinephrine.,70,Type_70,Yes
DB00210,Adapalene,DB06813,Pralatrexate,0.8245089054107666,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Adapalene.,73,Type_73,Yes
DB00014,Goserelin,DB00358,Mefloquine,0.9957895874977112,20,Type_20,Goserelin may increase the QTc-prolonging activities of Mefloquine.,20,Type_20,Yes
DB00281,Lidocaine,DB08880,Teriflunomide,0.6383985877037048,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Lidocaine.,75,Type_75,Yes
DB00565,Cisatracurium,DB01082,Streptomycin,0.999506950378418,40,Type_40,Cisatracurium may increase the respiratory depressant activities of Streptomycin.,40,Type_40,Yes
DB00496,Darifenacin,DB00497,Oxycodone,0.6718628406524658,47,Type_47,The metabolism of Oxycodone can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB01015,Sulfamethoxazole,DB09112,Nitrous acid,0.7583218812942505,49,Type_49,The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Nitrous acid.,49,Type_49,Yes
DB09009,Articaine,DB09117,Paraldehyde,0.9999797344207764,16,Type_16,Articaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00300,Tenofovir disoproxil,DB06769,Bendamustine,0.899435818195343,47,Type_47,The metabolism of Bendamustine can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB01609,Deferasirox,DB04930,Permethrin,0.9091708064079285,75,Type_75,The serum concentration of Permethrin can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00584,Enalapril,DB00903,Etacrynic acid,0.9278914332389832,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Etacrynic acid.,49,Type_49,Yes
DB00486,Nabilone,DB06712,Nilvadipine,0.945091962814331,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Nilvadipine.,49,Type_49,Yes
DB00246,Ziprasidone,DB00980,Ramelteon,0.7468892931938171,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00193,Tramadol,DB00292,Etomidate,0.9939258694648743,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Etomidate.,49,Type_49,Yes
DB00468,Quinine,DB00866,Alprenolol,0.7360877394676208,60,Type_60,Quinine may increase the hypotensive activities of Alprenolol.,60,Type_60,Yes
DB00343,Diltiazem,DB00732,Atracurium besylate,0.9660869240760803,21,Type_21,Diltiazem may increase the neuromuscular blocking activities of Atracurium besylate.,21,Type_21,Yes
DB00684,Tobramycin,DB09212,Loxoprofen,0.9999970197677612,72,Type_72,Tobramycin may decrease the excretion rate of Loxoprofen which could result in a higher serum level.,72,Type_72,Yes
DB00252,Phenytoin,DB01384,Paramethasone,0.8345819711685181,4,Type_4,The metabolism of Paramethasone can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00749,Etodolac,DB00770,Alprostadil,0.7393191456794739,53,Type_53,Etodolac may increase the antiplatelet activities of Alprostadil.,70,Type_70,No
DB00979,Cyclopentolate,DB01192,Oxymorphone,0.9999852180480957,49,Type_49,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Oxymorphone.,49,Type_49,Yes
DB05271,Rotigotine,DB09227,Barnidipine,0.9475446343421936,49,Type_49,The risk or severity of adverse effects can be increased when Rotigotine is combined with Barnidipine.,49,Type_49,Yes
DB08815,Lurasidone,DB09225,Zotepine,0.9889267683029175,49,Type_49,The risk or severity of adverse effects can be increased when Lurasidone is combined with Zotepine.,49,Type_49,Yes
DB00214,Torasemide,DB00594,Amiloride,0.9302894473075867,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Amiloride.,49,Type_49,Yes
DB00456,Cefalotin,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefalotin.,70,Type_70,Yes
DB00501,Cimetidine,DB04841,Flunarizine,0.7889940142631531,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Cimetidine.,73,Type_73,No
DB01069,Promethazine,DB01112,Cefuroxime,0.6155673265457153,75,Type_75,The serum concentration of Cefuroxime can be decreased when it is combined with Promethazine.,67,Type_67,No
DB00489,Sotalol,DB08981,Fenbufen,0.9322537779808044,37,Type_37,Sotalol may decrease the antihypertensive activities of Fenbufen.,37,Type_37,Yes
DB00949,Felbamate,DB01041,Thalidomide,0.9996523857116699,16,Type_16,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00622,Nicardipine,DB00751,Epinastine,0.9490931034088135,47,Type_47,The metabolism of Epinastine can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00547,Desoximetasone,DB01264,Darunavir,0.7400605082511902,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Desoximetasone.,73,Type_73,Yes
DB00246,Ziprasidone,DB00396,Progesterone,0.4664483070373535,47,Type_47,The metabolism of Progesterone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01174,Phenobarbital,DB09236,Lacidipine,0.6941985487937927,4,Type_4,The metabolism of Lacidipine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00349,Clobazam,DB09389,Norgestrel,0.7293413877487183,47,Type_47,The metabolism of Norgestrel can be decreased when combined with Clobazam.,75,Type_75,No
DB00494,Entacapone,DB00921,Buprenorphine,0.9990381002426147,16,Type_16,Entacapone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB08873,Boceprevir,DB09262,Imidafenacin,0.8167049884796143,47,Type_47,The metabolism of Imidafenacin can be decreased when combined with Boceprevir.,73,Type_73,No
DB00292,Etomidate,DB01545,Ethyl loflazepate,0.9987799525260925,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00370,Mirtazapine,DB01583,Liotrix,0.8007811903953552,73,Type_73,The serum concentration of Liotrix can be increased when it is combined with Mirtazapine.,82,Type_82,No
DB00619,Imatinib,DB01263,Posaconazole,0.8308727145195007,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Imatinib.,73,Type_73,No
DB00423,Methocarbamol,DB01242,Clomipramine,0.994895875453949,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Clomipramine.,49,Type_49,Yes
DB04951,Pirfenidone,DB09212,Loxoprofen,0.9516955614089966,49,Type_49,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Loxoprofen.,49,Type_49,Yes
DB00563,Methotrexate,DB00688,Mycophenolate mofetil,0.5466364622116089,73,Type_73,The serum concentration of Mycophenolate mofetil can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00889,Granisetron,DB05294,Vandetanib,0.8762102127075195,20,Type_20,Granisetron may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB06695,Dabigatran etexilate,DB06725,Lornoxicam,0.9520057439804077,6,Type_6,Dabigatran etexilate may increase the anticoagulant activities of Lornoxicam.,6,Type_6,Yes
DB01014,Balsalazide,DB01088,Iloprost,0.8863528966903687,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Balsalazide.,70,Type_70,Yes
DB00193,Tramadol,DB00215,Citalopram,0.5140184164047241,27,Type_27,Tramadol may increase the neuroexcitatory activities of Citalopram.,27,Type_27,Yes
DB00542,Benazepril,DB06292,Dapagliflozin,0.9964028596878052,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Dapagliflozin.,49,Type_49,Yes
DB00203,Sildenafil,DB01410,Ciclesonide,0.9194301962852478,47,Type_47,The metabolism of Ciclesonide can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00273,Topiramate,DB09300,Butylscopolamine,0.9548759460449219,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Butylscopolamine.,49,Type_49,Yes
DB00188,Bortezomib,DB00966,Telmisartan,0.6490851044654846,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Telmisartan.,49,Type_49,Yes
DB01050,Ibuprofen,DB01101,Capecitabine,0.8720600605010986,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Ibuprofen.,47,Type_47,Yes
DB01297,Practolol,DB06736,Aceclofenac,0.9986984729766846,37,Type_37,Practolol may decrease the antihypertensive activities of Aceclofenac.,37,Type_37,Yes
DB01054,Nitrendipine,DB09477,Enalaprilat,0.8135655522346497,60,Type_60,Nitrendipine may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00450,Droperidol,DB01232,Saquinavir,0.9769971370697021,20,Type_20,Droperidol may increase the QTc-prolonging activities of Saquinavir.,20,Type_20,Yes
DB00795,Sulfasalazine,DB00917,Dinoprostone,0.5230632424354553,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dinoprostone.,70,Type_70,No
DB00872,Conivaptan,DB06616,Bosutinib,0.9968430995941162,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00474,Methohexital,DB09279,Fimasartan,0.9775451421737671,60,Type_60,Methohexital may increase the hypotensive activities of Fimasartan.,60,Type_60,Yes
DB00091,Cyclosporine,DB00347,Trimethadione,0.8559045791625977,47,Type_47,The metabolism of Trimethadione can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01223,Aminophylline,DB09330,Osimertinib,0.7814977169036865,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Aminophylline.,73,Type_73,Yes
DB01463,Fencamfamin,DB01618,Molindone,0.7161065340042114,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Molindone.,49,Type_49,Yes
DB00474,Methohexital,DB01081,Diphenoxylate,0.9915169477462769,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Diphenoxylate.,49,Type_49,Yes
DB00615,Rifabutin,DB04871,Lorcaserin,0.7022623419761658,4,Type_4,The metabolism of Lorcaserin can be increased when combined with Rifabutin.,4,Type_4,Yes
DB01319,Fosamprenavir,DB04930,Permethrin,0.8372229337692261,47,Type_47,The metabolism of Permethrin can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB01082,Streptomycin,DB08991,Epirizole,0.9999817609786987,72,Type_72,Streptomycin may decrease the excretion rate of Epirizole which could result in a higher serum level.,72,Type_72,Yes
DB00569,Fondaparinux,DB06695,Dabigatran etexilate,0.9984183311462402,6,Type_6,Fondaparinux may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB04842,Fluspirilene,DB04896,Milnacipran,0.9968633651733398,49,Type_49,The risk or severity of adverse effects can be increased when Fluspirilene is combined with Milnacipran.,49,Type_49,Yes
DB00259,Sulfanilamide,DB06212,Tolvaptan,0.814121663570404,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Sulfanilamide.,73,Type_73,Yes
DB01201,Rifapentine,DB08903,Bedaquiline,0.9389840960502625,75,Type_75,The serum concentration of Bedaquiline can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00557,Hydroxyzine,DB01601,Lopinavir,0.4198399484157562,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Hydroxyzine.,20,Type_20,No
DB00527,Cinchocaine,DB01178,Chlormezanone,0.999998927116394,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Chlormezanone.,49,Type_49,Yes
DB04855,Dronedarone,DB05294,Vandetanib,0.3413969874382019,73,Type_73,The serum concentration of Vandetanib can be increased when it is combined with Dronedarone.,47,Type_47,No
DB00321,Amitriptyline,DB00907,Cocaine,0.6614376902580261,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cocaine.,47,Type_47,No
DB00213,Pantoprazole,DB00622,Nicardipine,0.8918136358261108,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00937,Diethylpropion,DB01390,Sodium bicarbonate,0.9982026815414429,72,Type_72,Diethylpropion may decrease the excretion rate of Sodium bicarbonate which could result in a higher serum level.,72,Type_72,Yes
DB06203,Alogliptin,DB06663,Pasireotide,0.5682896971702576,70,Type_70,The therapeutic efficacy of Pasireotide can be decreased when used in combination with Alogliptin.,70,Type_70,Yes
DB00588,Fluticasone propionate,DB00817,Rosoxacin,0.9792748093605042,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Rosoxacin.,49,Type_49,Yes
DB00608,Chloroquine,DB12332,Rucaparib,0.9512705206871033,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00748,Carbinoxamine,DB01167,Itraconazole,0.8615990877151489,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB00193,Tramadol,DB00228,Enflurane,0.9689568281173706,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Enflurane.,49,Type_49,Yes
DB00612,Bisoprolol,DB05676,Apremilast,0.9761871099472046,37,Type_37,Bisoprolol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB09244,Pirlindole,DB09477,Enalaprilat,0.9931225180625916,60,Type_60,Pirlindole may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00283,Clemastine,DB00482,Celecoxib,0.9952443242073059,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00390,Digoxin,DB00468,Quinine,0.6586684584617615,73,Type_73,The serum concentration of Quinine can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00528,Lercanidipine,DB00826,Natamycin,0.990292489528656,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Natamycin.,49,Type_49,Yes
DB00860,Prednisolone,DB04552,Niflumic acid,0.9997668862342834,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Niflumic acid.,49,Type_49,Yes
DB01054,Nitrendipine,DB09286,Pipamperone,0.8625156283378601,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Pipamperone.,49,Type_49,Yes
DB00455,Loratadine,DB01609,Deferasirox,0.9668462872505188,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Loratadine.,75,Type_75,Yes
DB00362,Anidulafungin,DB00396,Progesterone,0.9957564473152161,13,Type_13,The absorption of Progesterone can be decreased when combined with Anidulafungin.,13,Type_13,Yes
DB00281,Lidocaine,DB00924,Cyclobenzaprine,0.47488638758659363,47,Type_47,The metabolism of Cyclobenzaprine can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB01242,Clomipramine,DB05521,Telaprevir,0.7772603631019592,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Clomipramine.,47,Type_47,Yes
DB00273,Topiramate,DB01338,Pipecuronium,0.990196704864502,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Pipecuronium.,49,Type_49,Yes
DB00285,Venlafaxine,DB01608,Periciazine,0.5026837587356567,73,Type_73,The serum concentration of Periciazine can be increased when it is combined with Venlafaxine.,49,Type_49,No
DB01081,Diphenoxylate,DB01255,Lisdexamfetamine,0.9999579191207886,69,Type_69,Diphenoxylate may increase the analgesic activities of Lisdexamfetamine.,69,Type_69,Yes
DB00186,Lorazepam,DB00653,Magnesium sulfate,0.9412743449211121,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00470,Dronabinol,DB08872,Gabapentin enacarbil,0.9999418258666992,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,16,Type_16,Yes
DB06144,Sertindole,DB08873,Boceprevir,0.4847697615623474,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Sertindole.,47,Type_47,No
DB00482,Celecoxib,DB09555,Dexchlorpheniramine maleate,0.9932128190994263,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00216,Eletriptan,DB06708,Lumefantrine,0.812367856502533,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB06739,Seratrodast,DB08873,Boceprevir,0.9400023221969604,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Seratrodast.,47,Type_47,Yes
DB00186,Lorazepam,DB08815,Lurasidone,0.9955614805221558,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Lurasidone.,49,Type_49,Yes
DB00880,Chlorothiazide,DB08970,Fluprednidene,0.9997778534889221,83,Type_83,Chlorothiazide may increase the hypokalemic activities of Fluprednidene.,83,Type_83,Yes
DB01078,Deslanoside,DB09124,Medrogestone,0.9986855387687683,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Medrogestone.,58,Type_58,Yes
DB00648,Mitotane,DB00835,Brompheniramine,0.9410572648048401,75,Type_75,The serum concentration of Brompheniramine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00177,Valsartan,DB00969,Alosetron,0.9449921250343323,47,Type_47,The metabolism of Alosetron can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00349,Clobazam,DB00961,Mepivacaine,0.9965329170227051,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Mepivacaine.,49,Type_49,Yes
DB00228,Enflurane,DB08883,Perampanel,0.9070259928703308,16,Type_16,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00420,Promazine,DB09198,Lobeglitazone,0.993907630443573,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Promazine.,47,Type_47,Yes
DB00196,Fluconazole,DB00396,Progesterone,0.6377246379852295,47,Type_47,The metabolism of Progesterone can be decreased when combined with Fluconazole.,13,Type_13,No
DB00514,Dextromethorphan,DB00736,Esomeprazole,0.972179114818573,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB01151,Desipramine,DB08860,Pitavastatin,0.8549562692642212,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00210,Adapalene,DB00880,Chlorothiazide,0.9997441172599792,70,Type_70,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB01452,Diamorphine,DB08918,Levomilnacipran,0.85274738073349,64,Type_64,Diamorphine may increase the serotonergic activities of Levomilnacipran.,64,Type_64,Yes
DB00943,Zalcitabine,DB08865,Crizotinib,0.9213985800743103,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Zalcitabine.,47,Type_47,Yes
DB01367,Rasagiline,DB01393,Bezafibrate,0.5050009489059448,9,Type_9,Rasagiline may increase the hypoglycemic activities of Bezafibrate.,49,Type_49,No
DB04743,Nimesulide,DB09449,"Sodium phosphate, monobasic",0.956824004650116,57,Type_57,"Nimesulide may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB01264,Darunavir,DB09026,Aliskiren,0.8156532049179077,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Darunavir.,47,Type_47,Yes
DB08868,Fingolimod,DB09063,Ceritinib,0.4526330232620239,54,Type_54,Fingolimod may increase the bradycardic activities of Ceritinib.,73,Type_73,No
DB00240,Alclometasone,DB01014,Balsalazide,0.9941503405570984,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Balsalazide.,49,Type_49,Yes
DB00433,Prochlorperazine,DB01255,Lisdexamfetamine,0.9979475140571594,61,Type_61,Prochlorperazine may decrease the stimulatory activities of Lisdexamfetamine.,61,Type_61,Yes
DB00857,Terbinafine,DB04871,Lorcaserin,0.9643722176551819,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00677,Isoflurophate,DB01214,Metipranolol,0.9923684000968933,54,Type_54,Isoflurophate may increase the bradycardic activities of Metipranolol.,54,Type_54,Yes
DB01050,Ibuprofen,DB06813,Pralatrexate,0.824383556842804,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Ibuprofen.,73,Type_73,Yes
DB00701,Amprenavir,DB06636,Isavuconazonium,0.9489791989326477,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Amprenavir.,47,Type_47,Yes
DB00207,Azithromycin,DB01175,Escitalopram,0.7663393616676331,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Escitalopram.,20,Type_20,Yes
DB00201,Caffeine,DB00496,Darifenacin,0.8866738080978394,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00492,Fosinopril,DB09232,Cilnidipine,0.6495606303215027,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Cilnidipine.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB00933,Mesoridazine,0.9729042649269104,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Mesoridazine.,49,Type_49,Yes
DB00219,Oxyphenonium,DB00670,Pirenzepine,0.998477041721344,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pirenzepine.,49,Type_49,Yes
DB06772,Cabazitaxel,DB09031,Miltefosine,0.5523396134376526,47,Type_47,The metabolism of Miltefosine can be decreased when combined with Cabazitaxel.,49,Type_49,No
DB00876,Eprosartan,DB02709,Resveratrol,0.9154322147369385,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Resveratrol.,49,Type_49,Yes
DB00685,Trovafloxacin,DB13158,Clobetasone,0.9836575388908386,49,Type_49,The risk or severity of adverse effects can be increased when Trovafloxacin is combined with Clobetasone.,49,Type_49,Yes
DB00805,Minaprine,DB01120,Gliclazide,0.9986660480499268,9,Type_9,Minaprine may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00307,Bexarotene,DB09074,Olaparib,0.9143937230110168,47,Type_47,The metabolism of Olaparib can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00334,Olanzapine,DB00831,Trifluoperazine,0.9612293243408203,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Trifluoperazine.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB06193,Pixantrone,0.9999223947525024,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Pixantrone.,15,Type_15,Yes
DB01175,Escitalopram,DB01264,Darunavir,0.786878228187561,47,Type_47,The metabolism of Darunavir can be decreased when combined with Escitalopram.,73,Type_73,No
DB00812,Phenylbutazone,DB06781,Difluprednate,0.9997387528419495,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Difluprednate.,49,Type_49,Yes
DB00454,Meperidine,DB01028,Methoxyflurane,0.9784479737281799,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Methoxyflurane.,49,Type_49,Yes
DB00321,Amitriptyline,DB00816,Orciprenaline,0.9875471591949463,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Orciprenaline.,49,Type_49,Yes
DB00584,Enalapril,DB01072,Atazanavir,0.5592910647392273,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Enalapril.,47,Type_47,No
DB00232,Methyclothiazide,DB00940,Methantheline,0.9623923301696777,73,Type_73,The serum concentration of Methantheline can be increased when it is combined with Methyclothiazide.,73,Type_73,Yes
DB00967,Desloratadine,DB08872,Gabapentin enacarbil,0.9703593254089355,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB01282,Carbetocin,DB09026,Aliskiren,0.9200212955474854,49,Type_49,The risk or severity of adverse effects can be increased when Carbetocin is combined with Aliskiren.,49,Type_49,Yes
DB00187,Esmolol,DB06709,Methacholine,0.9998623132705688,46,Type_46,Esmolol may increase the bronchoconstrictory activities of Methacholine.,46,Type_46,Yes
DB01289,Glisoxepide,DB09204,Arotinolol,0.9989503026008606,9,Type_9,Glisoxepide may increase the hypoglycemic activities of Arotinolol.,9,Type_9,Yes
DB01176,Cyclizine,DB01595,Nitrazepam,0.9996834993362427,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Nitrazepam.,49,Type_49,Yes
DB00187,Esmolol,DB09227,Barnidipine,0.9624696373939514,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Barnidipine.,49,Type_49,Yes
DB01162,Terazosin,DB01364,Ephedrine,0.9996335506439209,5,Type_5,Terazosin may decrease the vasoconstricting activities of Ephedrine.,5,Type_5,Yes
DB00624,Testosterone,DB09238,Manidipine,0.9526668787002563,47,Type_47,The metabolism of Manidipine can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00404,Alprazolam,DB01201,Rifapentine,0.8608078956604004,4,Type_4,The metabolism of Rifapentine can be increased when combined with Alprazolam.,4,Type_4,Yes
DB01023,Felodipine,DB09038,Empagliflozin,0.986478865146637,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Empagliflozin.,49,Type_49,Yes
DB00904,Ondansetron,DB06288,Amisulpride,0.7761520147323608,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Amisulpride.,36,Type_36,No
DB01198,Zopiclone,DB01452,Diamorphine,0.999114453792572,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Diamorphine.,49,Type_49,Yes
DB01092,Ouabain,DB13145,Nedaplatin,0.9998868703842163,58,Type_58,Ouabain may decrease the cardiotoxic activities of Nedaplatin.,58,Type_58,Yes
DB00391,Sulpiride,DB06716,Fospropofol,0.9999977350234985,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Fospropofol.,49,Type_49,Yes
DB01420,Testosterone propionate,DB06335,Saxagliptin,0.9863430261611938,9,Type_9,Testosterone propionate may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00401,Nisoldipine,DB00834,Mifepristone,0.8482468128204346,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Nisoldipine.,73,Type_73,Yes
DB01072,Atazanavir,DB06589,Pazopanib,0.7911438941955566,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00472,Fluoxetine,DB06209,Prasugrel,0.8077710866928101,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB01264,Darunavir,DB11737,Icotinib,0.8359525203704834,47,Type_47,The metabolism of Icotinib can be decreased when combined with Darunavir.,47,Type_47,Yes
DB00266,Dicoumarol,DB03619,Deoxycholic acid,0.9999912977218628,49,Type_49,The risk or severity of adverse effects can be increased when Dicoumarol is combined with Deoxycholic acid.,49,Type_49,Yes
DB00492,Fosinopril,DB00559,Bosentan,0.8193793892860413,60,Type_60,Fosinopril may increase the hypotensive activities of Bosentan.,60,Type_60,Yes
DB00333,Methadone,DB00697,Tizanidine,0.8699164986610413,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Tizanidine.,20,Type_20,No
DB00418,Secobarbital,DB00812,Phenylbutazone,0.9713993072509766,4,Type_4,The metabolism of Phenylbutazone can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00181,Baclofen,DB00747,Scopolamine,0.9989294409751892,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Scopolamine.,49,Type_49,Yes
DB01097,Leflunomide,DB06697,Artemether,0.7493829131126404,47,Type_47,The metabolism of Artemether can be decreased when combined with Leflunomide.,47,Type_47,Yes
DB00218,Moxifloxacin,DB06708,Lumefantrine,0.8851019144058228,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Lumefantrine.,20,Type_20,Yes
DB06708,Lumefantrine,DB09183,Dasabuvir,0.9679459929466248,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Lumefantrine.,47,Type_47,Yes
DB00472,Fluoxetine,DB06290,Simeprevir,0.891118586063385,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00502,Haloperidol,DB00573,Fenoprofen,0.9722785353660583,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Fenoprofen.,49,Type_49,Yes
DB00696,Ergotamine,DB01590,Everolimus,0.8880007266998291,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Ergotamine.,73,Type_73,Yes
DB00252,Phenytoin,DB00394,Beclomethasone dipropionate,0.9583539366722107,75,Type_75,The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00734,Risperidone,DB00975,Dipyridamole,0.4554438889026642,60,Type_60,Risperidone may increase the hypotensive activities of Dipyridamole.,60,Type_60,Yes
DB04868,Nilotinib,DB06724,Calcium carbonate,0.5236237049102783,75,Type_75,The serum concentration of Calcium carbonate can be decreased when it is combined with Nilotinib.,75,Type_75,Yes
DB00461,Nabumetone,DB08808,Bupranolol,0.9981166124343872,37,Type_37,Nabumetone may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB00450,Droperidol,DB01035,Procainamide,0.9962822794914246,20,Type_20,Droperidol may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00376,Trihexyphenidyl,DB09290,Ramosetron,0.9999979734420776,39,Type_39,Trihexyphenidyl may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB00243,Ranolazine,DB01194,Brinzolamide,0.5173550844192505,47,Type_47,The metabolism of Brinzolamide can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB01209,Dezocine,DB01367,Rasagiline,0.9117193818092346,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Rasagiline.,49,Type_49,Yes
DB01028,Methoxyflurane,DB11304,Phenoxyethanol,0.9999970197677612,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Phenoxyethanol.,49,Type_49,Yes
DB00635,Prednisone,DB01059,Norfloxacin,0.6026743650436401,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Norfloxacin.,49,Type_49,Yes
DB00674,Galantamine,DB01036,Tolterodine,0.822311282157898,70,Type_70,The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.,70,Type_70,Yes
DB00486,Nabilone,DB01587,Ketazolam,0.993190348148346,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,16,Type_16,Yes
DB00455,Loratadine,DB08916,Afatinib,0.5399014353752136,75,Type_75,The serum concentration of Afatinib can be decreased when it is combined with Loratadine.,73,Type_73,No
DB01182,Propafenone,DB01624,Zuclopenthixol,0.5737731456756592,20,Type_20,Propafenone may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB06786,Halcinonide,DB08991,Epirizole,0.9994602799415588,49,Type_49,The risk or severity of adverse effects can be increased when Halcinonide is combined with Epirizole.,49,Type_49,Yes
DB00404,Alprazolam,DB00555,Lamotrigine,0.9968816041946411,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Lamotrigine.,49,Type_49,Yes
DB01192,Oxymorphone,DB09074,Olaparib,0.8543313145637512,47,Type_47,The metabolism of Olaparib can be decreased when combined with Oxymorphone.,47,Type_47,Yes
DB01297,Practolol,DB01396,Digitoxin,0.9975324869155884,54,Type_54,Practolol may increase the bradycardic activities of Digitoxin.,54,Type_54,Yes
DB00189,Ethchlorvynol,DB01615,Aceprometazine,0.9998297691345215,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Aceprometazine.,49,Type_49,Yes
DB01199,Tubocurarine,DB06702,Fesoterodine,0.8486661911010742,49,Type_49,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Fesoterodine.,49,Type_49,Yes
DB01501,Difenoxin,DB13025,Tiapride,0.9999549388885498,49,Type_49,The risk or severity of adverse effects can be increased when Difenoxin is combined with Tiapride.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB01198,Zopiclone,0.997307538986206,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zopiclone.,49,Type_49,Yes
DB00334,Olanzapine,DB00514,Dextromethorphan,0.42998552322387695,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Olanzapine.,49,Type_49,No
DB00296,Ropivacaine,DB00705,Delavirdine,0.816155195236206,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00220,Nelfinavir,DB00643,Mebendazole,0.7841780185699463,47,Type_47,The metabolism of Mebendazole can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00875,Flupentixol,DB00904,Ondansetron,0.894801676273346,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Ondansetron.,49,Type_49,No
DB00747,Scopolamine,DB01221,Ketamine,0.9955466985702515,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Ketamine.,49,Type_49,Yes
DB01045,Rifampicin,DB01409,Tiotropium,0.8031586408615112,4,Type_4,The metabolism of Tiotropium can be increased when combined with Rifampicin.,4,Type_4,Yes
DB04576,Fleroxacin,DB09218,Clonixin,0.9963723421096802,27,Type_27,Fleroxacin may increase the neuroexcitatory activities of Clonixin.,27,Type_27,Yes
DB00091,Cyclosporine,DB01034,Cerulenin,0.5773071050643921,47,Type_47,The metabolism of Cerulenin can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00179,Masoprocol,DB00919,Spectinomycin,0.9999221563339233,72,Type_72,Masoprocol may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB00653,Magnesium sulfate,DB01244,Bepridil,0.7923953533172607,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Bepridil.,49,Type_49,Yes
DB00184,Nicotine,DB08881,Vemurafenib,0.5458590388298035,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Nicotine.,73,Type_73,No
DB00531,Cyclophosphamide,DB00563,Methotrexate,0.906717836856842,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Methotrexate.,15,Type_15,Yes
DB00768,Olopatadine,DB00860,Prednisolone,0.9985526204109192,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Prednisolone.,49,Type_49,Yes
DB00758,Clopidogrel,DB01129,Rabeprazole,0.8060780167579651,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Clopidogrel.,11,Type_11,No
DB00945,Acetylsalicylic acid,DB00972,Azelastine,0.7158661484718323,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Azelastine.,49,Type_49,Yes
DB01028,Methoxyflurane,DB08883,Perampanel,0.6763515472412109,16,Type_16,Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00798,Gentamicin,DB07615,Tranilast,0.999277651309967,72,Type_72,Gentamicin may decrease the excretion rate of Tranilast which could result in a higher serum level.,72,Type_72,Yes
DB00475,Chlordiazepoxide,DB09048,Netupitant,0.9320605397224426,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Chlordiazepoxide.,73,Type_73,Yes
DB00921,Buprenorphine,DB01320,Fosphenytoin,0.894214391708374,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.,16,Type_16,Yes
DB00645,Dyclonine,DB08918,Levomilnacipran,0.9950279593467712,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Levomilnacipran.,49,Type_49,Yes
DB00734,Risperidone,DB01023,Felodipine,0.31799569725990295,47,Type_47,The metabolism of Felodipine can be decreased when combined with Risperidone.,60,Type_60,No
DB01601,Lopinavir,DB04878,Voglibose,0.7145216464996338,47,Type_47,The metabolism of Voglibose can be decreased when combined with Lopinavir.,70,Type_70,No
DB00240,Alclometasone,DB08899,Enzalutamide,0.9931527376174927,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Alclometasone.,75,Type_75,Yes
DB00866,Alprenolol,DB01012,Cinacalcet,0.8823897242546082,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Alprenolol.,47,Type_47,Yes
DB01501,Difenoxin,DB09009,Articaine,0.9999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Difenoxin is combined with Articaine.,49,Type_49,Yes
DB01248,Docetaxel,DB06772,Cabazitaxel,0.8828042149543762,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Cabazitaxel.,49,Type_49,Yes
DB00694,Daunorubicin,DB08873,Boceprevir,0.8967086672782898,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB00297,Bupivacaine,DB01567,Fludiazepam,0.9967978596687317,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fludiazepam.,49,Type_49,Yes
DB00881,Quinapril,DB12598,Nafamostat,0.6264810562133789,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Nafamostat.,49,Type_49,Yes
DB00663,Flumethasone,DB00812,Phenylbutazone,0.9996496438980103,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Phenylbutazone.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB01406,Danazol,0.9873126149177551,74,Type_74,Fluticasone propionate may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB09244,Pirlindole,DB13139,Levosalbutamol,0.9948916435241699,49,Type_49,The risk or severity of adverse effects can be increased when Pirlindole is combined with Levosalbutamol.,49,Type_49,Yes
DB00497,Oxycodone,DB01106,Levocabastine,0.9996917247772217,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Levocabastine.,49,Type_49,Yes
DB00559,Bosentan,DB01218,Halofantrine,0.9277865290641785,75,Type_75,The serum concentration of Halofantrine can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00224,Indinavir,DB01609,Deferasirox,0.8600097894668579,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Indinavir.,75,Type_75,Yes
DB00268,Ropinirole,DB00434,Cyproheptadine,0.9543891549110413,32,Type_32,Ropinirole may increase the sedative activities of Cyproheptadine.,32,Type_32,Yes
DB00590,Doxazosin,DB00899,Remifentanil,0.9371621012687683,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Remifentanil.,49,Type_49,Yes
DB01232,Saquinavir,DB06216,Asenapine,0.5137975215911865,20,Type_20,Saquinavir may increase the QTc-prolonging activities of Asenapine.,73,Type_73,No
DB01167,Itraconazole,DB04938,Ospemifene,0.7802188992500305,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Itraconazole.,73,Type_73,No
DB00880,Chlorothiazide,DB06802,Nepafenac,0.995316743850708,70,Type_70,The therapeutic efficacy of Nepafenac can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00486,Nabilone,DB01193,Acebutolol,0.9969967603683472,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Acebutolol.,85,Type_85,No
DB09073,Palbociclib,DB12001,Abemaciclib,0.977429986000061,73,Type_73,The serum concentration of Abemaciclib can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB04908,Flibanserin,DB09054,Idelalisib,0.6661599278450012,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Flibanserin.,73,Type_73,Yes
DB00883,Isosorbide dinitrate,DB01275,Hydralazine,0.9812140464782715,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Hydralazine.,49,Type_49,Yes
DB08907,Canagliflozin,DB09075,Edoxaban,0.5609329342842102,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Canagliflozin.,73,Type_73,Yes
DB00708,Sufentanil,DB12278,Propiverine,0.9999585151672363,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Propiverine.,49,Type_49,Yes
DB01263,Posaconazole,DB11581,Venetoclax,0.7640713453292847,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00277,Theophylline,DB00300,Tenofovir disoproxil,0.9828169345855713,47,Type_47,The metabolism of Tenofovir disoproxil can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00540,Nortriptyline,DB00715,Paroxetine,0.528048038482666,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Paroxetine.,49,Type_49,Yes
DB00395,Carisoprodol,DB00543,Amoxapine,0.966330885887146,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Amoxapine.,49,Type_49,Yes
DB00917,Dinoprostone,DB09198,Lobeglitazone,0.997109591960907,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Dinoprostone.,47,Type_47,Yes
DB00220,Nelfinavir,DB01151,Desipramine,0.526671290397644,47,Type_47,The metabolism of Desipramine can be decreased when combined with Nelfinavir.,73,Type_73,No
DB09017,Brotizolam,DB13025,Tiapride,0.9999831914901733,49,Type_49,The risk or severity of adverse effects can be increased when Brotizolam is combined with Tiapride.,49,Type_49,Yes
DB00220,Nelfinavir,DB00628,Clorazepic acid,0.8368753790855408,47,Type_47,The metabolism of Clorazepic acid can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00570,Vinblastine,DB05521,Telaprevir,0.7235280871391296,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB00207,Azithromycin,DB01220,Rifaximin,0.7552401423454285,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00091,Cyclosporine,DB00912,Repaglinide,0.7722473740577698,47,Type_47,The metabolism of Repaglinide can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00376,Trihexyphenidyl,DB00496,Darifenacin,0.9897508025169373,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Darifenacin.,49,Type_49,Yes
DB00877,Sirolimus,DB04855,Dronedarone,0.7784908413887024,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Sirolimus.,47,Type_47,Yes
DB06201,Rufinamide,DB08864,Rilpivirine,0.7956803441047668,49,Type_49,The risk or severity of adverse effects can be increased when Rufinamide is combined with Rilpivirine.,75,Type_75,No
DB00344,Protriptyline,DB04946,Iloperidone,0.5202265977859497,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Iloperidone.,20,Type_20,No
DB00854,Levorphanol,DB01403,Methotrimeprazine,0.899688184261322,16,Type_16,Levorphanol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00813,Fentanyl,DB00835,Brompheniramine,0.9876201152801514,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Brompheniramine.,49,Type_49,Yes
DB00625,Efavirenz,DB00991,Oxaprozin,0.8772320747375488,47,Type_47,The metabolism of Oxaprozin can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00696,Ergotamine,DB06212,Tolvaptan,0.8337070941925049,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Ergotamine.,73,Type_73,Yes
DB00227,Lovastatin,DB09054,Idelalisib,0.5270833373069763,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Lovastatin.,73,Type_73,No
DB00544,Fluorouracil,DB01248,Docetaxel,0.6397027373313904,49,Type_49,The risk or severity of adverse effects can be increased when Fluorouracil is combined with Docetaxel.,49,Type_49,Yes
DB00465,Ketorolac,DB08970,Fluprednidene,0.9999103546142578,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Fluprednidene.,49,Type_49,Yes
DB01320,Fosphenytoin,DB08905,Formestane,0.9050409197807312,75,Type_75,The serum concentration of Formestane can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB01177,Idarubicin,DB09216,Tolfenamic acid,0.9974384307861328,72,Type_72,Idarubicin may decrease the excretion rate of Tolfenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB00452,Framycetin,DB00945,Acetylsalicylic acid,0.9999465942382812,72,Type_72,Framycetin may decrease the excretion rate of Acetylsalicylic acid which could result in a higher serum level.,72,Type_72,Yes
DB04839,Cyproterone acetate,DB06774,Capsaicin,0.7550866603851318,73,Type_73,The serum concentration of Capsaicin can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB00712,Flurbiprofen,DB00744,Zileuton,0.9979113936424255,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zileuton.,49,Type_49,Yes
DB00645,Dyclonine,DB01159,Halothane,0.9971645474433899,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Halothane.,49,Type_49,Yes
DB00598,Labetalol,DB12332,Rucaparib,0.814817488193512,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Labetalol.,47,Type_47,Yes
DB01296,Glucosamine,DB12332,Rucaparib,0.9856910109519958,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Glucosamine.,47,Type_47,Yes
DB00808,Indapamide,DB11093,Calcium citrate,0.9228588342666626,72,Type_72,Indapamide may decrease the excretion rate of Calcium citrate which could result in a higher serum level.,72,Type_72,Yes
DB00280,Disopyramide,DB12332,Rucaparib,0.8174718022346497,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Disopyramide.,47,Type_47,Yes
DB01112,Cefuroxime,DB06724,Calcium carbonate,0.9008381962776184,75,Type_75,The serum concentration of Calcium carbonate can be decreased when it is combined with Cefuroxime.,75,Type_75,Yes
DB00289,Atomoxetine,DB00637,Astemizole,0.47345978021621704,47,Type_47,The metabolism of Astemizole can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00817,Rosoxacin,DB01223,Aminophylline,0.35351186990737915,73,Type_73,The serum concentration of Aminophylline can be increased when it is combined with Rosoxacin.,47,Type_47,No
DB00887,Bumetanide,DB08797,Salicylamide,0.9999786615371704,29,Type_29,Bumetanide may decrease the diuretic activities of Salicylamide.,29,Type_29,Yes
DB00264,Metoprolol,DB06708,Lumefantrine,0.4927603304386139,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Metoprolol.,73,Type_73,No
DB00871,Terbutaline,DB01365,Mephentermine,0.9999949932098389,49,Type_49,The risk or severity of adverse effects can be increased when Terbutaline is combined with Mephentermine.,49,Type_49,Yes
DB00804,Dicyclomine,DB01400,Neostigmine,0.9996017813682556,70,Type_70,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dicyclomine.,70,Type_70,Yes
DB01232,Saquinavir,DB04572,Thiotepa,0.8291005492210388,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00455,Loratadine,DB08910,Pomalidomide,0.9704703688621521,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Pomalidomide.,49,Type_49,Yes
DB00238,Nevirapine,DB00619,Imatinib,0.34863054752349854,47,Type_47,The metabolism of Imatinib can be decreased when combined with Nevirapine.,75,Type_75,No
DB00975,Dipyridamole,DB01295,Bevantolol,0.7145959734916687,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Bevantolol.,54,Type_54,No
DB00210,Adapalene,DB06810,Plicamycin,0.9999384880065918,72,Type_72,Adapalene may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00924,Cyclobenzaprine,DB08899,Enzalutamide,0.9082045555114746,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Cyclobenzaprine.,75,Type_75,Yes
DB00182,Amphetamine,DB01577,Metamfetamine,0.5356465578079224,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Metamfetamine.,49,Type_49,Yes
DB00708,Sufentanil,DB01595,Nitrazepam,0.9566940069198608,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Nitrazepam.,49,Type_49,Yes
DB00812,Phenylbutazone,DB09211,Limaprost,0.9282312989234924,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Phenylbutazone.,70,Type_70,Yes
DB01132,Pioglitazone,DB09118,Stiripentol,0.8991846442222595,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Pioglitazone.,73,Type_73,Yes
DB00184,Nicotine,DB00571,Propranolol,0.49085626006126404,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Propranolol.,49,Type_49,Yes
DB00245,Benzatropine,DB00486,Nabilone,0.9998599290847778,85,Type_85,Benzatropine may increase the tachycardic activities of Nabilone.,85,Type_85,Yes
DB00741,Hydrocortisone,DB08916,Afatinib,0.685196042060852,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Hydrocortisone.,73,Type_73,Yes
DB01154,Thiamylal,DB01418,Acenocoumarol,0.9277300238609314,4,Type_4,The metabolism of Acenocoumarol can be increased when combined with Thiamylal.,4,Type_4,Yes
DB06144,Sertindole,DB06690,Nitrous oxide,0.9997790455818176,49,Type_49,The risk or severity of adverse effects can be increased when Sertindole is combined with Nitrous oxide.,49,Type_49,Yes
DB00826,Natamycin,DB06694,Xylometazoline,0.9935519695281982,49,Type_49,The risk or severity of adverse effects can be increased when Natamycin is combined with Xylometazoline.,49,Type_49,Yes
DB00468,Quinine,DB09070,Tibolone,0.533039391040802,60,Type_60,Quinine may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00910,Paricalcitol,DB01167,Itraconazole,0.9560363292694092,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Paricalcitol.,73,Type_73,No
DB01174,Phenobarbital,DB08934,Sofosbuvir,0.9765968918800354,75,Type_75,The serum concentration of Sofosbuvir can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00278,Argatroban,DB00655,Estrone,0.6722898483276367,49,Type_49,The risk or severity of adverse effects can be increased when Argatroban is combined with Estrone.,12,Type_12,No
DB00193,Tramadol,DB00949,Felbamate,0.940668523311615,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Felbamate.,49,Type_49,Yes
DB01587,Ketazolam,DB01624,Zuclopenthixol,0.9849580526351929,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Zuclopenthixol.,49,Type_49,Yes
DB00939,Meclofenamic acid,DB00999,Hydrochlorothiazide,0.9993860721588135,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meclofenamic acid.,70,Type_70,Yes
DB00270,Isradipine,DB09220,Nicorandil,0.9983522891998291,60,Type_60,Isradipine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00904,Ondansetron,DB00918,Almotriptan,0.7360092401504517,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Almotriptan.,64,Type_64,No
DB00398,Sorafenib,DB01154,Thiamylal,0.7811562418937683,47,Type_47,The metabolism of Thiamylal can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00881,Quinapril,DB01261,Sitagliptin,0.833446204662323,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Sitagliptin.,49,Type_49,Yes
DB01156,Bupropion,DB01177,Idarubicin,0.9525739550590515,47,Type_47,The metabolism of Idarubicin can be decreased when combined with Bupropion.,47,Type_47,Yes
DB01089,Deserpidine,DB06403,Ambrisentan,0.9999556541442871,60,Type_60,Deserpidine may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00892,Oxybuprocaine,DB01149,Nefazodone,0.9838320016860962,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Nefazodone.,49,Type_49,Yes
DB00175,Pravastatin,DB01093,Dimethyl sulfoxide,0.6443952918052673,73,Type_73,The serum concentration of Dimethyl sulfoxide can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01174,Phenobarbital,DB11304,Phenoxyethanol,0.9995012283325195,49,Type_49,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Phenoxyethanol.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01297,Practolol,0.5685564279556274,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Practolol.,75,Type_75,No
DB00176,Fluvoxamine,DB08932,Macitentan,0.9678134322166443,47,Type_47,The metabolism of Macitentan can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00270,Isradipine,DB06589,Pazopanib,0.5105034112930298,47,Type_47,The metabolism of Pazopanib can be decreased when combined with Isradipine.,20,Type_20,No
DB00273,Topiramate,DB00831,Trifluoperazine,0.9884442687034607,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Trifluoperazine.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB00985,Dimenhydrinate,0.9598588943481445,76,Type_76,Pseudoephedrine may decrease the sedative activities of Dimenhydrinate.,76,Type_76,Yes
DB00514,Dextromethorphan,DB01241,Gemfibrozil,0.9629737734794617,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB00254,Doxycycline,DB00918,Almotriptan,0.9268225431442261,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00839,Tolazamide,DB01067,Glipizide,0.9985585808753967,9,Type_9,Tolazamide may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00270,Isradipine,DB00773,Etoposide,0.8677492141723633,47,Type_47,The metabolism of Etoposide can be decreased when combined with Isradipine.,47,Type_47,Yes
DB01227,Levacetylmethadol,DB09338,Mersalyl,0.9994341731071472,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Mersalyl.,49,Type_49,Yes
DB00235,Milrinone,DB00244,Mesalazine,0.4032706916332245,6,Type_6,Milrinone may increase the anticoagulant activities of Mesalazine.,49,Type_49,No
DB00961,Mepivacaine,DB01567,Fludiazepam,0.9994472861289978,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Fludiazepam.,49,Type_49,Yes
DB00489,Sotalol,DB05039,Indacaterol,0.7814145684242249,14,Type_14,Sotalol may decrease the bronchodilatory activities of Indacaterol.,20,Type_20,No
DB01239,Chlorprothixene,DB09166,Etizolam,0.9970254302024841,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Etizolam.,49,Type_49,Yes
DB00277,Theophylline,DB06715,Potassium Iodide,0.9759511947631836,73,Type_73,The serum concentration of Potassium Iodide can be increased when it is combined with Theophylline.,73,Type_73,Yes
DB00631,Clofarabine,DB01351,Amobarbital,0.5128136873245239,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Amobarbital.,60,Type_60,No
DB01069,Promethazine,DB01589,Quazepam,0.8505502343177795,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Quazepam.,73,Type_73,No
DB00974,Edetic acid,DB05266,Ibudilast,0.9970144033432007,6,Type_6,Edetic acid may increase the anticoagulant activities of Ibudilast.,6,Type_6,Yes
DB00363,Clozapine,DB01614,Acepromazine,0.7799044847488403,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Acepromazine.,49,Type_49,Yes
DB00968,Methyldopa,DB09282,Molsidomine,1.0,60,Type_60,Methyldopa may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00521,Carteolol,DB00559,Bosentan,0.9103734493255615,60,Type_60,Carteolol may increase the hypotensive activities of Bosentan.,60,Type_60,Yes
DB00871,Terbutaline,DB01577,Metamfetamine,0.9998087286949158,49,Type_49,The risk or severity of adverse effects can be increased when Terbutaline is combined with Metamfetamine.,49,Type_49,Yes
DB00606,Cyclothiazide,DB00796,Candesartan cilexetil,0.4424554705619812,49,Type_49,The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Candesartan cilexetil.,56,Type_56,No
DB01136,Carvedilol,DB09231,Benidipine,0.9666067957878113,60,Type_60,Carvedilol may increase the hypotensive activities of Benidipine.,60,Type_60,Yes
DB06697,Artemether,DB09076,Umeclidinium,0.9928931593894958,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Artemether.,47,Type_47,Yes
DB00978,Lomefloxacin,DB05812,Abiraterone,0.6966204047203064,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Lomefloxacin.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB01132,Pioglitazone,0.9740234017372131,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00193,Tramadol,DB00384,Triamterene,0.7093468308448792,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Triamterene.,49,Type_49,Yes
DB00875,Flupentixol,DB09085,Tetracaine,0.9999580383300781,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Tetracaine.,49,Type_49,Yes
DB01067,Glipizide,DB09280,Lumacaftor,0.41293227672576904,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Glipizide.,75,Type_75,No
DB00264,Metoprolol,DB00554,Piroxicam,0.9963529109954834,37,Type_37,Metoprolol may decrease the antihypertensive activities of Piroxicam.,37,Type_37,Yes
DB00570,Vinblastine,DB06145,Spiramycin,0.40166452527046204,73,Type_73,The serum concentration of Spiramycin can be increased when it is combined with Vinblastine.,73,Type_73,Yes
DB00266,Dicoumarol,DB05219,Crisaborole,0.9971979856491089,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Dicoumarol.,47,Type_47,Yes
DB01016,Glyburide,DB06595,Midostaurin,0.8143737316131592,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Glyburide.,47,Type_47,Yes
DB00673,Aprepitant,DB00843,Donepezil,0.9510353207588196,73,Type_73,The serum concentration of Donepezil can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00427,Triprolidine,DB00555,Lamotrigine,0.9978269934654236,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Lamotrigine.,49,Type_49,Yes
DB00503,Ritonavir,DB00514,Dextromethorphan,0.9378743767738342,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB01057,Echothiophate,DB03128,Acetylcholine,0.9759380221366882,49,Type_49,The risk or severity of adverse effects can be increased when Echothiophate is combined with Acetylcholine.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00751,Epinastine,0.8524156808853149,47,Type_47,The metabolism of Epinastine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01621,Pipotiazine,DB06153,Pizotifen,0.9935205578804016,49,Type_49,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Pizotifen.,49,Type_49,Yes
DB08860,Pitavastatin,DB09055,Acipimox,0.9940670728683472,48,Type_48,Pitavastatin may increase the myopathic rhabdomyolysis activities of Acipimox.,48,Type_48,Yes
DB01296,Glucosamine,DB04743,Nimesulide,0.8050557971000671,53,Type_53,Glucosamine may increase the antiplatelet activities of Nimesulide.,53,Type_53,Yes
DB06216,Asenapine,DB09039,Eliglustat,0.5180739164352417,20,Type_20,Asenapine may increase the QTc-prolonging activities of Eliglustat.,33,Type_33,No
DB04576,Fleroxacin,DB06203,Alogliptin,0.9995214939117432,9,Type_9,Fleroxacin may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00252,Phenytoin,DB06605,Apixaban,0.7768586874008179,4,Type_4,The metabolism of Apixaban can be increased when combined with Phenytoin.,75,Type_75,No
DB01621,Pipotiazine,DB09342,Propoxycaine,0.9999960660934448,49,Type_49,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Propoxycaine.,49,Type_49,Yes
DB00268,Ropinirole,DB00502,Haloperidol,0.967394232749939,32,Type_32,Ropinirole may increase the sedative activities of Haloperidol.,32,Type_32,Yes
DB00421,Spironolactone,DB01159,Halothane,0.9995805621147156,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Halothane.,49,Type_49,Yes
DB00391,Sulpiride,DB00436,Bendroflumethiazide,0.8568423986434937,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Bendroflumethiazide.,49,Type_49,Yes
DB00312,Pentobarbital,DB04938,Ospemifene,0.9764330983161926,4,Type_4,The metabolism of Ospemifene can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00622,Nicardipine,DB00788,Naproxen,0.8981669545173645,47,Type_47,The metabolism of Naproxen can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00350,Minoxidil,DB09244,Pirlindole,0.9974650144577026,60,Type_60,Minoxidil may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB01365,Mephentermine,DB01366,Procaterol,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Mephentermine is combined with Procaterol.,49,Type_49,Yes
DB00454,Meperidine,DB00575,Clonidine,0.9590050578117371,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Clonidine.,49,Type_49,Yes
DB00747,Scopolamine,DB01062,Oxybutynin,0.9518719911575317,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybutynin.,49,Type_49,Yes
DB01224,Quetiapine,DB06413,Armodafinil,0.9286019206047058,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Quetiapine.,47,Type_47,Yes
DB01160,Dinoprost tromethamine,DB08984,Etofenamate,0.7982041835784912,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB00490,Buspirone,DB00872,Conivaptan,0.9818626046180725,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Buspirone.,73,Type_73,Yes
DB00706,Tamsulosin,DB00966,Telmisartan,0.959321916103363,49,Type_49,The risk or severity of adverse effects can be increased when Tamsulosin is combined with Telmisartan.,49,Type_49,Yes
DB00358,Mefloquine,DB01137,Levofloxacin,0.8483079671859741,20,Type_20,Mefloquine may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB04878,Voglibose,DB06788,Histrelin,1.0,70,Type_70,The therapeutic efficacy of Histrelin can be decreased when used in combination with Voglibose.,70,Type_70,Yes
DB00187,Esmolol,DB00703,Methazolamide,0.9484763145446777,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Methazolamide.,49,Type_49,Yes
DB00246,Ziprasidone,DB00813,Fentanyl,0.8555164337158203,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Fentanyl.,73,Type_73,No
DB01035,Procainamide,DB08871,Eribulin,0.9950760006904602,20,Type_20,Procainamide may increase the QTc-prolonging activities of Eribulin.,20,Type_20,Yes
DB01435,Antipyrine,DB09204,Arotinolol,0.9999485015869141,37,Type_37,Antipyrine may decrease the antihypertensive activities of Arotinolol.,37,Type_37,Yes
DB00334,Olanzapine,DB01626,Pargyline,0.5690363645553589,64,Type_64,Olanzapine may increase the serotonergic activities of Pargyline.,64,Type_64,Yes
DB00371,Meprobamate,DB00647,Dextropropoxyphene,0.9964156150817871,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00678,Losartan,DB01157,Trimetrexate,0.6835126876831055,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Trimetrexate.,47,Type_47,No
DB00737,Meclizine,DB01174,Phenobarbital,0.8979321718215942,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Phenobarbital.,49,Type_49,Yes
DB00268,Ropinirole,DB00325,Nitroprusside,0.9432226419448853,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Nitroprusside.,49,Type_49,Yes
DB01161,Chloroprocaine,DB09085,Tetracaine,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Tetracaine.,49,Type_49,Yes
DB00343,Diltiazem,DB00564,Carbamazepine,0.7675411701202393,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Diltiazem.,73,Type_73,No
DB00351,Megestrol acetate,DB01248,Docetaxel,0.9866417646408081,49,Type_49,The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Docetaxel.,49,Type_49,Yes
DB00421,Spironolactone,DB00458,Imipramine,0.7943934202194214,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Imipramine.,49,Type_49,Yes
DB01319,Fosamprenavir,DB01394,Colchicine,0.9707057476043701,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Fosamprenavir.,73,Type_73,Yes
DB00224,Indinavir,DB00911,Tinidazole,0.9389402866363525,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00881,Quinapril,DB01113,Papaverine,0.9993396401405334,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Papaverine.,49,Type_49,Yes
DB00091,Cyclosporine,DB01254,Dasatinib,0.7413041591644287,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB01595,Nitrazepam,DB09048,Netupitant,0.9387531280517578,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Nitrazepam.,73,Type_73,Yes
DB00215,Citalopram,DB00541,Vincristine,0.46496230363845825,47,Type_47,The metabolism of Vincristine can be decreased when combined with Citalopram.,73,Type_73,No
DB00749,Etodolac,DB09084,Benzydamine,0.9946944117546082,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Benzydamine.,49,Type_49,Yes
DB00312,Pentobarbital,DB00875,Flupentixol,0.40660595893859863,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Flupentixol.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01240,Epoprostenol,0.31882697343826294,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Epoprostenol.,70,Type_70,No
DB01162,Terazosin,DB06267,Udenafil,0.7121310830116272,60,Type_60,Terazosin may increase the hypotensive activities of Udenafil.,60,Type_60,Yes
DB09117,Paraldehyde,DB13323,Trichloroethylene,0.9992035031318665,16,Type_16,Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.,16,Type_16,Yes
DB01214,Metipranolol,DB01253,Ergometrine,0.8361209034919739,19,Type_19,Metipranolol may increase the vasoconstricting activities of Ergometrine.,19,Type_19,Yes
DB00226,Guanadrel,DB11362,Selexipag,0.999991774559021,60,Type_60,Guanadrel may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB04946,Iloperidone,DB08882,Linagliptin,0.6305553913116455,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Iloperidone.,70,Type_70,Yes
DB00744,Zileuton,DB01177,Idarubicin,0.9970343112945557,72,Type_72,Zileuton may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB00297,Bupivacaine,DB01193,Acebutolol,0.5188260078430176,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Acebutolol.,73,Type_73,No
DB01174,Phenobarbital,DB09078,Lenvatinib,0.6144479513168335,4,Type_4,The metabolism of Lenvatinib can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00590,Doxazosin,DB00857,Terbinafine,0.852064847946167,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00831,Trifluoperazine,DB01466,Ethylmorphine,0.9917329549789429,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethylmorphine.,49,Type_49,Yes
DB00371,Meprobamate,DB09225,Zotepine,0.9996148347854614,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Zotepine.,49,Type_49,Yes
DB00963,Bromfenac,DB00966,Telmisartan,0.8752004504203796,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Telmisartan.,49,Type_49,Yes
DB00366,Doxylamine,DB01149,Nefazodone,0.7397484183311462,49,Type_49,The risk or severity of adverse effects can be increased when Doxylamine is combined with Nefazodone.,49,Type_49,Yes
DB00421,Spironolactone,DB00661,Verapamil,0.983828067779541,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Verapamil.,49,Type_49,Yes
DB00446,Chloramphenicol,DB12332,Rucaparib,0.9742035865783691,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00376,Trihexyphenidyl,DB00677,Isoflurophate,0.998852014541626,70,Type_70,The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Trihexyphenidyl.,70,Type_70,Yes
DB00887,Bumetanide,DB01174,Phenobarbital,0.8771120309829712,60,Type_60,Bumetanide may increase the hypotensive activities of Phenobarbital.,60,Type_60,Yes
DB00288,Amcinonide,DB06412,Oxymetholone,0.9904482960700989,74,Type_74,Amcinonide may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB00872,Conivaptan,DB01115,Nifedipine,0.5386849641799927,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Nifedipine.,73,Type_73,No
DB00393,Nimodipine,DB11362,Selexipag,0.999049723148346,60,Type_60,Nimodipine may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00331,Metformin,DB01325,Quinethazone,0.9979678988456726,70,Type_70,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00395,Carisoprodol,DB01081,Diphenoxylate,0.9992177486419678,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Diphenoxylate.,49,Type_49,Yes
DB00780,Phenelzine,DB06288,Amisulpride,0.9822142720222473,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Amisulpride.,49,Type_49,Yes
DB01403,Methotrimeprazine,DB13595,Almasilate,0.9762311577796936,67,Type_67,Methotrimeprazine can cause a decrease in the absorption of Almasilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00377,Palonosetron,DB06684,Vilazodone,0.979769229888916,64,Type_64,Palonosetron may increase the serotonergic activities of Vilazodone.,64,Type_64,Yes
DB00569,Fondaparinux,DB00784,Mefenamic acid,0.9984116554260254,6,Type_6,Fondaparinux may increase the anticoagulant activities of Mefenamic acid.,6,Type_6,Yes
DB01154,Thiamylal,DB01174,Phenobarbital,0.8019818067550659,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Thiamylal.,4,Type_4,Yes
DB00684,Tobramycin,DB06802,Nepafenac,0.9999973773956299,72,Type_72,Tobramycin may decrease the excretion rate of Nepafenac which could result in a higher serum level.,72,Type_72,Yes
DB00350,Minoxidil,DB01168,Procarbazine,0.8764536380767822,60,Type_60,Minoxidil may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00436,Bendroflumethiazide,DB00999,Hydrochlorothiazide,0.6388959884643555,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00802,Alfentanil,DB01588,Prazepam,0.9978569149971008,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Prazepam.,49,Type_49,Yes
DB00590,Doxazosin,DB00599,Thiopental,0.7127586603164673,60,Type_60,Doxazosin may increase the hypotensive activities of Thiopental.,60,Type_60,Yes
DB00675,Tamoxifen,DB06636,Isavuconazonium,0.6743835210800171,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB01567,Fludiazepam,DB01588,Prazepam,0.9997466206550598,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Prazepam.,49,Type_49,Yes
DB00278,Argatroban,DB00924,Cyclobenzaprine,0.870060920715332,73,Type_73,The serum concentration of Cyclobenzaprine can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00433,Prochlorperazine,DB00726,Trimipramine,0.948050856590271,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Trimipramine.,49,Type_49,Yes
DB00514,Dextromethorphan,DB02703,Fusidic acid,0.9998370409011841,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Dextromethorphan.,73,Type_73,Yes
DB00195,Betaxolol,DB08981,Fenbufen,0.9519891142845154,37,Type_37,Betaxolol may decrease the antihypertensive activities of Fenbufen.,37,Type_37,Yes
DB04855,Dronedarone,DB08899,Enzalutamide,0.9130974411964417,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Dronedarone.,75,Type_75,Yes
DB00374,Treprostinil,DB00418,Secobarbital,0.31424492597579956,60,Type_60,Treprostinil may increase the hypotensive activities of Secobarbital.,75,Type_75,No
DB00588,Fluticasone propionate,DB01142,Doxepin,0.9915551543235779,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Doxepin.,49,Type_49,Yes
DB00496,Darifenacin,DB01238,Aripiprazole,0.46038323640823364,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Darifenacin.,73,Type_73,Yes
DB00750,Prilocaine,DB00898,Ethanol,0.999834418296814,16,Type_16,Prilocaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00237,Butabarbital,DB01466,Ethylmorphine,0.9972319006919861,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Ethylmorphine.,49,Type_49,Yes
DB00564,Carbamazepine,DB00636,Clofibrate,0.9552651047706604,4,Type_4,The metabolism of Clofibrate can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00571,Propranolol,DB09054,Idelalisib,0.8905600309371948,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Propranolol.,47,Type_47,Yes
DB01126,Dutasteride,DB01232,Saquinavir,0.8819122314453125,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Dutasteride.,73,Type_73,No
DB00180,Flunisolide,DB00843,Donepezil,0.9659548401832581,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Donepezil.,49,Type_49,Yes
DB00594,Amiloride,DB08907,Canagliflozin,0.7833014726638794,68,Type_68,Amiloride may increase the hyperkalemic activities of Canagliflozin.,68,Type_68,Yes
DB00951,Isoniazid,DB01370,Aluminium,0.5412827730178833,75,Type_75,The serum concentration of Aluminium can be decreased when it is combined with Isoniazid.,67,Type_67,No
DB00521,Carteolol,DB01238,Aripiprazole,0.9952619075775146,60,Type_60,Carteolol may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB01248,Docetaxel,DB05265,Ecabet,0.9183589220046997,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Ecabet.,49,Type_49,Yes
DB01119,Diazoxide,DB01261,Sitagliptin,0.9157029390335083,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Diazoxide.,70,Type_70,Yes
DB01587,Ketazolam,DB09342,Propoxycaine,0.9999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Propoxycaine.,49,Type_49,Yes
DB08984,Etofenamate,DB09091,Tixocortol,0.9996763467788696,49,Type_49,The risk or severity of adverse effects can be increased when Etofenamate is combined with Tixocortol.,49,Type_49,Yes
DB00608,Chloroquine,DB08808,Bupranolol,0.5752820372581482,47,Type_47,The metabolism of Bupranolol can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB06663,Pasireotide,DB08907,Canagliflozin,0.5763517618179321,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Pasireotide.,70,Type_70,Yes
DB00472,Fluoxetine,DB01576,Dextroamphetamine,0.9161242246627808,47,Type_47,The metabolism of Dextroamphetamine can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00528,Lercanidipine,DB01236,Sevoflurane,0.7766676545143127,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sevoflurane.,49,Type_49,Yes
DB00231,Temazepam,DB00619,Imatinib,0.9240137338638306,47,Type_47,The metabolism of Imatinib can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00177,Valsartan,DB00835,Brompheniramine,0.9346696734428406,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00673,Aprepitant,DB01036,Tolterodine,0.8941977620124817,73,Type_73,The serum concentration of Tolterodine can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01114,Chlorpheniramine,DB01236,Sevoflurane,0.9251655340194702,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Sevoflurane.,49,Type_49,Yes
DB00313,Valproic acid,DB00962,Zaleplon,0.9517632126808167,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Zaleplon.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB13783,Acemetacin,0.9623010158538818,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Candesartan cilexetil.,70,Type_70,Yes
DB00678,Losartan,DB06207,Silodosin,0.9639751315116882,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Losartan.,73,Type_73,Yes
DB00203,Sildenafil,DB04876,Vildagliptin,0.6567815542221069,47,Type_47,The metabolism of Vildagliptin can be decreased when combined with Sildenafil.,73,Type_73,No
DB00559,Bosentan,DB01254,Dasatinib,0.6562208533287048,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Bosentan.,75,Type_75,No
DB00335,Atenolol,DB01054,Nitrendipine,0.662207305431366,60,Type_60,Atenolol may increase the hypotensive activities of Nitrendipine.,49,Type_49,No
DB00254,Doxycycline,DB00589,Lisuride,0.8567076325416565,47,Type_47,The metabolism of Lisuride can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00502,Haloperidol,DB00570,Vinblastine,0.877334713935852,47,Type_47,The metabolism of Vinblastine can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB01234,Dexamethasone,DB08984,Etofenamate,0.9940906167030334,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Etofenamate.,49,Type_49,Yes
DB00883,Isosorbide dinitrate,DB01211,Clarithromycin,0.5632792115211487,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Isosorbide dinitrate.,47,Type_47,Yes
DB00206,Reserpine,DB00835,Brompheniramine,0.9901944994926453,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Brompheniramine.,49,Type_49,Yes
DB00196,Fluconazole,DB08899,Enzalutamide,0.8956799507141113,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Fluconazole.,47,Type_47,No
DB01563,Chloral hydrate,DB05271,Rotigotine,0.9559722542762756,32,Type_32,Chloral hydrate may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00604,Cisapride,DB00898,Ethanol,0.33753976225852966,47,Type_47,The metabolism of Ethanol can be decreased when combined with Cisapride.,49,Type_49,No
DB00477,Chlorpromazine,DB00976,Telithromycin,0.42396479845046997,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Chlorpromazine.,20,Type_20,No
DB00738,Pentamidine,DB01072,Atazanavir,0.5190799236297607,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Atazanavir.,47,Type_47,No
DB00933,Mesoridazine,DB01218,Halofantrine,0.5078813433647156,47,Type_47,The metabolism of Halofantrine can be decreased when combined with Mesoridazine.,73,Type_73,No
DB00683,Midazolam,DB06282,Levocetirizine,0.9946101903915405,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Levocetirizine.,49,Type_49,Yes
DB01029,Irbesartan,DB01124,Tolbutamide,0.9551870226860046,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB04855,Dronedarone,DB06292,Dapagliflozin,0.8089575171470642,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00150,Tryptophan,DB00333,Methadone,0.9506188631057739,64,Type_64,Tryptophan may increase the serotonergic activities of Methadone.,64,Type_64,Yes
DB00625,Efavirenz,DB01171,Moclobemide,0.6040126085281372,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00317,Gefitinib,DB08806,Roxatidine acetate,0.7007142901420593,75,Type_75,The serum concentration of Roxatidine acetate can be decreased when it is combined with Gefitinib.,75,Type_75,Yes
DB00530,Erlotinib,DB00927,Famotidine,0.4689836800098419,75,Type_75,The serum concentration of Famotidine can be decreased when it is combined with Erlotinib.,75,Type_75,Yes
DB00370,Mirtazapine,DB08864,Rilpivirine,0.8697722554206848,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB00180,Flunisolide,DB06736,Aceclofenac,0.9987778067588806,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Aceclofenac.,49,Type_49,Yes
DB01233,Metoclopramide,DB09224,Melperone,0.7274084687232971,49,Type_49,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Melperone.,49,Type_49,Yes
DB00195,Betaxolol,DB00772,Malathion,0.9371156692504883,54,Type_54,Betaxolol may increase the bradycardic activities of Malathion.,54,Type_54,Yes
DB00214,Torasemide,DB06196,Icatibant,0.9998456239700317,29,Type_29,Torasemide may decrease the diuretic activities of Icatibant.,29,Type_29,Yes
DB01239,Chlorprothixene,DB08987,Etidocaine,0.9999675750732422,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Etidocaine.,49,Type_49,Yes
DB00492,Fosinopril,DB01242,Clomipramine,0.581692636013031,73,Type_73,The serum concentration of Clomipramine can be increased when it is combined with Fosinopril.,73,Type_73,Yes
DB00420,Promazine,DB01107,Methyprylon,0.9967184662818909,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Promazine.,47,Type_47,Yes
DB00690,Flurazepam,DB01176,Cyclizine,0.9999958276748657,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Cyclizine.,49,Type_49,Yes
DB00605,Sulindac,DB00795,Sulfasalazine,0.9991995692253113,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Sulfasalazine.,49,Type_49,Yes
DB01174,Phenobarbital,DB07615,Tranilast,0.7967273592948914,4,Type_4,The metabolism of Tranilast can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00393,Nimodipine,DB00486,Nabilone,0.9928635954856873,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Nabilone.,49,Type_49,Yes
DB06824,Triethylenetetramine,DB09146,Iron sucrose,0.7883635759353638,67,Type_67,Triethylenetetramine can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00238,Nevirapine,DB01559,Clotiazepam,0.9064680933952332,4,Type_4,The metabolism of Clotiazepam can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00814,Meloxicam,DB00939,Meclofenamic acid,0.9986633062362671,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Meclofenamic acid.,49,Type_49,Yes
DB00802,Alfentanil,DB00940,Methantheline,0.979004979133606,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Methantheline.,49,Type_49,Yes
DB00177,Valsartan,DB00633,Dexmedetomidine,0.5903919339179993,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Dexmedetomidine.,49,Type_49,Yes
DB01173,Orphenadrine,DB13025,Tiapride,0.9880213737487793,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Tiapride.,16,Type_16,Yes
DB00846,Flurandrenolide,DB09288,Propacetamol,0.9992321729660034,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Propacetamol.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB11304,Phenoxyethanol,0.999931812286377,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Phenoxyethanol.,49,Type_49,Yes
DB00908,Quinidine,DB04794,Bifonazole,0.5289629697799683,73,Type_73,The serum concentration of Bifonazole can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00844,Nalbuphine,DB01591,Solifenacin,0.999169111251831,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Solifenacin.,49,Type_49,Yes
DB00514,Dextromethorphan,DB01589,Quazepam,0.7823171019554138,47,Type_47,The metabolism of Quazepam can be decreased when combined with Dextromethorphan.,73,Type_73,No
DB00006,Bivalirudin,DB00458,Imipramine,0.5750676989555359,73,Type_73,The serum concentration of Imipramine can be increased when it is combined with Bivalirudin.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB00752,Tranylcypromine,0.668604850769043,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Magnesium sulfate.,16,Type_16,No
DB01254,Dasatinib,DB09048,Netupitant,0.9943994879722595,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00283,Clemastine,DB01191,Dexfenfluramine,0.9503795504570007,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00404,Alprazolam,DB08933,Luliconazole,0.9774575233459473,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Alprazolam.,73,Type_73,Yes
DB05812,Abiraterone,DB06204,Tapentadol,0.6254265904426575,73,Type_73,The serum concentration of Tapentadol can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00220,Nelfinavir,DB00246,Ziprasidone,0.5006098747253418,73,Type_73,The serum concentration of Ziprasidone can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00343,Diltiazem,DB04946,Iloperidone,0.6667187809944153,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00528,Lercanidipine,DB01189,Desflurane,0.9993696808815002,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Desflurane.,49,Type_49,Yes
DB00623,Fluphenazine,DB01452,Diamorphine,0.9912611842155457,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Diamorphine.,49,Type_49,Yes
DB00699,Nicergoline,DB06708,Lumefantrine,0.5085552334785461,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Nicergoline.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB00681,Amphotericin B,0.998389482498169,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Amphotericin B.,49,Type_49,Yes
DB00798,Gentamicin,DB01628,Etoricoxib,0.9997465014457703,72,Type_72,Gentamicin may decrease the excretion rate of Etoricoxib which could result in a higher serum level.,72,Type_72,Yes
DB00315,Zolmitriptan,DB00433,Prochlorperazine,0.9874565005302429,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prochlorperazine.,49,Type_49,Yes
DB01340,Cilazapril,DB09543,Methyl salicylate,0.953559398651123,37,Type_37,Cilazapril may decrease the antihypertensive activities of Methyl salicylate.,37,Type_37,Yes
DB01119,Diazoxide,DB01251,Gliquidone,0.9802302122116089,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Diazoxide.,70,Type_70,Yes
DB00518,Albendazole,DB09073,Palbociclib,0.996661901473999,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Albendazole.,73,Type_73,Yes
DB00413,Pramipexole,DB00421,Spironolactone,0.9987389445304871,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Spironolactone.,49,Type_49,Yes
DB00899,Remifentanil,DB01618,Molindone,0.9997177720069885,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Molindone.,49,Type_49,Yes
DB00280,Disopyramide,DB01210,Levobunolol,0.9053040742874146,54,Type_54,Disopyramide may increase the bradycardic activities of Levobunolol.,54,Type_54,Yes
DB00818,Propofol,DB01587,Ketazolam,0.9690863490104675,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Ketazolam.,49,Type_49,Yes
DB00938,Salmeterol,DB06636,Isavuconazonium,0.7582977414131165,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Salmeterol.,73,Type_73,No
DB00420,Promazine,DB00934,Maprotiline,0.44268032908439636,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Maprotiline.,20,Type_20,No
DB00838,Clocortolone,DB00890,Dienestrol,0.9951321482658386,73,Type_73,The serum concentration of Dienestrol can be increased when it is combined with Clocortolone.,73,Type_73,Yes
DB00474,Methohexital,DB04841,Flunarizine,0.9564982056617737,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Flunarizine.,49,Type_49,Yes
DB00401,Nisoldipine,DB06290,Simeprevir,0.9418349862098694,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Nisoldipine.,73,Type_73,Yes
DB00527,Cinchocaine,DB00575,Clonidine,0.9877381324768066,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Clonidine.,49,Type_49,Yes
DB00524,Metolazone,DB01199,Tubocurarine,0.9719156622886658,73,Type_73,The serum concentration of Tubocurarine can be increased when it is combined with Metolazone.,73,Type_73,Yes
DB00391,Sulpiride,DB00952,Naratriptan,0.9979464411735535,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Naratriptan.,49,Type_49,Yes
DB01412,Theobromine,DB13783,Acemetacin,0.8352431058883667,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Theobromine.,70,Type_70,Yes
DB01259,Lapatinib,DB08873,Boceprevir,0.48797786235809326,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Lapatinib.,73,Type_73,No
DB01367,Rasagiline,DB09042,Tedizolid phosphate,0.991138756275177,64,Type_64,Rasagiline may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB00530,Erlotinib,DB01015,Sulfamethoxazole,0.8472053408622742,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Erlotinib.,47,Type_47,Yes
DB00312,Pentobarbital,DB00717,Norethisterone,0.9737966060638428,4,Type_4,The metabolism of Norethisterone can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB06684,Vilazodone,DB08881,Vemurafenib,0.6344377994537354,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Vilazodone.,75,Type_75,No
DB00672,Chlorpropamide,DB02546,Vorinostat,0.7223684787750244,70,Type_70,The therapeutic efficacy of Vorinostat can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB01075,Diphenhydramine,DB01086,Benzocaine,0.9947342872619629,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Benzocaine.,49,Type_49,Yes
DB00318,Codeine,DB01595,Nitrazepam,0.9879410266876221,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Nitrazepam.,49,Type_49,Yes
DB00726,Trimipramine,DB01264,Darunavir,0.5538220405578613,47,Type_47,The metabolism of Darunavir can be decreased when combined with Trimipramine.,73,Type_73,No
DB00241,Butalbital,DB00904,Ondansetron,0.997314989566803,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Ondansetron.,49,Type_49,Yes
DB00333,Methadone,DB00489,Sotalol,0.43467551469802856,20,Type_20,Methadone may increase the QTc-prolonging activities of Sotalol.,20,Type_20,Yes
DB00653,Magnesium sulfate,DB04743,Nimesulide,0.9950240254402161,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Nimesulide.,49,Type_49,Yes
DB00205,Pyrimethamine,DB06414,Etravirine,0.8616018295288086,47,Type_47,The metabolism of Etravirine can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00246,Ziprasidone,DB00546,Adinazolam,0.9603959321975708,47,Type_47,The metabolism of Adinazolam can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00679,Thioridazine,DB01576,Dextroamphetamine,0.438124418258667,76,Type_76,Thioridazine may decrease the sedative activities of Dextroamphetamine.,73,Type_73,No
DB00805,Minaprine,DB00953,Rizatriptan,0.6386580467224121,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Rizatriptan.,47,Type_47,No
DB01192,Oxymorphone,DB09167,Dosulepin,0.4119246006011963,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Oxymorphone.,47,Type_47,Yes
DB00880,Chlorothiazide,DB00999,Hydrochlorothiazide,0.7132675647735596,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00482,Celecoxib,DB00908,Quinidine,0.9668983221054077,47,Type_47,The metabolism of Quinidine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00819,Acetazolamide,DB09352,Hydroxyamphetamine,0.9701074361801147,72,Type_72,Acetazolamide may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level.,72,Type_72,Yes
DB06016,Cariprazine,DB09054,Idelalisib,0.8404980301856995,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Cariprazine.,47,Type_47,Yes
DB01580,Oxprenolol,DB08868,Fingolimod,0.9706444144248962,54,Type_54,Oxprenolol may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB00312,Pentobarbital,DB01045,Rifampicin,0.9236592650413513,4,Type_4,The metabolism of Rifampicin can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01092,Ouabain,DB09054,Idelalisib,0.9867092967033386,58,Type_58,Ouabain may decrease the cardiotoxic activities of Idelalisib.,58,Type_58,Yes
DB00477,Chlorpromazine,DB00675,Tamoxifen,0.6072420477867126,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Chlorpromazine.,11,Type_11,No
DB00363,Clozapine,DB01628,Etoricoxib,0.7959204316139221,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00270,Isradipine,DB01026,Ketoconazole,0.6591533422470093,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00283,Clemastine,DB01075,Diphenhydramine,0.9381675124168396,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00985,Dimenhydrinate,DB05271,Rotigotine,0.9870519638061523,32,Type_32,Dimenhydrinate may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00571,Propranolol,DB08893,Mirabegron,0.7056740522384644,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Propranolol.,47,Type_47,Yes
DB00554,Piroxicam,DB09211,Limaprost,0.931660532951355,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Piroxicam.,70,Type_70,Yes
DB00281,Lidocaine,DB08933,Luliconazole,0.9792332053184509,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB00328,Indomethacin,DB00896,Rimexolone,0.9995139837265015,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Rimexolone.,49,Type_49,Yes
DB00909,Zonisamide,DB08912,Dabrafenib,0.951784610748291,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Zonisamide.,75,Type_75,Yes
DB00247,Methysergide,DB00696,Ergotamine,0.9491295218467712,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Ergotamine.,49,Type_49,Yes
DB00932,Tipranavir,DB06204,Tapentadol,0.9198833107948303,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00421,Spironolactone,DB00678,Losartan,0.9199477434158325,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.,49,Type_49,Yes
DB01129,Rabeprazole,DB06770,Benzyl alcohol,0.9673717617988586,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Rabeprazole.,47,Type_47,Yes
DB00349,Clobazam,DB01018,Guanfacine,0.8204295039176941,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Clobazam.,49,Type_49,No
DB00252,Phenytoin,DB01283,Lumiracoxib,0.8898945450782776,4,Type_4,The metabolism of Lumiracoxib can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00808,Indapamide,DB09065,Cobicistat,0.6016555428504944,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Indapamide.,47,Type_47,Yes
DB00455,Loratadine,DB09167,Dosulepin,0.8932817578315735,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Loratadine.,47,Type_47,Yes
DB00620,Triamcinolone,DB06819,Phenylbutyric acid,0.9560061693191528,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Triamcinolone.,70,Type_70,Yes
DB00367,Levonorgestrel,DB09075,Edoxaban,0.6326474547386169,12,Type_12,Levonorgestrel may decrease the anticoagulant activities of Edoxaban.,70,Type_70,No
DB00491,Miglitol,DB00695,Furosemide,0.9998194575309753,70,Type_70,The therapeutic efficacy of Furosemide can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00906,Tiagabine,DB09117,Paraldehyde,0.9998779296875,16,Type_16,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01086,Benzocaine,DB06480,Prucalopride,0.7253817319869995,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Benzocaine.,73,Type_73,Yes
DB00582,Voriconazole,DB13158,Clobetasone,0.9852741360664368,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB01081,Diphenoxylate,DB06153,Pizotifen,0.9986109733581543,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Pizotifen.,49,Type_49,Yes
DB00490,Buspirone,DB01403,Methotrimeprazine,0.49784988164901733,16,Type_16,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB03585,Oxyphenbutazone,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Oxyphenbutazone.,70,Type_70,Yes
DB00484,Brimonidine,DB00653,Magnesium sulfate,0.9999971389770508,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00184,Nicotine,DB00263,Sulfisoxazole,0.9724358320236206,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01201,Rifapentine,DB09054,Idelalisib,0.900786280632019,75,Type_75,The serum concentration of Idelalisib can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00575,Clonidine,DB00628,Clorazepic acid,0.9892783164978027,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Clorazepic acid.,49,Type_49,Yes
DB04861,Nebivolol,DB09083,Ivabradine,0.7274016737937927,54,Type_54,Nebivolol may increase the bradycardic activities of Ivabradine.,54,Type_54,Yes
DB00565,Cisatracurium,DB00684,Tobramycin,0.9996715784072876,40,Type_40,Cisatracurium may increase the respiratory depressant activities of Tobramycin.,40,Type_40,Yes
DB01087,Primaquine,DB01268,Sunitinib,0.9256992340087891,20,Type_20,Primaquine may increase the QTc-prolonging activities of Sunitinib.,20,Type_20,Yes
DB00752,Tranylcypromine,DB01365,Mephentermine,0.5468348860740662,69,Type_69,Tranylcypromine may increase the analgesic activities of Mephentermine.,71,Type_71,No
DB00694,Daunorubicin,DB01435,Antipyrine,0.9835916757583618,72,Type_72,Daunorubicin may decrease the excretion rate of Antipyrine which could result in a higher serum level.,72,Type_72,Yes
DB00224,Indinavir,DB00546,Adinazolam,0.8922841548919678,47,Type_47,The metabolism of Adinazolam can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00203,Sildenafil,DB01021,Trichlormethiazide,0.9797279238700867,10,Type_10,Sildenafil may increase the antihypertensive activities of Trichlormethiazide.,10,Type_10,Yes
DB00371,Meprobamate,DB11609,Normethadone,0.9990249872207642,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Normethadone.,49,Type_49,Yes
DB01501,Difenoxin,DB01545,Ethyl loflazepate,0.999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Difenoxin is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00246,Ziprasidone,DB09225,Zotepine,0.9507308006286621,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Zotepine.,49,Type_49,Yes
DB00605,Sulindac,DB04576,Fleroxacin,0.9993956089019775,27,Type_27,Sulindac may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00625,Efavirenz,DB09048,Netupitant,0.8513773083686829,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Efavirenz.,73,Type_73,Yes
DB01224,Quetiapine,DB09085,Tetracaine,0.9999148845672607,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Tetracaine.,49,Type_49,Yes
DB00184,Nicotine,DB01006,Letrozole,0.9197087287902832,47,Type_47,The metabolism of Letrozole can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00363,Clozapine,DB00906,Tiagabine,0.6093217730522156,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Tiagabine.,49,Type_49,Yes
DB00997,Doxorubicin,DB01232,Saquinavir,0.7394345998764038,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Doxorubicin.,47,Type_47,Yes
DB01072,Atazanavir,DB01142,Doxepin,0.4855714440345764,47,Type_47,The metabolism of Doxepin can be decreased when combined with Atazanavir.,75,Type_75,No
DB01348,Spirapril,DB02638,Terlipressin,0.9999829530715942,60,Type_60,Spirapril may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB01280,Nelarabine,DB08868,Fingolimod,0.9996273517608643,34,Type_34,Nelarabine may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00239,Oxiconazole,DB08933,Luliconazole,0.9743305444717407,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Oxiconazole.,73,Type_73,Yes
DB00396,Progesterone,DB00482,Celecoxib,0.3686694800853729,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Progesterone.,47,Type_47,Yes
DB01100,Pimozide,DB06153,Pizotifen,0.9932664632797241,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Pizotifen.,49,Type_49,Yes
DB00752,Tranylcypromine,DB09236,Lacidipine,0.8950282335281372,60,Type_60,Tranylcypromine may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00940,Methantheline,DB01273,Varenicline,0.6654670834541321,49,Type_49,The risk or severity of adverse effects can be increased when Methantheline is combined with Varenicline.,73,Type_73,No
DB00440,Trimethoprim,DB01357,Mestranol,0.5922876000404358,47,Type_47,The metabolism of Mestranol can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB01122,Ambenonium,DB08906,Fluticasone furoate,0.9991946816444397,49,Type_49,The risk or severity of adverse effects can be increased when Ambenonium is combined with Fluticasone furoate.,49,Type_49,Yes
DB00297,Bupivacaine,DB00774,Hydroflumethiazide,0.7278777956962585,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydroflumethiazide.,49,Type_49,Yes
DB00404,Alprazolam,DB01124,Tolbutamide,0.42078137397766113,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Alprazolam.,47,Type_47,No
DB01101,Capecitabine,DB06268,Sitaxentan,0.9285048842430115,47,Type_47,The metabolism of Sitaxentan can be decreased when combined with Capecitabine.,47,Type_47,Yes
DB00220,Nelfinavir,DB04835,Maraviroc,0.5440633893013,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Nelfinavir.,73,Type_73,No
DB00686,Pentosan polysulfate,DB08991,Epirizole,0.9944012761116028,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Epirizole.,6,Type_6,Yes
DB00999,Hydrochlorothiazide,DB01036,Tolterodine,0.9323222637176514,73,Type_73,The serum concentration of Tolterodine can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB00179,Masoprocol,DB00436,Bendroflumethiazide,0.9974609613418579,70,Type_70,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Masoprocol.,70,Type_70,Yes
DB01228,Encainide,DB06603,Panobinostat,0.7536712884902954,47,Type_47,The metabolism of Panobinostat can be decreased when combined with Encainide.,73,Type_73,No
DB00358,Mefloquine,DB00599,Thiopental,0.728013277053833,70,Type_70,The therapeutic efficacy of Thiopental can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00673,Aprepitant,DB09054,Idelalisib,0.9546834826469421,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00176,Fluvoxamine,DB00384,Triamterene,0.8110513687133789,73,Type_73,The serum concentration of Triamterene can be increased when it is combined with Fluvoxamine.,47,Type_47,No
DB00658,Sevelamer,DB01024,Mycophenolic acid,0.8575596213340759,67,Type_67,Sevelamer can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00916,Metronidazole,DB08865,Crizotinib,0.5305665135383606,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Metronidazole.,20,Type_20,No
DB01036,Tolterodine,DB06402,Telavancin,1.0,20,Type_20,Tolterodine may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00203,Sildenafil,DB00495,Zidovudine,0.786076009273529,47,Type_47,The metabolism of Zidovudine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00909,Zonisamide,DB00976,Telithromycin,0.8404994606971741,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Zonisamide.,47,Type_47,Yes
DB00309,Vindesine,DB09063,Ceritinib,0.9950181245803833,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Vindesine.,73,Type_73,Yes
DB00540,Nortriptyline,DB00622,Nicardipine,0.44248852133750916,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Nicardipine.,47,Type_47,No
DB00230,Pregabalin,DB08907,Canagliflozin,0.9868331551551819,50,Type_50,The risk or severity of heart failure can be increased when Canagliflozin is combined with Pregabalin.,50,Type_50,Yes
DB01392,Yohimbine,DB06403,Ambrisentan,0.812527596950531,37,Type_37,Yohimbine may decrease the antihypertensive activities of Ambrisentan.,37,Type_37,Yes
DB00873,Loteprednol,DB09065,Cobicistat,0.9681909680366516,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Loteprednol.,73,Type_73,Yes
DB00554,Piroxicam,DB06736,Aceclofenac,0.9985851049423218,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Aceclofenac.,49,Type_49,Yes
DB09555,Dexchlorpheniramine maleate,DB12332,Rucaparib,0.9772210121154785,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Dexchlorpheniramine maleate.,47,Type_47,Yes
DB00612,Bisoprolol,DB01264,Darunavir,0.6800002455711365,47,Type_47,The metabolism of Darunavir can be decreased when combined with Bisoprolol.,73,Type_73,No
DB00776,Oxcarbazepine,DB00880,Chlorothiazide,0.5820775032043457,49,Type_49,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Chlorothiazide.,49,Type_49,Yes
DB00692,Phentolamine,DB01119,Diazoxide,0.9986145496368408,60,Type_60,Phentolamine may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00186,Lorazepam,DB06204,Tapentadol,0.9996922016143799,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00169,Cholecalciferol,DB00783,Estradiol,0.6907573342323303,47,Type_47,The metabolism of Estradiol can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00412,Rosiglitazone,DB01198,Zopiclone,0.8646950125694275,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00273,Topiramate,DB01069,Promethazine,0.9881077408790588,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Promethazine.,49,Type_49,Yes
DB00268,Ropinirole,DB09085,Tetracaine,0.9995983242988586,32,Type_32,Ropinirole may increase the sedative activities of Tetracaine.,32,Type_32,Yes
DB00908,Quinidine,DB00940,Methantheline,0.7057554721832275,73,Type_73,The serum concentration of Methantheline can be increased when it is combined with Quinidine.,49,Type_49,No
DB01242,Clomipramine,DB09245,Toloxatone,0.9542421102523804,64,Type_64,Clomipramine may increase the serotonergic activities of Toloxatone.,64,Type_64,Yes
DB00006,Bivalirudin,DB04898,Ximelagatran,0.7709394097328186,6,Type_6,Bivalirudin may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00418,Secobarbital,DB00678,Losartan,0.5364624261856079,4,Type_4,The metabolism of Losartan can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00976,Telithromycin,DB12001,Abemaciclib,0.692650318145752,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Telithromycin.,49,Type_49,No
DB08981,Fenbufen,DB08984,Etofenamate,0.9991099238395691,49,Type_49,The risk or severity of adverse effects can be increased when Fenbufen is combined with Etofenamate.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB06695,Dabigatran etexilate,0.9273097515106201,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Candesartan cilexetil.,77,Type_77,Yes
DB00614,Furazolidone,DB00952,Naratriptan,0.6627389192581177,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Naratriptan.,47,Type_47,No
DB01232,Saquinavir,DB01380,Cortisone acetate,0.9461061954498291,47,Type_47,The metabolism of Cortisone acetate can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00292,Etomidate,DB08872,Gabapentin enacarbil,0.9999165534973145,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00618,Demeclocycline,DB05528,Mipomersen,0.9999197721481323,80,Type_80,Demeclocycline may increase the hepatotoxic activities of Mipomersen.,80,Type_80,Yes
DB00835,Brompheniramine,DB01075,Diphenhydramine,0.6332936882972717,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB00469,Tenoxicam,DB01325,Quinethazone,0.9989668130874634,70,Type_70,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Tenoxicam.,70,Type_70,Yes
DB00712,Flurbiprofen,DB00788,Naproxen,0.9972902536392212,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Naproxen.,49,Type_49,Yes
DB00334,Olanzapine,DB06201,Rufinamide,0.9701420664787292,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Rufinamide.,49,Type_49,Yes
DB06228,Rivaroxaban,DB09289,Tianeptine,0.7088871002197266,73,Type_73,The serum concentration of Tianeptine can be increased when it is combined with Rivaroxaban.,73,Type_73,Yes
DB00458,Imipramine,DB00657,Mecamylamine,0.6058081388473511,30,Type_30,Imipramine may increase the orthostatic hypotensive activities of Mecamylamine.,49,Type_49,No
DB00320,Dihydroergotamine,DB01072,Atazanavir,0.9558437466621399,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01224,Quetiapine,DB09224,Melperone,0.9939572811126709,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Melperone.,49,Type_49,Yes
DB00557,Hydroxyzine,DB00623,Fluphenazine,0.9986068606376648,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.,16,Type_16,Yes
DB01161,Chloroprocaine,DB08872,Gabapentin enacarbil,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00220,Nelfinavir,DB01174,Phenobarbital,0.40961694717407227,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Nelfinavir.,4,Type_4,Yes
DB01268,Sunitinib,DB01396,Digitoxin,0.9834662079811096,58,Type_58,Sunitinib may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB01020,Isosorbide mononitrate,DB01340,Cilazapril,0.9582056999206543,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Cilazapril.,49,Type_49,Yes
DB00248,Cabergoline,DB08815,Lurasidone,0.9523068070411682,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Lurasidone.,49,Type_49,Yes
DB00673,Aprepitant,DB00829,Diazepam,0.6152018308639526,73,Type_73,The serum concentration of Diazepam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00287,Travoprost,DB00401,Nisoldipine,0.9999563694000244,60,Type_60,Travoprost may increase the hypotensive activities of Nisoldipine.,60,Type_60,Yes
DB00754,Ethotoin,DB06153,Pizotifen,0.9928560256958008,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Pizotifen.,49,Type_49,Yes
DB01020,Isosorbide mononitrate,DB04868,Nilotinib,0.6618651747703552,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Isosorbide mononitrate.,47,Type_47,Yes
DB00472,Fluoxetine,DB08922,Perospirone,0.6594382524490356,47,Type_47,The metabolism of Perospirone can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00435,Nitric Oxide,DB01159,Halothane,0.9919434785842896,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Halothane.,49,Type_49,Yes
DB01592,Iron,DB09414,Dipotassium phosphate,0.9899147748947144,67,Type_67,Iron can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00263,Sulfisoxazole,DB00586,Diclofenac,0.8166435956954956,47,Type_47,The metabolism of Diclofenac can be decreased when combined with Sulfisoxazole.,73,Type_73,No
DB00794,Primidone,DB11609,Normethadone,0.981314480304718,49,Type_49,The risk or severity of adverse effects can be increased when Primidone is combined with Normethadone.,49,Type_49,Yes
DB00239,Oxiconazole,DB09230,Azelnidipine,0.9883646965026855,49,Type_49,The risk or severity of adverse effects can be increased when Oxiconazole is combined with Azelnidipine.,49,Type_49,Yes
DB01193,Acebutolol,DB06292,Dapagliflozin,0.9960733652114868,49,Type_49,The risk or severity of adverse effects can be increased when Acebutolol is combined with Dapagliflozin.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB00584,Enalapril,0.9197119474411011,37,Type_37,Aminosalicylic acid may decrease the antihypertensive activities of Enalapril.,37,Type_37,Yes
DB04948,Lofexidine,DB08907,Canagliflozin,0.8995140194892883,49,Type_49,The risk or severity of adverse effects can be increased when Lofexidine is combined with Canagliflozin.,49,Type_49,Yes
DB00214,Torasemide,DB06595,Midostaurin,0.5913720726966858,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Torasemide.,47,Type_47,Yes
DB00484,Brimonidine,DB00876,Eprosartan,0.6094450950622559,10,Type_10,Brimonidine may increase the antihypertensive activities of Eprosartan.,10,Type_10,Yes
DB01029,Irbesartan,DB01340,Cilazapril,0.9038863182067871,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Cilazapril.,49,Type_49,Yes
DB00340,Metixene,DB11315,Methscopolamine,0.984933078289032,49,Type_49,The risk or severity of adverse effects can be increased when Metixene is combined with Methscopolamine.,49,Type_49,Yes
DB00312,Pentobarbital,DB06616,Bosutinib,0.7551105618476868,75,Type_75,The serum concentration of Bosutinib can be decreased when it is combined with Pentobarbital.,75,Type_75,Yes
DB00780,Phenelzine,DB01069,Promethazine,0.8729274868965149,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Promethazine.,49,Type_49,Yes
DB00887,Bumetanide,DB01274,Arformoterol,0.9990049004554749,83,Type_83,Bumetanide may increase the hypokalemic activities of Arformoterol.,83,Type_83,Yes
DB00196,Fluconazole,DB01060,Amoxicillin,0.838796854019165,47,Type_47,The metabolism of Amoxicillin can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00224,Indinavir,DB08932,Macitentan,0.9003756046295166,47,Type_47,The metabolism of Macitentan can be decreased when combined with Indinavir.,73,Type_73,No
DB01407,Clenbuterol,DB04839,Cyproterone acetate,0.6607268452644348,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Clenbuterol.,75,Type_75,Yes
DB01357,Mestranol,DB04898,Ximelagatran,0.787866473197937,75,Type_75,The serum concentration of Ximelagatran can be decreased when it is combined with Mestranol.,75,Type_75,Yes
DB06290,Simeprevir,DB09143,Sonidegib,0.9905558228492737,73,Type_73,The serum concentration of Sonidegib can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00722,Lisinopril,DB00993,Azathioprine,0.9576886892318726,63,Type_63,Lisinopril may increase the myelosuppressive activities of Azathioprine.,63,Type_63,Yes
DB00201,Caffeine,DB00316,Acetaminophen,0.8906152248382568,47,Type_47,The metabolism of Acetaminophen can be decreased when combined with Caffeine.,47,Type_47,Yes
DB01062,Oxybutynin,DB01081,Diphenoxylate,0.8919195532798767,49,Type_49,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Diphenoxylate.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB11079,Trolamine salicylate,0.7060171365737915,9,Type_9,Sulfisoxazole may increase the hypoglycemic activities of Trolamine salicylate.,9,Type_9,Yes
DB00528,Lercanidipine,DB11126,Calcium gluconate,0.9876249432563782,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Lercanidipine.,70,Type_70,Yes
DB00925,Phenoxybenzamine,DB01162,Terazosin,0.9140388369560242,49,Type_49,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Terazosin.,49,Type_49,Yes
DB00349,Clobazam,DB08872,Gabapentin enacarbil,0.9999364614486694,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB01044,Gatifloxacin,DB08984,Etofenamate,0.9989416003227234,27,Type_27,Gatifloxacin may increase the neuroexcitatory activities of Etofenamate.,27,Type_27,Yes
DB00244,Mesalazine,DB01377,Magnesium oxide,0.8241534233093262,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Magnesium oxide.,70,Type_70,No
DB00458,Imipramine,DB00528,Lercanidipine,0.46444737911224365,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Lercanidipine.,49,Type_49,Yes
DB00863,Ranitidine,DB08864,Rilpivirine,0.6781547665596008,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Ranitidine.,75,Type_75,No
DB00206,Reserpine,DB06826,Unoprostone,0.9997721314430237,60,Type_60,Reserpine may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00468,Quinine,DB01142,Doxepin,0.6345683932304382,20,Type_20,Quinine may increase the QTc-prolonging activities of Doxepin.,20,Type_20,Yes
DB00243,Ranolazine,DB00444,Teniposide,0.5609848499298096,73,Type_73,The serum concentration of Teniposide can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00498,Phenindione,DB06802,Nepafenac,0.9999181032180786,6,Type_6,Phenindione may increase the anticoagulant activities of Nepafenac.,6,Type_6,Yes
DB00497,Oxycodone,DB00628,Clorazepic acid,0.996260404586792,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Clorazepic acid.,49,Type_49,Yes
DB00150,Tryptophan,DB00780,Phenelzine,0.5563770532608032,64,Type_64,Tryptophan may increase the serotonergic activities of Phenelzine.,64,Type_64,Yes
DB00694,Daunorubicin,DB06207,Silodosin,0.8200767040252686,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Daunorubicin.,73,Type_73,Yes
DB00343,Diltiazem,DB00731,Nateglinide,0.9821116924285889,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01198,Zopiclone,DB09225,Zotepine,0.9998408555984497,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Zotepine.,49,Type_49,Yes
DB00972,Azelastine,DB08933,Luliconazole,0.9656934142112732,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Azelastine.,73,Type_73,Yes
DB00199,Erythromycin,DB09232,Cilnidipine,0.6949267387390137,47,Type_47,The metabolism of Cilnidipine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00413,Pramipexole,DB00980,Ramelteon,0.9999605417251587,32,Type_32,Pramipexole may increase the sedative activities of Ramelteon.,32,Type_32,Yes
DB00754,Ethotoin,DB00909,Zonisamide,0.9926480054855347,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Zonisamide.,49,Type_49,Yes
DB00540,Nortriptyline,DB01224,Quetiapine,0.7766919136047363,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Quetiapine.,20,Type_20,No
DB00881,Quinapril,DB00905,Bimatoprost,0.9999954700469971,60,Type_60,Quinapril may increase the hypotensive activities of Bimatoprost.,60,Type_60,Yes
DB01001,Salbutamol,DB01232,Saquinavir,0.9604433178901672,20,Type_20,Salbutamol may increase the QTc-prolonging activities of Saquinavir.,20,Type_20,Yes
DB00921,Buprenorphine,DB06636,Isavuconazonium,0.6148910522460938,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Buprenorphine.,47,Type_47,Yes
DB00362,Anidulafungin,DB00364,Sucralfate,0.9702034592628479,67,Type_67,Anidulafungin can cause a decrease in the absorption of Sucralfate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00296,Ropivacaine,DB06716,Fospropofol,0.9953633546829224,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fospropofol.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB09555,Dexchlorpheniramine maleate,0.9908187985420227,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00862,Vardenafil,DB00875,Flupentixol,0.9406063556671143,20,Type_20,Vardenafil may increase the QTc-prolonging activities of Flupentixol.,20,Type_20,Yes
DB01263,Posaconazole,DB08820,Ivacaftor,0.9983945488929749,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Posaconazole.,73,Type_73,Yes
DB00527,Cinchocaine,DB01151,Desipramine,0.9986119270324707,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Desipramine.,49,Type_49,Yes
DB00224,Indinavir,DB08882,Linagliptin,0.4770682156085968,47,Type_47,The metabolism of Linagliptin can be decreased when combined with Indinavir.,75,Type_75,No
DB01045,Rifampicin,DB01153,Sertaconazole,0.7394753694534302,73,Type_73,The serum concentration of Sertaconazole can be increased when it is combined with Rifampicin.,73,Type_73,Yes
DB00344,Protriptyline,DB00501,Cimetidine,0.8818832039833069,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Protriptyline.,47,Type_47,Yes
DB00193,Tramadol,DB01069,Promethazine,0.9625452756881714,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Promethazine.,49,Type_49,Yes
DB01124,Tolbutamide,DB06414,Etravirine,0.6033411622047424,47,Type_47,The metabolism of Etravirine can be decreased when combined with Tolbutamide.,47,Type_47,Yes
DB01289,Glisoxepide,DB08907,Canagliflozin,0.9931134581565857,9,Type_9,Glisoxepide may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB00233,Aminosalicylic acid,DB00468,Quinine,0.8159343600273132,9,Type_9,Aminosalicylic acid may increase the hypoglycemic activities of Quinine.,9,Type_9,Yes
DB05266,Ibudilast,DB08954,Ifenprodil,0.7214810252189636,53,Type_53,Ibudilast may increase the antiplatelet activities of Ifenprodil.,53,Type_53,Yes
DB00484,Brimonidine,DB09009,Articaine,0.9794865846633911,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Articaine.,16,Type_16,Yes
DB00542,Benazepril,DB01261,Sitagliptin,0.7869241237640381,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Sitagliptin.,49,Type_49,Yes
DB00230,Pregabalin,DB01076,Atorvastatin,0.9952638149261475,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Atorvastatin.,49,Type_49,Yes
DB00206,Reserpine,DB00527,Cinchocaine,0.9988952279090881,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Cinchocaine.,49,Type_49,Yes
DB01283,Lumiracoxib,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Lumiracoxib.,70,Type_70,Yes
DB00622,Nicardipine,DB01189,Desflurane,0.9599125981330872,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Desflurane.,49,Type_49,Yes
DB00179,Masoprocol,DB01047,Fluocinonide,0.999897837638855,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluocinonide.,49,Type_49,Yes
DB03754,Tromethamine,DB09095,Difluocortolone,0.9839949607849121,3,Type_3,The bioavailability of Difluocortolone can be decreased when combined with Tromethamine.,3,Type_3,Yes
DB00675,Tamoxifen,DB08922,Perospirone,0.6012440919876099,47,Type_47,The metabolism of Perospirone can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB09220,Nicorandil,DB09232,Cilnidipine,0.5894513130187988,49,Type_49,The risk or severity of adverse effects can be increased when Nicorandil is combined with Cilnidipine.,60,Type_60,No
DB01069,Promethazine,DB06282,Levocetirizine,0.9889348149299622,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Levocetirizine.,49,Type_49,Yes
DB00296,Ropivacaine,DB00727,Nitroglycerin,0.9898834824562073,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nitroglycerin.,49,Type_49,Yes
DB01321,Josamycin,DB08864,Rilpivirine,0.9255162477493286,20,Type_20,Josamycin may increase the QTc-prolonging activities of Rilpivirine.,73,Type_73,No
DB00543,Amoxapine,DB00737,Meclizine,0.9947408437728882,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Meclizine.,49,Type_49,Yes
DB00598,Labetalol,DB09231,Benidipine,0.9232601523399353,60,Type_60,Labetalol may increase the hypotensive activities of Benidipine.,60,Type_60,Yes
DB00661,Verapamil,DB11079,Trolamine salicylate,0.8940069079399109,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Trolamine salicylate.,6,Type_6,No
DB00907,Cocaine,DB01588,Prazepam,0.8553808331489563,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Prazepam.,49,Type_49,Yes
DB00341,Cetirizine,DB00850,Perphenazine,0.9986823201179504,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Perphenazine.,49,Type_49,Yes
DB01558,Bromazepam,DB06770,Benzyl alcohol,0.9985314607620239,49,Type_49,The risk or severity of adverse effects can be increased when Bromazepam is combined with Benzyl alcohol.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB01104,Sertraline,0.7479355931282043,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Sertraline.,49,Type_49,Yes
DB00283,Clemastine,DB09085,Tetracaine,0.998635470867157,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Tetracaine.,49,Type_49,Yes
DB00321,Amitriptyline,DB00875,Flupentixol,0.5243385434150696,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flupentixol.,20,Type_20,No
DB00185,Cevimeline,DB00458,Imipramine,0.9722157716751099,47,Type_47,The metabolism of Imipramine can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00207,Azithromycin,DB00918,Almotriptan,0.7911462187767029,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00182,Amphetamine,DB01620,Pheniramine,0.9725849032402039,76,Type_76,Amphetamine may decrease the sedative activities of Pheniramine.,76,Type_76,Yes
DB01039,Fenofibrate,DB09073,Palbociclib,0.9718456268310547,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Fenofibrate.,73,Type_73,Yes
DB00255,Diethylstilbestrol,DB08882,Linagliptin,0.8847288489341736,75,Type_75,The serum concentration of Linagliptin can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB00091,Cyclosporine,DB08931,Riociguat,0.6441918015480042,47,Type_47,The metabolism of Riociguat can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00554,Piroxicam,DB06696,Arbekacin,0.9999383687973022,72,Type_72,Piroxicam may decrease the excretion rate of Arbekacin which could result in a higher serum level.,72,Type_72,Yes
DB00281,Lidocaine,DB09009,Articaine,0.999414324760437,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Articaine.,49,Type_49,Yes
DB00645,Dyclonine,DB08922,Perospirone,0.9995520710945129,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Perospirone.,49,Type_49,Yes
DB00712,Flurbiprofen,DB08816,Ticagrelor,0.8849514722824097,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Flurbiprofen.,47,Type_47,Yes
DB00604,Cisapride,DB01072,Atazanavir,0.4213366210460663,20,Type_20,Cisapride may increase the QTc-prolonging activities of Atazanavir.,47,Type_47,No
DB01200,Bromocriptine,DB01206,Lomustine,0.5772820711135864,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lomustine.,49,Type_49,Yes
DB00468,Quinine,DB01059,Norfloxacin,0.8925133347511292,20,Type_20,Quinine may increase the QTc-prolonging activities of Norfloxacin.,20,Type_20,Yes
DB00370,Mirtazapine,DB00813,Fentanyl,0.9992930889129639,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Fentanyl.,16,Type_16,Yes
DB00623,Fluphenazine,DB08881,Vemurafenib,0.40040960907936096,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Fluphenazine.,33,Type_33,No
DB00363,Clozapine,DB08882,Linagliptin,0.33245542645454407,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Clozapine.,70,Type_70,Yes
DB00977,Ethinylestradiol,DB08820,Ivacaftor,0.9458135962486267,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00189,Ethchlorvynol,DB08910,Pomalidomide,0.9997344613075256,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Pomalidomide.,49,Type_49,Yes
DB00252,Phenytoin,DB01380,Cortisone acetate,0.8889434933662415,4,Type_4,The metabolism of Cortisone acetate can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01349,Tasosartan,DB08881,Vemurafenib,0.5335805416107178,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Tasosartan.,75,Type_75,Yes
DB00297,Bupivacaine,DB00849,Methylphenobarbital,0.8246330618858337,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Methylphenobarbital.,49,Type_49,Yes
DB06781,Difluprednate,DB08439,Parecoxib,0.997685432434082,49,Type_49,The risk or severity of adverse effects can be increased when Difluprednate is combined with Parecoxib.,49,Type_49,Yes
DB01168,Procarbazine,DB06698,Betahistine,0.5900505781173706,73,Type_73,The serum concentration of Betahistine can be increased when it is combined with Procarbazine.,73,Type_73,Yes
DB00500,Tolmetin,DB00939,Meclofenamic acid,0.999517560005188,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Meclofenamic acid.,49,Type_49,Yes
DB01182,Propafenone,DB09167,Dosulepin,0.49630454182624817,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Propafenone.,73,Type_73,No
DB00497,Oxycodone,DB01171,Moclobemide,0.6220334768295288,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Moclobemide.,49,Type_49,Yes
DB01240,Epoprostenol,DB06725,Lornoxicam,0.4912627339363098,49,Type_49,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Lornoxicam.,70,Type_70,No
DB06148,Mianserin,DB08881,Vemurafenib,0.6812520623207092,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Mianserin.,73,Type_73,Yes
DB01590,Everolimus,DB11613,Velpatasvir,0.7039167284965515,73,Type_73,The serum concentration of Velpatasvir can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00206,Reserpine,DB01235,Levodopa,0.6714910864830017,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Levodopa.,30,Type_30,No
DB00697,Tizanidine,DB00706,Tamsulosin,0.8058004975318909,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Tamsulosin.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB06589,Pazopanib,0.3572193682193756,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Sulfisoxazole.,20,Type_20,No
DB00681,Amphotericin B,DB06263,Amrubicin,0.9845395684242249,57,Type_57,Amphotericin B may increase the nephrotoxic activities of Amrubicin.,57,Type_57,Yes
DB00512,Vancomycin,DB00936,Salicylic acid,0.6451062560081482,73,Type_73,The serum concentration of Salicylic acid can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00752,Tranylcypromine,DB00774,Hydroflumethiazide,0.6252461075782776,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Hydroflumethiazide.,60,Type_60,No
DB01200,Bromocriptine,DB01340,Cilazapril,0.6201244592666626,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Cilazapril.,49,Type_49,Yes
DB00390,Digoxin,DB06819,Phenylbutyric acid,0.9717221260070801,58,Type_58,Digoxin may decrease the cardiotoxic activities of Phenylbutyric acid.,58,Type_58,Yes
DB00849,Methylphenobarbital,DB01357,Mestranol,0.5314064621925354,70,Type_70,The therapeutic efficacy of Mestranol can be decreased when used in combination with Methylphenobarbital.,70,Type_70,Yes
DB00628,Clorazepic acid,DB04868,Nilotinib,0.8589984774589539,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Clorazepic acid.,47,Type_47,Yes
DB00188,Bortezomib,DB00927,Famotidine,0.4557276964187622,47,Type_47,The metabolism of Famotidine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00254,Doxycycline,DB00916,Metronidazole,0.8183404803276062,47,Type_47,The metabolism of Metronidazole can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01399,Salsalate,DB13783,Acemetacin,0.966437041759491,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Acemetacin.,49,Type_49,Yes
DB00363,Clozapine,DB01590,Everolimus,0.8788415789604187,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Clozapine.,49,Type_49,No
DB00540,Nortriptyline,DB06203,Alogliptin,0.6822446584701538,73,Type_73,The serum concentration of Alogliptin can be increased when it is combined with Nortriptyline.,73,Type_73,Yes
DB01176,Cyclizine,DB08922,Perospirone,0.9998201727867126,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Perospirone.,49,Type_49,Yes
DB00310,Chlorthalidone,DB04896,Milnacipran,0.9981138706207275,55,Type_55,Chlorthalidone may increase the hyponatremic activities of Milnacipran.,55,Type_55,Yes
DB00687,Fludrocortisone,DB03754,Tromethamine,0.9990593791007996,3,Type_3,The bioavailability of Tromethamine can be decreased when combined with Fludrocortisone.,3,Type_3,Yes
DB01623,Thiothixene,DB11304,Phenoxyethanol,0.9999409914016724,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Phenoxyethanol.,49,Type_49,Yes
DB00694,Daunorubicin,DB08865,Crizotinib,0.9383412003517151,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB06196,Icatibant,DB08895,Tofacitinib,0.9460201859474182,34,Type_34,Icatibant may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB01324,Polythiazide,DB11093,Calcium citrate,0.9990965127944946,72,Type_72,Polythiazide may decrease the excretion rate of Calcium citrate which could result in a higher serum level.,72,Type_72,Yes
DB00252,Phenytoin,DB01218,Halofantrine,0.647682249546051,4,Type_4,The metabolism of Halofantrine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00748,Carbinoxamine,DB09071,Tasimelteon,0.9993628859519958,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Tasimelteon.,49,Type_49,Yes
DB00230,Pregabalin,DB00334,Olanzapine,0.883514404296875,8,Type_8,The therapeutic efficacy of Olanzapine can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00270,Isradipine,DB01621,Pipotiazine,0.8586174249649048,47,Type_47,The metabolism of Pipotiazine can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00979,Cyclopentolate,DB01466,Ethylmorphine,0.9999710321426392,49,Type_49,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Ethylmorphine.,49,Type_49,Yes
DB00645,Dyclonine,DB01224,Quetiapine,0.9960604310035706,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Quetiapine.,49,Type_49,Yes
DB00472,Fluoxetine,DB09072,Sodium oxybate,0.9323468208312988,16,Type_16,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,49,Type_49,No
DB00555,Lamotrigine,DB01422,Nitroxoline,0.9787737727165222,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Nitroxoline.,49,Type_49,Yes
DB00358,Mefloquine,DB06207,Silodosin,0.9521462321281433,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB01142,Doxepin,DB08815,Lurasidone,0.8862113356590271,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Lurasidone.,49,Type_49,Yes
DB01047,Fluocinonide,DB01233,Metoclopramide,0.9927109479904175,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Metoclopramide.,49,Type_49,Yes
DB01154,Thiamylal,DB01215,Estazolam,0.9898054599761963,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Estazolam.,49,Type_49,Yes
DB01283,Lumiracoxib,DB01397,Magnesium salicylate,0.9953052997589111,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Magnesium salicylate.,49,Type_49,Yes
DB00834,Mifepristone,DB01020,Isosorbide mononitrate,0.9297152757644653,73,Type_73,The serum concentration of Isosorbide mononitrate can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00575,Clonidine,DB01089,Deserpidine,0.9982524514198303,60,Type_60,Clonidine may increase the hypotensive activities of Deserpidine.,60,Type_60,Yes
DB00809,Tropicamide,DB06204,Tapentadol,0.9999566078186035,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Tapentadol.,49,Type_49,Yes
DB00396,Progesterone,DB04898,Ximelagatran,0.39510399103164673,75,Type_75,The serum concentration of Ximelagatran can be decreased when it is combined with Progesterone.,70,Type_70,No
DB08912,Dabrafenib,DB09102,Daclatasvir,0.6327999830245972,75,Type_75,The serum concentration of Daclatasvir can be decreased when it is combined with Dabrafenib.,75,Type_75,Yes
DB00264,Metoprolol,DB00633,Dexmedetomidine,0.9871402382850647,25,Type_25,Metoprolol may increase the atrioventricular blocking (AV block) activities of Dexmedetomidine.,73,Type_73,No
DB00418,Secobarbital,DB00613,Amodiaquine,0.6306279301643372,4,Type_4,The metabolism of Amodiaquine can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00652,Pentazocine,DB00679,Thioridazine,0.7901240587234497,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Thioridazine.,49,Type_49,Yes
DB00703,Methazolamide,DB01018,Guanfacine,0.9741722345352173,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Guanfacine.,49,Type_49,Yes
DB00298,Dapiprazole,DB01267,Paliperidone,0.9246559143066406,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Paliperidone.,49,Type_49,Yes
DB06701,Dexmethylphenidate,DB09241,Methylene blue,0.6512928009033203,71,Type_71,Dexmethylphenidate may increase the hypertensive activities of Methylene blue.,71,Type_71,Yes
DB00401,Nisoldipine,DB01076,Atorvastatin,0.7315094470977783,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Atorvastatin.,49,Type_49,Yes
DB00745,Modafinil,DB00835,Brompheniramine,0.9541937112808228,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Modafinil.,47,Type_47,Yes
DB01353,Butobarbital,DB09286,Pipamperone,0.9996351003646851,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Pipamperone.,49,Type_49,Yes
DB01072,Atazanavir,DB08912,Dabrafenib,0.9598894119262695,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Atazanavir.,75,Type_75,Yes
DB00582,Voriconazole,DB08868,Fingolimod,0.5477635860443115,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00238,Nevirapine,DB03128,Acetylcholine,0.6972929835319519,47,Type_47,The metabolism of Acetylcholine can be decreased when combined with Nevirapine.,47,Type_47,Yes
DB00404,Alprazolam,DB01018,Guanfacine,0.9668972492218018,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Guanfacine.,49,Type_49,Yes
DB00418,Secobarbital,DB00854,Levorphanol,0.9812601804733276,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Levorphanol.,49,Type_49,Yes
DB00458,Imipramine,DB11304,Phenoxyethanol,0.9992462396621704,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Phenoxyethanol.,49,Type_49,Yes
DB00494,Entacapone,DB08815,Lurasidone,0.9990122318267822,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Lurasidone.,49,Type_49,Yes
DB00217,Bethanidine,DB00540,Nortriptyline,0.9997352957725525,37,Type_37,Bethanidine may decrease the antihypertensive activities of Nortriptyline.,37,Type_37,Yes
DB00619,Imatinib,DB06589,Pazopanib,0.6083291172981262,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Imatinib.,73,Type_73,Yes
DB00301,Flucloxacillin,DB01578,Metrizamide,0.9999704360961914,75,Type_75,The serum concentration of Metrizamide can be decreased when it is combined with Flucloxacillin.,75,Type_75,Yes
DB00241,Butalbital,DB00540,Nortriptyline,0.998643696308136,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Nortriptyline.,49,Type_49,Yes
DB00247,Methysergide,DB01166,Cilostazol,0.9815369248390198,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Cilostazol.,49,Type_49,Yes
DB00490,Buspirone,DB01086,Benzocaine,0.999215841293335,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Benzocaine.,49,Type_49,Yes
DB00349,Clobazam,DB01236,Sevoflurane,0.8579613566398621,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Clobazam.,49,Type_49,No
DB00408,Loxapine,DB01168,Procarbazine,0.9610838294029236,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Procarbazine.,49,Type_49,Yes
DB01001,Salbutamol,DB01200,Bromocriptine,0.3962542712688446,49,Type_49,The risk or severity of adverse effects can be increased when Salbutamol is combined with Bromocriptine.,71,Type_71,No
DB00291,Chlorambucil,DB01248,Docetaxel,0.9881598949432373,49,Type_49,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Docetaxel.,49,Type_49,Yes
DB01399,Salsalate,DB06228,Rivaroxaban,0.9920853972434998,6,Type_6,Salsalate may increase the anticoagulant activities of Rivaroxaban.,6,Type_6,Yes
DB01018,Guanfacine,DB01174,Phenobarbital,0.842291533946991,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Guanfacine.,75,Type_75,No
DB00454,Meperidine,DB00745,Modafinil,0.9181463122367859,47,Type_47,The metabolism of Modafinil can be decreased when combined with Meperidine.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB00933,Mesoridazine,0.9219511151313782,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mesoridazine.,49,Type_49,Yes
DB01043,Memantine,DB01136,Carvedilol,0.9997876286506653,54,Type_54,Memantine may increase the bradycardic activities of Carvedilol.,54,Type_54,Yes
DB08984,Etofenamate,DB09084,Benzydamine,0.9991637468338013,49,Type_49,The risk or severity of adverse effects can be increased when Etofenamate is combined with Benzydamine.,49,Type_49,Yes
DB00726,Trimipramine,DB05294,Vandetanib,0.5916800498962402,20,Type_20,Trimipramine may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00927,Famotidine,DB06698,Betahistine,0.9027639627456665,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Famotidine.,70,Type_70,Yes
DB00921,Buprenorphine,DB01367,Rasagiline,0.9626991152763367,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Rasagiline.,49,Type_49,Yes
DB00418,Secobarbital,DB00883,Isosorbide dinitrate,0.6273093819618225,60,Type_60,Secobarbital may increase the hypotensive activities of Isosorbide dinitrate.,60,Type_60,Yes
DB00690,Flurazepam,DB01437,Glutethimide,0.9999978542327881,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Glutethimide.,49,Type_49,Yes
DB00395,Carisoprodol,DB00405,Dexbrompheniramine,0.9999927282333374,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Dexbrompheniramine.,49,Type_49,Yes
DB01229,Paclitaxel,DB11581,Venetoclax,0.9193013310432434,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Venetoclax.,49,Type_49,Yes
DB00582,Voriconazole,DB00672,Chlorpropamide,0.9298521280288696,47,Type_47,The metabolism of Chlorpropamide can be decreased when combined with Voriconazole.,73,Type_73,No
DB00178,Ramipril,DB00287,Travoprost,0.9999939203262329,60,Type_60,Ramipril may increase the hypotensive activities of Travoprost.,60,Type_60,Yes
DB01209,Dezocine,DB08987,Etidocaine,0.9991894364356995,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Etidocaine.,49,Type_49,Yes
DB01067,Glipizide,DB01132,Pioglitazone,0.9758386015892029,9,Type_9,Glipizide may increase the hypoglycemic activities of Pioglitazone.,9,Type_9,Yes
DB00571,Propranolol,DB01120,Gliclazide,0.909217894077301,9,Type_9,Propranolol may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00457,Prazosin,DB00519,Trandolapril,0.6991173624992371,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Trandolapril.,49,Type_49,Yes
DB06813,Pralatrexate,DB13167,Alclofenac,0.6420050263404846,73,Type_73,The serum concentration of Alclofenac can be increased when it is combined with Pralatrexate.,73,Type_73,Yes
DB00484,Brimonidine,DB06144,Sertindole,0.90333092212677,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Sertindole.,16,Type_16,Yes
DB00545,Pyridostigmine,DB01580,Oxprenolol,0.9679613709449768,54,Type_54,Pyridostigmine may increase the bradycardic activities of Oxprenolol.,54,Type_54,Yes
DB01050,Ibuprofen,DB09216,Tolfenamic acid,0.9963324666023254,49,Type_49,The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tolfenamic acid.,49,Type_49,Yes
DB00521,Carteolol,DB01043,Memantine,0.9958757758140564,54,Type_54,Carteolol may increase the bradycardic activities of Memantine.,54,Type_54,Yes
DB00394,Beclomethasone dipropionate,DB00768,Olopatadine,0.9977720379829407,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Olopatadine.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB01214,Metipranolol,0.9658228754997253,25,Type_25,Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Metipranolol.,49,Type_49,No
DB00834,Mifepristone,DB04896,Milnacipran,0.6562157273292542,73,Type_73,The serum concentration of Milnacipran can be increased when it is combined with Mifepristone.,9,Type_9,No
DB01403,Methotrimeprazine,DB01437,Glutethimide,0.9565957188606262,16,Type_16,Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,16,Type_16,Yes
DB01124,Tolbutamide,DB01159,Halothane,0.739831268787384,70,Type_70,The therapeutic efficacy of Halothane can be decreased when used in combination with Tolbutamide.,47,Type_47,No
DB01133,Tiludronic acid,DB06737,Zaltoprofen,0.9970237612724304,49,Type_49,The risk or severity of adverse effects can be increased when Tiludronic acid is combined with Zaltoprofen.,49,Type_49,Yes
DB00035,Desmopressin,DB01435,Antipyrine,0.5192878246307373,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Antipyrine.,49,Type_49,Yes
DB00871,Terbutaline,DB06698,Betahistine,0.9984337687492371,70,Type_70,The therapeutic efficacy of Betahistine can be decreased when used in combination with Terbutaline.,70,Type_70,Yes
DB00232,Methyclothiazide,DB01291,Pirbuterol,0.9997889399528503,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Pirbuterol.,83,Type_83,Yes
DB00477,Chlorpromazine,DB09291,Rolapitant,0.8961243033409119,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00217,Bethanidine,DB00657,Mecamylamine,0.9905346035957336,60,Type_60,Bethanidine may increase the hypotensive activities of Mecamylamine.,60,Type_60,Yes
DB00176,Fluvoxamine,DB00395,Carisoprodol,0.6244048476219177,47,Type_47,The metabolism of Carisoprodol can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00818,Propofol,DB06717,Fosaprepitant,0.8159388899803162,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Propofol.,73,Type_73,Yes
DB00498,Phenindione,DB01139,Cefapirin,0.9999145269393921,6,Type_6,Phenindione may increase the anticoagulant activities of Cefapirin.,6,Type_6,Yes
DB00755,Tretinoin,DB01017,Minocycline,0.7221510410308838,75,Type_75,The serum concentration of Minocycline can be decreased when it is combined with Tretinoin.,49,Type_49,No
DB00547,Desoximetasone,DB00783,Estradiol,0.9723437428474426,73,Type_73,The serum concentration of Estradiol can be increased when it is combined with Desoximetasone.,73,Type_73,Yes
DB00436,Bendroflumethiazide,DB06663,Pasireotide,0.7653934955596924,70,Type_70,The therapeutic efficacy of Pasireotide can be decreased when used in combination with Bendroflumethiazide.,54,Type_54,No
DB01067,Glipizide,DB01155,Gemifloxacin,0.9957822561264038,9,Type_9,Glipizide may increase the hypoglycemic activities of Gemifloxacin.,9,Type_9,Yes
DB00296,Ropivacaine,DB08922,Perospirone,0.9505510330200195,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Perospirone.,49,Type_49,Yes
DB01030,Topotecan,DB01138,Sulfinpyrazone,0.9444798827171326,73,Type_73,The serum concentration of Sulfinpyrazone can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB00281,Lidocaine,DB04951,Pirfenidone,0.7735303044319153,47,Type_47,The metabolism of Pirfenidone can be decreased when combined with Lidocaine.,73,Type_73,No
DB00545,Pyridostigmine,DB00670,Pirenzepine,0.9933671355247498,70,Type_70,The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Pyridostigmine.,70,Type_70,Yes
DB00669,Sumatriptan,DB01175,Escitalopram,0.6083810329437256,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.,49,Type_49,Yes
DB00714,Apomorphine,DB01224,Quetiapine,0.6175997853279114,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Quetiapine.,20,Type_20,No
DB00615,Rifabutin,DB08873,Boceprevir,0.3959308862686157,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00326,Calcium glucoheptonate,DB01325,Quinethazone,0.963797390460968,72,Type_72,Calcium glucoheptonate may decrease the excretion rate of Quinethazone which could result in a higher serum level.,72,Type_72,Yes
DB00238,Nevirapine,DB04840,Debrisoquine,0.5093115568161011,47,Type_47,The metabolism of Debrisoquine can be decreased when combined with Nevirapine.,47,Type_47,Yes
DB00259,Sulfanilamide,DB00320,Dihydroergotamine,0.8851747512817383,73,Type_73,The serum concentration of Dihydroergotamine can be increased when it is combined with Sulfanilamide.,49,Type_49,No
DB09048,Netupitant,DB09570,Ixazomib,0.971578061580658,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Netupitant.,73,Type_73,Yes
DB01320,Fosphenytoin,DB06216,Asenapine,0.5047605037689209,4,Type_4,The metabolism of Asenapine can be increased when combined with Fosphenytoin.,4,Type_4,Yes
DB00246,Ziprasidone,DB06144,Sertindole,0.6054288148880005,47,Type_47,The metabolism of Sertindole can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00908,Quinidine,DB09073,Palbociclib,0.9929248094558716,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00673,Aprepitant,DB01174,Phenobarbital,0.9345340132713318,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Aprepitant.,4,Type_4,Yes
DB00849,Methylphenobarbital,DB01083,Orlistat,0.9983736276626587,75,Type_75,The serum concentration of Orlistat can be decreased when it is combined with Methylphenobarbital.,75,Type_75,Yes
DB00870,Suprofen,DB00896,Rimexolone,0.999735414981842,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Rimexolone.,49,Type_49,Yes
DB00470,Dronabinol,DB09065,Cobicistat,0.9467849135398865,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00604,Cisapride,DB02546,Vorinostat,0.7966033220291138,20,Type_20,Cisapride may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB00454,Meperidine,DB01587,Ketazolam,0.9746679067611694,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Ketazolam.,49,Type_49,Yes
DB00622,Nicardipine,DB09235,Efonidipine,0.7037335634231567,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Efonidipine.,60,Type_60,No
DB00224,Indinavir,DB00932,Tipranavir,0.7176972031593323,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Indinavir.,75,Type_75,No
DB00285,Venlafaxine,DB00820,Tadalafil,0.9357240796089172,47,Type_47,The metabolism of Tadalafil can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00248,Cabergoline,DB00570,Vinblastine,0.818043053150177,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Vinblastine.,49,Type_49,Yes
DB00175,Pravastatin,DB00207,Azithromycin,0.5296103954315186,73,Type_73,The serum concentration of Azithromycin can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00176,Fluvoxamine,DB12161,Deutetrabenazine,0.990189254283905,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB04951,Pirfenidone,DB09292,Sacubitril,0.9988285899162292,49,Type_49,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Sacubitril.,49,Type_49,Yes
DB02513,Thymol,DB04743,Nimesulide,0.9941301941871643,49,Type_49,The risk or severity of adverse effects can be increased when Thymol is combined with Nimesulide.,49,Type_49,Yes
DB06723,Aluminum hydroxide,DB09270,Ubidecarenone,0.9661666750907898,75,Type_75,The serum concentration of Ubidecarenone can be decreased when it is combined with Aluminum hydroxide.,75,Type_75,Yes
DB00557,Hydroxyzine,DB09117,Paraldehyde,1.0,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00224,Indinavir,DB01577,Metamfetamine,0.9805923700332642,47,Type_47,The metabolism of Metamfetamine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00349,Clobazam,DB01071,Mequitazine,0.647491991519928,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00451,Levothyroxine,DB01142,Doxepin,0.539036214351654,82,Type_82,Levothyroxine may increase the arrhythmogenic activities of Doxepin.,82,Type_82,Yes
DB04946,Iloperidone,DB06716,Fospropofol,0.9999779462814331,49,Type_49,The risk or severity of adverse effects can be increased when Iloperidone is combined with Fospropofol.,49,Type_49,Yes
DB00215,Citalopram,DB06702,Fesoterodine,0.9770479202270508,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Citalopram.,77,Type_77,Yes
DB00573,Fenoprofen,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Fenoprofen.,70,Type_70,Yes
DB01062,Oxybutynin,DB01174,Phenobarbital,0.9236195087432861,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Oxybutynin.,4,Type_4,Yes
DB00443,Betamethasone,DB00735,Naftifine,0.999574601650238,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Naftifine.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB06810,Plicamycin,0.8233235478401184,73,Type_73,The serum concentration of Plicamycin can be increased when it is combined with Tenofovir disoproxil.,73,Type_73,Yes
DB00705,Delavirdine,DB06148,Mianserin,0.8317146301269531,47,Type_47,The metabolism of Mianserin can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00784,Mefenamic acid,DB01088,Iloprost,0.9464820623397827,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Mefenamic acid.,70,Type_70,Yes
DB00691,Moexipril,DB06697,Artemether,0.3954351246356964,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Artemether.,20,Type_20,No
DB01076,Atorvastatin,DB09053,Ibrutinib,0.9482449293136597,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin.,73,Type_73,Yes
DB08903,Bedaquiline,DB09063,Ceritinib,0.9361460208892822,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Bedaquiline.,73,Type_73,Yes
DB00454,Meperidine,DB00653,Magnesium sulfate,0.9906008243560791,16,Type_16,Meperidine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB01180,Rescinnamine,DB01193,Acebutolol,0.7115598917007446,60,Type_60,Rescinnamine may increase the hypotensive activities of Acebutolol.,60,Type_60,Yes
DB01154,Thiamylal,DB01589,Quazepam,0.8850207328796387,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Quazepam.,49,Type_49,Yes
DB01054,Nitrendipine,DB01197,Captopril,0.6410527229309082,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Captopril.,60,Type_60,No
DB00823,Ethynodiol diacetate,DB01251,Gliquidone,0.9299864768981934,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ethynodiol diacetate.,70,Type_70,Yes
DB00988,Dopamine,DB01685,Topiroxostat,0.9987967014312744,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Dopamine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB01173,Orphenadrine,0.8897991180419922,16,Type_16,Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00697,Tizanidine,DB01087,Primaquine,0.9762935638427734,20,Type_20,Tizanidine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00721,Procaine,DB11609,Normethadone,0.9999220371246338,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Normethadone.,49,Type_49,Yes
DB00943,Zalcitabine,DB01264,Darunavir,0.7507259249687195,47,Type_47,The metabolism of Darunavir can be decreased when combined with Zalcitabine.,73,Type_73,No
DB00215,Citalopram,DB00849,Methylphenobarbital,0.660147488117218,47,Type_47,The metabolism of Methylphenobarbital can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00631,Clofarabine,DB00872,Conivaptan,0.9645195603370667,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Conivaptan.,49,Type_49,Yes
DB06595,Midostaurin,DB08865,Crizotinib,0.8507446050643921,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB06736,Aceclofenac,DB08880,Teriflunomide,0.7351831197738647,49,Type_49,The risk or severity of adverse effects can be increased when Aceclofenac is combined with Teriflunomide.,49,Type_49,Yes
DB00615,Rifabutin,DB01238,Aripiprazole,0.8395915627479553,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00436,Bendroflumethiazide,DB00800,Fenoldopam,0.8299601674079895,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Fenoldopam.,60,Type_60,Yes
DB00630,Alendronic acid,DB11348,Calcium Phosphate,0.9564962387084961,75,Type_75,The serum concentration of Calcium Phosphate can be decreased when it is combined with Alendronic acid.,75,Type_75,Yes
DB00189,Ethchlorvynol,DB00721,Procaine,0.9999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Procaine.,49,Type_49,Yes
DB00245,Benzatropine,DB00854,Levorphanol,0.9901575446128845,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Levorphanol.,49,Type_49,Yes
DB00569,Fondaparinux,DB08976,Floctafenine,0.9974843263626099,6,Type_6,Fondaparinux may increase the anticoagulant activities of Floctafenine.,6,Type_6,Yes
DB00328,Indomethacin,DB06595,Midostaurin,0.9708520174026489,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Indomethacin.,47,Type_47,Yes
DB00487,Pefloxacin,DB00839,Tolazamide,0.9988006353378296,9,Type_9,Pefloxacin may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00564,Carbamazepine,DB00850,Perphenazine,0.580962598323822,4,Type_4,The metabolism of Perphenazine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01110,Miconazole,DB09063,Ceritinib,0.9983207583427429,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Miconazole.,73,Type_73,Yes
DB00788,Naproxen,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Naproxen.,70,Type_70,Yes
DB00771,Clidinium,DB01159,Halothane,0.9985818862915039,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Halothane.,49,Type_49,Yes
DB01282,Carbetocin,DB01340,Cilazapril,0.9339267015457153,49,Type_49,The risk or severity of adverse effects can be increased when Carbetocin is combined with Cilazapril.,49,Type_49,Yes
DB00700,Eplerenone,DB01349,Tasosartan,0.8046987056732178,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Tasosartan.,68,Type_68,No
DB00834,Mifepristone,DB00865,Benzphetamine,0.8422126173973083,73,Type_73,The serum concentration of Benzphetamine can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00333,Methadone,DB00590,Doxazosin,0.762185275554657,47,Type_47,The metabolism of Doxazosin can be decreased when combined with Methadone.,47,Type_47,Yes
DB00257,Clotrimazole,DB08867,Ulipristal,0.6810794472694397,47,Type_47,The metabolism of Ulipristal can be decreased when combined with Clotrimazole.,73,Type_73,No
DB00196,Fluconazole,DB08896,Regorafenib,0.4990881085395813,73,Type_73,The serum concentration of Regorafenib can be increased when it is combined with Fluconazole.,47,Type_47,No
DB00334,Olanzapine,DB01577,Metamfetamine,0.9279907941818237,61,Type_61,Olanzapine may decrease the stimulatory activities of Metamfetamine.,61,Type_61,Yes
DB00338,Omeprazole,DB09330,Osimertinib,0.8460234999656677,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Omeprazole.,73,Type_73,Yes
DB00835,Brompheniramine,DB01320,Fosphenytoin,0.7807298302650452,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Brompheniramine.,4,Type_4,Yes
DB00976,Telithromycin,DB01234,Dexamethasone,0.8495267033576965,47,Type_47,The metabolism of Dexamethasone can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00497,Oxycodone,DB00801,Halazepam,0.9998974800109863,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Halazepam.,49,Type_49,Yes
DB00468,Quinine,DB01037,Selegiline,0.5098274350166321,9,Type_9,Quinine may increase the hypoglycemic activities of Selegiline.,9,Type_9,Yes
DB00446,Chloramphenicol,DB09268,Picosulfuric acid,0.9999985694885254,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Chloramphenicol.,70,Type_70,Yes
DB05521,Telaprevir,DB09297,Paritaprevir,0.8418970108032227,47,Type_47,The metabolism of Paritaprevir can be decreased when combined with Telaprevir.,47,Type_47,Yes
DB00497,Oxycodone,DB08873,Boceprevir,0.5914274454116821,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Oxycodone.,49,Type_49,No
DB00496,Darifenacin,DB01035,Procainamide,0.9433403611183167,47,Type_47,The metabolism of Procainamide can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00391,Sulpiride,DB01393,Bezafibrate,0.5530257821083069,70,Type_70,The therapeutic efficacy of Bezafibrate can be decreased when used in combination with Sulpiride.,49,Type_49,No
DB09093,Chlortetracycline,DB11156,Pyrantel,0.9994246959686279,21,Type_21,Chlortetracycline may increase the neuromuscular blocking activities of Pyrantel.,21,Type_21,Yes
DB00812,Phenylbutazone,DB06810,Plicamycin,0.9998812675476074,72,Type_72,Phenylbutazone may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00752,Tranylcypromine,DB01197,Captopril,0.7683228254318237,60,Type_60,Tranylcypromine may increase the hypotensive activities of Captopril.,47,Type_47,No
DB00747,Scopolamine,DB01621,Pipotiazine,0.996193528175354,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Pipotiazine.,49,Type_49,Yes
DB00166,Lipoic acid,DB11348,Calcium Phosphate,0.9586116075515747,67,Type_67,Lipoic acid can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00651,Dyphylline,DB00685,Trovafloxacin,0.6073442697525024,47,Type_47,The metabolism of Trovafloxacin can be decreased when combined with Dyphylline.,47,Type_47,Yes
DB01044,Gatifloxacin,DB08907,Canagliflozin,0.9681039452552795,9,Type_9,Gatifloxacin may increase the hypoglycemic activities of Canagliflozin.,9,Type_9,Yes
DB01013,Clobetasol propionate,DB12598,Nafamostat,0.9868987798690796,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Nafamostat.,49,Type_49,Yes
DB01000,Cyclacillin,DB01032,Probenecid,0.7603051662445068,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Cyclacillin.,73,Type_73,Yes
DB00245,Benzatropine,DB06595,Midostaurin,0.9132238030433655,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB00543,Amoxapine,DB00967,Desloratadine,0.9975612163543701,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Desloratadine.,49,Type_49,Yes
DB01355,Hexobarbital,DB08922,Perospirone,0.9554407000541687,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Perospirone.,49,Type_49,Yes
DB00997,Doxorubicin,DB01283,Lumiracoxib,0.9539658427238464,72,Type_72,Doxorubicin may decrease the excretion rate of Lumiracoxib which could result in a higher serum level.,72,Type_72,Yes
DB00436,Bendroflumethiazide,DB00539,Toremifene,0.503871738910675,51,Type_51,Bendroflumethiazide may increase the hypercalcemic activities of Toremifene.,51,Type_51,Yes
DB00661,Verapamil,DB06335,Saxagliptin,0.7949941158294678,47,Type_47,The metabolism of Saxagliptin can be decreased when combined with Verapamil.,73,Type_73,No
DB00322,Floxuridine,DB08895,Tofacitinib,0.7708755135536194,34,Type_34,Floxuridine may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB01072,Atazanavir,DB06697,Artemether,0.4976826310157776,73,Type_73,The serum concentration of Artemether can be increased when it is combined with Atazanavir.,47,Type_47,No
DB00296,Ropivacaine,DB01162,Terazosin,0.8473732471466064,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Terazosin.,49,Type_49,Yes
DB00297,Bupivacaine,DB00379,Mexiletine,0.963295578956604,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB00214,Torasemide,DB01116,Trimethaphan,0.9572421908378601,60,Type_60,Torasemide may increase the hypotensive activities of Trimethaphan.,60,Type_60,Yes
DB00575,Clonidine,DB01501,Difenoxin,0.9996933937072754,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Difenoxin.,49,Type_49,Yes
DB00445,Epirubicin,DB00814,Meloxicam,0.9959881901741028,72,Type_72,Epirubicin may decrease the excretion rate of Meloxicam which could result in a higher serum level.,72,Type_72,Yes
DB00270,Isradipine,DB06287,Temsirolimus,0.8618281483650208,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00006,Bivalirudin,DB00688,Mycophenolate mofetil,0.6526947617530823,6,Type_6,Bivalirudin may increase the anticoagulant activities of Mycophenolate mofetil.,6,Type_6,Yes
DB01110,Miconazole,DB09073,Palbociclib,0.9960294961929321,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Miconazole.,73,Type_73,Yes
DB00356,Chlorzoxazone,DB00458,Imipramine,0.6650117635726929,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Imipramine.,47,Type_47,No
DB00307,Bexarotene,DB00625,Efavirenz,0.7317631244659424,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00253,Medrysone,DB06819,Phenylbutyric acid,0.9522086977958679,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Medrysone.,70,Type_70,Yes
DB00373,Timolol,DB08893,Mirabegron,0.8237307667732239,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Timolol.,47,Type_47,Yes
DB00619,Imatinib,DB08881,Vemurafenib,0.5443093180656433,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Imatinib.,73,Type_73,Yes
DB00690,Flurazepam,DB09342,Propoxycaine,0.9999984502792358,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Propoxycaine.,49,Type_49,Yes
DB01178,Chlormezanone,DB13323,Trichloroethylene,0.9999938011169434,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Trichloroethylene.,49,Type_49,Yes
DB00402,Eszopiclone,DB00433,Prochlorperazine,0.9911482334136963,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Prochlorperazine.,49,Type_49,Yes
DB01203,Nadolol,DB09215,Droxicam,0.9971743822097778,37,Type_37,Nadolol may decrease the antihypertensive activities of Droxicam.,37,Type_37,Yes
DB00163,Vitamin E,DB09283,Trapidil,0.8468123078346252,53,Type_53,Vitamin E may increase the antiplatelet activities of Trapidil.,53,Type_53,Yes
DB00323,Tolcapone,DB01247,Isocarboxazid,0.9939777851104736,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Isocarboxazid.,49,Type_49,Yes
DB00521,Carteolol,DB01023,Felodipine,0.6164878010749817,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Felodipine.,49,Type_49,Yes
DB00872,Conivaptan,DB09118,Stiripentol,0.9969751834869385,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00186,Lorazepam,DB00404,Alprazolam,0.9761423468589783,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Alprazolam.,49,Type_49,Yes
DB00283,Clemastine,DB00808,Indapamide,0.692754328250885,47,Type_47,The metabolism of Indapamide can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00283,Clemastine,DB00344,Protriptyline,0.7377262115478516,47,Type_47,The metabolism of Protriptyline can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00508,Triflupromazine,DB01103,Quinacrine,0.6457296013832092,73,Type_73,The serum concentration of Quinacrine can be increased when it is combined with Triflupromazine.,73,Type_73,Yes
DB00469,Tenoxicam,DB01628,Etoricoxib,0.9987732768058777,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Etoricoxib.,49,Type_49,Yes
DB00283,Clemastine,DB06712,Nilvadipine,0.8964434862136841,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00227,Lovastatin,DB00842,Oxazepam,0.6679505705833435,47,Type_47,The metabolism of Oxazepam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00354,Buclizine,DB00852,Pseudoephedrine,0.9999631643295288,76,Type_76,Buclizine may decrease the sedative activities of Pseudoephedrine.,76,Type_76,Yes
DB01174,Phenobarbital,DB01175,Escitalopram,0.8750053644180298,4,Type_4,The metabolism of Escitalopram can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00805,Minaprine,DB13158,Clobetasone,0.8236963748931885,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Clobetasone.,49,Type_49,Yes
DB00765,Metyrosine,DB00904,Ondansetron,0.9665642380714417,32,Type_32,Metyrosine may increase the sedative activities of Ondansetron.,32,Type_32,Yes
DB00780,Phenelzine,DB08881,Vemurafenib,0.9830319881439209,33,Type_33,The risk or severity of QTc prolongation can be increased when Phenelzine is combined with Vemurafenib.,33,Type_33,Yes
DB00484,Brimonidine,DB00679,Thioridazine,0.9946820139884949,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thioridazine.,16,Type_16,Yes
DB00227,Lovastatin,DB00703,Methazolamide,0.6339767575263977,73,Type_73,The serum concentration of Methazolamide can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00970,Dactinomycin,DB09027,Ledipasvir,0.9658357501029968,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Dactinomycin.,73,Type_73,Yes
DB00370,Mirtazapine,DB01026,Ketoconazole,0.5480977892875671,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00358,Mefloquine,DB01118,Amiodarone,0.6147183775901794,20,Type_20,Mefloquine may increase the QTc-prolonging activities of Amiodarone.,47,Type_47,No
DB01032,Probenecid,DB09049,Naloxegol,0.9994949102401733,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00244,Mesalazine,DB01014,Balsalazide,0.97940993309021,57,Type_57,Mesalazine may increase the nephrotoxic activities of Balsalazide.,57,Type_57,Yes
DB00475,Chlordiazepoxide,DB04842,Fluspirilene,0.9973324537277222,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fluspirilene.,49,Type_49,Yes
DB00949,Felbamate,DB09034,Suvorexant,0.9995597004890442,16,Type_16,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00567,Cephalexin,DB00946,Phenprocoumon,0.8242962956428528,6,Type_6,Cephalexin may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00350,Minoxidil,DB01626,Pargyline,0.9943506121635437,60,Type_60,Minoxidil may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB01013,Clobetasol propionate,DB08804,Nandrolone decanoate,1.0,74,Type_74,Clobetasol propionate may increase the fluid retaining activities of Nandrolone decanoate.,74,Type_74,Yes
DB00434,Cyproheptadine,DB00721,Procaine,0.9998606443405151,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Procaine.,49,Type_49,Yes
DB00227,Lovastatin,DB00470,Dronabinol,0.8489217162132263,73,Type_73,The serum concentration of Dronabinol can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB06702,Fesoterodine,DB06820,Sulconazole,0.7022247910499573,77,Type_77,The serum concentration of the active metabolites of Sulconazole can be increased when Sulconazole is used in combination with Fesoterodine.,77,Type_77,Yes
DB00497,Oxycodone,DB13323,Trichloroethylene,0.9979502558708191,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Trichloroethylene.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB01242,Clomipramine,0.8115047216415405,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Sulfisoxazole.,20,Type_20,No
DB00422,Methylphenidate,DB00503,Ritonavir,0.940422773361206,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00393,Nimodipine,DB01203,Nadolol,0.7405669689178467,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Nadolol.,49,Type_49,Yes
DB00657,Mecamylamine,DB09286,Pipamperone,0.9817714691162109,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Pipamperone.,49,Type_49,Yes
DB00443,Betamethasone,DB08991,Epirizole,0.999845027923584,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Epirizole.,49,Type_49,Yes
DB00408,Loxapine,DB01588,Prazepam,0.9981719255447388,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Prazepam.,49,Type_49,Yes
DB00208,Ticlopidine,DB00571,Propranolol,0.9588979482650757,47,Type_47,The metabolism of Propranolol can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00387,Procyclidine,DB01339,Vecuronium,0.9953418970108032,49,Type_49,The risk or severity of adverse effects can be increased when Procyclidine is combined with Vecuronium.,49,Type_49,Yes
DB01708,Prasterone,DB06412,Oxymetholone,0.9959107637405396,74,Type_74,Prasterone may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB00254,Doxycycline,DB08931,Riociguat,0.8798190355300903,47,Type_47,The metabolism of Riociguat can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01618,Molindone,DB06204,Tapentadol,0.9851810932159424,16,Type_16,Molindone may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00508,Triflupromazine,DB01403,Methotrimeprazine,0.9877378940582275,16,Type_16,Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB09477,Enalaprilat,DB11362,Selexipag,0.9986218214035034,60,Type_60,Enalaprilat may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00846,Flurandrenolide,DB00999,Hydrochlorothiazide,0.9999866485595703,83,Type_83,Flurandrenolide may increase the hypokalemic activities of Hydrochlorothiazide.,83,Type_83,Yes
DB00598,Labetalol,DB00908,Quinidine,0.7775482535362244,47,Type_47,The metabolism of Quinidine can be decreased when combined with Labetalol.,47,Type_47,Yes
DB00628,Clorazepic acid,DB01175,Escitalopram,0.842199981212616,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Escitalopram.,49,Type_49,Yes
DB01614,Acepromazine,DB04953,Ezogabine,0.9776641726493835,49,Type_49,The risk or severity of adverse effects can be increased when Acepromazine is combined with Ezogabine.,49,Type_49,Yes
DB01246,Alimemazine,DB06335,Saxagliptin,0.4291380047798157,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Alimemazine.,75,Type_75,No
DB01185,Fluoxymesterone,DB01261,Sitagliptin,0.9999802112579346,9,Type_9,Fluoxymesterone may increase the hypoglycemic activities of Sitagliptin.,9,Type_9,Yes
DB00277,Theophylline,DB00917,Dinoprostone,0.3702901601791382,75,Type_75,The serum concentration of Dinoprostone can be decreased when it is combined with Theophylline.,47,Type_47,No
DB00418,Secobarbital,DB00829,Diazepam,0.9533370137214661,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Diazepam.,4,Type_4,No
DB01319,Fosamprenavir,DB01559,Clotiazepam,0.6723595857620239,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB01236,Sevoflurane,DB09053,Ibrutinib,0.7876652479171753,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Sevoflurane.,49,Type_49,No
DB00749,Etodolac,DB00783,Estradiol,0.593438446521759,81,Type_81,Etodolac may increase the thrombogenic activities of Estradiol.,81,Type_81,Yes
DB00320,Dihydroergotamine,DB00908,Quinidine,0.9634250998497009,47,Type_47,The metabolism of Quinidine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00679,Thioridazine,DB01577,Metamfetamine,0.3328034579753876,47,Type_47,The metabolism of Metamfetamine can be decreased when combined with Thioridazine.,73,Type_73,No
DB00750,Prilocaine,DB01154,Thiamylal,0.9998329877853394,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Thiamylal.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB09449,"Sodium phosphate, monobasic",0.978015124797821,57,Type_57,"Acetylsalicylic acid may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00206,Reserpine,DB06201,Rufinamide,0.9976500868797302,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Rufinamide.,49,Type_49,Yes
DB01080,Vigabatrin,DB01161,Chloroprocaine,0.9994489550590515,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Chloroprocaine.,49,Type_49,Yes
DB00490,Buspirone,DB08865,Crizotinib,0.8999024629592896,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Buspirone.,47,Type_47,Yes
DB00695,Furosemide,DB01234,Dexamethasone,0.9985319375991821,83,Type_83,Furosemide may increase the hypokalemic activities of Dexamethasone.,83,Type_83,Yes
DB00909,Zonisamide,DB08883,Perampanel,0.9310805201530457,16,Type_16,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00673,Aprepitant,DB05351,Dexlansoprazole,0.7277458906173706,73,Type_73,The serum concentration of Dexlansoprazole can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00244,Mesalazine,DB00489,Sotalol,0.9535413980484009,9,Type_9,Mesalazine may increase the hypoglycemic activities of Sotalol.,37,Type_37,No
DB00333,Methadone,DB00568,Cinnarizine,0.9524967074394226,47,Type_47,The metabolism of Cinnarizine can be decreased when combined with Methadone.,47,Type_47,Yes
DB01264,Darunavir,DB12070,Letermovir,0.47647616267204285,73,Type_73,The serum concentration of Letermovir can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB08916,Afatinib,0.8241469860076904,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Cyclophosphamide.,73,Type_73,Yes
DB00880,Chlorothiazide,DB09288,Propacetamol,0.9967719912528992,70,Type_70,The therapeutic efficacy of Propacetamol can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00398,Sorafenib,DB00991,Oxaprozin,0.777444064617157,47,Type_47,The metabolism of Oxaprozin can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00472,Fluoxetine,DB00949,Felbamate,0.6759315729141235,20,Type_20,Fluoxetine may increase the QTc-prolonging activities of Felbamate.,20,Type_20,Yes
DB00199,Erythromycin,DB08816,Ticagrelor,0.5069974660873413,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00594,Amiloride,DB09477,Enalaprilat,0.46763876080513,68,Type_68,Amiloride may increase the hyperkalemic activities of Enalaprilat.,68,Type_68,Yes
DB00203,Sildenafil,DB00451,Levothyroxine,0.9382402300834656,47,Type_47,The metabolism of Levothyroxine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00252,Phenytoin,DB01248,Docetaxel,0.753227949142456,4,Type_4,The metabolism of Docetaxel can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01080,Vigabatrin,DB09017,Brotizolam,0.9995074272155762,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Brotizolam.,49,Type_49,Yes
DB00938,Salmeterol,DB09078,Lenvatinib,0.9845967888832092,20,Type_20,Salmeterol may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00343,Diltiazem,DB08816,Ticagrelor,0.6616000533103943,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00199,Erythromycin,DB01035,Procainamide,0.7169365286827087,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00191,Phentermine,DB09128,Brexpiprazole,0.9969313144683838,61,Type_61,Phentermine may decrease the stimulatory activities of Brexpiprazole.,61,Type_61,Yes
DB05109,Trabectedin,DB09238,Manidipine,0.8637323975563049,47,Type_47,The metabolism of Manidipine can be decreased when combined with Trabectedin.,47,Type_47,Yes
DB01037,Selegiline,DB06403,Ambrisentan,0.948703944683075,60,Type_60,Selegiline may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00818,Propofol,DB09017,Brotizolam,0.9995961785316467,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Brotizolam.,49,Type_49,Yes
DB00323,Tolcapone,DB06292,Dapagliflozin,0.6355774402618408,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Dapagliflozin.,49,Type_49,Yes
DB06626,Axitinib,DB09054,Idelalisib,0.4294356405735016,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Axitinib.,73,Type_73,No
DB01367,Rasagiline,DB04948,Lofexidine,0.8860792517662048,60,Type_60,Rasagiline may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00489,Sotalol,DB00735,Naftifine,0.9534874558448792,37,Type_37,Sotalol may decrease the antihypertensive activities of Naftifine.,37,Type_37,Yes
DB00675,Tamoxifen,DB01165,Ofloxacin,0.9992460012435913,20,Type_20,Tamoxifen may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB01129,Rabeprazole,DB01174,Phenobarbital,0.7645801305770874,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Rabeprazole.,4,Type_4,Yes
DB00449,Dipivefrin,DB01203,Nadolol,0.9980813264846802,25,Type_25,Dipivefrin may increase the atrioventricular blocking (AV block) activities of Nadolol.,25,Type_25,Yes
DB00433,Prochlorperazine,DB01320,Fosphenytoin,0.4538589119911194,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fosphenytoin.,4,Type_4,No
DB00346,Alfuzosin,DB01203,Nadolol,0.6924410462379456,60,Type_60,Alfuzosin may increase the hypotensive activities of Nadolol.,60,Type_60,Yes
DB00244,Mesalazine,DB13783,Acemetacin,0.9270174503326416,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Acemetacin.,49,Type_49,Yes
DB00555,Lamotrigine,DB09280,Lumacaftor,0.6946851015090942,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Lamotrigine.,75,Type_75,Yes
DB00932,Tipranavir,DB01551,Dihydrocodeine,0.945986807346344,47,Type_47,The metabolism of Dihydrocodeine can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00705,Delavirdine,DB01248,Docetaxel,0.8257809281349182,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00738,Pentamidine,DB01067,Glipizide,0.8108840584754944,9,Type_9,Pentamidine may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00905,Bimatoprost,DB01283,Lumiracoxib,0.9712520837783813,70,Type_70,The therapeutic efficacy of Lumiracoxib can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00268,Ropinirole,DB00588,Fluticasone propionate,0.47720998525619507,70,Type_70,The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Ropinirole.,32,Type_32,No
DB01118,Amiodarone,DB12001,Abemaciclib,0.5044406056404114,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Amiodarone.,49,Type_49,No
DB00252,Phenytoin,DB01229,Paclitaxel,0.7009488344192505,4,Type_4,The metabolism of Paclitaxel can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01184,Domperidone,DB11730,Ribociclib,0.9187471270561218,33,Type_33,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Ribociclib.,33,Type_33,Yes
DB00582,Voriconazole,DB01166,Cilostazol,0.6161274313926697,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00508,Triflupromazine,DB01233,Metoclopramide,0.8561510443687439,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Metoclopramide.,49,Type_49,Yes
DB00281,Lidocaine,DB00450,Droperidol,0.999776303768158,16,Type_16,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Droperidol.,16,Type_16,Yes
DB00681,Amphotericin B,DB01143,Amifostine,0.9990407824516296,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amifostine.,49,Type_49,Yes
DB00717,Norethisterone,DB01251,Gliquidone,0.8936156034469604,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norethisterone.,70,Type_70,Yes
DB00196,Fluconazole,DB01169,Arsenic trioxide,0.8377180695533752,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB00325,Nitroprusside,DB01074,Perhexiline,0.981765866279602,60,Type_60,Nitroprusside may increase the hypotensive activities of Perhexiline.,60,Type_60,Yes
DB00294,Etonogestrel,DB06636,Isavuconazonium,0.8732013702392578,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Etonogestrel.,47,Type_47,Yes
DB00904,Ondansetron,DB09068,Vortioxetine,0.9729647040367126,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Vortioxetine.,64,Type_64,No
DB00283,Clemastine,DB00990,Exemestane,0.9337839484214783,47,Type_47,The metabolism of Exemestane can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00528,Lercanidipine,DB01377,Magnesium oxide,0.6312935948371887,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Lercanidipine.,49,Type_49,No
DB00521,Carteolol,DB00849,Methylphenobarbital,0.6655285954475403,60,Type_60,Carteolol may increase the hypotensive activities of Methylphenobarbital.,60,Type_60,Yes
DB00877,Sirolimus,DB01197,Captopril,0.73911052942276,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Captopril.,49,Type_49,Yes
DB00476,Duloxetine,DB01203,Nadolol,0.9515747427940369,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Nadolol.,30,Type_30,Yes
DB00177,Valsartan,DB00749,Etodolac,0.6627715229988098,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Etodolac.,47,Type_47,No
DB00310,Chlorthalidone,DB00820,Tadalafil,0.9999243021011353,10,Type_10,Chlorthalidone may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00327,Hydromorphone,DB06697,Artemether,0.7577986121177673,47,Type_47,The metabolism of Artemether can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB01235,Levodopa,DB01433,Methadyl acetate,0.997142493724823,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Methadyl acetate.,49,Type_49,Yes
DB00606,Cyclothiazide,DB01466,Ethylmorphine,0.9713796973228455,49,Type_49,The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Ethylmorphine.,49,Type_49,Yes
DB00929,Misoprostol,DB06802,Nepafenac,0.8244091272354126,70,Type_70,The therapeutic efficacy of Nepafenac can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB01296,Glucosamine,DB08954,Ifenprodil,0.9573717713356018,53,Type_53,Glucosamine may increase the antiplatelet activities of Ifenprodil.,53,Type_53,Yes
DB00295,Morphine,DB06144,Sertindole,0.8874065279960632,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Sertindole.,49,Type_49,Yes
DB00351,Megestrol acetate,DB00498,Phenindione,0.5256867408752441,70,Type_70,The therapeutic efficacy of Phenindione can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00261,Anagrelide,DB06697,Artemether,0.8734360337257385,33,Type_33,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Artemether.,33,Type_33,Yes
DB00544,Fluorouracil,DB00757,Dolasetron,0.9160844087600708,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00264,Metoprolol,DB09238,Manidipine,0.6880813241004944,60,Type_60,Metoprolol may increase the hypotensive activities of Manidipine.,73,Type_73,No
DB00270,Isradipine,DB00661,Verapamil,0.8508583903312683,47,Type_47,The metabolism of Verapamil can be decreased when combined with Isradipine.,49,Type_49,No
DB00195,Betaxolol,DB01074,Perhexiline,0.8877105116844177,60,Type_60,Betaxolol may increase the hypotensive activities of Perhexiline.,47,Type_47,No
DB00195,Betaxolol,DB00866,Alprenolol,0.69917893409729,30,Type_30,Betaxolol may increase the orthostatic hypotensive activities of Alprenolol.,47,Type_47,No
DB00390,Digoxin,DB04845,Ixabepilone,0.9786720275878906,58,Type_58,Digoxin may decrease the cardiotoxic activities of Ixabepilone.,58,Type_58,Yes
DB00211,Midodrine,DB01203,Nadolol,0.6640751361846924,54,Type_54,Midodrine may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB00467,Enoxacin,DB01016,Glyburide,0.993550181388855,9,Type_9,Enoxacin may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00270,Isradipine,DB01203,Nadolol,0.913151741027832,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Nadolol.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00843,Donepezil,0.9729346036911011,47,Type_47,The metabolism of Donepezil can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00501,Cimetidine,DB01244,Bepridil,0.7557665109634399,47,Type_47,The metabolism of Bepridil can be decreased when combined with Cimetidine.,73,Type_73,No
DB00571,Propranolol,DB00680,Moricizine,0.9181745648384094,60,Type_60,Propranolol may increase the hypotensive activities of Moricizine.,60,Type_60,Yes
DB00179,Masoprocol,DB00187,Esmolol,0.9995779395103455,37,Type_37,Masoprocol may decrease the antihypertensive activities of Esmolol.,37,Type_37,Yes
DB00188,Bortezomib,DB04574,Estrone sulfate,0.6883644461631775,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00175,Pravastatin,DB09167,Dosulepin,0.68128502368927,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB00295,Morphine,DB01356,Lithium cation,0.9614600539207458,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Lithium cation.,49,Type_49,Yes
DB00295,Morphine,DB06204,Tapentadol,0.9913960099220276,16,Type_16,Morphine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00547,Desoximetasone,DB00772,Malathion,0.9967760443687439,49,Type_49,The risk or severity of adverse effects can be increased when Desoximetasone is combined with Malathion.,49,Type_49,Yes
DB00972,Azelastine,DB01215,Estazolam,0.5149025321006775,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.,16,Type_16,Yes
DB01226,Mivacurium,DB01236,Sevoflurane,0.9925920963287354,21,Type_21,Mivacurium may increase the neuromuscular blocking activities of Sevoflurane.,21,Type_21,Yes
DB00620,Triamcinolone,DB09269,Phenylacetic acid,0.8925280570983887,70,Type_70,The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Triamcinolone.,70,Type_70,Yes
DB00827,Cinoxacin,DB06781,Difluprednate,0.9904597997665405,49,Type_49,The risk or severity of adverse effects can be increased when Cinoxacin is combined with Difluprednate.,49,Type_49,Yes
DB00615,Rifabutin,DB00620,Triamcinolone,0.8566613793373108,4,Type_4,The metabolism of Triamcinolone can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00213,Pantoprazole,DB00238,Nevirapine,0.7867553234100342,47,Type_47,The metabolism of Nevirapine can be decreased when combined with Pantoprazole.,4,Type_4,No
DB01595,Nitrazepam,DB08910,Pomalidomide,0.9702252149581909,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Pomalidomide.,49,Type_49,Yes
DB01149,Nefazodone,DB09078,Lenvatinib,0.5969361066818237,47,Type_47,The metabolism of Lenvatinib can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00186,Lorazepam,DB01142,Doxepin,0.9942089319229126,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Doxepin.,49,Type_49,Yes
DB00238,Nevirapine,DB08827,Lomitapide,0.5168878436088562,4,Type_4,The metabolism of Lomitapide can be increased when combined with Nevirapine.,73,Type_73,No
DB00337,Pimecrolimus,DB00591,Fluocinolone acetonide,0.9999072551727295,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocinolone acetonide.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB04861,Nebivolol,0.8476964831352234,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Nebivolol.,60,Type_60,Yes
DB00896,Rimexolone,DB01420,Testosterone propionate,0.9999045133590698,74,Type_74,Rimexolone may increase the fluid retaining activities of Testosterone propionate.,74,Type_74,Yes
DB00195,Betaxolol,DB01169,Arsenic trioxide,0.6990061402320862,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Arsenic trioxide.,49,Type_49,Yes
DB01401,Choline magnesium trisalicylate,DB06725,Lornoxicam,0.9995948672294617,49,Type_49,The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam.,49,Type_49,Yes
DB00413,Pramipexole,DB09112,Nitrous acid,0.9947670698165894,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitrous acid.,49,Type_49,Yes
DB00862,Vardenafil,DB01203,Nadolol,0.8301483392715454,10,Type_10,Vardenafil may increase the antihypertensive activities of Nadolol.,10,Type_10,Yes
DB01074,Perhexiline,DB01243,Chloroxine,0.9600046277046204,49,Type_49,The risk or severity of adverse effects can be increased when Perhexiline is combined with Chloroxine.,49,Type_49,Yes
DB08895,Tofacitinib,DB09053,Ibrutinib,0.8523024916648865,34,Type_34,Tofacitinib may increase the immunosuppressive activities of Ibrutinib.,34,Type_34,Yes
DB00474,Methohexital,DB01144,Diclofenamide,0.7743586301803589,60,Type_60,Methohexital may increase the hypotensive activities of Diclofenamide.,60,Type_60,Yes
DB00569,Fondaparinux,DB06730,Gestodene,0.8094807267189026,70,Type_70,The therapeutic efficacy of Gestodene can be decreased when used in combination with Fondaparinux.,70,Type_70,Yes
DB00661,Verapamil,DB01356,Lithium cation,0.4808703362941742,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Verapamil.,35,Type_35,No
DB00619,Imatinib,DB00655,Estrone,0.8750284314155579,47,Type_47,The metabolism of Estrone can be decreased when combined with Imatinib.,47,Type_47,Yes
DB01041,Thalidomide,DB01235,Levodopa,0.9146585464477539,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Levodopa.,30,Type_30,No
DB00400,Griseofulvin,DB00996,Gabapentin,0.9253879189491272,49,Type_49,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Gabapentin.,49,Type_49,Yes
DB00908,Quinidine,DB09289,Tianeptine,0.5228468775749207,20,Type_20,Quinidine may increase the QTc-prolonging activities of Tianeptine.,20,Type_20,Yes
DB00343,Diltiazem,DB09204,Arotinolol,0.8270739316940308,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Arotinolol.,49,Type_49,Yes
DB00273,Topiramate,DB00887,Bumetanide,0.9500518441200256,83,Type_83,Topiramate may increase the hypokalemic activities of Bumetanide.,83,Type_83,Yes
DB00176,Fluvoxamine,DB11574,Elbasvir,0.9888522624969482,47,Type_47,The metabolism of Elbasvir can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00285,Venlafaxine,DB06738,Ketobemidone,0.5124724507331848,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00682,Warfarin,DB01331,Cefoxitin,0.9999459981918335,6,Type_6,Warfarin may increase the anticoagulant activities of Cefoxitin.,6,Type_6,Yes
DB00246,Ziprasidone,DB08907,Canagliflozin,0.48464277386665344,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ziprasidone.,47,Type_47,No
DB01254,Dasatinib,DB05039,Indacaterol,0.47257527709007263,20,Type_20,Dasatinib may increase the QTc-prolonging activities of Indacaterol.,73,Type_73,No
DB00608,Chloroquine,DB00836,Loperamide,0.9149423837661743,47,Type_47,The metabolism of Loperamide can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB01200,Bromocriptine,DB08899,Enzalutamide,0.7533155083656311,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Bromocriptine.,75,Type_75,Yes
DB01016,Glyburide,DB08860,Pitavastatin,0.6739450097084045,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB00951,Isoniazid,DB06589,Pazopanib,0.621901273727417,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Isoniazid.,47,Type_47,No
DB08984,Etofenamate,DB09211,Limaprost,0.9793801307678223,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Etofenamate.,70,Type_70,Yes
DB01390,Sodium bicarbonate,DB08860,Pitavastatin,0.9634172320365906,75,Type_75,The serum concentration of Pitavastatin can be decreased when it is combined with Sodium bicarbonate.,75,Type_75,Yes
DB00571,Propranolol,DB00953,Rizatriptan,0.3909294903278351,73,Type_73,The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00175,Pravastatin,DB01685,Topiroxostat,0.9275473952293396,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB00223,Diflorasone,DB00255,Diethylstilbestrol,0.9519144296646118,73,Type_73,The serum concentration of Diethylstilbestrol can be increased when it is combined with Diflorasone.,73,Type_73,Yes
DB00892,Oxybuprocaine,DB09224,Melperone,0.9999877214431763,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Melperone.,49,Type_49,Yes
DB00921,Buprenorphine,DB01325,Quinethazone,0.9857640862464905,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Quinethazone.,49,Type_49,Yes
DB01621,Pipotiazine,DB09291,Rolapitant,0.9061135649681091,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Pipotiazine.,47,Type_47,Yes
DB08864,Rilpivirine,DB13139,Levosalbutamol,0.9280122518539429,73,Type_73,The serum concentration of Levosalbutamol can be increased when it is combined with Rilpivirine.,73,Type_73,Yes
DB00614,Furazolidone,DB00876,Eprosartan,0.9927520751953125,60,Type_60,Furazolidone may increase the hypotensive activities of Eprosartan.,60,Type_60,Yes
DB01041,Thalidomide,DB01151,Desipramine,0.9544791579246521,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Desipramine.,16,Type_16,Yes
DB00850,Perphenazine,DB09042,Tedizolid phosphate,0.9869813323020935,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Tedizolid phosphate.,49,Type_49,Yes
DB00685,Trovafloxacin,DB05676,Apremilast,0.9946354031562805,27,Type_27,Trovafloxacin may increase the neuroexcitatory activities of Apremilast.,27,Type_27,Yes
DB00277,Theophylline,DB08820,Ivacaftor,0.9941530823707581,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Theophylline.,73,Type_73,Yes
DB00870,Suprofen,DB00955,Netilmicin,0.9998805522918701,72,Type_72,Suprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB00227,Lovastatin,DB00554,Piroxicam,0.8152459859848022,47,Type_47,The metabolism of Piroxicam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00909,Zonisamide,DB01041,Thalidomide,0.9970510005950928,16,Type_16,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00500,Tolmetin,DB00821,Carprofen,0.9994257688522339,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Carprofen.,49,Type_49,Yes
DB01545,Ethyl loflazepate,DB06738,Ketobemidone,0.9965530633926392,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Ketobemidone.,49,Type_49,Yes
DB01580,Oxprenolol,DB06702,Fesoterodine,0.512664794921875,39,Type_39,Oxprenolol may increase the constipating activities of Fesoterodine.,77,Type_77,No
DB00861,Diflunisal,DB13158,Clobetasone,0.9967790246009827,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Clobetasone.,49,Type_49,Yes
DB00243,Ranolazine,DB00525,Tolnaftate,0.8037672638893127,73,Type_73,The serum concentration of Tolnaftate can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00321,Amitriptyline,DB06707,Levonordefrin,0.9990249872207642,37,Type_37,Amitriptyline may decrease the antihypertensive activities of Levonordefrin.,37,Type_37,Yes
DB00694,Daunorubicin,DB09330,Osimertinib,0.965573251247406,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Daunorubicin.,73,Type_73,Yes
DB00318,Codeine,DB00363,Clozapine,0.4719263017177582,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Clozapine.,70,Type_70,No
DB01059,Norfloxacin,DB09146,Iron sucrose,0.9472817182540894,75,Type_75,The serum concentration of Iron sucrose can be decreased when it is combined with Norfloxacin.,75,Type_75,Yes
DB00543,Amoxapine,DB06738,Ketobemidone,0.9469394683837891,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Ketobemidone.,49,Type_49,Yes
DB00343,Diltiazem,DB00910,Paricalcitol,0.5317877531051636,34,Type_34,Diltiazem may increase the immunosuppressive activities of Paricalcitol.,47,Type_47,No
DB00749,Etodolac,DB06696,Arbekacin,0.999702513217926,72,Type_72,Etodolac may decrease the excretion rate of Arbekacin which could result in a higher serum level.,72,Type_72,Yes
DB00343,Diltiazem,DB00806,Pentoxifylline,0.8758881092071533,60,Type_60,Diltiazem may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00327,Hydromorphone,DB00949,Felbamate,0.9810406565666199,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Felbamate.,49,Type_49,Yes
DB01210,Levobunolol,DB09235,Efonidipine,0.5740578770637512,49,Type_49,The risk or severity of adverse effects can be increased when Levobunolol is combined with Efonidipine.,49,Type_49,Yes
DB00795,Sulfasalazine,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Sulfasalazine.,70,Type_70,Yes
DB00322,Floxuridine,DB00338,Omeprazole,0.9668481945991516,47,Type_47,The metabolism of Omeprazole can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00241,Butalbital,DB00323,Tolcapone,0.9988580942153931,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Tolcapone.,49,Type_49,Yes
DB01215,Estazolam,DB01219,Dantrolene,0.9991324543952942,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Dantrolene.,49,Type_49,Yes
DB00316,Acetaminophen,DB06708,Lumefantrine,0.8893901705741882,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00501,Cimetidine,DB01101,Capecitabine,0.9388072490692139,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Cimetidine.,77,Type_77,No
DB00898,Ethanol,DB00949,Felbamate,0.9906434416770935,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Felbamate.,16,Type_16,Yes
DB00333,Methadone,DB00691,Moexipril,0.34467628598213196,20,Type_20,Methadone may increase the QTc-prolonging activities of Moexipril.,20,Type_20,Yes
DB01106,Levocabastine,DB13025,Tiapride,0.9999631643295288,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Tiapride.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00898,Ethanol,0.42854222655296326,30,Type_30,Methyclothiazide may increase the orthostatic hypotensive activities of Ethanol.,30,Type_30,Yes
DB00216,Eletriptan,DB00418,Secobarbital,0.7899597883224487,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Secobarbital.,4,Type_4,No
DB00224,Indinavir,DB00313,Valproic acid,0.6337154507637024,47,Type_47,The metabolism of Valproic acid can be decreased when combined with Indinavir.,75,Type_75,No
DB00794,Primidone,DB01283,Lumiracoxib,0.9517444372177124,4,Type_4,The metabolism of Lumiracoxib can be increased when combined with Primidone.,4,Type_4,Yes
DB00872,Conivaptan,DB08933,Luliconazole,0.9993102550506592,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00543,Amoxapine,DB00952,Naratriptan,0.8920151591300964,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Naratriptan.,49,Type_49,Yes
DB00943,Zalcitabine,DB01012,Cinacalcet,0.8687095642089844,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Zalcitabine.,47,Type_47,Yes
DB00421,Spironolactone,DB06480,Prucalopride,0.9806379079818726,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Spironolactone.,73,Type_73,Yes
DB06710,Methyltestosterone,DB09118,Stiripentol,0.8320731520652771,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Methyltestosterone.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB12161,Deutetrabenazine,0.9937008619308472,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00201,Caffeine,DB00518,Albendazole,0.9250997304916382,47,Type_47,The metabolism of Albendazole can be decreased when combined with Caffeine.,47,Type_47,Yes
DB01580,Oxprenolol,DB01622,Thioproperazine,0.9174540638923645,60,Type_60,Oxprenolol may increase the hypotensive activities of Thioproperazine.,60,Type_60,Yes
DB00625,Efavirenz,DB09224,Melperone,0.9990284442901611,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Melperone.,49,Type_49,Yes
DB00983,Formoterol,DB09245,Toloxatone,0.5867130160331726,71,Type_71,Formoterol may increase the hypertensive activities of Toloxatone.,49,Type_49,No
DB00734,Risperidone,DB01580,Oxprenolol,0.47721803188323975,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Oxprenolol.,60,Type_60,No
DB00582,Voriconazole,DB01396,Digitoxin,0.674274742603302,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Voriconazole.,47,Type_47,No
DB03793,Benzoic acid,DB09235,Efonidipine,0.9983705878257751,49,Type_49,The risk or severity of adverse effects can be increased when Benzoic acid is combined with Efonidipine.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01070,Dihydrotachysterol,0.9592819809913635,51,Type_51,Methyclothiazide may increase the hypercalcemic activities of Dihydrotachysterol.,51,Type_51,Yes
DB00281,Lidocaine,DB01159,Halothane,0.6571359038352966,47,Type_47,The metabolism of Halothane can be decreased when combined with Lidocaine.,49,Type_49,No
DB00343,Diltiazem,DB06694,Xylometazoline,0.7062839269638062,60,Type_60,Diltiazem may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB01357,Mestranol,DB06154,Pentaerythritol tetranitrate,0.858146071434021,12,Type_12,Mestranol may decrease the anticoagulant activities of Pentaerythritol tetranitrate.,12,Type_12,Yes
DB00232,Methyclothiazide,DB00531,Cyclophosphamide,0.878084123134613,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Cyclophosphamide.,49,Type_49,Yes
DB00795,Sulfasalazine,DB08984,Etofenamate,0.9826845526695251,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etofenamate.,49,Type_49,Yes
DB00331,Metformin,DB00687,Fludrocortisone,0.9903616905212402,70,Type_70,The therapeutic efficacy of Fludrocortisone can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00281,Lidocaine,DB00434,Cyproheptadine,0.9940862655639648,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Cyproheptadine.,49,Type_49,Yes
DB00778,Roxithromycin,DB01098,Rosuvastatin,0.5904109477996826,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Roxithromycin.,73,Type_73,Yes
DB00697,Tizanidine,DB00996,Gabapentin,0.8756092190742493,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Gabapentin.,49,Type_49,Yes
DB01016,Glyburide,DB06700,Desvenlafaxine,0.9673241376876831,9,Type_9,Glyburide may increase the hypoglycemic activities of Desvenlafaxine.,9,Type_9,Yes
DB00261,Anagrelide,DB00862,Vardenafil,0.9091487526893616,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Vardenafil.,20,Type_20,Yes
DB00402,Eszopiclone,DB00768,Olopatadine,0.8855873942375183,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Olopatadine.,49,Type_49,Yes
DB01032,Probenecid,DB08916,Afatinib,0.8963431119918823,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00188,Bortezomib,DB06403,Ambrisentan,0.873764157295227,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00176,Fluvoxamine,DB00907,Cocaine,0.7087965607643127,47,Type_47,The metabolism of Cocaine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00211,Midodrine,DB01210,Levobunolol,0.927830159664154,54,Type_54,Midodrine may increase the bradycardic activities of Levobunolol.,54,Type_54,Yes
DB00476,Duloxetine,DB01583,Liotrix,0.7104390263557434,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Liotrix.,70,Type_70,No
DB00734,Risperidone,DB01232,Saquinavir,0.550864040851593,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Risperidone.,47,Type_47,Yes
DB00754,Ethotoin,DB01452,Diamorphine,0.9949028491973877,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Diamorphine.,49,Type_49,Yes
DB00549,Zafirlukast,DB05812,Abiraterone,0.6241462230682373,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Zafirlukast.,73,Type_73,Yes
DB01222,Budesonide,DB01377,Magnesium oxide,0.998773992061615,3,Type_3,The bioavailability of Magnesium oxide can be decreased when combined with Budesonide.,3,Type_3,Yes
DB00695,Furosemide,DB00764,Mometasone,0.9878457188606262,83,Type_83,Furosemide may increase the hypokalemic activities of Mometasone.,83,Type_83,Yes
DB01229,Paclitaxel,DB08899,Enzalutamide,0.9712709784507751,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Paclitaxel.,75,Type_75,Yes
DB00243,Ranolazine,DB09083,Ivabradine,0.6588432192802429,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB06802,Nepafenac,DB09216,Tolfenamic acid,0.9976474642753601,49,Type_49,The risk or severity of adverse effects can be increased when Nepafenac is combined with Tolfenamic acid.,49,Type_49,Yes
DB00500,Tolmetin,DB00682,Warfarin,0.9999558925628662,6,Type_6,Tolmetin may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB06772,Cabazitaxel,DB09516,Mequinol,0.9987138509750366,49,Type_49,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Mequinol.,49,Type_49,Yes
DB01396,Digitoxin,DB06813,Pralatrexate,0.9964242577552795,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Pralatrexate.,58,Type_58,Yes
DB00366,Doxylamine,DB01068,Clonazepam,0.9999971389770508,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.,16,Type_16,Yes
DB00873,Loteprednol,DB06710,Methyltestosterone,0.9958235025405884,74,Type_74,Loteprednol may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB00356,Chlorzoxazone,DB09034,Suvorexant,0.9995218515396118,16,Type_16,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00802,Alfentanil,DB00887,Bumetanide,0.9965150356292725,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Bumetanide.,49,Type_49,Yes
DB00921,Buprenorphine,DB01086,Benzocaine,0.9995023012161255,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.,16,Type_16,Yes
DB00559,Bosentan,DB01256,Retapamulin,0.917559802532196,75,Type_75,The serum concentration of Retapamulin can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00370,Mirtazapine,DB00589,Lisuride,0.5492166876792908,71,Type_71,Mirtazapine may increase the hypertensive activities of Lisuride.,49,Type_49,No
DB00427,Triprolidine,DB00564,Carbamazepine,0.6185938119888306,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Carbamazepine.,49,Type_49,Yes
DB00503,Ritonavir,DB00726,Trimipramine,0.650031566619873,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00270,Isradipine,DB01136,Carvedilol,0.7719445824623108,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Carvedilol.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00697,Tizanidine,0.82229083776474,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Tizanidine.,49,Type_49,Yes
DB01069,Promethazine,DB01165,Ofloxacin,0.999442994594574,20,Type_20,Promethazine may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB01002,Levobupivacaine,DB01437,Glutethimide,0.9994031190872192,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Glutethimide.,49,Type_49,Yes
DB00418,Secobarbital,DB06700,Desvenlafaxine,0.7809087634086609,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Desvenlafaxine.,49,Type_49,Yes
DB00599,Thiopental,DB06690,Nitrous oxide,0.9996535778045654,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Nitrous oxide.,49,Type_49,Yes
DB04846,Celiprolol,DB09236,Lacidipine,0.973094642162323,60,Type_60,Celiprolol may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00285,Venlafaxine,DB06684,Vilazodone,0.558157742023468,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vilazodone.,73,Type_73,No
DB00590,Doxazosin,DB00780,Phenelzine,0.9625375270843506,60,Type_60,Doxazosin may increase the hypotensive activities of Phenelzine.,60,Type_60,Yes
DB00906,Tiagabine,DB09225,Zotepine,0.9996997117996216,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Zotepine.,49,Type_49,Yes
DB00215,Citalopram,DB01601,Lopinavir,0.720417320728302,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00221,Isoetharine,DB00285,Venlafaxine,0.746741771697998,85,Type_85,Isoetharine may increase the tachycardic activities of Venlafaxine.,85,Type_85,Yes
DB01319,Fosamprenavir,DB09570,Ixazomib,0.7082980871200562,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB01020,Isosorbide mononitrate,DB01229,Paclitaxel,0.9600685834884644,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Paclitaxel.,49,Type_49,Yes
DB01168,Procarbazine,DB01239,Chlorprothixene,0.9748225212097168,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Chlorprothixene.,49,Type_49,Yes
DB01614,Acepromazine,DB06282,Levocetirizine,0.994942843914032,49,Type_49,The risk or severity of adverse effects can be increased when Acepromazine is combined with Levocetirizine.,49,Type_49,Yes
DB00610,Metaraminol,DB01136,Carvedilol,0.9920123219490051,5,Type_5,Metaraminol may decrease the vasoconstricting activities of Carvedilol.,5,Type_5,Yes
DB00312,Pentobarbital,DB09288,Propacetamol,0.8035135269165039,4,Type_4,The metabolism of Propacetamol can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00468,Quinine,DB09027,Ledipasvir,0.838452160358429,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Quinine.,73,Type_73,Yes
DB00376,Trihexyphenidyl,DB01036,Tolterodine,0.9826322793960571,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Tolterodine.,49,Type_49,Yes
DB00296,Ropivacaine,DB05246,Methsuximide,0.9895355105400085,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Methsuximide.,49,Type_49,Yes
DB01215,Estazolam,DB08922,Perospirone,0.9964700937271118,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Perospirone.,49,Type_49,Yes
DB06595,Midostaurin,DB06770,Benzyl alcohol,0.902024507522583,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00470,Dronabinol,DB09224,Melperone,0.9994165897369385,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Melperone.,16,Type_16,Yes
DB00250,Dapsone,DB01131,Proguanil,0.9106024503707886,47,Type_47,The metabolism of Proguanil can be decreased when combined with Dapsone.,49,Type_49,No
DB00263,Sulfisoxazole,DB01044,Gatifloxacin,0.929154634475708,9,Type_9,Sulfisoxazole may increase the hypoglycemic activities of Gatifloxacin.,9,Type_9,Yes
DB00834,Mifepristone,DB06145,Spiramycin,0.9151289463043213,73,Type_73,The serum concentration of Spiramycin can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00327,Hydromorphone,DB01580,Oxprenolol,0.9674035906791687,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxprenolol.,49,Type_49,Yes
DB01264,Darunavir,DB05351,Dexlansoprazole,0.7852257490158081,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Darunavir.,47,Type_47,Yes
DB01319,Fosamprenavir,DB11828,Neratinib,0.8350380063056946,47,Type_47,The metabolism of Neratinib can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00872,Conivaptan,DB11614,Rupatadine,0.9733453989028931,73,Type_73,The serum concentration of Rupatadine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00381,Amlodipine,DB00752,Tranylcypromine,0.7240602374076843,60,Type_60,Amlodipine may increase the hypotensive activities of Tranylcypromine.,60,Type_60,Yes
DB00158,Folic acid,DB01600,Tiaprofenic acid,0.9438091516494751,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00344,Protriptyline,DB00734,Risperidone,0.6086971163749695,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Risperidone.,37,Type_37,No
DB00951,Isoniazid,DB09274,Artesunate,0.6857715845108032,11,Type_11,The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Isoniazid resulting in a loss in efficacy.,11,Type_11,Yes
DB00690,Flurazepam,DB09345,Pramocaine,0.9999985694885254,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Pramocaine.,49,Type_49,Yes
DB00582,Voriconazole,DB09555,Dexchlorpheniramine maleate,0.9327691197395325,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00254,Doxycycline,DB00680,Moricizine,0.9127041101455688,73,Type_73,The serum concentration of Moricizine can be increased when it is combined with Doxycycline.,73,Type_73,Yes
DB00715,Paroxetine,DB01253,Ergometrine,0.94432532787323,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Ergometrine.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB00496,Darifenacin,0.8873239755630493,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Darifenacin.,49,Type_49,Yes
DB06228,Rivaroxaban,DB09283,Trapidil,0.988867998123169,6,Type_6,Rivaroxaban may increase the anticoagulant activities of Trapidil.,6,Type_6,Yes
DB00324,Fluorometholone,DB00483,Gallamine triethiodide,0.9937525391578674,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Gallamine triethiodide.,49,Type_49,Yes
DB00238,Nevirapine,DB06684,Vilazodone,0.5483073592185974,4,Type_4,The metabolism of Vilazodone can be increased when combined with Nevirapine.,75,Type_75,No
DB00514,Dextromethorphan,DB06636,Isavuconazonium,0.8808528184890747,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB00682,Warfarin,DB01118,Amiodarone,0.5496934056282043,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Warfarin.,6,Type_6,No
DB00312,Pentobarbital,DB06694,Xylometazoline,0.9283502101898193,4,Type_4,The metabolism of Xylometazoline can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00270,Isradipine,DB09389,Norgestrel,0.7233303189277649,47,Type_47,The metabolism of Norgestrel can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00814,Meloxicam,DB00999,Hydrochlorothiazide,0.9964832067489624,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB00881,Quinapril,DB01244,Bepridil,0.5038294792175293,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Bepridil.,60,Type_60,No
DB00608,Chloroquine,DB01159,Halothane,0.7462837100028992,47,Type_47,The metabolism of Halothane can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB01214,Metipranolol,0.8616969585418701,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Metipranolol.,60,Type_60,No
DB01041,Thalidomide,DB01202,Levetiracetam,0.9997323155403137,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.,16,Type_16,Yes
DB00834,Mifepristone,DB08881,Vemurafenib,0.8008819222450256,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00737,Meclizine,DB00907,Cocaine,0.9856928586959839,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Cocaine.,49,Type_49,Yes
DB00539,Toremifene,DB01591,Solifenacin,0.9980937838554382,20,Type_20,Toremifene may increase the QTc-prolonging activities of Solifenacin.,20,Type_20,Yes
DB01171,Moclobemide,DB09235,Efonidipine,0.7321618795394897,60,Type_60,Moclobemide may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00233,Aminosalicylic acid,DB00620,Triamcinolone,0.9998939037322998,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Triamcinolone.,49,Type_49,Yes
DB00528,Lercanidipine,DB00876,Eprosartan,0.8807617425918579,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Eprosartan.,60,Type_60,No
DB00726,Trimipramine,DB00842,Oxazepam,0.9798437356948853,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Oxazepam.,49,Type_49,Yes
DB00735,Naftifine,DB00812,Phenylbutazone,0.9991462230682373,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Phenylbutazone.,49,Type_49,Yes
DB00237,Butabarbital,DB00296,Ropivacaine,0.9855175614356995,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Ropivacaine.,49,Type_49,Yes
DB00422,Methylphenidate,DB00898,Ethanol,0.5109192728996277,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Ethanol.,49,Type_49,Yes
DB00573,Fenoprofen,DB00864,Tacrolimus,0.9460213780403137,57,Type_57,Fenoprofen may increase the nephrotoxic activities of Tacrolimus.,57,Type_57,Yes
DB00705,Delavirdine,DB01221,Ketamine,0.9293756484985352,47,Type_47,The metabolism of Ketamine can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00277,Theophylline,DB00629,Guanabenz,0.8523122668266296,47,Type_47,The metabolism of Guanabenz can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB01002,Levobupivacaine,0.9481921792030334,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levobupivacaine.,49,Type_49,Yes
DB00476,Duloxetine,DB01239,Chlorprothixene,0.9540030360221863,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Chlorprothixene.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB01240,Epoprostenol,0.8192249536514282,60,Type_60,Arsenic trioxide may increase the hypotensive activities of Epoprostenol.,49,Type_49,No
DB00872,Conivaptan,DB00880,Chlorothiazide,0.948660135269165,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Chlorothiazide.,49,Type_49,Yes
DB01275,Hydralazine,DB04948,Lofexidine,0.9166897535324097,60,Type_60,Hydralazine may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB01158,Bretylium,DB04948,Lofexidine,0.9306285977363586,60,Type_60,Bretylium may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00491,Miglitol,DB00887,Bumetanide,0.999812662601471,70,Type_70,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00323,Tolcapone,DB00679,Thioridazine,0.9942086935043335,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Thioridazine.,49,Type_49,Yes
DB00927,Famotidine,DB01211,Clarithromycin,0.399209588766098,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Famotidine.,20,Type_20,No
DB00596,Ulobetasol,DB06819,Phenylbutyric acid,0.9517080783843994,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Ulobetasol.,70,Type_70,Yes
DB00264,Metoprolol,DB01242,Clomipramine,0.5026220083236694,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Metoprolol.,73,Type_73,No
DB01174,Phenobarbital,DB11560,Lesinurad,0.9872893691062927,4,Type_4,The metabolism of Lesinurad can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00177,Valsartan,DB00196,Fluconazole,0.949027955532074,47,Type_47,The metabolism of Fluconazole can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00309,Vindesine,DB04868,Nilotinib,0.6475734114646912,73,Type_73,The serum concentration of Nilotinib can be increased when it is combined with Vindesine.,73,Type_73,Yes
DB00692,Phentolamine,DB01210,Levobunolol,0.9613617658615112,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Levobunolol.,49,Type_49,Yes
DB00246,Ziprasidone,DB01104,Sertraline,0.7240791320800781,47,Type_47,The metabolism of Sertraline can be decreased when combined with Ziprasidone.,20,Type_20,No
DB00361,Vinorelbine,DB06212,Tolvaptan,0.9520317912101746,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB00519,Trandolapril,DB00606,Cyclothiazide,0.9882396459579468,60,Type_60,Trandolapril may increase the hypotensive activities of Cyclothiazide.,60,Type_60,Yes
DB00476,Duloxetine,DB00903,Etacrynic acid,0.7611145377159119,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Etacrynic acid.,30,Type_30,No
DB00997,Doxorubicin,DB08981,Fenbufen,0.9960422515869141,72,Type_72,Doxorubicin may decrease the excretion rate of Fenbufen which could result in a higher serum level.,72,Type_72,Yes
DB00312,Pentobarbital,DB00398,Sorafenib,0.5449544191360474,4,Type_4,The metabolism of Sorafenib can be increased when combined with Pentobarbital.,75,Type_75,No
DB00852,Pseudoephedrine,DB01192,Oxymorphone,0.9629554152488708,69,Type_69,Pseudoephedrine may increase the analgesic activities of Oxymorphone.,69,Type_69,Yes
DB01072,Atazanavir,DB06717,Fosaprepitant,0.8804275393486023,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB04868,Nilotinib,DB04938,Ospemifene,0.9313726425170898,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB00285,Venlafaxine,DB00629,Guanabenz,0.5749268531799316,47,Type_47,The metabolism of Guanabenz can be decreased when combined with Venlafaxine.,85,Type_85,No
DB00363,Clozapine,DB00952,Naratriptan,0.9741137623786926,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Naratriptan.,49,Type_49,Yes
DB01155,Gemifloxacin,DB13158,Clobetasone,0.9866183400154114,49,Type_49,The risk or severity of adverse effects can be increased when Gemifloxacin is combined with Clobetasone.,49,Type_49,Yes
DB00866,Alprenolol,DB01608,Periciazine,0.9592181444168091,60,Type_60,Alprenolol may increase the hypotensive activities of Periciazine.,60,Type_60,Yes
DB04840,Debrisoquine,DB09242,Moxonidine,0.9999853372573853,60,Type_60,Debrisoquine may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00764,Mometasone,DB09054,Idelalisib,0.9568854570388794,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Mometasone.,73,Type_73,Yes
DB00569,Fondaparinux,DB00788,Naproxen,0.9988723397254944,6,Type_6,Fondaparinux may increase the anticoagulant activities of Naproxen.,6,Type_6,Yes
DB08893,Mirabegron,DB08933,Luliconazole,0.988579511642456,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Mirabegron.,73,Type_73,Yes
DB06701,Dexmethylphenidate,DB08893,Mirabegron,0.6109657287597656,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Dexmethylphenidate.,47,Type_47,Yes
DB00212,Remikiren,DB00393,Nimodipine,0.9923702478408813,60,Type_60,Remikiren may increase the hypotensive activities of Nimodipine.,60,Type_60,Yes
DB00367,Levonorgestrel,DB09074,Olaparib,0.7932287454605103,47,Type_47,The metabolism of Olaparib can be decreased when combined with Levonorgestrel.,47,Type_47,Yes
DB00281,Lidocaine,DB01595,Nitrazepam,0.6084567904472351,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Nitrazepam.,49,Type_49,Yes
DB00869,Dorzolamide,DB01119,Diazoxide,0.975622832775116,60,Type_60,Dorzolamide may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00946,Phenprocoumon,DB01097,Leflunomide,0.998027503490448,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Leflunomide.,6,Type_6,Yes
DB00904,Ondansetron,DB01176,Cyclizine,0.9999436140060425,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Cyclizine.,49,Type_49,Yes
DB00744,Zileuton,DB09285,Morniflumate,0.9998868703842163,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Morniflumate.,49,Type_49,Yes
DB00524,Metolazone,DB08984,Etofenamate,0.9785444140434265,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00284,Acarbose,DB01104,Sertraline,0.9591419100761414,9,Type_9,Acarbose may increase the hypoglycemic activities of Sertraline.,9,Type_9,Yes
DB00379,Mexiletine,DB00932,Tipranavir,0.9659402966499329,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00625,Efavirenz,DB00784,Mefenamic acid,0.8917629718780518,47,Type_47,The metabolism of Mefenamic acid can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00153,Ergocalciferol,DB01092,Ouabain,0.9699462056159973,82,Type_82,Ergocalciferol may increase the arrhythmogenic activities of Ouabain.,82,Type_82,Yes
DB00206,Reserpine,DB01247,Isocarboxazid,0.6639242172241211,60,Type_60,Reserpine may increase the hypotensive activities of Isocarboxazid.,49,Type_49,No
DB00474,Methohexital,DB01065,Melatonin,0.9402031302452087,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Melatonin.,49,Type_49,Yes
DB00547,Desoximetasone,DB01400,Neostigmine,0.9978287816047668,49,Type_49,The risk or severity of adverse effects can be increased when Desoximetasone is combined with Neostigmine.,49,Type_49,Yes
DB00906,Tiagabine,DB01080,Vigabatrin,0.9936710596084595,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Vigabatrin.,49,Type_49,Yes
DB01149,Nefazodone,DB01210,Levobunolol,0.6803600788116455,73,Type_73,The serum concentration of Levobunolol can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00588,Fluticasone propionate,DB08899,Enzalutamide,0.9565249681472778,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Fluticasone propionate.,75,Type_75,Yes
DB04930,Permethrin,DB05521,Telaprevir,0.8673294186592102,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Permethrin.,47,Type_47,Yes
DB00196,Fluconazole,DB08907,Canagliflozin,0.5728874206542969,47,Type_47,The metabolism of Canagliflozin can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00201,Caffeine,DB08912,Dabrafenib,0.9918631315231323,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Caffeine.,75,Type_75,Yes
DB00951,Isoniazid,DB01201,Rifapentine,0.5398966073989868,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Isoniazid.,80,Type_80,No
DB00285,Venlafaxine,DB00405,Dexbrompheniramine,0.9668053984642029,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dexbrompheniramine.,49,Type_49,Yes
DB00324,Fluorometholone,DB00784,Mefenamic acid,0.9989293217658997,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mefenamic acid.,49,Type_49,Yes
DB00972,Azelastine,DB01384,Paramethasone,0.9918811917304993,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Paramethasone.,49,Type_49,Yes
DB00682,Warfarin,DB06781,Difluprednate,0.9431806206703186,6,Type_6,Warfarin may increase the anticoagulant activities of Difluprednate.,6,Type_6,Yes
DB00564,Carbamazepine,DB00613,Amodiaquine,0.7981786727905273,4,Type_4,The metabolism of Amodiaquine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00252,Phenytoin,DB00327,Hydromorphone,0.8145902752876282,4,Type_4,The metabolism of Hydromorphone can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00421,Spironolactone,DB00454,Meperidine,0.9935099482536316,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Meperidine.,49,Type_49,Yes
DB00252,Phenytoin,DB00737,Meclizine,0.9383129477500916,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Meclizine.,49,Type_49,Yes
DB00972,Azelastine,DB08880,Teriflunomide,0.5453670024871826,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Azelastine.,75,Type_75,Yes
DB00281,Lidocaine,DB01615,Aceprometazine,0.9581533074378967,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Aceprometazine.,49,Type_49,Yes
DB00619,Imatinib,DB00706,Tamsulosin,0.4828766882419586,73,Type_73,The serum concentration of Tamsulosin can be increased when it is combined with Imatinib.,47,Type_47,No
DB00277,Theophylline,DB01174,Phenobarbital,0.815110445022583,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Theophylline.,4,Type_4,Yes
DB01242,Clomipramine,DB01274,Arformoterol,0.40904000401496887,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Clomipramine.,47,Type_47,Yes
DB00261,Anagrelide,DB01418,Acenocoumarol,0.9483417272567749,6,Type_6,Anagrelide may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00619,Imatinib,DB09074,Olaparib,0.815906286239624,47,Type_47,The metabolism of Olaparib can be decreased when combined with Imatinib.,73,Type_73,No
DB00418,Secobarbital,DB00727,Nitroglycerin,0.6329977512359619,60,Type_60,Secobarbital may increase the hypotensive activities of Nitroglycerin.,60,Type_60,Yes
DB00790,Perindopril,DB08808,Bupranolol,0.5469662547111511,60,Type_60,Perindopril may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00908,Quinidine,DB09275,Bismuth subcitrate potassium,0.7772350907325745,72,Type_72,Quinidine may decrease the excretion rate of Bismuth subcitrate potassium which could result in a higher serum level.,72,Type_72,Yes
DB00450,Droperidol,DB01233,Metoclopramide,0.46353429555892944,49,Type_49,The risk or severity of adverse effects can be increased when Droperidol is combined with Metoclopramide.,49,Type_49,Yes
DB00346,Alfuzosin,DB01319,Fosamprenavir,0.7223138809204102,73,Type_73,The serum concentration of Fosamprenavir can be increased when it is combined with Alfuzosin.,73,Type_73,Yes
DB00795,Sulfasalazine,DB00880,Chlorothiazide,0.9930638670921326,70,Type_70,The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Sulfasalazine.,70,Type_70,Yes
DB00637,Astemizole,DB00908,Quinidine,0.5599013566970825,20,Type_20,Astemizole may increase the QTc-prolonging activities of Quinidine.,47,Type_47,No
DB00768,Olopatadine,DB00844,Nalbuphine,0.6851767301559448,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Nalbuphine.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB04840,Debrisoquine,0.9998577833175659,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB01238,Aripiprazole,DB01576,Dextroamphetamine,0.7001676559448242,61,Type_61,Aripiprazole may decrease the stimulatory activities of Dextroamphetamine.,61,Type_61,Yes
DB01151,Desipramine,DB01563,Chloral hydrate,0.9961068034172058,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Chloral hydrate.,49,Type_49,Yes
DB00443,Betamethasone,DB01609,Deferasirox,0.8540027737617493,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Deferasirox.,49,Type_49,Yes
DB00323,Tolcapone,DB08918,Levomilnacipran,0.8750907778739929,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Levomilnacipran.,49,Type_49,Yes
DB00091,Cyclosporine,DB05351,Dexlansoprazole,0.8262761235237122,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB09074,Olaparib,0.8117653131484985,47,Type_47,The metabolism of Olaparib can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00295,Morphine,DB02703,Fusidic acid,0.996807873249054,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Morphine.,73,Type_73,Yes
DB00801,Halazepam,DB00972,Azelastine,0.9544260501861572,16,Type_16,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00555,Lamotrigine,DB01501,Difenoxin,0.999902606010437,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Difenoxin.,49,Type_49,Yes
DB01088,Iloprost,DB01250,Olsalazine,0.6505863070487976,70,Type_70,The therapeutic efficacy of Olsalazine can be decreased when used in combination with Iloprost.,70,Type_70,Yes
DB00947,Fulvestrant,DB01118,Amiodarone,0.877641499042511,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Fulvestrant.,47,Type_47,Yes
DB00950,Fexofenadine,DB01390,Sodium bicarbonate,0.8067748546600342,75,Type_75,The serum concentration of Sodium bicarbonate can be decreased when it is combined with Fexofenadine.,75,Type_75,Yes
DB00951,Isoniazid,DB09104,Magnesium hydroxide,0.6225872039794922,67,Type_67,Isoniazid can cause a decrease in the absorption of Magnesium hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00285,Venlafaxine,DB00738,Pentamidine,0.6831028461456299,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00585,Nizatidine,DB09027,Ledipasvir,0.6818538308143616,75,Type_75,The serum concentration of Ledipasvir can be decreased when it is combined with Nizatidine.,75,Type_75,Yes
DB01551,Dihydrocodeine,DB04842,Fluspirilene,0.9989105463027954,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Fluspirilene.,49,Type_49,Yes
DB00199,Erythromycin,DB01190,Clindamycin,0.9480317831039429,47,Type_47,The metabolism of Clindamycin can be decreased when combined with Erythromycin.,70,Type_70,No
DB00635,Prednisone,DB00843,Donepezil,0.6961314082145691,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Donepezil.,49,Type_49,Yes
DB01248,Docetaxel,DB05260,Gallium nitrate,0.9958541393280029,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Gallium nitrate.,49,Type_49,Yes
DB00661,Verapamil,DB08822,Azilsartan medoxomil,0.9844846725463867,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00540,Nortriptyline,DB08880,Teriflunomide,0.4931538999080658,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB00343,Diltiazem,DB00877,Sirolimus,0.48677492141723633,47,Type_47,The metabolism of Sirolimus can be decreased when combined with Diltiazem.,49,Type_49,No
DB00257,Clotrimazole,DB00647,Dextropropoxyphene,0.9035362601280212,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00814,Meloxicam,DB00929,Misoprostol,0.9769269824028015,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB01009,Ketoprofen,DB01059,Norfloxacin,0.9976602792739868,27,Type_27,Ketoprofen may increase the neuroexcitatory activities of Norfloxacin.,27,Type_27,Yes
DB00897,Triazolam,DB00909,Zonisamide,0.9973004460334778,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Zonisamide.,49,Type_49,Yes
DB00818,Propofol,DB01221,Ketamine,0.9031463265419006,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Ketamine.,49,Type_49,Yes
DB00678,Losartan,DB01050,Ibuprofen,0.5333243012428284,47,Type_47,The metabolism of Ibuprofen can be decreased when combined with Losartan.,47,Type_47,Yes
DB00635,Prednisone,DB08881,Vemurafenib,0.7358095049858093,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Prednisone.,73,Type_73,No
DB00343,Diltiazem,DB00374,Treprostinil,0.9524399042129517,60,Type_60,Diltiazem may increase the hypotensive activities of Treprostinil.,60,Type_60,Yes
DB00555,Lamotrigine,DB00835,Brompheniramine,0.9891459941864014,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Brompheniramine.,49,Type_49,Yes
DB00281,Lidocaine,DB12161,Deutetrabenazine,0.9112398624420166,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00497,Oxycodone,DB05271,Rotigotine,0.9826488494873047,32,Type_32,Oxycodone may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00424,Hyoscyamine,DB01337,Pancuronium,0.9927547574043274,49,Type_49,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Pancuronium.,49,Type_49,Yes
DB00364,Sucralfate,DB00695,Furosemide,0.8490530848503113,75,Type_75,The serum concentration of Furosemide can be decreased when it is combined with Sucralfate.,75,Type_75,Yes
DB01283,Lumiracoxib,DB06595,Midostaurin,0.978859543800354,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Lumiracoxib.,47,Type_47,Yes
DB00310,Chlorthalidone,DB00881,Quinapril,0.945146918296814,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Quinapril.,49,Type_49,Yes
DB01356,Lithium cation,DB09477,Enalaprilat,0.7960984706878662,60,Type_60,Lithium cation may increase the hypotensive activities of Enalaprilat.,73,Type_73,No
DB00912,Repaglinide,DB09073,Palbociclib,0.980517566204071,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Repaglinide.,73,Type_73,Yes
DB08896,Regorafenib,DB08912,Dabrafenib,0.8827670812606812,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Regorafenib.,75,Type_75,Yes
DB01092,Ouabain,DB06810,Plicamycin,0.756169855594635,75,Type_75,The serum concentration of Plicamycin can be decreased when it is combined with Ouabain.,58,Type_58,No
DB00254,Doxycycline,DB00278,Argatroban,0.7440415024757385,47,Type_47,The metabolism of Argatroban can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00625,Efavirenz,DB06292,Dapagliflozin,0.38797563314437866,4,Type_4,The metabolism of Dapagliflozin can be increased when combined with Efavirenz.,47,Type_47,No
DB01623,Thiothixene,DB04896,Milnacipran,0.9827451109886169,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Milnacipran.,49,Type_49,Yes
DB00898,Ethanol,DB01463,Fencamfamin,0.9733536243438721,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin.,16,Type_16,Yes
DB00774,Hydroflumethiazide,DB01612,Amyl Nitrite,0.9850900173187256,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Amyl Nitrite.,49,Type_49,Yes
DB01159,Halothane,DB09068,Vortioxetine,0.9941997528076172,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Vortioxetine.,49,Type_49,Yes
DB00508,Triflupromazine,DB00908,Quinidine,0.5327675938606262,20,Type_20,Triflupromazine may increase the QTc-prolonging activities of Quinidine.,73,Type_73,No
DB01463,Fencamfamin,DB08987,Etidocaine,0.9999717473983765,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Etidocaine.,49,Type_49,Yes
DB02703,Fusidic acid,DB12483,Copanlisib,0.9925684928894043,73,Type_73,The serum concentration of Copanlisib can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00452,Framycetin,DB00482,Celecoxib,0.9921403527259827,72,Type_72,Framycetin may decrease the excretion rate of Celecoxib which could result in a higher serum level.,72,Type_72,Yes
DB00444,Teniposide,DB01232,Saquinavir,0.646312952041626,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Teniposide.,47,Type_47,Yes
DB00388,Phenylephrine,DB09288,Propacetamol,0.9113546013832092,76,Type_76,Phenylephrine may decrease the sedative activities of Propacetamol.,73,Type_73,No
DB00559,Bosentan,DB06708,Lumefantrine,0.9208031892776489,75,Type_75,The serum concentration of Lumefantrine can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00672,Chlorpropamide,DB01168,Procarbazine,0.9984490871429443,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Procarbazine.,9,Type_9,Yes
DB00561,Doxapram,DB01168,Procarbazine,0.9889383316040039,71,Type_71,Doxapram may increase the hypertensive activities of Procarbazine.,71,Type_71,Yes
DB00829,Diazepam,DB01224,Quetiapine,0.9688184857368469,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Quetiapine.,49,Type_49,Yes
DB00701,Amprenavir,DB01151,Desipramine,0.9431095719337463,47,Type_47,The metabolism of Desipramine can be decreased when combined with Amprenavir.,73,Type_73,No
DB00537,Ciprofloxacin,DB01076,Atorvastatin,0.6983969211578369,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Ciprofloxacin.,49,Type_49,No
DB00867,Ritodrine,DB01193,Acebutolol,0.9990047812461853,14,Type_14,Ritodrine may decrease the bronchodilatory activities of Acebutolol.,14,Type_14,Yes
DB01239,Chlorprothixene,DB01618,Molindone,0.9569674134254456,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Molindone.,49,Type_49,Yes
DB00552,Pentostatin,DB08868,Fingolimod,0.9996659755706787,34,Type_34,Pentostatin may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00699,Nicergoline,DB00912,Repaglinide,0.8833853006362915,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Repaglinide.,49,Type_49,Yes
DB00273,Topiramate,DB01242,Clomipramine,0.5029594302177429,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Clomipramine.,49,Type_49,Yes
DB00778,Roxithromycin,DB06717,Fosaprepitant,0.8803504705429077,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Roxithromycin.,73,Type_73,Yes
DB00337,Pimecrolimus,DB00498,Phenindione,0.9860462546348572,6,Type_6,Pimecrolimus may increase the anticoagulant activities of Phenindione.,6,Type_6,Yes
DB00312,Pentobarbital,DB00435,Nitric Oxide,0.9353278875350952,60,Type_60,Pentobarbital may increase the hypotensive activities of Nitric Oxide.,60,Type_60,Yes
DB00294,Etonogestrel,DB01132,Pioglitazone,0.4815310537815094,70,Type_70,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00312,Pentobarbital,DB00541,Vincristine,0.532204806804657,4,Type_4,The metabolism of Vincristine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00477,Chlorpromazine,DB01219,Dantrolene,0.8093876242637634,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Dantrolene.,49,Type_49,Yes
DB01029,Irbesartan,DB03585,Oxyphenbutazone,0.9201974272727966,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00820,Tadalafil,DB09220,Nicorandil,0.96296226978302,10,Type_10,Tadalafil may increase the antihypertensive activities of Nicorandil.,10,Type_10,Yes
DB00452,Framycetin,DB00744,Zileuton,0.9999310970306396,72,Type_72,Framycetin may decrease the excretion rate of Zileuton which could result in a higher serum level.,72,Type_72,Yes
DB08905,Formestane,DB09220,Nicorandil,0.8789647817611694,49,Type_49,The risk or severity of adverse effects can be increased when Formestane is combined with Nicorandil.,49,Type_49,Yes
DB00514,Dextromethorphan,DB00608,Chloroquine,0.9514126181602478,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB01007,Tioconazole,DB09216,Tolfenamic acid,0.9706965088844299,49,Type_49,The risk or severity of adverse effects can be increased when Tioconazole is combined with Tolfenamic acid.,49,Type_49,Yes
DB00248,Cabergoline,DB13179,Troleandomycin,0.6094372272491455,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Troleandomycin.,49,Type_49,Yes
DB00277,Theophylline,DB00404,Alprazolam,0.509406566619873,47,Type_47,The metabolism of Alprazolam can be decreased when combined with Theophylline.,70,Type_70,No
DB00476,Duloxetine,DB00921,Buprenorphine,0.5051929354667664,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Buprenorphine.,47,Type_47,No
DB00555,Lamotrigine,DB01157,Trimetrexate,0.8234196305274963,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Trimetrexate.,49,Type_49,Yes
DB01319,Fosamprenavir,DB09048,Netupitant,0.9694707989692688,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Fosamprenavir.,73,Type_73,Yes
DB01577,Metamfetamine,DB09245,Toloxatone,0.9882078766822815,71,Type_71,Metamfetamine may increase the hypertensive activities of Toloxatone.,71,Type_71,Yes
DB00698,Nitrofurantoin,DB08881,Vemurafenib,0.864329993724823,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Nitrofurantoin.,75,Type_75,No
DB01628,Etoricoxib,DB09279,Fimasartan,0.9943175911903381,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fimasartan.,49,Type_49,Yes
DB00277,Theophylline,DB00951,Isoniazid,0.7512326836585999,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Theophylline.,73,Type_73,No
DB00752,Tranylcypromine,DB01174,Phenobarbital,0.8630330562591553,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Phenobarbital.,49,Type_49,Yes
DB01106,Levocabastine,DB01580,Oxprenolol,0.9053419828414917,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Oxprenolol.,49,Type_49,Yes
DB01580,Oxprenolol,DB09212,Loxoprofen,0.924721360206604,37,Type_37,Oxprenolol may decrease the antihypertensive activities of Loxoprofen.,37,Type_37,Yes
DB06290,Simeprevir,DB06769,Bendamustine,0.9764485359191895,73,Type_73,The serum concentration of Bendamustine can be increased when it is combined with Simeprevir.,47,Type_47,No
DB01255,Lisdexamfetamine,DB06282,Levocetirizine,0.8309466242790222,76,Type_76,Lisdexamfetamine may decrease the sedative activities of Levocetirizine.,76,Type_76,Yes
DB00502,Haloperidol,DB01588,Prazepam,0.9110138416290283,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Prazepam.,49,Type_49,Yes
DB01238,Aripiprazole,DB09072,Sodium oxybate,0.9999996423721313,16,Type_16,Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00420,Promazine,DB01601,Lopinavir,0.5710051655769348,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Promazine.,47,Type_47,Yes
DB00257,Clotrimazole,DB00297,Bupivacaine,0.8687278628349304,47,Type_47,The metabolism of Bupivacaine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00420,Promazine,DB00831,Trifluoperazine,0.8596027493476868,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Trifluoperazine.,49,Type_49,Yes
DB00495,Zidovudine,DB06203,Alogliptin,0.3233639895915985,75,Type_75,The serum concentration of Alogliptin can be decreased when it is combined with Zidovudine.,75,Type_75,Yes
DB01110,Miconazole,DB06589,Pazopanib,0.8127549290657043,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Miconazole.,73,Type_73,Yes
DB00907,Cocaine,DB09128,Brexpiprazole,0.949904203414917,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Brexpiprazole.,73,Type_73,No
DB00317,Gefitinib,DB00420,Promazine,0.8142721652984619,47,Type_47,The metabolism of Promazine can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB00292,Etomidate,DB00697,Tizanidine,0.8073727488517761,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Tizanidine.,49,Type_49,Yes
DB00623,Fluphenazine,DB01068,Clonazepam,0.9836514592170715,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonazepam.,49,Type_49,Yes
DB00420,Promazine,DB06825,Triptorelin,0.9988403916358948,20,Type_20,Promazine may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00227,Lovastatin,DB01120,Gliclazide,0.9453620910644531,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00220,Nelfinavir,DB01587,Ketazolam,0.8186646699905396,47,Type_47,The metabolism of Ketazolam can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB06153,Pizotifen,DB06288,Amisulpride,0.9998828172683716,49,Type_49,The risk or severity of adverse effects can be increased when Pizotifen is combined with Amisulpride.,49,Type_49,Yes
DB00743,Gadobenic acid,DB04855,Dronedarone,0.9999996423721313,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Dronedarone.,20,Type_20,Yes
DB00472,Fluoxetine,DB01202,Levetiracetam,0.9696553945541382,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Levetiracetam.,49,Type_49,Yes
DB06717,Fosaprepitant,DB08877,Ruxolitinib,0.747068464756012,73,Type_73,The serum concentration of Ruxolitinib can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB00284,Acarbose,DB00672,Chlorpropamide,0.9906313419342041,9,Type_9,Acarbose may increase the hypoglycemic activities of Chlorpropamide.,9,Type_9,Yes
DB00976,Telithromycin,DB06694,Xylometazoline,0.5074278712272644,47,Type_47,The metabolism of Xylometazoline can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00409,Remoxipride,DB00909,Zonisamide,0.9978887438774109,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Zonisamide.,49,Type_49,Yes
DB00732,Atracurium besylate,DB09231,Benidipine,0.999997615814209,21,Type_21,Atracurium besylate may increase the neuromuscular blocking activities of Benidipine.,21,Type_21,Yes
DB01182,Propafenone,DB04861,Nebivolol,0.7270059585571289,54,Type_54,Propafenone may increase the bradycardic activities of Nebivolol.,73,Type_73,No
DB00370,Mirtazapine,DB08883,Perampanel,0.9992524981498718,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00490,Buspirone,DB00757,Dolasetron,0.5690758228302002,64,Type_64,Buspirone may increase the serotonergic activities of Dolasetron.,64,Type_64,Yes
DB00715,Paroxetine,DB01041,Thalidomide,0.8644217252731323,47,Type_47,The metabolism of Thalidomide can be decreased when combined with Paroxetine.,49,Type_49,No
DB01129,Rabeprazole,DB06817,Raltegravir,0.9938488602638245,73,Type_73,The serum concentration of Raltegravir can be increased when it is combined with Rabeprazole.,73,Type_73,Yes
DB00199,Erythromycin,DB01623,Thiothixene,0.40005478262901306,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00628,Clorazepic acid,DB06716,Fospropofol,0.9966769218444824,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Fospropofol.,49,Type_49,Yes
DB00468,Quinine,DB01074,Perhexiline,0.7092803716659546,47,Type_47,The metabolism of Perhexiline can be decreased when combined with Quinine.,47,Type_47,Yes
DB00899,Remifentanil,DB01114,Chlorpheniramine,0.9970159530639648,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorpheniramine.,49,Type_49,Yes
DB00321,Amitriptyline,DB00854,Levorphanol,0.9789401888847351,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levorphanol.,49,Type_49,Yes
DB00196,Fluconazole,DB00556,Perflutren,0.999972939491272,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Perflutren.,20,Type_20,Yes
DB01144,Diclofenamide,DB09286,Pipamperone,0.9920056462287903,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenamide is combined with Pipamperone.,49,Type_49,Yes
DB00540,Nortriptyline,DB01235,Levodopa,0.7913951277732849,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levodopa.,49,Type_49,Yes
DB00575,Clonidine,DB00949,Felbamate,0.9257012009620667,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Felbamate.,49,Type_49,Yes
DB01587,Ketazolam,DB06616,Bosutinib,0.8044769763946533,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ketazolam.,73,Type_73,Yes
DB00556,Perflutren,DB06589,Pazopanib,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB01238,Aripiprazole,DB06770,Benzyl alcohol,0.9298436045646667,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzyl alcohol.,49,Type_49,Yes
DB00549,Zafirlukast,DB00679,Thioridazine,0.6615957021713257,47,Type_47,The metabolism of Thioridazine can be decreased when combined with Zafirlukast.,73,Type_73,No
DB01410,Ciclesonide,DB09218,Clonixin,0.9994373917579651,49,Type_49,The risk or severity of adverse effects can be increased when Ciclesonide is combined with Clonixin.,49,Type_49,Yes
DB00975,Dipyridamole,DB08941,Isoxsuprine,0.9963570237159729,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Isoxsuprine.,49,Type_49,Yes
DB00238,Nevirapine,DB06700,Desvenlafaxine,0.8270063996315002,4,Type_4,The metabolism of Desvenlafaxine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB01018,Guanfacine,DB01351,Amobarbital,0.5902591943740845,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Amobarbital.,49,Type_49,Yes
DB00571,Propranolol,DB00734,Risperidone,0.3873927891254425,60,Type_60,Propranolol may increase the hypotensive activities of Risperidone.,60,Type_60,Yes
DB06710,Methyltestosterone,DB09063,Ceritinib,0.9920644164085388,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Methyltestosterone.,73,Type_73,Yes
DB00374,Treprostinil,DB00586,Diclofenac,0.8862408995628357,49,Type_49,The risk or severity of adverse effects can be increased when Treprostinil is combined with Diclofenac.,49,Type_49,Yes
DB04841,Flunarizine,DB04842,Fluspirilene,0.9980112314224243,49,Type_49,The risk or severity of adverse effects can be increased when Flunarizine is combined with Fluspirilene.,49,Type_49,Yes
DB05039,Indacaterol,DB08906,Fluticasone furoate,0.9936100840568542,83,Type_83,Indacaterol may increase the hypokalemic activities of Fluticasone furoate.,83,Type_83,Yes
DB00375,Colestipol,DB00482,Celecoxib,0.898192822933197,67,Type_67,Colestipol can cause a decrease in the absorption of Celecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00946,Phenprocoumon,DB09265,Lixisenatide,0.832886278629303,67,Type_67,Phenprocoumon can cause a decrease in the absorption of Lixisenatide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00371,Meprobamate,DB00564,Carbamazepine,0.7191299796104431,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Meprobamate.,4,Type_4,Yes
DB07615,Tranilast,DB09214,Dexketoprofen,0.9093326330184937,49,Type_49,The risk or severity of adverse effects can be increased when Tranilast is combined with Dexketoprofen.,49,Type_49,Yes
DB00244,Mesalazine,DB00919,Spectinomycin,0.9978020787239075,72,Type_72,Mesalazine may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB01032,Probenecid,DB01414,Cefacetrile,0.7789401412010193,73,Type_73,The serum concentration of Cefacetrile can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00847,Cysteamine,DB00863,Ranitidine,0.7193472385406494,49,Type_49,The risk or severity of adverse effects can be increased when Cysteamine is combined with Ranitidine.,70,Type_70,No
DB00196,Fluconazole,DB00528,Lercanidipine,0.6737298965454102,47,Type_47,The metabolism of Lercanidipine can be decreased when combined with Fluconazole.,73,Type_73,No
DB00697,Tizanidine,DB01563,Chloral hydrate,0.9913173913955688,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Chloral hydrate.,49,Type_49,Yes
DB00780,Phenelzine,DB01100,Pimozide,0.9320663213729858,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Pimozide.,49,Type_49,Yes
DB08932,Macitentan,DB09074,Olaparib,0.9912207722663879,47,Type_47,The metabolism of Olaparib can be decreased when combined with Macitentan.,47,Type_47,Yes
DB00289,Atomoxetine,DB01628,Etoricoxib,0.9571260809898376,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00321,Amitriptyline,DB00455,Loratadine,0.84257972240448,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Loratadine.,49,Type_49,Yes
DB00394,Beclomethasone dipropionate,DB00870,Suprofen,0.9996458292007446,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Suprofen.,49,Type_49,Yes
DB01182,Propafenone,DB06480,Prucalopride,0.948803186416626,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Propafenone.,73,Type_73,Yes
DB00842,Oxazepam,DB01587,Ketazolam,0.9966889023780823,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Ketazolam.,49,Type_49,Yes
DB00712,Flurbiprofen,DB00808,Indapamide,0.950397789478302,70,Type_70,The therapeutic efficacy of Indapamide can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB00196,Fluconazole,DB04871,Lorcaserin,0.7965359687805176,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01149,Nefazodone,DB06777,Chenodeoxycholic acid,0.9265016317367554,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00283,Clemastine,DB06605,Apixaban,0.7775120139122009,47,Type_47,The metabolism of Apixaban can be decreased when combined with Clemastine.,73,Type_73,No
DB00490,Buspirone,DB01618,Molindone,0.9993426203727722,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Molindone.,49,Type_49,Yes
DB00541,Vincristine,DB00705,Delavirdine,0.45434707403182983,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Vincristine.,47,Type_47,Yes
DB00747,Scopolamine,DB01614,Acepromazine,0.9988781809806824,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Acepromazine.,49,Type_49,Yes
DB01002,Levobupivacaine,DB01466,Ethylmorphine,0.9902797341346741,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ethylmorphine.,49,Type_49,Yes
DB00412,Rosiglitazone,DB09075,Edoxaban,0.7406243681907654,6,Type_6,Rosiglitazone may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB01708,Prasterone,DB05039,Indacaterol,0.9944167137145996,83,Type_83,Prasterone may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00986,Glycopyrronium,DB01192,Oxymorphone,0.9990291595458984,49,Type_49,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Oxymorphone.,49,Type_49,Yes
DB00254,Doxycycline,DB00678,Losartan,0.9479788541793823,47,Type_47,The metabolism of Losartan can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00222,Glimepiride,DB00823,Ethynodiol diacetate,0.996801495552063,70,Type_70,The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Glimepiride.,70,Type_70,Yes
DB01235,Levodopa,DB06770,Benzyl alcohol,0.9949105381965637,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Benzyl alcohol.,49,Type_49,Yes
DB00331,Metformin,DB02546,Vorinostat,0.9251883625984192,70,Type_70,The therapeutic efficacy of Vorinostat can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB01591,Solifenacin,DB06216,Asenapine,0.6051952838897705,20,Type_20,Solifenacin may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00985,Dimenhydrinate,DB06201,Rufinamide,0.9396935701370239,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Rufinamide.,49,Type_49,Yes
DB01144,Diclofenamide,DB01320,Fosphenytoin,0.6681358814239502,75,Type_75,The serum concentration of Fosphenytoin can be decreased when it is combined with Diclofenamide.,49,Type_49,No
DB00312,Pentobarbital,DB00584,Enalapril,0.6125113368034363,60,Type_60,Pentobarbital may increase the hypotensive activities of Enalapril.,4,Type_4,No
DB00422,Methylphenidate,DB06708,Lumefantrine,0.8591016530990601,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00603,Medroxyprogesterone acetate,DB01396,Digitoxin,0.9862451553344727,58,Type_58,Medroxyprogesterone acetate may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00175,Pravastatin,DB00703,Methazolamide,0.7049655914306641,73,Type_73,The serum concentration of Methazolamide can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00849,Methylphenobarbital,DB09292,Sacubitril,0.8712732791900635,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Sacubitril.,60,Type_60,Yes
DB00648,Mitotane,DB01182,Propafenone,0.9938158988952637,75,Type_75,The serum concentration of Propafenone can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00554,Piroxicam,DB08905,Formestane,0.9996824264526367,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Formestane.,49,Type_49,Yes
DB00883,Isosorbide dinitrate,DB02703,Fusidic acid,0.9996994733810425,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Isosorbide dinitrate.,73,Type_73,Yes
DB00264,Metoprolol,DB00810,Biperiden,0.9093708992004395,73,Type_73,The serum concentration of Biperiden can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00228,Enflurane,DB06700,Desvenlafaxine,0.9908847212791443,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Desvenlafaxine.,49,Type_49,Yes
DB00765,Metyrosine,DB13323,Trichloroethylene,0.976356029510498,32,Type_32,Metyrosine may increase the sedative activities of Trichloroethylene.,32,Type_32,Yes
DB00246,Ziprasidone,DB00490,Buspirone,0.8006147146224976,47,Type_47,The metabolism of Buspirone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01221,Ketamine,DB01264,Darunavir,0.814650297164917,47,Type_47,The metabolism of Darunavir can be decreased when combined with Ketamine.,47,Type_47,Yes
DB00956,Hydrocodone,DB08883,Perampanel,0.999962568283081,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00250,Dapsone,DB00750,Prilocaine,0.5213215351104736,70,Type_70,The therapeutic efficacy of Prilocaine can be decreased when used in combination with Dapsone.,49,Type_49,No
DB00872,Conivaptan,DB01159,Halothane,0.842645525932312,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Halothane.,73,Type_73,No
DB00807,Proparacaine,DB01215,Estazolam,0.9997984766960144,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Estazolam.,49,Type_49,Yes
DB00278,Argatroban,DB01397,Magnesium salicylate,0.9814968109130859,6,Type_6,Argatroban may increase the anticoagulant activities of Magnesium salicylate.,6,Type_6,Yes
DB00270,Isradipine,DB00969,Alosetron,0.9768081903457642,47,Type_47,The metabolism of Alosetron can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00322,Floxuridine,DB00980,Ramelteon,0.9652660489082336,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Floxuridine.,73,Type_73,No
DB00679,Thioridazine,DB00751,Epinastine,0.6271766424179077,47,Type_47,The metabolism of Epinastine can be decreased when combined with Thioridazine.,73,Type_73,No
DB00672,Chlorpropamide,DB06335,Saxagliptin,0.8931851983070374,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB01068,Clonazepam,DB01319,Fosamprenavir,0.6258184313774109,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Clonazepam.,47,Type_47,Yes
DB00924,Cyclobenzaprine,DB01621,Pipotiazine,0.9637218713760376,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Pipotiazine.,49,Type_49,Yes
DB00247,Methysergide,DB00622,Nicardipine,0.9997792840003967,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Nicardipine.,49,Type_49,Yes
DB00489,Sotalol,DB01016,Glyburide,0.8773452639579773,9,Type_9,Sotalol may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00997,Doxorubicin,DB01197,Captopril,0.5676292777061462,73,Type_73,The serum concentration of Captopril can be increased when it is combined with Doxorubicin.,73,Type_73,Yes
DB00193,Tramadol,DB09085,Tetracaine,0.9841535687446594,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Tetracaine.,49,Type_49,Yes
DB00991,Oxaprozin,DB01044,Gatifloxacin,0.9997314810752869,27,Type_27,Oxaprozin may increase the neuroexcitatory activities of Gatifloxacin.,27,Type_27,Yes
DB00257,Clotrimazole,DB06710,Methyltestosterone,0.9872385263442993,47,Type_47,The metabolism of Methyltestosterone can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00708,Sufentanil,DB00976,Telithromycin,0.5991765856742859,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Sufentanil.,47,Type_47,Yes
DB00418,Secobarbital,DB00747,Scopolamine,0.9977083206176758,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Scopolamine.,49,Type_49,Yes
DB00814,Meloxicam,DB01160,Dinoprost tromethamine,0.9807233214378357,70,Type_70,The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB00396,Progesterone,DB00589,Lisuride,0.9876692891120911,49,Type_49,The risk or severity of adverse effects can be increased when Progesterone is combined with Lisuride.,49,Type_49,Yes
DB00872,Conivaptan,DB00877,Sirolimus,0.8806486129760742,73,Type_73,The serum concentration of Sirolimus can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00324,Fluorometholone,DB04573,Estriol,0.9936615228652954,73,Type_73,The serum concentration of Estriol can be increased when it is combined with Fluorometholone.,73,Type_73,Yes
DB00839,Tolazamide,DB00860,Prednisolone,0.9940150380134583,70,Type_70,The therapeutic efficacy of Prednisolone can be decreased when used in combination with Tolazamide.,70,Type_70,Yes
DB00929,Misoprostol,DB08439,Parecoxib,0.7093777656555176,70,Type_70,The therapeutic efficacy of Parecoxib can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB00231,Temazepam,DB01319,Fosamprenavir,0.8058997988700867,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Temazepam.,47,Type_47,Yes
DB01024,Mycophenolic acid,DB01129,Rabeprazole,0.37709900736808777,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Mycophenolic acid.,75,Type_75,No
DB00215,Citalopram,DB00409,Remoxipride,0.504768431186676,47,Type_47,The metabolism of Remoxipride can be decreased when combined with Citalopram.,47,Type_47,Yes
DB05351,Dexlansoprazole,DB09063,Ceritinib,0.9943293929100037,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Dexlansoprazole.,73,Type_73,Yes
DB00376,Trihexyphenidyl,DB00956,Hydrocodone,0.9999785423278809,49,Type_49,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hydrocodone.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01366,Procaterol,0.9997876286506653,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Procaterol.,83,Type_83,Yes
DB00601,Linezolid,DB01623,Thiothixene,0.9602106809616089,49,Type_49,The risk or severity of adverse effects can be increased when Linezolid is combined with Thiothixene.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00204,Dofetilide,0.5080180168151855,75,Type_75,The serum concentration of Dofetilide can be decreased when it is combined with Fluvoxamine.,73,Type_73,No
DB00652,Pentazocine,DB01355,Hexobarbital,0.9967557787895203,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Hexobarbital.,49,Type_49,Yes
DB01098,Rosuvastatin,DB11633,Isavuconazole,0.9299032688140869,49,Type_49,The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Isavuconazole.,49,Type_49,Yes
DB00370,Mirtazapine,DB00678,Losartan,0.6501134037971497,47,Type_47,The metabolism of Losartan can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00645,Dyclonine,DB00831,Trifluoperazine,0.9996435642242432,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Trifluoperazine.,49,Type_49,Yes
DB00268,Ropinirole,DB00682,Warfarin,0.8712694048881531,47,Type_47,The metabolism of Warfarin can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00762,Irinotecan,DB00794,Primidone,0.5035788416862488,4,Type_4,The metabolism of Primidone can be increased when combined with Irinotecan.,75,Type_75,No
DB01080,Vigabatrin,DB04953,Ezogabine,0.9858065843582153,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Ezogabine.,49,Type_49,Yes
DB00951,Isoniazid,DB01234,Dexamethasone,0.8122824430465698,47,Type_47,The metabolism of Dexamethasone can be decreased when combined with Isoniazid.,75,Type_75,No
DB01178,Chlormezanone,DB01392,Yohimbine,0.9880980849266052,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Yohimbine.,70,Type_70,No
DB00492,Fosinopril,DB00735,Naftifine,0.9706206917762756,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Naftifine.,49,Type_49,Yes
DB00180,Flunisolide,DB00500,Tolmetin,0.9993483424186707,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Tolmetin.,49,Type_49,Yes
DB00590,Doxazosin,DB00925,Phenoxybenzamine,0.5047085285186768,60,Type_60,Doxazosin may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB00266,Dicoumarol,DB01185,Fluoxymesterone,0.9995465874671936,6,Type_6,Dicoumarol may increase the anticoagulant activities of Fluoxymesterone.,6,Type_6,Yes
DB00222,Glimepiride,DB00999,Hydrochlorothiazide,0.9989907145500183,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Glimepiride.,70,Type_70,Yes
DB00528,Lercanidipine,DB09235,Efonidipine,0.8252916932106018,60,Type_60,Lercanidipine may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00780,Phenelzine,DB00952,Naratriptan,0.9713147282600403,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Naratriptan.,49,Type_49,Yes
DB00495,Zidovudine,DB06595,Midostaurin,0.6716946959495544,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB01210,Levobunolol,DB08984,Etofenamate,0.9986801743507385,37,Type_37,Levobunolol may decrease the antihypertensive activities of Etofenamate.,37,Type_37,Yes
DB00320,Dihydroergotamine,DB00402,Eszopiclone,0.7465654611587524,47,Type_47,The metabolism of Eszopiclone can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01142,Doxepin,DB06700,Desvenlafaxine,0.8398566246032715,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Desvenlafaxine.,49,Type_49,Yes
DB00006,Bivalirudin,DB00346,Alfuzosin,0.7661117315292358,60,Type_60,Bivalirudin may increase the hypotensive activities of Alfuzosin.,73,Type_73,No
DB00612,Bisoprolol,DB00800,Fenoldopam,0.9273698925971985,60,Type_60,Bisoprolol may increase the hypotensive activities of Fenoldopam.,60,Type_60,Yes
DB00193,Tramadol,DB01072,Atazanavir,0.7230619192123413,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Tramadol.,73,Type_73,No
DB00559,Bosentan,DB01466,Ethylmorphine,0.5989730358123779,75,Type_75,The serum concentration of Ethylmorphine can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00540,Nortriptyline,DB08820,Ivacaftor,0.998336672782898,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Nortriptyline.,73,Type_73,Yes
DB00612,Bisoprolol,DB09074,Olaparib,0.9701035022735596,47,Type_47,The metabolism of Olaparib can be decreased when combined with Bisoprolol.,47,Type_47,Yes
DB00188,Bortezomib,DB06016,Cariprazine,0.7849449515342712,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01320,Fosphenytoin,DB04574,Estrone sulfate,0.7996717691421509,4,Type_4,The metabolism of Estrone sulfate can be increased when combined with Fosphenytoin.,70,Type_70,No
DB01193,Acebutolol,DB03128,Acetylcholine,0.6330789923667908,49,Type_49,The risk or severity of adverse effects can be increased when Acebutolol is combined with Acetylcholine.,49,Type_49,Yes
DB00612,Bisoprolol,DB01120,Gliclazide,0.9220145344734192,9,Type_9,Bisoprolol may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00223,Diflorasone,DB01400,Neostigmine,0.997870922088623,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Neostigmine.,49,Type_49,Yes
DB00184,Nicotine,DB00918,Almotriptan,0.6121298670768738,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01229,Paclitaxel,DB09270,Ubidecarenone,0.7577986717224121,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Paclitaxel.,73,Type_73,Yes
DB00808,Indapamide,DB00870,Suprofen,0.9026358127593994,70,Type_70,The therapeutic efficacy of Suprofen can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00241,Butalbital,DB00747,Scopolamine,0.9998190999031067,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Scopolamine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00822,Disulfiram,0.956402599811554,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB01250,Olsalazine,DB08887,Icosapent ethyl,0.9127747416496277,49,Type_49,The risk or severity of adverse effects can be increased when Olsalazine is combined with Icosapent ethyl.,49,Type_49,Yes
DB04855,Dronedarone,DB06212,Tolvaptan,0.9830994606018066,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Dronedarone.,73,Type_73,Yes
DB00625,Efavirenz,DB06712,Nilvadipine,0.5259022116661072,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Efavirenz.,75,Type_75,No
DB00338,Omeprazole,DB09138,Technetium Tc-99m medronate,0.7802445292472839,70,Type_70,The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Omeprazole.,70,Type_70,Yes
DB00469,Tenoxicam,DB01349,Tasosartan,0.5358614921569824,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Tasosartan.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB00821,Carprofen,0.9995346069335938,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Carprofen.,49,Type_49,Yes
DB00484,Brimonidine,DB01238,Aripiprazole,0.6316522359848022,60,Type_60,Brimonidine may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00231,Temazepam,DB00615,Rifabutin,0.9277664422988892,4,Type_4,The metabolism of Rifabutin can be increased when combined with Temazepam.,4,Type_4,Yes
DB00281,Lidocaine,DB00967,Desloratadine,0.9994200468063354,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Desloratadine.,49,Type_49,Yes
DB00562,Benzthiazide,DB09214,Dexketoprofen,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Benzthiazide is combined with Dexketoprofen.,49,Type_49,Yes
DB00737,Meclizine,DB01086,Benzocaine,0.9999814033508301,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Benzocaine.,49,Type_49,Yes
DB00908,Quinidine,DB00933,Mesoridazine,0.649542510509491,73,Type_73,The serum concentration of Mesoridazine can be increased when it is combined with Quinidine.,47,Type_47,No
DB00864,Tacrolimus,DB01127,Econazole,0.4804571568965912,47,Type_47,The metabolism of Econazole can be decreased when combined with Tacrolimus.,47,Type_47,Yes
DB01227,Levacetylmethadol,DB09073,Palbociclib,0.9732123613357544,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Levacetylmethadol.,73,Type_73,Yes
DB00257,Clotrimazole,DB00280,Disopyramide,0.8645784854888916,47,Type_47,The metabolism of Disopyramide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00888,Mechlorethamine,DB06772,Cabazitaxel,0.9834692478179932,49,Type_49,The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Cabazitaxel.,49,Type_49,Yes
DB01410,Ciclesonide,DB04576,Fleroxacin,0.9552693367004395,49,Type_49,The risk or severity of adverse effects can be increased when Ciclesonide is combined with Fleroxacin.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB00929,Misoprostol,0.9777721166610718,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Mycophenolate mofetil.,70,Type_70,Yes
DB00277,Theophylline,DB00359,Sulfadiazine,0.9906007051467896,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Theophylline.,47,Type_47,Yes
DB01254,Dasatinib,DB08815,Lurasidone,0.8608132600784302,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00615,Rifabutin,DB08883,Perampanel,0.8251087665557861,75,Type_75,The serum concentration of Perampanel can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00233,Aminosalicylic acid,DB01261,Sitagliptin,0.9797637462615967,9,Type_9,Aminosalicylic acid may increase the hypoglycemic activities of Sitagliptin.,9,Type_9,Yes
DB01174,Phenobarbital,DB06016,Cariprazine,0.8598356246948242,4,Type_4,The metabolism of Cariprazine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00417,Phenoxymethylpenicillin,DB00563,Methotrexate,0.3157733678817749,67,Type_67,Phenoxymethylpenicillin can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.,73,Type_73,No
DB00379,Mexiletine,DB00622,Nicardipine,0.9826467633247375,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00374,Treprostinil,DB00477,Chlorpromazine,0.8586478233337402,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Chlorpromazine.,20,Type_20,Yes
DB00972,Azelastine,DB08860,Pitavastatin,0.8194645047187805,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Azelastine.,73,Type_73,Yes
DB00880,Chlorothiazide,DB06736,Aceclofenac,0.9925438165664673,70,Type_70,The therapeutic efficacy of Aceclofenac can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00623,Fluphenazine,DB01440,gamma-Hydroxybutyric acid,0.9999799728393555,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00193,Tramadol,DB09270,Ubidecarenone,0.8949618339538574,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Tramadol.,73,Type_73,Yes
DB00628,Clorazepic acid,DB01403,Methotrimeprazine,0.9797142148017883,16,Type_16,Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00295,Morphine,DB05219,Crisaborole,0.9982542395591736,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Morphine.,47,Type_47,Yes
DB00599,Thiopental,DB01240,Epoprostenol,0.7731726169586182,4,Type_4,The metabolism of Epoprostenol can be increased when combined with Thiopental.,60,Type_60,No
DB00476,Duloxetine,DB01069,Promethazine,0.7160118222236633,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Promethazine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00641,Simvastatin,0.8604751825332642,47,Type_47,The metabolism of Simvastatin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00363,Clozapine,DB00699,Nicergoline,0.9150597453117371,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Nicergoline.,47,Type_47,No
DB01177,Idarubicin,DB09288,Propacetamol,0.9960248470306396,72,Type_72,Idarubicin may decrease the excretion rate of Propacetamol which could result in a higher serum level.,72,Type_72,Yes
DB05294,Vandetanib,DB08899,Enzalutamide,0.9604841470718384,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Vandetanib.,75,Type_75,Yes
DB00373,Timolol,DB00524,Metolazone,0.7929814457893372,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Metolazone.,49,Type_49,Yes
DB01563,Chloral hydrate,DB04844,Tetrabenazine,0.9999494552612305,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Tetrabenazine.,49,Type_49,Yes
DB01609,Deferasirox,DB05521,Telaprevir,0.59099942445755,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Deferasirox.,75,Type_75,No
DB00818,Propofol,DB02703,Fusidic acid,0.9975147247314453,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Propofol.,73,Type_73,Yes
DB00175,Pravastatin,DB06616,Bosutinib,0.9532648921012878,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB04842,Fluspirilene,DB09345,Pramocaine,0.999996542930603,49,Type_49,The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pramocaine.,49,Type_49,Yes
DB01058,Praziquantel,DB01072,Atazanavir,0.4781332015991211,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00668,Epinephrine,DB06207,Silodosin,0.9997087121009827,5,Type_5,Epinephrine may decrease the vasoconstricting activities of Silodosin.,5,Type_5,Yes
DB06786,Halcinonide,DB08981,Fenbufen,0.9994572997093201,49,Type_49,The risk or severity of adverse effects can be increased when Halcinonide is combined with Fenbufen.,49,Type_49,Yes
DB01137,Levofloxacin,DB04844,Tetrabenazine,0.9784440398216248,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00091,Cyclosporine,DB00700,Eplerenone,0.9274187088012695,42,Type_42,The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Eplerenone.,68,Type_68,No
DB00861,Diflunisal,DB01297,Practolol,0.9989457726478577,37,Type_37,Diflunisal may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00343,Diltiazem,DB06717,Fosaprepitant,0.9038798809051514,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB06708,Lumefantrine,DB13783,Acemetacin,0.5646140575408936,75,Type_75,The serum concentration of Acemetacin can be decreased when it is combined with Lumefantrine.,70,Type_70,No
DB00199,Erythromycin,DB02703,Fusidic acid,0.999596893787384,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Erythromycin.,73,Type_73,Yes
DB00213,Pantoprazole,DB00849,Methylphenobarbital,0.8305923342704773,47,Type_47,The metabolism of Methylphenobarbital can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB01041,Thalidomide,DB01158,Bretylium,0.999021053314209,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Bretylium.,49,Type_49,Yes
DB00315,Zolmitriptan,DB00408,Loxapine,0.9989084005355835,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loxapine.,49,Type_49,Yes
DB00327,Hydromorphone,DB01466,Ethylmorphine,0.9907065033912659,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethylmorphine.,49,Type_49,Yes
DB01065,Melatonin,DB08910,Pomalidomide,0.998698353767395,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Pomalidomide.,49,Type_49,Yes
DB01175,Escitalopram,DB09085,Tetracaine,0.9847448468208313,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Tetracaine.,49,Type_49,Yes
DB00817,Rosoxacin,DB13231,Calcium lactate,0.6582141518592834,67,Type_67,Rosoxacin can cause a decrease in the absorption of Calcium lactate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00091,Cyclosporine,DB01590,Everolimus,0.8430482149124146,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00857,Terbinafine,DB01591,Solifenacin,0.9535143375396729,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00238,Nevirapine,DB00661,Verapamil,0.7213155627250671,4,Type_4,The metabolism of Verapamil can be increased when combined with Nevirapine.,4,Type_4,Yes
DB01151,Desipramine,DB01267,Paliperidone,0.5392916798591614,20,Type_20,Desipramine may increase the QTc-prolonging activities of Paliperidone.,37,Type_37,No
DB00619,Imatinib,DB01595,Nitrazepam,0.911217987537384,47,Type_47,The metabolism of Nitrazepam can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00216,Eletriptan,DB00715,Paroxetine,0.5635336637496948,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Paroxetine.,47,Type_47,No
DB00564,Carbamazepine,DB01621,Pipotiazine,0.6862885355949402,4,Type_4,The metabolism of Pipotiazine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00455,Loratadine,DB01580,Oxprenolol,0.42891189455986023,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Oxprenolol.,49,Type_49,Yes
DB00420,Promazine,DB09281,Magnesium trisilicate,0.9716723561286926,67,Type_67,Promazine can cause a decrease in the absorption of Magnesium trisilicate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00472,Fluoxetine,DB01087,Primaquine,0.6487494111061096,20,Type_20,Fluoxetine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00788,Naproxen,DB00866,Alprenolol,0.9999380111694336,37,Type_37,Naproxen may decrease the antihypertensive activities of Alprenolol.,37,Type_37,Yes
DB00964,Apraclonidine,DB01351,Amobarbital,0.9677273631095886,30,Type_30,Apraclonidine may increase the orthostatic hypotensive activities of Amobarbital.,60,Type_60,No
DB01062,Oxybutynin,DB01209,Dezocine,0.899634063243866,49,Type_49,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dezocine.,49,Type_49,Yes
DB00203,Sildenafil,DB01238,Aripiprazole,0.5476382374763489,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB01065,Melatonin,DB01106,Levocabastine,0.9999959468841553,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Levocabastine.,49,Type_49,Yes
DB00872,Conivaptan,DB01236,Sevoflurane,0.7336863875389099,73,Type_73,The serum concentration of Sevoflurane can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB01628,Etoricoxib,DB08971,Fluocortolone,0.9998457431793213,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fluocortolone.,49,Type_49,Yes
DB00783,Estradiol,DB05265,Ecabet,0.5183888673782349,70,Type_70,The therapeutic efficacy of Ecabet can be decreased when used in combination with Estradiol.,75,Type_75,No
DB01289,Glisoxepide,DB04339,Carbocisteine,0.9999942779541016,49,Type_49,The risk or severity of adverse effects can be increased when Glisoxepide is combined with Carbocisteine.,49,Type_49,Yes
DB00188,Bortezomib,DB00312,Pentobarbital,0.5672227144241333,4,Type_4,The metabolism of Pentobarbital can be increased when combined with Bortezomib.,75,Type_75,No
DB00435,Nitric Oxide,DB00528,Lercanidipine,0.9941737055778503,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Lercanidipine.,49,Type_49,Yes
DB01195,Flecainide,DB01254,Dasatinib,0.732643187046051,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Flecainide.,20,Type_20,No
DB01076,Atorvastatin,DB12598,Nafamostat,0.4920014441013336,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Nafamostat.,73,Type_73,No
DB00268,Ropinirole,DB00904,Ondansetron,0.9824062585830688,32,Type_32,Ropinirole may increase the sedative activities of Ondansetron.,32,Type_32,Yes
DB01211,Clarithromycin,DB12332,Rucaparib,0.4929885268211365,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Clarithromycin.,47,Type_47,No
DB00281,Lidocaine,DB06290,Simeprevir,0.9301981925964355,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB04743,Nimesulide,DB13158,Clobetasone,0.9822239279747009,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Clobetasone.,49,Type_49,Yes
DB00322,Floxuridine,DB00983,Formoterol,0.9138737320899963,47,Type_47,The metabolism of Formoterol can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB00844,Nalbuphine,0.9996042847633362,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Nalbuphine.,49,Type_49,Yes
DB00318,Codeine,DB01466,Ethylmorphine,0.9848104119300842,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Ethylmorphine.,49,Type_49,Yes
DB00615,Rifabutin,DB00635,Prednisone,0.5473700761795044,4,Type_4,The metabolism of Prednisone can be increased when combined with Rifabutin.,75,Type_75,No
DB01030,Topotecan,DB08868,Fingolimod,0.9963994026184082,34,Type_34,Topotecan may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB01168,Procarbazine,DB04844,Tetrabenazine,0.9438520669937134,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Tetrabenazine.,49,Type_49,Yes
DB00455,Loratadine,DB00956,Hydrocodone,0.8841832280158997,16,Type_16,Loratadine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,16,Type_16,Yes
DB06207,Silodosin,DB09118,Stiripentol,0.9990886449813843,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Silodosin.,73,Type_73,Yes
DB00184,Nicotine,DB00195,Betaxolol,0.5776599645614624,47,Type_47,The metabolism of Betaxolol can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00321,Amitriptyline,DB12332,Rucaparib,0.8452964425086975,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB06413,Armodafinil,DB06605,Apixaban,0.8145068287849426,47,Type_47,The metabolism of Apixaban can be decreased when combined with Armodafinil.,47,Type_47,Yes
DB00810,Biperiden,DB06207,Silodosin,0.9309340715408325,5,Type_5,Biperiden may decrease the vasoconstricting activities of Silodosin.,73,Type_73,No
DB00220,Nelfinavir,DB00313,Valproic acid,0.5431811809539795,47,Type_47,The metabolism of Valproic acid can be decreased when combined with Nelfinavir.,75,Type_75,No
DB01174,Phenobarbital,DB06335,Saxagliptin,0.710604727268219,4,Type_4,The metabolism of Saxagliptin can be increased when combined with Phenobarbital.,75,Type_75,No
DB01198,Zopiclone,DB06290,Simeprevir,0.9537259340286255,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Zopiclone.,73,Type_73,Yes
DB00324,Fluorometholone,DB08439,Parecoxib,0.9965314269065857,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Parecoxib.,49,Type_49,Yes
DB01435,Antipyrine,DB09238,Manidipine,0.9580439329147339,47,Type_47,The metabolism of Manidipine can be decreased when combined with Antipyrine.,47,Type_47,Yes
DB00486,Nabilone,DB00875,Flupentixol,0.9855637550354004,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.,16,Type_16,Yes
DB00872,Conivaptan,DB06207,Silodosin,0.9988284707069397,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00864,Tacrolimus,DB00932,Tipranavir,0.6009893417358398,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Tacrolimus.,47,Type_47,Yes
DB06702,Fesoterodine,DB11315,Methscopolamine,0.6290736794471741,39,Type_39,Fesoterodine may increase the constipating activities of Methscopolamine.,49,Type_49,No
DB00482,Celecoxib,DB13874,Enasidenib,0.9892461895942688,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00238,Nevirapine,DB01190,Clindamycin,0.632680356502533,4,Type_4,The metabolism of Clindamycin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00656,Trazodone,DB08912,Dabrafenib,0.8382816910743713,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Trazodone.,75,Type_75,Yes
DB06700,Desvenlafaxine,DB09048,Netupitant,0.9883919358253479,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Desvenlafaxine.,73,Type_73,Yes
DB00854,Levorphanol,DB12278,Propiverine,0.9998760223388672,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Propiverine.,49,Type_49,Yes
DB00335,Atenolol,DB00755,Tretinoin,0.9060704708099365,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Tretinoin.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB09072,Sodium oxybate,0.9999995231628418,16,Type_16,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01215,Estazolam,DB06144,Sertindole,0.9978758096694946,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Sertindole.,49,Type_49,Yes
DB00349,Clobazam,DB01242,Clomipramine,0.8944287300109863,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00615,Rifabutin,DB00957,Norgestimate,0.8504212498664856,75,Type_75,The serum concentration of Norgestimate can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB01359,Penbutolol,DB06802,Nepafenac,0.9922844767570496,37,Type_37,Penbutolol may decrease the antihypertensive activities of Nepafenac.,37,Type_37,Yes
DB01215,Estazolam,DB01580,Oxprenolol,0.952386200428009,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Oxprenolol.,49,Type_49,Yes
DB00181,Baclofen,DB00690,Flurazepam,0.9990795850753784,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Flurazepam.,49,Type_49,Yes
DB00293,Raltitrexed,DB00363,Clozapine,0.754858672618866,70,Type_70,The therapeutic efficacy of Clozapine can be decreased when used in combination with Raltitrexed.,49,Type_49,No
DB01247,Isocarboxazid,DB06684,Vilazodone,0.9819141030311584,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Vilazodone.,49,Type_49,Yes
DB00235,Milrinone,DB04272,Citric acid,0.9997346997261047,6,Type_6,Milrinone may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00397,Phenylpropanolamine,DB00841,Dobutamine,0.9991694688796997,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Dobutamine.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB08931,Riociguat,0.5349364280700684,60,Type_60,Bendroflumethiazide may increase the hypotensive activities of Riociguat.,49,Type_49,No
DB00932,Tipranavir,DB09128,Brexpiprazole,0.8912965059280396,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB00759,Tetracycline,DB09063,Ceritinib,0.9963082075119019,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Tetracycline.,73,Type_73,Yes
DB00321,Amitriptyline,DB00752,Tranylcypromine,0.7688586711883545,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tranylcypromine.,49,Type_49,Yes
DB00747,Scopolamine,DB08918,Levomilnacipran,0.9774588942527771,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Levomilnacipran.,49,Type_49,Yes
DB06589,Pazopanib,DB09102,Daclatasvir,0.7170834541320801,73,Type_73,The serum concentration of Daclatasvir can be increased when it is combined with Pazopanib.,73,Type_73,Yes
DB00697,Tizanidine,DB06663,Pasireotide,0.8698636293411255,20,Type_20,Tizanidine may increase the QTc-prolonging activities of Pasireotide.,54,Type_54,No
DB00511,Acetyldigitoxin,DB01041,Thalidomide,0.8747042417526245,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Thalidomide.,58,Type_58,Yes
DB00341,Cetirizine,DB00906,Tiagabine,0.9994677901268005,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Tiagabine.,49,Type_49,Yes
DB00489,Sotalol,DB00945,Acetylsalicylic acid,0.9843721985816956,37,Type_37,Sotalol may decrease the antihypertensive activities of Acetylsalicylic acid.,37,Type_37,Yes
DB00308,Ibutilide,DB01026,Ketoconazole,0.9523652195930481,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Ketoconazole.,20,Type_20,Yes
DB00483,Gallamine triethiodide,DB00772,Malathion,0.8391849994659424,70,Type_70,The therapeutic efficacy of Malathion can be decreased when used in combination with Gallamine triethiodide.,70,Type_70,Yes
DB00519,Trandolapril,DB09216,Tolfenamic acid,0.9117425084114075,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Tolfenamic acid.,49,Type_49,Yes
DB03585,Oxyphenbutazone,DB08984,Etofenamate,0.9993759989738464,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Etofenamate.,49,Type_49,Yes
DB00270,Isradipine,DB00575,Clonidine,0.46633249521255493,47,Type_47,The metabolism of Clonidine can be decreased when combined with Isradipine.,49,Type_49,No
DB00768,Olopatadine,DB09095,Difluocortolone,0.9995790123939514,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Difluocortolone.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB11362,Selexipag,0.8827096819877625,47,Type_47,The metabolism of Selexipag can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01116,Trimethaphan,DB01247,Isocarboxazid,0.8533197045326233,60,Type_60,Trimethaphan may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB01026,Ketoconazole,DB09039,Eliglustat,0.5980566143989563,73,Type_73,The serum concentration of Eliglustat can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00866,Alprenolol,DB01273,Varenicline,0.9913095235824585,49,Type_49,The risk or severity of adverse effects can be increased when Alprenolol is combined with Varenicline.,49,Type_49,Yes
DB09030,Vorapaxar,DB12598,Nafamostat,0.8536810278892517,6,Type_6,Vorapaxar may increase the anticoagulant activities of Nafamostat.,49,Type_49,No
DB00213,Pantoprazole,DB00446,Chloramphenicol,0.9947197437286377,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00819,Acetazolamide,DB00921,Buprenorphine,0.6412492394447327,49,Type_49,The risk or severity of adverse effects can be increased when Acetazolamide is combined with Buprenorphine.,49,Type_49,Yes
DB01587,Ketazolam,DB04844,Tetrabenazine,0.9943232536315918,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Tetrabenazine.,49,Type_49,Yes
DB01355,Hexobarbital,DB01452,Diamorphine,0.9962749481201172,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Diamorphine.,49,Type_49,Yes
DB01095,Fluvastatin,DB01418,Acenocoumarol,0.8001963496208191,6,Type_6,Fluvastatin may increase the anticoagulant activities of Acenocoumarol.,47,Type_47,No
DB00184,Nicotine,DB00359,Sulfadiazine,0.9271209239959717,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00862,Vardenafil,DB06154,Pentaerythritol tetranitrate,0.587942361831665,38,Type_38,Vardenafil may increase the vasodilatory activities of Pentaerythritol tetranitrate.,38,Type_38,Yes
DB00568,Cinnarizine,DB00715,Paroxetine,0.8461561799049377,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Cinnarizine.,47,Type_47,Yes
DB00678,Losartan,DB01119,Diazoxide,0.9646231532096863,60,Type_60,Losartan may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00487,Pefloxacin,DB00744,Zileuton,0.9994296431541443,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Zileuton.,27,Type_27,Yes
DB00470,Dronabinol,DB01239,Chlorprothixene,0.9984990358352661,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.,16,Type_16,Yes
DB00484,Brimonidine,DB00872,Conivaptan,0.9897624850273132,49,Type_49,The risk or severity of adverse effects can be increased when Brimonidine is combined with Conivaptan.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB01069,Promethazine,0.9998038411140442,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Promethazine.,49,Type_49,Yes
DB00391,Sulpiride,DB01588,Prazepam,0.9160436391830444,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Prazepam.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00782,Propantheline,0.9899861216545105,73,Type_73,The serum concentration of Propantheline can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB00294,Etonogestrel,DB06605,Apixaban,0.5479015111923218,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Etonogestrel.,70,Type_70,No
DB00231,Temazepam,DB00238,Nevirapine,0.4434811770915985,47,Type_47,The metabolism of Nevirapine can be decreased when combined with Temazepam.,4,Type_4,No
DB00817,Rosoxacin,DB07615,Tranilast,0.7492888569831848,27,Type_27,Rosoxacin may increase the neuroexcitatory activities of Tranilast.,27,Type_27,Yes
DB00356,Chlorzoxazone,DB00641,Simvastatin,0.7117048501968384,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Chlorzoxazone.,73,Type_73,Yes
DB01072,Atazanavir,DB01104,Sertraline,0.658938467502594,47,Type_47,The metabolism of Sertraline can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB01452,Diamorphine,DB13872,Lormetazepam,0.9999194145202637,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Lormetazepam.,49,Type_49,Yes
DB00468,Quinine,DB09244,Pirlindole,0.919745922088623,9,Type_9,Quinine may increase the hypoglycemic activities of Pirlindole.,9,Type_9,Yes
DB00388,Phenylephrine,DB09167,Dosulepin,0.998056948184967,84,Type_84,Phenylephrine may increase the vasopressor activities of Dosulepin.,84,Type_84,Yes
DB00681,Amphotericin B,DB01169,Arsenic trioxide,0.9961424469947815,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Arsenic trioxide.,49,Type_49,Yes
DB00458,Imipramine,DB01291,Pirbuterol,0.978797197341919,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Pirbuterol.,49,Type_49,Yes
DB05541,Brivaracetam,DB06717,Fosaprepitant,0.7943560481071472,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Brivaracetam.,73,Type_73,Yes
DB00939,Meclofenamic acid,DB01418,Acenocoumarol,0.9997654557228088,6,Type_6,Meclofenamic acid may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB06267,Udenafil,DB09070,Tibolone,0.965950608253479,10,Type_10,Udenafil may increase the antihypertensive activities of Tibolone.,10,Type_10,Yes
DB00304,Desogestrel,DB12598,Nafamostat,0.5830963253974915,75,Type_75,The serum concentration of Nafamostat can be decreased when it is combined with Desogestrel.,70,Type_70,No
DB00425,Zolpidem,DB09017,Brotizolam,0.9915192723274231,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.,16,Type_16,Yes
DB01077,Etidronic acid,DB01377,Magnesium oxide,0.9312148690223694,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Etidronic acid.,75,Type_75,Yes
DB01047,Fluocinonide,DB13595,Almasilate,0.9998283386230469,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Fluocinonide.,3,Type_3,Yes
DB00653,Magnesium sulfate,DB01545,Ethyl loflazepate,0.9682373404502869,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.,16,Type_16,Yes
DB00279,Liothyronine,DB11126,Calcium gluconate,0.4386375844478607,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00726,Trimipramine,DB01102,Arbutamine,0.9920306205749512,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Arbutamine.,49,Type_49,Yes
DB00177,Valsartan,DB00327,Hydromorphone,0.6984244585037231,47,Type_47,The metabolism of Hydromorphone can be decreased when combined with Valsartan.,47,Type_47,Yes
DB01239,Chlorprothixene,DB04842,Fluspirilene,0.8734199404716492,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Fluspirilene.,49,Type_49,Yes
DB00527,Cinchocaine,DB01589,Quazepam,0.999127209186554,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Quazepam.,49,Type_49,Yes
DB01067,Glipizide,DB01167,Itraconazole,0.7732871770858765,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Glipizide.,47,Type_47,Yes
DB00294,Etonogestrel,DB00312,Pentobarbital,0.8142439126968384,70,Type_70,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Etonogestrel.,4,Type_4,No
DB01297,Practolol,DB01400,Neostigmine,0.9968045949935913,54,Type_54,Practolol may increase the bradycardic activities of Neostigmine.,54,Type_54,Yes
DB01045,Rifampicin,DB01211,Clarithromycin,0.5059312582015991,75,Type_75,The serum concentration of Clarithromycin can be decreased when it is combined with Rifampicin.,77,Type_77,No
DB00248,Cabergoline,DB00433,Prochlorperazine,0.9797883629798889,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Prochlorperazine.,49,Type_49,Yes
DB00812,Phenylbutazone,DB00834,Mifepristone,0.8098672032356262,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Phenylbutazone.,73,Type_73,Yes
DB01160,Dinoprost tromethamine,DB05676,Apremilast,0.6462342739105225,70,Type_70,The therapeutic efficacy of Apremilast can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB01034,Cerulenin,DB04841,Flunarizine,0.965601921081543,49,Type_49,The risk or severity of adverse effects can be increased when Cerulenin is combined with Flunarizine.,49,Type_49,Yes
DB00544,Fluorouracil,DB00983,Formoterol,0.8934046626091003,47,Type_47,The metabolism of Formoterol can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB01156,Bupropion,DB01166,Cilostazol,0.6016483306884766,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Bupropion.,47,Type_47,No
DB09117,Paraldehyde,DB11304,Phenoxyethanol,0.9998056292533875,16,Type_16,Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Phenoxyethanol.,16,Type_16,Yes
DB00783,Estradiol,DB01319,Fosamprenavir,0.49749013781547546,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Estradiol.,75,Type_75,No
DB00298,Dapiprazole,DB00949,Felbamate,0.9673106670379639,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Felbamate.,49,Type_49,Yes
DB00944,Demecarium,DB09076,Umeclidinium,0.992743730545044,70,Type_70,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Demecarium.,70,Type_70,Yes
DB00398,Sorafenib,DB06148,Mianserin,0.886775016784668,47,Type_47,The metabolism of Mianserin can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB01397,Magnesium salicylate,DB04576,Fleroxacin,0.5967115163803101,27,Type_27,Magnesium salicylate may increase the neuroexcitatory activities of Fleroxacin.,75,Type_75,No
DB00244,Mesalazine,DB08991,Epirizole,0.9365313649177551,57,Type_57,Mesalazine may increase the nephrotoxic activities of Epirizole.,57,Type_57,Yes
DB00178,Ramipril,DB01351,Amobarbital,0.8150702118873596,60,Type_60,Ramipril may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00191,Phentermine,DB00252,Phenytoin,0.967114269733429,4,Type_4,The metabolism of Phenytoin can be increased when combined with Phentermine.,75,Type_75,No
DB00559,Bosentan,DB09235,Efonidipine,0.9126356244087219,60,Type_60,Bosentan may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00968,Methyldopa,DB01359,Penbutolol,0.5075428485870361,49,Type_49,The risk or severity of adverse effects can be increased when Methyldopa is combined with Penbutolol.,49,Type_49,Yes
DB00559,Bosentan,DB00625,Efavirenz,0.8706066012382507,75,Type_75,The serum concentration of Efavirenz can be decreased when it is combined with Bosentan.,73,Type_73,No
DB00232,Methyclothiazide,DB00794,Primidone,0.7180271744728088,30,Type_30,Methyclothiazide may increase the orthostatic hypotensive activities of Primidone.,30,Type_30,Yes
DB00339,Pyrazinamide,DB01601,Lopinavir,0.7960547208786011,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Pyrazinamide.,47,Type_47,Yes
DB00091,Cyclosporine,DB00819,Acetazolamide,0.7845627665519714,68,Type_68,Cyclosporine may increase the hyperkalemic activities of Acetazolamide.,73,Type_73,No
DB00749,Etodolac,DB01104,Sertraline,0.690989077091217,53,Type_53,Etodolac may increase the antiplatelet activities of Sertraline.,53,Type_53,Yes
DB00454,Meperidine,DB04841,Flunarizine,0.9229547381401062,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Flunarizine.,49,Type_49,Yes
DB00943,Zalcitabine,DB01095,Fluvastatin,0.7202248573303223,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Zalcitabine.,47,Type_47,No
DB08820,Ivacaftor,DB09101,Elvitegravir,0.9905459880828857,73,Type_73,The serum concentration of Elvitegravir can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB00637,Astemizole,DB06290,Simeprevir,0.9670202732086182,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Astemizole.,73,Type_73,Yes
DB00584,Enalapril,DB00870,Suprofen,0.9571769833564758,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Suprofen.,49,Type_49,Yes
DB00196,Fluconazole,DB01155,Gemifloxacin,0.976702094078064,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00622,Nicardipine,DB02638,Terlipressin,0.9683690071105957,60,Type_60,Nicardipine may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00656,Trazodone,DB00918,Almotriptan,0.786941647529602,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Almotriptan.,49,Type_49,Yes
DB01226,Mivacurium,DB06263,Amrubicin,0.9982410669326782,40,Type_40,Mivacurium may increase the respiratory depressant activities of Amrubicin.,40,Type_40,Yes
DB01115,Nifedipine,DB13142,Calcium glubionate anhydrous,0.995919942855835,70,Type_70,The therapeutic efficacy of Calcium glubionate anhydrous can be decreased when used in combination with Nifedipine.,70,Type_70,Yes
DB01197,Captopril,DB06207,Silodosin,0.6345474123954773,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Captopril.,73,Type_73,Yes
DB00924,Cyclobenzaprine,DB01167,Itraconazole,0.4822050631046295,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Cyclobenzaprine.,47,Type_47,Yes
DB01708,Prasterone,DB08873,Boceprevir,0.7232712507247925,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Prasterone.,47,Type_47,Yes
DB00254,Doxycycline,DB00531,Cyclophosphamide,0.4764661192893982,49,Type_49,The risk or severity of adverse effects can be increased when Doxycycline is combined with Cyclophosphamide.,47,Type_47,No
DB00390,Digoxin,DB05109,Trabectedin,0.8393561840057373,58,Type_58,Digoxin may decrease the cardiotoxic activities of Trabectedin.,58,Type_58,Yes
DB00757,Dolasetron,DB09238,Manidipine,0.9501475095748901,47,Type_47,The metabolism of Manidipine can be decreased when combined with Dolasetron.,47,Type_47,Yes
DB00936,Salicylic acid,DB01348,Spirapril,0.6883587837219238,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Spirapril.,37,Type_37,No
DB01601,Lopinavir,DB06684,Vilazodone,0.6831164956092834,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Lopinavir.,73,Type_73,No
DB01176,Cyclizine,DB01558,Bromazepam,0.9999240636825562,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Bromazepam.,49,Type_49,Yes
DB00325,Nitroprusside,DB09232,Cilnidipine,0.5923206806182861,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Cilnidipine.,60,Type_60,No
DB00217,Bethanidine,DB00797,Tolazoline,0.9999986886978149,60,Type_60,Bethanidine may increase the hypotensive activities of Tolazoline.,60,Type_60,Yes
DB01008,Busulfan,DB06772,Cabazitaxel,0.9828186631202698,49,Type_49,The risk or severity of adverse effects can be increased when Busulfan is combined with Cabazitaxel.,49,Type_49,Yes
DB00246,Ziprasidone,DB01609,Deferasirox,0.8868902325630188,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Ziprasidone.,75,Type_75,Yes
DB00343,Diltiazem,DB01023,Felodipine,0.4566270709037781,47,Type_47,The metabolism of Felodipine can be decreased when combined with Diltiazem.,49,Type_49,No
DB00243,Ranolazine,DB00619,Imatinib,0.5724507570266724,73,Type_73,The serum concentration of Imatinib can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00708,Sufentanil,DB06216,Asenapine,0.8780761957168579,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Asenapine.,49,Type_49,Yes
DB00956,Hydrocodone,DB06290,Simeprevir,0.8174493312835693,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Hydrocodone.,73,Type_73,Yes
DB00257,Clotrimazole,DB01184,Domperidone,0.7836974263191223,47,Type_47,The metabolism of Domperidone can be decreased when combined with Clotrimazole.,73,Type_73,No
DB00247,Methysergide,DB01601,Lopinavir,0.966390073299408,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Lopinavir.,49,Type_49,Yes
DB00312,Pentobarbital,DB00333,Methadone,0.9115806818008423,4,Type_4,The metabolism of Methadone can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00308,Ibutilide,DB08912,Dabrafenib,0.9999730587005615,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Dabrafenib.,20,Type_20,Yes
DB00294,Etonogestrel,DB01167,Itraconazole,0.8584306240081787,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Etonogestrel.,47,Type_47,Yes
DB00240,Alclometasone,DB00661,Verapamil,0.8246691226959229,47,Type_47,The metabolism of Verapamil can be decreased when combined with Alclometasone.,47,Type_47,Yes
DB00715,Paroxetine,DB08987,Etidocaine,0.9858848452568054,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Etidocaine.,49,Type_49,Yes
DB01233,Metoclopramide,DB09118,Stiripentol,0.8699485659599304,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Metoclopramide.,47,Type_47,No
DB00241,Butalbital,DB01440,gamma-Hydroxybutyric acid,0.9999970197677612,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00243,Ranolazine,DB01384,Paramethasone,0.8207309246063232,47,Type_47,The metabolism of Paramethasone can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB01104,Sertraline,DB01211,Clarithromycin,0.5833083987236023,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00563,Methotrexate,DB00864,Tacrolimus,0.4330713748931885,49,Type_49,The risk or severity of adverse effects can be increased when Methotrexate is combined with Tacrolimus.,49,Type_49,Yes
DB00370,Mirtazapine,DB00582,Voriconazole,0.6685734391212463,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00224,Indinavir,DB00820,Tadalafil,0.6827889084815979,47,Type_47,The metabolism of Tadalafil can be decreased when combined with Indinavir.,73,Type_73,No
DB01104,Sertraline,DB04946,Iloperidone,0.3519948124885559,20,Type_20,Sertraline may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB01396,Digitoxin,DB06791,Lanreotide,0.8653978705406189,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Lanreotide.,58,Type_58,Yes
DB00255,Diethylstilbestrol,DB00278,Argatroban,0.432417631149292,70,Type_70,The therapeutic efficacy of Argatroban can be decreased when used in combination with Diethylstilbestrol.,75,Type_75,No
DB01009,Ketoprofen,DB09477,Enalaprilat,0.8772705793380737,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Enalaprilat.,49,Type_49,Yes
DB01044,Gatifloxacin,DB08970,Fluprednidene,0.9347615242004395,49,Type_49,The risk or severity of adverse effects can be increased when Gatifloxacin is combined with Fluprednidene.,49,Type_49,Yes
DB00349,Clobazam,DB00842,Oxazepam,0.5536301136016846,47,Type_47,The metabolism of Oxazepam can be decreased when combined with Clobazam.,49,Type_49,No
DB00726,Trimipramine,DB09065,Cobicistat,0.7115398645401001,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00648,Mitotane,DB01624,Zuclopenthixol,0.988477349281311,75,Type_75,The serum concentration of Zuclopenthixol can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01201,Rifapentine,DB06739,Seratrodast,0.8858546614646912,4,Type_4,The metabolism of Seratrodast can be increased when combined with Rifapentine.,4,Type_4,Yes
DB00408,Loxapine,DB01501,Difenoxin,0.9999368190765381,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Difenoxin.,49,Type_49,Yes
DB01100,Pimozide,DB01595,Nitrazepam,0.9113751649856567,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Nitrazepam.,49,Type_49,Yes
DB01089,Deserpidine,DB06237,Avanafil,0.9901072978973389,10,Type_10,Deserpidine may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00598,Labetalol,DB01403,Methotrimeprazine,0.6844966411590576,60,Type_60,Labetalol may increase the hypotensive activities of Methotrimeprazine.,47,Type_47,No
DB00394,Beclomethasone dipropionate,DB09218,Clonixin,0.9997057318687439,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Clonixin.,49,Type_49,Yes
DB08875,Cabozantinib,DB08912,Dabrafenib,0.9697608947753906,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Cabozantinib.,75,Type_75,Yes
DB00624,Testosterone,DB00687,Fludrocortisone,0.9997758269309998,74,Type_74,Testosterone may increase the fluid retaining activities of Fludrocortisone.,74,Type_74,Yes
DB01622,Thioproperazine,DB08918,Levomilnacipran,0.7625377178192139,49,Type_49,The risk or severity of adverse effects can be increased when Thioproperazine is combined with Levomilnacipran.,49,Type_49,Yes
DB00614,Furazolidone,DB00865,Benzphetamine,0.8390489816665649,71,Type_71,Furazolidone may increase the hypertensive activities of Benzphetamine.,71,Type_71,Yes
DB01132,Pioglitazone,DB08865,Crizotinib,0.9238711595535278,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Pioglitazone.,47,Type_47,Yes
DB00334,Olanzapine,DB00847,Cysteamine,0.9476113319396973,70,Type_70,The therapeutic efficacy of Cysteamine can be decreased when used in combination with Olanzapine.,70,Type_70,Yes
DB00611,Butorphanol,DB08910,Pomalidomide,0.9968936443328857,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Pomalidomide.,49,Type_49,Yes
DB00296,Ropivacaine,DB04861,Nebivolol,0.5572354197502136,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nebivolol.,49,Type_49,Yes
DB01283,Lumiracoxib,DB09204,Arotinolol,0.9998905658721924,37,Type_37,Lumiracoxib may decrease the antihypertensive activities of Arotinolol.,37,Type_37,Yes
DB00629,Guanabenz,DB01340,Cilazapril,0.9836176633834839,60,Type_60,Guanabenz may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB00844,Nalbuphine,DB13025,Tiapride,0.9990977048873901,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiapride.,49,Type_49,Yes
DB00861,Diflunisal,DB01024,Mycophenolic acid,0.6352416276931763,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Mycophenolic acid.,49,Type_49,Yes
DB00275,Olmesartan,DB00991,Oxaprozin,0.9143616557121277,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Oxaprozin.,49,Type_49,Yes
DB00938,Salmeterol,DB09245,Toloxatone,0.8990366458892822,49,Type_49,The risk or severity of adverse effects can be increased when Salmeterol is combined with Toloxatone.,49,Type_49,Yes
DB00176,Fluvoxamine,DB09389,Norgestrel,0.9617723226547241,47,Type_47,The metabolism of Norgestrel can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00379,Mexiletine,DB00655,Estrone,0.9867597222328186,47,Type_47,The metabolism of Estrone can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00390,Digoxin,DB01578,Metrizamide,0.8439838886260986,75,Type_75,The serum concentration of Metrizamide can be decreased when it is combined with Digoxin.,75,Type_75,Yes
DB00215,Citalopram,DB00373,Timolol,0.6879124045372009,47,Type_47,The metabolism of Timolol can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00413,Pramipexole,DB00661,Verapamil,0.987415611743927,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Verapamil.,49,Type_49,Yes
DB00497,Oxycodone,DB01168,Procarbazine,0.9199370741844177,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Procarbazine.,49,Type_49,Yes
DB00091,Cyclosporine,DB04871,Lorcaserin,0.9735649228096008,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00343,Diltiazem,DB09270,Ubidecarenone,0.7047269940376282,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB00705,Delavirdine,DB01142,Doxepin,0.8181717991828918,47,Type_47,The metabolism of Doxepin can be decreased when combined with Delavirdine.,67,Type_67,No
DB00264,Metoprolol,DB00543,Amoxapine,0.7011144757270813,73,Type_73,The serum concentration of Amoxapine can be increased when it is combined with Metoprolol.,47,Type_47,No
DB00821,Carprofen,DB01059,Norfloxacin,0.9865468740463257,27,Type_27,Carprofen may increase the neuroexcitatory activities of Norfloxacin.,27,Type_27,Yes
DB00517,Anisotropine methylbromide,DB00808,Indapamide,0.9952816367149353,73,Type_73,The serum concentration of Indapamide can be increased when it is combined with Anisotropine methylbromide.,73,Type_73,Yes
DB00195,Betaxolol,DB01118,Amiodarone,0.6731641292572021,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Betaxolol.,54,Type_54,No
DB00486,Nabilone,DB00796,Candesartan cilexetil,0.9658137559890747,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Candesartan cilexetil.,49,Type_49,Yes
DB00918,Almotriptan,DB06204,Tapentadol,0.6231628060340881,49,Type_49,The risk or severity of adverse effects can be increased when Almotriptan is combined with Tapentadol.,49,Type_49,Yes
DB00266,Dicoumarol,DB01331,Cefoxitin,0.999925971031189,6,Type_6,Dicoumarol may increase the anticoagulant activities of Cefoxitin.,6,Type_6,Yes
DB01114,Chlorpheniramine,DB09054,Idelalisib,0.8441455960273743,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Chlorpheniramine.,47,Type_47,Yes
DB04846,Celiprolol,DB09212,Loxoprofen,0.994952917098999,37,Type_37,Celiprolol may decrease the antihypertensive activities of Loxoprofen.,37,Type_37,Yes
DB00474,Methohexital,DB01395,Drospirenone,0.5018135905265808,4,Type_4,The metabolism of Drospirenone can be increased when combined with Methohexital.,70,Type_70,No
DB00983,Formoterol,DB06589,Pazopanib,0.4848053455352783,20,Type_20,Formoterol may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB00206,Reserpine,DB00899,Remifentanil,0.9678893685340881,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Remifentanil.,49,Type_49,Yes
DB00991,Oxaprozin,DB01283,Lumiracoxib,0.9927006959915161,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Lumiracoxib.,49,Type_49,Yes
DB00434,Cyproheptadine,DB08815,Lurasidone,0.9640962481498718,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Lurasidone.,49,Type_49,Yes
DB00476,Duloxetine,DB00593,Ethosuximide,0.8969132304191589,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Ethosuximide.,49,Type_49,Yes
DB01128,Bicalutamide,DB01264,Darunavir,0.7892972826957703,47,Type_47,The metabolism of Darunavir can be decreased when combined with Bicalutamide.,47,Type_47,Yes
DB00421,Spironolactone,DB01551,Dihydrocodeine,0.9728596806526184,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Dihydrocodeine.,49,Type_49,Yes
DB00288,Amcinonide,DB01232,Saquinavir,0.8446448445320129,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Amcinonide.,73,Type_73,Yes
DB00622,Nicardipine,DB00964,Apraclonidine,0.933146595954895,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Apraclonidine.,49,Type_49,Yes
DB00683,Midazolam,DB08912,Dabrafenib,0.9822809100151062,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Midazolam.,75,Type_75,Yes
DB00712,Flurbiprofen,DB01348,Spirapril,0.9709794521331787,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Spirapril.,49,Type_49,Yes
DB00392,Profenamine,DB01400,Neostigmine,0.9988105297088623,70,Type_70,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Profenamine.,70,Type_70,Yes
DB00370,Mirtazapine,DB08882,Linagliptin,0.7528696060180664,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB00619,Imatinib,DB01591,Solifenacin,0.9649427533149719,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00708,Sufentanil,DB00966,Telmisartan,0.949783444404602,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Telmisartan.,49,Type_49,Yes
DB02659,Cholic Acid,DB08934,Sofosbuvir,0.985410213470459,75,Type_75,The serum concentration of Sofosbuvir can be decreased when it is combined with Cholic Acid.,75,Type_75,Yes
DB00593,Ethosuximide,DB00807,Proparacaine,0.9988080263137817,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Proparacaine.,49,Type_49,Yes
DB01155,Gemifloxacin,DB09218,Clonixin,0.9969795942306519,27,Type_27,Gemifloxacin may increase the neuroexcitatory activities of Clonixin.,27,Type_27,Yes
DB00484,Brimonidine,DB01173,Orphenadrine,0.9994155168533325,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00223,Diflorasone,DB13783,Acemetacin,0.9694170355796814,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Acemetacin.,49,Type_49,Yes
DB00549,Zafirlukast,DB00812,Phenylbutazone,0.9187156558036804,47,Type_47,The metabolism of Phenylbutazone can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB01018,Guanfacine,0.9816174507141113,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Guanfacine.,49,Type_49,Yes
DB00237,Butabarbital,DB00660,Metaxalone,0.9999974966049194,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Metaxalone.,49,Type_49,Yes
DB01087,Primaquine,DB01165,Ofloxacin,0.9949357509613037,20,Type_20,Primaquine may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00593,Ethosuximide,DB00801,Halazepam,0.9991313815116882,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Halazepam.,49,Type_49,Yes
DB00670,Pirenzepine,DB01233,Metoclopramide,0.974304735660553,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Pirenzepine.,70,Type_70,Yes
DB00428,Streptozocin,DB08981,Fenbufen,0.997665286064148,72,Type_72,Streptozocin may decrease the excretion rate of Fenbufen which could result in a higher serum level.,72,Type_72,Yes
DB00780,Phenelzine,DB09204,Arotinolol,0.7013092041015625,60,Type_60,Phenelzine may increase the hypotensive activities of Arotinolol.,49,Type_49,No
DB00250,Dapsone,DB09065,Cobicistat,0.6061499118804932,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Dapsone.,47,Type_47,Yes
DB00359,Sulfadiazine,DB08881,Vemurafenib,0.5510780811309814,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Sulfadiazine.,75,Type_75,Yes
DB01142,Doxepin,DB09162,Ferric Citrate,0.7351610064506531,67,Type_67,Doxepin can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00318,Codeine,DB01142,Doxepin,0.9606876373291016,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Doxepin.,49,Type_49,Yes
DB00543,Amoxapine,DB06684,Vilazodone,0.9393301606178284,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Vilazodone.,49,Type_49,Yes
DB06203,Alogliptin,DB06414,Etravirine,0.3682921528816223,47,Type_47,The metabolism of Etravirine can be decreased when combined with Alogliptin.,75,Type_75,No
DB00292,Etomidate,DB09128,Brexpiprazole,0.9761976599693298,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Brexpiprazole.,49,Type_49,Yes
DB01192,Oxymorphone,DB01338,Pipecuronium,0.9999254941940308,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Pipecuronium.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB00571,Propranolol,0.915596604347229,47,Type_47,The metabolism of Propranolol can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00860,Prednisolone,DB01325,Quinethazone,0.9999945163726807,83,Type_83,Prednisolone may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB00351,Megestrol acetate,DB00672,Chlorpropamide,0.8739616274833679,70,Type_70,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00956,Hydrocodone,DB01221,Ketamine,0.9785746335983276,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,16,Type_16,Yes
DB00335,Atenolol,DB01235,Levodopa,0.9162821769714355,30,Type_30,Atenolol may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00622,Nicardipine,DB01184,Domperidone,0.5462622046470642,47,Type_47,The metabolism of Domperidone can be decreased when combined with Nicardipine.,20,Type_20,No
DB01188,Ciclopirox,DB01220,Rifaximin,0.9594945907592773,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Ciclopirox.,73,Type_73,Yes
DB00691,Moexipril,DB06196,Icatibant,0.9869142174720764,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Icatibant.,37,Type_37,No
DB00520,Caspofungin,DB09049,Naloxegol,0.999041736125946,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Caspofungin.,73,Type_73,Yes
DB00908,Quinidine,DB01015,Sulfamethoxazole,0.6203731894493103,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Quinidine.,20,Type_20,No
DB00814,Meloxicam,DB08807,Bopindolol,0.9999589920043945,37,Type_37,Meloxicam may decrease the antihypertensive activities of Bopindolol.,37,Type_37,Yes
DB00264,Metoprolol,DB06218,Lacosamide,0.9814832806587219,25,Type_25,Metoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.,25,Type_25,Yes
DB00591,Fluocinolone acetonide,DB00744,Zileuton,0.999607503414154,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Zileuton.,49,Type_49,Yes
DB00675,Tamoxifen,DB09078,Lenvatinib,0.8402020931243896,20,Type_20,Tamoxifen may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00939,Meclofenamic acid,DB13167,Alclofenac,0.9975520968437195,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alclofenac.,49,Type_49,Yes
DB00539,Toremifene,DB01254,Dasatinib,0.7689241766929626,20,Type_20,Toremifene may increase the QTc-prolonging activities of Dasatinib.,73,Type_73,No
DB00224,Indinavir,DB08864,Rilpivirine,0.7842237949371338,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB01092,Ouabain,DB05294,Vandetanib,0.9842461347579956,58,Type_58,Ouabain may decrease the cardiotoxic activities of Vandetanib.,58,Type_58,Yes
DB00916,Metronidazole,DB02703,Fusidic acid,0.9996262788772583,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Metronidazole.,73,Type_73,Yes
DB00590,Doxazosin,DB01026,Ketoconazole,0.7617032527923584,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00654,Latanoprost,DB00691,Moexipril,0.9999971389770508,60,Type_60,Latanoprost may increase the hypotensive activities of Moexipril.,60,Type_60,Yes
DB00555,Lamotrigine,DB01065,Melatonin,0.9992159605026245,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Melatonin.,49,Type_49,Yes
DB00214,Torasemide,DB00975,Dipyridamole,0.9984071850776672,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Dipyridamole.,49,Type_49,Yes
DB00795,Sulfasalazine,DB11921,Deflazacort,0.9981850981712341,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Deflazacort.,49,Type_49,Yes
DB00246,Ziprasidone,DB09117,Paraldehyde,0.9355035424232483,16,Type_16,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00268,Ropinirole,DB00903,Etacrynic acid,0.9318557381629944,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Etacrynic acid.,49,Type_49,Yes
DB00313,Valproic acid,DB01009,Ketoprofen,0.8512519598007202,47,Type_47,The metabolism of Ketoprofen can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB00270,Isradipine,DB00622,Nicardipine,0.6475386619567871,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Nicardipine.,49,Type_49,Yes
DB00899,Remifentanil,DB01452,Diamorphine,0.9980935454368591,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Diamorphine.,49,Type_49,Yes
DB00254,Doxycycline,DB00938,Salmeterol,0.9627227783203125,47,Type_47,The metabolism of Salmeterol can be decreased when combined with Doxycycline.,73,Type_73,No
DB06288,Amisulpride,DB09009,Articaine,0.9999924898147583,49,Type_49,The risk or severity of adverse effects can be increased when Amisulpride is combined with Articaine.,49,Type_49,Yes
DB00527,Cinchocaine,DB01104,Sertraline,0.994522213935852,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Sertraline.,49,Type_49,Yes
DB00373,Timolol,DB00796,Candesartan cilexetil,0.9054176807403564,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Candesartan cilexetil.,49,Type_49,Yes
DB01082,Streptomycin,DB07615,Tranilast,0.9989401698112488,72,Type_72,Streptomycin may decrease the excretion rate of Tranilast which could result in a higher serum level.,72,Type_72,Yes
DB00945,Acetylsalicylic acid,DB06228,Rivaroxaban,0.9940077066421509,6,Type_6,Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.,6,Type_6,Yes
DB01045,Rifampicin,DB06155,Rimonabant,0.9371766448020935,4,Type_4,The metabolism of Rimonabant can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00788,Naproxen,DB13783,Acemetacin,0.9097622036933899,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Acemetacin.,49,Type_49,Yes
DB00808,Indapamide,DB00887,Bumetanide,0.9450815320014954,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Bumetanide.,49,Type_49,Yes
DB01030,Topotecan,DB03796,Palmitic Acid,0.9986554384231567,73,Type_73,The serum concentration of Palmitic Acid can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB00877,Sirolimus,DB09118,Stiripentol,0.8293834924697876,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Sirolimus.,73,Type_73,Yes
DB00990,Exemestane,DB01026,Ketoconazole,0.7463197708129883,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Exemestane.,47,Type_47,Yes
DB06697,Artemether,DB09330,Osimertinib,0.9463124871253967,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Artemether.,73,Type_73,Yes
DB01247,Isocarboxazid,DB13139,Levosalbutamol,0.9968724846839905,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levosalbutamol.,49,Type_49,Yes
DB00264,Metoprolol,DB00390,Digoxin,0.7218953967094421,54,Type_54,Metoprolol may increase the bradycardic activities of Digoxin.,54,Type_54,Yes
DB00270,Isradipine,DB00490,Buspirone,0.884530782699585,47,Type_47,The metabolism of Buspirone can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00802,Alfentanil,DB09204,Arotinolol,0.8256292939186096,54,Type_54,Alfentanil may increase the bradycardic activities of Arotinolol.,54,Type_54,Yes
DB00564,Carbamazepine,DB00801,Halazepam,0.9679994583129883,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Halazepam.,49,Type_49,Yes
DB00753,Isoflurane,DB09224,Melperone,0.9988270401954651,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Melperone.,49,Type_49,Yes
DB01340,Cilazapril,DB06616,Bosutinib,0.775852620601654,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Cilazapril.,73,Type_73,Yes
DB00267,Cefmenoxime,DB01032,Probenecid,0.5684473514556885,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Cefmenoxime.,73,Type_73,Yes
DB00377,Palonosetron,DB09054,Idelalisib,0.9672672748565674,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Palonosetron.,47,Type_47,Yes
DB00373,Timolol,DB06700,Desvenlafaxine,0.6939113736152649,73,Type_73,The serum concentration of Desvenlafaxine can be increased when it is combined with Timolol.,73,Type_73,Yes
DB00323,Tolcapone,DB01236,Sevoflurane,0.9765052795410156,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Sevoflurane.,49,Type_49,Yes
DB00188,Bortezomib,DB00373,Timolol,0.7369651198387146,47,Type_47,The metabolism of Timolol can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00697,Tizanidine,DB00801,Halazepam,0.9922845363616943,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Halazepam.,49,Type_49,Yes
DB00318,Codeine,DB00979,Cyclopentolate,0.9992623925209045,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Cyclopentolate.,49,Type_49,Yes
DB00434,Cyproheptadine,DB01068,Clonazepam,0.9990339279174805,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Clonazepam.,49,Type_49,Yes
DB00257,Clotrimazole,DB01218,Halofantrine,0.7554324269294739,47,Type_47,The metabolism of Halofantrine can be decreased when combined with Clotrimazole.,73,Type_73,No
DB00961,Mepivacaine,DB01100,Pimozide,0.9988440275192261,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Pimozide.,49,Type_49,Yes
DB01226,Mivacurium,DB04574,Estrone sulfate,0.4053514003753662,22,Type_22,Mivacurium may increase the adverse neuromuscular activities of Estrone sulfate.,22,Type_22,Yes
DB00440,Trimethoprim,DB08933,Luliconazole,0.9808881878852844,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Trimethoprim.,73,Type_73,Yes
DB00614,Furazolidone,DB01366,Procaterol,0.8845409750938416,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Procaterol.,49,Type_49,Yes
DB00435,Nitric Oxide,DB01203,Nadolol,0.9990434050559998,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nadolol.,49,Type_49,Yes
DB06789,Hydroxyprogesterone caproate,DB09063,Ceritinib,0.9550918340682983,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Hydroxyprogesterone caproate.,73,Type_73,Yes
DB00203,Sildenafil,DB01261,Sitagliptin,0.5700847506523132,47,Type_47,The metabolism of Sitagliptin can be decreased when combined with Sildenafil.,73,Type_73,No
DB00582,Voriconazole,DB06789,Hydroxyprogesterone caproate,0.7838597297668457,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00599,Thiopental,DB01621,Pipotiazine,0.9624678492546082,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Pipotiazine.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB06695,Dabigatran etexilate,0.4866788685321808,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Cyclophosphamide.,77,Type_77,Yes
DB00176,Fluvoxamine,DB06654,Safinamide,0.9825770258903503,47,Type_47,The metabolism of Safinamide can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00673,Aprepitant,DB01068,Clonazepam,0.7219188213348389,73,Type_73,The serum concentration of Clonazepam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00312,Pentobarbital,DB01431,Allylestrenol,0.991550087928772,4,Type_4,The metabolism of Allylestrenol can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00653,Magnesium sulfate,DB01192,Oxymorphone,0.9863131046295166,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,16,Type_16,Yes
DB06212,Tolvaptan,DB13179,Troleandomycin,0.9502043128013611,73,Type_73,The serum concentration of Troleandomycin can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB00661,Verapamil,DB06292,Dapagliflozin,0.582347571849823,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Dapagliflozin.,49,Type_49,Yes
DB00590,Doxazosin,DB08808,Bupranolol,0.5408130288124084,30,Type_30,Doxazosin may increase the orthostatic hypotensive activities of Bupranolol.,30,Type_30,Yes
DB06209,Prasugrel,DB09118,Stiripentol,0.9041633605957031,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Prasugrel.,73,Type_73,Yes
DB00328,Indomethacin,DB00571,Propranolol,0.9994848966598511,37,Type_37,Indomethacin may decrease the antihypertensive activities of Propranolol.,37,Type_37,Yes
DB00681,Amphotericin B,DB04920,Clevidipine,0.9994888305664062,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clevidipine.,49,Type_49,Yes
DB05676,Apremilast,DB06786,Halcinonide,0.9996160268783569,49,Type_49,The risk or severity of adverse effects can be increased when Apremilast is combined with Halcinonide.,49,Type_49,Yes
DB00461,Nabumetone,DB01578,Metrizamide,0.9998972415924072,72,Type_72,Nabumetone may decrease the excretion rate of Metrizamide which could result in a higher serum level.,72,Type_72,Yes
DB01424,Aminophenazone,DB08816,Ticagrelor,0.8866226077079773,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Aminophenazone.,47,Type_47,Yes
DB00266,Dicoumarol,DB00751,Epinastine,0.9883026480674744,6,Type_6,Dicoumarol may increase the anticoagulant activities of Epinastine.,6,Type_6,Yes
DB00182,Amphetamine,DB00215,Citalopram,0.5818547606468201,47,Type_47,The metabolism of Citalopram can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB00692,Phentolamine,DB01037,Selegiline,0.8957471251487732,60,Type_60,Phentolamine may increase the hypotensive activities of Selegiline.,60,Type_60,Yes
DB01124,Tolbutamide,DB04339,Carbocisteine,0.9998206496238708,49,Type_49,The risk or severity of adverse effects can be increased when Tolbutamide is combined with Carbocisteine.,49,Type_49,Yes
DB01194,Brinzolamide,DB05521,Telaprevir,0.7575387954711914,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Brinzolamide.,73,Type_73,No
DB00897,Triazolam,DB04876,Vildagliptin,0.8387374877929688,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Triazolam.,73,Type_73,No
DB00215,Citalopram,DB00308,Ibutilide,0.9001376628875732,20,Type_20,Citalopram may increase the QTc-prolonging activities of Ibutilide.,33,Type_33,No
DB01211,Clarithromycin,DB06742,Ambroxol,0.9046452641487122,47,Type_47,The metabolism of Ambroxol can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00727,Nitroglycerin,DB00968,Methyldopa,0.9999628067016602,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Methyldopa.,49,Type_49,Yes
DB01452,Diamorphine,DB09076,Umeclidinium,0.9931831955909729,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Umeclidinium.,49,Type_49,Yes
DB06589,Pazopanib,DB13595,Almasilate,0.658708930015564,67,Type_67,Pazopanib can cause a decrease in the absorption of Almasilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00313,Valproic acid,DB00420,Promazine,0.44818317890167236,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Promazine.,49,Type_49,Yes
DB00214,Torasemide,DB00867,Ritodrine,0.9999194145202637,83,Type_83,Torasemide may increase the hypokalemic activities of Ritodrine.,83,Type_83,Yes
DB00201,Caffeine,DB00530,Erlotinib,0.7480451464653015,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00288,Amcinonide,DB09281,Magnesium trisilicate,0.9991499185562134,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Amcinonide.,3,Type_3,Yes
DB01029,Irbesartan,DB08864,Rilpivirine,0.9229975938796997,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Irbesartan.,73,Type_73,Yes
DB00487,Pefloxacin,DB13167,Alclofenac,0.9991806149482727,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Alclofenac.,27,Type_27,Yes
DB00881,Quinapril,DB09242,Moxonidine,0.8543049097061157,60,Type_60,Quinapril may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00396,Progesterone,DB00736,Esomeprazole,0.9253492951393127,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Progesterone.,47,Type_47,Yes
DB00645,Dyclonine,DB00801,Halazepam,0.999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Halazepam.,49,Type_49,Yes
DB00706,Tamsulosin,DB09073,Palbociclib,0.9984341263771057,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Tamsulosin.,73,Type_73,Yes
DB00337,Pimecrolimus,DB00700,Eplerenone,0.7440491318702698,37,Type_37,Pimecrolimus may decrease the antihypertensive activities of Eplerenone.,37,Type_37,Yes
DB00648,Mitotane,DB09166,Etizolam,0.9743967652320862,75,Type_75,The serum concentration of Etizolam can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00623,Fluphenazine,DB00906,Tiagabine,0.992466151714325,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tiagabine.,49,Type_49,Yes
DB00238,Nevirapine,DB00420,Promazine,0.7435441017150879,4,Type_4,The metabolism of Promazine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB01201,Rifapentine,DB01232,Saquinavir,0.738301694393158,75,Type_75,The serum concentration of Saquinavir can be decreased when it is combined with Rifapentine.,4,Type_4,No
DB00661,Verapamil,DB00822,Disulfiram,0.8868138194084167,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Verapamil.,47,Type_47,Yes
DB01340,Cilazapril,DB06292,Dapagliflozin,0.9946712851524353,49,Type_49,The risk or severity of adverse effects can be increased when Cilazapril is combined with Dapagliflozin.,49,Type_49,Yes
DB00371,Meprobamate,DB01198,Zopiclone,0.9921029210090637,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Zopiclone.,49,Type_49,Yes
DB01216,Finasteride,DB09074,Olaparib,0.9432664513587952,47,Type_47,The metabolism of Olaparib can be decreased when combined with Finasteride.,47,Type_47,Yes
DB01029,Irbesartan,DB01065,Melatonin,0.6990830898284912,47,Type_47,The metabolism of Melatonin can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00297,Bupivacaine,DB01037,Selegiline,0.8243783116340637,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Selegiline.,49,Type_49,Yes
DB00529,Foscarnet,DB00887,Bumetanide,0.4780323803424835,73,Type_73,The serum concentration of Bumetanide can be increased when it is combined with Foscarnet.,73,Type_73,Yes
DB00914,Phenformin,DB09009,Articaine,0.9995961785316467,70,Type_70,The therapeutic efficacy of Articaine can be decreased when used in combination with Phenformin.,70,Type_70,Yes
DB01197,Captopril,DB08880,Teriflunomide,0.700875461101532,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Teriflunomide.,49,Type_49,Yes
DB00393,Nimodipine,DB04868,Nilotinib,0.5500051975250244,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Nimodipine.,73,Type_73,No
DB00477,Chlorpromazine,DB00972,Azelastine,0.9397844672203064,16,Type_16,Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00257,Clotrimazole,DB00912,Repaglinide,0.9454658627510071,47,Type_47,The metabolism of Repaglinide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00918,Almotriptan,DB09291,Rolapitant,0.8729720115661621,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Almotriptan.,47,Type_47,Yes
DB09048,Netupitant,DB09198,Lobeglitazone,0.7311757206916809,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Netupitant.,47,Type_47,Yes
DB00854,Levorphanol,DB01545,Ethyl loflazepate,0.9996647834777832,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00323,Tolcapone,DB00475,Chlordiazepoxide,0.9993370175361633,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Chlordiazepoxide.,49,Type_49,Yes
DB01009,Ketoprofen,DB01356,Lithium cation,0.7989184856414795,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Ketoprofen.,73,Type_73,Yes
DB00412,Rosiglitazone,DB06710,Methyltestosterone,0.894693911075592,9,Type_9,Rosiglitazone may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB00231,Temazepam,DB00844,Nalbuphine,0.9974073767662048,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Nalbuphine.,49,Type_49,Yes
DB00679,Thioridazine,DB09076,Umeclidinium,0.6977138519287109,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Thioridazine.,47,Type_47,Yes
DB06712,Nilvadipine,DB09026,Aliskiren,0.7981741428375244,60,Type_60,Nilvadipine may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB01029,Irbesartan,DB06694,Xylometazoline,0.9242437481880188,60,Type_60,Irbesartan may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB01154,Thiamylal,DB01240,Epoprostenol,0.6249630451202393,4,Type_4,The metabolism of Epoprostenol can be increased when combined with Thiamylal.,60,Type_60,No
DB00426,Famciclovir,DB08912,Dabrafenib,0.9915879368782043,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Famciclovir.,75,Type_75,Yes
DB01018,Guanfacine,DB01463,Fencamfamin,0.9935752749443054,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Fencamfamin.,49,Type_49,Yes
DB00470,Dronabinol,DB00619,Imatinib,0.4617202877998352,73,Type_73,The serum concentration of Imatinib can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00936,Salicylic acid,DB01193,Acebutolol,0.9904381632804871,37,Type_37,Salicylic acid may decrease the antihypertensive activities of Acebutolol.,37,Type_37,Yes
DB01201,Rifapentine,DB01589,Quazepam,0.94487065076828,4,Type_4,The metabolism of Quazepam can be increased when combined with Rifapentine.,4,Type_4,Yes
DB00842,Oxazepam,DB01463,Fencamfamin,0.9973182082176208,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Fencamfamin.,49,Type_49,Yes
DB00988,Dopamine,DB13323,Trichloroethylene,0.9607638716697693,49,Type_49,The risk or severity of adverse effects can be increased when Dopamine is combined with Trichloroethylene.,82,Type_82,No
DB00216,Eletriptan,DB01075,Diphenhydramine,0.6289099454879761,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB00189,Ethchlorvynol,DB00402,Eszopiclone,0.9998797178268433,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Eszopiclone.,49,Type_49,Yes
DB00912,Repaglinide,DB01247,Isocarboxazid,0.9960837364196777,9,Type_9,Repaglinide may increase the hypoglycemic activities of Isocarboxazid.,9,Type_9,Yes
DB00250,Dapsone,DB00316,Acetaminophen,0.8210548162460327,47,Type_47,The metabolism of Acetaminophen can be decreased when combined with Dapsone.,49,Type_49,No
DB00831,Trifluoperazine,DB00961,Mepivacaine,0.9999339580535889,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Mepivacaine.,49,Type_49,Yes
DB00674,Galantamine,DB06709,Methacholine,0.8912067413330078,49,Type_49,The risk or severity of adverse effects can be increased when Galantamine is combined with Methacholine.,49,Type_49,Yes
DB00264,Metoprolol,DB01036,Tolterodine,0.7110587358474731,47,Type_47,The metabolism of Tolterodine can be decreased when combined with Metoprolol.,47,Type_47,Yes
DB01023,Felodipine,DB01193,Acebutolol,0.7860493063926697,60,Type_60,Felodipine may increase the hypotensive activities of Acebutolol.,49,Type_49,No
DB00735,Naftifine,DB09212,Loxoprofen,0.9997215867042542,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Loxoprofen.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB04868,Nilotinib,0.578002393245697,20,Type_20,Sulfamethoxazole may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB01578,Metrizamide,DB08797,Salicylamide,0.9999971389770508,72,Type_72,Metrizamide may decrease the excretion rate of Salicylamide which could result in a higher serum level.,72,Type_72,Yes
DB00582,Voriconazole,DB11560,Lesinurad,0.934147298336029,47,Type_47,The metabolism of Lesinurad can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00470,Dronabinol,DB00745,Modafinil,0.7597123980522156,47,Type_47,The metabolism of Modafinil can be decreased when combined with Dronabinol.,47,Type_47,Yes
DB00188,Bortezomib,DB00231,Temazepam,0.8564406037330627,47,Type_47,The metabolism of Temazepam can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01245,Decamethonium,DB06696,Arbekacin,0.9993407130241394,40,Type_40,Decamethonium may increase the respiratory depressant activities of Arbekacin.,40,Type_40,Yes
DB00674,Galantamine,DB08877,Ruxolitinib,0.518214225769043,47,Type_47,The metabolism of Ruxolitinib can be decreased when combined with Galantamine.,54,Type_54,No
DB00338,Omeprazole,DB06292,Dapagliflozin,0.9157605171203613,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00176,Fluvoxamine,DB00567,Cephalexin,0.9946122169494629,47,Type_47,The metabolism of Cephalexin can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00582,Voriconazole,DB00751,Epinastine,0.8921216130256653,47,Type_47,The metabolism of Epinastine can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00326,Calcium glucoheptonate,DB01023,Felodipine,0.6389285326004028,70,Type_70,The therapeutic efficacy of Felodipine can be decreased when used in combination with Calcium glucoheptonate.,70,Type_70,Yes
DB00486,Nabilone,DB06288,Amisulpride,0.9896200299263,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Amisulpride.,16,Type_16,Yes
DB01253,Ergometrine,DB01261,Sitagliptin,0.5719610452651978,73,Type_73,The serum concentration of Sitagliptin can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00212,Remikiren,DB00774,Hydroflumethiazide,0.9992327690124512,60,Type_60,Remikiren may increase the hypotensive activities of Hydroflumethiazide.,60,Type_60,Yes
DB00255,Diethylstilbestrol,DB00503,Ritonavir,0.616917073726654,75,Type_75,The serum concentration of Ritonavir can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB00448,Lansoprazole,DB09147,Ferric pyrophosphate,0.8339580297470093,67,Type_67,Lansoprazole can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00528,Lercanidipine,DB00678,Losartan,0.9067627191543579,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Losartan.,60,Type_60,No
DB01130,Prednicarbate,DB01324,Polythiazide,0.9999873638153076,83,Type_83,Prednicarbate may increase the hypokalemic activities of Polythiazide.,83,Type_83,Yes
DB00688,Mycophenolate mofetil,DB01082,Streptomycin,0.9979863166809082,72,Type_72,Mycophenolate mofetil may decrease the excretion rate of Streptomycin which could result in a higher serum level.,72,Type_72,Yes
DB01075,Diphenhydramine,DB04842,Fluspirilene,0.9770132303237915,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Fluspirilene.,49,Type_49,Yes
DB00559,Bosentan,DB06710,Methyltestosterone,0.9501581192016602,75,Type_75,The serum concentration of Methyltestosterone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00193,Tramadol,DB00819,Acetazolamide,0.618728518486023,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Acetazolamide.,49,Type_49,Yes
DB01161,Chloroprocaine,DB09117,Paraldehyde,0.9998944997787476,16,Type_16,Chloroprocaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00335,Atenolol,DB06196,Icatibant,0.8922675848007202,37,Type_37,Atenolol may decrease the antihypertensive activities of Icatibant.,37,Type_37,Yes
DB00278,Argatroban,DB00821,Carprofen,0.9896369576454163,6,Type_6,Argatroban may increase the anticoagulant activities of Carprofen.,6,Type_6,Yes
DB00202,Succinylcholine,DB00919,Spectinomycin,0.9999974966049194,40,Type_40,Succinylcholine may increase the respiratory depressant activities of Spectinomycin.,40,Type_40,Yes
DB00215,Citalopram,DB01169,Arsenic trioxide,0.9524534344673157,20,Type_20,Citalopram may increase the QTc-prolonging activities of Arsenic trioxide.,33,Type_33,No
DB06290,Simeprevir,DB09073,Palbociclib,0.9987218976020813,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00669,Sumatriptan,DB00997,Doxorubicin,0.8533968925476074,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Sumatriptan.,73,Type_73,Yes
DB00497,Oxycodone,DB00750,Prilocaine,0.9988023042678833,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Prilocaine.,49,Type_49,Yes
DB00641,Simvastatin,DB00997,Doxorubicin,0.6984217166900635,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00735,Naftifine,DB00974,Edetic acid,0.9980219602584839,6,Type_6,Naftifine may increase the anticoagulant activities of Edetic acid.,6,Type_6,Yes
DB00261,Anagrelide,DB09039,Eliglustat,0.7722776532173157,33,Type_33,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Eliglustat.,33,Type_33,Yes
DB00653,Magnesium sulfate,DB00827,Cinoxacin,0.4942859411239624,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Cinoxacin.,75,Type_75,No
DB01132,Pioglitazone,DB08860,Pitavastatin,0.8261865973472595,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Pioglitazone.,47,Type_47,No
DB00289,Atomoxetine,DB00636,Clofibrate,0.9896405339241028,47,Type_47,The metabolism of Clofibrate can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB01155,Gemifloxacin,DB06792,Lanthanum carbonate,0.9811737537384033,75,Type_75,The serum concentration of Lanthanum carbonate can be decreased when it is combined with Gemifloxacin.,75,Type_75,Yes
DB00232,Methyclothiazide,DB00672,Chlorpropamide,0.9900722503662109,70,Type_70,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB00266,Dicoumarol,DB01254,Dasatinib,0.92530357837677,6,Type_6,Dicoumarol may increase the anticoagulant activities of Dasatinib.,6,Type_6,Yes
DB00270,Isradipine,DB00370,Mirtazapine,0.45137444138526917,37,Type_37,Isradipine may decrease the antihypertensive activities of Mirtazapine.,47,Type_47,No
DB00605,Sulindac,DB00827,Cinoxacin,0.9994162321090698,27,Type_27,Sulindac may increase the neuroexcitatory activities of Cinoxacin.,27,Type_27,Yes
DB00783,Estradiol,DB00834,Mifepristone,0.6346642971038818,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB00420,Promazine,DB01567,Fludiazepam,0.9966787099838257,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Fludiazepam.,49,Type_49,Yes
DB00474,Methohexital,DB00682,Warfarin,0.8835247159004211,4,Type_4,The metabolism of Warfarin can be increased when combined with Methohexital.,4,Type_4,Yes
DB00176,Fluvoxamine,DB00647,Dextropropoxyphene,0.5778747797012329,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00193,Tramadol,DB00641,Simvastatin,0.602376401424408,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Tramadol.,73,Type_73,Yes
DB00722,Lisinopril,DB09026,Aliskiren,0.5616095662117004,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Aliskiren.,68,Type_68,No
DB00553,Methoxsalen,DB05521,Telaprevir,0.8846853971481323,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB00691,Moexipril,DB09245,Toloxatone,0.9973577857017517,60,Type_60,Moexipril may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB01028,Methoxyflurane,DB01463,Fencamfamin,0.9905999302864075,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Fencamfamin.,49,Type_49,Yes
DB00337,Pimecrolimus,DB09026,Aliskiren,0.9241936206817627,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aliskiren.,37,Type_37,No
DB00186,Lorazepam,DB11304,Phenoxyethanol,0.9624942541122437,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Phenoxyethanol.,49,Type_49,Yes
DB00862,Vardenafil,DB09063,Ceritinib,0.7287130951881409,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Vardenafil.,73,Type_73,Yes
DB00720,Clodronic acid,DB09288,Propacetamol,0.9931256771087646,49,Type_49,The risk or severity of adverse effects can be increased when Clodronic acid is combined with Propacetamol.,49,Type_49,Yes
DB00203,Sildenafil,DB09102,Daclatasvir,0.7898101806640625,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00350,Minoxidil,DB00869,Dorzolamide,0.9889418482780457,60,Type_60,Minoxidil may increase the hypotensive activities of Dorzolamide.,60,Type_60,Yes
DB00619,Imatinib,DB01018,Guanfacine,0.8707899451255798,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00199,Erythromycin,DB00818,Propofol,0.5066537261009216,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Propofol.,20,Type_20,Yes
DB01029,Irbesartan,DB08922,Perospirone,0.6982346773147583,47,Type_47,The metabolism of Perospirone can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00695,Furosemide,DB01578,Metrizamide,0.912931501865387,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Metrizamide.,49,Type_49,Yes
DB01580,Oxprenolol,DB05676,Apremilast,0.9096177816390991,37,Type_37,Oxprenolol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB00834,Mifepristone,DB06207,Silodosin,0.9992005228996277,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00699,Nicergoline,DB01030,Topotecan,0.6961919665336609,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Topotecan.,49,Type_49,Yes
DB00737,Meclizine,DB01351,Amobarbital,0.995140552520752,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Amobarbital.,49,Type_49,Yes
DB00412,Rosiglitazone,DB09241,Methylene blue,0.9841761589050293,9,Type_9,Rosiglitazone may increase the hypoglycemic activities of Methylene blue.,9,Type_9,Yes
DB00339,Pyrazinamide,DB06636,Isavuconazonium,0.835105836391449,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Pyrazinamide.,47,Type_47,Yes
DB01295,Bevantolol,DB09241,Methylene blue,0.9910898208618164,60,Type_60,Bevantolol may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00783,Estradiol,DB08905,Formestane,0.9845571517944336,73,Type_73,The serum concentration of Formestane can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB01243,Chloroxine,DB01248,Docetaxel,0.6754204630851746,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Chloroxine.,47,Type_47,Yes
DB00285,Venlafaxine,DB00472,Fluoxetine,0.7399721145629883,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Venlafaxine.,20,Type_20,No
DB00343,Diltiazem,DB00705,Delavirdine,0.920255184173584,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01275,Hydralazine,DB01600,Tiaprofenic acid,0.9006202220916748,37,Type_37,Hydralazine may decrease the antihypertensive activities of Tiaprofenic acid.,37,Type_37,Yes
DB01007,Tioconazole,DB01268,Sunitinib,0.5964476466178894,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Tioconazole.,47,Type_47,No
DB00273,Topiramate,DB00653,Magnesium sulfate,0.9730349183082581,16,Type_16,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00320,Dihydroergotamine,DB00738,Pentamidine,0.6712318658828735,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00861,Diflunisal,DB06292,Dapagliflozin,0.9361315369606018,9,Type_9,Diflunisal may increase the hypoglycemic activities of Dapagliflozin.,9,Type_9,Yes
DB00490,Buspirone,DB00771,Clidinium,0.9999803304672241,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Clidinium.,49,Type_49,Yes
DB00883,Isosorbide dinitrate,DB09054,Idelalisib,0.7305894494056702,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Isosorbide dinitrate.,47,Type_47,Yes
DB00541,Vincristine,DB00790,Perindopril,0.7113134860992432,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00435,Nitric Oxide,DB01612,Amyl Nitrite,0.9996703863143921,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Amyl Nitrite.,49,Type_49,Yes
DB01236,Sevoflurane,DB06290,Simeprevir,0.9581284523010254,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Sevoflurane.,73,Type_73,Yes
DB00268,Ropinirole,DB00531,Cyclophosphamide,0.6048662662506104,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00189,Ethchlorvynol,DB01545,Ethyl loflazepate,0.9999905824661255,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00188,Bortezomib,DB08864,Rilpivirine,0.7408457398414612,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Bortezomib.,73,Type_73,Yes
DB00458,Imipramine,DB13874,Enasidenib,0.8947376012802124,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Imipramine.,47,Type_47,Yes
DB06636,Isavuconazonium,DB09330,Osimertinib,0.9216241240501404,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Isavuconazonium.,73,Type_73,Yes
DB00420,Promazine,DB01580,Oxprenolol,0.5470763444900513,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Oxprenolol.,49,Type_49,Yes
DB00415,Ampicillin,DB01032,Probenecid,0.41503238677978516,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Ampicillin.,73,Type_73,Yes
DB00396,Progesterone,DB09291,Rolapitant,0.9367468953132629,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Progesterone.,47,Type_47,Yes
DB09118,Stiripentol,DB11304,Phenoxyethanol,0.9996862411499023,49,Type_49,The risk or severity of adverse effects can be increased when Stiripentol is combined with Phenoxyethanol.,49,Type_49,Yes
DB01028,Methoxyflurane,DB06282,Levocetirizine,0.9960657954216003,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Levocetirizine.,49,Type_49,Yes
DB01023,Felodipine,DB01118,Amiodarone,0.8303617835044861,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Felodipine.,47,Type_47,Yes
DB00240,Alclometasone,DB00688,Mycophenolate mofetil,0.9979009628295898,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00899,Remifentanil,DB00924,Cyclobenzaprine,0.920699954032898,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclobenzaprine.,49,Type_49,Yes
DB01026,Ketoconazole,DB05351,Dexlansoprazole,0.9199548363685608,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Ketoconazole.,75,Type_75,No
DB02709,Resveratrol,DB08970,Fluprednidene,0.9997714161872864,49,Type_49,The risk or severity of adverse effects can be increased when Resveratrol is combined with Fluprednidene.,49,Type_49,Yes
DB00916,Metronidazole,DB01169,Arsenic trioxide,0.8711350560188293,20,Type_20,Metronidazole may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB01002,Levobupivacaine,DB06636,Isavuconazonium,0.8448079228401184,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Levobupivacaine.,47,Type_47,Yes
DB00245,Benzatropine,DB00986,Glycopyrronium,0.974898636341095,2,Type_2,Benzatropine may increase the anticholinergic activities of Glycopyrronium.,2,Type_2,Yes
DB00313,Valproic acid,DB11148,Butamben,0.8768786787986755,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Butamben.,49,Type_49,Yes
DB01463,Fencamfamin,DB09224,Melperone,0.9636907577514648,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Melperone.,49,Type_49,Yes
DB00191,Phentermine,DB00988,Dopamine,0.8737487196922302,49,Type_49,The risk or severity of adverse effects can be increased when Phentermine is combined with Dopamine.,49,Type_49,Yes
DB04844,Tetrabenazine,DB08865,Crizotinib,0.8411741852760315,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB00976,Telithromycin,DB06292,Dapagliflozin,0.8597170114517212,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB01193,Acebutolol,DB01267,Paliperidone,0.7086430191993713,25,Type_25,Acebutolol may increase the atrioventricular blocking (AV block) activities of Paliperidone.,25,Type_25,Yes
DB00633,Dexmedetomidine,DB01621,Pipotiazine,0.9657413363456726,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Pipotiazine.,49,Type_49,Yes
DB00290,Bleomycin,DB01248,Docetaxel,0.9937758445739746,49,Type_49,The risk or severity of adverse effects can be increased when Bleomycin is combined with Docetaxel.,49,Type_49,Yes
DB00327,Hydromorphone,DB00849,Methylphenobarbital,0.9777213931083679,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methylphenobarbital.,49,Type_49,Yes
DB00252,Phenytoin,DB06737,Zaltoprofen,0.9215257167816162,4,Type_4,The metabolism of Zaltoprofen can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00282,Pamidronic acid,DB13783,Acemetacin,0.8330608010292053,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Acemetacin.,49,Type_49,Yes
DB00180,Flunisolide,DB13595,Almasilate,0.9997058510780334,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Flunisolide.,3,Type_3,Yes
DB00270,Isradipine,DB09143,Sonidegib,0.8175581097602844,73,Type_73,The serum concentration of Sonidegib can be increased when it is combined with Isradipine.,73,Type_73,Yes
DB00434,Cyproheptadine,DB06716,Fospropofol,0.9997184872627258,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Fospropofol.,49,Type_49,Yes
DB00333,Methadone,DB05294,Vandetanib,0.8043642044067383,20,Type_20,Methadone may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00203,Sildenafil,DB00818,Propofol,0.8433730006217957,47,Type_47,The metabolism of Propofol can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00611,Butorphanol,DB00852,Pseudoephedrine,0.9933215975761414,69,Type_69,Butorphanol may increase the analgesic activities of Pseudoephedrine.,69,Type_69,Yes
DB01240,Epoprostenol,DB11268,Protocatechualdehyde,0.9872150421142578,6,Type_6,Epoprostenol may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00703,Methazolamide,DB01197,Captopril,0.9725763201713562,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Captopril.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB00697,Tizanidine,0.9031859040260315,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Tizanidine.,49,Type_49,Yes
DB05812,Abiraterone,DB08798,Sulfamoxole,0.6900795102119446,73,Type_73,The serum concentration of Sulfamoxole can be increased when it is combined with Abiraterone.,47,Type_47,No
DB00379,Mexiletine,DB01418,Acenocoumarol,0.6906293034553528,47,Type_47,The metabolism of Acenocoumarol can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01621,Pipotiazine,DB04871,Lorcaserin,0.7332879304885864,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Pipotiazine.,47,Type_47,Yes
DB00613,Amodiaquine,DB00764,Mometasone,0.6280364394187927,73,Type_73,The serum concentration of Mometasone can be increased when it is combined with Amodiaquine.,73,Type_73,Yes
DB00445,Epirubicin,DB01000,Cyclacillin,0.9754123687744141,75,Type_75,The serum concentration of Cyclacillin can be decreased when it is combined with Epirubicin.,75,Type_75,Yes
DB00179,Masoprocol,DB06154,Pentaerythritol tetranitrate,0.9999194145202637,6,Type_6,Masoprocol may increase the anticoagulant activities of Pentaerythritol tetranitrate.,6,Type_6,Yes
DB00285,Venlafaxine,DB00412,Rosiglitazone,0.9782971143722534,47,Type_47,The metabolism of Rosiglitazone can be decreased when combined with Venlafaxine.,9,Type_9,No
DB00401,Nisoldipine,DB01188,Ciclopirox,0.992435872554779,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Ciclopirox.,49,Type_49,Yes
DB00278,Argatroban,DB13167,Alclofenac,0.9910702705383301,6,Type_6,Argatroban may increase the anticoagulant activities of Alclofenac.,6,Type_6,Yes
DB00423,Methocarbamol,DB09342,Propoxycaine,0.9999984502792358,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Propoxycaine.,49,Type_49,Yes
DB00180,Flunisolide,DB00989,Rivastigmine,0.9967617988586426,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Rivastigmine.,49,Type_49,Yes
DB00525,Tolnaftate,DB01045,Rifampicin,0.5770139098167419,73,Type_73,The serum concentration of Rifampicin can be increased when it is combined with Tolnaftate.,73,Type_73,Yes
DB00475,Chlordiazepoxide,DB00932,Tipranavir,0.8816445469856262,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00227,Lovastatin,DB00255,Diethylstilbestrol,0.6320338249206543,47,Type_47,The metabolism of Diethylstilbestrol can be decreased when combined with Lovastatin.,73,Type_73,No
DB00524,Metolazone,DB00573,Fenoprofen,0.9795439839363098,70,Type_70,The therapeutic efficacy of Fenoprofen can be decreased when used in combination with Metolazone.,70,Type_70,Yes
DB00175,Pravastatin,DB00997,Doxorubicin,0.7380338907241821,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00404,Alprazolam,DB01595,Nitrazepam,0.9854753017425537,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Nitrazepam.,49,Type_49,Yes
DB00690,Flurazepam,DB09118,Stiripentol,0.6460985541343689,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Flurazepam.,73,Type_73,Yes
DB00880,Chlorothiazide,DB04861,Nebivolol,0.8185114860534668,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Nebivolol.,49,Type_49,Yes
DB00599,Thiopental,DB04842,Fluspirilene,0.9982947707176208,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Fluspirilene.,49,Type_49,Yes
DB00215,Citalopram,DB00374,Treprostinil,0.4284816086292267,20,Type_20,Citalopram may increase the QTc-prolonging activities of Treprostinil.,20,Type_20,Yes
DB01137,Levofloxacin,DB12598,Nafamostat,0.892775297164917,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Nafamostat.,27,Type_27,Yes
DB01208,Sparfloxacin,DB08881,Vemurafenib,0.6688616871833801,33,Type_33,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Vemurafenib.,73,Type_73,No
DB00497,Oxycodone,DB04871,Lorcaserin,0.6509541273117065,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Lorcaserin.,47,Type_47,No
DB00320,Dihydroergotamine,DB01588,Prazepam,0.5811837315559387,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prazepam.,47,Type_47,No
DB00677,Isoflurophate,DB01013,Clobetasol propionate,0.995162844657898,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Clobetasol propionate.,49,Type_49,Yes
DB00623,Fluphenazine,DB01012,Cinacalcet,0.7427880167961121,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Fluphenazine.,47,Type_47,Yes
DB01182,Propafenone,DB01201,Rifapentine,0.9307004809379578,4,Type_4,The metabolism of Rifapentine can be increased when combined with Propafenone.,75,Type_75,No
DB01067,Glipizide,DB01359,Penbutolol,0.9958639144897461,9,Type_9,Glipizide may increase the hypoglycemic activities of Penbutolol.,9,Type_9,Yes
DB00615,Rifabutin,DB09232,Cilnidipine,0.32711148262023926,4,Type_4,The metabolism of Cilnidipine can be increased when combined with Rifabutin.,75,Type_75,No
DB00599,Thiopental,DB00823,Ethynodiol diacetate,0.7148458957672119,70,Type_70,The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Thiopental.,70,Type_70,Yes
DB00726,Trimipramine,DB04948,Lofexidine,0.872570812702179,37,Type_37,Trimipramine may decrease the antihypertensive activities of Lofexidine.,37,Type_37,Yes
DB00196,Fluconazole,DB01015,Sulfamethoxazole,0.5612860321998596,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00341,Cetirizine,DB00849,Methylphenobarbital,0.817624568939209,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Methylphenobarbital.,49,Type_49,Yes
DB00956,Hydrocodone,DB08872,Gabapentin enacarbil,0.970548152923584,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,16,Type_16,Yes
DB06414,Etravirine,DB08873,Boceprevir,0.4761848747730255,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Etravirine.,75,Type_75,No
DB00554,Piroxicam,DB01032,Probenecid,0.8707690238952637,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Piroxicam.,73,Type_73,Yes
DB01036,Tolterodine,DB01254,Dasatinib,0.6708559393882751,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Tolterodine.,73,Type_73,Yes
DB00486,Nabilone,DB01219,Dantrolene,0.9015524387359619,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.,16,Type_16,Yes
DB06654,Safinamide,DB09291,Rolapitant,0.9814132452011108,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Safinamide.,73,Type_73,No
DB00706,Tamsulosin,DB00935,Oxymetazoline,0.9997538924217224,5,Type_5,Tamsulosin may decrease the vasoconstricting activities of Oxymetazoline.,5,Type_5,Yes
DB00807,Proparacaine,DB01142,Doxepin,0.9920410513877869,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Doxepin.,49,Type_49,Yes
DB00420,Promazine,DB01026,Ketoconazole,0.49779847264289856,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Promazine.,47,Type_47,Yes
DB01080,Vigabatrin,DB09072,Sodium oxybate,1.0,16,Type_16,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00282,Pamidronic acid,DB00936,Salicylic acid,0.9947413206100464,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Salicylic acid.,49,Type_49,Yes
DB00091,Cyclosporine,DB00514,Dextromethorphan,0.958870530128479,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB00949,Felbamate,0.6127502918243408,47,Type_47,The metabolism of Felbamate can be decreased when combined with Sulfisoxazole.,20,Type_20,No
DB00816,Orciprenaline,DB01151,Desipramine,0.9712600708007812,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Desipramine.,49,Type_49,Yes
DB00608,Chloroquine,DB00814,Meloxicam,0.5432629585266113,47,Type_47,The metabolism of Meloxicam can be decreased when combined with Chloroquine.,49,Type_49,No
DB00599,Thiopental,DB01588,Prazepam,0.9896296858787537,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Prazepam.,49,Type_49,Yes
DB01115,Nifedipine,DB01154,Thiamylal,0.40614742040634155,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Thiamylal.,60,Type_60,No
DB00175,Pravastatin,DB08912,Dabrafenib,0.9266756176948547,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Pravastatin.,75,Type_75,Yes
DB00468,Quinine,DB00697,Tizanidine,0.8783502578735352,20,Type_20,Quinine may increase the QTc-prolonging activities of Tizanidine.,20,Type_20,Yes
DB00277,Theophylline,DB00477,Chlorpromazine,0.8870076537132263,47,Type_47,The metabolism of Chlorpromazine can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00421,Spironolactone,DB06695,Dabigatran etexilate,0.9858992099761963,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Spironolactone.,77,Type_77,Yes
DB00224,Indinavir,DB00604,Cisapride,0.6428873538970947,47,Type_47,The metabolism of Cisapride can be decreased when combined with Indinavir.,73,Type_73,No
DB00823,Ethynodiol diacetate,DB05521,Telaprevir,0.7999000549316406,75,Type_75,The serum concentration of Telaprevir can be decreased when it is combined with Ethynodiol diacetate.,75,Type_75,Yes
DB00699,Nicergoline,DB01115,Nifedipine,0.9981235861778259,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Nifedipine.,49,Type_49,Yes
DB01154,Thiamylal,DB01452,Diamorphine,0.9962466359138489,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Diamorphine.,49,Type_49,Yes
DB00391,Sulpiride,DB00628,Clorazepic acid,0.9975261092185974,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Clorazepic acid.,49,Type_49,Yes
DB00721,Procaine,DB00898,Ethanol,0.9998726844787598,16,Type_16,Procaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB01159,Halothane,DB08941,Isoxsuprine,0.9832760095596313,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Isoxsuprine.,49,Type_49,Yes
DB00477,Chlorpromazine,DB00802,Alfentanil,0.8238583207130432,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Alfentanil.,49,Type_49,Yes
DB00590,Doxazosin,DB09090,Pinaverium,0.6674630045890808,60,Type_60,Doxazosin may increase the hypotensive activities of Pinaverium.,60,Type_60,Yes
DB00726,Trimipramine,DB13323,Trichloroethylene,0.9957341551780701,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Trichloroethylene.,49,Type_49,Yes
DB01567,Fludiazepam,DB09034,Suvorexant,0.9960078001022339,16,Type_16,Fludiazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB01248,Docetaxel,DB06789,Hydroxyprogesterone caproate,0.9211702346801758,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Hydroxyprogesterone caproate.,49,Type_49,Yes
DB00185,Cevimeline,DB08893,Mirabegron,0.9635547995567322,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00364,Sucralfate,DB00735,Naftifine,0.909615695476532,67,Type_67,Sucralfate can cause a decrease in the absorption of Naftifine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00571,Propranolol,DB00742,Mannitol,0.9777078032493591,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Mannitol.,49,Type_49,Yes
DB00544,Fluorouracil,DB05812,Abiraterone,0.7264470458030701,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Fluorouracil.,73,Type_73,Yes
DB00764,Mometasone,DB01009,Ketoprofen,0.9996387958526611,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Ketoprofen.,49,Type_49,Yes
DB01142,Doxepin,DB01348,Spirapril,0.8546367287635803,73,Type_73,The serum concentration of Spirapril can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB00450,Droperidol,DB08865,Crizotinib,0.9940124154090881,20,Type_20,Droperidol may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB00555,Lamotrigine,DB00980,Ramelteon,0.9973397850990295,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ramelteon.,49,Type_49,Yes
DB00661,Verapamil,DB01041,Thalidomide,0.909660279750824,47,Type_47,The metabolism of Thalidomide can be decreased when combined with Verapamil.,49,Type_49,No
DB00585,Nizatidine,DB01263,Posaconazole,0.5895887613296509,67,Type_67,Nizatidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB01558,Bromazepam,DB09063,Ceritinib,0.9894692897796631,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Bromazepam.,73,Type_73,Yes
DB00468,Quinine,DB00779,Nalidixic acid,0.9269624352455139,9,Type_9,Quinine may increase the hypoglycemic activities of Nalidixic acid.,9,Type_9,Yes
DB01614,Acepromazine,DB09345,Pramocaine,0.9999905824661255,49,Type_49,The risk or severity of adverse effects can be increased when Acepromazine is combined with Pramocaine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01177,Idarubicin,0.988158643245697,47,Type_47,The metabolism of Idarubicin can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00603,Medroxyprogesterone acetate,DB11268,Protocatechualdehyde,0.9344150424003601,70,Type_70,The therapeutic efficacy of Protocatechualdehyde can be decreased when used in combination with Medroxyprogesterone acetate.,70,Type_70,Yes
DB00715,Paroxetine,DB01394,Colchicine,0.9198993444442749,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Paroxetine.,73,Type_73,Yes
DB00208,Ticlopidine,DB11921,Deflazacort,0.9113077521324158,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00672,Chlorpropamide,DB04576,Fleroxacin,0.9971234202384949,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Fleroxacin.,9,Type_9,Yes
DB00268,Ropinirole,DB01215,Estazolam,0.9749535918235779,32,Type_32,Ropinirole may increase the sedative activities of Estazolam.,32,Type_32,Yes
DB00863,Ranitidine,DB01112,Cefuroxime,0.5699057579040527,75,Type_75,The serum concentration of Cefuroxime can be decreased when it is combined with Ranitidine.,67,Type_67,No
DB01392,Yohimbine,DB01588,Prazepam,0.7282086610794067,47,Type_47,The metabolism of Prazepam can be decreased when combined with Yohimbine.,70,Type_70,No
DB00241,Butalbital,DB08918,Levomilnacipran,0.9936732053756714,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Levomilnacipran.,49,Type_49,Yes
DB00243,Ranolazine,DB01339,Vecuronium,0.6561926007270813,21,Type_21,Ranolazine may increase the neuromuscular blocking activities of Vecuronium.,73,Type_73,No
DB00953,Rizatriptan,DB01356,Lithium cation,0.6446718573570251,49,Type_49,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Lithium cation.,49,Type_49,Yes
DB00195,Betaxolol,DB00542,Benazepril,0.9201459288597107,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Benazepril.,49,Type_49,Yes
DB00521,Carteolol,DB01628,Etoricoxib,0.96388840675354,37,Type_37,Carteolol may decrease the antihypertensive activities of Etoricoxib.,37,Type_37,Yes
DB00289,Atomoxetine,DB00368,Norepinephrine,0.793812096118927,71,Type_71,Atomoxetine may increase the hypertensive activities of Norepinephrine.,71,Type_71,Yes
DB00594,Amiloride,DB09227,Barnidipine,0.9836734533309937,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Barnidipine.,49,Type_49,Yes
DB00615,Rifabutin,DB00726,Trimipramine,0.9402163028717041,4,Type_4,The metabolism of Trimipramine can be increased when combined with Rifabutin.,4,Type_4,Yes
DB06738,Ketobemidone,DB09074,Olaparib,0.8527138829231262,47,Type_47,The metabolism of Olaparib can be decreased when combined with Ketobemidone.,47,Type_47,Yes
DB00465,Ketorolac,DB01029,Irbesartan,0.8683755993843079,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Irbesartan.,49,Type_49,Yes
DB00323,Tolcapone,DB00588,Fluticasone propionate,0.9487175345420837,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Fluticasone propionate.,49,Type_49,Yes
DB00471,Montelukast,DB00625,Efavirenz,0.7580338716506958,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Montelukast.,47,Type_47,Yes
DB06694,Xylometazoline,DB13783,Acemetacin,0.9442859888076782,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Xylometazoline.,70,Type_70,Yes
DB00623,Fluphenazine,DB00628,Clorazepic acid,0.9931144118309021,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clorazepic acid.,49,Type_49,Yes
DB00773,Etoposide,DB06695,Dabigatran etexilate,0.7692061066627502,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Etoposide.,77,Type_77,Yes
DB00776,Oxcarbazepine,DB09065,Cobicistat,0.8077037334442139,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Oxcarbazepine.,75,Type_75,No
DB01201,Rifapentine,DB09235,Efonidipine,0.7907456755638123,4,Type_4,The metabolism of Efonidipine can be increased when combined with Rifapentine.,75,Type_75,No
DB01275,Hydralazine,DB09038,Empagliflozin,0.9715444445610046,49,Type_49,The risk or severity of adverse effects can be increased when Hydralazine is combined with Empagliflozin.,49,Type_49,Yes
DB00547,Desoximetasone,DB09054,Idelalisib,0.9571306705474854,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Desoximetasone.,73,Type_73,Yes
DB00297,Bupivacaine,DB00590,Doxazosin,0.6423775553703308,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Doxazosin.,49,Type_49,Yes
DB00850,Perphenazine,DB09291,Rolapitant,0.7677997946739197,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Perphenazine.,47,Type_47,Yes
DB00641,Simvastatin,DB01093,Dimethyl sulfoxide,0.84206622838974,73,Type_73,The serum concentration of Dimethyl sulfoxide can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00682,Warfarin,DB01708,Prasterone,0.9162523150444031,6,Type_6,Warfarin may increase the anticoagulant activities of Prasterone.,6,Type_6,Yes
DB00653,Magnesium sulfate,DB00898,Ethanol,0.9999988079071045,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00697,Tizanidine,DB08807,Bopindolol,0.8709437847137451,25,Type_25,Tizanidine may increase the atrioventricular blocking (AV block) activities of Bopindolol.,25,Type_25,Yes
DB00912,Repaglinide,DB09048,Netupitant,0.928266704082489,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Repaglinide.,73,Type_73,Yes
DB01283,Lumiracoxib,DB13167,Alclofenac,0.9931801557540894,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Alclofenac.,49,Type_49,Yes
DB00734,Risperidone,DB01020,Isosorbide mononitrate,0.8900655508041382,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Isosorbide mononitrate.,60,Type_60,No
DB00870,Suprofen,DB09212,Loxoprofen,0.9989413619041443,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Loxoprofen.,49,Type_49,Yes
DB00268,Ropinirole,DB00976,Telithromycin,0.9478614330291748,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00408,Loxapine,DB09286,Pipamperone,0.9682016968727112,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Pipamperone.,49,Type_49,Yes
DB00350,Minoxidil,DB00691,Moexipril,0.6080829501152039,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Moexipril.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB00628,Clorazepic acid,0.9997672438621521,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Clorazepic acid.,49,Type_49,Yes
DB00468,Quinine,DB00843,Donepezil,0.9199873208999634,47,Type_47,The metabolism of Donepezil can be decreased when combined with Quinine.,47,Type_47,Yes
DB00257,Clotrimazole,DB00412,Rosiglitazone,0.968421220779419,47,Type_47,The metabolism of Rosiglitazone can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB02703,Fusidic acid,DB06770,Benzyl alcohol,0.9971879124641418,73,Type_73,The serum concentration of Benzyl alcohol can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB08893,Mirabegron,DB09238,Manidipine,0.9840700626373291,47,Type_47,The metabolism of Manidipine can be decreased when combined with Mirabegron.,47,Type_47,Yes
DB00991,Oxaprozin,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Oxaprozin.,70,Type_70,Yes
DB00834,Mifepristone,DB01591,Solifenacin,0.7322658896446228,73,Type_73,The serum concentration of Solifenacin can be increased when it is combined with Mifepristone.,20,Type_20,No
DB04861,Nebivolol,DB06700,Desvenlafaxine,0.8925959467887878,73,Type_73,The serum concentration of Desvenlafaxine can be increased when it is combined with Nebivolol.,85,Type_85,No
DB00421,Spironolactone,DB00703,Methazolamide,0.7648559212684631,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Methazolamide.,49,Type_49,Yes
DB00264,Metoprolol,DB11614,Rupatadine,0.5653465986251831,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Metoprolol.,47,Type_47,Yes
DB00920,Ketotifen,DB01255,Lisdexamfetamine,0.9999995231628418,76,Type_76,Ketotifen may decrease the sedative activities of Lisdexamfetamine.,76,Type_76,Yes
DB00227,Lovastatin,DB01559,Clotiazepam,0.5251489877700806,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01220,Rifaximin,DB01229,Paclitaxel,0.4154624938964844,4,Type_4,The metabolism of Paclitaxel can be increased when combined with Rifaximin.,73,Type_73,No
DB01131,Proguanil,DB01264,Darunavir,0.87300705909729,47,Type_47,The metabolism of Darunavir can be decreased when combined with Proguanil.,47,Type_47,Yes
DB00244,Mesalazine,DB08970,Fluprednidene,0.998073935508728,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Fluprednidene.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00379,Mexiletine,0.9983912110328674,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00861,Diflunisal,DB01160,Dinoprost tromethamine,0.9956432580947876,70,Type_70,The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Diflunisal.,70,Type_70,Yes
DB01104,Sertraline,DB01433,Methadyl acetate,0.5394081473350525,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Methadyl acetate.,64,Type_64,No
DB00800,Fenoldopam,DB04920,Clevidipine,0.8797645568847656,49,Type_49,The risk or severity of adverse effects can be increased when Fenoldopam is combined with Clevidipine.,49,Type_49,Yes
DB00331,Metformin,DB01247,Isocarboxazid,0.9967638254165649,9,Type_9,Metformin may increase the hypoglycemic activities of Isocarboxazid.,9,Type_9,Yes
DB00590,Doxazosin,DB06694,Xylometazoline,0.9960741996765137,60,Type_60,Doxazosin may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00906,Tiagabine,DB01227,Levacetylmethadol,0.9808699488639832,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Levacetylmethadol.,49,Type_49,Yes
DB01092,Ouabain,DB01097,Leflunomide,0.9278443455696106,58,Type_58,Ouabain may decrease the cardiotoxic activities of Leflunomide.,58,Type_58,Yes
DB00691,Moexipril,DB02638,Terlipressin,0.999962568283081,60,Type_60,Moexipril may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00252,Phenytoin,DB00623,Fluphenazine,0.36366209387779236,73,Type_73,The serum concentration of Fluphenazine can be increased when it is combined with Phenytoin.,49,Type_49,No
DB01609,Deferasirox,DB06736,Aceclofenac,0.49501433968544006,75,Type_75,The serum concentration of Aceclofenac can be decreased when it is combined with Deferasirox.,49,Type_49,No
DB01236,Sevoflurane,DB01247,Isocarboxazid,0.792455792427063,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Isocarboxazid.,49,Type_49,Yes
DB00870,Suprofen,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Suprofen.,70,Type_70,Yes
DB00189,Ethchlorvynol,DB00206,Reserpine,0.9563332200050354,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Reserpine.,49,Type_49,Yes
DB00683,Midazolam,DB09048,Netupitant,0.9361752867698669,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Midazolam.,73,Type_73,Yes
DB00790,Perindopril,DB06695,Dabigatran etexilate,0.8536099195480347,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Perindopril.,77,Type_77,Yes
DB00284,Acarbose,DB01250,Olsalazine,0.9994125366210938,9,Type_9,Acarbose may increase the hypoglycemic activities of Olsalazine.,9,Type_9,Yes
DB00655,Estrone,DB08797,Salicylamide,0.9569916725158691,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Salicylamide.,49,Type_49,Yes
DB00150,Tryptophan,DB09241,Methylene blue,0.5487317442893982,64,Type_64,Tryptophan may increase the serotonergic activities of Methylene blue.,64,Type_64,Yes
DB01026,Ketoconazole,DB08916,Afatinib,0.5814244151115417,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB01156,Bupropion,DB09053,Ibrutinib,0.7566524744033813,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Bupropion.,47,Type_47,No
DB00346,Alfuzosin,DB01119,Diazoxide,0.9982116222381592,60,Type_60,Alfuzosin may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00741,Hydrocortisone,DB06723,Aluminum hydroxide,0.9992985725402832,3,Type_3,The bioavailability of Aluminum hydroxide can be decreased when combined with Hydrocortisone.,3,Type_3,Yes
DB00246,Ziprasidone,DB09342,Propoxycaine,0.9997584223747253,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Propoxycaine.,49,Type_49,Yes
DB08922,Perospirone,DB09039,Eliglustat,0.4897426664829254,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Perospirone.,47,Type_47,Yes
DB01229,Paclitaxel,DB08875,Cabozantinib,0.9162883758544922,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Cabozantinib.,49,Type_49,Yes
DB00972,Azelastine,DB01395,Drospirenone,0.8656243681907654,73,Type_73,The serum concentration of Drospirenone can be increased when it is combined with Azelastine.,68,Type_68,No
DB00300,Tenofovir disoproxil,DB00503,Ritonavir,0.9512937068939209,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB01591,Solifenacin,DB11315,Methscopolamine,0.6763944029808044,49,Type_49,The risk or severity of adverse effects can be increased when Solifenacin is combined with Methscopolamine.,49,Type_49,Yes
DB00654,Latanoprost,DB00797,Tolazoline,0.9999998807907104,60,Type_60,Latanoprost may increase the hypotensive activities of Tolazoline.,60,Type_60,Yes
DB08933,Luliconazole,DB13874,Enasidenib,0.9786714315414429,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Luliconazole.,73,Type_73,Yes
DB00692,Phentolamine,DB01235,Levodopa,0.8516015410423279,30,Type_30,Phentolamine may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB01201,Rifapentine,DB09078,Lenvatinib,0.746040940284729,75,Type_75,The serum concentration of Lenvatinib can be decreased when it is combined with Rifapentine.,4,Type_4,No
DB00091,Cyclosporine,DB01394,Colchicine,0.8622255325317383,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00310,Chlorthalidone,DB00747,Scopolamine,0.9549233317375183,73,Type_73,The serum concentration of Scopolamine can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB00682,Warfarin,DB13873,Fenofibric acid,0.9998798370361328,6,Type_6,Warfarin may increase the anticoagulant activities of Fenofibric acid.,6,Type_6,Yes
DB00169,Cholecalciferol,DB06636,Isavuconazonium,0.9125022888183594,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00700,Eplerenone,DB01359,Penbutolol,0.979978621006012,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Penbutolol.,49,Type_49,Yes
DB09074,Olaparib,DB12026,Voxilaprevir,0.8656799793243408,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Olaparib.,47,Type_47,Yes
DB01174,Phenobarbital,DB01210,Levobunolol,0.6656221151351929,75,Type_75,The serum concentration of Levobunolol can be decreased when it is combined with Phenobarbital.,60,Type_60,No
DB00393,Nimodipine,DB00692,Phentolamine,0.7418365478515625,60,Type_60,Nimodipine may increase the hypotensive activities of Phentolamine.,60,Type_60,Yes
DB00696,Ergotamine,DB00714,Apomorphine,0.3267110586166382,25,Type_25,Ergotamine may increase the atrioventricular blocking (AV block) activities of Apomorphine.,19,Type_19,No
DB00333,Methadone,DB01501,Difenoxin,0.9821962118148804,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Difenoxin.,49,Type_49,Yes
DB00921,Buprenorphine,DB01159,Halothane,0.9933591485023499,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Halothane.,16,Type_16,Yes
DB00575,Clonidine,DB00966,Telmisartan,0.7134677767753601,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Telmisartan.,49,Type_49,Yes
DB00224,Indinavir,DB00247,Methysergide,0.9914679527282715,49,Type_49,The risk or severity of adverse effects can be increased when Indinavir is combined with Methysergide.,49,Type_49,Yes
DB01435,Antipyrine,DB12332,Rucaparib,0.9846142530441284,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Antipyrine.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB06153,Pizotifen,0.9811035394668579,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pizotifen.,49,Type_49,Yes
DB00422,Methylphenidate,DB08808,Bupranolol,0.5222617387771606,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB01168,Procarbazine,DB01340,Cilazapril,0.8117983937263489,60,Type_60,Procarbazine may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB00652,Pentazocine,DB09049,Naloxegol,0.9959890246391296,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Pentazocine.,49,Type_49,No
DB01255,Lisdexamfetamine,DB09000,Cyamemazine,0.9999933242797852,61,Type_61,Lisdexamfetamine may decrease the stimulatory activities of Cyamemazine.,61,Type_61,Yes
DB00670,Pirenzepine,DB00844,Nalbuphine,0.9952995777130127,49,Type_49,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Nalbuphine.,49,Type_49,Yes
DB00812,Phenylbutazone,DB01088,Iloprost,0.9480695724487305,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Phenylbutazone.,70,Type_70,Yes
DB01136,Carvedilol,DB01611,Hydroxychloroquine,0.6333389282226562,73,Type_73,The serum concentration of Hydroxychloroquine can be increased when it is combined with Carvedilol.,47,Type_47,No
DB00312,Pentobarbital,DB00977,Ethinylestradiol,0.7156108617782593,4,Type_4,The metabolism of Ethinylestradiol can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00313,Valproic acid,DB09071,Tasimelteon,0.9680458307266235,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Tasimelteon.,49,Type_49,Yes
DB00318,Codeine,DB00909,Zonisamide,0.9964516162872314,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Zonisamide.,49,Type_49,Yes
DB06153,Pizotifen,DB12532,Oxetacaine,0.5455514788627625,49,Type_49,The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxetacaine.,49,Type_49,Yes
DB00444,Teniposide,DB01319,Fosamprenavir,0.6402276754379272,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Teniposide.,47,Type_47,Yes
DB00651,Dyphylline,DB06695,Dabigatran etexilate,0.6701255440711975,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Dyphylline.,75,Type_75,No
DB01216,Finasteride,DB05521,Telaprevir,0.8682961463928223,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Finasteride.,47,Type_47,Yes
DB00976,Telithromycin,DB08883,Perampanel,0.6311641931533813,47,Type_47,The metabolism of Perampanel can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00359,Sulfadiazine,DB09112,Nitrous acid,0.9109301567077637,49,Type_49,The risk or severity of adverse effects can be increased when Sulfadiazine is combined with Nitrous acid.,49,Type_49,Yes
DB00904,Ondansetron,DB01012,Cinacalcet,0.9335179328918457,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Ondansetron.,47,Type_47,Yes
DB01685,Topiroxostat,DB11613,Velpatasvir,0.9963562488555908,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00283,Clemastine,DB00696,Ergotamine,0.6146644949913025,47,Type_47,The metabolism of Ergotamine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00454,Meperidine,DB00470,Dronabinol,0.9989314675331116,16,Type_16,Meperidine may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.,16,Type_16,Yes
DB00611,Butorphanol,DB01624,Zuclopenthixol,0.9913632869720459,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Zuclopenthixol.,49,Type_49,Yes
DB01104,Sertraline,DB06203,Alogliptin,0.7661331295967102,9,Type_9,Sertraline may increase the hypoglycemic activities of Alogliptin.,47,Type_47,No
DB00390,Digoxin,DB00861,Diflunisal,0.7355939149856567,73,Type_73,The serum concentration of Diflunisal can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB01222,Budesonide,DB06739,Seratrodast,0.9965770840644836,49,Type_49,The risk or severity of adverse effects can be increased when Budesonide is combined with Seratrodast.,49,Type_49,Yes
DB00866,Alprenolol,DB00905,Bimatoprost,0.9999321699142456,60,Type_60,Alprenolol may increase the hypotensive activities of Bimatoprost.,60,Type_60,Yes
DB01072,Atazanavir,DB01259,Lapatinib,0.48133525252342224,73,Type_73,The serum concentration of Lapatinib can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB11586,Asunaprevir,0.7873117327690125,47,Type_47,The metabolism of Asunaprevir can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB01708,Prasterone,DB06710,Methyltestosterone,0.9968552589416504,74,Type_74,Prasterone may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB00788,Naproxen,DB01201,Rifapentine,0.909473180770874,4,Type_4,The metabolism of Rifapentine can be increased when combined with Naproxen.,4,Type_4,Yes
DB00408,Loxapine,DB00754,Ethotoin,0.9989609718322754,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Ethotoin.,49,Type_49,Yes
DB00341,Cetirizine,DB01544,Flunitrazepam,0.9985806941986084,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Flunitrazepam.,49,Type_49,Yes
DB00673,Aprepitant,DB01587,Ketazolam,0.8799973130226135,73,Type_73,The serum concentration of Ketazolam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00332,Ipratropium,DB01409,Tiotropium,0.9500211477279663,2,Type_2,Ipratropium may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB00796,Candesartan cilexetil,DB06414,Etravirine,0.4874666631221771,47,Type_47,The metabolism of Etravirine can be decreased when combined with Candesartan cilexetil.,47,Type_47,Yes
DB06605,Apixaban,DB08820,Ivacaftor,0.8450850248336792,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Apixaban.,73,Type_73,Yes
DB00731,Nateglinide,DB00827,Cinoxacin,0.9910633563995361,9,Type_9,Nateglinide may increase the hypoglycemic activities of Cinoxacin.,9,Type_9,Yes
DB01161,Chloroprocaine,DB01209,Dezocine,0.9993212223052979,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Dezocine.,49,Type_49,Yes
DB01267,Paliperidone,DB02546,Vorinostat,0.9727185368537903,20,Type_20,Paliperidone may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB01370,Aluminium,DB08860,Pitavastatin,0.8571909070014954,75,Type_75,The serum concentration of Pitavastatin can be decreased when it is combined with Aluminium.,75,Type_75,Yes
DB00809,Tropicamide,DB01057,Echothiophate,0.9992700219154358,70,Type_70,The therapeutic efficacy of Echothiophate can be decreased when used in combination with Tropicamide.,70,Type_70,Yes
DB06144,Sertindole,DB08912,Dabrafenib,0.7828372716903687,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Sertindole.,75,Type_75,Yes
DB00715,Paroxetine,DB01189,Desflurane,0.546299159526825,20,Type_20,Paroxetine may increase the QTc-prolonging activities of Desflurane.,49,Type_49,No
DB00758,Clopidogrel,DB00794,Primidone,0.8881981372833252,4,Type_4,The metabolism of Primidone can be increased when combined with Clopidogrel.,4,Type_4,Yes
DB01440,gamma-Hydroxybutyric acid,DB08922,Perospirone,0.9998393058776855,49,Type_49,The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Perospirone.,49,Type_49,Yes
DB00993,Azathioprine,DB01656,Roflumilast,0.7669101357460022,34,Type_34,Azathioprine may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00681,Amphotericin B,DB01282,Carbetocin,0.9999698400497437,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carbetocin.,49,Type_49,Yes
DB00909,Zonisamide,DB06148,Mianserin,0.47500234842300415,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Zonisamide.,70,Type_70,Yes
DB00590,Doxazosin,DB09119,Eslicarbazepine acetate,0.8755665421485901,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB06267,Udenafil,DB09063,Ceritinib,0.9878295660018921,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Udenafil.,73,Type_73,Yes
DB00564,Carbamazepine,DB04908,Flibanserin,0.8669818043708801,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Flibanserin.,75,Type_75,No
DB00476,Duloxetine,DB00714,Apomorphine,0.9909306168556213,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Apomorphine.,30,Type_30,Yes
DB01209,Dezocine,DB01242,Clomipramine,0.8129037022590637,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Clomipramine.,49,Type_49,Yes
DB00246,Ziprasidone,DB01169,Arsenic trioxide,0.7771517038345337,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Arsenic trioxide.,33,Type_33,No
DB00643,Mebendazole,DB01611,Hydroxychloroquine,0.7374899983406067,47,Type_47,The metabolism of Hydroxychloroquine can be decreased when combined with Mebendazole.,75,Type_75,No
DB00287,Travoprost,DB09244,Pirlindole,0.9999946355819702,60,Type_60,Travoprost may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00593,Ethosuximide,DB00898,Ethanol,0.9998220801353455,16,Type_16,Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00285,Venlafaxine,DB08877,Ruxolitinib,0.908814549446106,47,Type_47,The metabolism of Ruxolitinib can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00292,Etomidate,DB01589,Quazepam,0.9706740379333496,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Quazepam.,49,Type_49,Yes
DB00297,Bupivacaine,DB00831,Trifluoperazine,0.9626937508583069,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Trifluoperazine.,49,Type_49,Yes
DB01017,Minocycline,DB01239,Chlorprothixene,0.9893746376037598,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.,16,Type_16,Yes
DB01587,Ketazolam,DB05271,Rotigotine,0.997221827507019,32,Type_32,Ketazolam may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00177,Valsartan,DB00880,Chlorothiazide,0.7657685875892639,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Chlorothiazide.,49,Type_49,Yes
DB00452,Framycetin,DB01000,Cyclacillin,0.9914723038673401,75,Type_75,The serum concentration of Cyclacillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB00180,Flunisolide,DB06710,Methyltestosterone,0.9957350492477417,74,Type_74,Flunisolide may increase the fluid retaining activities of Methyltestosterone.,74,Type_74,Yes
DB01058,Praziquantel,DB04868,Nilotinib,0.5511413812637329,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00367,Levonorgestrel,DB04878,Voglibose,0.9999239444732666,70,Type_70,The therapeutic efficacy of Voglibose can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00706,Tamsulosin,DB01274,Arformoterol,0.9970080256462097,5,Type_5,Tamsulosin may decrease the vasoconstricting activities of Arformoterol.,5,Type_5,Yes
DB00705,Delavirdine,DB01105,Sibutramine,0.905460774898529,47,Type_47,The metabolism of Sibutramine can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00619,Imatinib,DB01559,Clotiazepam,0.8707468509674072,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00881,Quinapril,DB13167,Alclofenac,0.9868389964103699,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Alclofenac.,49,Type_49,Yes
DB01072,Atazanavir,DB09027,Ledipasvir,0.8640261888504028,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00743,Gadobenic acid,DB01601,Lopinavir,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Lopinavir.,20,Type_20,Yes
DB00744,Zileuton,DB01193,Acebutolol,0.9987725615501404,37,Type_37,Zileuton may decrease the antihypertensive activities of Acebutolol.,37,Type_37,Yes
DB00903,Etacrynic acid,DB01452,Diamorphine,0.9902375340461731,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Diamorphine.,49,Type_49,Yes
DB00696,Ergotamine,DB13139,Levosalbutamol,0.6183717250823975,71,Type_71,Ergotamine may increase the hypertensive activities of Levosalbutamol.,49,Type_49,No
DB00367,Levonorgestrel,DB00839,Tolazamide,0.926070511341095,70,Type_70,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00201,Caffeine,DB00549,Zafirlukast,0.8634173274040222,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00207,Azithromycin,DB00346,Alfuzosin,0.6959918737411499,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Alfuzosin.,20,Type_20,Yes
DB00413,Pramipexole,DB00849,Methylphenobarbital,0.9988056421279907,32,Type_32,Pramipexole may increase the sedative activities of Methylphenobarbital.,32,Type_32,Yes
DB00726,Trimipramine,DB01029,Irbesartan,0.4229919910430908,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Trimipramine.,47,Type_47,Yes
DB01095,Fluvastatin,DB09227,Barnidipine,0.5530199408531189,49,Type_49,The risk or severity of adverse effects can be increased when Fluvastatin is combined with Barnidipine.,49,Type_49,Yes
DB01340,Cilazapril,DB01349,Tasosartan,0.8818467855453491,49,Type_49,The risk or severity of adverse effects can be increased when Cilazapril is combined with Tasosartan.,49,Type_49,Yes
DB00517,Anisotropine methylbromide,DB08897,Aclidinium,0.9277238249778748,2,Type_2,Anisotropine methylbromide may increase the anticholinergic activities of Aclidinium.,2,Type_2,Yes
DB00418,Secobarbital,DB12026,Voxilaprevir,0.9309236407279968,4,Type_4,The metabolism of Voxilaprevir can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00752,Tranylcypromine,DB06739,Seratrodast,0.6961338520050049,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Tranylcypromine.,47,Type_47,Yes
DB00862,Vardenafil,DB01324,Polythiazide,0.9345090985298157,10,Type_10,Vardenafil may increase the antihypertensive activities of Polythiazide.,10,Type_10,Yes
DB01349,Tasosartan,DB08899,Enzalutamide,0.8479316234588623,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Tasosartan.,75,Type_75,Yes
DB00288,Amcinonide,DB01283,Lumiracoxib,0.9989928603172302,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Lumiracoxib.,49,Type_49,Yes
DB08797,Salicylamide,DB09138,Technetium Tc-99m medronate,0.9970093965530396,49,Type_49,The risk or severity of adverse effects can be increased when Salicylamide is combined with Technetium Tc-99m medronate.,49,Type_49,Yes
DB00461,Nabumetone,DB06736,Aceclofenac,0.9954105019569397,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Aceclofenac.,49,Type_49,Yes
DB00784,Mefenamic acid,DB08822,Azilsartan medoxomil,0.9989100694656372,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB01089,Deserpidine,DB01116,Trimethaphan,0.9998821020126343,60,Type_60,Deserpidine may increase the hypotensive activities of Trimethaphan.,60,Type_60,Yes
DB00203,Sildenafil,DB01196,Estramustine,0.7926821708679199,47,Type_47,The metabolism of Estramustine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00467,Enoxacin,DB00500,Tolmetin,0.9993581175804138,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Tolmetin.,27,Type_27,Yes
DB00428,Streptozocin,DB06736,Aceclofenac,0.9940311312675476,72,Type_72,Streptozocin may decrease the excretion rate of Aceclofenac which could result in a higher serum level.,72,Type_72,Yes
DB00177,Valsartan,DB09167,Dosulepin,0.9503358602523804,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00399,Zoledronic acid,DB08439,Parecoxib,0.9924219250679016,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Parecoxib.,49,Type_49,Yes
DB01047,Fluocinonide,DB09084,Benzydamine,0.9997648596763611,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Benzydamine.,49,Type_49,Yes
DB01001,Salbutamol,DB06402,Telavancin,1.0,20,Type_20,Salbutamol may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00289,Atomoxetine,DB06710,Methyltestosterone,0.9691817164421082,47,Type_47,The metabolism of Methyltestosterone can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00176,Fluvoxamine,DB05541,Brivaracetam,0.979978621006012,47,Type_47,The metabolism of Brivaracetam can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00582,Voriconazole,DB13179,Troleandomycin,0.8626033663749695,47,Type_47,The metabolism of Troleandomycin can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB01044,Gatifloxacin,DB01047,Fluocinonide,0.9350821375846863,49,Type_49,The risk or severity of adverse effects can be increased when Gatifloxacin is combined with Fluocinonide.,49,Type_49,Yes
DB00468,Quinine,DB09291,Rolapitant,0.9848916530609131,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Quinine.,47,Type_47,Yes
DB00421,Spironolactone,DB01240,Epoprostenol,0.8130188584327698,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Epoprostenol.,49,Type_49,Yes
DB00705,Delavirdine,DB05246,Methsuximide,0.9193593263626099,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00285,Venlafaxine,DB00608,Chloroquine,0.6448604464530945,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Venlafaxine.,20,Type_20,No
DB00188,Bortezomib,DB00772,Malathion,0.9318895936012268,47,Type_47,The metabolism of Malathion can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00772,Malathion,DB01589,Quazepam,0.44214412569999695,73,Type_73,The serum concentration of Quazepam can be increased when it is combined with Malathion.,73,Type_73,Yes
DB00337,Pimecrolimus,DB01211,Clarithromycin,0.6371873617172241,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Pimecrolimus.,47,Type_47,Yes
DB00474,Methohexital,DB09090,Pinaverium,0.9897017478942871,4,Type_4,The metabolism of Pinaverium can be increased when combined with Methohexital.,4,Type_4,Yes
DB00596,Ulobetasol,DB00783,Estradiol,0.9731160998344421,73,Type_73,The serum concentration of Estradiol can be increased when it is combined with Ulobetasol.,73,Type_73,Yes
DB00384,Triamterene,DB05271,Rotigotine,0.9610484838485718,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Rotigotine.,49,Type_49,Yes
DB00838,Clocortolone,DB01185,Fluoxymesterone,1.0,74,Type_74,Clocortolone may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB00366,Doxylamine,DB00434,Cyproheptadine,0.9999973773956299,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.,16,Type_16,Yes
DB01299,Sulfadoxine,DB09214,Dexketoprofen,0.7388623952865601,73,Type_73,The serum concentration of Dexketoprofen can be increased when it is combined with Sulfadoxine.,49,Type_49,No
DB01253,Ergometrine,DB05381,Histamine,0.5130406618118286,49,Type_49,The risk or severity of adverse effects can be increased when Ergometrine is combined with Histamine.,49,Type_49,Yes
DB00179,Masoprocol,DB01222,Budesonide,0.999756395816803,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Budesonide.,49,Type_49,Yes
DB00524,Metolazone,DB00753,Isoflurane,0.9981270432472229,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Isoflurane.,49,Type_49,Yes
DB00887,Bumetanide,DB08970,Fluprednidene,0.9996169805526733,83,Type_83,Bumetanide may increase the hypokalemic activities of Fluprednidene.,83,Type_83,Yes
DB00224,Indinavir,DB00336,Nitrofural,0.9978797435760498,47,Type_47,The metabolism of Nitrofural can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00400,Griseofulvin,DB04743,Nimesulide,0.9345787763595581,49,Type_49,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Nimesulide.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB01024,Mycophenolic acid,0.9088037014007568,70,Type_70,The therapeutic efficacy of Mycophenolic acid can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB00564,Carbamazepine,DB00788,Naproxen,0.9772586226463318,4,Type_4,The metabolism of Naproxen can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00391,Sulpiride,DB00679,Thioridazine,0.4729197025299072,36,Type_36,Sulpiride may increase the antipsychotic activities of Thioridazine.,36,Type_36,Yes
DB00585,Nizatidine,DB00937,Diethylpropion,0.9476379752159119,76,Type_76,Nizatidine may decrease the sedative activities of Diethylpropion.,76,Type_76,Yes
DB01199,Tubocurarine,DB01380,Cortisone acetate,0.9986158609390259,49,Type_49,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cortisone acetate.,49,Type_49,Yes
DB00797,Tolazoline,DB01224,Quetiapine,0.8090834021568298,49,Type_49,The risk or severity of adverse effects can be increased when Tolazoline is combined with Quetiapine.,49,Type_49,Yes
DB01113,Papaverine,DB01210,Levobunolol,0.9997891783714294,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Levobunolol.,49,Type_49,Yes
DB00754,Ethotoin,DB01189,Desflurane,0.9572533369064331,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Desflurane.,49,Type_49,Yes
DB01609,Deferasirox,DB06616,Bosutinib,0.7650216817855835,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Deferasirox.,75,Type_75,No
DB01080,Vigabatrin,DB08910,Pomalidomide,0.9994183778762817,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Pomalidomide.,49,Type_49,Yes
DB00268,Ropinirole,DB00335,Atenolol,0.7058027982711792,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Atenolol.,25,Type_25,No
DB00182,Amphetamine,DB06603,Panobinostat,0.9200429916381836,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Amphetamine.,73,Type_73,Yes
DB00813,Fentanyl,DB04953,Ezogabine,0.995122492313385,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Ezogabine.,49,Type_49,Yes
DB00213,Pantoprazole,DB01283,Lumiracoxib,0.9570813179016113,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00749,Etodolac,DB01401,Choline magnesium trisalicylate,0.9946320056915283,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00278,Argatroban,DB00469,Tenoxicam,0.9502820372581482,6,Type_6,Argatroban may increase the anticoagulant activities of Tenoxicam.,6,Type_6,Yes
DB00238,Nevirapine,DB00997,Doxorubicin,0.6962336897850037,4,Type_4,The metabolism of Doxorubicin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00254,Doxycycline,DB11737,Icotinib,0.9742366075515747,47,Type_47,The metabolism of Icotinib can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00349,Clobazam,DB08918,Levomilnacipran,0.8024794459342957,47,Type_47,The metabolism of Levomilnacipran can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00203,Sildenafil,DB01349,Tasosartan,0.9384899735450745,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00338,Omeprazole,DB00471,Montelukast,0.9195486903190613,47,Type_47,The metabolism of Montelukast can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00455,Loratadine,DB09330,Osimertinib,0.904472291469574,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Loratadine.,73,Type_73,Yes
DB01018,Guanfacine,DB01182,Propafenone,0.6636694073677063,54,Type_54,Guanfacine may increase the bradycardic activities of Propafenone.,54,Type_54,Yes
DB00370,Mirtazapine,DB00625,Efavirenz,0.880832850933075,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Efavirenz.,16,Type_16,Yes
DB00542,Benazepril,DB00872,Conivaptan,0.6172481179237366,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Conivaptan.,49,Type_49,Yes
DB01118,Amiodarone,DB02546,Vorinostat,0.9390864968299866,20,Type_20,Amiodarone may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB00502,Haloperidol,DB01030,Topotecan,0.9821401238441467,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Haloperidol.,73,Type_73,Yes
DB00967,Desloratadine,DB09352,Hydroxyamphetamine,0.9999542236328125,76,Type_76,Desloratadine may decrease the sedative activities of Hydroxyamphetamine.,76,Type_76,Yes
DB00258,Calcium acetate,DB01054,Nitrendipine,0.8823980689048767,70,Type_70,The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium acetate.,70,Type_70,Yes
DB00393,Nimodipine,DB01026,Ketoconazole,0.3969751298427582,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Nimodipine.,73,Type_73,No
DB06263,Amrubicin,DB13167,Alclofenac,0.999954342842102,72,Type_72,Amrubicin may decrease the excretion rate of Alclofenac which could result in a higher serum level.,72,Type_72,Yes
DB00691,Moexipril,DB01214,Metipranolol,0.7701468467712402,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Metipranolol.,49,Type_49,Yes
DB00465,Ketorolac,DB01397,Magnesium salicylate,0.9997695088386536,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Magnesium salicylate.,49,Type_49,Yes
DB00623,Fluphenazine,DB00865,Benzphetamine,0.9576267004013062,61,Type_61,Fluphenazine may decrease the stimulatory activities of Benzphetamine.,61,Type_61,Yes
DB00390,Digoxin,DB00688,Mycophenolate mofetil,0.586699366569519,73,Type_73,The serum concentration of Mycophenolate mofetil can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB01251,Gliquidone,DB04846,Celiprolol,0.5814454555511475,9,Type_9,Gliquidone may increase the hypoglycemic activities of Celiprolol.,9,Type_9,Yes
DB00588,Fluticasone propionate,DB01098,Rosuvastatin,0.9085041880607605,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Fluticasone propionate.,73,Type_73,Yes
DB00196,Fluconazole,DB09083,Ivabradine,0.7777794599533081,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Ivabradine.,73,Type_73,No
DB00244,Mesalazine,DB12364,Betrixaban,0.9999884366989136,66,Type_66,The risk or severity of bleeding can be increased when Mesalazine is combined with Betrixaban.,66,Type_66,Yes
DB00674,Galantamine,DB01035,Procainamide,0.9320520162582397,20,Type_20,Galantamine may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00751,Epinastine,DB08814,Triflusal,0.7076900005340576,53,Type_53,Epinastine may increase the antiplatelet activities of Triflusal.,6,Type_6,No
DB00502,Haloperidol,DB01253,Ergometrine,0.9659745693206787,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Ergometrine.,49,Type_49,Yes
DB00370,Mirtazapine,DB01132,Pioglitazone,0.5955710411071777,73,Type_73,The serum concentration of Pioglitazone can be increased when it is combined with Mirtazapine.,47,Type_47,No
DB00622,Nicardipine,DB06203,Alogliptin,0.5445167422294617,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00393,Nimodipine,DB00735,Naftifine,0.9460948705673218,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Naftifine.,49,Type_49,Yes
DB00296,Ropivacaine,DB09292,Sacubitril,0.742685079574585,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Sacubitril.,49,Type_49,Yes
DB01078,Deslanoside,DB06715,Potassium Iodide,0.9284058213233948,73,Type_73,The serum concentration of Potassium Iodide can be increased when it is combined with Deslanoside.,73,Type_73,Yes
DB01167,Itraconazole,DB09281,Magnesium trisilicate,0.6634886264801025,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Itraconazole.,75,Type_75,Yes
DB01076,Atorvastatin,DB01418,Acenocoumarol,0.4064546227455139,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Acenocoumarol.,6,Type_6,No
DB01104,Sertraline,DB06290,Simeprevir,0.9465837478637695,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Sertraline.,73,Type_73,Yes
DB00903,Etacrynic acid,DB01032,Probenecid,0.6032294631004333,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Etacrynic acid.,49,Type_49,No
DB00843,Donepezil,DB00986,Glycopyrronium,0.9887662529945374,70,Type_70,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.,70,Type_70,Yes
DB01355,Hexobarbital,DB09048,Netupitant,0.9049451351165771,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Hexobarbital.,73,Type_73,Yes
DB00257,Clotrimazole,DB01016,Glyburide,0.8790551424026489,47,Type_47,The metabolism of Glyburide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00598,Labetalol,DB09292,Sacubitril,0.9991795420646667,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Sacubitril.,49,Type_49,Yes
DB00950,Fexofenadine,DB09128,Brexpiprazole,0.9987354874610901,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Brexpiprazole.,49,Type_49,Yes
DB01407,Clenbuterol,DB09245,Toloxatone,0.9040254950523376,71,Type_71,Clenbuterol may increase the hypertensive activities of Toloxatone.,49,Type_49,No
DB00559,Bosentan,DB06616,Bosutinib,0.5227001309394836,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Bosentan.,75,Type_75,No
DB00489,Sotalol,DB00678,Losartan,0.9594209790229797,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Losartan.,49,Type_49,Yes
DB00243,Ranolazine,DB06820,Sulconazole,0.6960784196853638,73,Type_73,The serum concentration of Sulconazole can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00390,Digoxin,DB06212,Tolvaptan,0.9437503218650818,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00695,Furosemide,DB09026,Aliskiren,0.909392774105072,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Aliskiren.,75,Type_75,No
DB00544,Fluorouracil,DB00936,Salicylic acid,0.861731767654419,47,Type_47,The metabolism of Salicylic acid can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB01142,Doxepin,DB01174,Phenobarbital,0.898400604724884,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Doxepin.,4,Type_4,Yes
DB00356,Chlorzoxazone,DB00673,Aprepitant,0.93239825963974,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Chlorzoxazone.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB00700,Eplerenone,0.5809100866317749,68,Type_68,Sulfisoxazole may increase the hyperkalemic activities of Eplerenone.,73,Type_73,No
DB01092,Ouabain,DB01229,Paclitaxel,0.9246734380722046,58,Type_58,Ouabain may decrease the cardiotoxic activities of Paclitaxel.,58,Type_58,Yes
DB00945,Acetylsalicylic acid,DB01174,Phenobarbital,0.9632533192634583,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Acetylsalicylic acid.,4,Type_4,Yes
DB00909,Zonisamide,DB01198,Zopiclone,0.9984036087989807,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Zopiclone.,49,Type_49,Yes
DB00870,Suprofen,DB04743,Nimesulide,0.995989978313446,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Nimesulide.,49,Type_49,Yes
DB06201,Rufinamide,DB09118,Stiripentol,0.3968179523944855,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Rufinamide.,49,Type_49,No
DB00356,Chlorzoxazone,DB00813,Fentanyl,0.9990615248680115,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fentanyl.,49,Type_49,Yes
DB00214,Torasemide,DB00489,Sotalol,0.923075258731842,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Sotalol.,49,Type_49,Yes
DB00835,Brompheniramine,DB06636,Isavuconazonium,0.8919689655303955,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB01236,Sevoflurane,DB04861,Nebivolol,0.552472710609436,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Nebivolol.,49,Type_49,Yes
DB00230,Pregabalin,DB00740,Riluzole,0.7689340710639954,70,Type_70,The therapeutic efficacy of Riluzole can be decreased when used in combination with Pregabalin.,70,Type_70,Yes
DB01087,Primaquine,DB09073,Palbociclib,0.9982154369354248,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Primaquine.,73,Type_73,Yes
DB00722,Lisinopril,DB01351,Amobarbital,0.8122697472572327,60,Type_60,Lisinopril may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB04844,Tetrabenazine,DB05039,Indacaterol,0.8950406312942505,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00470,Dronabinol,DB06616,Bosutinib,0.9731634855270386,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB01406,Danazol,DB08970,Fluprednidene,0.9999922513961792,74,Type_74,Danazol may increase the fluid retaining activities of Fluprednidene.,74,Type_74,Yes
DB00180,Flunisolide,DB00586,Diclofenac,0.9970031380653381,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Diclofenac.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB01261,Sitagliptin,0.9595962166786194,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Arsenic trioxide.,70,Type_70,Yes
DB00976,Telithromycin,DB01587,Ketazolam,0.8595419526100159,47,Type_47,The metabolism of Ketazolam can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00987,Cytarabine,DB08865,Crizotinib,0.9577106833457947,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Cytarabine.,47,Type_47,Yes
DB00692,Phentolamine,DB01242,Clomipramine,0.8633185029029846,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Clomipramine.,49,Type_49,Yes
DB01247,Isocarboxazid,DB01355,Hexobarbital,0.8829290270805359,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Hexobarbital.,60,Type_60,No
DB00904,Ondansetron,DB04839,Cyproterone acetate,0.6936734914779663,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Ondansetron.,75,Type_75,Yes
DB04871,Lorcaserin,DB09286,Pipamperone,0.9006640315055847,49,Type_49,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pipamperone.,49,Type_49,Yes
DB09102,Daclatasvir,DB09330,Osimertinib,0.9749243855476379,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Daclatasvir.,73,Type_73,Yes
DB01026,Ketoconazole,DB09030,Vorapaxar,0.8807077407836914,73,Type_73,The serum concentration of Vorapaxar can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB01216,Finasteride,DB01320,Fosphenytoin,0.9783616662025452,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Finasteride.,4,Type_4,Yes
DB00542,Benazepril,DB00695,Furosemide,0.9892190098762512,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Furosemide.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB06826,Unoprostone,0.9999774694442749,60,Type_60,Candesartan cilexetil may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00539,Toremifene,DB00714,Apomorphine,0.8455007672309875,20,Type_20,Toremifene may increase the QTc-prolonging activities of Apomorphine.,20,Type_20,Yes
DB00703,Methazolamide,DB00780,Phenelzine,0.9310628175735474,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Phenelzine.,49,Type_49,Yes
DB01054,Nitrendipine,DB01254,Dasatinib,0.842353105545044,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Nitrendipine.,73,Type_73,Yes
DB00213,Pantoprazole,DB00281,Lidocaine,0.8949356079101562,47,Type_47,The metabolism of Lidocaine can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00332,Ipratropium,DB09073,Palbociclib,0.9927131533622742,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Ipratropium.,73,Type_73,Yes
DB00694,Daunorubicin,DB00710,Ibandronate,0.9955203533172607,24,Type_24,Daunorubicin may increase the hypocalcemic activities of Ibandronate.,24,Type_24,Yes
DB00292,Etomidate,DB09342,Propoxycaine,0.9999687671661377,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Propoxycaine.,49,Type_49,Yes
DB00398,Sorafenib,DB01559,Clotiazepam,0.5834094882011414,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00216,Eletriptan,DB09280,Lumacaftor,0.6612828373908997,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Eletriptan.,75,Type_75,No
DB00564,Carbamazepine,DB01115,Nifedipine,0.693713366985321,4,Type_4,The metabolism of Nifedipine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01168,Procarbazine,DB01615,Aceprometazine,0.956746518611908,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Aceprometazine.,49,Type_49,Yes
DB06690,Nitrous oxide,DB12532,Oxetacaine,0.999994158744812,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Oxetacaine.,49,Type_49,Yes
DB00559,Bosentan,DB01223,Aminophylline,0.9515490531921387,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00318,Codeine,DB12332,Rucaparib,0.9075493812561035,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Codeine.,70,Type_70,No
DB01081,Diphenoxylate,DB04946,Iloperidone,0.9887418150901794,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Iloperidone.,49,Type_49,Yes
DB00178,Ramipril,DB01041,Thalidomide,0.9120541214942932,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Thalidomide.,49,Type_49,Yes
DB00208,Ticlopidine,DB04840,Debrisoquine,0.9931964874267578,47,Type_47,The metabolism of Debrisoquine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00455,Loratadine,DB00721,Procaine,0.9999890327453613,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Procaine.,49,Type_49,Yes
DB01177,Idarubicin,DB01603,Meticillin,0.9109717011451721,75,Type_75,The serum concentration of Meticillin can be decreased when it is combined with Idarubicin.,75,Type_75,Yes
DB01043,Memantine,DB01410,Ciclesonide,0.9995275735855103,49,Type_49,The risk or severity of adverse effects can be increased when Memantine is combined with Ciclesonide.,49,Type_49,Yes
DB00696,Ergotamine,DB00741,Hydrocortisone,0.9668291211128235,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Hydrocortisone.,49,Type_49,Yes
DB00528,Lercanidipine,DB09286,Pipamperone,0.959013044834137,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Pipamperone.,49,Type_49,Yes
DB00865,Benzphetamine,DB06144,Sertindole,0.9673865437507629,61,Type_61,Benzphetamine may decrease the stimulatory activities of Sertindole.,61,Type_61,Yes
DB00419,Miglustat,DB01120,Gliclazide,0.9957484602928162,9,Type_9,Miglustat may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00892,Oxybuprocaine,DB01198,Zopiclone,0.9999856948852539,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zopiclone.,49,Type_49,Yes
DB01229,Paclitaxel,DB08895,Tofacitinib,0.9815645813941956,34,Type_34,Paclitaxel may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB00270,Isradipine,DB08815,Lurasidone,0.8020409941673279,20,Type_20,Isradipine may increase the QTc-prolonging activities of Lurasidone.,73,Type_73,No
DB00320,Dihydroergotamine,DB01223,Aminophylline,0.9512411952018738,47,Type_47,The metabolism of Aminophylline can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00179,Masoprocol,DB00511,Acetyldigitoxin,0.9055490493774414,58,Type_58,Masoprocol may decrease the cardiotoxic activities of Acetyldigitoxin.,58,Type_58,Yes
DB00619,Imatinib,DB01126,Dutasteride,0.9431200623512268,47,Type_47,The metabolism of Dutasteride can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00481,Raloxifene,DB08899,Enzalutamide,0.9773589372634888,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Raloxifene.,75,Type_75,Yes
DB00208,Ticlopidine,DB01235,Levodopa,0.9053133130073547,47,Type_47,The metabolism of Levodopa can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00270,Isradipine,DB06292,Dapagliflozin,0.7498877644538879,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Dapagliflozin.,49,Type_49,Yes
DB00489,Sotalol,DB00961,Mepivacaine,0.4719561040401459,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Mepivacaine.,73,Type_73,No
DB01621,Pipotiazine,DB12532,Oxetacaine,0.9999967813491821,49,Type_49,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Oxetacaine.,49,Type_49,Yes
DB00611,Butorphanol,DB01339,Vecuronium,0.998274564743042,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Vecuronium.,49,Type_49,Yes
DB00726,Trimipramine,DB00802,Alfentanil,0.9657601118087769,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Alfentanil.,49,Type_49,Yes
DB01156,Bupropion,DB04844,Tetrabenazine,0.4851232171058655,47,Type_47,The metabolism of Tetrabenazine can be decreased when combined with Bupropion.,73,Type_73,No
DB00933,Mesoridazine,DB09034,Suvorexant,0.9999361038208008,16,Type_16,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00842,Oxazepam,DB04868,Nilotinib,0.8243691921234131,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Oxazepam.,47,Type_47,Yes
DB00091,Cyclosporine,DB04920,Clevidipine,0.6453057527542114,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB06589,Pazopanib,DB08901,Ponatinib,0.42809975147247314,73,Type_73,The serum concentration of Ponatinib can be increased when it is combined with Pazopanib.,73,Type_73,Yes
DB00688,Mycophenolate mofetil,DB06739,Seratrodast,0.965667188167572,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Seratrodast.,49,Type_49,Yes
DB00623,Fluphenazine,DB01037,Selegiline,0.6494359374046326,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Selegiline.,49,Type_49,Yes
DB01577,Metamfetamine,DB06148,Mianserin,0.7632933855056763,76,Type_76,Metamfetamine may decrease the sedative activities of Mianserin.,70,Type_70,No
DB06335,Saxagliptin,DB06710,Methyltestosterone,0.9030970335006714,9,Type_9,Saxagliptin may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB01045,Rifampicin,DB01177,Idarubicin,0.9213680028915405,4,Type_4,The metabolism of Idarubicin can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00582,Voriconazole,DB01251,Gliquidone,0.46061256527900696,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Voriconazole.,73,Type_73,No
DB00622,Nicardipine,DB08931,Riociguat,0.394163578748703,60,Type_60,Nicardipine may increase the hypotensive activities of Riociguat.,49,Type_49,No
DB00254,Doxycycline,DB00296,Ropivacaine,0.9309247732162476,47,Type_47,The metabolism of Ropivacaine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01098,Rosuvastatin,DB06203,Alogliptin,0.7974576950073242,73,Type_73,The serum concentration of Alogliptin can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00232,Methyclothiazide,DB06204,Tapentadol,0.9251538515090942,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Tapentadol.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB08882,Linagliptin,0.5918139219284058,47,Type_47,The metabolism of Linagliptin can be decreased when combined with Sulfamethoxazole.,9,Type_9,No
DB00496,Darifenacin,DB00999,Hydrochlorothiazide,0.9220489859580994,73,Type_73,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Darifenacin.,73,Type_73,Yes
DB01095,Fluvastatin,DB01201,Rifapentine,0.8624589443206787,4,Type_4,The metabolism of Rifapentine can be increased when combined with Fluvastatin.,4,Type_4,Yes
DB00968,Methyldopa,DB09227,Barnidipine,0.7569997310638428,49,Type_49,The risk or severity of adverse effects can be increased when Methyldopa is combined with Barnidipine.,49,Type_49,Yes
DB00708,Sufentanil,DB01026,Ketoconazole,0.5592712759971619,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Sufentanil.,47,Type_47,Yes
DB01399,Salsalate,DB06725,Lornoxicam,0.9996163845062256,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Lornoxicam.,49,Type_49,Yes
DB00541,Vincristine,DB01232,Saquinavir,0.5222434997558594,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Vincristine.,47,Type_47,No
DB00347,Trimethadione,DB05812,Abiraterone,0.4232408404350281,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Trimethadione.,73,Type_73,No
DB00283,Clemastine,DB00864,Tacrolimus,0.9368266463279724,47,Type_47,The metabolism of Tacrolimus can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00458,Imipramine,DB01408,Bambuterol,0.9852347373962402,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Bambuterol.,49,Type_49,Yes
DB00573,Fenoprofen,DB09449,"Sodium phosphate, monobasic",0.9475540518760681,57,Type_57,"Fenoprofen may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00409,Remoxipride,DB09167,Dosulepin,0.6539421677589417,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Remoxipride.,47,Type_47,Yes
DB00794,Primidone,DB09026,Aliskiren,0.42955905199050903,4,Type_4,The metabolism of Aliskiren can be increased when combined with Primidone.,4,Type_4,Yes
DB00258,Calcium acetate,DB00779,Nalidixic acid,0.830740213394165,67,Type_67,Calcium acetate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00470,Dronabinol,DB00541,Vincristine,0.9221858382225037,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00393,Nimodipine,DB00519,Trandolapril,0.6182186603546143,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Trandolapril.,49,Type_49,Yes
DB00214,Torasemide,DB01201,Rifapentine,0.9282985329627991,4,Type_4,The metabolism of Rifapentine can be increased when combined with Torasemide.,4,Type_4,Yes
DB00582,Voriconazole,DB01283,Lumiracoxib,0.9432070255279541,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB06204,Tapentadol,DB09286,Pipamperone,0.94963139295578,16,Type_16,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.,16,Type_16,Yes
DB00802,Alfentanil,DB01203,Nadolol,0.8420652151107788,54,Type_54,Alfentanil may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB01016,Glyburide,DB01026,Ketoconazole,0.7803722023963928,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Glyburide.,47,Type_47,Yes
DB00297,Bupivacaine,DB08883,Perampanel,0.9825758934020996,16,Type_16,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00934,Maprotiline,DB01440,gamma-Hydroxybutyric acid,0.9999877214431763,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00570,Vinblastine,DB00648,Mitotane,0.9835216999053955,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Vinblastine.,75,Type_75,Yes
DB01283,Lumiracoxib,DB09477,Enalaprilat,0.9081710577011108,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Enalaprilat.,49,Type_49,Yes
DB01124,Tolbutamide,DB01175,Escitalopram,0.9905210733413696,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Escitalopram.,9,Type_9,Yes
DB01229,Paclitaxel,DB01656,Roflumilast,0.9344035387039185,34,Type_34,Paclitaxel may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00443,Betamethasone,DB01043,Memantine,0.9996206760406494,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Memantine.,49,Type_49,Yes
DB00960,Pindolol,DB06595,Midostaurin,0.9142438769340515,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Pindolol.,47,Type_47,Yes
DB01205,Flumazenil,DB09034,Suvorexant,0.8869644999504089,16,Type_16,Flumazenil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,76,Type_76,No
DB00601,Linezolid,DB01267,Paliperidone,0.8181237578392029,64,Type_64,Linezolid may increase the serotonergic activities of Paliperidone.,49,Type_49,No
DB00393,Nimodipine,DB00629,Guanabenz,0.9744645357131958,60,Type_60,Nimodipine may increase the hypotensive activities of Guanabenz.,60,Type_60,Yes
DB00317,Gefitinib,DB00472,Fluoxetine,0.935268759727478,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB01136,Carvedilol,DB01236,Sevoflurane,0.5236569046974182,49,Type_49,The risk or severity of adverse effects can be increased when Carvedilol is combined with Sevoflurane.,49,Type_49,Yes
DB00228,Enflurane,DB00829,Diazepam,0.9488371014595032,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Diazepam.,49,Type_49,Yes
DB00869,Dorzolamide,DB01167,Itraconazole,0.9753545522689819,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Dorzolamide.,47,Type_47,Yes
DB00333,Methadone,DB00376,Trihexyphenidyl,0.980189859867096,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Trihexyphenidyl.,49,Type_49,Yes
DB00860,Prednisolone,DB09067,Corticorelin ovine triflutate,0.9999995231628418,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone.,70,Type_70,Yes
DB00202,Succinylcholine,DB00805,Minaprine,0.7099827527999878,70,Type_70,The therapeutic efficacy of Minaprine can be decreased when used in combination with Succinylcholine.,73,Type_73,No
DB00861,Diflunisal,DB01088,Iloprost,0.9322371482849121,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Diflunisal.,49,Type_49,No
DB00203,Sildenafil,DB00726,Trimipramine,0.8568616509437561,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00633,Dexmedetomidine,DB00691,Moexipril,0.8390419483184814,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Moexipril.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB08820,Ivacaftor,0.9817744493484497,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Sulfamethoxazole.,73,Type_73,Yes
DB00953,Rizatriptan,DB01253,Ergometrine,0.9922773838043213,49,Type_49,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Ergometrine.,49,Type_49,Yes
DB00972,Azelastine,DB04908,Flibanserin,0.9474539756774902,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,16,Type_16,Yes
DB01685,Topiroxostat,DB08798,Sulfamoxole,0.9963687658309937,47,Type_47,The metabolism of Sulfamoxole can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00472,Fluoxetine,DB04920,Clevidipine,0.6934888958930969,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB06267,Udenafil,DB08865,Crizotinib,0.7055251002311707,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Udenafil.,47,Type_47,Yes
DB00704,Naltrexone,DB01466,Ethylmorphine,0.5506306886672974,73,Type_73,The serum concentration of Ethylmorphine can be increased when it is combined with Naltrexone.,70,Type_70,No
DB00298,Dapiprazole,DB01624,Zuclopenthixol,0.801461398601532,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Zuclopenthixol.,49,Type_49,Yes
DB00321,Amitriptyline,DB01165,Ofloxacin,0.9985197186470032,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB01220,Rifaximin,DB01340,Cilazapril,0.8958226442337036,75,Type_75,The serum concentration of Cilazapril can be decreased when it is combined with Rifaximin.,73,Type_73,No
DB00091,Cyclosporine,DB08873,Boceprevir,0.8377296328544617,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Cyclosporine.,73,Type_73,No
DB01429,Aprindine,DB05812,Abiraterone,0.9473598599433899,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Aprindine.,73,Type_73,No
DB01065,Melatonin,DB01124,Tolbutamide,0.5000168085098267,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Melatonin.,47,Type_47,No
DB00991,Oxaprozin,DB01380,Cortisone acetate,0.9994592070579529,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Cortisone acetate.,49,Type_49,Yes
DB00731,Nateglinide,DB01059,Norfloxacin,0.9245036840438843,9,Type_9,Nateglinide may increase the hypoglycemic activities of Norfloxacin.,9,Type_9,Yes
DB00656,Trazodone,DB00909,Zonisamide,0.9932722449302673,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Zonisamide.,49,Type_49,Yes
DB00334,Olanzapine,DB01233,Metoclopramide,0.7080920338630676,20,Type_20,Olanzapine may increase the QTc-prolonging activities of Metoclopramide.,49,Type_49,No
DB01090,Pentolinium,DB01173,Orphenadrine,0.7885435819625854,49,Type_49,The risk or severity of adverse effects can be increased when Pentolinium is combined with Orphenadrine.,49,Type_49,Yes
DB00867,Ritodrine,DB01021,Trichlormethiazide,0.9991101622581482,83,Type_83,Ritodrine may increase the hypokalemic activities of Trichlormethiazide.,83,Type_83,Yes
DB00821,Carprofen,DB09211,Limaprost,0.9613257050514221,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Carprofen.,70,Type_70,Yes
DB00333,Methadone,DB00794,Primidone,0.7134078741073608,4,Type_4,The metabolism of Primidone can be increased when combined with Methadone.,75,Type_75,No
DB00512,Vancomycin,DB00554,Piroxicam,0.9269536733627319,73,Type_73,The serum concentration of Piroxicam can be increased when it is combined with Vancomycin.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB04861,Nebivolol,0.990220308303833,54,Type_54,Acetyldigitoxin may increase the bradycardic activities of Nebivolol.,54,Type_54,Yes
DB00339,Pyrazinamide,DB00794,Primidone,0.8864290714263916,4,Type_4,The metabolism of Primidone can be increased when combined with Pyrazinamide.,4,Type_4,Yes
DB00992,Methyl aminolevulinate,DB01229,Paclitaxel,0.9994311928749084,49,Type_49,The risk or severity of adverse effects can be increased when Methyl aminolevulinate is combined with Paclitaxel.,49,Type_49,Yes
DB04868,Nilotinib,DB06788,Histrelin,0.9995372295379639,20,Type_20,Nilotinib may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB01118,Amiodarone,DB06209,Prasugrel,0.5769431591033936,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Amiodarone.,11,Type_11,No
DB00226,Guanadrel,DB00880,Chlorothiazide,0.9999991655349731,60,Type_60,Guanadrel may increase the hypotensive activities of Chlorothiazide.,60,Type_60,Yes
DB00500,Tolmetin,DB01359,Penbutolol,0.9991222023963928,37,Type_37,Tolmetin may decrease the antihypertensive activities of Penbutolol.,37,Type_37,Yes
DB00377,Palonosetron,DB01167,Itraconazole,0.9601602554321289,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Palonosetron.,47,Type_47,Yes
DB00211,Midodrine,DB00867,Ritodrine,0.9970523118972778,49,Type_49,The risk or severity of adverse effects can be increased when Midodrine is combined with Ritodrine.,49,Type_49,Yes
DB00201,Caffeine,DB09120,Zucapsaicin,0.9982819557189941,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00266,Dicoumarol,DB00641,Simvastatin,0.6367541551589966,6,Type_6,Dicoumarol may increase the anticoagulant activities of Simvastatin.,6,Type_6,Yes
DB00622,Nicardipine,DB01065,Melatonin,0.8349993228912354,47,Type_47,The metabolism of Melatonin can be decreased when combined with Nicardipine.,37,Type_37,No
DB00313,Valproic acid,DB01086,Benzocaine,0.8939008712768555,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Benzocaine.,49,Type_49,Yes
DB00925,Phenoxybenzamine,DB12332,Rucaparib,0.9690958261489868,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Phenoxybenzamine.,47,Type_47,Yes
DB00484,Brimonidine,DB06201,Rufinamide,0.9997491240501404,49,Type_49,The risk or severity of adverse effects can be increased when Brimonidine is combined with Rufinamide.,49,Type_49,Yes
DB00622,Nicardipine,DB00648,Mitotane,0.897902250289917,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Nicardipine.,75,Type_75,Yes
DB00722,Lisinopril,DB00866,Alprenolol,0.6698769330978394,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Alprenolol.,60,Type_60,No
DB01320,Fosphenytoin,DB06148,Mianserin,0.8983205556869507,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Fosphenytoin.,70,Type_70,Yes
DB00612,Bisoprolol,DB00872,Conivaptan,0.6652498841285706,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Conivaptan.,73,Type_73,No
DB00203,Sildenafil,DB01355,Hexobarbital,0.7353659272193909,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00541,Vincristine,DB01137,Levofloxacin,0.6761510372161865,73,Type_73,The serum concentration of Levofloxacin can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00402,Eszopiclone,DB00842,Oxazepam,0.9976052045822144,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxazepam.,49,Type_49,Yes
DB00549,Zafirlukast,DB02703,Fusidic acid,0.9996984004974365,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Zafirlukast.,73,Type_73,Yes
DB00228,Enflurane,DB00752,Tranylcypromine,0.9423666000366211,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Tranylcypromine.,49,Type_49,Yes
DB00422,Methylphenidate,DB01239,Chlorprothixene,0.9702345132827759,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Chlorprothixene.,49,Type_49,Yes
DB00363,Clozapine,DB00708,Sufentanil,0.4858652353286743,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Sufentanil.,49,Type_49,Yes
DB01026,Ketoconazole,DB01544,Flunitrazepam,0.8568580150604248,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00844,Nalbuphine,DB01587,Ketazolam,0.9959724545478821,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketazolam.,49,Type_49,Yes
DB00425,Zolpidem,DB05812,Abiraterone,0.8424267172813416,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Zolpidem.,73,Type_73,Yes
DB01002,Levobupivacaine,DB09292,Sacubitril,0.7589468955993652,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Sacubitril.,49,Type_49,Yes
DB00605,Sulindac,DB00866,Alprenolol,0.9996912479400635,37,Type_37,Sulindac may decrease the antihypertensive activities of Alprenolol.,37,Type_37,Yes
DB01104,Sertraline,DB01236,Sevoflurane,0.583493709564209,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Sevoflurane.,47,Type_47,No
DB00695,Furosemide,DB01275,Hydralazine,0.972599446773529,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Hydralazine.,49,Type_49,Yes
DB00295,Morphine,DB00794,Primidone,0.9813699722290039,4,Type_4,The metabolism of Primidone can be increased when combined with Morphine.,4,Type_4,Yes
DB00240,Alclometasone,DB00461,Nabumetone,0.9977754950523376,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Nabumetone.,49,Type_49,Yes
DB00641,Simvastatin,DB01238,Aripiprazole,0.942236065864563,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Simvastatin.,75,Type_75,No
DB00813,Fentanyl,DB06690,Nitrous oxide,0.99998939037323,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Nitrous oxide.,49,Type_49,Yes
DB00280,Disopyramide,DB01075,Diphenhydramine,0.9067182540893555,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Diphenhydramine.,20,Type_20,Yes
DB00316,Acetaminophen,DB06636,Isavuconazonium,0.9391065835952759,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00215,Citalopram,DB01227,Levacetylmethadol,0.5243867039680481,47,Type_47,The metabolism of Levacetylmethadol can be decreased when combined with Citalopram.,64,Type_64,No
DB00400,Griseofulvin,DB00528,Lercanidipine,0.9785138964653015,49,Type_49,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Lercanidipine.,49,Type_49,Yes
DB00807,Proparacaine,DB01567,Fludiazepam,0.9970454573631287,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Fludiazepam.,49,Type_49,Yes
DB01229,Paclitaxel,DB01236,Sevoflurane,0.927226185798645,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Sevoflurane.,49,Type_49,Yes
DB00150,Tryptophan,DB00652,Pentazocine,0.9078672528266907,64,Type_64,Tryptophan may increase the serotonergic activities of Pentazocine.,64,Type_64,Yes
DB00754,Ethotoin,DB01161,Chloroprocaine,0.9832196831703186,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Chloroprocaine.,49,Type_49,Yes
DB00408,Loxapine,DB01159,Halothane,0.9828190207481384,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Halothane.,49,Type_49,Yes
DB00237,Butabarbital,DB00391,Sulpiride,0.994182288646698,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Sulpiride.,49,Type_49,Yes
DB01283,Lumiracoxib,DB01359,Penbutolol,0.9990835189819336,37,Type_37,Lumiracoxib may decrease the antihypertensive activities of Penbutolol.,37,Type_37,Yes
DB00539,Toremifene,DB09074,Olaparib,0.7757232785224915,47,Type_47,The metabolism of Olaparib can be decreased when combined with Toremifene.,47,Type_47,Yes
DB00917,Dinoprostone,DB08981,Fenbufen,0.9304174184799194,70,Type_70,The therapeutic efficacy of Fenbufen can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00444,Teniposide,DB01264,Darunavir,0.6198582053184509,47,Type_47,The metabolism of Darunavir can be decreased when combined with Teniposide.,47,Type_47,Yes
DB01377,Magnesium oxide,DB08906,Fluticasone furoate,0.975426197052002,3,Type_3,The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium oxide.,3,Type_3,Yes
DB00996,Gabapentin,DB01238,Aripiprazole,0.9415846467018127,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Aripiprazole.,49,Type_49,Yes
DB00248,Cabergoline,DB00278,Argatroban,0.6222584247589111,73,Type_73,The serum concentration of Argatroban can be increased when it is combined with Cabergoline.,73,Type_73,Yes
DB00213,Pantoprazole,DB08912,Dabrafenib,0.9785032868385315,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Pantoprazole.,75,Type_75,Yes
DB00872,Conivaptan,DB06145,Spiramycin,0.9841094613075256,73,Type_73,The serum concentration of Spiramycin can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00754,Ethotoin,DB01563,Chloral hydrate,0.9788674116134644,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Chloral hydrate.,49,Type_49,Yes
DB00872,Conivaptan,DB06702,Fesoterodine,0.8751890063285828,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Conivaptan.,73,Type_73,No
DB01431,Allylestrenol,DB08933,Luliconazole,0.9298352003097534,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Allylestrenol.,73,Type_73,Yes
DB00253,Medrysone,DB01185,Fluoxymesterone,1.0,74,Type_74,Medrysone may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB00475,Chlordiazepoxide,DB09073,Palbociclib,0.9911208748817444,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Chlordiazepoxide.,73,Type_73,Yes
DB00842,Oxazepam,DB01624,Zuclopenthixol,0.9871922731399536,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Zuclopenthixol.,49,Type_49,Yes
DB08970,Fluprednidene,DB11079,Trolamine salicylate,0.9958328604698181,49,Type_49,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Trolamine salicylate.,49,Type_49,Yes
DB00870,Suprofen,DB00946,Phenprocoumon,0.9996292591094971,6,Type_6,Suprofen may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00244,Mesalazine,DB00288,Amcinonide,0.9981203675270081,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Amcinonide.,49,Type_49,Yes
DB01029,Irbesartan,DB08918,Levomilnacipran,0.33116623759269714,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Levomilnacipran.,47,Type_47,No
DB00091,Cyclosporine,DB00612,Bisoprolol,0.6544556021690369,47,Type_47,The metabolism of Bisoprolol can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00744,Zileuton,DB08905,Formestane,0.9996080994606018,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Formestane.,49,Type_49,Yes
DB00487,Pefloxacin,DB00959,Methylprednisolone,0.9647775888442993,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Methylprednisolone.,49,Type_49,Yes
DB00323,Tolcapone,DB00405,Dexbrompheniramine,0.997581958770752,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Dexbrompheniramine.,49,Type_49,Yes
DB00715,Paroxetine,DB13874,Enasidenib,0.868657648563385,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00335,Atenolol,DB00991,Oxaprozin,0.9953574538230896,37,Type_37,Atenolol may decrease the antihypertensive activities of Oxaprozin.,37,Type_37,Yes
DB01065,Melatonin,DB01589,Quazepam,0.9931966066360474,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Quazepam.,49,Type_49,Yes
DB01544,Flunitrazepam,DB11148,Butamben,0.9999982118606567,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Butamben.,49,Type_49,Yes
DB00751,Epinastine,DB01088,Iloprost,0.9990864992141724,53,Type_53,Epinastine may increase the antiplatelet activities of Iloprost.,53,Type_53,Yes
DB00571,Propranolol,DB08895,Tofacitinib,0.933052659034729,54,Type_54,Propranolol may increase the bradycardic activities of Tofacitinib.,54,Type_54,Yes
DB01578,Metrizamide,DB06725,Lornoxicam,0.9999687671661377,72,Type_72,Metrizamide may decrease the excretion rate of Lornoxicam which could result in a higher serum level.,72,Type_72,Yes
DB00375,Colestipol,DB11921,Deflazacort,0.9886971712112427,67,Type_67,Colestipol can cause a decrease in the absorption of Deflazacort resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00625,Efavirenz,DB01041,Thalidomide,0.9818145632743835,16,Type_16,Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB02703,Fusidic acid,DB08899,Enzalutamide,0.7061265707015991,73,Type_73,The serum concentration of Enzalutamide can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00091,Cyclosporine,DB08439,Parecoxib,0.966439962387085,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Parecoxib.,57,Type_57,Yes
DB01023,Felodipine,DB01037,Selegiline,0.861524760723114,60,Type_60,Felodipine may increase the hypotensive activities of Selegiline.,60,Type_60,Yes
DB00692,Phentolamine,DB09244,Pirlindole,0.9969929456710815,60,Type_60,Phentolamine may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00207,Azithromycin,DB01264,Darunavir,0.6349312663078308,47,Type_47,The metabolism of Darunavir can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB01319,Fosamprenavir,DB04938,Ospemifene,0.7994028925895691,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00185,Cevimeline,DB00363,Clozapine,0.9705669283866882,47,Type_47,The metabolism of Clozapine can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00278,Argatroban,DB08912,Dabrafenib,0.9509702920913696,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Argatroban.,75,Type_75,Yes
DB00890,Dienestrol,DB06335,Saxagliptin,0.851733386516571,75,Type_75,The serum concentration of Saxagliptin can be decreased when it is combined with Dienestrol.,75,Type_75,Yes
DB00313,Valproic acid,DB04898,Ximelagatran,0.5070492625236511,47,Type_47,The metabolism of Ximelagatran can be decreased when combined with Valproic acid.,75,Type_75,No
DB00292,Etomidate,DB01198,Zopiclone,0.9967507123947144,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Zopiclone.,49,Type_49,Yes
DB00492,Fosinopril,DB00821,Carprofen,0.9486467242240906,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Carprofen.,49,Type_49,Yes
DB00573,Fenoprofen,DB00860,Prednisolone,0.9996896982192993,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Prednisolone.,49,Type_49,Yes
DB01142,Doxepin,DB01587,Ketazolam,0.9334190487861633,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Ketazolam.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00490,Buspirone,0.6875371336936951,64,Type_64,Dihydroergotamine may increase the serotonergic activities of Buspirone.,49,Type_49,No
DB00663,Flumethasone,DB00827,Cinoxacin,0.9920469522476196,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Cinoxacin.,49,Type_49,Yes
DB11362,Selexipag,DB12332,Rucaparib,0.9902741312980652,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Selexipag.,47,Type_47,Yes
DB01059,Norfloxacin,DB05294,Vandetanib,0.5633600354194641,20,Type_20,Norfloxacin may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00564,Carbamazepine,DB01259,Lapatinib,0.5601795315742493,4,Type_4,The metabolism of Lapatinib can be increased when combined with Carbamazepine.,75,Type_75,No
DB01078,Deslanoside,DB01580,Oxprenolol,0.6449341773986816,25,Type_25,Deslanoside may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,54,Type_54,No
DB00818,Propofol,DB00904,Ondansetron,0.4983956515789032,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Ondansetron.,20,Type_20,No
DB00285,Venlafaxine,DB01708,Prasterone,0.8874675035476685,47,Type_47,The metabolism of Prasterone can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00443,Betamethasone,DB01045,Rifampicin,0.9210931658744812,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Betamethasone.,75,Type_75,Yes
DB00841,Dobutamine,DB00871,Terbutaline,0.9996583461761475,49,Type_49,The risk or severity of adverse effects can be increased when Dobutamine is combined with Terbutaline.,49,Type_49,Yes
DB06772,Cabazitaxel,DB09143,Sonidegib,0.9492902159690857,49,Type_49,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Sonidegib.,49,Type_49,Yes
DB01100,Pimozide,DB08881,Vemurafenib,0.41386649012565613,33,Type_33,The risk or severity of QTc prolongation can be increased when Pimozide is combined with Vemurafenib.,73,Type_73,No
DB01232,Saquinavir,DB04953,Ezogabine,0.8150765299797058,20,Type_20,Saquinavir may increase the QTc-prolonging activities of Ezogabine.,20,Type_20,Yes
DB00818,Propofol,DB06282,Levocetirizine,0.980022132396698,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Levocetirizine.,49,Type_49,Yes
DB01072,Atazanavir,DB01370,Aluminium,0.7012889981269836,67,Type_67,Atazanavir can cause a decrease in the absorption of Aluminium resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00499,Flutamide,DB08880,Teriflunomide,0.8246142864227295,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Flutamide.,75,Type_75,Yes
DB01012,Cinacalcet,DB01235,Levodopa,0.8383569717407227,47,Type_47,The metabolism of Levodopa can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00228,Enflurane,DB01174,Phenobarbital,0.7562362551689148,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Phenobarbital.,49,Type_49,Yes
DB01320,Fosphenytoin,DB06176,Romidepsin,0.6108699440956116,75,Type_75,The serum concentration of Romidepsin can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB00199,Erythromycin,DB01200,Bromocriptine,0.7736983299255371,47,Type_47,The metabolism of Bromocriptine can be decreased when combined with Erythromycin.,73,Type_73,No
DB00584,Enalapril,DB00862,Vardenafil,0.951166570186615,10,Type_10,Enalapril may increase the antihypertensive activities of Vardenafil.,10,Type_10,Yes
DB00373,Timolol,DB09241,Methylene blue,0.9897601008415222,60,Type_60,Timolol may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB04574,Estrone sulfate,DB09067,Corticorelin ovine triflutate,0.9999797344207764,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Estrone sulfate.,70,Type_70,Yes
DB01142,Doxepin,DB05246,Methsuximide,0.9130804538726807,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Methsuximide.,49,Type_49,Yes
DB00655,Estrone,DB01151,Desipramine,0.7274054288864136,47,Type_47,The metabolism of Desipramine can be decreased when combined with Estrone.,47,Type_47,Yes
DB00427,Triprolidine,DB06700,Desvenlafaxine,0.9864565134048462,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Desvenlafaxine.,49,Type_49,Yes
DB00589,Lisuride,DB00912,Repaglinide,0.6919667720794678,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Repaglinide.,49,Type_49,Yes
DB00014,Goserelin,DB00543,Amoxapine,0.9992541670799255,20,Type_20,Goserelin may increase the QTc-prolonging activities of Amoxapine.,20,Type_20,Yes
DB00392,Profenamine,DB01199,Tubocurarine,0.9981820583343506,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Tubocurarine.,49,Type_49,Yes
DB00401,Nisoldipine,DB02703,Fusidic acid,0.9956509470939636,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Nisoldipine.,73,Type_73,Yes
DB00214,Torasemide,DB00818,Propofol,0.9699568748474121,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Propofol.,49,Type_49,Yes
DB01118,Amiodarone,DB08901,Ponatinib,0.8855116963386536,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Amiodarone.,73,Type_73,No
DB00615,Rifabutin,DB01183,Naloxone,0.9819076657295227,4,Type_4,The metabolism of Naloxone can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00239,Oxiconazole,DB00745,Modafinil,0.9665142297744751,47,Type_47,The metabolism of Modafinil can be decreased when combined with Oxiconazole.,47,Type_47,Yes
DB00312,Pentobarbital,DB09227,Barnidipine,0.648950457572937,4,Type_4,The metabolism of Barnidipine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00695,Furosemide,DB09286,Pipamperone,0.9920348525047302,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Pipamperone.,49,Type_49,Yes
DB09242,Moxonidine,DB09292,Sacubitril,0.997399091720581,49,Type_49,The risk or severity of adverse effects can be increased when Moxonidine is combined with Sacubitril.,49,Type_49,Yes
DB00648,Mitotane,DB11575,Grazoprevir,0.9677464365959167,75,Type_75,The serum concentration of Grazoprevir can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00686,Pentosan polysulfate,DB04575,Quinestrol,0.913821280002594,12,Type_12,Pentosan polysulfate may decrease the anticoagulant activities of Quinestrol.,12,Type_12,Yes
DB00337,Pimecrolimus,DB00744,Zileuton,0.9952653646469116,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zileuton.,49,Type_49,Yes
DB00622,Nicardipine,DB01394,Colchicine,0.9631834030151367,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB00393,Nimodipine,DB00528,Lercanidipine,0.5388578176498413,60,Type_60,Nimodipine may increase the hypotensive activities of Lercanidipine.,60,Type_60,Yes
DB00501,Cimetidine,DB00932,Tipranavir,0.8904895186424255,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00556,Perflutren,DB00726,Trimipramine,0.9999992847442627,20,Type_20,Perflutren may increase the QTc-prolonging activities of Trimipramine.,20,Type_20,Yes
DB00755,Tretinoin,DB09279,Fimasartan,0.9676865935325623,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Fimasartan.,49,Type_49,Yes
DB01183,Naloxone,DB08873,Boceprevir,0.863312840461731,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Naloxone.,47,Type_47,Yes
DB01076,Atorvastatin,DB01301,Rolitetracycline,0.7860216498374939,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Rolitetracycline.,49,Type_49,Yes
DB00484,Brimonidine,DB00521,Carteolol,0.6455957889556885,10,Type_10,Brimonidine may increase the antihypertensive activities of Carteolol.,10,Type_10,Yes
DB00967,Desloratadine,DB01224,Quetiapine,0.9828948974609375,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Quetiapine.,49,Type_49,Yes
DB06603,Panobinostat,DB08918,Levomilnacipran,0.8385017514228821,73,Type_73,The serum concentration of Levomilnacipran can be increased when it is combined with Panobinostat.,73,Type_73,Yes
DB00613,Amodiaquine,DB00780,Phenelzine,0.6665714979171753,47,Type_47,The metabolism of Phenelzine can be decreased when combined with Amodiaquine.,73,Type_73,No
DB00686,Pentosan polysulfate,DB00977,Ethinylestradiol,0.840169370174408,12,Type_12,Pentosan polysulfate may decrease the anticoagulant activities of Ethinylestradiol.,12,Type_12,Yes
DB08864,Rilpivirine,DB09119,Eslicarbazepine acetate,0.9674792289733887,73,Type_73,The serum concentration of Eslicarbazepine acetate can be increased when it is combined with Rilpivirine.,75,Type_75,No
DB01155,Gemifloxacin,DB04844,Tetrabenazine,0.9949705004692078,20,Type_20,Gemifloxacin may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00736,Esomeprazole,DB00983,Formoterol,0.8157798647880554,47,Type_47,The metabolism of Formoterol can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB09075,Edoxaban,DB09462,Glycerin,0.8460927605628967,73,Type_73,The serum concentration of Glycerin can be increased when it is combined with Edoxaban.,73,Type_73,Yes
DB00546,Adinazolam,DB08881,Vemurafenib,0.6194770932197571,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Adinazolam.,75,Type_75,Yes
DB04844,Tetrabenazine,DB08881,Vemurafenib,0.9284238219261169,33,Type_33,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Vemurafenib.,33,Type_33,Yes
DB01239,Chlorprothixene,DB13872,Lormetazepam,0.9991816878318787,49,Type_49,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Lormetazepam.,49,Type_49,Yes
DB00199,Erythromycin,DB01621,Pipotiazine,0.8311586976051331,47,Type_47,The metabolism of Pipotiazine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00379,Mexiletine,DB00472,Fluoxetine,0.9931204319000244,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00734,Risperidone,DB01295,Bevantolol,0.9081995487213135,25,Type_25,Risperidone may increase the atrioventricular blocking (AV block) activities of Bevantolol.,25,Type_25,Yes
DB00195,Betaxolol,DB00814,Meloxicam,0.9816635847091675,37,Type_37,Betaxolol may decrease the antihypertensive activities of Meloxicam.,37,Type_37,Yes
DB01618,Molindone,DB09118,Stiripentol,0.5840628147125244,49,Type_49,The risk or severity of adverse effects can be increased when Molindone is combined with Stiripentol.,49,Type_49,Yes
DB00681,Amphotericin B,DB01214,Metipranolol,0.9985333681106567,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metipranolol.,49,Type_49,Yes
DB00418,Secobarbital,DB00964,Apraclonidine,0.8155356645584106,60,Type_60,Secobarbital may increase the hypotensive activities of Apraclonidine.,60,Type_60,Yes
DB00647,Dextropropoxyphene,DB04868,Nilotinib,0.7974026203155518,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Dextropropoxyphene.,47,Type_47,Yes
DB00458,Imipramine,DB06704,Iobenguane,0.5204147696495056,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Imipramine.,70,Type_70,Yes
DB01072,Atazanavir,DB01377,Magnesium oxide,0.9073556065559387,67,Type_67,Atazanavir can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB09084,Benzydamine,DB12598,Nafamostat,0.6577165722846985,6,Type_6,Benzydamine may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB00967,Desloratadine,DB04946,Iloperidone,0.984079897403717,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Iloperidone.,49,Type_49,Yes
DB00412,Rosiglitazone,DB08899,Enzalutamide,0.6687018275260925,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Rosiglitazone.,47,Type_47,No
DB00831,Trifluoperazine,DB08815,Lurasidone,0.9919565916061401,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lurasidone.,49,Type_49,Yes
DB00424,Hyoscyamine,DB09076,Umeclidinium,0.9995262622833252,2,Type_2,Hyoscyamine may increase the anticholinergic activities of Umeclidinium.,2,Type_2,Yes
DB00492,Fosinopril,DB08938,Magaldrate,0.8632380366325378,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Fosinopril.,75,Type_75,Yes
DB01291,Pirbuterol,DB09167,Dosulepin,0.906162679195404,49,Type_49,The risk or severity of adverse effects can be increased when Pirbuterol is combined with Dosulepin.,49,Type_49,Yes
DB00363,Clozapine,DB09072,Sodium oxybate,1.0,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00866,Alprenolol,DB01359,Penbutolol,0.5376408696174622,54,Type_54,Alprenolol may increase the bradycardic activities of Penbutolol.,60,Type_60,No
DB00643,Mebendazole,DB00794,Primidone,0.8612568974494934,4,Type_4,The metabolism of Primidone can be increased when combined with Mebendazole.,4,Type_4,Yes
DB00458,Imipramine,DB00668,Epinephrine,0.8490099310874939,37,Type_37,Imipramine may decrease the antihypertensive activities of Epinephrine.,37,Type_37,Yes
DB00035,Desmopressin,DB08984,Etofenamate,0.7784155607223511,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Desmopressin.,49,Type_49,No
DB00283,Clemastine,DB01229,Paclitaxel,0.8626545667648315,47,Type_47,The metabolism of Paclitaxel can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00695,Furosemide,DB00812,Phenylbutazone,0.999967098236084,29,Type_29,Furosemide may decrease the diuretic activities of Phenylbutazone.,29,Type_29,Yes
DB00243,Ranolazine,DB01107,Methyprylon,0.985195517539978,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB00588,Fluticasone propionate,0.9967265129089355,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fluticasone propionate.,49,Type_49,Yes
DB00695,Furosemide,DB01396,Digitoxin,0.5536422729492188,82,Type_82,Furosemide may increase the arrhythmogenic activities of Digitoxin.,49,Type_49,No
DB00820,Tadalafil,DB01201,Rifapentine,0.5987272262573242,4,Type_4,The metabolism of Rifapentine can be increased when combined with Tadalafil.,75,Type_75,No
DB00454,Meperidine,DB01351,Amobarbital,0.9676859378814697,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Amobarbital.,16,Type_16,No
DB00476,Duloxetine,DB01615,Aceprometazine,0.9766669273376465,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Aceprometazine.,49,Type_49,Yes
DB01095,Fluvastatin,DB09073,Palbociclib,0.995810866355896,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00683,Midazolam,DB01223,Aminophylline,0.5249193906784058,47,Type_47,The metabolism of Aminophylline can be decreased when combined with Midazolam.,70,Type_70,No
DB00477,Chlorpromazine,DB13874,Enasidenib,0.8938869833946228,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB01357,Mestranol,DB06203,Alogliptin,0.7371201515197754,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Mestranol.,75,Type_75,No
DB00422,Methylphenidate,DB06595,Midostaurin,0.7980626225471497,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00959,Methylprednisolone,DB01283,Lumiracoxib,0.9986869692802429,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Lumiracoxib.,49,Type_49,Yes
DB01072,Atazanavir,DB01120,Gliclazide,0.6832517385482788,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Atazanavir.,70,Type_70,No
DB00187,Esmolol,DB08907,Canagliflozin,0.9748618006706238,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Canagliflozin.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00691,Moexipril,0.9861966967582703,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Moexipril.,49,Type_49,Yes
DB00736,Esomeprazole,DB08881,Vemurafenib,0.6488391757011414,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Esomeprazole.,75,Type_75,Yes
DB01501,Difenoxin,DB06716,Fospropofol,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Difenoxin is combined with Fospropofol.,49,Type_49,Yes
DB00244,Mesalazine,DB00608,Chloroquine,0.7690014839172363,57,Type_57,Mesalazine may increase the nephrotoxic activities of Chloroquine.,57,Type_57,Yes
DB01198,Zopiclone,DB01551,Dihydrocodeine,0.9926618337631226,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Dihydrocodeine.,49,Type_49,Yes
DB00350,Minoxidil,DB00999,Hydrochlorothiazide,0.7696607708930969,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB01136,Carvedilol,0.49090883135795593,47,Type_47,The metabolism of Carvedilol can be decreased when combined with Sulfamethoxazole.,73,Type_73,No
DB00890,Dienestrol,DB08882,Linagliptin,0.9148808121681213,75,Type_75,The serum concentration of Linagliptin can be decreased when it is combined with Dienestrol.,75,Type_75,Yes
DB00220,Nelfinavir,DB00683,Midazolam,0.6814194321632385,47,Type_47,The metabolism of Midazolam can be decreased when combined with Nelfinavir.,73,Type_73,No
DB00206,Reserpine,DB00421,Spironolactone,0.9870888590812683,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Spironolactone.,49,Type_49,Yes
DB00877,Sirolimus,DB01149,Nefazodone,0.9108867049217224,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Sirolimus.,47,Type_47,Yes
DB00413,Pramipexole,DB00964,Apraclonidine,0.9989137649536133,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Apraclonidine.,49,Type_49,Yes
DB01189,Desflurane,DB01621,Pipotiazine,0.9618638753890991,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Pipotiazine.,49,Type_49,Yes
DB01100,Pimozide,DB09128,Brexpiprazole,0.8215322494506836,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Brexpiprazole.,49,Type_49,Yes
DB09048,Netupitant,DB09128,Brexpiprazole,0.9957696199417114,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Netupitant.,73,Type_73,Yes
DB00238,Nevirapine,DB00873,Loteprednol,0.880543053150177,75,Type_75,The serum concentration of Loteprednol can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00801,Halazepam,DB01086,Benzocaine,0.9999945163726807,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Benzocaine.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB01131,Proguanil,0.9685746431350708,47,Type_47,The metabolism of Proguanil can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB01340,Cilazapril,DB09449,"Sodium phosphate, monobasic",0.8399945497512817,57,Type_57,"Cilazapril may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00521,Carteolol,DB01200,Bromocriptine,0.7517991662025452,25,Type_25,Carteolol may increase the atrioventricular blocking (AV block) activities of Bromocriptine.,25,Type_25,Yes
DB00281,Lidocaine,DB01356,Lithium cation,0.7357407808303833,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Lithium cation.,49,Type_49,Yes
DB00697,Tizanidine,DB00806,Pentoxifylline,0.7486394047737122,60,Type_60,Tizanidine may increase the hypotensive activities of Pentoxifylline.,73,Type_73,No
DB00323,Tolcapone,DB09118,Stiripentol,0.9240145683288574,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Stiripentol.,49,Type_49,Yes
DB00612,Bisoprolol,DB06700,Desvenlafaxine,0.796761155128479,73,Type_73,The serum concentration of Desvenlafaxine can be increased when it is combined with Bisoprolol.,73,Type_73,Yes
DB00433,Prochlorperazine,DB01440,gamma-Hydroxybutyric acid,0.9999790191650391,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00869,Dorzolamide,0.8625426888465881,60,Type_60,Chlorthalidone may increase the hypotensive activities of Dorzolamide.,60,Type_60,Yes
DB00802,Alfentanil,DB06767,Ammonium chloride,0.9880895018577576,65,Type_65,Alfentanil may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,65,Type_65,Yes
DB01210,Levobunolol,DB13167,Alclofenac,0.9989601373672485,37,Type_37,Levobunolol may decrease the antihypertensive activities of Alclofenac.,37,Type_37,Yes
DB01044,Gatifloxacin,DB01390,Sodium bicarbonate,0.9767638444900513,67,Type_67,Gatifloxacin can cause a decrease in the absorption of Sodium bicarbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00475,Chlordiazepoxide,DB00490,Buspirone,0.8967214822769165,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Buspirone.,49,Type_49,Yes
DB00207,Azithromycin,DB00946,Phenprocoumon,0.3558485805988312,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Azithromycin.,73,Type_73,No
DB00625,Efavirenz,DB09080,Olodaterol,0.6059591174125671,47,Type_47,The metabolism of Olodaterol can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB01045,Rifampicin,DB01120,Gliclazide,0.8157863020896912,4,Type_4,The metabolism of Gliclazide can be increased when combined with Rifampicin.,75,Type_75,No
DB00006,Bivalirudin,DB11268,Protocatechualdehyde,0.9939356446266174,6,Type_6,Bivalirudin may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00371,Meprobamate,DB00842,Oxazepam,0.9943467974662781,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Oxazepam.,49,Type_49,Yes
DB00820,Tadalafil,DB02703,Fusidic acid,0.999850869178772,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Tadalafil.,73,Type_73,Yes
DB00243,Ranolazine,DB00497,Oxycodone,0.7097204327583313,47,Type_47,The metabolism of Oxycodone can be decreased when combined with Ranolazine.,49,Type_49,No
DB00498,Phenindione,DB01357,Mestranol,0.9911483526229858,12,Type_12,Phenindione may decrease the anticoagulant activities of Mestranol.,12,Type_12,Yes
DB00543,Amoxapine,DB01151,Desipramine,0.6952109932899475,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Desipramine.,49,Type_49,Yes
DB00589,Lisuride,DB00624,Testosterone,0.4493521749973297,73,Type_73,The serum concentration of Testosterone can be increased when it is combined with Lisuride.,49,Type_49,No
DB00393,Nimodipine,DB01359,Penbutolol,0.5264468789100647,60,Type_60,Nimodipine may increase the hypotensive activities of Penbutolol.,49,Type_49,No
DB00281,Lidocaine,DB00653,Magnesium sulfate,0.6638641953468323,16,Type_16,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00270,Isradipine,DB09101,Elvitegravir,0.9766206741333008,47,Type_47,The metabolism of Elvitegravir can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00257,Clotrimazole,DB08903,Bedaquiline,0.4714350700378418,73,Type_73,The serum concentration of Bedaquiline can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00829,Diazepam,DB01356,Lithium cation,0.881254255771637,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Lithium cation.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01256,Retapamulin,0.9796594381332397,47,Type_47,The metabolism of Retapamulin can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01078,Deslanoside,DB01339,Vecuronium,0.9968602657318115,82,Type_82,Deslanoside may increase the arrhythmogenic activities of Vecuronium.,82,Type_82,Yes
DB00214,Torasemide,DB01009,Ketoprofen,0.9997077584266663,29,Type_29,Torasemide may decrease the diuretic activities of Ketoprofen.,29,Type_29,Yes
DB01120,Gliclazide,DB01395,Drospirenone,0.9388506412506104,70,Type_70,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Gliclazide.,70,Type_70,Yes
DB00091,Cyclosporine,DB00845,Clofazimine,0.5884600877761841,47,Type_47,The metabolism of Clofazimine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00849,Methylphenobarbital,DB01026,Ketoconazole,0.6947454810142517,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Methylphenobarbital.,47,Type_47,Yes
DB05351,Dexlansoprazole,DB06414,Etravirine,0.8377121090888977,47,Type_47,The metabolism of Etravirine can be decreased when combined with Dexlansoprazole.,47,Type_47,Yes
DB00458,Imipramine,DB00706,Tamsulosin,0.4315660893917084,73,Type_73,The serum concentration of Tamsulosin can be increased when it is combined with Imipramine.,47,Type_47,No
DB00248,Cabergoline,DB01601,Lopinavir,0.7967115044593811,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Cabergoline.,47,Type_47,Yes
DB00188,Bortezomib,DB00738,Pentamidine,0.5232711434364319,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB01167,Itraconazole,DB01424,Aminophenazone,0.8435075879096985,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00270,Isradipine,DB04845,Ixabepilone,0.8533477187156677,47,Type_47,The metabolism of Ixabepilone can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00408,Loxapine,DB01624,Zuclopenthixol,0.9435980916023254,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Zuclopenthixol.,49,Type_49,Yes
DB01263,Posaconazole,DB06292,Dapagliflozin,0.8754180669784546,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00508,Triflupromazine,DB00960,Pindolol,0.9699028134346008,60,Type_60,Triflupromazine may increase the hypotensive activities of Pindolol.,60,Type_60,Yes
DB01089,Deserpidine,DB09220,Nicorandil,1.0,60,Type_60,Deserpidine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB01242,Clomipramine,DB09039,Eliglustat,0.43456822633743286,20,Type_20,Clomipramine may increase the QTc-prolonging activities of Eliglustat.,73,Type_73,No
DB00310,Chlorthalidone,DB00670,Pirenzepine,0.9856463074684143,73,Type_73,The serum concentration of Pirenzepine can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB00852,Pseudoephedrine,DB04946,Iloperidone,0.9955854415893555,61,Type_61,Pseudoephedrine may decrease the stimulatory activities of Iloperidone.,61,Type_61,Yes
DB01356,Lithium cation,DB09342,Propoxycaine,0.9999189376831055,49,Type_49,The risk or severity of adverse effects can be increased when Lithium cation is combined with Propoxycaine.,49,Type_49,Yes
DB00492,Fosinopril,DB01023,Felodipine,0.6448789238929749,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Felodipine.,49,Type_49,Yes
DB00175,Pravastatin,DB08882,Linagliptin,0.698032557964325,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01021,Trichlormethiazide,DB02709,Resveratrol,0.9909723997116089,70,Type_70,The therapeutic efficacy of Resveratrol can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB00458,Imipramine,DB00983,Formoterol,0.5227148532867432,20,Type_20,Imipramine may increase the QTc-prolonging activities of Formoterol.,47,Type_47,No
DB00537,Ciprofloxacin,DB09082,Vilanterol,0.9829720854759216,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Vilanterol.,20,Type_20,Yes
DB00241,Butalbital,DB06716,Fospropofol,0.9999986886978149,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Fospropofol.,49,Type_49,Yes
DB00318,Codeine,DB00370,Mirtazapine,0.978472113609314,16,Type_16,Codeine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,16,Type_16,Yes
DB01590,Everolimus,DB02703,Fusidic acid,0.9993996620178223,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB01228,Encainide,DB01264,Darunavir,0.9784325361251831,47,Type_47,The metabolism of Darunavir can be decreased when combined with Encainide.,73,Type_73,No
DB00808,Indapamide,DB09235,Efonidipine,0.6261827945709229,60,Type_60,Indapamide may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00678,Losartan,DB00753,Isoflurane,0.8543538451194763,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Isoflurane.,49,Type_49,Yes
DB00443,Betamethasone,DB09084,Benzydamine,0.9998517036437988,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Benzydamine.,49,Type_49,Yes
DB00396,Progesterone,DB01201,Rifapentine,0.9410567283630371,4,Type_4,The metabolism of Rifapentine can be increased when combined with Progesterone.,4,Type_4,Yes
DB00497,Oxycodone,DB00875,Flupentixol,0.9825740456581116,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Flupentixol.,49,Type_49,Yes
DB03128,Acetylcholine,DB04868,Nilotinib,0.9397307634353638,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Acetylcholine.,47,Type_47,Yes
DB00697,Tizanidine,DB08903,Bedaquiline,0.9914524555206299,20,Type_20,Tizanidine may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00635,Prednisone,DB09275,Bismuth subcitrate potassium,0.998051643371582,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Prednisone.,3,Type_3,Yes
DB01189,Desflurane,DB08865,Crizotinib,0.9749441742897034,20,Type_20,Desflurane may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB06267,Udenafil,DB09054,Idelalisib,0.5929098129272461,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Udenafil.,47,Type_47,Yes
DB01012,Cinacalcet,DB08868,Fingolimod,0.7753573060035706,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00203,Sildenafil,DB00401,Nisoldipine,0.5170503258705139,10,Type_10,Sildenafil may increase the antihypertensive activities of Nisoldipine.,10,Type_10,Yes
DB00494,Entacapone,DB00802,Alfentanil,0.9989879727363586,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Alfentanil.,49,Type_49,Yes
DB00961,Mepivacaine,DB01437,Glutethimide,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Glutethimide.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB01016,Glyburide,0.6736879944801331,9,Type_9,Aminosalicylic acid may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00412,Rosiglitazone,DB00468,Quinine,0.790007472038269,47,Type_47,The metabolism of Quinine can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00749,Etodolac,DB00817,Rosoxacin,0.9353260397911072,27,Type_27,Etodolac may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB00699,Nicergoline,DB00989,Rivastigmine,0.9926230907440186,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Rivastigmine.,49,Type_49,Yes
DB00835,Brompheniramine,DB01567,Fludiazepam,0.9998536109924316,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Fludiazepam.,49,Type_49,Yes
DB01325,Quinethazone,DB01355,Hexobarbital,0.6672613620758057,30,Type_30,Quinethazone may increase the orthostatic hypotensive activities of Hexobarbital.,30,Type_30,Yes
DB00226,Guanadrel,DB01247,Isocarboxazid,0.9999862909317017,60,Type_60,Guanadrel may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB00834,Mifepristone,DB01149,Nefazodone,0.9522257447242737,73,Type_73,The serum concentration of Nefazodone can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00800,Fenoldopam,DB01214,Metipranolol,0.5264878869056702,60,Type_60,Fenoldopam may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00390,Digoxin,DB00665,Nilutamide,0.9524616599082947,58,Type_58,Digoxin may decrease the cardiotoxic activities of Nilutamide.,58,Type_58,Yes
DB00402,Eszopiclone,DB00771,Clidinium,0.9989476799964905,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clidinium.,49,Type_49,Yes
DB01017,Minocycline,DB06153,Pizotifen,0.9338860511779785,49,Type_49,The risk or severity of adverse effects can be increased when Minocycline is combined with Pizotifen.,16,Type_16,No
DB00228,Enflurane,DB01114,Chlorpheniramine,0.997425377368927,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Chlorpheniramine.,49,Type_49,Yes
DB00889,Granisetron,DB01591,Solifenacin,0.4516218602657318,20,Type_20,Granisetron may increase the QTc-prolonging activities of Solifenacin.,20,Type_20,Yes
DB00919,Spectinomycin,DB01337,Pancuronium,0.9996746778488159,40,Type_40,Spectinomycin may increase the respiratory depressant activities of Pancuronium.,40,Type_40,Yes
DB01232,Saquinavir,DB09128,Brexpiprazole,0.8674851059913635,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00395,Carisoprodol,DB00985,Dimenhydrinate,0.9999768733978271,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Dimenhydrinate.,49,Type_49,Yes
DB00679,Thioridazine,DB00850,Perphenazine,0.7283434271812439,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Perphenazine.,73,Type_73,No
DB00277,Theophylline,DB00584,Enalapril,0.7195045948028564,75,Type_75,The serum concentration of Enalapril can be decreased when it is combined with Theophylline.,75,Type_75,Yes
DB00373,Timolol,DB01403,Methotrimeprazine,0.7192042469978333,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Timolol.,47,Type_47,Yes
DB00751,Epinastine,DB09073,Palbociclib,0.9944626688957214,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Epinastine.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB01075,Diphenhydramine,0.9734092354774475,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Cyclophosphamide.,47,Type_47,Yes
DB00975,Dipyridamole,DB09236,Lacidipine,0.9175319075584412,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Lacidipine.,49,Type_49,Yes
DB01081,Diphenoxylate,DB08872,Gabapentin enacarbil,0.9991258978843689,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00908,Quinidine,DB09280,Lumacaftor,0.7742980718612671,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Quinidine.,73,Type_73,No
DB00273,Topiramate,DB09076,Umeclidinium,0.681808590888977,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Topiramate.,49,Type_49,No
DB00482,Celecoxib,DB06595,Midostaurin,0.989734411239624,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00814,Meloxicam,DB08881,Vemurafenib,0.5306139588356018,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Meloxicam.,75,Type_75,No
DB00349,Clobazam,DB00567,Cephalexin,0.9835519194602966,47,Type_47,The metabolism of Cephalexin can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00246,Ziprasidone,DB00925,Phenoxybenzamine,0.7733566164970398,47,Type_47,The metabolism of Phenoxybenzamine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00503,Ritonavir,DB01175,Escitalopram,0.7445032000541687,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Ritonavir.,20,Type_20,No
DB00091,Cyclosporine,DB01598,Imipenem,0.5757578611373901,73,Type_73,The serum concentration of Imipenem can be increased when it is combined with Cyclosporine.,35,Type_35,No
DB09104,Magnesium hydroxide,DB09267,Strontium ranelate,0.9999511241912842,75,Type_75,The serum concentration of Strontium ranelate can be decreased when it is combined with Magnesium hydroxide.,75,Type_75,Yes
DB01303,Oxtriphylline,DB06595,Midostaurin,0.7916564345359802,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Oxtriphylline.,47,Type_47,Yes
DB00313,Valproic acid,DB00921,Buprenorphine,0.999326229095459,16,Type_16,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00679,Thioridazine,DB00889,Granisetron,0.9405179023742676,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Granisetron.,73,Type_73,No
DB00907,Cocaine,DB01621,Pipotiazine,0.6369909048080444,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Pipotiazine.,47,Type_47,No
DB01018,Guanfacine,DB06791,Lanreotide,0.8998529314994812,54,Type_54,Guanfacine may increase the bradycardic activities of Lanreotide.,54,Type_54,Yes
DB00486,Nabilone,DB06216,Asenapine,0.9986398816108704,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,16,Type_16,Yes
DB00188,Bortezomib,DB08439,Parecoxib,0.9434217214584351,47,Type_47,The metabolism of Parecoxib can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01009,Ketoprofen,DB01401,Choline magnesium trisalicylate,0.9973077774047852,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00932,Tipranavir,DB01241,Gemfibrozil,0.8425019979476929,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00380,Dexrazoxane,DB06772,Cabazitaxel,0.9959618449211121,49,Type_49,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Cabazitaxel.,49,Type_49,Yes
DB00525,Tolnaftate,DB00661,Verapamil,0.49757227301597595,47,Type_47,The metabolism of Verapamil can be decreased when combined with Tolnaftate.,49,Type_49,No
DB00289,Atomoxetine,DB00933,Mesoridazine,0.768021821975708,47,Type_47,The metabolism of Mesoridazine can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00333,Methadone,DB00988,Dopamine,0.933607280254364,47,Type_47,The metabolism of Dopamine can be decreased when combined with Methadone.,47,Type_47,Yes
DB00307,Bexarotene,DB09167,Dosulepin,0.8830211162567139,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB06713,Norelgestromin,DB09065,Cobicistat,0.6880614161491394,75,Type_75,The serum concentration of Cobicistat can be decreased when it is combined with Norelgestromin.,73,Type_73,No
DB00268,Ropinirole,DB01080,Vigabatrin,0.8168432712554932,32,Type_32,Ropinirole may increase the sedative activities of Vigabatrin.,32,Type_32,Yes
DB00193,Tramadol,DB09117,Paraldehyde,0.9999570846557617,16,Type_16,Tramadol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00908,Quinidine,DB09039,Eliglustat,0.514616072177887,20,Type_20,Quinidine may increase the QTc-prolonging activities of Eliglustat.,73,Type_73,No
DB00543,Amoxapine,DB00871,Terbutaline,0.8530857563018799,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Terbutaline.,49,Type_49,Yes
DB00281,Lidocaine,DB00908,Quinidine,0.9482396841049194,47,Type_47,The metabolism of Quinidine can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00312,Pentobarbital,DB00768,Olopatadine,0.761979877948761,4,Type_4,The metabolism of Olopatadine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00710,Ibandronate,DB01184,Domperidone,0.9952907562255859,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Domperidone.,20,Type_20,Yes
DB00712,Flurbiprofen,DB00774,Hydroflumethiazide,0.9962372779846191,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB00549,Zafirlukast,DB06702,Fesoterodine,0.9116073250770569,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Zafirlukast.,77,Type_77,Yes
DB00470,Dronabinol,DB13025,Tiapride,0.9992682337760925,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Tiapride.,16,Type_16,Yes
DB00715,Paroxetine,DB12332,Rucaparib,0.8576619625091553,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00440,Trimethoprim,DB00489,Sotalol,0.4223655164241791,49,Type_49,The risk or severity of adverse effects can be increased when Trimethoprim is combined with Sotalol.,20,Type_20,No
DB00850,Perphenazine,DB00921,Buprenorphine,0.9999033212661743,16,Type_16,Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00296,Ropivacaine,DB00857,Terbinafine,0.7889935374259949,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB01587,Ketazolam,DB01589,Quazepam,0.9743162989616394,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Quazepam.,49,Type_49,Yes
DB01104,Sertraline,DB06626,Axitinib,0.46861201524734497,73,Type_73,The serum concentration of Axitinib can be increased when it is combined with Sertraline.,47,Type_47,No
DB00353,Methylergometrine,DB00549,Zafirlukast,0.7829329371452332,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Zafirlukast.,49,Type_49,Yes
DB00334,Olanzapine,DB13323,Trichloroethylene,0.9995988011360168,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Trichloroethylene.,49,Type_49,Yes
DB00484,Brimonidine,DB09244,Pirlindole,0.9061907529830933,49,Type_49,The risk or severity of adverse effects can be increased when Brimonidine is combined with Pirlindole.,49,Type_49,Yes
DB00887,Bumetanide,DB06262,Droxidopa,0.9971743822097778,83,Type_83,Bumetanide may increase the hypokalemic activities of Droxidopa.,83,Type_83,Yes
DB09039,Eliglustat,DB09065,Cobicistat,0.6290930509567261,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Eliglustat.,73,Type_73,Yes
DB00457,Prazosin,DB09280,Lumacaftor,0.7378953099250793,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Prazosin.,75,Type_75,No
DB00684,Tobramycin,DB00712,Flurbiprofen,0.9999428987503052,72,Type_72,Tobramycin may decrease the excretion rate of Flurbiprofen which could result in a higher serum level.,72,Type_72,Yes
DB01026,Ketoconazole,DB13179,Troleandomycin,0.823712170124054,47,Type_47,The metabolism of Troleandomycin can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00482,Celecoxib,DB01600,Tiaprofenic acid,0.9514129757881165,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Tiaprofenic acid.,49,Type_49,Yes
DB09042,Tedizolid phosphate,DB09352,Hydroxyamphetamine,0.999259889125824,71,Type_71,Tedizolid phosphate may increase the hypertensive activities of Hydroxyamphetamine.,71,Type_71,Yes
DB01589,Quazepam,DB09034,Suvorexant,0.9850173592567444,16,Type_16,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00737,Meclizine,DB04946,Iloperidone,0.9944899082183838,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Iloperidone.,49,Type_49,Yes
DB00477,Chlorpromazine,DB09027,Ledipasvir,0.646506667137146,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Chlorpromazine.,73,Type_73,Yes
DB00482,Celecoxib,DB01088,Iloprost,0.7380862236022949,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Celecoxib.,70,Type_70,Yes
DB00224,Indinavir,DB04946,Iloperidone,0.6371142864227295,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Indinavir.,77,Type_77,No
DB00469,Tenoxicam,DB00686,Pentosan polysulfate,0.9757669568061829,6,Type_6,Tenoxicam may increase the anticoagulant activities of Pentosan polysulfate.,6,Type_6,Yes
DB04871,Lorcaserin,DB06267,Udenafil,0.9763486385345459,47,Type_47,The metabolism of Udenafil can be decreased when combined with Lorcaserin.,49,Type_49,No
DB01095,Fluvastatin,DB01128,Bicalutamide,0.6840828657150269,73,Type_73,The serum concentration of Bicalutamide can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00283,Clemastine,DB00381,Amlodipine,0.9181051254272461,47,Type_47,The metabolism of Amlodipine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01167,Itraconazole,DB09065,Cobicistat,0.8293342590332031,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB04840,Debrisoquine,DB06268,Sitaxentan,0.9949951171875,60,Type_60,Debrisoquine may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB01340,Cilazapril,DB08984,Etofenamate,0.9580863118171692,49,Type_49,The risk or severity of adverse effects can be increased when Cilazapril is combined with Etofenamate.,49,Type_49,Yes
DB00614,Furazolidone,DB01275,Hydralazine,0.992300271987915,60,Type_60,Furazolidone may increase the hypotensive activities of Hydralazine.,60,Type_60,Yes
DB01151,Desipramine,DB08881,Vemurafenib,0.5037834644317627,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00424,Hyoscyamine,DB01081,Diphenoxylate,0.9999216794967651,49,Type_49,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Diphenoxylate.,49,Type_49,Yes
DB00302,Tranexamic acid,DB00783,Estradiol,1.0,81,Type_81,Tranexamic acid may increase the thrombogenic activities of Estradiol.,81,Type_81,Yes
DB00487,Pefloxacin,DB01410,Ciclesonide,0.8993451595306396,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Ciclesonide.,49,Type_49,Yes
DB00325,Nitroprusside,DB00964,Apraclonidine,0.9910858273506165,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Apraclonidine.,49,Type_49,Yes
DB01037,Selegiline,DB09065,Cobicistat,0.7407697439193726,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Selegiline.,47,Type_47,No
DB00203,Sildenafil,DB01174,Phenobarbital,0.9030274152755737,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Sildenafil.,4,Type_4,Yes
DB00208,Ticlopidine,DB00783,Estradiol,0.7999107241630554,47,Type_47,The metabolism of Estradiol can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00338,Omeprazole,DB01118,Amiodarone,0.8761459589004517,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00006,Bivalirudin,DB01211,Clarithromycin,0.7484238743782043,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Bivalirudin.,70,Type_70,No
DB01200,Bromocriptine,DB08909,Glycerol phenylbutyrate,0.7834448218345642,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Glycerol phenylbutyrate.,49,Type_49,Yes
DB00334,Olanzapine,DB00834,Mifepristone,0.9122903943061829,20,Type_20,Olanzapine may increase the QTc-prolonging activities of Mifepristone.,20,Type_20,Yes
DB00661,Verapamil,DB01380,Cortisone acetate,0.9119818806648254,47,Type_47,The metabolism of Cortisone acetate can be decreased when combined with Verapamil.,47,Type_47,Yes
DB01138,Sulfinpyrazone,DB01259,Lapatinib,0.8825923800468445,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Sulfinpyrazone.,47,Type_47,Yes
DB00283,Clemastine,DB00427,Triprolidine,0.833611786365509,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Triprolidine.,49,Type_49,Yes
DB00238,Nevirapine,DB06786,Halcinonide,0.8870294094085693,75,Type_75,The serum concentration of Halcinonide can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB01264,Darunavir,DB08865,Crizotinib,0.7136756777763367,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Darunavir.,73,Type_73,No
DB00297,Bupivacaine,DB00972,Azelastine,0.776244580745697,16,Type_16,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00433,Prochlorperazine,DB06717,Fosaprepitant,0.8247270584106445,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Prochlorperazine.,73,Type_73,Yes
DB00312,Pentobarbital,DB09345,Pramocaine,0.9999333620071411,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Pramocaine.,49,Type_49,Yes
DB01008,Busulfan,DB08868,Fingolimod,0.9778847098350525,34,Type_34,Busulfan may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00710,Ibandronate,DB09281,Magnesium trisilicate,0.9849951863288879,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Ibandronate.,75,Type_75,Yes
DB00199,Erythromycin,DB06742,Ambroxol,0.9717996716499329,47,Type_47,The metabolism of Ambroxol can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00933,Mesoridazine,DB01136,Carvedilol,0.7358074188232422,60,Type_60,Mesoridazine may increase the hypotensive activities of Carvedilol.,60,Type_60,Yes
DB00827,Cinoxacin,DB09084,Benzydamine,0.9945850968360901,27,Type_27,Cinoxacin may increase the neuroexcitatory activities of Benzydamine.,27,Type_27,Yes
DB06594,Agomelatine,DB09009,Articaine,0.9999991655349731,49,Type_49,The risk or severity of adverse effects can be increased when Agomelatine is combined with Articaine.,49,Type_49,Yes
DB00794,Primidone,DB06781,Difluprednate,0.9918826222419739,75,Type_75,The serum concentration of Difluprednate can be decreased when it is combined with Primidone.,75,Type_75,Yes
DB00353,Methylergometrine,DB00629,Guanabenz,0.806321918964386,71,Type_71,Methylergometrine may increase the hypertensive activities of Guanabenz.,71,Type_71,Yes
DB00898,Ethanol,DB01367,Rasagiline,0.9391925930976868,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Rasagiline.,49,Type_49,Yes
DB00257,Clotrimazole,DB00539,Toremifene,0.5357785820960999,47,Type_47,The metabolism of Toremifene can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB06626,Axitinib,DB09065,Cobicistat,0.8265805244445801,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Axitinib.,73,Type_73,Yes
DB00678,Losartan,DB04552,Niflumic acid,0.9586395621299744,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Niflumic acid.,49,Type_49,Yes
DB00136,Calcitriol,DB06781,Difluprednate,0.8781144618988037,70,Type_70,The therapeutic efficacy of Difluprednate can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB01567,Fludiazepam,DB09166,Etizolam,0.9997479319572449,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Etizolam.,49,Type_49,Yes
DB00238,Nevirapine,DB00384,Triamterene,0.4952734708786011,73,Type_73,The serum concentration of Triamterene can be increased when it is combined with Nevirapine.,47,Type_47,No
DB01149,Nefazodone,DB09054,Idelalisib,0.5363270044326782,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Nefazodone.,73,Type_73,No
DB00906,Tiagabine,DB09224,Melperone,0.9996225833892822,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Melperone.,49,Type_49,Yes
DB00243,Ranolazine,DB00334,Olanzapine,0.6335094571113586,73,Type_73,The serum concentration of Olanzapine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB05271,Rotigotine,DB08907,Canagliflozin,0.8670274615287781,49,Type_49,The risk or severity of adverse effects can be increased when Rotigotine is combined with Canagliflozin.,49,Type_49,Yes
DB00275,Olmesartan,DB09286,Pipamperone,0.9207037091255188,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Pipamperone.,49,Type_49,Yes
DB00564,Carbamazepine,DB13025,Tiapride,0.9665907621383667,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tiapride.,49,Type_49,Yes
DB00390,Digoxin,DB01158,Bretylium,0.9879140257835388,54,Type_54,Digoxin may increase the bradycardic activities of Bretylium.,54,Type_54,Yes
DB00224,Indinavir,DB00317,Gefitinib,0.7422256469726562,47,Type_47,The metabolism of Gefitinib can be decreased when combined with Indinavir.,47,Type_47,Yes
DB04845,Ixabepilone,DB08912,Dabrafenib,0.9447863698005676,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Ixabepilone.,75,Type_75,Yes
DB01345,Potassium cation,DB01452,Diamorphine,0.9944631457328796,49,Type_49,The risk or severity of adverse effects can be increased when Potassium cation is combined with Diamorphine.,49,Type_49,Yes
DB00474,Methohexital,DB13025,Tiapride,0.9990119934082031,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Tiapride.,49,Type_49,Yes
DB06694,Xylometazoline,DB13142,Calcium glubionate anhydrous,0.608902096748352,70,Type_70,The therapeutic efficacy of Calcium glubionate anhydrous can be decreased when used in combination with Xylometazoline.,70,Type_70,Yes
DB00598,Labetalol,DB00869,Dorzolamide,0.9946390986442566,60,Type_60,Labetalol may increase the hypotensive activities of Dorzolamide.,60,Type_60,Yes
DB00875,Flupentixol,DB01178,Chlormezanone,0.9996626377105713,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Chlormezanone.,49,Type_49,Yes
DB00324,Fluorometholone,DB06335,Saxagliptin,0.8678815364837646,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Fluorometholone.,75,Type_75,No
DB00653,Magnesium sulfate,DB01161,Chloroprocaine,0.9855676889419556,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.,16,Type_16,Yes
DB00450,Droperidol,DB01433,Methadyl acetate,0.9984273910522461,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate.,16,Type_16,Yes
DB00925,Phenoxybenzamine,DB09238,Manidipine,0.9702826738357544,60,Type_60,Phenoxybenzamine may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00384,Triamterene,DB01250,Olsalazine,0.9966338276863098,37,Type_37,Triamterene may decrease the antihypertensive activities of Olsalazine.,37,Type_37,Yes
DB00864,Tacrolimus,DB08882,Linagliptin,0.42376628518104553,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Tacrolimus.,75,Type_75,No
DB00206,Reserpine,DB00722,Lisinopril,0.8694937825202942,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Lisinopril.,49,Type_49,Yes
DB00570,Vinblastine,DB01590,Everolimus,0.90427166223526,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Vinblastine.,73,Type_73,Yes
DB03615,Ribostamycin,DB06802,Nepafenac,0.9999969005584717,72,Type_72,Ribostamycin may decrease the excretion rate of Nepafenac which could result in a higher serum level.,72,Type_72,Yes
DB00246,Ziprasidone,DB00491,Miglitol,0.9408039450645447,70,Type_70,The therapeutic efficacy of Miglitol can be decreased when used in combination with Ziprasidone.,70,Type_70,Yes
DB01175,Escitalopram,DB02546,Vorinostat,0.9495949745178223,20,Type_20,Escitalopram may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB00590,Doxazosin,DB09027,Ledipasvir,0.8697910904884338,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Doxazosin.,73,Type_73,Yes
DB00602,Ivermectin,DB01394,Colchicine,0.6479448676109314,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Ivermectin.,73,Type_73,Yes
DB00822,Disulfiram,DB00834,Mifepristone,0.8919121026992798,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Disulfiram.,73,Type_73,Yes
DB05812,Abiraterone,DB06148,Mianserin,0.49957889318466187,73,Type_73,The serum concentration of Mianserin can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00250,Dapsone,DB08933,Luliconazole,0.9552080035209656,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Dapsone.,73,Type_73,Yes
DB06264,Tolperisone,DB06290,Simeprevir,0.9740361571311951,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Tolperisone.,47,Type_47,No
DB00564,Carbamazepine,DB00999,Hydrochlorothiazide,0.47247475385665894,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB01156,Bupropion,DB04946,Iloperidone,0.5435305237770081,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Bupropion.,77,Type_77,No
DB00688,Mycophenolate mofetil,DB00694,Daunorubicin,0.9471105933189392,72,Type_72,Mycophenolate mofetil may decrease the excretion rate of Daunorubicin which could result in a higher serum level.,72,Type_72,Yes
DB00498,Phenindione,DB00916,Metronidazole,0.8494430780410767,73,Type_73,The serum concentration of Metronidazole can be increased when it is combined with Phenindione.,73,Type_73,Yes
DB00872,Conivaptan,DB09078,Lenvatinib,0.9693070650100708,73,Type_73,The serum concentration of Lenvatinib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00181,Baclofen,DB01104,Sertraline,0.9719547629356384,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Sertraline.,49,Type_49,Yes
DB00254,Doxycycline,DB11574,Elbasvir,0.9822694063186646,47,Type_47,The metabolism of Elbasvir can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00423,Methocarbamol,DB01623,Thiothixene,0.9888794422149658,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Thiothixene.,49,Type_49,Yes
DB00323,Tolcapone,DB00420,Promazine,0.9914088845252991,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Promazine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01764,Dalfopristin,0.9640892148017883,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dalfopristin.,49,Type_49,Yes
DB00524,Metolazone,DB11609,Normethadone,0.9996299743652344,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Normethadone.,49,Type_49,Yes
DB00425,Zolpidem,DB01080,Vigabatrin,0.9992929697036743,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,16,Type_16,Yes
DB00710,Ibandronate,DB04844,Tetrabenazine,0.999942421913147,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB06288,Amisulpride,DB09017,Brotizolam,0.9999712705612183,49,Type_49,The risk or severity of adverse effects can be increased when Amisulpride is combined with Brotizolam.,49,Type_49,Yes
DB01045,Rifampicin,DB09074,Olaparib,0.43542593717575073,75,Type_75,The serum concentration of Olaparib can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00177,Valsartan,DB00335,Atenolol,0.8957880139350891,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Atenolol.,49,Type_49,Yes
DB01126,Dutasteride,DB08873,Boceprevir,0.825951099395752,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Dutasteride.,73,Type_73,No
DB00475,Chlordiazepoxide,DB11148,Butamben,0.9999983310699463,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Butamben.,49,Type_49,Yes
DB00582,Voriconazole,DB00951,Isoniazid,0.5580533146858215,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00668,Epinephrine,DB09038,Empagliflozin,0.835783839225769,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Epinephrine.,70,Type_70,Yes
DB01100,Pimozide,DB01174,Phenobarbital,0.6131998896598816,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Pimozide.,4,Type_4,Yes
DB00313,Valproic acid,DB09280,Lumacaftor,0.6613640189170837,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Valproic acid.,75,Type_75,Yes
DB00340,Metixene,DB00424,Hyoscyamine,0.9996652603149414,49,Type_49,The risk or severity of adverse effects can be increased when Metixene is combined with Hyoscyamine.,49,Type_49,Yes
DB00862,Vardenafil,DB12267,Brigatinib,0.6393118500709534,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Vardenafil.,75,Type_75,No
DB00169,Cholecalciferol,DB00289,Atomoxetine,0.9722943902015686,47,Type_47,The metabolism of Atomoxetine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00959,Methylprednisolone,DB09220,Nicorandil,0.9757399559020996,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Nicorandil.,49,Type_49,Yes
DB00582,Voriconazole,DB01128,Bicalutamide,0.8224449753761292,47,Type_47,The metabolism of Bicalutamide can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00606,Cyclothiazide,DB09449,"Sodium phosphate, monobasic",0.994845986366272,57,Type_57,"Cyclothiazide may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00182,Amphetamine,DB00491,Miglitol,0.990630567073822,9,Type_9,Amphetamine may increase the hypoglycemic activities of Miglitol.,9,Type_9,Yes
DB06616,Bosutinib,DB09104,Magnesium hydroxide,0.658328115940094,75,Type_75,The serum concentration of Magnesium hydroxide can be decreased when it is combined with Bosutinib.,75,Type_75,Yes
DB00458,Imipramine,DB04948,Lofexidine,0.5804007053375244,37,Type_37,Imipramine may decrease the antihypertensive activities of Lofexidine.,37,Type_37,Yes
DB06228,Rivaroxaban,DB09084,Benzydamine,0.9623775482177734,6,Type_6,Rivaroxaban may increase the anticoagulant activities of Benzydamine.,6,Type_6,Yes
DB00547,Desoximetasone,DB06412,Oxymetholone,0.9900649189949036,74,Type_74,Desoximetasone may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB01041,Thalidomide,DB01193,Acebutolol,0.6187575459480286,49,Type_49,The risk or severity of adverse effects can be increased when Thalidomide is combined with Acebutolol.,49,Type_49,Yes
DB00649,Stavudine,DB00811,Ribavirin,0.5948609113693237,73,Type_73,The serum concentration of Ribavirin can be increased when it is combined with Stavudine.,80,Type_80,No
DB04953,Ezogabine,DB09071,Tasimelteon,0.9928648471832275,49,Type_49,The risk or severity of adverse effects can be increased when Ezogabine is combined with Tasimelteon.,49,Type_49,Yes
DB00321,Amitriptyline,DB08883,Perampanel,0.974044680595398,16,Type_16,Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00543,Amoxapine,DB01149,Nefazodone,0.3662082850933075,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Nefazodone.,49,Type_49,Yes
DB00821,Carprofen,DB13783,Acemetacin,0.9665815830230713,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Acemetacin.,49,Type_49,Yes
DB00899,Remifentanil,DB01229,Paclitaxel,0.999548614025116,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Paclitaxel.,49,Type_49,Yes
DB00420,Promazine,DB01403,Methotrimeprazine,0.902687668800354,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00827,Cinoxacin,DB01628,Etoricoxib,0.9973011612892151,27,Type_27,Cinoxacin may increase the neuroexcitatory activities of Etoricoxib.,27,Type_27,Yes
DB00381,Amlodipine,DB09270,Ubidecarenone,0.8400269150733948,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Amlodipine.,73,Type_73,Yes
DB00203,Sildenafil,DB01198,Zopiclone,0.9126039147377014,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Sildenafil.,73,Type_73,No
DB00592,Piperazine,DB09167,Dosulepin,0.8352494239807129,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Piperazine.,47,Type_47,Yes
DB00268,Ropinirole,DB09039,Eliglustat,0.8931742906570435,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Ropinirole.,73,Type_73,No
DB00810,Biperiden,DB08916,Afatinib,0.3780083656311035,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Biperiden.,73,Type_73,Yes
DB01029,Irbesartan,DB01357,Mestranol,0.7199788093566895,47,Type_47,The metabolism of Mestranol can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00808,Indapamide,DB00972,Azelastine,0.9909049868583679,70,Type_70,The therapeutic efficacy of Azelastine can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00771,Clidinium,DB01075,Diphenhydramine,0.9934940934181213,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Diphenhydramine.,49,Type_49,Yes
DB00321,Amitriptyline,DB00454,Meperidine,0.7915182709693909,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Meperidine.,49,Type_49,Yes
DB00458,Imipramine,DB00737,Meclizine,0.9949937462806702,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Meclizine.,49,Type_49,Yes
DB01099,Flucytosine,DB06414,Etravirine,0.5693240165710449,47,Type_47,The metabolism of Etravirine can be decreased when combined with Flucytosine.,73,Type_73,No
DB00834,Mifepristone,DB09389,Norgestrel,0.6012521982192993,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Mifepristone.,73,Type_73,No
DB01215,Estazolam,DB01595,Nitrazepam,0.9955863952636719,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Nitrazepam.,49,Type_49,Yes
DB01204,Mitoxantrone,DB06772,Cabazitaxel,0.9733553528785706,49,Type_49,The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cabazitaxel.,49,Type_49,Yes
DB00266,Dicoumarol,DB00735,Naftifine,0.9991378784179688,6,Type_6,Dicoumarol may increase the anticoagulant activities of Naftifine.,6,Type_6,Yes
DB00543,Amoxapine,DB00599,Thiopental,0.4939801096916199,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Thiopental.,4,Type_4,No
DB00573,Fenoprofen,DB01177,Idarubicin,0.9995297193527222,72,Type_72,Fenoprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB01223,Aminophylline,DB01351,Amobarbital,0.8064789175987244,70,Type_70,The therapeutic efficacy of Amobarbital can be decreased when used in combination with Aminophylline.,75,Type_75,No
DB00202,Succinylcholine,DB00772,Malathion,0.9974073767662048,73,Type_73,The serum concentration of Malathion can be increased when it is combined with Succinylcholine.,73,Type_73,Yes
DB00390,Digoxin,DB08808,Bupranolol,0.9520843625068665,54,Type_54,Digoxin may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB00267,Cefmenoxime,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefmenoxime.,70,Type_70,Yes
DB06216,Asenapine,DB06699,Degarelix,0.9998700618743896,20,Type_20,Asenapine may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00765,Metyrosine,DB00881,Quinapril,0.9483362436294556,60,Type_60,Metyrosine may increase the hypotensive activities of Quinapril.,60,Type_60,Yes
DB00896,Rimexolone,DB08991,Epirizole,0.999743640422821,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Epirizole.,49,Type_49,Yes
DB00909,Zonisamide,DB01209,Dezocine,0.9989547729492188,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Dezocine.,49,Type_49,Yes
DB00243,Ranolazine,DB01182,Propafenone,0.7171151041984558,73,Type_73,The serum concentration of Propafenone can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01098,Rosuvastatin,DB09102,Daclatasvir,0.8796820044517517,73,Type_73,The serum concentration of Daclatasvir can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00211,Midodrine,DB00924,Cyclobenzaprine,0.9851941466331482,84,Type_84,Midodrine may increase the vasopressor activities of Cyclobenzaprine.,84,Type_84,Yes
DB01016,Glyburide,DB01208,Sparfloxacin,0.9863166213035583,9,Type_9,Glyburide may increase the hypoglycemic activities of Sparfloxacin.,9,Type_9,Yes
DB00484,Brimonidine,DB01433,Methadyl acetate,0.9611485004425049,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate.,16,Type_16,Yes
DB09320,Procaine benzylpenicillin,DB13783,Acemetacin,0.6080892086029053,72,Type_72,Procaine benzylpenicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level.,72,Type_72,Yes
DB00805,Minaprine,DB00934,Maprotiline,0.5485166311264038,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Maprotiline.,49,Type_49,Yes
DB00708,Sufentanil,DB01246,Alimemazine,0.8401293158531189,60,Type_60,Sufentanil may increase the hypotensive activities of Alimemazine.,60,Type_60,Yes
DB00732,Atracurium besylate,DB01081,Diphenoxylate,0.9987241625785828,49,Type_49,The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Diphenoxylate.,49,Type_49,Yes
DB00881,Quinapril,DB09286,Pipamperone,0.8881853818893433,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Pipamperone.,49,Type_49,Yes
DB00413,Pramipexole,DB00922,Levosimendan,0.9774491190910339,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Levosimendan.,49,Type_49,Yes
DB01384,Paramethasone,DB04868,Nilotinib,0.7541942000389099,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Paramethasone.,47,Type_47,Yes
DB01023,Felodipine,DB08931,Riociguat,0.5933939218521118,60,Type_60,Felodipine may increase the hypotensive activities of Riociguat.,49,Type_49,No
DB00865,Benzphetamine,DB01621,Pipotiazine,0.6132379174232483,61,Type_61,Benzphetamine may decrease the stimulatory activities of Pipotiazine.,61,Type_61,Yes
DB00349,Clobazam,DB00906,Tiagabine,0.5345619320869446,47,Type_47,The metabolism of Tiagabine can be decreased when combined with Clobazam.,49,Type_49,No
DB00281,Lidocaine,DB12532,Oxetacaine,0.9990659356117249,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Oxetacaine.,49,Type_49,Yes
DB00818,Propofol,DB08987,Etidocaine,0.999619722366333,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Etidocaine.,49,Type_49,Yes
DB00751,Epinastine,DB06616,Bosutinib,0.8410558700561523,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Epinastine.,75,Type_75,No
DB01114,Chlorpheniramine,DB01232,Saquinavir,0.7531676888465881,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Chlorpheniramine.,47,Type_47,Yes
DB00483,Gallamine triethiodide,DB00896,Rimexolone,0.9964731335639954,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Rimexolone.,49,Type_49,Yes
DB00221,Isoetharine,DB00805,Minaprine,0.886179506778717,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Minaprine.,49,Type_49,Yes
DB00700,Eplerenone,DB00752,Tranylcypromine,0.4838889539241791,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Tranylcypromine.,49,Type_49,Yes
DB00455,Loratadine,DB01618,Molindone,0.9979369640350342,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Molindone.,49,Type_49,Yes
DB00972,Azelastine,DB08964,Gemeprost,1.0,70,Type_70,The therapeutic efficacy of Gemeprost can be decreased when used in combination with Azelastine.,70,Type_70,Yes
DB00328,Indomethacin,DB00744,Zileuton,0.9944724440574646,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Zileuton.,49,Type_49,Yes
DB00599,Thiopental,DB00706,Tamsulosin,0.6759138107299805,60,Type_60,Thiopental may increase the hypotensive activities of Tamsulosin.,60,Type_60,Yes
DB07615,Tranilast,DB09218,Clonixin,0.9794815182685852,49,Type_49,The risk or severity of adverse effects can be increased when Tranilast is combined with Clonixin.,49,Type_49,Yes
DB00370,Mirtazapine,DB00549,Zafirlukast,0.7170860767364502,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00191,Phentermine,DB08922,Perospirone,0.9603832960128784,61,Type_61,Phentermine may decrease the stimulatory activities of Perospirone.,61,Type_61,Yes
DB09073,Palbociclib,DB11362,Selexipag,0.8372185230255127,73,Type_73,The serum concentration of Selexipag can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB00673,Aprepitant,DB06413,Armodafinil,0.8317286372184753,73,Type_73,The serum concentration of Armodafinil can be increased when it is combined with Aprepitant.,47,Type_47,No
DB00370,Mirtazapine,DB08820,Ivacaftor,0.9996902942657471,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB01050,Ibuprofen,DB09084,Benzydamine,0.9986289739608765,49,Type_49,The risk or severity of adverse effects can be increased when Ibuprofen is combined with Benzydamine.,49,Type_49,Yes
DB00584,Enalapril,DB09276,Sodium aurothiomalate,0.9999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Sodium aurothiomalate.,49,Type_49,Yes
DB00188,Bortezomib,DB00938,Salmeterol,0.6073319315910339,47,Type_47,The metabolism of Salmeterol can be decreased when combined with Bortezomib.,73,Type_73,No
DB00496,Darifenacin,DB08873,Boceprevir,0.843726396560669,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00283,Clemastine,DB00690,Flurazepam,0.860191822052002,47,Type_47,The metabolism of Flurazepam can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00614,Furazolidone,DB00871,Terbutaline,0.9476299285888672,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Terbutaline.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00489,Sotalol,0.9821743965148926,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Sotalol.,49,Type_49,Yes
DB00412,Rosiglitazone,DB06825,Triptorelin,0.9997705817222595,70,Type_70,The therapeutic efficacy of Triptorelin can be decreased when used in combination with Rosiglitazone.,70,Type_70,Yes
DB00331,Metformin,DB09009,Articaine,0.9999228715896606,70,Type_70,The therapeutic efficacy of Articaine can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB01023,Felodipine,DB12267,Brigatinib,0.8474597334861755,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Felodipine.,75,Type_75,No
DB00747,Scopolamine,DB00907,Cocaine,0.9976561069488525,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Cocaine.,49,Type_49,Yes
DB01356,Lithium cation,DB01399,Salsalate,0.8047671318054199,73,Type_73,The serum concentration of Salsalate can be increased when it is combined with Lithium cation.,73,Type_73,Yes
DB00240,Alclometasone,DB06739,Seratrodast,0.9947670698165894,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Seratrodast.,49,Type_49,Yes
DB01184,Domperidone,DB04844,Tetrabenazine,0.9289331436157227,20,Type_20,Domperidone may increase the QTc-prolonging activities of Tetrabenazine.,33,Type_33,No
DB01380,Cortisone acetate,DB04876,Vildagliptin,0.9757834076881409,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Cortisone acetate.,70,Type_70,Yes
DB00608,Chloroquine,DB01087,Primaquine,0.7476000189781189,20,Type_20,Chloroquine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00193,Tramadol,DB00454,Meperidine,0.8925281763076782,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Meperidine.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB01544,Flunitrazepam,0.9938451647758484,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Flunitrazepam.,49,Type_49,Yes
DB00184,Nicotine,DB01264,Darunavir,0.8604500889778137,47,Type_47,The metabolism of Darunavir can be decreased when combined with Nicotine.,73,Type_73,No
DB00679,Thioridazine,DB01624,Zuclopenthixol,0.6783748269081116,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Zuclopenthixol.,47,Type_47,No
DB00285,Venlafaxine,DB04835,Maraviroc,0.6542916893959045,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01607,Ticarcillin,DB06810,Plicamycin,0.9983810186386108,75,Type_75,The serum concentration of Plicamycin can be decreased when it is combined with Ticarcillin.,75,Type_75,Yes
DB00370,Mirtazapine,DB00494,Entacapone,0.9990209341049194,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Entacapone.,16,Type_16,Yes
DB00705,Delavirdine,DB09275,Bismuth subcitrate potassium,0.9470916986465454,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Delavirdine.,75,Type_75,Yes
DB00502,Haloperidol,DB01074,Perhexiline,0.7789700031280518,47,Type_47,The metabolism of Perhexiline can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00645,Dyclonine,DB00907,Cocaine,0.9954468607902527,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Cocaine.,49,Type_49,Yes
DB01401,Choline magnesium trisalicylate,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Choline magnesium trisalicylate.,70,Type_70,Yes
DB00571,Propranolol,DB00883,Isosorbide dinitrate,0.9619783759117126,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00411,Carbamoylcholine,DB01580,Oxprenolol,0.9997847676277161,49,Type_49,The risk or severity of adverse effects can be increased when Carbamoylcholine is combined with Oxprenolol.,49,Type_49,Yes
DB00681,Amphotericin B,DB08958,Hexetidine,0.9641387462615967,70,Type_70,The therapeutic efficacy of Hexetidine can be decreased when used in combination with Amphotericin B.,70,Type_70,Yes
DB00483,Gallamine triethiodide,DB01234,Dexamethasone,0.9689119458198547,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Dexamethasone.,49,Type_49,Yes
DB00661,Verapamil,DB01181,Ifosfamide,0.8898016810417175,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Verapamil.,11,Type_11,No
DB01220,Rifaximin,DB01268,Sunitinib,0.6589133739471436,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Rifaximin.,73,Type_73,Yes
DB00206,Reserpine,DB00625,Efavirenz,0.981639564037323,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Efavirenz.,49,Type_49,Yes
DB00412,Rosiglitazone,DB12026,Voxilaprevir,0.9487125277519226,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00257,Clotrimazole,DB08901,Ponatinib,0.942803680896759,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00585,Nizatidine,DB01577,Metamfetamine,0.9623941779136658,76,Type_76,Nizatidine may decrease the sedative activities of Metamfetamine.,76,Type_76,Yes
DB00961,Mepivacaine,DB09345,Pramocaine,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Pramocaine.,49,Type_49,Yes
DB00091,Cyclosporine,DB00790,Perindopril,0.41198351979255676,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00227,Lovastatin,DB01241,Gemfibrozil,0.6846874952316284,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Lovastatin.,48,Type_48,No
DB00818,Propofol,DB01202,Levetiracetam,0.9949643611907959,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Levetiracetam.,49,Type_49,Yes
DB00214,Torasemide,DB00240,Alclometasone,0.9994353652000427,83,Type_83,Torasemide may increase the hypokalemic activities of Alclometasone.,83,Type_83,Yes
DB00188,Bortezomib,DB00706,Tamsulosin,0.4538499116897583,47,Type_47,The metabolism of Tamsulosin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00687,Fludrocortisone,DB06736,Aceclofenac,0.9997896552085876,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Aceclofenac.,49,Type_49,Yes
DB00850,Perphenazine,DB06697,Artemether,0.6980587840080261,47,Type_47,The metabolism of Artemether can be decreased when combined with Perphenazine.,73,Type_73,No
DB00952,Naratriptan,DB09241,Methylene blue,0.7434036731719971,47,Type_47,The metabolism of Methylene blue can be decreased when combined with Naratriptan.,47,Type_47,Yes
DB00281,Lidocaine,DB01198,Zopiclone,0.717752993106842,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Zopiclone.,49,Type_49,Yes
DB00802,Alfentanil,DB01433,Methadyl acetate,0.9931786060333252,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Methadyl acetate.,49,Type_49,Yes
DB00254,Doxycycline,DB00482,Celecoxib,0.9684200882911682,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01241,Gemfibrozil,DB05246,Methsuximide,0.9519564509391785,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Gemfibrozil.,47,Type_47,Yes
DB00343,Diltiazem,DB06695,Dabigatran etexilate,0.6115138530731201,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Diltiazem.,77,Type_77,Yes
DB00201,Caffeine,DB06414,Etravirine,0.7377246618270874,47,Type_47,The metabolism of Etravirine can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00277,Theophylline,DB09054,Idelalisib,0.9344419836997986,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Theophylline.,47,Type_47,Yes
DB01113,Papaverine,DB04948,Lofexidine,0.9879783391952515,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Lofexidine.,49,Type_49,Yes
DB00331,Metformin,DB01208,Sparfloxacin,0.9894890189170837,9,Type_9,Metformin may increase the hypoglycemic activities of Sparfloxacin.,9,Type_9,Yes
DB00193,Tramadol,DB06636,Isavuconazonium,0.814341127872467,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Tramadol.,47,Type_47,Yes
DB01591,Solifenacin,DB01624,Zuclopenthixol,0.6822478175163269,20,Type_20,Solifenacin may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB01355,Hexobarbital,DB01359,Penbutolol,0.5124930143356323,60,Type_60,Hexobarbital may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00320,Dihydroergotamine,DB11581,Venetoclax,0.8735157251358032,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00181,Baclofen,DB00750,Prilocaine,0.9999986886978149,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Prilocaine.,49,Type_49,Yes
DB00991,Oxaprozin,DB09211,Limaprost,0.8760626316070557,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Oxaprozin.,70,Type_70,Yes
DB00278,Argatroban,DB00313,Valproic acid,0.33585578203201294,70,Type_70,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Argatroban.,75,Type_75,No
DB00764,Mometasone,DB01264,Darunavir,0.7391715049743652,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Mometasone.,73,Type_73,Yes
DB00250,Dapsone,DB00263,Sulfisoxazole,0.9853037595748901,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Dapsone.,47,Type_47,Yes
DB00207,Azithromycin,DB04871,Lorcaserin,0.8517202138900757,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00805,Minaprine,DB00975,Dipyridamole,0.5012338757514954,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Dipyridamole.,70,Type_70,No
DB08807,Bopindolol,DB09216,Tolfenamic acid,0.9714595675468445,37,Type_37,Bopindolol may decrease the antihypertensive activities of Tolfenamic acid.,37,Type_37,Yes
DB00726,Trimipramine,DB01626,Pargyline,0.6127312183380127,64,Type_64,Trimipramine may increase the serotonergic activities of Pargyline.,64,Type_64,Yes
DB01159,Halothane,DB09167,Dosulepin,0.8201517462730408,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Halothane.,47,Type_47,Yes
DB00461,Nabumetone,DB01250,Olsalazine,0.9445644617080688,57,Type_57,Nabumetone may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB00908,Quinidine,DB08943,Isoconazole,0.551829993724823,73,Type_73,The serum concentration of Isoconazole can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00214,Torasemide,DB09026,Aliskiren,0.8749877214431763,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Aliskiren.,49,Type_49,Yes
DB04846,Celiprolol,DB06636,Isavuconazonium,0.9280861616134644,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Celiprolol.,47,Type_47,Yes
DB01059,Norfloxacin,DB07615,Tranilast,0.8894702196121216,27,Type_27,Norfloxacin may increase the neuroexcitatory activities of Tranilast.,27,Type_27,Yes
DB00715,Paroxetine,DB00943,Zalcitabine,0.8853575587272644,47,Type_47,The metabolism of Zalcitabine can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB00610,Metaraminol,0.9658374190330505,71,Type_71,Dihydroergotamine may increase the hypertensive activities of Metaraminol.,71,Type_71,Yes
DB00692,Phentolamine,DB08931,Riociguat,0.8437562584877014,60,Type_60,Phentolamine may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB01024,Mycophenolic acid,DB01377,Magnesium oxide,0.5516127347946167,67,Type_67,Mycophenolic acid can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB01128,Bicalutamide,DB09054,Idelalisib,0.8988136649131775,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Bicalutamide.,47,Type_47,Yes
DB01075,Diphenhydramine,DB06292,Dapagliflozin,0.9459388256072998,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Diphenhydramine.,47,Type_47,Yes
DB01232,Saquinavir,DB11362,Selexipag,0.9282645583152771,47,Type_47,The metabolism of Selexipag can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00401,Nisoldipine,DB01170,Guanethidine,0.9992056488990784,60,Type_60,Nisoldipine may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB00641,Simvastatin,DB01072,Atazanavir,0.7284761071205139,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00677,Isoflurophate,DB01380,Cortisone acetate,0.9819369912147522,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Cortisone acetate.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB01026,Ketoconazole,0.8242743015289307,73,Type_73,The serum concentration of Ketoconazole can be increased when it is combined with Fluocinolone acetonide.,73,Type_73,Yes
DB00630,Alendronic acid,DB13231,Calcium lactate,0.9770028591156006,75,Type_75,The serum concentration of Calcium lactate can be decreased when it is combined with Alendronic acid.,75,Type_75,Yes
DB00224,Indinavir,DB06616,Bosutinib,0.9250056743621826,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00232,Methyclothiazide,DB04876,Vildagliptin,0.9871659874916077,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Methyclothiazide.,70,Type_70,Yes
DB01420,Testosterone propionate,DB06203,Alogliptin,0.995402455329895,9,Type_9,Testosterone propionate may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00501,Cimetidine,DB06637,Dalfampridine,0.8623119592666626,47,Type_47,The metabolism of Dalfampridine can be decreased when combined with Cimetidine.,73,Type_73,No
DB01545,Ethyl loflazepate,DB04842,Fluspirilene,0.9953998923301697,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Fluspirilene.,49,Type_49,Yes
DB00214,Torasemide,DB00252,Phenytoin,0.5794553160667419,29,Type_29,Torasemide may decrease the diuretic activities of Phenytoin.,29,Type_29,Yes
DB00296,Ropivacaine,DB05521,Telaprevir,0.7699881196022034,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB01090,Pentolinium,DB01348,Spirapril,0.9998382329940796,60,Type_60,Pentolinium may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00226,Guanadrel,DB09026,Aliskiren,0.9999496936798096,60,Type_60,Guanadrel may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB00554,Piroxicam,DB00774,Hydroflumethiazide,0.9968974590301514,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Piroxicam.,70,Type_70,Yes
DB00796,Candesartan cilexetil,DB09292,Sacubitril,0.8451130986213684,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Sacubitril.,49,Type_49,Yes
DB00323,Tolcapone,DB00876,Eprosartan,0.6397334337234497,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Eprosartan.,49,Type_49,Yes
DB01167,Itraconazole,DB06148,Mianserin,0.7963020205497742,47,Type_47,The metabolism of Mianserin can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00628,Clorazepic acid,DB01161,Chloroprocaine,0.9981057643890381,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Chloroprocaine.,49,Type_49,Yes
DB05521,Telaprevir,DB06626,Axitinib,0.5984736680984497,73,Type_73,The serum concentration of Axitinib can be increased when it is combined with Telaprevir.,73,Type_73,Yes
DB00541,Vincristine,DB00673,Aprepitant,0.9813516736030579,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00433,Prochlorperazine,DB00854,Levorphanol,0.987689733505249,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Levorphanol.,49,Type_49,Yes
DB00162,Vitamin A,DB00511,Acetyldigitoxin,0.9999529123306274,58,Type_58,Vitamin A may decrease the cardiotoxic activities of Acetyldigitoxin.,58,Type_58,Yes
DB00918,Almotriptan,DB01156,Bupropion,0.7586779594421387,47,Type_47,The metabolism of Bupropion can be decreased when combined with Almotriptan.,47,Type_47,Yes
DB00266,Dicoumarol,DB09320,Procaine benzylpenicillin,0.8997194170951843,6,Type_6,Dicoumarol may increase the anticoagulant activities of Procaine benzylpenicillin.,6,Type_6,Yes
DB00528,Lercanidipine,DB01275,Hydralazine,0.5684091448783875,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Hydralazine.,60,Type_60,No
DB00203,Sildenafil,DB00477,Chlorpromazine,0.8085486888885498,47,Type_47,The metabolism of Chlorpromazine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB05039,Indacaterol,DB08881,Vemurafenib,0.5661274194717407,33,Type_33,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vemurafenib.,73,Type_73,No
DB00320,Dihydroergotamine,DB00358,Mefloquine,0.765816867351532,47,Type_47,The metabolism of Mefloquine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00653,Magnesium sulfate,DB01154,Thiamylal,0.9133040308952332,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.,16,Type_16,Yes
DB00629,Guanabenz,DB01143,Amifostine,0.8888615965843201,60,Type_60,Guanabenz may increase the hypotensive activities of Amifostine.,60,Type_60,Yes
DB00599,Thiopental,DB01143,Amifostine,0.9611091613769531,60,Type_60,Thiopental may increase the hypotensive activities of Amifostine.,60,Type_60,Yes
DB00873,Loteprednol,DB01325,Quinethazone,0.9999788999557495,83,Type_83,Loteprednol may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB00673,Aprepitant,DB00682,Warfarin,0.9259123206138611,73,Type_73,The serum concentration of Warfarin can be increased when it is combined with Aprepitant.,75,Type_75,No
DB00735,Naftifine,DB09095,Difluocortolone,0.9996885061264038,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Difluocortolone.,49,Type_49,Yes
DB00963,Bromfenac,DB01708,Prasterone,0.9989413619041443,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Prasterone.,49,Type_49,Yes
DB00312,Pentobarbital,DB01105,Sibutramine,0.9882612824440002,4,Type_4,The metabolism of Sibutramine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00631,Clofarabine,DB09292,Sacubitril,0.9476390480995178,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Sacubitril.,49,Type_49,Yes
DB00484,Brimonidine,DB01551,Dihydrocodeine,0.9684883952140808,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.,16,Type_16,Yes
DB00508,Triflupromazine,DB00660,Metaxalone,0.999988317489624,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Metaxalone.,49,Type_49,Yes
DB00474,Methohexital,DB00966,Telmisartan,0.9642040729522705,60,Type_60,Methohexital may increase the hypotensive activities of Telmisartan.,60,Type_60,Yes
DB00748,Carbinoxamine,DB12532,Oxetacaine,0.9999985694885254,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Oxetacaine.,49,Type_49,Yes
DB00313,Valproic acid,DB01261,Sitagliptin,0.5459209084510803,75,Type_75,The serum concentration of Sitagliptin can be decreased when it is combined with Valproic acid.,75,Type_75,Yes
DB01023,Felodipine,DB08907,Canagliflozin,0.931317150592804,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Canagliflozin.,49,Type_49,Yes
DB01244,Bepridil,DB04855,Dronedarone,0.5087337493896484,20,Type_20,Bepridil may increase the QTc-prolonging activities of Dronedarone.,47,Type_47,No
DB00091,Cyclosporine,DB00454,Meperidine,0.9354460835456848,47,Type_47,The metabolism of Meperidine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00482,Celecoxib,DB00502,Haloperidol,0.9672594666481018,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Celecoxib.,49,Type_49,No
DB00887,Bumetanide,DB12598,Nafamostat,0.9926847219467163,29,Type_29,Bumetanide may decrease the diuretic activities of Nafamostat.,29,Type_29,Yes
DB00394,Beclomethasone dipropionate,DB06196,Icatibant,0.9998196959495544,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Icatibant.,49,Type_49,Yes
DB00014,Goserelin,DB01104,Sertraline,0.9995306730270386,20,Type_20,Goserelin may increase the QTc-prolonging activities of Sertraline.,20,Type_20,Yes
DB00175,Pravastatin,DB01138,Sulfinpyrazone,0.4378880262374878,73,Type_73,The serum concentration of Sulfinpyrazone can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00674,Galantamine,DB09280,Lumacaftor,0.6328591704368591,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Galantamine.,4,Type_4,No
DB00169,Cholecalciferol,DB00567,Cephalexin,0.9837715029716492,47,Type_47,The metabolism of Cephalexin can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00531,Cyclophosphamide,DB00544,Fluorouracil,0.9054393768310547,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Fluorouracil.,15,Type_15,Yes
DB00216,Eletriptan,DB00924,Cyclobenzaprine,0.9089867472648621,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00503,Ritonavir,DB00635,Prednisone,0.9265101552009583,47,Type_47,The metabolism of Prednisone can be decreased when combined with Ritonavir.,73,Type_73,No
DB00273,Topiramate,DB11148,Butamben,0.9961115717887878,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Butamben.,49,Type_49,Yes
DB00861,Diflunisal,DB01214,Metipranolol,0.9991008043289185,37,Type_37,Diflunisal may decrease the antihypertensive activities of Metipranolol.,37,Type_37,Yes
DB00747,Scopolamine,DB00844,Nalbuphine,0.9997285008430481,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Nalbuphine.,49,Type_49,Yes
DB00612,Bisoprolol,DB08941,Isoxsuprine,0.9950725436210632,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isoxsuprine.,49,Type_49,Yes
DB00220,Nelfinavir,DB01179,Podofilox,0.8836159706115723,47,Type_47,The metabolism of Podofilox can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00283,Clemastine,DB00451,Levothyroxine,0.9795469641685486,47,Type_47,The metabolism of Levothyroxine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00243,Ranolazine,DB01559,Clotiazepam,0.5634042024612427,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00715,Paroxetine,DB01087,Primaquine,0.6226837635040283,20,Type_20,Paroxetine may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB00208,Ticlopidine,DB01426,Ajmaline,0.8988895416259766,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB06210,Eltrombopag,DB11817,Baricitinib,0.48303794860839844,47,Type_47,The metabolism of Baricitinib can be decreased when combined with Eltrombopag.,73,Type_73,No
DB01254,Dasatinib,DB09396,Dextropropoxyphene napsylate,0.737251341342926,73,Type_73,The serum concentration of Dextropropoxyphene napsylate can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00208,Ticlopidine,DB00246,Ziprasidone,0.8852142691612244,47,Type_47,The metabolism of Ziprasidone can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00312,Pentobarbital,DB06713,Norelgestromin,0.6449423432350159,75,Type_75,The serum concentration of Norelgestromin can be decreased when it is combined with Pentobarbital.,70,Type_70,No
DB00620,Triamcinolone,DB01120,Gliclazide,0.9661815166473389,70,Type_70,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triamcinolone.,70,Type_70,Yes
DB00204,Dofetilide,DB00679,Thioridazine,0.34030574560165405,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Dofetilide.,33,Type_33,No
DB00333,Methadone,DB00398,Sorafenib,0.636062502861023,47,Type_47,The metabolism of Sorafenib can be decreased when combined with Methadone.,20,Type_20,No
DB00555,Lamotrigine,DB01220,Rifaximin,0.5337185859680176,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Lamotrigine.,75,Type_75,No
DB00645,Dyclonine,DB00697,Tizanidine,0.93863844871521,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Tizanidine.,49,Type_49,Yes
DB00247,Methysergide,DB00370,Mirtazapine,0.940764844417572,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Mirtazapine.,49,Type_49,Yes
DB09073,Palbociclib,DB12026,Voxilaprevir,0.8734932541847229,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB01080,Vigabatrin,DB01356,Lithium cation,0.9993522763252258,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Lithium cation.,49,Type_49,Yes
DB00268,Ropinirole,DB00567,Cephalexin,0.9786821603775024,47,Type_47,The metabolism of Cephalexin can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00715,Paroxetine,DB06738,Ketobemidone,0.4453890919685364,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Ketobemidone.,47,Type_47,No
DB01045,Rifampicin,DB06210,Eltrombopag,0.9014623165130615,4,Type_4,The metabolism of Eltrombopag can be increased when combined with Rifampicin.,4,Type_4,Yes
DB06789,Hydroxyprogesterone caproate,DB08873,Boceprevir,0.7453458309173584,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Hydroxyprogesterone caproate.,47,Type_47,Yes
DB00394,Beclomethasone dipropionate,DB06717,Fosaprepitant,0.8770341277122498,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Beclomethasone dipropionate.,73,Type_73,Yes
DB00224,Indinavir,DB01166,Cilostazol,0.6136164665222168,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00559,Bosentan,DB13783,Acemetacin,0.6733500361442566,75,Type_75,The serum concentration of Acemetacin can be decreased when it is combined with Bosentan.,70,Type_70,No
DB00475,Chlordiazepoxide,DB00494,Entacapone,0.9983792304992676,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Entacapone.,49,Type_49,Yes
DB00527,Cinchocaine,DB01545,Ethyl loflazepate,0.9999971389770508,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00712,Flurbiprofen,DB01324,Polythiazide,0.9982143640518188,70,Type_70,The therapeutic efficacy of Polythiazide can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB00907,Cocaine,DB06684,Vilazodone,0.8451661467552185,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Vilazodone.,47,Type_47,No
DB00524,Metolazone,DB04861,Nebivolol,0.8933560848236084,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Nebivolol.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB03615,Ribostamycin,1.0,40,Type_40,Gallamine triethiodide may increase the respiratory depressant activities of Ribostamycin.,40,Type_40,Yes
DB00297,Bupivacaine,DB00742,Mannitol,0.7969907522201538,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Mannitol.,49,Type_49,Yes
DB00782,Propantheline,DB01227,Levacetylmethadol,0.9999856948852539,49,Type_49,The risk or severity of adverse effects can be increased when Propantheline is combined with Levacetylmethadol.,49,Type_49,Yes
DB00285,Venlafaxine,DB01253,Ergometrine,0.8174542188644409,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ergometrine.,49,Type_49,Yes
DB00402,Eszopiclone,DB00734,Risperidone,0.9964444041252136,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Risperidone.,49,Type_49,Yes
DB00956,Hydrocodone,DB01337,Pancuronium,0.9965360164642334,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Pancuronium.,49,Type_49,Yes
DB00208,Ticlopidine,DB00980,Ramelteon,0.9802519679069519,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00808,Indapamide,DB06786,Halcinonide,0.9994146823883057,83,Type_83,Indapamide may increase the hypokalemic activities of Halcinonide.,83,Type_83,Yes
DB00207,Azithromycin,DB01182,Propafenone,0.8503893613815308,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Propafenone.,20,Type_20,Yes
DB00220,Nelfinavir,DB00471,Montelukast,0.9341316819190979,47,Type_47,The metabolism of Montelukast can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00289,Atomoxetine,DB00564,Carbamazepine,0.5108801126480103,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Atomoxetine.,4,Type_4,Yes
DB00246,Ziprasidone,DB01020,Isosorbide mononitrate,0.9403412938117981,47,Type_47,The metabolism of Isosorbide mononitrate can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00599,Thiopental,DB00924,Cyclobenzaprine,0.7949504256248474,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Cyclobenzaprine.,4,Type_4,No
DB00316,Acetaminophen,DB09167,Dosulepin,0.9154272079467773,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB04846,Celiprolol,DB05521,Telaprevir,0.8261104226112366,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Celiprolol.,47,Type_47,Yes
DB01211,Clarithromycin,DB08970,Fluprednidene,0.9866863489151001,73,Type_73,The serum concentration of Fluprednidene can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB01424,Aminophenazone,DB08880,Teriflunomide,0.4218376874923706,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Aminophenazone.,75,Type_75,Yes
DB00273,Topiramate,DB00586,Diclofenac,0.6101752519607544,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Diclofenac.,47,Type_47,No
DB00253,Medrysone,DB01357,Mestranol,0.9971336126327515,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Medrysone.,73,Type_73,Yes
DB00633,Dexmedetomidine,DB09026,Aliskiren,0.5870526432991028,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Aliskiren.,49,Type_49,Yes
DB00571,Propranolol,DB09242,Moxonidine,0.5003034472465515,25,Type_25,Propranolol may increase the atrioventricular blocking (AV block) activities of Moxonidine.,25,Type_25,Yes
DB00205,Pyrimethamine,DB01246,Alimemazine,0.6012149453163147,73,Type_73,The serum concentration of Alimemazine can be increased when it is combined with Pyrimethamine.,73,Type_73,Yes
DB00854,Levorphanol,DB01588,Prazepam,0.9987146854400635,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Prazepam.,49,Type_49,Yes
DB00195,Betaxolol,DB00514,Dextromethorphan,0.7157535552978516,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00796,Candesartan cilexetil,DB01580,Oxprenolol,0.667261004447937,60,Type_60,Candesartan cilexetil may increase the hypotensive activities of Oxprenolol.,60,Type_60,Yes
DB00395,Carisoprodol,DB00909,Zonisamide,0.9984215497970581,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zonisamide.,49,Type_49,Yes
DB01407,Clenbuterol,DB09241,Methylene blue,0.6712238788604736,71,Type_71,Clenbuterol may increase the hypertensive activities of Methylene blue.,49,Type_49,No
DB01115,Nifedipine,DB01243,Chloroxine,0.9929071664810181,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Chloroxine.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB08912,Dabrafenib,0.7008655071258545,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Cyclobenzaprine.,75,Type_75,Yes
DB00614,Furazolidone,DB06403,Ambrisentan,0.9919772744178772,60,Type_60,Furazolidone may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00247,Methysergide,DB00863,Ranitidine,0.9980205297470093,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Ranitidine.,49,Type_49,Yes
DB00656,Trazodone,DB01609,Deferasirox,0.9257478713989258,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Trazodone.,75,Type_75,Yes
DB00182,Amphetamine,DB08808,Bupranolol,0.9280379414558411,60,Type_60,Amphetamine may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00784,Mefenamic acid,DB08439,Parecoxib,0.9957408905029297,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Parecoxib.,49,Type_49,Yes
DB00275,Olmesartan,DB00465,Ketorolac,0.9492262005805969,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Ketorolac.,49,Type_49,Yes
DB01601,Lopinavir,DB11581,Venetoclax,0.8354560732841492,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB00412,Rosiglitazone,DB00487,Pefloxacin,0.9698876738548279,9,Type_9,Rosiglitazone may increase the hypoglycemic activities of Pefloxacin.,9,Type_9,Yes
DB01627,Lincomycin,DB13450,Cisatracurium besylate,0.9999994039535522,21,Type_21,Lincomycin may increase the neuromuscular blocking activities of Cisatracurium besylate.,21,Type_21,Yes
DB00814,Meloxicam,DB06826,Unoprostone,0.9979594945907593,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Meloxicam.,70,Type_70,Yes
DB00539,Toremifene,DB00880,Chlorothiazide,0.9637816548347473,51,Type_51,Toremifene may increase the hypercalcemic activities of Chlorothiazide.,51,Type_51,Yes
DB00337,Pimecrolimus,DB08970,Fluprednidene,0.9999034404754639,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluprednidene.,49,Type_49,Yes
DB00455,Loratadine,DB01365,Mephentermine,0.9915084838867188,76,Type_76,Loratadine may decrease the sedative activities of Mephentermine.,76,Type_76,Yes
DB01199,Tubocurarine,DB06696,Arbekacin,0.9999972581863403,40,Type_40,Tubocurarine may increase the respiratory depressant activities of Arbekacin.,40,Type_40,Yes
DB00177,Valsartan,DB01580,Oxprenolol,0.6040389537811279,60,Type_60,Valsartan may increase the hypotensive activities of Oxprenolol.,60,Type_60,Yes
DB01142,Doxepin,DB01201,Rifapentine,0.8800803422927856,4,Type_4,The metabolism of Rifapentine can be increased when combined with Doxepin.,4,Type_4,Yes
DB00208,Ticlopidine,DB01118,Amiodarone,0.8769720792770386,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01059,Norfloxacin,DB13595,Almasilate,0.8957359790802002,67,Type_67,Norfloxacin can cause a decrease in the absorption of Almasilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00239,Oxiconazole,DB00661,Verapamil,0.7954425811767578,47,Type_47,The metabolism of Verapamil can be decreased when combined with Oxiconazole.,49,Type_49,No
DB00963,Bromfenac,DB01193,Acebutolol,0.9957929849624634,37,Type_37,Bromfenac may decrease the antihypertensive activities of Acebutolol.,37,Type_37,Yes
DB06414,Etravirine,DB06636,Isavuconazonium,0.49177664518356323,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Etravirine.,47,Type_47,Yes
DB00399,Zoledronic acid,DB00688,Mycophenolate mofetil,0.9941704273223877,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB06589,Pazopanib,0.8407469987869263,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Pazopanib.,73,Type_73,No
DB00717,Norethisterone,DB08867,Ulipristal,0.6269950270652771,47,Type_47,The metabolism of Ulipristal can be decreased when combined with Norethisterone.,70,Type_70,No
DB01353,Butobarbital,DB13323,Trichloroethylene,0.9999942779541016,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Trichloroethylene.,49,Type_49,Yes
DB00608,Chloroquine,DB01214,Metipranolol,0.43090736865997314,37,Type_37,Chloroquine may decrease the antihypertensive activities of Metipranolol.,47,Type_47,No
DB00813,Fentanyl,DB00904,Ondansetron,0.9705641269683838,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Ondansetron.,64,Type_64,No
DB00254,Doxycycline,DB00773,Etoposide,0.8979739546775818,47,Type_47,The metabolism of Etoposide can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00699,Nicergoline,DB01764,Dalfopristin,0.9992971420288086,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Dalfopristin.,49,Type_49,Yes
DB00210,Adapalene,DB01130,Prednicarbate,0.9999547004699707,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Prednicarbate.,49,Type_49,Yes
DB00363,Clozapine,DB01075,Diphenhydramine,0.6966399550437927,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Clozapine.,20,Type_20,No
DB00691,Moexipril,DB01076,Atorvastatin,0.6716464161872864,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Atorvastatin.,73,Type_73,No
DB00565,Cisatracurium,DB01356,Lithium cation,0.9999874830245972,21,Type_21,Cisatracurium may increase the neuromuscular blocking activities of Lithium cation.,21,Type_21,Yes
DB01399,Salsalate,DB11921,Deflazacort,0.9996935129165649,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Deflazacort.,49,Type_49,Yes
DB01047,Fluocinonide,DB01320,Fosphenytoin,0.9612239599227905,75,Type_75,The serum concentration of Fosphenytoin can be decreased when it is combined with Fluocinonide.,75,Type_75,Yes
DB00593,Ethosuximide,DB06153,Pizotifen,0.9890131950378418,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Pizotifen.,49,Type_49,Yes
DB00297,Bupivacaine,DB01267,Paliperidone,0.9767658710479736,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Paliperidone.,49,Type_49,Yes
DB00625,Efavirenz,DB00673,Aprepitant,0.6640462279319763,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Efavirenz.,73,Type_73,Yes
DB00554,Piroxicam,DB08808,Bupranolol,0.9999358654022217,37,Type_37,Piroxicam may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB01424,Aminophenazone,DB04868,Nilotinib,0.8805445432662964,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Aminophenazone.,47,Type_47,Yes
DB01325,Quinethazone,DB08897,Aclidinium,0.999049961566925,73,Type_73,The serum concentration of Aclidinium can be increased when it is combined with Quinethazone.,73,Type_73,Yes
DB09073,Palbociclib,DB09078,Lenvatinib,0.9843984842300415,73,Type_73,The serum concentration of Lenvatinib can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB00440,Trimethoprim,DB01009,Ketoprofen,0.8746868371963501,47,Type_47,The metabolism of Ketoprofen can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB01339,Vecuronium,0.9914395809173584,73,Type_73,The serum concentration of Vecuronium can be increased when it is combined with Hydroflumethiazide.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB01065,Melatonin,0.8960078954696655,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Melatonin.,16,Type_16,Yes
DB00575,Clonidine,DB01440,gamma-Hydroxybutyric acid,0.9999120235443115,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00960,Pindolol,DB08932,Macitentan,0.9985594153404236,60,Type_60,Pindolol may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00381,Amlodipine,DB01612,Amyl Nitrite,0.9839537143707275,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Amyl Nitrite.,49,Type_49,Yes
DB00908,Quinidine,DB01224,Quetiapine,0.8166413903236389,20,Type_20,Quinidine may increase the QTc-prolonging activities of Quetiapine.,47,Type_47,No
DB00542,Benazepril,DB01240,Epoprostenol,0.6017712354660034,60,Type_60,Benazepril may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB00489,Sotalol,DB01608,Periciazine,0.8726356625556946,60,Type_60,Sotalol may increase the hypotensive activities of Periciazine.,60,Type_60,Yes
DB00502,Haloperidol,DB01233,Metoclopramide,0.6513542532920837,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00237,Butabarbital,DB00366,Doxylamine,0.9999988079071045,16,Type_16,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00333,Methadone,DB01149,Nefazodone,0.7177639603614807,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Methadone.,47,Type_47,Yes
DB05812,Abiraterone,DB08932,Macitentan,0.6285693645477295,73,Type_73,The serum concentration of Macitentan can be increased when it is combined with Abiraterone.,47,Type_47,No
DB08797,Salicylamide,DB09279,Fimasartan,0.9994671940803528,49,Type_49,The risk or severity of adverse effects can be increased when Salicylamide is combined with Fimasartan.,49,Type_49,Yes
DB00768,Olopatadine,DB04896,Milnacipran,0.9743953943252563,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Milnacipran.,49,Type_49,Yes
DB00873,Loteprednol,DB01406,Danazol,0.9976916313171387,74,Type_74,Loteprednol may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB00208,Ticlopidine,DB06777,Chenodeoxycholic acid,0.9500625729560852,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00670,Pirenzepine,DB00674,Galantamine,0.9996645450592041,70,Type_70,The therapeutic efficacy of Galantamine can be decreased when used in combination with Pirenzepine.,70,Type_70,Yes
DB00946,Phenprocoumon,DB01127,Econazole,0.5119920372962952,73,Type_73,The serum concentration of Econazole can be increased when it is combined with Phenprocoumon.,73,Type_73,Yes
DB00191,Phentermine,DB01356,Lithium cation,0.8212172985076904,61,Type_61,Phentermine may decrease the stimulatory activities of Lithium cation.,61,Type_61,Yes
DB00489,Sotalol,DB01263,Posaconazole,0.4836636483669281,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Sotalol.,20,Type_20,No
DB01023,Felodipine,DB11093,Calcium citrate,0.988092303276062,70,Type_70,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Felodipine.,70,Type_70,Yes
DB00285,Venlafaxine,DB00977,Ethinylestradiol,0.7685181498527527,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00903,Etacrynic acid,DB01162,Terazosin,0.98371821641922,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Terazosin.,49,Type_49,Yes
DB01186,Pergolide,DB05521,Telaprevir,0.8211289048194885,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Pergolide.,47,Type_47,Yes
DB01589,Quazepam,DB08873,Boceprevir,0.4858301281929016,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Quazepam.,47,Type_47,No
DB00730,Thiabendazole,DB09330,Osimertinib,0.9700608253479004,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Thiabendazole.,75,Type_75,No
DB00584,Enalapril,DB06414,Etravirine,0.3289853632450104,75,Type_75,The serum concentration of Etravirine can be decreased when it is combined with Enalapril.,75,Type_75,Yes
DB09071,Tasimelteon,DB09118,Stiripentol,0.8238000869750977,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Tasimelteon.,73,Type_73,Yes
DB00873,Loteprednol,DB00963,Bromfenac,0.999722421169281,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Bromfenac.,49,Type_49,Yes
DB00490,Buspirone,DB06216,Asenapine,0.7346158027648926,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Asenapine.,49,Type_49,Yes
DB00549,Zafirlukast,DB01544,Flunitrazepam,0.9367856383323669,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00215,Citalopram,DB00805,Minaprine,0.8145312666893005,9,Type_9,Citalopram may increase the hypoglycemic activities of Minaprine.,47,Type_47,No
DB00575,Clonidine,DB08815,Lurasidone,0.8312728404998779,60,Type_60,Clonidine may increase the hypotensive activities of Lurasidone.,49,Type_49,No
DB00896,Rimexolone,DB01357,Mestranol,0.9971103668212891,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Rimexolone.,73,Type_73,Yes
DB00385,Valrubicin,DB01606,Tazobactam,0.9923621416091919,75,Type_75,The serum concentration of Tazobactam can be decreased when it is combined with Valrubicin.,75,Type_75,Yes
DB00281,Lidocaine,DB00398,Sorafenib,0.78448086977005,47,Type_47,The metabolism of Sorafenib can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB09295,Talniflumate,DB12598,Nafamostat,0.9998334646224976,49,Type_49,The risk or severity of adverse effects can be increased when Talniflumate is combined with Nafamostat.,49,Type_49,Yes
DB00218,Moxifloxacin,DB00949,Felbamate,0.9997958540916443,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Felbamate.,20,Type_20,Yes
DB01260,Desonide,DB05039,Indacaterol,0.992928683757782,83,Type_83,Desonide may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB01058,Praziquantel,DB01211,Clarithromycin,0.46446454524993896,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Praziquantel.,47,Type_47,No
DB01238,Aripiprazole,DB01588,Prazepam,0.9061445593833923,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Prazepam.,49,Type_49,Yes
DB00394,Beclomethasone dipropionate,DB00582,Voriconazole,0.8228532075881958,73,Type_73,The serum concentration of Voriconazole can be increased when it is combined with Beclomethasone dipropionate.,73,Type_73,Yes
DB00968,Methyldopa,DB08868,Fingolimod,0.9987351298332214,54,Type_54,Methyldopa may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB00343,Diltiazem,DB00486,Nabilone,0.9885118007659912,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Nabilone.,49,Type_49,Yes
DB00615,Rifabutin,DB00694,Daunorubicin,0.9916431903839111,4,Type_4,The metabolism of Daunorubicin can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00679,Thioridazine,DB00950,Fexofenadine,0.9265502691268921,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Fexofenadine.,73,Type_73,No
DB00237,Butabarbital,DB09286,Pipamperone,0.9964691400527954,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Pipamperone.,49,Type_49,Yes
DB00599,Thiopental,DB07615,Tranilast,0.6605547070503235,4,Type_4,The metabolism of Tranilast can be increased when combined with Thiopental.,4,Type_4,Yes
DB00287,Travoprost,DB01090,Pentolinium,0.999854564666748,60,Type_60,Travoprost may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00196,Fluconazole,DB11921,Deflazacort,0.9571019411087036,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00206,Reserpine,DB00850,Perphenazine,0.9304965734481812,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Perphenazine.,49,Type_49,Yes
DB00619,Imatinib,DB06267,Udenafil,0.9189163446426392,47,Type_47,The metabolism of Udenafil can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00218,Moxifloxacin,DB00220,Nelfinavir,0.9987727999687195,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Nelfinavir.,20,Type_20,Yes
DB00625,Efavirenz,DB05351,Dexlansoprazole,0.650068461894989,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00091,Cyclosporine,DB00370,Mirtazapine,0.8938398957252502,47,Type_47,The metabolism of Mirtazapine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00215,Citalopram,DB00297,Bupivacaine,0.7618992328643799,47,Type_47,The metabolism of Bupivacaine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB04865,Omacetaxine mepesuccinate,DB06605,Apixaban,0.9650802612304688,66,Type_66,The risk or severity of bleeding can be increased when Omacetaxine mepesuccinate is combined with Apixaban.,66,Type_66,Yes
DB00705,Delavirdine,DB01076,Atorvastatin,0.39360272884368896,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Delavirdine.,49,Type_49,No
DB00788,Naproxen,DB09292,Sacubitril,0.9977485537528992,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Sacubitril.,49,Type_49,Yes
DB00220,Nelfinavir,DB00294,Etonogestrel,0.653191089630127,47,Type_47,The metabolism of Etonogestrel can be decreased when combined with Nelfinavir.,75,Type_75,No
DB00873,Loteprednol,DB01072,Atazanavir,0.8640141487121582,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Loteprednol.,73,Type_73,Yes
DB00257,Clotrimazole,DB00528,Lercanidipine,0.8138850331306458,47,Type_47,The metabolism of Lercanidipine can be decreased when combined with Clotrimazole.,49,Type_49,No
DB00310,Chlorthalidone,DB00392,Profenamine,0.9986631870269775,73,Type_73,The serum concentration of Profenamine can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB00503,Ritonavir,DB00690,Flurazepam,0.9019792079925537,47,Type_47,The metabolism of Flurazepam can be decreased when combined with Ritonavir.,73,Type_73,No
DB01247,Isocarboxazid,DB06712,Nilvadipine,0.950245201587677,60,Type_60,Isocarboxazid may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00312,Pentobarbital,DB00722,Lisinopril,0.7261996865272522,60,Type_60,Pentobarbital may increase the hypotensive activities of Lisinopril.,60,Type_60,Yes
DB01092,Ouabain,DB06699,Degarelix,0.9943965673446655,58,Type_58,Ouabain may decrease the cardiotoxic activities of Degarelix.,58,Type_58,Yes
DB00255,Diethylstilbestrol,DB09095,Difluocortolone,0.990608811378479,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00596,Ulobetasol,DB09054,Idelalisib,0.9571539163589478,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Ulobetasol.,73,Type_73,Yes
DB00363,Clozapine,DB00575,Clonidine,0.49311697483062744,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Clonidine.,47,Type_47,No
DB01242,Clomipramine,DB04842,Fluspirilene,0.9865431785583496,49,Type_49,The risk or severity of adverse effects can be increased when Clomipramine is combined with Fluspirilene.,49,Type_49,Yes
DB00470,Dronabinol,DB01241,Gemfibrozil,0.7135769128799438,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Dronabinol.,73,Type_73,No
DB00363,Clozapine,DB01615,Aceprometazine,0.7735550403594971,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Aceprometazine.,49,Type_49,Yes
DB00390,Digoxin,DB09296,Ombitasvir,0.5188915133476257,73,Type_73,The serum concentration of Ombitasvir can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00313,Valproic acid,DB06595,Midostaurin,0.866828978061676,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB01259,Lapatinib,DB05812,Abiraterone,0.8178372383117676,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Lapatinib.,73,Type_73,Yes
DB01149,Nefazodone,DB01622,Thioproperazine,0.849340558052063,73,Type_73,The serum concentration of Thioproperazine can be increased when it is combined with Nefazodone.,49,Type_49,No
DB00631,Clofarabine,DB00925,Phenoxybenzamine,0.9976268410682678,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Phenoxybenzamine.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB09279,Fimasartan,0.9985576272010803,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Fimasartan.,49,Type_49,Yes
DB00281,Lidocaine,DB01149,Nefazodone,0.7435976266860962,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB01254,Dasatinib,DB08932,Macitentan,0.6363057494163513,73,Type_73,The serum concentration of Macitentan can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB01708,Prasterone,DB09212,Loxoprofen,0.999504566192627,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Loxoprofen.,49,Type_49,Yes
DB01077,Etidronic acid,DB02709,Resveratrol,0.9981129169464111,49,Type_49,The risk or severity of adverse effects can be increased when Etidronic acid is combined with Resveratrol.,49,Type_49,Yes
DB00675,Tamoxifen,DB00799,Tazarotene,0.9105101227760315,47,Type_47,The metabolism of Tazarotene can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB00316,Acetaminophen,DB00625,Efavirenz,0.856039822101593,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00748,Carbinoxamine,DB09225,Zotepine,0.9996728897094727,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Zotepine.,49,Type_49,Yes
DB01204,Mitoxantrone,DB09027,Ledipasvir,0.9500203132629395,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Mitoxantrone.,73,Type_73,Yes
DB00991,Oxaprozin,DB09292,Sacubitril,0.996360719203949,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Sacubitril.,49,Type_49,Yes
DB01029,Irbesartan,DB05271,Rotigotine,0.44462886452674866,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Irbesartan.,49,Type_49,No
DB00735,Naftifine,DB00908,Quinidine,0.5286235213279724,47,Type_47,The metabolism of Quinidine can be decreased when combined with Naftifine.,73,Type_73,No
DB00320,Dihydroergotamine,DB01217,Anastrozole,0.5306774377822876,73,Type_73,The serum concentration of Anastrozole can be increased when it is combined with Dihydroergotamine.,49,Type_49,No
DB00214,Torasemide,DB00682,Warfarin,0.519763171672821,73,Type_73,The serum concentration of Warfarin can be increased when it is combined with Torasemide.,73,Type_73,Yes
DB00852,Pseudoephedrine,DB08938,Magaldrate,0.9321873784065247,72,Type_72,Pseudoephedrine may decrease the excretion rate of Magaldrate which could result in a higher serum level.,72,Type_72,Yes
DB00623,Fluphenazine,DB13323,Trichloroethylene,0.9999018907546997,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trichloroethylene.,49,Type_49,Yes
DB00270,Isradipine,DB00612,Bisoprolol,0.6179221272468567,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Bisoprolol.,49,Type_49,Yes
DB00812,Phenylbutazone,DB00939,Meclofenamic acid,0.9988823533058167,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Meclofenamic acid.,49,Type_49,Yes
DB01136,Carvedilol,DB01201,Rifapentine,0.5627363920211792,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Carvedilol.,4,Type_4,No
DB00208,Ticlopidine,DB00784,Mefenamic acid,0.9770346879959106,47,Type_47,The metabolism of Mefenamic acid can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00308,Ibutilide,DB06699,Degarelix,0.9676802158355713,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00991,Oxaprozin,DB08797,Salicylamide,0.9966323971748352,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Salicylamide.,49,Type_49,Yes
DB00175,Pravastatin,DB05381,Histamine,0.6310187578201294,73,Type_73,The serum concentration of Histamine can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00900,Didanosine,DB01034,Cerulenin,0.8894048929214478,67,Type_67,Didanosine can cause a decrease in the absorption of Cerulenin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00549,Zafirlukast,DB00564,Carbamazepine,0.7975820302963257,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Zafirlukast.,4,Type_4,Yes
DB00483,Gallamine triethiodide,DB00873,Loteprednol,0.9964178800582886,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Loteprednol.,49,Type_49,Yes
DB00619,Imatinib,DB01068,Clonazepam,0.9307886362075806,47,Type_47,The metabolism of Clonazepam can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00235,Milrinone,DB01296,Glucosamine,0.9722986817359924,53,Type_53,Milrinone may increase the antiplatelet activities of Glucosamine.,53,Type_53,Yes
DB00905,Bimatoprost,DB01193,Acebutolol,0.9999581575393677,60,Type_60,Bimatoprost may increase the hypotensive activities of Acebutolol.,60,Type_60,Yes
DB00849,Methylphenobarbital,DB08815,Lurasidone,0.8921574950218201,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Lurasidone.,49,Type_49,Yes
DB01137,Levofloxacin,DB06203,Alogliptin,0.9954608082771301,9,Type_9,Levofloxacin may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00774,Hydroflumethiazide,DB06237,Avanafil,0.9965149164199829,10,Type_10,Hydroflumethiazide may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00483,Gallamine triethiodide,DB01580,Oxprenolol,0.5564392805099487,82,Type_82,Gallamine triethiodide may increase the arrhythmogenic activities of Oxprenolol.,54,Type_54,No
DB01002,Levobupivacaine,DB01169,Arsenic trioxide,0.767500102519989,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Arsenic trioxide.,49,Type_49,Yes
DB01151,Desipramine,DB05812,Abiraterone,0.8029782772064209,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00199,Erythromycin,DB00624,Testosterone,0.9519332647323608,47,Type_47,The metabolism of Testosterone can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00379,Mexiletine,DB00496,Darifenacin,0.9830370545387268,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00420,Promazine,DB01106,Levocabastine,0.9991704225540161,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Levocabastine.,49,Type_49,Yes
DB00252,Phenytoin,DB00924,Cyclobenzaprine,0.7891415953636169,4,Type_4,The metabolism of Cyclobenzaprine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01026,Ketoconazole,DB01264,Darunavir,0.45775243639945984,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00254,Doxycycline,DB00367,Levonorgestrel,0.6868602633476257,47,Type_47,The metabolism of Levonorgestrel can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00339,Pyrazinamide,DB00559,Bosentan,0.7507221102714539,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Pyrazinamide.,75,Type_75,Yes
DB06414,Etravirine,DB08816,Ticagrelor,0.49721312522888184,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Etravirine.,47,Type_47,Yes
DB00331,Metformin,DB01175,Escitalopram,0.9915492534637451,9,Type_9,Metformin may increase the hypoglycemic activities of Escitalopram.,9,Type_9,Yes
DB00474,Methohexital,DB04953,Ezogabine,0.9972290396690369,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Ezogabine.,49,Type_49,Yes
DB08896,Regorafenib,DB08899,Enzalutamide,0.9212332367897034,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Regorafenib.,75,Type_75,Yes
DB01403,Methotrimeprazine,DB11730,Ribociclib,0.5801723003387451,33,Type_33,The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Ribociclib.,33,Type_33,Yes
DB00483,Gallamine triethiodide,DB01245,Decamethonium,0.9754717350006104,70,Type_70,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Gallamine triethiodide.,70,Type_70,Yes
DB00677,Isoflurophate,DB08970,Fluprednidene,0.9952034950256348,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Fluprednidene.,49,Type_49,Yes
DB00035,Desmopressin,DB00210,Adapalene,0.8509253859519958,70,Type_70,The therapeutic efficacy of Adapalene can be decreased when used in combination with Desmopressin.,49,Type_49,No
DB00571,Propranolol,DB01242,Clomipramine,0.8262377977371216,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Propranolol.,49,Type_49,No
DB05676,Apremilast,DB09065,Cobicistat,0.6663769483566284,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Apremilast.,47,Type_47,Yes
DB06694,Xylometazoline,DB11362,Selexipag,0.9995357990264893,60,Type_60,Xylometazoline may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB08820,Ivacaftor,DB09053,Ibrutinib,0.9968256950378418,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB00358,Mefloquine,DB00732,Atracurium besylate,0.7686157822608948,70,Type_70,The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00774,Hydroflumethiazide,DB08439,Parecoxib,0.9888734817504883,70,Type_70,The therapeutic efficacy of Parecoxib can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00323,Tolcapone,DB04908,Flibanserin,0.9967229962348938,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Flibanserin.,49,Type_49,Yes
DB00768,Olopatadine,DB01059,Norfloxacin,0.9854671955108643,27,Type_27,Olopatadine may increase the neuroexcitatory activities of Norfloxacin.,27,Type_27,Yes
DB01595,Nitrazepam,DB11148,Butamben,0.9992746710777283,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Butamben.,49,Type_49,Yes
DB01203,Nadolol,DB06739,Seratrodast,0.9976637363433838,37,Type_37,Nadolol may decrease the antihypertensive activities of Seratrodast.,37,Type_37,Yes
DB02703,Fusidic acid,DB08883,Perampanel,0.9738978743553162,73,Type_73,The serum concentration of Perampanel can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00712,Flurbiprofen,DB00827,Cinoxacin,0.9949819445610046,27,Type_27,Flurbiprofen may increase the neuroexcitatory activities of Cinoxacin.,27,Type_27,Yes
DB00619,Imatinib,DB00752,Tranylcypromine,0.9624389410018921,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00446,Chloramphenicol,DB05812,Abiraterone,0.6801432967185974,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00358,Mefloquine,DB08933,Luliconazole,0.9339434504508972,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB00496,Darifenacin,DB00571,Propranolol,0.9022488594055176,47,Type_47,The metabolism of Propranolol can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00981,Physostigmine,DB01591,Solifenacin,0.9837467074394226,70,Type_70,The therapeutic efficacy of Solifenacin can be decreased when used in combination with Physostigmine.,70,Type_70,Yes
DB09280,Lumacaftor,DB11817,Baricitinib,0.6413144469261169,75,Type_75,The serum concentration of Baricitinib can be decreased when it is combined with Lumacaftor.,75,Type_75,Yes
DB00925,Phenoxybenzamine,DB09242,Moxonidine,0.8764406442642212,60,Type_60,Phenoxybenzamine may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00224,Indinavir,DB06626,Axitinib,0.5413884520530701,47,Type_47,The metabolism of Axitinib can be decreased when combined with Indinavir.,73,Type_73,No
DB06737,Zaltoprofen,DB09285,Morniflumate,0.9998801946640015,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Morniflumate.,49,Type_49,Yes
DB08807,Bopindolol,DB09242,Moxonidine,0.9215791821479797,25,Type_25,Bopindolol may increase the atrioventricular blocking (AV block) activities of Moxonidine.,25,Type_25,Yes
DB00691,Moexipril,DB06268,Sitaxentan,0.9975549578666687,60,Type_60,Moexipril may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00807,Proparacaine,DB01189,Desflurane,0.999523401260376,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Desflurane.,49,Type_49,Yes
DB00370,Mirtazapine,DB01124,Tolbutamide,0.6446580290794373,73,Type_73,The serum concentration of Tolbutamide can be increased when it is combined with Mirtazapine.,47,Type_47,No
DB00449,Dipivefrin,DB00598,Labetalol,0.9733343124389648,25,Type_25,Dipivefrin may increase the atrioventricular blocking (AV block) activities of Labetalol.,25,Type_25,Yes
DB00333,Methadone,DB09068,Vortioxetine,0.6792990565299988,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Vortioxetine.,49,Type_49,Yes
DB00593,Ethosuximide,DB01086,Benzocaine,0.9991058707237244,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Benzocaine.,49,Type_49,Yes
DB00482,Celecoxib,DB00605,Sulindac,0.9112150073051453,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Sulindac.,49,Type_49,Yes
DB00780,Phenelzine,DB00903,Etacrynic acid,0.9799953103065491,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Etacrynic acid.,49,Type_49,Yes
DB06817,Raltegravir,DB08860,Pitavastatin,0.5504480600357056,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Raltegravir.,48,Type_48,No
DB00528,Lercanidipine,DB01367,Rasagiline,0.9801219701766968,60,Type_60,Lercanidipine may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00264,Metoprolol,DB03128,Acetylcholine,0.5829126834869385,47,Type_47,The metabolism of Acetylcholine can be decreased when combined with Metoprolol.,47,Type_47,Yes
DB00195,Betaxolol,DB00715,Paroxetine,0.848571240901947,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00614,Furazolidone,DB06292,Dapagliflozin,0.9471431374549866,9,Type_9,Furazolidone may increase the hypoglycemic activities of Dapagliflozin.,9,Type_9,Yes
DB13158,Clobetasone,DB13783,Acemetacin,0.9351308345794678,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasone is combined with Acemetacin.,49,Type_49,Yes
DB00860,Prednisolone,DB09053,Ibrutinib,0.7262919545173645,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Prednisolone.,73,Type_73,Yes
DB00854,Levorphanol,DB09244,Pirlindole,0.9007092714309692,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Pirlindole.,49,Type_49,Yes
DB04846,Celiprolol,DB09084,Benzydamine,0.9924668669700623,37,Type_37,Celiprolol may decrease the antihypertensive activities of Benzydamine.,37,Type_37,Yes
DB01370,Aluminium,DB08912,Dabrafenib,0.9525116086006165,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Aluminium.,75,Type_75,Yes
DB01185,Fluoxymesterone,DB13158,Clobetasone,1.0,74,Type_74,Fluoxymesterone may increase the fluid retaining activities of Clobetasone.,74,Type_74,Yes
DB00749,Etodolac,DB13158,Clobetasone,0.9985846281051636,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Clobetasone.,49,Type_49,Yes
DB01218,Halofantrine,DB06595,Midostaurin,0.8272348642349243,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Halofantrine.,47,Type_47,Yes
DB06262,Droxidopa,DB06700,Desvenlafaxine,0.9983270764350891,85,Type_85,Droxidopa may increase the tachycardic activities of Desvenlafaxine.,85,Type_85,Yes
DB00501,Cimetidine,DB01131,Proguanil,0.9780412316322327,47,Type_47,The metabolism of Proguanil can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB01211,Clarithromycin,DB01559,Clotiazepam,0.6954289674758911,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB09074,Olaparib,DB11817,Baricitinib,0.9354120492935181,47,Type_47,The metabolism of Baricitinib can be decreased when combined with Olaparib.,47,Type_47,Yes
DB01247,Isocarboxazid,DB01624,Zuclopenthixol,0.9764644503593445,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Zuclopenthixol.,49,Type_49,Yes
DB01018,Guanfacine,DB09085,Tetracaine,0.9998699426651001,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Tetracaine.,49,Type_49,Yes
DB01144,Diclofenamide,DB08822,Azilsartan medoxomil,0.9998525381088257,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenamide is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00381,Amlodipine,DB08808,Bupranolol,0.8030251860618591,60,Type_60,Amlodipine may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00502,Haloperidol,DB00549,Zafirlukast,0.9057402014732361,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00318,Codeine,DB02703,Fusidic acid,0.9974437952041626,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Codeine.,73,Type_73,Yes
DB00285,Venlafaxine,DB01247,Isocarboxazid,0.7248684167861938,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Isocarboxazid.,49,Type_49,Yes
DB00482,Celecoxib,DB09211,Limaprost,0.8741297721862793,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Celecoxib.,70,Type_70,Yes
DB00774,Hydroflumethiazide,DB01070,Dihydrotachysterol,0.9845051169395447,51,Type_51,Hydroflumethiazide may increase the hypercalcemic activities of Dihydrotachysterol.,51,Type_51,Yes
DB00253,Medrysone,DB00673,Aprepitant,0.9964085221290588,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Medrysone.,73,Type_73,Yes
DB00220,Nelfinavir,DB01393,Bezafibrate,0.8244597315788269,47,Type_47,The metabolism of Bezafibrate can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01244,Bepridil,DB01392,Yohimbine,0.9974727034568787,37,Type_37,Bepridil may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00812,Phenylbutazone,DB04865,Omacetaxine mepesuccinate,0.8517594337463379,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00614,Furazolidone,0.5930702090263367,47,Type_47,The metabolism of Furazolidone can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00494,Entacapone,DB00996,Gabapentin,0.9988203644752502,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Gabapentin.,49,Type_49,Yes
DB00705,Delavirdine,DB09102,Daclatasvir,0.5696913003921509,47,Type_47,The metabolism of Daclatasvir can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB06786,Halcinonide,0.999778687953949,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Halcinonide.,83,Type_83,Yes
DB00263,Sulfisoxazole,DB06204,Tapentadol,0.9645967483520508,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00324,Fluorometholone,DB01043,Memantine,0.9998315572738647,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Memantine.,49,Type_49,Yes
DB00446,Chloramphenicol,DB00468,Quinine,0.989941418170929,47,Type_47,The metabolism of Quinine can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00391,Sulpiride,DB09009,Articaine,0.9999793767929077,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Articaine.,49,Type_49,Yes
DB00458,Imipramine,DB00530,Erlotinib,0.740291178226471,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Imipramine.,47,Type_47,Yes
DB01069,Promethazine,DB09072,Sodium oxybate,1.0,16,Type_16,Promethazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00356,Chlorzoxazone,DB00508,Triflupromazine,0.998779833316803,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Triflupromazine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB01250,Olsalazine,0.626976490020752,9,Type_9,Sulfisoxazole may increase the hypoglycemic activities of Olsalazine.,9,Type_9,Yes
DB00774,Hydroflumethiazide,DB08931,Riociguat,0.5065967440605164,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Riociguat.,60,Type_60,No
DB00988,Dopamine,DB06603,Panobinostat,0.9296363592147827,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Dopamine.,73,Type_73,Yes
DB05109,Trabectedin,DB08816,Ticagrelor,0.5522463321685791,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Trabectedin.,47,Type_47,Yes
DB00881,Quinapril,DB09276,Sodium aurothiomalate,0.9999996423721313,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Sodium aurothiomalate.,49,Type_49,Yes
DB01009,Ketoprofen,DB04865,Omacetaxine mepesuccinate,0.852018415927887,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB00980,Ramelteon,DB01176,Cyclizine,0.9999979734420776,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Cyclizine.,49,Type_49,Yes
DB00462,Methscopolamine bromide,DB00844,Nalbuphine,0.9999760389328003,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Nalbuphine.,49,Type_49,Yes
DB00876,Eprosartan,DB01238,Aripiprazole,0.9862568974494934,60,Type_60,Eprosartan may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB01222,Budesonide,DB08895,Tofacitinib,0.9991618394851685,34,Type_34,Budesonide may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB00243,Ranolazine,DB00862,Vardenafil,0.7606766819953918,73,Type_73,The serum concentration of Vardenafil can be increased when it is combined with Ranolazine.,47,Type_47,No
DB01028,Methoxyflurane,DB09009,Articaine,0.999998927116394,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Articaine.,49,Type_49,Yes
DB00234,Reboxetine,DB00559,Bosentan,0.49282634258270264,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Reboxetine.,75,Type_75,Yes
DB00834,Mifepristone,DB01171,Moclobemide,0.5321110486984253,9,Type_9,Mifepristone may increase the hypoglycemic activities of Moclobemide.,73,Type_73,No
DB00896,Rimexolone,DB01600,Tiaprofenic acid,0.9995500445365906,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Tiaprofenic acid.,49,Type_49,Yes
DB01183,Naloxone,DB09280,Lumacaftor,0.8482053279876709,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Naloxone.,73,Type_73,No
DB00694,Daunorubicin,DB01283,Lumiracoxib,0.9861966967582703,72,Type_72,Daunorubicin may decrease the excretion rate of Lumiracoxib which could result in a higher serum level.,72,Type_72,Yes
DB00808,Indapamide,DB09204,Arotinolol,0.9941188097000122,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Arotinolol.,49,Type_49,Yes
DB00268,Ropinirole,DB01440,gamma-Hydroxybutyric acid,0.9993608593940735,32,Type_32,Ropinirole may increase the sedative activities of gamma-Hydroxybutyric acid.,32,Type_32,Yes
DB01170,Guanethidine,DB01203,Nadolol,0.9999529123306274,60,Type_60,Guanethidine may increase the hypotensive activities of Nadolol.,60,Type_60,Yes
DB00371,Meprobamate,DB00409,Remoxipride,0.9962424039840698,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Remoxipride.,49,Type_49,Yes
DB00177,Valsartan,DB09245,Toloxatone,0.8385434150695801,60,Type_60,Valsartan may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00465,Ketorolac,DB04272,Citric acid,0.9996953010559082,6,Type_6,Ketorolac may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB08439,Parecoxib,DB09280,Lumacaftor,0.6637421250343323,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Parecoxib.,75,Type_75,Yes
DB06218,Lacosamide,DB06663,Pasireotide,0.812694787979126,25,Type_25,Lacosamide may increase the atrioventricular blocking (AV block) activities of Pasireotide.,25,Type_25,Yes
DB00401,Nisoldipine,DB00474,Methohexital,0.8702342510223389,60,Type_60,Nisoldipine may increase the hypotensive activities of Methohexital.,60,Type_60,Yes
DB01319,Fosamprenavir,DB08912,Dabrafenib,0.9622333645820618,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Fosamprenavir.,75,Type_75,Yes
DB00741,Hydrocortisone,DB04951,Pirfenidone,0.9996577501296997,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pirfenidone.,49,Type_49,Yes
DB00648,Mitotane,DB01128,Bicalutamide,0.9929916858673096,75,Type_75,The serum concentration of Bicalutamide can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00752,Tranylcypromine,DB01348,Spirapril,0.9823655486106873,60,Type_60,Tranylcypromine may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00608,Chloroquine,DB00734,Risperidone,0.7552822232246399,20,Type_20,Chloroquine may increase the QTc-prolonging activities of Risperidone.,20,Type_20,Yes
DB00182,Amphetamine,DB08799,Antazoline,0.998808741569519,76,Type_76,Amphetamine may decrease the sedative activities of Antazoline.,76,Type_76,Yes
DB01069,Promethazine,DB09042,Tedizolid phosphate,0.821079432964325,64,Type_64,Promethazine may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB00708,Sufentanil,DB00834,Mifepristone,0.7977880239486694,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Sufentanil.,73,Type_73,Yes
DB01210,Levobunolol,DB09241,Methylene blue,0.9906607270240784,60,Type_60,Levobunolol may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00547,Desoximetasone,DB01185,Fluoxymesterone,1.0,74,Type_74,Desoximetasone may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB00873,Loteprednol,DB01397,Magnesium salicylate,0.9862043857574463,49,Type_49,The risk or severity of adverse effects can be increased when Loteprednol is combined with Magnesium salicylate.,49,Type_49,Yes
DB00757,Dolasetron,DB00908,Quinidine,0.8069807291030884,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Quinidine.,47,Type_47,No
DB00091,Cyclosporine,DB08958,Hexetidine,0.552500307559967,47,Type_47,The metabolism of Hexetidine can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00232,Methyclothiazide,DB01090,Pentolinium,0.9170450568199158,73,Type_73,The serum concentration of Pentolinium can be increased when it is combined with Methyclothiazide.,73,Type_73,Yes
DB00208,Ticlopidine,DB01058,Praziquantel,0.8425048589706421,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00722,Lisinopril,DB04920,Clevidipine,0.9554960131645203,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Clevidipine.,49,Type_49,Yes
DB04868,Nilotinib,DB08907,Canagliflozin,0.7435200214385986,47,Type_47,The metabolism of Canagliflozin can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB00619,Imatinib,DB00862,Vardenafil,0.8326023817062378,47,Type_47,The metabolism of Vardenafil can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00967,Desloratadine,DB06204,Tapentadol,0.9284587502479553,16,Type_16,Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00924,Cyclobenzaprine,DB01209,Dezocine,0.9805709719657898,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Dezocine.,49,Type_49,Yes
DB08860,Pitavastatin,DB09120,Zucapsaicin,0.7314066290855408,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Pitavastatin.,73,Type_73,No
DB00542,Benazepril,DB06237,Avanafil,0.9795345067977905,10,Type_10,Benazepril may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB00599,Thiopental,DB00950,Fexofenadine,0.9950011372566223,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Fexofenadine.,49,Type_49,Yes
DB00257,Clotrimazole,DB01403,Methotrimeprazine,0.5363678932189941,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00179,Masoprocol,DB00684,Tobramycin,0.9999668598175049,72,Type_72,Masoprocol may decrease the excretion rate of Tobramycin which could result in a higher serum level.,72,Type_72,Yes
DB06697,Artemether,DB09118,Stiripentol,0.87161785364151,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Artemether.,73,Type_73,Yes
DB00486,Nabilone,DB08918,Levomilnacipran,0.9226218461990356,85,Type_85,Nabilone may increase the tachycardic activities of Levomilnacipran.,49,Type_49,No
DB01076,Atorvastatin,DB06817,Raltegravir,0.9721356630325317,48,Type_48,Atorvastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.,48,Type_48,Yes
DB00228,Enflurane,DB06594,Agomelatine,0.9999301433563232,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Agomelatine.,49,Type_49,Yes
DB00656,Trazodone,DB04844,Tetrabenazine,0.4979097843170166,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Tetrabenazine.,20,Type_20,No
DB01091,Butenafine,DB09238,Manidipine,0.8491258025169373,49,Type_49,The risk or severity of adverse effects can be increased when Butenafine is combined with Manidipine.,49,Type_49,Yes
DB01037,Selegiline,DB08912,Dabrafenib,0.5484151840209961,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Selegiline.,75,Type_75,Yes
DB00790,Perindopril,DB08931,Riociguat,0.6569073796272278,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Riociguat.,73,Type_73,No
DB01264,Darunavir,DB08896,Regorafenib,0.5437774062156677,73,Type_73,The serum concentration of Regorafenib can be increased when it is combined with Darunavir.,47,Type_47,No
DB00934,Maprotiline,DB01028,Methoxyflurane,0.991619348526001,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Methoxyflurane.,49,Type_49,Yes
DB00737,Meclizine,DB04841,Flunarizine,0.9958088397979736,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Flunarizine.,49,Type_49,Yes
DB00715,Paroxetine,DB12161,Deutetrabenazine,0.9383126497268677,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00257,Clotrimazole,DB01228,Encainide,0.9982617497444153,47,Type_47,The metabolism of Encainide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00136,Calcitriol,DB12332,Rucaparib,0.9732326865196228,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Calcitriol.,47,Type_47,Yes
DB00254,Doxycycline,DB00898,Ethanol,0.37731727957725525,47,Type_47,The metabolism of Ethanol can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01178,Chlormezanone,DB01624,Zuclopenthixol,0.9991418123245239,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zuclopenthixol.,49,Type_49,Yes
DB00812,Phenylbutazone,DB13158,Clobetasone,0.9993410706520081,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Clobetasone.,49,Type_49,Yes
DB00221,Isoetharine,DB01136,Carvedilol,0.7398337721824646,5,Type_5,Isoetharine may decrease the vasoconstricting activities of Carvedilol.,5,Type_5,Yes
DB00491,Miglitol,DB00936,Salicylic acid,0.9997623562812805,9,Type_9,Miglitol may increase the hypoglycemic activities of Salicylic acid.,9,Type_9,Yes
DB00401,Nisoldipine,DB00622,Nicardipine,0.8843306303024292,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Nicardipine.,49,Type_49,Yes
DB00484,Brimonidine,DB01175,Escitalopram,0.9131761789321899,85,Type_85,Brimonidine may increase the tachycardic activities of Escitalopram.,49,Type_49,No
DB00381,Amlodipine,DB00559,Bosentan,0.5022923946380615,60,Type_60,Amlodipine may increase the hypotensive activities of Bosentan.,75,Type_75,No
DB00418,Secobarbital,DB08807,Bopindolol,0.6749345660209656,60,Type_60,Secobarbital may increase the hypotensive activities of Bopindolol.,75,Type_75,No
DB00238,Nevirapine,DB00361,Vinorelbine,0.6642897725105286,4,Type_4,The metabolism of Vinorelbine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00968,Methyldopa,DB09235,Efonidipine,0.9288583397865295,60,Type_60,Methyldopa may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00188,Bortezomib,DB01264,Darunavir,0.7580648064613342,47,Type_47,The metabolism of Darunavir can be decreased when combined with Bortezomib.,73,Type_73,No
DB08808,Bupranolol,DB09235,Efonidipine,0.848829984664917,60,Type_60,Bupranolol may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB00681,Amphotericin B,DB00922,Levosimendan,0.9999710321426392,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Levosimendan.,49,Type_49,Yes
DB00424,Hyoscyamine,DB09272,Eluxadoline,0.9997765421867371,39,Type_39,Hyoscyamine may increase the constipating activities of Eluxadoline.,39,Type_39,Yes
DB00747,Scopolamine,DB01075,Diphenhydramine,0.9812026023864746,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Diphenhydramine.,49,Type_49,Yes
DB00728,Rocuronium,DB09093,Chlortetracycline,1.0,21,Type_21,Rocuronium may increase the neuromuscular blocking activities of Chlortetracycline.,21,Type_21,Yes
DB00193,Tramadol,DB01239,Chlorprothixene,0.9916000366210938,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Chlorprothixene.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09297,Paritaprevir,0.8305555582046509,73,Type_73,The serum concentration of Paritaprevir can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00484,Brimonidine,DB09227,Barnidipine,0.7368213534355164,49,Type_49,The risk or severity of adverse effects can be increased when Brimonidine is combined with Barnidipine.,49,Type_49,Yes
DB00575,Clonidine,DB09227,Barnidipine,0.968936026096344,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Barnidipine.,49,Type_49,Yes
DB00502,Haloperidol,DB00807,Proparacaine,0.9995399713516235,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Proparacaine.,49,Type_49,Yes
DB01133,Tiludronic acid,DB08880,Teriflunomide,0.9317417740821838,49,Type_49,The risk or severity of adverse effects can be increased when Tiludronic acid is combined with Teriflunomide.,49,Type_49,Yes
DB00912,Repaglinide,DB01626,Pargyline,0.9990315437316895,9,Type_9,Repaglinide may increase the hypoglycemic activities of Pargyline.,9,Type_9,Yes
DB00370,Mirtazapine,DB06589,Pazopanib,0.7904439568519592,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Mirtazapine.,20,Type_20,No
DB00744,Zileuton,DB12332,Rucaparib,0.9677191972732544,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Zileuton.,47,Type_47,Yes
DB00541,Vincristine,DB08864,Rilpivirine,0.9572168588638306,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00615,Rifabutin,DB08868,Fingolimod,0.6435378789901733,75,Type_75,The serum concentration of Fingolimod can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00623,Fluphenazine,DB00625,Efavirenz,0.9565385580062866,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Efavirenz.,49,Type_49,Yes
DB00224,Indinavir,DB01426,Ajmaline,0.7595424056053162,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00411,Carbamoylcholine,DB01203,Nadolol,0.9988889098167419,49,Type_49,The risk or severity of adverse effects can be increased when Carbamoylcholine is combined with Nadolol.,49,Type_49,Yes
DB00679,Thioridazine,DB09236,Lacidipine,0.9639242887496948,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Lacidipine.,49,Type_49,Yes
DB00285,Venlafaxine,DB00736,Esomeprazole,0.9564716219902039,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00501,Cimetidine,DB08932,Macitentan,0.9697292447090149,47,Type_47,The metabolism of Macitentan can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00590,Doxazosin,DB01295,Bevantolol,0.6345866918563843,30,Type_30,Doxazosin may increase the orthostatic hypotensive activities of Bevantolol.,30,Type_30,Yes
DB01024,Mycophenolic acid,DB09212,Loxoprofen,0.9361076951026917,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Loxoprofen.,49,Type_49,Yes
DB00738,Pentamidine,DB04871,Lorcaserin,0.7745030522346497,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Pentamidine.,47,Type_47,Yes
DB00224,Indinavir,DB00276,Amsacrine,0.8833168148994446,47,Type_47,The metabolism of Amsacrine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01001,Salbutamol,DB01171,Moclobemide,0.986375093460083,49,Type_49,The risk or severity of adverse effects can be increased when Salbutamol is combined with Moclobemide.,49,Type_49,Yes
DB00672,Chlorpropamide,DB00936,Salicylic acid,0.9918555021286011,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Salicylic acid.,9,Type_9,Yes
DB00091,Cyclosporine,DB00518,Albendazole,0.8933044075965881,47,Type_47,The metabolism of Albendazole can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00405,Dexbrompheniramine,DB08815,Lurasidone,0.9996851682662964,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Lurasidone.,49,Type_49,Yes
DB01045,Rifampicin,DB01190,Clindamycin,0.7197170257568359,4,Type_4,The metabolism of Clindamycin can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00783,Estradiol,DB01384,Paramethasone,0.9306843280792236,73,Type_73,The serum concentration of Paramethasone can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB09330,Osimertinib,DB12026,Voxilaprevir,0.7475751042366028,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Osimertinib.,73,Type_73,Yes
DB00817,Rosoxacin,DB06725,Lornoxicam,0.9897350072860718,27,Type_27,Rosoxacin may increase the neuroexcitatory activities of Lornoxicam.,27,Type_27,Yes
DB00555,Lamotrigine,DB00625,Efavirenz,0.9713931083679199,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Efavirenz.,75,Type_75,No
DB01092,Ouabain,DB08808,Bupranolol,0.9911643862724304,54,Type_54,Ouabain may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB09054,Idelalisib,DB11575,Grazoprevir,0.9129540324211121,47,Type_47,The metabolism of Grazoprevir can be decreased when combined with Idelalisib.,47,Type_47,Yes
DB00850,Perphenazine,DB08933,Luliconazole,0.9850732684135437,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Perphenazine.,73,Type_73,Yes
DB00425,Zolpidem,DB08899,Enzalutamide,0.8861724734306335,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Zolpidem.,75,Type_75,Yes
DB00904,Ondansetron,DB04953,Ezogabine,0.9411893486976624,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Ezogabine.,20,Type_20,No
DB01059,Norfloxacin,DB09274,Artesunate,0.6034650206565857,11,Type_11,The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Norfloxacin resulting in a loss in efficacy.,11,Type_11,Yes
DB00227,Lovastatin,DB06803,Niclosamide,0.8378959894180298,47,Type_47,The metabolism of Niclosamide can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00972,Azelastine,DB01283,Lumiracoxib,0.7938538193702698,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Lumiracoxib.,49,Type_49,Yes
DB00573,Fenoprofen,DB09026,Aliskiren,0.6590636968612671,37,Type_37,Fenoprofen may decrease the antihypertensive activities of Aliskiren.,37,Type_37,Yes
DB00370,Mirtazapine,DB00980,Ramelteon,0.9991543292999268,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.,16,Type_16,Yes
DB00285,Venlafaxine,DB01567,Fludiazepam,0.9564751982688904,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fludiazepam.,49,Type_49,Yes
DB00184,Nicotine,DB00227,Lovastatin,0.7367873191833496,47,Type_47,The metabolism of Lovastatin can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00115,Cyanocobalamin,DB00446,Chloramphenicol,0.8482596278190613,70,Type_70,The therapeutic efficacy of Chloramphenicol can be decreased when used in combination with Cyanocobalamin.,70,Type_70,Yes
DB00358,Mefloquine,DB01090,Pentolinium,0.9860925078392029,70,Type_70,The therapeutic efficacy of Pentolinium can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00934,Maprotiline,DB01018,Guanfacine,0.6728368997573853,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Guanfacine.,49,Type_49,Yes
DB00472,Fluoxetine,DB00527,Cinchocaine,0.9841030836105347,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Cinchocaine.,49,Type_49,Yes
DB01409,Tiotropium,DB09063,Ceritinib,0.8923009634017944,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Tiotropium.,73,Type_73,Yes
DB00458,Imipramine,DB09238,Manidipine,0.916671872138977,47,Type_47,The metabolism of Manidipine can be decreased when combined with Imipramine.,47,Type_47,Yes
DB00700,Eplerenone,DB00808,Indapamide,0.9758553504943848,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Indapamide.,49,Type_49,Yes
DB00333,Methadone,DB00774,Hydroflumethiazide,0.8374794721603394,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Hydroflumethiazide.,49,Type_49,Yes
DB00540,Nortriptyline,DB01238,Aripiprazole,0.5797966718673706,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Aripiprazole.,49,Type_49,No
DB01196,Estramustine,DB04868,Nilotinib,0.8269462585449219,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Estramustine.,47,Type_47,Yes
DB00425,Zolpidem,DB13323,Trichloroethylene,0.9939785003662109,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.,16,Type_16,Yes
DB00375,Colestipol,DB00808,Indapamide,0.9953998923301697,67,Type_67,Colestipol can cause a decrease in the absorption of Indapamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01367,Rasagiline,DB06738,Ketobemidone,0.9865608811378479,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Ketobemidone.,49,Type_49,Yes
DB01127,Econazole,DB09230,Azelnidipine,0.9997788071632385,49,Type_49,The risk or severity of adverse effects can be increased when Econazole is combined with Azelnidipine.,49,Type_49,Yes
DB01026,Ketoconazole,DB12332,Rucaparib,0.6307471394538879,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00169,Cholecalciferol,DB00788,Naproxen,0.9191027879714966,47,Type_47,The metabolism of Naproxen can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00184,Nicotine,DB04572,Thiotepa,0.9499300122261047,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01024,Mycophenolic acid,DB01609,Deferasirox,0.5831265449523926,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Deferasirox.,49,Type_49,Yes
DB00765,Metyrosine,DB06268,Sitaxentan,0.9887650012969971,60,Type_60,Metyrosine may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00420,Promazine,DB00530,Erlotinib,0.7897886037826538,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Promazine.,47,Type_47,Yes
DB00338,Omeprazole,DB06739,Seratrodast,0.927208662033081,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00972,Azelastine,DB13158,Clobetasone,0.9934350252151489,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Clobetasone.,49,Type_49,Yes
DB01118,Amiodarone,DB01173,Orphenadrine,0.8210976719856262,47,Type_47,The metabolism of Orphenadrine can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00467,Enoxacin,DB00784,Mefenamic acid,0.9996908903121948,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Mefenamic acid.,27,Type_27,Yes
DB00195,Betaxolol,DB06697,Artemether,0.9229336977005005,47,Type_47,The metabolism of Artemether can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00258,Calcium acetate,DB06410,Doxercalciferol,0.9655903577804565,49,Type_49,The risk or severity of adverse effects can be increased when Calcium acetate is combined with Doxercalciferol.,49,Type_49,Yes
DB00705,Delavirdine,DB12332,Rucaparib,0.707144558429718,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00006,Bivalirudin,DB00939,Meclofenamic acid,0.9886431097984314,6,Type_6,Bivalirudin may increase the anticoagulant activities of Meclofenamic acid.,6,Type_6,Yes
DB01131,Proguanil,DB09054,Idelalisib,0.8281124830245972,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Proguanil.,47,Type_47,Yes
DB04871,Lorcaserin,DB08933,Luliconazole,0.9715867638587952,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Lorcaserin.,73,Type_73,Yes
DB00255,Diethylstilbestrol,DB01418,Acenocoumarol,0.9750443696975708,12,Type_12,Diethylstilbestrol may decrease the anticoagulant activities of Acenocoumarol.,12,Type_12,Yes
DB00468,Quinine,DB01426,Ajmaline,0.9060221314430237,20,Type_20,Quinine may increase the QTc-prolonging activities of Ajmaline.,47,Type_47,No
DB00283,Clemastine,DB00475,Chlordiazepoxide,0.8397880792617798,47,Type_47,The metabolism of Chlordiazepoxide can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00637,Astemizole,DB09118,Stiripentol,0.9340367317199707,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Astemizole.,73,Type_73,Yes
DB00445,Epirubicin,DB01607,Ticarcillin,0.9756115674972534,75,Type_75,The serum concentration of Ticarcillin can be decreased when it is combined with Epirubicin.,75,Type_75,Yes
DB00208,Ticlopidine,DB00332,Ipratropium,0.9537898898124695,47,Type_47,The metabolism of Ipratropium can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00332,Ipratropium,DB08893,Mirabegron,0.8135807514190674,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Ipratropium.,49,Type_49,No
DB00178,Ramipril,DB00337,Pimecrolimus,0.9740279316902161,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Pimecrolimus.,49,Type_49,Yes
DB01178,Chlormezanone,DB01588,Prazepam,0.9998794794082642,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Prazepam.,49,Type_49,Yes
DB01012,Cinacalcet,DB09167,Dosulepin,0.8712790012359619,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Cinacalcet.,73,Type_73,No
DB00706,Tamsulosin,DB00753,Isoflurane,0.9276074171066284,49,Type_49,The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isoflurane.,49,Type_49,Yes
DB00852,Pseudoephedrine,DB06697,Artemether,0.9840126037597656,47,Type_47,The metabolism of Artemether can be decreased when combined with Pseudoephedrine.,47,Type_47,Yes
DB00907,Cocaine,DB09345,Pramocaine,0.9999872446060181,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Pramocaine.,49,Type_49,Yes
DB00949,Felbamate,DB00962,Zaleplon,0.9009448885917664,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Zaleplon.,49,Type_49,Yes
DB00413,Pramipexole,DB01214,Metipranolol,0.9553061127662659,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Metipranolol.,49,Type_49,Yes
DB00524,Metolazone,DB00747,Scopolamine,0.9415082931518555,73,Type_73,The serum concentration of Scopolamine can be increased when it is combined with Metolazone.,73,Type_73,Yes
DB00273,Topiramate,DB01129,Rabeprazole,0.8746944069862366,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Topiramate.,47,Type_47,Yes
DB00541,Vincristine,DB08899,Enzalutamide,0.9236096739768982,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Vincristine.,75,Type_75,Yes
DB00735,Naftifine,DB00966,Telmisartan,0.9753544330596924,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Telmisartan.,49,Type_49,Yes
DB00482,Celecoxib,DB00783,Estradiol,0.6172351837158203,47,Type_47,The metabolism of Estradiol can be decreased when combined with Celecoxib.,81,Type_81,No
DB00765,Metyrosine,DB00829,Diazepam,0.9999961853027344,32,Type_32,Metyrosine may increase the sedative activities of Diazepam.,32,Type_32,Yes
DB01408,Bambuterol,DB08808,Bupranolol,0.9955201148986816,14,Type_14,Bambuterol may decrease the bronchodilatory activities of Bupranolol.,14,Type_14,Yes
DB00418,Secobarbital,DB08992,Eperisone,0.9639854431152344,4,Type_4,The metabolism of Eperisone can be increased when combined with Secobarbital.,4,Type_4,Yes
DB06736,Aceclofenac,DB09288,Propacetamol,0.9980539083480835,49,Type_49,The risk or severity of adverse effects can be increased when Aceclofenac is combined with Propacetamol.,49,Type_49,Yes
DB06287,Temsirolimus,DB08912,Dabrafenib,0.9444668292999268,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Temsirolimus.,75,Type_75,Yes
DB00961,Mepivacaine,DB01154,Thiamylal,0.9986974596977234,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Thiamylal.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00521,Carteolol,0.8127058744430542,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carteolol.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB01167,Itraconazole,0.8975592255592346,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00253,Medrysone,DB00774,Hydroflumethiazide,0.9999879598617554,83,Type_83,Medrysone may increase the hypokalemic activities of Hydroflumethiazide.,83,Type_83,Yes
DB00976,Telithromycin,DB01103,Quinacrine,0.7889949083328247,47,Type_47,The metabolism of Quinacrine can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00268,Ropinirole,DB00586,Diclofenac,0.7591938972473145,47,Type_47,The metabolism of Diclofenac can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00610,Metaraminol,DB00805,Minaprine,0.9960434436798096,71,Type_71,Metaraminol may increase the hypertensive activities of Minaprine.,71,Type_71,Yes
DB00899,Remifentanil,DB01238,Aripiprazole,0.5820660591125488,60,Type_60,Remifentanil may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00104,Octreotide,DB08907,Canagliflozin,0.5222910642623901,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Octreotide.,70,Type_70,Yes
DB00246,Ziprasidone,DB01576,Dextroamphetamine,0.9758054614067078,47,Type_47,The metabolism of Dextroamphetamine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00469,Tenoxicam,DB00903,Etacrynic acid,0.9999397993087769,29,Type_29,Tenoxicam may decrease the diuretic activities of Etacrynic acid.,29,Type_29,Yes
DB01232,Saquinavir,DB01241,Gemfibrozil,0.8826290369033813,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00237,Butabarbital,DB00628,Clorazepic acid,0.9987635612487793,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Clorazepic acid.,49,Type_49,Yes
DB00484,Brimonidine,DB01203,Nadolol,0.9073449373245239,10,Type_10,Brimonidine may increase the antihypertensive activities of Nadolol.,10,Type_10,Yes
DB00625,Efavirenz,DB09009,Articaine,0.9939602613449097,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Articaine.,49,Type_49,Yes
DB00217,Bethanidine,DB00521,Carteolol,0.9178991913795471,25,Type_25,Bethanidine may increase the atrioventricular blocking (AV block) activities of Carteolol.,25,Type_25,Yes
DB01601,Lopinavir,DB08906,Fluticasone furoate,0.9063376188278198,47,Type_47,The metabolism of Fluticasone furoate can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB01072,Atazanavir,DB08815,Lurasidone,0.8465698957443237,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00186,Lorazepam,DB00296,Ropivacaine,0.9848111867904663,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Ropivacaine.,49,Type_49,Yes
DB00452,Framycetin,DB00605,Sulindac,0.999994158744812,72,Type_72,Framycetin may decrease the excretion rate of Sulindac which could result in a higher serum level.,72,Type_72,Yes
DB00252,Phenytoin,DB08868,Fingolimod,0.6363531351089478,75,Type_75,The serum concentration of Fingolimod can be decreased when it is combined with Phenytoin.,4,Type_4,No
DB04743,Nimesulide,DB05676,Apremilast,0.9928816556930542,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Apremilast.,49,Type_49,Yes
DB06712,Nilvadipine,DB09220,Nicorandil,0.9986591339111328,60,Type_60,Nilvadipine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00880,Chlorothiazide,DB01229,Paclitaxel,0.9978579878807068,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Paclitaxel.,49,Type_49,Yes
DB00594,Amiloride,DB01159,Halothane,0.9992092847824097,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Halothane.,49,Type_49,Yes
DB00270,Isradipine,DB01091,Butenafine,0.8692758679389954,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Butenafine.,49,Type_49,Yes
DB00408,Loxapine,DB01463,Fencamfamin,0.8762052059173584,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Fencamfamin.,49,Type_49,Yes
DB01104,Sertraline,DB09053,Ibrutinib,0.841405987739563,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Sertraline.,73,Type_73,Yes
DB00270,Isradipine,DB00531,Cyclophosphamide,0.6688638925552368,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00598,Labetalol,DB00623,Fluphenazine,0.862220048904419,60,Type_60,Labetalol may increase the hypotensive activities of Fluphenazine.,60,Type_60,Yes
DB04844,Tetrabenazine,DB09286,Pipamperone,0.9659565091133118,49,Type_49,The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Pipamperone.,49,Type_49,Yes
DB00940,Methantheline,DB01072,Atazanavir,0.6447330713272095,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Methantheline.,75,Type_75,No
DB01192,Oxymorphone,DB01440,gamma-Hydroxybutyric acid,0.9977796673774719,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00582,Voriconazole,DB00872,Conivaptan,0.9778928160667419,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB01223,Aminophylline,DB01340,Cilazapril,0.8592355251312256,75,Type_75,The serum concentration of Cilazapril can be decreased when it is combined with Aminophylline.,75,Type_75,Yes
DB00381,Amlodipine,DB00903,Etacrynic acid,0.8518417477607727,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Etacrynic acid.,49,Type_49,Yes
DB00208,Ticlopidine,DB00295,Morphine,0.973091721534729,47,Type_47,The metabolism of Morphine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00861,Diflunisal,DB01210,Levobunolol,0.9988447427749634,37,Type_37,Diflunisal may decrease the antihypertensive activities of Levobunolol.,37,Type_37,Yes
DB01088,Iloprost,DB04898,Ximelagatran,0.9620704650878906,6,Type_6,Iloprost may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00396,Progesterone,DB00997,Doxorubicin,0.4461570978164673,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Progesterone.,73,Type_73,No
DB00375,Colestipol,DB00846,Flurandrenolide,0.9516860246658325,67,Type_67,Colestipol can cause a decrease in the absorption of Flurandrenolide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00285,Venlafaxine,DB00914,Phenformin,0.7669350504875183,9,Type_9,Venlafaxine may increase the hypoglycemic activities of Phenformin.,47,Type_47,No
DB00748,Carbinoxamine,DB08918,Levomilnacipran,0.9622160196304321,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Levomilnacipran.,49,Type_49,Yes
DB01009,Ketoprofen,DB01609,Deferasirox,0.5264772176742554,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Ketoprofen.,49,Type_49,No
DB00625,Efavirenz,DB01601,Lopinavir,0.6501010656356812,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Efavirenz.,75,Type_75,No
DB00690,Flurazepam,DB01154,Thiamylal,0.9301049113273621,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Thiamylal.,49,Type_49,Yes
DB00623,Fluphenazine,DB00656,Trazodone,0.7328313589096069,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trazodone.,49,Type_49,Yes
DB00285,Venlafaxine,DB01394,Colchicine,0.9751366376876831,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Venlafaxine.,73,Type_73,Yes
DB01355,Hexobarbital,DB01601,Lopinavir,0.8507170677185059,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Hexobarbital.,47,Type_47,Yes
DB00598,Labetalol,DB01158,Bretylium,0.48375508189201355,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Bretylium.,54,Type_54,No
DB00682,Warfarin,DB06717,Fosaprepitant,0.7859784960746765,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Warfarin.,75,Type_75,No
DB00320,Dihydroergotamine,DB00519,Trandolapril,0.5325528979301453,73,Type_73,The serum concentration of Trandolapril can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB00231,Temazepam,DB00366,Doxylamine,0.9999998807907104,16,Type_16,Temazepam may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00705,Delavirdine,DB06292,Dapagliflozin,0.9468240141868591,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00482,Celecoxib,DB00615,Rifabutin,0.5364924073219299,4,Type_4,The metabolism of Rifabutin can be increased when combined with Celecoxib.,4,Type_4,Yes
DB00177,Valsartan,DB00657,Mecamylamine,0.8054038286209106,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Mecamylamine.,49,Type_49,Yes
DB00753,Isoflurane,DB01242,Clomipramine,0.4263555705547333,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Isoflurane.,49,Type_49,No
DB04835,Maraviroc,DB04855,Dronedarone,0.5779721736907959,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Maraviroc.,47,Type_47,Yes
DB00284,Acarbose,DB00443,Betamethasone,0.9995043277740479,70,Type_70,The therapeutic efficacy of Betamethasone can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00461,Nabumetone,DB00682,Warfarin,0.9998733997344971,6,Type_6,Nabumetone may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00231,Temazepam,DB06413,Armodafinil,0.9497829079627991,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00233,Aminosalicylic acid,DB01014,Balsalazide,0.9109565615653992,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Balsalazide.,6,Type_6,No
DB00770,Alprostadil,DB06737,Zaltoprofen,0.9361150860786438,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00555,Lamotrigine,DB06216,Asenapine,0.9755374193191528,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Asenapine.,49,Type_49,Yes
DB00482,Celecoxib,DB09075,Edoxaban,0.9527677297592163,6,Type_6,Celecoxib may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB00559,Bosentan,DB01348,Spirapril,0.68294757604599,60,Type_60,Bosentan may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00588,Fluticasone propionate,DB00835,Brompheniramine,0.9972026348114014,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Brompheniramine.,49,Type_49,Yes
DB00296,Ropivacaine,DB01236,Sevoflurane,0.786899745464325,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Sevoflurane.,49,Type_49,Yes
DB00321,Amitriptyline,DB11304,Phenoxyethanol,0.9990609288215637,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenoxyethanol.,49,Type_49,Yes
DB00612,Bisoprolol,DB06292,Dapagliflozin,0.9932385683059692,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dapagliflozin.,49,Type_49,Yes
DB00593,Ethosuximide,DB00834,Mifepristone,0.8460930585861206,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Ethosuximide.,73,Type_73,Yes
DB00747,Scopolamine,DB00892,Oxybuprocaine,0.9999325275421143,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybuprocaine.,49,Type_49,Yes
DB00231,Temazepam,DB04842,Fluspirilene,0.9997650980949402,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Fluspirilene.,49,Type_49,Yes
DB01253,Ergometrine,DB09224,Melperone,0.996788501739502,49,Type_49,The risk or severity of adverse effects can be increased when Ergometrine is combined with Melperone.,49,Type_49,Yes
DB00898,Ethanol,DB01095,Fluvastatin,0.5738440752029419,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Ethanol.,73,Type_73,Yes
DB00950,Fexofenadine,DB05271,Rotigotine,0.9967001080513,32,Type_32,Fexofenadine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00584,Enalapril,DB00939,Meclofenamic acid,0.9744634032249451,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Meclofenamic acid.,49,Type_49,Yes
DB00398,Sorafenib,DB08828,Vismodegib,0.6287631988525391,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00418,Secobarbital,DB00474,Methohexital,0.6966691613197327,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Methohexital.,49,Type_49,Yes
DB01192,Oxymorphone,DB08873,Boceprevir,0.5492168068885803,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Oxymorphone.,47,Type_47,Yes
DB00921,Buprenorphine,DB09048,Netupitant,0.9526925086975098,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Buprenorphine.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB01204,Mitoxantrone,0.9877231121063232,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Mitoxantrone.,15,Type_15,Yes
DB00193,Tramadol,DB06016,Cariprazine,0.4879145324230194,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Tramadol.,49,Type_49,No
DB00608,Chloroquine,DB00817,Rosoxacin,0.666845440864563,27,Type_27,Chloroquine may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB00363,Clozapine,DB09236,Lacidipine,0.977588415145874,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Lacidipine.,49,Type_49,Yes
DB00502,Haloperidol,DB00952,Naratriptan,0.983727216720581,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Naratriptan.,49,Type_49,Yes
DB00391,Sulpiride,DB08922,Perospirone,0.7123825550079346,36,Type_36,Sulpiride may increase the antipsychotic activities of Perospirone.,36,Type_36,Yes
DB01241,Gemfibrozil,DB01435,Antipyrine,0.9464159607887268,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Gemfibrozil.,47,Type_47,Yes
DB00392,Profenamine,DB00940,Methantheline,0.9872775673866272,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Methantheline.,49,Type_49,Yes
DB00420,Promazine,DB00956,Hydrocodone,0.9877188205718994,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,16,Type_16,Yes
DB00448,Lansoprazole,DB06595,Midostaurin,0.8516305088996887,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Lansoprazole.,47,Type_47,Yes
DB08881,Vemurafenib,DB13146,Fluciclovine (18F),0.5946505069732666,75,Type_75,The serum concentration of Fluciclovine (18F) can be decreased when it is combined with Vemurafenib.,73,Type_73,No
DB00687,Fludrocortisone,DB01232,Saquinavir,0.8723075985908508,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Fludrocortisone.,73,Type_73,Yes
DB00254,Doxycycline,DB04835,Maraviroc,0.8717923164367676,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00946,Phenprocoumon,DB09030,Vorapaxar,0.8156100511550903,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Vorapaxar.,49,Type_49,No
DB01256,Retapamulin,DB06290,Simeprevir,0.8758296370506287,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Retapamulin.,73,Type_73,Yes
DB00647,Dextropropoxyphene,DB01437,Glutethimide,0.9995743632316589,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Glutethimide.,49,Type_49,Yes
DB00991,Oxaprozin,DB08984,Etofenamate,0.9965757727622986,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Etofenamate.,49,Type_49,Yes
DB00006,Bivalirudin,DB09283,Trapidil,0.8850792050361633,6,Type_6,Bivalirudin may increase the anticoagulant activities of Trapidil.,6,Type_6,Yes
DB00661,Verapamil,DB08916,Afatinib,0.8737091422080994,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Verapamil.,75,Type_75,No
DB01215,Estazolam,DB09342,Propoxycaine,0.9912168979644775,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Propoxycaine.,49,Type_49,Yes
DB01264,Darunavir,DB08971,Fluocortolone,0.7981070876121521,73,Type_73,The serum concentration of Fluocortolone can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB01623,Thiothixene,DB06204,Tapentadol,0.9979023933410645,16,Type_16,Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00243,Ranolazine,DB00276,Amsacrine,0.5656356811523438,47,Type_47,The metabolism of Amsacrine can be decreased when combined with Ranolazine.,73,Type_73,No
DB00584,Enalapril,DB00598,Labetalol,0.9671507477760315,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Labetalol.,49,Type_49,Yes
DB00542,Benazepril,DB00922,Levosimendan,0.9306291937828064,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Levosimendan.,49,Type_49,Yes
DB04855,Dronedarone,DB08815,Lurasidone,0.4541727900505066,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Dronedarone.,73,Type_73,Yes
DB00343,Diltiazem,DB00594,Amiloride,0.9716342091560364,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Amiloride.,49,Type_49,Yes
DB01609,Deferasirox,DB08867,Ulipristal,0.5661064386367798,73,Type_73,The serum concentration of Ulipristal can be increased when it is combined with Deferasirox.,75,Type_75,No
DB00742,Mannitol,DB01229,Paclitaxel,0.9973491430282593,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Paclitaxel.,49,Type_49,Yes
DB00470,Dronabinol,DB00543,Amoxapine,0.9982264637947083,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.,16,Type_16,Yes
DB00641,Simvastatin,DB06207,Silodosin,0.9891514778137207,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00206,Reserpine,DB01114,Chlorpheniramine,0.9907481074333191,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Chlorpheniramine.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB06717,Fosaprepitant,0.7410889863967896,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Ethinylestradiol.,75,Type_75,Yes
DB00559,Bosentan,DB09330,Osimertinib,0.6619745492935181,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Bosentan.,73,Type_73,Yes
DB00298,Dapiprazole,DB00318,Codeine,0.9899835586547852,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Codeine.,49,Type_49,Yes
DB00237,Butabarbital,DB00985,Dimenhydrinate,0.9999841451644897,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Dimenhydrinate.,49,Type_49,Yes
DB00221,Isoetharine,DB08807,Bopindolol,0.999121367931366,14,Type_14,Isoetharine may decrease the bronchodilatory activities of Bopindolol.,14,Type_14,Yes
DB00327,Hydromorphone,DB09244,Pirlindole,0.8867291212081909,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pirlindole.,49,Type_49,Yes
DB00486,Nabilone,DB00508,Triflupromazine,0.9986756443977356,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.,16,Type_16,Yes
DB06335,Saxagliptin,DB09270,Ubidecarenone,0.7280665040016174,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Saxagliptin.,8,Type_8,No
DB00199,Erythromycin,DB00334,Olanzapine,0.8628312945365906,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Olanzapine.,20,Type_20,Yes
DB00697,Tizanidine,DB01588,Prazepam,0.8974589705467224,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Prazepam.,49,Type_49,Yes
DB01268,Sunitinib,DB09038,Empagliflozin,0.9748993515968323,9,Type_9,Sunitinib may increase the hypoglycemic activities of Empagliflozin.,9,Type_9,Yes
DB00588,Fluticasone propionate,DB09212,Loxoprofen,0.9995251893997192,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Loxoprofen.,49,Type_49,Yes
DB01628,Etoricoxib,DB12332,Rucaparib,0.988355278968811,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Etoricoxib.,47,Type_47,Yes
DB00816,Orciprenaline,DB00903,Etacrynic acid,0.9923122525215149,83,Type_83,Orciprenaline may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB00653,Magnesium sulfate,DB00758,Clopidogrel,0.40805938839912415,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Magnesium sulfate.,70,Type_70,No
DB00238,Nevirapine,DB05381,Histamine,0.8868985176086426,4,Type_4,The metabolism of Histamine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00227,Lovastatin,DB08895,Tofacitinib,0.5988409519195557,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00374,Treprostinil,DB00738,Pentamidine,0.97678542137146,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00623,Fluphenazine,DB00660,Metaxalone,0.9999620914459229,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Metaxalone.,49,Type_49,Yes
DB00768,Olopatadine,DB01440,gamma-Hydroxybutyric acid,0.9948315620422363,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00838,Clocortolone,DB00977,Ethinylestradiol,0.9971272349357605,73,Type_73,The serum concentration of Ethinylestradiol can be increased when it is combined with Clocortolone.,73,Type_73,Yes
DB06616,Bosutinib,DB08907,Canagliflozin,0.5363806486129761,73,Type_73,The serum concentration of Canagliflozin can be increased when it is combined with Bosutinib.,73,Type_73,Yes
DB00193,Tramadol,DB00985,Dimenhydrinate,0.9800614714622498,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Dimenhydrinate.,49,Type_49,Yes
DB00224,Indinavir,DB00712,Flurbiprofen,0.9458011984825134,47,Type_47,The metabolism of Flurbiprofen can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00960,Pindolol,DB06700,Desvenlafaxine,0.730099618434906,73,Type_73,The serum concentration of Desvenlafaxine can be increased when it is combined with Pindolol.,73,Type_73,Yes
DB00934,Maprotiline,DB09017,Brotizolam,0.9999834299087524,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Brotizolam.,49,Type_49,Yes
DB01167,Itraconazole,DB09075,Edoxaban,0.9875417351722717,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00402,Eszopiclone,DB04841,Flunarizine,0.994901180267334,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flunarizine.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB08943,Isoconazole,0.6540517210960388,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Isoconazole.,49,Type_49,Yes
DB00288,Amcinonide,DB00483,Gallamine triethiodide,0.9986751675605774,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Gallamine triethiodide.,49,Type_49,Yes
DB00220,Nelfinavir,DB09053,Ibrutinib,0.8102672100067139,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Nelfinavir.,73,Type_73,Yes
DB00808,Indapamide,DB00869,Dorzolamide,0.9575750231742859,60,Type_60,Indapamide may increase the hypotensive activities of Dorzolamide.,60,Type_60,Yes
DB09242,Moxonidine,DB09244,Pirlindole,0.996559202671051,60,Type_60,Moxonidine may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00921,Buprenorphine,DB01045,Rifampicin,0.8379385471343994,4,Type_4,The metabolism of Rifampicin can be increased when combined with Buprenorphine.,4,Type_4,Yes
DB00422,Methylphenidate,DB00800,Fenoldopam,0.9999932050704956,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Fenoldopam.,37,Type_37,Yes
DB01087,Primaquine,DB06697,Artemether,0.3288588523864746,33,Type_33,The risk or severity of QTc prolongation can be increased when Primaquine is combined with Artemether.,33,Type_33,Yes
DB09027,Ledipasvir,DB12070,Letermovir,0.9489680528640747,73,Type_73,The serum concentration of Letermovir can be increased when it is combined with Ledipasvir.,73,Type_73,Yes
DB00594,Amiloride,DB00679,Thioridazine,0.8505097031593323,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Thioridazine.,49,Type_49,Yes
DB00318,Codeine,DB01106,Levocabastine,0.9997013211250305,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Levocabastine.,49,Type_49,Yes
DB00765,Metyrosine,DB00797,Tolazoline,0.9968794584274292,60,Type_60,Metyrosine may increase the hypotensive activities of Tolazoline.,60,Type_60,Yes
DB01355,Hexobarbital,DB01427,Amrinone,0.9653999209403992,4,Type_4,The metabolism of Amrinone can be increased when combined with Hexobarbital.,4,Type_4,Yes
DB00381,Amlodipine,DB01580,Oxprenolol,0.7216802835464478,60,Type_60,Amlodipine may increase the hypotensive activities of Oxprenolol.,60,Type_60,Yes
DB00248,Cabergoline,DB01263,Posaconazole,0.5747849345207214,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Cabergoline.,47,Type_47,Yes
DB00215,Citalopram,DB01628,Etoricoxib,0.5192694067955017,53,Type_53,Citalopram may increase the antiplatelet activities of Etoricoxib.,53,Type_53,Yes
DB00454,Meperidine,DB09477,Enalaprilat,0.507592499256134,60,Type_60,Meperidine may increase the hypotensive activities of Enalaprilat.,49,Type_49,No
DB01198,Zopiclone,DB06201,Rufinamide,0.9954543113708496,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Rufinamide.,49,Type_49,Yes
DB00349,Clobazam,DB09120,Zucapsaicin,0.9986599683761597,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00395,Carisoprodol,DB00907,Cocaine,0.6247637271881104,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cocaine.,49,Type_49,Yes
DB01008,Busulfan,DB09118,Stiripentol,0.8248651623725891,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Busulfan.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB06817,Raltegravir,0.9606817960739136,73,Type_73,The serum concentration of Raltegravir can be increased when it is combined with Magnesium sulfate.,75,Type_75,No
DB00779,Nalidixic acid,DB09215,Droxicam,0.9991426467895508,27,Type_27,Nalidixic acid may increase the neuroexcitatory activities of Droxicam.,27,Type_27,Yes
DB00797,Tolazoline,DB06403,Ambrisentan,0.9999359846115112,60,Type_60,Tolazoline may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00467,Enoxacin,DB06802,Nepafenac,0.9995131492614746,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Nepafenac.,27,Type_27,Yes
DB00701,Amprenavir,DB09053,Ibrutinib,0.7164131999015808,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Amprenavir.,73,Type_73,Yes
DB00333,Methadone,DB00633,Dexmedetomidine,0.8316595554351807,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Dexmedetomidine.,49,Type_49,Yes
DB00539,Toremifene,DB01319,Fosamprenavir,0.5353185534477234,73,Type_73,The serum concentration of Fosamprenavir can be increased when it is combined with Toremifene.,47,Type_47,No
DB00264,Metoprolol,DB01023,Felodipine,0.5183553099632263,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Felodipine.,73,Type_73,No
DB00987,Cytarabine,DB01319,Fosamprenavir,0.7995777726173401,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Cytarabine.,47,Type_47,Yes
DB01283,Lumiracoxib,DB08981,Fenbufen,0.9978154897689819,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Fenbufen.,49,Type_49,Yes
DB01072,Atazanavir,DB09270,Ubidecarenone,0.9598161578178406,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00657,Mecamylamine,DB01172,Kanamycin,0.9773598313331604,21,Type_21,Mecamylamine may increase the neuromuscular blocking activities of Kanamycin.,21,Type_21,Yes
DB00390,Digoxin,DB01234,Dexamethasone,0.966791033744812,58,Type_58,Digoxin may decrease the cardiotoxic activities of Dexamethasone.,58,Type_58,Yes
DB06708,Lumefantrine,DB09048,Netupitant,0.9417073130607605,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Lumefantrine.,73,Type_73,Yes
DB00468,Quinine,DB00932,Tipranavir,0.8736519813537598,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Quinine.,47,Type_47,Yes
DB00366,Doxylamine,DB00454,Meperidine,0.9997268319129944,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Meperidine.,16,Type_16,Yes
DB00486,Nabilone,DB00790,Perindopril,0.8446980118751526,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Perindopril.,49,Type_49,Yes
DB00227,Lovastatin,DB06228,Rivaroxaban,0.7305287718772888,47,Type_47,The metabolism of Rivaroxaban can be decreased when combined with Lovastatin.,73,Type_73,No
DB00465,Ketorolac,DB01136,Carvedilol,0.9994575381278992,37,Type_37,Ketorolac may decrease the antihypertensive activities of Carvedilol.,37,Type_37,Yes
DB00953,Rizatriptan,DB01100,Pimozide,0.9538784027099609,49,Type_49,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Pimozide.,49,Type_49,Yes
DB00427,Triprolidine,DB00737,Meclizine,0.9999617338180542,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Meclizine.,49,Type_49,Yes
DB01018,Guanfacine,DB01124,Tolbutamide,0.30233100056648254,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Guanfacine.,47,Type_47,Yes
DB00462,Methscopolamine bromide,DB00899,Remifentanil,0.9999234676361084,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Remifentanil.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB00866,Alprenolol,0.9935036301612854,25,Type_25,Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Alprenolol.,25,Type_25,Yes
DB01198,Zopiclone,DB13323,Trichloroethylene,0.9999855756759644,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Trichloroethylene.,49,Type_49,Yes
DB00950,Fexofenadine,DB09017,Brotizolam,0.9999963045120239,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Brotizolam.,49,Type_49,Yes
DB00469,Tenoxicam,DB01130,Prednicarbate,0.9998377561569214,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Prednicarbate.,49,Type_49,Yes
DB00806,Pentoxifylline,DB00905,Bimatoprost,0.99843829870224,60,Type_60,Pentoxifylline may increase the hypotensive activities of Bimatoprost.,60,Type_60,Yes
DB00177,Valsartan,DB00631,Clofarabine,0.989543080329895,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Clofarabine.,49,Type_49,Yes
DB00972,Azelastine,DB01340,Cilazapril,0.5004906058311462,73,Type_73,The serum concentration of Cilazapril can be increased when it is combined with Azelastine.,49,Type_49,No
DB00188,Bortezomib,DB00705,Delavirdine,0.8008267879486084,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01221,Ketamine,DB09118,Stiripentol,0.5897364616394043,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ketamine.,73,Type_73,Yes
DB00790,Perindopril,DB00800,Fenoldopam,0.8939579129219055,60,Type_60,Perindopril may increase the hypotensive activities of Fenoldopam.,60,Type_60,Yes
DB01320,Fosphenytoin,DB09030,Vorapaxar,0.5462062954902649,75,Type_75,The serum concentration of Vorapaxar can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB00608,Chloroquine,DB09288,Propacetamol,0.7064790725708008,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Propacetamol.,49,Type_49,Yes
DB00252,Phenytoin,DB01226,Mivacurium,0.8995295763015747,17,Type_17,Phenytoin may decrease the neuromuscular blocking activities of Mivacurium.,17,Type_17,Yes
DB00370,Mirtazapine,DB01068,Clonazepam,0.9996448755264282,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.,16,Type_16,Yes
DB01106,Levocabastine,DB06738,Ketobemidone,0.9976964592933655,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Ketobemidone.,49,Type_49,Yes
DB00318,Codeine,DB08933,Luliconazole,0.9391953349113464,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Codeine.,73,Type_73,Yes
DB01024,Mycophenolic acid,DB01605,Pivmecillinam,0.6668047904968262,11,Type_11,The serum concentration of the active metabolites of Pivmecillinam can be reduced when Pivmecillinam is used in combination with Mycophenolic acid resulting in a loss in efficacy.,11,Type_11,Yes
DB00557,Hydroxyzine,DB01211,Clarithromycin,0.5949239134788513,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Hydroxyzine.,20,Type_20,No
DB01418,Acenocoumarol,DB13783,Acemetacin,0.8963627219200134,66,Type_66,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Acemetacin.,66,Type_66,Yes
DB01036,Tolterodine,DB01264,Darunavir,0.4923163652420044,47,Type_47,The metabolism of Darunavir can be decreased when combined with Tolterodine.,73,Type_73,No
DB01174,Phenobarbital,DB08970,Fluprednidene,0.9924497604370117,75,Type_75,The serum concentration of Fluprednidene can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB01103,Quinacrine,DB09073,Palbociclib,0.9972645044326782,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Quinacrine.,73,Type_73,Yes
DB01054,Nitrendipine,DB01154,Thiamylal,0.45146146416664124,4,Type_4,The metabolism of Thiamylal can be increased when combined with Nitrendipine.,4,Type_4,Yes
DB00903,Etacrynic acid,DB01384,Paramethasone,0.9997816681861877,83,Type_83,Etacrynic acid may increase the hypokalemic activities of Paramethasone.,83,Type_83,Yes
DB00745,Modafinil,DB05246,Methsuximide,0.9621825814247131,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00325,Nitroprusside,DB00780,Phenelzine,0.9745999574661255,60,Type_60,Nitroprusside may increase the hypotensive activities of Phenelzine.,60,Type_60,Yes
DB00243,Ranolazine,DB01071,Mequitazine,0.5345513820648193,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00175,Pravastatin,DB01151,Desipramine,0.5921026468276978,47,Type_47,The metabolism of Desipramine can be decreased when combined with Pravastatin.,73,Type_73,No
DB00721,Procaine,DB00907,Cocaine,0.9967113733291626,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Cocaine.,49,Type_49,Yes
DB00402,Eszopiclone,DB00555,Lamotrigine,0.9885381460189819,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lamotrigine.,49,Type_49,Yes
DB00613,Amodiaquine,DB01092,Ouabain,0.5102389454841614,58,Type_58,Amodiaquine may decrease the cardiotoxic activities of Ouabain.,73,Type_73,No
DB00178,Ramipril,DB11079,Trolamine salicylate,0.9195992946624756,37,Type_37,Ramipril may decrease the antihypertensive activities of Trolamine salicylate.,37,Type_37,Yes
DB00227,Lovastatin,DB00699,Nicergoline,0.698157787322998,49,Type_49,The risk or severity of adverse effects can be increased when Lovastatin is combined with Nicergoline.,49,Type_49,Yes
DB00266,Dicoumarol,DB01060,Amoxicillin,0.9618528485298157,6,Type_6,Dicoumarol may increase the anticoagulant activities of Amoxicillin.,6,Type_6,Yes
DB01403,Methotrimeprazine,DB08883,Perampanel,0.9998338222503662,16,Type_16,Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01427,Amrinone,DB02513,Thymol,0.9797024130821228,49,Type_49,The risk or severity of adverse effects can be increased when Amrinone is combined with Thymol.,49,Type_49,Yes
DB00476,Duloxetine,DB00726,Trimipramine,0.44647082686424255,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Trimipramine.,64,Type_64,No
DB00270,Isradipine,DB09238,Manidipine,0.5238710045814514,47,Type_47,The metabolism of Manidipine can be decreased when combined with Isradipine.,60,Type_60,No
DB00381,Amlodipine,DB01235,Levodopa,0.9038206338882446,30,Type_30,Amlodipine may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB01168,Procarbazine,DB06216,Asenapine,0.906236469745636,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Asenapine.,49,Type_49,Yes
DB00623,Fluphenazine,DB04844,Tetrabenazine,0.8816841244697571,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetrabenazine.,49,Type_49,Yes
DB00656,Trazodone,DB01236,Sevoflurane,0.5458824038505554,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Sevoflurane.,49,Type_49,Yes
DB00519,Trandolapril,DB01238,Aripiprazole,0.9736349582672119,60,Type_60,Trandolapril may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00731,Nateglinide,DB00864,Tacrolimus,0.4511260688304901,34,Type_34,Nateglinide may increase the immunosuppressive activities of Tacrolimus.,70,Type_70,No
DB00350,Minoxidil,DB00477,Chlorpromazine,0.9063273668289185,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Chlorpromazine.,49,Type_49,Yes
DB00661,Verapamil,DB01397,Magnesium salicylate,0.7329035997390747,73,Type_73,The serum concentration of Magnesium salicylate can be increased when it is combined with Verapamil.,49,Type_49,No
DB00679,Thioridazine,DB09204,Arotinolol,0.4298493564128876,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Arotinolol.,60,Type_60,No
DB00235,Milrinone,DB00936,Salicylic acid,0.40919315814971924,70,Type_70,The therapeutic efficacy of Salicylic acid can be decreased when used in combination with Milrinone.,49,Type_49,No
DB00283,Clemastine,DB00751,Epinastine,0.9839359521865845,47,Type_47,The metabolism of Epinastine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01184,Domperidone,DB01367,Rasagiline,0.6685511469841003,49,Type_49,The risk or severity of adverse effects can be increased when Domperidone is combined with Rasagiline.,49,Type_49,Yes
DB00584,Enalapril,DB01171,Moclobemide,0.8392152786254883,60,Type_60,Enalapril may increase the hypotensive activities of Moclobemide.,60,Type_60,Yes
DB00611,Butorphanol,DB01367,Rasagiline,0.9341604709625244,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.,49,Type_49,Yes
DB00496,Darifenacin,DB06702,Fesoterodine,0.9563330411911011,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Darifenacin.,77,Type_77,Yes
DB01245,Decamethonium,DB01297,Practolol,0.9999638795852661,54,Type_54,Decamethonium may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB00287,Travoprost,DB01397,Magnesium salicylate,0.7367357015609741,70,Type_70,The therapeutic efficacy of Magnesium salicylate can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB05521,Telaprevir,DB09091,Tixocortol,0.896622359752655,73,Type_73,The serum concentration of Tixocortol can be increased when it is combined with Telaprevir.,75,Type_75,No
DB00232,Methyclothiazide,DB00741,Hydrocortisone,0.9989398121833801,83,Type_83,Methyclothiazide may increase the hypokalemic activities of Hydrocortisone.,83,Type_83,Yes
DB01333,Cefradine,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefradine.,70,Type_70,Yes
DB00625,Efavirenz,DB08439,Parecoxib,0.8939650654792786,47,Type_47,The metabolism of Parecoxib can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00310,Chlorthalidone,DB00814,Meloxicam,0.98117595911026,70,Type_70,The therapeutic efficacy of Meloxicam can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00104,Octreotide,DB06402,Telavancin,0.9999997615814209,20,Type_20,Octreotide may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00402,Eszopiclone,DB00486,Nabilone,0.999659538269043,16,Type_16,Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Nabilone.,16,Type_16,Yes
DB00887,Bumetanide,DB01158,Bretylium,0.8835170865058899,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Bretylium.,49,Type_49,Yes
DB00283,Clemastine,DB00962,Zaleplon,0.7337062358856201,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Zaleplon.,47,Type_47,No
DB00511,Acetyldigitoxin,DB08877,Ruxolitinib,0.9982013702392578,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Ruxolitinib.,58,Type_58,Yes
DB01037,Selegiline,DB06700,Desvenlafaxine,0.8932121992111206,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Desvenlafaxine.,49,Type_49,Yes
DB00768,Olopatadine,DB01045,Rifampicin,0.6980648636817932,4,Type_4,The metabolism of Rifampicin can be increased when combined with Olopatadine.,4,Type_4,Yes
DB00246,Ziprasidone,DB01103,Quinacrine,0.8778848052024841,47,Type_47,The metabolism of Quinacrine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00802,Alfentanil,DB12532,Oxetacaine,0.9999910593032837,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Oxetacaine.,49,Type_49,Yes
DB00749,Etodolac,DB00936,Salicylic acid,0.4967895746231079,57,Type_57,Etodolac may increase the nephrotoxic activities of Salicylic acid.,49,Type_49,No
DB00361,Vinorelbine,DB09291,Rolapitant,0.7295489311218262,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB00806,Pentoxifylline,DB01207,Ridogrel,0.8534368872642517,53,Type_53,Pentoxifylline may increase the antiplatelet activities of Ridogrel.,53,Type_53,Yes
DB00421,Spironolactone,DB00712,Flurbiprofen,0.9800074696540833,37,Type_37,Spironolactone may decrease the antihypertensive activities of Flurbiprofen.,37,Type_37,Yes
DB01016,Glyburide,DB09048,Netupitant,0.9497928023338318,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB01072,Atazanavir,DB01411,Pranlukast,0.8759933710098267,73,Type_73,The serum concentration of Pranlukast can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB01103,Quinacrine,DB01149,Nefazodone,0.7172163724899292,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Quinacrine.,47,Type_47,Yes
DB00880,Chlorothiazide,DB00967,Desloratadine,0.9894770383834839,73,Type_73,The serum concentration of Desloratadine can be increased when it is combined with Chlorothiazide.,73,Type_73,Yes
DB00188,Bortezomib,DB06739,Seratrodast,0.919729471206665,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01028,Methoxyflurane,DB01101,Capecitabine,0.9567019939422607,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00700,Eplerenone,DB01264,Darunavir,0.6012309789657593,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Eplerenone.,73,Type_73,Yes
DB01029,Irbesartan,DB01600,Tiaprofenic acid,0.9412828087806702,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Tiaprofenic acid.,49,Type_49,Yes
DB00260,Cycloserine,DB00609,Ethionamide,0.8087565302848816,49,Type_49,The risk or severity of adverse effects can be increased when Cycloserine is combined with Ethionamide.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB09236,Lacidipine,0.4515034854412079,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Lacidipine.,4,Type_4,No
DB01189,Desflurane,DB01232,Saquinavir,0.9960461258888245,20,Type_20,Desflurane may increase the QTc-prolonging activities of Saquinavir.,20,Type_20,Yes
DB00962,Zaleplon,DB01264,Darunavir,0.416765034198761,47,Type_47,The metabolism of Darunavir can be decreased when combined with Zaleplon.,47,Type_47,Yes
DB00933,Mesoridazine,DB01189,Desflurane,0.994212806224823,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Desflurane.,49,Type_49,Yes
DB00875,Flupentixol,DB09083,Ivabradine,0.9940578937530518,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB00594,Amiloride,DB00960,Pindolol,0.9663922190666199,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Pindolol.,49,Type_49,Yes
DB00651,Dyphylline,DB01359,Penbutolol,0.9973016977310181,14,Type_14,Dyphylline may decrease the bronchodilatory activities of Penbutolol.,14,Type_14,Yes
DB00384,Triamterene,DB00800,Fenoldopam,0.8850551843643188,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Fenoldopam.,49,Type_49,Yes
DB00552,Pentostatin,DB01097,Leflunomide,0.9923827052116394,49,Type_49,The risk or severity of adverse effects can be increased when Pentostatin is combined with Leflunomide.,49,Type_49,Yes
DB00557,Hydroxyzine,DB01068,Clonazepam,0.9985733032226562,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.,16,Type_16,Yes
DB00177,Valsartan,DB06595,Midostaurin,0.9583390355110168,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00524,Metolazone,DB00531,Cyclophosphamide,0.8832660913467407,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Cyclophosphamide.,49,Type_49,Yes
DB01032,Probenecid,DB01397,Magnesium salicylate,0.8426300287246704,73,Type_73,The serum concentration of Magnesium salicylate can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB00327,Hydromorphone,DB00549,Zafirlukast,0.6988363265991211,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB00224,Indinavir,DB00296,Ropivacaine,0.7846006155014038,47,Type_47,The metabolism of Ropivacaine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00343,Diltiazem,DB09118,Stiripentol,0.8401219844818115,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB00700,Eplerenone,DB09084,Benzydamine,0.9867408871650696,37,Type_37,Eplerenone may decrease the antihypertensive activities of Benzydamine.,37,Type_37,Yes
DB01623,Thiothixene,DB06201,Rufinamide,0.9532963037490845,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Rufinamide.,49,Type_49,Yes
DB01037,Selegiline,DB01143,Amifostine,0.7960243225097656,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Amifostine.,49,Type_49,Yes
DB01147,Cloxacillin,DB01421,Paromomycin,0.9999936819076538,75,Type_75,The serum concentration of Paromomycin can be decreased when it is combined with Cloxacillin.,75,Type_75,Yes
DB00620,Triamcinolone,DB00834,Mifepristone,0.8714057803153992,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Triamcinolone.,73,Type_73,Yes
DB00771,Clidinium,DB06153,Pizotifen,0.9483822584152222,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Pizotifen.,49,Type_49,Yes
DB00800,Fenoldopam,DB00964,Apraclonidine,0.9929289221763611,49,Type_49,The risk or severity of adverse effects can be increased when Fenoldopam is combined with Apraclonidine.,49,Type_49,Yes
DB00866,Alprenolol,DB04948,Lofexidine,0.9564516544342041,25,Type_25,Alprenolol may increase the atrioventricular blocking (AV block) activities of Lofexidine.,25,Type_25,Yes
DB00495,Zidovudine,DB09238,Manidipine,0.5540804862976074,47,Type_47,The metabolism of Manidipine can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB00922,Levosimendan,DB01193,Acebutolol,0.955390214920044,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Acebutolol.,49,Type_49,Yes
DB00991,Oxaprozin,DB04576,Fleroxacin,0.9977291226387024,27,Type_27,Oxaprozin may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00692,Phentolamine,DB00765,Metyrosine,0.9996483325958252,60,Type_60,Phentolamine may increase the hypotensive activities of Metyrosine.,60,Type_60,Yes
DB00933,Mesoridazine,DB01161,Chloroprocaine,0.9999836683273315,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chloroprocaine.,49,Type_49,Yes
DB00479,Amikacin,DB08991,Epirizole,0.9999940395355225,72,Type_72,Amikacin may decrease the excretion rate of Epirizole which could result in a higher serum level.,72,Type_72,Yes
DB04574,Estrone sulfate,DB09070,Tibolone,0.32928162813186646,75,Type_75,The serum concentration of Tibolone can be decreased when it is combined with Estrone sulfate.,73,Type_73,No
DB00314,Capreomycin,DB01226,Mivacurium,1.0,21,Type_21,Capreomycin may increase the neuromuscular blocking activities of Mivacurium.,21,Type_21,Yes
DB00482,Celecoxib,DB00881,Quinapril,0.5176693797111511,47,Type_47,The metabolism of Quinapril can be decreased when combined with Celecoxib.,49,Type_49,No
DB00366,Doxylamine,DB00875,Flupentixol,0.9999090433120728,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.,16,Type_16,Yes
DB00455,Loratadine,DB00765,Metyrosine,0.9992213249206543,32,Type_32,Loratadine may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00946,Phenprocoumon,DB09008,Cefaloridine,0.9999505281448364,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Cefaloridine.,6,Type_6,Yes
DB00903,Etacrynic acid,DB01421,Paromomycin,0.9490613341331482,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Paromomycin.,49,Type_49,Yes
DB06268,Sitaxentan,DB09236,Lacidipine,0.9763527512550354,60,Type_60,Sitaxentan may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB01252,Mitiglinide,DB06791,Lanreotide,0.8046867847442627,9,Type_9,Mitiglinide may increase the hypoglycemic activities of Lanreotide.,70,Type_70,No
DB01403,Methotrimeprazine,DB01588,Prazepam,0.9107420444488525,16,Type_16,Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Prazepam.,16,Type_16,Yes
DB00966,Telmisartan,DB09282,Molsidomine,1.0,60,Type_60,Telmisartan may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00755,Tretinoin,DB01029,Irbesartan,0.8980849981307983,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Irbesartan.,47,Type_47,No
DB01229,Paclitaxel,DB01355,Hexobarbital,0.4634099006652832,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Paclitaxel.,60,Type_60,No
DB00327,Hydromorphone,DB00850,Perphenazine,0.9884709119796753,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Perphenazine.,49,Type_49,Yes
DB00936,Salicylic acid,DB01136,Carvedilol,0.999632716178894,37,Type_37,Salicylic acid may decrease the antihypertensive activities of Carvedilol.,37,Type_37,Yes
DB01174,Phenobarbital,DB05246,Methsuximide,0.6798346638679504,49,Type_49,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Methsuximide.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB01198,Zopiclone,0.9998021721839905,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zopiclone.,49,Type_49,Yes
DB00208,Ticlopidine,DB00661,Verapamil,0.8689867258071899,47,Type_47,The metabolism of Verapamil can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00933,Mesoridazine,DB08883,Perampanel,0.9905509948730469,16,Type_16,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00881,Quinapril,DB04840,Debrisoquine,0.999472439289093,60,Type_60,Quinapril may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00541,Vincristine,DB00794,Primidone,0.5405836701393127,4,Type_4,The metabolism of Primidone can be increased when combined with Vincristine.,4,Type_4,Yes
DB01200,Bromocriptine,DB06203,Alogliptin,0.562705397605896,9,Type_9,Bromocriptine may increase the hypoglycemic activities of Alogliptin.,73,Type_73,No
DB00496,Darifenacin,DB00835,Brompheniramine,0.9345110058784485,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00238,Nevirapine,DB04908,Flibanserin,0.5725096464157104,4,Type_4,The metabolism of Flibanserin can be increased when combined with Nevirapine.,49,Type_49,No
DB00177,Valsartan,DB04861,Nebivolol,0.7820634245872498,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Nebivolol.,49,Type_49,Yes
DB04861,Nebivolol,DB09477,Enalaprilat,0.9751410484313965,60,Type_60,Nebivolol may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB06263,Amrubicin,DB08981,Fenbufen,0.9999629259109497,72,Type_72,Amrubicin may decrease the excretion rate of Fenbufen which could result in a higher serum level.,72,Type_72,Yes
DB00201,Caffeine,DB00213,Pantoprazole,0.9307780265808105,47,Type_47,The metabolism of Pantoprazole can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB00327,Hydromorphone,0.9839678406715393,47,Type_47,The metabolism of Hydromorphone can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00842,Oxazepam,DB06153,Pizotifen,0.9956781268119812,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Pizotifen.,49,Type_49,Yes
DB01014,Balsalazide,DB01047,Fluocinonide,0.9989942908287048,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Fluocinonide.,49,Type_49,Yes
DB00224,Indinavir,DB09091,Tixocortol,0.7993517518043518,73,Type_73,The serum concentration of Tixocortol can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00639,Butoconazole,DB06712,Nilvadipine,0.993014931678772,49,Type_49,The risk or severity of adverse effects can be increased when Butoconazole is combined with Nilvadipine.,49,Type_49,Yes
DB00575,Clonidine,DB00976,Telithromycin,0.365469366312027,20,Type_20,Clonidine may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB00199,Erythromycin,DB01274,Arformoterol,0.7473372220993042,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Arformoterol.,20,Type_20,Yes
DB00700,Eplerenone,DB00794,Primidone,0.7824872136116028,60,Type_60,Eplerenone may increase the hypotensive activities of Primidone.,4,Type_4,No
DB00720,Clodronic acid,DB01164,Calcium chloride,0.9524399042129517,75,Type_75,The serum concentration of Calcium chloride can be decreased when it is combined with Clodronic acid.,75,Type_75,Yes
DB00374,Treprostinil,DB00519,Trandolapril,0.9940422177314758,60,Type_60,Treprostinil may increase the hypotensive activities of Trandolapril.,60,Type_60,Yes
DB00231,Temazepam,DB01545,Ethyl loflazepate,0.9999942779541016,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Ethyl loflazepate.,49,Type_49,Yes
DB01233,Metoclopramide,DB01580,Oxprenolol,0.9848778247833252,54,Type_54,Metoclopramide may increase the bradycardic activities of Oxprenolol.,54,Type_54,Yes
DB00335,Atenolol,DB00899,Remifentanil,0.9282387495040894,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Remifentanil.,49,Type_49,Yes
DB00450,Droperidol,DB00582,Voriconazole,0.9636245369911194,20,Type_20,Droperidol may increase the QTc-prolonging activities of Voriconazole.,20,Type_20,Yes
DB00661,Verapamil,DB01184,Domperidone,0.8455346822738647,47,Type_47,The metabolism of Domperidone can be decreased when combined with Verapamil.,73,Type_73,No
DB00809,Tropicamide,DB00956,Hydrocodone,0.9999856948852539,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Hydrocodone.,49,Type_49,Yes
DB01209,Dezocine,DB01215,Estazolam,0.9962483048439026,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Estazolam.,49,Type_49,Yes
DB00224,Indinavir,DB09101,Elvitegravir,0.8301751017570496,47,Type_47,The metabolism of Elvitegravir can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00938,Salmeterol,DB09167,Dosulepin,0.6443045139312744,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Salmeterol.,49,Type_49,No
DB00932,Tipranavir,DB06717,Fosaprepitant,0.6830037832260132,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB00679,Thioridazine,DB06413,Armodafinil,0.681595504283905,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Thioridazine.,47,Type_47,Yes
DB00904,Ondansetron,DB01621,Pipotiazine,0.8723071217536926,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Pipotiazine.,49,Type_49,Yes
DB00938,Salmeterol,DB13783,Acemetacin,0.8838011026382446,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Salmeterol.,70,Type_70,Yes
DB00227,Lovastatin,DB01253,Ergometrine,0.36365795135498047,47,Type_47,The metabolism of Ergometrine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00612,Bisoprolol,DB00681,Amphotericin B,0.9942994117736816,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Amphotericin B.,49,Type_49,Yes
DB00227,Lovastatin,DB00784,Mefenamic acid,0.8397960662841797,47,Type_47,The metabolism of Mefenamic acid can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00641,Simvastatin,DB09236,Lacidipine,0.7512598037719727,49,Type_49,The risk or severity of adverse effects can be increased when Simvastatin is combined with Lacidipine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01392,Yohimbine,0.8624006509780884,37,Type_37,Chlorthalidone may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB00196,Fluconazole,DB00927,Famotidine,0.45395520329475403,47,Type_47,The metabolism of Famotidine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00363,Clozapine,DB00865,Benzphetamine,0.7827497124671936,47,Type_47,The metabolism of Benzphetamine can be decreased when combined with Clozapine.,61,Type_61,No
DB00246,Ziprasidone,DB01215,Estazolam,0.8004297018051147,47,Type_47,The metabolism of Estazolam can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01466,Ethylmorphine,DB12278,Propiverine,0.9997730851173401,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Propiverine.,49,Type_49,Yes
DB00936,Salicylic acid,DB01295,Bevantolol,0.9987727999687195,37,Type_37,Salicylic acid may decrease the antihypertensive activities of Bevantolol.,37,Type_37,Yes
DB00275,Olmesartan,DB00963,Bromfenac,0.9480180740356445,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Bromfenac.,49,Type_49,Yes
DB00298,Dapiprazole,DB00323,Tolcapone,0.9961011409759521,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Tolcapone.,49,Type_49,Yes
DB00654,Latanoprost,DB06196,Icatibant,0.980724573135376,70,Type_70,The therapeutic efficacy of Icatibant can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB00344,Protriptyline,DB00647,Dextropropoxyphene,0.8825942277908325,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00304,Desogestrel,DB01120,Gliclazide,0.9604046940803528,70,Type_70,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Desogestrel.,70,Type_70,Yes
DB01601,Lopinavir,DB06267,Udenafil,0.7693536281585693,47,Type_47,The metabolism of Udenafil can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB04938,Ospemifene,DB09073,Palbociclib,0.9972437620162964,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Ospemifene.,73,Type_73,Yes
DB00270,Isradipine,DB01588,Prazepam,0.880335807800293,47,Type_47,The metabolism of Prazepam can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00564,Carbamazepine,DB09117,Paraldehyde,0.9731311798095703,16,Type_16,Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB08820,Ivacaftor,DB11575,Grazoprevir,0.9869993329048157,73,Type_73,The serum concentration of Grazoprevir can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB04839,Cyproterone acetate,DB12026,Voxilaprevir,0.6328437328338623,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Cyproterone acetate.,75,Type_75,No
DB08899,Enzalutamide,DB09570,Ixazomib,0.8001344799995422,75,Type_75,The serum concentration of Ixazomib can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB00956,Hydrocodone,DB01159,Halothane,0.8278601765632629,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Halothane.,16,Type_16,Yes
DB01076,Atorvastatin,DB01115,Nifedipine,0.8544093370437622,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Nifedipine.,49,Type_49,Yes
DB00370,Mirtazapine,DB00477,Chlorpromazine,0.7497026920318604,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.,16,Type_16,Yes
DB00949,Felbamate,DB06594,Agomelatine,0.9969639182090759,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Agomelatine.,49,Type_49,Yes
DB00244,Mesalazine,DB09449,"Sodium phosphate, monobasic",0.9991959929466248,57,Type_57,"Mesalazine may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB01075,Diphenhydramine,DB01215,Estazolam,0.7988026142120361,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Estazolam.,49,Type_49,Yes
DB01045,Rifampicin,DB01590,Everolimus,0.5582755208015442,75,Type_75,The serum concentration of Everolimus can be decreased when it is combined with Rifampicin.,73,Type_73,No
DB00999,Hydrochlorothiazide,DB01062,Oxybutynin,0.9194273948669434,73,Type_73,The serum concentration of Oxybutynin can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB01232,Saquinavir,DB08864,Rilpivirine,0.8807709813117981,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00091,Cyclosporine,DB00972,Azelastine,0.5692010521888733,47,Type_47,The metabolism of Azelastine can be decreased when combined with Cyclosporine.,57,Type_57,No
DB00440,Trimethoprim,DB00972,Azelastine,0.9175308346748352,47,Type_47,The metabolism of Azelastine can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00347,Trimethadione,DB00412,Rosiglitazone,0.5642986297607422,47,Type_47,The metabolism of Rosiglitazone can be decreased when combined with Trimethadione.,47,Type_47,Yes
DB00612,Bisoprolol,DB08912,Dabrafenib,0.9570128321647644,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Bisoprolol.,75,Type_75,Yes
DB00337,Pimecrolimus,DB00768,Olopatadine,0.997448205947876,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Olopatadine.,49,Type_49,Yes
DB00321,Amitriptyline,DB01069,Promethazine,0.8159548044204712,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Promethazine.,49,Type_49,Yes
DB00542,Benazepril,DB01020,Isosorbide mononitrate,0.9895703792572021,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Isosorbide mononitrate.,49,Type_49,Yes
DB00790,Perindopril,DB08880,Teriflunomide,0.6906524300575256,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Teriflunomide.,49,Type_49,Yes
DB00220,Nelfinavir,DB06777,Chenodeoxycholic acid,0.895375669002533,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00648,Mitotane,DB08971,Fluocortolone,0.994803249835968,75,Type_75,The serum concentration of Fluocortolone can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00468,Quinine,DB05219,Crisaborole,0.9979750514030457,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Quinine.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB04855,Dronedarone,0.5863128900527954,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Fluticasone propionate.,47,Type_47,Yes
DB00176,Fluvoxamine,DB09198,Lobeglitazone,0.998310923576355,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00765,Metyrosine,DB01545,Ethyl loflazepate,0.9982580542564392,32,Type_32,Metyrosine may increase the sedative activities of Ethyl loflazepate.,32,Type_32,Yes
DB09054,Idelalisib,DB09123,Dienogest,0.6952213048934937,47,Type_47,The metabolism of Dienogest can be decreased when combined with Idelalisib.,73,Type_73,No
DB01208,Sparfloxacin,DB01401,Choline magnesium trisalicylate,0.9968791007995605,27,Type_27,Sparfloxacin may increase the neuroexcitatory activities of Choline magnesium trisalicylate.,27,Type_27,Yes
DB00238,Nevirapine,DB01173,Orphenadrine,0.8768889307975769,4,Type_4,The metabolism of Orphenadrine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00237,Butabarbital,DB09128,Brexpiprazole,0.9940310120582581,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Brexpiprazole.,49,Type_49,Yes
DB00178,Ramipril,DB00678,Losartan,0.8617698550224304,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Losartan.,49,Type_49,Yes
DB00622,Nicardipine,DB01171,Moclobemide,0.7760647535324097,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00518,Albendazole,DB01232,Saquinavir,0.8453277349472046,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Albendazole.,47,Type_47,Yes
DB01324,Polythiazide,DB02709,Resveratrol,0.9896292090415955,70,Type_70,The therapeutic efficacy of Resveratrol can be decreased when used in combination with Polythiazide.,70,Type_70,Yes
DB00976,Telithromycin,DB01254,Dasatinib,0.8751615285873413,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Telithromycin.,73,Type_73,Yes
DB00310,Chlorthalidone,DB13142,Calcium glubionate anhydrous,0.9862572550773621,72,Type_72,Chlorthalidone may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level.,72,Type_72,Yes
DB00860,Prednisolone,DB06819,Phenylbutyric acid,0.6441784501075745,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisolone.,70,Type_70,Yes
DB00708,Sufentanil,DB01466,Ethylmorphine,0.9749016165733337,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Ethylmorphine.,49,Type_49,Yes
DB00477,Chlorpromazine,DB00674,Galantamine,0.8328900337219238,20,Type_20,Chlorpromazine may increase the QTc-prolonging activities of Galantamine.,20,Type_20,Yes
DB00187,Esmolol,DB04920,Clevidipine,0.7534143924713135,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Clevidipine.,49,Type_49,Yes
DB00765,Metyrosine,DB04908,Flibanserin,0.9999991655349731,32,Type_32,Metyrosine may increase the sedative activities of Flibanserin.,32,Type_32,Yes
DB00385,Valrubicin,DB01078,Deslanoside,0.7316056489944458,58,Type_58,Valrubicin may decrease the cardiotoxic activities of Deslanoside.,58,Type_58,Yes
DB01132,Pioglitazone,DB04839,Cyproterone acetate,0.3655102252960205,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Pioglitazone.,70,Type_70,No
DB00990,Exemestane,DB09065,Cobicistat,0.6317665576934814,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Exemestane.,47,Type_47,No
DB00564,Carbamazepine,DB00694,Daunorubicin,0.9855321049690247,4,Type_4,The metabolism of Daunorubicin can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01104,Sertraline,DB06684,Vilazodone,0.8090965151786804,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Vilazodone.,49,Type_49,Yes
DB00889,Granisetron,DB01118,Amiodarone,0.8419882655143738,20,Type_20,Granisetron may increase the QTc-prolonging activities of Amiodarone.,47,Type_47,No
DB00647,Dextropropoxyphene,DB01544,Flunitrazepam,0.9928314685821533,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Flunitrazepam.,49,Type_49,Yes
DB00502,Haloperidol,DB01142,Doxepin,0.4790458381175995,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Doxepin.,20,Type_20,Yes
DB00641,Simvastatin,DB00745,Modafinil,0.5080520510673523,47,Type_47,The metabolism of Modafinil can be decreased when combined with Simvastatin.,73,Type_73,No
DB08865,Crizotinib,DB11575,Grazoprevir,0.9620984792709351,47,Type_47,The metabolism of Grazoprevir can be decreased when combined with Crizotinib.,47,Type_47,Yes
DB00266,Dicoumarol,DB00673,Aprepitant,0.9454476237297058,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Dicoumarol.,4,Type_4,No
DB00373,Timolol,DB00936,Salicylic acid,0.9881972670555115,37,Type_37,Timolol may decrease the antihypertensive activities of Salicylic acid.,37,Type_37,Yes
DB00586,Diclofenac,DB04552,Niflumic acid,0.9935278296470642,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Niflumic acid.,49,Type_49,Yes
DB00423,Methocarbamol,DB00813,Fentanyl,0.9998917579650879,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fentanyl.,49,Type_49,Yes
DB00598,Labetalol,DB01118,Amiodarone,0.4167073965072632,54,Type_54,Labetalol may increase the bradycardic activities of Amiodarone.,54,Type_54,Yes
DB00818,Propofol,DB09330,Osimertinib,0.7394551038742065,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Propofol.,73,Type_73,Yes
DB00734,Risperidone,DB06288,Amisulpride,0.9505302309989929,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Amisulpride.,36,Type_36,No
DB01396,Digitoxin,DB09078,Lenvatinib,0.8465181589126587,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Lenvatinib.,58,Type_58,Yes
DB00898,Ethanol,DB06335,Saxagliptin,0.9291986227035522,75,Type_75,The serum concentration of Saxagliptin can be decreased when it is combined with Ethanol.,75,Type_75,Yes
DB00818,Propofol,DB00956,Hydrocodone,0.99566650390625,16,Type_16,Propofol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,16,Type_16,Yes
DB00390,Digoxin,DB13142,Calcium glubionate anhydrous,0.8248295187950134,82,Type_82,Digoxin may increase the arrhythmogenic activities of Calcium glubionate anhydrous.,82,Type_82,Yes
DB01174,Phenobarbital,DB11921,Deflazacort,0.8602101802825928,4,Type_4,The metabolism of Deflazacort can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00334,Olanzapine,DB00690,Flurazepam,0.9243595004081726,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Flurazepam.,49,Type_49,Yes
DB00420,Promazine,DB00998,Frovatriptan,0.7611857652664185,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Frovatriptan.,49,Type_49,Yes
DB01085,Pilocarpine,DB08820,Ivacaftor,0.9988662004470825,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Pilocarpine.,73,Type_73,Yes
DB00182,Amphetamine,DB01274,Arformoterol,0.6485052704811096,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Arformoterol.,49,Type_49,Yes
DB00877,Sirolimus,DB01167,Itraconazole,0.8064442276954651,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Sirolimus.,73,Type_73,No
DB01211,Clarithromycin,DB09027,Ledipasvir,0.9348965287208557,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB00754,Ethotoin,DB01224,Quetiapine,0.9942084550857544,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Quetiapine.,49,Type_49,Yes
DB00655,Estrone,DB04552,Niflumic acid,0.9572899341583252,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Niflumic acid.,49,Type_49,Yes
DB01104,Sertraline,DB05271,Rotigotine,0.8037446141242981,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Sertraline.,47,Type_47,Yes
DB01118,Amiodarone,DB09128,Brexpiprazole,0.8324894905090332,73,Type_73,The serum concentration of Brexpiprazole can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00732,Atracurium besylate,DB01017,Minocycline,0.9999866485595703,21,Type_21,Atracurium besylate may increase the neuromuscular blocking activities of Minocycline.,21,Type_21,Yes
DB00215,Citalopram,DB00628,Clorazepic acid,0.7011935710906982,47,Type_47,The metabolism of Clorazepic acid can be decreased when combined with Citalopram.,49,Type_49,No
DB00283,Clemastine,DB00726,Trimipramine,0.8454184532165527,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00503,Ritonavir,DB06217,Vernakalant,0.9853889346122742,47,Type_47,The metabolism of Vernakalant can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00471,Montelukast,DB01241,Gemfibrozil,0.9719703793525696,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Montelukast.,73,Type_73,No
DB00413,Pramipexole,DB00883,Isosorbide dinitrate,0.9542441964149475,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00850,Perphenazine,DB00985,Dimenhydrinate,0.9996939897537231,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Dimenhydrinate.,49,Type_49,Yes
DB00661,Verapamil,DB01182,Propafenone,0.6585444211959839,47,Type_47,The metabolism of Propafenone can be decreased when combined with Verapamil.,73,Type_73,No
DB00892,Oxybuprocaine,DB01239,Chlorprothixene,0.9999262094497681,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Chlorprothixene.,49,Type_49,Yes
DB00294,Etonogestrel,DB00834,Mifepristone,0.4368704557418823,75,Type_75,The serum concentration of Mifepristone can be decreased when it is combined with Etonogestrel.,73,Type_73,No
DB00897,Triazolam,DB01463,Fencamfamin,0.9990636706352234,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Fencamfamin.,49,Type_49,Yes
DB00875,Flupentixol,DB06589,Pazopanib,0.46821388602256775,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Flupentixol.,73,Type_73,Yes
DB09220,Nicorandil,DB09289,Tianeptine,0.7912443280220032,49,Type_49,The risk or severity of adverse effects can be increased when Nicorandil is combined with Tianeptine.,60,Type_60,No
DB00904,Ondansetron,DB09117,Paraldehyde,0.9641109704971313,16,Type_16,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00373,Timolol,DB08933,Luliconazole,0.9714429378509521,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Timolol.,73,Type_73,Yes
DB00705,Delavirdine,DB00866,Alprenolol,0.8648809194564819,47,Type_47,The metabolism of Alprenolol can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00863,Ranitidine,DB09198,Lobeglitazone,0.9995237588882446,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Ranitidine.,47,Type_47,Yes
DB01002,Levobupivacaine,DB04842,Fluspirilene,0.9977065324783325,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fluspirilene.,49,Type_49,Yes
DB06626,Axitinib,DB08865,Crizotinib,0.8120439648628235,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Axitinib.,47,Type_47,Yes
DB00482,Celecoxib,DB00519,Trandolapril,0.41744115948677063,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Trandolapril.,49,Type_49,Yes
DB00975,Dipyridamole,DB06712,Nilvadipine,0.7184195518493652,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Nilvadipine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB08893,Mirabegron,0.8346530795097351,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00672,Chlorpropamide,DB00887,Bumetanide,0.992291271686554,70,Type_70,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB01211,Clarithromycin,DB11614,Rupatadine,0.8434127569198608,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00912,Repaglinide,DB01076,Atorvastatin,0.717719316482544,9,Type_9,Repaglinide may increase the hypoglycemic activities of Atorvastatin.,49,Type_49,No
DB00673,Aprepitant,DB05239,Cobimetinib,0.9859652519226074,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01024,Mycophenolic acid,DB01234,Dexamethasone,0.7604910135269165,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Dexamethasone.,49,Type_49,Yes
DB00220,Nelfinavir,DB00324,Fluorometholone,0.8917919397354126,47,Type_47,The metabolism of Fluorometholone can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00182,Amphetamine,DB01623,Thiothixene,0.9921403527259827,61,Type_61,Amphetamine may decrease the stimulatory activities of Thiothixene.,61,Type_61,Yes
DB00419,Miglustat,DB01264,Darunavir,0.7745567560195923,70,Type_70,The therapeutic efficacy of Darunavir can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB00623,Fluphenazine,DB00669,Sumatriptan,0.8519021272659302,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sumatriptan.,49,Type_49,Yes
DB00648,Mitotane,DB00673,Aprepitant,0.9962008595466614,75,Type_75,The serum concentration of Aprepitant can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB04946,Iloperidone,DB06204,Tapentadol,0.9989602565765381,16,Type_16,Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00241,Butalbital,DB04896,Milnacipran,0.9983738660812378,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Milnacipran.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB00625,Efavirenz,0.6709578037261963,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Cyclophosphamide.,47,Type_47,Yes
DB00390,Digoxin,DB01097,Leflunomide,0.6407088041305542,73,Type_73,The serum concentration of Leflunomide can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00370,Mirtazapine,DB00543,Amoxapine,0.9068319201469421,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.,16,Type_16,Yes
DB01176,Cyclizine,DB01589,Quazepam,0.9993550181388855,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Quazepam.,49,Type_49,Yes
DB00805,Minaprine,DB08905,Formestane,0.9137756824493408,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Formestane.,49,Type_49,Yes
DB00917,Dinoprostone,DB13783,Acemetacin,0.928648054599762,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00385,Valrubicin,DB01605,Pivmecillinam,0.9923680424690247,75,Type_75,The serum concentration of Pivmecillinam can be decreased when it is combined with Valrubicin.,75,Type_75,Yes
DB00461,Nabumetone,DB06813,Pralatrexate,0.7277884483337402,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Nabumetone.,73,Type_73,Yes
DB00268,Ropinirole,DB01254,Dasatinib,0.5909431576728821,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Ropinirole.,73,Type_73,Yes
DB01030,Topotecan,DB01396,Digitoxin,0.9905962944030762,58,Type_58,Topotecan may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB06636,Isavuconazonium,DB08910,Pomalidomide,0.9374276399612427,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00224,Indinavir,DB00934,Maprotiline,0.692094087600708,47,Type_47,The metabolism of Maprotiline can be decreased when combined with Indinavir.,47,Type_47,Yes
DB04948,Lofexidine,DB09292,Sacubitril,0.9738382697105408,49,Type_49,The risk or severity of adverse effects can be increased when Lofexidine is combined with Sacubitril.,49,Type_49,Yes
DB00557,Hydroxyzine,DB01614,Acepromazine,0.9991025924682617,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.,16,Type_16,Yes
DB00870,Suprofen,DB00972,Azelastine,0.991245448589325,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Azelastine.,49,Type_49,Yes
DB00564,Carbamazepine,DB01124,Tolbutamide,0.8588405251502991,4,Type_4,The metabolism of Tolbutamide can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01248,Docetaxel,DB06626,Axitinib,0.8874238133430481,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Axitinib.,49,Type_49,Yes
DB01059,Norfloxacin,DB09063,Ceritinib,0.6567955017089844,20,Type_20,Norfloxacin may increase the QTc-prolonging activities of Ceritinib.,20,Type_20,Yes
DB00596,Ulobetasol,DB01357,Mestranol,0.9971255660057068,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Ulobetasol.,73,Type_73,Yes
DB00852,Pseudoephedrine,DB06016,Cariprazine,0.9070292115211487,61,Type_61,Pseudoephedrine may decrease the stimulatory activities of Cariprazine.,61,Type_61,Yes
DB00622,Nicardipine,DB00863,Ranitidine,0.965018630027771,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB06290,Simeprevir,DB09083,Ivabradine,0.8521360754966736,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00412,Rosiglitazone,DB01435,Antipyrine,0.7757947444915771,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00737,Meclizine,DB01621,Pipotiazine,0.9981402158737183,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Pipotiazine.,49,Type_49,Yes
DB00193,Tramadol,DB06212,Tolvaptan,0.8764426708221436,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Tramadol.,73,Type_73,Yes
DB00178,Ramipril,DB09026,Aliskiren,0.6204476356506348,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Aliskiren.,68,Type_68,No
DB06237,Avanafil,DB09063,Ceritinib,0.9735909104347229,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Avanafil.,73,Type_73,Yes
DB05521,Telaprevir,DB09026,Aliskiren,0.8283795714378357,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Telaprevir.,47,Type_47,Yes
DB00182,Amphetamine,DB06698,Betahistine,0.5737944841384888,73,Type_73,The serum concentration of Betahistine can be increased when it is combined with Amphetamine.,73,Type_73,Yes
DB00292,Etomidate,DB00985,Dimenhydrinate,0.999642014503479,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Dimenhydrinate.,49,Type_49,Yes
DB00241,Butalbital,DB00921,Buprenorphine,0.9990333318710327,16,Type_16,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00949,Felbamate,DB01165,Ofloxacin,0.9995840191841125,20,Type_20,Felbamate may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00353,Methylergometrine,DB00678,Losartan,0.916628897190094,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Losartan.,49,Type_49,Yes
DB00324,Fluorometholone,DB06718,Stanozolol,1.0,74,Type_74,Fluorometholone may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB01418,Acenocoumarol,DB08795,Azidocillin,0.9881368279457092,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Azidocillin.,6,Type_6,Yes
DB00281,Lidocaine,DB00315,Zolmitriptan,0.5173388123512268,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Zolmitriptan.,47,Type_47,No
DB00966,Telmisartan,DB01024,Mycophenolic acid,0.9006965160369873,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Mycophenolic acid.,49,Type_49,Yes
DB00221,Isoetharine,DB00726,Trimipramine,0.9708132743835449,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Trimipramine.,49,Type_49,Yes
DB00153,Ergocalciferol,DB04855,Dronedarone,0.8621420860290527,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Ergocalciferol.,47,Type_47,Yes
DB00601,Linezolid,DB08941,Isoxsuprine,0.6957301497459412,71,Type_71,Linezolid may increase the hypertensive activities of Isoxsuprine.,71,Type_71,Yes
DB00755,Tretinoin,DB09286,Pipamperone,0.978099524974823,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Pipamperone.,49,Type_49,Yes
DB00909,Zonisamide,DB06290,Simeprevir,0.9279981851577759,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Zonisamide.,73,Type_73,Yes
DB00951,Isoniazid,DB04839,Cyproterone acetate,0.6032549142837524,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Isoniazid.,75,Type_75,Yes
DB00492,Fosinopril,DB13595,Almasilate,0.4819902181625366,75,Type_75,The serum concentration of Almasilate can be decreased when it is combined with Fosinopril.,75,Type_75,Yes
DB01024,Mycophenolic acid,DB01349,Tasosartan,0.5041192770004272,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Mycophenolic acid.,49,Type_49,No
DB00783,Estradiol,DB00974,Edetic acid,0.46555647253990173,70,Type_70,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Estradiol.,12,Type_12,No
DB00726,Trimipramine,DB06695,Dabigatran etexilate,0.8887312412261963,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Trimipramine.,77,Type_77,Yes
DB01319,Fosamprenavir,DB01396,Digitoxin,0.6985917687416077,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Fosamprenavir.,47,Type_47,No
DB00854,Levorphanol,DB01247,Isocarboxazid,0.8861603140830994,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Isocarboxazid.,49,Type_49,Yes
DB00426,Famciclovir,DB01201,Rifapentine,0.9605121612548828,4,Type_4,The metabolism of Rifapentine can be increased when combined with Famciclovir.,4,Type_4,Yes
DB01264,Darunavir,DB09083,Ivabradine,0.6982096433639526,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB00779,Nalidixic acid,DB07615,Tranilast,0.9911864399909973,27,Type_27,Nalidixic acid may increase the neuroexcitatory activities of Tranilast.,27,Type_27,Yes
DB00624,Testosterone,DB09118,Stiripentol,0.8146456480026245,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Testosterone.,73,Type_73,Yes
DB00705,Delavirdine,DB00911,Tinidazole,0.9580442905426025,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01403,Methotrimeprazine,DB08938,Magaldrate,0.8439343571662903,67,Type_67,Methotrimeprazine can cause a decrease in the absorption of Magaldrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00398,Sorafenib,DB01137,Levofloxacin,0.6724070906639099,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB00731,Nateglinide,DB06335,Saxagliptin,0.4705096185207367,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Nateglinide.,9,Type_9,No
DB00924,Cyclobenzaprine,DB09220,Nicorandil,0.8880318403244019,60,Type_60,Cyclobenzaprine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00612,Bisoprolol,DB01407,Clenbuterol,0.9977478384971619,14,Type_14,Bisoprolol may decrease the bronchodilatory activities of Clenbuterol.,14,Type_14,Yes
DB00233,Aminosalicylic acid,DB01144,Diclofenamide,0.9514767527580261,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Diclofenamide.,49,Type_49,Yes
DB04920,Clevidipine,DB08864,Rilpivirine,0.7795776128768921,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Clevidipine.,75,Type_75,No
DB00248,Cabergoline,DB01365,Mephentermine,0.8426110148429871,71,Type_71,Cabergoline may increase the hypertensive activities of Mephentermine.,71,Type_71,Yes
DB00391,Sulpiride,DB00572,Atropine,0.9933843016624451,2,Type_2,Sulpiride may increase the anticholinergic activities of Atropine.,2,Type_2,Yes
DB08880,Teriflunomide,DB09477,Enalaprilat,0.6736934781074524,49,Type_49,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Enalaprilat.,49,Type_49,Yes
DB00325,Nitroprusside,DB01113,Papaverine,0.999279797077179,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Papaverine.,49,Type_49,Yes
DB00178,Ramipril,DB01275,Hydralazine,0.6925817131996155,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Hydralazine.,49,Type_49,Yes
DB06016,Cariprazine,DB09039,Eliglustat,0.6454201936721802,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Cariprazine.,47,Type_47,Yes
DB01234,Dexamethasone,DB01238,Aripiprazole,0.6294397115707397,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Dexamethasone.,75,Type_75,No
DB00498,Phenindione,DB08887,Icosapent ethyl,0.9977165460586548,6,Type_6,Phenindione may increase the anticoagulant activities of Icosapent ethyl.,6,Type_6,Yes
DB00834,Mifepristone,DB01559,Clotiazepam,0.9153512120246887,73,Type_73,The serum concentration of Clotiazepam can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB09076,Umeclidinium,DB09290,Ramosetron,1.0,39,Type_39,Umeclidinium may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB00498,Phenindione,DB01355,Hexobarbital,0.9663986563682556,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Phenindione.,4,Type_4,Yes
DB00245,Benzatropine,DB01452,Diamorphine,0.9917623996734619,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Diamorphine.,49,Type_49,Yes
DB00974,Edetic acid,DB09212,Loxoprofen,0.9970964193344116,6,Type_6,Edetic acid may increase the anticoagulant activities of Loxoprofen.,6,Type_6,Yes
DB00458,Imipramine,DB06216,Asenapine,0.7873767614364624,20,Type_20,Imipramine may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00476,Duloxetine,DB00633,Dexmedetomidine,0.9079264998435974,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Dexmedetomidine.,30,Type_30,Yes
DB00529,Foscarnet,DB00556,Perflutren,0.9999938011169434,20,Type_20,Foscarnet may increase the QTc-prolonging activities of Perflutren.,20,Type_20,Yes
DB00284,Acarbose,DB06412,Oxymetholone,0.9997522234916687,9,Type_9,Acarbose may increase the hypoglycemic activities of Oxymetholone.,9,Type_9,Yes
DB00527,Cinchocaine,DB04953,Ezogabine,0.988751232624054,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ezogabine.,49,Type_49,Yes
DB00813,Fentanyl,DB00924,Cyclobenzaprine,0.9601580500602722,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Cyclobenzaprine.,49,Type_49,Yes
DB06702,Fesoterodine,DB09076,Umeclidinium,0.9955465793609619,2,Type_2,Fesoterodine may increase the anticholinergic activities of Umeclidinium.,2,Type_2,Yes
DB00714,Apomorphine,DB01115,Nifedipine,0.9863773584365845,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nifedipine.,49,Type_49,Yes
DB00321,Amitriptyline,DB00722,Lisinopril,0.6695914268493652,73,Type_73,The serum concentration of Lisinopril can be increased when it is combined with Amitriptyline.,73,Type_73,Yes
DB00820,Tadalafil,DB01170,Guanethidine,0.8971490263938904,10,Type_10,Tadalafil may increase the antihypertensive activities of Guanethidine.,10,Type_10,Yes
DB00321,Amitriptyline,DB00771,Clidinium,0.9996296167373657,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clidinium.,49,Type_49,Yes
DB00457,Prazosin,DB00622,Nicardipine,0.7739853262901306,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Nicardipine.,49,Type_49,Yes
DB00264,Metoprolol,DB09049,Naloxegol,0.9995599389076233,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00349,Clobazam,DB00508,Triflupromazine,0.9225907325744629,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Triflupromazine.,49,Type_49,Yes
DB01069,Promethazine,DB01161,Chloroprocaine,0.998496413230896,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Chloroprocaine.,49,Type_49,Yes
DB06335,Saxagliptin,DB09074,Olaparib,0.7333278059959412,47,Type_47,The metabolism of Olaparib can be decreased when combined with Saxagliptin.,73,Type_73,No
DB00324,Fluorometholone,DB00608,Chloroquine,0.6994370818138123,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Chloroquine.,49,Type_49,Yes
DB00328,Indomethacin,DB00605,Sulindac,0.9961068034172058,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Sulindac.,49,Type_49,Yes
DB01182,Propafenone,DB06791,Lanreotide,0.625704824924469,54,Type_54,Propafenone may increase the bradycardic activities of Lanreotide.,54,Type_54,Yes
DB00896,Rimexolone,DB04576,Fleroxacin,0.992059588432312,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Fleroxacin.,49,Type_49,Yes
DB00238,Nevirapine,DB01320,Fosphenytoin,0.7903415560722351,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00209,Trospium,DB01233,Metoclopramide,0.9877080917358398,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Trospium.,70,Type_70,Yes
DB00861,Diflunisal,DB01399,Salsalate,0.9778124690055847,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Salsalate.,49,Type_49,Yes
DB00972,Azelastine,DB01399,Salsalate,0.9870293140411377,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Salsalate.,49,Type_49,Yes
DB06636,Isavuconazonium,DB13874,Enasidenib,0.856533944606781,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00699,Nicergoline,DB01118,Amiodarone,0.8696198463439941,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Amiodarone.,47,Type_47,No
DB06791,Lanreotide,DB09063,Ceritinib,0.7343314290046692,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Lanreotide.,54,Type_54,No
DB00216,Eletriptan,DB01104,Sertraline,0.6268879771232605,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.,49,Type_49,Yes
DB00622,Nicardipine,DB00681,Amphotericin B,0.8263070583343506,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Amphotericin B.,49,Type_49,Yes
DB00838,Clocortolone,DB01601,Lopinavir,0.9451743960380554,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Clocortolone.,73,Type_73,Yes
DB00497,Oxycodone,DB00976,Telithromycin,0.7865520119667053,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Oxycodone.,49,Type_49,No
DB00224,Indinavir,DB06335,Saxagliptin,0.4321860373020172,47,Type_47,The metabolism of Saxagliptin can be decreased when combined with Indinavir.,73,Type_73,No
DB00589,Lisuride,DB00622,Nicardipine,0.843561053276062,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Nicardipine.,47,Type_47,No
DB00887,Bumetanide,DB01078,Deslanoside,0.9160125255584717,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Deslanoside.,49,Type_49,Yes
DB00377,Palonosetron,DB08933,Luliconazole,0.9324004054069519,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Palonosetron.,73,Type_73,Yes
DB01076,Atorvastatin,DB06636,Isavuconazonium,0.43801236152648926,73,Type_73,The serum concentration of Isavuconazonium can be increased when it is combined with Atorvastatin.,49,Type_49,No
DB00312,Pentobarbital,DB04835,Maraviroc,0.625228226184845,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Pentobarbital.,75,Type_75,No
DB09118,Stiripentol,DB13158,Clobetasone,0.48137032985687256,75,Type_75,The serum concentration of Clobetasone can be decreased when it is combined with Stiripentol.,73,Type_73,No
DB04842,Fluspirilene,DB06594,Agomelatine,0.9991612434387207,49,Type_49,The risk or severity of adverse effects can be increased when Fluspirilene is combined with Agomelatine.,49,Type_49,Yes
DB00712,Flurbiprofen,DB09215,Droxicam,0.9975607395172119,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Droxicam.,49,Type_49,Yes
DB02638,Terlipressin,DB08931,Riociguat,0.9927122592926025,60,Type_60,Terlipressin may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00802,Alfentanil,DB08916,Afatinib,0.5826065540313721,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Alfentanil.,73,Type_73,Yes
DB00648,Mitotane,DB11581,Venetoclax,0.993228018283844,75,Type_75,The serum concentration of Venetoclax can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01028,Methoxyflurane,DB01353,Butobarbital,0.9999899864196777,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Butobarbital.,49,Type_49,Yes
DB00572,Atropine,DB01081,Diphenoxylate,0.9973117113113403,49,Type_49,The risk or severity of adverse effects can be increased when Atropine is combined with Diphenoxylate.,49,Type_49,Yes
DB00501,Cimetidine,DB09183,Dasabuvir,0.9640220999717712,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00325,Nitroprusside,DB00413,Pramipexole,0.5441112518310547,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Pramipexole.,49,Type_49,Yes
DB00598,Labetalol,DB04896,Milnacipran,0.8338523507118225,73,Type_73,The serum concentration of Milnacipran can be increased when it is combined with Labetalol.,73,Type_73,Yes
DB01551,Dihydrocodeine,DB11106,Pamabrom,0.9985080361366272,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Pamabrom.,49,Type_49,Yes
DB01355,Hexobarbital,DB09235,Efonidipine,0.4251953661441803,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Efonidipine.,4,Type_4,No
DB00264,Metoprolol,DB01136,Carvedilol,0.7348412871360779,30,Type_30,Metoprolol may increase the orthostatic hypotensive activities of Carvedilol.,30,Type_30,Yes
DB00802,Alfentanil,DB06201,Rufinamide,0.998113751411438,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Rufinamide.,49,Type_49,Yes
DB01122,Ambenonium,DB09091,Tixocortol,0.9992707371711731,49,Type_49,The risk or severity of adverse effects can be increased when Ambenonium is combined with Tixocortol.,49,Type_49,Yes
DB00962,Zaleplon,DB01623,Thiothixene,0.9796862006187439,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Thiothixene.,49,Type_49,Yes
DB00972,Azelastine,DB01207,Ridogrel,0.645313560962677,53,Type_53,Azelastine may increase the antiplatelet activities of Ridogrel.,53,Type_53,Yes
DB00208,Ticlopidine,DB09068,Vortioxetine,0.9655340313911438,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00796,Candesartan cilexetil,DB00819,Acetazolamide,0.7206945419311523,56,Type_56,The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Acetazolamide.,56,Type_56,Yes
DB00514,Dextromethorphan,DB08899,Enzalutamide,0.9220348000526428,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Dextromethorphan.,75,Type_75,Yes
DB01015,Sulfamethoxazole,DB06697,Artemether,0.6734902262687683,47,Type_47,The metabolism of Artemether can be decreased when combined with Sulfamethoxazole.,20,Type_20,No
DB00238,Nevirapine,DB00443,Betamethasone,0.785890519618988,75,Type_75,The serum concentration of Betamethasone can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00598,Labetalol,DB00963,Bromfenac,0.9948834776878357,37,Type_37,Labetalol may decrease the antihypertensive activities of Bromfenac.,37,Type_37,Yes
DB00511,Acetyldigitoxin,DB01168,Procarbazine,0.8739339709281921,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Procarbazine.,58,Type_58,Yes
DB01591,Solifenacin,DB09039,Eliglustat,0.8144813179969788,20,Type_20,Solifenacin may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB06786,Halcinonide,DB09543,Methyl salicylate,0.9934768080711365,49,Type_49,The risk or severity of adverse effects can be increased when Halcinonide is combined with Methyl salicylate.,49,Type_49,Yes
DB00373,Timolol,DB00705,Delavirdine,0.915991485118866,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Timolol.,47,Type_47,Yes
DB00373,Timolol,DB00586,Diclofenac,0.9810745120048523,37,Type_37,Timolol may decrease the antihypertensive activities of Diclofenac.,37,Type_37,Yes
DB06810,Plicamycin,DB13783,Acemetacin,0.9991059899330139,72,Type_72,Plicamycin may decrease the excretion rate of Acemetacin which could result in a higher serum level.,72,Type_72,Yes
DB08868,Fingolimod,DB09330,Osimertinib,0.9807688593864441,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Fingolimod.,73,Type_73,Yes
DB01263,Posaconazole,DB04572,Thiotepa,0.8713486790657043,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00344,Protriptyline,DB00451,Levothyroxine,0.5384685397148132,47,Type_47,The metabolism of Levothyroxine can be decreased when combined with Protriptyline.,82,Type_82,No
DB00196,Fluconazole,DB01320,Fosphenytoin,0.49265962839126587,73,Type_73,The serum concentration of Fosphenytoin can be increased when it is combined with Fluconazole.,73,Type_73,Yes
DB00936,Salicylic acid,DB08981,Fenbufen,0.8637427091598511,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Fenbufen.,49,Type_49,Yes
DB00252,Phenytoin,DB00772,Malathion,0.8572093844413757,4,Type_4,The metabolism of Malathion can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00263,Sulfisoxazole,DB11581,Venetoclax,0.9634714722633362,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB09048,Netupitant,DB12161,Deutetrabenazine,0.9504563808441162,73,Type_73,The serum concentration of Deutetrabenazine can be increased when it is combined with Netupitant.,73,Type_73,Yes
DB01068,Clonazepam,DB06290,Simeprevir,0.8898252844810486,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Clonazepam.,73,Type_73,Yes
DB00385,Valrubicin,DB00713,Oxacillin,0.9650583863258362,75,Type_75,The serum concentration of Oxacillin can be decreased when it is combined with Valrubicin.,75,Type_75,Yes
DB00188,Bortezomib,DB00831,Trifluoperazine,0.6193187236785889,47,Type_47,The metabolism of Trifluoperazine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00169,Cholecalciferol,DB00176,Fluvoxamine,0.9816064834594727,47,Type_47,The metabolism of Fluvoxamine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01167,Itraconazole,DB08883,Perampanel,0.48515620827674866,73,Type_73,The serum concentration of Perampanel can be increased when it is combined with Itraconazole.,47,Type_47,No
DB00591,Fluocinolone acetonide,DB00677,Isoflurophate,0.9968104958534241,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Isoflurophate.,49,Type_49,Yes
DB00829,Diazepam,DB09048,Netupitant,0.8987558484077454,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB01013,Clobetasol propionate,DB13783,Acemetacin,0.9682080745697021,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Acemetacin.,49,Type_49,Yes
DB00396,Progesterone,DB01590,Everolimus,0.929135799407959,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00679,Thioridazine,DB06288,Amisulpride,0.5483677387237549,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Amisulpride.,36,Type_36,No
DB00201,Caffeine,DB01097,Leflunomide,0.9265828132629395,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB01407,Clenbuterol,0.9990507960319519,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Clenbuterol.,83,Type_83,Yes
DB00457,Prazosin,DB01021,Trichlormethiazide,0.9819478988647461,60,Type_60,Prazosin may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB00241,Butalbital,DB00961,Mepivacaine,0.9999983310699463,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Mepivacaine.,49,Type_49,Yes
DB00768,Olopatadine,DB00963,Bromfenac,0.9995465874671936,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Bromfenac.,49,Type_49,Yes
DB00284,Acarbose,DB04946,Iloperidone,0.9732927680015564,70,Type_70,The therapeutic efficacy of Iloperidone can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00252,Phenytoin,DB00295,Morphine,0.9531306624412537,4,Type_4,The metabolism of Morphine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00673,Aprepitant,DB08893,Mirabegron,0.8212828636169434,73,Type_73,The serum concentration of Mirabegron can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00418,Secobarbital,DB01159,Halothane,0.7341573238372803,4,Type_4,The metabolism of Halothane can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00343,Diltiazem,DB01100,Pimozide,0.7042375206947327,47,Type_47,The metabolism of Pimozide can be decreased when combined with Diltiazem.,73,Type_73,No
DB00370,Mirtazapine,DB09000,Cyamemazine,0.8126933574676514,49,Type_49,The risk or severity of adverse effects can be increased when Mirtazapine is combined with Cyamemazine.,49,Type_49,Yes
DB00503,Ritonavir,DB08864,Rilpivirine,0.8388775587081909,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB00489,Sotalol,DB09286,Pipamperone,0.7096387147903442,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Pipamperone.,49,Type_49,Yes
DB00281,Lidocaine,DB11304,Phenoxyethanol,0.9996117949485779,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Phenoxyethanol.,49,Type_49,Yes
DB00933,Mesoridazine,DB01068,Clonazepam,0.9796701669692993,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clonazepam.,49,Type_49,Yes
DB00257,Clotrimazole,DB01068,Clonazepam,0.8366985321044922,47,Type_47,The metabolism of Clonazepam can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00553,Methoxsalen,DB09074,Olaparib,0.9403925538063049,47,Type_47,The metabolism of Olaparib can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB00238,Nevirapine,DB04835,Maraviroc,0.4731423258781433,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Nevirapine.,75,Type_75,No
DB00771,Clidinium,DB01545,Ethyl loflazepate,0.9999964237213135,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00556,Perflutren,DB01182,Propafenone,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Propafenone.,20,Type_20,Yes
DB01071,Mequitazine,DB04946,Iloperidone,0.9872409701347351,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Iloperidone.,82,Type_82,Yes
DB00415,Ampicillin,DB00946,Phenprocoumon,0.8649880290031433,6,Type_6,Ampicillin may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB01002,Levobupivacaine,DB08910,Pomalidomide,0.8774595260620117,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pomalidomide.,49,Type_49,Yes
DB02709,Resveratrol,DB09091,Tixocortol,0.9996067881584167,49,Type_49,The risk or severity of adverse effects can be increased when Resveratrol is combined with Tixocortol.,49,Type_49,Yes
DB00897,Triazolam,DB06228,Rivaroxaban,0.674034833908081,73,Type_73,The serum concentration of Rivaroxaban can be increased when it is combined with Triazolam.,73,Type_73,Yes
DB00379,Mexiletine,DB01182,Propafenone,0.7965795397758484,47,Type_47,The metabolism of Propafenone can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00346,Alfuzosin,DB00539,Toremifene,0.9637719988822937,20,Type_20,Alfuzosin may increase the QTc-prolonging activities of Toremifene.,20,Type_20,Yes
DB00408,Loxapine,DB00508,Triflupromazine,0.9919055700302124,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Triflupromazine.,49,Type_49,Yes
DB00936,Salicylic acid,DB08912,Dabrafenib,0.9076625108718872,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Salicylic acid.,75,Type_75,Yes
DB00623,Fluphenazine,DB01220,Rifaximin,0.8069421052932739,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Fluphenazine.,73,Type_73,Yes
DB08881,Vemurafenib,DB09286,Pipamperone,0.9176141023635864,33,Type_33,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pipamperone.,33,Type_33,Yes
DB00586,Diclofenac,DB06802,Nepafenac,0.992222249507904,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac.,49,Type_49,Yes
DB00794,Primidone,DB00875,Flupentixol,0.4395756721496582,75,Type_75,The serum concentration of Flupentixol can be decreased when it is combined with Primidone.,49,Type_49,No
DB00425,Zolpidem,DB09074,Olaparib,0.7242646813392639,47,Type_47,The metabolism of Olaparib can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB00635,Prednisone,DB01137,Levofloxacin,0.7572320103645325,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Levofloxacin.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB09292,Sacubitril,0.9895473718643188,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Sacubitril.,49,Type_49,Yes
DB01045,Rifampicin,DB01393,Bezafibrate,0.9449253678321838,4,Type_4,The metabolism of Bezafibrate can be increased when combined with Rifampicin.,4,Type_4,Yes
DB06589,Pazopanib,DB06636,Isavuconazonium,0.46936091780662537,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Pazopanib.,73,Type_73,No
DB00853,Temozolomide,DB01248,Docetaxel,0.9938574433326721,49,Type_49,The risk or severity of adverse effects can be increased when Temozolomide is combined with Docetaxel.,49,Type_49,Yes
DB00362,Anidulafungin,DB00604,Cisapride,0.7364548444747925,73,Type_73,The serum concentration of Cisapride can be increased when it is combined with Anidulafungin.,73,Type_73,Yes
DB00857,Terbinafine,DB09119,Eslicarbazepine acetate,0.947698175907135,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00490,Buspirone,DB09224,Melperone,0.9997648596763611,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Melperone.,49,Type_49,Yes
DB01587,Ketazolam,DB06738,Ketobemidone,0.9940495491027832,49,Type_49,The risk or severity of adverse effects can be increased when Ketazolam is combined with Ketobemidone.,49,Type_49,Yes
DB01182,Propafenone,DB08873,Boceprevir,0.5968326926231384,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Propafenone.,73,Type_73,Yes
DB01708,Prasterone,DB06212,Tolvaptan,0.879307746887207,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Prasterone.,73,Type_73,Yes
DB00191,Phentermine,DB09224,Melperone,0.9995864033699036,61,Type_61,Phentermine may decrease the stimulatory activities of Melperone.,61,Type_61,Yes
DB00896,Rimexolone,DB13167,Alclofenac,0.9996544122695923,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Alclofenac.,49,Type_49,Yes
DB06144,Sertindole,DB09017,Brotizolam,0.9999711513519287,49,Type_49,The risk or severity of adverse effects can be increased when Sertindole is combined with Brotizolam.,49,Type_49,Yes
DB01320,Fosphenytoin,DB08918,Levomilnacipran,0.87897789478302,4,Type_4,The metabolism of Levomilnacipran can be increased when combined with Fosphenytoin.,4,Type_4,Yes
DB00224,Indinavir,DB01260,Desonide,0.8949852585792542,73,Type_73,The serum concentration of Desonide can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00622,Nicardipine,DB06737,Zaltoprofen,0.8913019895553589,47,Type_47,The metabolism of Zaltoprofen can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00091,Cyclosporine,DB01156,Bupropion,0.969551146030426,47,Type_47,The metabolism of Bupropion can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00324,Fluorometholone,DB00814,Meloxicam,0.9984330534934998,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Meloxicam.,49,Type_49,Yes
DB00412,Rosiglitazone,DB01207,Ridogrel,0.9938416481018066,6,Type_6,Rosiglitazone may increase the anticoagulant activities of Ridogrel.,6,Type_6,Yes
DB01685,Topiroxostat,DB09570,Ixazomib,0.9929793477058411,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00452,Framycetin,DB01602,Bacampicillin,0.9914203882217407,75,Type_75,The serum concentration of Bacampicillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB00310,Chlorthalidone,DB01200,Bromocriptine,0.9930903315544128,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Bromocriptine.,49,Type_49,Yes
DB00268,Ropinirole,DB04908,Flibanserin,0.9967707395553589,32,Type_32,Ropinirole may increase the sedative activities of Flibanserin.,32,Type_32,Yes
DB05271,Rotigotine,DB09330,Osimertinib,0.8185911178588867,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Rotigotine.,73,Type_73,Yes
DB00933,Mesoridazine,DB13323,Trichloroethylene,0.9999402761459351,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Trichloroethylene.,49,Type_49,Yes
DB00277,Theophylline,DB06292,Dapagliflozin,0.7135242223739624,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00752,Tranylcypromine,DB09289,Tianeptine,0.5175884366035461,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Tranylcypromine.,49,Type_49,No
DB00214,Torasemide,DB09449,"Sodium phosphate, monobasic",0.9990355968475342,57,Type_57,"Torasemide may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00737,Meclizine,DB00854,Levorphanol,0.9955376386642456,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Levorphanol.,49,Type_49,Yes
DB01609,Deferasirox,DB09389,Norgestrel,0.9954934120178223,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB01013,Clobetasol propionate,DB01026,Ketoconazole,0.8256868124008179,73,Type_73,The serum concentration of Ketoconazole can be increased when it is combined with Clobetasol propionate.,73,Type_73,Yes
DB00936,Salicylic acid,DB01297,Practolol,0.9987441301345825,37,Type_37,Salicylic acid may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00846,Flurandrenolide,DB04576,Fleroxacin,0.9920070171356201,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Fleroxacin.,49,Type_49,Yes
DB00455,Loratadine,DB01589,Quazepam,0.7878674864768982,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Quazepam.,49,Type_49,Yes
DB00593,Ethosuximide,DB01068,Clonazepam,0.9976065158843994,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Clonazepam.,49,Type_49,Yes
DB00624,Testosterone,DB01029,Irbesartan,0.7663406729698181,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00231,Temazepam,DB09017,Brotizolam,0.9999969005584717,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Brotizolam.,49,Type_49,Yes
DB00454,Meperidine,DB06697,Artemether,0.7005414366722107,47,Type_47,The metabolism of Artemether can be decreased when combined with Meperidine.,47,Type_47,Yes
DB01264,Darunavir,DB06148,Mianserin,0.6938846707344055,47,Type_47,The metabolism of Mianserin can be decreased when combined with Darunavir.,73,Type_73,No
DB00104,Octreotide,DB00199,Erythromycin,0.9723446369171143,20,Type_20,Octreotide may increase the QTc-prolonging activities of Erythromycin.,20,Type_20,Yes
DB00753,Isoflurane,DB09128,Brexpiprazole,0.9777883887290955,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Brexpiprazole.,49,Type_49,Yes
DB00181,Baclofen,DB00237,Butabarbital,0.9999641180038452,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Butabarbital.,49,Type_49,Yes
DB00950,Fexofenadine,DB01220,Rifaximin,0.8213698863983154,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Fexofenadine.,73,Type_73,Yes
DB00854,Levorphanol,DB08897,Aclidinium,0.9970324039459229,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Aclidinium.,49,Type_49,Yes
DB00184,Nicotine,DB00866,Alprenolol,0.6274926066398621,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Alprenolol.,49,Type_49,Yes
DB00936,Salicylic acid,DB08992,Eperisone,0.9415283203125,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Eperisone.,49,Type_49,Yes
DB00468,Quinine,DB00852,Pseudoephedrine,0.9778203368186951,47,Type_47,The metabolism of Pseudoephedrine can be decreased when combined with Quinine.,47,Type_47,Yes
DB01399,Salsalate,DB01708,Prasterone,0.9993017911911011,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Prasterone.,49,Type_49,Yes
DB00695,Furosemide,DB00870,Suprofen,0.9999629259109497,29,Type_29,Furosemide may decrease the diuretic activities of Suprofen.,29,Type_29,Yes
DB00559,Bosentan,DB00762,Irinotecan,0.8226456046104431,75,Type_75,The serum concentration of Irinotecan can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB06712,Nilvadipine,DB08931,Riociguat,0.9036794900894165,60,Type_60,Nilvadipine may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00483,Gallamine triethiodide,DB00732,Atracurium besylate,0.8428818583488464,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Atracurium besylate.,49,Type_49,Yes
DB00476,Duloxetine,DB00796,Candesartan cilexetil,0.8035465478897095,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Candesartan cilexetil.,30,Type_30,Yes
DB00204,Dofetilide,DB09031,Miltefosine,0.8978167176246643,73,Type_73,The serum concentration of Miltefosine can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB00708,Sufentanil,DB08868,Fingolimod,0.993611752986908,54,Type_54,Sufentanil may increase the bradycardic activities of Fingolimod.,54,Type_54,Yes
DB00764,Mometasone,DB03585,Oxyphenbutazone,0.9997326731681824,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Oxyphenbutazone.,49,Type_49,Yes
DB01207,Ridogrel,DB01296,Glucosamine,0.5904682278633118,6,Type_6,Ridogrel may increase the anticoagulant activities of Glucosamine.,53,Type_53,No
DB00774,Hydroflumethiazide,DB00812,Phenylbutazone,0.9920011758804321,70,Type_70,The therapeutic efficacy of Phenylbutazone can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00343,Diltiazem,DB09330,Osimertinib,0.9468870759010315,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB00629,Guanabenz,DB09120,Zucapsaicin,0.9941284656524658,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Guanabenz.,47,Type_47,Yes
DB00675,Tamoxifen,DB00794,Primidone,0.5402281880378723,4,Type_4,The metabolism of Primidone can be increased when combined with Tamoxifen.,4,Type_4,Yes
DB00212,Remikiren,DB01054,Nitrendipine,0.993035614490509,60,Type_60,Remikiren may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB00263,Sulfisoxazole,DB00871,Terbutaline,0.9057711362838745,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Terbutaline.,20,Type_20,Yes
DB00524,Metolazone,DB00964,Apraclonidine,0.929513692855835,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Apraclonidine.,49,Type_49,Yes
DB00685,Trovafloxacin,DB00846,Flurandrenolide,0.9904363751411438,49,Type_49,The risk or severity of adverse effects can be increased when Trovafloxacin is combined with Flurandrenolide.,49,Type_49,Yes
DB00564,Carbamazepine,DB00916,Metronidazole,0.8632035851478577,4,Type_4,The metabolism of Metronidazole can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00179,Masoprocol,DB00591,Fluocinolone acetonide,0.9999004602432251,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluocinolone acetonide.,49,Type_49,Yes
DB01247,Isocarboxazid,DB09279,Fimasartan,0.9728920459747314,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Fimasartan.,49,Type_49,Yes
DB00433,Prochlorperazine,DB06288,Amisulpride,0.7256779074668884,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Amisulpride.,36,Type_36,No
DB02513,Thymol,DB09216,Tolfenamic acid,0.995653510093689,49,Type_49,The risk or severity of adverse effects can be increased when Thymol is combined with Tolfenamic acid.,49,Type_49,Yes
DB00907,Cocaine,DB01589,Quazepam,0.5567446947097778,47,Type_47,The metabolism of Quazepam can be decreased when combined with Cocaine.,49,Type_49,No
DB01021,Trichlormethiazide,DB01102,Arbutamine,0.9988275170326233,83,Type_83,Trichlormethiazide may increase the hypokalemic activities of Arbutamine.,83,Type_83,Yes
DB01184,Domperidone,DB06216,Asenapine,0.8841585516929626,20,Type_20,Domperidone may increase the QTc-prolonging activities of Asenapine.,33,Type_33,No
DB09118,Stiripentol,DB11828,Neratinib,0.537849485874176,73,Type_73,The serum concentration of Neratinib can be increased when it is combined with Stiripentol.,73,Type_73,Yes
DB01166,Cilostazol,DB02703,Fusidic acid,0.995383083820343,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB00392,Profenamine,DB00802,Alfentanil,0.9999697208404541,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Alfentanil.,49,Type_49,Yes
DB00363,Clozapine,DB05246,Methsuximide,0.8764638900756836,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Methsuximide.,49,Type_49,Yes
DB00239,Oxiconazole,DB00625,Efavirenz,0.7975032329559326,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Oxiconazole.,47,Type_47,Yes
DB00808,Indapamide,DB04844,Tetrabenazine,0.621254026889801,20,Type_20,Indapamide may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00254,Doxycycline,DB00327,Hydromorphone,0.9577269554138184,47,Type_47,The metabolism of Hydromorphone can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00278,Argatroban,DB00304,Desogestrel,0.9725514054298401,70,Type_70,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Argatroban.,70,Type_70,Yes
DB00338,Omeprazole,DB01264,Darunavir,0.8460201025009155,47,Type_47,The metabolism of Darunavir can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00625,Efavirenz,DB01264,Darunavir,0.4857916831970215,47,Type_47,The metabolism of Darunavir can be decreased when combined with Efavirenz.,73,Type_73,No
DB00499,Flutamide,DB00673,Aprepitant,0.9549694061279297,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Flutamide.,73,Type_73,Yes
DB01089,Deserpidine,DB01359,Penbutolol,0.999984860420227,60,Type_60,Deserpidine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00974,Edetic acid,DB08981,Fenbufen,0.9972546696662903,6,Type_6,Edetic acid may increase the anticoagulant activities of Fenbufen.,6,Type_6,Yes
DB01041,Thalidomide,DB01227,Levacetylmethadol,0.9944267272949219,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Levacetylmethadol.,16,Type_16,Yes
DB00381,Amlodipine,DB00887,Bumetanide,0.8600012063980103,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Bumetanide.,49,Type_49,Yes
DB00371,Meprobamate,DB00540,Nortriptyline,0.9359198808670044,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Nortriptyline.,49,Type_49,Yes
DB00802,Alfentanil,DB01235,Levodopa,0.9926149845123291,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Levodopa.,49,Type_49,Yes
DB00742,Mannitol,DB05271,Rotigotine,0.8068268895149231,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Rotigotine.,49,Type_49,Yes
DB00289,Atomoxetine,DB01366,Procaterol,0.862095296382904,71,Type_71,Atomoxetine may increase the hypertensive activities of Procaterol.,71,Type_71,Yes
DB01348,Spirapril,DB04743,Nimesulide,0.8989180326461792,49,Type_49,The risk or severity of adverse effects can be increased when Spirapril is combined with Nimesulide.,49,Type_49,Yes
DB00254,Doxycycline,DB00778,Roxithromycin,0.9122809767723083,47,Type_47,The metabolism of Roxithromycin can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00588,Fluticasone propionate,DB01069,Promethazine,0.9789519309997559,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Promethazine.,49,Type_49,Yes
DB00283,Clemastine,DB00448,Lansoprazole,0.9648452997207642,47,Type_47,The metabolism of Lansoprazole can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00214,Torasemide,DB00752,Tranylcypromine,0.5137550234794617,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Tranylcypromine.,60,Type_60,No
DB00035,Desmopressin,DB06204,Tapentadol,0.9901610612869263,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Tapentadol.,49,Type_49,Yes
DB00184,Nicotine,DB01403,Methotrimeprazine,0.6214224696159363,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00800,Fenoldopam,DB09286,Pipamperone,0.9667289853096008,49,Type_49,The risk or severity of adverse effects can be increased when Fenoldopam is combined with Pipamperone.,49,Type_49,Yes
DB01081,Diphenoxylate,DB01563,Chloral hydrate,0.9990724325180054,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Chloral hydrate.,49,Type_49,Yes
DB01161,Chloroprocaine,DB04946,Iloperidone,0.9990726709365845,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Iloperidone.,49,Type_49,Yes
DB00270,Isradipine,DB00922,Levosimendan,0.9886080026626587,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Levosimendan.,49,Type_49,Yes
DB00349,Clobazam,DB00951,Isoniazid,0.864024817943573,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00412,Rosiglitazone,DB01319,Fosamprenavir,0.9069560766220093,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Rosiglitazone.,70,Type_70,No
DB01072,Atazanavir,DB01101,Capecitabine,0.6762140989303589,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB06702,Fesoterodine,DB08897,Aclidinium,0.9981751441955566,2,Type_2,Fesoterodine may increase the anticholinergic activities of Aclidinium.,2,Type_2,Yes
DB00363,Clozapine,DB01353,Butobarbital,0.9961522221565247,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Butobarbital.,49,Type_49,Yes
DB00374,Treprostinil,DB00598,Labetalol,0.9692363739013672,60,Type_60,Treprostinil may increase the hypotensive activities of Labetalol.,60,Type_60,Yes
DB00454,Meperidine,DB01452,Diamorphine,0.9715533256530762,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Diamorphine.,49,Type_49,Yes
DB00224,Indinavir,DB01195,Flecainide,0.48132428526878357,73,Type_73,The serum concentration of Flecainide can be increased when it is combined with Indinavir.,47,Type_47,No
DB00914,Phenformin,DB01234,Dexamethasone,0.9279718995094299,70,Type_70,The therapeutic efficacy of Dexamethasone can be decreased when used in combination with Phenformin.,70,Type_70,Yes
DB00328,Indomethacin,DB00861,Diflunisal,0.6903871297836304,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Diflunisal.,49,Type_49,Yes
DB01149,Nefazodone,DB01597,Cilastatin,0.7999548316001892,47,Type_47,The metabolism of Cilastatin can be decreased when combined with Nefazodone.,73,Type_73,No
DB00490,Buspirone,DB06697,Artemether,0.8190857768058777,47,Type_47,The metabolism of Artemether can be decreased when combined with Buspirone.,47,Type_47,Yes
DB01233,Metoclopramide,DB04861,Nebivolol,0.9632566571235657,54,Type_54,Metoclopramide may increase the bradycardic activities of Nebivolol.,54,Type_54,Yes
DB00384,Triamterene,DB06738,Ketobemidone,0.9807143807411194,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Ketobemidone.,49,Type_49,Yes
DB00925,Phenoxybenzamine,DB09054,Idelalisib,0.8853672742843628,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Phenoxybenzamine.,47,Type_47,Yes
DB00238,Nevirapine,DB00471,Montelukast,0.9540677070617676,4,Type_4,The metabolism of Montelukast can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00972,Azelastine,DB01077,Etidronic acid,0.6848804354667664,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Etidronic acid.,49,Type_49,Yes
DB00528,Lercanidipine,DB00976,Telithromycin,0.7877435684204102,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Lercanidipine.,73,Type_73,No
DB00312,Pentobarbital,DB01559,Clotiazepam,0.9757604598999023,4,Type_4,The metabolism of Clotiazepam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01235,Levodopa,DB09085,Tetracaine,0.9999511241912842,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Tetracaine.,49,Type_49,Yes
DB01320,Fosphenytoin,DB12332,Rucaparib,0.5634718537330627,75,Type_75,The serum concentration of Rucaparib can be decreased when it is combined with Fosphenytoin.,4,Type_4,No
DB00502,Haloperidol,DB00821,Carprofen,0.9814648032188416,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Carprofen.,49,Type_49,Yes
DB00457,Prazosin,DB06267,Udenafil,0.5805951356887817,60,Type_60,Prazosin may increase the hypotensive activities of Udenafil.,60,Type_60,Yes
DB00195,Betaxolol,DB11614,Rupatadine,0.8997867107391357,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00387,Procyclidine,DB00436,Bendroflumethiazide,0.9872762560844421,73,Type_73,The serum concentration of Bendroflumethiazide can be increased when it is combined with Procyclidine.,73,Type_73,Yes
DB01215,Estazolam,DB01236,Sevoflurane,0.9916538596153259,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Sevoflurane.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB00991,Oxaprozin,0.9844409227371216,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Oxaprozin.,49,Type_49,Yes
DB00802,Alfentanil,DB08808,Bupranolol,0.821148157119751,54,Type_54,Alfentanil may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB00268,Ropinirole,DB00977,Ethinylestradiol,0.8208504319190979,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Ropinirole.,73,Type_73,No
DB00559,Bosentan,DB09282,Molsidomine,0.9999980926513672,60,Type_60,Bosentan may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB00283,Clemastine,DB01708,Prasterone,0.9302369356155396,47,Type_47,The metabolism of Prasterone can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01085,Pilocarpine,DB01253,Ergometrine,0.5075511932373047,49,Type_49,The risk or severity of adverse effects can be increased when Pilocarpine is combined with Ergometrine.,49,Type_49,Yes
DB01201,Rifapentine,DB09230,Azelnidipine,0.4981105923652649,75,Type_75,The serum concentration of Azelnidipine can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB01002,Levobupivacaine,DB01175,Escitalopram,0.6971392035484314,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Escitalopram.,49,Type_49,Yes
DB00425,Zolpidem,DB01551,Dihydrocodeine,0.9500471949577332,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.,16,Type_16,Yes
DB00193,Tramadol,DB00496,Darifenacin,0.5257232785224915,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Tramadol.,70,Type_70,No
DB00374,Treprostinil,DB06154,Pentaerythritol tetranitrate,0.9362907409667969,6,Type_6,Treprostinil may increase the anticoagulant activities of Pentaerythritol tetranitrate.,6,Type_6,Yes
DB00346,Alfuzosin,DB06267,Udenafil,0.8637589812278748,10,Type_10,Alfuzosin may increase the antihypertensive activities of Udenafil.,60,Type_60,No
DB00654,Latanoprost,DB01171,Moclobemide,0.9999464750289917,60,Type_60,Latanoprost may increase the hypotensive activities of Moclobemide.,60,Type_60,Yes
DB00307,Bexarotene,DB00418,Secobarbital,0.6594288945198059,4,Type_4,The metabolism of Secobarbital can be increased when combined with Bexarotene.,4,Type_4,Yes
DB00715,Paroxetine,DB01015,Sulfamethoxazole,0.6363266706466675,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Paroxetine.,9,Type_9,No
DB00546,Adinazolam,DB00559,Bosentan,0.7741813659667969,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Adinazolam.,75,Type_75,Yes
DB00857,Terbinafine,DB09227,Barnidipine,0.9659650921821594,49,Type_49,The risk or severity of adverse effects can be increased when Terbinafine is combined with Barnidipine.,49,Type_49,Yes
DB00853,Temozolomide,DB08895,Tofacitinib,0.9960610270500183,34,Type_34,Temozolomide may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB09242,Moxonidine,DB09279,Fimasartan,0.997384250164032,49,Type_49,The risk or severity of adverse effects can be increased when Moxonidine is combined with Fimasartan.,49,Type_49,Yes
DB00243,Ranolazine,DB00911,Tinidazole,0.7816085815429688,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB08909,Glycerol phenylbutyrate,DB11921,Deflazacort,0.910122275352478,70,Type_70,The therapeutic efficacy of Deflazacort can be decreased when used in combination with Glycerol phenylbutyrate.,70,Type_70,Yes
DB00189,Ethchlorvynol,DB00312,Pentobarbital,0.9734734892845154,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Pentobarbital.,49,Type_49,Yes
DB06738,Ketobemidone,DB09166,Etizolam,0.9951908588409424,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Etizolam.,49,Type_49,Yes
DB00921,Buprenorphine,DB09352,Hydroxyamphetamine,0.9999899864196777,69,Type_69,Buprenorphine may increase the analgesic activities of Hydroxyamphetamine.,69,Type_69,Yes
DB01075,Diphenhydramine,DB05246,Methsuximide,0.9936962723731995,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Methsuximide.,49,Type_49,Yes
DB00883,Isosorbide dinitrate,DB05521,Telaprevir,0.5901463031768799,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Isosorbide dinitrate.,47,Type_47,Yes
DB00630,Alendronic acid,DB08439,Parecoxib,0.9948145747184753,49,Type_49,The risk or severity of adverse effects can be increased when Alendronic acid is combined with Parecoxib.,49,Type_49,Yes
DB00270,Isradipine,DB00277,Theophylline,0.9745882749557495,47,Type_47,The metabolism of Theophylline can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00418,Secobarbital,DB09112,Nitrous acid,0.8821160793304443,60,Type_60,Secobarbital may increase the hypotensive activities of Nitrous acid.,60,Type_60,Yes
DB00747,Scopolamine,DB06616,Bosutinib,0.9077960252761841,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Scopolamine.,73,Type_73,Yes
DB00917,Dinoprostone,DB01009,Ketoprofen,0.7215506434440613,70,Type_70,The therapeutic efficacy of Ketoprofen can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00537,Ciprofloxacin,DB00875,Flupentixol,0.7112703323364258,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Flupentixol.,20,Type_20,Yes
DB00185,Cevimeline,DB00981,Physostigmine,0.9954961538314819,49,Type_49,The risk or severity of adverse effects can be increased when Cevimeline is combined with Physostigmine.,49,Type_49,Yes
DB00238,Nevirapine,DB00978,Lomefloxacin,0.5527264475822449,75,Type_75,The serum concentration of Lomefloxacin can be decreased when it is combined with Nevirapine.,47,Type_47,No
DB00220,Nelfinavir,DB08922,Perospirone,0.6080923080444336,47,Type_47,The metabolism of Perospirone can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00934,Maprotiline,DB13323,Trichloroethylene,0.9999377727508545,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Trichloroethylene.,49,Type_49,Yes
DB00876,Eprosartan,DB01580,Oxprenolol,0.9144020080566406,60,Type_60,Eprosartan may increase the hypotensive activities of Oxprenolol.,60,Type_60,Yes
DB00239,Oxiconazole,DB06414,Etravirine,0.7371307611465454,47,Type_47,The metabolism of Etravirine can be decreased when combined with Oxiconazole.,73,Type_73,No
DB00216,Eletriptan,DB00908,Quinidine,0.7138929963111877,64,Type_64,Eletriptan may increase the serotonergic activities of Quinidine.,47,Type_47,No
DB04946,Iloperidone,DB06616,Bosutinib,0.802727997303009,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Iloperidone.,73,Type_73,Yes
DB00783,Estradiol,DB01241,Gemfibrozil,0.5898192524909973,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Estradiol.,47,Type_47,Yes
DB00268,Ropinirole,DB00530,Erlotinib,0.8631387948989868,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00423,Methocarbamol,DB06700,Desvenlafaxine,0.993312656879425,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Desvenlafaxine.,49,Type_49,Yes
DB00295,Morphine,DB09235,Efonidipine,0.9881649017333984,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Efonidipine.,49,Type_49,Yes
DB00323,Tolcapone,DB00980,Ramelteon,0.9997308850288391,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Ramelteon.,49,Type_49,Yes
DB00966,Telmisartan,DB01244,Bepridil,0.5823451280593872,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Bepridil.,60,Type_60,No
DB00589,Lisuride,DB00951,Isoniazid,0.4286419451236725,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Isoniazid.,47,Type_47,No
DB00217,Bethanidine,DB00226,Guanadrel,1.0,60,Type_60,Bethanidine may increase the hypotensive activities of Guanadrel.,60,Type_60,Yes
DB00663,Flumethasone,DB08880,Teriflunomide,0.9494222402572632,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Teriflunomide.,49,Type_49,Yes
DB00450,Droperidol,DB01151,Desipramine,0.8956414461135864,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desipramine.,16,Type_16,Yes
DB06209,Prasugrel,DB06695,Dabigatran etexilate,0.8516386151313782,6,Type_6,Prasugrel may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00270,Isradipine,DB11581,Venetoclax,0.9517906904220581,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00257,Clotrimazole,DB00469,Tenoxicam,0.9517594575881958,47,Type_47,The metabolism of Tenoxicam can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00285,Venlafaxine,DB09166,Etizolam,0.7504521608352661,47,Type_47,The metabolism of Etizolam can be decreased when combined with Venlafaxine.,49,Type_49,No
DB00687,Fludrocortisone,DB07615,Tranilast,0.996048629283905,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Tranilast.,49,Type_49,Yes
DB00428,Streptozocin,DB01092,Ouabain,0.9972827434539795,58,Type_58,Streptozocin may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00692,Phentolamine,DB00742,Mannitol,0.9512437582015991,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Mannitol.,49,Type_49,Yes
DB00328,Indomethacin,DB00374,Treprostinil,0.8314682841300964,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Treprostinil.,49,Type_49,Yes
DB00618,Demeclocycline,DB01226,Mivacurium,0.9999898672103882,21,Type_21,Demeclocycline may increase the neuromuscular blocking activities of Mivacurium.,21,Type_21,Yes
DB00870,Suprofen,DB01203,Nadolol,0.9999215602874756,37,Type_37,Suprofen may decrease the antihypertensive activities of Nadolol.,37,Type_37,Yes
DB00446,Chloramphenicol,DB00736,Esomeprazole,0.9782479405403137,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00660,Metaxalone,DB00752,Tranylcypromine,0.9967331886291504,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Tranylcypromine.,49,Type_49,Yes
DB00243,Ranolazine,DB01201,Rifapentine,0.6964616775512695,4,Type_4,The metabolism of Rifapentine can be increased when combined with Ranolazine.,4,Type_4,Yes
DB00690,Flurazepam,DB01355,Hexobarbital,0.9311432242393494,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Hexobarbital.,49,Type_49,Yes
DB00346,Alfuzosin,DB00598,Labetalol,0.7536113858222961,30,Type_30,Alfuzosin may increase the orthostatic hypotensive activities of Labetalol.,60,Type_60,No
DB00656,Trazodone,DB01086,Benzocaine,0.9994677901268005,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Benzocaine.,49,Type_49,Yes
DB00508,Triflupromazine,DB01377,Magnesium oxide,0.904296875,67,Type_67,Triflupromazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00673,Aprepitant,DB09053,Ibrutinib,0.9935012459754944,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00412,Rosiglitazone,DB00503,Ritonavir,0.6654291152954102,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Rosiglitazone.,70,Type_70,No
DB01601,Lopinavir,DB09075,Edoxaban,0.9917922019958496,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00489,Sotalol,DB00727,Nitroglycerin,0.9999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Nitroglycerin.,49,Type_49,Yes
DB01156,Bupropion,DB06603,Panobinostat,0.8607091307640076,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Bupropion.,73,Type_73,Yes
DB00816,Orciprenaline,DB09167,Dosulepin,0.9035364985466003,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Dosulepin.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB01185,Fluoxymesterone,0.9999935626983643,74,Type_74,Fluticasone propionate may increase the fluid retaining activities of Fluoxymesterone.,74,Type_74,Yes
DB08909,Glycerol phenylbutyrate,DB08971,Fluocortolone,0.99872225522995,70,Type_70,The therapeutic efficacy of Fluocortolone can be decreased when used in combination with Glycerol phenylbutyrate.,70,Type_70,Yes
DB00324,Fluorometholone,DB00808,Indapamide,0.9977239966392517,83,Type_83,Fluorometholone may increase the hypokalemic activities of Indapamide.,83,Type_83,Yes
DB00628,Clorazepic acid,DB01615,Aceprometazine,0.9922829270362854,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Aceprometazine.,49,Type_49,Yes
DB00862,Vardenafil,DB00908,Quinidine,0.9542703628540039,20,Type_20,Vardenafil may increase the QTc-prolonging activities of Quinidine.,20,Type_20,Yes
DB00922,Levosimendan,DB01367,Rasagiline,0.9798945784568787,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Rasagiline.,49,Type_49,Yes
DB00318,Codeine,DB01624,Zuclopenthixol,0.9478381276130676,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Zuclopenthixol.,49,Type_49,Yes
DB01044,Gatifloxacin,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Gatifloxacin.,70,Type_70,Yes
DB00927,Famotidine,DB06414,Etravirine,0.5512083172798157,47,Type_47,The metabolism of Etravirine can be decreased when combined with Famotidine.,47,Type_47,Yes
DB00734,Risperidone,DB01609,Deferasirox,0.9235159754753113,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Risperidone.,75,Type_75,Yes
DB00327,Hydromorphone,DB12332,Rucaparib,0.8743108510971069,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB00343,Diltiazem,DB08916,Afatinib,0.829433798789978,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Diltiazem.,73,Type_73,Yes
DB01023,Felodipine,DB09238,Manidipine,0.8932197690010071,60,Type_60,Felodipine may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00784,Mefenamic acid,DB01295,Bevantolol,0.9999752044677734,37,Type_37,Mefenamic acid may decrease the antihypertensive activities of Bevantolol.,37,Type_37,Yes
DB08826,Deferiprone,DB13142,Calcium glubionate anhydrous,0.9979574680328369,75,Type_75,The serum concentration of Calcium glubionate anhydrous can be decreased when it is combined with Deferiprone.,75,Type_75,Yes
DB00770,Alprostadil,DB08976,Floctafenine,0.9120665192604065,70,Type_70,The therapeutic efficacy of Floctafenine can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00834,Mifepristone,DB01098,Rosuvastatin,0.9849386215209961,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB08864,Rilpivirine,DB09104,Magnesium hydroxide,0.592038094997406,75,Type_75,The serum concentration of Magnesium hydroxide can be decreased when it is combined with Rilpivirine.,75,Type_75,Yes
DB00543,Amoxapine,DB00722,Lisinopril,0.7280520796775818,73,Type_73,The serum concentration of Lisinopril can be increased when it is combined with Amoxapine.,73,Type_73,Yes
DB00418,Secobarbital,DB00836,Loperamide,0.9185878038406372,4,Type_4,The metabolism of Loperamide can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00898,Ethanol,DB00982,Isotretinoin,0.746927797794342,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Isotretinoin.,49,Type_49,Yes
DB00426,Famciclovir,DB01026,Ketoconazole,0.945120632648468,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Famciclovir.,47,Type_47,Yes
DB01015,Sulfamethoxazole,DB01367,Rasagiline,0.9528821110725403,9,Type_9,Sulfamethoxazole may increase the hypoglycemic activities of Rasagiline.,9,Type_9,Yes
DB00612,Bisoprolol,DB00706,Tamsulosin,0.5736610889434814,49,Type_49,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Tamsulosin.,30,Type_30,No
DB00750,Prilocaine,DB01173,Orphenadrine,0.9616860747337341,16,Type_16,Prilocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00474,Methohexital,DB00898,Ethanol,0.9950188398361206,16,Type_16,Methohexital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB01075,Diphenhydramine,DB01236,Sevoflurane,0.5247654318809509,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Diphenhydramine.,49,Type_49,No
DB01367,Rasagiline,DB11699,Tropisetron,0.9999998807907104,64,Type_64,Rasagiline may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00338,Omeprazole,DB06209,Prasugrel,0.5663310289382935,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00470,Dronabinol,DB01176,Cyclizine,0.9999158382415771,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.,16,Type_16,Yes
DB00224,Indinavir,DB00764,Mometasone,0.8944928050041199,73,Type_73,The serum concentration of Mometasone can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00310,Chlorthalidone,DB00986,Glycopyrronium,0.9794573783874512,73,Type_73,The serum concentration of Glycopyrronium can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB00169,Cholecalciferol,DB01424,Aminophenazone,0.9252583980560303,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00215,Citalopram,DB04844,Tetrabenazine,0.920166552066803,20,Type_20,Citalopram may increase the QTc-prolonging activities of Tetrabenazine.,47,Type_47,No
DB00283,Clemastine,DB04908,Flibanserin,0.8785824775695801,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Flibanserin.,49,Type_49,Yes
DB00699,Nicergoline,DB00972,Azelastine,0.9892784953117371,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Azelastine.,49,Type_49,Yes
DB01253,Ergometrine,DB08916,Afatinib,0.9241736531257629,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00831,Trifluoperazine,DB01106,Levocabastine,0.9999196529388428,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levocabastine.,49,Type_49,Yes
DB00424,Hyoscyamine,DB01324,Polythiazide,0.995908260345459,73,Type_73,The serum concentration of Polythiazide can be increased when it is combined with Hyoscyamine.,73,Type_73,Yes
DB00896,Rimexolone,DB01399,Salsalate,0.9996609687805176,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Salsalate.,49,Type_49,Yes
DB00422,Methylphenidate,DB00590,Doxazosin,0.9988356232643127,37,Type_37,Methylphenidate may decrease the antihypertensive activities of Doxazosin.,37,Type_37,Yes
DB00268,Ropinirole,DB00660,Metaxalone,0.9976254105567932,32,Type_32,Ropinirole may increase the sedative activities of Metaxalone.,32,Type_32,Yes
DB06712,Nilvadipine,DB08860,Pitavastatin,0.6118904948234558,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Nilvadipine.,73,Type_73,Yes
DB00178,Ramipril,DB00768,Olopatadine,0.9030029773712158,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Olopatadine.,49,Type_49,Yes
DB00596,Ulobetasol,DB00605,Sulindac,0.9996337890625,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Sulindac.,49,Type_49,Yes
DB00808,Indapamide,DB09236,Lacidipine,0.7208560705184937,60,Type_60,Indapamide may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00195,Betaxolol,DB00411,Carbamoylcholine,0.7811644673347473,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Carbamoylcholine.,49,Type_49,Yes
DB01222,Budesonide,DB09104,Magnesium hydroxide,0.9983318448066711,3,Type_3,The bioavailability of Magnesium hydroxide can be decreased when combined with Budesonide.,3,Type_3,Yes
DB00476,Duloxetine,DB00660,Metaxalone,0.9959970712661743,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Metaxalone.,49,Type_49,Yes
DB01199,Tubocurarine,DB04574,Estrone sulfate,0.9141896367073059,49,Type_49,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Estrone sulfate.,49,Type_49,Yes
DB00203,Sildenafil,DB06207,Silodosin,0.9398136138916016,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Sildenafil.,60,Type_60,No
DB00710,Ibandronate,DB01169,Arsenic trioxide,0.8390695452690125,20,Type_20,Ibandronate may increase the QTc-prolonging activities of Arsenic trioxide.,20,Type_20,Yes
DB00543,Amoxapine,DB08922,Perospirone,0.9377259016036987,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Perospirone.,49,Type_49,Yes
DB00253,Medrysone,DB01263,Posaconazole,0.8465294241905212,73,Type_73,The serum concentration of Posaconazole can be increased when it is combined with Medrysone.,73,Type_73,Yes
DB00468,Quinine,DB01090,Pentolinium,0.5005012154579163,60,Type_60,Quinine may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00455,Loratadine,DB00656,Trazodone,0.7334425449371338,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Trazodone.,49,Type_49,Yes
DB00409,Remoxipride,DB01580,Oxprenolol,0.6591367125511169,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Oxprenolol.,49,Type_49,Yes
DB00540,Nortriptyline,DB09280,Lumacaftor,0.47470623254776,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB00270,Isradipine,DB01196,Estramustine,0.9128376245498657,47,Type_47,The metabolism of Estramustine can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00201,Caffeine,DB01241,Gemfibrozil,0.9621185660362244,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00797,Tolazoline,DB00903,Etacrynic acid,0.9992610812187195,49,Type_49,The risk or severity of adverse effects can be increased when Tolazoline is combined with Etacrynic acid.,49,Type_49,Yes
DB00203,Sildenafil,DB09026,Aliskiren,0.6764159202575684,10,Type_10,Sildenafil may increase the antihypertensive activities of Aliskiren.,10,Type_10,Yes
DB01196,Estramustine,DB06695,Dabigatran etexilate,0.31747177243232727,75,Type_75,The serum concentration of Dabigatran etexilate can be decreased when it is combined with Estramustine.,77,Type_77,No
DB00312,Pentobarbital,DB00596,Ulobetasol,0.7963321805000305,75,Type_75,The serum concentration of Ulobetasol can be decreased when it is combined with Pentobarbital.,75,Type_75,Yes
DB00484,Brimonidine,DB01348,Spirapril,0.9109557271003723,10,Type_10,Brimonidine may increase the antihypertensive activities of Spirapril.,10,Type_10,Yes
DB00594,Amiloride,DB01401,Choline magnesium trisalicylate,0.9968233108520508,37,Type_37,Amiloride may decrease the antihypertensive activities of Choline magnesium trisalicylate.,37,Type_37,Yes
DB00384,Triamterene,DB00808,Indapamide,0.9094055891036987,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Indapamide.,49,Type_49,Yes
DB00498,Phenindione,DB01017,Minocycline,0.9649271965026855,6,Type_6,Phenindione may increase the anticoagulant activities of Minocycline.,6,Type_6,Yes
DB00333,Methadone,DB13323,Trichloroethylene,0.9671978950500488,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Trichloroethylene.,49,Type_49,Yes
DB00337,Pimecrolimus,DB12598,Nafamostat,0.6584522128105164,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nafamostat.,49,Type_49,Yes
DB00961,Mepivacaine,DB08910,Pomalidomide,0.999708354473114,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Pomalidomide.,49,Type_49,Yes
DB00251,Terconazole,DB00604,Cisapride,0.502680242061615,73,Type_73,The serum concentration of Cisapride can be increased when it is combined with Terconazole.,73,Type_73,Yes
DB00732,Atracurium besylate,DB00761,Potassium chloride,0.999975323677063,59,Type_59,Atracurium besylate may increase the ulcerogenic activities of Potassium chloride.,59,Type_59,Yes
DB00179,Masoprocol,DB00421,Spironolactone,0.7706197500228882,37,Type_37,Masoprocol may decrease the antihypertensive activities of Spironolactone.,37,Type_37,Yes
DB00185,Cevimeline,DB06708,Lumefantrine,0.9651128053665161,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00617,Paramethadione,DB06636,Isavuconazonium,0.9544966220855713,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Paramethadione.,47,Type_47,Yes
DB01175,Escitalopram,DB09034,Suvorexant,0.963517427444458,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Suvorexant.,49,Type_49,Yes
DB00557,Hydroxyzine,DB01173,Orphenadrine,0.9999411106109619,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00238,Nevirapine,DB08907,Canagliflozin,0.8788312673568726,4,Type_4,The metabolism of Canagliflozin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00285,Venlafaxine,DB00461,Nabumetone,0.6205897331237793,47,Type_47,The metabolism of Nabumetone can be decreased when combined with Venlafaxine.,53,Type_53,No
DB01002,Levobupivacaine,DB09038,Empagliflozin,0.8622415065765381,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Empagliflozin.,49,Type_49,Yes
DB00620,Triamcinolone,DB01174,Phenobarbital,0.6374958753585815,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Triamcinolone.,4,Type_4,Yes
DB01324,Polythiazide,DB01380,Cortisone acetate,0.9999078512191772,83,Type_83,Polythiazide may increase the hypokalemic activities of Cortisone acetate.,83,Type_83,Yes
DB00201,Caffeine,DB08864,Rilpivirine,0.7689706683158875,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Caffeine.,73,Type_73,Yes
DB00418,Secobarbital,DB12532,Oxetacaine,0.9985190033912659,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Oxetacaine.,49,Type_49,Yes
DB08883,Perampanel,DB09286,Pipamperone,0.7882299423217773,16,Type_16,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.,16,Type_16,Yes
DB00480,Lenalidomide,DB01396,Digitoxin,0.9997745156288147,58,Type_58,Lenalidomide may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00285,Venlafaxine,DB01615,Aceprometazine,0.502380907535553,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Aceprometazine.,49,Type_49,Yes
DB00490,Buspirone,DB00527,Cinchocaine,0.9999806880950928,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Cinchocaine.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB06144,Sertindole,0.9662588238716125,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Sertindole.,49,Type_49,Yes
DB01154,Thiamylal,DB01161,Chloroprocaine,0.9997344613075256,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Chloroprocaine.,49,Type_49,Yes
DB00966,Telmisartan,DB08907,Canagliflozin,0.9384340047836304,68,Type_68,Telmisartan may increase the hyperkalemic activities of Canagliflozin.,68,Type_68,Yes
DB01176,Cyclizine,DB04841,Flunarizine,0.9993811845779419,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Flunarizine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01229,Paclitaxel,0.49204716086387634,47,Type_47,The metabolism of Paclitaxel can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00653,Magnesium sulfate,DB01002,Levobupivacaine,0.9136530756950378,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,16,Type_16,Yes
DB00559,Bosentan,DB01175,Escitalopram,0.9513972997665405,75,Type_75,The serum concentration of Escitalopram can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB09054,Idelalisib,DB09166,Etizolam,0.8520607352256775,47,Type_47,The metabolism of Etizolam can be decreased when combined with Idelalisib.,73,Type_73,No
DB00678,Losartan,DB01131,Proguanil,0.9416112899780273,47,Type_47,The metabolism of Proguanil can be decreased when combined with Losartan.,47,Type_47,Yes
DB00458,Imipramine,DB01063,Acetophenazine,0.9084423184394836,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Acetophenazine.,49,Type_49,Yes
DB01116,Trimethaphan,DB01580,Oxprenolol,0.7549512982368469,10,Type_10,Trimethaphan may increase the antihypertensive activities of Oxprenolol.,60,Type_60,No
DB01092,Ouabain,DB08896,Regorafenib,0.9953354001045227,58,Type_58,Ouabain may decrease the cardiotoxic activities of Regorafenib.,58,Type_58,Yes
DB00880,Chlorothiazide,DB01168,Procarbazine,0.9047310948371887,60,Type_60,Chlorothiazide may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00520,Caspofungin,DB00653,Magnesium sulfate,0.9741180539131165,49,Type_49,The risk or severity of adverse effects can be increased when Caspofungin is combined with Magnesium sulfate.,49,Type_49,Yes
DB00268,Ropinirole,DB00652,Pentazocine,0.9999079704284668,32,Type_32,Ropinirole may increase the sedative activities of Pentazocine.,32,Type_32,Yes
DB00228,Enflurane,DB00831,Trifluoperazine,0.9989588260650635,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Trifluoperazine.,49,Type_49,Yes
DB00976,Telithromycin,DB06176,Romidepsin,0.7419342398643494,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Telithromycin.,73,Type_73,No
DB08820,Ivacaftor,DB09079,Nintedanib,0.999110758304596,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB00312,Pentobarbital,DB00690,Flurazepam,0.9259689450263977,4,Type_4,The metabolism of Flurazepam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00912,Repaglinide,DB01395,Drospirenone,0.98615962266922,70,Type_70,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Repaglinide.,70,Type_70,Yes
DB00726,Trimipramine,DB09027,Ledipasvir,0.816896915435791,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00247,Methysergide,DB00989,Rivastigmine,0.9998170733451843,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Rivastigmine.,49,Type_49,Yes
DB00503,Ritonavir,DB00568,Cinnarizine,0.9004466533660889,47,Type_47,The metabolism of Cinnarizine can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00921,Buprenorphine,DB06204,Tapentadol,0.9999994039535522,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00324,Fluorometholone,DB01406,Danazol,0.9998148083686829,74,Type_74,Fluorometholone may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB00461,Nabumetone,DB06786,Halcinonide,0.9988424181938171,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Halcinonide.,49,Type_49,Yes
DB01219,Dantrolene,DB09034,Suvorexant,0.9995531439781189,16,Type_16,Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB01184,Domperidone,DB04946,Iloperidone,0.8535974621772766,20,Type_20,Domperidone may increase the QTc-prolonging activities of Iloperidone.,33,Type_33,No
DB00363,Clozapine,DB01255,Lisdexamfetamine,0.9784294366836548,61,Type_61,Clozapine may decrease the stimulatory activities of Lisdexamfetamine.,61,Type_61,Yes
DB00368,Norepinephrine,DB00614,Furazolidone,0.9991022348403931,71,Type_71,Norepinephrine may increase the hypertensive activities of Furazolidone.,71,Type_71,Yes
DB00697,Tizanidine,DB00898,Ethanol,0.9966021776199341,16,Type_16,Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00401,Nisoldipine,DB00457,Prazosin,0.8302788734436035,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Prazosin.,49,Type_49,Yes
DB00444,Teniposide,DB09270,Ubidecarenone,0.9286771416664124,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Teniposide.,73,Type_73,Yes
DB00697,Tizanidine,DB05812,Abiraterone,0.9321568608283997,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Tizanidine.,73,Type_73,Yes
DB00598,Labetalol,DB01174,Phenobarbital,0.9522466063499451,60,Type_60,Labetalol may increase the hypotensive activities of Phenobarbital.,60,Type_60,Yes
DB00924,Cyclobenzaprine,DB09065,Cobicistat,0.8027809262275696,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Cyclobenzaprine.,73,Type_73,Yes
DB00683,Midazolam,DB01197,Captopril,0.3947034180164337,47,Type_47,The metabolism of Captopril can be decreased when combined with Midazolam.,73,Type_73,No
DB00320,Dihydroergotamine,DB01214,Metipranolol,0.9465867280960083,25,Type_25,Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metipranolol.,19,Type_19,No
DB01234,Dexamethasone,DB13783,Acemetacin,0.9101378917694092,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Acemetacin.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00764,Mometasone,0.9999070167541504,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mometasone.,49,Type_49,Yes
DB01324,Polythiazide,DB01435,Antipyrine,0.9875981211662292,70,Type_70,The therapeutic efficacy of Antipyrine can be decreased when used in combination with Polythiazide.,70,Type_70,Yes
DB08797,Salicylamide,DB08906,Fluticasone furoate,0.9988424181938171,49,Type_49,The risk or severity of adverse effects can be increased when Salicylamide is combined with Fluticasone furoate.,49,Type_49,Yes
DB01092,Ouabain,DB08875,Cabozantinib,0.9984608888626099,58,Type_58,Ouabain may decrease the cardiotoxic activities of Cabozantinib.,58,Type_58,Yes
DB00641,Simvastatin,DB01201,Rifapentine,0.9235670566558838,4,Type_4,The metabolism of Rifapentine can be increased when combined with Simvastatin.,4,Type_4,Yes
DB00270,Isradipine,DB12483,Copanlisib,0.9821681976318359,47,Type_47,The metabolism of Copanlisib can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00892,Oxybuprocaine,DB01104,Sertraline,0.9942620992660522,49,Type_49,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Sertraline.,49,Type_49,Yes
DB00283,Clemastine,DB01198,Zopiclone,0.747582197189331,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Clemastine.,73,Type_73,No
DB01065,Melatonin,DB06700,Desvenlafaxine,0.9841390252113342,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Desvenlafaxine.,49,Type_49,Yes
DB00622,Nicardipine,DB06694,Xylometazoline,0.9018858671188354,60,Type_60,Nicardipine may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00867,Ritodrine,DB00871,Terbutaline,0.9999344348907471,49,Type_49,The risk or severity of adverse effects can be increased when Ritodrine is combined with Terbutaline.,49,Type_49,Yes
DB00178,Ramipril,DB01018,Guanfacine,0.7398572564125061,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Guanfacine.,49,Type_49,Yes
DB00364,Sucralfate,DB00936,Salicylic acid,0.4657513201236725,75,Type_75,The serum concentration of Salicylic acid can be decreased when it is combined with Sucralfate.,67,Type_67,No
DB00176,Fluvoxamine,DB11560,Lesinurad,0.990165650844574,47,Type_47,The metabolism of Lesinurad can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00367,Levonorgestrel,DB00569,Fondaparinux,0.43381425738334656,12,Type_12,Levonorgestrel may decrease the anticoagulant activities of Fondaparinux.,70,Type_70,No
DB00648,Mitotane,DB05271,Rotigotine,0.9691357016563416,75,Type_75,The serum concentration of Rotigotine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00476,Duloxetine,DB01174,Phenobarbital,0.8400107622146606,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Duloxetine.,49,Type_49,No
DB00207,Azithromycin,DB01254,Dasatinib,0.8145250082015991,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB06176,Romidepsin,DB08899,Enzalutamide,0.960506021976471,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Romidepsin.,75,Type_75,Yes
DB00312,Pentobarbital,DB00635,Prednisone,0.7441621422767639,4,Type_4,The metabolism of Prednisone can be increased when combined with Pentobarbital.,75,Type_75,No
DB00865,Benzphetamine,DB01239,Chlorprothixene,0.9985877275466919,61,Type_61,Benzphetamine may decrease the stimulatory activities of Chlorprothixene.,61,Type_61,Yes
DB00614,Furazolidone,DB02638,Terlipressin,0.9999668598175049,60,Type_60,Furazolidone may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB01559,Clotiazepam,DB06290,Simeprevir,0.9437857270240784,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Clotiazepam.,73,Type_73,Yes
DB00316,Acetaminophen,DB01241,Gemfibrozil,0.9456328749656677,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB01178,Chlormezanone,DB01563,Chloral hydrate,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Chloral hydrate.,49,Type_49,Yes
DB00492,Fosinopril,DB01143,Amifostine,0.5647966265678406,60,Type_60,Fosinopril may increase the hypotensive activities of Amifostine.,60,Type_60,Yes
DB00339,Pyrazinamide,DB00976,Telithromycin,0.8325492739677429,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Pyrazinamide.,47,Type_47,Yes
DB01590,Everolimus,DB11730,Ribociclib,0.902529776096344,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00750,Prilocaine,DB00794,Primidone,0.7231040000915527,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Primidone.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB00866,Alprenolol,0.6538458466529846,60,Type_60,Hydroflumethiazide may increase the hypotensive activities of Alprenolol.,60,Type_60,Yes
DB01708,Prasterone,DB09280,Lumacaftor,0.780228853225708,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Prasterone.,4,Type_4,No
DB00846,Flurandrenolide,DB01167,Itraconazole,0.9228036403656006,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Flurandrenolide.,73,Type_73,Yes
DB00586,Diclofenac,DB06636,Isavuconazonium,0.9838479161262512,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Diclofenac.,47,Type_47,Yes
DB00625,Efavirenz,DB09296,Ombitasvir,0.7781469225883484,47,Type_47,The metabolism of Ombitasvir can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00540,Nortriptyline,DB09000,Cyamemazine,0.9709720611572266,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cyamemazine.,49,Type_49,Yes
DB00976,Telithromycin,DB09236,Lacidipine,0.5824539661407471,49,Type_49,The risk or severity of adverse effects can be increased when Telithromycin is combined with Lacidipine.,47,Type_47,No
DB00243,Ranolazine,DB04841,Flunarizine,0.5092008113861084,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00700,Eplerenone,DB00887,Bumetanide,0.9988151788711548,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Bumetanide.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB01138,Sulfinpyrazone,0.9333195686340332,47,Type_47,The metabolism of Sulfinpyrazone can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB01384,Paramethasone,DB08909,Glycerol phenylbutyrate,0.946904718875885,70,Type_70,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Paramethasone.,70,Type_70,Yes
DB00854,Levorphanol,DB13872,Lormetazepam,0.9996572732925415,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Lormetazepam.,49,Type_49,Yes
DB01029,Irbesartan,DB01544,Flunitrazepam,0.8842452168464661,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00185,Cevimeline,DB00794,Primidone,0.9977074861526489,4,Type_4,The metabolism of Primidone can be increased when combined with Cevimeline.,4,Type_4,Yes
DB00726,Trimipramine,DB01065,Melatonin,0.9878553748130798,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Melatonin.,49,Type_49,Yes
DB00476,Duloxetine,DB01297,Practolol,0.9573795795440674,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Practolol.,73,Type_73,No
DB01466,Ethylmorphine,DB09118,Stiripentol,0.434759259223938,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ethylmorphine.,73,Type_73,Yes
DB00206,Reserpine,DB00312,Pentobarbital,0.7923312783241272,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Pentobarbital.,49,Type_49,Yes
DB00332,Ipratropium,DB00834,Mifepristone,0.918851912021637,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Ipratropium.,73,Type_73,Yes
DB00790,Perindopril,DB00808,Indapamide,0.7877742648124695,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Indapamide.,49,Type_49,Yes
DB00470,Dronabinol,DB06216,Asenapine,0.9979537725448608,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,16,Type_16,Yes
DB00908,Quinidine,DB09300,Butylscopolamine,0.6530603170394897,49,Type_49,The risk or severity of adverse effects can be increased when Quinidine is combined with Butylscopolamine.,49,Type_49,Yes
DB00283,Clemastine,DB01175,Escitalopram,0.947478711605072,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB11613,Velpatasvir,0.9861214756965637,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01240,Epoprostenol,DB09204,Arotinolol,0.8418852686882019,30,Type_30,Epoprostenol may increase the orthostatic hypotensive activities of Arotinolol.,49,Type_49,No
DB00227,Lovastatin,DB01234,Dexamethasone,0.875564455986023,47,Type_47,The metabolism of Dexamethasone can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00691,Moexipril,DB01283,Lumiracoxib,0.8596185445785522,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Lumiracoxib.,49,Type_49,Yes
DB00820,Tadalafil,DB01116,Trimethaphan,0.9827269315719604,10,Type_10,Tadalafil may increase the antihypertensive activities of Trimethaphan.,10,Type_10,Yes
DB01356,Lithium cation,DB11156,Pyrantel,0.9997732043266296,21,Type_21,Lithium cation may increase the neuromuscular blocking activities of Pyrantel.,21,Type_21,Yes
DB00647,Dextropropoxyphene,DB00771,Clidinium,0.9997692704200745,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Clidinium.,49,Type_49,Yes
DB00614,Furazolidone,DB01452,Diamorphine,0.890117883682251,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Diamorphine.,49,Type_49,Yes
DB00748,Carbinoxamine,DB09280,Lumacaftor,0.39028865098953247,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Carbinoxamine.,73,Type_73,No
DB01080,Vigabatrin,DB04842,Fluspirilene,0.9999650716781616,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fluspirilene.,49,Type_49,Yes
DB01092,Ouabain,DB08913,Radium Ra 223 dichloride,0.999990701675415,58,Type_58,Ouabain may decrease the cardiotoxic activities of Radium Ra 223 dichloride.,58,Type_58,Yes
DB01236,Sevoflurane,DB08987,Etidocaine,0.9995859265327454,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Etidocaine.,49,Type_49,Yes
DB00490,Buspirone,DB00690,Flurazepam,0.7962308526039124,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Flurazepam.,49,Type_49,Yes
DB00545,Pyridostigmine,DB02187,Equilin,0.999886155128479,49,Type_49,The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Equilin.,49,Type_49,Yes
DB00318,Codeine,DB00421,Spironolactone,0.9594386219978333,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Spironolactone.,49,Type_49,Yes
DB00268,Ropinirole,DB01609,Deferasirox,0.821191132068634,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Ropinirole.,75,Type_75,Yes
DB00437,Allopurinol,DB03754,Tromethamine,0.8257362246513367,67,Type_67,Allopurinol can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00594,Amiloride,DB06737,Zaltoprofen,0.9981106519699097,37,Type_37,Amiloride may decrease the antihypertensive activities of Zaltoprofen.,37,Type_37,Yes
DB01124,Tolbutamide,DB08808,Bupranolol,0.9494404196739197,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Bupranolol.,9,Type_9,Yes
DB01106,Levocabastine,DB01219,Dantrolene,0.9996823072433472,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Dantrolene.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB08976,Floctafenine,0.9997499585151672,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Floctafenine.,49,Type_49,Yes
DB00742,Mannitol,DB01020,Isosorbide mononitrate,0.9934318661689758,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Isosorbide mononitrate.,49,Type_49,Yes
DB00179,Masoprocol,DB00774,Hydroflumethiazide,0.9994775652885437,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Masoprocol.,70,Type_70,Yes
DB00146,Calcifediol,DB11093,Calcium citrate,0.9747281670570374,49,Type_49,The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium citrate.,49,Type_49,Yes
DB02187,Equilin,DB08804,Nandrolone decanoate,1.0,74,Type_74,Equilin may increase the fluid retaining activities of Nandrolone decanoate.,74,Type_74,Yes
DB00176,Fluvoxamine,DB06710,Methyltestosterone,0.9210785031318665,47,Type_47,The metabolism of Methyltestosterone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00946,Phenprocoumon,DB01185,Fluoxymesterone,0.9997077584266663,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Fluoxymesterone.,6,Type_6,Yes
DB00708,Sufentanil,DB09236,Lacidipine,0.9905827045440674,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Lacidipine.,49,Type_49,Yes
DB01424,Aminophenazone,DB08881,Vemurafenib,0.610863208770752,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Aminophenazone.,73,Type_73,No
DB00608,Chloroquine,DB01107,Methyprylon,0.9993487000465393,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00366,Doxylamine,DB00933,Mesoridazine,0.9999982118606567,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.,16,Type_16,Yes
DB00204,Dofetilide,DB00246,Ziprasidone,0.9238613247871399,33,Type_33,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Ziprasidone.,73,Type_73,No
DB00656,Trazodone,DB00680,Moricizine,0.3942677676677704,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Moricizine.,49,Type_49,Yes
DB01002,Levobupivacaine,DB01229,Paclitaxel,0.6956116557121277,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Paclitaxel.,49,Type_49,Yes
DB00615,Rifabutin,DB00959,Methylprednisolone,0.7837522029876709,75,Type_75,The serum concentration of Methylprednisolone can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB01128,Bicalutamide,DB01186,Pergolide,0.9652153849601746,49,Type_49,The risk or severity of adverse effects can be increased when Bicalutamide is combined with Pergolide.,49,Type_49,Yes
DB00706,Tamsulosin,DB00922,Levosimendan,0.9247424602508545,49,Type_49,The risk or severity of adverse effects can be increased when Tamsulosin is combined with Levosimendan.,49,Type_49,Yes
DB00863,Ranitidine,DB09146,Iron sucrose,0.7194991707801819,67,Type_67,Ranitidine can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00967,Desloratadine,DB06770,Benzyl alcohol,0.986163318157196,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Benzyl alcohol.,49,Type_49,Yes
DB00691,Moexipril,DB00705,Delavirdine,0.309862345457077,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Moexipril.,75,Type_75,No
DB01182,Propafenone,DB01223,Aminophylline,0.5936402678489685,73,Type_73,The serum concentration of Aminophylline can be increased when it is combined with Propafenone.,73,Type_73,Yes
DB01426,Ajmaline,DB06702,Fesoterodine,0.9234607219696045,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Ajmaline.,77,Type_77,Yes
DB00177,Valsartan,DB00706,Tamsulosin,0.8979625105857849,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Tamsulosin.,49,Type_49,Yes
DB03619,Deoxycholic acid,DB09030,Vorapaxar,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Deoxycholic acid is combined with Vorapaxar.,49,Type_49,Yes
DB01466,Ethylmorphine,DB01626,Pargyline,0.8990554213523865,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pargyline.,49,Type_49,Yes
DB01232,Saquinavir,DB06402,Telavancin,0.9999860525131226,20,Type_20,Saquinavir may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB01045,Rifampicin,DB06292,Dapagliflozin,0.9521841406822205,4,Type_4,The metabolism of Dapagliflozin can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00334,Olanzapine,DB00852,Pseudoephedrine,0.9819934964179993,61,Type_61,Olanzapine may decrease the stimulatory activities of Pseudoephedrine.,61,Type_61,Yes
DB00218,Moxifloxacin,DB01236,Sevoflurane,0.9984610080718994,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Sevoflurane.,20,Type_20,Yes
DB00287,Travoprost,DB01214,Metipranolol,0.9999951124191284,60,Type_60,Travoprost may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00394,Beclomethasone dipropionate,DB00685,Trovafloxacin,0.9917768239974976,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Trovafloxacin.,49,Type_49,Yes
DB00678,Losartan,DB09449,"Sodium phosphate, monobasic",0.6121395230293274,57,Type_57,"Losartan may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00177,Valsartan,DB00222,Glimepiride,0.8043029308319092,47,Type_47,The metabolism of Glimepiride can be decreased when combined with Valsartan.,47,Type_47,Yes
DB06335,Saxagliptin,DB06595,Midostaurin,0.5299007892608643,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Saxagliptin.,75,Type_75,No
DB00620,Triamcinolone,DB00944,Demecarium,0.9996743202209473,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Demecarium.,49,Type_49,Yes
DB00252,Phenytoin,DB08880,Teriflunomide,0.9549001455307007,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Phenytoin.,47,Type_47,No
DB00691,Moexipril,DB09215,Droxicam,0.9844980835914612,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Droxicam.,49,Type_49,Yes
DB01164,Calcium chloride,DB02300,Calcipotriol,0.7178210616111755,49,Type_49,The risk or severity of adverse effects can be increased when Calcium chloride is combined with Calcipotriol.,49,Type_49,Yes
DB00486,Nabilone,DB01020,Isosorbide mononitrate,0.9412388801574707,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Isosorbide mononitrate.,49,Type_49,Yes
DB00423,Methocarbamol,DB09085,Tetracaine,0.9999985694885254,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Tetracaine.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB01114,Chlorpheniramine,0.9998181462287903,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Chlorpheniramine.,49,Type_49,Yes
DB00933,Mesoridazine,DB01242,Clomipramine,0.7833728790283203,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clomipramine.,47,Type_47,No
DB00567,Cephalexin,DB01075,Diphenhydramine,0.9916015267372131,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Cephalexin.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB06788,Histrelin,0.9999998807907104,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB00333,Methadone,DB01601,Lopinavir,0.6728590726852417,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Methadone.,20,Type_20,No
DB01159,Halothane,DB06282,Levocetirizine,0.9973533153533936,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Levocetirizine.,49,Type_49,Yes
DB01201,Rifapentine,DB13179,Troleandomycin,0.7763421535491943,4,Type_4,The metabolism of Troleandomycin can be increased when combined with Rifapentine.,4,Type_4,Yes
DB00575,Clonidine,DB09232,Cilnidipine,0.9745015501976013,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Cilnidipine.,49,Type_49,Yes
DB00663,Flumethasone,DB01357,Mestranol,0.9971154928207397,73,Type_73,The serum concentration of Mestranol can be increased when it is combined with Flumethasone.,73,Type_73,Yes
DB01175,Escitalopram,DB06704,Iobenguane,0.9142400622367859,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Escitalopram.,70,Type_70,Yes
DB00296,Ropivacaine,DB00818,Propofol,0.6092534065246582,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Propofol.,73,Type_73,No
DB00975,Dipyridamole,DB09026,Aliskiren,0.9784529805183411,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Aliskiren.,49,Type_49,Yes
DB01110,Miconazole,DB01254,Dasatinib,0.8733886480331421,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Miconazole.,73,Type_73,Yes
DB01015,Sulfamethoxazole,DB06738,Ketobemidone,0.9615079760551453,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00321,Amitriptyline,DB01615,Aceprometazine,0.9663953185081482,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Aceprometazine.,49,Type_49,Yes
DB01023,Felodipine,DB01355,Hexobarbital,0.7638614177703857,60,Type_60,Felodipine may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00813,Fentanyl,DB09183,Dasabuvir,0.8748668432235718,73,Type_73,The serum concentration of Dasabuvir can be increased when it is combined with Fentanyl.,73,Type_73,Yes
DB00526,Oxaliplatin,DB08868,Fingolimod,0.9537047743797302,34,Type_34,Oxaliplatin may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB01708,Prasterone,DB13167,Alclofenac,0.9992904663085938,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Alclofenac.,49,Type_49,Yes
DB01244,Bepridil,DB08893,Mirabegron,0.6120020747184753,20,Type_20,Bepridil may increase the QTc-prolonging activities of Mirabegron.,47,Type_47,No
DB01099,Flucytosine,DB01115,Nifedipine,0.9833570718765259,49,Type_49,The risk or severity of adverse effects can be increased when Flucytosine is combined with Nifedipine.,49,Type_49,Yes
DB01062,Oxybutynin,DB01325,Quinethazone,0.9910662770271301,73,Type_73,The serum concentration of Quinethazone can be increased when it is combined with Oxybutynin.,73,Type_73,Yes
DB08865,Crizotinib,DB11581,Venetoclax,0.9104986786842346,47,Type_47,The metabolism of Venetoclax can be decreased when combined with Crizotinib.,47,Type_47,Yes
DB00261,Anagrelide,DB00738,Pentamidine,0.8890311121940613,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00320,Dihydroergotamine,DB01200,Bromocriptine,0.281630277633667,19,Type_19,Dihydroergotamine may increase the vasoconstricting activities of Bromocriptine.,49,Type_49,No
DB08822,Azilsartan medoxomil,DB08976,Floctafenine,0.9985659718513489,49,Type_49,The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Floctafenine.,49,Type_49,Yes
DB00897,Triazolam,DB01068,Clonazepam,0.992280125617981,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Clonazepam.,49,Type_49,Yes
DB00468,Quinine,DB06702,Fesoterodine,0.9617815613746643,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Quinine.,77,Type_77,Yes
DB01407,Clenbuterol,DB06764,Tetryzoline,0.9777105450630188,49,Type_49,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Tetryzoline.,49,Type_49,Yes
DB00665,Nilutamide,DB09198,Lobeglitazone,0.9976770281791687,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Nilutamide.,47,Type_47,Yes
DB00273,Topiramate,DB00370,Mirtazapine,0.980887770652771,16,Type_16,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,16,Type_16,Yes
DB00898,Ethanol,DB01545,Ethyl loflazepate,0.9116689562797546,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.,16,Type_16,Yes
DB00214,Torasemide,DB00270,Isradipine,0.8331465125083923,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Isradipine.,49,Type_49,Yes
DB00514,Dextromethorphan,DB00757,Dolasetron,0.8361995220184326,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Dextromethorphan.,64,Type_64,No
DB00195,Betaxolol,DB00935,Oxymetazoline,0.9997039437294006,25,Type_25,Betaxolol may increase the atrioventricular blocking (AV block) activities of Oxymetazoline.,25,Type_25,Yes
DB00248,Cabergoline,DB00635,Prednisone,0.9733852744102478,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Prednisone.,49,Type_49,Yes
DB01264,Darunavir,DB06217,Vernakalant,0.9621415138244629,47,Type_47,The metabolism of Vernakalant can be decreased when combined with Darunavir.,73,Type_73,No
DB00450,Droperidol,DB00808,Indapamide,0.6259554028511047,49,Type_49,The risk or severity of adverse effects can be increased when Droperidol is combined with Indapamide.,20,Type_20,No
DB01626,Pargyline,DB06203,Alogliptin,0.9977728724479675,9,Type_9,Pargyline may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB01103,Quinacrine,DB01264,Darunavir,0.7048795819282532,47,Type_47,The metabolism of Darunavir can be decreased when combined with Quinacrine.,47,Type_47,Yes
DB01208,Sparfloxacin,DB01229,Paclitaxel,0.9319945573806763,49,Type_49,The risk or severity of adverse effects can be increased when Sparfloxacin is combined with Paclitaxel.,49,Type_49,Yes
DB00324,Fluorometholone,DB00779,Nalidixic acid,0.9057428240776062,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Nalidixic acid.,49,Type_49,Yes
DB00186,Lorazepam,DB06201,Rufinamide,0.9783231019973755,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Rufinamide.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB01558,Bromazepam,0.9856112003326416,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Bromazepam.,49,Type_49,Yes
DB00201,Caffeine,DB00582,Voriconazole,0.9794294834136963,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00762,Irinotecan,DB09074,Olaparib,0.8342941999435425,47,Type_47,The metabolism of Olaparib can be decreased when combined with Irinotecan.,47,Type_47,Yes
DB00622,Nicardipine,DB06684,Vilazodone,0.7572202086448669,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00804,Dicyclomine,DB00979,Cyclopentolate,0.8539376854896545,49,Type_49,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Cyclopentolate.,49,Type_49,Yes
DB00975,Dipyridamole,DB01580,Oxprenolol,0.6789777278900146,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Oxprenolol.,54,Type_54,No
DB00555,Lamotrigine,DB00647,Dextropropoxyphene,0.993540346622467,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00361,Vinorelbine,DB01590,Everolimus,0.9541447758674622,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB01209,Dezocine,DB01623,Thiothixene,0.9931164979934692,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Thiothixene.,49,Type_49,Yes
DB00264,Metoprolol,DB01253,Ergometrine,0.7918446063995361,19,Type_19,Metoprolol may increase the vasoconstricting activities of Ergometrine.,19,Type_19,Yes
DB00710,Ibandronate,DB06725,Lornoxicam,0.9958257675170898,49,Type_49,The risk or severity of adverse effects can be increased when Ibandronate is combined with Lornoxicam.,49,Type_49,Yes
DB00203,Sildenafil,DB00238,Nevirapine,0.5188889503479004,47,Type_47,The metabolism of Nevirapine can be decreased when combined with Sildenafil.,4,Type_4,No
DB01203,Nadolol,DB01608,Periciazine,0.947933554649353,60,Type_60,Nadolol may increase the hypotensive activities of Periciazine.,60,Type_60,Yes
DB00794,Primidone,DB11362,Selexipag,0.808207094669342,4,Type_4,The metabolism of Selexipag can be increased when combined with Primidone.,4,Type_4,Yes
DB00682,Warfarin,DB09215,Droxicam,0.9998743534088135,6,Type_6,Warfarin may increase the anticoagulant activities of Droxicam.,6,Type_6,Yes
DB00384,Triamterene,DB09038,Empagliflozin,0.6134994626045227,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Empagliflozin.,49,Type_49,Yes
DB00232,Methyclothiazide,DB00742,Mannitol,0.9970985651016235,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Mannitol.,49,Type_49,Yes
DB01206,Lomustine,DB08868,Fingolimod,0.9029406905174255,34,Type_34,Lomustine may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00599,Thiopental,DB04920,Clevidipine,0.509033739566803,4,Type_4,The metabolism of Clevidipine can be increased when combined with Thiopental.,60,Type_60,No
DB00661,Verapamil,DB09053,Ibrutinib,0.5808348655700684,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Verapamil.,73,Type_73,Yes
DB00006,Bivalirudin,DB00864,Tacrolimus,0.41075074672698975,73,Type_73,The serum concentration of Tacrolimus can be increased when it is combined with Bivalirudin.,47,Type_47,No
DB01201,Rifapentine,DB08905,Formestane,0.9946475625038147,75,Type_75,The serum concentration of Formestane can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00193,Tramadol,DB01324,Polythiazide,0.978847086429596,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Polythiazide.,49,Type_49,Yes
DB01558,Bromazepam,DB08912,Dabrafenib,0.8816705942153931,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Bromazepam.,75,Type_75,Yes
DB00408,Loxapine,DB01017,Minocycline,0.9974756836891174,16,Type_16,Loxapine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00668,Epinephrine,DB08808,Bupranolol,0.9949592351913452,25,Type_25,Epinephrine may increase the atrioventricular blocking (AV block) activities of Bupranolol.,25,Type_25,Yes
DB00674,Galantamine,DB04896,Milnacipran,0.8401538133621216,49,Type_49,The risk or severity of adverse effects can be increased when Galantamine is combined with Milnacipran.,47,Type_47,No
DB01029,Irbesartan,DB08880,Teriflunomide,0.7077354192733765,47,Type_47,The metabolism of Teriflunomide can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00312,Pentobarbital,DB01216,Finasteride,0.9648370742797852,4,Type_4,The metabolism of Finasteride can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00206,Reserpine,DB01089,Deserpidine,0.9997850060462952,60,Type_60,Reserpine may increase the hypotensive activities of Deserpidine.,60,Type_60,Yes
DB00245,Benzatropine,DB01010,Edrophonium,0.9899135828018188,70,Type_70,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Benzatropine.,70,Type_70,Yes
DB00543,Amoxapine,DB09291,Rolapitant,0.8073493242263794,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Amoxapine.,47,Type_47,Yes
DB06595,Midostaurin,DB09183,Dasabuvir,0.9156039953231812,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Midostaurin.,47,Type_47,Yes
DB00897,Triazolam,DB01154,Thiamylal,0.9496923685073853,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Thiamylal.,49,Type_49,Yes
DB01175,Escitalopram,DB09120,Zucapsaicin,0.9961557984352112,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Escitalopram.,47,Type_47,Yes
DB01149,Nefazodone,DB01227,Levacetylmethadol,0.7272788882255554,47,Type_47,The metabolism of Levacetylmethadol can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00191,Phentermine,DB01193,Acebutolol,0.7436967492103577,49,Type_49,The risk or severity of adverse effects can be increased when Phentermine is combined with Acebutolol.,49,Type_49,Yes
DB00385,Valrubicin,DB00728,Rocuronium,0.9999802112579346,40,Type_40,Valrubicin may increase the respiratory depressant activities of Rocuronium.,40,Type_40,Yes
DB08827,Lomitapide,DB09075,Edoxaban,0.9124945402145386,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Lomitapide.,73,Type_73,Yes
DB00623,Fluphenazine,DB01173,Orphenadrine,0.9999179840087891,16,Type_16,Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00215,Citalopram,DB00230,Pregabalin,0.5069037079811096,47,Type_47,The metabolism of Pregabalin can be decreased when combined with Citalopram.,49,Type_49,No
DB00591,Fluocinolone acetonide,DB00861,Diflunisal,0.9987700581550598,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Diflunisal.,49,Type_49,Yes
DB00906,Tiagabine,DB09345,Pramocaine,0.9918519854545593,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Pramocaine.,49,Type_49,Yes
DB00468,Quinine,DB08916,Afatinib,0.8604849576950073,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Quinine.,73,Type_73,Yes
DB01172,Kanamycin,DB04951,Pirfenidone,0.9999440908432007,72,Type_72,Kanamycin may decrease the excretion rate of Pirfenidone which could result in a higher serum level.,72,Type_72,Yes
DB00244,Mesalazine,DB00335,Atenolol,0.983359694480896,37,Type_37,Mesalazine may decrease the antihypertensive activities of Atenolol.,37,Type_37,Yes
DB00281,Lidocaine,DB00850,Perphenazine,0.6392884254455566,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Perphenazine.,47,Type_47,No
DB00307,Bexarotene,DB09238,Manidipine,0.839682400226593,47,Type_47,The metabolism of Manidipine can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB00708,Sufentanil,DB01345,Potassium cation,0.9997910857200623,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Potassium cation.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB01008,Busulfan,0.9864271283149719,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Busulfan.,15,Type_15,Yes
DB00297,Bupivacaine,DB08880,Teriflunomide,0.7791468501091003,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Bupivacaine.,75,Type_75,Yes
DB00316,Acetaminophen,DB00474,Methohexital,0.7459524273872375,4,Type_4,The metabolism of Methohexital can be increased when combined with Acetaminophen.,4,Type_4,Yes
DB00549,Zafirlukast,DB01065,Melatonin,0.9639977216720581,47,Type_47,The metabolism of Melatonin can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00203,Sildenafil,DB00346,Alfuzosin,0.4327082335948944,10,Type_10,Sildenafil may increase the antihypertensive activities of Alfuzosin.,60,Type_60,No
DB00426,Famciclovir,DB00673,Aprepitant,0.9106429815292358,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Famciclovir.,73,Type_73,Yes
DB00295,Morphine,DB06697,Artemether,0.8647118806838989,47,Type_47,The metabolism of Artemether can be decreased when combined with Morphine.,47,Type_47,Yes
DB01232,Saquinavir,DB01267,Paliperidone,0.6139480471611023,20,Type_20,Saquinavir may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00295,Morphine,DB01198,Zopiclone,0.9314698576927185,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Zopiclone.,49,Type_49,Yes
DB01014,Balsalazide,DB01260,Desonide,0.9990345239639282,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Desonide.,49,Type_49,Yes
DB00227,Lovastatin,DB08827,Lomitapide,0.8826190233230591,73,Type_73,The serum concentration of Lomitapide can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00736,Esomeprazole,DB01041,Thalidomide,0.9087445139884949,47,Type_47,The metabolism of Thalidomide can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB00758,Clopidogrel,DB00806,Pentoxifylline,0.9032061100006104,6,Type_6,Clopidogrel may increase the anticoagulant activities of Pentoxifylline.,53,Type_53,No
DB00195,Betaxolol,DB06144,Sertindole,0.7430030703544617,47,Type_47,The metabolism of Sertindole can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00443,Betamethasone,DB00674,Galantamine,0.9676405787467957,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Galantamine.,49,Type_49,Yes
DB00324,Fluorometholone,DB01399,Salsalate,0.9995423555374146,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Salsalate.,49,Type_49,Yes
DB00184,Nicotine,DB00818,Propofol,0.5648530125617981,47,Type_47,The metabolism of Propofol can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00871,Terbutaline,DB01175,Escitalopram,0.8710733652114868,49,Type_49,The risk or severity of adverse effects can be increased when Terbutaline is combined with Escitalopram.,20,Type_20,No
DB00492,Fosinopril,DB04948,Lofexidine,0.7502936720848083,60,Type_60,Fosinopril may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00264,Metoprolol,DB06694,Xylometazoline,0.6344529390335083,60,Type_60,Metoprolol may increase the hypotensive activities of Xylometazoline.,25,Type_25,No
DB00285,Venlafaxine,DB00962,Zaleplon,0.534390926361084,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zaleplon.,47,Type_47,No
DB00470,Dronabinol,DB00653,Magnesium sulfate,0.9999709129333496,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB00321,Amitriptyline,DB01622,Thioproperazine,0.8767620921134949,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Thioproperazine.,49,Type_49,Yes
DB00877,Sirolimus,DB01120,Gliclazide,0.45758238434791565,70,Type_70,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Sirolimus.,70,Type_70,Yes
DB00175,Pravastatin,DB00877,Sirolimus,0.3710479438304901,73,Type_73,The serum concentration of Sirolimus can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00450,Droperidol,DB01452,Diamorphine,0.9962416887283325,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diamorphine.,16,Type_16,Yes
DB01624,Zuclopenthixol,DB09074,Olaparib,0.8325252532958984,47,Type_47,The metabolism of Olaparib can be decreased when combined with Zuclopenthixol.,73,Type_73,No
DB00218,Moxifloxacin,DB06216,Asenapine,0.996414303779602,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB01259,Lapatinib,DB09063,Ceritinib,0.9797971844673157,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Lapatinib.,73,Type_73,Yes
DB00697,Tizanidine,DB00737,Meclizine,0.8275496959686279,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Meclizine.,49,Type_49,Yes
DB00423,Methocarbamol,DB09224,Melperone,0.9995883107185364,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Melperone.,49,Type_49,Yes
DB00214,Torasemide,DB00479,Amikacin,0.9905995726585388,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Amikacin.,49,Type_49,Yes
DB00608,Chloroquine,DB06217,Vernakalant,0.9966915845870972,47,Type_47,The metabolism of Vernakalant can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB01355,Hexobarbital,DB06144,Sertindole,0.9413707256317139,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Sertindole.,49,Type_49,Yes
DB00974,Edetic acid,DB08797,Salicylamide,0.9972698092460632,6,Type_6,Edetic acid may increase the anticoagulant activities of Salicylamide.,6,Type_6,Yes
DB00794,Primidone,DB01020,Isosorbide mononitrate,0.9514333605766296,4,Type_4,The metabolism of Isosorbide mononitrate can be increased when combined with Primidone.,4,Type_4,Yes
DB01086,Benzocaine,DB01615,Aceprometazine,0.9998626708984375,49,Type_49,The risk or severity of adverse effects can be increased when Benzocaine is combined with Aceprometazine.,49,Type_49,Yes
DB01132,Pioglitazone,DB06702,Fesoterodine,0.4946017563343048,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pioglitazone.,77,Type_77,Yes
DB00214,Torasemide,DB00780,Phenelzine,0.6284124851226807,60,Type_60,Torasemide may increase the hypotensive activities of Phenelzine.,60,Type_60,Yes
DB00300,Tenofovir disoproxil,DB00435,Nitric Oxide,0.8869523406028748,47,Type_47,The metabolism of Nitric Oxide can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00412,Rosiglitazone,DB00864,Tacrolimus,0.8127447962760925,47,Type_47,The metabolism of Tacrolimus can be decreased when combined with Rosiglitazone.,70,Type_70,No
DB00599,Thiopental,DB00999,Hydrochlorothiazide,0.8898960947990417,30,Type_30,Thiopental may increase the orthostatic hypotensive activities of Hydrochlorothiazide.,30,Type_30,Yes
DB00346,Alfuzosin,DB00477,Chlorpromazine,0.6511622667312622,20,Type_20,Alfuzosin may increase the QTc-prolonging activities of Chlorpromazine.,20,Type_20,Yes
DB00268,Ropinirole,DB01169,Arsenic trioxide,0.6329412460327148,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Arsenic trioxide.,49,Type_49,Yes
DB00455,Loratadine,DB09017,Brotizolam,0.999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Brotizolam.,49,Type_49,Yes
DB02513,Thymol,DB06712,Nilvadipine,0.9984948635101318,49,Type_49,The risk or severity of adverse effects can be increased when Thymol is combined with Nilvadipine.,49,Type_49,Yes
DB00252,Phenytoin,DB00362,Anidulafungin,0.926265299320221,73,Type_73,The serum concentration of Anidulafungin can be increased when it is combined with Phenytoin.,73,Type_73,Yes
DB00206,Reserpine,DB00865,Benzphetamine,0.9869862198829651,61,Type_61,Reserpine may decrease the stimulatory activities of Benzphetamine.,61,Type_61,Yes
DB00359,Sulfadiazine,DB01250,Olsalazine,0.9209670424461365,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Olsalazine.,9,Type_9,Yes
DB00880,Chlorothiazide,DB09214,Dexketoprofen,0.7688712477684021,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Dexketoprofen.,49,Type_49,Yes
DB00802,Alfentanil,DB01601,Lopinavir,0.6559948325157166,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Alfentanil.,47,Type_47,Yes
DB01236,Sevoflurane,DB01263,Posaconazole,0.55238938331604,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Sevoflurane.,47,Type_47,Yes
DB00875,Flupentixol,DB01274,Arformoterol,0.8708915710449219,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Arformoterol.,20,Type_20,Yes
DB00794,Primidone,DB06739,Seratrodast,0.9767671227455139,4,Type_4,The metabolism of Seratrodast can be increased when combined with Primidone.,4,Type_4,Yes
DB00742,Mannitol,DB09477,Enalaprilat,0.8358739614486694,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Enalaprilat.,49,Type_49,Yes
DB00245,Benzatropine,DB00392,Profenamine,0.9938283562660217,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Profenamine.,49,Type_49,Yes
DB01174,Phenobarbital,DB09231,Benidipine,0.41740530729293823,4,Type_4,The metabolism of Benidipine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00715,Paroxetine,DB01184,Domperidone,0.6875765323638916,20,Type_20,Paroxetine may increase the QTc-prolonging activities of Domperidone.,20,Type_20,Yes
DB00252,Phenytoin,DB01440,gamma-Hydroxybutyric acid,0.9922609925270081,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00712,Flurbiprofen,DB04272,Citric acid,0.9979199767112732,6,Type_6,Flurbiprofen may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00601,Linezolid,DB06684,Vilazodone,0.6466493606567383,64,Type_64,Linezolid may increase the serotonergic activities of Vilazodone.,49,Type_49,No
DB01551,Dihydrocodeine,DB09245,Toloxatone,0.5921569466590881,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Toloxatone.,49,Type_49,Yes
DB00490,Buspirone,DB09128,Brexpiprazole,0.9886202812194824,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Brexpiprazole.,49,Type_49,Yes
DB00586,Diclofenac,DB08899,Enzalutamide,0.9624506235122681,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Diclofenac.,75,Type_75,Yes
DB00238,Nevirapine,DB00425,Zolpidem,0.5622234344482422,73,Type_73,The serum concentration of Zolpidem can be increased when it is combined with Nevirapine.,4,Type_4,No
DB00253,Medrysone,DB00939,Meclofenamic acid,0.9997358918190002,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Meclofenamic acid.,49,Type_49,Yes
DB00870,Suprofen,DB01578,Metrizamide,0.9999141693115234,72,Type_72,Suprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level.,72,Type_72,Yes
DB09078,Lenvatinib,DB09083,Ivabradine,0.989587664604187,20,Type_20,Lenvatinib may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB01184,Domperidone,DB08880,Teriflunomide,0.41578975319862366,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Domperidone.,75,Type_75,No
DB00396,Progesterone,DB06616,Bosutinib,0.9580872654914856,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00748,Carbinoxamine,DB01097,Leflunomide,0.9570925235748291,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB01098,Rosuvastatin,DB09183,Dasabuvir,0.8294084668159485,73,Type_73,The serum concentration of Dasabuvir can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00341,Cetirizine,DB06690,Nitrous oxide,0.9999915361404419,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Nitrous oxide.,49,Type_49,Yes
DB00608,Chloroquine,DB01390,Sodium bicarbonate,0.982331395149231,67,Type_67,Chloroquine can cause a decrease in the absorption of Sodium bicarbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00341,Cetirizine,DB06144,Sertindole,0.9972866773605347,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Sertindole.,49,Type_49,Yes
DB00215,Citalopram,DB00740,Riluzole,0.8012928366661072,47,Type_47,The metabolism of Riluzole can be decreased when combined with Citalopram.,47,Type_47,Yes
DB01211,Clarithromycin,DB13158,Clobetasone,0.9895301461219788,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Clarithromycin.,73,Type_73,Yes
DB00518,Albendazole,DB01254,Dasatinib,0.8492092490196228,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Albendazole.,73,Type_73,Yes
DB00263,Sulfisoxazole,DB01103,Quinacrine,0.9350276589393616,47,Type_47,The metabolism of Quinacrine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00336,Nitrofural,DB01104,Sertraline,0.9947112798690796,47,Type_47,The metabolism of Sertraline can be decreased when combined with Nitrofural.,47,Type_47,Yes
DB00683,Midazolam,DB00985,Dimenhydrinate,0.9999533891677856,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Dimenhydrinate.,49,Type_49,Yes
DB06810,Plicamycin,DB09216,Tolfenamic acid,0.9996639490127563,72,Type_72,Plicamycin may decrease the excretion rate of Tolfenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB01168,Procarbazine,DB09235,Efonidipine,0.7297384142875671,60,Type_60,Procarbazine may increase the hypotensive activities of Efonidipine.,60,Type_60,Yes
DB09048,Netupitant,DB09118,Stiripentol,0.9952794313430786,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Netupitant.,47,Type_47,No
DB00182,Amphetamine,DB01171,Moclobemide,0.4442932605743408,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Moclobemide.,49,Type_49,Yes
DB00498,Phenindione,DB01331,Cefoxitin,0.9999314546585083,6,Type_6,Phenindione may increase the anticoagulant activities of Cefoxitin.,6,Type_6,Yes
DB01139,Cefapirin,DB01418,Acenocoumarol,0.957028329372406,6,Type_6,Cefapirin may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB06216,Asenapine,DB09162,Ferric Citrate,0.908363401889801,67,Type_67,Asenapine can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01149,Nefazodone,DB13158,Clobetasone,0.7211592793464661,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00795,Sulfasalazine,DB06802,Nepafenac,0.9792766571044922,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Nepafenac.,49,Type_49,Yes
DB00418,Secobarbital,DB01086,Benzocaine,0.9990304708480835,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Benzocaine.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB06717,Fosaprepitant,0.7437209486961365,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Medroxyprogesterone acetate.,75,Type_75,Yes
DB00906,Tiagabine,DB01002,Levobupivacaine,0.9924790859222412,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Levobupivacaine.,49,Type_49,Yes
DB00898,Ethanol,DB00946,Phenprocoumon,0.6363748908042908,75,Type_75,The serum concentration of Phenprocoumon can be decreased when it is combined with Ethanol.,75,Type_75,Yes
DB01100,Pimozide,DB04868,Nilotinib,0.4381953179836273,20,Type_20,Pimozide may increase the QTc-prolonging activities of Nilotinib.,73,Type_73,No
DB00673,Aprepitant,DB05541,Brivaracetam,0.8609511852264404,73,Type_73,The serum concentration of Brivaracetam can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00637,Astemizole,DB01128,Bicalutamide,0.6490117907524109,47,Type_47,The metabolism of Bicalutamide can be decreased when combined with Astemizole.,73,Type_73,No
DB00285,Venlafaxine,DB00674,Galantamine,0.6004506349563599,47,Type_47,The metabolism of Galantamine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00962,Zaleplon,DB08815,Lurasidone,0.988874077796936,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Lurasidone.,49,Type_49,Yes
DB04898,Ximelagatran,DB09198,Lobeglitazone,0.9821797013282776,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Ximelagatran.,47,Type_47,Yes
DB00593,Ethosuximide,DB01161,Chloroprocaine,0.998691737651825,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Chloroprocaine.,49,Type_49,Yes
DB00468,Quinine,DB00654,Latanoprost,0.997175931930542,60,Type_60,Quinine may increase the hypotensive activities of Latanoprost.,60,Type_60,Yes
DB01253,Ergometrine,DB08816,Ticagrelor,0.6311259269714355,49,Type_49,The risk or severity of adverse effects can be increased when Ergometrine is combined with Ticagrelor.,49,Type_49,Yes
DB00353,Methylergometrine,DB00492,Fosinopril,0.7226595878601074,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Fosinopril.,73,Type_73,No
DB06402,Telavancin,DB06699,Degarelix,1.0,20,Type_20,Telavancin may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00374,Treprostinil,DB01241,Gemfibrozil,0.7527475953102112,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Treprostinil.,47,Type_47,Yes
DB00187,Esmolol,DB00363,Clozapine,0.8175851702690125,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Clozapine.,49,Type_49,Yes
DB09283,Trapidil,DB11268,Protocatechualdehyde,0.9984207153320312,6,Type_6,Trapidil may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00337,Pimecrolimus,DB09295,Talniflumate,0.9999610185623169,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Talniflumate.,49,Type_49,Yes
DB00238,Nevirapine,DB00683,Midazolam,0.5819203853607178,4,Type_4,The metabolism of Midazolam can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00320,Dihydroergotamine,DB08907,Canagliflozin,0.47582384943962097,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Canagliflozin.,47,Type_47,No
DB00420,Promazine,DB08865,Crizotinib,0.45978978276252747,20,Type_20,Promazine may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB06196,Icatibant,DB06263,Amrubicin,0.9995632767677307,72,Type_72,Icatibant may decrease the excretion rate of Amrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00280,Disopyramide,DB00734,Risperidone,0.952560305595398,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Risperidone.,20,Type_20,Yes
DB00283,Clemastine,DB01403,Methotrimeprazine,0.9726444482803345,16,Type_16,Clemastine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00528,Lercanidipine,DB09031,Miltefosine,0.9517179727554321,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Miltefosine.,49,Type_49,Yes
DB00292,Etomidate,DB01433,Methadyl acetate,0.9987761378288269,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Methadyl acetate.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB00853,Temozolomide,0.9999836683273315,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Temozolomide.,58,Type_58,Yes
DB00490,Buspirone,DB01595,Nitrazepam,0.8880571126937866,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Nitrazepam.,49,Type_49,Yes
DB08439,Parecoxib,DB08906,Fluticasone furoate,0.9951633214950562,49,Type_49,The risk or severity of adverse effects can be increased when Parecoxib is combined with Fluticasone furoate.,49,Type_49,Yes
DB00205,Pyrimethamine,DB01072,Atazanavir,0.762563169002533,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00619,Imatinib,DB00647,Dextropropoxyphene,0.9743684530258179,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00559,Bosentan,DB09049,Naloxegol,0.9912300109863281,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Bosentan.,75,Type_75,No
DB00598,Labetalol,DB01626,Pargyline,0.9767488241195679,60,Type_60,Labetalol may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00673,Aprepitant,DB00717,Norethisterone,0.8607422709465027,73,Type_73,The serum concentration of Norethisterone can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00726,Trimipramine,DB01320,Fosphenytoin,0.7919907569885254,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Trimipramine.,4,Type_4,Yes
DB06148,Mianserin,DB08899,Enzalutamide,0.8558390140533447,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Mianserin.,75,Type_75,Yes
DB00813,Fentanyl,DB01072,Atazanavir,0.8563697338104248,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Fentanyl.,73,Type_73,Yes
DB01026,Ketoconazole,DB09118,Stiripentol,0.9425691366195679,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00181,Baclofen,DB01041,Thalidomide,0.9987824559211731,16,Type_16,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00443,Betamethasone,DB06718,Stanozolol,1.0,74,Type_74,Betamethasone may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB00180,Flunisolide,DB00244,Mesalazine,0.9926729798316956,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Mesalazine.,49,Type_49,Yes
DB00956,Hydrocodone,DB00972,Azelastine,0.9999862909317017,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB01118,Amiodarone,DB04855,Dronedarone,0.5251896977424622,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Amiodarone.,73,Type_73,No
DB04920,Clevidipine,DB09038,Empagliflozin,0.9919800758361816,49,Type_49,The risk or severity of adverse effects can be increased when Clevidipine is combined with Empagliflozin.,49,Type_49,Yes
DB00557,Hydroxyzine,DB00898,Ethanol,0.999997615814209,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00264,Metoprolol,DB01019,Bethanechol,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Bethanechol.,49,Type_49,Yes
DB00935,Oxymetazoline,DB00960,Pindolol,0.994657039642334,25,Type_25,Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Pindolol.,25,Type_25,Yes
DB00778,Roxithromycin,DB01167,Itraconazole,0.8732751607894897,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Roxithromycin.,47,Type_47,Yes
DB00682,Warfarin,DB06209,Prasugrel,0.9929956793785095,6,Type_6,Warfarin may increase the anticoagulant activities of Prasugrel.,6,Type_6,Yes
DB00762,Irinotecan,DB01167,Itraconazole,0.7021415829658508,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Irinotecan.,73,Type_73,No
DB00934,Maprotiline,DB01567,Fludiazepam,0.9996166229248047,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Fludiazepam.,49,Type_49,Yes
DB00238,Nevirapine,DB00620,Triamcinolone,0.960015058517456,4,Type_4,The metabolism of Triamcinolone can be increased when combined with Nevirapine.,4,Type_4,Yes
DB05271,Rotigotine,DB06292,Dapagliflozin,0.8321841955184937,49,Type_49,The risk or severity of adverse effects can be increased when Rotigotine is combined with Dapagliflozin.,49,Type_49,Yes
DB01324,Polythiazide,DB06267,Udenafil,0.9940834641456604,10,Type_10,Polythiazide may increase the antihypertensive activities of Udenafil.,10,Type_10,Yes
DB00647,Dextropropoxyphene,DB01325,Quinethazone,0.9707540273666382,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Quinethazone.,49,Type_49,Yes
DB00818,Propofol,DB06201,Rufinamide,0.9986029267311096,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Rufinamide.,49,Type_49,Yes
DB01107,Methyprylon,DB04855,Dronedarone,0.9801816344261169,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Methyprylon.,47,Type_47,Yes
DB01220,Rifaximin,DB09230,Azelnidipine,0.5579339861869812,75,Type_75,The serum concentration of Azelnidipine can be decreased when it is combined with Rifaximin.,75,Type_75,Yes
DB01609,Deferasirox,DB01628,Etoricoxib,0.6438333988189697,75,Type_75,The serum concentration of Etoricoxib can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00421,Spironolactone,DB00657,Mecamylamine,0.9987786412239075,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Mecamylamine.,49,Type_49,Yes
DB00559,Bosentan,DB00589,Lisuride,0.9148948788642883,75,Type_75,The serum concentration of Lisuride can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB01029,Irbesartan,DB12598,Nafamostat,0.6203979253768921,47,Type_47,The metabolism of Nafamostat can be decreased when combined with Irbesartan.,49,Type_49,No
DB00310,Chlorthalidone,DB00340,Metixene,0.9941926598548889,73,Type_73,The serum concentration of Metixene can be increased when it is combined with Chlorthalidone.,73,Type_73,Yes
DB01080,Vigabatrin,DB06690,Nitrous oxide,0.9998959302902222,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Nitrous oxide.,49,Type_49,Yes
DB09104,Magnesium hydroxide,DB13450,Cisatracurium besylate,0.9760595560073853,21,Type_21,Magnesium hydroxide may increase the neuromuscular blocking activities of Cisatracurium besylate.,21,Type_21,Yes
DB00277,Theophylline,DB00377,Palonosetron,0.9861225485801697,47,Type_47,The metabolism of Palonosetron can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00208,Ticlopidine,DB00861,Diflunisal,0.5012929439544678,6,Type_6,Ticlopidine may increase the anticoagulant activities of Diflunisal.,49,Type_49,No
DB00363,Clozapine,DB00950,Fexofenadine,0.8369999527931213,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Fexofenadine.,49,Type_49,Yes
DB06786,Halcinonide,DB09118,Stiripentol,0.9206260442733765,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Halcinonide.,73,Type_73,Yes
DB00413,Pramipexole,DB01161,Chloroprocaine,0.9999873638153076,32,Type_32,Pramipexole may increase the sedative activities of Chloroprocaine.,32,Type_32,Yes
DB00470,Dronabinol,DB00854,Levorphanol,0.999762237071991,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.,16,Type_16,Yes
DB00596,Ulobetasol,DB00681,Amphotericin B,0.9992402791976929,83,Type_83,Ulobetasol may increase the hypokalemic activities of Amphotericin B.,83,Type_83,Yes
DB01587,Ketazolam,DB01609,Deferasirox,0.9784827828407288,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Ketazolam.,75,Type_75,Yes
DB00199,Erythromycin,DB09236,Lacidipine,0.7018976211547852,47,Type_47,The metabolism of Lacidipine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00652,Pentazocine,DB01018,Guanfacine,0.9919036030769348,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Guanfacine.,49,Type_49,Yes
DB01626,Pargyline,DB06701,Dexmethylphenidate,0.5547192096710205,71,Type_71,Pargyline may increase the hypertensive activities of Dexmethylphenidate.,71,Type_71,Yes
DB00391,Sulpiride,DB00502,Haloperidol,0.5316885709762573,36,Type_36,Sulpiride may increase the antipsychotic activities of Haloperidol.,36,Type_36,Yes
DB00353,Methylergometrine,DB01166,Cilostazol,0.672203779220581,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Cilostazol.,49,Type_49,Yes
DB01609,Deferasirox,DB08912,Dabrafenib,0.9926581978797913,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB05812,Abiraterone,DB09118,Stiripentol,0.9375553727149963,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB01580,Oxprenolol,DB08910,Pomalidomide,0.4472482204437256,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Pomalidomide.,49,Type_49,Yes
DB00254,Doxycycline,DB08895,Tofacitinib,0.8663899302482605,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB06772,Cabazitaxel,DB06825,Triptorelin,0.7184064984321594,49,Type_49,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Triptorelin.,49,Type_49,Yes
DB00470,Dronabinol,DB00615,Rifabutin,0.6411435604095459,73,Type_73,The serum concentration of Rifabutin can be increased when it is combined with Dronabinol.,75,Type_75,No
DB00195,Betaxolol,DB00608,Chloroquine,0.5350971221923828,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00761,Potassium chloride,DB11315,Methscopolamine,0.9999905824661255,59,Type_59,Potassium chloride may increase the ulcerogenic activities of Methscopolamine.,59,Type_59,Yes
DB00524,Metolazone,DB06702,Fesoterodine,0.9862127304077148,73,Type_73,The serum concentration of Fesoterodine can be increased when it is combined with Metolazone.,73,Type_73,Yes
DB01264,Darunavir,DB11817,Baricitinib,0.8385283946990967,47,Type_47,The metabolism of Baricitinib can be decreased when combined with Darunavir.,47,Type_47,Yes
DB00836,Loperamide,DB01132,Pioglitazone,0.7837692499160767,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Loperamide.,47,Type_47,Yes
DB08883,Perampanel,DB09065,Cobicistat,0.6894807815551758,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Perampanel.,47,Type_47,No
DB00199,Erythromycin,DB00911,Tinidazole,0.9637972712516785,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00657,Mecamylamine,DB00862,Vardenafil,0.8492900133132935,10,Type_10,Mecamylamine may increase the antihypertensive activities of Vardenafil.,10,Type_10,Yes
DB04573,Estriol,DB08439,Parecoxib,0.48290887475013733,73,Type_73,The serum concentration of Parecoxib can be increased when it is combined with Estriol.,81,Type_81,No
DB01065,Melatonin,DB01685,Topiroxostat,0.9921903014183044,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Melatonin.,47,Type_47,Yes
DB00980,Ramelteon,DB09225,Zotepine,0.9997971653938293,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Zotepine.,49,Type_49,Yes
DB00804,Dicyclomine,DB00880,Chlorothiazide,0.9988653659820557,73,Type_73,The serum concentration of Chlorothiazide can be increased when it is combined with Dicyclomine.,73,Type_73,Yes
DB01224,Quetiapine,DB06700,Desvenlafaxine,0.898974597454071,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Desvenlafaxine.,49,Type_49,Yes
DB00207,Azithromycin,DB00714,Apomorphine,0.7220922708511353,20,Type_20,Azithromycin may increase the QTc-prolonging activities of Apomorphine.,20,Type_20,Yes
DB00363,Clozapine,DB00601,Linezolid,0.8962716460227966,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Linezolid.,49,Type_49,Yes
DB00312,Pentobarbital,DB01367,Rasagiline,0.5112016797065735,60,Type_60,Pentobarbital may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00337,Pimecrolimus,DB07615,Tranilast,0.9965406060218811,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tranilast.,49,Type_49,Yes
DB00472,Fluoxetine,DB01167,Itraconazole,0.7629466652870178,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00494,Entacapone,DB11304,Phenoxyethanol,0.9999964237213135,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Phenoxyethanol.,49,Type_49,Yes
DB00593,Ethosuximide,DB00633,Dexmedetomidine,0.9939550757408142,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Dexmedetomidine.,49,Type_49,Yes
DB01601,Lopinavir,DB08905,Formestane,0.9718704223632812,73,Type_73,The serum concentration of Formestane can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00691,Moexipril,DB01041,Thalidomide,0.9509965181350708,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Thalidomide.,49,Type_49,Yes
DB00450,Droperidol,DB06716,Fospropofol,0.9995840191841125,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.,16,Type_16,Yes
DB00938,Salmeterol,DB08918,Levomilnacipran,0.9888452887535095,85,Type_85,Salmeterol may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00219,Oxyphenonium,DB01337,Pancuronium,0.9993583559989929,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pancuronium.,49,Type_49,Yes
DB00925,Phenoxybenzamine,DB09118,Stiripentol,0.7743208408355713,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Phenoxybenzamine.,73,Type_73,Yes
DB01251,Gliquidone,DB04861,Nebivolol,0.9493790864944458,9,Type_9,Gliquidone may increase the hypoglycemic activities of Nebivolol.,9,Type_9,Yes
DB00946,Phenprocoumon,DB01264,Darunavir,0.5352662205696106,47,Type_47,The metabolism of Darunavir can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB00521,Carteolol,DB00714,Apomorphine,0.8169756531715393,25,Type_25,Carteolol may increase the atrioventricular blocking (AV block) activities of Apomorphine.,25,Type_25,Yes
DB00344,Protriptyline,DB00677,Isoflurophate,0.7891072034835815,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Isoflurophate.,73,Type_73,No
DB00726,Trimipramine,DB00850,Perphenazine,0.9604633450508118,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Perphenazine.,49,Type_49,Yes
DB00104,Octreotide,DB00575,Clonidine,0.5536149144172668,54,Type_54,Octreotide may increase the bradycardic activities of Clonidine.,54,Type_54,Yes
DB00214,Torasemide,DB09286,Pipamperone,0.9628642201423645,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Pipamperone.,49,Type_49,Yes
DB00831,Trifluoperazine,DB12532,Oxetacaine,0.9999889135360718,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxetacaine.,49,Type_49,Yes
DB00697,Tizanidine,DB08941,Isoxsuprine,0.9900880455970764,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Isoxsuprine.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB01395,Drospirenone,0.8701542615890503,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Drospirenone.,49,Type_49,Yes
DB00898,Ethanol,DB06595,Midostaurin,0.6254537105560303,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Ethanol.,47,Type_47,Yes
DB00461,Nabumetone,DB01175,Escitalopram,0.7216509580612183,53,Type_53,Nabumetone may increase the antiplatelet activities of Escitalopram.,53,Type_53,Yes
DB01221,Ketamine,DB08933,Luliconazole,0.9519094824790955,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Ketamine.,73,Type_73,Yes
DB00285,Venlafaxine,DB04948,Lofexidine,0.4544457495212555,85,Type_85,Venlafaxine may increase the tachycardic activities of Lofexidine.,85,Type_85,Yes
DB00489,Sotalol,DB01240,Epoprostenol,0.8609241247177124,60,Type_60,Sotalol may increase the hypotensive activities of Epoprostenol.,49,Type_49,No
DB00514,Dextromethorphan,DB01624,Zuclopenthixol,0.47938594222068787,49,Type_49,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Zuclopenthixol.,49,Type_49,Yes
DB00592,Piperazine,DB00622,Nicardipine,0.5984035134315491,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Piperazine.,47,Type_47,Yes
DB00458,Imipramine,DB00951,Isoniazid,0.7368212938308716,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Imipramine.,47,Type_47,Yes
DB00922,Levosimendan,DB06292,Dapagliflozin,0.9987510442733765,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Dapagliflozin.,49,Type_49,Yes
DB00458,Imipramine,DB00736,Esomeprazole,0.9526548385620117,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Imipramine.,47,Type_47,Yes
DB00866,Alprenolol,DB01366,Procaterol,0.9974561333656311,14,Type_14,Alprenolol may decrease the bronchodilatory activities of Procaterol.,14,Type_14,Yes
DB00624,Testosterone,DB00839,Tolazamide,0.9972901344299316,9,Type_9,Testosterone may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB00951,Isoniazid,DB01238,Aripiprazole,0.4868145287036896,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Isoniazid.,73,Type_73,No
DB00413,Pramipexole,DB09166,Etizolam,0.9999939203262329,32,Type_32,Pramipexole may increase the sedative activities of Etizolam.,32,Type_32,Yes
DB00752,Tranylcypromine,DB01219,Dantrolene,0.8521422743797302,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Dantrolene.,49,Type_49,Yes
DB00614,Furazolidone,DB01136,Carvedilol,0.9055024981498718,60,Type_60,Furazolidone may increase the hypotensive activities of Carvedilol.,60,Type_60,Yes
DB00788,Naproxen,DB00881,Quinapril,0.8703572154045105,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Quinapril.,49,Type_49,Yes
DB00834,Mifepristone,DB01136,Carvedilol,0.9598699808120728,73,Type_73,The serum concentration of Carvedilol can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00796,Candesartan cilexetil,DB01247,Isocarboxazid,0.7927222847938538,60,Type_60,Candesartan cilexetil may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB01197,Captopril,DB01210,Levobunolol,0.994310736656189,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Levobunolol.,49,Type_49,Yes
DB00474,Methohexital,DB01189,Desflurane,0.8659398555755615,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Desflurane.,49,Type_49,Yes
DB00872,Conivaptan,DB08895,Tofacitinib,0.5460578203201294,54,Type_54,Conivaptan may increase the bradycardic activities of Tofacitinib.,73,Type_73,No
DB00189,Ethchlorvynol,DB00907,Cocaine,0.995235025882721,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Cocaine.,49,Type_49,Yes
DB00494,Entacapone,DB00497,Oxycodone,0.9962599277496338,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Oxycodone.,49,Type_49,Yes
DB01155,Gemifloxacin,DB08981,Fenbufen,0.9962228536605835,27,Type_27,Gemifloxacin may increase the neuroexcitatory activities of Fenbufen.,27,Type_27,Yes
DB00625,Efavirenz,DB00870,Suprofen,0.8994418978691101,47,Type_47,The metabolism of Suprofen can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00261,Anagrelide,DB01195,Flecainide,0.6364302635192871,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB06335,Saxagliptin,DB09048,Netupitant,0.9849694967269897,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Saxagliptin.,73,Type_73,Yes
DB00006,Bivalirudin,DB06737,Zaltoprofen,0.8689099550247192,6,Type_6,Bivalirudin may increase the anticoagulant activities of Zaltoprofen.,6,Type_6,Yes
DB00263,Sulfisoxazole,DB00990,Exemestane,0.9213288426399231,47,Type_47,The metabolism of Exemestane can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00835,Brompheniramine,DB08987,Etidocaine,0.9999938011169434,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Etidocaine.,49,Type_49,Yes
DB02709,Resveratrol,DB08860,Pitavastatin,0.614142656326294,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Resveratrol.,73,Type_73,Yes
DB00800,Fenoldopam,DB00806,Pentoxifylline,0.9844498038291931,60,Type_60,Fenoldopam may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00655,Estrone,DB09084,Benzydamine,0.9488879442214966,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Benzydamine.,49,Type_49,Yes
DB00238,Nevirapine,DB00628,Clorazepic acid,0.7517107725143433,4,Type_4,The metabolism of Clorazepic acid can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00238,Nevirapine,DB00549,Zafirlukast,0.5711448788642883,4,Type_4,The metabolism of Zafirlukast can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00648,Mitotane,DB00764,Mometasone,0.9945685863494873,75,Type_75,The serum concentration of Mometasone can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00458,Imipramine,DB06480,Prucalopride,0.9022409915924072,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Imipramine.,73,Type_73,Yes
DB00408,Loxapine,DB09034,Suvorexant,0.9992251396179199,16,Type_16,Loxapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00343,Diltiazem,DB00402,Eszopiclone,0.9479520916938782,47,Type_47,The metabolism of Eszopiclone can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00594,Amiloride,DB00780,Phenelzine,0.8692622184753418,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Phenelzine.,49,Type_49,Yes
DB00332,Ipratropium,DB09330,Osimertinib,0.7611837387084961,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Ipratropium.,73,Type_73,Yes
DB00175,Pravastatin,DB01166,Cilostazol,0.8434149026870728,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00384,Triamterene,DB09084,Benzydamine,0.994098424911499,37,Type_37,Triamterene may decrease the antihypertensive activities of Benzydamine.,37,Type_37,Yes
DB01065,Melatonin,DB06716,Fospropofol,0.9999971389770508,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Fospropofol.,49,Type_49,Yes
DB01091,Butenafine,DB06712,Nilvadipine,0.9962841868400574,49,Type_49,The risk or severity of adverse effects can be increased when Butenafine is combined with Nilvadipine.,49,Type_49,Yes
DB06697,Artemether,DB08865,Crizotinib,0.610015869140625,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Artemether.,47,Type_47,Yes
DB00381,Amlodipine,DB00571,Propranolol,0.5245348215103149,60,Type_60,Amlodipine may increase the hypotensive activities of Propranolol.,49,Type_49,No
DB00861,Diflunisal,DB01380,Cortisone acetate,0.9993952512741089,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Cortisone acetate.,49,Type_49,Yes
DB00683,Midazolam,DB00750,Prilocaine,0.9999821186065674,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Prilocaine.,49,Type_49,Yes
DB00695,Furosemide,DB00955,Netilmicin,0.9233839511871338,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Netilmicin.,49,Type_49,Yes
DB00321,Amitriptyline,DB00673,Aprepitant,0.9704157114028931,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Amitriptyline.,73,Type_73,Yes
DB01193,Acebutolol,DB01626,Pargyline,0.9710581302642822,60,Type_60,Acebutolol may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB00792,Tripelennamine,DB01255,Lisdexamfetamine,0.9999709129333496,76,Type_76,Tripelennamine may decrease the sedative activities of Lisdexamfetamine.,76,Type_76,Yes
DB01589,Quazepam,DB08820,Ivacaftor,0.9976455569267273,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Quazepam.,73,Type_73,Yes
DB00927,Famotidine,DB00937,Diethylpropion,0.997689962387085,76,Type_76,Famotidine may decrease the sedative activities of Diethylpropion.,76,Type_76,Yes
DB00487,Pefloxacin,DB00812,Phenylbutazone,0.9994311928749084,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Phenylbutazone.,27,Type_27,Yes
DB01433,Methadyl acetate,DB09009,Articaine,0.9976590871810913,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Articaine.,49,Type_49,Yes
DB00808,Indapamide,DB05676,Apremilast,0.9144120812416077,70,Type_70,The therapeutic efficacy of Apremilast can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00235,Milrinone,DB00682,Warfarin,0.9999805688858032,6,Type_6,Milrinone may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00373,Timolol,DB00805,Minaprine,0.6805684566497803,54,Type_54,Timolol may increase the bradycardic activities of Minaprine.,54,Type_54,Yes
DB05812,Abiraterone,DB09074,Olaparib,0.6084937453269958,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Abiraterone.,47,Type_47,No
DB00475,Chlordiazepoxide,DB09238,Manidipine,0.9553427696228027,47,Type_47,The metabolism of Manidipine can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00333,Methadone,DB01355,Hexobarbital,0.5375998616218567,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Hexobarbital.,49,Type_49,Yes
DB00390,Digoxin,DB11093,Calcium citrate,0.8211647868156433,82,Type_82,Digoxin may increase the arrhythmogenic activities of Calcium citrate.,82,Type_82,Yes
DB01029,Irbesartan,DB08881,Vemurafenib,0.7366605401039124,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Irbesartan.,73,Type_73,Yes
DB00601,Linezolid,DB00805,Minaprine,0.7086073160171509,71,Type_71,Linezolid may increase the hypertensive activities of Minaprine.,49,Type_49,No
DB00214,Torasemide,DB09091,Tixocortol,0.9978659749031067,83,Type_83,Torasemide may increase the hypokalemic activities of Tixocortol.,83,Type_83,Yes
DB00821,Carprofen,DB00864,Tacrolimus,0.9692084789276123,57,Type_57,Carprofen may increase the nephrotoxic activities of Tacrolimus.,57,Type_57,Yes
DB01348,Spirapril,DB01349,Tasosartan,0.7684668302536011,49,Type_49,The risk or severity of adverse effects can be increased when Spirapril is combined with Tasosartan.,49,Type_49,Yes
DB00594,Amiloride,DB00966,Telmisartan,0.5415585041046143,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Telmisartan.,49,Type_49,Yes
DB00455,Loratadine,DB00996,Gabapentin,0.9872776865959167,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Gabapentin.,49,Type_49,Yes
DB00454,Meperidine,DB01236,Sevoflurane,0.9668145775794983,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Sevoflurane.,49,Type_49,Yes
DB01012,Cinacalcet,DB09065,Cobicistat,0.4688396155834198,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Cinacalcet.,47,Type_47,No
DB00104,Octreotide,DB01195,Flecainide,0.9409090876579285,20,Type_20,Octreotide may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00395,Carisoprodol,DB04844,Tetrabenazine,0.9894636869430542,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Tetrabenazine.,49,Type_49,Yes
DB00418,Secobarbital,DB08901,Ponatinib,0.6103163957595825,4,Type_4,The metabolism of Ponatinib can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01261,Sitagliptin,DB05219,Crisaborole,0.9904277324676514,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Sitagliptin.,47,Type_47,Yes
DB01591,Solifenacin,DB09076,Umeclidinium,0.9995689988136292,2,Type_2,Solifenacin may increase the anticholinergic activities of Umeclidinium.,2,Type_2,Yes
DB00468,Quinine,DB01435,Antipyrine,0.9236657023429871,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Quinine.,47,Type_47,Yes
DB00818,Propofol,DB09345,Pramocaine,0.9981651902198792,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Pramocaine.,49,Type_49,Yes
DB00747,Scopolamine,DB00904,Ondansetron,0.9912062287330627,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Ondansetron.,49,Type_49,Yes
DB00285,Venlafaxine,DB00603,Medroxyprogesterone acetate,0.9236934781074524,47,Type_47,The metabolism of Medroxyprogesterone acetate can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00770,Alprostadil,DB01014,Balsalazide,0.7131728529930115,70,Type_70,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00543,Amoxapine,DB00757,Dolasetron,0.9382317662239075,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Dolasetron.,20,Type_20,Yes
DB01127,Econazole,DB01186,Pergolide,0.7801098227500916,49,Type_49,The risk or severity of adverse effects can be increased when Econazole is combined with Pergolide.,49,Type_49,Yes
DB00477,Chlorpromazine,DB01159,Halothane,0.5755420327186584,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Halothane.,47,Type_47,No
DB01137,Levofloxacin,DB08971,Fluocortolone,0.9891652464866638,49,Type_49,The risk or severity of adverse effects can be increased when Levofloxacin is combined with Fluocortolone.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB01045,Rifampicin,0.6566186547279358,4,Type_4,The metabolism of Rifampicin can be increased when combined with Ethinylestradiol.,4,Type_4,Yes
DB00391,Sulpiride,DB01200,Bromocriptine,0.8088827133178711,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Bromocriptine.,49,Type_49,Yes
DB01018,Guanfacine,DB04920,Clevidipine,0.9686068296432495,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Clevidipine.,49,Type_49,Yes
DB00590,Doxazosin,DB00983,Formoterol,0.9465767741203308,5,Type_5,Doxazosin may decrease the vasoconstricting activities of Formoterol.,5,Type_5,Yes
DB01219,Dantrolene,DB01452,Diamorphine,0.9979640245437622,49,Type_49,The risk or severity of adverse effects can be increased when Dantrolene is combined with Diamorphine.,49,Type_49,Yes
DB00289,Atomoxetine,DB00422,Methylphenidate,0.8837235569953918,47,Type_47,The metabolism of Methylphenidate can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00555,Lamotrigine,DB00557,Hydroxyzine,0.9986656904220581,16,Type_16,Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB00899,Remifentanil,DB09227,Barnidipine,0.9991424083709717,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Barnidipine.,49,Type_49,Yes
DB00604,Cisapride,DB01026,Ketoconazole,0.4932976961135864,20,Type_20,Cisapride may increase the QTc-prolonging activities of Ketoconazole.,73,Type_73,No
DB00370,Mirtazapine,DB00750,Prilocaine,0.9949058294296265,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.,16,Type_16,Yes
DB00208,Ticlopidine,DB01181,Ifosfamide,0.8810026049613953,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Ticlopidine.,11,Type_11,No
DB01254,Dasatinib,DB06403,Ambrisentan,0.41059550642967224,73,Type_73,The serum concentration of Ambrisentan can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00754,Ethotoin,DB01202,Levetiracetam,0.9311203956604004,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Levetiracetam.,49,Type_49,Yes
DB00656,Trazodone,DB01618,Molindone,0.9985623955726624,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Molindone.,49,Type_49,Yes
DB01167,Itraconazole,DB06694,Xylometazoline,0.4955741763114929,49,Type_49,The risk or severity of adverse effects can be increased when Itraconazole is combined with Xylometazoline.,49,Type_49,Yes
DB00281,Lidocaine,DB00349,Clobazam,0.45267611742019653,47,Type_47,The metabolism of Clobazam can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00253,Medrysone,DB07615,Tranilast,0.9939635396003723,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Tranilast.,49,Type_49,Yes
DB00391,Sulpiride,DB01142,Doxepin,0.9519424438476562,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Doxepin.,49,Type_49,Yes
DB00448,Lansoprazole,DB00615,Rifabutin,0.4693753719329834,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Lansoprazole.,4,Type_4,No
DB01244,Bepridil,DB09204,Arotinolol,0.8657145500183105,49,Type_49,The risk or severity of adverse effects can be increased when Bepridil is combined with Arotinolol.,49,Type_49,Yes
DB00252,Phenytoin,DB06697,Artemether,0.5480794310569763,75,Type_75,The serum concentration of Artemether can be decreased when it is combined with Phenytoin.,11,Type_11,No
DB00184,Nicotine,DB00224,Indinavir,0.9132187962532043,47,Type_47,The metabolism of Indinavir can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00727,Nitroglycerin,DB01282,Carbetocin,0.9999998807907104,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Carbetocin.,49,Type_49,Yes
DB06712,Nilvadipine,DB08820,Ivacaftor,0.9962238073348999,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Nilvadipine.,73,Type_73,Yes
DB01255,Lisdexamfetamine,DB08806,Roxatidine acetate,0.9971789121627808,76,Type_76,Lisdexamfetamine may decrease the sedative activities of Roxatidine acetate.,76,Type_76,Yes
DB00798,Gentamicin,DB00884,Risedronic acid,0.8306879997253418,24,Type_24,Gentamicin may increase the hypocalcemic activities of Risedronic acid.,24,Type_24,Yes
DB01168,Procarbazine,DB11609,Normethadone,0.9904518127441406,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Normethadone.,49,Type_49,Yes
DB00946,Phenprocoumon,DB01208,Sparfloxacin,0.9808334112167358,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Sparfloxacin.,6,Type_6,Yes
DB00899,Remifentanil,DB06712,Nilvadipine,0.9849358201026917,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Nilvadipine.,49,Type_49,Yes
DB00181,Baclofen,DB00477,Chlorpromazine,0.9857532978057861,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Chlorpromazine.,49,Type_49,Yes
DB00490,Buspirone,DB00508,Triflupromazine,0.9977541565895081,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Triflupromazine.,49,Type_49,Yes
DB00418,Secobarbital,DB09570,Ixazomib,0.38247397541999817,4,Type_4,The metabolism of Ixazomib can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01396,Digitoxin,DB06699,Degarelix,0.738450825214386,58,Type_58,Digitoxin may decrease the cardiotoxic activities of Degarelix.,58,Type_58,Yes
DB00327,Hydromorphone,DB01247,Isocarboxazid,0.931577742099762,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Isocarboxazid.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB00899,Remifentanil,0.9944695234298706,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Remifentanil.,49,Type_49,Yes
DB00503,Ritonavir,DB09076,Umeclidinium,0.9664681553840637,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00593,Ethosuximide,DB13872,Lormetazepam,0.9994233846664429,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Lormetazepam.,49,Type_49,Yes
DB01254,Dasatinib,DB01595,Nitrazepam,0.6225345730781555,73,Type_73,The serum concentration of Nitrazepam can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00810,Biperiden,DB01452,Diamorphine,0.9998812675476074,49,Type_49,The risk or severity of adverse effects can be increased when Biperiden is combined with Diamorphine.,49,Type_49,Yes
DB01656,Roflumilast,DB06772,Cabazitaxel,0.42601388692855835,4,Type_4,The metabolism of Cabazitaxel can be increased when combined with Roflumilast.,34,Type_34,No
DB00371,Meprobamate,DB01220,Rifaximin,0.6389675140380859,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Meprobamate.,73,Type_73,Yes
DB00182,Amphetamine,DB01576,Dextroamphetamine,0.5795542001724243,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Dextroamphetamine.,49,Type_49,Yes
DB01072,Atazanavir,DB13595,Almasilate,0.8523155450820923,75,Type_75,The serum concentration of Almasilate can be decreased when it is combined with Atazanavir.,67,Type_67,No
DB00210,Adapalene,DB09288,Propacetamol,0.9994099140167236,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Propacetamol.,49,Type_49,Yes
DB01161,Chloroprocaine,DB09128,Brexpiprazole,0.9990584254264832,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Brexpiprazole.,49,Type_49,Yes
DB00703,Methazolamide,DB09204,Arotinolol,0.9891959428787231,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Arotinolol.,49,Type_49,Yes
DB00193,Tramadol,DB00405,Dexbrompheniramine,0.9850652813911438,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Dexbrompheniramine.,49,Type_49,Yes
DB00654,Latanoprost,DB09288,Propacetamol,0.9606286287307739,70,Type_70,The therapeutic efficacy of Propacetamol can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB00899,Remifentanil,DB01242,Clomipramine,0.785230815410614,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Clomipramine.,49,Type_49,Yes
DB00292,Etomidate,DB00370,Mirtazapine,0.6242712736129761,37,Type_37,Etomidate may decrease the antihypertensive activities of Mirtazapine.,37,Type_37,Yes
DB00700,Eplerenone,DB01395,Drospirenone,0.8985869288444519,68,Type_68,Eplerenone may increase the hyperkalemic activities of Drospirenone.,68,Type_68,Yes
DB00822,Disulfiram,DB01264,Darunavir,0.8595675826072693,47,Type_47,The metabolism of Darunavir can be decreased when combined with Disulfiram.,47,Type_47,Yes
DB00899,Remifentanil,DB01142,Doxepin,0.9802466630935669,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Doxepin.,49,Type_49,Yes
DB00875,Flupentixol,DB00899,Remifentanil,0.9469265341758728,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Remifentanil.,49,Type_49,Yes
DB00444,Teniposide,DB01656,Roflumilast,0.9918760061264038,34,Type_34,Teniposide may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00412,Rosiglitazone,DB00482,Celecoxib,0.8363526463508606,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00925,Phenoxybenzamine,DB09236,Lacidipine,0.9014257788658142,60,Type_60,Phenoxybenzamine may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00377,Palonosetron,DB00998,Frovatriptan,0.9854080080986023,64,Type_64,Palonosetron may increase the serotonergic activities of Frovatriptan.,64,Type_64,Yes
DB09227,Barnidipine,DB11126,Calcium gluconate,0.986671507358551,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Barnidipine.,70,Type_70,Yes
DB00541,Vincristine,DB08873,Boceprevir,0.6179755926132202,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Vincristine.,47,Type_47,No
DB00881,Quinapril,DB09215,Droxicam,0.9891811013221741,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Droxicam.,49,Type_49,Yes
DB00908,Quinidine,DB01220,Rifaximin,0.6149303317070007,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Quinidine.,75,Type_75,No
DB00656,Trazodone,DB09286,Pipamperone,0.9840624928474426,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Pipamperone.,49,Type_49,Yes
DB00771,Clidinium,DB01028,Methoxyflurane,0.9998589754104614,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Methoxyflurane.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00724,Imiquimod,0.873113214969635,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Imiquimod.,49,Type_49,Yes
DB00196,Fluconazole,DB00349,Clobazam,0.7688450217247009,47,Type_47,The metabolism of Clobazam can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB09074,Olaparib,DB09330,Osimertinib,0.9724154472351074,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Olaparib.,73,Type_73,Yes
DB00294,Etonogestrel,DB09048,Netupitant,0.574846625328064,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Etonogestrel.,73,Type_73,Yes
DB00890,Dienestrol,DB00949,Felbamate,0.3812405467033386,70,Type_70,The therapeutic efficacy of Felbamate can be decreased when used in combination with Dienestrol.,75,Type_75,No
DB01017,Minocycline,DB11093,Calcium citrate,0.7448158860206604,75,Type_75,The serum concentration of Calcium citrate can be decreased when it is combined with Minocycline.,75,Type_75,Yes
DB01397,Magnesium salicylate,DB09211,Limaprost,0.938958466053009,70,Type_70,The therapeutic efficacy of Limaprost can be decreased when used in combination with Magnesium salicylate.,70,Type_70,Yes
DB00500,Tolmetin,DB00588,Fluticasone propionate,0.9966350197792053,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Fluticasone propionate.,49,Type_49,Yes
DB00624,Testosterone,DB09330,Osimertinib,0.8196350932121277,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Testosterone.,73,Type_73,Yes
DB00175,Pravastatin,DB01377,Magnesium oxide,0.6481351852416992,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Pravastatin.,75,Type_75,Yes
DB00368,Norepinephrine,DB00774,Hydroflumethiazide,0.9973443150520325,83,Type_83,Norepinephrine may increase the hypokalemic activities of Hydroflumethiazide.,83,Type_83,Yes
DB01179,Podofilox,DB09280,Lumacaftor,0.4935370087623596,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Podofilox.,75,Type_75,Yes
DB01211,Clarithromycin,DB01609,Deferasirox,0.8283780813217163,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Clarithromycin.,75,Type_75,Yes
DB00596,Ulobetasol,DB01263,Posaconazole,0.8461076021194458,73,Type_73,The serum concentration of Posaconazole can be increased when it is combined with Ulobetasol.,73,Type_73,Yes
DB00195,Betaxolol,DB08865,Crizotinib,0.7287594676017761,54,Type_54,Betaxolol may increase the bradycardic activities of Crizotinib.,54,Type_54,Yes
DB00628,Clorazepic acid,DB05246,Methsuximide,0.9953739047050476,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Methsuximide.,49,Type_49,Yes
DB00678,Losartan,DB00757,Dolasetron,0.9834070801734924,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Losartan.,47,Type_47,Yes
DB01221,Ketamine,DB06480,Prucalopride,0.750372588634491,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Ketamine.,73,Type_73,Yes
DB01095,Fluvastatin,DB06712,Nilvadipine,0.4574452042579651,73,Type_73,The serum concentration of Nilvadipine can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00295,Morphine,DB04953,Ezogabine,0.9941442608833313,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Ezogabine.,49,Type_49,Yes
DB00975,Dipyridamole,DB09204,Arotinolol,0.827627420425415,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Arotinolol.,54,Type_54,No
DB00747,Scopolamine,DB01198,Zopiclone,0.9993438124656677,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Zopiclone.,49,Type_49,Yes
DB00390,Digoxin,DB00542,Benazepril,0.8475127220153809,73,Type_73,The serum concentration of Benazepril can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00612,Bisoprolol,DB01611,Hydroxychloroquine,0.8209943175315857,47,Type_47,The metabolism of Hydroxychloroquine can be decreased when combined with Bisoprolol.,47,Type_47,Yes
DB00734,Risperidone,DB00889,Granisetron,0.6224973797798157,20,Type_20,Risperidone may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB01355,Hexobarbital,DB09286,Pipamperone,0.9106574058532715,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pipamperone.,49,Type_49,Yes
DB01085,Pilocarpine,DB09274,Artesunate,0.551313579082489,47,Type_47,The metabolism of Artesunate can be decreased when combined with Pilocarpine.,11,Type_11,No
DB00472,Fluoxetine,DB00960,Pindolol,0.4284290373325348,47,Type_47,The metabolism of Pindolol can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB01320,Fosphenytoin,DB06287,Temsirolimus,0.48861488699913025,75,Type_75,The serum concentration of Temsirolimus can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB00384,Triamterene,DB00939,Meclofenamic acid,0.9973840117454529,37,Type_37,Triamterene may decrease the antihypertensive activities of Meclofenamic acid.,37,Type_37,Yes
DB00715,Paroxetine,DB01580,Oxprenolol,0.5140020251274109,64,Type_64,Paroxetine may increase the serotonergic activities of Oxprenolol.,73,Type_73,No
DB01107,Methyprylon,DB09291,Rolapitant,0.9942039847373962,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Methyprylon.,47,Type_47,Yes
DB00554,Piroxicam,DB00582,Voriconazole,0.9846181869506836,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Piroxicam.,47,Type_47,Yes
DB00233,Aminosalicylic acid,DB00261,Anagrelide,0.5250726342201233,6,Type_6,Aminosalicylic acid may increase the anticoagulant activities of Anagrelide.,49,Type_49,No
DB00227,Lovastatin,DB00889,Granisetron,0.8583483695983887,47,Type_47,The metabolism of Granisetron can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01130,Prednicarbate,DB13595,Almasilate,0.9998196959495544,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Prednicarbate.,3,Type_3,Yes
DB01433,Methadyl acetate,DB09118,Stiripentol,0.639597475528717,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Stiripentol.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01198,Zopiclone,0.670477569103241,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB00318,Codeine,DB01609,Deferasirox,0.9746110439300537,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Codeine.,75,Type_75,Yes
DB01227,Levacetylmethadol,DB01587,Ketazolam,0.9364150166511536,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Ketazolam.,49,Type_49,Yes
DB01407,Clenbuterol,DB06290,Simeprevir,0.9786125421524048,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Clenbuterol.,47,Type_47,No
DB00575,Clonidine,DB00881,Quinapril,0.9001576900482178,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Quinapril.,49,Type_49,Yes
DB00593,Ethosuximide,DB01045,Rifampicin,0.9429916739463806,4,Type_4,The metabolism of Rifampicin can be increased when combined with Ethosuximide.,4,Type_4,Yes
DB00252,Phenytoin,DB09065,Cobicistat,0.4641111195087433,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Phenytoin.,75,Type_75,No
DB00216,Eletriptan,DB01200,Bromocriptine,0.8582366704940796,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Bromocriptine.,49,Type_49,Yes
DB00278,Argatroban,DB00458,Imipramine,0.7105769515037537,73,Type_73,The serum concentration of Imipramine can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00960,Pindolol,DB01168,Procarbazine,0.9133329391479492,60,Type_60,Pindolol may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00283,Clemastine,DB00822,Disulfiram,0.9456416964530945,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00381,Amlodipine,DB09074,Olaparib,0.9350740313529968,47,Type_47,The metabolism of Olaparib can be decreased when combined with Amlodipine.,47,Type_47,Yes
DB00335,Atenolol,DB00468,Quinine,0.7498310208320618,47,Type_47,The metabolism of Quinine can be decreased when combined with Atenolol.,60,Type_60,No
DB00402,Eszopiclone,DB01174,Phenobarbital,0.7945453524589539,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Eszopiclone.,4,Type_4,Yes
DB00207,Azithromycin,DB06626,Axitinib,0.537952721118927,73,Type_73,The serum concentration of Axitinib can be increased when it is combined with Azithromycin.,47,Type_47,No
DB00559,Bosentan,DB01058,Praziquantel,0.5091941952705383,73,Type_73,The serum concentration of Praziquantel can be increased when it is combined with Bosentan.,75,Type_75,No
DB01130,Prednicarbate,DB01263,Posaconazole,0.8467631340026855,73,Type_73,The serum concentration of Posaconazole can be increased when it is combined with Prednicarbate.,73,Type_73,Yes
DB01365,Mephentermine,DB06216,Asenapine,0.9890623688697815,61,Type_61,Mephentermine may decrease the stimulatory activities of Asenapine.,61,Type_61,Yes
DB00805,Minaprine,DB06781,Difluprednate,0.8906880021095276,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Difluprednate.,49,Type_49,Yes
DB00794,Primidone,DB06712,Nilvadipine,0.6554597616195679,4,Type_4,The metabolism of Nilvadipine can be increased when combined with Primidone.,4,Type_4,Yes
DB00475,Chlordiazepoxide,DB09065,Cobicistat,0.5427532196044922,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Chlordiazepoxide.,73,Type_73,No
DB01016,Glyburide,DB01185,Fluoxymesterone,0.9999140501022339,9,Type_9,Glyburide may increase the hypoglycemic activities of Fluoxymesterone.,9,Type_9,Yes
DB00575,Clonidine,DB08872,Gabapentin enacarbil,0.9998948574066162,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB01130,Prednicarbate,DB01250,Olsalazine,0.9980302453041077,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Olsalazine.,49,Type_49,Yes
DB00835,Brompheniramine,DB01589,Quazepam,0.9214891791343689,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Quazepam.,73,Type_73,No
DB00615,Rifabutin,DB09041,Tavaborole,0.916140079498291,73,Type_73,The serum concentration of Tavaborole can be increased when it is combined with Rifabutin.,73,Type_73,Yes
DB01240,Epoprostenol,DB04846,Celiprolol,0.9785462021827698,60,Type_60,Epoprostenol may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB00624,Testosterone,DB00860,Prednisolone,0.9972214698791504,74,Type_74,Testosterone may increase the fluid retaining activities of Prednisolone.,74,Type_74,Yes
DB00254,Doxycycline,DB01708,Prasterone,0.7946593165397644,47,Type_47,The metabolism of Prasterone can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00979,Cyclopentolate,DB00981,Physostigmine,0.9995738863945007,70,Type_70,The therapeutic efficacy of Physostigmine can be decreased when used in combination with Cyclopentolate.,70,Type_70,Yes
DB00444,Teniposide,DB06212,Tolvaptan,0.9271338582038879,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Teniposide.,73,Type_73,Yes
DB01098,Rosuvastatin,DB09272,Eluxadoline,0.9530754685401917,73,Type_73,The serum concentration of Eluxadoline can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00808,Indapamide,DB01600,Tiaprofenic acid,0.9413257837295532,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00575,Clonidine,DB00961,Mepivacaine,0.9994487166404724,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Mepivacaine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB08798,Sulfamoxole,0.9873858690261841,47,Type_47,The metabolism of Sulfamoxole can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00237,Butabarbital,DB00555,Lamotrigine,0.9986284971237183,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Lamotrigine.,49,Type_49,Yes
DB00316,Acetaminophen,DB01685,Topiroxostat,0.9970007538795471,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00188,Bortezomib,DB00692,Phentolamine,0.9786986112594604,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Phentolamine.,49,Type_49,Yes
DB06263,Amrubicin,DB08984,Etofenamate,0.9999624490737915,72,Type_72,Amrubicin may decrease the excretion rate of Etofenamate which could result in a higher serum level.,72,Type_72,Yes
DB09093,Chlortetracycline,DB09323,Benzylpenicillin benzathine hydrate,0.7679155468940735,70,Type_70,The therapeutic efficacy of Benzylpenicillin benzathine hydrate can be decreased when used in combination with Chlortetracycline.,70,Type_70,Yes
DB00214,Torasemide,DB01214,Metipranolol,0.9623828530311584,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Metipranolol.,49,Type_49,Yes
DB00248,Cabergoline,DB00353,Methylergometrine,0.9746705293655396,19,Type_19,Cabergoline may increase the vasoconstricting activities of Methylergometrine.,49,Type_49,No
DB00273,Topiramate,DB00972,Azelastine,0.9774396419525146,16,Type_16,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00554,Piroxicam,DB04576,Fleroxacin,0.9973021745681763,27,Type_27,Piroxicam may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB01219,Dantrolene,DB09342,Propoxycaine,0.9999972581863403,49,Type_49,The risk or severity of adverse effects can be increased when Dantrolene is combined with Propoxycaine.,49,Type_49,Yes
DB00793,Haloprogin,DB09236,Lacidipine,0.9993653893470764,49,Type_49,The risk or severity of adverse effects can be increased when Haloprogin is combined with Lacidipine.,49,Type_49,Yes
DB02703,Fusidic acid,DB06777,Chenodeoxycholic acid,0.9845883250236511,73,Type_73,The serum concentration of Chenodeoxycholic acid can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00854,Levorphanol,DB00887,Bumetanide,0.9993175268173218,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Bumetanide.,49,Type_49,Yes
DB06702,Fesoterodine,DB06738,Ketobemidone,0.6811944842338562,49,Type_49,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Ketobemidone.,49,Type_49,Yes
DB08814,Triflusal,DB11362,Selexipag,0.8850225806236267,6,Type_6,Triflusal may increase the anticoagulant activities of Selexipag.,6,Type_6,Yes
DB00571,Propranolol,DB00933,Mesoridazine,0.7626180648803711,60,Type_60,Propranolol may increase the hypotensive activities of Mesoridazine.,60,Type_60,Yes
DB00672,Chlorpropamide,DB06203,Alogliptin,0.9879865050315857,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00521,Carteolol,DB01021,Trichlormethiazide,0.9677736759185791,60,Type_60,Carteolol may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB00408,Loxapine,DB00497,Oxycodone,0.9930233955383301,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Oxycodone.,49,Type_49,Yes
DB00654,Latanoprost,DB01050,Ibuprofen,0.9522147178649902,70,Type_70,The therapeutic efficacy of Ibuprofen can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB00976,Telithromycin,DB01609,Deferasirox,0.8415877819061279,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Telithromycin.,75,Type_75,Yes
DB00223,Diflorasone,DB09543,Methyl salicylate,0.9958772659301758,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Methyl salicylate.,49,Type_49,Yes
DB00238,Nevirapine,DB00738,Pentamidine,0.680064857006073,4,Type_4,The metabolism of Pentamidine can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00476,Duloxetine,DB01081,Diphenoxylate,0.8730528950691223,64,Type_64,Duloxetine may increase the serotonergic activities of Diphenoxylate.,64,Type_64,Yes
DB00298,Dapiprazole,DB00844,Nalbuphine,0.9984108209609985,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Nalbuphine.,49,Type_49,Yes
DB00685,Trovafloxacin,DB01397,Magnesium salicylate,0.6547327041625977,49,Type_49,The risk or severity of adverse effects can be increased when Trovafloxacin is combined with Magnesium salicylate.,75,Type_75,No
DB00877,Sirolimus,DB01186,Pergolide,0.9412618279457092,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Pergolide.,49,Type_49,Yes
DB00206,Reserpine,DB01151,Desipramine,0.8552906513214111,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Desipramine.,49,Type_49,Yes
DB00648,Mitotane,DB06738,Ketobemidone,0.9253526926040649,75,Type_75,The serum concentration of Ketobemidone can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00605,Sulindac,DB00684,Tobramycin,0.9999594688415527,72,Type_72,Sulindac may decrease the excretion rate of Tobramycin which could result in a higher serum level.,72,Type_72,Yes
DB00268,Ropinirole,DB00296,Ropivacaine,0.9942704439163208,32,Type_32,Ropinirole may increase the sedative activities of Ropivacaine.,32,Type_32,Yes
DB00519,Trandolapril,DB00899,Remifentanil,0.9749673008918762,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Remifentanil.,49,Type_49,Yes
DB00598,Labetalol,DB01151,Desipramine,0.42489105463027954,47,Type_47,The metabolism of Desipramine can be decreased when combined with Labetalol.,47,Type_47,Yes
DB00695,Furosemide,DB11079,Trolamine salicylate,0.9973536729812622,29,Type_29,Furosemide may decrease the diuretic activities of Trolamine salicylate.,29,Type_29,Yes
DB01072,Atazanavir,DB06777,Chenodeoxycholic acid,0.7851312160491943,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00468,Quinine,DB09477,Enalaprilat,0.9393447637557983,60,Type_60,Quinine may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00203,Sildenafil,DB00990,Exemestane,0.8488051295280457,47,Type_47,The metabolism of Exemestane can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01167,Itraconazole,DB06228,Rivaroxaban,0.7014018297195435,73,Type_73,The serum concentration of Rivaroxaban can be increased when it is combined with Itraconazole.,47,Type_47,No
DB00423,Methocarbamol,DB06282,Levocetirizine,0.9996323585510254,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Levocetirizine.,49,Type_49,Yes
DB00712,Flurbiprofen,DB00972,Azelastine,0.990373969078064,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Azelastine.,49,Type_49,Yes
DB01232,Saquinavir,DB12483,Copanlisib,0.888997495174408,47,Type_47,The metabolism of Copanlisib can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00181,Baclofen,DB00628,Clorazepic acid,0.9981777667999268,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Clorazepic acid.,49,Type_49,Yes
DB00150,Tryptophan,DB01168,Procarbazine,0.7014445662498474,49,Type_49,The risk or severity of adverse effects can be increased when Tryptophan is combined with Procarbazine.,49,Type_49,Yes
DB00881,Quinapril,DB01224,Quetiapine,0.7820594906806946,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Quetiapine.,49,Type_49,Yes
DB00457,Prazosin,DB00883,Isosorbide dinitrate,0.9822323322296143,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Isosorbide dinitrate.,49,Type_49,Yes
DB00252,Phenytoin,DB11581,Venetoclax,0.5269318222999573,4,Type_4,The metabolism of Venetoclax can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00540,Nortriptyline,DB01159,Halothane,0.9236142039299011,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Halothane.,49,Type_49,Yes
DB00243,Ranolazine,DB08816,Ticagrelor,0.3772604763507843,73,Type_73,The serum concentration of Ticagrelor can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01110,Miconazole,DB01263,Posaconazole,0.8497698903083801,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Miconazole.,47,Type_47,Yes
DB06770,Benzyl alcohol,DB09065,Cobicistat,0.524304211139679,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Benzyl alcohol.,73,Type_73,No
DB00641,Simvastatin,DB00921,Buprenorphine,0.49059411883354187,73,Type_73,The serum concentration of Buprenorphine can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB01180,Rescinnamine,DB09238,Manidipine,0.9960765242576599,60,Type_60,Rescinnamine may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB08880,Teriflunomide,DB12161,Deutetrabenazine,0.6017054319381714,73,Type_73,The serum concentration of Deutetrabenazine can be increased when it is combined with Teriflunomide.,75,Type_75,No
DB01563,Chloral hydrate,DB09072,Sodium oxybate,1.0,16,Type_16,Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00765,Metyrosine,DB01359,Penbutolol,0.9944122433662415,60,Type_60,Metyrosine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB01267,Paliperidone,DB11304,Phenoxyethanol,0.9998799562454224,49,Type_49,The risk or severity of adverse effects can be increased when Paliperidone is combined with Phenoxyethanol.,49,Type_49,Yes
DB06262,Droxidopa,DB08918,Levomilnacipran,0.9961698651313782,85,Type_85,Droxidopa may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB01232,Saquinavir,DB01349,Tasosartan,0.9756185412406921,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00869,Dorzolamide,DB01367,Rasagiline,0.9682125449180603,60,Type_60,Dorzolamide may increase the hypotensive activities of Rasagiline.,60,Type_60,Yes
DB00470,Dronabinol,DB09073,Palbociclib,0.9973477125167847,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00418,Secobarbital,DB00788,Naproxen,0.9733180999755859,4,Type_4,The metabolism of Naproxen can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00598,Labetalol,DB00752,Tranylcypromine,0.6624392867088318,60,Type_60,Labetalol may increase the hypotensive activities of Tranylcypromine.,47,Type_47,No
DB00872,Conivaptan,DB08875,Cabozantinib,0.9886858463287354,73,Type_73,The serum concentration of Cabozantinib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00207,Azithromycin,DB00863,Ranitidine,0.8686915040016174,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00672,Chlorpropamide,DB05812,Abiraterone,0.49973633885383606,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Chlorpropamide.,47,Type_47,Yes
DB00208,Ticlopidine,DB04908,Flibanserin,0.5583547353744507,73,Type_73,The serum concentration of Flibanserin can be increased when it is combined with Ticlopidine.,73,Type_73,Yes
DB00301,Flucloxacillin,DB01418,Acenocoumarol,0.9593654274940491,12,Type_12,Flucloxacillin may decrease the anticoagulant activities of Acenocoumarol.,12,Type_12,Yes
DB00814,Meloxicam,DB00972,Azelastine,0.9893802404403687,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Azelastine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00563,Methotrexate,0.6274898052215576,73,Type_73,The serum concentration of Methotrexate can be increased when it is combined with Sulfisoxazole.,49,Type_49,No
DB00961,Mepivacaine,DB01440,gamma-Hydroxybutyric acid,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00216,Eletriptan,DB09068,Vortioxetine,0.9815282821655273,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Vortioxetine.,49,Type_49,Yes
DB00195,Betaxolol,DB00545,Pyridostigmine,0.9238735437393188,54,Type_54,Betaxolol may increase the bradycardic activities of Pyridostigmine.,54,Type_54,Yes
DB00604,Cisapride,DB09041,Tavaborole,0.8804951906204224,73,Type_73,The serum concentration of Tavaborole can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00752,Tranylcypromine,DB01215,Estazolam,0.7840341329574585,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Estazolam.,49,Type_49,Yes
DB00818,Propofol,DB01189,Desflurane,0.9882943630218506,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Desflurane.,49,Type_49,Yes
DB00384,Triamterene,DB09288,Propacetamol,0.9987419247627258,37,Type_37,Triamterene may decrease the antihypertensive activities of Propacetamol.,37,Type_37,Yes
DB00521,Carteolol,DB00631,Clofarabine,0.9903964996337891,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Clofarabine.,49,Type_49,Yes
DB00474,Methohexital,DB01192,Oxymorphone,0.969545304775238,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Oxymorphone.,49,Type_49,Yes
DB00864,Tacrolimus,DB00898,Ethanol,0.5643187761306763,47,Type_47,The metabolism of Ethanol can be decreased when combined with Tacrolimus.,18,Type_18,No
DB06212,Tolvaptan,DB09330,Osimertinib,0.9944755434989929,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB00842,Oxazepam,DB01588,Prazepam,0.99769127368927,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Prazepam.,49,Type_49,Yes
DB01069,Promethazine,DB01075,Diphenhydramine,0.5137158036231995,20,Type_20,Promethazine may increase the QTc-prolonging activities of Diphenhydramine.,47,Type_47,No
DB00285,Venlafaxine,DB00647,Dextropropoxyphene,0.5115991234779358,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00896,Rimexolone,DB08899,Enzalutamide,0.9830514192581177,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Rimexolone.,75,Type_75,Yes
DB01355,Hexobarbital,DB01621,Pipotiazine,0.9666309356689453,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pipotiazine.,49,Type_49,Yes
DB00296,Ropivacaine,DB00395,Carisoprodol,0.9119575619697571,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Carisoprodol.,49,Type_49,Yes
DB00429,Carboprost tromethamine,DB09215,Droxicam,0.8215605616569519,70,Type_70,The therapeutic efficacy of Droxicam can be decreased when used in combination with Carboprost tromethamine.,70,Type_70,Yes
DB00588,Fluticasone propionate,DB06412,Oxymetholone,0.8565661907196045,74,Type_74,Fluticasone propionate may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB00288,Amcinonide,DB09280,Lumacaftor,0.8817538022994995,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Amcinonide.,75,Type_75,Yes
DB00193,Tramadol,DB00433,Prochlorperazine,0.8306904435157776,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Prochlorperazine.,49,Type_49,Yes
DB00742,Mannitol,DB06263,Amrubicin,0.9984006285667419,57,Type_57,Mannitol may increase the nephrotoxic activities of Amrubicin.,57,Type_57,Yes
DB01021,Trichlormethiazide,DB06736,Aceclofenac,0.9918643236160278,70,Type_70,The therapeutic efficacy of Aceclofenac can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB01628,Etoricoxib,DB04951,Pirfenidone,0.9924077987670898,49,Type_49,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Pirfenidone.,49,Type_49,Yes
DB04846,Celiprolol,DB06704,Iobenguane,0.9887380599975586,70,Type_70,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Celiprolol.,70,Type_70,Yes
DB00371,Meprobamate,DB00997,Doxorubicin,0.8524765372276306,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Meprobamate.,73,Type_73,No
DB00677,Isoflurophate,DB00687,Fludrocortisone,0.9966945648193359,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Fludrocortisone.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB09292,Sacubitril,0.9985690116882324,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Sacubitril.,49,Type_49,Yes
DB05676,Apremilast,DB08820,Ivacaftor,0.9941521286964417,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Apremilast.,73,Type_73,Yes
DB00176,Fluvoxamine,DB00917,Dinoprostone,0.6837400794029236,47,Type_47,The metabolism of Dinoprostone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00298,Dapiprazole,DB01071,Mequitazine,0.9878863096237183,82,Type_82,Dapiprazole may increase the arrhythmogenic activities of Mequitazine.,82,Type_82,Yes
DB01044,Gatifloxacin,DB11348,Calcium Phosphate,0.9022873640060425,67,Type_67,Gatifloxacin can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00213,Pantoprazole,DB01242,Clomipramine,0.9768537878990173,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB01192,Oxymorphone,DB08883,Perampanel,0.9955350160598755,16,Type_16,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00751,Epinastine,DB06441,Cangrelor,0.7132511734962463,49,Type_49,The risk or severity of adverse effects can be increased when Epinastine is combined with Cangrelor.,6,Type_6,No
DB04572,Thiotepa,DB09063,Ceritinib,0.9862398505210876,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Thiotepa.,73,Type_73,Yes
DB00557,Hydroxyzine,DB00850,Perphenazine,0.9978218078613281,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.,16,Type_16,Yes
DB00237,Butabarbital,DB00564,Carbamazepine,0.9158666729927063,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Carbamazepine.,49,Type_49,Yes
DB01324,Polythiazide,DB09038,Empagliflozin,0.9074224829673767,49,Type_49,The risk or severity of adverse effects can be increased when Polythiazide is combined with Empagliflozin.,70,Type_70,No
DB01211,Clarithromycin,DB01551,Dihydrocodeine,0.8313267230987549,47,Type_47,The metabolism of Dihydrocodeine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB01118,Amiodarone,DB09030,Vorapaxar,0.8057198524475098,73,Type_73,The serum concentration of Vorapaxar can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00661,Verapamil,DB01259,Lapatinib,0.8873452544212341,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Verapamil.,47,Type_47,Yes
DB08875,Cabozantinib,DB09054,Idelalisib,0.7621164321899414,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Cabozantinib.,73,Type_73,No
DB01200,Bromocriptine,DB04876,Vildagliptin,0.9233679175376892,9,Type_9,Bromocriptine may increase the hypoglycemic activities of Vildagliptin.,73,Type_73,No
DB01002,Levobupivacaine,DB04953,Ezogabine,0.99755859375,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ezogabine.,49,Type_49,Yes
DB00196,Fluconazole,DB00425,Zolpidem,0.5390341877937317,47,Type_47,The metabolism of Zolpidem can be decreased when combined with Fluconazole.,73,Type_73,No
DB00539,Toremifene,DB08820,Ivacaftor,0.9961525797843933,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Toremifene.,73,Type_73,Yes
DB00704,Naltrexone,DB00899,Remifentanil,0.5218213796615601,49,Type_49,The risk or severity of adverse effects can be increased when Naltrexone is combined with Remifentanil.,70,Type_70,No
DB00972,Azelastine,DB13872,Lormetazepam,0.9652944803237915,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.,16,Type_16,Yes
DB01171,Moclobemide,DB01255,Lisdexamfetamine,0.9051837921142578,71,Type_71,Moclobemide may increase the hypertensive activities of Lisdexamfetamine.,71,Type_71,Yes
DB00904,Ondansetron,DB06699,Degarelix,0.999392032623291,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00333,Methadone,DB00933,Mesoridazine,0.4904695153236389,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Mesoridazine.,47,Type_47,No
DB01708,Prasterone,DB09218,Clonixin,0.9994691014289856,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Clonixin.,49,Type_49,Yes
DB01320,Fosphenytoin,DB09167,Dosulepin,0.8316212296485901,4,Type_4,The metabolism of Dosulepin can be increased when combined with Fosphenytoin.,47,Type_47,No
DB00420,Promazine,DB00508,Triflupromazine,0.9035744667053223,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Triflupromazine.,49,Type_49,Yes
DB00313,Valproic acid,DB06153,Pizotifen,0.9955629110336304,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Pizotifen.,49,Type_49,Yes
DB01047,Fluocinonide,DB09275,Bismuth subcitrate potassium,0.998828113079071,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Fluocinonide.,3,Type_3,Yes
DB00524,Metolazone,DB01171,Moclobemide,0.8560882210731506,60,Type_60,Metolazone may increase the hypotensive activities of Moclobemide.,60,Type_60,Yes
DB00872,Conivaptan,DB01268,Sunitinib,0.9199296236038208,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB01026,Ketoconazole,DB07615,Tranilast,0.6478005051612854,47,Type_47,The metabolism of Tranilast can be decreased when combined with Ketoconazole.,49,Type_49,No
DB01105,Sibutramine,DB06636,Isavuconazonium,0.9534491896629333,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Sibutramine.,47,Type_47,Yes
DB00208,Ticlopidine,DB00863,Ranitidine,0.9552136659622192,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00881,Quinapril,DB01158,Bretylium,0.7281090617179871,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Bretylium.,49,Type_49,Yes
DB01143,Amifostine,DB04920,Clevidipine,0.9465152621269226,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Clevidipine.,49,Type_49,Yes
DB01602,Bacampicillin,DB06263,Amrubicin,0.9985343217849731,75,Type_75,The serum concentration of Amrubicin can be decreased when it is combined with Bacampicillin.,75,Type_75,Yes
DB01021,Trichlormethiazide,DB01600,Tiaprofenic acid,0.9977849721908569,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Trichlormethiazide.,70,Type_70,Yes
DB08872,Gabapentin enacarbil,DB09034,Suvorexant,0.9999901056289673,16,Type_16,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00353,Methylergometrine,DB01248,Docetaxel,0.979689359664917,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Docetaxel.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB13167,Alclofenac,0.9320459961891174,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Alclofenac.,49,Type_49,Yes
DB00264,Metoprolol,DB01366,Procaterol,0.9028785228729248,14,Type_14,Metoprolol may decrease the bronchodilatory activities of Procaterol.,14,Type_14,Yes
DB00543,Amoxapine,DB11609,Normethadone,0.9683607220649719,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Normethadone.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01189,Desflurane,0.999620795249939,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Desflurane.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB00696,Ergotamine,0.9167625904083252,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Ergotamine.,49,Type_49,Yes
DB00660,Metaxalone,DB01086,Benzocaine,0.9999980926513672,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Benzocaine.,49,Type_49,Yes
DB00496,Darifenacin,DB00782,Propantheline,0.9936776757240295,49,Type_49,The risk or severity of adverse effects can be increased when Darifenacin is combined with Propantheline.,49,Type_49,Yes
DB00813,Fentanyl,DB00898,Ethanol,0.997893750667572,16,Type_16,Fentanyl may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00316,Acetaminophen,DB01032,Probenecid,0.9040956497192383,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Acetaminophen.,73,Type_73,Yes
DB00883,Isosorbide dinitrate,DB01238,Aripiprazole,0.9235784411430359,60,Type_60,Isosorbide dinitrate may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00338,Omeprazole,DB00673,Aprepitant,0.8573688864707947,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Omeprazole.,73,Type_73,Yes
DB00376,Trihexyphenidyl,DB00486,Nabilone,0.9745703935623169,85,Type_85,Trihexyphenidyl may increase the tachycardic activities of Nabilone.,85,Type_85,Yes
DB00502,Haloperidol,DB01615,Aceprometazine,0.944445788860321,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Aceprometazine.,49,Type_49,Yes
DB01104,Sertraline,DB09280,Lumacaftor,0.5305325984954834,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Sertraline.,75,Type_75,No
DB00752,Tranylcypromine,DB00983,Formoterol,0.4961341321468353,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Formoterol.,47,Type_47,No
DB00297,Bupivacaine,DB01088,Iloprost,0.6897525787353516,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Iloprost.,49,Type_49,Yes
DB00508,Triflupromazine,DB01041,Thalidomide,0.9965556859970093,16,Type_16,Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB01567,Fludiazepam,DB11609,Normethadone,0.9980871677398682,49,Type_49,The risk or severity of adverse effects can be increased when Fludiazepam is combined with Normethadone.,49,Type_49,Yes
DB00283,Clemastine,DB04861,Nebivolol,0.7141544818878174,73,Type_73,The serum concentration of Nebivolol can be increased when it is combined with Clemastine.,73,Type_73,Yes
DB00569,Fondaparinux,DB01250,Olsalazine,0.9823268055915833,6,Type_6,Fondaparinux may increase the anticoagulant activities of Olsalazine.,6,Type_6,Yes
DB00675,Tamoxifen,DB01319,Fosamprenavir,0.5622870922088623,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB00391,Sulpiride,DB06770,Benzyl alcohol,0.9946469664573669,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Benzyl alcohol.,49,Type_49,Yes
DB00527,Cinchocaine,DB06216,Asenapine,0.9980870485305786,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Asenapine.,49,Type_49,Yes
DB00210,Adapalene,DB01401,Choline magnesium trisalicylate,0.99928218126297,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB04846,Celiprolol,0.9967283010482788,37,Type_37,Mycophenolic acid may decrease the antihypertensive activities of Celiprolol.,37,Type_37,Yes
DB00358,Mefloquine,DB09079,Nintedanib,0.8220236897468567,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB01151,Desipramine,DB01601,Lopinavir,0.6981915235519409,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Desipramine.,20,Type_20,No
DB00284,Acarbose,DB00687,Fludrocortisone,0.9995263814926147,70,Type_70,The therapeutic efficacy of Fludrocortisone can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00920,Ketotifen,DB01576,Dextroamphetamine,0.9999953508377075,76,Type_76,Ketotifen may decrease the sedative activities of Dextroamphetamine.,76,Type_76,Yes
DB00541,Vincristine,DB11363,Alectinib,0.9679549336433411,73,Type_73,The serum concentration of Alectinib can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00467,Enoxacin,DB06196,Icatibant,0.9994763731956482,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Icatibant.,27,Type_27,Yes
DB00788,Naproxen,DB01241,Gemfibrozil,0.881758987903595,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Naproxen.,47,Type_47,Yes
DB00226,Guanadrel,DB00960,Pindolol,0.9999901056289673,60,Type_60,Guanadrel may increase the hypotensive activities of Pindolol.,60,Type_60,Yes
DB00738,Pentamidine,DB00779,Nalidixic acid,0.804258406162262,9,Type_9,Pentamidine may increase the hypoglycemic activities of Nalidixic acid.,9,Type_9,Yes
DB01136,Carvedilol,DB08893,Mirabegron,0.6108997464179993,73,Type_73,The serum concentration of Mirabegron can be increased when it is combined with Carvedilol.,47,Type_47,No
DB01200,Bromocriptine,DB01320,Fosphenytoin,0.8404938578605652,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Bromocriptine.,4,Type_4,Yes
DB00590,Doxazosin,DB01045,Rifampicin,0.935097873210907,4,Type_4,The metabolism of Rifampicin can be increased when combined with Doxazosin.,4,Type_4,Yes
DB01069,Promethazine,DB01136,Carvedilol,0.7014742493629456,73,Type_73,The serum concentration of Carvedilol can be increased when it is combined with Promethazine.,60,Type_60,No
DB00207,Azithromycin,DB09118,Stiripentol,0.9200471639633179,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00450,Droperidol,DB01065,Melatonin,0.9973638653755188,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melatonin.,16,Type_16,Yes
DB00247,Methysergide,DB00678,Losartan,0.9992584586143494,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Losartan.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB01576,Dextroamphetamine,0.968502402305603,69,Type_69,Dextropropoxyphene may increase the analgesic activities of Dextroamphetamine.,69,Type_69,Yes
DB00617,Paramethadione,DB04855,Dronedarone,0.9313859939575195,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Paramethadione.,47,Type_47,Yes
DB00489,Sotalol,DB09288,Propacetamol,0.9617705345153809,37,Type_37,Sotalol may decrease the antihypertensive activities of Propacetamol.,37,Type_37,Yes
DB00457,Prazosin,DB00794,Primidone,0.9325681328773499,60,Type_60,Prazosin may increase the hypotensive activities of Primidone.,60,Type_60,Yes
DB08880,Teriflunomide,DB09295,Talniflumate,0.9996169805526733,49,Type_49,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Talniflumate.,49,Type_49,Yes
DB01463,Fencamfamin,DB01576,Dextroamphetamine,0.9994015693664551,61,Type_61,Fencamfamin may decrease the stimulatory activities of Dextroamphetamine.,61,Type_61,Yes
DB00356,Chlorzoxazone,DB01211,Clarithromycin,0.8048833608627319,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Chlorzoxazone.,47,Type_47,Yes
DB00503,Ritonavir,DB00872,Conivaptan,0.970261812210083,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB00790,Perindopril,0.590165376663208,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Perindopril.,49,Type_49,Yes
DB00446,Chloramphenicol,DB06413,Armodafinil,0.9907011985778809,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB01100,Pimozide,DB01353,Butobarbital,0.9999394416809082,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Butobarbital.,49,Type_49,Yes
DB00489,Sotalol,DB01010,Edrophonium,0.9991538524627686,54,Type_54,Sotalol may increase the bradycardic activities of Edrophonium.,54,Type_54,Yes
DB00203,Sildenafil,DB00765,Metyrosine,0.9052634239196777,10,Type_10,Sildenafil may increase the antihypertensive activities of Metyrosine.,10,Type_10,Yes
DB01104,Sertraline,DB06701,Dexmethylphenidate,0.7026050090789795,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00470,Dronabinol,DB00794,Primidone,0.9959490299224854,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Primidone.,16,Type_16,Yes
DB00243,Ranolazine,DB01196,Estramustine,0.5213313698768616,47,Type_47,The metabolism of Estramustine can be decreased when combined with Ranolazine.,73,Type_73,No
DB00224,Indinavir,DB01067,Glipizide,0.9125620722770691,47,Type_47,The metabolism of Glipizide can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00300,Tenofovir disoproxil,DB04920,Clevidipine,0.730520486831665,47,Type_47,The metabolism of Clevidipine can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB06737,Zaltoprofen,DB08808,Bupranolol,0.9999420642852783,37,Type_37,Zaltoprofen may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB01151,Desipramine,DB01221,Ketamine,0.8138971328735352,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Ketamine.,49,Type_49,Yes
DB00866,Alprenolol,DB09220,Nicorandil,0.9994725584983826,60,Type_60,Alprenolol may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB00196,Fluconazole,DB00374,Treprostinil,0.8281177282333374,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Treprostinil.,47,Type_47,No
DB00287,Travoprost,DB00866,Alprenolol,0.9999934434890747,60,Type_60,Travoprost may increase the hypotensive activities of Alprenolol.,60,Type_60,Yes
DB00863,Ranitidine,DB01577,Metamfetamine,0.6218889355659485,76,Type_76,Ranitidine may decrease the sedative activities of Metamfetamine.,76,Type_76,Yes
DB00278,Argatroban,DB00688,Mycophenolate mofetil,0.7650850415229797,6,Type_6,Argatroban may increase the anticoagulant activities of Mycophenolate mofetil.,6,Type_6,Yes
DB00254,Doxycycline,DB01242,Clomipramine,0.9588122367858887,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00188,Bortezomib,DB08941,Isoxsuprine,0.6671937704086304,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Isoxsuprine.,49,Type_49,Yes
DB01431,Allylestrenol,DB09280,Lumacaftor,0.7223464846611023,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Allylestrenol.,4,Type_4,Yes
DB00178,Ramipril,DB08822,Azilsartan medoxomil,0.9662762880325317,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB01034,Cerulenin,DB01074,Perhexiline,0.9905173182487488,49,Type_49,The risk or severity of adverse effects can be increased when Cerulenin is combined with Perhexiline.,49,Type_49,Yes
DB00864,Tacrolimus,DB05260,Gallium nitrate,0.9173703789710999,49,Type_49,The risk or severity of adverse effects can be increased when Tacrolimus is combined with Gallium nitrate.,49,Type_49,Yes
DB09104,Magnesium hydroxide,DB09162,Ferric Citrate,0.7923083305358887,67,Type_67,Magnesium hydroxide can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00918,Almotriptan,DB09054,Idelalisib,0.6540477871894836,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Almotriptan.,73,Type_73,No
DB00539,Toremifene,DB09073,Palbociclib,0.9906587600708008,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Toremifene.,73,Type_73,Yes
DB00361,Vinorelbine,DB01220,Rifaximin,0.8027250170707703,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB01178,Chlormezanone,DB09071,Tasimelteon,0.9999657869338989,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Tasimelteon.,49,Type_49,Yes
DB01235,Levodopa,DB01614,Acepromazine,0.9962977766990662,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Acepromazine.,49,Type_49,Yes
DB00374,Treprostinil,DB00468,Quinine,0.650097131729126,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Quinine.,20,Type_20,Yes
DB00434,Cyproheptadine,DB00985,Dimenhydrinate,0.9993914365768433,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Dimenhydrinate.,49,Type_49,Yes
DB00594,Amiloride,DB09449,"Sodium phosphate, monobasic",0.99845290184021,57,Type_57,"Amiloride may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00557,Hydroxyzine,DB00588,Fluticasone propionate,0.9977770447731018,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.,16,Type_16,Yes
DB00243,Ranolazine,DB00345,Aminohippuric acid,0.967448890209198,73,Type_73,The serum concentration of Aminohippuric acid can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01193,Acebutolol,DB06262,Droxidopa,0.9962742328643799,25,Type_25,Acebutolol may increase the atrioventricular blocking (AV block) activities of Droxidopa.,25,Type_25,Yes
DB00418,Secobarbital,DB00749,Etodolac,0.8988698720932007,4,Type_4,The metabolism of Etodolac can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00176,Fluvoxamine,DB00921,Buprenorphine,0.7822955846786499,16,Type_16,Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00461,Nabumetone,DB04898,Ximelagatran,0.9831238985061646,6,Type_6,Nabumetone may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB04844,Tetrabenazine,DB04855,Dronedarone,0.780406653881073,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Dronedarone.,47,Type_47,No
DB00503,Ritonavir,DB01394,Colchicine,0.9823135733604431,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB00790,Perindopril,DB00922,Levosimendan,0.8039218783378601,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Levosimendan.,49,Type_49,Yes
DB00482,Celecoxib,DB05676,Apremilast,0.9476462006568909,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Apremilast.,49,Type_49,Yes
DB00246,Ziprasidone,DB00468,Quinine,0.7936294078826904,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Quinine.,47,Type_47,No
DB00479,Amikacin,DB09218,Clonixin,0.9999935626983643,72,Type_72,Amikacin may decrease the excretion rate of Clonixin which could result in a higher serum level.,72,Type_72,Yes
DB00660,Metaxalone,DB06144,Sertindole,0.999860405921936,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Sertindole.,49,Type_49,Yes
DB00230,Pregabalin,DB09128,Brexpiprazole,0.9755609631538391,8,Type_8,The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00683,Midazolam,DB01221,Ketamine,0.988469660282135,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Ketamine.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB00518,Albendazole,0.9904955625534058,47,Type_47,The metabolism of Albendazole can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00625,Efavirenz,DB01580,Oxprenolol,0.36427101492881775,73,Type_73,The serum concentration of Oxprenolol can be increased when it is combined with Efavirenz.,49,Type_49,No
DB00254,Doxycycline,DB00933,Mesoridazine,0.5867785811424255,73,Type_73,The serum concentration of Mesoridazine can be increased when it is combined with Doxycycline.,73,Type_73,Yes
DB00158,Folic acid,DB00939,Meclofenamic acid,0.9148448705673218,70,Type_70,The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Folic acid.,70,Type_70,Yes
DB00436,Bendroflumethiazide,DB11609,Normethadone,0.9997535347938538,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Normethadone.,49,Type_49,Yes
DB00972,Azelastine,DB01132,Pioglitazone,0.9474292993545532,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Azelastine.,47,Type_47,Yes
DB00288,Amcinonide,DB00784,Mefenamic acid,0.9997121691703796,49,Type_49,The risk or severity of adverse effects can be increased when Amcinonide is combined with Mefenamic acid.,49,Type_49,Yes
DB00620,Triamcinolone,DB00774,Hydroflumethiazide,0.999742329120636,83,Type_83,Triamcinolone may increase the hypokalemic activities of Hydroflumethiazide.,83,Type_83,Yes
DB00956,Hydrocodone,DB09015,Canrenoic acid,0.9993624091148376,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Canrenoic acid.,49,Type_49,Yes
DB00752,Tranylcypromine,DB00889,Granisetron,0.4811716079711914,64,Type_64,Tranylcypromine may increase the serotonergic activities of Granisetron.,64,Type_64,Yes
DB00374,Treprostinil,DB09167,Dosulepin,0.5178326368331909,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Treprostinil.,47,Type_47,Yes
DB00469,Tenoxicam,DB01009,Ketoprofen,0.998429000377655,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Ketoprofen.,49,Type_49,Yes
DB00887,Bumetanide,DB13139,Levosalbutamol,0.9723395705223083,83,Type_83,Bumetanide may increase the hypokalemic activities of Levosalbutamol.,83,Type_83,Yes
DB00594,Amiloride,DB06712,Nilvadipine,0.8452058434486389,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Nilvadipine.,49,Type_49,Yes
DB00418,Secobarbital,DB01171,Moclobemide,0.6312649846076965,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Moclobemide.,4,Type_4,No
DB00196,Fluconazole,DB00717,Norethisterone,0.9303178191184998,47,Type_47,The metabolism of Norethisterone can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00734,Risperidone,DB08903,Bedaquiline,0.9221718311309814,20,Type_20,Risperidone may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00571,Propranolol,DB01238,Aripiprazole,0.9953429698944092,60,Type_60,Propranolol may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00788,Naproxen,DB12332,Rucaparib,0.975611686706543,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Naproxen.,47,Type_47,Yes
DB01037,Selegiline,DB01081,Diphenoxylate,0.9779291749000549,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Diphenoxylate.,49,Type_49,Yes
DB00205,Pyrimethamine,DB01045,Rifampicin,0.7601037621498108,4,Type_4,The metabolism of Rifampicin can be increased when combined with Pyrimethamine.,47,Type_47,No
DB00487,Pefloxacin,DB13158,Clobetasone,0.9036375880241394,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Clobetasone.,49,Type_49,Yes
DB01026,Ketoconazole,DB09048,Netupitant,0.9712544083595276,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00451,Levothyroxine,DB00977,Ethinylestradiol,0.5635007619857788,81,Type_81,Levothyroxine may increase the thrombogenic activities of Ethinylestradiol.,70,Type_70,No
DB00185,Cevimeline,DB08873,Boceprevir,0.8457902073860168,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB00934,Maprotiline,DB08918,Levomilnacipran,0.9564587473869324,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Levomilnacipran.,49,Type_49,Yes
DB00593,Ethosuximide,DB01028,Methoxyflurane,0.9959911704063416,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Methoxyflurane.,49,Type_49,Yes
DB09068,Vortioxetine,DB09074,Olaparib,0.9202974438667297,47,Type_47,The metabolism of Olaparib can be decreased when combined with Vortioxetine.,47,Type_47,Yes
DB00178,Ramipril,DB00925,Phenoxybenzamine,0.5981471538543701,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Phenoxybenzamine.,60,Type_60,No
DB00278,Argatroban,DB04855,Dronedarone,0.6351858973503113,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Argatroban.,47,Type_47,Yes
DB04908,Flibanserin,DB09074,Olaparib,0.5862871408462524,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Flibanserin.,49,Type_49,No
DB00487,Pefloxacin,DB00663,Flumethasone,0.9377701282501221,49,Type_49,The risk or severity of adverse effects can be increased when Pefloxacin is combined with Flumethasone.,49,Type_49,Yes
DB01137,Levofloxacin,DB09288,Propacetamol,0.9673473834991455,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Propacetamol.,27,Type_27,Yes
DB06203,Alogliptin,DB08873,Boceprevir,0.5163988471031189,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Alogliptin.,75,Type_75,No
DB00278,Argatroban,DB01151,Desipramine,0.759828507900238,73,Type_73,The serum concentration of Desipramine can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00381,Amlodipine,DB06712,Nilvadipine,0.6298148036003113,60,Type_60,Amlodipine may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00797,Tolazoline,DB01118,Amiodarone,0.5591711401939392,60,Type_60,Tolazoline may increase the hypotensive activities of Amiodarone.,49,Type_49,No
DB00205,Pyrimethamine,DB00455,Loratadine,0.8942920565605164,47,Type_47,The metabolism of Loratadine can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB01232,Saquinavir,DB11737,Icotinib,0.892217755317688,47,Type_47,The metabolism of Icotinib can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00402,Eszopiclone,DB00909,Zonisamide,0.998637855052948,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zonisamide.,49,Type_49,Yes
DB00694,Daunorubicin,DB09074,Olaparib,0.9635886549949646,47,Type_47,The metabolism of Olaparib can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB00737,Meclizine,DB09117,Paraldehyde,0.9998486042022705,16,Type_16,Meclizine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00451,Levothyroxine,DB09146,Iron sucrose,0.7623130679130554,75,Type_75,The serum concentration of Iron sucrose can be decreased when it is combined with Levothyroxine.,75,Type_75,Yes
DB00769,Hydrocortamate,DB01238,Aripiprazole,0.9479981660842896,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Hydrocortamate.,75,Type_75,Yes
DB00390,Digoxin,DB00794,Primidone,0.809650719165802,4,Type_4,The metabolism of Primidone can be increased when combined with Digoxin.,4,Type_4,Yes
DB00398,Sorafenib,DB00818,Propofol,0.6254115700721741,47,Type_47,The metabolism of Propofol can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB00206,Reserpine,DB01356,Lithium cation,0.656723141670227,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Lithium cation.,35,Type_35,No
DB00545,Pyridostigmine,DB08864,Rilpivirine,0.8265233039855957,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Pyridostigmine.,75,Type_75,No
DB00681,Amphotericin B,DB01159,Halothane,0.9994731545448303,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Halothane.,49,Type_49,Yes
DB00962,Zaleplon,DB09117,Paraldehyde,0.999993085861206,16,Type_16,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB06636,Isavuconazonium,DB08922,Perospirone,0.5915846824645996,47,Type_47,The metabolism of Perospirone can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00546,Adinazolam,DB09120,Zucapsaicin,0.9982056617736816,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00519,Trandolapril,DB00735,Naftifine,0.966230571269989,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Naftifine.,49,Type_49,Yes
DB00722,Lisinopril,DB01054,Nitrendipine,0.7007824182510376,60,Type_60,Lisinopril may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB00227,Lovastatin,DB06636,Isavuconazonium,0.6276926398277283,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00862,Vardenafil,DB01232,Saquinavir,0.5030153393745422,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Vardenafil.,73,Type_73,Yes
DB00207,Azithromycin,DB00296,Ropivacaine,0.8040800094604492,47,Type_47,The metabolism of Ropivacaine can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00503,Ritonavir,DB00834,Mifepristone,0.5352750420570374,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Ritonavir.,20,Type_20,No
DB00474,Methohexital,DB00967,Desloratadine,0.998618483543396,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Desloratadine.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB01233,Metoclopramide,0.9928032755851746,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Metoclopramide.,49,Type_49,Yes
DB00752,Tranylcypromine,DB00880,Chlorothiazide,0.5782256722450256,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Chlorothiazide.,60,Type_60,No
DB01351,Amobarbital,DB01551,Dihydrocodeine,0.9945770502090454,49,Type_49,The risk or severity of adverse effects can be increased when Amobarbital is combined with Dihydrocodeine.,49,Type_49,Yes
DB01621,Pipotiazine,DB09117,Paraldehyde,0.9924558401107788,16,Type_16,Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00615,Rifabutin,DB11581,Venetoclax,0.6302048563957214,4,Type_4,The metabolism of Venetoclax can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00628,Clorazepic acid,DB00656,Trazodone,0.9925290942192078,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Trazodone.,49,Type_49,Yes
DB00446,Chloramphenicol,DB00571,Propranolol,0.9731864333152771,47,Type_47,The metabolism of Propranolol can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00753,Isoflurane,DB00755,Tretinoin,0.8863064050674438,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Tretinoin.,49,Type_49,Yes
DB00455,Loratadine,DB00906,Tiagabine,0.9838055372238159,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Tiagabine.,49,Type_49,Yes
DB00898,Ethanol,DB00921,Buprenorphine,0.9999984502792358,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00647,Dextropropoxyphene,DB00747,Scopolamine,0.9994227886199951,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Scopolamine.,49,Type_49,Yes
DB00218,Moxifloxacin,DB05039,Indacaterol,0.9998804330825806,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00834,Mifepristone,DB09065,Cobicistat,0.9851605892181396,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00419,Miglustat,DB00877,Sirolimus,0.9889983534812927,70,Type_70,The therapeutic efficacy of Sirolimus can be decreased when used in combination with Miglustat.,70,Type_70,Yes
DB01254,Dasatinib,DB01377,Magnesium oxide,0.898023784160614,67,Type_67,Dasatinib can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00802,Alfentanil,DB01614,Acepromazine,0.9975221753120422,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Acepromazine.,49,Type_49,Yes
DB00953,Rizatriptan,DB04896,Milnacipran,0.8732152581214905,49,Type_49,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Milnacipran.,49,Type_49,Yes
DB01122,Ambenonium,DB01222,Budesonide,0.9996709823608398,49,Type_49,The risk or severity of adverse effects can be increased when Ambenonium is combined with Budesonide.,49,Type_49,Yes
DB01030,Topotecan,DB12332,Rucaparib,0.9320482015609741,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB01624,Zuclopenthixol,DB08899,Enzalutamide,0.933306872844696,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Zuclopenthixol.,75,Type_75,Yes
DB08867,Ulipristal,DB09120,Zucapsaicin,0.9864525198936462,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Ulipristal.,47,Type_47,Yes
DB00753,Isoflurane,DB01580,Oxprenolol,0.9693803191184998,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxprenolol.,49,Type_49,Yes
DB05812,Abiraterone,DB06697,Artemether,0.5701484084129333,73,Type_73,The serum concentration of Artemether can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00325,Nitroprusside,DB00528,Lercanidipine,0.8383124470710754,60,Type_60,Nitroprusside may increase the hypotensive activities of Lercanidipine.,60,Type_60,Yes
DB00332,Ipratropium,DB06738,Ketobemidone,0.997733473777771,49,Type_49,The risk or severity of adverse effects can be increased when Ipratropium is combined with Ketobemidone.,49,Type_49,Yes
DB06212,Tolvaptan,DB08909,Glycerol phenylbutyrate,0.8374385833740234,73,Type_73,The serum concentration of Glycerol phenylbutyrate can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB01043,Memantine,DB09275,Bismuth subcitrate potassium,0.4778922498226166,73,Type_73,The serum concentration of Bismuth subcitrate potassium can be increased when it is combined with Memantine.,73,Type_73,Yes
DB00176,Fluvoxamine,DB04839,Cyproterone acetate,0.6017647981643677,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Fluvoxamine.,75,Type_75,Yes
DB00230,Pregabalin,DB00734,Risperidone,0.9945725798606873,8,Type_8,The therapeutic efficacy of Risperidone can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00661,Verapamil,DB09026,Aliskiren,0.4498468339443207,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Verapamil.,73,Type_73,No
DB01024,Mycophenolic acid,DB01197,Captopril,0.7049755454063416,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Captopril.,49,Type_49,Yes
DB00726,Trimipramine,DB01192,Oxymorphone,0.9329065680503845,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Oxymorphone.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB01240,Epoprostenol,0.536808431148529,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Epoprostenol.,49,Type_49,Yes
DB00682,Warfarin,DB09320,Procaine benzylpenicillin,0.9057359099388123,6,Type_6,Warfarin may increase the anticoagulant activities of Procaine benzylpenicillin.,6,Type_6,Yes
DB01069,Promethazine,DB01544,Flunitrazepam,0.9649919867515564,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Flunitrazepam.,49,Type_49,Yes
DB00425,Zolpidem,DB00933,Mesoridazine,0.9977807402610779,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.,16,Type_16,Yes
DB01609,Deferasirox,DB11828,Neratinib,0.9095802903175354,75,Type_75,The serum concentration of Neratinib can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB01059,Norfloxacin,DB08906,Fluticasone furoate,0.8461460471153259,49,Type_49,The risk or severity of adverse effects can be increased when Norfloxacin is combined with Fluticasone furoate.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00814,Meloxicam,0.9636143445968628,70,Type_70,The therapeutic efficacy of Meloxicam can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00946,Phenprocoumon,DB13167,Alclofenac,0.9997881054878235,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Alclofenac.,6,Type_6,Yes
DB00610,Metaraminol,DB00780,Phenelzine,0.9954577684402466,71,Type_71,Metaraminol may increase the hypertensive activities of Phenelzine.,71,Type_71,Yes
DB00398,Sorafenib,DB09288,Propacetamol,0.5989194512367249,47,Type_47,The metabolism of Propacetamol can be decreased when combined with Sorafenib.,80,Type_80,No
DB00246,Ziprasidone,DB09224,Melperone,0.9617902040481567,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Melperone.,49,Type_49,Yes
DB00333,Methadone,DB00366,Doxylamine,0.9999996423721313,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB00270,Isradipine,DB00880,Chlorothiazide,0.9522342681884766,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Chlorothiazide.,49,Type_49,Yes
DB00900,Didanosine,DB01004,Ganciclovir,0.8555915355682373,49,Type_49,The risk or severity of adverse effects can be increased when Didanosine is combined with Ganciclovir.,49,Type_49,Yes
DB00425,Zolpidem,DB01002,Levobupivacaine,0.9934225678443909,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,16,Type_16,Yes
DB00911,Tinidazole,DB05521,Telaprevir,0.9156686663627625,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Tinidazole.,47,Type_47,Yes
DB00180,Flunisolide,DB00788,Naproxen,0.9982746839523315,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Naproxen.,49,Type_49,Yes
DB00987,Cytarabine,DB01248,Docetaxel,0.969907283782959,49,Type_49,The risk or severity of adverse effects can be increased when Cytarabine is combined with Docetaxel.,49,Type_49,Yes
DB00206,Reserpine,DB00297,Bupivacaine,0.8834505081176758,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Bupivacaine.,49,Type_49,Yes
DB00755,Tretinoin,DB01235,Levodopa,0.918655514717102,30,Type_30,Tretinoin may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00794,Primidone,DB03756,Doconexent,0.9902188181877136,4,Type_4,The metabolism of Doconexent can be increased when combined with Primidone.,4,Type_4,Yes
DB00334,Olanzapine,DB09085,Tetracaine,0.9999059438705444,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Tetracaine.,49,Type_49,Yes
DB00335,Atenolol,DB09282,Molsidomine,1.0,60,Type_60,Atenolol may increase the hypotensive activities of Molsidomine.,60,Type_60,Yes
DB01026,Ketoconazole,DB09049,Naloxegol,0.9997896552085876,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB01001,Salbutamol,DB06589,Pazopanib,0.9476430416107178,20,Type_20,Salbutamol may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB00475,Chlordiazepoxide,DB01563,Chloral hydrate,0.9999860525131226,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Chloral hydrate.,49,Type_49,Yes
DB00245,Benzatropine,DB00340,Metixene,0.9984351992607117,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Metixene.,49,Type_49,Yes
DB01366,Procaterol,DB04861,Nebivolol,0.9926873445510864,14,Type_14,Procaterol may decrease the bronchodilatory activities of Nebivolol.,14,Type_14,Yes
DB01130,Prednicarbate,DB09288,Propacetamol,0.9992353916168213,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Propacetamol.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB01367,Rasagiline,0.9127662777900696,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Rasagiline.,49,Type_49,Yes
DB00673,Aprepitant,DB08912,Dabrafenib,0.9489843845367432,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Aprepitant.,75,Type_75,Yes
DB01050,Ibuprofen,DB01349,Tasosartan,0.580285370349884,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Ibuprofen.,49,Type_49,No
DB00392,Profenamine,DB01081,Diphenoxylate,0.9999779462814331,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Diphenoxylate.,49,Type_49,Yes
DB00169,Cholecalciferol,DB04871,Lorcaserin,0.9862149357795715,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB06282,Levocetirizine,DB09117,Paraldehyde,0.9979487061500549,16,Type_16,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00224,Indinavir,DB00374,Treprostinil,0.6605467796325684,47,Type_47,The metabolism of Treprostinil can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00191,Phentermine,DB06764,Tetryzoline,0.9999157190322876,49,Type_49,The risk or severity of adverse effects can be increased when Phentermine is combined with Tetryzoline.,49,Type_49,Yes
DB00245,Benzatropine,DB09272,Eluxadoline,0.9997071623802185,39,Type_39,Benzatropine may increase the constipating activities of Eluxadoline.,39,Type_39,Yes
DB00877,Sirolimus,DB01229,Paclitaxel,0.5919421911239624,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Paclitaxel.,49,Type_49,Yes
DB00936,Salicylic acid,DB01088,Iloprost,0.916157066822052,70,Type_70,The therapeutic efficacy of Iloprost can be decreased when used in combination with Salicylic acid.,49,Type_49,No
DB00255,Diethylstilbestrol,DB01154,Thiamylal,0.743929922580719,70,Type_70,The therapeutic efficacy of Thiamylal can be decreased when used in combination with Diethylstilbestrol.,70,Type_70,Yes
DB00834,Mifepristone,DB01201,Rifapentine,0.6980938911437988,4,Type_4,The metabolism of Rifapentine can be increased when combined with Mifepristone.,75,Type_75,No
DB00344,Protriptyline,DB01501,Difenoxin,0.9996671676635742,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Difenoxin.,49,Type_49,Yes
DB00338,Omeprazole,DB05246,Methsuximide,0.7525412440299988,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB01120,Gliclazide,DB04861,Nebivolol,0.9486523270606995,9,Type_9,Gliclazide may increase the hypoglycemic activities of Nebivolol.,9,Type_9,Yes
DB00557,Hydroxyzine,DB01178,Chlormezanone,0.9977559447288513,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.,16,Type_16,Yes
DB00188,Bortezomib,DB00196,Fluconazole,0.34707239270210266,47,Type_47,The metabolism of Fluconazole can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00313,Valproic acid,DB00818,Propofol,0.6435617804527283,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Propofol.,49,Type_49,Yes
DB01232,Saquinavir,DB06209,Prasugrel,0.5970332026481628,11,Type_11,The serum concentration of the active metabolites of Prasugrel can be reduced when Prasugrel is used in combination with Saquinavir resulting in a loss in efficacy.,11,Type_11,Yes
DB00564,Carbamazepine,DB06695,Dabigatran etexilate,0.7373313307762146,4,Type_4,The metabolism of Dabigatran etexilate can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00842,Oxazepam,DB01154,Thiamylal,0.9653996825218201,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Thiamylal.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB01115,Nifedipine,0.9497441053390503,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Nifedipine.,49,Type_49,Yes
DB00594,Amiloride,DB00681,Amphotericin B,0.9924497604370117,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Amphotericin B.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB09093,Chlortetracycline,0.9999996423721313,21,Type_21,Gallamine triethiodide may increase the neuromuscular blocking activities of Chlortetracycline.,21,Type_21,Yes
DB00682,Warfarin,DB00860,Prednisolone,0.7015063166618347,6,Type_6,Warfarin may increase the anticoagulant activities of Prednisolone.,6,Type_6,Yes
DB01159,Halothane,DB01282,Carbetocin,0.9973269701004028,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Carbetocin.,49,Type_49,Yes
DB01067,Glipizide,DB06825,Triptorelin,0.9996217489242554,70,Type_70,The therapeutic efficacy of Triptorelin can be decreased when used in combination with Glipizide.,70,Type_70,Yes
DB01120,Gliclazide,DB01264,Darunavir,0.5879907608032227,47,Type_47,The metabolism of Darunavir can be decreased when combined with Gliclazide.,70,Type_70,No
DB00754,Ethotoin,DB00835,Brompheniramine,0.9945060610771179,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Brompheniramine.,49,Type_49,Yes
DB00270,Isradipine,DB01193,Acebutolol,0.48871538043022156,47,Type_47,The metabolism of Acebutolol can be decreased when combined with Isradipine.,49,Type_49,No
DB00169,Cholecalciferol,DB06016,Cariprazine,0.8122381567955017,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00619,Imatinib,DB00724,Imiquimod,0.9270731210708618,47,Type_47,The metabolism of Imiquimod can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00555,Lamotrigine,DB00977,Ethinylestradiol,0.6218910217285156,70,Type_70,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Lamotrigine.,75,Type_75,No
DB00316,Acetaminophen,DB00752,Tranylcypromine,0.9302167296409607,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Acetaminophen.,47,Type_47,Yes
DB00287,Travoprost,DB00795,Sulfasalazine,0.7171674966812134,70,Type_70,The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB00830,Phenmetrazine,DB00935,Oxymetazoline,0.9823687672615051,49,Type_49,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Oxymetazoline.,49,Type_49,Yes
DB08873,Boceprevir,DB09048,Netupitant,0.9618091583251953,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Boceprevir.,73,Type_73,Yes
DB01136,Carvedilol,DB01170,Guanethidine,0.9997379183769226,60,Type_60,Carvedilol may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB01214,Metipranolol,DB09232,Cilnidipine,0.7999371290206909,49,Type_49,The risk or severity of adverse effects can be increased when Metipranolol is combined with Cilnidipine.,49,Type_49,Yes
DB04871,Lorcaserin,DB05109,Trabectedin,0.8990646600723267,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Lorcaserin.,47,Type_47,Yes
DB00418,Secobarbital,DB01466,Ethylmorphine,0.901964008808136,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Ethylmorphine.,49,Type_49,Yes
DB00967,Desloratadine,DB09071,Tasimelteon,0.9932439923286438,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Tasimelteon.,49,Type_49,Yes
DB00214,Torasemide,DB00457,Prazosin,0.9839252233505249,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Prazosin.,49,Type_49,Yes
DB00797,Tolazoline,DB04920,Clevidipine,0.8785824179649353,49,Type_49,The risk or severity of adverse effects can be increased when Tolazoline is combined with Clevidipine.,49,Type_49,Yes
DB00951,Isoniazid,DB06684,Vilazodone,0.7230185866355896,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB01097,Leflunomide,DB01397,Magnesium salicylate,0.9673835039138794,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Magnesium salicylate.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01220,Rifaximin,0.42700251936912537,47,Type_47,The metabolism of Rifaximin can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB00248,Cabergoline,DB00492,Fosinopril,0.5404167771339417,73,Type_73,The serum concentration of Fosinopril can be increased when it is combined with Cabergoline.,73,Type_73,Yes
DB00726,Trimipramine,DB01142,Doxepin,0.8772410750389099,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Doxepin.,49,Type_49,Yes
DB00091,Cyclosporine,DB01172,Kanamycin,0.9873955845832825,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Kanamycin.,57,Type_57,Yes
DB00246,Ziprasidone,DB00346,Alfuzosin,0.7692665457725525,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Alfuzosin.,20,Type_20,Yes
DB00705,Delavirdine,DB00980,Ramelteon,0.9207260608673096,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Delavirdine.,73,Type_73,No
DB00227,Lovastatin,DB11586,Asunaprevir,0.530216634273529,47,Type_47,The metabolism of Asunaprevir can be decreased when combined with Lovastatin.,73,Type_73,No
DB00959,Methylprednisolone,DB01319,Fosamprenavir,0.7002306580543518,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Methylprednisolone.,47,Type_47,Yes
DB00921,Buprenorphine,DB09054,Idelalisib,0.7663587331771851,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Buprenorphine.,47,Type_47,Yes
DB00178,Ramipril,DB06212,Tolvaptan,0.9671785831451416,68,Type_68,Ramipril may increase the hyperkalemic activities of Tolvaptan.,68,Type_68,Yes
DB00575,Clonidine,DB09330,Osimertinib,0.9247134923934937,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Clonidine.,73,Type_73,Yes
DB00747,Scopolamine,DB01068,Clonazepam,0.9888156652450562,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Clonazepam.,49,Type_49,Yes
DB00176,Fluvoxamine,DB09000,Cyamemazine,0.8985661864280701,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Cyamemazine.,49,Type_49,Yes
DB00264,Metoprolol,DB06736,Aceclofenac,0.9956597685813904,37,Type_37,Metoprolol may decrease the antihypertensive activities of Aceclofenac.,37,Type_37,Yes
DB05246,Methsuximide,DB09068,Vortioxetine,0.9999120235443115,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Vortioxetine.,49,Type_49,Yes
DB00529,Foscarnet,DB01195,Flecainide,0.9918219447135925,20,Type_20,Foscarnet may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00203,Sildenafil,DB11560,Lesinurad,0.9394939541816711,47,Type_47,The metabolism of Lesinurad can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00502,Haloperidol,DB05521,Telaprevir,0.7845811247825623,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00850,Perphenazine,DB01577,Metamfetamine,0.7209773659706116,61,Type_61,Perphenazine may decrease the stimulatory activities of Metamfetamine.,61,Type_61,Yes
DB00224,Indinavir,DB00741,Hydrocortisone,0.889247715473175,47,Type_47,The metabolism of Hydrocortisone can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00682,Warfarin,DB01050,Ibuprofen,0.9993913173675537,6,Type_6,Warfarin may increase the anticoagulant activities of Ibuprofen.,6,Type_6,Yes
DB00695,Furosemide,DB00945,Acetylsalicylic acid,0.9999960660934448,29,Type_29,Furosemide may decrease the diuretic activities of Acetylsalicylic acid.,29,Type_29,Yes
DB00178,Ramipril,DB00968,Methyldopa,0.8497092127799988,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Methyldopa.,49,Type_49,Yes
DB01017,Minocycline,DB01551,Dihydrocodeine,0.9495304822921753,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.,16,Type_16,Yes
DB00829,Diazepam,DB00872,Conivaptan,0.6893457770347595,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Diazepam.,73,Type_73,Yes
DB09038,Empagliflozin,DB09279,Fimasartan,0.9992607235908508,49,Type_49,The risk or severity of adverse effects can be increased when Empagliflozin is combined with Fimasartan.,49,Type_49,Yes
DB01588,Prazepam,DB04844,Tetrabenazine,0.9963145852088928,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Tetrabenazine.,49,Type_49,Yes
DB00586,Diclofenac,DB09212,Loxoprofen,0.9937745332717896,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Loxoprofen.,49,Type_49,Yes
DB00091,Cyclosporine,DB00224,Indinavir,0.9205880165100098,47,Type_47,The metabolism of Indinavir can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00599,Thiopental,DB09292,Sacubitril,0.9302631616592407,60,Type_60,Thiopental may increase the hypotensive activities of Sacubitril.,60,Type_60,Yes
DB01180,Rescinnamine,DB09218,Clonixin,0.9857696294784546,49,Type_49,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Clonixin.,49,Type_49,Yes
DB01189,Desflurane,DB06738,Ketobemidone,0.969581663608551,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Ketobemidone.,49,Type_49,Yes
DB00735,Naftifine,DB01201,Rifapentine,0.5584300756454468,4,Type_4,The metabolism of Rifapentine can be increased when combined with Naftifine.,73,Type_73,No
DB00615,Rifabutin,DB01058,Praziquantel,0.3701780140399933,75,Type_75,The serum concentration of Praziquantel can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00999,Hydrochlorothiazide,DB01236,Sevoflurane,0.8740144371986389,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Sevoflurane.,49,Type_49,Yes
DB00208,Ticlopidine,DB08932,Macitentan,0.993063747882843,47,Type_47,The metabolism of Macitentan can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00393,Nimodipine,DB01157,Trimetrexate,0.9708976149559021,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Trimetrexate.,49,Type_49,Yes
DB01238,Aripiprazole,DB01365,Mephentermine,0.9917935729026794,61,Type_61,Aripiprazole may decrease the stimulatory activities of Mephentermine.,61,Type_61,Yes
DB01466,Ethylmorphine,DB06690,Nitrous oxide,0.9985451698303223,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Nitrous oxide.,49,Type_49,Yes
DB00501,Cimetidine,DB01466,Ethylmorphine,0.9648247361183167,47,Type_47,The metabolism of Ethylmorphine can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00455,Loratadine,DB04855,Dronedarone,0.7935134768486023,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Loratadine.,47,Type_47,Yes
DB00196,Fluconazole,DB01628,Etoricoxib,0.9634804725646973,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00768,Olopatadine,DB01401,Choline magnesium trisalicylate,0.9995699524879456,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00312,Pentobarbital,DB01612,Amyl Nitrite,0.8152607679367065,60,Type_60,Pentobarbital may increase the hypotensive activities of Amyl Nitrite.,60,Type_60,Yes
DB01431,Allylestrenol,DB12598,Nafamostat,0.4719640016555786,70,Type_70,The therapeutic efficacy of Nafamostat can be decreased when used in combination with Allylestrenol.,70,Type_70,Yes
DB00648,Mitotane,DB08864,Rilpivirine,0.9990401864051819,75,Type_75,The serum concentration of Rilpivirine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00246,Ziprasidone,DB08899,Enzalutamide,0.9490317106246948,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Ziprasidone.,75,Type_75,Yes
DB00656,Trazodone,DB09280,Lumacaftor,0.562483012676239,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Trazodone.,4,Type_4,No
DB00774,Hydroflumethiazide,DB01014,Balsalazide,0.9911515116691589,70,Type_70,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00741,Hydrocortisone,DB09543,Methyl salicylate,0.997723400592804,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Methyl salicylate.,49,Type_49,Yes
DB00818,Propofol,DB01193,Acebutolol,0.3647673428058624,47,Type_47,The metabolism of Acebutolol can be decreased when combined with Propofol.,49,Type_49,No
DB00571,Propranolol,DB01113,Papaverine,0.9998526573181152,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Papaverine.,49,Type_49,Yes
DB00313,Valproic acid,DB01440,gamma-Hydroxybutyric acid,0.9872261881828308,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00555,Lamotrigine,DB01081,Diphenoxylate,0.9918328523635864,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Diphenoxylate.,49,Type_49,Yes
DB00584,Enalapril,DB01029,Irbesartan,0.7055795192718506,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Irbesartan.,49,Type_49,Yes
DB00498,Phenindione,DB00775,Tirofiban,0.997735857963562,6,Type_6,Phenindione may increase the anticoagulant activities of Tirofiban.,6,Type_6,Yes
DB00205,Pyrimethamine,DB00731,Nateglinide,0.9783092141151428,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00295,Morphine,DB00997,Doxorubicin,0.7645033597946167,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Morphine.,73,Type_73,No
DB00819,Acetazolamide,DB00945,Acetylsalicylic acid,0.5658479928970337,49,Type_49,The risk or severity of adverse effects can be increased when Acetazolamide is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB00678,Losartan,DB01609,Deferasirox,0.8441203236579895,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Losartan.,75,Type_75,Yes
DB06636,Isavuconazonium,DB11613,Velpatasvir,0.809651792049408,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Isavuconazonium.,47,Type_47,Yes
DB00924,Cyclobenzaprine,DB09224,Melperone,0.9959307312965393,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Melperone.,49,Type_49,Yes
DB00445,Epirubicin,DB06802,Nepafenac,0.9986100196838379,72,Type_72,Epirubicin may decrease the excretion rate of Nepafenac which could result in a higher serum level.,72,Type_72,Yes
DB00247,Methysergide,DB00647,Dextropropoxyphene,0.9979185461997986,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Dextropropoxyphene.,49,Type_49,Yes
DB08865,Crizotinib,DB09083,Ivabradine,0.5724040865898132,20,Type_20,Crizotinib may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB01008,Busulfan,DB01248,Docetaxel,0.9808500409126282,49,Type_49,The risk or severity of adverse effects can be increased when Busulfan is combined with Docetaxel.,49,Type_49,Yes
DB00224,Indinavir,DB00696,Ergotamine,0.7331246137619019,47,Type_47,The metabolism of Ergotamine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00177,Valsartan,DB00373,Timolol,0.6001927852630615,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Timolol.,49,Type_49,Yes
DB00549,Zafirlukast,DB00589,Lisuride,0.4367501139640808,47,Type_47,The metabolism of Lisuride can be decreased when combined with Zafirlukast.,49,Type_49,No
DB00182,Amphetamine,DB06764,Tetryzoline,0.6962516903877258,71,Type_71,Amphetamine may increase the hypertensive activities of Tetryzoline.,71,Type_71,Yes
DB01120,Gliclazide,DB06413,Armodafinil,0.9497470855712891,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Gliclazide.,47,Type_47,Yes
DB00448,Lansoprazole,DB01576,Dextroamphetamine,0.7133505940437317,47,Type_47,The metabolism of Dextroamphetamine can be decreased when combined with Lansoprazole.,18,Type_18,No
DB00877,Sirolimus,DB08992,Eperisone,0.967345118522644,49,Type_49,The risk or severity of adverse effects can be increased when Sirolimus is combined with Eperisone.,49,Type_49,Yes
DB00427,Triprolidine,DB01501,Difenoxin,0.9999902248382568,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Difenoxin.,49,Type_49,Yes
DB00257,Clotrimazole,DB09270,Ubidecarenone,0.8896772265434265,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Clotrimazole.,73,Type_73,Yes
DB00866,Alprenolol,DB04855,Dronedarone,0.9041821956634521,54,Type_54,Alprenolol may increase the bradycardic activities of Dronedarone.,54,Type_54,Yes
DB00647,Dextropropoxyphene,DB01068,Clonazepam,0.9940295219421387,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Clonazepam.,49,Type_49,Yes
DB00752,Tranylcypromine,DB08881,Vemurafenib,0.7175874710083008,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Tranylcypromine.,33,Type_33,No
DB00264,Metoprolol,DB01118,Amiodarone,0.4447389841079712,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Metoprolol.,73,Type_73,No
DB00726,Trimipramine,DB01407,Clenbuterol,0.8629001379013062,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Clenbuterol.,49,Type_49,Yes
DB08873,Boceprevir,DB09227,Barnidipine,0.38232263922691345,47,Type_47,The metabolism of Barnidipine can be decreased when combined with Boceprevir.,73,Type_73,No
DB00476,Duloxetine,DB01028,Methoxyflurane,0.8513248562812805,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Methoxyflurane.,47,Type_47,No
DB00304,Desogestrel,DB01072,Atazanavir,0.8911935687065125,75,Type_75,The serum concentration of Atazanavir can be decreased when it is combined with Desogestrel.,73,Type_73,No
DB00555,Lamotrigine,DB08958,Hexetidine,0.9897659420967102,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Hexetidine.,49,Type_49,Yes
DB01087,Primaquine,DB01396,Digitoxin,0.348667711019516,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Primaquine.,73,Type_73,Yes
DB00443,Betamethasone,DB00688,Mycophenolate mofetil,0.9996172189712524,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00371,Meprobamate,DB01595,Nitrazepam,0.9914745092391968,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Nitrazepam.,49,Type_49,Yes
DB00289,Atomoxetine,DB01071,Mequitazine,0.9223538637161255,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00421,Spironolactone,DB00594,Amiloride,0.4764649271965027,68,Type_68,Spironolactone may increase the hyperkalemic activities of Amiloride.,68,Type_68,Yes
DB00774,Hydroflumethiazide,DB00816,Orciprenaline,0.9999082088470459,83,Type_83,Hydroflumethiazide may increase the hypokalemic activities of Orciprenaline.,83,Type_83,Yes
DB00196,Fluconazole,DB00426,Famciclovir,0.9582735896110535,47,Type_47,The metabolism of Famciclovir can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00474,Methohexital,DB00972,Azelastine,0.6767867207527161,16,Type_16,Methohexital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00743,Gadobenic acid,DB01072,Atazanavir,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Atazanavir.,20,Type_20,Yes
DB00524,Metolazone,DB11126,Calcium gluconate,0.9843431711196899,72,Type_72,Metolazone may decrease the excretion rate of Calcium gluconate which could result in a higher serum level.,72,Type_72,Yes
DB00220,Nelfinavir,DB00625,Efavirenz,0.41233938932418823,73,Type_73,The serum concentration of Efavirenz can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00584,Enalapril,DB01014,Balsalazide,0.542552649974823,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Balsalazide.,49,Type_49,Yes
DB00255,Diethylstilbestrol,DB09280,Lumacaftor,0.9540978670120239,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB00254,Doxycycline,DB00502,Haloperidol,0.891490638256073,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00434,Cyproheptadine,DB01367,Rasagiline,0.7974865436553955,2,Type_2,Cyproheptadine may increase the anticholinergic activities of Rasagiline.,2,Type_2,Yes
DB00880,Chlorothiazide,DB13167,Alclofenac,0.9944960474967957,70,Type_70,The therapeutic efficacy of Alclofenac can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00512,Vancomycin,DB00684,Tobramycin,0.9989849925041199,57,Type_57,Vancomycin may increase the nephrotoxic activities of Tobramycin.,57,Type_57,Yes
DB00584,Enalapril,DB01030,Topotecan,0.9787856340408325,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Enalapril.,73,Type_73,Yes
DB00842,Oxazepam,DB09048,Netupitant,0.9374436140060425,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Oxazepam.,73,Type_73,Yes
DB00611,Butorphanol,DB00908,Quinidine,0.5579748153686523,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Quinidine.,49,Type_49,Yes
DB01238,Aripiprazole,DB09292,Sacubitril,0.9955670237541199,60,Type_60,Aripiprazole may increase the hypotensive activities of Sacubitril.,60,Type_60,Yes
DB00228,Enflurane,DB00690,Flurazepam,0.9955748319625854,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Flurazepam.,49,Type_49,Yes
DB00590,Doxazosin,DB01612,Amyl Nitrite,0.982731282711029,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Amyl Nitrite.,49,Type_49,Yes
DB00605,Sulindac,DB00779,Nalidixic acid,0.9997026324272156,27,Type_27,Sulindac may increase the neuroexcitatory activities of Nalidixic acid.,27,Type_27,Yes
DB00932,Tipranavir,DB01156,Bupropion,0.8536551594734192,47,Type_47,The metabolism of Bupropion can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00412,Rosiglitazone,DB06605,Apixaban,0.36815112829208374,6,Type_6,Rosiglitazone may increase the anticoagulant activities of Apixaban.,6,Type_6,Yes
DB00734,Risperidone,DB11609,Normethadone,0.9918351173400879,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Normethadone.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00404,Alprazolam,0.9871731996536255,47,Type_47,The metabolism of Alprazolam can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00444,Teniposide,DB05812,Abiraterone,0.8177326917648315,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Teniposide.,47,Type_47,No
DB00564,Carbamazepine,DB00586,Diclofenac,0.9712167382240295,4,Type_4,The metabolism of Diclofenac can be increased when combined with Carbamazepine.,75,Type_75,No
DB00364,Sucralfate,DB01188,Ciclopirox,0.9924407005310059,67,Type_67,Sucralfate can cause a decrease in the absorption of Ciclopirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01071,Mequitazine,DB01151,Desipramine,0.7758236527442932,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Desipramine.,47,Type_47,No
DB06738,Ketobemidone,DB09125,Potassium citrate,0.9991342425346375,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Potassium citrate.,49,Type_49,Yes
DB01100,Pimozide,DB08916,Afatinib,0.7246920466423035,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Pimozide.,73,Type_73,Yes
DB00715,Paroxetine,DB01233,Metoclopramide,0.4463505744934082,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Metoclopramide.,49,Type_49,Yes
DB00884,Risedronic acid,DB06739,Seratrodast,0.9164604544639587,49,Type_49,The risk or severity of adverse effects can be increased when Risedronic acid is combined with Seratrodast.,49,Type_49,Yes
DB00818,Propofol,DB01612,Amyl Nitrite,0.9804784655570984,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Amyl Nitrite.,49,Type_49,Yes
DB00608,Chloroquine,DB01046,Lubiprostone,0.9999994039535522,70,Type_70,The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Chloroquine.,70,Type_70,Yes
DB00220,Nelfinavir,DB00699,Nicergoline,0.869648814201355,47,Type_47,The metabolism of Nicergoline can be decreased when combined with Nelfinavir.,49,Type_49,No
DB00395,Carisoprodol,DB01356,Lithium cation,0.9632882475852966,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Lithium cation.,49,Type_49,Yes
DB00524,Metolazone,DB00715,Paroxetine,0.985564649105072,55,Type_55,Metolazone may increase the hyponatremic activities of Paroxetine.,55,Type_55,Yes
DB00622,Nicardipine,DB09063,Ceritinib,0.9661426544189453,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Nicardipine.,73,Type_73,Yes
DB00677,Isoflurophate,DB01223,Aminophylline,0.7843997478485107,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Isoflurophate.,75,Type_75,Yes
DB00790,Perindopril,DB01340,Cilazapril,0.8014336228370667,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Cilazapril.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01036,Tolterodine,0.8062811493873596,47,Type_47,The metabolism of Tolterodine can be decreased when combined with Tranylcypromine.,47,Type_47,Yes
DB01075,Diphenhydramine,DB09280,Lumacaftor,0.6213067173957825,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Diphenhydramine.,75,Type_75,Yes
DB00682,Warfarin,DB09074,Olaparib,0.7947733998298645,47,Type_47,The metabolism of Olaparib can be decreased when combined with Warfarin.,47,Type_47,Yes
DB00678,Losartan,DB00727,Nitroglycerin,0.9989734888076782,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Nitroglycerin.,49,Type_49,Yes
DB00292,Etomidate,DB01551,Dihydrocodeine,0.9975919723510742,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Dihydrocodeine.,49,Type_49,Yes
DB01320,Fosphenytoin,DB09166,Etizolam,0.7485339641571045,4,Type_4,The metabolism of Etizolam can be increased when combined with Fosphenytoin.,73,Type_73,No
DB01127,Econazole,DB06712,Nilvadipine,0.9966884255409241,49,Type_49,The risk or severity of adverse effects can be increased when Econazole is combined with Nilvadipine.,49,Type_49,Yes
DB00528,Lercanidipine,DB00999,Hydrochlorothiazide,0.6177388429641724,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Hydrochlorothiazide.,60,Type_60,No
DB00313,Valproic acid,DB00904,Ondansetron,0.6553979516029358,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Ondansetron.,49,Type_49,Yes
DB00663,Flumethasone,DB05039,Indacaterol,0.993029773235321,83,Type_83,Flumethasone may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00199,Erythromycin,DB01222,Budesonide,0.8461819887161255,47,Type_47,The metabolism of Budesonide can be decreased when combined with Erythromycin.,73,Type_73,No
DB00474,Methohexital,DB09128,Brexpiprazole,0.9838497638702393,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Brexpiprazole.,49,Type_49,Yes
DB00912,Repaglinide,DB08815,Lurasidone,0.9941934943199158,70,Type_70,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Repaglinide.,70,Type_70,Yes
DB01201,Rifapentine,DB01422,Nitroxoline,0.6148845553398132,75,Type_75,The serum concentration of Nitroxoline can be decreased when it is combined with Rifapentine.,73,Type_73,No
DB01067,Glipizide,DB01208,Sparfloxacin,0.9940308928489685,9,Type_9,Glipizide may increase the hypoglycemic activities of Sparfloxacin.,9,Type_9,Yes
DB00391,Sulpiride,DB01353,Butobarbital,0.9998806715011597,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Butobarbital.,49,Type_49,Yes
DB00227,Lovastatin,DB00881,Quinapril,0.5529931783676147,73,Type_73,The serum concentration of Quinapril can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00668,Epinephrine,DB01151,Desipramine,0.9133945107460022,37,Type_37,Epinephrine may decrease the antihypertensive activities of Desipramine.,37,Type_37,Yes
DB00359,Sulfadiazine,DB01124,Tolbutamide,0.5570065379142761,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Tolbutamide.,47,Type_47,No
DB00661,Verapamil,DB04898,Ximelagatran,0.8395857214927673,47,Type_47,The metabolism of Ximelagatran can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00757,Dolasetron,DB04953,Ezogabine,0.9791924953460693,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Ezogabine.,20,Type_20,Yes
DB00251,Terconazole,DB00615,Rifabutin,0.5447219014167786,73,Type_73,The serum concentration of Rifabutin can be increased when it is combined with Terconazole.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB13450,Cisatracurium besylate,0.9995669722557068,82,Type_82,Acetyldigitoxin may increase the arrhythmogenic activities of Cisatracurium besylate.,82,Type_82,Yes
DB01028,Methoxyflurane,DB09118,Stiripentol,0.7021155953407288,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Methoxyflurane.,73,Type_73,Yes
DB01032,Probenecid,DB08984,Etofenamate,0.9608021378517151,73,Type_73,The serum concentration of Etofenamate can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB05246,Methsuximide,DB09017,Brotizolam,0.9974574446678162,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Brotizolam.,49,Type_49,Yes
DB00708,Sufentanil,DB00950,Fexofenadine,0.9951760768890381,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Fexofenadine.,49,Type_49,Yes
DB00482,Celecoxib,DB09238,Manidipine,0.9809474945068359,47,Type_47,The metabolism of Manidipine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01203,Nadolol,DB09286,Pipamperone,0.8991180062294006,49,Type_49,The risk or severity of adverse effects can be increased when Nadolol is combined with Pipamperone.,49,Type_49,Yes
DB00613,Amodiaquine,DB01608,Periciazine,0.7268723845481873,73,Type_73,The serum concentration of Periciazine can be increased when it is combined with Amodiaquine.,73,Type_73,Yes
DB00975,Dipyridamole,DB09543,Methyl salicylate,0.8900196552276611,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Methyl salicylate.,49,Type_49,Yes
DB00445,Epirubicin,DB00884,Risedronic acid,0.9005879163742065,24,Type_24,Epirubicin may increase the hypocalcemic activities of Risedronic acid.,24,Type_24,Yes
DB00653,Magnesium sulfate,DB01026,Ketoconazole,0.4555767774581909,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Magnesium sulfate.,49,Type_49,No
DB00396,Progesterone,DB01418,Acenocoumarol,0.43363696336746216,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Progesterone.,70,Type_70,No
DB00647,Dextropropoxyphene,DB05271,Rotigotine,0.9910962581634521,32,Type_32,Dextropropoxyphene may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00462,Methscopolamine bromide,DB01338,Pipecuronium,0.993049144744873,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Pipecuronium.,49,Type_49,Yes
DB00196,Fluconazole,DB01232,Saquinavir,0.44778141379356384,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Fluconazole.,20,Type_20,No
DB00178,Ramipril,DB09288,Propacetamol,0.9640334248542786,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Propacetamol.,49,Type_49,Yes
DB00668,Epinephrine,DB01021,Trichlormethiazide,0.838236391544342,60,Type_60,Epinephrine may increase the hypotensive activities of Trichlormethiazide.,83,Type_83,No
DB00186,Lorazepam,DB00737,Meclizine,0.9925041198730469,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Meclizine.,49,Type_49,Yes
DB01227,Levacetylmethadol,DB01463,Fencamfamin,0.9754152297973633,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Fencamfamin.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB00844,Nalbuphine,0.9983152151107788,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Nalbuphine.,49,Type_49,Yes
DB00331,Metformin,DB01194,Brinzolamide,0.662180483341217,70,Type_70,The therapeutic efficacy of Brinzolamide can be decreased when used in combination with Metformin.,49,Type_49,No
DB05541,Brivaracetam,DB09054,Idelalisib,0.91947340965271,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Brivaracetam.,47,Type_47,Yes
DB01202,Levetiracetam,DB06716,Fospropofol,0.9793809056282043,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fospropofol.,49,Type_49,Yes
DB00304,Desogestrel,DB04876,Vildagliptin,0.8135934472084045,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Desogestrel.,70,Type_70,Yes
DB00409,Remoxipride,DB01069,Promethazine,0.9845904111862183,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Promethazine.,49,Type_49,Yes
DB00247,Methysergide,DB00668,Epinephrine,0.859782338142395,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Epinephrine.,49,Type_49,Yes
DB00596,Ulobetasol,DB09288,Propacetamol,0.9992345571517944,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Propacetamol.,49,Type_49,Yes
DB00808,Indapamide,DB09279,Fimasartan,0.9955734014511108,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Fimasartan.,49,Type_49,Yes
DB01127,Econazole,DB08881,Vemurafenib,0.5354629158973694,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Econazole.,33,Type_33,No
DB06684,Vilazodone,DB09065,Cobicistat,0.5461774468421936,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Vilazodone.,73,Type_73,Yes
DB00999,Hydrochlorothiazide,DB01348,Spirapril,0.9620935320854187,60,Type_60,Hydrochlorothiazide may increase the hypotensive activities of Spirapril.,60,Type_60,Yes
DB00476,Duloxetine,DB09017,Brotizolam,0.989300549030304,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Brotizolam.,49,Type_49,Yes
DB00470,Dronabinol,DB00935,Oxymetazoline,0.998275876045227,85,Type_85,Dronabinol may increase the tachycardic activities of Oxymetazoline.,85,Type_85,Yes
DB00374,Treprostinil,DB08887,Icosapent ethyl,0.962444007396698,53,Type_53,Treprostinil may increase the antiplatelet activities of Icosapent ethyl.,53,Type_53,Yes
DB00341,Cetirizine,DB04844,Tetrabenazine,0.999434769153595,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Tetrabenazine.,49,Type_49,Yes
DB00206,Reserpine,DB00922,Levosimendan,0.9525797963142395,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Levosimendan.,49,Type_49,Yes
DB00862,Vardenafil,DB08881,Vemurafenib,0.3779270648956299,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Vardenafil.,75,Type_75,No
DB00368,Norepinephrine,DB09167,Dosulepin,0.6840868592262268,37,Type_37,Norepinephrine may decrease the antihypertensive activities of Dosulepin.,37,Type_37,Yes
DB00370,Mirtazapine,DB01544,Flunitrazepam,0.9976465106010437,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.,16,Type_16,Yes
DB00790,Perindopril,DB00999,Hydrochlorothiazide,0.6614671945571899,60,Type_60,Perindopril may increase the hypotensive activities of Hydrochlorothiazide.,49,Type_49,No
DB00859,Penicillamine,DB09281,Magnesium trisilicate,0.8282835483551025,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Penicillamine.,75,Type_75,Yes
DB00598,Labetalol,DB01580,Oxprenolol,0.95432049036026,25,Type_25,Labetalol may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,30,Type_30,No
DB00794,Primidone,DB01551,Dihydrocodeine,0.9379149079322815,4,Type_4,The metabolism of Dihydrocodeine can be increased when combined with Primidone.,4,Type_4,Yes
DB00922,Levosimendan,DB09292,Sacubitril,0.9999910593032837,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Sacubitril.,49,Type_49,Yes
DB00497,Oxycodone,DB00999,Hydrochlorothiazide,0.9944484233856201,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01018,Guanfacine,0.9049611687660217,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Guanfacine.,49,Type_49,Yes
DB01037,Selegiline,DB01466,Ethylmorphine,0.9360499382019043,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Ethylmorphine.,49,Type_49,Yes
DB00423,Methocarbamol,DB01544,Flunitrazepam,0.9993253946304321,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Flunitrazepam.,49,Type_49,Yes
DB00295,Morphine,DB06695,Dabigatran etexilate,0.6159648299217224,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Morphine.,77,Type_77,Yes
DB00715,Paroxetine,DB01264,Darunavir,0.7216607928276062,47,Type_47,The metabolism of Darunavir can be decreased when combined with Paroxetine.,75,Type_75,No
DB00436,Bendroflumethiazide,DB09215,Droxicam,0.9776210188865662,70,Type_70,The therapeutic efficacy of Droxicam can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00298,Dapiprazole,DB00726,Trimipramine,0.9905710220336914,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Trimipramine.,49,Type_49,Yes
DB00726,Trimipramine,DB08903,Bedaquiline,0.9067211747169495,20,Type_20,Trimipramine may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00749,Etodolac,DB09216,Tolfenamic acid,0.9788479208946228,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Tolfenamic acid.,49,Type_49,Yes
DB00712,Flurbiprofen,DB04951,Pirfenidone,0.983389675617218,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pirfenidone.,49,Type_49,Yes
DB00808,Indapamide,DB01396,Digitoxin,0.7111691236495972,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Digitoxin.,49,Type_49,Yes
DB00425,Zolpidem,DB09280,Lumacaftor,0.5757165551185608,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Zolpidem.,75,Type_75,Yes
DB01184,Domperidone,DB01233,Metoclopramide,0.9884832501411438,20,Type_20,Domperidone may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB01088,Iloprost,DB01367,Rasagiline,0.513072669506073,60,Type_60,Iloprost may increase the hypotensive activities of Rasagiline.,49,Type_49,No
DB00527,Cinchocaine,DB00802,Alfentanil,0.9999535083770752,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Alfentanil.,49,Type_49,Yes
DB00208,Ticlopidine,DB05351,Dexlansoprazole,0.9586093425750732,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00594,Amiloride,DB01283,Lumiracoxib,0.9929405450820923,37,Type_37,Amiloride may decrease the antihypertensive activities of Lumiracoxib.,37,Type_37,Yes
DB00257,Clotrimazole,DB01319,Fosamprenavir,0.6127905249595642,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00570,Vinblastine,DB06772,Cabazitaxel,0.9834282994270325,49,Type_49,The risk or severity of adverse effects can be increased when Vinblastine is combined with Cabazitaxel.,49,Type_49,Yes
DB01023,Felodipine,DB01397,Magnesium salicylate,0.8247459530830383,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Magnesium salicylate.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00604,Cisapride,0.633948564529419,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Cisapride.,47,Type_47,No
DB08873,Boceprevir,DB09053,Ibrutinib,0.838961124420166,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Boceprevir.,73,Type_73,Yes
DB00605,Sulindac,DB00946,Phenprocoumon,0.9998087286949158,6,Type_6,Sulindac may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00703,Methazolamide,DB00797,Tolazoline,0.7014646530151367,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Tolazoline.,49,Type_49,Yes
DB00993,Azathioprine,DB04854,Febuxostat,0.9954409599304199,73,Type_73,The serum concentration of Febuxostat can be increased when it is combined with Azathioprine.,73,Type_73,Yes
DB00320,Dihydroergotamine,DB00420,Promazine,0.8382022380828857,47,Type_47,The metabolism of Promazine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00747,Scopolamine,DB01463,Fencamfamin,0.9995558857917786,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Fencamfamin.,49,Type_49,Yes
DB00744,Zileuton,DB04865,Omacetaxine mepesuccinate,0.8159477710723877,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB01685,Topiroxostat,DB06697,Artemether,0.9958378076553345,47,Type_47,The metabolism of Artemether can be decreased when combined with Topiroxostat.,47,Type_47,Yes
DB00246,Ziprasidone,DB06616,Bosutinib,0.8190034031867981,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ziprasidone.,73,Type_73,Yes
DB00250,Dapsone,DB00254,Doxycycline,0.951441764831543,47,Type_47,The metabolism of Doxycycline can be decreased when combined with Dapsone.,49,Type_49,No
DB00559,Bosentan,DB00977,Ethinylestradiol,0.7925403118133545,75,Type_75,The serum concentration of Ethinylestradiol can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00344,Protriptyline,DB13323,Trichloroethylene,0.9958470463752747,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Trichloroethylene.,49,Type_49,Yes
DB00359,Sulfadiazine,DB00619,Imatinib,0.9778655767440796,47,Type_47,The metabolism of Imatinib can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00820,Tadalafil,DB01167,Itraconazole,0.7665106058120728,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Tadalafil.,73,Type_73,Yes
DB00264,Metoprolol,DB09080,Olodaterol,0.7493380308151245,14,Type_14,Metoprolol may decrease the bronchodilatory activities of Olodaterol.,14,Type_14,Yes
DB00699,Nicergoline,DB00857,Terbinafine,0.8511698842048645,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Terbinafine.,47,Type_47,No
DB00588,Fluticasone propionate,DB09084,Benzydamine,0.999601423740387,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Benzydamine.,49,Type_49,Yes
DB00648,Mitotane,DB06700,Desvenlafaxine,0.9885950684547424,75,Type_75,The serum concentration of Desvenlafaxine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01384,Paramethasone,DB01601,Lopinavir,0.8444671034812927,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Paramethasone.,47,Type_47,Yes
DB00568,Cinnarizine,DB00852,Pseudoephedrine,0.3500136733055115,76,Type_76,Cinnarizine may decrease the sedative activities of Pseudoephedrine.,76,Type_76,Yes
DB00210,Adapalene,DB00999,Hydrochlorothiazide,0.9997567534446716,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00914,Phenformin,DB01232,Saquinavir,0.49189111590385437,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Phenformin.,70,Type_70,No
DB00226,Guanadrel,DB01089,Deserpidine,0.9999998807907104,60,Type_60,Guanadrel may increase the hypotensive activities of Deserpidine.,60,Type_60,Yes
DB00500,Tolmetin,DB00838,Clocortolone,0.9999243021011353,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Clocortolone.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB06813,Pralatrexate,0.6048252582550049,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Mycophenolate mofetil.,73,Type_73,Yes
DB00279,Liothyronine,DB09070,Tibolone,0.4314347207546234,70,Type_70,The therapeutic efficacy of Tibolone can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00844,Nalbuphine,DB01081,Diphenoxylate,0.9983654618263245,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diphenoxylate.,49,Type_49,Yes
DB00468,Quinine,DB00715,Paroxetine,0.5709983706474304,20,Type_20,Quinine may increase the QTc-prolonging activities of Paroxetine.,20,Type_20,Yes
DB01184,Domperidone,DB12332,Rucaparib,0.7895815968513489,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Domperidone.,73,Type_73,No
DB00384,Triamterene,DB09227,Barnidipine,0.980647087097168,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Barnidipine.,49,Type_49,Yes
DB00594,Amiloride,DB00849,Methylphenobarbital,0.56863933801651,60,Type_60,Amiloride may increase the hypotensive activities of Methylphenobarbital.,60,Type_60,Yes
DB00544,Fluorouracil,DB01050,Ibuprofen,0.847042977809906,47,Type_47,The metabolism of Ibuprofen can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00503,Ritonavir,DB04844,Tetrabenazine,0.8758578300476074,20,Type_20,Ritonavir may increase the QTc-prolonging activities of Tetrabenazine.,73,Type_73,No
DB00695,Furosemide,DB04878,Voglibose,0.9999035596847534,70,Type_70,The therapeutic efficacy of Voglibose can be decreased when used in combination with Furosemide.,70,Type_70,Yes
DB00262,Carmustine,DB00281,Lidocaine,0.9282057881355286,47,Type_47,The metabolism of Lidocaine can be decreased when combined with Carmustine.,47,Type_47,Yes
DB01095,Fluvastatin,DB08992,Eperisone,0.6209264993667603,73,Type_73,The serum concentration of Eperisone can be increased when it is combined with Fluvastatin.,49,Type_49,No
DB00805,Minaprine,DB01186,Pergolide,0.5635234713554382,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Pergolide.,47,Type_47,No
DB00996,Gabapentin,DB04896,Milnacipran,0.9883875250816345,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Milnacipran.,49,Type_49,Yes
DB00210,Adapalene,DB00827,Cinoxacin,0.9991577863693237,27,Type_27,Adapalene may increase the neuroexcitatory activities of Cinoxacin.,27,Type_27,Yes
DB00318,Codeine,DB09245,Toloxatone,0.6283609867095947,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Toloxatone.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00629,Guanabenz,0.8380410075187683,47,Type_47,The metabolism of Guanabenz can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00366,Doxylamine,DB01224,Quetiapine,0.999971866607666,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,16,Type_16,Yes
DB01082,Streptomycin,DB01396,Digitoxin,0.5147719383239746,58,Type_58,Streptomycin may decrease the cardiotoxic activities of Digitoxin.,75,Type_75,No
DB00543,Amoxapine,DB00620,Triamcinolone,0.9869533181190491,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Triamcinolone.,70,Type_70,No
DB00418,Secobarbital,DB01242,Clomipramine,0.7891740202903748,4,Type_4,The metabolism of Clomipramine can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01170,Guanethidine,DB01240,Epoprostenol,0.9994401335716248,60,Type_60,Guanethidine may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB00340,Metixene,DB06148,Mianserin,0.7849523425102234,2,Type_2,Metixene may increase the anticholinergic activities of Mianserin.,2,Type_2,Yes
DB01244,Bepridil,DB06712,Nilvadipine,0.9569134712219238,60,Type_60,Bepridil may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB01254,Dasatinib,DB06772,Cabazitaxel,0.7996218204498291,49,Type_49,The risk or severity of adverse effects can be increased when Dasatinib is combined with Cabazitaxel.,73,Type_73,No
DB00232,Methyclothiazide,DB00584,Enalapril,0.9409488439559937,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Enalapril.,49,Type_49,Yes
DB00788,Naproxen,DB13158,Clobetasone,0.999257504940033,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Clobetasone.,49,Type_49,Yes
DB01059,Norfloxacin,DB01155,Gemifloxacin,0.5371178984642029,20,Type_20,Norfloxacin may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00834,Mifepristone,DB01045,Rifampicin,0.4381599724292755,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Mifepristone.,73,Type_73,No
DB00876,Eprosartan,DB06802,Nepafenac,0.9510345458984375,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Nepafenac.,49,Type_49,Yes
DB00641,Simvastatin,DB06820,Sulconazole,0.5179704427719116,73,Type_73,The serum concentration of Sulconazole can be increased when it is combined with Simvastatin.,49,Type_49,No
DB00481,Raloxifene,DB09270,Ubidecarenone,0.8749885559082031,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Raloxifene.,73,Type_73,Yes
DB00932,Tipranavir,DB05351,Dexlansoprazole,0.557436466217041,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Tipranavir.,75,Type_75,No
DB00969,Alosetron,DB08873,Boceprevir,0.5338744521141052,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Alosetron.,73,Type_73,No
DB00849,Methylphenobarbital,DB01544,Flunitrazepam,0.9683359265327454,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Flunitrazepam.,49,Type_49,Yes
DB00780,Phenelzine,DB00898,Ethanol,0.8992098569869995,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Ethanol.,49,Type_49,Yes
DB00349,Clobazam,DB00652,Pentazocine,0.992566704750061,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Pentazocine.,49,Type_49,Yes
DB00528,Lercanidipine,DB01023,Felodipine,0.5018322467803955,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Felodipine.,60,Type_60,No
DB00264,Metoprolol,DB01232,Saquinavir,0.5324049592018127,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00489,Sotalol,DB00964,Apraclonidine,0.9921517372131348,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Apraclonidine.,49,Type_49,Yes
DB00400,Griseofulvin,DB00849,Methylphenobarbital,0.6875607371330261,49,Type_49,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Methylphenobarbital.,75,Type_75,No
DB00945,Acetylsalicylic acid,DB08814,Triflusal,0.6185646057128906,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triflusal.,49,Type_49,Yes
DB00238,Nevirapine,DB12001,Abemaciclib,0.3461586534976959,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Nevirapine.,75,Type_75,No
DB00754,Ethotoin,DB09118,Stiripentol,0.9102972745895386,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Stiripentol.,49,Type_49,Yes
DB00679,Thioridazine,DB00780,Phenelzine,0.7842631936073303,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Phenelzine.,49,Type_49,Yes
DB00252,Phenytoin,DB00865,Benzphetamine,0.40504005551338196,70,Type_70,The therapeutic efficacy of Benzphetamine can be decreased when used in combination with Phenytoin.,75,Type_75,No
DB00475,Chlordiazepoxide,DB00508,Triflupromazine,0.9984203577041626,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Triflupromazine.,49,Type_49,Yes
DB01253,Ergometrine,DB08918,Levomilnacipran,0.9334004521369934,49,Type_49,The risk or severity of adverse effects can be increased when Ergometrine is combined with Levomilnacipran.,49,Type_49,Yes
DB01177,Idarubicin,DB03585,Oxyphenbutazone,0.9996217489242554,72,Type_72,Idarubicin may decrease the excretion rate of Oxyphenbutazone which could result in a higher serum level.,72,Type_72,Yes
DB00861,Diflunisal,DB08991,Epirizole,0.9225958585739136,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Epirizole.,49,Type_49,Yes
DB00564,Carbamazepine,DB01406,Danazol,0.46185019612312317,75,Type_75,The serum concentration of Danazol can be decreased when it is combined with Carbamazepine.,47,Type_47,No
DB04844,Tetrabenazine,DB06282,Levocetirizine,0.9816311001777649,49,Type_49,The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Levocetirizine.,49,Type_49,Yes
DB00887,Bumetanide,DB06786,Halcinonide,0.999914288520813,83,Type_83,Bumetanide may increase the hypokalemic activities of Halcinonide.,83,Type_83,Yes
DB01190,Clindamycin,DB01201,Rifapentine,0.8132026195526123,4,Type_4,The metabolism of Rifapentine can be increased when combined with Clindamycin.,4,Type_4,Yes
DB00252,Phenytoin,DB01614,Acepromazine,0.47360894083976746,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Acepromazine.,49,Type_49,Yes
DB00765,Metyrosine,DB01615,Aceprometazine,0.9999487400054932,32,Type_32,Metyrosine may increase the sedative activities of Aceprometazine.,32,Type_32,Yes
DB00136,Calcitriol,DB00687,Fludrocortisone,0.8399932980537415,70,Type_70,The therapeutic efficacy of Fludrocortisone can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB00864,Tacrolimus,DB09218,Clonixin,0.9933131337165833,57,Type_57,Tacrolimus may increase the nephrotoxic activities of Clonixin.,57,Type_57,Yes
DB00615,Rifabutin,DB00849,Methylphenobarbital,0.8225687742233276,4,Type_4,The metabolism of Methylphenobarbital can be increased when combined with Rifabutin.,4,Type_4,Yes
DB01600,Tiaprofenic acid,DB09288,Propacetamol,0.9987596273422241,49,Type_49,The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Propacetamol.,49,Type_49,Yes
DB01174,Phenobarbital,DB04572,Thiotepa,0.795636773109436,4,Type_4,The metabolism of Thiotepa can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB08881,Vemurafenib,DB09082,Vilanterol,0.5940466523170471,75,Type_75,The serum concentration of Vilanterol can be decreased when it is combined with Vemurafenib.,75,Type_75,Yes
DB00136,Calcitriol,DB01377,Magnesium oxide,0.6873559355735779,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Calcitriol.,73,Type_73,No
DB00268,Ropinirole,DB00270,Isradipine,0.584741473197937,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Isradipine.,47,Type_47,No
DB00266,Dicoumarol,DB00689,Cephaloglycin,0.9999258518218994,6,Type_6,Dicoumarol may increase the anticoagulant activities of Cephaloglycin.,6,Type_6,Yes
DB01353,Butobarbital,DB01615,Aceprometazine,0.9999147653579712,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Aceprometazine.,49,Type_49,Yes
DB00210,Adapalene,DB01340,Cilazapril,0.932759165763855,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Cilazapril.,49,Type_49,Yes
DB00615,Rifabutin,DB00822,Disulfiram,0.8456641435623169,4,Type_4,The metabolism of Disulfiram can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00557,Hydroxyzine,DB00737,Meclizine,0.9987800717353821,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meclizine.,16,Type_16,Yes
DB00929,Misoprostol,DB01014,Balsalazide,0.7015561461448669,49,Type_49,The risk or severity of adverse effects can be increased when Misoprostol is combined with Balsalazide.,70,Type_70,No
DB00228,Enflurane,DB06204,Tapentadol,0.9966222047805786,16,Type_16,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00608,Chloroquine,DB00846,Flurandrenolide,0.998033344745636,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Flurandrenolide.,49,Type_49,Yes
DB00672,Chlorpropamide,DB04839,Cyproterone acetate,0.6861012578010559,70,Type_70,The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB00529,Foscarnet,DB00694,Daunorubicin,0.4864458441734314,57,Type_57,Foscarnet may increase the nephrotoxic activities of Daunorubicin.,57,Type_57,Yes
DB04272,Citric acid,DB13783,Acemetacin,0.8258501887321472,66,Type_66,The risk or severity of bleeding can be increased when Citric acid is combined with Acemetacin.,66,Type_66,Yes
DB00179,Masoprocol,DB00814,Meloxicam,0.9985363483428955,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Meloxicam.,49,Type_49,Yes
DB00514,Dextromethorphan,DB09128,Brexpiprazole,0.8679189682006836,49,Type_49,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Brexpiprazole.,49,Type_49,Yes
DB00219,Oxyphenonium,DB01081,Diphenoxylate,0.9999854564666748,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Diphenoxylate.,49,Type_49,Yes
DB00195,Betaxolol,DB00461,Nabumetone,0.987899124622345,37,Type_37,Betaxolol may decrease the antihypertensive activities of Nabumetone.,37,Type_37,Yes
DB00904,Ondansetron,DB04946,Iloperidone,0.8268641829490662,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Iloperidone.,49,Type_49,No
DB00323,Tolcapone,DB00543,Amoxapine,0.9946324825286865,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Amoxapine.,49,Type_49,Yes
DB00674,Galantamine,DB11315,Methscopolamine,0.9961820244789124,70,Type_70,The therapeutic efficacy of Methscopolamine can be decreased when used in combination with Galantamine.,70,Type_70,Yes
DB00266,Dicoumarol,DB01208,Sparfloxacin,0.9783819913864136,6,Type_6,Dicoumarol may increase the anticoagulant activities of Sparfloxacin.,6,Type_6,Yes
DB00675,Tamoxifen,DB09027,Ledipasvir,0.9460850954055786,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Tamoxifen.,73,Type_73,Yes
DB00691,Moexipril,DB00808,Indapamide,0.554354190826416,60,Type_60,Moexipril may increase the hypotensive activities of Indapamide.,49,Type_49,No
DB00798,Gentamicin,DB06739,Seratrodast,0.998772919178009,72,Type_72,Gentamicin may decrease the excretion rate of Seratrodast which could result in a higher serum level.,72,Type_72,Yes
DB00287,Travoprost,DB00797,Tolazoline,0.9999998807907104,60,Type_60,Travoprost may increase the hypotensive activities of Tolazoline.,60,Type_60,Yes
DB01080,Vigabatrin,DB01463,Fencamfamin,0.9999663829803467,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fencamfamin.,49,Type_49,Yes
DB00657,Mecamylamine,DB00708,Sufentanil,0.9906901121139526,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Sufentanil.,49,Type_49,Yes
DB00409,Remoxipride,DB00427,Triprolidine,0.9982938170433044,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Triprolidine.,49,Type_49,Yes
DB00808,Indapamide,DB01339,Vecuronium,0.9877957105636597,73,Type_73,The serum concentration of Vecuronium can be increased when it is combined with Indapamide.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB09063,Ceritinib,0.8922284841537476,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Ceritinib.,73,Type_73,No
DB00976,Telithromycin,DB04841,Flunarizine,0.6986899971961975,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00502,Haloperidol,DB00889,Granisetron,0.9230868220329285,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00794,Primidone,DB06210,Eltrombopag,0.9781569838523865,4,Type_4,The metabolism of Eltrombopag can be increased when combined with Primidone.,4,Type_4,Yes
DB00808,Indapamide,DB00834,Mifepristone,0.5455514788627625,20,Type_20,Indapamide may increase the QTc-prolonging activities of Mifepristone.,20,Type_20,Yes
DB00524,Metolazone,DB00661,Verapamil,0.9865929484367371,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Verapamil.,49,Type_49,Yes
DB00381,Amlodipine,DB01359,Penbutolol,0.5719473958015442,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Penbutolol.,49,Type_49,Yes
DB00834,Mifepristone,DB06717,Fosaprepitant,0.9500235319137573,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00199,Erythromycin,DB00294,Etonogestrel,0.8655720949172974,47,Type_47,The metabolism of Etonogestrel can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB06712,Nilvadipine,DB08943,Isoconazole,0.9676427245140076,49,Type_49,The risk or severity of adverse effects can be increased when Nilvadipine is combined with Isoconazole.,49,Type_49,Yes
DB01291,Pirbuterol,DB08918,Levomilnacipran,0.9882090091705322,85,Type_85,Pirbuterol may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00684,Tobramycin,DB01628,Etoricoxib,0.9998492002487183,72,Type_72,Tobramycin may decrease the excretion rate of Etoricoxib which could result in a higher serum level.,72,Type_72,Yes
DB00652,Pentazocine,DB01199,Tubocurarine,0.9982971549034119,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Tubocurarine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01409,Tiotropium,0.9928841590881348,73,Type_73,The serum concentration of Tiotropium can be increased when it is combined with Chlorothiazide.,73,Type_73,Yes
DB00661,Verapamil,DB00752,Tranylcypromine,0.6486217379570007,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00503,Ritonavir,DB05109,Trabectedin,0.8039406538009644,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00701,Amprenavir,DB01241,Gemfibrozil,0.935809314250946,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Amprenavir.,47,Type_47,Yes
DB01131,Proguanil,DB01319,Fosamprenavir,0.8871859908103943,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Proguanil.,47,Type_47,Yes
DB00697,Tizanidine,DB01115,Nifedipine,0.8995844721794128,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Nifedipine.,73,Type_73,No
DB00476,Duloxetine,DB08824,Ioflupane I-123,0.9999276399612427,45,Type_45,Duloxetine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.,45,Type_45,Yes
DB00880,Chlorothiazide,DB09218,Clonixin,0.9955272078514099,70,Type_70,The therapeutic efficacy of Clonixin can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00618,Demeclocycline,DB01053,Benzylpenicillin,0.982494056224823,70,Type_70,The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Demeclocycline.,70,Type_70,Yes
DB00655,Estrone,DB00814,Meloxicam,0.9188454747200012,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Meloxicam.,49,Type_49,Yes
DB00224,Indinavir,DB04572,Thiotepa,0.923337996006012,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00630,Alendronic acid,DB01435,Antipyrine,0.9936933517456055,49,Type_49,The risk or severity of adverse effects can be increased when Alendronic acid is combined with Antipyrine.,49,Type_49,Yes
DB00324,Fluorometholone,DB01245,Decamethonium,0.9992852807044983,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Decamethonium.,49,Type_49,Yes
DB00472,Fluoxetine,DB01181,Ifosfamide,0.9420244693756104,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00838,Clocortolone,DB09067,Corticorelin ovine triflutate,0.9999995231628418,70,Type_70,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Clocortolone.,70,Type_70,Yes
DB00246,Ziprasidone,DB00458,Imipramine,0.6067972779273987,47,Type_47,The metabolism of Imipramine can be decreased when combined with Ziprasidone.,20,Type_20,No
DB00835,Brompheniramine,DB00844,Nalbuphine,0.9980669617652893,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Nalbuphine.,49,Type_49,Yes
DB00655,Estrone,DB00932,Tipranavir,0.39388272166252136,73,Type_73,The serum concentration of Tipranavir can be increased when it is combined with Estrone.,28,Type_28,No
DB00180,Flunisolide,DB00461,Nabumetone,0.9978421926498413,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Nabumetone.,49,Type_49,Yes
DB01030,Topotecan,DB13878,Pibrentasvir,0.645946741104126,73,Type_73,The serum concentration of Pibrentasvir can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB01397,Magnesium salicylate,DB09561,Sodium glycerophosphate,0.6369464993476868,67,Type_67,Magnesium salicylate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00285,Venlafaxine,DB00313,Valproic acid,0.8162082433700562,47,Type_47,The metabolism of Valproic acid can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01175,Escitalopram,DB05521,Telaprevir,0.7180838584899902,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Escitalopram.,75,Type_75,No
DB01254,Dasatinib,DB01256,Retapamulin,0.564099907875061,73,Type_73,The serum concentration of Retapamulin can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB01259,Lapatinib,DB06739,Seratrodast,0.7431850433349609,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Lapatinib.,47,Type_47,Yes
DB00768,Olopatadine,DB06770,Benzyl alcohol,0.9428975582122803,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Benzyl alcohol.,49,Type_49,Yes
DB01028,Methoxyflurane,DB01114,Chlorpheniramine,0.9893514513969421,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Chlorpheniramine.,49,Type_49,Yes
DB01154,Thiamylal,DB07615,Tranilast,0.5089608430862427,4,Type_4,The metabolism of Tranilast can be increased when combined with Thiamylal.,4,Type_4,Yes
DB00479,Amikacin,DB01339,Vecuronium,0.9999639987945557,40,Type_40,Amikacin may increase the respiratory depressant activities of Vecuronium.,40,Type_40,Yes
DB01201,Rifapentine,DB01210,Levobunolol,0.7690175771713257,75,Type_75,The serum concentration of Levobunolol can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB01045,Rifampicin,DB01118,Amiodarone,0.5955227017402649,4,Type_4,The metabolism of Amiodarone can be increased when combined with Rifampicin.,11,Type_11,No
DB00176,Fluvoxamine,DB00555,Lamotrigine,0.9570693969726562,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Lamotrigine.,49,Type_49,Yes
DB00288,Amcinonide,DB06724,Calcium carbonate,0.9986425042152405,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Amcinonide.,3,Type_3,Yes
DB01142,Doxepin,DB01592,Iron,0.7871558666229248,67,Type_67,Doxepin can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00599,Thiopental,DB09017,Brotizolam,0.9998965263366699,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Brotizolam.,49,Type_49,Yes
DB00678,Losartan,DB01232,Saquinavir,0.9042672514915466,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Losartan.,47,Type_47,Yes
DB00655,Estrone,DB00974,Edetic acid,0.8024522066116333,12,Type_12,Estrone may decrease the anticoagulant activities of Edetic acid.,12,Type_12,Yes
DB00208,Ticlopidine,DB01407,Clenbuterol,0.8644953370094299,47,Type_47,The metabolism of Clenbuterol can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00813,Fentanyl,DB04841,Flunarizine,0.9733869433403015,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Flunarizine.,49,Type_49,Yes
DB00289,Atomoxetine,DB00643,Mebendazole,0.9051505923271179,47,Type_47,The metabolism of Mebendazole can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00889,Granisetron,DB04868,Nilotinib,0.8393018245697021,20,Type_20,Granisetron may increase the QTc-prolonging activities of Nilotinib.,47,Type_47,No
DB01018,Guanfacine,DB09198,Lobeglitazone,0.9904161691665649,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Guanfacine.,47,Type_47,Yes
DB00472,Fluoxetine,DB08903,Bedaquiline,0.8175451159477234,20,Type_20,Fluoxetine may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB01104,Sertraline,DB06144,Sertindole,0.5720119476318359,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Sertindole.,47,Type_47,No
DB00734,Risperidone,DB01054,Nitrendipine,0.5332845449447632,60,Type_60,Risperidone may increase the hypotensive activities of Nitrendipine.,60,Type_60,Yes
DB01392,Yohimbine,DB06712,Nilvadipine,0.9947275519371033,37,Type_37,Yohimbine may decrease the antihypertensive activities of Nilvadipine.,37,Type_37,Yes
DB01174,Phenobarbital,DB01282,Carbetocin,0.9847635626792908,60,Type_60,Phenobarbital may increase the hypotensive activities of Carbetocin.,60,Type_60,Yes
DB00735,Naftifine,DB06802,Nepafenac,0.9996597766876221,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Nepafenac.,49,Type_49,Yes
DB00987,Cytarabine,DB06772,Cabazitaxel,0.9686520099639893,49,Type_49,The risk or severity of adverse effects can be increased when Cytarabine is combined with Cabazitaxel.,49,Type_49,Yes
DB01158,Bretylium,DB06694,Xylometazoline,0.9981281161308289,60,Type_60,Bretylium may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00623,Fluphenazine,DB01154,Thiamylal,0.9020881652832031,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiamylal.,49,Type_49,Yes
DB00738,Pentamidine,DB06825,Triptorelin,0.9988468885421753,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00755,Tretinoin,DB09112,Nitrous acid,0.9951164722442627,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Nitrous acid.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09167,Dosulepin,0.5364959836006165,73,Type_73,The serum concentration of Dosulepin can be increased when it is combined with Rosuvastatin.,47,Type_47,No
DB00540,Nortriptyline,DB00904,Ondansetron,0.5630465149879456,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ondansetron.,20,Type_20,No
DB00570,Vinblastine,DB04871,Lorcaserin,0.9002817273139954,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB00222,Glimepiride,DB00627,Niacin,0.7534845471382141,70,Type_70,The therapeutic efficacy of Niacin can be decreased when used in combination with Glimepiride.,70,Type_70,Yes
DB00204,Dofetilide,DB00458,Imipramine,0.41602274775505066,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Imipramine.,20,Type_20,Yes
DB01043,Memantine,DB01156,Bupropion,0.5115772485733032,49,Type_49,The risk or severity of adverse effects can be increased when Memantine is combined with Bupropion.,73,Type_73,No
DB00617,Paramethadione,DB08912,Dabrafenib,0.9918466806411743,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Paramethadione.,75,Type_75,Yes
DB01242,Clomipramine,DB01291,Pirbuterol,0.9620760083198547,49,Type_49,The risk or severity of adverse effects can be increased when Clomipramine is combined with Pirbuterol.,49,Type_49,Yes
DB00422,Methylphenidate,DB08938,Magaldrate,0.999704897403717,18,Type_18,Methylphenidate can cause an increase in the absorption of Magaldrate resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB06218,Lacosamide,DB09054,Idelalisib,0.7160106301307678,75,Type_75,The serum concentration of Idelalisib can be decreased when it is combined with Lacosamide.,73,Type_73,No
DB00614,Furazolidone,DB06698,Betahistine,0.5199007987976074,73,Type_73,The serum concentration of Betahistine can be increased when it is combined with Furazolidone.,73,Type_73,Yes
DB00748,Carbinoxamine,DB09074,Olaparib,0.9406115412712097,47,Type_47,The metabolism of Olaparib can be decreased when combined with Carbinoxamine.,47,Type_47,Yes
DB01161,Chloroprocaine,DB01618,Molindone,0.9999412298202515,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Molindone.,49,Type_49,Yes
DB00176,Fluvoxamine,DB06292,Dapagliflozin,0.8765080571174622,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB01174,Phenobarbital,DB01253,Ergometrine,0.8593149185180664,4,Type_4,The metabolism of Ergometrine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB01193,Acebutolol,DB01274,Arformoterol,0.7458964586257935,14,Type_14,Acebutolol may decrease the bronchodilatory activities of Arformoterol.,14,Type_14,Yes
DB01092,Ouabain,DB01245,Decamethonium,0.9907802939414978,82,Type_82,Ouabain may increase the arrhythmogenic activities of Decamethonium.,82,Type_82,Yes
DB06663,Pasireotide,DB06697,Artemether,0.8889067769050598,20,Type_20,Pasireotide may increase the QTc-prolonging activities of Artemether.,20,Type_20,Yes
DB00199,Erythromycin,DB00768,Olopatadine,0.8026815056800842,47,Type_47,The metabolism of Olopatadine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00687,Fludrocortisone,DB06203,Alogliptin,0.9499930739402771,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Fludrocortisone.,70,Type_70,Yes
DB00588,Fluticasone propionate,DB06716,Fospropofol,0.9986178874969482,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fospropofol.,49,Type_49,Yes
DB01435,Antipyrine,DB06697,Artemether,0.9860638380050659,47,Type_47,The metabolism of Artemether can be decreased when combined with Antipyrine.,47,Type_47,Yes
DB00433,Prochlorperazine,DB01168,Procarbazine,0.7645989656448364,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Procarbazine.,49,Type_49,Yes
DB01045,Rifampicin,DB06739,Seratrodast,0.9066896438598633,4,Type_4,The metabolism of Seratrodast can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00531,Cyclophosphamide,DB01103,Quinacrine,0.9132285714149475,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Quinacrine.,15,Type_15,Yes
DB00705,Delavirdine,DB00736,Esomeprazole,0.7564936280250549,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Delavirdine.,75,Type_75,No
DB01151,Desipramine,DB06605,Apixaban,0.7983949780464172,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB00492,Fosinopril,DB01174,Phenobarbital,0.6275497674942017,60,Type_60,Fosinopril may increase the hypotensive activities of Phenobarbital.,60,Type_60,Yes
DB01175,Escitalopram,DB09244,Pirlindole,0.9783018827438354,64,Type_64,Escitalopram may increase the serotonergic activities of Pirlindole.,64,Type_64,Yes
DB00737,Meclizine,DB09345,Pramocaine,0.9999949932098389,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Pramocaine.,49,Type_49,Yes
DB01589,Quazepam,DB04930,Permethrin,0.8515141010284424,47,Type_47,The metabolism of Permethrin can be decreased when combined with Quazepam.,73,Type_73,No
DB09218,Clonixin,DB13783,Acemetacin,0.945514976978302,49,Type_49,The risk or severity of adverse effects can be increased when Clonixin is combined with Acemetacin.,49,Type_49,Yes
DB00962,Zaleplon,DB09342,Propoxycaine,0.5944666266441345,16,Type_16,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Propoxycaine.,49,Type_49,No
DB00608,Chloroquine,DB08971,Fluocortolone,0.9978684186935425,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Fluocortolone.,49,Type_49,Yes
DB01028,Methoxyflurane,DB01072,Atazanavir,0.8363681435585022,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00652,Pentazocine,DB00683,Midazolam,0.971961259841919,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Midazolam.,49,Type_49,Yes
DB00199,Erythromycin,DB01054,Nitrendipine,0.9542397260665894,47,Type_47,The metabolism of Nitrendipine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00631,Clofarabine,DB01023,Felodipine,0.9940059185028076,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Felodipine.,49,Type_49,Yes
DB00196,Fluconazole,DB00471,Montelukast,0.9593929052352905,47,Type_47,The metabolism of Montelukast can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00289,Atomoxetine,DB06595,Midostaurin,0.9315718412399292,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Atomoxetine.,73,Type_73,No
DB00802,Alfentanil,DB01440,gamma-Hydroxybutyric acid,0.999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB01345,Potassium cation,DB01466,Ethylmorphine,0.9964027404785156,49,Type_49,The risk or severity of adverse effects can be increased when Potassium cation is combined with Ethylmorphine.,49,Type_49,Yes
DB00863,Ranitidine,DB01124,Tolbutamide,0.7846932411193848,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Ranitidine.,73,Type_73,No
DB00492,Fosinopril,DB00742,Mannitol,0.9442402720451355,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Mannitol.,49,Type_49,Yes
DB01046,Lubiprostone,DB07615,Tranilast,0.9999653100967407,70,Type_70,The therapeutic efficacy of Tranilast can be decreased when used in combination with Lubiprostone.,70,Type_70,Yes
DB01161,Chloroprocaine,DB01588,Prazepam,0.999902606010437,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Prazepam.,49,Type_49,Yes
DB00334,Olanzapine,DB01544,Flunitrazepam,0.9438197612762451,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Flunitrazepam.,49,Type_49,Yes
DB01221,Ketamine,DB01236,Sevoflurane,0.9566965103149414,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Sevoflurane.,49,Type_49,Yes
DB00425,Zolpidem,DB00705,Delavirdine,0.6209416389465332,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB00958,Carboplatin,DB08895,Tofacitinib,0.9998550415039062,34,Type_34,Carboplatin may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB01075,Diphenhydramine,DB01142,Doxepin,0.38881295919418335,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Doxepin.,47,Type_47,No
DB00543,Amoxapine,DB08873,Boceprevir,0.6221184134483337,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Amoxapine.,73,Type_73,Yes
DB00246,Ziprasidone,DB00598,Labetalol,0.5756564736366272,47,Type_47,The metabolism of Labetalol can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00193,Tramadol,DB00283,Clemastine,0.4125804901123047,16,Type_16,Tramadol may increase the central nervous system depressant (CNS depressant) activities of Clemastine.,70,Type_70,No
DB00800,Fenoldopam,DB08931,Riociguat,0.8402014374732971,60,Type_60,Fenoldopam may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB01255,Lisdexamfetamine,DB08802,Isothipendyl,0.9998924732208252,76,Type_76,Lisdexamfetamine may decrease the sedative activities of Isothipendyl.,76,Type_76,Yes
DB00517,Anisotropine methylbromide,DB01043,Memantine,0.9990804195404053,70,Type_70,The therapeutic efficacy of Memantine can be decreased when used in combination with Anisotropine methylbromide.,70,Type_70,Yes
DB00413,Pramipexole,DB00420,Promazine,0.9957700371742249,32,Type_32,Pramipexole may increase the sedative activities of Promazine.,32,Type_32,Yes
DB00682,Warfarin,DB00948,Mezlocillin,0.9939895868301392,6,Type_6,Warfarin may increase the anticoagulant activities of Mezlocillin.,6,Type_6,Yes
DB00401,Nisoldipine,DB00708,Sufentanil,0.9586374759674072,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Sufentanil.,49,Type_49,Yes
DB00248,Cabergoline,DB00615,Rifabutin,0.7522839307785034,4,Type_4,The metabolism of Rifabutin can be increased when combined with Cabergoline.,4,Type_4,Yes
DB00934,Maprotiline,DB06216,Asenapine,0.5289055705070496,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Asenapine.,20,Type_20,No
DB00397,Phenylpropanolamine,DB00695,Furosemide,0.9492735862731934,83,Type_83,Phenylpropanolamine may increase the hypokalemic activities of Furosemide.,83,Type_83,Yes
DB00371,Meprobamate,DB01621,Pipotiazine,0.9866448044776917,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Pipotiazine.,49,Type_49,Yes
DB00870,Suprofen,DB11921,Deflazacort,0.9996989965438843,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Deflazacort.,49,Type_49,Yes
DB01072,Atazanavir,DB08806,Roxatidine acetate,0.5673882365226746,75,Type_75,The serum concentration of Roxatidine acetate can be decreased when it is combined with Atazanavir.,75,Type_75,Yes
DB06636,Isavuconazonium,DB09053,Ibrutinib,0.7781938910484314,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Isavuconazonium.,73,Type_73,Yes
DB00839,Tolazamide,DB04574,Estrone sulfate,0.978463351726532,70,Type_70,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Tolazamide.,70,Type_70,Yes
DB00434,Cyproheptadine,DB01198,Zopiclone,0.9996315240859985,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Zopiclone.,49,Type_49,Yes
DB00307,Bexarotene,DB01211,Clarithromycin,0.8013906478881836,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Bexarotene.,47,Type_47,Yes
DB01590,Everolimus,DB13874,Enasidenib,0.8806126713752747,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB01110,Miconazole,DB08933,Luliconazole,0.9312576651573181,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Miconazole.,73,Type_73,Yes
DB00997,Doxorubicin,DB13878,Pibrentasvir,0.915332019329071,73,Type_73,The serum concentration of Pibrentasvir can be increased when it is combined with Doxorubicin.,73,Type_73,Yes
DB00898,Ethanol,DB01595,Nitrazepam,0.9365934729576111,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.,16,Type_16,Yes
DB06287,Temsirolimus,DB06702,Fesoterodine,0.917669415473938,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Temsirolimus.,77,Type_77,Yes
DB01263,Posaconazole,DB09183,Dasabuvir,0.8821979761123657,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB01240,Epoprostenol,DB09286,Pipamperone,0.5831382274627686,60,Type_60,Epoprostenol may increase the hypotensive activities of Pipamperone.,49,Type_49,No
DB00349,Clobazam,DB01624,Zuclopenthixol,0.5908053517341614,47,Type_47,The metabolism of Zuclopenthixol can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01220,Rifaximin,DB09270,Ubidecarenone,0.8446500301361084,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Rifaximin.,75,Type_75,No
DB00494,Entacapone,DB00508,Triflupromazine,0.9994831085205078,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Triflupromazine.,49,Type_49,Yes
DB00539,Toremifene,DB00673,Aprepitant,0.9597715735435486,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Toremifene.,73,Type_73,Yes
DB00243,Ranolazine,DB00400,Griseofulvin,0.4836382567882538,47,Type_47,The metabolism of Griseofulvin can be decreased when combined with Ranolazine.,73,Type_73,No
DB00619,Imatinib,DB01097,Leflunomide,0.7474028468132019,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Imatinib.,49,Type_49,No
DB00338,Omeprazole,DB04871,Lorcaserin,0.9823729991912842,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00495,Zidovudine,DB06605,Apixaban,0.3891862630844116,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Zidovudine.,75,Type_75,Yes
DB00213,Pantoprazole,DB00282,Pamidronic acid,0.9411575794219971,70,Type_70,The therapeutic efficacy of Pamidronic acid can be decreased when used in combination with Pantoprazole.,70,Type_70,Yes
DB01558,Bromazepam,DB12532,Oxetacaine,0.9999983310699463,49,Type_49,The risk or severity of adverse effects can be increased when Bromazepam is combined with Oxetacaine.,49,Type_49,Yes
DB00446,Chloramphenicol,DB00586,Diclofenac,0.96869957447052,47,Type_47,The metabolism of Diclofenac can be decreased when combined with Chloramphenicol.,47,Type_47,Yes
DB00035,Desmopressin,DB00573,Fenoprofen,0.7878683805465698,70,Type_70,The therapeutic efficacy of Fenoprofen can be decreased when used in combination with Desmopressin.,49,Type_49,No
DB00961,Mepivacaine,DB01215,Estazolam,0.9998679161071777,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Estazolam.,49,Type_49,Yes
DB01202,Levetiracetam,DB04844,Tetrabenazine,0.9720116257667542,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Tetrabenazine.,49,Type_49,Yes
DB00904,Ondansetron,DB01029,Irbesartan,0.8721166849136353,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Ondansetron.,47,Type_47,Yes
DB00281,Lidocaine,DB05812,Abiraterone,0.6710981130599976,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB00738,Pentamidine,DB01233,Metoclopramide,0.963144838809967,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00921,Buprenorphine,DB09245,Toloxatone,0.8537500500679016,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Toloxatone.,49,Type_49,Yes
DB00887,Bumetanide,DB01340,Cilazapril,0.8387826085090637,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Cilazapril.,49,Type_49,Yes
DB00927,Famotidine,DB09063,Ceritinib,0.9377687573432922,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Famotidine.,20,Type_20,No
DB00411,Carbamoylcholine,DB00483,Gallamine triethiodide,0.9084820747375488,21,Type_21,Carbamoylcholine may increase the neuromuscular blocking activities of Gallamine triethiodide.,49,Type_49,No
DB00945,Acetylsalicylic acid,DB01349,Tasosartan,0.717094898223877,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Acetylsalicylic acid.,49,Type_49,No
DB00934,Maprotiline,DB09286,Pipamperone,0.990802526473999,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Pipamperone.,49,Type_49,Yes
DB01092,Ouabain,DB01157,Trimetrexate,0.9921703934669495,58,Type_58,Ouabain may decrease the cardiotoxic activities of Trimetrexate.,58,Type_58,Yes
DB01232,Saquinavir,DB06203,Alogliptin,0.5544270277023315,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00006,Bivalirudin,DB06206,Sugammadex,0.8216677308082581,6,Type_6,Bivalirudin may increase the anticoagulant activities of Sugammadex.,6,Type_6,Yes
DB00543,Amoxapine,DB00608,Chloroquine,0.5547792315483093,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Chloroquine.,20,Type_20,Yes
DB01036,Tolterodine,DB09198,Lobeglitazone,0.9992753863334656,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Tolterodine.,47,Type_47,Yes
DB01029,Irbesartan,DB01131,Proguanil,0.9357253909111023,47,Type_47,The metabolism of Proguanil can be decreased when combined with Irbesartan.,47,Type_47,Yes
DB00363,Clozapine,DB01191,Dexfenfluramine,0.904000461101532,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00686,Pentosan polysulfate,DB01166,Cilostazol,0.8586994409561157,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Cilostazol.,49,Type_49,No
DB00241,Butalbital,DB00768,Olopatadine,0.9896275997161865,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Olopatadine.,49,Type_49,Yes
DB00582,Voriconazole,DB01165,Ofloxacin,0.9990383386611938,20,Type_20,Voriconazole may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00925,Phenoxybenzamine,DB09065,Cobicistat,0.5725032091140747,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Phenoxybenzamine.,47,Type_47,No
DB01359,Penbutolol,DB09288,Propacetamol,0.9972648620605469,37,Type_37,Penbutolol may decrease the antihypertensive activities of Propacetamol.,37,Type_37,Yes
DB00983,Formoterol,DB01232,Saquinavir,0.3502761423587799,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Formoterol.,20,Type_20,No
DB00427,Triprolidine,DB06594,Agomelatine,0.999931812286377,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Agomelatine.,49,Type_49,Yes
DB00904,Ondansetron,DB00932,Tipranavir,0.8731724619865417,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Ondansetron.,47,Type_47,Yes
DB00898,Ethanol,DB04946,Iloperidone,0.9878969192504883,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.,16,Type_16,Yes
DB00246,Ziprasidone,DB01614,Acepromazine,0.715892493724823,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Acepromazine.,49,Type_49,Yes
DB00396,Progesterone,DB01263,Posaconazole,0.7227474451065063,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Progesterone.,13,Type_13,No
DB00177,Valsartan,DB01193,Acebutolol,0.44332781434059143,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Acebutolol.,49,Type_49,Yes
DB01215,Estazolam,DB01353,Butobarbital,0.9998561143875122,49,Type_49,The risk or severity of adverse effects can be increased when Estazolam is combined with Butobarbital.,49,Type_49,Yes
DB00340,Metixene,DB00572,Atropine,0.9986563920974731,49,Type_49,The risk or severity of adverse effects can be increased when Metixene is combined with Atropine.,49,Type_49,Yes
DB00195,Betaxolol,DB06203,Alogliptin,0.6655287146568298,9,Type_9,Betaxolol may increase the hypoglycemic activities of Alogliptin.,47,Type_47,No
DB01173,Orphenadrine,DB06738,Ketobemidone,0.8630963563919067,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Ketobemidone.,16,Type_16,Yes
DB00586,Diclofenac,DB06207,Silodosin,0.8909137845039368,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Diclofenac.,73,Type_73,Yes
DB00738,Pentamidine,DB09054,Idelalisib,0.7594929337501526,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Pentamidine.,47,Type_47,Yes
DB00788,Naproxen,DB06736,Aceclofenac,0.9973715543746948,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Aceclofenac.,49,Type_49,Yes
DB01248,Docetaxel,DB04865,Omacetaxine mepesuccinate,0.9753301739692688,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB01037,Selegiline,DB08918,Levomilnacipran,0.8900604844093323,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Levomilnacipran.,49,Type_49,Yes
DB01016,Glyburide,DB09204,Arotinolol,0.9979138970375061,9,Type_9,Glyburide may increase the hypoglycemic activities of Arotinolol.,9,Type_9,Yes
DB01037,Selegiline,DB08873,Boceprevir,0.4432772994041443,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Selegiline.,47,Type_47,No
DB00682,Warfarin,DB01240,Epoprostenol,0.9784491062164307,6,Type_6,Warfarin may increase the anticoagulant activities of Epoprostenol.,6,Type_6,Yes
DB00741,Hydrocortisone,DB01122,Ambenonium,0.9972701668739319,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Ambenonium.,49,Type_49,Yes
DB00384,Triamterene,DB00703,Methazolamide,0.6868569850921631,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Methazolamide.,49,Type_49,Yes
DB00186,Lorazepam,DB00370,Mirtazapine,0.9893717765808105,16,Type_16,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,16,Type_16,Yes
DB00744,Zileuton,DB00798,Gentamicin,0.9998376369476318,72,Type_72,Zileuton may decrease the excretion rate of Gentamicin which could result in a higher serum level.,72,Type_72,Yes
DB00324,Fluorometholone,DB00945,Acetylsalicylic acid,0.995692789554596,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB00091,Cyclosporine,DB00359,Sulfadiazine,0.5831694006919861,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Sulfadiazine.,57,Type_57,Yes
DB00571,Propranolol,DB01014,Balsalazide,0.9971619844436646,37,Type_37,Propranolol may decrease the antihypertensive activities of Balsalazide.,37,Type_37,Yes
DB00418,Secobarbital,DB00617,Paramethadione,0.8836084008216858,4,Type_4,The metabolism of Paramethadione can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01088,Iloprost,DB01162,Terazosin,0.5130492448806763,60,Type_60,Iloprost may increase the hypotensive activities of Terazosin.,49,Type_49,No
DB09080,Olodaterol,DB09238,Manidipine,0.7970966696739197,47,Type_47,The metabolism of Manidipine can be decreased when combined with Olodaterol.,47,Type_47,Yes
DB01047,Fluocinonide,DB01400,Neostigmine,0.9977898597717285,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinonide is combined with Neostigmine.,49,Type_49,Yes
DB00278,Argatroban,DB01097,Leflunomide,0.9115239381790161,6,Type_6,Argatroban may increase the anticoagulant activities of Leflunomide.,6,Type_6,Yes
DB00263,Sulfisoxazole,DB00401,Nisoldipine,0.9021605253219604,47,Type_47,The metabolism of Nisoldipine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00177,Valsartan,DB00482,Celecoxib,0.8052884340286255,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00445,Epirubicin,DB01283,Lumiracoxib,0.9957719445228577,72,Type_72,Epirubicin may decrease the excretion rate of Lumiracoxib which could result in a higher serum level.,72,Type_72,Yes
DB00374,Treprostinil,DB04840,Debrisoquine,0.9939898252487183,60,Type_60,Treprostinil may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00227,Lovastatin,DB09040,Efinaconazole,0.6364915370941162,73,Type_73,The serum concentration of Efinaconazole can be increased when it is combined with Lovastatin.,49,Type_49,No
DB01227,Levacetylmethadol,DB09068,Vortioxetine,0.9954845905303955,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Vortioxetine.,49,Type_49,Yes
DB01580,Oxprenolol,DB09009,Articaine,0.9857338666915894,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Articaine.,49,Type_49,Yes
DB00283,Clemastine,DB01189,Desflurane,0.9815955758094788,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Desflurane.,49,Type_49,Yes
DB00327,Hydromorphone,DB00897,Triazolam,0.9765140414237976,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam.,49,Type_49,Yes
DB00495,Zidovudine,DB01264,Darunavir,0.525012195110321,47,Type_47,The metabolism of Darunavir can be decreased when combined with Zidovudine.,75,Type_75,No
DB06153,Pizotifen,DB09017,Brotizolam,0.997234046459198,49,Type_49,The risk or severity of adverse effects can be increased when Pizotifen is combined with Brotizolam.,49,Type_49,Yes
DB00273,Topiramate,DB00835,Brompheniramine,0.9800844192504883,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Brompheniramine.,49,Type_49,Yes
DB00384,Triamterene,DB01236,Sevoflurane,0.9835806488990784,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Sevoflurane.,49,Type_49,Yes
DB01006,Letrozole,DB01264,Darunavir,0.8401501178741455,47,Type_47,The metabolism of Darunavir can be decreased when combined with Letrozole.,47,Type_47,Yes
DB00412,Rosiglitazone,DB01241,Gemfibrozil,0.9565694332122803,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB01240,Epoprostenol,DB09167,Dosulepin,0.8608328700065613,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Epoprostenol.,47,Type_47,Yes
DB00207,Azithromycin,DB00315,Zolmitriptan,0.49634647369384766,47,Type_47,The metabolism of Zolmitriptan can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00985,Dimenhydrinate,DB06700,Desvenlafaxine,0.9786591529846191,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Desvenlafaxine.,49,Type_49,Yes
DB00474,Methohexital,DB00904,Ondansetron,0.9302121996879578,49,Type_49,The risk or severity of adverse effects can be increased when Methohexital is combined with Ondansetron.,49,Type_49,Yes
DB00810,Biperiden,DB09075,Edoxaban,0.3571321964263916,12,Type_12,Biperiden may decrease the anticoagulant activities of Edoxaban.,73,Type_73,No
DB00498,Phenindione,DB01600,Tiaprofenic acid,0.9998646974563599,6,Type_6,Phenindione may increase the anticoagulant activities of Tiaprofenic acid.,6,Type_6,Yes
DB01238,Aripiprazole,DB08822,Azilsartan medoxomil,0.9956450462341309,60,Type_60,Aripiprazole may increase the hypotensive activities of Azilsartan medoxomil.,60,Type_60,Yes
DB00224,Indinavir,DB06712,Nilvadipine,0.8467469811439514,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00608,Chloroquine,DB01130,Prednicarbate,0.9980641007423401,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Prednicarbate.,49,Type_49,Yes
DB01424,Aminophenazone,DB12332,Rucaparib,0.9614877104759216,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Aminophenazone.,47,Type_47,Yes
DB00435,Nitric Oxide,DB05271,Rotigotine,0.9741000533103943,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Rotigotine.,49,Type_49,Yes
DB01601,Lopinavir,DB06770,Benzyl alcohol,0.8440945148468018,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB00215,Citalopram,DB00420,Promazine,0.597721517086029,20,Type_20,Citalopram may increase the QTc-prolonging activities of Promazine.,47,Type_47,No
DB00458,Imipramine,DB00543,Amoxapine,0.6319649815559387,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Amoxapine.,49,Type_49,Yes
DB08912,Dabrafenib,DB08918,Levomilnacipran,0.7089617252349854,73,Type_73,The serum concentration of Levomilnacipran can be increased when it is combined with Dabrafenib.,75,Type_75,No
DB00283,Clemastine,DB01173,Orphenadrine,0.9866923689842224,16,Type_16,Clemastine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00870,Suprofen,DB09084,Benzydamine,0.998678982257843,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Benzydamine.,49,Type_49,Yes
DB00253,Medrysone,DB00812,Phenylbutazone,0.9996476173400879,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Phenylbutazone.,49,Type_49,Yes
DB01128,Bicalutamide,DB09063,Ceritinib,0.979752779006958,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Bicalutamide.,73,Type_73,Yes
DB00755,Tretinoin,DB06730,Gestodene,0.5238058567047119,75,Type_75,The serum concentration of Gestodene can be decreased when it is combined with Tretinoin.,70,Type_70,No
DB01092,Ouabain,DB11641,Vinflunine,0.9999475479125977,58,Type_58,Ouabain may decrease the cardiotoxic activities of Vinflunine.,58,Type_58,Yes
DB01103,Quinacrine,DB01211,Clarithromycin,0.6232926845550537,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Quinacrine.,47,Type_47,Yes
DB01086,Benzocaine,DB04953,Ezogabine,0.9950773119926453,49,Type_49,The risk or severity of adverse effects can be increased when Benzocaine is combined with Ezogabine.,49,Type_49,Yes
DB00323,Tolcapone,DB00657,Mecamylamine,0.9625978469848633,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Mecamylamine.,49,Type_49,Yes
DB06696,Arbekacin,DB08795,Azidocillin,0.9927171468734741,75,Type_75,The serum concentration of Azidocillin can be decreased when it is combined with Arbekacin.,75,Type_75,Yes
DB00387,Procyclidine,DB00921,Buprenorphine,0.999916672706604,49,Type_49,The risk or severity of adverse effects can be increased when Procyclidine is combined with Buprenorphine.,49,Type_49,Yes
DB00285,Venlafaxine,DB06155,Rimonabant,0.9670639634132385,47,Type_47,The metabolism of Rimonabant can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01238,Aripiprazole,DB09074,Olaparib,0.831332266330719,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Aripiprazole.,73,Type_73,Yes
DB00475,Chlordiazepoxide,DB00679,Thioridazine,0.7617504596710205,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Thioridazine.,47,Type_47,No
DB00599,Thiopental,DB01220,Rifaximin,0.4491525888442993,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Thiopental.,4,Type_4,No
DB01081,Diphenoxylate,DB09009,Articaine,0.9992265701293945,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Articaine.,49,Type_49,Yes
DB00872,Conivaptan,DB06717,Fosaprepitant,0.9921391606330872,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB05676,Apremilast,DB09048,Netupitant,0.9802618026733398,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Apremilast.,73,Type_73,Yes
DB00418,Secobarbital,DB00708,Sufentanil,0.8783285617828369,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Sufentanil.,49,Type_49,Yes
DB00678,Losartan,DB01037,Selegiline,0.42820534110069275,60,Type_60,Losartan may increase the hypotensive activities of Selegiline.,49,Type_49,No
DB00586,Diclofenac,DB00896,Rimexolone,0.9992314577102661,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Rimexolone.,49,Type_49,Yes
DB00390,Digoxin,DB01611,Hydroxychloroquine,0.6407145857810974,73,Type_73,The serum concentration of Hydroxychloroquine can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB00374,Treprostinil,DB09075,Edoxaban,0.5508587956428528,6,Type_6,Treprostinil may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB01028,Methoxyflurane,DB08912,Dabrafenib,0.784034788608551,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Methoxyflurane.,75,Type_75,Yes
DB00241,Butalbital,DB01236,Sevoflurane,0.9787980914115906,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Sevoflurane.,49,Type_49,Yes
DB00610,Metaraminol,DB01142,Doxepin,0.9933605790138245,84,Type_84,Metaraminol may increase the vasopressor activities of Doxepin.,84,Type_84,Yes
DB00359,Sulfadiazine,DB01132,Pioglitazone,0.8970654606819153,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00735,Naftifine,DB01399,Salsalate,0.9997567534446716,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Salsalate.,49,Type_49,Yes
DB00846,Flurandrenolide,DB06724,Calcium carbonate,0.9986568689346313,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Flurandrenolide.,3,Type_3,Yes
DB00959,Methylprednisolone,DB03585,Oxyphenbutazone,0.999815046787262,49,Type_49,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Oxyphenbutazone.,49,Type_49,Yes
DB01628,Etoricoxib,DB09048,Netupitant,0.8875037431716919,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Etoricoxib.,73,Type_73,Yes
DB00244,Mesalazine,DB00834,Mifepristone,0.9812464118003845,9,Type_9,Mesalazine may increase the hypoglycemic activities of Mifepristone.,9,Type_9,Yes
DB00573,Fenoprofen,DB04576,Fleroxacin,0.9970715045928955,27,Type_27,Fenoprofen may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00402,Eszopiclone,DB01198,Zopiclone,0.997094988822937,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zopiclone.,49,Type_49,Yes
DB00246,Ziprasidone,DB00655,Estrone,0.9209526777267456,47,Type_47,The metabolism of Estrone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00308,Ibutilide,DB04855,Dronedarone,0.860203742980957,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Dronedarone.,33,Type_33,No
DB00243,Ranolazine,DB00433,Prochlorperazine,0.5851607322692871,73,Type_73,The serum concentration of Prochlorperazine can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00661,Verapamil,DB00690,Flurazepam,0.9555139541625977,47,Type_47,The metabolism of Flurazepam can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00231,Temazepam,DB01209,Dezocine,0.9991742968559265,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Dezocine.,49,Type_49,Yes
DB00482,Celecoxib,DB00570,Vinblastine,0.8888135552406311,47,Type_47,The metabolism of Vinblastine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01595,Nitrazepam,DB01614,Acepromazine,0.9922930002212524,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Acepromazine.,49,Type_49,Yes
DB00279,Liothyronine,DB00651,Dyphylline,0.5737911462783813,75,Type_75,The serum concentration of Dyphylline can be decreased when it is combined with Liothyronine.,4,Type_4,No
DB01064,Isoprenaline,DB01367,Rasagiline,0.864868700504303,49,Type_49,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Rasagiline.,49,Type_49,Yes
DB01240,Epoprostenol,DB09244,Pirlindole,0.9883735775947571,60,Type_60,Epoprostenol may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00949,Felbamate,DB01086,Benzocaine,0.9864308834075928,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Benzocaine.,49,Type_49,Yes
DB00722,Lisinopril,DB01002,Levobupivacaine,0.6782069802284241,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Levobupivacaine.,49,Type_49,Yes
DB00569,Fondaparinux,DB00870,Suprofen,0.9961942434310913,6,Type_6,Fondaparinux may increase the anticoagulant activities of Suprofen.,6,Type_6,Yes
DB00737,Meclizine,DB00752,Tranylcypromine,0.9111819267272949,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Tranylcypromine.,49,Type_49,Yes
DB00420,Promazine,DB08893,Mirabegron,0.5854113698005676,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Promazine.,20,Type_20,No
DB00691,Moexipril,DB01189,Desflurane,0.9692007303237915,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Desflurane.,49,Type_49,Yes
DB00677,Isoflurophate,DB00959,Methylprednisolone,0.9858012795448303,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Methylprednisolone.,49,Type_49,Yes
DB01236,Sevoflurane,DB09117,Paraldehyde,0.978958785533905,16,Type_16,Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00318,Codeine,DB01338,Pipecuronium,0.9997450709342957,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Pipecuronium.,49,Type_49,Yes
DB00835,Brompheniramine,DB01544,Flunitrazepam,0.9833810329437256,49,Type_49,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Flunitrazepam.,49,Type_49,Yes
DB00722,Lisinopril,DB00862,Vardenafil,0.9520081281661987,10,Type_10,Lisinopril may increase the antihypertensive activities of Vardenafil.,10,Type_10,Yes
DB00976,Telithromycin,DB01591,Solifenacin,0.49512243270874023,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00734,Risperidone,DB01002,Levobupivacaine,0.9663203954696655,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Levobupivacaine.,60,Type_60,No
DB00945,Acetylsalicylic acid,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Acetylsalicylic acid.,70,Type_70,Yes
DB00979,Cyclopentolate,DB01433,Methadyl acetate,0.9999945163726807,49,Type_49,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Methadyl acetate.,49,Type_49,Yes
DB00872,Conivaptan,DB09038,Empagliflozin,0.9175719618797302,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Empagliflozin.,49,Type_49,Yes
DB00257,Clotrimazole,DB01224,Quetiapine,0.680647611618042,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00461,Nabumetone,DB04951,Pirfenidone,0.9637368321418762,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Pirfenidone.,49,Type_49,Yes
DB00384,Triamterene,DB00795,Sulfasalazine,0.9998729228973389,37,Type_37,Triamterene may decrease the antihypertensive activities of Sulfasalazine.,37,Type_37,Yes
DB00599,Thiopental,DB01295,Bevantolol,0.6157411932945251,60,Type_60,Thiopental may increase the hypotensive activities of Bevantolol.,75,Type_75,No
DB00091,Cyclosporine,DB06412,Oxymetholone,0.9506347179412842,80,Type_80,Cyclosporine may increase the hepatotoxic activities of Oxymetholone.,80,Type_80,Yes
DB00201,Caffeine,DB06207,Silodosin,0.9254645705223083,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Caffeine.,73,Type_73,Yes
DB00408,Loxapine,DB01221,Ketamine,0.9975735545158386,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Ketamine.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01080,Vigabatrin,0.988822340965271,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Vigabatrin.,49,Type_49,Yes
DB00420,Promazine,DB01173,Orphenadrine,0.9998087286949158,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB01169,Arsenic trioxide,DB09477,Enalaprilat,0.6107386946678162,60,Type_60,Arsenic trioxide may increase the hypotensive activities of Enalaprilat.,49,Type_49,No
DB00210,Adapalene,DB00939,Meclofenamic acid,0.9997161030769348,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Meclofenamic acid.,49,Type_49,Yes
DB00962,Zaleplon,DB01263,Posaconazole,0.7276055812835693,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Zaleplon.,47,Type_47,Yes
DB00872,Conivaptan,DB08827,Lomitapide,0.9840794205665588,73,Type_73,The serum concentration of Lomitapide can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00951,Isoniazid,DB11921,Deflazacort,0.49322912096977234,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Isoniazid.,75,Type_75,No
DB00700,Eplerenone,DB01229,Paclitaxel,0.9968293309211731,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Paclitaxel.,49,Type_49,Yes
DB00940,Methantheline,DB00944,Demecarium,0.98895263671875,70,Type_70,The therapeutic efficacy of Demecarium can be decreased when used in combination with Methantheline.,70,Type_70,Yes
DB00490,Buspirone,DB01351,Amobarbital,0.9509778618812561,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Amobarbital.,49,Type_49,Yes
DB00906,Tiagabine,DB13872,Lormetazepam,0.9993517994880676,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Lormetazepam.,49,Type_49,Yes
DB00203,Sildenafil,DB00700,Eplerenone,0.6955869197845459,73,Type_73,The serum concentration of Eplerenone can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB00492,Fosinopril,DB04846,Celiprolol,0.6997748613357544,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Celiprolol.,60,Type_60,No
DB00619,Imatinib,DB06636,Isavuconazonium,0.7085747718811035,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Imatinib.,73,Type_73,No
DB00643,Mebendazole,DB06290,Simeprevir,0.9666467905044556,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Mebendazole.,73,Type_73,Yes
DB00434,Cyproheptadine,DB00660,Metaxalone,0.999835729598999,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Metaxalone.,49,Type_49,Yes
DB01219,Dantrolene,DB06700,Desvenlafaxine,0.9830597639083862,49,Type_49,The risk or severity of adverse effects can be increased when Dantrolene is combined with Desvenlafaxine.,49,Type_49,Yes
DB01349,Tasosartan,DB08981,Fenbufen,0.9845107793807983,49,Type_49,The risk or severity of adverse effects can be increased when Tasosartan is combined with Fenbufen.,49,Type_49,Yes
DB00909,Zonisamide,DB09074,Olaparib,0.901107907295227,47,Type_47,The metabolism of Olaparib can be decreased when combined with Zonisamide.,47,Type_47,Yes
DB00943,Zalcitabine,DB09330,Osimertinib,0.9420997500419617,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Zalcitabine.,73,Type_73,Yes
DB00408,Loxapine,DB00472,Fluoxetine,0.5681968927383423,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Fluoxetine.,49,Type_49,Yes
DB00350,Minoxidil,DB01018,Guanfacine,0.6912155151367188,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Guanfacine.,49,Type_49,Yes
DB00186,Lorazepam,DB04946,Iloperidone,0.9869416356086731,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Iloperidone.,49,Type_49,Yes
DB00708,Sufentanil,DB08918,Levomilnacipran,0.8303515315055847,64,Type_64,Sufentanil may increase the serotonergic activities of Levomilnacipran.,64,Type_64,Yes
DB09245,Toloxatone,DB13139,Levosalbutamol,0.9923402070999146,49,Type_49,The risk or severity of adverse effects can be increased when Toloxatone is combined with Levosalbutamol.,49,Type_49,Yes
DB01002,Levobupivacaine,DB01118,Amiodarone,0.8507591485977173,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Levobupivacaine.,73,Type_73,No
DB00421,Spironolactone,DB06204,Tapentadol,0.9823580384254456,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Tapentadol.,49,Type_49,Yes
DB00502,Haloperidol,DB02709,Resveratrol,0.7178316712379456,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Resveratrol.,49,Type_49,Yes
DB00393,Nimodipine,DB01023,Felodipine,0.5242229104042053,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Felodipine.,49,Type_49,Yes
DB00736,Esomeprazole,DB01576,Dextroamphetamine,0.9671739339828491,18,Type_18,Esomeprazole can cause an increase in the absorption of Dextroamphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB00258,Calcium acetate,DB06210,Eltrombopag,0.9001114964485168,75,Type_75,The serum concentration of Eltrombopag can be decreased when it is combined with Calcium acetate.,75,Type_75,Yes
DB00582,Voriconazole,DB00663,Flumethasone,0.9755797386169434,73,Type_73,The serum concentration of Flumethasone can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB01053,Benzylpenicillin,DB06696,Arbekacin,0.9998856782913208,75,Type_75,The serum concentration of Arbekacin can be decreased when it is combined with Benzylpenicillin.,75,Type_75,Yes
DB00881,Quinapril,DB01018,Guanfacine,0.7927202582359314,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Guanfacine.,49,Type_49,Yes
DB00208,Ticlopidine,DB09074,Olaparib,0.7344212532043457,47,Type_47,The metabolism of Olaparib can be decreased when combined with Ticlopidine.,73,Type_73,No
DB01151,Desipramine,DB04896,Milnacipran,0.8048837780952454,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Milnacipran.,49,Type_49,Yes
DB00289,Atomoxetine,DB01590,Everolimus,0.9725767970085144,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Atomoxetine.,73,Type_73,Yes
DB00611,Butorphanol,DB01154,Thiamylal,0.9969030022621155,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiamylal.,49,Type_49,Yes
DB00178,Ramipril,DB04948,Lofexidine,0.8401578068733215,60,Type_60,Ramipril may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00180,Flunisolide,DB00554,Piroxicam,0.9986417889595032,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Piroxicam.,49,Type_49,Yes
DB00270,Isradipine,DB00482,Celecoxib,0.9220294952392578,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00206,Reserpine,DB09242,Moxonidine,0.529245913028717,60,Type_60,Reserpine may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB01623,Thiothixene,DB08881,Vemurafenib,0.7870480418205261,33,Type_33,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vemurafenib.,73,Type_73,No
DB00374,Treprostinil,DB01580,Oxprenolol,0.8797425031661987,60,Type_60,Treprostinil may increase the hypotensive activities of Oxprenolol.,60,Type_60,Yes
DB01193,Acebutolol,DB08931,Riociguat,0.46223849058151245,49,Type_49,The risk or severity of adverse effects can be increased when Acebutolol is combined with Riociguat.,49,Type_49,Yes
DB00625,Efavirenz,DB00752,Tranylcypromine,0.33149972558021545,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Tranylcypromine.,49,Type_49,Yes
DB00715,Paroxetine,DB08918,Levomilnacipran,0.7530587315559387,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Levomilnacipran.,47,Type_47,No
DB00675,Tamoxifen,DB06402,Telavancin,0.9999872446060181,20,Type_20,Tamoxifen may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB01068,Clonazepam,DB06636,Isavuconazonium,0.7693397402763367,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Clonazepam.,47,Type_47,Yes
DB00182,Amphetamine,DB01238,Aripiprazole,0.8376214504241943,61,Type_61,Amphetamine may decrease the stimulatory activities of Aripiprazole.,61,Type_61,Yes
DB00796,Candesartan cilexetil,DB01401,Choline magnesium trisalicylate,0.9370349049568176,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00321,Amitriptyline,DB01030,Topotecan,0.992798924446106,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Amitriptyline.,73,Type_73,Yes
DB00266,Dicoumarol,DB00713,Oxacillin,0.9862313866615295,6,Type_6,Dicoumarol may increase the anticoagulant activities of Oxacillin.,6,Type_6,Yes
DB01551,Dihydrocodeine,DB06700,Desvenlafaxine,0.9178467392921448,64,Type_64,Dihydrocodeine may increase the serotonergic activities of Desvenlafaxine.,64,Type_64,Yes
DB00656,Trazodone,DB01356,Lithium cation,0.6269695162773132,35,Type_35,Trazodone may increase the neurotoxic activities of Lithium cation.,49,Type_49,No
DB01017,Minocycline,DB01174,Phenobarbital,0.8751657605171204,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.,16,Type_16,Yes
DB00679,Thioridazine,DB09274,Artesunate,0.6001161932945251,73,Type_73,The serum concentration of Artesunate can be increased when it is combined with Thioridazine.,73,Type_73,Yes
DB01410,Ciclesonide,DB09084,Benzydamine,0.9995576739311218,49,Type_49,The risk or severity of adverse effects can be increased when Ciclesonide is combined with Benzydamine.,49,Type_49,Yes
DB00262,Carmustine,DB01609,Deferasirox,0.7893033623695374,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Carmustine.,73,Type_73,No
DB00091,Cyclosporine,DB00426,Famciclovir,0.8347694277763367,47,Type_47,The metabolism of Famciclovir can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB01080,Vigabatrin,DB01106,Levocabastine,0.9968904852867126,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Levocabastine.,49,Type_49,Yes
DB08439,Parecoxib,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Parecoxib.,70,Type_70,Yes
DB01120,Gliclazide,DB09009,Articaine,0.9990513920783997,70,Type_70,The therapeutic efficacy of Articaine can be decreased when used in combination with Gliclazide.,70,Type_70,Yes
DB00690,Flurazepam,DB01563,Chloral hydrate,0.9999806880950928,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Chloral hydrate.,49,Type_49,Yes
DB06413,Armodafinil,DB09570,Ixazomib,0.9415354132652283,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Armodafinil.,47,Type_47,Yes
DB00469,Tenoxicam,DB00955,Netilmicin,0.9999150037765503,72,Type_72,Tenoxicam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB00570,Vinblastine,DB06708,Lumefantrine,0.7908486127853394,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB01200,Bromocriptine,DB01626,Pargyline,0.4295137822628021,47,Type_47,The metabolism of Pargyline can be decreased when combined with Bromocriptine.,9,Type_9,No
DB00254,Doxycycline,DB06792,Lanthanum carbonate,0.9935530424118042,75,Type_75,The serum concentration of Lanthanum carbonate can be decreased when it is combined with Doxycycline.,75,Type_75,Yes
DB01110,Miconazole,DB09232,Cilnidipine,0.998127281665802,49,Type_49,The risk or severity of adverse effects can be increased when Miconazole is combined with Cilnidipine.,49,Type_49,Yes
DB00246,Ziprasidone,DB13025,Tiapride,0.963546872138977,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tiapride.,49,Type_49,Yes
DB00673,Aprepitant,DB00758,Clopidogrel,0.6179257035255432,73,Type_73,The serum concentration of Clopidogrel can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00909,Zonisamide,DB00934,Maprotiline,0.9988334774971008,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Maprotiline.,49,Type_49,Yes
DB00461,Nabumetone,DB01029,Irbesartan,0.6182443499565125,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Nabumetone.,49,Type_49,No
DB00806,Pentoxifylline,DB04272,Citric acid,0.9974651336669922,6,Type_6,Pentoxifylline may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00255,Diethylstilbestrol,DB01095,Fluvastatin,0.5430572032928467,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00907,Cocaine,DB09068,Vortioxetine,0.8717502951622009,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Vortioxetine.,73,Type_73,No
DB00296,Ropivacaine,DB00379,Mexiletine,0.9664674401283264,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00215,Citalopram,DB08933,Luliconazole,0.9737367630004883,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Citalopram.,73,Type_73,Yes
DB00321,Amitriptyline,DB00675,Tamoxifen,0.40789350867271423,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Tamoxifen.,47,Type_47,No
DB00204,Dofetilide,DB01151,Desipramine,0.3813542425632477,73,Type_73,The serum concentration of Desipramine can be increased when it is combined with Dofetilide.,20,Type_20,No
DB04951,Pirfenidone,DB09214,Dexketoprofen,0.9068695902824402,49,Type_49,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Dexketoprofen.,49,Type_49,Yes
DB00656,Trazodone,DB01142,Doxepin,0.671696662902832,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Doxepin.,49,Type_49,Yes
DB01393,Bezafibrate,DB06817,Raltegravir,0.7385422587394714,48,Type_48,Bezafibrate may increase the myopathic rhabdomyolysis activities of Raltegravir.,48,Type_48,Yes
DB00384,Triamterene,DB06737,Zaltoprofen,0.9953533411026001,37,Type_37,Triamterene may decrease the antihypertensive activities of Zaltoprofen.,37,Type_37,Yes
DB01600,Tiaprofenic acid,DB06810,Plicamycin,0.9999626874923706,72,Type_72,Tiaprofenic acid may decrease the excretion rate of Plicamycin which could result in a higher serum level.,72,Type_72,Yes
DB00908,Quinidine,DB01107,Methyprylon,0.9978247880935669,47,Type_47,The metabolism of Methyprylon can be decreased when combined with Quinidine.,47,Type_47,Yes
DB01200,Bromocriptine,DB09063,Ceritinib,0.9956662654876709,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Bromocriptine.,73,Type_73,Yes
DB00266,Dicoumarol,DB00993,Azathioprine,0.6032277345657349,12,Type_12,Dicoumarol may decrease the anticoagulant activities of Azathioprine.,12,Type_12,Yes
DB00967,Desloratadine,DB01149,Nefazodone,0.7966325879096985,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Nefazodone.,49,Type_49,Yes
DB00374,Treprostinil,DB00794,Primidone,0.6398111581802368,4,Type_4,The metabolism of Primidone can be increased when combined with Treprostinil.,75,Type_75,No
DB01183,Naloxone,DB01263,Posaconazole,0.9547752141952515,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Naloxone.,47,Type_47,Yes
DB00511,Acetyldigitoxin,DB00550,Propylthiouracil,0.9750995635986328,73,Type_73,The serum concentration of Propylthiouracil can be increased when it is combined with Acetyldigitoxin.,73,Type_73,Yes
DB00321,Amitriptyline,DB00889,Granisetron,0.8294153213500977,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00224,Indinavir,DB01380,Cortisone acetate,0.9370075464248657,47,Type_47,The metabolism of Cortisone acetate can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01075,Diphenhydramine,DB09017,Brotizolam,0.9999532699584961,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Brotizolam.,49,Type_49,Yes
DB00334,Olanzapine,DB00502,Haloperidol,0.8869873285293579,20,Type_20,Olanzapine may increase the QTc-prolonging activities of Haloperidol.,20,Type_20,Yes
DB00468,Quinine,DB00530,Erlotinib,0.9509442448616028,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Quinine.,47,Type_47,Yes
DB00964,Apraclonidine,DB01355,Hexobarbital,0.9589211940765381,30,Type_30,Apraclonidine may increase the orthostatic hypotensive activities of Hexobarbital.,60,Type_60,No
DB00391,Sulpiride,DB00645,Dyclonine,0.9978929162025452,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Dyclonine.,49,Type_49,Yes
DB01200,Bromocriptine,DB06774,Capsaicin,0.757530152797699,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Capsaicin.,49,Type_49,Yes
DB00876,Eprosartan,DB00999,Hydrochlorothiazide,0.7754032015800476,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00502,Haloperidol,DB00556,Perflutren,0.9999650716781616,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Perflutren.,20,Type_20,Yes
DB06725,Lornoxicam,DB08970,Fluprednidene,0.99974125623703,49,Type_49,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fluprednidene.,49,Type_49,Yes
DB00951,Isoniazid,DB01184,Domperidone,0.6150804758071899,47,Type_47,The metabolism of Domperidone can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB04871,Lorcaserin,DB06414,Etravirine,0.8685898780822754,47,Type_47,The metabolism of Etravirine can be decreased when combined with Lorcaserin.,47,Type_47,Yes
DB00270,Isradipine,DB00802,Alfentanil,0.683605432510376,47,Type_47,The metabolism of Alfentanil can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB01380,Cortisone acetate,0.7413007020950317,47,Type_47,The metabolism of Cortisone acetate can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00186,Lorazepam,DB00715,Paroxetine,0.9443585872650146,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Paroxetine.,49,Type_49,Yes
DB00434,Cyproheptadine,DB00593,Ethosuximide,0.9995012283325195,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Ethosuximide.,49,Type_49,Yes
DB00370,Mirtazapine,DB01403,Methotrimeprazine,0.9990615248680115,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00273,Topiramate,DB00999,Hydrochlorothiazide,0.5833110809326172,83,Type_83,Topiramate may increase the hypokalemic activities of Hydrochlorothiazide.,83,Type_83,Yes
DB00781,Polymyxin B,DB01336,Metocurine,1.0,21,Type_21,Polymyxin B may increase the neuromuscular blocking activities of Metocurine.,21,Type_21,Yes
DB01185,Fluoxymesterone,DB06786,Halcinonide,0.9999998807907104,74,Type_74,Fluoxymesterone may increase the fluid retaining activities of Halcinonide.,74,Type_74,Yes
DB00201,Caffeine,DB01065,Melatonin,0.8010578155517578,47,Type_47,The metabolism of Melatonin can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00681,Amphotericin B,DB09477,Enalaprilat,0.9943406581878662,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Enalaprilat.,49,Type_49,Yes
DB00425,Zolpidem,DB01012,Cinacalcet,0.7025757431983948,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Zolpidem.,47,Type_47,Yes
DB01010,Edrophonium,DB08808,Bupranolol,0.9954344630241394,54,Type_54,Edrophonium may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB08881,Vemurafenib,DB11581,Venetoclax,0.6787200570106506,73,Type_73,The serum concentration of Venetoclax can be increased when it is combined with Vemurafenib.,73,Type_73,Yes
DB00633,Dexmedetomidine,DB01178,Chlormezanone,0.9991658926010132,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Chlormezanone.,49,Type_49,Yes
DB00384,Triamterene,DB00611,Butorphanol,0.9885541796684265,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Butorphanol.,49,Type_49,Yes
DB00373,Timolol,DB09218,Clonixin,0.9045020341873169,37,Type_37,Timolol may decrease the antihypertensive activities of Clonixin.,37,Type_37,Yes
DB00582,Voriconazole,DB00752,Tranylcypromine,0.8608332276344299,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00328,Indomethacin,DB00663,Flumethasone,0.9995167255401611,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Flumethasone.,49,Type_49,Yes
DB00521,Carteolol,DB06603,Panobinostat,0.8412851095199585,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Carteolol.,73,Type_73,Yes
DB00582,Voriconazole,DB01431,Allylestrenol,0.9391596913337708,47,Type_47,The metabolism of Allylestrenol can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00899,Remifentanil,DB01075,Diphenhydramine,0.9456615447998047,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Diphenhydramine.,49,Type_49,Yes
DB00327,Hydromorphone,DB00909,Zonisamide,0.996411144733429,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zonisamide.,49,Type_49,Yes
DB00304,Desogestrel,DB01601,Lopinavir,0.7925398349761963,75,Type_75,The serum concentration of Lopinavir can be decreased when it is combined with Desogestrel.,75,Type_75,Yes
DB06772,Cabazitaxel,DB09330,Osimertinib,0.6653241515159607,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Cabazitaxel.,73,Type_73,Yes
DB00922,Levosimendan,DB01235,Levodopa,0.9029016494750977,30,Type_30,Levosimendan may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00394,Beclomethasone dipropionate,DB01397,Magnesium salicylate,0.9862098097801208,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Magnesium salicylate.,49,Type_49,Yes
DB00784,Mefenamic acid,DB00790,Perindopril,0.9289681911468506,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Perindopril.,49,Type_49,Yes
DB00559,Bosentan,DB00656,Trazodone,0.8559035658836365,75,Type_75,The serum concentration of Trazodone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB06212,Tolvaptan,DB11730,Ribociclib,0.9895826578140259,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB00344,Protriptyline,DB01030,Topotecan,0.9916770458221436,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Protriptyline.,73,Type_73,Yes
DB00296,Ropivacaine,DB00904,Ondansetron,0.9430378079414368,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ondansetron.,49,Type_49,Yes
DB00648,Mitotane,DB06292,Dapagliflozin,0.9654720425605774,75,Type_75,The serum concentration of Dapagliflozin can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00498,Phenindione,DB00564,Carbamazepine,0.9837786555290222,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Phenindione.,75,Type_75,No
DB00180,Flunisolide,DB00805,Minaprine,0.8957264423370361,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Minaprine.,49,Type_49,Yes
DB00657,Mecamylamine,DB06696,Arbekacin,0.9439036846160889,21,Type_21,Mecamylamine may increase the neuromuscular blocking activities of Arbekacin.,21,Type_21,Yes
DB00652,Pentazocine,DB00754,Ethotoin,0.9954223036766052,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Ethotoin.,49,Type_49,Yes
DB00454,Meperidine,DB00999,Hydrochlorothiazide,0.9868707656860352,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00259,Sulfanilamide,DB09270,Ubidecarenone,0.8385531306266785,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Sulfanilamide.,73,Type_73,Yes
DB00199,Erythromycin,DB06414,Etravirine,0.7685043811798096,47,Type_47,The metabolism of Etravirine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00312,Pentobarbital,DB01072,Atazanavir,0.5907628536224365,4,Type_4,The metabolism of Atazanavir can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01018,Guanfacine,DB06216,Asenapine,0.7468772530555725,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Asenapine.,49,Type_49,Yes
DB00812,Phenylbutazone,DB01059,Norfloxacin,0.9972289204597473,27,Type_27,Phenylbutazone may increase the neuroexcitatory activities of Norfloxacin.,27,Type_27,Yes
DB01244,Bepridil,DB05521,Telaprevir,0.7537640929222107,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Bepridil.,49,Type_49,No
DB01166,Cilostazol,DB06636,Isavuconazonium,0.3910660743713379,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Cilostazol.,73,Type_73,No
DB00374,Treprostinil,DB06268,Sitaxentan,0.9710220694541931,60,Type_60,Treprostinil may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00961,Mepivacaine,DB00972,Azelastine,0.9504089951515198,16,Type_16,Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00193,Tramadol,DB00850,Perphenazine,0.8996834754943848,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Perphenazine.,49,Type_49,Yes
DB00387,Procyclidine,DB00899,Remifentanil,0.9999487400054932,49,Type_49,The risk or severity of adverse effects can be increased when Procyclidine is combined with Remifentanil.,49,Type_49,Yes
DB01588,Prazepam,DB08820,Ivacaftor,0.9968564510345459,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Prazepam.,73,Type_73,Yes
DB00831,Trifluoperazine,DB01215,Estazolam,0.9969363212585449,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Estazolam.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB06292,Dapagliflozin,0.9609997272491455,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00257,Clotrimazole,DB00869,Dorzolamide,0.9403976202011108,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01113,Papaverine,DB09236,Lacidipine,0.9775813817977905,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Lacidipine.,49,Type_49,Yes
DB01192,Oxymorphone,DB09225,Zotepine,0.99856036901474,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Zotepine.,49,Type_49,Yes
DB00014,Goserelin,DB00656,Trazodone,0.9998080134391785,20,Type_20,Goserelin may increase the QTc-prolonging activities of Trazodone.,20,Type_20,Yes
DB00607,Nafcillin,DB00661,Verapamil,0.3297172784805298,73,Type_73,The serum concentration of Verapamil can be increased when it is combined with Nafcillin.,4,Type_4,No
DB00681,Amphotericin B,DB00742,Mannitol,0.9994864463806152,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Mannitol.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB00611,Butorphanol,0.9983046054840088,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Butorphanol.,49,Type_49,Yes
DB00749,Etodolac,DB00808,Indapamide,0.9533897042274475,70,Type_70,The therapeutic efficacy of Indapamide can be decreased when used in combination with Etodolac.,70,Type_70,Yes
DB00208,Ticlopidine,DB00933,Mesoridazine,0.712949275970459,47,Type_47,The metabolism of Mesoridazine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00188,Bortezomib,DB04835,Maraviroc,0.8031517863273621,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00623,Fluphenazine,DB06595,Midostaurin,0.7235462069511414,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Fluphenazine.,47,Type_47,Yes
DB00816,Orciprenaline,DB01367,Rasagiline,0.9913649559020996,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Rasagiline.,49,Type_49,Yes
DB00582,Voriconazole,DB05246,Methsuximide,0.8895320892333984,47,Type_47,The metabolism of Methsuximide can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB01138,Sulfinpyrazone,DB08880,Teriflunomide,0.4669392704963684,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Sulfinpyrazone.,47,Type_47,No
DB00373,Timolol,DB05812,Abiraterone,0.476811945438385,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Timolol.,73,Type_73,Yes
DB00563,Methotrexate,DB00963,Bromfenac,0.7812365293502808,73,Type_73,The serum concentration of Bromfenac can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB01092,Ouabain,DB06626,Axitinib,0.9995394945144653,58,Type_58,Ouabain may decrease the cardiotoxic activities of Axitinib.,58,Type_58,Yes
DB00344,Protriptyline,DB01608,Periciazine,0.8951982259750366,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Periciazine.,49,Type_49,Yes
DB01077,Etidronic acid,DB09216,Tolfenamic acid,0.9980735778808594,49,Type_49,The risk or severity of adverse effects can be increased when Etidronic acid is combined with Tolfenamic acid.,49,Type_49,Yes
DB01236,Sevoflurane,DB13323,Trichloroethylene,0.9942750334739685,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Trichloroethylene.,49,Type_49,Yes
DB01268,Sunitinib,DB09054,Idelalisib,0.5414830446243286,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Sunitinib.,47,Type_47,Yes
DB00498,Phenindione,DB00713,Oxacillin,0.9870303273200989,6,Type_6,Phenindione may increase the anticoagulant activities of Oxacillin.,6,Type_6,Yes
DB08899,Enzalutamide,DB09123,Dienogest,0.5506224036216736,75,Type_75,The serum concentration of Dienogest can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB01114,Chlorpheniramine,DB09330,Osimertinib,0.8966363668441772,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Chlorpheniramine.,73,Type_73,Yes
DB01097,Leflunomide,DB09138,Technetium Tc-99m medronate,0.9994024038314819,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Technetium Tc-99m medronate.,49,Type_49,Yes
DB00527,Cinchocaine,DB00850,Perphenazine,0.9998393058776855,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Perphenazine.,49,Type_49,Yes
DB08971,Fluocortolone,DB08981,Fenbufen,0.9997541308403015,49,Type_49,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Fenbufen.,49,Type_49,Yes
DB00346,Alfuzosin,DB08933,Luliconazole,0.9977858066558838,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Alfuzosin.,73,Type_73,Yes
DB01245,Decamethonium,DB01380,Cortisone acetate,0.9918374419212341,49,Type_49,The risk or severity of adverse effects can be increased when Decamethonium is combined with Cortisone acetate.,49,Type_49,Yes
DB00690,Flurazepam,DB09166,Etizolam,0.9944513440132141,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Etizolam.,49,Type_49,Yes
DB00264,Metoprolol,DB06480,Prucalopride,0.9870758652687073,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00191,Phentermine,DB00708,Sufentanil,0.9971129894256592,69,Type_69,Phentermine may increase the analgesic activities of Sufentanil.,69,Type_69,Yes
DB00266,Dicoumarol,DB01061,Azlocillin,0.9904054999351501,6,Type_6,Dicoumarol may increase the anticoagulant activities of Azlocillin.,6,Type_6,Yes
DB01355,Hexobarbital,DB05271,Rotigotine,0.9887902736663818,32,Type_32,Hexobarbital may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00381,Amlodipine,DB00922,Levosimendan,0.8415107131004333,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Levosimendan.,49,Type_49,Yes
DB01059,Norfloxacin,DB01273,Varenicline,0.5632809996604919,73,Type_73,The serum concentration of Varenicline can be increased when it is combined with Norfloxacin.,73,Type_73,Yes
DB00238,Nevirapine,DB01074,Perhexiline,0.6167332530021667,4,Type_4,The metabolism of Perhexiline can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00802,Alfentanil,DB00804,Dicyclomine,0.9999938011169434,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Dicyclomine.,49,Type_49,Yes
DB00091,Cyclosporine,DB01601,Lopinavir,0.8812841176986694,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00398,Sorafenib,DB06292,Dapagliflozin,0.8888131380081177,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB01253,Ergometrine,DB01365,Mephentermine,0.5905922055244446,71,Type_71,Ergometrine may increase the hypertensive activities of Mephentermine.,71,Type_71,Yes
DB00482,Celecoxib,DB00750,Prilocaine,0.9963070154190063,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Prilocaine.,49,Type_49,Yes
DB00691,Moexipril,DB04861,Nebivolol,0.5245131254196167,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Nebivolol.,49,Type_49,Yes
DB01068,Clonazepam,DB01219,Dantrolene,0.992833137512207,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Dantrolene.,49,Type_49,Yes
DB00620,Triamcinolone,DB09215,Droxicam,0.9996316432952881,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Droxicam.,49,Type_49,Yes
DB00188,Bortezomib,DB00497,Oxycodone,0.8384816646575928,47,Type_47,The metabolism of Oxycodone can be decreased when combined with Bortezomib.,49,Type_49,No
DB00914,Phenformin,DB01120,Gliclazide,0.9771361351013184,9,Type_9,Phenformin may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB01170,Guanethidine,DB01214,Metipranolol,0.9999537467956543,60,Type_60,Guanethidine may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00870,Suprofen,DB06781,Difluprednate,0.9997357726097107,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Difluprednate.,49,Type_49,Yes
DB00104,Octreotide,DB06216,Asenapine,0.974430501461029,20,Type_20,Octreotide may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00715,Paroxetine,DB01238,Aripiprazole,0.5301999449729919,20,Type_20,Paroxetine may increase the QTc-prolonging activities of Aripiprazole.,49,Type_49,No
DB00337,Pimecrolimus,DB00870,Suprofen,0.9969643950462341,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Suprofen.,49,Type_49,Yes
DB00906,Tiagabine,DB01351,Amobarbital,0.9930821061134338,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Amobarbital.,49,Type_49,Yes
DB01214,Metipranolol,DB01242,Clomipramine,0.4541339576244354,73,Type_73,The serum concentration of Clomipramine can be increased when it is combined with Metipranolol.,49,Type_49,No
DB00230,Pregabalin,DB00486,Nabilone,0.6561487317085266,70,Type_70,The therapeutic efficacy of Nabilone can be decreased when used in combination with Pregabalin.,16,Type_16,No
DB00687,Fludrocortisone,DB00903,Etacrynic acid,0.9999631643295288,83,Type_83,Fludrocortisone may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB01210,Levobunolol,DB08865,Crizotinib,0.9486839771270752,54,Type_54,Levobunolol may increase the bradycardic activities of Crizotinib.,54,Type_54,Yes
DB00907,Cocaine,DB13025,Tiapride,0.998314380645752,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Tiapride.,49,Type_49,Yes
DB00379,Mexiletine,DB04572,Thiotepa,0.9902750253677368,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01248,Docetaxel,DB02513,Thymol,0.7213536500930786,47,Type_47,The metabolism of Thymol can be decreased when combined with Docetaxel.,47,Type_47,Yes
DB00297,Bupivacaine,DB00967,Desloratadine,0.9976303577423096,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Desloratadine.,49,Type_49,Yes
DB00243,Ranolazine,DB00639,Butoconazole,0.7563451528549194,73,Type_73,The serum concentration of Butoconazole can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00391,Sulpiride,DB00829,Diazepam,0.987992525100708,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Diazepam.,49,Type_49,Yes
DB01144,Diclofenamide,DB09112,Nitrous acid,0.9985021352767944,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenamide is combined with Nitrous acid.,49,Type_49,Yes
DB06207,Silodosin,DB09048,Netupitant,0.9995482563972473,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Silodosin.,73,Type_73,Yes
DB00482,Celecoxib,DB03128,Acetylcholine,0.9877449870109558,47,Type_47,The metabolism of Acetylcholine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00846,Flurandrenolide,DB08880,Teriflunomide,0.9485230445861816,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Teriflunomide.,49,Type_49,Yes
DB00806,Pentoxifylline,DB08808,Bupranolol,0.9887338876724243,60,Type_60,Pentoxifylline may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00433,Prochlorperazine,DB00648,Mitotane,0.9898854494094849,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Prochlorperazine.,75,Type_75,Yes
DB00176,Fluvoxamine,DB00285,Venlafaxine,0.8529724478721619,47,Type_47,The metabolism of Venlafaxine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00758,Clopidogrel,DB01244,Bepridil,0.6289994716644287,47,Type_47,The metabolism of Bepridil can be decreased when combined with Clopidogrel.,70,Type_70,No
DB00518,Albendazole,DB01174,Phenobarbital,0.9283662438392639,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Albendazole.,11,Type_11,No
DB01466,Ethylmorphine,DB08910,Pomalidomide,0.9764566421508789,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pomalidomide.,49,Type_49,Yes
DB02703,Fusidic acid,DB08893,Mirabegron,0.9981048107147217,73,Type_73,The serum concentration of Mirabegron can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB00207,Azithromycin,DB01097,Leflunomide,0.5728961825370789,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00301,Flucloxacillin,DB06810,Plicamycin,0.999910831451416,75,Type_75,The serum concentration of Plicamycin can be decreased when it is combined with Flucloxacillin.,75,Type_75,Yes
DB00582,Voriconazole,DB01274,Arformoterol,0.6778692603111267,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00396,Progesterone,DB01075,Diphenhydramine,0.9564557671546936,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Progesterone.,47,Type_47,Yes
DB00788,Naproxen,DB08816,Ticagrelor,0.8560805916786194,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Naproxen.,47,Type_47,Yes
DB00420,Promazine,DB00601,Linezolid,0.8899480104446411,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Linezolid.,49,Type_49,Yes
DB00208,Ticlopidine,DB05109,Trabectedin,0.8698402643203735,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00492,Fosinopril,DB00608,Chloroquine,0.5116475820541382,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Chloroquine.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB08912,Dabrafenib,0.5098265409469604,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Ciprofloxacin.,20,Type_20,No
DB00237,Butabarbital,DB00599,Thiopental,0.9981813430786133,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Thiopental.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB06684,Vilazodone,0.4971226751804352,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vilazodone.,73,Type_73,No
DB00252,Phenytoin,DB06712,Nilvadipine,0.5501756072044373,4,Type_4,The metabolism of Nilvadipine can be increased when combined with Phenytoin.,73,Type_73,No
DB00669,Sumatriptan,DB09286,Pipamperone,0.95610511302948,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pipamperone.,49,Type_49,Yes
DB00641,Simvastatin,DB06603,Panobinostat,0.9635036587715149,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00412,Rosiglitazone,DB08954,Ifenprodil,0.9757964611053467,6,Type_6,Rosiglitazone may increase the anticoagulant activities of Ifenprodil.,6,Type_6,Yes
DB00227,Lovastatin,DB00519,Trandolapril,0.5533505082130432,73,Type_73,The serum concentration of Trandolapril can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00195,Betaxolol,DB09070,Tibolone,0.9980276226997375,60,Type_60,Betaxolol may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB01167,Itraconazole,DB01260,Desonide,0.945174515247345,73,Type_73,The serum concentration of Desonide can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00363,Clozapine,DB00780,Phenelzine,0.690604567527771,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Phenelzine.,49,Type_49,Yes
DB00178,Ramipril,DB08907,Canagliflozin,0.8593284487724304,68,Type_68,Ramipril may increase the hyperkalemic activities of Canagliflozin.,68,Type_68,Yes
DB00564,Carbamazepine,DB01227,Levacetylmethadol,0.7485390901565552,4,Type_4,The metabolism of Levacetylmethadol can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00741,Hydrocortisone,DB09074,Olaparib,0.7810202240943909,47,Type_47,The metabolism of Olaparib can be decreased when combined with Hydrocortisone.,47,Type_47,Yes
DB00630,Alendronic acid,DB00955,Netilmicin,0.9999387264251709,24,Type_24,Alendronic acid may increase the hypocalcemic activities of Netilmicin.,24,Type_24,Yes
DB01075,Diphenhydramine,DB11148,Butamben,0.9997642636299133,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Butamben.,49,Type_49,Yes
DB01155,Gemifloxacin,DB01233,Metoclopramide,0.9856647253036499,20,Type_20,Gemifloxacin may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB03756,Doconexent,DB06595,Midostaurin,0.9504687190055847,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Doconexent.,47,Type_47,Yes
DB00343,Diltiazem,DB09198,Lobeglitazone,0.995938777923584,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01068,Clonazepam,DB06738,Ketobemidone,0.9819865226745605,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Ketobemidone.,49,Type_49,Yes
DB00797,Tolazoline,DB01041,Thalidomide,0.9511169195175171,49,Type_49,The risk or severity of adverse effects can be increased when Tolazoline is combined with Thalidomide.,49,Type_49,Yes
DB01171,Moclobemide,DB01614,Acepromazine,0.7975549697875977,49,Type_49,The risk or severity of adverse effects can be increased when Moclobemide is combined with Acepromazine.,49,Type_49,Yes
DB01174,Phenobarbital,DB09345,Pramocaine,0.999171257019043,49,Type_49,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Pramocaine.,49,Type_49,Yes
DB00281,Lidocaine,DB00972,Azelastine,0.888009250164032,16,Type_16,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00343,Diltiazem,DB00502,Haloperidol,0.7184010148048401,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00543,Amoxapine,DB01501,Difenoxin,0.9982262253761292,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Difenoxin.,49,Type_49,Yes
DB00203,Sildenafil,DB00296,Ropivacaine,0.846419095993042,47,Type_47,The metabolism of Ropivacaine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00797,Tolazoline,DB01018,Guanfacine,0.5183463096618652,49,Type_49,The risk or severity of adverse effects can be increased when Tolazoline is combined with Guanfacine.,60,Type_60,No
DB01201,Rifapentine,DB01587,Ketazolam,0.9310126900672913,4,Type_4,The metabolism of Ketazolam can be increased when combined with Rifapentine.,4,Type_4,Yes
DB00396,Progesterone,DB01030,Topotecan,0.9789904356002808,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00209,Trospium,DB00708,Sufentanil,0.9990940093994141,49,Type_49,The risk or severity of adverse effects can be increased when Trospium is combined with Sufentanil.,49,Type_49,Yes
DB00571,Propranolol,DB00907,Cocaine,0.8709609508514404,47,Type_47,The metabolism of Cocaine can be decreased when combined with Propranolol.,47,Type_47,Yes
DB00741,Hydrocortisone,DB01263,Posaconazole,0.6532034873962402,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Hydrocortisone.,47,Type_47,Yes
DB00467,Enoxacin,DB09147,Ferric pyrophosphate,0.9503259658813477,75,Type_75,The serum concentration of Ferric pyrophosphate can be decreased when it is combined with Enoxacin.,75,Type_75,Yes
DB05271,Rotigotine,DB06204,Tapentadol,0.7669976949691772,16,Type_16,Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,32,Type_32,No
DB00445,Epirubicin,DB01135,Doxacurium,0.9998750686645508,40,Type_40,Epirubicin may increase the respiratory depressant activities of Doxacurium.,40,Type_40,Yes
DB00599,Thiopental,DB09112,Nitrous acid,0.6385782361030579,60,Type_60,Thiopental may increase the hypotensive activities of Nitrous acid.,60,Type_60,Yes
DB00142,Glutamic acid,DB00191,Phentermine,0.9994403719902039,75,Type_75,The serum concentration of Phentermine can be decreased when it is combined with Glutamic acid.,75,Type_75,Yes
DB00187,Esmolol,DB01024,Mycophenolic acid,0.9920503497123718,37,Type_37,Esmolol may decrease the antihypertensive activities of Mycophenolic acid.,37,Type_37,Yes
DB00188,Bortezomib,DB00232,Methyclothiazide,0.9689072370529175,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Methyclothiazide.,49,Type_49,Yes
DB00540,Nortriptyline,DB00949,Felbamate,0.6342287063598633,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Felbamate.,49,Type_49,Yes
DB00783,Estradiol,DB01097,Leflunomide,0.8202070593833923,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Estradiol.,47,Type_47,Yes
DB00972,Azelastine,DB06288,Amisulpride,0.9663807153701782,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Amisulpride.,16,Type_16,Yes
DB00673,Aprepitant,DB05521,Telaprevir,0.9577324390411377,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00235,Milrinone,DB04743,Nimesulide,0.7586643695831299,53,Type_53,Milrinone may increase the antiplatelet activities of Nimesulide.,53,Type_53,Yes
DB06594,Agomelatine,DB09017,Brotizolam,0.9999958276748657,49,Type_49,The risk or severity of adverse effects can be increased when Agomelatine is combined with Brotizolam.,49,Type_49,Yes
DB00606,Cyclothiazide,DB00999,Hydrochlorothiazide,0.9923703670501709,60,Type_60,Cyclothiazide may increase the hypotensive activities of Hydrochlorothiazide.,60,Type_60,Yes
DB01609,Deferasirox,DB06216,Asenapine,0.9738922119140625,75,Type_75,The serum concentration of Asenapine can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB01026,Ketoconazole,DB01179,Podofilox,0.8417426943778992,47,Type_47,The metabolism of Podofilox can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00867,Ritodrine,DB08941,Isoxsuprine,0.9931339025497437,49,Type_49,The risk or severity of adverse effects can be increased when Ritodrine is combined with Isoxsuprine.,49,Type_49,Yes
DB00635,Prednisone,DB00735,Naftifine,0.9951706528663635,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Naftifine.,49,Type_49,Yes
DB08893,Mirabegron,DB09065,Cobicistat,0.6233091950416565,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Mirabegron.,73,Type_73,Yes
DB00687,Fludrocortisone,DB00880,Chlorothiazide,0.9999958276748657,83,Type_83,Fludrocortisone may increase the hypokalemic activities of Chlorothiazide.,83,Type_83,Yes
DB00625,Efavirenz,DB08872,Gabapentin enacarbil,0.9982403516769409,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00678,Losartan,DB06204,Tapentadol,0.753085196018219,47,Type_47,The metabolism of Tapentadol can be decreased when combined with Losartan.,47,Type_47,Yes
DB00622,Nicardipine,DB01026,Ketoconazole,0.7601564526557922,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB01120,Gliclazide,DB01268,Sunitinib,0.9700560569763184,9,Type_9,Gliclazide may increase the hypoglycemic activities of Sunitinib.,9,Type_9,Yes
DB00362,Anidulafungin,DB01320,Fosphenytoin,0.6401205658912659,73,Type_73,The serum concentration of Fosphenytoin can be increased when it is combined with Anidulafungin.,75,Type_75,No
DB00997,Doxorubicin,DB01435,Antipyrine,0.8579026460647583,72,Type_72,Doxorubicin may decrease the excretion rate of Antipyrine which could result in a higher serum level.,72,Type_72,Yes
DB01397,Magnesium salicylate,DB08992,Eperisone,0.8833011984825134,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Eperisone.,49,Type_49,Yes
DB00358,Mefloquine,DB00997,Doxorubicin,0.4006543457508087,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB08815,Lurasidone,DB08881,Vemurafenib,0.6258993148803711,33,Type_33,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Vemurafenib.,75,Type_75,No
DB00774,Hydroflumethiazide,DB01466,Ethylmorphine,0.9503301382064819,49,Type_49,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Ethylmorphine.,49,Type_49,Yes
DB00604,Cisapride,DB00857,Terbinafine,0.8117584586143494,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Cisapride.,73,Type_73,No
DB04844,Tetrabenazine,DB08864,Rilpivirine,0.7913443446159363,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Rilpivirine.,20,Type_20,Yes
DB01254,Dasatinib,DB08912,Dabrafenib,0.8427022695541382,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Dasatinib.,75,Type_75,Yes
DB01209,Dezocine,DB01567,Fludiazepam,0.9985047578811646,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Fludiazepam.,49,Type_49,Yes
DB00423,Methocarbamol,DB00950,Fexofenadine,0.9998279809951782,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fexofenadine.,49,Type_49,Yes
DB00753,Isoflurane,DB00813,Fentanyl,0.9961819648742676,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Fentanyl.,49,Type_49,Yes
DB00254,Doxycycline,DB00802,Alfentanil,0.7009834051132202,47,Type_47,The metabolism of Alfentanil can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00670,Pirenzepine,DB01591,Solifenacin,0.9596613645553589,49,Type_49,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Solifenacin.,49,Type_49,Yes
DB00973,Ezetimibe,DB01076,Atorvastatin,0.7553172707557678,49,Type_49,The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin.,49,Type_49,Yes
DB01129,Rabeprazole,DB06701,Dexmethylphenidate,0.6453953981399536,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Rabeprazole.,18,Type_18,No
DB00211,Midodrine,DB00935,Oxymetazoline,0.88824462890625,71,Type_71,Midodrine may increase the hypertensive activities of Oxymetazoline.,49,Type_49,No
DB00305,Mitomycin,DB08916,Afatinib,0.9546762108802795,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Mitomycin.,73,Type_73,Yes
DB00175,Pravastatin,DB06268,Sitaxentan,0.5755144357681274,73,Type_73,The serum concentration of Sitaxentan can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01210,Levobunolol,DB09227,Barnidipine,0.9751158952713013,49,Type_49,The risk or severity of adverse effects can be increased when Levobunolol is combined with Barnidipine.,49,Type_49,Yes
DB00870,Suprofen,DB13158,Clobetasone,0.9993382096290588,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Clobetasone.,49,Type_49,Yes
DB00458,Imipramine,DB00679,Thioridazine,0.5421707630157471,20,Type_20,Imipramine may increase the QTc-prolonging activities of Thioridazine.,73,Type_73,No
DB00182,Amphetamine,DB00519,Trandolapril,0.9957465529441833,60,Type_60,Amphetamine may increase the hypotensive activities of Trandolapril.,60,Type_60,Yes
DB00691,Moexipril,DB01601,Lopinavir,0.37010836601257324,20,Type_20,Moexipril may increase the QTc-prolonging activities of Lopinavir.,20,Type_20,Yes
DB00180,Flunisolide,DB06819,Phenylbutyric acid,0.9676468372344971,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Flunisolide.,70,Type_70,Yes
DB00545,Pyridostigmine,DB01260,Desonide,0.9998888969421387,49,Type_49,The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Desonide.,49,Type_49,Yes
DB00401,Nisoldipine,DB01422,Nitroxoline,0.9902206659317017,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Nitroxoline.,49,Type_49,Yes
DB00338,Omeprazole,DB01023,Felodipine,0.8870741724967957,47,Type_47,The metabolism of Felodipine can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB06228,Rivaroxaban,DB06441,Cangrelor,0.9739233255386353,6,Type_6,Rivaroxaban may increase the anticoagulant activities of Cangrelor.,6,Type_6,Yes
DB01097,Leflunomide,DB01124,Tolbutamide,0.8741996884346008,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Leflunomide.,73,Type_73,No
DB00440,Trimethoprim,DB00700,Eplerenone,0.48249951004981995,68,Type_68,Trimethoprim may increase the hyperkalemic activities of Eplerenone.,68,Type_68,Yes
DB00752,Tranylcypromine,DB01016,Glyburide,0.663557231426239,9,Type_9,Tranylcypromine may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00945,Acetylsalicylic acid,DB01044,Gatifloxacin,0.9994538426399231,27,Type_27,Acetylsalicylic acid may increase the neuroexcitatory activities of Gatifloxacin.,27,Type_27,Yes
DB01437,Glutethimide,DB01589,Quazepam,0.9999016523361206,49,Type_49,The risk or severity of adverse effects can be increased when Glutethimide is combined with Quazepam.,49,Type_49,Yes
DB08815,Lurasidone,DB12532,Oxetacaine,0.9999655485153198,49,Type_49,The risk or severity of adverse effects can be increased when Lurasidone is combined with Oxetacaine.,49,Type_49,Yes
DB06290,Simeprevir,DB08932,Macitentan,0.7329705357551575,73,Type_73,The serum concentration of Macitentan can be increased when it is combined with Simeprevir.,73,Type_73,Yes
DB00622,Nicardipine,DB09570,Ixazomib,0.897638738155365,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00244,Mesalazine,DB08880,Teriflunomide,0.41167324781417847,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Teriflunomide.,57,Type_57,No
DB00179,Masoprocol,DB00210,Adapalene,0.999472439289093,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Adapalene.,49,Type_49,Yes
DB01587,Ketazolam,DB05521,Telaprevir,0.8077207207679749,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Ketazolam.,47,Type_47,Yes
DB01345,Potassium cation,DB06738,Ketobemidone,0.9972508549690247,49,Type_49,The risk or severity of adverse effects can be increased when Potassium cation is combined with Ketobemidone.,49,Type_49,Yes
DB00637,Astemizole,DB09049,Naloxegol,0.9997617602348328,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Astemizole.,73,Type_73,Yes
DB00203,Sildenafil,DB01110,Miconazole,0.8985621929168701,47,Type_47,The metabolism of Miconazole can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB01091,Butenafine,DB07615,Tranilast,0.9745436906814575,49,Type_49,The risk or severity of adverse effects can be increased when Butenafine is combined with Tranilast.,49,Type_49,Yes
DB00216,Eletriptan,DB00252,Phenytoin,0.9352997541427612,4,Type_4,The metabolism of Phenytoin can be increased when combined with Eletriptan.,4,Type_4,Yes
DB00908,Quinidine,DB06216,Asenapine,0.7669793367385864,20,Type_20,Quinidine may increase the QTc-prolonging activities of Asenapine.,33,Type_33,No
DB01136,Carvedilol,DB08439,Parecoxib,0.9950847029685974,37,Type_37,Carvedilol may decrease the antihypertensive activities of Parecoxib.,37,Type_37,Yes
DB00401,Nisoldipine,DB00966,Telmisartan,0.9071319103240967,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Telmisartan.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01295,Bevantolol,0.565057098865509,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Bevantolol.,75,Type_75,No
DB00686,Pentosan polysulfate,DB05676,Apremilast,0.9982268214225769,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Apremilast.,6,Type_6,Yes
DB00320,Dihydroergotamine,DB01622,Thioproperazine,0.5010038614273071,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thioproperazine.,49,Type_49,Yes
DB00318,Codeine,DB04842,Fluspirilene,0.9985164999961853,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Fluspirilene.,49,Type_49,Yes
DB01551,Dihydrocodeine,DB06153,Pizotifen,0.9990249872207642,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Pizotifen.,49,Type_49,Yes
DB00281,Lidocaine,DB09048,Netupitant,0.9422965049743652,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB00737,Meclizine,DB00875,Flupentixol,0.9819449186325073,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Flupentixol.,49,Type_49,Yes
DB01141,Micafungin,DB01268,Sunitinib,0.6526939272880554,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Micafungin.,47,Type_47,No
DB00678,Losartan,DB09112,Nitrous acid,0.9930950999259949,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Nitrous acid.,49,Type_49,Yes
DB00611,Butorphanol,DB09224,Melperone,0.9998862743377686,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Melperone.,49,Type_49,Yes
DB00682,Warfarin,DB01196,Estramustine,0.668306291103363,12,Type_12,Warfarin may decrease the anticoagulant activities of Estramustine.,12,Type_12,Yes
DB06216,Asenapine,DB06589,Pazopanib,0.5899807214736938,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Asenapine.,67,Type_67,No
DB00257,Clotrimazole,DB00751,Epinastine,0.9336305856704712,47,Type_47,The metabolism of Epinastine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00472,Fluoxetine,DB09009,Articaine,0.9980670809745789,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Articaine.,49,Type_49,Yes
DB01253,Ergometrine,DB06616,Bosutinib,0.43166473507881165,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00549,Zafirlukast,DB01240,Epoprostenol,0.8922873139381409,47,Type_47,The metabolism of Epoprostenol can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00398,Sorafenib,DB06702,Fesoterodine,0.8954346179962158,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Sorafenib.,77,Type_77,Yes
DB00193,Tramadol,DB00263,Sulfisoxazole,0.7419754266738892,47,Type_47,The metabolism of Sulfisoxazole can be decreased when combined with Tramadol.,47,Type_47,Yes
DB00268,Ropinirole,DB01612,Amyl Nitrite,0.9965977072715759,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Amyl Nitrite.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB06176,Romidepsin,0.8596659898757935,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00238,Nevirapine,DB00864,Tacrolimus,0.39556217193603516,47,Type_47,The metabolism of Tacrolimus can be decreased when combined with Nevirapine.,4,Type_4,No
DB00564,Carbamazepine,DB04855,Dronedarone,0.6974573135375977,75,Type_75,The serum concentration of Dronedarone can be decreased when it is combined with Carbamazepine.,75,Type_75,Yes
DB00701,Amprenavir,DB00834,Mifepristone,0.8914422392845154,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Amprenavir.,73,Type_73,Yes
DB00363,Clozapine,DB08868,Fingolimod,0.4944905638694763,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Clozapine.,20,Type_20,No
DB01167,Itraconazole,DB02187,Equilin,0.9457126259803772,73,Type_73,The serum concentration of Equilin can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00472,Fluoxetine,DB01120,Gliclazide,0.6222063899040222,9,Type_9,Fluoxetine may increase the hypoglycemic activities of Gliclazide.,47,Type_47,No
DB00775,Tirofiban,DB11079,Trolamine salicylate,0.8162131905555725,49,Type_49,The risk or severity of adverse effects can be increased when Tirofiban is combined with Trolamine salicylate.,49,Type_49,Yes
DB01072,Atazanavir,DB08439,Parecoxib,0.759463369846344,47,Type_47,The metabolism of Parecoxib can be decreased when combined with Atazanavir.,73,Type_73,No
DB00703,Methazolamide,DB06712,Nilvadipine,0.7730465531349182,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Nilvadipine.,49,Type_49,Yes
DB00428,Streptozocin,DB01199,Tubocurarine,0.9995303153991699,40,Type_40,Streptozocin may increase the respiratory depressant activities of Tubocurarine.,40,Type_40,Yes
DB00176,Fluvoxamine,DB00950,Fexofenadine,0.9532108306884766,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Fexofenadine.,49,Type_49,Yes
DB00586,Diclofenac,DB09288,Propacetamol,0.9893594980239868,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Propacetamol.,49,Type_49,Yes
DB00237,Butabarbital,DB00490,Buspirone,0.9967526197433472,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Buspirone.,49,Type_49,Yes
DB00732,Atracurium besylate,DB09238,Manidipine,0.9999281167984009,21,Type_21,Atracurium besylate may increase the neuromuscular blocking activities of Manidipine.,21,Type_21,Yes
DB01221,Ketamine,DB09085,Tetracaine,0.9999927282333374,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Tetracaine.,49,Type_49,Yes
DB00482,Celecoxib,DB00835,Brompheniramine,0.9122217893600464,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01156,Bupropion,DB01609,Deferasirox,0.9221439361572266,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Bupropion.,75,Type_75,Yes
DB00359,Sulfadiazine,DB00980,Ramelteon,0.9946141839027405,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Sulfadiazine.,73,Type_73,No
DB08873,Boceprevir,DB11614,Rupatadine,0.807960569858551,47,Type_47,The metabolism of Rupatadine can be decreased when combined with Boceprevir.,47,Type_47,Yes
DB01244,Bepridil,DB11730,Ribociclib,0.8173306584358215,33,Type_33,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Ribociclib.,33,Type_33,Yes
DB00193,Tramadol,DB01254,Dasatinib,0.7420144081115723,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Tramadol.,73,Type_73,Yes
DB00210,Adapalene,DB00465,Ketorolac,0.999735414981842,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Ketorolac.,49,Type_49,Yes
DB00564,Carbamazepine,DB08907,Canagliflozin,0.8042157292366028,4,Type_4,The metabolism of Canagliflozin can be increased when combined with Carbamazepine.,75,Type_75,No
DB01036,Tolterodine,DB08933,Luliconazole,0.9861306548118591,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Tolterodine.,73,Type_73,Yes
DB00244,Mesalazine,DB01401,Choline magnesium trisalicylate,0.7768076062202454,57,Type_57,Mesalazine may increase the nephrotoxic activities of Choline magnesium trisalicylate.,57,Type_57,Yes
DB00499,Flutamide,DB05812,Abiraterone,0.5777260661125183,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Flutamide.,73,Type_73,Yes
DB00215,Citalopram,DB09072,Sodium oxybate,0.7529318332672119,16,Type_16,Citalopram may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,49,Type_49,No
DB00277,Theophylline,DB00321,Amitriptyline,0.8630691170692444,47,Type_47,The metabolism of Amitriptyline can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00468,Quinine,DB01095,Fluvastatin,0.6683270335197449,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Quinine.,73,Type_73,No
DB00500,Tolmetin,DB00997,Doxorubicin,0.998110294342041,72,Type_72,Tolmetin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,72,Type_72,Yes
DB00606,Cyclothiazide,DB01143,Amifostine,0.9985044002532959,60,Type_60,Cyclothiazide may increase the hypotensive activities of Amifostine.,60,Type_60,Yes
DB00373,Timolol,DB01264,Darunavir,0.7321006059646606,47,Type_47,The metabolism of Darunavir can be decreased when combined with Timolol.,73,Type_73,No
DB00450,Droperidol,DB01567,Fludiazepam,0.9999488592147827,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fludiazepam.,16,Type_16,Yes
DB00846,Flurandrenolide,DB00963,Bromfenac,0.9997319579124451,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Bromfenac.,49,Type_49,Yes
DB00393,Nimodipine,DB00700,Eplerenone,0.9924623966217041,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Eplerenone.,49,Type_49,Yes
DB00207,Azithromycin,DB00783,Estradiol,0.7380480170249939,47,Type_47,The metabolism of Estradiol can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB01273,Varenicline,DB09204,Arotinolol,0.9800107479095459,49,Type_49,The risk or severity of adverse effects can be increased when Varenicline is combined with Arotinolol.,49,Type_49,Yes
DB00227,Lovastatin,DB01006,Letrozole,0.8691821098327637,47,Type_47,The metabolism of Letrozole can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01355,Hexobarbital,DB09074,Olaparib,0.893192708492279,47,Type_47,The metabolism of Olaparib can be decreased when combined with Hexobarbital.,47,Type_47,Yes
DB00749,Etodolac,DB00955,Netilmicin,0.9997550845146179,72,Type_72,Etodolac may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB00715,Paroxetine,DB11609,Normethadone,0.9516221284866333,64,Type_64,Paroxetine may increase the serotonergic activities of Normethadone.,64,Type_64,Yes
DB00374,Treprostinil,DB11079,Trolamine salicylate,0.9655944108963013,49,Type_49,The risk or severity of adverse effects can be increased when Treprostinil is combined with Trolamine salicylate.,49,Type_49,Yes
DB00696,Ergotamine,DB01623,Thiothixene,0.9106395840644836,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Thiothixene.,49,Type_49,Yes
DB00376,Trihexyphenidyl,DB00808,Indapamide,0.9814643263816833,73,Type_73,The serum concentration of Indapamide can be increased when it is combined with Trihexyphenidyl.,73,Type_73,Yes
DB01043,Memantine,DB09300,Butylscopolamine,0.9999195337295532,70,Type_70,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Memantine.,70,Type_70,Yes
DB00835,Brompheniramine,DB00898,Ethanol,0.9992635846138,16,Type_16,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00333,Methadone,DB09085,Tetracaine,0.9844720959663391,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Tetracaine.,49,Type_49,Yes
DB01418,Acenocoumarol,DB08984,Etofenamate,0.9998012185096741,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Etofenamate.,6,Type_6,Yes
DB04896,Milnacipran,DB09345,Pramocaine,0.9962988495826721,49,Type_49,The risk or severity of adverse effects can be increased when Milnacipran is combined with Pramocaine.,49,Type_49,Yes
DB01067,Glipizide,DB01120,Gliclazide,0.9890579581260681,9,Type_9,Glipizide may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00188,Bortezomib,DB00673,Aprepitant,0.812382161617279,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Bortezomib.,73,Type_73,Yes
DB00661,Verapamil,DB01235,Levodopa,0.5864359736442566,47,Type_47,The metabolism of Levodopa can be decreased when combined with Verapamil.,30,Type_30,No
DB00647,Dextropropoxyphene,DB01609,Deferasirox,0.9738678932189941,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Dextropropoxyphene.,75,Type_75,Yes
DB00976,Telithromycin,DB08868,Fingolimod,0.5883444547653198,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB01418,Acenocoumarol,DB05676,Apremilast,0.9999284744262695,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Apremilast.,6,Type_6,Yes
DB00310,Chlorthalidone,DB00542,Benazepril,0.9449424147605896,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Benazepril.,49,Type_49,Yes
DB01182,Propafenone,DB01242,Clomipramine,0.5688880681991577,20,Type_20,Propafenone may increase the QTc-prolonging activities of Clomipramine.,73,Type_73,No
DB00496,Darifenacin,DB00517,Anisotropine methylbromide,0.9938149452209473,49,Type_49,The risk or severity of adverse effects can be increased when Darifenacin is combined with Anisotropine methylbromide.,49,Type_49,Yes
DB00614,Furazolidone,DB06701,Dexmethylphenidate,0.6734673976898193,71,Type_71,Furazolidone may increase the hypertensive activities of Dexmethylphenidate.,71,Type_71,Yes
DB04896,Milnacipran,DB09038,Empagliflozin,0.9320274591445923,9,Type_9,Milnacipran may increase the hypoglycemic activities of Empagliflozin.,9,Type_9,Yes
DB00394,Beclomethasone dipropionate,DB00788,Naproxen,0.9996354579925537,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Naproxen.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00904,Ondansetron,0.7384558916091919,47,Type_47,The metabolism of Ondansetron can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00557,Hydroxyzine,DB08910,Pomalidomide,0.9988921284675598,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.,16,Type_16,Yes
DB00761,Potassium chloride,DB00940,Methantheline,1.0,59,Type_59,Potassium chloride may increase the ulcerogenic activities of Methantheline.,59,Type_59,Yes
DB00752,Tranylcypromine,DB06702,Fesoterodine,0.9548102617263794,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Tranylcypromine.,77,Type_77,Yes
DB00553,Methoxsalen,DB01149,Nefazodone,0.9642624855041504,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB00765,Metyrosine,DB01090,Pentolinium,0.967413604259491,60,Type_60,Metyrosine may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00521,Carteolol,DB00753,Isoflurane,0.9413090348243713,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Isoflurane.,49,Type_49,Yes
DB00313,Valproic acid,DB09345,Pramocaine,0.9784866571426392,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Pramocaine.,49,Type_49,Yes
DB01221,Ketamine,DB09198,Lobeglitazone,0.9986415505409241,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Ketamine.,47,Type_47,Yes
DB01081,Diphenoxylate,DB09225,Zotepine,0.9997864365577698,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Zotepine.,49,Type_49,Yes
DB00363,Clozapine,DB01189,Desflurane,0.7780750393867493,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Desflurane.,20,Type_20,No
DB00169,Cholecalciferol,DB00245,Benzatropine,0.9164067506790161,47,Type_47,The metabolism of Benzatropine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01218,Halofantrine,DB05812,Abiraterone,0.7890570759773254,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Halofantrine.,73,Type_73,Yes
DB00747,Scopolamine,DB01176,Cyclizine,0.9996477365493774,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Cyclizine.,49,Type_49,Yes
DB00035,Desmopressin,DB00454,Meperidine,0.9999186992645264,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Meperidine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB05381,Histamine,0.9770416617393494,47,Type_47,The metabolism of Histamine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00207,Azithromycin,DB01078,Deslanoside,0.6484941840171814,58,Type_58,Azithromycin may decrease the cardiotoxic activities of Deslanoside.,73,Type_73,No
DB00839,Tolazamide,DB01132,Pioglitazone,0.9970133304595947,9,Type_9,Tolazamide may increase the hypoglycemic activities of Pioglitazone.,9,Type_9,Yes
DB00494,Entacapone,DB00633,Dexmedetomidine,0.9467046856880188,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Dexmedetomidine.,49,Type_49,Yes
DB01069,Promethazine,DB01178,Chlormezanone,0.9991527795791626,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Chlormezanone.,49,Type_49,Yes
DB00091,Cyclosporine,DB09118,Stiripentol,0.7898920774459839,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00836,Loperamide,DB00997,Doxorubicin,0.7088626623153687,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Loperamide.,47,Type_47,Yes
DB00208,Ticlopidine,DB01131,Proguanil,0.9171602129936218,47,Type_47,The metabolism of Proguanil can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00230,Pregabalin,DB00590,Doxazosin,0.6791567802429199,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Doxazosin.,60,Type_60,No
DB00951,Isoniazid,DB01071,Mequitazine,0.4396167993545532,75,Type_75,The serum concentration of Mequitazine can be decreased when it is combined with Isoniazid.,47,Type_47,No
DB01092,Ouabain,DB01177,Idarubicin,0.9745261669158936,58,Type_58,Ouabain may decrease the cardiotoxic activities of Idarubicin.,58,Type_58,Yes
DB00960,Pindolol,DB06262,Droxidopa,0.9982811212539673,25,Type_25,Pindolol may increase the atrioventricular blocking (AV block) activities of Droxidopa.,25,Type_25,Yes
DB00312,Pentobarbital,DB01190,Clindamycin,0.8635703921318054,4,Type_4,The metabolism of Clindamycin can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00195,Betaxolol,DB08941,Isoxsuprine,0.9940136075019836,49,Type_49,The risk or severity of adverse effects can be increased when Betaxolol is combined with Isoxsuprine.,49,Type_49,Yes
DB01466,Ethylmorphine,DB06603,Panobinostat,0.6750122904777527,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Ethylmorphine.,73,Type_73,Yes
DB00391,Sulpiride,DB00921,Buprenorphine,0.9980366826057434,16,Type_16,Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00203,Sildenafil,DB01319,Fosamprenavir,0.7318998575210571,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Sildenafil.,73,Type_73,No
DB00690,Flurazepam,DB00875,Flupentixol,0.9804636836051941,49,Type_49,The risk or severity of adverse effects can be increased when Flurazepam is combined with Flupentixol.,49,Type_49,Yes
DB00248,Cabergoline,DB09000,Cyamemazine,0.9847065806388855,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Cyamemazine.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00440,Trimethoprim,0.9846757054328918,47,Type_47,The metabolism of Trimethoprim can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00195,Betaxolol,DB00396,Progesterone,0.48815301060676575,47,Type_47,The metabolism of Progesterone can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00887,Bumetanide,DB01238,Aripiprazole,0.9879207611083984,60,Type_60,Bumetanide may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00283,Clemastine,DB04846,Celiprolol,0.8498125076293945,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB01229,Paclitaxel,0.5829719305038452,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Paclitaxel.,49,Type_49,Yes
DB00287,Travoprost,DB00796,Candesartan cilexetil,0.9998387098312378,60,Type_60,Travoprost may increase the hypotensive activities of Candesartan cilexetil.,60,Type_60,Yes
DB00637,Astemizole,DB01156,Bupropion,0.840938925743103,47,Type_47,The metabolism of Bupropion can be decreased when combined with Astemizole.,47,Type_47,Yes
DB01142,Doxepin,DB09146,Iron sucrose,0.854133665561676,67,Type_67,Doxepin can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00511,Acetyldigitoxin,DB08807,Bopindolol,0.9907858371734619,54,Type_54,Acetyldigitoxin may increase the bradycardic activities of Bopindolol.,54,Type_54,Yes
DB00497,Oxycodone,DB00657,Mecamylamine,0.9843878746032715,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Mecamylamine.,49,Type_49,Yes
DB00188,Bortezomib,DB01175,Escitalopram,0.6572100520133972,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Bortezomib.,20,Type_20,No
DB00261,Anagrelide,DB04953,Ezogabine,0.9815956950187683,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Ezogabine.,20,Type_20,Yes
DB00806,Pentoxifylline,DB09053,Ibrutinib,0.5474879145622253,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Pentoxifylline.,49,Type_49,No
DB01015,Sulfamethoxazole,DB09118,Stiripentol,0.7986997961997986,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Sulfamethoxazole.,73,Type_73,Yes
DB00182,Amphetamine,DB00214,Torasemide,0.8993251323699951,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Torasemide.,60,Type_60,No
DB09138,Technetium Tc-99m medronate,DB13167,Alclofenac,0.8386144042015076,49,Type_49,The risk or severity of adverse effects can be increased when Technetium Tc-99m medronate is combined with Alclofenac.,49,Type_49,Yes
DB00865,Benzphetamine,DB06717,Fosaprepitant,0.5788417458534241,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Benzphetamine.,73,Type_73,Yes
DB00413,Pramipexole,DB01028,Methoxyflurane,0.9973356127738953,32,Type_32,Pramipexole may increase the sedative activities of Methoxyflurane.,32,Type_32,Yes
DB01133,Tiludronic acid,DB01600,Tiaprofenic acid,0.9978355765342712,49,Type_49,The risk or severity of adverse effects can be increased when Tiludronic acid is combined with Tiaprofenic acid.,49,Type_49,Yes
DB00780,Phenelzine,DB00968,Methyldopa,0.6169916391372681,60,Type_60,Phenelzine may increase the hypotensive activities of Methyldopa.,31,Type_31,No
DB00199,Erythromycin,DB00726,Trimipramine,0.4593316316604614,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Erythromycin.,20,Type_20,No
DB01192,Oxymorphone,DB08987,Etidocaine,0.9978464841842651,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Etidocaine.,49,Type_49,Yes
DB00569,Fondaparinux,DB03619,Deoxycholic acid,0.9999984502792358,49,Type_49,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Deoxycholic acid.,49,Type_49,Yes
DB00483,Gallamine triethiodide,DB01324,Polythiazide,0.9687340259552002,73,Type_73,The serum concentration of Polythiazide can be increased when it is combined with Gallamine triethiodide.,73,Type_73,Yes
DB00491,Miglitol,DB00687,Fludrocortisone,0.9999774694442749,70,Type_70,The therapeutic efficacy of Fludrocortisone can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00615,Rifabutin,DB00637,Astemizole,0.6887621879577637,4,Type_4,The metabolism of Astemizole can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00783,Estradiol,DB01351,Amobarbital,0.686954915523529,70,Type_70,The therapeutic efficacy of Amobarbital can be decreased when used in combination with Estradiol.,70,Type_70,Yes
DB00590,Doxazosin,DB00745,Modafinil,0.9118662476539612,47,Type_47,The metabolism of Modafinil can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00178,Ramipril,DB08991,Epirizole,0.9720326662063599,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Epirizole.,49,Type_49,Yes
DB00176,Fluvoxamine,DB04946,Iloperidone,0.6815364360809326,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00178,Ramipril,DB00321,Amitriptyline,0.6514230966567993,73,Type_73,The serum concentration of Amitriptyline can be increased when it is combined with Ramipril.,73,Type_73,Yes
DB01367,Rasagiline,DB06262,Droxidopa,0.6162087917327881,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Droxidopa.,49,Type_49,Yes
DB00905,Bimatoprost,DB09216,Tolfenamic acid,0.9759079217910767,70,Type_70,The therapeutic efficacy of Tolfenamic acid can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00481,Raloxifene,DB01026,Ketoconazole,0.9625474810600281,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB01156,Bupropion,DB01435,Antipyrine,0.9371607899665833,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Bupropion.,47,Type_47,Yes
DB00483,Gallamine triethiodide,DB06696,Arbekacin,1.0,40,Type_40,Gallamine triethiodide may increase the respiratory depressant activities of Arbekacin.,40,Type_40,Yes
DB00246,Ziprasidone,DB06176,Romidepsin,0.8695932626724243,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00705,Delavirdine,DB00820,Tadalafil,0.6479151248931885,47,Type_47,The metabolism of Tadalafil can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00545,Pyridostigmine,DB00596,Ulobetasol,0.9998916387557983,49,Type_49,The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Ulobetasol.,49,Type_49,Yes
DB00691,Moexipril,DB02709,Resveratrol,0.917320728302002,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Resveratrol.,49,Type_49,Yes
DB00295,Morphine,DB01221,Ketamine,0.8515570163726807,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Ketamine.,49,Type_49,Yes
DB00844,Nalbuphine,DB06216,Asenapine,0.9719997048377991,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Asenapine.,49,Type_49,Yes
DB00305,Mitomycin,DB08868,Fingolimod,0.9989491105079651,34,Type_34,Mitomycin may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00990,Exemestane,DB01092,Ouabain,0.9997240900993347,58,Type_58,Exemestane may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB06717,Fosaprepitant,DB08970,Fluprednidene,0.5612100958824158,73,Type_73,The serum concentration of Fluprednidene can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB00241,Butalbital,DB01239,Chlorprothixene,0.9983920454978943,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorprothixene.,49,Type_49,Yes
DB00670,Pirenzepine,DB09072,Sodium oxybate,0.9998511075973511,16,Type_16,Pirenzepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00321,Amitriptyline,DB00950,Fexofenadine,0.9886040687561035,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fexofenadine.,49,Type_49,Yes
DB00292,Etomidate,DB00333,Methadone,0.9721871018409729,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Methadone.,49,Type_49,Yes
DB00343,Diltiazem,DB09280,Lumacaftor,0.4168572723865509,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Diltiazem.,73,Type_73,No
DB00749,Etodolac,DB01133,Tiludronic acid,0.947357714176178,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Tiludronic acid.,49,Type_49,Yes
DB00737,Meclizine,DB01463,Fencamfamin,0.9950656294822693,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Fencamfamin.,49,Type_49,Yes
DB00318,Codeine,DB00423,Methocarbamol,0.9998689889907837,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Methocarbamol.,49,Type_49,Yes
DB00243,Ranolazine,DB01254,Dasatinib,0.9462969303131104,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00563,Methotrexate,DB09288,Propacetamol,0.7277330756187439,73,Type_73,The serum concentration of Propacetamol can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00237,Butabarbital,DB00474,Methohexital,0.9969989061355591,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Methohexital.,49,Type_49,Yes
DB00497,Oxycodone,DB00575,Clonidine,0.985611081123352,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Clonidine.,49,Type_49,Yes
DB00500,Tolmetin,DB04576,Fleroxacin,0.9976164102554321,27,Type_27,Tolmetin may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00680,Moricizine,DB01377,Magnesium oxide,0.7945675253868103,67,Type_67,Moricizine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01175,Escitalopram,DB09068,Vortioxetine,0.8403182625770569,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Vortioxetine.,49,Type_49,Yes
DB00790,Perindopril,DB06792,Lanthanum carbonate,0.9546449184417725,75,Type_75,The serum concentration of Lanthanum carbonate can be decreased when it is combined with Perindopril.,75,Type_75,Yes
DB00695,Furosemide,DB01435,Antipyrine,0.9999880790710449,29,Type_29,Furosemide may decrease the diuretic activities of Antipyrine.,29,Type_29,Yes
DB01211,Clarithromycin,DB05271,Rotigotine,0.7993186712265015,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00312,Pentobarbital,DB00683,Midazolam,0.515708863735199,4,Type_4,The metabolism of Midazolam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00924,Cyclobenzaprine,DB01597,Cilastatin,0.5382093787193298,73,Type_73,The serum concentration of Cilastatin can be increased when it is combined with Cyclobenzaprine.,73,Type_73,Yes
DB00486,Nabilone,DB00622,Nicardipine,0.8894506096839905,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Nicardipine.,49,Type_49,Yes
DB00783,Estradiol,DB00849,Methylphenobarbital,0.579587459564209,70,Type_70,The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Estradiol.,70,Type_70,Yes
DB01624,Zuclopenthixol,DB09117,Paraldehyde,0.9989857077598572,16,Type_16,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01173,Orphenadrine,DB01563,Chloral hydrate,0.989869236946106,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.,16,Type_16,Yes
DB00714,Apomorphine,DB01054,Nitrendipine,0.8717764616012573,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitrendipine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00963,Bromfenac,0.9934861063957214,70,Type_70,The therapeutic efficacy of Bromfenac can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00519,Trandolapril,DB06292,Dapagliflozin,0.9938758015632629,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Dapagliflozin.,49,Type_49,Yes
DB00215,Citalopram,DB01303,Oxtriphylline,0.8120839595794678,47,Type_47,The metabolism of Oxtriphylline can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00908,Quinidine,DB02546,Vorinostat,0.993506669998169,20,Type_20,Quinidine may increase the QTc-prolonging activities of Vorinostat.,20,Type_20,Yes
DB08860,Pitavastatin,DB09238,Manidipine,0.636241614818573,73,Type_73,The serum concentration of Manidipine can be increased when it is combined with Pitavastatin.,47,Type_47,No
DB00206,Reserpine,DB00214,Torasemide,0.5201113820075989,60,Type_60,Reserpine may increase the hypotensive activities of Torasemide.,49,Type_49,No
DB00721,Procaine,DB00801,Halazepam,0.9999988079071045,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Halazepam.,49,Type_49,Yes
DB01235,Levodopa,DB01589,Quazepam,0.9667398929595947,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Quazepam.,49,Type_49,Yes
DB00783,Estradiol,DB11586,Asunaprevir,0.4592609405517578,70,Type_70,The therapeutic efficacy of Asunaprevir can be decreased when used in combination with Estradiol.,75,Type_75,No
DB00966,Telmisartan,DB06737,Zaltoprofen,0.9510614275932312,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Zaltoprofen.,49,Type_49,Yes
DB00434,Cyproheptadine,DB01151,Desipramine,0.9968256950378418,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Desipramine.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00588,Fluticasone propionate,0.9865037202835083,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fluticasone propionate.,49,Type_49,Yes
DB00246,Ziprasidone,DB01110,Miconazole,0.6263267397880554,47,Type_47,The metabolism of Miconazole can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01137,Levofloxacin,DB09218,Clonixin,0.9809289574623108,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Clonixin.,27,Type_27,Yes
DB01149,Nefazodone,DB05271,Rotigotine,0.9634810090065002,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00681,Amphotericin B,DB01268,Sunitinib,0.8591113686561584,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Sunitinib.,47,Type_47,No
DB00375,Colestipol,DB00687,Fludrocortisone,0.9683919548988342,67,Type_67,Colestipol can cause a decrease in the absorption of Fludrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01190,Clindamycin,DB13450,Cisatracurium besylate,0.9999963045120239,21,Type_21,Clindamycin may increase the neuromuscular blocking activities of Cisatracurium besylate.,21,Type_21,Yes
DB01338,Pipecuronium,DB09290,Ramosetron,0.9999852180480957,39,Type_39,Pipecuronium may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB01189,Desflurane,DB01203,Nadolol,0.9953710436820984,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Nadolol.,49,Type_49,Yes
DB00639,Butoconazole,DB09270,Ubidecarenone,0.5289282202720642,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Butoconazole.,49,Type_49,No
DB06697,Artemether,DB12332,Rucaparib,0.7872220277786255,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Artemether.,47,Type_47,Yes
DB00253,Medrysone,DB00903,Etacrynic acid,0.9998950958251953,83,Type_83,Medrysone may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB06212,Tolvaptan,DB09063,Ceritinib,0.9996659755706787,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Tolvaptan.,73,Type_73,Yes
DB00544,Fluorouracil,DB00604,Cisapride,0.7074693441390991,47,Type_47,The metabolism of Cisapride can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00731,Nateglinide,DB01325,Quinethazone,0.9977326393127441,70,Type_70,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Nateglinide.,70,Type_70,Yes
DB04878,Voglibose,DB06825,Triptorelin,0.9992592930793762,70,Type_70,The therapeutic efficacy of Triptorelin can be decreased when used in combination with Voglibose.,70,Type_70,Yes
DB00991,Oxaprozin,DB01250,Olsalazine,0.6249738335609436,57,Type_57,Oxaprozin may increase the nephrotoxic activities of Olsalazine.,57,Type_57,Yes
DB01466,Ethylmorphine,DB09291,Rolapitant,0.9192951917648315,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Ethylmorphine.,47,Type_47,Yes
DB00297,Bupivacaine,DB01247,Isocarboxazid,0.821438193321228,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Isocarboxazid.,49,Type_49,Yes
DB00542,Benazepril,DB01401,Choline magnesium trisalicylate,0.9505502581596375,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00364,Sucralfate,DB09449,"Sodium phosphate, monobasic",0.9518104195594788,67,Type_67,"Sucralfate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.",67,Type_67,Yes
DB00289,Atomoxetine,DB06738,Ketobemidone,0.8447748422622681,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00298,Dapiprazole,DB00907,Cocaine,0.9507471919059753,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Cocaine.,49,Type_49,Yes
DB00784,Mefenamic acid,DB00861,Diflunisal,0.8705762624740601,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Diflunisal.,49,Type_49,Yes
DB00014,Goserelin,DB00622,Nicardipine,0.9996175765991211,20,Type_20,Goserelin may increase the QTc-prolonging activities of Nicardipine.,20,Type_20,Yes
DB00679,Thioridazine,DB00922,Levosimendan,0.8318021893501282,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Levosimendan.,49,Type_49,Yes
DB01074,Perhexiline,DB01162,Terazosin,0.5972533226013184,49,Type_49,The risk or severity of adverse effects can be increased when Perhexiline is combined with Terazosin.,60,Type_60,No
DB00491,Miglitol,DB00668,Epinephrine,0.6768342852592468,70,Type_70,The therapeutic efficacy of Epinephrine can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00350,Minoxidil,DB00722,Lisinopril,0.8564435839653015,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Lisinopril.,49,Type_49,Yes
DB00571,Propranolol,DB08880,Teriflunomide,0.9502071142196655,37,Type_37,Propranolol may decrease the antihypertensive activities of Teriflunomide.,75,Type_75,No
DB00404,Alprazolam,DB12267,Brigatinib,0.846520721912384,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Alprazolam.,75,Type_75,No
DB00285,Venlafaxine,DB01128,Bicalutamide,0.9030271768569946,47,Type_47,The metabolism of Bicalutamide can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01200,Bromocriptine,DB06216,Asenapine,0.4917348027229309,73,Type_73,The serum concentration of Asenapine can be increased when it is combined with Bromocriptine.,70,Type_70,No
DB00726,Trimipramine,DB01002,Levobupivacaine,0.7903155088424683,4,Type_4,The metabolism of Levobupivacaine can be increased when combined with Trimipramine.,49,Type_49,No
DB00350,Minoxidil,DB00695,Furosemide,0.9993329644203186,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Furosemide.,49,Type_49,Yes
DB00248,Cabergoline,DB01301,Rolitetracycline,0.9698367714881897,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Rolitetracycline.,49,Type_49,Yes
DB00312,Pentobarbital,DB05812,Abiraterone,0.5002188086509705,75,Type_75,The serum concentration of Abiraterone can be decreased when it is combined with Pentobarbital.,75,Type_75,Yes
DB00603,Medroxyprogesterone acetate,DB01211,Clarithromycin,0.45579445362091064,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Medroxyprogesterone acetate.,73,Type_73,No
DB00808,Indapamide,DB01118,Amiodarone,0.5806012153625488,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Amiodarone.,47,Type_47,No
DB01043,Memantine,DB01062,Oxybutynin,0.8773001432418823,70,Type_70,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Memantine.,70,Type_70,Yes
DB01137,Levofloxacin,DB06697,Artemether,0.433016836643219,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Artemether.,20,Type_20,Yes
DB00289,Atomoxetine,DB00446,Chloramphenicol,0.986758291721344,47,Type_47,The metabolism of Chloramphenicol can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00350,Minoxidil,DB00418,Secobarbital,0.9641273617744446,60,Type_60,Minoxidil may increase the hypotensive activities of Secobarbital.,60,Type_60,Yes
DB00849,Methylphenobarbital,DB01621,Pipotiazine,0.9340296387672424,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Pipotiazine.,49,Type_49,Yes
DB00960,Pindolol,DB00966,Telmisartan,0.9555018544197083,49,Type_49,The risk or severity of adverse effects can be increased when Pindolol is combined with Telmisartan.,49,Type_49,Yes
DB00363,Clozapine,DB00898,Ethanol,0.9901522994041443,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,16,Type_16,Yes
DB00501,Cimetidine,DB00757,Dolasetron,0.9700224995613098,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00916,Metronidazole,DB09063,Ceritinib,0.9412571787834167,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Metronidazole.,73,Type_73,Yes
DB00285,Venlafaxine,DB01349,Tasosartan,0.9930487871170044,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01234,Dexamethasone,DB01628,Etoricoxib,0.9469273686408997,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Etoricoxib.,49,Type_49,Yes
DB01167,Itraconazole,DB06712,Nilvadipine,0.5479010343551636,47,Type_47,The metabolism of Nilvadipine can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB01016,Glyburide,DB04946,Iloperidone,0.7662360072135925,70,Type_70,The therapeutic efficacy of Iloperidone can be decreased when used in combination with Glyburide.,70,Type_70,Yes
DB00996,Gabapentin,DB06724,Calcium carbonate,0.5585747361183167,75,Type_75,The serum concentration of Calcium carbonate can be decreased when it is combined with Gabapentin.,75,Type_75,Yes
DB00679,Thioridazine,DB01062,Oxybutynin,0.8737277984619141,16,Type_16,Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.,73,Type_73,No
DB01136,Carvedilol,DB01247,Isocarboxazid,0.928004264831543,60,Type_60,Carvedilol may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB00404,Alprazolam,DB04841,Flunarizine,0.9951190948486328,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Flunarizine.,49,Type_49,Yes
DB00252,Phenytoin,DB00757,Dolasetron,0.9457067251205444,4,Type_4,The metabolism of Dolasetron can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00844,Nalbuphine,DB01466,Ethylmorphine,0.991324782371521,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ethylmorphine.,49,Type_49,Yes
DB00500,Tolmetin,DB00502,Haloperidol,0.963731586933136,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Haloperidol.,49,Type_49,Yes
DB00180,Flunisolide,DB01232,Saquinavir,0.8214154243469238,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Flunisolide.,47,Type_47,Yes
DB00224,Indinavir,DB00227,Lovastatin,0.594641923904419,47,Type_47,The metabolism of Lovastatin can be decreased when combined with Indinavir.,73,Type_73,No
DB00896,Rimexolone,DB02709,Resveratrol,0.9994889497756958,49,Type_49,The risk or severity of adverse effects can be increased when Rimexolone is combined with Resveratrol.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB00564,Carbamazepine,0.7412778735160828,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Chlorzoxazone.,4,Type_4,Yes
DB00700,Eplerenone,DB08822,Azilsartan medoxomil,0.872096598148346,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Azilsartan medoxomil.,68,Type_68,No
DB01241,Gemfibrozil,DB01418,Acenocoumarol,0.7437382340431213,6,Type_6,Gemfibrozil may increase the anticoagulant activities of Acenocoumarol.,47,Type_47,No
DB00425,Zolpidem,DB01356,Lithium cation,0.9720150828361511,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Lithium cation.,16,Type_16,Yes
DB00472,Fluoxetine,DB00669,Sumatriptan,0.6526771187782288,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.,49,Type_49,Yes
DB00944,Demecarium,DB01047,Fluocinonide,0.9998631477355957,49,Type_49,The risk or severity of adverse effects can be increased when Demecarium is combined with Fluocinonide.,49,Type_49,Yes
DB00455,Loratadine,DB01353,Butobarbital,0.999988317489624,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Butobarbital.,49,Type_49,Yes
DB00467,Enoxacin,DB01032,Probenecid,0.5840585827827454,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Enoxacin.,73,Type_73,Yes
DB00755,Tretinoin,DB01203,Nadolol,0.9723748564720154,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Nadolol.,49,Type_49,Yes
DB00798,Gentamicin,DB01338,Pipecuronium,0.9998273849487305,40,Type_40,Gentamicin may increase the respiratory depressant activities of Pipecuronium.,40,Type_40,Yes
DB00243,Ranolazine,DB04846,Celiprolol,0.5510376691818237,73,Type_73,The serum concentration of Celiprolol can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00647,Dextropropoxyphene,DB06702,Fesoterodine,0.6551744341850281,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Fesoterodine.,77,Type_77,No
DB00788,Naproxen,DB01097,Leflunomide,0.4452120065689087,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Naproxen.,47,Type_47,Yes
DB00180,Flunisolide,DB01043,Memantine,0.9998314380645752,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Memantine.,49,Type_49,Yes
DB00153,Ergocalciferol,DB00208,Ticlopidine,0.9879312515258789,47,Type_47,The metabolism of Ticlopidine can be decreased when combined with Ergocalciferol.,47,Type_47,Yes
DB00527,Cinchocaine,DB04946,Iloperidone,0.9992870688438416,49,Type_49,The risk or severity of adverse effects can be increased when Cinchocaine is combined with Iloperidone.,49,Type_49,Yes
DB00841,Dobutamine,DB13142,Calcium glubionate anhydrous,0.8042681217193604,70,Type_70,The therapeutic efficacy of Calcium glubionate anhydrous can be decreased when used in combination with Dobutamine.,70,Type_70,Yes
DB01136,Carvedilol,DB09477,Enalaprilat,0.703682005405426,60,Type_60,Carvedilol may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00279,Liothyronine,DB00326,Calcium glucoheptonate,0.7178105115890503,70,Type_70,The therapeutic efficacy of Calcium glucoheptonate can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB06701,Dexmethylphenidate,DB09238,Manidipine,0.9231982827186584,47,Type_47,The metabolism of Manidipine can be decreased when combined with Dexmethylphenidate.,47,Type_47,Yes
DB00695,Furosemide,DB11921,Deflazacort,0.9992996454238892,83,Type_83,Furosemide may increase the hypokalemic activities of Deflazacort.,83,Type_83,Yes
DB00528,Lercanidipine,DB06237,Avanafil,0.9563241600990295,10,Type_10,Lercanidipine may increase the antihypertensive activities of Avanafil.,10,Type_10,Yes
DB01131,Proguanil,DB04839,Cyproterone acetate,0.5310626029968262,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Proguanil.,75,Type_75,Yes
DB00492,Fosinopril,DB01024,Mycophenolic acid,0.9215819239616394,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Mycophenolic acid.,49,Type_49,Yes
DB00254,Doxycycline,DB00808,Indapamide,0.4587756395339966,47,Type_47,The metabolism of Indapamide can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01247,Isocarboxazid,DB06262,Droxidopa,0.5586300492286682,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Droxidopa.,49,Type_49,Yes
DB04868,Nilotinib,DB09068,Vortioxetine,0.9180443286895752,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB08872,Gabapentin enacarbil,DB09166,Etizolam,0.9999723434448242,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Etizolam.,49,Type_49,Yes
DB00764,Mometasone,DB04951,Pirfenidone,0.9995025396347046,49,Type_49,The risk or severity of adverse effects can be increased when Mometasone is combined with Pirfenidone.,49,Type_49,Yes
DB00568,Cinnarizine,DB09280,Lumacaftor,0.43662503361701965,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Cinnarizine.,75,Type_75,Yes
DB00300,Tenofovir disoproxil,DB00917,Dinoprostone,0.9229620099067688,47,Type_47,The metabolism of Dinoprostone can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00966,Telmisartan,DB09070,Tibolone,0.9989632368087769,60,Type_60,Telmisartan may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00485,Dicloxacillin,DB06263,Amrubicin,0.9999816417694092,75,Type_75,The serum concentration of Amrubicin can be decreased when it is combined with Dicloxacillin.,75,Type_75,Yes
DB00224,Indinavir,DB00731,Nateglinide,0.9724674224853516,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01193,Acebutolol,DB04840,Debrisoquine,0.9995692372322083,60,Type_60,Acebutolol may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00281,Lidocaine,DB01232,Saquinavir,0.667681097984314,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Lidocaine.,82,Type_82,No
DB00500,Tolmetin,DB01234,Dexamethasone,0.9945290684700012,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Dexamethasone.,49,Type_49,Yes
DB00191,Phentermine,DB00899,Remifentanil,0.9995410442352295,69,Type_69,Phentermine may increase the analgesic activities of Remifentanil.,69,Type_69,Yes
DB00334,Olanzapine,DB09017,Brotizolam,0.9999125003814697,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Brotizolam.,49,Type_49,Yes
DB01224,Quetiapine,DB06788,Histrelin,1.0,20,Type_20,Quetiapine may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB00800,Fenoldopam,DB00966,Telmisartan,0.8687387108802795,49,Type_49,The risk or severity of adverse effects can be increased when Fenoldopam is combined with Telmisartan.,60,Type_60,No
DB08976,Floctafenine,DB12598,Nafamostat,0.6374152898788452,6,Type_6,Floctafenine may increase the anticoagulant activities of Nafamostat.,49,Type_49,No
DB00244,Mesalazine,DB00751,Epinastine,0.9814580082893372,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Epinastine.,70,Type_70,No
DB00818,Propofol,DB01154,Thiamylal,0.5364737510681152,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Thiamylal.,49,Type_49,Yes
DB00457,Prazosin,DB04861,Nebivolol,0.9453607201576233,30,Type_30,Prazosin may increase the orthostatic hypotensive activities of Nebivolol.,30,Type_30,Yes
DB00281,Lidocaine,DB01182,Propafenone,0.464742511510849,73,Type_73,The serum concentration of Propafenone can be increased when it is combined with Lidocaine.,47,Type_47,No
DB00582,Voriconazole,DB06777,Chenodeoxycholic acid,0.9071387052536011,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00287,Travoprost,DB00806,Pentoxifylline,0.9990334510803223,60,Type_60,Travoprost may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00224,Indinavir,DB00476,Duloxetine,0.8857560157775879,47,Type_47,The metabolism of Duloxetine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00999,Hydrochlorothiazide,DB01116,Trimethaphan,0.9555068612098694,73,Type_73,The serum concentration of Trimethaphan can be increased when it is combined with Hydrochlorothiazide.,73,Type_73,Yes
DB00959,Methylprednisolone,DB06724,Calcium carbonate,0.9993048906326294,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Methylprednisolone.,3,Type_3,Yes
DB00379,Mexiletine,DB01175,Escitalopram,0.9878993630409241,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB01222,Budesonide,DB01406,Danazol,0.9995224475860596,74,Type_74,Budesonide may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB01544,Flunitrazepam,DB04841,Flunarizine,0.9888651371002197,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Flunarizine.,49,Type_49,Yes
DB06799,Methenamine,DB09352,Hydroxyamphetamine,0.8926248550415039,72,Type_72,Methenamine may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level.,75,Type_75,No
DB00771,Clidinium,DB04953,Ezogabine,0.9884461164474487,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Ezogabine.,49,Type_49,Yes
DB00738,Pentamidine,DB09038,Empagliflozin,0.5098974108695984,49,Type_49,The risk or severity of adverse effects can be increased when Pentamidine is combined with Empagliflozin.,70,Type_70,No
DB00366,Doxylamine,DB13025,Tiapride,0.9999935626983643,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Tiapride.,16,Type_16,Yes
DB00344,Protriptyline,DB00494,Entacapone,0.9934996366500854,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Entacapone.,49,Type_49,Yes
DB00285,Venlafaxine,DB00624,Testosterone,0.8901410102844238,47,Type_47,The metabolism of Testosterone can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00434,Cyproheptadine,DB00656,Trazodone,0.9918071627616882,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Trazodone.,49,Type_49,Yes
DB00312,Pentobarbital,DB00959,Methylprednisolone,0.8376238942146301,4,Type_4,The metabolism of Methylprednisolone can be increased when combined with Pentobarbital.,75,Type_75,No
DB00452,Framycetin,DB08976,Floctafenine,0.9999971389770508,72,Type_72,Framycetin may decrease the excretion rate of Floctafenine which could result in a higher serum level.,72,Type_72,Yes
DB00501,Cimetidine,DB00656,Trazodone,0.9457674026489258,47,Type_47,The metabolism of Trazodone can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00371,Meprobamate,DB01028,Methoxyflurane,0.9803555011749268,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Methoxyflurane.,49,Type_49,Yes
DB00541,Vincristine,DB01110,Miconazole,0.3964667022228241,73,Type_73,The serum concentration of Miconazole can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00373,Timolol,DB01224,Quetiapine,0.34190064668655396,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Quetiapine.,49,Type_49,Yes
DB01621,Pipotiazine,DB06204,Tapentadol,0.9962602853775024,16,Type_16,Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00759,Tetracycline,DB09280,Lumacaftor,0.7192057967185974,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Tetracycline.,4,Type_4,Yes
DB00768,Olopatadine,DB08976,Floctafenine,0.9996008276939392,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Floctafenine.,49,Type_49,Yes
DB00287,Travoprost,DB00614,Furazolidone,0.9999982118606567,60,Type_60,Travoprost may increase the hypotensive activities of Furazolidone.,60,Type_60,Yes
DB00361,Vinorelbine,DB00661,Verapamil,0.6394815444946289,47,Type_47,The metabolism of Verapamil can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB01029,Irbesartan,0.7784392833709717,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Chlorpromazine.,49,Type_49,No
DB01098,Rosuvastatin,DB09040,Efinaconazole,0.6222119331359863,49,Type_49,The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Efinaconazole.,49,Type_49,Yes
DB00349,Clobazam,DB00433,Prochlorperazine,0.4688069820404053,47,Type_47,The metabolism of Prochlorperazine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01351,Amobarbital,DB09216,Tolfenamic acid,0.655549943447113,4,Type_4,The metabolism of Tolfenamic acid can be increased when combined with Amobarbital.,4,Type_4,Yes
DB06781,Difluprednate,DB09275,Bismuth subcitrate potassium,0.9988522529602051,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Difluprednate.,3,Type_3,Yes
DB00688,Mycophenolate mofetil,DB01172,Kanamycin,0.9995612502098083,72,Type_72,Mycophenolate mofetil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,72,Type_72,Yes
DB00285,Venlafaxine,DB01036,Tolterodine,0.7474935054779053,47,Type_47,The metabolism of Tolterodine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00829,Diazepam,DB08865,Crizotinib,0.9086625576019287,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Diazepam.,47,Type_47,Yes
DB00268,Ropinirole,DB00956,Hydrocodone,0.9940283298492432,32,Type_32,Ropinirole may increase the sedative activities of Hydrocodone.,32,Type_32,Yes
DB00916,Metronidazole,DB01008,Busulfan,0.7957375049591064,47,Type_47,The metabolism of Busulfan can be decreased when combined with Metronidazole.,73,Type_73,No
DB01355,Hexobarbital,DB05521,Telaprevir,0.6594438552856445,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Hexobarbital.,47,Type_47,Yes
DB00451,Levothyroxine,DB09065,Cobicistat,0.6600080728530884,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Levothyroxine.,47,Type_47,Yes
DB00283,Clemastine,DB01045,Rifampicin,0.3724396228790283,47,Type_47,The metabolism of Rifampicin can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00924,Cyclobenzaprine,DB06636,Isavuconazonium,0.631375789642334,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Cyclobenzaprine.,47,Type_47,Yes
DB01068,Clonazepam,DB04868,Nilotinib,0.7880802154541016,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Clonazepam.,47,Type_47,Yes
DB00091,Cyclosporine,DB01369,Quinupristin,0.5126580595970154,73,Type_73,The serum concentration of Quinupristin can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00686,Pentosan polysulfate,DB01628,Etoricoxib,0.9896456003189087,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Etoricoxib.,6,Type_6,Yes
DB00593,Ethosuximide,DB00924,Cyclobenzaprine,0.9796245098114014,49,Type_49,The risk or severity of adverse effects can be increased when Ethosuximide is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00844,Nalbuphine,DB00934,Maprotiline,0.9990692734718323,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Maprotiline.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB13158,Clobetasone,0.9964411854743958,73,Type_73,The serum concentration of Clobetasone can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00402,Eszopiclone,DB04844,Tetrabenazine,0.9948797225952148,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tetrabenazine.,49,Type_49,Yes
DB00757,Dolasetron,DB00794,Primidone,0.8256676197052002,4,Type_4,The metabolism of Primidone can be increased when combined with Dolasetron.,4,Type_4,Yes
DB06781,Difluprednate,DB08909,Glycerol phenylbutyrate,0.9630319476127625,70,Type_70,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Difluprednate.,70,Type_70,Yes
DB00420,Promazine,DB05271,Rotigotine,0.9894701242446899,32,Type_32,Promazine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00452,Framycetin,DB01604,Pivampicillin,0.9913928508758545,75,Type_75,The serum concentration of Pivampicillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB00327,Hydromorphone,DB00356,Chlorzoxazone,0.9955911636352539,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorzoxazone.,49,Type_49,Yes
DB00477,Chlorpromazine,DB09117,Paraldehyde,0.9923903346061707,16,Type_16,Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00475,Chlordiazepoxide,DB09074,Olaparib,0.9429265856742859,47,Type_47,The metabolism of Olaparib can be decreased when combined with Chlordiazepoxide.,47,Type_47,Yes
DB00388,Phenylephrine,DB00813,Fentanyl,0.7261069416999817,75,Type_75,The serum concentration of Fentanyl can be decreased when it is combined with Phenylephrine.,75,Type_75,Yes
DB00949,Felbamate,DB01192,Oxymorphone,0.9602447748184204,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Oxymorphone.,49,Type_49,Yes
DB00951,Isoniazid,DB06292,Dapagliflozin,0.8228004574775696,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB01242,Clomipramine,DB06717,Fosaprepitant,0.9259911179542542,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Clomipramine.,73,Type_73,Yes
DB00481,Raloxifene,DB01095,Fluvastatin,0.6786772012710571,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Raloxifene.,73,Type_73,No
DB04743,Nimesulide,DB09214,Dexketoprofen,0.9474165439605713,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Dexketoprofen.,49,Type_49,Yes
DB00540,Nortriptyline,DB01227,Levacetylmethadol,0.9164866805076599,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levacetylmethadol.,49,Type_49,Yes
DB00331,Metformin,DB01185,Fluoxymesterone,0.999988317489624,9,Type_9,Metformin may increase the hypoglycemic activities of Fluoxymesterone.,9,Type_9,Yes
DB00458,Imipramine,DB09071,Tasimelteon,0.9747874140739441,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Tasimelteon.,49,Type_49,Yes
DB01130,Prednicarbate,DB13783,Acemetacin,0.9688302278518677,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Acemetacin.,49,Type_49,Yes
DB01119,Diazoxide,DB06403,Ambrisentan,0.999860405921936,60,Type_60,Diazoxide may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00602,Ivermectin,DB09074,Olaparib,0.9655287265777588,47,Type_47,The metabolism of Olaparib can be decreased when combined with Ivermectin.,47,Type_47,Yes
DB00266,Dicoumarol,DB00564,Carbamazepine,0.9765027761459351,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Dicoumarol.,75,Type_75,No
DB00228,Enflurane,DB01463,Fencamfamin,0.9832956194877625,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Fencamfamin.,49,Type_49,Yes
DB00169,Cholecalciferol,DB09183,Dasabuvir,0.9261494874954224,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00321,Amitriptyline,DB01238,Aripiprazole,0.6771060824394226,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Aripiprazole.,49,Type_49,No
DB00844,Nalbuphine,DB01440,gamma-Hydroxybutyric acid,0.9979792237281799,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB00617,Paramethadione,DB01045,Rifampicin,0.8809215426445007,4,Type_4,The metabolism of Rifampicin can be increased when combined with Paramethadione.,4,Type_4,Yes
DB00188,Bortezomib,DB01060,Amoxicillin,0.7749852538108826,47,Type_47,The metabolism of Amoxicillin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00285,Venlafaxine,DB09123,Dienogest,0.7192063331604004,47,Type_47,The metabolism of Dienogest can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB04896,Milnacipran,DB06292,Dapagliflozin,0.5792140960693359,30,Type_30,Milnacipran may increase the orthostatic hypotensive activities of Dapagliflozin.,9,Type_9,No
DB00555,Lamotrigine,DB01558,Bromazepam,0.9912999272346497,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Bromazepam.,49,Type_49,Yes
DB00292,Etomidate,DB00363,Clozapine,0.8841710090637207,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Clozapine.,49,Type_49,Yes
DB00325,Nitroprusside,DB00474,Methohexital,0.9625232815742493,60,Type_60,Nitroprusside may increase the hypotensive activities of Methohexital.,60,Type_60,Yes
DB00899,Remifentanil,DB01412,Theobromine,0.9123036861419678,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Theobromine.,49,Type_49,Yes
DB00655,Estrone,DB00834,Mifepristone,0.8722411394119263,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Estrone.,73,Type_73,Yes
DB00620,Triamcinolone,DB08938,Magaldrate,0.9971233010292053,3,Type_3,The bioavailability of Magaldrate can be decreased when combined with Triamcinolone.,3,Type_3,Yes
DB00434,Cyproheptadine,DB06700,Desvenlafaxine,0.9673224687576294,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Desvenlafaxine.,70,Type_70,No
DB00318,Codeine,DB00705,Delavirdine,0.8864225745201111,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Codeine.,70,Type_70,No
DB00312,Pentobarbital,DB01588,Prazepam,0.8450039625167847,4,Type_4,The metabolism of Prazepam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00346,Alfuzosin,DB01064,Isoprenaline,0.9802010655403137,5,Type_5,Alfuzosin may decrease the vasoconstricting activities of Isoprenaline.,5,Type_5,Yes
DB00569,Fondaparinux,DB06725,Lornoxicam,0.9972553849220276,6,Type_6,Fondaparinux may increase the anticoagulant activities of Lornoxicam.,6,Type_6,Yes
DB00872,Conivaptan,DB01114,Chlorpheniramine,0.9851332902908325,73,Type_73,The serum concentration of Chlorpheniramine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00586,Diclofenac,DB00673,Aprepitant,0.8754954934120178,73,Type_73,The serum concentration of Aprepitant can be increased when it is combined with Diclofenac.,73,Type_73,Yes
DB04844,Tetrabenazine,DB06825,Triptorelin,0.9993727803230286,20,Type_20,Tetrabenazine may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00205,Pyrimethamine,DB05381,Histamine,0.9372764229774475,47,Type_47,The metabolism of Histamine can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB00564,Carbamazepine,0.5710120797157288,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Chlorpromazine.,4,Type_4,Yes
DB00834,Mifepristone,DB01114,Chlorpheniramine,0.8909843564033508,73,Type_73,The serum concentration of Chlorpheniramine can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00402,Eszopiclone,DB00470,Dronabinol,0.9996870756149292,16,Type_16,Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.,16,Type_16,Yes
DB00610,Metaraminol,DB04846,Celiprolol,0.8968867659568787,49,Type_49,The risk or severity of adverse effects can be increased when Metaraminol is combined with Celiprolol.,49,Type_49,Yes
DB00593,Ethosuximide,DB01403,Methotrimeprazine,0.9761616587638855,16,Type_16,Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00482,Celecoxib,DB01071,Mequitazine,0.5231883525848389,82,Type_82,Celecoxib may increase the arrhythmogenic activities of Mequitazine.,47,Type_47,No
DB00544,Fluorouracil,DB01098,Rosuvastatin,0.719062089920044,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Fluorouracil.,47,Type_47,No
DB00615,Rifabutin,DB09065,Cobicistat,0.3870006799697876,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Rifabutin.,47,Type_47,No
DB01203,Nadolol,DB01435,Antipyrine,0.9987055063247681,37,Type_37,Nadolol may decrease the antihypertensive activities of Antipyrine.,37,Type_37,Yes
DB00790,Perindopril,DB06712,Nilvadipine,0.8815944194793701,60,Type_60,Perindopril may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00765,Metyrosine,DB01088,Iloprost,0.9672685265541077,60,Type_60,Metyrosine may increase the hypotensive activities of Iloprost.,60,Type_60,Yes
DB00344,Protriptyline,DB06153,Pizotifen,0.998957633972168,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Pizotifen.,49,Type_49,Yes
DB04868,Nilotinib,DB08882,Linagliptin,0.6994032859802246,47,Type_47,The metabolism of Linagliptin can be decreased when combined with Nilotinib.,70,Type_70,No
DB00480,Lenalidomide,DB00977,Ethinylestradiol,0.7614392042160034,81,Type_81,Lenalidomide may increase the thrombogenic activities of Ethinylestradiol.,81,Type_81,Yes
DB00932,Tipranavir,DB09183,Dasabuvir,0.6693573594093323,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB01005,Hydroxyurea,DB06772,Cabazitaxel,0.7817438840866089,15,Type_15,Hydroxyurea may increase the cardiotoxic activities of Cabazitaxel.,49,Type_49,No
DB00544,Fluorouracil,DB00755,Tretinoin,0.7312322854995728,47,Type_47,The metabolism of Tretinoin can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00831,Trifluoperazine,DB01587,Ketazolam,0.9950059056282043,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ketazolam.,49,Type_49,Yes
DB00517,Anisotropine methylbromide,DB01337,Pancuronium,0.9991027116775513,49,Type_49,The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Pancuronium.,49,Type_49,Yes
DB06605,Apixaban,DB08797,Salicylamide,0.9637287259101868,6,Type_6,Apixaban may increase the anticoagulant activities of Salicylamide.,6,Type_6,Yes
DB00203,Sildenafil,DB01248,Docetaxel,0.8971976637840271,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00370,Mirtazapine,DB06636,Isavuconazonium,0.720529317855835,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB06626,Axitinib,DB06636,Isavuconazonium,0.6056513786315918,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Axitinib.,47,Type_47,Yes
DB00313,Valproic acid,DB01075,Diphenhydramine,0.44769370555877686,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Valproic acid.,49,Type_49,No
DB00244,Mesalazine,DB00960,Pindolol,0.9596342444419861,37,Type_37,Mesalazine may decrease the antihypertensive activities of Pindolol.,37,Type_37,Yes
DB00750,Prilocaine,DB01081,Diphenoxylate,0.9985647797584534,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Diphenoxylate.,49,Type_49,Yes
DB00752,Tranylcypromine,DB00937,Diethylpropion,0.9564670324325562,71,Type_71,Tranylcypromine may increase the hypertensive activities of Diethylpropion.,71,Type_71,Yes
DB00531,Cyclophosphamide,DB00622,Nicardipine,0.632749080657959,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Nicardipine.,47,Type_47,No
DB06203,Alogliptin,DB09063,Ceritinib,0.8954953551292419,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Alogliptin.,73,Type_73,Yes
DB00370,Mirtazapine,DB01023,Felodipine,0.5157349705696106,47,Type_47,The metabolism of Felodipine can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB01201,Rifapentine,DB09039,Eliglustat,0.959602415561676,75,Type_75,The serum concentration of Eliglustat can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB01189,Desflurane,DB09112,Nitrous acid,0.9999961853027344,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Nitrous acid.,49,Type_49,Yes
DB00401,Nisoldipine,DB08822,Azilsartan medoxomil,0.9982631802558899,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00625,Efavirenz,DB00976,Telithromycin,0.4626016914844513,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB01037,Selegiline,DB09000,Cyamemazine,0.9761928915977478,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Cyamemazine.,49,Type_49,Yes
DB00753,Isoflurane,DB09117,Paraldehyde,0.977919340133667,16,Type_16,Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00681,Amphotericin B,DB04861,Nebivolol,0.9900541305541992,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol.,49,Type_49,Yes
DB00199,Erythromycin,DB00317,Gefitinib,0.6203478574752808,47,Type_47,The metabolism of Gefitinib can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB06403,Ambrisentan,DB08932,Macitentan,0.9937229752540588,60,Type_60,Ambrisentan may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB01166,Cilostazol,DB09118,Stiripentol,0.92923504114151,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB01100,Pimozide,DB01151,Desipramine,0.37425926327705383,20,Type_20,Pimozide may increase the QTc-prolonging activities of Desipramine.,20,Type_20,Yes
DB00647,Dextropropoxyphene,DB06800,Methylnaltrexone,0.9659743309020996,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Methylnaltrexone.,49,Type_49,Yes
DB00196,Fluconazole,DB00222,Glimepiride,0.6977169513702393,47,Type_47,The metabolism of Glimepiride can be decreased when combined with Fluconazole.,73,Type_73,No
DB00320,Dihydroergotamine,DB00790,Perindopril,0.43831896781921387,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB00332,Ipratropium,DB00772,Malathion,0.9914358258247375,70,Type_70,The therapeutic efficacy of Malathion can be decreased when used in combination with Ipratropium.,70,Type_70,Yes
DB00421,Spironolactone,DB01340,Cilazapril,0.8576342463493347,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.,49,Type_49,Yes
DB00899,Remifentanil,DB08881,Vemurafenib,0.511558473110199,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Remifentanil.,33,Type_33,No
DB00239,Oxiconazole,DB12332,Rucaparib,0.9249424338340759,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Oxiconazole.,47,Type_47,Yes
DB00521,Carteolol,DB00586,Diclofenac,0.9958114624023438,37,Type_37,Carteolol may decrease the antihypertensive activities of Diclofenac.,37,Type_37,Yes
DB04794,Bifonazole,DB06616,Bosutinib,0.9554610848426819,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Bifonazole.,73,Type_73,Yes
DB02187,Equilin,DB04576,Fleroxacin,0.991777777671814,49,Type_49,The risk or severity of adverse effects can be increased when Equilin is combined with Fleroxacin.,49,Type_49,Yes
DB00657,Mecamylamine,DB01392,Yohimbine,0.9930524230003357,37,Type_37,Mecamylamine may decrease the antihypertensive activities of Yohimbine.,37,Type_37,Yes
DB12598,Nafamostat,DB13158,Clobetasone,0.7430123686790466,49,Type_49,The risk or severity of adverse effects can be increased when Nafamostat is combined with Clobetasone.,49,Type_49,Yes
DB01435,Antipyrine,DB09288,Propacetamol,0.9928939938545227,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Propacetamol.,49,Type_49,Yes
DB01156,Bupropion,DB01244,Bepridil,0.8539064526557922,47,Type_47,The metabolism of Bepridil can be decreased when combined with Bupropion.,47,Type_47,Yes
DB00889,Granisetron,DB04844,Tetrabenazine,0.9713252782821655,20,Type_20,Granisetron may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00282,Pamidronic acid,DB01396,Digitoxin,0.9999407529830933,58,Type_58,Pamidronic acid may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00208,Ticlopidine,DB00435,Nitric Oxide,0.7066352367401123,47,Type_47,The metabolism of Nitric Oxide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00865,Benzphetamine,DB01407,Clenbuterol,0.967556357383728,49,Type_49,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Clenbuterol.,49,Type_49,Yes
DB00283,Clemastine,DB08867,Ulipristal,0.8577921986579895,47,Type_47,The metabolism of Ulipristal can be decreased when combined with Clemastine.,73,Type_73,No
DB00227,Lovastatin,DB00973,Ezetimibe,0.8024680614471436,73,Type_73,The serum concentration of Ezetimibe can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB08922,Perospirone,DB09291,Rolapitant,0.8312894701957703,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Perospirone.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB00543,Amoxapine,0.5784851312637329,37,Type_37,Dihydroergotamine may decrease the antihypertensive activities of Amoxapine.,49,Type_49,No
DB00706,Tamsulosin,DB00820,Tadalafil,0.7053824067115784,10,Type_10,Tamsulosin may increase the antihypertensive activities of Tadalafil.,60,Type_60,No
DB00573,Fenoprofen,DB01024,Mycophenolic acid,0.9362359642982483,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Mycophenolic acid.,49,Type_49,Yes
DB00489,Sotalol,DB01122,Ambenonium,0.9992786049842834,54,Type_54,Sotalol may increase the bradycardic activities of Ambenonium.,54,Type_54,Yes
DB06789,Hydroxyprogesterone caproate,DB09038,Empagliflozin,0.9804359674453735,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Hydroxyprogesterone caproate.,70,Type_70,Yes
DB01601,Lopinavir,DB09039,Eliglustat,0.5204407572746277,73,Type_73,The serum concentration of Eliglustat can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB01576,Dextroamphetamine,DB09286,Pipamperone,0.938349187374115,61,Type_61,Dextroamphetamine may decrease the stimulatory activities of Pipamperone.,61,Type_61,Yes
DB00742,Mannitol,DB01162,Terazosin,0.995795726776123,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Terazosin.,49,Type_49,Yes
DB00648,Mitotane,DB00814,Meloxicam,0.9896236062049866,75,Type_75,The serum concentration of Meloxicam can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01054,Nitrendipine,DB06697,Artemether,0.867096483707428,47,Type_47,The metabolism of Artemether can be decreased when combined with Nitrendipine.,49,Type_49,No
DB01014,Balsalazide,DB01033,Mercaptopurine,0.462738573551178,47,Type_47,The metabolism of Mercaptopurine can be decreased when combined with Balsalazide.,47,Type_47,Yes
DB00779,Nalidixic acid,DB01120,Gliclazide,0.9966199398040771,9,Type_9,Nalidixic acid may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00508,Triflupromazine,DB01131,Proguanil,0.4779176712036133,47,Type_47,The metabolism of Proguanil can be decreased when combined with Triflupromazine.,73,Type_73,No
DB00268,Ropinirole,DB00695,Furosemide,0.9735950827598572,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Furosemide.,49,Type_49,Yes
DB00394,Beclomethasone dipropionate,DB07615,Tranilast,0.99395352602005,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Tranilast.,49,Type_49,Yes
DB01037,Selegiline,DB01169,Arsenic trioxide,0.8349376916885376,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Arsenic trioxide.,49,Type_49,Yes
DB01157,Trimetrexate,DB01427,Amrinone,0.9549012780189514,49,Type_49,The risk or severity of adverse effects can be increased when Trimetrexate is combined with Amrinone.,49,Type_49,Yes
DB00285,Venlafaxine,DB01223,Aminophylline,0.9333986043930054,47,Type_47,The metabolism of Aminophylline can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00289,Atomoxetine,DB00567,Cephalexin,0.9937029480934143,47,Type_47,The metabolism of Cephalexin can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00899,Remifentanil,DB01275,Hydralazine,0.9787458181381226,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydralazine.,49,Type_49,Yes
DB00936,Salicylic acid,DB00991,Oxaprozin,0.7124049663543701,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Oxaprozin.,49,Type_49,Yes
DB00813,Fentanyl,DB01116,Trimethaphan,0.9870207905769348,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Trimethaphan.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB00591,Fluocinolone acetonide,0.9984394907951355,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Fluocinolone acetonide.,83,Type_83,Yes
DB00398,Sorafenib,DB00762,Irinotecan,0.4727509915828705,73,Type_73,The serum concentration of Irinotecan can be increased when it is combined with Sorafenib.,73,Type_73,Yes
DB00373,Timolol,DB09238,Manidipine,0.9187992811203003,60,Type_60,Timolol may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00448,Lansoprazole,DB00696,Ergotamine,0.8259013295173645,49,Type_49,The risk or severity of adverse effects can be increased when Lansoprazole is combined with Ergotamine.,49,Type_49,Yes
DB00327,Hydromorphone,DB06212,Tolvaptan,0.7467321753501892,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Hydromorphone.,49,Type_49,No
DB01194,Brinzolamide,DB01601,Lopinavir,0.8870887160301208,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Brinzolamide.,73,Type_73,No
DB00852,Pseudoephedrine,DB01063,Acetophenazine,0.9999805688858032,61,Type_61,Pseudoephedrine may decrease the stimulatory activities of Acetophenazine.,61,Type_61,Yes
DB00611,Butorphanol,DB00656,Trazodone,0.9791810512542725,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Trazodone.,49,Type_49,Yes
DB00321,Amitriptyline,DB01023,Felodipine,0.40599945187568665,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Felodipine.,47,Type_47,No
DB00795,Sulfasalazine,DB07615,Tranilast,0.9735299944877625,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tranilast.,49,Type_49,Yes
DB00353,Methylergometrine,DB04868,Nilotinib,0.8313620090484619,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Nilotinib.,49,Type_49,Yes
DB00322,Floxuridine,DB06803,Niclosamide,0.9451265931129456,47,Type_47,The metabolism of Niclosamide can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00914,Phenformin,DB12332,Rucaparib,0.8364374041557312,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Phenformin.,47,Type_47,Yes
DB01149,Nefazodone,DB11699,Tropisetron,0.9999997615814209,64,Type_64,Nefazodone may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00593,Ethosuximide,DB00972,Azelastine,0.9527693390846252,16,Type_16,Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00738,Pentamidine,DB09083,Ivabradine,0.9662860035896301,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Ivabradine.,20,Type_20,Yes
DB00458,Imipramine,DB01609,Deferasirox,0.8768527507781982,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Imipramine.,75,Type_75,Yes
DB01067,Glipizide,DB01241,Gemfibrozil,0.6951791644096375,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Glipizide.,47,Type_47,Yes
DB00750,Prilocaine,DB00802,Alfentanil,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Alfentanil.,49,Type_49,Yes
DB01174,Phenobarbital,DB09074,Olaparib,0.5969151854515076,75,Type_75,The serum concentration of Olaparib can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00622,Nicardipine,DB01168,Procarbazine,0.7377174496650696,60,Type_60,Nicardipine may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00450,Droperidol,DB00949,Felbamate,0.9889203906059265,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Felbamate.,16,Type_16,Yes
DB00520,Caspofungin,DB00696,Ergotamine,0.8423848152160645,49,Type_49,The risk or severity of adverse effects can be increased when Caspofungin is combined with Ergotamine.,49,Type_49,Yes
DB00374,Treprostinil,DB07615,Tranilast,0.6233479380607605,49,Type_49,The risk or severity of adverse effects can be increased when Treprostinil is combined with Tranilast.,49,Type_49,Yes
DB00619,Imatinib,DB00932,Tipranavir,0.7451928853988647,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Imatinib.,47,Type_47,Yes
DB01356,Lithium cation,DB08881,Vemurafenib,0.5899959802627563,20,Type_20,Lithium cation may increase the QTc-prolonging activities of Vemurafenib.,33,Type_33,No
DB00477,Chlorpromazine,DB01215,Estazolam,0.8647741079330444,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Estazolam.,49,Type_49,Yes
DB00624,Testosterone,DB01320,Fosphenytoin,0.9000406861305237,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Testosterone.,4,Type_4,Yes
DB00854,Levorphanol,DB09338,Mersalyl,0.9997096657752991,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Mersalyl.,49,Type_49,Yes
DB00203,Sildenafil,DB01181,Ifosfamide,0.9519981741905212,47,Type_47,The metabolism of Ifosfamide can be decreased when combined with Sildenafil.,11,Type_11,No
DB00564,Carbamazepine,DB01339,Vecuronium,0.511565625667572,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vecuronium.,75,Type_75,No
DB01254,Dasatinib,DB04835,Maraviroc,0.94551020860672,73,Type_73,The serum concentration of Maraviroc can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00482,Celecoxib,DB01050,Ibuprofen,0.7284828424453735,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Ibuprofen.,47,Type_47,No
DB00705,Delavirdine,DB09101,Elvitegravir,0.7549145817756653,47,Type_47,The metabolism of Elvitegravir can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB01083,Orlistat,DB01595,Nitrazepam,0.9309872984886169,75,Type_75,The serum concentration of Nitrazepam can be decreased when it is combined with Orlistat.,75,Type_75,Yes
DB00875,Flupentixol,DB01209,Dezocine,0.9724063277244568,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Dezocine.,49,Type_49,Yes
DB01241,Gemfibrozil,DB09048,Netupitant,0.8882750868797302,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Gemfibrozil.,73,Type_73,Yes
DB01092,Ouabain,DB04846,Celiprolol,0.8397634029388428,54,Type_54,Ouabain may increase the bradycardic activities of Celiprolol.,54,Type_54,Yes
DB00586,Diclofenac,DB01320,Fosphenytoin,0.8195086121559143,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Diclofenac.,75,Type_75,No
DB01251,Gliquidone,DB09270,Ubidecarenone,0.7272766828536987,8,Type_8,The therapeutic efficacy of Ubidecarenone can be increased when used in combination with Gliquidone.,8,Type_8,Yes
DB00208,Ticlopidine,DB01236,Sevoflurane,0.9513319134712219,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00259,Sulfanilamide,DB00699,Nicergoline,0.9910069108009338,49,Type_49,The risk or severity of adverse effects can be increased when Sulfanilamide is combined with Nicergoline.,49,Type_49,Yes
DB00515,Cisplatin,DB06263,Amrubicin,0.9945429563522339,57,Type_57,Cisplatin may increase the nephrotoxic activities of Amrubicin.,57,Type_57,Yes
DB00479,Amikacin,DB00608,Chloroquine,0.9938493371009827,72,Type_72,Amikacin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,72,Type_72,Yes
DB00601,Linezolid,DB01171,Moclobemide,0.9597948789596558,49,Type_49,The risk or severity of adverse effects can be increased when Linezolid is combined with Moclobemide.,49,Type_49,Yes
DB00656,Trazodone,DB01437,Glutethimide,0.9999785423278809,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Glutethimide.,49,Type_49,Yes
DB00839,Tolazamide,DB04846,Celiprolol,0.9433048367500305,9,Type_9,Tolazamide may increase the hypoglycemic activities of Celiprolol.,9,Type_9,Yes
DB00778,Roxithromycin,DB06212,Tolvaptan,0.9007676839828491,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Roxithromycin.,73,Type_73,Yes
DB00178,Ramipril,DB09218,Clonixin,0.9685037136077881,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Clonixin.,49,Type_49,Yes
DB00801,Halazepam,DB01351,Amobarbital,0.9993144273757935,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Amobarbital.,49,Type_49,Yes
DB00974,Edetic acid,DB01088,Iloprost,0.8346804976463318,6,Type_6,Edetic acid may increase the anticoagulant activities of Iloprost.,6,Type_6,Yes
DB00629,Guanabenz,DB09289,Tianeptine,0.7741577625274658,37,Type_37,Guanabenz may decrease the antihypertensive activities of Tianeptine.,37,Type_37,Yes
DB00956,Hydrocodone,DB12332,Rucaparib,0.8293085694313049,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Hydrocodone.,73,Type_73,No
DB00745,Modafinil,DB01124,Tolbutamide,0.9174203276634216,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00278,Argatroban,DB00582,Voriconazole,0.8579089641571045,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Argatroban.,47,Type_47,Yes
DB00217,Bethanidine,DB04840,Debrisoquine,0.9996175765991211,60,Type_60,Bethanidine may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00224,Indinavir,DB06739,Seratrodast,0.9113815426826477,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00483,Gallamine triethiodide,DB01210,Levobunolol,0.9918791055679321,54,Type_54,Gallamine triethiodide may increase the bradycardic activities of Levobunolol.,54,Type_54,Yes
DB00204,Dofetilide,DB00370,Mirtazapine,0.4192981421947479,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Mirtazapine.,20,Type_20,Yes
DB00212,Remikiren,DB09236,Lacidipine,0.9962450861930847,60,Type_60,Remikiren may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00224,Indinavir,DB00863,Ranitidine,0.830123245716095,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Indinavir.,75,Type_75,No
DB00503,Ritonavir,DB00914,Phenformin,0.656482458114624,47,Type_47,The metabolism of Phenformin can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB08804,Nandrolone decanoate,DB09095,Difluocortolone,1.0,74,Type_74,Nandrolone decanoate may increase the fluid retaining activities of Difluocortolone.,74,Type_74,Yes
DB00325,Nitroprusside,DB06268,Sitaxentan,0.9981247782707214,60,Type_60,Nitroprusside may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00540,Nortriptyline,DB09078,Lenvatinib,0.9257045984268188,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00283,Clemastine,DB06016,Cariprazine,0.9267702102661133,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01324,Polythiazide,DB08880,Teriflunomide,0.9815049767494202,70,Type_70,The therapeutic efficacy of Teriflunomide can be decreased when used in combination with Polythiazide.,70,Type_70,Yes
DB00263,Sulfisoxazole,DB00685,Trovafloxacin,0.944163978099823,9,Type_9,Sulfisoxazole may increase the hypoglycemic activities of Trovafloxacin.,9,Type_9,Yes
DB00608,Chloroquine,DB03585,Oxyphenbutazone,0.965377151966095,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Oxyphenbutazone.,49,Type_49,Yes
DB01397,Magnesium salicylate,DB02709,Resveratrol,0.9971420168876648,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Resveratrol.,49,Type_49,Yes
DB00695,Furosemide,DB13158,Clobetasone,0.9927089214324951,83,Type_83,Furosemide may increase the hypokalemic activities of Clobetasone.,83,Type_83,Yes
DB00270,Isradipine,DB00745,Modafinil,0.964257001876831,47,Type_47,The metabolism of Modafinil can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00397,Phenylpropanolamine,DB00852,Pseudoephedrine,0.9999897480010986,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Pseudoephedrine.,49,Type_49,Yes
DB00310,Chlorthalidone,DB04876,Vildagliptin,0.9922239780426025,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00455,Loratadine,DB00645,Dyclonine,0.9999697208404541,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Dyclonine.,49,Type_49,Yes
DB00201,Caffeine,DB01156,Bupropion,0.9808508157730103,47,Type_47,The metabolism of Bupropion can be decreased when combined with Caffeine.,47,Type_47,Yes
DB01122,Ambenonium,DB08808,Bupranolol,0.9995669722557068,54,Type_54,Ambenonium may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB06216,Asenapine,DB06594,Agomelatine,0.997479259967804,49,Type_49,The risk or severity of adverse effects can be increased when Asenapine is combined with Agomelatine.,49,Type_49,Yes
DB00524,Metolazone,DB01193,Acebutolol,0.6207165122032166,83,Type_83,Metolazone may increase the hypokalemic activities of Acebutolol.,49,Type_49,No
DB00827,Cinoxacin,DB09146,Iron sucrose,0.9520263671875,75,Type_75,The serum concentration of Iron sucrose can be decreased when it is combined with Cinoxacin.,75,Type_75,Yes
DB01024,Mycophenolic acid,DB01097,Leflunomide,0.7366819381713867,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Leflunomide.,49,Type_49,Yes
DB00246,Ziprasidone,DB00844,Nalbuphine,0.745453417301178,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Nalbuphine.,49,Type_49,Yes
DB01183,Naloxone,DB01601,Lopinavir,0.9520206451416016,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Naloxone.,47,Type_47,Yes
DB00252,Phenytoin,DB00799,Tazarotene,0.9479756355285645,4,Type_4,The metabolism of Tazarotene can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01104,Sertraline,DB09289,Tianeptine,0.540082573890686,49,Type_49,The risk or severity of adverse effects can be increased when Sertraline is combined with Tianeptine.,49,Type_49,Yes
DB01193,Acebutolol,DB01400,Neostigmine,0.9926224946975708,54,Type_54,Acebutolol may increase the bradycardic activities of Neostigmine.,54,Type_54,Yes
DB00191,Phentermine,DB00405,Dexbrompheniramine,0.9583421945571899,76,Type_76,Phentermine may decrease the sedative activities of Dexbrompheniramine.,76,Type_76,Yes
DB00849,Methylphenobarbital,DB01356,Lithium cation,0.8322325944900513,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Lithium cation.,49,Type_49,Yes
DB00363,Clozapine,DB09026,Aliskiren,0.5215172171592712,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Clozapine.,49,Type_49,No
DB00615,Rifabutin,DB09389,Norgestrel,0.6782418489456177,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00409,Remoxipride,DB00502,Haloperidol,0.8496516346931458,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Haloperidol.,47,Type_47,No
DB09034,Suvorexant,DB09068,Vortioxetine,0.8683480024337769,16,Type_16,Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,16,Type_16,Yes
DB00482,Celecoxib,DB00912,Repaglinide,0.5518468022346497,47,Type_47,The metabolism of Repaglinide can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00813,Fentanyl,DB01104,Sertraline,0.8900974988937378,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Sertraline.,49,Type_49,Yes
DB00215,Citalopram,DB01071,Mequitazine,0.7216868996620178,47,Type_47,The metabolism of Mequitazine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00324,Fluorometholone,DB00783,Estradiol,0.7183787226676941,73,Type_73,The serum concentration of Estradiol can be increased when it is combined with Fluorometholone.,73,Type_73,Yes
DB00196,Fluconazole,DB00503,Ritonavir,0.44236087799072266,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00207,Azithromycin,DB01211,Clarithromycin,0.3927310109138489,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Azithromycin.,20,Type_20,No
DB01098,Rosuvastatin,DB05521,Telaprevir,0.8136115074157715,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB01110,Miconazole,DB08881,Vemurafenib,0.7401502132415771,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Miconazole.,75,Type_75,No
DB01072,Atazanavir,DB06228,Rivaroxaban,0.7565532326698303,73,Type_73,The serum concentration of Rivaroxaban can be increased when it is combined with Atazanavir.,47,Type_47,No
DB08808,Bupranolol,DB09288,Propacetamol,0.9990033507347107,37,Type_37,Bupranolol may decrease the antihypertensive activities of Propacetamol.,37,Type_37,Yes
DB00567,Cephalexin,DB00619,Imatinib,0.9713028073310852,47,Type_47,The metabolism of Imatinib can be decreased when combined with Cephalexin.,47,Type_47,Yes
DB00136,Calcitriol,DB01410,Ciclesonide,0.7704881429672241,70,Type_70,The therapeutic efficacy of Ciclesonide can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB00911,Tinidazole,DB01254,Dasatinib,0.8096945285797119,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Tinidazole.,73,Type_73,Yes
DB00454,Meperidine,DB01149,Nefazodone,0.44596272706985474,64,Type_64,Meperidine may increase the serotonergic activities of Nefazodone.,47,Type_47,No
DB01114,Chlorpheniramine,DB01209,Dezocine,0.9993352293968201,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Dezocine.,49,Type_49,Yes
DB00794,Primidone,DB01325,Quinethazone,0.4574730694293976,30,Type_30,Primidone may increase the orthostatic hypotensive activities of Quinethazone.,30,Type_30,Yes
DB00668,Epinephrine,DB00866,Alprenolol,0.9745875000953674,25,Type_25,Epinephrine may increase the atrioventricular blocking (AV block) activities of Alprenolol.,25,Type_25,Yes
DB00615,Rifabutin,DB01243,Chloroxine,0.8999342918395996,73,Type_73,The serum concentration of Chloroxine can be increased when it is combined with Rifabutin.,73,Type_73,Yes
DB00700,Eplerenone,DB12598,Nafamostat,0.9193434119224548,37,Type_37,Eplerenone may decrease the antihypertensive activities of Nafamostat.,37,Type_37,Yes
DB00199,Erythromycin,DB00454,Meperidine,0.923087477684021,47,Type_47,The metabolism of Meperidine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00340,Metixene,DB00782,Propantheline,0.9998538494110107,49,Type_49,The risk or severity of adverse effects can be increased when Metixene is combined with Propantheline.,49,Type_49,Yes
DB00458,Imipramine,DB01608,Periciazine,0.6036348342895508,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Periciazine.,49,Type_49,Yes
DB00177,Valsartan,DB00268,Ropinirole,0.6910046935081482,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Ropinirole.,49,Type_49,Yes
DB06717,Fosaprepitant,DB09555,Dexchlorpheniramine maleate,0.7638385891914368,73,Type_73,The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Fosaprepitant.,73,Type_73,Yes
DB01367,Rasagiline,DB04871,Lorcaserin,0.9312630295753479,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Lorcaserin.,49,Type_49,Yes
DB00391,Sulpiride,DB00807,Proparacaine,0.9992043375968933,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Proparacaine.,49,Type_49,Yes
DB00187,Esmolol,DB01435,Antipyrine,0.9984802603721619,37,Type_37,Esmolol may decrease the antihypertensive activities of Antipyrine.,37,Type_37,Yes
DB00814,Meloxicam,DB01349,Tasosartan,0.6501936316490173,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Meloxicam.,49,Type_49,No
DB01176,Cyclizine,DB01356,Lithium cation,0.9586578607559204,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Lithium cation.,49,Type_49,Yes
DB01600,Tiaprofenic acid,DB09477,Enalaprilat,0.835587739944458,49,Type_49,The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Enalaprilat.,49,Type_49,Yes
DB06636,Isavuconazonium,DB08860,Pitavastatin,0.664393424987793,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Isavuconazonium.,73,Type_73,Yes
DB00712,Flurbiprofen,DB00887,Bumetanide,0.9999904632568359,29,Type_29,Flurbiprofen may decrease the diuretic activities of Bumetanide.,29,Type_29,Yes
DB00215,Citalopram,DB09073,Palbociclib,0.994392991065979,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Citalopram.,73,Type_73,Yes
DB00268,Ropinirole,DB00966,Telmisartan,0.8246855139732361,49,Type_49,The risk or severity of adverse effects can be increased when Ropinirole is combined with Telmisartan.,49,Type_49,Yes
DB08815,Lurasidone,DB11148,Butamben,0.9999872446060181,49,Type_49,The risk or severity of adverse effects can be increased when Lurasidone is combined with Butamben.,49,Type_49,Yes
DB01115,Nifedipine,DB04855,Dronedarone,0.799072265625,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Nifedipine.,47,Type_47,Yes
DB00312,Pentobarbital,DB01196,Estramustine,0.5228629112243652,75,Type_75,The serum concentration of Estramustine can be decreased when it is combined with Pentobarbital.,4,Type_4,No
DB00623,Fluphenazine,DB03754,Tromethamine,0.9803339838981628,67,Type_67,Fluphenazine can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00660,Metaxalone,DB04946,Iloperidone,0.9995169639587402,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Iloperidone.,49,Type_49,Yes
DB01115,Nifedipine,DB09038,Empagliflozin,0.9879292249679565,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Empagliflozin.,49,Type_49,Yes
DB00203,Sildenafil,DB01324,Polythiazide,0.9529801607131958,10,Type_10,Sildenafil may increase the antihypertensive activities of Polythiazide.,10,Type_10,Yes
DB01242,Clomipramine,DB09238,Manidipine,0.9480981826782227,47,Type_47,The metabolism of Manidipine can be decreased when combined with Clomipramine.,47,Type_47,Yes
DB00490,Buspirone,DB12267,Brigatinib,0.9291734099388123,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Buspirone.,75,Type_75,No
DB00257,Clotrimazole,DB00531,Cyclophosphamide,0.4722539782524109,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00715,Paroxetine,DB06697,Artemether,0.5119553804397583,47,Type_47,The metabolism of Artemether can be decreased when combined with Paroxetine.,20,Type_20,No
DB01340,Cilazapril,DB06826,Unoprostone,0.9999938011169434,60,Type_60,Cilazapril may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00295,Morphine,DB00849,Methylphenobarbital,0.8308178782463074,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Methylphenobarbital.,49,Type_49,Yes
DB00287,Travoprost,DB08932,Macitentan,0.9999927282333374,60,Type_60,Travoprost may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00610,Metaraminol,DB01162,Terazosin,0.9999681711196899,5,Type_5,Metaraminol may decrease the vasoconstricting activities of Terazosin.,5,Type_5,Yes
DB00834,Mifepristone,DB09074,Olaparib,0.8798940181732178,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB01227,Levacetylmethadol,0.9976790547370911,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Levacetylmethadol.,16,Type_16,Yes
DB00492,Fosinopril,DB06737,Zaltoprofen,0.9689976572990417,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Zaltoprofen.,49,Type_49,Yes
DB00220,Nelfinavir,DB01023,Felodipine,0.846504807472229,47,Type_47,The metabolism of Felodipine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01029,Irbesartan,DB08931,Riociguat,0.5937751531600952,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Riociguat.,49,Type_49,Yes
DB00435,Nitric Oxide,DB01235,Levodopa,0.9602019190788269,30,Type_30,Nitric Oxide may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00655,Estrone,DB01059,Norfloxacin,0.3073115944862366,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Norfloxacin.,49,Type_49,Yes
DB00276,Amsacrine,DB00476,Duloxetine,0.6760106086730957,47,Type_47,The metabolism of Duloxetine can be decreased when combined with Amsacrine.,47,Type_47,Yes
DB00193,Tramadol,DB08864,Rilpivirine,0.49402227997779846,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Tramadol.,75,Type_75,No
DB00195,Betaxolol,DB01124,Tolbutamide,0.7795264720916748,9,Type_9,Betaxolol may increase the hypoglycemic activities of Tolbutamide.,9,Type_9,Yes
DB00191,Phentermine,DB01619,Phenindamine,0.9999984502792358,76,Type_76,Phentermine may decrease the sedative activities of Phenindamine.,76,Type_76,Yes
DB00745,Modafinil,DB05521,Telaprevir,0.7012428045272827,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00343,Diltiazem,DB06282,Levocetirizine,0.8887993097305298,47,Type_47,The metabolism of Levocetirizine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01133,Tiludronic acid,DB01370,Aluminium,0.9925603866577148,75,Type_75,The serum concentration of Aluminium can be decreased when it is combined with Tiludronic acid.,75,Type_75,Yes
DB00014,Goserelin,DB09063,Ceritinib,0.9992209672927856,20,Type_20,Goserelin may increase the QTc-prolonging activities of Ceritinib.,20,Type_20,Yes
DB00205,Pyrimethamine,DB01240,Epoprostenol,0.8014706969261169,47,Type_47,The metabolism of Epoprostenol can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00337,Pimecrolimus,DB00445,Epirubicin,0.8060529232025146,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Epirubicin.,49,Type_49,Yes
DB00420,Promazine,DB09054,Idelalisib,0.7214065790176392,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Promazine.,47,Type_47,Yes
DB00337,Pimecrolimus,DB01136,Carvedilol,0.928686797618866,37,Type_37,Pimecrolimus may decrease the antihypertensive activities of Carvedilol.,37,Type_37,Yes
DB06724,Calcium carbonate,DB08931,Riociguat,0.48802265524864197,75,Type_75,The serum concentration of Riociguat can be decreased when it is combined with Calcium carbonate.,75,Type_75,Yes
DB00708,Sufentanil,DB00765,Metyrosine,0.8341009020805359,32,Type_32,Sufentanil may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00675,Tamoxifen,DB09280,Lumacaftor,0.6175461411476135,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Tamoxifen.,75,Type_75,Yes
DB01193,Acebutolol,DB04896,Milnacipran,0.7966764569282532,73,Type_73,The serum concentration of Milnacipran can be increased when it is combined with Acebutolol.,73,Type_73,Yes
DB00347,Trimethadione,DB09118,Stiripentol,0.7308740615844727,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Trimethadione.,73,Type_73,Yes
DB00390,Digoxin,DB00860,Prednisolone,0.8711371421813965,58,Type_58,Digoxin may decrease the cardiotoxic activities of Prednisolone.,58,Type_58,Yes
DB01243,Chloroxine,DB09231,Benidipine,0.9994375109672546,49,Type_49,The risk or severity of adverse effects can be increased when Chloroxine is combined with Benidipine.,49,Type_49,Yes
DB00539,Toremifene,DB00674,Galantamine,0.9935507774353027,20,Type_20,Toremifene may increase the QTc-prolonging activities of Galantamine.,20,Type_20,Yes
DB01424,Aminophenazone,DB04855,Dronedarone,0.8932929039001465,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Aminophenazone.,47,Type_47,Yes
DB01130,Prednicarbate,DB03585,Oxyphenbutazone,0.9997345805168152,49,Type_49,The risk or severity of adverse effects can be increased when Prednicarbate is combined with Oxyphenbutazone.,49,Type_49,Yes
DB01224,Quetiapine,DB08822,Azilsartan medoxomil,0.8709896206855774,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00289,Atomoxetine,DB06764,Tetryzoline,0.9358709454536438,71,Type_71,Atomoxetine may increase the hypertensive activities of Tetryzoline.,71,Type_71,Yes
DB00555,Lamotrigine,DB00633,Dexmedetomidine,0.9768511056900024,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Dexmedetomidine.,49,Type_49,Yes
DB00285,Venlafaxine,DB00934,Maprotiline,0.4426650404930115,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Maprotiline.,49,Type_49,Yes
DB00961,Mepivacaine,DB09166,Etizolam,0.9997403025627136,49,Type_49,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Etizolam.,49,Type_49,Yes
DB00681,Amphotericin B,DB01037,Selegiline,0.8604328632354736,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Selegiline.,49,Type_49,Yes
DB00734,Risperidone,DB01035,Procainamide,0.7811618447303772,20,Type_20,Risperidone may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00768,Olopatadine,DB11304,Phenoxyethanol,0.9961140155792236,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Phenoxyethanol.,49,Type_49,Yes
DB01206,Lomustine,DB04871,Lorcaserin,0.9859843850135803,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Lomustine.,47,Type_47,Yes
DB00660,Metaxalone,DB01018,Guanfacine,0.9855638742446899,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Guanfacine.,49,Type_49,Yes
DB00153,Ergocalciferol,DB00257,Clotrimazole,0.9817635416984558,47,Type_47,The metabolism of Clotrimazole can be decreased when combined with Ergocalciferol.,47,Type_47,Yes
DB00328,Indomethacin,DB00695,Furosemide,0.9991357922554016,29,Type_29,Indomethacin may decrease the diuretic activities of Furosemide.,29,Type_29,Yes
DB01074,Perhexiline,DB01589,Quazepam,0.43024367094039917,47,Type_47,The metabolism of Quazepam can be decreased when combined with Perhexiline.,73,Type_73,No
DB09041,Tavaborole,DB09236,Lacidipine,0.9995676875114441,49,Type_49,The risk or severity of adverse effects can be increased when Tavaborole is combined with Lacidipine.,49,Type_49,Yes
DB00187,Esmolol,DB00880,Chlorothiazide,0.944731593132019,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Chlorothiazide.,49,Type_49,Yes
DB01028,Methoxyflurane,DB09198,Lobeglitazone,0.9991959929466248,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00793,Haloprogin,DB09231,Benidipine,0.998909592628479,49,Type_49,The risk or severity of adverse effects can be increased when Haloprogin is combined with Benidipine.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB00950,Fexofenadine,0.9923104047775269,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Fexofenadine.,49,Type_49,Yes
DB01201,Rifapentine,DB01580,Oxprenolol,0.6835790872573853,75,Type_75,The serum concentration of Oxprenolol can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00490,Buspirone,DB09286,Pipamperone,0.997877836227417,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Pipamperone.,49,Type_49,Yes
DB00939,Meclofenamic acid,DB01029,Irbesartan,0.8602392077445984,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Irbesartan.,49,Type_49,Yes
DB00861,Diflunisal,DB01708,Prasterone,0.9996991157531738,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Prasterone.,49,Type_49,Yes
DB00336,Nitrofural,DB00420,Promazine,0.9926295280456543,47,Type_47,The metabolism of Promazine can be decreased when combined with Nitrofural.,47,Type_47,Yes
DB00541,Vincristine,DB06145,Spiramycin,0.771074652671814,73,Type_73,The serum concentration of Spiramycin can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00035,Desmopressin,DB00608,Chloroquine,0.7027766108512878,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Chloroquine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB01006,Letrozole,0.9859309196472168,47,Type_47,The metabolism of Letrozole can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00350,Minoxidil,DB00436,Bendroflumethiazide,0.9504675269126892,49,Type_49,The risk or severity of adverse effects can be increased when Minoxidil is combined with Bendroflumethiazide.,49,Type_49,Yes
DB00705,Delavirdine,DB08901,Ponatinib,0.9303861260414124,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00556,Perflutren,DB04946,Iloperidone,0.9999998807907104,20,Type_20,Perflutren may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB00721,Procaine,DB01154,Thiamylal,0.9995571970939636,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Thiamylal.,49,Type_49,Yes
DB00405,Dexbrompheniramine,DB00423,Methocarbamol,0.9999905824661255,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Methocarbamol.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB01356,Lithium cation,0.5008944869041443,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lithium cation.,49,Type_49,Yes
DB00458,Imipramine,DB00701,Amprenavir,0.7326143383979797,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Imipramine.,73,Type_73,No
DB00006,Bivalirudin,DB06414,Etravirine,0.4134521782398224,47,Type_47,The metabolism of Etravirine can be decreased when combined with Bivalirudin.,75,Type_75,No
DB00696,Ergotamine,DB09330,Osimertinib,0.8944551944732666,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Ergotamine.,73,Type_73,Yes
DB00484,Brimonidine,DB01239,Chlorprothixene,0.9773446917533875,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.,16,Type_16,Yes
DB01211,Clarithromycin,DB01601,Lopinavir,0.6379284858703613,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Clarithromycin.,20,Type_20,No
DB00397,Phenylpropanolamine,DB00457,Prazosin,0.8597722053527832,5,Type_5,Phenylpropanolamine may decrease the vasoconstricting activities of Prazosin.,5,Type_5,Yes
DB00619,Imatinib,DB09238,Manidipine,0.9675431847572327,47,Type_47,The metabolism of Manidipine can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00460,Verteporfin,DB00531,Cyclophosphamide,0.9929007291793823,15,Type_15,Verteporfin may increase the cardiotoxic activities of Cyclophosphamide.,15,Type_15,Yes
DB00436,Bendroflumethiazide,DB00620,Triamcinolone,0.9982354640960693,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Triamcinolone.,83,Type_83,Yes
DB00006,Bivalirudin,DB00788,Naproxen,0.9568126201629639,6,Type_6,Bivalirudin may increase the anticoagulant activities of Naproxen.,6,Type_6,Yes
DB01283,Lumiracoxib,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Lumiracoxib.,70,Type_70,Yes
DB01018,Guanfacine,DB01037,Selegiline,0.6301742196083069,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Selegiline.,60,Type_60,No
DB01161,Chloroprocaine,DB06770,Benzyl alcohol,0.9999547004699707,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Benzyl alcohol.,49,Type_49,Yes
DB01436,Alfacalcidol,DB09104,Magnesium hydroxide,0.99863201379776,73,Type_73,The serum concentration of Magnesium hydroxide can be increased when it is combined with Alfacalcidol.,73,Type_73,Yes
DB00575,Clonidine,DB01623,Thiothixene,0.8840199708938599,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Thiothixene.,49,Type_49,Yes
DB00458,Imipramine,DB01143,Amifostine,0.9675067663192749,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Amifostine.,49,Type_49,Yes
DB00363,Clozapine,DB04953,Ezogabine,0.7835938930511475,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Ezogabine.,20,Type_20,No
DB00818,Propofol,DB08880,Teriflunomide,0.6644224524497986,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Propofol.,75,Type_75,Yes
DB00696,Ergotamine,DB01609,Deferasirox,0.6344680786132812,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Ergotamine.,75,Type_75,Yes
DB00208,Ticlopidine,DB06654,Safinamide,0.9902432560920715,47,Type_47,The metabolism of Safinamide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00625,Efavirenz,DB01154,Thiamylal,0.7684876322746277,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Thiamylal.,49,Type_49,Yes
DB00590,Doxazosin,DB01041,Thalidomide,0.7991989254951477,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Thalidomide.,49,Type_49,Yes
DB01255,Lisdexamfetamine,DB09286,Pipamperone,0.9996538162231445,61,Type_61,Lisdexamfetamine may decrease the stimulatory activities of Pipamperone.,61,Type_61,Yes
DB01124,Tolbutamide,DB01131,Proguanil,0.7325401306152344,47,Type_47,The metabolism of Proguanil can be decreased when combined with Tolbutamide.,47,Type_47,Yes
DB01355,Hexobarbital,DB13323,Trichloroethylene,0.9983806610107422,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Trichloroethylene.,49,Type_49,Yes
DB00298,Dapiprazole,DB01614,Acepromazine,0.8435701131820679,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Acepromazine.,49,Type_49,Yes
DB00374,Treprostinil,DB06826,Unoprostone,0.9997268319129944,60,Type_60,Treprostinil may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00614,Furazolidone,DB01015,Sulfamethoxazole,0.7735636830329895,9,Type_9,Furazolidone may increase the hypoglycemic activities of Sulfamethoxazole.,9,Type_9,Yes
DB00176,Fluvoxamine,DB00185,Cevimeline,0.9951627254486084,47,Type_47,The metabolism of Cevimeline can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00215,Citalopram,DB00734,Risperidone,0.5228790640830994,64,Type_64,Citalopram may increase the serotonergic activities of Risperidone.,47,Type_47,No
DB00655,Estrone,DB06786,Halcinonide,0.8311975002288818,73,Type_73,The serum concentration of Halcinonide can be increased when it is combined with Estrone.,73,Type_73,Yes
DB00420,Promazine,DB06217,Vernakalant,0.9812102913856506,47,Type_47,The metabolism of Vernakalant can be decreased when combined with Promazine.,47,Type_47,Yes
DB01057,Echothiophate,DB01193,Acebutolol,0.9923040270805359,54,Type_54,Echothiophate may increase the bradycardic activities of Acebutolol.,54,Type_54,Yes
DB00611,Butorphanol,DB08881,Vemurafenib,0.5544746518135071,33,Type_33,The risk or severity of QTc prolongation can be increased when Butorphanol is combined with Vemurafenib.,33,Type_33,Yes
DB00661,Verapamil,DB01256,Retapamulin,0.9850833415985107,47,Type_47,The metabolism of Retapamulin can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00379,Mexiletine,DB06210,Eltrombopag,0.9180169701576233,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00916,Metronidazole,DB06589,Pazopanib,0.7268628478050232,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Metronidazole.,20,Type_20,No
DB00476,Duloxetine,DB01407,Clenbuterol,0.941665530204773,85,Type_85,Duloxetine may increase the tachycardic activities of Clenbuterol.,85,Type_85,Yes
DB01028,Methoxyflurane,DB09120,Zucapsaicin,0.9972112774848938,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00834,Mifepristone,DB06216,Asenapine,0.8221092820167542,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Asenapine.,73,Type_73,No
DB00679,Thioridazine,DB01155,Gemifloxacin,0.9723225831985474,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00261,Anagrelide,DB01211,Clarithromycin,0.3885681927204132,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Anagrelide.,20,Type_20,No
DB01041,Thalidomide,DB13872,Lormetazepam,0.992175281047821,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.,16,Type_16,Yes
DB01069,Promethazine,DB01247,Isocarboxazid,0.7045977711677551,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Isocarboxazid.,49,Type_49,Yes
DB00335,Atenolol,DB00966,Telmisartan,0.9543577432632446,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Telmisartan.,49,Type_49,Yes
DB00295,Morphine,DB00366,Doxylamine,0.9999755620956421,16,Type_16,Morphine may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB08880,Teriflunomide,DB09296,Ombitasvir,0.6025992631912231,73,Type_73,The serum concentration of Ombitasvir can be increased when it is combined with Teriflunomide.,73,Type_73,Yes
DB00582,Voriconazole,DB04930,Permethrin,0.933032751083374,47,Type_47,The metabolism of Permethrin can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB01181,Ifosfamide,DB08860,Pitavastatin,0.5584385991096497,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Ifosfamide.,73,Type_73,Yes
DB00618,Demeclocycline,DB01061,Azlocillin,0.9782644510269165,70,Type_70,The therapeutic efficacy of Azlocillin can be decreased when used in combination with Demeclocycline.,70,Type_70,Yes
DB00831,Trifluoperazine,DB06738,Ketobemidone,0.9877291917800903,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ketobemidone.,49,Type_49,Yes
DB00420,Promazine,DB08883,Perampanel,0.995625376701355,16,Type_16,Promazine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00686,Pentosan polysulfate,DB11268,Protocatechualdehyde,0.9996484518051147,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00182,Amphetamine,DB01119,Diazoxide,0.920552134513855,60,Type_60,Amphetamine may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB04868,Nilotinib,DB05109,Trabectedin,0.8594792485237122,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB02703,Fusidic acid,DB09389,Norgestrel,0.8880982995033264,75,Type_75,The serum concentration of Norgestrel can be decreased when it is combined with Fusidic acid.,73,Type_73,No
DB01203,Nadolol,DB08931,Riociguat,0.7316994071006775,49,Type_49,The risk or severity of adverse effects can be increased when Nadolol is combined with Riociguat.,49,Type_49,Yes
DB00998,Frovatriptan,DB04946,Iloperidone,0.9566465616226196,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Iloperidone.,49,Type_49,Yes
DB00599,Thiopental,DB00960,Pindolol,0.7030240297317505,60,Type_60,Thiopental may increase the hypotensive activities of Pindolol.,60,Type_60,Yes
DB00270,Isradipine,DB06717,Fosaprepitant,0.9058002829551697,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Isradipine.,73,Type_73,Yes
DB00907,Cocaine,DB01236,Sevoflurane,0.657253623008728,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Sevoflurane.,49,Type_49,Yes
DB00749,Etodolac,DB00764,Mometasone,0.9994257688522339,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Mometasone.,49,Type_49,Yes
DB00599,Thiopental,DB00622,Nicardipine,0.39552393555641174,4,Type_4,The metabolism of Nicardipine can be increased when combined with Thiopental.,60,Type_60,No
DB00623,Fluphenazine,DB00721,Procaine,0.999953031539917,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Procaine.,49,Type_49,Yes
DB00678,Losartan,DB00899,Remifentanil,0.8707520961761475,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Remifentanil.,49,Type_49,Yes
DB00334,Olanzapine,DB01166,Cilostazol,0.6794252395629883,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Olanzapine.,73,Type_73,Yes
DB00501,Cimetidine,DB01283,Lumiracoxib,0.8645420074462891,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00564,Carbamazepine,DB08918,Levomilnacipran,0.9321063756942749,4,Type_4,The metabolism of Levomilnacipran can be increased when combined with Carbamazepine.,47,Type_47,No
DB00807,Proparacaine,DB09166,Etizolam,0.999757707118988,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Etizolam.,49,Type_49,Yes
DB01189,Desflurane,DB04861,Nebivolol,0.9947441816329956,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Nebivolol.,49,Type_49,Yes
DB00349,Clobazam,DB01466,Ethylmorphine,0.5001068711280823,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Ethylmorphine.,47,Type_47,No
DB00215,Citalopram,DB00680,Moricizine,0.454028457403183,73,Type_73,The serum concentration of Moricizine can be increased when it is combined with Citalopram.,49,Type_49,No
DB00654,Latanoprost,DB00712,Flurbiprofen,0.9468904733657837,70,Type_70,The therapeutic efficacy of Flurbiprofen can be decreased when used in combination with Latanoprost.,70,Type_70,Yes
DB00268,Ropinirole,DB00526,Oxaliplatin,0.8930751085281372,47,Type_47,The metabolism of Oxaliplatin can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00203,Sildenafil,DB08860,Pitavastatin,0.5827020406723022,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Sildenafil.,47,Type_47,No
DB00542,Benazepril,DB01097,Leflunomide,0.7981724143028259,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Leflunomide.,49,Type_49,Yes
DB06802,Nepafenac,DB08439,Parecoxib,0.9934773445129395,49,Type_49,The risk or severity of adverse effects can be increased when Nepafenac is combined with Parecoxib.,49,Type_49,Yes
DB00321,Amitriptyline,DB00398,Sorafenib,0.3924501836299896,73,Type_73,The serum concentration of Sorafenib can be increased when it is combined with Amitriptyline.,47,Type_47,No
DB01093,Dimethyl sulfoxide,DB01200,Bromocriptine,0.7736350297927856,49,Type_49,The risk or severity of adverse effects can be increased when Dimethyl sulfoxide is combined with Bromocriptine.,49,Type_49,Yes
DB01092,Ouabain,DB01217,Anastrozole,0.9925017356872559,58,Type_58,Ouabain may decrease the cardiotoxic activities of Anastrozole.,58,Type_58,Yes
DB01155,Gemifloxacin,DB13595,Almasilate,0.9884640574455261,67,Type_67,Gemifloxacin can cause a decrease in the absorption of Almasilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00636,Clofibrate,DB02703,Fusidic acid,0.9945677518844604,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Clofibrate.,73,Type_73,Yes
DB00091,Cyclosporine,DB01166,Cilostazol,0.4950261414051056,47,Type_47,The metabolism of Cilostazol can be decreased when combined with Cyclosporine.,73,Type_73,No
DB01211,Clarithromycin,DB06216,Asenapine,0.4687393009662628,73,Type_73,The serum concentration of Asenapine can be increased when it is combined with Clarithromycin.,47,Type_47,No
DB04855,Dronedarone,DB06684,Vilazodone,0.6997830271720886,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Dronedarone.,73,Type_73,No
DB00296,Ropivacaine,DB00997,Doxorubicin,0.7363388538360596,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Ropivacaine.,47,Type_47,No
DB09241,Methylene blue,DB09242,Moxonidine,0.9989719390869141,60,Type_60,Methylene blue may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00997,Doxorubicin,DB01110,Miconazole,0.7346351742744446,47,Type_47,The metabolism of Miconazole can be decreased when combined with Doxorubicin.,73,Type_73,No
DB00946,Phenprocoumon,DB05812,Abiraterone,0.501499354839325,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Phenprocoumon.,73,Type_73,Yes
DB00685,Trovafloxacin,DB08976,Floctafenine,0.9948447942733765,27,Type_27,Trovafloxacin may increase the neuroexcitatory activities of Floctafenine.,27,Type_27,Yes
DB01058,Praziquantel,DB01611,Hydroxychloroquine,0.5782225728034973,47,Type_47,The metabolism of Hydroxychloroquine can be decreased when combined with Praziquantel.,75,Type_75,No
DB00700,Eplerenone,DB00797,Tolazoline,0.9003666639328003,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Tolazoline.,49,Type_49,Yes
DB00679,Thioridazine,DB00797,Tolazoline,0.823427140712738,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Tolazoline.,49,Type_49,Yes
DB01138,Sulfinpyrazone,DB01254,Dasatinib,0.6085452437400818,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Sulfinpyrazone.,73,Type_73,Yes
DB00622,Nicardipine,DB00820,Tadalafil,0.7024996876716614,10,Type_10,Nicardipine may increase the antihypertensive activities of Tadalafil.,10,Type_10,Yes
DB00749,Etodolac,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Etodolac.,70,Type_70,Yes
DB01115,Nifedipine,DB01186,Pergolide,0.745842456817627,37,Type_37,Nifedipine may decrease the antihypertensive activities of Pergolide.,49,Type_49,No
DB00281,Lidocaine,DB01080,Vigabatrin,0.998091995716095,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Vigabatrin.,49,Type_49,Yes
DB00747,Scopolamine,DB06695,Dabigatran etexilate,0.8699110746383667,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Scopolamine.,77,Type_77,Yes
DB00252,Phenytoin,DB00850,Perphenazine,0.41637420654296875,4,Type_4,The metabolism of Perphenazine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB09166,Etizolam,DB12332,Rucaparib,0.90595543384552,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Etizolam.,47,Type_47,Yes
DB00270,Isradipine,DB01036,Tolterodine,0.9330002665519714,20,Type_20,Isradipine may increase the QTc-prolonging activities of Tolterodine.,47,Type_47,No
DB00091,Cyclosporine,DB09330,Osimertinib,0.9601715803146362,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00289,Atomoxetine,DB00934,Maprotiline,0.6289676427841187,47,Type_47,The metabolism of Maprotiline can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB01267,Paliperidone,DB09063,Ceritinib,0.7319212555885315,20,Type_20,Paliperidone may increase the QTc-prolonging activities of Ceritinib.,20,Type_20,Yes
DB00887,Bumetanide,DB06203,Alogliptin,0.9746082425117493,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Bumetanide.,70,Type_70,Yes
DB08976,Floctafenine,DB09138,Technetium Tc-99m medronate,0.9977061748504639,49,Type_49,The risk or severity of adverse effects can be increased when Floctafenine is combined with Technetium Tc-99m medronate.,49,Type_49,Yes
DB00909,Zonisamide,DB01558,Bromazepam,0.9982122182846069,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Bromazepam.,49,Type_49,Yes
DB00605,Sulindac,DB00682,Warfarin,0.9997565150260925,6,Type_6,Sulindac may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB01016,Glyburide,DB08804,Nandrolone decanoate,0.9999070167541504,9,Type_9,Glyburide may increase the hypoglycemic activities of Nandrolone decanoate.,9,Type_9,Yes
DB00136,Calcitriol,DB00620,Triamcinolone,0.5952675938606262,70,Type_70,The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB00177,Valsartan,DB01124,Tolbutamide,0.9385291337966919,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Valsartan.,47,Type_47,Yes
DB00628,Clorazepic acid,DB01151,Desipramine,0.90104740858078,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Desipramine.,49,Type_49,Yes
DB00683,Midazolam,DB08820,Ivacaftor,0.9981428384780884,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Midazolam.,73,Type_73,Yes
DB00945,Acetylsalicylic acid,DB00946,Phenprocoumon,0.9998180270195007,6,Type_6,Acetylsalicylic acid may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00287,Travoprost,DB08931,Riociguat,0.9999494552612305,60,Type_60,Travoprost may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00503,Ritonavir,DB00743,Gadobenic acid,0.9999911785125732,20,Type_20,Ritonavir may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB01149,Nefazodone,DB08932,Macitentan,0.9656383991241455,47,Type_47,The metabolism of Macitentan can be decreased when combined with Nefazodone.,73,Type_73,No
DB00500,Tolmetin,DB00876,Eprosartan,0.9241957664489746,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Eprosartan.,49,Type_49,Yes
DB01421,Paromomycin,DB03585,Oxyphenbutazone,0.9999982118606567,72,Type_72,Paromomycin may decrease the excretion rate of Oxyphenbutazone which could result in a higher serum level.,72,Type_72,Yes
DB00697,Tizanidine,DB00960,Pindolol,0.9656406044960022,25,Type_25,Tizanidine may increase the atrioventricular blocking (AV block) activities of Pindolol.,25,Type_25,Yes
DB01253,Ergometrine,DB06207,Silodosin,0.9871565699577332,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00861,Diflunisal,DB04574,Estrone sulfate,0.9821765422821045,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Estrone sulfate.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB04861,Nebivolol,0.9992058873176575,37,Type_37,Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.,37,Type_37,Yes
DB00708,Sufentanil,DB01193,Acebutolol,0.7543800473213196,54,Type_54,Sufentanil may increase the bradycardic activities of Acebutolol.,54,Type_54,Yes
DB00748,Carbinoxamine,DB01106,Levocabastine,0.9999819993972778,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Levocabastine.,49,Type_49,Yes
DB00726,Trimipramine,DB11609,Normethadone,0.9613850712776184,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Normethadone.,49,Type_49,Yes
DB00675,Tamoxifen,DB09238,Manidipine,0.9377647638320923,47,Type_47,The metabolism of Manidipine can be decreased when combined with Tamoxifen.,11,Type_11,No
DB00343,Diltiazem,DB09396,Dextropropoxyphene napsylate,0.9636118412017822,47,Type_47,The metabolism of Dextropropoxyphene napsylate can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00295,Morphine,DB01567,Fludiazepam,0.997093677520752,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Fludiazepam.,49,Type_49,Yes
DB00390,Digoxin,DB01164,Calcium chloride,0.9606084227561951,82,Type_82,Digoxin may increase the arrhythmogenic activities of Calcium chloride.,82,Type_82,Yes
DB00196,Fluconazole,DB09026,Aliskiren,0.8802109956741333,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00377,Palonosetron,DB00619,Imatinib,0.9649900197982788,47,Type_47,The metabolism of Imatinib can be decreased when combined with Palonosetron.,47,Type_47,Yes
DB00700,Eplerenone,DB00922,Levosimendan,0.9989412426948547,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Levosimendan.,49,Type_49,Yes
DB00419,Miglustat,DB06663,Pasireotide,0.7953568696975708,9,Type_9,Miglustat may increase the hypoglycemic activities of Pasireotide.,70,Type_70,No
DB06203,Alogliptin,DB08804,Nandrolone decanoate,0.999968409538269,9,Type_9,Alogliptin may increase the hypoglycemic activities of Nandrolone decanoate.,9,Type_9,Yes
DB00374,Treprostinil,DB00472,Fluoxetine,0.7167815566062927,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Fluoxetine.,20,Type_20,Yes
DB00359,Sulfadiazine,DB00514,Dextromethorphan,0.992904007434845,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00804,Dicyclomine,DB01021,Trichlormethiazide,0.999294638633728,73,Type_73,The serum concentration of Trichlormethiazide can be increased when it is combined with Dicyclomine.,73,Type_73,Yes
DB00294,Etonogestrel,DB01252,Mitiglinide,0.99997878074646,70,Type_70,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00838,Clocortolone,DB06412,Oxymetholone,0.990287184715271,74,Type_74,Clocortolone may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB00320,Dihydroergotamine,DB00359,Sulfadiazine,0.9820091724395752,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB00809,Tropicamide,0.9997734427452087,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Tropicamide.,49,Type_49,Yes
DB01017,Minocycline,DB01189,Desflurane,0.47771012783050537,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Desflurane.,16,Type_16,Yes
DB09074,Olaparib,DB11737,Icotinib,0.9343224763870239,47,Type_47,The metabolism of Icotinib can be decreased when combined with Olaparib.,47,Type_47,Yes
DB00977,Ethinylestradiol,DB01340,Cilazapril,0.8318732380867004,75,Type_75,The serum concentration of Cilazapril can be decreased when it is combined with Ethinylestradiol.,75,Type_75,Yes
DB02709,Resveratrol,DB04576,Fleroxacin,0.9970756769180298,27,Type_27,Resveratrol may increase the neuroexcitatory activities of Fleroxacin.,27,Type_27,Yes
DB00321,Amitriptyline,DB01081,Diphenoxylate,0.9791353344917297,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Diphenoxylate.,49,Type_49,Yes
DB00363,Clozapine,DB00937,Diethylpropion,0.8480052351951599,61,Type_61,Clozapine may decrease the stimulatory activities of Diethylpropion.,61,Type_61,Yes
DB00652,Pentazocine,DB08883,Perampanel,0.9971621632575989,16,Type_16,Pentazocine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00470,Dronabinol,DB00670,Pirenzepine,0.9816238284111023,85,Type_85,Dronabinol may increase the tachycardic activities of Pirenzepine.,85,Type_85,Yes
DB01399,Salsalate,DB09091,Tixocortol,0.9996193647384644,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Tixocortol.,49,Type_49,Yes
DB00778,Roxithromycin,DB09073,Palbociclib,0.9931972026824951,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Roxithromycin.,73,Type_73,Yes
DB00957,Norgestimate,DB01201,Rifapentine,0.8125010132789612,75,Type_75,The serum concentration of Rifapentine can be decreased when it is combined with Norgestimate.,75,Type_75,Yes
DB00872,Conivaptan,DB01609,Deferasirox,0.857047975063324,73,Type_73,The serum concentration of Deferasirox can be increased when it is combined with Conivaptan.,75,Type_75,No
DB00353,Methylergometrine,DB00668,Epinephrine,0.9826541543006897,71,Type_71,Methylergometrine may increase the hypertensive activities of Epinephrine.,49,Type_49,No
DB00196,Fluconazole,DB01110,Miconazole,0.7110579013824463,47,Type_47,The metabolism of Miconazole can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00482,Celecoxib,DB01047,Fluocinonide,0.9963738322257996,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Fluocinonide.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB08881,Vemurafenib,0.5404619574546814,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Acetylsalicylic acid.,73,Type_73,No
DB00720,Clodronic acid,DB06725,Lornoxicam,0.9952467083930969,49,Type_49,The risk or severity of adverse effects can be increased when Clodronic acid is combined with Lornoxicam.,49,Type_49,Yes
DB00678,Losartan,DB09198,Lobeglitazone,0.9992425441741943,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Losartan.,47,Type_47,Yes
DB00224,Indinavir,DB01167,Itraconazole,0.4796057641506195,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Indinavir.,73,Type_73,No
DB00482,Celecoxib,DB02709,Resveratrol,0.8862890601158142,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Resveratrol.,49,Type_49,Yes
DB01348,Spirapril,DB06403,Ambrisentan,0.9979733824729919,60,Type_60,Spirapril may increase the hypotensive activities of Ambrisentan.,60,Type_60,Yes
DB00570,Vinblastine,DB00907,Cocaine,0.7928470373153687,47,Type_47,The metabolism of Cocaine can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB00363,Clozapine,DB00849,Methylphenobarbital,0.28825250267982483,60,Type_60,Clozapine may increase the hypotensive activities of Methylphenobarbital.,49,Type_49,No
DB00426,Famciclovir,DB00564,Carbamazepine,0.9509103894233704,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Famciclovir.,4,Type_4,Yes
DB00400,Griseofulvin,DB01418,Acenocoumarol,0.4004024863243103,75,Type_75,The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.,75,Type_75,Yes
DB01078,Deslanoside,DB08865,Crizotinib,0.7637152075767517,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Crizotinib.,58,Type_58,Yes
DB00196,Fluconazole,DB09074,Olaparib,0.6210569143295288,47,Type_47,The metabolism of Olaparib can be decreased when combined with Fluconazole.,73,Type_73,No
DB01128,Bicalutamide,DB08860,Pitavastatin,0.8704824447631836,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Bicalutamide.,73,Type_73,Yes
DB00359,Sulfadiazine,DB06710,Methyltestosterone,0.6550059914588928,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB00758,Clopidogrel,DB05521,Telaprevir,0.6655433773994446,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Clopidogrel.,47,Type_47,Yes
DB00972,Azelastine,DB06700,Desvenlafaxine,0.7118841409683228,53,Type_53,Azelastine may increase the antiplatelet activities of Desvenlafaxine.,49,Type_49,No
DB00564,Carbamazepine,DB01340,Cilazapril,0.7748748064041138,75,Type_75,The serum concentration of Cilazapril can be decreased when it is combined with Carbamazepine.,4,Type_4,No
DB00546,Adinazolam,DB01104,Sertraline,0.9838607311248779,47,Type_47,The metabolism of Sertraline can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB00266,Dicoumarol,DB00313,Valproic acid,0.5565991401672363,47,Type_47,The metabolism of Valproic acid can be decreased when combined with Dicoumarol.,47,Type_47,Yes
DB00905,Bimatoprost,DB01024,Mycophenolic acid,0.9958796501159668,70,Type_70,The therapeutic efficacy of Mycophenolic acid can be decreased when used in combination with Bimatoprost.,70,Type_70,Yes
DB00747,Scopolamine,DB09272,Eluxadoline,0.9430782198905945,39,Type_39,Scopolamine may increase the constipating activities of Eluxadoline.,39,Type_39,Yes
DB00607,Nafcillin,DB00977,Ethinylestradiol,0.4193236529827118,70,Type_70,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Nafcillin.,4,Type_4,No
DB00363,Clozapine,DB01076,Atorvastatin,0.8358978629112244,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Atorvastatin.,49,Type_49,Yes
DB00359,Sulfadiazine,DB01044,Gatifloxacin,0.9840543866157532,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Gatifloxacin.,9,Type_9,Yes
DB01090,Pentolinium,DB01119,Diazoxide,0.9706739783287048,60,Type_60,Pentolinium may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00294,Etonogestrel,DB01154,Thiamylal,0.880273699760437,70,Type_70,The therapeutic efficacy of Thiamylal can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB04840,Debrisoquine,DB06712,Nilvadipine,0.9992998838424683,60,Type_60,Debrisoquine may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00814,Meloxicam,DB01418,Acenocoumarol,0.9982386827468872,6,Type_6,Meloxicam may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00972,Azelastine,DB01104,Sertraline,0.8230336308479309,47,Type_47,The metabolism of Sertraline can be decreased when combined with Azelastine.,47,Type_47,Yes
DB01435,Antipyrine,DB08912,Dabrafenib,0.8733701705932617,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Antipyrine.,75,Type_75,Yes
DB01348,Spirapril,DB01628,Etoricoxib,0.9650763869285583,49,Type_49,The risk or severity of adverse effects can be increased when Spirapril is combined with Etoricoxib.,49,Type_49,Yes
DB00634,Sulfacetamide,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Sulfacetamide.,70,Type_70,Yes
DB01161,Chloroprocaine,DB01198,Zopiclone,0.9999715089797974,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Zopiclone.,49,Type_49,Yes
DB00599,Thiopental,DB01219,Dantrolene,0.96142578125,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Dantrolene.,49,Type_49,Yes
DB00337,Pimecrolimus,DB00452,Framycetin,0.9940721392631531,72,Type_72,Pimecrolimus may decrease the excretion rate of Framycetin which could result in a higher serum level.,72,Type_72,Yes
DB00683,Midazolam,DB06738,Ketobemidone,0.9888719916343689,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Ketobemidone.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09119,Eslicarbazepine acetate,0.7018389701843262,73,Type_73,The serum concentration of Eslicarbazepine acetate can be increased when it is combined with Rosuvastatin.,75,Type_75,No
DB00193,Tramadol,DB09330,Osimertinib,0.696199893951416,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Tramadol.,73,Type_73,Yes
DB00904,Ondansetron,DB01219,Dantrolene,0.9662269949913025,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Dantrolene.,49,Type_49,Yes
DB00497,Oxycodone,DB06716,Fospropofol,0.9993982315063477,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Fospropofol.,49,Type_49,Yes
DB00559,Bosentan,DB08815,Lurasidone,0.9380753040313721,75,Type_75,The serum concentration of Lurasidone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00823,Ethynodiol diacetate,DB08873,Boceprevir,0.8439797163009644,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Ethynodiol diacetate.,73,Type_73,No
DB01149,Nefazodone,DB06605,Apixaban,0.4859018623828888,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00849,Methylphenobarbital,DB01069,Promethazine,0.9751616716384888,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Promethazine.,49,Type_49,Yes
DB00554,Piroxicam,DB00887,Bumetanide,0.9999915361404419,29,Type_29,Piroxicam may decrease the diuretic activities of Bumetanide.,29,Type_29,Yes
DB00187,Esmolol,DB01233,Metoclopramide,0.7309641242027283,54,Type_54,Esmolol may increase the bradycardic activities of Metoclopramide.,54,Type_54,Yes
DB00405,Dexbrompheniramine,DB00765,Metyrosine,0.9995893836021423,32,Type_32,Dexbrompheniramine may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00457,Prazosin,DB09049,Naloxegol,0.9996395111083984,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Prazosin.,73,Type_73,Yes
DB01201,Rifapentine,DB08970,Fluprednidene,0.9970011115074158,75,Type_75,The serum concentration of Fluprednidene can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00091,Cyclosporine,DB05239,Cobimetinib,0.9063625931739807,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB01186,Pergolide,DB09167,Dosulepin,0.6551807522773743,37,Type_37,Pergolide may decrease the antihypertensive activities of Dosulepin.,37,Type_37,Yes
DB00503,Ritonavir,DB08903,Bedaquiline,0.7142479419708252,20,Type_20,Ritonavir may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00498,Phenindione,DB00688,Mycophenolate mofetil,0.9932066202163696,6,Type_6,Phenindione may increase the anticoagulant activities of Mycophenolate mofetil.,6,Type_6,Yes
DB01267,Paliperidone,DB01268,Sunitinib,0.8923448920249939,20,Type_20,Paliperidone may increase the QTc-prolonging activities of Sunitinib.,20,Type_20,Yes
DB00686,Pentosan polysulfate,DB06154,Pentaerythritol tetranitrate,0.9997960925102234,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Pentaerythritol tetranitrate.,6,Type_6,Yes
DB01403,Methotrimeprazine,DB03754,Tromethamine,0.8938287496566772,67,Type_67,Methotrimeprazine can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00399,Zoledronic acid,DB00963,Bromfenac,0.9934072494506836,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Bromfenac.,49,Type_49,Yes
DB00180,Flunisolide,DB00794,Primidone,0.7642333507537842,4,Type_4,The metabolism of Primidone can be increased when combined with Flunisolide.,4,Type_4,Yes
DB00390,Digoxin,DB01359,Penbutolol,0.9105820655822754,54,Type_54,Digoxin may increase the bradycardic activities of Penbutolol.,54,Type_54,Yes
DB01072,Atazanavir,DB06772,Cabazitaxel,0.4670375883579254,73,Type_73,The serum concentration of Cabazitaxel can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00623,Fluphenazine,DB08808,Bupranolol,0.808475911617279,60,Type_60,Fluphenazine may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00230,Pregabalin,DB01091,Butenafine,0.9730408191680908,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Butenafine.,49,Type_49,Yes
DB01319,Fosamprenavir,DB01431,Allylestrenol,0.8496140241622925,47,Type_47,The metabolism of Allylestrenol can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00691,Moexipril,DB00784,Mefenamic acid,0.9416212439537048,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Mefenamic acid.,49,Type_49,Yes
DB01016,Glyburide,DB01168,Procarbazine,0.9900822043418884,9,Type_9,Glyburide may increase the hypoglycemic activities of Procarbazine.,9,Type_9,Yes
DB00189,Ethchlorvynol,DB00283,Clemastine,0.9027831554412842,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Clemastine.,49,Type_49,Yes
DB00927,Famotidine,DB01224,Quetiapine,0.8046846985816956,20,Type_20,Famotidine may increase the QTc-prolonging activities of Quetiapine.,20,Type_20,Yes
DB00572,Atropine,DB01043,Memantine,0.9993341565132141,70,Type_70,The therapeutic efficacy of Memantine can be decreased when used in combination with Atropine.,70,Type_70,Yes
DB06605,Apixaban,DB08880,Teriflunomide,0.6685899496078491,6,Type_6,Apixaban may increase the anticoagulant activities of Teriflunomide.,75,Type_75,No
DB00582,Voriconazole,DB06207,Silodosin,0.9825506806373596,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00312,Pentobarbital,DB00976,Telithromycin,0.5212099552154541,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Pentobarbital.,4,Type_4,No
DB00243,Ranolazine,DB01074,Perhexiline,0.5379766225814819,47,Type_47,The metabolism of Perhexiline can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00176,Fluvoxamine,DB01008,Busulfan,0.9441042542457581,47,Type_47,The metabolism of Busulfan can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00363,Clozapine,DB00496,Darifenacin,0.9451025128364563,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Clozapine.,47,Type_47,Yes
DB01072,Atazanavir,DB09078,Lenvatinib,0.6908286809921265,20,Type_20,Atazanavir may increase the QTc-prolonging activities of Lenvatinib.,47,Type_47,No
DB00334,Olanzapine,DB00405,Dexbrompheniramine,0.999622106552124,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Dexbrompheniramine.,49,Type_49,Yes
DB00222,Glimepiride,DB01174,Phenobarbital,0.970219075679779,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Glimepiride.,4,Type_4,Yes
DB00605,Sulindac,DB00919,Spectinomycin,0.9999150037765503,72,Type_72,Sulindac may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB00206,Reserpine,DB09072,Sodium oxybate,0.9909819960594177,16,Type_16,Reserpine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00624,Testosterone,DB00625,Efavirenz,0.879669189453125,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Testosterone.,47,Type_47,Yes
DB06712,Nilvadipine,DB09330,Osimertinib,0.8862048983573914,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Nilvadipine.,73,Type_73,Yes
DB00794,Primidone,DB01232,Saquinavir,0.6811496019363403,4,Type_4,The metabolism of Saquinavir can be increased when combined with Primidone.,4,Type_4,Yes
DB01563,Chloral hydrate,DB01618,Molindone,0.999980092048645,49,Type_49,The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Molindone.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB01356,Lithium cation,0.879220187664032,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Lithium cation.,49,Type_49,Yes
DB08820,Ivacaftor,DB13874,Enasidenib,0.9946461319923401,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Ivacaftor.,73,Type_73,Yes
DB00199,Erythromycin,DB01110,Miconazole,0.8488436937332153,47,Type_47,The metabolism of Miconazole can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00191,Phentermine,DB00543,Amoxapine,0.967210590839386,23,Type_23,Phentermine may increase the stimulatory activities of Amoxapine.,23,Type_23,Yes
DB00603,Medroxyprogesterone acetate,DB06772,Cabazitaxel,0.6249439120292664,49,Type_49,The risk or severity of adverse effects can be increased when Medroxyprogesterone acetate is combined with Cabazitaxel.,49,Type_49,Yes
DB00980,Ramelteon,DB01589,Quazepam,0.9597311615943909,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Quazepam.,49,Type_49,Yes
DB00652,Pentazocine,DB01104,Sertraline,0.5940088033676147,64,Type_64,Pentazocine may increase the serotonergic activities of Sertraline.,64,Type_64,Yes
DB00375,Colestipol,DB00461,Nabumetone,0.9915302991867065,67,Type_67,Colestipol can cause a decrease in the absorption of Nabumetone resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00497,Oxycodone,DB08910,Pomalidomide,0.9770763516426086,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Pomalidomide.,49,Type_49,Yes
DB04871,Lorcaserin,DB06701,Dexmethylphenidate,0.8564420342445374,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Lorcaserin.,47,Type_47,Yes
DB00696,Ergotamine,DB00794,Primidone,0.9420023560523987,4,Type_4,The metabolism of Primidone can be increased when combined with Ergotamine.,4,Type_4,Yes
DB00802,Alfentanil,DB08807,Bopindolol,0.8861792087554932,54,Type_54,Alfentanil may increase the bradycardic activities of Bopindolol.,54,Type_54,Yes
DB01601,Lopinavir,DB08899,Enzalutamide,0.9216316342353821,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Lopinavir.,75,Type_75,Yes
DB00252,Phenytoin,DB01181,Ifosfamide,0.7425974011421204,4,Type_4,The metabolism of Ifosfamide can be increased when combined with Phenytoin.,77,Type_77,No
DB00608,Chloroquine,DB00914,Phenformin,0.5478895902633667,9,Type_9,Chloroquine may increase the hypoglycemic activities of Phenformin.,47,Type_47,No
DB01189,Desflurane,DB08815,Lurasidone,0.7034522294998169,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Lurasidone.,49,Type_49,Yes
DB00524,Metolazone,DB00979,Cyclopentolate,0.9887183904647827,73,Type_73,The serum concentration of Cyclopentolate can be increased when it is combined with Metolazone.,73,Type_73,Yes
DB00254,Doxycycline,DB01098,Rosuvastatin,0.4931774437427521,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB09227,Barnidipine,DB09270,Ubidecarenone,0.7688453793525696,49,Type_49,The risk or severity of adverse effects can be increased when Barnidipine is combined with Ubidecarenone.,49,Type_49,Yes
DB00871,Terbutaline,DB04861,Nebivolol,0.9952136278152466,14,Type_14,Terbutaline may decrease the bronchodilatory activities of Nebivolol.,14,Type_14,Yes
DB00462,Methscopolamine bromide,DB00999,Hydrochlorothiazide,0.9973564147949219,73,Type_73,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methscopolamine bromide.,73,Type_73,Yes
DB00966,Telmisartan,DB01628,Etoricoxib,0.960167407989502,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Etoricoxib.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB06413,Armodafinil,0.906218945980072,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Methylphenobarbital.,47,Type_47,Yes
DB00697,Tizanidine,DB06153,Pizotifen,0.9580428600311279,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Pizotifen.,49,Type_49,Yes
DB00206,Reserpine,DB01086,Benzocaine,0.9981471300125122,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Benzocaine.,49,Type_49,Yes
DB00232,Methyclothiazide,DB01054,Nitrendipine,0.6400758624076843,60,Type_60,Methyclothiazide may increase the hypotensive activities of Nitrendipine.,49,Type_49,No
DB00695,Furosemide,DB00844,Nalbuphine,0.9631803035736084,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Nalbuphine.,49,Type_49,Yes
DB09082,Vilanterol,DB09167,Dosulepin,0.7971335053443909,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Vilanterol.,49,Type_49,No
DB00897,Triazolam,DB08918,Levomilnacipran,0.9765249490737915,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Levomilnacipran.,49,Type_49,Yes
DB01609,Deferasirox,DB06144,Sertindole,0.9309453368186951,75,Type_75,The serum concentration of Sertindole can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB06825,Triptorelin,DB09039,Eliglustat,0.9944368600845337,20,Type_20,Triptorelin may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00292,Etomidate,DB00564,Carbamazepine,0.8316412568092346,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Carbamazepine.,49,Type_49,Yes
DB00779,Nalidixic acid,DB01032,Probenecid,0.6047803163528442,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Nalidixic acid.,73,Type_73,Yes
DB00222,Glimepiride,DB08807,Bopindolol,0.9948646426200867,9,Type_9,Glimepiride may increase the hypoglycemic activities of Bopindolol.,9,Type_9,Yes
DB00390,Digoxin,DB06791,Lanreotide,0.8842045068740845,58,Type_58,Digoxin may decrease the cardiotoxic activities of Lanreotide.,58,Type_58,Yes
DB08883,Perampanel,DB11609,Normethadone,0.7483600378036499,16,Type_16,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Normethadone.,16,Type_16,Yes
DB00821,Carprofen,DB09295,Talniflumate,0.9996451139450073,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Talniflumate.,49,Type_49,Yes
DB00435,Nitric Oxide,DB01238,Aripiprazole,0.8752114772796631,60,Type_60,Nitric Oxide may increase the hypotensive activities of Aripiprazole.,60,Type_60,Yes
DB00898,Ethanol,DB01104,Sertraline,0.4535352885723114,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Sertraline.,49,Type_49,Yes
DB01601,Lopinavir,DB09053,Ibrutinib,0.8186527490615845,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00542,Benazepril,DB01023,Felodipine,0.6553274393081665,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Felodipine.,49,Type_49,Yes
DB00240,Alclometasone,DB00252,Phenytoin,0.9531371593475342,4,Type_4,The metabolism of Phenytoin can be increased when combined with Alclometasone.,4,Type_4,Yes
DB00191,Phentermine,DB00967,Desloratadine,0.9992227554321289,76,Type_76,Phentermine may decrease the sedative activities of Desloratadine.,76,Type_76,Yes
DB00714,Apomorphine,DB08822,Azilsartan medoxomil,0.9949591159820557,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00374,Treprostinil,DB00743,Gadobenic acid,1.0,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB00412,Rosiglitazone,DB09296,Ombitasvir,0.9486426711082458,47,Type_47,The metabolism of Ombitasvir can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00343,Diltiazem,DB12332,Rucaparib,0.8792216181755066,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00193,Tramadol,DB00392,Profenamine,0.9955025315284729,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Profenamine.,49,Type_49,Yes
DB00685,Trovafloxacin,DB11093,Calcium citrate,0.8941164016723633,67,Type_67,Trovafloxacin can cause a decrease in the absorption of Calcium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00800,Fenoldopam,DB00866,Alprenolol,0.9483360648155212,60,Type_60,Fenoldopam may increase the hypotensive activities of Alprenolol.,60,Type_60,Yes
DB01210,Levobunolol,DB06791,Lanreotide,0.9808756113052368,54,Type_54,Levobunolol may increase the bradycardic activities of Lanreotide.,54,Type_54,Yes
DB00211,Midodrine,DB00373,Timolol,0.9025567770004272,54,Type_54,Midodrine may increase the bradycardic activities of Timolol.,54,Type_54,Yes
DB00564,Carbamazepine,DB01433,Methadyl acetate,0.882315456867218,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Methadyl acetate.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB03754,Tromethamine,0.971287727355957,3,Type_3,The bioavailability of Tromethamine can be decreased when combined with Fluticasone propionate.,3,Type_3,Yes
DB00956,Hydrocodone,DB01614,Acepromazine,0.991878867149353,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.,16,Type_16,Yes
DB00795,Sulfasalazine,DB09215,Droxicam,0.964672327041626,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Droxicam.,49,Type_49,Yes
DB00983,Formoterol,DB01118,Amiodarone,0.5019417405128479,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Formoterol.,20,Type_20,No
DB00663,Flumethasone,DB06725,Lornoxicam,0.9996522665023804,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Lornoxicam.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB04846,Celiprolol,0.9991487264633179,37,Type_37,Mycophenolate mofetil may decrease the antihypertensive activities of Celiprolol.,37,Type_37,Yes
DB00294,Etonogestrel,DB00474,Methohexital,0.8886973261833191,70,Type_70,The therapeutic efficacy of Methohexital can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB01255,Lisdexamfetamine,DB01433,Methadyl acetate,0.9995554089546204,69,Type_69,Lisdexamfetamine may increase the analgesic activities of Methadyl acetate.,69,Type_69,Yes
DB00196,Fluconazole,DB00469,Tenoxicam,0.944311797618866,47,Type_47,The metabolism of Tenoxicam can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01078,Deslanoside,DB01226,Mivacurium,0.9771996140480042,82,Type_82,Deslanoside may increase the arrhythmogenic activities of Mivacurium.,82,Type_82,Yes
DB01095,Fluvastatin,DB09281,Magnesium trisilicate,0.9639803171157837,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Fluvastatin.,75,Type_75,Yes
DB00384,Triamterene,DB04951,Pirfenidone,0.9907494187355042,37,Type_37,Triamterene may decrease the antihypertensive activities of Pirfenidone.,37,Type_37,Yes
DB00212,Remikiren,DB01018,Guanfacine,0.8263648152351379,60,Type_60,Remikiren may increase the hypotensive activities of Guanfacine.,60,Type_60,Yes
DB00956,Hydrocodone,DB06770,Benzyl alcohol,0.9659585356712341,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.,16,Type_16,Yes
DB06605,Apixaban,DB08865,Crizotinib,0.7576943039894104,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Apixaban.,73,Type_73,No
DB00802,Alfentanil,DB01036,Tolterodine,0.9353320598602295,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Tolterodine.,49,Type_49,Yes
DB00343,Diltiazem,DB00646,Nystatin,0.5699565410614014,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Nystatin.,49,Type_49,Yes
DB00243,Ranolazine,DB09076,Umeclidinium,0.8408123254776001,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Ranolazine.,73,Type_73,No
DB00527,Cinchocaine,DB01017,Minocycline,0.9981275200843811,16,Type_16,Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00753,Isoflurane,DB09232,Cilnidipine,0.9991576671600342,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Cilnidipine.,49,Type_49,Yes
DB00242,Cladribine,DB08880,Teriflunomide,0.521499514579773,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Cladribine.,73,Type_73,Yes
DB00880,Chlorothiazide,DB01143,Amifostine,0.8390127420425415,60,Type_60,Chlorothiazide may increase the hypotensive activities of Amifostine.,60,Type_60,Yes
DB00946,Phenprocoumon,DB08873,Boceprevir,0.6191682815551758,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB00216,Eletriptan,DB00502,Haloperidol,0.7257701754570007,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Haloperidol.,47,Type_47,No
DB00337,Pimecrolimus,DB00465,Ketorolac,0.998991072177887,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ketorolac.,49,Type_49,Yes
DB01153,Sertaconazole,DB08881,Vemurafenib,0.5478609204292297,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Sertaconazole.,33,Type_33,No
DB00661,Verapamil,DB00683,Midazolam,0.9182592630386353,47,Type_47,The metabolism of Midazolam can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00540,Nortriptyline,DB09477,Enalaprilat,0.5779051780700684,73,Type_73,The serum concentration of Enalaprilat can be increased when it is combined with Nortriptyline.,73,Type_73,Yes
DB00857,Terbinafine,DB06701,Dexmethylphenidate,0.9467027187347412,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00363,Clozapine,DB09080,Olodaterol,0.6907239556312561,20,Type_20,Clozapine may increase the QTc-prolonging activities of Olodaterol.,20,Type_20,Yes
DB00341,Cetirizine,DB01215,Estazolam,0.9996352195739746,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Estazolam.,49,Type_49,Yes
DB01236,Sevoflurane,DB04896,Milnacipran,0.6258956789970398,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Milnacipran.,49,Type_49,Yes
DB00708,Sufentanil,DB01158,Bretylium,0.9689481854438782,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Bretylium.,54,Type_54,No
DB00647,Dextropropoxyphene,DB01246,Alimemazine,0.4738273024559021,60,Type_60,Dextropropoxyphene may increase the hypotensive activities of Alimemazine.,60,Type_60,Yes
DB00681,Amphotericin B,DB01240,Epoprostenol,0.9140150547027588,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Epoprostenol.,49,Type_49,Yes
DB00443,Betamethasone,DB01245,Decamethonium,0.9987878203392029,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Decamethonium.,49,Type_49,Yes
DB00540,Nortriptyline,DB08910,Pomalidomide,0.9648227691650391,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pomalidomide.,49,Type_49,Yes
DB00805,Minaprine,DB01261,Sitagliptin,0.9988290667533875,9,Type_9,Minaprine may increase the hypoglycemic activities of Sitagliptin.,9,Type_9,Yes
DB00588,Fluticasone propionate,DB11079,Trolamine salicylate,0.9989748001098633,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Trolamine salicylate.,49,Type_49,Yes
DB00458,Imipramine,DB00537,Ciprofloxacin,0.827543318271637,20,Type_20,Imipramine may increase the QTc-prolonging activities of Ciprofloxacin.,20,Type_20,Yes
DB00351,Megestrol acetate,DB01418,Acenocoumarol,0.4804513156414032,70,Type_70,The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00238,Nevirapine,DB00358,Mefloquine,0.46594321727752686,47,Type_47,The metabolism of Mefloquine can be decreased when combined with Nevirapine.,4,Type_4,No
DB09073,Palbociclib,DB11575,Grazoprevir,0.8424625992774963,73,Type_73,The serum concentration of Grazoprevir can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB00909,Zonisamide,DB11148,Butamben,0.9995711445808411,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Butamben.,49,Type_49,Yes
DB04574,Estrone sulfate,DB06412,Oxymetholone,0.601702094078064,49,Type_49,The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Oxymetholone.,74,Type_74,No
DB00363,Clozapine,DB00454,Meperidine,0.6725885272026062,47,Type_47,The metabolism of Meperidine can be decreased when combined with Clozapine.,47,Type_47,Yes
DB08439,Parecoxib,DB09095,Difluocortolone,0.9982492923736572,49,Type_49,The risk or severity of adverse effects can be increased when Parecoxib is combined with Difluocortolone.,49,Type_49,Yes
DB00385,Valrubicin,DB00887,Bumetanide,0.9462073445320129,49,Type_49,The risk or severity of adverse effects can be increased when Valrubicin is combined with Bumetanide.,49,Type_49,Yes
DB00203,Sildenafil,DB06717,Fosaprepitant,0.9221584796905518,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB00724,Imiquimod,DB01320,Fosphenytoin,0.6915315389633179,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Imiquimod.,4,Type_4,Yes
DB00511,Acetyldigitoxin,DB01008,Busulfan,0.9989476799964905,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Busulfan.,58,Type_58,Yes
DB00222,Glimepiride,DB00373,Timolol,0.9905149936676025,9,Type_9,Glimepiride may increase the hypoglycemic activities of Timolol.,9,Type_9,Yes
DB00540,Nortriptyline,DB06636,Isavuconazonium,0.7344850301742554,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Nortriptyline.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB08912,Dabrafenib,0.9296793341636658,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Dextropropoxyphene.,75,Type_75,Yes
DB01197,Captopril,DB04552,Niflumic acid,0.9756500720977783,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Niflumic acid.,49,Type_49,Yes
DB00214,Torasemide,DB06781,Difluprednate,0.9973469972610474,83,Type_83,Torasemide may increase the hypokalemic activities of Difluprednate.,83,Type_83,Yes
DB00483,Gallamine triethiodide,DB00596,Ulobetasol,0.996426522731781,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Ulobetasol.,49,Type_49,Yes
DB00559,Bosentan,DB04948,Lofexidine,0.9995977282524109,60,Type_60,Bosentan may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00743,Gadobenic acid,DB08868,Fingolimod,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Fingolimod.,20,Type_20,Yes
DB00521,Carteolol,DB01186,Pergolide,0.9536008238792419,25,Type_25,Carteolol may increase the atrioventricular blocking (AV block) activities of Pergolide.,25,Type_25,Yes
DB06605,Apixaban,DB09074,Olaparib,0.6931043267250061,47,Type_47,The metabolism of Olaparib can be decreased when combined with Apixaban.,73,Type_73,No
DB00771,Clidinium,DB01587,Ketazolam,0.9999266862869263,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Ketazolam.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB01233,Metoclopramide,0.9897686243057251,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Metoclopramide.,49,Type_49,Yes
DB00628,Clorazepic acid,DB01069,Promethazine,0.997742772102356,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Promethazine.,49,Type_49,Yes
DB09117,Paraldehyde,DB09166,Etizolam,0.6845117807388306,49,Type_49,The risk or severity of adverse effects can be increased when Paraldehyde is combined with Etizolam.,16,Type_16,No
DB00817,Rosoxacin,DB08970,Fluprednidene,0.9970967769622803,49,Type_49,The risk or severity of adverse effects can be increased when Rosoxacin is combined with Fluprednidene.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB09063,Ceritinib,0.9866336584091187,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00245,Benzatropine,DB01551,Dihydrocodeine,0.969899594783783,49,Type_49,The risk or severity of adverse effects can be increased when Benzatropine is combined with Dihydrocodeine.,49,Type_49,Yes
DB00482,Celecoxib,DB06736,Aceclofenac,0.7999265193939209,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Aceclofenac.,49,Type_49,Yes
DB00490,Buspirone,DB00854,Levorphanol,0.9989646673202515,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Levorphanol.,49,Type_49,Yes
DB00981,Physostigmine,DB08808,Bupranolol,0.9992104768753052,54,Type_54,Physostigmine may increase the bradycardic activities of Bupranolol.,54,Type_54,Yes
DB00665,Nilutamide,DB09277,Choline C 11,1.0,70,Type_70,The therapeutic efficacy of Choline C 11 can be decreased when used in combination with Nilutamide.,70,Type_70,Yes
DB00358,Mefloquine,DB00906,Tiagabine,0.844388484954834,70,Type_70,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00637,Astemizole,DB08864,Rilpivirine,0.8372094631195068,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Astemizole.,73,Type_73,Yes
DB00176,Fluvoxamine,DB00502,Haloperidol,0.7196930646896362,47,Type_47,The metabolism of Haloperidol can be decreased when combined with Fluvoxamine.,73,Type_73,No
DB00938,Salmeterol,DB04844,Tetrabenazine,0.9601726531982422,20,Type_20,Salmeterol may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00257,Clotrimazole,DB00688,Mycophenolate mofetil,0.9425376057624817,47,Type_47,The metabolism of Mycophenolate mofetil can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00661,Verapamil,DB01247,Isocarboxazid,0.7017595171928406,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Isocarboxazid.,49,Type_49,Yes
DB00876,Eprosartan,DB01247,Isocarboxazid,0.9605258107185364,60,Type_60,Eprosartan may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB00749,Etodolac,DB00774,Hydroflumethiazide,0.9903765320777893,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Etodolac.,70,Type_70,Yes
DB00318,Codeine,DB12532,Oxetacaine,0.9979724287986755,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Oxetacaine.,49,Type_49,Yes
DB00660,Metaxalone,DB00715,Paroxetine,0.9887703657150269,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Paroxetine.,49,Type_49,Yes
DB00340,Metixene,DB08897,Aclidinium,0.8661050796508789,2,Type_2,Metixene may increase the anticholinergic activities of Aclidinium.,2,Type_2,Yes
DB00420,Promazine,DB00745,Modafinil,0.910220742225647,47,Type_47,The metabolism of Modafinil can be decreased when combined with Promazine.,47,Type_47,Yes
DB01170,Guanethidine,DB09245,Toloxatone,0.9999852180480957,60,Type_60,Guanethidine may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00343,Diltiazem,DB00575,Clonidine,0.725914478302002,47,Type_47,The metabolism of Clonidine can be decreased when combined with Diltiazem.,25,Type_25,No
DB00690,Flurazepam,DB09048,Netupitant,0.9104549884796143,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Flurazepam.,73,Type_73,Yes
DB00814,Meloxicam,DB00887,Bumetanide,0.9999905824661255,29,Type_29,Meloxicam may decrease the diuretic activities of Bumetanide.,29,Type_29,Yes
DB00596,Ulobetasol,DB00712,Flurbiprofen,0.9996395111083984,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Flurbiprofen.,49,Type_49,Yes
DB00800,Fenoldopam,DB01359,Penbutolol,0.8680058121681213,60,Type_60,Fenoldopam may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00523,Alitretinoin,DB08881,Vemurafenib,0.6760978102684021,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Alitretinoin.,73,Type_73,Yes
DB00202,Succinylcholine,DB00358,Mefloquine,0.9770719408988953,73,Type_73,The serum concentration of Mefloquine can be increased when it is combined with Succinylcholine.,73,Type_73,Yes
DB00341,Cetirizine,DB00623,Fluphenazine,0.9989166259765625,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Fluphenazine.,49,Type_49,Yes
DB00655,Estrone,DB01319,Fosamprenavir,0.8088698387145996,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Estrone.,47,Type_47,Yes
DB00999,Hydrochlorothiazide,DB09232,Cilnidipine,0.9457324147224426,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Cilnidipine.,49,Type_49,Yes
DB00614,Furazolidone,DB00912,Repaglinide,0.999344527721405,9,Type_9,Furazolidone may increase the hypoglycemic activities of Repaglinide.,9,Type_9,Yes
DB04846,Celiprolol,DB07615,Tranilast,0.9349492788314819,37,Type_37,Celiprolol may decrease the antihypertensive activities of Tranilast.,37,Type_37,Yes
DB00567,Cephalexin,DB01072,Atazanavir,0.9540956020355225,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Cephalexin.,47,Type_47,Yes
DB01201,Rifapentine,DB06789,Hydroxyprogesterone caproate,0.6325384974479675,75,Type_75,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Rifapentine.,4,Type_4,No
DB00472,Fluoxetine,DB01124,Tolbutamide,0.6304653882980347,9,Type_9,Fluoxetine may increase the hypoglycemic activities of Tolbutamide.,47,Type_47,No
DB00359,Sulfadiazine,DB06636,Isavuconazonium,0.9893543720245361,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00542,Benazepril,DB11362,Selexipag,0.9977602958679199,60,Type_60,Benazepril may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00320,Dihydroergotamine,DB00669,Sumatriptan,0.49278169870376587,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sumatriptan.,49,Type_49,Yes
DB06737,Zaltoprofen,DB09216,Tolfenamic acid,0.9968440532684326,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Tolfenamic acid.,49,Type_49,Yes
DB00960,Pindolol,DB06268,Sitaxentan,0.9047479629516602,60,Type_60,Pindolol may increase the hypotensive activities of Sitaxentan.,60,Type_60,Yes
DB00531,Cyclophosphamide,DB00722,Lisinopril,0.7193703055381775,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Lisinopril.,49,Type_49,Yes
DB00612,Bisoprolol,DB00780,Phenelzine,0.9174204468727112,60,Type_60,Bisoprolol may increase the hypotensive activities of Phenelzine.,60,Type_60,Yes
DB00759,Tetracycline,DB06616,Bosutinib,0.8029145002365112,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Tetracycline.,73,Type_73,Yes
DB00983,Formoterol,DB04844,Tetrabenazine,0.9608109593391418,20,Type_20,Formoterol may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB00327,Hydromorphone,DB00363,Clozapine,0.6472192406654358,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clozapine.,47,Type_47,No
DB04946,Iloperidone,DB12532,Oxetacaine,0.9999860525131226,49,Type_49,The risk or severity of adverse effects can be increased when Iloperidone is combined with Oxetacaine.,49,Type_49,Yes
DB01203,Nadolol,DB01580,Oxprenolol,0.4677235186100006,25,Type_25,Nadolol may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,60,Type_60,No
DB00889,Granisetron,DB01045,Rifampicin,0.8561431765556335,4,Type_4,The metabolism of Rifampicin can be increased when combined with Granisetron.,4,Type_4,Yes
DB01176,Cyclizine,DB06716,Fospropofol,0.9999990463256836,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Fospropofol.,49,Type_49,Yes
DB00213,Pantoprazole,DB00705,Delavirdine,0.8943370580673218,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Pantoprazole.,75,Type_75,No
DB01210,Levobunolol,DB01608,Periciazine,0.9600146412849426,60,Type_60,Levobunolol may increase the hypotensive activities of Periciazine.,60,Type_60,Yes
DB00178,Ramipril,DB00688,Mycophenolate mofetil,0.9456849098205566,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Mycophenolate mofetil.,49,Type_49,Yes
DB00628,Clorazepic acid,DB01211,Clarithromycin,0.8018283843994141,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Clorazepic acid.,47,Type_47,Yes
DB00223,Diflorasone,DB01045,Rifampicin,0.9434604644775391,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Diflorasone.,75,Type_75,Yes
DB01349,Tasosartan,DB01600,Tiaprofenic acid,0.9920135140419006,49,Type_49,The risk or severity of adverse effects can be increased when Tasosartan is combined with Tiaprofenic acid.,49,Type_49,Yes
DB01015,Sulfamethoxazole,DB12026,Voxilaprevir,0.939935564994812,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Sulfamethoxazole.,47,Type_47,Yes
DB00907,Cocaine,DB06770,Benzyl alcohol,0.716714084148407,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Benzyl alcohol.,47,Type_47,No
DB05521,Telaprevir,DB08932,Macitentan,0.8990428447723389,47,Type_47,The metabolism of Macitentan can be decreased when combined with Telaprevir.,73,Type_73,No
DB01222,Budesonide,DB13595,Almasilate,0.9998893737792969,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Budesonide.,3,Type_3,Yes
DB00972,Azelastine,DB06413,Armodafinil,0.9570965766906738,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Azelastine.,47,Type_47,Yes
DB00979,Cyclopentolate,DB01233,Metoclopramide,0.9888830780982971,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Cyclopentolate.,70,Type_70,Yes
DB00221,Isoetharine,DB00598,Labetalol,0.9662983417510986,14,Type_14,Isoetharine may decrease the bronchodilatory activities of Labetalol.,5,Type_5,No
DB00472,Fluoxetine,DB09225,Zotepine,0.9267560243606567,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Zotepine.,49,Type_49,Yes
DB08881,Vemurafenib,DB09396,Dextropropoxyphene napsylate,0.5410183072090149,73,Type_73,The serum concentration of Dextropropoxyphene napsylate can be increased when it is combined with Vemurafenib.,75,Type_75,No
DB00201,Caffeine,DB04946,Iloperidone,0.9117144346237183,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00564,Carbamazepine,DB01192,Oxymorphone,0.7808046936988831,4,Type_4,The metabolism of Oxymorphone can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00897,Triazolam,DB01118,Amiodarone,0.8335646390914917,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Triazolam.,47,Type_47,Yes
DB01149,Nefazodone,DB01248,Docetaxel,0.8756282329559326,47,Type_47,The metabolism of Docetaxel can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00827,Cinoxacin,DB09267,Strontium ranelate,0.8663391470909119,75,Type_75,The serum concentration of Strontium ranelate can be decreased when it is combined with Cinoxacin.,75,Type_75,Yes
DB01168,Procarbazine,DB08895,Tofacitinib,0.9180057644844055,54,Type_54,Procarbazine may increase the bradycardic activities of Tofacitinib.,34,Type_34,No
DB00586,Diclofenac,DB01014,Balsalazide,0.7967666387557983,57,Type_57,Diclofenac may increase the nephrotoxic activities of Balsalazide.,49,Type_49,No
DB00655,Estrone,DB01217,Anastrozole,0.6573469042778015,70,Type_70,The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrone.,70,Type_70,Yes
DB00503,Ritonavir,DB04861,Nebivolol,0.4910019338130951,47,Type_47,The metabolism of Nebivolol can be decreased when combined with Ritonavir.,73,Type_73,No
DB00458,Imipramine,DB04861,Nebivolol,0.4632565677165985,73,Type_73,The serum concentration of Nebivolol can be increased when it is combined with Imipramine.,73,Type_73,Yes
DB00541,Vincristine,DB12026,Voxilaprevir,0.6378094553947449,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB01263,Posaconazole,DB09082,Vilanterol,0.5625252723693848,47,Type_47,The metabolism of Vilanterol can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00846,Flurandrenolide,DB01044,Gatifloxacin,0.9862187504768372,49,Type_49,The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Gatifloxacin.,49,Type_49,Yes
DB01177,Idarubicin,DB06772,Cabazitaxel,0.9600434303283691,49,Type_49,The risk or severity of adverse effects can be increased when Idarubicin is combined with Cabazitaxel.,49,Type_49,Yes
DB00939,Meclofenamic acid,DB08981,Fenbufen,0.9992693066596985,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fenbufen.,49,Type_49,Yes
DB00401,Nisoldipine,DB09238,Manidipine,0.9607499837875366,60,Type_60,Nisoldipine may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00604,Cisapride,DB04855,Dronedarone,0.7131273150444031,20,Type_20,Cisapride may increase the QTc-prolonging activities of Dronedarone.,47,Type_47,No
DB00738,Pentamidine,DB01261,Sitagliptin,0.4186145067214966,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Pentamidine.,70,Type_70,Yes
DB00285,Venlafaxine,DB01156,Bupropion,0.9477691650390625,47,Type_47,The metabolism of Bupropion can be decreased when combined with Venlafaxine.,73,Type_73,No
DB00370,Mirtazapine,DB05246,Methsuximide,0.9992032647132874,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.,16,Type_16,Yes
DB00758,Clopidogrel,DB09230,Azelnidipine,0.9537034630775452,70,Type_70,The therapeutic efficacy of Azelnidipine can be decreased when used in combination with Clopidogrel.,70,Type_70,Yes
DB01168,Procarbazine,DB09080,Olodaterol,0.9880274534225464,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Olodaterol.,49,Type_49,Yes
DB00802,Alfentanil,DB11148,Butamben,0.9999953508377075,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Butamben.,49,Type_49,Yes
DB00333,Methadone,DB11304,Phenoxyethanol,0.9823997020721436,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Phenoxyethanol.,49,Type_49,Yes
DB00586,Diclofenac,DB11921,Deflazacort,0.9993731379508972,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Deflazacort.,49,Type_49,Yes
DB01181,Ifosfamide,DB08880,Teriflunomide,0.5164576768875122,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Ifosfamide.,47,Type_47,No
DB01037,Selegiline,DB11609,Normethadone,0.9670266509056091,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Normethadone.,49,Type_49,Yes
DB01238,Aripiprazole,DB04878,Voglibose,0.9987432360649109,70,Type_70,The therapeutic efficacy of Voglibose can be decreased when used in combination with Aripiprazole.,70,Type_70,Yes
DB00712,Flurbiprofen,DB01580,Oxprenolol,0.9802117347717285,37,Type_37,Flurbiprofen may decrease the antihypertensive activities of Oxprenolol.,37,Type_37,Yes
DB00472,Fluoxetine,DB08816,Ticagrelor,0.7404201030731201,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00831,Trifluoperazine,DB05271,Rotigotine,0.9949110150337219,32,Type_32,Trifluoperazine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00976,Telithromycin,DB06203,Alogliptin,0.693454384803772,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00243,Ranolazine,DB00694,Daunorubicin,0.8197846412658691,47,Type_47,The metabolism of Daunorubicin can be decreased when combined with Ranolazine.,73,Type_73,No
DB00273,Topiramate,DB06148,Mianserin,0.6242043375968933,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Topiramate.,70,Type_70,Yes
DB04574,Estrone sulfate,DB09167,Dosulepin,0.9350648522377014,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Estrone sulfate.,47,Type_47,Yes
DB00783,Estradiol,DB00846,Flurandrenolide,0.9851192831993103,73,Type_73,The serum concentration of Flurandrenolide can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB00370,Mirtazapine,DB08860,Pitavastatin,0.9564679861068726,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB00363,Clozapine,DB09570,Ixazomib,0.7659921050071716,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00331,Metformin,DB00440,Trimethoprim,0.4679570198059082,73,Type_73,The serum concentration of Trimethoprim can be increased when it is combined with Metformin.,73,Type_73,Yes
DB01028,Methoxyflurane,DB01437,Glutethimide,0.9999985694885254,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Glutethimide.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB00961,Mepivacaine,0.979121744632721,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.,16,Type_16,Yes
DB06595,Midostaurin,DB09071,Tasimelteon,0.6248717308044434,73,Type_73,The serum concentration of Tasimelteon can be increased when it is combined with Midostaurin.,73,Type_73,Yes
DB00257,Clotrimazole,DB01384,Paramethasone,0.9703932404518127,47,Type_47,The metabolism of Paramethasone can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00531,Cyclophosphamide,DB00691,Moexipril,0.8958098292350769,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Moexipril.,49,Type_49,Yes
DB00208,Ticlopidine,DB00951,Isoniazid,0.8157361745834351,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00321,Amitriptyline,DB00490,Buspirone,0.7495966553688049,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Buspirone.,49,Type_49,Yes
DB09065,Cobicistat,DB09330,Osimertinib,0.9759818315505981,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00230,Pregabalin,DB00520,Caspofungin,0.968113124370575,49,Type_49,The risk or severity of adverse effects can be increased when Pregabalin is combined with Caspofungin.,49,Type_49,Yes
DB00682,Warfarin,DB09120,Zucapsaicin,0.98809415102005,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Warfarin.,47,Type_47,Yes
DB00641,Simvastatin,DB00682,Warfarin,0.9097096920013428,6,Type_6,Simvastatin may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00652,Pentazocine,DB00737,Meclizine,0.9992808699607849,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Meclizine.,49,Type_49,Yes
DB00228,Enflurane,DB00753,Isoflurane,0.9969769716262817,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Isoflurane.,49,Type_49,Yes
DB00521,Carteolol,DB00677,Isoflurophate,0.986158013343811,54,Type_54,Carteolol may increase the bradycardic activities of Isoflurophate.,54,Type_54,Yes
DB00611,Butorphanol,DB09342,Propoxycaine,0.997170627117157,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Propoxycaine.,49,Type_49,Yes
DB00185,Cevimeline,DB01609,Deferasirox,0.9428081512451172,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Cevimeline.,75,Type_75,Yes
DB01220,Rifaximin,DB01221,Ketamine,0.32572370767593384,4,Type_4,The metabolism of Ketamine can be increased when combined with Rifaximin.,73,Type_73,No
DB01021,Trichlormethiazide,DB01070,Dihydrotachysterol,0.9943968057632446,51,Type_51,Trichlormethiazide may increase the hypercalcemic activities of Dihydrotachysterol.,51,Type_51,Yes
DB01236,Sevoflurane,DB06594,Agomelatine,0.9973379969596863,49,Type_49,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Agomelatine.,49,Type_49,Yes
DB01320,Fosphenytoin,DB01588,Prazepam,0.651814341545105,4,Type_4,The metabolism of Prazepam can be increased when combined with Fosphenytoin.,73,Type_73,No
DB00243,Ranolazine,DB00724,Imiquimod,0.6366362571716309,47,Type_47,The metabolism of Imiquimod can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB08806,Roxatidine acetate,DB09162,Ferric Citrate,0.944258987903595,67,Type_67,Roxatidine acetate can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00333,Methadone,DB00752,Tranylcypromine,0.5277659893035889,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Methadone.,49,Type_49,No
DB00598,Labetalol,DB00723,Methoxamine,0.9895686507225037,5,Type_5,Labetalol may decrease the vasoconstricting activities of Methoxamine.,5,Type_5,Yes
DB00238,Nevirapine,DB01062,Oxybutynin,0.8311222791671753,4,Type_4,The metabolism of Oxybutynin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00921,Buprenorphine,DB01215,Estazolam,0.9995018243789673,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.,16,Type_16,Yes
DB00238,Nevirapine,DB00346,Alfuzosin,0.951198935508728,4,Type_4,The metabolism of Alfuzosin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00738,Pentamidine,DB06791,Lanreotide,0.6724929213523865,9,Type_9,Pentamidine may increase the hypoglycemic activities of Lanreotide.,9,Type_9,Yes
DB00734,Risperidone,DB01545,Ethyl loflazepate,0.9993612170219421,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00321,Amitriptyline,DB01221,Ketamine,0.9528935551643372,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ketamine.,49,Type_49,Yes
DB00645,Dyclonine,DB01236,Sevoflurane,0.9822277426719666,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Sevoflurane.,49,Type_49,Yes
DB00705,Delavirdine,DB06203,Alogliptin,0.7331446409225464,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Delavirdine.,75,Type_75,No
DB00734,Risperidone,DB12332,Rucaparib,0.8963685035705566,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Risperidone.,47,Type_47,Yes
DB01401,Choline magnesium trisalicylate,DB08797,Salicylamide,0.9997828602790833,49,Type_49,The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Salicylamide.,49,Type_49,Yes
DB00744,Zileuton,DB09073,Palbociclib,0.992675244808197,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Zileuton.,73,Type_73,Yes
DB00180,Flunisolide,DB00375,Colestipol,0.657710075378418,75,Type_75,The serum concentration of Colestipol can be decreased when it is combined with Flunisolide.,67,Type_67,No
DB01234,Dexamethasone,DB06736,Aceclofenac,0.9669601917266846,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Aceclofenac.,49,Type_49,Yes
DB00821,Carprofen,DB04743,Nimesulide,0.9980105757713318,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Nimesulide.,49,Type_49,Yes
DB00996,Gabapentin,DB01068,Clonazepam,0.9931724667549133,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Clonazepam.,49,Type_49,Yes
DB00248,Cabergoline,DB01463,Fencamfamin,0.9975608587265015,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Fencamfamin.,49,Type_49,Yes
DB00521,Carteolol,DB09112,Nitrous acid,0.9946464896202087,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Nitrous acid.,49,Type_49,Yes
DB00699,Nicergoline,DB01264,Darunavir,0.6114212870597839,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Darunavir.,73,Type_73,No
DB01179,Podofilox,DB09118,Stiripentol,0.8676297664642334,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Podofilox.,73,Type_73,Yes
DB00663,Flumethasone,DB00805,Minaprine,0.8617125749588013,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Minaprine.,49,Type_49,Yes
DB01094,Hesperetin,DB08881,Vemurafenib,0.6905823945999146,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Hesperetin.,73,Type_73,Yes
DB00849,Methylphenobarbital,DB08822,Azilsartan medoxomil,0.871614396572113,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Azilsartan medoxomil.,60,Type_60,Yes
DB00696,Ergotamine,DB00759,Tetracycline,0.6001601219177246,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Tetracycline.,49,Type_49,Yes
DB00492,Fosinopril,DB00774,Hydroflumethiazide,0.7013387680053711,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Hydroflumethiazide.,60,Type_60,No
DB00169,Cholecalciferol,DB01232,Saquinavir,0.8772666454315186,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00622,Nicardipine,DB01324,Polythiazide,0.7757461071014404,60,Type_60,Nicardipine may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00780,Phenelzine,DB06706,Isometheptene,0.9999979734420776,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Isometheptene.,49,Type_49,Yes
DB00555,Lamotrigine,DB08918,Levomilnacipran,0.9677470922470093,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Levomilnacipran.,49,Type_49,Yes
DB01203,Nadolol,DB07615,Tranilast,0.9896535277366638,37,Type_37,Nadolol may decrease the antihypertensive activities of Tranilast.,37,Type_37,Yes
DB00270,Isradipine,DB05239,Cobimetinib,0.8089675903320312,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Isradipine.,73,Type_73,Yes
DB01178,Chlormezanone,DB01242,Clomipramine,0.9971862435340881,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Clomipramine.,49,Type_49,Yes
DB01023,Felodipine,DB01113,Papaverine,0.9970557689666748,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Papaverine.,49,Type_49,Yes
DB06145,Spiramycin,DB09063,Ceritinib,0.9962838292121887,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Spiramycin.,73,Type_73,Yes
DB00226,Guanadrel,DB00790,Perindopril,0.9999852180480957,60,Type_60,Guanadrel may increase the hypotensive activities of Perindopril.,60,Type_60,Yes
DB00247,Methysergide,DB01204,Mitoxantrone,0.9980663657188416,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Mitoxantrone.,49,Type_49,Yes
DB00297,Bupivacaine,DB09034,Suvorexant,0.9997698664665222,16,Type_16,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB05351,Dexlansoprazole,DB09065,Cobicistat,0.6731768250465393,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Dexlansoprazole.,47,Type_47,Yes
DB00268,Ropinirole,DB01174,Phenobarbital,0.725023627281189,32,Type_32,Ropinirole may increase the sedative activities of Phenobarbital.,32,Type_32,Yes
DB00476,Duloxetine,DB01206,Lomustine,0.6915057897567749,47,Type_47,The metabolism of Lomustine can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB00745,Modafinil,DB06414,Etravirine,0.7670486569404602,47,Type_47,The metabolism of Etravirine can be decreased when combined with Modafinil.,47,Type_47,Yes
DB01023,Felodipine,DB01359,Penbutolol,0.5325510501861572,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Penbutolol.,49,Type_49,Yes
DB01137,Levofloxacin,DB06207,Silodosin,0.729793906211853,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Levofloxacin.,73,Type_73,Yes
DB00230,Pregabalin,DB00681,Amphotericin B,0.8893412351608276,70,Type_70,The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Pregabalin.,49,Type_49,No
DB00559,Bosentan,DB05109,Trabectedin,0.8778269290924072,75,Type_75,The serum concentration of Trabectedin can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00385,Valrubicin,DB08797,Salicylamide,0.9999562501907349,72,Type_72,Valrubicin may decrease the excretion rate of Salicylamide which could result in a higher serum level.,72,Type_72,Yes
DB00795,Sulfasalazine,DB01234,Dexamethasone,0.9813780784606934,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dexamethasone.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00546,Adinazolam,0.9777013063430786,47,Type_47,The metabolism of Adinazolam can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00972,Azelastine,DB01621,Pipotiazine,0.9473149180412292,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.,16,Type_16,Yes
DB00451,Levothyroxine,DB08865,Crizotinib,0.9690659642219543,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Levothyroxine.,47,Type_47,Yes
DB00660,Metaxalone,DB09072,Sodium oxybate,1.0,16,Type_16,Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00722,Lisinopril,DB09241,Methylene blue,0.9991742968559265,60,Type_60,Lisinopril may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00641,Simvastatin,DB08815,Lurasidone,0.8809680938720703,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB01250,Olsalazine,DB13158,Clobetasone,0.9967468976974487,49,Type_49,The risk or severity of adverse effects can be increased when Olsalazine is combined with Clobetasone.,49,Type_49,Yes
DB00940,Methantheline,DB01433,Methadyl acetate,0.9998892545700073,49,Type_49,The risk or severity of adverse effects can be increased when Methantheline is combined with Methadyl acetate.,49,Type_49,Yes
DB00295,Morphine,DB00831,Trifluoperazine,0.9303455948829651,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Trifluoperazine.,49,Type_49,Yes
DB00656,Trazodone,DB01433,Methadyl acetate,0.9979081153869629,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Methadyl acetate.,49,Type_49,Yes
DB00502,Haloperidol,DB00794,Primidone,0.5365546941757202,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Primidone.,4,Type_4,No
DB00318,Codeine,DB00427,Triprolidine,0.9991275668144226,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Triprolidine.,49,Type_49,Yes
DB01336,Metocurine,DB06810,Plicamycin,0.9989596605300903,40,Type_40,Metocurine may increase the respiratory depressant activities of Plicamycin.,40,Type_40,Yes
DB00977,Ethinylestradiol,DB01197,Captopril,0.8845797777175903,75,Type_75,The serum concentration of Captopril can be decreased when it is combined with Ethinylestradiol.,75,Type_75,Yes
DB01211,Clarithromycin,DB01227,Levacetylmethadol,0.714433491230011,47,Type_47,The metabolism of Levacetylmethadol can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00752,Tranylcypromine,DB08931,Riociguat,0.4114735722541809,60,Type_60,Tranylcypromine may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00939,Meclofenamic acid,DB09215,Droxicam,0.9982045888900757,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Droxicam.,49,Type_49,Yes
DB01014,Balsalazide,DB06813,Pralatrexate,0.6109094619750977,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Balsalazide.,73,Type_73,Yes
DB00797,Tolazoline,DB08808,Bupranolol,0.9943283200263977,60,Type_60,Tolazoline may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB00849,Methylphenobarbital,DB11304,Phenoxyethanol,0.840196967124939,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Phenoxyethanol.,49,Type_49,Yes
DB01026,Ketoconazole,DB03756,Doconexent,0.899837076663971,47,Type_47,The metabolism of Doconexent can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00257,Clotrimazole,DB01069,Promethazine,0.7197296023368835,47,Type_47,The metabolism of Promethazine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00387,Procyclidine,DB01325,Quinethazone,0.9996459484100342,73,Type_73,The serum concentration of Quinethazone can be increased when it is combined with Procyclidine.,73,Type_73,Yes
DB00697,Tizanidine,DB00967,Desloratadine,0.9699224233627319,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Desloratadine.,49,Type_49,Yes
DB00537,Ciprofloxacin,DB01197,Captopril,0.41266247630119324,82,Type_82,Ciprofloxacin may increase the arrhythmogenic activities of Captopril.,82,Type_82,Yes
DB01243,Chloroxine,DB01591,Solifenacin,0.5489537715911865,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Chloroxine.,47,Type_47,Yes
DB00282,Pamidronic acid,DB09275,Bismuth subcitrate potassium,0.9669002294540405,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Pamidronic acid.,75,Type_75,Yes
DB00621,Oxandrolone,DB00860,Prednisolone,0.9999977350234985,74,Type_74,Oxandrolone may increase the fluid retaining activities of Prednisolone.,74,Type_74,Yes
DB00904,Ondansetron,DB01544,Flunitrazepam,0.8940609097480774,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Flunitrazepam.,49,Type_49,Yes
DB00215,Citalopram,DB05039,Indacaterol,0.45408105850219727,20,Type_20,Citalopram may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00933,Mesoridazine,DB01551,Dihydrocodeine,0.9788786172866821,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dihydrocodeine.,49,Type_49,Yes
DB00471,Montelukast,DB01072,Atazanavir,0.9113783836364746,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Montelukast.,47,Type_47,Yes
DB04841,Flunarizine,DB09286,Pipamperone,0.9652527570724487,49,Type_49,The risk or severity of adverse effects can be increased when Flunarizine is combined with Pipamperone.,49,Type_49,Yes
DB01176,Cyclizine,DB09118,Stiripentol,0.9760653376579285,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Stiripentol.,49,Type_49,Yes
DB00283,Clemastine,DB00721,Procaine,0.9863995313644409,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Procaine.,49,Type_49,Yes
DB00248,Cabergoline,DB01297,Practolol,0.9687636494636536,19,Type_19,Cabergoline may increase the vasoconstricting activities of Practolol.,19,Type_19,Yes
DB00257,Clotrimazole,DB01167,Itraconazole,0.5203060507774353,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00285,Venlafaxine,DB06770,Benzyl alcohol,0.8206783533096313,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00980,Ramelteon,DB13872,Lormetazepam,0.9999159574508667,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Lormetazepam.,49,Type_49,Yes
DB00934,Maprotiline,DB01227,Levacetylmethadol,0.9494504332542419,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Levacetylmethadol.,49,Type_49,Yes
DB00318,Codeine,DB13323,Trichloroethylene,0.9971984624862671,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Trichloroethylene.,49,Type_49,Yes
DB01007,Tioconazole,DB01220,Rifaximin,0.9370294213294983,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Tioconazole.,73,Type_73,Yes
DB00390,Digoxin,DB00877,Sirolimus,0.9101545810699463,58,Type_58,Digoxin may decrease the cardiotoxic activities of Sirolimus.,58,Type_58,Yes
DB00960,Pindolol,DB01151,Desipramine,0.5743523836135864,47,Type_47,The metabolism of Desipramine can be decreased when combined with Pindolol.,47,Type_47,Yes
DB00727,Nitroglycerin,DB00752,Tranylcypromine,0.9799251556396484,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Tranylcypromine.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB01242,Clomipramine,0.4372602105140686,4,Type_4,The metabolism of Clomipramine can be increased when combined with Methylphenobarbital.,4,Type_4,Yes
DB00254,Doxycycline,DB01045,Rifampicin,0.5869115591049194,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Doxycycline.,75,Type_75,Yes
DB00232,Methyclothiazide,DB01104,Sertraline,0.9656572937965393,55,Type_55,Methyclothiazide may increase the hyponatremic activities of Sertraline.,55,Type_55,Yes
DB00501,Cimetidine,DB09075,Edoxaban,0.6423220634460449,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Cimetidine.,73,Type_73,Yes
DB04855,Dronedarone,DB09065,Cobicistat,0.6373961567878723,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Dronedarone.,73,Type_73,Yes
DB00805,Minaprine,DB09095,Difluocortolone,0.8849092721939087,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Difluocortolone.,49,Type_49,Yes
DB00705,Delavirdine,DB04898,Ximelagatran,0.48338672518730164,47,Type_47,The metabolism of Ximelagatran can be decreased when combined with Delavirdine.,75,Type_75,No
DB01377,Magnesium oxide,DB04574,Estrone sulfate,0.3502271771430969,73,Type_73,The serum concentration of Estrone sulfate can be increased when it is combined with Magnesium oxide.,3,Type_3,No
DB00454,Meperidine,DB01118,Amiodarone,0.7503706812858582,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Meperidine.,47,Type_47,Yes
DB00285,Venlafaxine,DB00531,Cyclophosphamide,0.6415128707885742,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB01136,Carvedilol,DB01407,Clenbuterol,0.7071860432624817,5,Type_5,Carvedilol may decrease the vasoconstricting activities of Clenbuterol.,5,Type_5,Yes
DB00335,Atenolol,DB01250,Olsalazine,0.996757447719574,37,Type_37,Atenolol may decrease the antihypertensive activities of Olsalazine.,37,Type_37,Yes
DB06695,Dabigatran etexilate,DB09084,Benzydamine,0.9825398921966553,6,Type_6,Dabigatran etexilate may increase the anticoagulant activities of Benzydamine.,6,Type_6,Yes
DB00908,Quinidine,DB01192,Oxymorphone,0.48537033796310425,47,Type_47,The metabolism of Oxymorphone can be decreased when combined with Quinidine.,47,Type_47,Yes
DB01227,Levacetylmethadol,DB01615,Aceprometazine,0.7299696207046509,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Aceprometazine.,49,Type_49,Yes
DB00321,Amitriptyline,DB01189,Desflurane,0.8583268523216248,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desflurane.,49,Type_49,Yes
DB00381,Amlodipine,DB00849,Methylphenobarbital,0.5223085880279541,60,Type_60,Amlodipine may increase the hypotensive activities of Methylphenobarbital.,60,Type_60,Yes
DB00220,Nelfinavir,DB00373,Timolol,0.7770623564720154,47,Type_47,The metabolism of Timolol can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB01193,Acebutolol,DB04948,Lofexidine,0.9878652691841125,25,Type_25,Acebutolol may increase the atrioventricular blocking (AV block) activities of Lofexidine.,25,Type_25,Yes
DB00226,Guanadrel,DB09236,Lacidipine,0.9999886751174927,60,Type_60,Guanadrel may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB01012,Cinacalcet,DB06203,Alogliptin,0.6913548111915588,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00296,Ropivacaine,DB01144,Diclofenamide,0.9489985108375549,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Diclofenamide.,49,Type_49,Yes
DB01124,Tolbutamide,DB09238,Manidipine,0.8451557159423828,47,Type_47,The metabolism of Manidipine can be decreased when combined with Tolbutamide.,47,Type_47,Yes
DB00310,Chlorthalidone,DB00854,Levorphanol,0.9896231293678284,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Levorphanol.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB08815,Lurasidone,0.9707412123680115,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lurasidone.,49,Type_49,Yes
DB09167,Dosulepin,DB09183,Dasabuvir,0.9107334017753601,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Dosulepin.,47,Type_47,Yes
DB01576,Dextroamphetamine,DB09488,Acrivastine,0.9999550580978394,76,Type_76,Dextroamphetamine may decrease the sedative activities of Acrivastine.,76,Type_76,Yes
DB00230,Pregabalin,DB00950,Fexofenadine,0.9723371267318726,8,Type_8,The therapeutic efficacy of Fexofenadine can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB01157,Trimetrexate,DB09232,Cilnidipine,0.99517422914505,49,Type_49,The risk or severity of adverse effects can be increased when Trimetrexate is combined with Cilnidipine.,49,Type_49,Yes
DB00951,Isoniazid,DB01166,Cilostazol,0.5005326271057129,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Isoniazid.,73,Type_73,Yes
DB00997,Doxorubicin,DB06770,Benzyl alcohol,0.9022623896598816,47,Type_47,The metabolism of Benzyl alcohol can be decreased when combined with Doxorubicin.,47,Type_47,Yes
DB00254,Doxycycline,DB01085,Pilocarpine,0.984706461429596,47,Type_47,The metabolism of Pilocarpine can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00490,Buspirone,DB00835,Brompheniramine,0.8663983345031738,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Brompheniramine.,49,Type_49,Yes
DB00661,Verapamil,DB01359,Penbutolol,0.721700131893158,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Penbutolol.,49,Type_49,Yes
DB00807,Proparacaine,DB06700,Desvenlafaxine,0.9956201910972595,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Desvenlafaxine.,49,Type_49,Yes
DB00541,Vincristine,DB00908,Quinidine,0.6603214144706726,47,Type_47,The metabolism of Quinidine can be decreased when combined with Vincristine.,73,Type_73,No
DB00472,Fluoxetine,DB04846,Celiprolol,0.7348566055297852,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Fluoxetine.,73,Type_73,No
DB00697,Tizanidine,DB01217,Anastrozole,0.8944834470748901,70,Type_70,The therapeutic efficacy of Anastrozole can be decreased when used in combination with Tizanidine.,73,Type_73,No
DB00714,Apomorphine,DB09063,Ceritinib,0.6150818467140198,20,Type_20,Apomorphine may increase the QTc-prolonging activities of Ceritinib.,20,Type_20,Yes
DB00796,Candesartan cilexetil,DB04846,Celiprolol,0.6933523416519165,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Celiprolol.,60,Type_60,No
DB09053,Ibrutinib,DB09291,Rolapitant,0.6747251749038696,73,Type_73,The serum concentration of Rolapitant can be increased when it is combined with Ibrutinib.,47,Type_47,No
DB01175,Escitalopram,DB08912,Dabrafenib,0.682832658290863,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Escitalopram.,75,Type_75,Yes
DB00544,Fluorouracil,DB08895,Tofacitinib,0.8628982305526733,34,Type_34,Fluorouracil may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB00469,Tenoxicam,DB04861,Nebivolol,0.9998419284820557,37,Type_37,Tenoxicam may decrease the antihypertensive activities of Nebivolol.,37,Type_37,Yes
DB01202,Levetiracetam,DB01466,Ethylmorphine,0.9941954016685486,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Ethylmorphine.,49,Type_49,Yes
DB00648,Mitotane,DB00972,Azelastine,0.9943757057189941,75,Type_75,The serum concentration of Azelastine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB01192,Oxymorphone,DB06767,Ammonium chloride,0.9976686835289001,65,Type_65,Oxymorphone may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,65,Type_65,Yes
DB00333,Methadone,DB01045,Rifampicin,0.8426210880279541,4,Type_4,The metabolism of Rifampicin can be increased when combined with Methadone.,75,Type_75,No
DB00898,Ethanol,DB13872,Lormetazepam,0.9425005316734314,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.,16,Type_16,Yes
DB00188,Bortezomib,DB08932,Macitentan,0.8085599541664124,47,Type_47,The metabolism of Macitentan can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB01708,Prasterone,DB09215,Droxicam,0.9993621706962585,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Droxicam.,49,Type_49,Yes
DB00794,Primidone,DB08910,Pomalidomide,0.606902003288269,4,Type_4,The metabolism of Pomalidomide can be increased when combined with Primidone.,4,Type_4,Yes
DB00866,Alprenolol,DB00944,Demecarium,0.9991022348403931,54,Type_54,Alprenolol may increase the bradycardic activities of Demecarium.,54,Type_54,Yes
DB01095,Fluvastatin,DB06595,Midostaurin,0.5596126914024353,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00839,Tolazamide,DB06710,Methyltestosterone,0.9980727434158325,9,Type_9,Tolazamide may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB00246,Ziprasidone,DB00933,Mesoridazine,0.49659624695777893,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Mesoridazine.,47,Type_47,No
DB00820,Tadalafil,DB01200,Bromocriptine,0.813795804977417,49,Type_49,The risk or severity of adverse effects can be increased when Tadalafil is combined with Bromocriptine.,49,Type_49,Yes
DB00996,Gabapentin,DB09009,Articaine,0.9999481439590454,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Articaine.,49,Type_49,Yes
DB00392,Profenamine,DB00545,Pyridostigmine,0.9951679706573486,70,Type_70,The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Profenamine.,70,Type_70,Yes
DB00254,Doxycycline,DB05239,Cobimetinib,0.8403180241584778,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Doxycycline.,73,Type_73,Yes
DB00722,Lisinopril,DB01224,Quetiapine,0.7655056118965149,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Quetiapine.,49,Type_49,Yes
DB00379,Mexiletine,DB01589,Quazepam,0.9840752482414246,47,Type_47,The metabolism of Quazepam can be decreased when combined with Mexiletine.,73,Type_73,No
DB05271,Rotigotine,DB11609,Normethadone,0.676899790763855,32,Type_32,Rotigotine may increase the sedative activities of Normethadone.,32,Type_32,Yes
DB00999,Hydrochlorothiazide,DB01261,Sitagliptin,0.9679003953933716,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Hydrochlorothiazide.,70,Type_70,Yes
DB00208,Ticlopidine,DB08931,Riociguat,0.965368926525116,47,Type_47,The metabolism of Riociguat can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00484,Brimonidine,DB09342,Propoxycaine,0.9443050026893616,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Propoxycaine.,16,Type_16,Yes
DB00571,Propranolol,DB01355,Hexobarbital,0.876699686050415,60,Type_60,Propranolol may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00475,Chlordiazepoxide,DB08912,Dabrafenib,0.9225919246673584,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Chlordiazepoxide.,75,Type_75,Yes
DB00295,Morphine,DB00755,Tretinoin,0.4687328040599823,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Tretinoin.,49,Type_49,Yes
DB00736,Esomeprazole,DB01167,Itraconazole,0.8304421901702881,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Esomeprazole.,75,Type_75,No
DB01045,Rifampicin,DB01198,Zopiclone,0.9450294971466064,4,Type_4,The metabolism of Zopiclone can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00801,Halazepam,DB01224,Quetiapine,0.998594343662262,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Quetiapine.,49,Type_49,Yes
DB00734,Risperidone,DB01264,Darunavir,0.6041556000709534,47,Type_47,The metabolism of Darunavir can be decreased when combined with Risperidone.,73,Type_73,No
DB01124,Tolbutamide,DB08439,Parecoxib,0.6921171545982361,70,Type_70,The therapeutic efficacy of Parecoxib can be decreased when used in combination with Tolbutamide.,73,Type_73,No
DB00363,Clozapine,DB06595,Midostaurin,0.87467360496521,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Clozapine.,73,Type_73,No
DB00934,Maprotiline,DB06695,Dabigatran etexilate,0.6843256950378418,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Maprotiline.,77,Type_77,Yes
DB00182,Amphetamine,DB00496,Darifenacin,0.5486197471618652,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB00257,Clotrimazole,DB06267,Udenafil,0.8807012438774109,47,Type_47,The metabolism of Udenafil can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00749,Etodolac,DB00946,Phenprocoumon,0.9998899698257446,6,Type_6,Etodolac may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00268,Ropinirole,DB01426,Ajmaline,0.9150190949440002,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00321,Amitriptyline,DB01365,Mephentermine,0.9621874690055847,84,Type_84,Amitriptyline may increase the vasopressor activities of Mephentermine.,84,Type_84,Yes
DB00343,Diltiazem,DB00906,Tiagabine,0.9134712219238281,47,Type_47,The metabolism of Tiagabine can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB06616,Bosutinib,DB06742,Ambroxol,0.7925583720207214,73,Type_73,The serum concentration of Ambroxol can be increased when it is combined with Bosutinib.,73,Type_73,Yes
DB00176,Fluvoxamine,DB06736,Aceclofenac,0.9309576749801636,47,Type_47,The metabolism of Aceclofenac can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00285,Venlafaxine,DB09068,Vortioxetine,0.47928813099861145,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Venlafaxine.,49,Type_49,No
DB00599,Thiopental,DB08907,Canagliflozin,0.4198325276374817,60,Type_60,Thiopental may increase the hypotensive activities of Canagliflozin.,60,Type_60,Yes
DB00585,Nizatidine,DB06616,Bosutinib,0.5806467533111572,75,Type_75,The serum concentration of Bosutinib can be decreased when it is combined with Nizatidine.,75,Type_75,Yes
DB01120,Gliclazide,DB05812,Abiraterone,0.37275272607803345,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Gliclazide.,47,Type_47,No
DB00657,Mecamylamine,DB01170,Guanethidine,0.9990517497062683,60,Type_60,Mecamylamine may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB01463,Fencamfamin,DB12532,Oxetacaine,0.9999960660934448,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Oxetacaine.,49,Type_49,Yes
DB00454,Meperidine,DB01075,Diphenhydramine,0.8546268939971924,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Diphenhydramine.,47,Type_47,No
DB00201,Caffeine,DB01132,Pioglitazone,0.47903385758399963,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB04855,Dronedarone,0.4413437247276306,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB01166,Cilostazol,DB05246,Methsuximide,0.7742378115653992,49,Type_49,The risk or severity of adverse effects can be increased when Cilostazol is combined with Methsuximide.,73,Type_73,No
DB01240,Epoprostenol,DB08912,Dabrafenib,0.96635901927948,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Epoprostenol.,75,Type_75,Yes
DB00445,Epirubicin,DB00963,Bromfenac,0.9983691573143005,72,Type_72,Epirubicin may decrease the excretion rate of Bromfenac which could result in a higher serum level.,72,Type_72,Yes
DB00481,Raloxifene,DB06290,Simeprevir,0.9216044545173645,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Raloxifene.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB00829,Diazepam,0.9689435958862305,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Diazepam.,16,Type_16,Yes
DB00337,Pimecrolimus,DB00884,Risedronic acid,0.9979839324951172,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Risedronic acid.,49,Type_49,Yes
DB01081,Diphenoxylate,DB01235,Levodopa,0.9988730549812317,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Levodopa.,49,Type_49,Yes
DB00364,Sucralfate,DB09031,Miltefosine,0.9896430969238281,67,Type_67,Sucralfate can cause a decrease in the absorption of Miltefosine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00289,Atomoxetine,DB00624,Testosterone,0.9612874984741211,47,Type_47,The metabolism of Testosterone can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00352,Tioguanine,DB08868,Fingolimod,0.9919346570968628,34,Type_34,Tioguanine may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00761,Potassium chloride,DB01090,Pentolinium,0.9999998807907104,59,Type_59,Potassium chloride may increase the ulcerogenic activities of Pentolinium.,59,Type_59,Yes
DB01267,Paliperidone,DB01466,Ethylmorphine,0.9683455228805542,49,Type_49,The risk or severity of adverse effects can be increased when Paliperidone is combined with Ethylmorphine.,49,Type_49,Yes
DB00613,Amodiaquine,DB06708,Lumefantrine,0.7826232314109802,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Amodiaquine.,33,Type_33,No
DB00741,Hydrocortisone,DB08895,Tofacitinib,0.9980145692825317,34,Type_34,Hydrocortisone may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB00420,Promazine,DB00836,Loperamide,0.7420663833618164,47,Type_47,The metabolism of Loperamide can be decreased when combined with Promazine.,47,Type_47,Yes
DB00838,Clocortolone,DB06819,Phenylbutyric acid,0.9518860578536987,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Clocortolone.,70,Type_70,Yes
DB00582,Voriconazole,DB06616,Bosutinib,0.965321958065033,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00827,Cinoxacin,DB06725,Lornoxicam,0.997734785079956,27,Type_27,Cinoxacin may increase the neuroexcitatory activities of Lornoxicam.,27,Type_27,Yes
DB00263,Sulfisoxazole,DB00820,Tadalafil,0.8732545375823975,47,Type_47,The metabolism of Tadalafil can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01138,Sulfinpyrazone,DB08816,Ticagrelor,0.811193585395813,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Sulfinpyrazone.,47,Type_47,Yes
DB00325,Nitroprusside,DB00697,Tizanidine,0.9404352307319641,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tizanidine.,49,Type_49,Yes
DB00658,Sevelamer,DB01044,Gatifloxacin,0.6444777250289917,67,Type_67,Sevelamer can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00751,Epinastine,DB01264,Darunavir,0.48053035140037537,47,Type_47,The metabolism of Darunavir can be decreased when combined with Epinastine.,73,Type_73,No
DB00246,Ziprasidone,DB11737,Icotinib,0.9723613262176514,47,Type_47,The metabolism of Icotinib can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00967,Desloratadine,DB01192,Oxymorphone,0.9963690042495728,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxymorphone.,49,Type_49,Yes
DB00246,Ziprasidone,DB06403,Ambrisentan,0.971756100654602,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01208,Sparfloxacin,DB13783,Acemetacin,0.9985036849975586,27,Type_27,Sparfloxacin may increase the neuroexcitatory activities of Acemetacin.,27,Type_27,Yes
DB01615,Aceprometazine,DB09117,Paraldehyde,0.9998180270195007,16,Type_16,Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00569,Fondaparinux,DB00608,Chloroquine,0.9991819262504578,6,Type_6,Fondaparinux may increase the anticoagulant activities of Chloroquine.,6,Type_6,Yes
DB00660,Metaxalone,DB06690,Nitrous oxide,0.9999966621398926,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Nitrous oxide.,49,Type_49,Yes
DB00457,Prazosin,DB00755,Tretinoin,0.8870711922645569,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Tretinoin.,49,Type_49,Yes
DB00706,Tamsulosin,DB01143,Amifostine,0.6363286375999451,60,Type_60,Tamsulosin may increase the hypotensive activities of Amifostine.,49,Type_49,No
DB00275,Olmesartan,DB01090,Pentolinium,0.9996641874313354,60,Type_60,Olmesartan may increase the hypotensive activities of Pentolinium.,60,Type_60,Yes
DB00966,Telmisartan,DB09279,Fimasartan,0.8993993997573853,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Fimasartan.,49,Type_49,Yes
DB00969,Alosetron,DB01254,Dasatinib,0.9541303515434265,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Alosetron.,73,Type_73,Yes
DB00647,Dextropropoxyphene,DB09063,Ceritinib,0.9230383038520813,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Dextropropoxyphene.,73,Type_73,Yes
DB01013,Clobetasol propionate,DB01397,Magnesium salicylate,0.9861564636230469,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Magnesium salicylate.,49,Type_49,Yes
DB00771,Clidinium,DB09117,Paraldehyde,0.9998440742492676,16,Type_16,Clidinium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00768,Olopatadine,DB09117,Paraldehyde,0.9968110918998718,16,Type_16,Olopatadine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00647,Dextropropoxyphene,DB00708,Sufentanil,0.9915703535079956,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Sufentanil.,49,Type_49,Yes
DB00471,Montelukast,DB01254,Dasatinib,0.7008198499679565,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Montelukast.,73,Type_73,Yes
DB00184,Nicotine,DB06413,Armodafinil,0.969009518623352,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00608,Chloroquine,DB00884,Risedronic acid,0.8939621448516846,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Risedronic acid.,49,Type_49,Yes
DB00996,Gabapentin,DB01095,Fluvastatin,0.5429919958114624,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Gabapentin.,49,Type_49,No
DB06203,Alogliptin,DB06595,Midostaurin,0.6932410597801208,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Alogliptin.,47,Type_47,Yes
DB00376,Trihexyphenidyl,DB00436,Bendroflumethiazide,0.9826562404632568,73,Type_73,The serum concentration of Bendroflumethiazide can be increased when it is combined with Trihexyphenidyl.,73,Type_73,Yes
DB00297,Bupivacaine,DB00679,Thioridazine,0.532412052154541,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Thioridazine.,47,Type_47,No
DB00179,Masoprocol,DB01177,Idarubicin,0.9986991882324219,72,Type_72,Masoprocol may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB00177,Valsartan,DB00881,Quinapril,0.9543051719665527,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Quinapril.,49,Type_49,Yes
DB00762,Irinotecan,DB01254,Dasatinib,0.8631247878074646,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Irinotecan.,73,Type_73,Yes
DB00796,Candesartan cilexetil,DB08880,Teriflunomide,0.46096479892730713,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Candesartan cilexetil.,49,Type_49,No
DB00370,Mirtazapine,DB01095,Fluvastatin,0.8476343154907227,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Mirtazapine.,47,Type_47,No
DB00540,Nortriptyline,DB00575,Clonidine,0.8680872321128845,37,Type_37,Nortriptyline may decrease the antihypertensive activities of Clonidine.,37,Type_37,Yes
DB00310,Chlorthalidone,DB00936,Salicylic acid,0.9907140731811523,70,Type_70,The therapeutic efficacy of Salicylic acid can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB00178,Ramipril,DB09449,"Sodium phosphate, monobasic",0.9101171493530273,57,Type_57,"Ramipril may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB01122,Ambenonium,DB09095,Difluocortolone,0.9994204044342041,49,Type_49,The risk or severity of adverse effects can be increased when Ambenonium is combined with Difluocortolone.,49,Type_49,Yes
DB00252,Phenytoin,DB05351,Dexlansoprazole,0.8455373048782349,4,Type_4,The metabolism of Dexlansoprazole can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01118,Amiodarone,DB06702,Fesoterodine,0.9047262072563171,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Amiodarone.,77,Type_77,Yes
DB00545,Pyridostigmine,DB06702,Fesoterodine,0.9267178177833557,70,Type_70,The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Pyridostigmine.,70,Type_70,Yes
DB00182,Amphetamine,DB00850,Perphenazine,0.5769420266151428,61,Type_61,Amphetamine may decrease the stimulatory activities of Perphenazine.,61,Type_61,Yes
DB06196,Icatibant,DB06781,Difluprednate,0.999891996383667,49,Type_49,The risk or severity of adverse effects can be increased when Icatibant is combined with Difluprednate.,49,Type_49,Yes
DB00937,Diethylpropion,DB01084,Emedastine,0.99998939037323,76,Type_76,Diethylpropion may decrease the sedative activities of Emedastine.,76,Type_76,Yes
DB00324,Fluorometholone,DB01010,Edrophonium,0.9994852542877197,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Edrophonium.,49,Type_49,Yes
DB00839,Tolazamide,DB00903,Etacrynic acid,0.9954474568367004,70,Type_70,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Tolazamide.,70,Type_70,Yes
DB00582,Voriconazole,DB01195,Flecainide,0.5696322321891785,73,Type_73,The serum concentration of Flecainide can be increased when it is combined with Voriconazole.,20,Type_20,No
DB01126,Dutasteride,DB01263,Posaconazole,0.9391226768493652,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Dutasteride.,73,Type_73,No
DB06287,Temsirolimus,DB09073,Palbociclib,0.996707558631897,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Temsirolimus.,73,Type_73,Yes
DB00211,Midodrine,DB01064,Isoprenaline,0.9990749359130859,49,Type_49,The risk or severity of adverse effects can be increased when Midodrine is combined with Isoprenaline.,49,Type_49,Yes
DB01043,Memantine,DB09204,Arotinolol,0.9996891021728516,54,Type_54,Memantine may increase the bradycardic activities of Arotinolol.,54,Type_54,Yes
DB01127,Econazole,DB01220,Rifaximin,0.9136975407600403,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Econazole.,73,Type_73,Yes
DB00637,Astemizole,DB01151,Desipramine,0.5727073550224304,20,Type_20,Astemizole may increase the QTc-prolonging activities of Desipramine.,47,Type_47,No
DB01589,Quazepam,DB13874,Enasidenib,0.8300521969795227,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Quazepam.,73,Type_73,No
DB00179,Masoprocol,DB00588,Fluticasone propionate,0.9984960556030273,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluticasone propionate.,49,Type_49,Yes
DB01083,Orlistat,DB09118,Stiripentol,0.9913083910942078,75,Type_75,The serum concentration of Stiripentol can be decreased when it is combined with Orlistat.,75,Type_75,Yes
DB01359,Penbutolol,DB01400,Neostigmine,0.9994015693664551,54,Type_54,Penbutolol may increase the bradycardic activities of Neostigmine.,54,Type_54,Yes
DB05676,Apremilast,DB06813,Pralatrexate,0.7955624461174011,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Apremilast.,73,Type_73,Yes
DB00254,Doxycycline,DB00910,Paricalcitol,0.8427242040634155,47,Type_47,The metabolism of Paricalcitol can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00231,Temazepam,DB00976,Telithromycin,0.9145820736885071,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Temazepam.,47,Type_47,Yes
DB00880,Chlorothiazide,DB00912,Repaglinide,0.9765376448631287,70,Type_70,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00625,Efavirenz,DB00924,Cyclobenzaprine,0.578548789024353,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00863,Ranitidine,DB00884,Risedronic acid,0.44063833355903625,70,Type_70,The therapeutic efficacy of Risedronic acid can be decreased when used in combination with Ranitidine.,18,Type_18,No
DB00586,Diclofenac,DB01097,Leflunomide,0.6081902980804443,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Diclofenac.,49,Type_49,No
DB00843,Donepezil,DB08933,Luliconazole,0.9375929236412048,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Donepezil.,73,Type_73,Yes
DB00333,Methadone,DB00450,Droperidol,0.999769389629364,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Droperidol.,16,Type_16,Yes
DB06268,Sitaxentan,DB06414,Etravirine,0.6642820239067078,47,Type_47,The metabolism of Etravirine can be decreased when combined with Sitaxentan.,47,Type_47,Yes
DB00367,Levonorgestrel,DB00418,Secobarbital,0.6282707452774048,70,Type_70,The therapeutic efficacy of Secobarbital can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00496,Darifenacin,DB06595,Midostaurin,0.9519585371017456,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00307,Bexarotene,DB00564,Carbamazepine,0.730482280254364,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Bexarotene.,4,Type_4,Yes
DB00227,Lovastatin,DB01127,Econazole,0.6144101619720459,73,Type_73,The serum concentration of Econazole can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB01397,Magnesium salicylate,DB08826,Deferiprone,0.970864474773407,75,Type_75,The serum concentration of Deferiprone can be decreased when it is combined with Magnesium salicylate.,75,Type_75,Yes
DB01026,Ketoconazole,DB01236,Sevoflurane,0.516048789024353,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00655,Estrone,DB00744,Zileuton,0.9386224746704102,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Zileuton.,49,Type_49,Yes
DB00343,Diltiazem,DB06237,Avanafil,0.738004207611084,10,Type_10,Diltiazem may increase the antihypertensive activities of Avanafil.,73,Type_73,No
DB01551,Dihydrocodeine,DB06717,Fosaprepitant,0.7197389006614685,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Dihydrocodeine.,73,Type_73,Yes
DB06154,Pentaerythritol tetranitrate,DB09212,Loxoprofen,0.9998761415481567,6,Type_6,Pentaerythritol tetranitrate may increase the anticoagulant activities of Loxoprofen.,6,Type_6,Yes
DB00611,Butorphanol,DB00747,Scopolamine,0.9998482465744019,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Scopolamine.,49,Type_49,Yes
DB00665,Nilutamide,DB01026,Ketoconazole,0.8428420424461365,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Nilutamide.,47,Type_47,Yes
DB00907,Cocaine,DB00961,Mepivacaine,0.9994868040084839,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Mepivacaine.,49,Type_49,Yes
DB00252,Phenytoin,DB01126,Dutasteride,0.9481125473976135,4,Type_4,The metabolism of Dutasteride can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00608,Chloroquine,DB01058,Praziquantel,0.8345623016357422,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Chloroquine.,75,Type_75,No
DB00390,Digoxin,DB01204,Mitoxantrone,0.9443671107292175,58,Type_58,Digoxin may decrease the cardiotoxic activities of Mitoxantrone.,58,Type_58,Yes
DB00268,Ropinirole,DB00758,Clopidogrel,0.9663483500480652,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00675,Tamoxifen,DB06595,Midostaurin,0.7863121032714844,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Tamoxifen.,73,Type_73,No
DB01076,Atorvastatin,DB01340,Cilazapril,0.6254696846008301,73,Type_73,The serum concentration of Cilazapril can be increased when it is combined with Atorvastatin.,73,Type_73,Yes
DB08922,Perospirone,DB09118,Stiripentol,0.7779250741004944,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Perospirone.,73,Type_73,Yes
DB00899,Remifentanil,DB01173,Orphenadrine,0.8623417615890503,16,Type_16,Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00590,Doxazosin,DB01174,Phenobarbital,0.8230403065681458,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Doxazosin.,60,Type_60,No
DB00295,Morphine,DB00413,Pramipexole,0.9032601118087769,32,Type_32,Morphine may increase the sedative activities of Pramipexole.,32,Type_32,Yes
DB00449,Dipivefrin,DB06148,Mianserin,0.9699464440345764,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Dipivefrin.,70,Type_70,Yes
DB00683,Midazolam,DB01589,Quazepam,0.8608372807502747,49,Type_49,The risk or severity of adverse effects can be increased when Midazolam is combined with Quazepam.,73,Type_73,No
DB00264,Metoprolol,DB08984,Etofenamate,0.9956817626953125,37,Type_37,Metoprolol may decrease the antihypertensive activities of Etofenamate.,37,Type_37,Yes
DB00605,Sulindac,DB01021,Trichlormethiazide,0.9982129335403442,70,Type_70,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Sulindac.,70,Type_70,Yes
DB00238,Nevirapine,DB01218,Halofantrine,0.8002593517303467,4,Type_4,The metabolism of Halofantrine can be increased when combined with Nevirapine.,73,Type_73,No
DB06723,Aluminum hydroxide,DB09241,Methylene blue,0.9667521715164185,67,Type_67,Aluminum hydroxide can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00643,Mebendazole,DB05521,Telaprevir,0.7385120987892151,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Mebendazole.,47,Type_47,Yes
DB00503,Ritonavir,DB06616,Bosutinib,0.91102135181427,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB01222,Budesonide,DB01232,Saquinavir,0.49350982904434204,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Budesonide.,73,Type_73,No
DB01030,Topotecan,DB01394,Colchicine,0.9637362360954285,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB00455,Loratadine,DB06594,Agomelatine,0.9998551607131958,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Agomelatine.,49,Type_49,Yes
DB00281,Lidocaine,DB06282,Levocetirizine,0.8356460928916931,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Levocetirizine.,49,Type_49,Yes
DB00997,Doxorubicin,DB13167,Alclofenac,0.9975320100784302,72,Type_72,Doxorubicin may decrease the excretion rate of Alclofenac which could result in a higher serum level.,72,Type_72,Yes
DB01064,Isoprenaline,DB08941,Isoxsuprine,0.9971812963485718,49,Type_49,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Isoxsuprine.,49,Type_49,Yes
DB01262,Decitabine,DB01396,Digitoxin,0.999638557434082,58,Type_58,Decitabine may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00395,Carisoprodol,DB00434,Cyproheptadine,0.9999314546585083,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cyproheptadine.,49,Type_49,Yes
DB01095,Fluvastatin,DB04855,Dronedarone,0.48568323254585266,73,Type_73,The serum concentration of Dronedarone can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB08860,Pitavastatin,DB08938,Magaldrate,0.9751978516578674,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Pitavastatin.,75,Type_75,Yes
DB00865,Benzphetamine,DB09167,Dosulepin,0.6557108759880066,37,Type_37,Benzphetamine may decrease the antihypertensive activities of Dosulepin.,37,Type_37,Yes
DB00298,Dapiprazole,DB09072,Sodium oxybate,0.9999998807907104,16,Type_16,Dapiprazole may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00844,Nalbuphine,DB06288,Amisulpride,0.9967498779296875,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amisulpride.,49,Type_49,Yes
DB00395,Carisoprodol,DB09117,Paraldehyde,0.9980395436286926,16,Type_16,Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00238,Nevirapine,DB01015,Sulfamethoxazole,0.9251185059547424,4,Type_4,The metabolism of Sulfamethoxazole can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00937,Diethylpropion,DB01618,Molindone,0.9999417066574097,61,Type_61,Diethylpropion may decrease the stimulatory activities of Molindone.,61,Type_61,Yes
DB00252,Phenytoin,DB00611,Butorphanol,0.9137823581695557,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Butorphanol.,49,Type_49,Yes
DB00620,Triamcinolone,DB03585,Oxyphenbutazone,0.9997077584266663,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00353,Methylergometrine,DB00575,Clonidine,0.630167543888092,71,Type_71,Methylergometrine may increase the hypertensive activities of Clonidine.,71,Type_71,Yes
DB01137,Levofloxacin,DB01164,Calcium chloride,0.9120215177536011,67,Type_67,Levofloxacin can cause a decrease in the absorption of Calcium chloride resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB01100,Pimozide,DB06702,Fesoterodine,0.9931955337524414,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pimozide.,77,Type_77,Yes
DB00922,Levosimendan,DB01037,Selegiline,0.9917532205581665,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Selegiline.,49,Type_49,Yes
DB00679,Thioridazine,DB01236,Sevoflurane,0.6697701811790466,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Sevoflurane.,20,Type_20,Yes
DB00628,Clorazepic acid,DB00818,Propofol,0.985928475856781,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Propofol.,49,Type_49,Yes
DB00458,Imipramine,DB01274,Arformoterol,0.485146164894104,20,Type_20,Imipramine may increase the QTc-prolonging activities of Arformoterol.,47,Type_47,No
DB00244,Mesalazine,DB00864,Tacrolimus,0.968921422958374,57,Type_57,Mesalazine may increase the nephrotoxic activities of Tacrolimus.,57,Type_57,Yes
DB00764,Mometasone,DB01324,Polythiazide,0.9999871253967285,83,Type_83,Mometasone may increase the hypokalemic activities of Polythiazide.,83,Type_83,Yes
DB01159,Halothane,DB01403,Methotrimeprazine,0.970475971698761,16,Type_16,Halothane may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB00912,Repaglinide,DB01201,Rifapentine,0.9775300621986389,4,Type_4,The metabolism of Rifapentine can be increased when combined with Repaglinide.,4,Type_4,Yes
DB00524,Metolazone,DB05271,Rotigotine,0.9014958143234253,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Rotigotine.,49,Type_49,Yes
DB00363,Clozapine,DB00656,Trazodone,0.7744380831718445,20,Type_20,Clozapine may increase the QTc-prolonging activities of Trazodone.,20,Type_20,Yes
DB00738,Pentamidine,DB04953,Ezogabine,0.9896726608276367,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Ezogabine.,20,Type_20,Yes
DB00454,Meperidine,DB06770,Benzyl alcohol,0.9760931730270386,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Benzyl alcohol.,49,Type_49,Yes
DB01193,Acebutolol,DB01351,Amobarbital,0.804284930229187,60,Type_60,Acebutolol may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00195,Betaxolol,DB01071,Mequitazine,0.5257301926612854,70,Type_70,The therapeutic efficacy of Mequitazine can be decreased when used in combination with Betaxolol.,47,Type_47,No
DB00384,Triamterene,DB00458,Imipramine,0.6770929098129272,37,Type_37,Triamterene may decrease the antihypertensive activities of Imipramine.,49,Type_49,No
DB00245,Benzatropine,DB01156,Bupropion,0.9396308660507202,47,Type_47,The metabolism of Bupropion can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB06480,Prucalopride,DB08864,Rilpivirine,0.808892011642456,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Prucalopride.,73,Type_73,Yes
DB00678,Losartan,DB01236,Sevoflurane,0.5548496842384338,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Losartan.,49,Type_49,No
DB00358,Mefloquine,DB01611,Hydroxychloroquine,0.8420254588127136,47,Type_47,The metabolism of Hydroxychloroquine can be decreased when combined with Mefloquine.,49,Type_49,No
DB00273,Topiramate,DB00603,Medroxyprogesterone acetate,0.5430891513824463,47,Type_47,The metabolism of Medroxyprogesterone acetate can be decreased when combined with Topiramate.,75,Type_75,No
DB00298,Dapiprazole,DB04908,Flibanserin,0.999512791633606,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Flibanserin.,49,Type_49,Yes
DB01018,Guanfacine,DB01101,Capecitabine,0.8043893575668335,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Guanfacine.,47,Type_47,Yes
DB00220,Nelfinavir,DB00539,Toremifene,0.6415832042694092,20,Type_20,Nelfinavir may increase the QTc-prolonging activities of Toremifene.,49,Type_49,No
DB00521,Carteolol,DB00722,Lisinopril,0.8012880682945251,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Lisinopril.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB01124,Tolbutamide,0.8645214438438416,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Medroxyprogesterone acetate.,70,Type_70,Yes
DB00243,Ranolazine,DB01126,Dutasteride,0.8199698328971863,47,Type_47,The metabolism of Dutasteride can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB04946,Iloperidone,DB09198,Lobeglitazone,0.9960598349571228,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Iloperidone.,47,Type_47,Yes
DB00692,Phentolamine,DB02638,Terlipressin,0.9999840259552002,60,Type_60,Phentolamine may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB00594,Amiloride,DB09112,Nitrous acid,0.9999847412109375,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Nitrous acid.,49,Type_49,Yes
DB00496,Darifenacin,DB01184,Domperidone,0.9367554783821106,47,Type_47,The metabolism of Domperidone can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB01452,Diamorphine,DB09118,Stiripentol,0.6838021278381348,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Stiripentol.,49,Type_49,Yes
DB00273,Topiramate,DB01199,Tubocurarine,0.9836683869361877,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Tubocurarine.,49,Type_49,Yes
DB00186,Lorazepam,DB00849,Methylphenobarbital,0.9319364428520203,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Methylphenobarbital.,49,Type_49,Yes
DB00297,Bupivacaine,DB01241,Gemfibrozil,0.8557574152946472,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB00254,Doxycycline,DB00619,Imatinib,0.7810568809509277,47,Type_47,The metabolism of Imatinib can be decreased when combined with Doxycycline.,73,Type_73,No
DB01028,Methoxyflurane,DB09224,Melperone,0.9994531273841858,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Melperone.,49,Type_49,Yes
DB00622,Nicardipine,DB00734,Risperidone,0.6260910630226135,47,Type_47,The metabolism of Risperidone can be decreased when combined with Nicardipine.,60,Type_60,No
DB00521,Carteolol,DB03585,Oxyphenbutazone,0.9768038988113403,37,Type_37,Carteolol may decrease the antihypertensive activities of Oxyphenbutazone.,37,Type_37,Yes
DB00349,Clobazam,DB09076,Umeclidinium,0.9789164066314697,47,Type_47,The metabolism of Umeclidinium can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00220,Nelfinavir,DB00497,Oxycodone,0.8187873959541321,47,Type_47,The metabolism of Oxycodone can be decreased when combined with Nelfinavir.,49,Type_49,No
DB00458,Imipramine,DB12532,Oxetacaine,0.9992997646331787,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Oxetacaine.,49,Type_49,Yes
DB00861,Diflunisal,DB08954,Ifenprodil,0.9525740146636963,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Ifenprodil.,49,Type_49,Yes
DB00468,Quinine,DB00743,Gadobenic acid,0.9998576641082764,20,Type_20,Quinine may increase the QTc-prolonging activities of Gadobenic acid.,20,Type_20,Yes
DB01182,Propafenone,DB06695,Dabigatran etexilate,0.8738314509391785,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Propafenone.,77,Type_77,Yes
DB00199,Erythromycin,DB09101,Elvitegravir,0.9151660799980164,47,Type_47,The metabolism of Elvitegravir can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01319,Fosamprenavir,DB06287,Temsirolimus,0.6442253589630127,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Fosamprenavir.,49,Type_49,No
DB00287,Travoprost,DB06267,Udenafil,0.9908013939857483,10,Type_10,Travoprost may increase the antihypertensive activities of Udenafil.,10,Type_10,Yes
DB00343,Diltiazem,DB00501,Cimetidine,0.9291273951530457,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Diltiazem.,73,Type_73,No
DB01104,Sertraline,DB01580,Oxprenolol,0.5626499056816101,64,Type_64,Sertraline may increase the serotonergic activities of Oxprenolol.,73,Type_73,No
DB00327,Hydromorphone,DB11609,Normethadone,0.9981856942176819,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Normethadone.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01193,Acebutolol,0.6432609558105469,60,Type_60,Tranylcypromine may increase the hypotensive activities of Acebutolol.,60,Type_60,Yes
DB00557,Hydroxyzine,DB00865,Benzphetamine,0.991434633731842,76,Type_76,Hydroxyzine may decrease the sedative activities of Benzphetamine.,76,Type_76,Yes
DB00409,Remoxipride,DB01567,Fludiazepam,0.999618411064148,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Fludiazepam.,49,Type_49,Yes
DB06781,Difluprednate,DB08880,Teriflunomide,0.9468168616294861,49,Type_49,The risk or severity of adverse effects can be increased when Difluprednate is combined with Teriflunomide.,49,Type_49,Yes
DB00296,Ropivacaine,DB06594,Agomelatine,0.9966118931770325,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Agomelatine.,49,Type_49,Yes
DB01263,Posaconazole,DB08910,Pomalidomide,0.9513576030731201,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB04953,Ezogabine,DB11304,Phenoxyethanol,0.9244455099105835,49,Type_49,The risk or severity of adverse effects can be increased when Ezogabine is combined with Phenoxyethanol.,49,Type_49,Yes
DB01600,Tiaprofenic acid,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Tiaprofenic acid.,70,Type_70,Yes
DB00768,Olopatadine,DB00771,Clidinium,0.9907903671264648,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Clidinium.,49,Type_49,Yes
DB00193,Tramadol,DB01081,Diphenoxylate,0.9960655570030212,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Diphenoxylate.,49,Type_49,Yes
DB00690,Flurazepam,DB09075,Edoxaban,0.9870023727416992,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Flurazepam.,73,Type_73,Yes
DB00619,Imatinib,DB04908,Flibanserin,0.677474856376648,73,Type_73,The serum concentration of Flibanserin can be increased when it is combined with Imatinib.,49,Type_49,No
DB00345,Aminohippuric acid,DB06480,Prucalopride,0.9882503747940063,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Aminohippuric acid.,73,Type_73,Yes
DB01551,Dihydrocodeine,DB11609,Normethadone,0.997469425201416,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Normethadone.,49,Type_49,Yes
DB00484,Brimonidine,DB00703,Methazolamide,0.9935017228126526,49,Type_49,The risk or severity of adverse effects can be increased when Brimonidine is combined with Methazolamide.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB00960,Pindolol,0.7655562162399292,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Pindolol.,60,Type_60,Yes
DB00427,Triprolidine,DB01580,Oxprenolol,0.3207687735557556,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Oxprenolol.,49,Type_49,Yes
DB00870,Suprofen,DB03615,Ribostamycin,0.9999265670776367,72,Type_72,Suprofen may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,72,Type_72,Yes
DB06786,Halcinonide,DB09065,Cobicistat,0.9074564576148987,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Halcinonide.,73,Type_73,Yes
DB00758,Clopidogrel,DB01045,Rifampicin,0.6487141251564026,4,Type_4,The metabolism of Rifampicin can be increased when combined with Clopidogrel.,49,Type_49,No
DB00614,Furazolidone,DB06148,Mianserin,0.39263010025024414,2,Type_2,Furazolidone may increase the anticholinergic activities of Mianserin.,49,Type_49,No
DB00230,Pregabalin,DB00985,Dimenhydrinate,0.9985504746437073,8,Type_8,The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB00454,Meperidine,DB00794,Primidone,0.6122446060180664,4,Type_4,The metabolism of Primidone can be increased when combined with Meperidine.,16,Type_16,No
DB00210,Adapalene,DB00884,Risedronic acid,0.9551911354064941,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Risedronic acid.,49,Type_49,Yes
DB00880,Chlorothiazide,DB01023,Felodipine,0.5429506301879883,60,Type_60,Chlorothiazide may increase the hypotensive activities of Felodipine.,49,Type_49,No
DB06605,Apixaban,DB09280,Lumacaftor,0.6997113823890686,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Apixaban.,73,Type_73,No
DB00189,Ethchlorvynol,DB08918,Levomilnacipran,0.9931539297103882,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Levomilnacipran.,49,Type_49,Yes
DB01364,Ephedrine,DB09273,Doxofylline,0.7986031174659729,49,Type_49,The risk or severity of adverse effects can be increased when Ephedrine is combined with Doxofylline.,49,Type_49,Yes
DB00252,Phenytoin,DB00947,Fulvestrant,0.6753160357475281,4,Type_4,The metabolism of Fulvestrant can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00723,Methoxamine,DB09244,Pirlindole,0.9980992674827576,71,Type_71,Methoxamine may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB00678,Losartan,DB11362,Selexipag,0.9680441617965698,60,Type_60,Losartan may increase the hypotensive activities of Selexipag.,47,Type_47,No
DB00812,Phenylbutazone,DB04743,Nimesulide,0.9957371950149536,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Nimesulide.,49,Type_49,Yes
DB00428,Streptozocin,DB00657,Mecamylamine,0.8473387360572815,49,Type_49,The risk or severity of adverse effects can be increased when Streptozocin is combined with Mecamylamine.,21,Type_21,No
DB00647,Dextropropoxyphene,DB08864,Rilpivirine,0.5257458090782166,75,Type_75,The serum concentration of Rilpivirine can be decreased when it is combined with Dextropropoxyphene.,75,Type_75,Yes
DB00206,Reserpine,DB08931,Riociguat,0.665683925151825,60,Type_60,Reserpine may increase the hypotensive activities of Riociguat.,49,Type_49,No
DB01580,Oxprenolol,DB09080,Olodaterol,0.6394767165184021,5,Type_5,Oxprenolol may decrease the vasoconstricting activities of Olodaterol.,14,Type_14,No
DB00774,Hydroflumethiazide,DB01193,Acebutolol,0.6744799017906189,83,Type_83,Hydroflumethiazide may increase the hypokalemic activities of Acebutolol.,60,Type_60,No
DB00633,Dexmedetomidine,DB01159,Halothane,0.8155061602592468,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Halothane.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB01186,Pergolide,0.7673233151435852,49,Type_49,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pergolide.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB09330,Osimertinib,0.9014488458633423,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Chlordiazepoxide.,73,Type_73,Yes
DB04898,Ximelagatran,DB08873,Boceprevir,0.2925577163696289,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Ximelagatran.,75,Type_75,Yes
DB00238,Nevirapine,DB06594,Agomelatine,0.3377542197704315,4,Type_4,The metabolism of Agomelatine can be increased when combined with Nevirapine.,73,Type_73,No
DB09102,Daclatasvir,DB12332,Rucaparib,0.7937099933624268,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Daclatasvir.,47,Type_47,Yes
DB00182,Amphetamine,DB04840,Debrisoquine,0.779837429523468,60,Type_60,Amphetamine may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00604,Cisapride,DB08958,Hexetidine,0.8855796456336975,73,Type_73,The serum concentration of Hexetidine can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00436,Bendroflumethiazide,DB01118,Amiodarone,0.6297922134399414,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Amiodarone.,54,Type_54,No
DB00169,Cholecalciferol,DB00623,Fluphenazine,0.7948987483978271,47,Type_47,The metabolism of Fluphenazine can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01190,Clindamycin,DB09053,Ibrutinib,0.6564021706581116,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Clindamycin.,73,Type_73,Yes
DB00287,Travoprost,DB01399,Salsalate,0.9928170442581177,70,Type_70,The therapeutic efficacy of Salsalate can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB00300,Tenofovir disoproxil,DB01014,Balsalazide,0.9130091071128845,49,Type_49,The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Balsalazide.,49,Type_49,Yes
DB09128,Brexpiprazole,DB09225,Zotepine,0.846727728843689,49,Type_49,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Zotepine.,49,Type_49,Yes
DB00715,Paroxetine,DB01228,Encainide,0.9976564645767212,47,Type_47,The metabolism of Encainide can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00544,Fluorouracil,DB01104,Sertraline,0.9286475777626038,47,Type_47,The metabolism of Sertraline can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00356,Chlorzoxazone,DB00679,Thioridazine,0.7513675093650818,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Thioridazine.,47,Type_47,No
DB01029,Irbesartan,DB09244,Pirlindole,0.7182032465934753,60,Type_60,Irbesartan may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00866,Alprenolol,DB00932,Tipranavir,0.6817401051521301,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Alprenolol.,47,Type_47,Yes
DB00501,Cimetidine,DB01030,Topotecan,0.9575774073600769,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Cimetidine.,73,Type_73,Yes
DB00343,Diltiazem,DB00350,Minoxidil,0.8295980095863342,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Minoxidil.,49,Type_49,Yes
DB01243,Chloroxine,DB09268,Picosulfuric acid,0.9999297857284546,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Chloroxine.,70,Type_70,Yes
DB01297,Practolol,DB01577,Metamfetamine,0.9572591185569763,25,Type_25,Practolol may increase the atrioventricular blocking (AV block) activities of Metamfetamine.,25,Type_25,Yes
DB00575,Clonidine,DB01012,Cinacalcet,0.7520310878753662,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Clonidine.,47,Type_47,Yes
DB00270,Isradipine,DB01035,Procainamide,0.9305287599563599,20,Type_20,Isradipine may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00371,Meprobamate,DB01045,Rifampicin,0.9125775098800659,4,Type_4,The metabolism of Rifampicin can be increased when combined with Meprobamate.,4,Type_4,Yes
DB00254,Doxycycline,DB08912,Dabrafenib,0.9737963676452637,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Doxycycline.,47,Type_47,No
DB00203,Sildenafil,DB08918,Levomilnacipran,0.9287556409835815,47,Type_47,The metabolism of Levomilnacipran can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00273,Topiramate,DB04938,Ospemifene,0.903476357460022,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Topiramate.,47,Type_47,Yes
DB01380,Cortisone acetate,DB01399,Salsalate,0.9996469020843506,49,Type_49,The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Salsalate.,49,Type_49,Yes
DB00525,Tolnaftate,DB04920,Clevidipine,0.9994081258773804,49,Type_49,The risk or severity of adverse effects can be increased when Tolnaftate is combined with Clevidipine.,49,Type_49,Yes
DB00268,Ropinirole,DB05812,Abiraterone,0.5409467220306396,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Ropinirole.,73,Type_73,Yes
DB00486,Nabilone,DB00691,Moexipril,0.7884004712104797,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Moexipril.,49,Type_49,Yes
DB04842,Fluspirilene,DB12532,Oxetacaine,0.999995231628418,49,Type_49,The risk or severity of adverse effects can be increased when Fluspirilene is combined with Oxetacaine.,49,Type_49,Yes
DB00780,Phenelzine,DB01236,Sevoflurane,0.8853142857551575,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Sevoflurane.,49,Type_49,Yes
DB01115,Nifedipine,DB01340,Cilazapril,0.9532525539398193,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Cilazapril.,49,Type_49,Yes
DB00470,Dronabinol,DB00875,Flupentixol,0.995329737663269,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.,16,Type_16,Yes
DB00297,Bupivacaine,DB01437,Glutethimide,0.9985864162445068,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Glutethimide.,49,Type_49,Yes
DB00328,Indomethacin,DB05812,Abiraterone,0.5200951099395752,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Indomethacin.,47,Type_47,Yes
DB00697,Tizanidine,DB08822,Azilsartan medoxomil,0.986185610294342,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB01151,Desipramine,DB05109,Trabectedin,0.7095398902893066,47,Type_47,The metabolism of Trabectedin can be decreased when combined with Desipramine.,47,Type_47,Yes
DB00887,Bumetanide,DB05271,Rotigotine,0.9444841742515564,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Rotigotine.,49,Type_49,Yes
DB00413,Pramipexole,DB01198,Zopiclone,0.999948263168335,32,Type_32,Pramipexole may increase the sedative activities of Zopiclone.,32,Type_32,Yes
DB00210,Adapalene,DB00783,Estradiol,0.7504774928092957,70,Type_70,The therapeutic efficacy of Estradiol can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00237,Butabarbital,DB00924,Cyclobenzaprine,0.9990376234054565,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Cyclobenzaprine.,49,Type_49,Yes
DB00185,Cevimeline,DB00571,Propranolol,0.7191744446754456,49,Type_49,The risk or severity of adverse effects can be increased when Cevimeline is combined with Propranolol.,49,Type_49,Yes
DB00620,Triamcinolone,DB06802,Nepafenac,0.9996745586395264,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Nepafenac.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01219,Dantrolene,0.47292476892471313,47,Type_47,The metabolism of Dantrolene can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01037,Selegiline,DB01355,Hexobarbital,0.8050484657287598,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Hexobarbital.,60,Type_60,No
DB01370,Aluminium,DB04576,Fleroxacin,0.8352789282798767,67,Type_67,Aluminium can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00261,Anagrelide,DB06402,Telavancin,1.0,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00224,Indinavir,DB09389,Norgestrel,0.5795804858207703,47,Type_47,The metabolism of Norgestrel can be decreased when combined with Indinavir.,47,Type_47,Yes
DB01129,Rabeprazole,DB08865,Crizotinib,0.9380101561546326,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Rabeprazole.,47,Type_47,Yes
DB00465,Ketorolac,DB00838,Clocortolone,0.9999103546142578,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Clocortolone.,49,Type_49,Yes
DB01253,Ergometrine,DB08893,Mirabegron,0.5739747285842896,71,Type_71,Ergometrine may increase the hypertensive activities of Mirabegron.,71,Type_71,Yes
DB00907,Cocaine,DB05521,Telaprevir,0.810798168182373,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00296,Ropivacaine,DB09071,Tasimelteon,0.9964003562927246,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Tasimelteon.,49,Type_49,Yes
DB06148,Mianserin,DB09280,Lumacaftor,0.6727874279022217,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Mianserin.,75,Type_75,Yes
DB00246,Ziprasidone,DB08864,Rilpivirine,0.6799752712249756,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Ziprasidone.,73,Type_73,Yes
DB00343,Diltiazem,DB00727,Nitroglycerin,0.996898889541626,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Nitroglycerin.,49,Type_49,Yes
DB06282,Levocetirizine,DB08899,Enzalutamide,0.9209744334220886,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Levocetirizine.,75,Type_75,Yes
DB01115,Nifedipine,DB01321,Josamycin,0.549735426902771,47,Type_47,The metabolism of Josamycin can be decreased when combined with Nifedipine.,47,Type_47,Yes
DB00709,Lamivudine,DB08880,Teriflunomide,0.7115922570228577,49,Type_49,The risk or severity of adverse effects can be increased when Lamivudine is combined with Teriflunomide.,73,Type_73,No
DB00257,Clotrimazole,DB06739,Seratrodast,0.9320313930511475,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01463,Fencamfamin,DB01624,Zuclopenthixol,0.7910287380218506,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Zuclopenthixol.,49,Type_49,Yes
DB00338,Omeprazole,DB06701,Dexmethylphenidate,0.8070569634437561,18,Type_18,Omeprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB00409,Remoxipride,DB01587,Ketazolam,0.9958714842796326,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Ketazolam.,49,Type_49,Yes
DB00540,Nortriptyline,DB00816,Orciprenaline,0.985405445098877,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Orciprenaline.,49,Type_49,Yes
DB00215,Citalopram,DB00501,Cimetidine,0.9484838247299194,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Citalopram.,73,Type_73,No
DB00326,Calcium glucoheptonate,DB00487,Pefloxacin,0.8309302926063538,67,Type_67,Calcium glucoheptonate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00696,Ergotamine,DB01622,Thioproperazine,0.7396737933158875,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Thioproperazine.,49,Type_49,Yes
DB00353,Methylergometrine,DB01384,Paramethasone,0.9956169128417969,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Paramethasone.,49,Type_49,Yes
DB01171,Moclobemide,DB01214,Metipranolol,0.8200332522392273,60,Type_60,Moclobemide may increase the hypotensive activities of Metipranolol.,60,Type_60,Yes
DB00450,Droperidol,DB00909,Zonisamide,0.9991199374198914,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,16,Type_16,Yes
DB00266,Dicoumarol,DB08887,Icosapent ethyl,0.9981033802032471,6,Type_6,Dicoumarol may increase the anticoagulant activities of Icosapent ethyl.,6,Type_6,Yes
DB00838,Clocortolone,DB06718,Stanozolol,1.0,74,Type_74,Clocortolone may increase the fluid retaining activities of Stanozolol.,74,Type_74,Yes
DB00320,Dihydroergotamine,DB11828,Neratinib,0.9731734395027161,47,Type_47,The metabolism of Neratinib can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00376,Trihexyphenidyl,DB01409,Tiotropium,0.9680211544036865,2,Type_2,Trihexyphenidyl may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB01142,Doxepin,DB01155,Gemifloxacin,0.9335364103317261,20,Type_20,Doxepin may increase the QTc-prolonging activities of Gemifloxacin.,20,Type_20,Yes
DB00639,Butoconazole,DB00678,Losartan,0.6242599487304688,49,Type_49,The risk or severity of adverse effects can be increased when Butoconazole is combined with Losartan.,47,Type_47,No
DB00298,Dapiprazole,DB09345,Pramocaine,0.9999973773956299,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Pramocaine.,49,Type_49,Yes
DB00457,Prazosin,DB01210,Levobunolol,0.8409590721130371,30,Type_30,Prazosin may increase the orthostatic hypotensive activities of Levobunolol.,49,Type_49,No
DB00218,Moxifloxacin,DB04868,Nilotinib,0.9710846543312073,20,Type_20,Moxifloxacin may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB00280,Disopyramide,DB08820,Ivacaftor,0.9963105320930481,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Disopyramide.,73,Type_73,Yes
DB00950,Fexofenadine,DB11304,Phenoxyethanol,0.9999934434890747,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Phenoxyethanol.,49,Type_49,Yes
DB00399,Zoledronic acid,DB00744,Zileuton,0.9930728077888489,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Zileuton.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB00807,Proparacaine,0.9999982118606567,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Proparacaine.,49,Type_49,Yes
DB00966,Telmisartan,DB04840,Debrisoquine,0.9994286894798279,60,Type_60,Telmisartan may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00484,Brimonidine,DB00801,Halazepam,0.987246036529541,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,16,Type_16,Yes
DB00502,Haloperidol,DB00641,Simvastatin,0.5029969215393066,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Haloperidol.,47,Type_47,No
DB00842,Oxazepam,DB01264,Darunavir,0.7360527515411377,47,Type_47,The metabolism of Darunavir can be decreased when combined with Oxazepam.,47,Type_47,Yes
DB08897,Aclidinium,DB11315,Methscopolamine,0.8994080424308777,2,Type_2,Aclidinium may increase the anticholinergic activities of Methscopolamine.,2,Type_2,Yes
DB00590,Doxazosin,DB01427,Amrinone,0.984771192073822,60,Type_60,Doxazosin may increase the hypotensive activities of Amrinone.,60,Type_60,Yes
DB00293,Raltitrexed,DB01092,Ouabain,0.9998795986175537,58,Type_58,Raltitrexed may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00412,Rosiglitazone,DB00959,Methylprednisolone,0.9469857215881348,70,Type_70,The therapeutic efficacy of Methylprednisolone can be decreased when used in combination with Rosiglitazone.,70,Type_70,Yes
DB00413,Pramipexole,DB00598,Labetalol,0.870145320892334,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Labetalol.,49,Type_49,Yes
DB01035,Procainamide,DB01100,Pimozide,0.704605758190155,20,Type_20,Procainamide may increase the QTc-prolonging activities of Pimozide.,33,Type_33,No
DB00213,Pantoprazole,DB00245,Benzatropine,0.9770426750183105,47,Type_47,The metabolism of Benzatropine can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00751,Epinastine,DB09211,Limaprost,0.8693932890892029,53,Type_53,Epinastine may increase the antiplatelet activities of Limaprost.,53,Type_53,Yes
DB00829,Diazepam,DB09054,Idelalisib,0.8773229122161865,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Diazepam.,47,Type_47,Yes
DB00869,Dorzolamide,DB00880,Chlorothiazide,0.987400233745575,60,Type_60,Dorzolamide may increase the hypotensive activities of Chlorothiazide.,60,Type_60,Yes
DB01009,Ketoprofen,DB06826,Unoprostone,0.9981575608253479,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ketoprofen.,70,Type_70,Yes
DB01254,Dasatinib,DB06216,Asenapine,0.7612016201019287,73,Type_73,The serum concentration of Asenapine can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00537,Ciprofloxacin,DB01348,Spirapril,0.6707214117050171,82,Type_82,Ciprofloxacin may increase the arrhythmogenic activities of Spirapril.,82,Type_82,Yes
DB00208,Ticlopidine,DB00356,Chlorzoxazone,0.9617236852645874,47,Type_47,The metabolism of Chlorzoxazone can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00648,Mitotane,DB00997,Doxorubicin,0.9882247447967529,75,Type_75,The serum concentration of Doxorubicin can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00373,Timolol,DB01233,Metoclopramide,0.7467015981674194,54,Type_54,Timolol may increase the bradycardic activities of Metoclopramide.,54,Type_54,Yes
DB00166,Lipoic acid,DB13231,Calcium lactate,0.9767405390739441,67,Type_67,Lipoic acid can cause a decrease in the absorption of Calcium lactate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00497,Oxycodone,DB06717,Fosaprepitant,0.6944607496261597,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Oxycodone.,73,Type_73,Yes
DB01054,Nitrendipine,DB01174,Phenobarbital,0.6825657486915588,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Nitrendipine.,4,Type_4,Yes
DB01452,Diamorphine,DB01563,Chloral hydrate,0.9992185831069946,49,Type_49,The risk or severity of adverse effects can be increased when Diamorphine is combined with Chloral hydrate.,49,Type_49,Yes
DB01186,Pergolide,DB01211,Clarithromycin,0.7777002453804016,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Pergolide.,47,Type_47,Yes
DB00805,Minaprine,DB06292,Dapagliflozin,0.9061697125434875,9,Type_9,Minaprine may increase the hypoglycemic activities of Dapagliflozin.,9,Type_9,Yes
DB00418,Secobarbital,DB01261,Sitagliptin,0.5543279051780701,4,Type_4,The metabolism of Sitagliptin can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00182,Amphetamine,DB09273,Doxofylline,0.8113639950752258,60,Type_60,Amphetamine may increase the hypotensive activities of Doxofylline.,49,Type_49,No
DB00790,Perindopril,DB00806,Pentoxifylline,0.9057657122612,60,Type_60,Perindopril may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB00647,Dextropropoxyphene,DB00831,Trifluoperazine,0.9919106364250183,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Trifluoperazine.,49,Type_49,Yes
DB00091,Cyclosporine,DB00829,Diazepam,0.8795866370201111,47,Type_47,The metabolism of Diazepam can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB06826,Unoprostone,DB08984,Etofenamate,0.9802746176719666,70,Type_70,The therapeutic efficacy of Etofenamate can be decreased when used in combination with Unoprostone.,70,Type_70,Yes
DB00630,Alendronic acid,DB01014,Balsalazide,0.9824002981185913,49,Type_49,The risk or severity of adverse effects can be increased when Alendronic acid is combined with Balsalazide.,49,Type_49,Yes
DB00678,Losartan,DB08828,Vismodegib,0.7773330211639404,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Losartan.,47,Type_47,Yes
DB09218,Clonixin,DB09295,Talniflumate,0.9996241331100464,49,Type_49,The risk or severity of adverse effects can be increased when Clonixin is combined with Talniflumate.,49,Type_49,Yes
DB00623,Fluphenazine,DB00934,Maprotiline,0.9888429641723633,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Maprotiline.,49,Type_49,Yes
DB00208,Ticlopidine,DB00974,Edetic acid,0.9716262221336365,6,Type_6,Ticlopidine may increase the anticoagulant activities of Edetic acid.,6,Type_6,Yes
DB00712,Flurbiprofen,DB01421,Paromomycin,0.9999368190765381,72,Type_72,Flurbiprofen may decrease the excretion rate of Paromomycin which could result in a higher serum level.,72,Type_72,Yes
DB00321,Amitriptyline,DB06701,Dexmethylphenidate,0.5124754309654236,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dexmethylphenidate.,49,Type_49,Yes
DB00408,Loxapine,DB00477,Chlorpromazine,0.8730601668357849,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorpromazine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB13139,Levosalbutamol,0.9861761927604675,83,Type_83,Chlorothiazide may increase the hypokalemic activities of Levosalbutamol.,83,Type_83,Yes
DB00919,Spectinomycin,DB01607,Ticarcillin,0.9910247325897217,75,Type_75,The serum concentration of Ticarcillin can be decreased when it is combined with Spectinomycin.,75,Type_75,Yes
DB00223,Diflorasone,DB01628,Etoricoxib,0.9994199275970459,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Etoricoxib.,49,Type_49,Yes
DB01083,Orlistat,DB09119,Eslicarbazepine acetate,0.494873046875,75,Type_75,The serum concentration of Eslicarbazepine acetate can be decreased when it is combined with Orlistat.,75,Type_75,Yes
DB00204,Dofetilide,DB00999,Hydrochlorothiazide,0.9986422657966614,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Hydrochlorothiazide.,20,Type_20,Yes
DB00253,Medrysone,DB00586,Diclofenac,0.999160647392273,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Diclofenac.,49,Type_49,Yes
DB00564,Carbamazepine,DB01186,Pergolide,0.581037163734436,4,Type_4,The metabolism of Pergolide can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00470,Dronabinol,DB01030,Topotecan,0.9857690930366516,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00187,Esmolol,DB09083,Ivabradine,0.9394248127937317,54,Type_54,Esmolol may increase the bradycardic activities of Ivabradine.,54,Type_54,Yes
DB01149,Nefazodone,DB01238,Aripiprazole,0.7215300798416138,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00257,Clotrimazole,DB04572,Thiotepa,0.9193287491798401,47,Type_47,The metabolism of Thiotepa can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00741,Hydrocortisone,DB00795,Sulfasalazine,0.9992827773094177,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Sulfasalazine.,49,Type_49,Yes
DB00206,Reserpine,DB04841,Flunarizine,0.9477126002311707,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Flunarizine.,49,Type_49,Yes
DB00801,Halazepam,DB04842,Fluspirilene,0.9962949156761169,49,Type_49,The risk or severity of adverse effects can be increased when Halazepam is combined with Fluspirilene.,49,Type_49,Yes
DB01069,Promethazine,DB03754,Tromethamine,0.8455699682235718,67,Type_67,Promethazine can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00808,Indapamide,DB09300,Butylscopolamine,0.9970818161964417,73,Type_73,The serum concentration of Butylscopolamine can be increased when it is combined with Indapamide.,73,Type_73,Yes
DB01136,Carvedilol,DB06725,Lornoxicam,0.988602876663208,37,Type_37,Carvedilol may decrease the antihypertensive activities of Lornoxicam.,37,Type_37,Yes
DB00755,Tretinoin,DB00823,Ethynodiol diacetate,0.5219799280166626,75,Type_75,The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Tretinoin.,70,Type_70,No
DB00697,Tizanidine,DB00822,Disulfiram,0.4217119514942169,73,Type_73,The serum concentration of Disulfiram can be increased when it is combined with Tizanidine.,73,Type_73,Yes
DB00947,Fulvestrant,DB09065,Cobicistat,0.4965629577636719,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Fulvestrant.,47,Type_47,No
DB00180,Flunisolide,DB00661,Verapamil,0.8212399482727051,47,Type_47,The metabolism of Verapamil can be decreased when combined with Flunisolide.,47,Type_47,Yes
DB00321,Amitriptyline,DB01236,Sevoflurane,0.8150269389152527,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sevoflurane.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB08907,Canagliflozin,0.8003368973731995,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Canagliflozin.,49,Type_49,Yes
DB09118,Stiripentol,DB09330,Osimertinib,0.9453563094139099,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Stiripentol.,75,Type_75,No
DB00210,Adapalene,DB01180,Rescinnamine,0.995864987373352,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Rescinnamine.,49,Type_49,Yes
DB01418,Acenocoumarol,DB09323,Benzylpenicillin benzathine hydrate,0.49964427947998047,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Benzylpenicillin benzathine hydrate.,6,Type_6,Yes
DB00648,Mitotane,DB11828,Neratinib,0.9670758247375488,75,Type_75,The serum concentration of Neratinib can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00184,Nicotine,DB08868,Fingolimod,0.783500611782074,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00378,Dydrogesterone,DB01418,Acenocoumarol,0.9999659061431885,70,Type_70,The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Dydrogesterone.,70,Type_70,Yes
DB00482,Celecoxib,DB09570,Ixazomib,0.891015887260437,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00091,Cyclosporine,DB11156,Pyrantel,0.623251736164093,21,Type_21,Cyclosporine may increase the neuromuscular blocking activities of Pyrantel.,21,Type_21,Yes
DB00814,Meloxicam,DB08816,Ticagrelor,0.8861919641494751,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Meloxicam.,47,Type_47,Yes
DB01229,Paclitaxel,DB09063,Ceritinib,0.8225005865097046,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Paclitaxel.,73,Type_73,Yes
DB00684,Tobramycin,DB00884,Risedronic acid,0.6844071745872498,24,Type_24,Tobramycin may increase the hypocalcemic activities of Risedronic acid.,24,Type_24,Yes
DB00975,Dipyridamole,DB01340,Cilazapril,0.9626787900924683,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Cilazapril.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB09275,Bismuth subcitrate potassium,0.9869019985198975,3,Type_3,The bioavailability of Bismuth subcitrate potassium can be decreased when combined with Fluticasone propionate.,3,Type_3,Yes
DB00743,Gadobenic acid,DB01263,Posaconazole,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Posaconazole.,20,Type_20,Yes
DB00866,Alprenolol,DB08439,Parecoxib,0.9971153736114502,37,Type_37,Alprenolol may decrease the antihypertensive activities of Parecoxib.,37,Type_37,Yes
DB00470,Dronabinol,DB01624,Zuclopenthixol,0.9952883720397949,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,16,Type_16,Yes
DB00783,Estradiol,DB04272,Citric acid,0.5909540057182312,12,Type_12,Estradiol may decrease the anticoagulant activities of Citric acid.,12,Type_12,Yes
DB00735,Naftifine,DB00929,Misoprostol,0.9930509328842163,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Naftifine.,70,Type_70,Yes
DB00346,Alfuzosin,DB01274,Arformoterol,0.8704692721366882,5,Type_5,Alfuzosin may decrease the vasoconstricting activities of Arformoterol.,5,Type_5,Yes
DB00422,Methylphenidate,DB00863,Ranitidine,0.8659196496009827,18,Type_18,Methylphenidate can cause an increase in the absorption of Ranitidine resulting in an increased serum concentration and potentially a worsening of adverse effects.,18,Type_18,Yes
DB00742,Mannitol,DB01580,Oxprenolol,0.6319975256919861,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Oxprenolol.,49,Type_49,Yes
DB04846,Celiprolol,DB09074,Olaparib,0.9774693846702576,47,Type_47,The metabolism of Olaparib can be decreased when combined with Celiprolol.,47,Type_47,Yes
DB04908,Flibanserin,DB06153,Pizotifen,0.9967793822288513,49,Type_49,The risk or severity of adverse effects can be increased when Flibanserin is combined with Pizotifen.,49,Type_49,Yes
DB04855,Dronedarone,DB06403,Ambrisentan,0.9029331207275391,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00462,Methscopolamine bromide,DB01081,Diphenoxylate,0.9999637603759766,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Diphenoxylate.,49,Type_49,Yes
DB01624,Zuclopenthixol,DB05246,Methsuximide,0.995074450969696,49,Type_49,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Methsuximide.,49,Type_49,Yes
DB00277,Theophylline,DB00788,Naproxen,0.9280708432197571,47,Type_47,The metabolism of Naproxen can be decreased when combined with Theophylline.,47,Type_47,Yes
DB01320,Fosphenytoin,DB06781,Difluprednate,0.9583777785301208,75,Type_75,The serum concentration of Difluprednate can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB01259,Lapatinib,DB06413,Armodafinil,0.8895984888076782,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Lapatinib.,47,Type_47,Yes
DB00540,Nortriptyline,DB00647,Dextropropoxyphene,0.8826045989990234,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00335,Atenolol,DB01001,Salbutamol,0.9289166927337646,14,Type_14,Atenolol may decrease the bronchodilatory activities of Salbutamol.,14,Type_14,Yes
DB00451,Levothyroxine,DB04575,Quinestrol,0.2985643744468689,67,Type_67,Levothyroxine can cause a decrease in the absorption of Quinestrol resulting in a reduced serum concentration and potentially a decrease in efficacy.,70,Type_70,No
DB00774,Hydroflumethiazide,DB01090,Pentolinium,0.9513843655586243,73,Type_73,The serum concentration of Pentolinium can be increased when it is combined with Hydroflumethiazide.,73,Type_73,Yes
DB00594,Amiloride,DB01002,Levobupivacaine,0.8201905488967896,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Levobupivacaine.,49,Type_49,Yes
DB00465,Ketorolac,DB01210,Levobunolol,0.999950647354126,37,Type_37,Ketorolac may decrease the antihypertensive activities of Levobunolol.,37,Type_37,Yes
DB00252,Phenytoin,DB01232,Saquinavir,0.5023171305656433,75,Type_75,The serum concentration of Saquinavir can be decreased when it is combined with Phenytoin.,4,Type_4,No
DB00499,Flutamide,DB01171,Moclobemide,0.9332637786865234,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Flutamide.,47,Type_47,Yes
DB00762,Irinotecan,DB06772,Cabazitaxel,0.9723424315452576,49,Type_49,The risk or severity of adverse effects can be increased when Irinotecan is combined with Cabazitaxel.,49,Type_49,Yes
DB00726,Trimipramine,DB00854,Levorphanol,0.9814245700836182,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Levorphanol.,49,Type_49,Yes
DB00191,Phentermine,DB09225,Zotepine,0.9995427131652832,61,Type_61,Phentermine may decrease the stimulatory activities of Zotepine.,61,Type_61,Yes
DB00708,Sufentanil,DB00964,Apraclonidine,0.9975141286849976,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Apraclonidine.,49,Type_49,Yes
DB00188,Bortezomib,DB01590,Everolimus,0.8923037052154541,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Bortezomib.,73,Type_73,Yes
DB00612,Bisoprolol,DB00714,Apomorphine,0.6888883709907532,25,Type_25,Bisoprolol may increase the atrioventricular blocking (AV block) activities of Apomorphine.,25,Type_25,Yes
DB00438,Ceftazidime,DB01418,Acenocoumarol,0.963866114616394,6,Type_6,Ceftazidime may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB00903,Etacrynic acid,DB13450,Cisatracurium besylate,0.9996408224105835,17,Type_17,Etacrynic acid may decrease the neuromuscular blocking activities of Cisatracurium besylate.,17,Type_17,Yes
DB01100,Pimozide,DB06480,Prucalopride,0.8023696541786194,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Pimozide.,73,Type_73,Yes
DB00246,Ziprasidone,DB01394,Colchicine,0.87661212682724,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Ziprasidone.,73,Type_73,Yes
DB00963,Bromfenac,DB08439,Parecoxib,0.9955590963363647,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Parecoxib.,49,Type_49,Yes
DB00614,Furazolidone,DB00998,Frovatriptan,0.6409922242164612,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Frovatriptan.,47,Type_47,No
DB00397,Phenylpropanolamine,DB00723,Methoxamine,0.9994018077850342,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Methoxamine.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB00675,Tamoxifen,0.5254700183868408,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Tamoxifen.,15,Type_15,No
DB00921,Buprenorphine,DB06800,Methylnaltrexone,0.795050323009491,49,Type_49,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Methylnaltrexone.,49,Type_49,Yes
DB00486,Nabilone,DB00737,Meclizine,0.9997696280479431,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Meclizine.,16,Type_16,Yes
DB01017,Minocycline,DB05528,Mipomersen,0.9953621029853821,80,Type_80,Minocycline may increase the hepatotoxic activities of Mipomersen.,80,Type_80,Yes
DB01359,Penbutolol,DB01407,Clenbuterol,0.9812695980072021,14,Type_14,Penbutolol may decrease the bronchodilatory activities of Clenbuterol.,14,Type_14,Yes
DB00647,Dextropropoxyphene,DB00768,Olopatadine,0.8017587661743164,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Olopatadine.,49,Type_49,Yes
DB00353,Methylergometrine,DB11574,Elbasvir,0.8892326354980469,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Elbasvir.,49,Type_49,Yes
DB00297,Bupivacaine,DB00472,Fluoxetine,0.5294817686080933,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB01221,Ketamine,DB06594,Agomelatine,0.9999775886535645,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Agomelatine.,49,Type_49,Yes
DB00612,Bisoprolol,DB06709,Methacholine,0.9999829530715942,46,Type_46,Bisoprolol may increase the bronchoconstrictory activities of Methacholine.,46,Type_46,Yes
DB00363,Clozapine,DB08865,Crizotinib,0.5792611241340637,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Clozapine.,20,Type_20,No
DB00960,Pindolol,DB01401,Choline magnesium trisalicylate,0.972328782081604,37,Type_37,Pindolol may decrease the antihypertensive activities of Choline magnesium trisalicylate.,37,Type_37,Yes
DB00461,Nabumetone,DB00635,Prednisone,0.9986588954925537,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Prednisone.,49,Type_49,Yes
DB00612,Bisoprolol,DB01087,Primaquine,0.654659628868103,47,Type_47,The metabolism of Primaquine can be decreased when combined with Bisoprolol.,47,Type_47,Yes
DB00312,Pentobarbital,DB01006,Letrozole,0.8111312985420227,4,Type_4,The metabolism of Letrozole can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01023,Felodipine,DB01320,Fosphenytoin,0.6668877601623535,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Felodipine.,73,Type_73,No
DB00636,Clofibrate,DB00705,Delavirdine,0.959648847579956,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Clofibrate.,47,Type_47,Yes
DB00655,Estrone,DB00768,Olopatadine,0.7329517602920532,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Olopatadine.,49,Type_49,Yes
DB00285,Venlafaxine,DB01076,Atorvastatin,0.44598695635795593,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin.,49,Type_49,Yes
DB00283,Clemastine,DB06267,Udenafil,0.9266727566719055,47,Type_47,The metabolism of Udenafil can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00279,Liothyronine,DB06695,Dabigatran etexilate,0.44805195927619934,6,Type_6,Liothyronine may increase the anticoagulant activities of Dabigatran etexilate.,75,Type_75,No
DB00215,Citalopram,DB00477,Chlorpromazine,0.5399143099784851,20,Type_20,Citalopram may increase the QTc-prolonging activities of Chlorpromazine.,47,Type_47,No
DB00208,Ticlopidine,DB00936,Salicylic acid,0.9466322064399719,47,Type_47,The metabolism of Salicylic acid can be decreased when combined with Ticlopidine.,49,Type_49,No
DB00252,Phenytoin,DB08918,Levomilnacipran,0.8481396436691284,4,Type_4,The metabolism of Levomilnacipran can be increased when combined with Phenytoin.,4,Type_4,Yes
DB08931,Riociguat,DB13595,Almasilate,0.697409451007843,75,Type_75,The serum concentration of Almasilate can be decreased when it is combined with Riociguat.,75,Type_75,Yes
DB00691,Moexipril,DB01240,Epoprostenol,0.9405967593193054,60,Type_60,Moexipril may increase the hypotensive activities of Epoprostenol.,60,Type_60,Yes
DB00743,Gadobenic acid,DB01087,Primaquine,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Primaquine.,20,Type_20,Yes
DB06288,Amisulpride,DB06716,Fospropofol,0.9999896287918091,49,Type_49,The risk or severity of adverse effects can be increased when Amisulpride is combined with Fospropofol.,49,Type_49,Yes
DB01186,Pergolide,DB13874,Enasidenib,0.6457405090332031,49,Type_49,The risk or severity of adverse effects can be increased when Pergolide is combined with Enasidenib.,49,Type_49,Yes
DB00321,Amitriptyline,DB00715,Paroxetine,0.4662042558193207,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Paroxetine.,49,Type_49,Yes
DB01161,Chloroprocaine,DB04896,Milnacipran,0.9981666803359985,49,Type_49,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Milnacipran.,49,Type_49,Yes
DB00440,Trimethoprim,DB01041,Thalidomide,0.9458519816398621,47,Type_47,The metabolism of Thalidomide can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB01235,Levodopa,DB04842,Fluspirilene,0.9985201954841614,49,Type_49,The risk or severity of adverse effects can be increased when Levodopa is combined with Fluspirilene.,49,Type_49,Yes
DB00972,Azelastine,DB00996,Gabapentin,0.9848766326904297,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,16,Type_16,Yes
DB00289,Atomoxetine,DB00678,Losartan,0.9832838773727417,47,Type_47,The metabolism of Losartan can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB00344,Protriptyline,0.4903213679790497,47,Type_47,The metabolism of Protriptyline can be decreased when combined with Sulfisoxazole.,20,Type_20,No
DB00860,Prednisolone,DB00991,Oxaprozin,0.9977796673774719,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Oxaprozin.,49,Type_49,Yes
DB00343,Diltiazem,DB00481,Raloxifene,0.8320342898368835,47,Type_47,The metabolism of Raloxifene can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00612,Bisoprolol,DB01012,Cinacalcet,0.8840318918228149,47,Type_47,The metabolism of Cinacalcet can be decreased when combined with Bisoprolol.,47,Type_47,Yes
DB00564,Carbamazepine,DB00946,Phenprocoumon,0.9418173432350159,4,Type_4,The metabolism of Phenprocoumon can be increased when combined with Carbamazepine.,75,Type_75,No
DB01167,Itraconazole,DB01220,Rifaximin,0.9249916672706604,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00413,Pramipexole,DB00436,Bendroflumethiazide,0.9975284934043884,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Bendroflumethiazide.,49,Type_49,Yes
DB00678,Losartan,DB01141,Micafungin,0.601753294467926,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Micafungin.,47,Type_47,No
DB00252,Phenytoin,DB12001,Abemaciclib,0.5550774335861206,75,Type_75,The serum concentration of Abemaciclib can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00653,Magnesium sulfate,DB08918,Levomilnacipran,0.9631057977676392,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Levomilnacipran.,49,Type_49,Yes
DB00175,Pravastatin,DB00678,Losartan,0.44079530239105225,47,Type_47,The metabolism of Losartan can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB00998,Frovatriptan,DB01142,Doxepin,0.9570488929748535,49,Type_49,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Doxepin.,49,Type_49,Yes
DB08906,Fluticasone furoate,DB08912,Dabrafenib,0.9065893888473511,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Fluticasone furoate.,75,Type_75,Yes
DB00363,Clozapine,DB01235,Levodopa,0.606622040271759,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Levodopa.,30,Type_30,No
DB00502,Haloperidol,DB00678,Losartan,0.9125298857688904,47,Type_47,The metabolism of Losartan can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00346,Alfuzosin,DB12598,Nafamostat,0.5350898504257202,47,Type_47,The metabolism of Nafamostat can be decreased when combined with Alfuzosin.,73,Type_73,No
DB00844,Nalbuphine,DB00903,Etacrynic acid,0.9991580247879028,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etacrynic acid.,49,Type_49,Yes
DB00305,Mitomycin,DB01097,Leflunomide,0.836226761341095,49,Type_49,The risk or severity of adverse effects can be increased when Mitomycin is combined with Leflunomide.,49,Type_49,Yes
DB05676,Apremilast,DB08964,Gemeprost,1.0,70,Type_70,The therapeutic efficacy of Gemeprost can be decreased when used in combination with Apremilast.,70,Type_70,Yes
DB00747,Scopolamine,DB01236,Sevoflurane,0.9988501071929932,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Sevoflurane.,49,Type_49,Yes
DB00765,Metyrosine,DB01351,Amobarbital,0.9999971389770508,32,Type_32,Metyrosine may increase the sedative activities of Amobarbital.,32,Type_32,Yes
DB00972,Azelastine,DB06209,Prasugrel,0.7560548186302185,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Azelastine.,6,Type_6,No
DB06810,Plicamycin,DB08991,Epirizole,0.9999908208847046,72,Type_72,Plicamycin may decrease the excretion rate of Epirizole which could result in a higher serum level.,72,Type_72,Yes
DB00571,Propranolol,DB01283,Lumiracoxib,0.9838594198226929,37,Type_37,Propranolol may decrease the antihypertensive activities of Lumiracoxib.,37,Type_37,Yes
DB00189,Ethchlorvynol,DB01018,Guanfacine,0.9770359396934509,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Guanfacine.,49,Type_49,Yes
DB01223,Aminophylline,DB06228,Rivaroxaban,0.543947160243988,75,Type_75,The serum concentration of Rivaroxaban can be decreased when it is combined with Aminophylline.,75,Type_75,Yes
DB01609,Deferasirox,DB04908,Flibanserin,0.980655312538147,75,Type_75,The serum concentration of Flibanserin can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB04868,Nilotinib,DB11613,Velpatasvir,0.9561723470687866,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB01438,Phenazopyridine,DB09112,Nitrous acid,1.0,49,Type_49,The risk or severity of adverse effects can be increased when Phenazopyridine is combined with Nitrous acid.,49,Type_49,Yes
DB00323,Tolcapone,DB00366,Doxylamine,0.9995356798171997,16,Type_16,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.,16,Type_16,Yes
DB01189,Desflurane,DB06282,Levocetirizine,0.9888845682144165,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Levocetirizine.,49,Type_49,Yes
DB00771,Clidinium,DB01563,Chloral hydrate,0.9999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Chloral hydrate.,49,Type_49,Yes
DB00457,Prazosin,DB11362,Selexipag,0.999677300453186,60,Type_60,Prazosin may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00608,Chloroquine,DB01325,Quinethazone,0.9848355054855347,70,Type_70,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Chloroquine.,70,Type_70,Yes
DB00434,Cyproheptadine,DB13323,Trichloroethylene,0.9998714923858643,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Trichloroethylene.,49,Type_49,Yes
DB00932,Tipranavir,DB01118,Amiodarone,0.633284330368042,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Tipranavir.,73,Type_73,No
DB00717,Norethisterone,DB08881,Vemurafenib,0.6205019354820251,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Norethisterone.,75,Type_75,Yes
DB00467,Enoxacin,DB01380,Cortisone acetate,0.9218903183937073,49,Type_49,The risk or severity of adverse effects can be increased when Enoxacin is combined with Cortisone acetate.,49,Type_49,Yes
DB00390,Digoxin,DB08912,Dabrafenib,0.5863378643989563,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Digoxin.,75,Type_75,Yes
DB08808,Bupranolol,DB09026,Aliskiren,0.5583535432815552,60,Type_60,Bupranolol may increase the hypotensive activities of Aliskiren.,60,Type_60,Yes
DB00692,Phentolamine,DB00805,Minaprine,0.9737634658813477,60,Type_60,Phentolamine may increase the hypotensive activities of Minaprine.,60,Type_60,Yes
DB00321,Amitriptyline,DB09080,Olodaterol,0.6585314273834229,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Olodaterol.,49,Type_49,Yes
DB00169,Cholecalciferol,DB03756,Doconexent,0.9271928071975708,47,Type_47,The metabolism of Doconexent can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00413,Pramipexole,DB00722,Lisinopril,0.947100043296814,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Lisinopril.,49,Type_49,Yes
DB00268,Ropinirole,DB01589,Quazepam,0.9781846404075623,32,Type_32,Ropinirole may increase the sedative activities of Quazepam.,32,Type_32,Yes
DB01036,Tolterodine,DB01149,Nefazodone,0.6566699147224426,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Tolterodine.,73,Type_73,No
DB05812,Abiraterone,DB09071,Tasimelteon,0.9776278138160706,73,Type_73,The serum concentration of Tasimelteon can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00708,Sufentanil,DB06791,Lanreotide,0.9867280125617981,54,Type_54,Sufentanil may increase the bradycardic activities of Lanreotide.,54,Type_54,Yes
DB00588,Fluticasone propionate,DB00593,Ethosuximide,0.9940274953842163,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ethosuximide.,49,Type_49,Yes
DB00264,Metoprolol,DB00353,Methylergometrine,0.7945852279663086,19,Type_19,Metoprolol may increase the vasoconstricting activities of Methylergometrine.,19,Type_19,Yes
DB00227,Lovastatin,DB08992,Eperisone,0.6029422879219055,47,Type_47,The metabolism of Eperisone can be decreased when combined with Lovastatin.,49,Type_49,No
DB00325,Nitroprusside,DB09279,Fimasartan,0.9996881484985352,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Fimasartan.,49,Type_49,Yes
DB01244,Bepridil,DB06820,Sulconazole,0.9026850461959839,49,Type_49,The risk or severity of adverse effects can be increased when Bepridil is combined with Sulconazole.,49,Type_49,Yes
DB00696,Ergotamine,DB01364,Ephedrine,0.9948881268501282,71,Type_71,Ergotamine may increase the hypertensive activities of Ephedrine.,71,Type_71,Yes
DB01100,Pimozide,DB01165,Ofloxacin,0.9985114932060242,20,Type_20,Pimozide may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00344,Protriptyline,DB01211,Clarithromycin,0.5791979432106018,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Protriptyline.,20,Type_20,No
DB00557,Hydroxyzine,DB00921,Buprenorphine,0.9999979734420776,16,Type_16,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB00867,Ritodrine,DB01288,Fenoterol,0.9999914169311523,49,Type_49,The risk or severity of adverse effects can be increased when Ritodrine is combined with Fenoterol.,49,Type_49,Yes
DB00849,Methylphenobarbital,DB09017,Brotizolam,0.9232081174850464,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Brotizolam.,49,Type_49,Yes
DB00872,Conivaptan,DB01192,Oxymorphone,0.5557312965393066,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Oxymorphone.,73,Type_73,No
DB00949,Felbamate,DB01452,Diamorphine,0.9932023882865906,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Diamorphine.,49,Type_49,Yes
DB00196,Fluconazole,DB00240,Alclometasone,0.9694592952728271,47,Type_47,The metabolism of Alclometasone can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00571,Propranolol,DB00706,Tamsulosin,0.5333865284919739,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Tamsulosin.,30,Type_30,No
DB00469,Tenoxicam,DB00798,Gentamicin,0.9999077320098877,72,Type_72,Tenoxicam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,72,Type_72,Yes
DB00230,Pregabalin,DB09009,Articaine,0.5925016403198242,8,Type_8,The therapeutic efficacy of Articaine can be increased when used in combination with Pregabalin.,8,Type_8,Yes
DB01580,Oxprenolol,DB01588,Prazepam,0.4335366487503052,73,Type_73,The serum concentration of Prazepam can be increased when it is combined with Oxprenolol.,49,Type_49,No
DB01238,Aripiprazole,DB06153,Pizotifen,0.9556313157081604,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pizotifen.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01075,Diphenhydramine,0.9136680364608765,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00178,Ramipril,DB00734,Risperidone,0.7776577472686768,60,Type_60,Ramipril may increase the hypotensive activities of Risperidone.,60,Type_60,Yes
DB00310,Chlorthalidone,DB13158,Clobetasone,0.9999270439147949,83,Type_83,Chlorthalidone may increase the hypokalemic activities of Clobetasone.,83,Type_83,Yes
DB00909,Zonisamide,DB04896,Milnacipran,0.991936206817627,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Milnacipran.,49,Type_49,Yes
DB00321,Amitriptyline,DB09198,Lobeglitazone,0.995406985282898,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB00349,Clobazam,0.9754356145858765,47,Type_47,The metabolism of Clobazam can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00390,Digoxin,DB00460,Verteporfin,0.9925907850265503,58,Type_58,Digoxin may decrease the cardiotoxic activities of Verteporfin.,58,Type_58,Yes
DB00320,Dihydroergotamine,DB00598,Labetalol,0.8275645971298218,25,Type_25,Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.,25,Type_25,Yes
DB01288,Fenoterol,DB09245,Toloxatone,0.9823346138000488,49,Type_49,The risk or severity of adverse effects can be increased when Fenoterol is combined with Toloxatone.,49,Type_49,Yes
DB00909,Zonisamide,DB01595,Nitrazepam,0.9963717460632324,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Nitrazepam.,49,Type_49,Yes
DB00549,Zafirlukast,DB01076,Atorvastatin,0.4667145609855652,47,Type_47,The metabolism of Atorvastatin can be decreased when combined with Zafirlukast.,49,Type_49,No
DB01319,Fosamprenavir,DB01435,Antipyrine,0.8799207806587219,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00297,Bupivacaine,DB00477,Chlorpromazine,0.3556719422340393,4,Type_4,The metabolism of Chlorpromazine can be increased when combined with Bupivacaine.,47,Type_47,No
DB00203,Sildenafil,DB08820,Ivacaftor,0.99907386302948,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Sildenafil.,73,Type_73,Yes
DB01081,Diphenoxylate,DB01466,Ethylmorphine,0.9957885146141052,49,Type_49,The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Ethylmorphine.,49,Type_49,Yes
DB01097,Leflunomide,DB01356,Lithium cation,0.6401507258415222,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Leflunomide.,73,Type_73,Yes
DB00543,Amoxapine,DB06695,Dabigatran etexilate,0.7680631279945374,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Amoxapine.,73,Type_73,No
DB00424,Hyoscyamine,DB00899,Remifentanil,0.9999377727508545,49,Type_49,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Remifentanil.,49,Type_49,Yes
DB00673,Aprepitant,DB01118,Amiodarone,0.8962748050689697,73,Type_73,The serum concentration of Amiodarone can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00428,Streptozocin,DB00997,Doxorubicin,0.9951332211494446,24,Type_24,Streptozocin may increase the hypocalcemic activities of Doxorubicin.,75,Type_75,No
DB00255,Diethylstilbestrol,DB01024,Mycophenolic acid,0.7649707198143005,75,Type_75,The serum concentration of Mycophenolic acid can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB01251,Gliquidone,DB04839,Cyproterone acetate,0.922099232673645,70,Type_70,The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB00275,Olmesartan,DB00999,Hydrochlorothiazide,0.773120105266571,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00238,Nevirapine,DB00553,Methoxsalen,0.8557632565498352,4,Type_4,The metabolism of Methoxsalen can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00270,Isradipine,DB01197,Captopril,0.710955798625946,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Captopril.,49,Type_49,Yes
DB00470,Dronabinol,DB00575,Clonidine,0.9835952520370483,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Clonidine.,16,Type_16,Yes
DB00604,Cisapride,DB01238,Aripiprazole,0.7408871054649353,20,Type_20,Cisapride may increase the QTc-prolonging activities of Aripiprazole.,20,Type_20,Yes
DB00814,Meloxicam,DB01032,Probenecid,0.8661377429962158,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Meloxicam.,73,Type_73,Yes
DB00544,Fluorouracil,DB00850,Perphenazine,0.8754259347915649,47,Type_47,The metabolism of Perphenazine can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00950,Fexofenadine,DB01501,Difenoxin,0.9999960660934448,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Difenoxin.,49,Type_49,Yes
DB09084,Benzydamine,DB13783,Acemetacin,0.954416811466217,49,Type_49,The risk or severity of adverse effects can be increased when Benzydamine is combined with Acemetacin.,49,Type_49,Yes
DB00622,Nicardipine,DB01283,Lumiracoxib,0.9205825924873352,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB06708,Lumefantrine,0.6570461392402649,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00675,Tamoxifen,DB00758,Clopidogrel,0.5459008812904358,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Tamoxifen.,47,Type_47,Yes
DB01017,Minocycline,DB11304,Phenoxyethanol,0.7362154126167297,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Phenoxyethanol.,16,Type_16,Yes
DB00526,Oxaliplatin,DB01030,Topotecan,0.8133692145347595,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Oxaliplatin.,49,Type_49,No
DB05521,Telaprevir,DB11730,Ribociclib,0.9323951601982117,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Telaprevir.,73,Type_73,Yes
DB00252,Phenytoin,DB01264,Darunavir,0.4240761399269104,75,Type_75,The serum concentration of Darunavir can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00467,Enoxacin,DB08976,Floctafenine,0.9989644289016724,27,Type_27,Enoxacin may increase the neuroexcitatory activities of Floctafenine.,27,Type_27,Yes
DB00503,Ritonavir,DB01628,Etoricoxib,0.9584795236587524,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00278,Argatroban,DB04865,Omacetaxine mepesuccinate,0.9809173345565796,66,Type_66,The risk or severity of bleeding can be increased when Argatroban is combined with Omacetaxine mepesuccinate.,66,Type_66,Yes
DB00857,Terbinafine,DB06413,Armodafinil,0.9469144344329834,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Terbinafine.,47,Type_47,Yes
DB00210,Adapalene,DB00563,Methotrexate,0.5042705535888672,73,Type_73,The serum concentration of Methotrexate can be increased when it is combined with Adapalene.,73,Type_73,Yes
DB00875,Flupentixol,DB01211,Clarithromycin,0.37456393241882324,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB08883,Perampanel,DB08918,Levomilnacipran,0.7957727909088135,49,Type_49,The risk or severity of adverse effects can be increased when Perampanel is combined with Levomilnacipran.,49,Type_49,Yes
DB01078,Deslanoside,DB01169,Arsenic trioxide,0.9695605635643005,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Arsenic trioxide.,58,Type_58,Yes
DB00571,Propranolol,DB00788,Naproxen,0.9916402101516724,37,Type_37,Propranolol may decrease the antihypertensive activities of Naproxen.,37,Type_37,Yes
DB00918,Almotriptan,DB06413,Armodafinil,0.9250832796096802,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Almotriptan.,47,Type_47,Yes
DB00420,Promazine,DB00637,Astemizole,0.4920383393764496,20,Type_20,Promazine may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB00613,Amodiaquine,DB01394,Colchicine,0.9499086141586304,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Amodiaquine.,73,Type_73,Yes
DB00402,Eszopiclone,DB01045,Rifampicin,0.9176675081253052,4,Type_4,The metabolism of Rifampicin can be increased when combined with Eszopiclone.,4,Type_4,Yes
DB01177,Idarubicin,DB05219,Crisaborole,0.996817946434021,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Idarubicin.,47,Type_47,Yes
DB00486,Nabilone,DB00598,Labetalol,0.994874894618988,49,Type_49,The risk or severity of adverse effects can be increased when Nabilone is combined with Labetalol.,85,Type_85,No
DB00472,Fluoxetine,DB04896,Milnacipran,0.5997191071510315,64,Type_64,Fluoxetine may increase the serotonergic activities of Milnacipran.,49,Type_49,No
DB00818,Propofol,DB08873,Boceprevir,0.6887534260749817,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Propofol.,47,Type_47,Yes
DB04896,Milnacipran,DB11148,Butamben,0.9997392296791077,49,Type_49,The risk or severity of adverse effects can be increased when Milnacipran is combined with Butamben.,49,Type_49,Yes
DB00208,Ticlopidine,DB00762,Irinotecan,0.7289609909057617,47,Type_47,The metabolism of Irinotecan can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00742,Mannitol,DB09236,Lacidipine,0.5355643630027771,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Lacidipine.,49,Type_49,Yes
DB01012,Cinacalcet,DB01201,Rifapentine,0.8648416996002197,4,Type_4,The metabolism of Rifapentine can be increased when combined with Cinacalcet.,4,Type_4,Yes
DB00543,Amoxapine,DB00748,Carbinoxamine,0.921512246131897,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Carbinoxamine.,49,Type_49,Yes
DB01240,Epoprostenol,DB05219,Crisaborole,0.999235987663269,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Epoprostenol.,47,Type_47,Yes
DB00567,Cephalexin,DB00908,Quinidine,0.9356339573860168,47,Type_47,The metabolism of Quinidine can be decreased when combined with Cephalexin.,47,Type_47,Yes
DB01014,Balsalazide,DB02187,Equilin,0.9989916682243347,49,Type_49,The risk or severity of adverse effects can be increased when Balsalazide is combined with Equilin.,49,Type_49,Yes
DB04841,Flunarizine,DB11148,Butamben,0.9994931221008301,49,Type_49,The risk or severity of adverse effects can be increased when Flunarizine is combined with Butamben.,49,Type_49,Yes
DB00565,Cisatracurium,DB01627,Lincomycin,0.9999998807907104,21,Type_21,Cisatracurium may increase the neuromuscular blocking activities of Lincomycin.,21,Type_21,Yes
DB01192,Oxymorphone,DB01466,Ethylmorphine,0.9807527661323547,49,Type_49,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ethylmorphine.,49,Type_49,Yes
DB00337,Pimecrolimus,DB06736,Aceclofenac,0.9974405765533447,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aceclofenac.,49,Type_49,Yes
DB09067,Corticorelin ovine triflutate,DB09091,Tixocortol,0.9999935626983643,70,Type_70,The therapeutic efficacy of Tixocortol can be decreased when used in combination with Corticorelin ovine triflutate.,70,Type_70,Yes
DB00805,Minaprine,DB01119,Diazoxide,0.9857618808746338,60,Type_60,Minaprine may increase the hypotensive activities of Diazoxide.,60,Type_60,Yes
DB00796,Candesartan cilexetil,DB06589,Pazopanib,0.8833820819854736,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Candesartan cilexetil.,73,Type_73,Yes
DB00245,Benzatropine,DB00937,Diethylpropion,0.9957826137542725,76,Type_76,Benzatropine may decrease the sedative activities of Diethylpropion.,76,Type_76,Yes
DB00489,Sotalol,DB01211,Clarithromycin,0.348854660987854,20,Type_20,Sotalol may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00849,Methylphenobarbital,DB06144,Sertindole,0.9230536222457886,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Sertindole.,49,Type_49,Yes
DB00807,Proparacaine,DB09068,Vortioxetine,0.9998883008956909,49,Type_49,The risk or severity of adverse effects can be increased when Proparacaine is combined with Vortioxetine.,49,Type_49,Yes
DB01320,Fosphenytoin,DB08899,Enzalutamide,0.9474983215332031,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB01142,Doxepin,DB09073,Palbociclib,0.9938568472862244,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB01422,Nitroxoline,DB09230,Azelnidipine,0.9996598958969116,49,Type_49,The risk or severity of adverse effects can be increased when Nitroxoline is combined with Azelnidipine.,49,Type_49,Yes
DB00862,Vardenafil,DB01214,Metipranolol,0.8726797699928284,10,Type_10,Vardenafil may increase the antihypertensive activities of Metipranolol.,10,Type_10,Yes
DB01157,Trimetrexate,DB01229,Paclitaxel,0.5238833427429199,49,Type_49,The risk or severity of adverse effects can be increased when Trimetrexate is combined with Paclitaxel.,49,Type_49,Yes
DB00285,Venlafaxine,DB00696,Ergotamine,0.6941070556640625,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ergotamine.,49,Type_49,Yes
DB00327,Hydromorphone,DB01685,Topiroxostat,0.9953582882881165,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Hydromorphone.,47,Type_47,Yes
DB00490,Buspirone,DB01153,Sertaconazole,0.6646497845649719,47,Type_47,The metabolism of Sertaconazole can be decreased when combined with Buspirone.,47,Type_47,Yes
DB00283,Clemastine,DB01222,Budesonide,0.7453963160514832,47,Type_47,The metabolism of Budesonide can be decreased when combined with Clemastine.,73,Type_73,No
DB00298,Dapiprazole,DB08987,Etidocaine,0.9999771118164062,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Etidocaine.,49,Type_49,Yes
DB00323,Tolcapone,DB00455,Loratadine,0.9983739852905273,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Loratadine.,49,Type_49,Yes
DB00753,Isoflurane,DB08822,Azilsartan medoxomil,0.9924039244651794,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00297,Bupivacaine,DB01104,Sertraline,0.5796183347702026,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Sertraline.,47,Type_47,No
DB00501,Cimetidine,DB01365,Mephentermine,0.98569655418396,76,Type_76,Cimetidine may decrease the sedative activities of Mephentermine.,76,Type_76,Yes
DB00278,Argatroban,DB09073,Palbociclib,0.8211497664451599,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB00692,Phentolamine,DB01200,Bromocriptine,0.9970651268959045,49,Type_49,The risk or severity of adverse effects can be increased when Phentolamine is combined with Bromocriptine.,49,Type_49,Yes
DB05271,Rotigotine,DB09198,Lobeglitazone,0.9985606074333191,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Rotigotine.,47,Type_47,Yes
DB00543,Amoxapine,DB06697,Artemether,0.455567866563797,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Artemether.,20,Type_20,Yes
DB01167,Itraconazole,DB09232,Cilnidipine,0.7638709545135498,49,Type_49,The risk or severity of adverse effects can be increased when Itraconazole is combined with Cilnidipine.,49,Type_49,Yes
DB00264,Metoprolol,DB09038,Empagliflozin,0.9412424564361572,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Empagliflozin.,49,Type_49,Yes
DB00699,Nicergoline,DB00813,Fentanyl,0.9959419369697571,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Fentanyl.,49,Type_49,Yes
DB00472,Fluoxetine,DB00531,Cyclophosphamide,0.4608791470527649,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB01275,Hydralazine,DB09216,Tolfenamic acid,0.45335444808006287,37,Type_37,Hydralazine may decrease the antihypertensive activities of Tolfenamic acid.,37,Type_37,Yes
DB01224,Quetiapine,DB01544,Flunitrazepam,0.9424907565116882,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Flunitrazepam.,49,Type_49,Yes
DB09288,Propacetamol,DB11921,Deflazacort,0.9996223449707031,49,Type_49,The risk or severity of adverse effects can be increased when Propacetamol is combined with Deflazacort.,49,Type_49,Yes
DB00404,Alprazolam,DB06770,Benzyl alcohol,0.9951850771903992,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Benzyl alcohol.,49,Type_49,Yes
DB00808,Indapamide,DB01708,Prasterone,0.9978848099708557,83,Type_83,Indapamide may increase the hypokalemic activities of Prasterone.,83,Type_83,Yes
DB01118,Amiodarone,DB09063,Ceritinib,0.9637438654899597,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Amiodarone.,73,Type_73,Yes
DB00876,Eprosartan,DB01136,Carvedilol,0.8459945917129517,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Carvedilol.,49,Type_49,Yes
DB00214,Torasemide,DB00661,Verapamil,0.9070080518722534,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Verapamil.,49,Type_49,Yes
DB00423,Methocarbamol,DB01159,Halothane,0.994206428527832,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Halothane.,49,Type_49,Yes
DB00203,Sildenafil,DB00247,Methysergide,0.9926208257675171,49,Type_49,The risk or severity of adverse effects can be increased when Sildenafil is combined with Methysergide.,49,Type_49,Yes
DB00696,Ergotamine,DB00953,Rizatriptan,0.7521597146987915,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Rizatriptan.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00370,Mirtazapine,0.704731285572052,37,Type_37,Dihydroergotamine may decrease the antihypertensive activities of Mirtazapine.,37,Type_37,Yes
DB01621,Pipotiazine,DB05271,Rotigotine,0.996802806854248,32,Type_32,Pipotiazine may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00623,Fluphenazine,DB00907,Cocaine,0.6312095522880554,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cocaine.,47,Type_47,No
DB00899,Remifentanil,DB01235,Levodopa,0.996839165687561,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Levodopa.,30,Type_30,No
DB00435,Nitric Oxide,DB00750,Prilocaine,0.6838306784629822,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Prilocaine.,49,Type_49,Yes
DB00455,Loratadine,DB00622,Nicardipine,0.9166303873062134,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Loratadine.,47,Type_47,Yes
DB00695,Furosemide,DB00802,Alfentanil,0.998176097869873,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Alfentanil.,49,Type_49,Yes
DB00672,Chlorpropamide,DB09543,Methyl salicylate,0.9953666925430298,9,Type_9,Chlorpropamide may increase the hypoglycemic activities of Methyl salicylate.,9,Type_9,Yes
DB00835,Brompheniramine,DB01263,Posaconazole,0.8958911895751953,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Brompheniramine.,47,Type_47,Yes
DB01059,Norfloxacin,DB13167,Alclofenac,0.9963619112968445,27,Type_27,Norfloxacin may increase the neuroexcitatory activities of Alclofenac.,27,Type_27,Yes
DB00663,Flumethasone,DB01024,Mycophenolic acid,0.978536069393158,49,Type_49,The risk or severity of adverse effects can be increased when Flumethasone is combined with Mycophenolic acid.,49,Type_49,Yes
DB01026,Ketoconazole,DB01418,Acenocoumarol,0.5418744683265686,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB01149,Nefazodone,DB06144,Sertindole,0.5545738935470581,47,Type_47,The metabolism of Sertindole can be decreased when combined with Nefazodone.,47,Type_47,Yes
DB00700,Eplerenone,DB01348,Spirapril,0.4469310939311981,68,Type_68,Eplerenone may increase the hyperkalemic activities of Spirapril.,68,Type_68,Yes
DB00333,Methadone,DB01435,Antipyrine,0.973753035068512,47,Type_47,The metabolism of Antipyrine can be decreased when combined with Methadone.,47,Type_47,Yes
DB00335,Atenolol,DB01628,Etoricoxib,0.9658789038658142,37,Type_37,Atenolol may decrease the antihypertensive activities of Etoricoxib.,37,Type_37,Yes
DB00754,Ethotoin,DB01580,Oxprenolol,0.7923446297645569,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Oxprenolol.,49,Type_49,Yes
DB00622,Nicardipine,DB00714,Apomorphine,0.9405250549316406,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Apomorphine.,49,Type_49,Yes
DB00318,Codeine,DB00933,Mesoridazine,0.9876058101654053,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Mesoridazine.,49,Type_49,Yes
DB00559,Bosentan,DB01159,Halothane,0.5153425335884094,4,Type_4,The metabolism of Halothane can be increased when combined with Bosentan.,75,Type_75,No
DB00637,Astemizole,DB01232,Saquinavir,0.44293248653411865,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Astemizole.,73,Type_73,No
DB00215,Citalopram,DB00333,Methadone,0.5256944298744202,47,Type_47,The metabolism of Methadone can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00181,Baclofen,DB00323,Tolcapone,0.9938732385635376,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Tolcapone.,49,Type_49,Yes
DB00482,Celecoxib,DB09054,Idelalisib,0.9674697518348694,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00393,Nimodipine,DB00706,Tamsulosin,0.8491417765617371,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Tamsulosin.,60,Type_60,No
DB00865,Benzphetamine,DB06288,Amisulpride,0.9999576807022095,61,Type_61,Benzphetamine may decrease the stimulatory activities of Amisulpride.,61,Type_61,Yes
DB00615,Rifabutin,DB08931,Riociguat,0.602750301361084,4,Type_4,The metabolism of Riociguat can be increased when combined with Rifabutin.,4,Type_4,Yes
DB01591,Solifenacin,DB06148,Mianserin,0.8854175806045532,2,Type_2,Solifenacin may increase the anticholinergic activities of Mianserin.,2,Type_2,Yes
DB00555,Lamotrigine,DB11348,Calcium Phosphate,0.9192318320274353,70,Type_70,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lamotrigine.,70,Type_70,Yes
DB00293,Raltitrexed,DB01229,Paclitaxel,0.9744707942008972,49,Type_49,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Paclitaxel.,49,Type_49,Yes
DB00554,Piroxicam,DB00687,Fludrocortisone,0.9999456405639648,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Fludrocortisone.,49,Type_49,Yes
DB00361,Vinorelbine,DB00679,Thioridazine,0.44359904527664185,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB00440,Trimethoprim,DB05219,Crisaborole,0.9951462149620056,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00270,Isradipine,DB00436,Bendroflumethiazide,0.9612478613853455,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Bendroflumethiazide.,49,Type_49,Yes
DB00283,Clemastine,DB09083,Ivabradine,0.4305001199245453,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Clemastine.,73,Type_73,Yes
DB00203,Sildenafil,DB00966,Telmisartan,0.5782111883163452,10,Type_10,Sildenafil may increase the antihypertensive activities of Telmisartan.,10,Type_10,Yes
DB04876,Vildagliptin,DB09063,Ceritinib,0.5753882527351379,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Vildagliptin.,70,Type_70,No
DB00765,Metyrosine,DB00818,Propofol,0.9998912811279297,32,Type_32,Metyrosine may increase the sedative activities of Propofol.,32,Type_32,Yes
DB00508,Triflupromazine,DB00780,Phenelzine,0.6210440397262573,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Phenelzine.,49,Type_49,Yes
DB00738,Pentamidine,DB08868,Fingolimod,0.5411652326583862,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Fingolimod.,20,Type_20,Yes
DB00732,Atracurium besylate,DB09093,Chlortetracycline,0.9999997615814209,21,Type_21,Atracurium besylate may increase the neuromuscular blocking activities of Chlortetracycline.,21,Type_21,Yes
DB00246,Ziprasidone,DB00915,Amantadine,0.40746939182281494,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Amantadine.,20,Type_20,Yes
DB00492,Fosinopril,DB01253,Ergometrine,0.562084436416626,73,Type_73,The serum concentration of Ergometrine can be increased when it is combined with Fosinopril.,73,Type_73,Yes
DB00189,Ethchlorvynol,DB01086,Benzocaine,0.9999923706054688,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Benzocaine.,49,Type_49,Yes
DB00813,Fentanyl,DB01236,Sevoflurane,0.9236785173416138,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Sevoflurane.,49,Type_49,Yes
DB00748,Carbinoxamine,DB01567,Fludiazepam,0.9998530149459839,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Fludiazepam.,49,Type_49,Yes
DB09166,Etizolam,DB13872,Lormetazepam,0.9997802376747131,49,Type_49,The risk or severity of adverse effects can be increased when Etizolam is combined with Lormetazepam.,49,Type_49,Yes
DB01137,Levofloxacin,DB13167,Alclofenac,0.98216313123703,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Alclofenac.,27,Type_27,Yes
DB00359,Sulfadiazine,DB00715,Paroxetine,0.8161828517913818,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Sulfadiazine.,9,Type_9,No
DB00758,Clopidogrel,DB04898,Ximelagatran,0.9225298166275024,6,Type_6,Clopidogrel may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00472,Fluoxetine,DB09224,Melperone,0.929387092590332,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Melperone.,49,Type_49,Yes
DB00448,Lansoprazole,DB06290,Simeprevir,0.9273301362991333,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Lansoprazole.,73,Type_73,Yes
DB02703,Fusidic acid,DB12026,Voxilaprevir,0.9880244135856628,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB01227,Levacetylmethadol,DB09071,Tasimelteon,0.9790696501731873,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Tasimelteon.,49,Type_49,Yes
DB00399,Zoledronic acid,DB09104,Magnesium hydroxide,0.910933792591095,75,Type_75,The serum concentration of Magnesium hydroxide can be decreased when it is combined with Zoledronic acid.,75,Type_75,Yes
DB00385,Valrubicin,DB01024,Mycophenolic acid,0.9300256371498108,72,Type_72,Valrubicin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,72,Type_72,Yes
DB05260,Gallium nitrate,DB08868,Fingolimod,0.9996381998062134,34,Type_34,Gallium nitrate may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB00951,Isoniazid,DB01195,Flecainide,0.4553627669811249,73,Type_73,The serum concentration of Flecainide can be increased when it is combined with Isoniazid.,47,Type_47,No
DB00620,Triamcinolone,DB00989,Rivastigmine,0.9912545680999756,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rivastigmine.,49,Type_49,Yes
DB00220,Nelfinavir,DB00283,Clemastine,0.43291470408439636,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00435,Nitric Oxide,DB00774,Hydroflumethiazide,0.9997825026512146,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Hydroflumethiazide.,49,Type_49,Yes
DB01351,Amobarbital,DB01466,Ethylmorphine,0.992131769657135,49,Type_49,The risk or severity of adverse effects can be increased when Amobarbital is combined with Ethylmorphine.,49,Type_49,Yes
DB00209,Trospium,DB00981,Physostigmine,0.9969629645347595,70,Type_70,The therapeutic efficacy of Physostigmine can be decreased when used in combination with Trospium.,70,Type_70,Yes
DB00907,Cocaine,DB08883,Perampanel,0.9643208980560303,16,Type_16,Cocaine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00153,Ergocalciferol,DB00615,Rifabutin,0.9293146133422852,4,Type_4,The metabolism of Rifabutin can be increased when combined with Ergocalciferol.,4,Type_4,Yes
DB00966,Telmisartan,DB01612,Amyl Nitrite,0.9858702421188354,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Amyl Nitrite.,49,Type_49,Yes
DB00699,Nicergoline,DB09118,Stiripentol,0.4544980227947235,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Stiripentol.,47,Type_47,No
DB06697,Artemether,DB09053,Ibrutinib,0.6839681267738342,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Artemether.,47,Type_47,No
DB00361,Vinorelbine,DB09074,Olaparib,0.7711291909217834,47,Type_47,The metabolism of Olaparib can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB00703,Methazolamide,DB01235,Levodopa,0.5640776753425598,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Levodopa.,30,Type_30,No
DB01131,Proguanil,DB09119,Eslicarbazepine acetate,0.9634798765182495,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Proguanil.,47,Type_47,Yes
DB00864,Tacrolimus,DB09082,Vilanterol,0.860765814781189,49,Type_49,The risk or severity of adverse effects can be increased when Tacrolimus is combined with Vilanterol.,49,Type_49,Yes
DB00486,Nabilone,DB09071,Tasimelteon,0.9534890651702881,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.,16,Type_16,Yes
DB01167,Itraconazole,DB05239,Cobimetinib,0.9905840158462524,73,Type_73,The serum concentration of Cobimetinib can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00575,Clonidine,DB00921,Buprenorphine,0.9663481116294861,16,Type_16,Clonidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,16,Type_16,Yes
DB08868,Fingolimod,DB09074,Olaparib,0.7924707531929016,47,Type_47,The metabolism of Olaparib can be decreased when combined with Fingolimod.,47,Type_47,Yes
DB00477,Chlorpromazine,DB08899,Enzalutamide,0.973191499710083,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Chlorpromazine.,75,Type_75,Yes
DB01149,Nefazodone,DB09072,Sodium oxybate,0.9287378191947937,16,Type_16,Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,49,Type_49,No
DB00223,Diflorasone,DB00944,Demecarium,0.9997195601463318,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Demecarium.,49,Type_49,Yes
DB00208,Ticlopidine,DB08910,Pomalidomide,0.9936250448226929,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00541,Vincristine,DB13878,Pibrentasvir,0.5191537141799927,73,Type_73,The serum concentration of Pibrentasvir can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00292,Etomidate,DB00484,Brimonidine,0.5190380811691284,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Brimonidine.,16,Type_16,No
DB00495,Zidovudine,DB08881,Vemurafenib,0.6207858324050903,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Zidovudine.,73,Type_73,No
DB00371,Meprobamate,DB00557,Hydroxyzine,0.996385931968689,16,Type_16,Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB00381,Amlodipine,DB00800,Fenoldopam,0.7869756817817688,60,Type_60,Amlodipine may increase the hypotensive activities of Fenoldopam.,60,Type_60,Yes
DB00798,Gentamicin,DB00948,Mezlocillin,0.9921477437019348,75,Type_75,The serum concentration of Mezlocillin can be decreased when it is combined with Gentamicin.,75,Type_75,Yes
DB00208,Ticlopidine,DB06701,Dexmethylphenidate,0.9290799498558044,47,Type_47,The metabolism of Dexmethylphenidate can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01160,Dinoprost tromethamine,DB01397,Magnesium salicylate,0.8509588241577148,70,Type_70,The therapeutic efficacy of Magnesium salicylate can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB00653,Magnesium sulfate,DB01133,Tiludronic acid,0.6657900214195251,75,Type_75,The serum concentration of Tiludronic acid can be decreased when it is combined with Magnesium sulfate.,75,Type_75,Yes
DB00381,Amlodipine,DB01098,Rosuvastatin,0.4923946261405945,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Amlodipine.,73,Type_73,No
DB00589,Lisuride,DB08827,Lomitapide,0.7845487594604492,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Lomitapide.,49,Type_49,Yes
DB00370,Mirtazapine,DB00906,Tiagabine,0.9993199110031128,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.,16,Type_16,Yes
DB00502,Haloperidol,DB00862,Vardenafil,0.9002231359481812,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Vardenafil.,20,Type_20,Yes
DB00379,Mexiletine,DB01201,Rifapentine,0.742264449596405,4,Type_4,The metabolism of Rifapentine can be increased when combined with Mexiletine.,4,Type_4,Yes
DB00876,Eprosartan,DB09026,Aliskiren,0.5402926206588745,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Aliskiren.,68,Type_68,No
DB00494,Entacapone,DB00907,Cocaine,0.8796510100364685,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Cocaine.,49,Type_49,Yes
DB06700,Desvenlafaxine,DB09224,Melperone,0.9876041412353516,49,Type_49,The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Melperone.,49,Type_49,Yes
DB00176,Fluvoxamine,DB01050,Ibuprofen,0.9416332840919495,47,Type_47,The metabolism of Ibuprofen can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00636,Clofibrate,DB01264,Darunavir,0.9307570457458496,47,Type_47,The metabolism of Darunavir can be decreased when combined with Clofibrate.,47,Type_47,Yes
DB00591,Fluocinolone acetonide,DB01401,Choline magnesium trisalicylate,0.9997310042381287,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB00586,Diclofenac,DB06781,Difluprednate,0.9992246627807617,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Difluprednate.,49,Type_49,Yes
DB00543,Amoxapine,DB00907,Cocaine,0.6879987120628357,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Cocaine.,47,Type_47,No
DB00196,Fluconazole,DB00444,Teniposide,0.6712787747383118,47,Type_47,The metabolism of Teniposide can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00361,Vinorelbine,DB00476,Duloxetine,0.38455620408058167,49,Type_49,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Duloxetine.,47,Type_47,No
DB00708,Sufentanil,DB09015,Canrenoic acid,0.9980422258377075,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Canrenoic acid.,49,Type_49,Yes
DB00624,Testosterone,DB01609,Deferasirox,0.9202579855918884,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Testosterone.,75,Type_75,Yes
DB01171,Moclobemide,DB01544,Flunitrazepam,0.536434531211853,49,Type_49,The risk or severity of adverse effects can be increased when Moclobemide is combined with Flunitrazepam.,47,Type_47,No
DB01463,Fencamfamin,DB04841,Flunarizine,0.9902850985527039,49,Type_49,The risk or severity of adverse effects can be increased when Fencamfamin is combined with Flunarizine.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB01222,Budesonide,0.9996578693389893,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Budesonide.,83,Type_83,Yes
DB00553,Methoxsalen,DB01072,Atazanavir,0.8589474558830261,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB01395,Drospirenone,DB08439,Parecoxib,0.7010248899459839,68,Type_68,Drospirenone may increase the hyperkalemic activities of Parecoxib.,68,Type_68,Yes
DB00983,Formoterol,DB01264,Darunavir,0.4576191306114197,47,Type_47,The metabolism of Darunavir can be decreased when combined with Formoterol.,73,Type_73,No
DB00904,Ondansetron,DB09166,Etizolam,0.9661489129066467,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Etizolam.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB11609,Normethadone,0.9986201524734497,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Normethadone.,49,Type_49,Yes
DB00673,Aprepitant,DB01186,Pergolide,0.6295580267906189,73,Type_73,The serum concentration of Pergolide can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00245,Benzatropine,DB00805,Minaprine,0.9781461954116821,71,Type_71,Benzatropine may increase the hypertensive activities of Minaprine.,70,Type_70,No
DB00361,Vinorelbine,DB00857,Terbinafine,0.7117335200309753,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB01156,Bupropion,DB01242,Clomipramine,0.8771260380744934,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Bupropion.,47,Type_47,Yes
DB01175,Escitalopram,DB01463,Fencamfamin,0.9825500845909119,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Fencamfamin.,49,Type_49,Yes
DB00337,Pimecrolimus,DB01045,Rifampicin,0.6807406544685364,4,Type_4,The metabolism of Rifampicin can be increased when combined with Pimecrolimus.,4,Type_4,Yes
DB09216,Tolfenamic acid,DB09295,Talniflumate,0.9999579191207886,49,Type_49,The risk or severity of adverse effects can be increased when Tolfenamic acid is combined with Talniflumate.,49,Type_49,Yes
DB00717,Norethisterone,DB06154,Pentaerythritol tetranitrate,0.5184023380279541,70,Type_70,The therapeutic efficacy of Pentaerythritol tetranitrate can be decreased when used in combination with Norethisterone.,70,Type_70,Yes
DB00255,Diethylstilbestrol,DB06335,Saxagliptin,0.850432276725769,75,Type_75,The serum concentration of Saxagliptin can be decreased when it is combined with Diethylstilbestrol.,75,Type_75,Yes
DB00908,Quinidine,DB01403,Methotrimeprazine,0.6951010823249817,20,Type_20,Quinidine may increase the QTc-prolonging activities of Methotrimeprazine.,20,Type_20,Yes
DB00281,Lidocaine,DB04908,Flibanserin,0.9728155732154846,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Flibanserin.,49,Type_49,Yes
DB00641,Simvastatin,DB09281,Magnesium trisilicate,0.9796216487884521,75,Type_75,The serum concentration of Magnesium trisilicate can be decreased when it is combined with Simvastatin.,75,Type_75,Yes
DB01037,Selegiline,DB01162,Terazosin,0.7648294568061829,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Terazosin.,49,Type_49,Yes
DB00349,Clobazam,DB00530,Erlotinib,0.9670974612236023,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00282,Pamidronic acid,DB01609,Deferasirox,0.7370187640190125,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Pamidronic acid.,49,Type_49,No
DB00454,Meperidine,DB09015,Canrenoic acid,0.9993354678153992,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Canrenoic acid.,49,Type_49,Yes
DB01041,Thalidomide,DB04908,Flibanserin,0.9947698712348938,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,16,Type_16,Yes
DB00233,Aminosalicylic acid,DB04743,Nimesulide,0.9844900965690613,49,Type_49,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Nimesulide.,49,Type_49,Yes
DB00652,Pentazocine,DB08897,Aclidinium,0.9966452717781067,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Aclidinium.,49,Type_49,Yes
DB00362,Anidulafungin,DB00528,Lercanidipine,0.9975857734680176,49,Type_49,The risk or severity of adverse effects can be increased when Anidulafungin is combined with Lercanidipine.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB01100,Pimozide,0.9785748720169067,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Pimozide.,49,Type_49,Yes
DB06712,Nilvadipine,DB06820,Sulconazole,0.9640932083129883,49,Type_49,The risk or severity of adverse effects can be increased when Nilvadipine is combined with Sulconazole.,49,Type_49,Yes
DB00808,Indapamide,DB01009,Ketoprofen,0.9086284637451172,70,Type_70,The therapeutic efficacy of Ketoprofen can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB01232,Saquinavir,DB04574,Estrone sulfate,0.8453196287155151,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00976,Telithromycin,DB09063,Ceritinib,0.9831646084785461,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Telithromycin.,73,Type_73,Yes
DB00641,Simvastatin,DB04876,Vildagliptin,0.5289171934127808,73,Type_73,The serum concentration of Vildagliptin can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00736,Esomeprazole,DB00745,Modafinil,0.9685338139533997,47,Type_47,The metabolism of Modafinil can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB00712,Flurbiprofen,DB01059,Norfloxacin,0.9968155026435852,27,Type_27,Flurbiprofen may increase the neuroexcitatory activities of Norfloxacin.,27,Type_27,Yes
DB00660,Metaxalone,DB01235,Levodopa,0.9999167919158936,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Levodopa.,49,Type_49,Yes
DB00243,Ranolazine,DB01264,Darunavir,0.5967336893081665,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00404,Alprazolam,DB01200,Bromocriptine,0.820486843585968,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Bromocriptine.,49,Type_49,Yes
DB00996,Gabapentin,DB08883,Perampanel,0.9686480164527893,16,Type_16,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01103,Quinacrine,DB09280,Lumacaftor,0.6396262049674988,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Quinacrine.,4,Type_4,No
DB00622,Nicardipine,DB01320,Fosphenytoin,0.689747154712677,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Nicardipine.,73,Type_73,No
DB00974,Edetic acid,DB04272,Citric acid,0.9994489550590515,6,Type_6,Edetic acid may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB01364,Ephedrine,DB04846,Celiprolol,0.5751122236251831,49,Type_49,The risk or severity of adverse effects can be increased when Ephedrine is combined with Celiprolol.,49,Type_49,Yes
DB00371,Meprobamate,DB09049,Naloxegol,0.9990529417991638,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Meprobamate.,73,Type_73,Yes
DB00530,Erlotinib,DB01377,Magnesium oxide,0.8062073588371277,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Erlotinib.,75,Type_75,Yes
DB00628,Clorazepic acid,DB01589,Quazepam,0.9640585780143738,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Quazepam.,49,Type_49,Yes
DB00279,Liothyronine,DB00476,Duloxetine,0.4082369804382324,9,Type_9,Liothyronine may increase the hypoglycemic activities of Duloxetine.,70,Type_70,No
DB00264,Metoprolol,DB00275,Olmesartan,0.9622810482978821,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Olmesartan.,49,Type_49,Yes
DB00384,Triamterene,DB00880,Chlorothiazide,0.7617384195327759,49,Type_49,The risk or severity of adverse effects can be increased when Triamterene is combined with Chlorothiazide.,49,Type_49,Yes
DB00440,Trimethoprim,DB01264,Darunavir,0.7968941926956177,47,Type_47,The metabolism of Darunavir can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00223,Diflorasone,DB00586,Diclofenac,0.9991670846939087,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Diclofenac.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB08882,Linagliptin,0.45108526945114136,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Cyclophosphamide.,49,Type_49,No
DB08918,Levomilnacipran,DB09238,Manidipine,0.5199660658836365,47,Type_47,The metabolism of Manidipine can be decreased when combined with Levomilnacipran.,47,Type_47,Yes
DB00850,Perphenazine,DB00996,Gabapentin,0.9747656583786011,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Gabapentin.,49,Type_49,Yes
DB00672,Chlorpropamide,DB08815,Lurasidone,0.9951397180557251,70,Type_70,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB00951,Isoniazid,DB06702,Fesoterodine,0.965515673160553,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Isoniazid.,77,Type_77,Yes
DB01037,Selegiline,DB01395,Drospirenone,0.3819330036640167,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Drospirenone.,73,Type_73,No
DB00344,Protriptyline,DB04876,Vildagliptin,0.5762418508529663,70,Type_70,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Protriptyline.,73,Type_73,No
DB01165,Ofloxacin,DB08865,Crizotinib,0.9993082284927368,20,Type_20,Ofloxacin may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB01250,Olsalazine,DB04552,Niflumic acid,0.8612325191497803,57,Type_57,Olsalazine may increase the nephrotoxic activities of Niflumic acid.,57,Type_57,Yes
DB00448,Lansoprazole,DB01030,Topotecan,0.9622254371643066,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Lansoprazole.,73,Type_73,Yes
DB00370,Mirtazapine,DB00653,Magnesium sulfate,0.9979524612426758,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB01069,Promethazine,DB08987,Etidocaine,0.9981991648674011,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Etidocaine.,49,Type_49,Yes
DB01590,Everolimus,DB08874,Fidaxomicin,0.8324841260910034,73,Type_73,The serum concentration of Fidaxomicin can be increased when it is combined with Everolimus.,73,Type_73,Yes
DB00328,Indomethacin,DB08881,Vemurafenib,0.5571182370185852,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Indomethacin.,73,Type_73,Yes
DB01198,Zopiclone,DB08933,Luliconazole,0.9729589819908142,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Zopiclone.,73,Type_73,Yes
DB00359,Sulfadiazine,DB09073,Palbociclib,0.9761068820953369,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Sulfadiazine.,73,Type_73,Yes
DB00247,Methysergide,DB00481,Raloxifene,0.9978623986244202,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Raloxifene.,49,Type_49,Yes
DB00220,Nelfinavir,DB00708,Sufentanil,0.6180874705314636,47,Type_47,The metabolism of Sufentanil can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00768,Olopatadine,DB13025,Tiapride,0.8816304802894592,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Tiapride.,49,Type_49,Yes
DB00500,Tolmetin,DB00605,Sulindac,0.9988586902618408,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Sulindac.,49,Type_49,Yes
DB00298,Dapiprazole,DB00980,Ramelteon,0.9987806677818298,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Ramelteon.,49,Type_49,Yes
DB00816,Orciprenaline,DB01136,Carvedilol,0.7289575338363647,5,Type_5,Orciprenaline may decrease the vasoconstricting activities of Carvedilol.,5,Type_5,Yes
DB00575,Clonidine,DB08807,Bopindolol,0.9637651443481445,25,Type_25,Clonidine may increase the atrioventricular blocking (AV block) activities of Bopindolol.,25,Type_25,Yes
DB00263,Sulfisoxazole,DB01177,Idarubicin,0.9224362969398499,47,Type_47,The metabolism of Idarubicin can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00195,Betaxolol,DB00904,Ondansetron,0.7496917247772217,47,Type_47,The metabolism of Ondansetron can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00364,Sucralfate,DB01017,Minocycline,0.6558619141578674,75,Type_75,The serum concentration of Minocycline can be decreased when it is combined with Sucralfate.,67,Type_67,No
DB00498,Phenindione,DB09008,Cefaloridine,0.9999338388442993,6,Type_6,Phenindione may increase the anticoagulant activities of Cefaloridine.,6,Type_6,Yes
DB00349,Clobazam,DB00612,Bisoprolol,0.8565270304679871,47,Type_47,The metabolism of Bisoprolol can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01017,Minocycline,DB01065,Melatonin,0.9860618710517883,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Melatonin.,16,Type_16,Yes
DB00182,Amphetamine,DB00780,Phenelzine,0.5137494206428528,71,Type_71,Amphetamine may increase the hypertensive activities of Phenelzine.,71,Type_71,Yes
DB00238,Nevirapine,DB01195,Flecainide,0.42154166102409363,75,Type_75,The serum concentration of Flecainide can be decreased when it is combined with Nevirapine.,47,Type_47,No
DB00647,Dextropropoxyphene,DB08872,Gabapentin enacarbil,0.999500036239624,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00731,Nateglinide,DB00734,Risperidone,0.7255598902702332,70,Type_70,The therapeutic efficacy of Risperidone can be decreased when used in combination with Nateglinide.,70,Type_70,Yes
DB01132,Pioglitazone,DB01289,Glisoxepide,0.9978628754615784,9,Type_9,Pioglitazone may increase the hypoglycemic activities of Glisoxepide.,9,Type_9,Yes
DB01551,Dihydrocodeine,DB09345,Pramocaine,0.9956373572349548,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Pramocaine.,49,Type_49,Yes
DB00276,Amsacrine,DB01118,Amiodarone,0.8818069100379944,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Amsacrine.,47,Type_47,Yes
DB00289,Atomoxetine,DB00860,Prednisolone,0.9580949544906616,47,Type_47,The metabolism of Prednisolone can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00390,Digoxin,DB00586,Diclofenac,0.8344574570655823,73,Type_73,The serum concentration of Diclofenac can be increased when it is combined with Digoxin.,73,Type_73,Yes
DB02187,Equilin,DB06819,Phenylbutyric acid,0.9516527652740479,70,Type_70,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Equilin.,70,Type_70,Yes
DB00257,Clotrimazole,DB01396,Digitoxin,0.5794624090194702,47,Type_47,The metabolism of Digitoxin can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01435,Antipyrine,DB09091,Tixocortol,0.9992824196815491,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Tixocortol.,49,Type_49,Yes
DB01060,Amoxicillin,DB01601,Lopinavir,0.9081400632858276,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Amoxicillin.,4,Type_4,No
DB00404,Alprazolam,DB01174,Phenobarbital,0.7087717056274414,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Alprazolam.,4,Type_4,Yes
DB00468,Quinine,DB01244,Bepridil,0.35966384410858154,20,Type_20,Quinine may increase the QTc-prolonging activities of Bepridil.,60,Type_60,No
DB08873,Boceprevir,DB08875,Cabozantinib,0.705126166343689,47,Type_47,The metabolism of Cabozantinib can be decreased when combined with Boceprevir.,73,Type_73,No
DB00318,Codeine,DB00753,Isoflurane,0.9891664385795593,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Isoflurane.,49,Type_49,Yes
DB00500,Tolmetin,DB01260,Desonide,0.9999265670776367,49,Type_49,The risk or severity of adverse effects can be increased when Tolmetin is combined with Desonide.,49,Type_49,Yes
DB00590,Doxazosin,DB00706,Tamsulosin,0.6295987963676453,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Tamsulosin.,49,Type_49,Yes
DB01202,Levetiracetam,DB01239,Chlorprothixene,0.9986066222190857,49,Type_49,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Chlorprothixene.,49,Type_49,Yes
DB00395,Carisoprodol,DB05246,Methsuximide,0.9992226362228394,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Methsuximide.,49,Type_49,Yes
DB00508,Triflupromazine,DB00831,Trifluoperazine,0.9892956614494324,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Trifluoperazine.,49,Type_49,Yes
DB02187,Equilin,DB09280,Lumacaftor,0.8846144080162048,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Equilin.,75,Type_75,Yes
DB01175,Escitalopram,DB13323,Trichloroethylene,0.9227486252784729,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Trichloroethylene.,49,Type_49,Yes
DB00921,Buprenorphine,DB01618,Molindone,0.9997020363807678,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Molindone.,16,Type_16,Yes
DB00366,Doxylamine,DB09017,Brotizolam,1.0,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.,16,Type_16,Yes
DB00337,Pimecrolimus,DB12364,Betrixaban,0.9841909408569336,66,Type_66,The risk or severity of bleeding can be increased when Pimecrolimus is combined with Betrixaban.,66,Type_66,Yes
DB01120,Gliclazide,DB02546,Vorinostat,0.847698986530304,70,Type_70,The therapeutic efficacy of Vorinostat can be decreased when used in combination with Gliclazide.,70,Type_70,Yes
DB00657,Mecamylamine,DB06738,Ketobemidone,0.9985606074333191,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Ketobemidone.,49,Type_49,Yes
DB00199,Erythromycin,DB00897,Triazolam,0.843890905380249,47,Type_47,The metabolism of Triazolam can be decreased when combined with Erythromycin.,73,Type_73,No
DB00454,Meperidine,DB00810,Biperiden,0.9996225833892822,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Biperiden.,49,Type_49,Yes
DB00679,Thioridazine,DB01219,Dantrolene,0.7871093153953552,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Dantrolene.,49,Type_49,Yes
DB00472,Fluoxetine,DB09071,Tasimelteon,0.7700842022895813,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Tasimelteon.,49,Type_49,Yes
DB00864,Tacrolimus,DB09183,Dasabuvir,0.7506043910980225,47,Type_47,The metabolism of Dasabuvir can be decreased when combined with Tacrolimus.,73,Type_73,No
DB01098,Rosuvastatin,DB08816,Ticagrelor,0.6381239295005798,73,Type_73,The serum concentration of Ticagrelor can be increased when it is combined with Rosuvastatin.,47,Type_47,No
DB01288,Fenoterol,DB06700,Desvenlafaxine,0.9958751797676086,85,Type_85,Fenoterol may increase the tachycardic activities of Desvenlafaxine.,85,Type_85,Yes
DB00470,Dronabinol,DB00598,Labetalol,0.5785908699035645,85,Type_85,Dronabinol may increase the tachycardic activities of Labetalol.,85,Type_85,Yes
DB00497,Oxycodone,DB01320,Fosphenytoin,0.7870364785194397,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Oxycodone.,4,Type_4,Yes
DB00253,Medrysone,DB00814,Meloxicam,0.9996272325515747,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Meloxicam.,49,Type_49,Yes
DB08895,Tofacitinib,DB09120,Zucapsaicin,0.9572516679763794,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Tofacitinib.,47,Type_47,Yes
DB01170,Guanethidine,DB01359,Penbutolol,0.9997984766960144,60,Type_60,Guanethidine may increase the hypotensive activities of Penbutolol.,60,Type_60,Yes
DB00852,Pseudoephedrine,DB09289,Tianeptine,0.9806641340255737,37,Type_37,Pseudoephedrine may decrease the antihypertensive activities of Tianeptine.,37,Type_37,Yes
DB00691,Moexipril,DB00753,Isoflurane,0.9566238522529602,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Isoflurane.,49,Type_49,Yes
DB00999,Hydrochlorothiazide,DB06700,Desvenlafaxine,0.9862955212593079,55,Type_55,Hydrochlorothiazide may increase the hyponatremic activities of Desvenlafaxine.,55,Type_55,Yes
DB00701,Amprenavir,DB01048,Abacavir,0.9039596319198608,75,Type_75,The serum concentration of Abacavir can be decreased when it is combined with Amprenavir.,75,Type_75,Yes
DB00904,Ondansetron,DB01466,Ethylmorphine,0.9815564155578613,49,Type_49,The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethylmorphine.,49,Type_49,Yes
DB00266,Dicoumarol,DB01022,Phylloquinone,0.4730337858200073,70,Type_70,The therapeutic efficacy of Phylloquinone can be decreased when used in combination with Dicoumarol.,12,Type_12,No
DB00673,Aprepitant,DB00947,Fulvestrant,0.9696271419525146,73,Type_73,The serum concentration of Fulvestrant can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00804,Dicyclomine,DB01043,Memantine,0.9991915822029114,70,Type_70,The therapeutic efficacy of Memantine can be decreased when used in combination with Dicyclomine.,70,Type_70,Yes
DB00458,Imipramine,DB09082,Vilanterol,0.6146827936172485,20,Type_20,Imipramine may increase the QTc-prolonging activities of Vilanterol.,49,Type_49,No
DB00321,Amitriptyline,DB00946,Phenprocoumon,0.9894443154335022,6,Type_6,Amitriptyline may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00628,Clorazepic acid,DB00829,Diazepam,0.9928866028785706,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Diazepam.,49,Type_49,Yes
DB00326,Calcium glucoheptonate,DB09238,Manidipine,0.556668758392334,70,Type_70,The therapeutic efficacy of Manidipine can be decreased when used in combination with Calcium glucoheptonate.,70,Type_70,Yes
DB00199,Erythromycin,DB05351,Dexlansoprazole,0.9656449556350708,47,Type_47,The metabolism of Dexlansoprazole can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00482,Celecoxib,DB08912,Dabrafenib,0.9269844889640808,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Celecoxib.,75,Type_75,Yes
DB00208,Ticlopidine,DB00945,Acetylsalicylic acid,0.9107701182365417,47,Type_47,The metabolism of Acetylsalicylic acid can be decreased when combined with Ticlopidine.,49,Type_49,No
DB06594,Agomelatine,DB09117,Paraldehyde,0.9992836117744446,16,Type_16,Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00620,Triamcinolone,DB00999,Hydrochlorothiazide,0.9996886253356934,83,Type_83,Triamcinolone may increase the hypokalemic activities of Hydrochlorothiazide.,83,Type_83,Yes
DB00582,Voriconazole,DB00863,Ranitidine,0.860056459903717,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00898,Ethanol,DB04896,Milnacipran,0.866248607635498,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Milnacipran.,49,Type_49,Yes
DB00270,Isradipine,DB00421,Spironolactone,0.9988362193107605,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Spironolactone.,49,Type_49,Yes
DB00771,Clidinium,DB00933,Mesoridazine,0.9999517202377319,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Mesoridazine.,49,Type_49,Yes
DB00981,Physostigmine,DB04574,Estrone sulfate,0.958473265171051,49,Type_49,The risk or severity of adverse effects can be increased when Physostigmine is combined with Estrone sulfate.,49,Type_49,Yes
DB00715,Paroxetine,DB00960,Pindolol,0.3786318302154541,73,Type_73,The serum concentration of Pindolol can be increased when it is combined with Paroxetine.,47,Type_47,No
DB00422,Methylphenidate,DB00472,Fluoxetine,0.6204591393470764,47,Type_47,The metabolism of Fluoxetine can be decreased when combined with Methylphenidate.,47,Type_47,Yes
DB00238,Nevirapine,DB00252,Phenytoin,0.7850130200386047,4,Type_4,The metabolism of Phenytoin can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00178,Ramipril,DB00346,Alfuzosin,0.8923323750495911,60,Type_60,Ramipril may increase the hypotensive activities of Alfuzosin.,60,Type_60,Yes
DB00344,Protriptyline,DB06605,Apixaban,0.771805465221405,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Protriptyline.,73,Type_73,Yes
DB00308,Ibutilide,DB01167,Itraconazole,0.9147303700447083,20,Type_20,Ibutilide may increase the QTc-prolonging activities of Itraconazole.,20,Type_20,Yes
DB00313,Valproic acid,DB06716,Fospropofol,0.9859142303466797,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Fospropofol.,49,Type_49,Yes
DB05812,Abiraterone,DB12161,Deutetrabenazine,0.6512445211410522,73,Type_73,The serum concentration of Deutetrabenazine can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB01155,Gemifloxacin,DB04951,Pirfenidone,0.9961220622062683,27,Type_27,Gemifloxacin may increase the neuroexcitatory activities of Pirfenidone.,27,Type_27,Yes
DB00612,Bisoprolol,DB00715,Paroxetine,0.8697780966758728,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Bisoprolol.,47,Type_47,Yes
DB00314,Capreomycin,DB00445,Epirubicin,0.9939408302307129,21,Type_21,Capreomycin may increase the neuromuscular blocking activities of Epirubicin.,21,Type_21,Yes
DB00747,Scopolamine,DB00850,Perphenazine,0.995567262172699,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Perphenazine.,49,Type_49,Yes
DB00519,Trandolapril,DB06414,Etravirine,0.36350733041763306,75,Type_75,The serum concentration of Etravirine can be decreased when it is combined with Trandolapril.,75,Type_75,Yes
DB01319,Fosamprenavir,DB09167,Dosulepin,0.683984637260437,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Fosamprenavir.,73,Type_73,No
DB01167,Itraconazole,DB01377,Magnesium oxide,0.6402599811553955,67,Type_67,Itraconazole can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00492,Fosinopril,DB01041,Thalidomide,0.9315903782844543,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Thalidomide.,49,Type_49,Yes
DB00408,Loxapine,DB01200,Bromocriptine,0.9149020910263062,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Bromocriptine.,70,Type_70,No
DB00363,Clozapine,DB00557,Hydroxyzine,0.9791260957717896,16,Type_16,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,16,Type_16,Yes
DB00027,Gramicidin D,DB01590,Everolimus,0.9726893305778503,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Gramicidin D.,73,Type_73,Yes
DB01044,Gatifloxacin,DB01435,Antipyrine,0.999407172203064,27,Type_27,Gatifloxacin may increase the neuroexcitatory activities of Antipyrine.,27,Type_27,Yes
DB00460,Verteporfin,DB00511,Acetyldigitoxin,0.9986078143119812,58,Type_58,Verteporfin may decrease the cardiotoxic activities of Acetyldigitoxin.,58,Type_58,Yes
DB00280,Disopyramide,DB08873,Boceprevir,0.4336363673210144,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Disopyramide.,47,Type_47,No
DB00266,Dicoumarol,DB13873,Fenofibric acid,0.9999071359634399,6,Type_6,Dicoumarol may increase the anticoagulant activities of Fenofibric acid.,6,Type_6,Yes
DB00310,Chlorthalidone,DB00622,Nicardipine,0.7471451759338379,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Nicardipine.,49,Type_49,Yes
DB00014,Goserelin,DB00916,Metronidazole,0.9997838139533997,20,Type_20,Goserelin may increase the QTc-prolonging activities of Metronidazole.,20,Type_20,Yes
DB01466,Ethylmorphine,DB06700,Desvenlafaxine,0.8648583292961121,64,Type_64,Ethylmorphine may increase the serotonergic activities of Desvenlafaxine.,64,Type_64,Yes
DB00924,Cyclobenzaprine,DB06153,Pizotifen,0.9995959401130676,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Pizotifen.,49,Type_49,Yes
DB00199,Erythromycin,DB00802,Alfentanil,0.6994050741195679,47,Type_47,The metabolism of Alfentanil can be decreased when combined with Erythromycin.,73,Type_73,No
DB00514,Dextromethorphan,DB05521,Telaprevir,0.8304361701011658,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Dextromethorphan.,47,Type_47,Yes
DB00661,Verapamil,DB09038,Empagliflozin,0.9882351160049438,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Empagliflozin.,49,Type_49,Yes
DB01142,Doxepin,DB01168,Procarbazine,0.8415747284889221,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Procarbazine.,49,Type_49,Yes
DB00234,Reboxetine,DB00246,Ziprasidone,0.9403604865074158,47,Type_47,The metabolism of Ziprasidone can be decreased when combined with Reboxetine.,47,Type_47,Yes
DB00686,Pentosan polysulfate,DB06737,Zaltoprofen,0.9705734252929688,6,Type_6,Pentosan polysulfate may increase the anticoagulant activities of Zaltoprofen.,6,Type_6,Yes
DB00196,Fluconazole,DB01179,Podofilox,0.9214718341827393,47,Type_47,The metabolism of Podofilox can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00491,Miglitol,DB01601,Lopinavir,0.9060887694358826,70,Type_70,The therapeutic efficacy of Lopinavir can be decreased when used in combination with Miglitol.,70,Type_70,Yes
DB00324,Fluorometholone,DB00749,Etodolac,0.9967275857925415,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Etodolac.,49,Type_49,Yes
DB00773,Etoposide,DB01026,Ketoconazole,0.848205029964447,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Etoposide.,47,Type_47,Yes
DB00399,Zoledronic acid,DB06696,Arbekacin,0.9999771118164062,24,Type_24,Zoledronic acid may increase the hypocalcemic activities of Arbekacin.,24,Type_24,Yes
DB00674,Galantamine,DB00986,Glycopyrronium,0.9913964867591858,70,Type_70,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.,70,Type_70,Yes
DB00264,Metoprolol,DB00972,Azelastine,0.9817034602165222,37,Type_37,Metoprolol may decrease the antihypertensive activities of Azelastine.,73,Type_73,No
DB00312,Pentobarbital,DB01149,Nefazodone,0.5463927388191223,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Pentobarbital.,4,Type_4,No
DB00207,Azithromycin,DB01037,Selegiline,0.4344256520271301,47,Type_47,The metabolism of Selegiline can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB01050,Ibuprofen,DB01380,Cortisone acetate,0.9994833469390869,49,Type_49,The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortisone acetate.,49,Type_49,Yes
DB01544,Flunitrazepam,DB13025,Tiapride,0.999733030796051,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Tiapride.,49,Type_49,Yes
DB00872,Conivaptan,DB06603,Panobinostat,0.9984079003334045,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00472,Fluoxetine,DB09054,Idelalisib,0.8312665820121765,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00865,Benzphetamine,DB01075,Diphenhydramine,0.8895367980003357,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Benzphetamine.,76,Type_76,No
DB00933,Mesoridazine,DB01440,gamma-Hydroxybutyric acid,0.9999856948852539,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB01359,Penbutolol,DB05039,Indacaterol,0.9995564818382263,14,Type_14,Penbutolol may decrease the bronchodilatory activities of Indacaterol.,14,Type_14,Yes
DB00677,Isoflurophate,DB01200,Bromocriptine,0.7341453433036804,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Bromocriptine.,73,Type_73,No
DB00184,Nicotine,DB00835,Brompheniramine,0.7991726994514465,47,Type_47,The metabolism of Brompheniramine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00245,Benzatropine,DB00501,Cimetidine,0.8389231562614441,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB01118,Amiodarone,DB06789,Hydroxyprogesterone caproate,0.8252029418945312,47,Type_47,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00715,Paroxetine,DB01159,Halothane,0.7652164697647095,47,Type_47,The metabolism of Halothane can be decreased when combined with Paroxetine.,47,Type_47,Yes
DB00487,Pefloxacin,DB00682,Warfarin,0.992837131023407,6,Type_6,Pefloxacin may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00193,Tramadol,DB00285,Venlafaxine,0.36246493458747864,64,Type_64,Tramadol may increase the serotonergic activities of Venlafaxine.,27,Type_27,No
DB00258,Calcium acetate,DB01325,Quinethazone,0.9638286232948303,72,Type_72,Calcium acetate may decrease the excretion rate of Quinethazone which could result in a higher serum level.,72,Type_72,Yes
DB00588,Fluticasone propionate,DB08865,Crizotinib,0.7576048970222473,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Fluticasone propionate.,47,Type_47,Yes
DB00932,Tipranavir,DB01252,Mitiglinide,0.9992079138755798,70,Type_70,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Tipranavir.,70,Type_70,Yes
DB00340,Metixene,DB00674,Galantamine,0.9987537860870361,70,Type_70,The therapeutic efficacy of Galantamine can be decreased when used in combination with Metixene.,70,Type_70,Yes
DB00714,Apomorphine,DB00742,Mannitol,0.9959012866020203,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Mannitol.,49,Type_49,Yes
DB01036,Tolterodine,DB06216,Asenapine,0.7799381613731384,20,Type_20,Tolterodine may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB08439,Parecoxib,DB11921,Deflazacort,0.9961877465248108,49,Type_49,The risk or severity of adverse effects can be increased when Parecoxib is combined with Deflazacort.,49,Type_49,Yes
DB01095,Fluvastatin,DB01377,Magnesium oxide,0.9261600971221924,75,Type_75,The serum concentration of Magnesium oxide can be decreased when it is combined with Fluvastatin.,75,Type_75,Yes
DB00363,Clozapine,DB06697,Artemether,0.41667887568473816,47,Type_47,The metabolism of Artemether can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB00500,Tolmetin,0.9857757091522217,70,Type_70,The therapeutic efficacy of Tolmetin can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00468,Quinine,DB06725,Lornoxicam,0.8900493383407593,47,Type_47,The metabolism of Lornoxicam can be decreased when combined with Quinine.,47,Type_47,Yes
DB00264,Metoprolol,DB00680,Moricizine,0.583623468875885,60,Type_60,Metoprolol may increase the hypotensive activities of Moricizine.,60,Type_60,Yes
DB01169,Arsenic trioxide,DB01254,Dasatinib,0.5511760711669922,20,Type_20,Arsenic trioxide may increase the QTc-prolonging activities of Dasatinib.,20,Type_20,Yes
DB00381,Amlodipine,DB08916,Afatinib,0.664603054523468,75,Type_75,The serum concentration of Afatinib can be decreased when it is combined with Amlodipine.,73,Type_73,No
DB00521,Carteolol,DB01245,Decamethonium,0.9787399768829346,54,Type_54,Carteolol may increase the bradycardic activities of Decamethonium.,54,Type_54,Yes
DB00450,Droperidol,DB01356,Lithium cation,0.7196449637413025,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lithium cation.,16,Type_16,Yes
DB00204,Dofetilide,DB05039,Indacaterol,0.999302864074707,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB05294,Vandetanib,DB12332,Rucaparib,0.4081009328365326,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Vandetanib.,47,Type_47,Yes
DB01087,Primaquine,DB01136,Carvedilol,0.6909139156341553,73,Type_73,The serum concentration of Carvedilol can be increased when it is combined with Primaquine.,47,Type_47,No
DB00205,Pyrimethamine,DB01098,Rosuvastatin,0.5436869859695435,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00625,Efavirenz,DB00932,Tipranavir,0.7364929914474487,47,Type_47,The metabolism of Tipranavir can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB01211,Clarithromycin,DB11921,Deflazacort,0.8839263916015625,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00934,Maprotiline,DB04953,Ezogabine,0.993704617023468,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Ezogabine.,49,Type_49,Yes
DB00845,Clofazimine,DB08820,Ivacaftor,0.9983450174331665,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Clofazimine.,73,Type_73,Yes
DB05812,Abiraterone,DB06144,Sertindole,0.9201182126998901,73,Type_73,The serum concentration of Sertindole can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00584,Enalapril,DB00975,Dipyridamole,0.9966369867324829,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Dipyridamole.,49,Type_49,Yes
DB00176,Fluvoxamine,DB00371,Meprobamate,0.6259086728096008,47,Type_47,The metabolism of Meprobamate can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00645,Dyclonine,DB00985,Dimenhydrinate,0.9999933242797852,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Dimenhydrinate.,49,Type_49,Yes
DB00180,Flunisolide,DB00821,Carprofen,0.9993416666984558,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Carprofen.,49,Type_49,Yes
DB09161,Technetium Tc-99m sestamibi,DB09280,Lumacaftor,0.6968738436698914,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Technetium Tc-99m sestamibi.,75,Type_75,Yes
DB00946,Phenprocoumon,DB01254,Dasatinib,0.9712350964546204,6,Type_6,Phenprocoumon may increase the anticoagulant activities of Dasatinib.,6,Type_6,Yes
DB00176,Fluvoxamine,DB00544,Fluorouracil,0.9646763801574707,47,Type_47,The metabolism of Fluorouracil can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB05812,Abiraterone,DB06268,Sitaxentan,0.6169762015342712,73,Type_73,The serum concentration of Sitaxentan can be increased when it is combined with Abiraterone.,47,Type_47,No
DB00264,Metoprolol,DB00697,Tizanidine,0.9768705368041992,25,Type_25,Metoprolol may increase the atrioventricular blocking (AV block) activities of Tizanidine.,25,Type_25,Yes
DB00883,Isosorbide dinitrate,DB01193,Acebutolol,0.9864787459373474,49,Type_49,The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Acebutolol.,49,Type_49,Yes
DB00963,Bromfenac,DB01180,Rescinnamine,0.9954190254211426,49,Type_49,The risk or severity of adverse effects can be increased when Bromfenac is combined with Rescinnamine.,49,Type_49,Yes
DB00810,Biperiden,DB01233,Metoclopramide,0.9915099143981934,70,Type_70,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Biperiden.,70,Type_70,Yes
DB00623,Fluphenazine,DB01131,Proguanil,0.8411680459976196,47,Type_47,The metabolism of Proguanil can be decreased when combined with Fluphenazine.,73,Type_73,No
DB09091,Tixocortol,DB09118,Stiripentol,0.9015777707099915,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Tixocortol.,73,Type_73,Yes
DB00338,Omeprazole,DB00705,Delavirdine,0.8653955459594727,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Omeprazole.,75,Type_75,No
DB00199,Erythromycin,DB06710,Methyltestosterone,0.9824480414390564,47,Type_47,The metabolism of Methyltestosterone can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00418,Secobarbital,DB01274,Arformoterol,0.5175584554672241,4,Type_4,The metabolism of Arformoterol can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01089,Deserpidine,DB06712,Nilvadipine,0.9999867677688599,60,Type_60,Deserpidine may increase the hypotensive activities of Nilvadipine.,60,Type_60,Yes
DB00752,Tranylcypromine,DB09225,Zotepine,0.9694415926933289,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Zotepine.,49,Type_49,Yes
DB00677,Isoflurophate,DB13158,Clobetasone,0.9966247081756592,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Clobetasone.,49,Type_49,Yes
DB01250,Olsalazine,DB03615,Ribostamycin,0.9997472167015076,72,Type_72,Olsalazine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,72,Type_72,Yes
DB00455,Loratadine,DB00641,Simvastatin,0.5963969230651855,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Loratadine.,73,Type_73,Yes
DB00310,Chlorthalidone,DB01180,Rescinnamine,0.8283716440200806,60,Type_60,Chlorthalidone may increase the hypotensive activities of Rescinnamine.,60,Type_60,Yes
DB01011,Metyrapone,DB08864,Rilpivirine,0.9141185283660889,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Metyrapone.,73,Type_73,Yes
DB00599,Thiopental,DB08864,Rilpivirine,0.5758713483810425,75,Type_75,The serum concentration of Rilpivirine can be decreased when it is combined with Thiopental.,73,Type_73,No
DB00284,Acarbose,DB06710,Methyltestosterone,0.9516198635101318,9,Type_9,Acarbose may increase the hypoglycemic activities of Methyltestosterone.,9,Type_9,Yes
DB00736,Esomeprazole,DB01124,Tolbutamide,0.682087242603302,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Esomeprazole.,47,Type_47,Yes
DB01076,Atorvastatin,DB08880,Teriflunomide,0.6170515418052673,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Atorvastatin.,73,Type_73,Yes
DB00624,Testosterone,DB01151,Desipramine,0.8428359627723694,47,Type_47,The metabolism of Desipramine can be decreased when combined with Testosterone.,47,Type_47,Yes
DB00619,Imatinib,DB01182,Propafenone,0.6129600405693054,47,Type_47,The metabolism of Propafenone can be decreased when combined with Imatinib.,73,Type_73,No
DB00715,Paroxetine,DB12532,Oxetacaine,0.9979894161224365,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Oxetacaine.,49,Type_49,Yes
DB00246,Ziprasidone,DB00822,Disulfiram,0.9032105803489685,47,Type_47,The metabolism of Disulfiram can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00622,Nicardipine,DB00972,Azelastine,0.9250581860542297,47,Type_47,The metabolism of Azelastine can be decreased when combined with Nicardipine.,47,Type_47,Yes
DB04743,Nimesulide,DB08976,Floctafenine,0.9887865781784058,49,Type_49,The risk or severity of adverse effects can be increased when Nimesulide is combined with Floctafenine.,49,Type_49,Yes
DB00204,Dofetilide,DB01184,Domperidone,0.7018187642097473,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Domperidone.,33,Type_33,No
DB01076,Atorvastatin,DB09055,Acipimox,0.9941457509994507,48,Type_48,Atorvastatin may increase the myopathic rhabdomyolysis activities of Acipimox.,48,Type_48,Yes
DB00261,Anagrelide,DB00379,Mexiletine,0.8184167742729187,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Anagrelide.,47,Type_47,Yes
DB00831,Trifluoperazine,DB00904,Ondansetron,0.9517396688461304,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ondansetron.,49,Type_49,Yes
DB00530,Erlotinib,DB00675,Tamoxifen,0.7322381138801575,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Erlotinib.,47,Type_47,Yes
DB00872,Conivaptan,DB01173,Orphenadrine,0.5628405213356018,73,Type_73,The serum concentration of Orphenadrine can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00251,Terconazole,DB00425,Zolpidem,0.5056122541427612,73,Type_73,The serum concentration of Zolpidem can be increased when it is combined with Terconazole.,73,Type_73,Yes
DB00217,Bethanidine,DB09220,Nicorandil,1.0,60,Type_60,Bethanidine may increase the hypotensive activities of Nicorandil.,60,Type_60,Yes
DB01142,Doxepin,DB06480,Prucalopride,0.9035228490829468,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB00850,Perphenazine,DB01264,Darunavir,0.4555118680000305,47,Type_47,The metabolism of Darunavir can be decreased when combined with Perphenazine.,73,Type_73,No
DB08815,Lurasidone,DB09053,Ibrutinib,0.9163187742233276,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Lurasidone.,73,Type_73,Yes
DB00679,Thioridazine,DB00710,Ibandronate,0.7220578789710999,20,Type_20,Thioridazine may increase the QTc-prolonging activities of Ibandronate.,20,Type_20,Yes
DB00390,Digoxin,DB00582,Voriconazole,0.8666568398475647,73,Type_73,The serum concentration of Voriconazole can be increased when it is combined with Digoxin.,47,Type_47,No
DB01466,Ethylmorphine,DB04871,Lorcaserin,0.6680006980895996,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Lorcaserin.,47,Type_47,No
DB00458,Imipramine,DB06684,Vilazodone,0.860841691493988,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Vilazodone.,49,Type_49,Yes
DB00321,Amitriptyline,DB01072,Atazanavir,0.47771310806274414,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB06441,Cangrelor,DB08887,Icosapent ethyl,0.6285006999969482,6,Type_6,Cangrelor may increase the anticoagulant activities of Icosapent ethyl.,6,Type_6,Yes
DB00924,Cyclobenzaprine,DB06204,Tapentadol,0.9441638588905334,16,Type_16,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00323,Tolcapone,DB00678,Losartan,0.6415143013000488,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Losartan.,49,Type_49,Yes
DB00304,Desogestrel,DB01351,Amobarbital,0.8098695874214172,70,Type_70,The therapeutic efficacy of Amobarbital can be decreased when used in combination with Desogestrel.,70,Type_70,Yes
DB00706,Tamsulosin,DB08899,Enzalutamide,0.9015297293663025,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Tamsulosin.,75,Type_75,Yes
DB01324,Polythiazide,DB01337,Pancuronium,0.9831992983818054,73,Type_73,The serum concentration of Pancuronium can be increased when it is combined with Polythiazide.,73,Type_73,Yes
DB01193,Acebutolol,DB08941,Isoxsuprine,0.9907644987106323,49,Type_49,The risk or severity of adverse effects can be increased when Acebutolol is combined with Isoxsuprine.,49,Type_49,Yes
DB00220,Nelfinavir,DB00972,Azelastine,0.8120124936103821,47,Type_47,The metabolism of Azelastine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00774,Hydroflumethiazide,DB06262,Droxidopa,0.9918449521064758,83,Type_83,Hydroflumethiazide may increase the hypokalemic activities of Droxidopa.,83,Type_83,Yes
DB00248,Cabergoline,DB01016,Glyburide,0.49483826756477356,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Glyburide.,49,Type_49,Yes
DB00341,Cetirizine,DB01075,Diphenhydramine,0.9688255786895752,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Diphenhydramine.,49,Type_49,Yes
DB00619,Imatinib,DB01092,Ouabain,0.9563518762588501,58,Type_58,Imatinib may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB01624,Zuclopenthixol,DB09072,Sodium oxybate,0.9999998807907104,16,Type_16,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01080,Vigabatrin,DB01142,Doxepin,0.9997318387031555,49,Type_49,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Doxepin.,49,Type_49,Yes
DB00605,Sulindac,DB01349,Tasosartan,0.8102089166641235,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Tasosartan.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB01155,Gemifloxacin,0.9979104399681091,27,Type_27,Acetylsalicylic acid may increase the neuroexcitatory activities of Gemifloxacin.,27,Type_27,Yes
DB00996,Gabapentin,DB01157,Trimetrexate,0.723352313041687,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Trimetrexate.,49,Type_49,Yes
DB00412,Rosiglitazone,DB00448,Lansoprazole,0.6499688029289246,47,Type_47,The metabolism of Lansoprazole can be decreased when combined with Rosiglitazone.,47,Type_47,Yes
DB00860,Prednisolone,DB01251,Gliquidone,0.9883566498756409,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Prednisolone.,70,Type_70,Yes
DB00452,Framycetin,DB01135,Doxacurium,0.9999985694885254,40,Type_40,Framycetin may increase the respiratory depressant activities of Doxacurium.,40,Type_40,Yes
DB06268,Sitaxentan,DB08895,Tofacitinib,0.916772723197937,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Sitaxentan.,73,Type_73,No
DB00673,Aprepitant,DB06595,Midostaurin,0.942962646484375,73,Type_73,The serum concentration of Midostaurin can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00295,Morphine,DB00590,Doxazosin,0.8524065613746643,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Doxazosin.,49,Type_49,Yes
DB01268,Sunitinib,DB04946,Iloperidone,0.8810122013092041,20,Type_20,Sunitinib may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB00312,Pentobarbital,DB09238,Manidipine,0.9097536206245422,4,Type_4,The metabolism of Manidipine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00367,Levonorgestrel,DB01072,Atazanavir,0.4401661455631256,75,Type_75,The serum concentration of Atazanavir can be decreased when it is combined with Levonorgestrel.,73,Type_73,No
DB00508,Triflupromazine,DB08910,Pomalidomide,0.9961131811141968,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Pomalidomide.,49,Type_49,Yes
DB00181,Baclofen,DB00246,Ziprasidone,0.9836204051971436,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Ziprasidone.,49,Type_49,Yes
DB00705,Delavirdine,DB01283,Lumiracoxib,0.9251080751419067,47,Type_47,The metabolism of Lumiracoxib can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00420,Promazine,DB01189,Desflurane,0.8823872804641724,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Desflurane.,20,Type_20,No
DB00813,Fentanyl,DB06153,Pizotifen,0.9966059923171997,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Pizotifen.,49,Type_49,Yes
DB01062,Oxybutynin,DB01338,Pipecuronium,0.9930643439292908,49,Type_49,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pipecuronium.,49,Type_49,Yes
DB00695,Furosemide,DB00768,Olopatadine,0.9991232752799988,29,Type_29,Furosemide may decrease the diuretic activities of Olopatadine.,29,Type_29,Yes
DB00518,Albendazole,DB01601,Lopinavir,0.8747432827949524,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Albendazole.,47,Type_47,Yes
DB00635,Prednisone,DB13595,Almasilate,0.9996337890625,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Prednisone.,3,Type_3,Yes
DB00391,Sulpiride,DB01154,Thiamylal,0.9772202372550964,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Thiamylal.,49,Type_49,Yes
DB00564,Carbamazepine,DB11730,Ribociclib,0.8948583602905273,75,Type_75,The serum concentration of Ribociclib can be decreased when it is combined with Carbamazepine.,75,Type_75,Yes
DB00502,Haloperidol,DB00521,Carteolol,0.5200951099395752,47,Type_47,The metabolism of Carteolol can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00691,Moexipril,DB00864,Tacrolimus,0.781194269657135,73,Type_73,The serum concentration of Tacrolimus can be increased when it is combined with Moexipril.,47,Type_47,No
DB00227,Lovastatin,DB01355,Hexobarbital,0.5379947423934937,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00338,Omeprazole,DB00675,Tamoxifen,0.8890954256057739,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00363,Clozapine,DB01577,Metamfetamine,0.8912528157234192,47,Type_47,The metabolism of Metamfetamine can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00511,Acetyldigitoxin,DB01128,Bicalutamide,0.9684452414512634,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Bicalutamide.,58,Type_58,Yes
DB00554,Piroxicam,DB00873,Loteprednol,0.9997963309288025,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Loteprednol.,49,Type_49,Yes
DB01319,Fosamprenavir,DB11613,Velpatasvir,0.7331018447875977,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00338,Omeprazole,DB01221,Ketamine,0.9569806456565857,47,Type_47,The metabolism of Ketamine can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00420,Promazine,DB12070,Letermovir,0.5485954880714417,73,Type_73,The serum concentration of Letermovir can be increased when it is combined with Promazine.,47,Type_47,No
DB00203,Sildenafil,DB00869,Dorzolamide,0.703245997428894,10,Type_10,Sildenafil may increase the antihypertensive activities of Dorzolamide.,10,Type_10,Yes
DB00564,Carbamazepine,DB01181,Ifosfamide,0.8615380525588989,4,Type_4,The metabolism of Ifosfamide can be increased when combined with Carbamazepine.,77,Type_77,No
DB00333,Methadone,DB00695,Furosemide,0.910337507724762,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Furosemide.,49,Type_49,Yes
DB00908,Quinidine,DB01174,Phenobarbital,0.7640421390533447,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Quinidine.,80,Type_80,No
DB00524,Metolazone,DB00588,Fluticasone propionate,0.9269280433654785,83,Type_83,Metolazone may increase the hypokalemic activities of Fluticasone propionate.,83,Type_83,Yes
DB00755,Tretinoin,DB08868,Fingolimod,0.9286701679229736,34,Type_34,Tretinoin may increase the immunosuppressive activities of Fingolimod.,34,Type_34,Yes
DB01251,Gliquidone,DB09123,Dienogest,0.994484007358551,70,Type_70,The therapeutic efficacy of Dienogest can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB00237,Butabarbital,DB00765,Metyrosine,0.9944719076156616,32,Type_32,Butabarbital may increase the sedative activities of Metyrosine.,32,Type_32,Yes
DB00568,Cinnarizine,DB01099,Flucytosine,0.8693448305130005,49,Type_49,The risk or severity of adverse effects can be increased when Cinnarizine is combined with Flucytosine.,49,Type_49,Yes
DB00325,Nitroprusside,DB00925,Phenoxybenzamine,0.8910920023918152,60,Type_60,Nitroprusside may increase the hypotensive activities of Phenoxybenzamine.,60,Type_60,Yes
DB00647,Dextropropoxyphene,DB01545,Ethyl loflazepate,0.9999463558197021,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Ethyl loflazepate.,49,Type_49,Yes
DB06712,Nilvadipine,DB11126,Calcium gluconate,0.9804385900497437,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Nilvadipine.,70,Type_70,Yes
DB01072,Atazanavir,DB01260,Desonide,0.9804046750068665,73,Type_73,The serum concentration of Desonide can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00489,Sotalol,DB00938,Salmeterol,0.8515927195549011,20,Type_20,Sotalol may increase the QTc-prolonging activities of Salmeterol.,20,Type_20,Yes
DB09235,Efonidipine,DB09236,Lacidipine,0.9436991810798645,60,Type_60,Efonidipine may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00241,Butalbital,DB00985,Dimenhydrinate,0.9999896287918091,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Dimenhydrinate.,49,Type_49,Yes
DB00398,Sorafenib,DB00751,Epinastine,0.7000026702880859,47,Type_47,The metabolism of Epinastine can be decreased when combined with Sorafenib.,47,Type_47,Yes
DB05266,Ibudilast,DB09211,Limaprost,0.8159592747688293,53,Type_53,Ibudilast may increase the antiplatelet activities of Limaprost.,53,Type_53,Yes
DB01136,Carvedilol,DB06717,Fosaprepitant,0.9617531299591064,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Carvedilol.,73,Type_73,Yes
DB00495,Zidovudine,DB05265,Ecabet,0.4539729654788971,47,Type_47,The metabolism of Ecabet can be decreased when combined with Zidovudine.,75,Type_75,No
DB00584,Enalapril,DB01229,Paclitaxel,0.9899633526802063,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Paclitaxel.,49,Type_49,Yes
DB01072,Atazanavir,DB08828,Vismodegib,0.714387834072113,47,Type_47,The metabolism of Vismodegib can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00404,Alprazolam,DB00904,Ondansetron,0.958818256855011,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Ondansetron.,49,Type_49,Yes
DB00325,Nitroprusside,DB00880,Chlorothiazide,0.5122298002243042,49,Type_49,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Chlorothiazide.,49,Type_49,Yes
DB01621,Pipotiazine,DB09352,Hydroxyamphetamine,0.9465751647949219,61,Type_61,Pipotiazine may decrease the stimulatory activities of Hydroxyamphetamine.,61,Type_61,Yes
DB00808,Indapamide,DB01397,Magnesium salicylate,0.9714636206626892,70,Type_70,The therapeutic efficacy of Magnesium salicylate can be decreased when used in combination with Indapamide.,70,Type_70,Yes
DB00608,Chloroquine,DB09330,Osimertinib,0.8515772223472595,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Chloroquine.,73,Type_73,Yes
DB01320,Fosphenytoin,DB08798,Sulfamoxole,0.9253415465354919,4,Type_4,The metabolism of Sulfamoxole can be increased when combined with Fosphenytoin.,4,Type_4,Yes
DB00679,Thioridazine,DB06700,Desvenlafaxine,0.8522939682006836,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Desvenlafaxine.,49,Type_49,Yes
DB01002,Levobupivacaine,DB13323,Trichloroethylene,0.9968620538711548,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Trichloroethylene.,49,Type_49,Yes
DB01137,Levofloxacin,DB08880,Teriflunomide,0.8730165362358093,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Teriflunomide.,73,Type_73,No
DB00312,Pentobarbital,DB00494,Entacapone,0.5797533392906189,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Entacapone.,49,Type_49,Yes
DB01227,Levacetylmethadol,DB08912,Dabrafenib,0.9100944399833679,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Levacetylmethadol.,75,Type_75,Yes
DB00169,Cholecalciferol,DB00675,Tamoxifen,0.9351378083229065,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Cholecalciferol.,11,Type_11,No
DB00227,Lovastatin,DB00755,Tretinoin,0.7303846478462219,47,Type_47,The metabolism of Tretinoin can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB01394,Colchicine,DB12026,Voxilaprevir,0.9160280227661133,73,Type_73,The serum concentration of Voxilaprevir can be increased when it is combined with Colchicine.,73,Type_73,Yes
DB00333,Methadone,DB01221,Ketamine,0.36612892150878906,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,49,Type_49,No
DB01544,Flunitrazepam,DB09068,Vortioxetine,0.9966237545013428,49,Type_49,The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Vortioxetine.,49,Type_49,Yes
DB01171,Moclobemide,DB09570,Ixazomib,0.8482763171195984,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Moclobemide.,47,Type_47,Yes
DB01054,Nitrendipine,DB06207,Silodosin,0.7069112658500671,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Nitrendipine.,73,Type_73,Yes
DB00872,Conivaptan,DB01081,Diphenoxylate,0.8893253803253174,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Diphenoxylate.,49,Type_49,Yes
DB00805,Minaprine,DB00938,Salmeterol,0.7832529544830322,49,Type_49,The risk or severity of adverse effects can be increased when Minaprine is combined with Salmeterol.,49,Type_49,Yes
DB00672,Chlorpropamide,DB00695,Furosemide,0.9608472585678101,70,Type_70,The therapeutic efficacy of Furosemide can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB01215,Estazolam,DB08865,Crizotinib,0.9102623462677002,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Estazolam.,47,Type_47,Yes
DB00722,Lisinopril,DB04948,Lofexidine,0.8324226140975952,60,Type_60,Lisinopril may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00203,Sildenafil,DB01115,Nifedipine,0.6603754758834839,47,Type_47,The metabolism of Nifedipine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00780,Phenelzine,DB01614,Acepromazine,0.9509984254837036,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Acepromazine.,49,Type_49,Yes
DB00420,Promazine,DB01167,Itraconazole,0.4763861894607544,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Promazine.,47,Type_47,Yes
DB00556,Perflutren,DB00808,Indapamide,1.0,20,Type_20,Perflutren may increase the QTc-prolonging activities of Indapamide.,20,Type_20,Yes
DB08882,Linagliptin,DB09289,Tianeptine,0.4856811463832855,73,Type_73,The serum concentration of Tianeptine can be increased when it is combined with Linagliptin.,73,Type_73,Yes
DB00178,Ramipril,DB00945,Acetylsalicylic acid,0.6830257773399353,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Acetylsalicylic acid.,37,Type_37,No
DB00945,Acetylsalicylic acid,DB09091,Tixocortol,0.9990891218185425,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tixocortol.,49,Type_49,Yes
DB01030,Topotecan,DB01229,Paclitaxel,0.970048725605011,49,Type_49,The risk or severity of adverse effects can be increased when Topotecan is combined with Paclitaxel.,73,Type_73,No
DB01028,Methoxyflurane,DB01167,Itraconazole,0.9053475260734558,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Methoxyflurane.,47,Type_47,Yes
DB00222,Glimepiride,DB09167,Dosulepin,0.8278513550758362,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Glimepiride.,47,Type_47,Yes
DB00559,Bosentan,DB00962,Zaleplon,0.7155511379241943,75,Type_75,The serum concentration of Zaleplon can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00681,Amphotericin B,DB09232,Cilnidipine,0.9995817542076111,49,Type_49,The risk or severity of adverse effects can be increased when Amphotericin B is combined with Cilnidipine.,49,Type_49,Yes
DB00497,Oxycodone,DB00835,Brompheniramine,0.9948933124542236,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Brompheniramine.,49,Type_49,Yes
DB01093,Dimethyl sulfoxide,DB09053,Ibrutinib,0.7745475172996521,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Dimethyl sulfoxide.,73,Type_73,Yes
DB00418,Secobarbital,DB01169,Arsenic trioxide,0.48095399141311646,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Arsenic trioxide.,60,Type_60,No
DB00227,Lovastatin,DB00324,Fluorometholone,0.8979753255844116,47,Type_47,The metabolism of Fluorometholone can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00776,Oxcarbazepine,DB09027,Ledipasvir,0.5754765868186951,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Oxcarbazepine.,75,Type_75,No
DB00182,Amphetamine,DB01244,Bepridil,0.9810652136802673,60,Type_60,Amphetamine may increase the hypotensive activities of Bepridil.,60,Type_60,Yes
DB00809,Tropicamide,DB00908,Quinidine,0.9638941884040833,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Quinidine.,49,Type_49,Yes
DB01041,Thalidomide,DB01545,Ethyl loflazepate,0.9793497920036316,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.,16,Type_16,Yes
DB00312,Pentobarbital,DB01320,Fosphenytoin,0.6982679963111877,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00224,Indinavir,DB01016,Glyburide,0.854103147983551,47,Type_47,The metabolism of Glyburide can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00988,Dopamine,DB05219,Crisaborole,0.99825519323349,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Dopamine.,47,Type_47,Yes
DB01260,Desonide,DB08938,Magaldrate,0.9983264803886414,3,Type_3,The bioavailability of Magaldrate can be decreased when combined with Desonide.,3,Type_3,Yes
DB00182,Amphetamine,DB01209,Dezocine,0.9846637845039368,69,Type_69,Amphetamine may increase the analgesic activities of Dezocine.,69,Type_69,Yes
DB00849,Methylphenobarbital,DB09477,Enalaprilat,0.8559844493865967,60,Type_60,Methylphenobarbital may increase the hypotensive activities of Enalaprilat.,60,Type_60,Yes
DB00620,Triamcinolone,DB06412,Oxymetholone,0.9945734143257141,74,Type_74,Triamcinolone may increase the fluid retaining activities of Oxymetholone.,74,Type_74,Yes
DB01014,Balsalazide,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Balsalazide.,70,Type_70,Yes
DB01154,Thiamylal,DB01219,Dantrolene,0.9600054025650024,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Dantrolene.,49,Type_49,Yes
DB00752,Tranylcypromine,DB01143,Amifostine,0.5985148549079895,60,Type_60,Tranylcypromine may increase the hypotensive activities of Amifostine.,49,Type_49,No
DB00647,Dextropropoxyphene,DB06144,Sertindole,0.9915779829025269,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Sertindole.,49,Type_49,Yes
DB00976,Telithromycin,DB09078,Lenvatinib,0.5366607904434204,20,Type_20,Telithromycin may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00312,Pentobarbital,DB05246,Methsuximide,0.7327531576156616,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Methsuximide.,49,Type_49,Yes
DB00712,Flurbiprofen,DB09091,Tixocortol,0.999588668346405,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tixocortol.,49,Type_49,Yes
DB09167,Dosulepin,DB11586,Asunaprevir,0.8003040552139282,47,Type_47,The metabolism of Asunaprevir can be decreased when combined with Dosulepin.,73,Type_73,No
DB00237,Butabarbital,DB09071,Tasimelteon,0.9998408555984497,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Tasimelteon.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB08932,Macitentan,0.9999445676803589,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00524,Metolazone,DB01168,Procarbazine,0.8761550188064575,60,Type_60,Metolazone may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00794,Primidone,DB00904,Ondansetron,0.8245618343353271,4,Type_4,The metabolism of Ondansetron can be increased when combined with Primidone.,4,Type_4,Yes
DB00333,Methadone,DB00753,Isoflurane,0.5186153054237366,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Isoflurane.,20,Type_20,No
DB00511,Acetyldigitoxin,DB00685,Trovafloxacin,0.9952654838562012,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Trovafloxacin.,58,Type_58,Yes
DB00310,Chlorthalidone,DB01435,Antipyrine,0.9722895622253418,70,Type_70,The therapeutic efficacy of Antipyrine can be decreased when used in combination with Chlorthalidone.,70,Type_70,Yes
DB08797,Salicylamide,DB08984,Etofenamate,0.9990959167480469,49,Type_49,The risk or severity of adverse effects can be increased when Salicylamide is combined with Etofenamate.,49,Type_49,Yes
DB01151,Desipramine,DB01608,Periciazine,0.5781807899475098,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Periciazine.,49,Type_49,Yes
DB00643,Mebendazole,DB09280,Lumacaftor,0.5260506868362427,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Mebendazole.,4,Type_4,No
DB00673,Aprepitant,DB00749,Etodolac,0.8764365315437317,73,Type_73,The serum concentration of Etodolac can be increased when it is combined with Aprepitant.,4,Type_4,No
DB00502,Haloperidol,DB00731,Nateglinide,0.6710782051086426,47,Type_47,The metabolism of Nateglinide can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00420,Promazine,DB00794,Primidone,0.5424122214317322,4,Type_4,The metabolism of Primidone can be increased when combined with Promazine.,4,Type_4,Yes
DB00337,Pimecrolimus,DB08873,Boceprevir,0.7149255275726318,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Pimecrolimus.,47,Type_47,Yes
DB00633,Dexmedetomidine,DB01403,Methotrimeprazine,0.6663284301757812,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Methotrimeprazine.,16,Type_16,No
DB00270,Isradipine,DB00956,Hydrocodone,0.7074082493782043,47,Type_47,The metabolism of Hydrocodone can be decreased when combined with Isradipine.,73,Type_73,No
DB00472,Fluoxetine,DB01424,Aminophenazone,0.9745312333106995,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB09039,Eliglustat,DB09078,Lenvatinib,0.7815878391265869,20,Type_20,Eliglustat may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00570,Vinblastine,DB08865,Crizotinib,0.934845507144928,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Vinblastine.,47,Type_47,Yes
DB08933,Luliconazole,DB09049,Naloxegol,0.9999388456344604,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Luliconazole.,73,Type_73,Yes
DB01151,Desipramine,DB04908,Flibanserin,0.9841637015342712,49,Type_49,The risk or severity of adverse effects can be increased when Desipramine is combined with Flibanserin.,49,Type_49,Yes
DB00497,Oxycodone,DB01558,Bromazepam,0.9971069693565369,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Bromazepam.,49,Type_49,Yes
DB01320,Fosphenytoin,DB09118,Stiripentol,0.7664881348609924,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Fosphenytoin.,47,Type_47,No
DB01012,Cinacalcet,DB06684,Vilazodone,0.895133912563324,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00838,Clocortolone,DB08899,Enzalutamide,0.9830800294876099,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Clocortolone.,75,Type_75,Yes
DB00333,Methadone,DB00927,Famotidine,0.546136736869812,47,Type_47,The metabolism of Famotidine can be decreased when combined with Methadone.,20,Type_20,No
DB01174,Phenobarbital,DB01324,Polythiazide,0.5774494409561157,60,Type_60,Phenobarbital may increase the hypotensive activities of Polythiazide.,30,Type_30,No
DB00496,Darifenacin,DB09073,Palbociclib,0.9969315528869629,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Darifenacin.,73,Type_73,Yes
DB00318,Codeine,DB01337,Pancuronium,0.9997472167015076,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Pancuronium.,49,Type_49,Yes
DB00945,Acetylsalicylic acid,DB01137,Levofloxacin,0.9901536107063293,27,Type_27,Acetylsalicylic acid may increase the neuroexcitatory activities of Levofloxacin.,27,Type_27,Yes
DB00338,Omeprazole,DB00399,Zoledronic acid,0.9024109244346619,70,Type_70,The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Omeprazole.,70,Type_70,Yes
DB00678,Losartan,DB06738,Ketobemidone,0.7005861401557922,47,Type_47,The metabolism of Ketobemidone can be decreased when combined with Losartan.,47,Type_47,Yes
DB00459,Acitretin,DB06713,Norelgestromin,0.9910755157470703,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Acitretin.,70,Type_70,Yes
DB00883,Isosorbide dinitrate,DB08912,Dabrafenib,0.971319317817688,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Isosorbide dinitrate.,75,Type_75,Yes
DB00838,Clocortolone,DB06196,Icatibant,0.9998167157173157,49,Type_49,The risk or severity of adverse effects can be increased when Clocortolone is combined with Icatibant.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB01406,Danazol,0.997670590877533,74,Type_74,Fluocinolone acetonide may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB00412,Rosiglitazone,DB00467,Enoxacin,0.9792109131813049,9,Type_9,Rosiglitazone may increase the hypoglycemic activities of Enoxacin.,9,Type_9,Yes
DB00678,Losartan,DB01250,Olsalazine,0.9005621671676636,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Olsalazine.,49,Type_49,Yes
DB00358,Mefloquine,DB08883,Perampanel,0.7968165874481201,70,Type_70,The therapeutic efficacy of Perampanel can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB01424,Aminophenazone,DB09120,Zucapsaicin,0.9986740350723267,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Aminophenazone.,47,Type_47,Yes
DB01041,Thalidomide,DB06290,Simeprevir,0.8179757595062256,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Thalidomide.,47,Type_47,No
DB00476,Duloxetine,DB00494,Entacapone,0.8709802031517029,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Entacapone.,49,Type_49,Yes
DB01197,Captopril,DB11079,Trolamine salicylate,0.9290609359741211,37,Type_37,Captopril may decrease the antihypertensive activities of Trolamine salicylate.,37,Type_37,Yes
DB00214,Torasemide,DB08931,Riociguat,0.9214584231376648,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Riociguat.,49,Type_49,Yes
DB00193,Tramadol,DB01116,Trimethaphan,0.9941112399101257,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Trimethaphan.,49,Type_49,Yes
DB00443,Betamethasone,DB01021,Trichlormethiazide,0.9999669790267944,83,Type_83,Betamethasone may increase the hypokalemic activities of Trichlormethiazide.,83,Type_83,Yes
DB01167,Itraconazole,DB09030,Vorapaxar,0.9365854263305664,73,Type_73,The serum concentration of Vorapaxar can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB08971,Fluocortolone,DB09070,Tibolone,0.952257513999939,73,Type_73,The serum concentration of Tibolone can be increased when it is combined with Fluocortolone.,73,Type_73,Yes
DB00544,Fluorouracil,DB00946,Phenprocoumon,0.5336856842041016,73,Type_73,The serum concentration of Phenprocoumon can be increased when it is combined with Fluorouracil.,73,Type_73,Yes
DB00794,Primidone,DB01182,Propafenone,0.7107607126235962,4,Type_4,The metabolism of Propafenone can be increased when combined with Primidone.,75,Type_75,No
DB00402,Eszopiclone,DB01437,Glutethimide,0.9987215399742126,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Glutethimide.,49,Type_49,Yes
DB00201,Caffeine,DB01058,Praziquantel,0.8067141175270081,47,Type_47,The metabolism of Praziquantel can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00377,Palonosetron,DB08820,Ivacaftor,0.9976807832717896,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Palonosetron.,73,Type_73,Yes
DB00603,Medroxyprogesterone acetate,DB06228,Rivaroxaban,0.5024348497390747,70,Type_70,The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Medroxyprogesterone acetate.,70,Type_70,Yes
DB00968,Methyldopa,DB09147,Ferric pyrophosphate,0.5603381395339966,75,Type_75,The serum concentration of Ferric pyrophosphate can be decreased when it is combined with Methyldopa.,75,Type_75,Yes
DB01029,Irbesartan,DB06712,Nilvadipine,0.5443814396858215,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Nilvadipine.,60,Type_60,No
DB00424,Hyoscyamine,DB11315,Methscopolamine,0.9511400461196899,49,Type_49,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methscopolamine.,49,Type_49,Yes
DB01263,Posaconazole,DB01609,Deferasirox,0.7369274497032166,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Posaconazole.,75,Type_75,Yes
DB00476,Duloxetine,DB13874,Enasidenib,0.650818407535553,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB00402,Eszopiclone,DB01609,Deferasirox,0.9612913727760315,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Eszopiclone.,75,Type_75,Yes
DB01325,Quinethazone,DB01435,Antipyrine,0.9865309596061707,70,Type_70,The therapeutic efficacy of Antipyrine can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB00446,Chloramphenicol,DB01095,Fluvastatin,0.8215734362602234,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Chloramphenicol.,73,Type_73,No
DB00332,Ipratropium,DB00774,Hydroflumethiazide,0.9906615614891052,73,Type_73,The serum concentration of Hydroflumethiazide can be increased when it is combined with Ipratropium.,73,Type_73,Yes
DB00208,Ticlopidine,DB08868,Fingolimod,0.8721762895584106,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00726,Trimipramine,DB09080,Olodaterol,0.7179200053215027,49,Type_49,The risk or severity of adverse effects can be increased when Trimipramine is combined with Olodaterol.,49,Type_49,Yes
DB00210,Adapalene,DB08807,Bopindolol,0.9999217987060547,37,Type_37,Adapalene may decrease the antihypertensive activities of Bopindolol.,37,Type_37,Yes
DB00175,Pravastatin,DB00622,Nicardipine,0.35676106810569763,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB00335,Atenolol,DB00784,Mefenamic acid,0.977056086063385,37,Type_37,Atenolol may decrease the antihypertensive activities of Mefenamic acid.,37,Type_37,Yes
DB06218,Lacosamide,DB06595,Midostaurin,0.8446969985961914,75,Type_75,The serum concentration of Midostaurin can be decreased when it is combined with Lacosamide.,73,Type_73,No
DB05271,Rotigotine,DB09225,Zotepine,0.9550843238830566,32,Type_32,Rotigotine may increase the sedative activities of Zotepine.,32,Type_32,Yes
DB00444,Teniposide,DB00541,Vincristine,0.7171798944473267,73,Type_73,The serum concentration of Vincristine can be increased when it is combined with Teniposide.,35,Type_35,No
DB00571,Propranolol,DB00908,Quinidine,0.920367956161499,47,Type_47,The metabolism of Quinidine can be decreased when combined with Propranolol.,73,Type_73,No
DB00598,Labetalol,DB00795,Sulfasalazine,0.9997969269752502,37,Type_37,Labetalol may decrease the antihypertensive activities of Sulfasalazine.,37,Type_37,Yes
DB00287,Travoprost,DB01024,Mycophenolic acid,0.9958181977272034,70,Type_70,The therapeutic efficacy of Mycophenolic acid can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB00573,Fenoprofen,DB04743,Nimesulide,0.9981057643890381,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Nimesulide.,49,Type_49,Yes
DB00754,Ethotoin,DB00829,Diazepam,0.9796733856201172,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Diazepam.,49,Type_49,Yes
DB00805,Minaprine,DB00940,Methantheline,0.9690069556236267,70,Type_70,The therapeutic efficacy of Methantheline can be decreased when used in combination with Minaprine.,70,Type_70,Yes
DB01197,Captopril,DB04948,Lofexidine,0.8258917331695557,60,Type_60,Captopril may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB00428,Streptozocin,DB03585,Oxyphenbutazone,0.9975554943084717,72,Type_72,Streptozocin may decrease the excretion rate of Oxyphenbutazone which could result in a higher serum level.,72,Type_72,Yes
DB00783,Estradiol,DB00873,Loteprednol,0.9850381016731262,73,Type_73,The serum concentration of Loteprednol can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB09078,Lenvatinib,DB09291,Rolapitant,0.848039984703064,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Lenvatinib.,73,Type_73,No
DB01184,Domperidone,DB01267,Paliperidone,0.655727207660675,20,Type_20,Domperidone may increase the QTc-prolonging activities of Paliperidone.,33,Type_33,No
DB00187,Esmolol,DB00706,Tamsulosin,0.7585256695747375,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Tamsulosin.,30,Type_30,No
DB01118,Amiodarone,DB01409,Tiotropium,0.9350873827934265,47,Type_47,The metabolism of Tiotropium can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00434,Cyproheptadine,DB01235,Levodopa,0.9975537657737732,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Levodopa.,49,Type_49,Yes
DB00869,Dorzolamide,DB04868,Nilotinib,0.9858689308166504,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Dorzolamide.,47,Type_47,Yes
DB01618,Molindone,DB06716,Fospropofol,0.9999964237213135,49,Type_49,The risk or severity of adverse effects can be increased when Molindone is combined with Fospropofol.,49,Type_49,Yes
DB00375,Colestipol,DB12598,Nafamostat,0.5699394345283508,67,Type_67,Colestipol can cause a decrease in the absorption of Nafamostat resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00189,Ethchlorvynol,DB00237,Butabarbital,0.9999955892562866,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Butabarbital.,49,Type_49,Yes
DB01041,Thalidomide,DB08881,Vemurafenib,0.8505054712295532,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Thalidomide.,73,Type_73,No
DB00502,Haloperidol,DB00945,Acetylsalicylic acid,0.5377624034881592,47,Type_47,The metabolism of Acetylsalicylic acid can be decreased when combined with Haloperidol.,49,Type_49,No
DB00518,Albendazole,DB01118,Amiodarone,0.8761308789253235,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Albendazole.,47,Type_47,Yes
DB00234,Reboxetine,DB12332,Rucaparib,0.9503946304321289,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Reboxetine.,47,Type_47,Yes
DB00818,Propofol,DB05521,Telaprevir,0.7980040311813354,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Propofol.,47,Type_47,Yes
DB00844,Nalbuphine,DB01209,Dezocine,0.9977545142173767,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dezocine.,49,Type_49,Yes
DB00233,Aminosalicylic acid,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Aminosalicylic acid.,70,Type_70,Yes
DB00571,Propranolol,DB06290,Simeprevir,0.9373898506164551,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB01367,Rasagiline,DB09238,Manidipine,0.8303795456886292,60,Type_60,Rasagiline may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB00690,Flurazepam,DB01167,Itraconazole,0.8963639736175537,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Flurazepam.,47,Type_47,Yes
DB00216,Eletriptan,DB09120,Zucapsaicin,0.9922965168952942,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Eletriptan.,47,Type_47,Yes
DB06016,Cariprazine,DB06708,Lumefantrine,0.8732183575630188,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Cariprazine.,47,Type_47,Yes
DB00328,Indomethacin,DB00487,Pefloxacin,0.998865008354187,27,Type_27,Indomethacin may increase the neuroexcitatory activities of Pefloxacin.,27,Type_27,Yes
DB00757,Dolasetron,DB01591,Solifenacin,0.6514418125152588,20,Type_20,Dolasetron may increase the QTc-prolonging activities of Solifenacin.,20,Type_20,Yes
DB00555,Lamotrigine,DB08910,Pomalidomide,0.9952892065048218,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Pomalidomide.,49,Type_49,Yes
DB00712,Flurbiprofen,DB00936,Salicylic acid,0.8848583102226257,49,Type_49,The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Salicylic acid.,49,Type_49,Yes
DB00185,Cevimeline,DB06636,Isavuconazonium,0.9518930315971375,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Cevimeline.,47,Type_47,Yes
DB01244,Bepridil,DB09039,Eliglustat,0.6436232328414917,20,Type_20,Bepridil may increase the QTc-prolonging activities of Eliglustat.,47,Type_47,No
DB08916,Afatinib,DB09049,Naloxegol,0.9971864819526672,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Afatinib.,73,Type_73,Yes
DB01551,Dihydrocodeine,DB01615,Aceprometazine,0.9896036386489868,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Aceprometazine.,49,Type_49,Yes
DB01200,Bromocriptine,DB01238,Aripiprazole,0.9420250654220581,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Bromocriptine.,60,Type_60,No
DB00648,Mitotane,DB00925,Phenoxybenzamine,0.9873506426811218,75,Type_75,The serum concentration of Phenoxybenzamine can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00543,Amoxapine,DB00747,Scopolamine,0.9989149570465088,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Scopolamine.,49,Type_49,Yes
DB00836,Loperamide,DB04871,Lorcaserin,0.9668060541152954,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Loperamide.,47,Type_47,Yes
DB00678,Losartan,DB01167,Itraconazole,0.9316766858100891,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Losartan.,47,Type_47,Yes
DB00351,Megestrol acetate,DB00731,Nateglinide,0.970180094242096,70,Type_70,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00208,Ticlopidine,DB00261,Anagrelide,0.6227880120277405,47,Type_47,The metabolism of Anagrelide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00230,Pregabalin,DB00313,Valproic acid,0.5912707448005676,70,Type_70,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Pregabalin.,70,Type_70,Yes
DB00476,Duloxetine,DB00625,Efavirenz,0.7962655425071716,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Duloxetine.,49,Type_49,No
DB01221,Ketamine,DB06636,Isavuconazonium,0.9076864719390869,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Ketamine.,47,Type_47,Yes
DB00715,Paroxetine,DB01418,Acenocoumarol,0.6424627900123596,6,Type_6,Paroxetine may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01032,Probenecid,DB11079,Trolamine salicylate,0.8094435334205627,73,Type_73,The serum concentration of Trolamine salicylate can be increased when it is combined with Probenecid.,70,Type_70,No
DB00489,Sotalol,DB06723,Aluminum hydroxide,0.611532986164093,75,Type_75,The serum concentration of Aluminum hydroxide can be decreased when it is combined with Sotalol.,75,Type_75,Yes
DB00476,Duloxetine,DB01115,Nifedipine,0.8653628826141357,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Nifedipine.,30,Type_30,Yes
DB00612,Bisoprolol,DB01118,Amiodarone,0.6632992029190063,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Bisoprolol.,54,Type_54,No
DB00575,Clonidine,DB00806,Pentoxifylline,0.9932968020439148,60,Type_60,Clonidine may increase the hypotensive activities of Pentoxifylline.,60,Type_60,Yes
DB01259,Lapatinib,DB09119,Eslicarbazepine acetate,0.8655556440353394,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Lapatinib.,47,Type_47,Yes
DB01399,Salsalate,DB09204,Arotinolol,0.9996505975723267,37,Type_37,Salsalate may decrease the antihypertensive activities of Arotinolol.,37,Type_37,Yes
DB00297,Bupivacaine,DB00925,Phenoxybenzamine,0.5586227178573608,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Phenoxybenzamine.,49,Type_49,Yes
DB00591,Fluocinolone acetonide,DB01264,Darunavir,0.7396875023841858,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Fluocinolone acetonide.,73,Type_73,Yes
DB00936,Salicylic acid,DB06335,Saxagliptin,0.7053709030151367,9,Type_9,Salicylic acid may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB00188,Bortezomib,DB00370,Mirtazapine,0.6265228390693665,47,Type_47,The metabolism of Mirtazapine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00598,Labetalol,DB01193,Acebutolol,0.4228212535381317,25,Type_25,Labetalol may increase the atrioventricular blocking (AV block) activities of Acebutolol.,30,Type_30,No
DB00443,Betamethasone,DB01072,Atazanavir,0.8567795753479004,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Betamethasone.,73,Type_73,Yes
DB00244,Mesalazine,DB06203,Alogliptin,0.9997040629386902,9,Type_9,Mesalazine may increase the hypoglycemic activities of Alogliptin.,9,Type_9,Yes
DB00665,Nilutamide,DB12332,Rucaparib,0.9320104718208313,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Nilutamide.,47,Type_47,Yes
DB00443,Betamethasone,DB01325,Quinethazone,0.9999963045120239,83,Type_83,Betamethasone may increase the hypokalemic activities of Quinethazone.,83,Type_83,Yes
DB00418,Secobarbital,DB01612,Amyl Nitrite,0.8538551926612854,60,Type_60,Secobarbital may increase the hypotensive activities of Amyl Nitrite.,60,Type_60,Yes
DB00252,Phenytoin,DB08987,Etidocaine,0.9941999912261963,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Etidocaine.,49,Type_49,Yes
DB00543,Amoxapine,DB00976,Telithromycin,0.8005712628364563,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Telithromycin.,20,Type_20,Yes
DB01268,Sunitinib,DB08903,Bedaquiline,0.9724339246749878,20,Type_20,Sunitinib may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB01097,Leflunomide,DB06209,Prasugrel,0.6132188439369202,47,Type_47,The metabolism of Prasugrel can be decreased when combined with Leflunomide.,47,Type_47,Yes
DB01037,Selegiline,DB01320,Fosphenytoin,0.7022698521614075,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Selegiline.,4,Type_4,Yes
DB01232,Saquinavir,DB08899,Enzalutamide,0.9396836757659912,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Saquinavir.,75,Type_75,Yes
DB00220,Nelfinavir,DB00865,Benzphetamine,0.9919156432151794,47,Type_47,The metabolism of Benzphetamine can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00975,Dipyridamole,DB09027,Ledipasvir,0.8835291266441345,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Dipyridamole.,73,Type_73,Yes
DB00831,Trifluoperazine,DB01203,Nadolol,0.9638141989707947,60,Type_60,Trifluoperazine may increase the hypotensive activities of Nadolol.,60,Type_60,Yes
DB04574,Estrone sulfate,DB05521,Telaprevir,0.8496407866477966,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Estrone sulfate.,75,Type_75,No
DB00673,Aprepitant,DB08865,Crizotinib,0.873086154460907,73,Type_73,The serum concentration of Crizotinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB01030,Topotecan,DB09102,Daclatasvir,0.9726848006248474,73,Type_73,The serum concentration of Daclatasvir can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB00188,Bortezomib,DB00486,Nabilone,0.9896092414855957,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Nabilone.,49,Type_49,Yes
DB00987,Cytarabine,DB09280,Lumacaftor,0.4943767189979553,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Cytarabine.,4,Type_4,No
DB01410,Ciclesonide,DB08909,Glycerol phenylbutyrate,0.9467719793319702,70,Type_70,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Ciclesonide.,70,Type_70,Yes
DB00708,Sufentanil,DB00734,Risperidone,0.8794644474983215,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Risperidone.,60,Type_60,No
DB00747,Scopolamine,DB01544,Flunitrazepam,0.9979361295700073,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Flunitrazepam.,49,Type_49,Yes
DB00752,Tranylcypromine,DB09042,Tedizolid phosphate,0.993798553943634,64,Type_64,Tranylcypromine may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB09232,Cilnidipine,DB09286,Pipamperone,0.9991269707679749,49,Type_49,The risk or severity of adverse effects can be increased when Cilnidipine is combined with Pipamperone.,49,Type_49,Yes
DB00277,Theophylline,DB00827,Cinoxacin,0.8450238108634949,47,Type_47,The metabolism of Cinoxacin can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00903,Etacrynic acid,DB01001,Salbutamol,0.9999686479568481,83,Type_83,Etacrynic acid may increase the hypokalemic activities of Salbutamol.,83,Type_83,Yes
DB00652,Pentazocine,DB00887,Bumetanide,0.9994587302207947,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Bumetanide.,49,Type_49,Yes
DB00543,Amoxapine,DB05521,Telaprevir,0.5226119160652161,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Amoxapine.,73,Type_73,Yes
DB01168,Procarbazine,DB09082,Vilanterol,0.9710744023323059,49,Type_49,The risk or severity of adverse effects can be increased when Procarbazine is combined with Vilanterol.,49,Type_49,Yes
DB00596,Ulobetasol,DB01233,Metoclopramide,0.9927979111671448,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Metoclopramide.,49,Type_49,Yes
DB00788,Naproxen,DB01234,Dexamethasone,0.9677773714065552,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Dexamethasone.,49,Type_49,Yes
DB00987,Cytarabine,DB08873,Boceprevir,0.8246188759803772,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Cytarabine.,47,Type_47,Yes
DB01159,Halothane,DB01242,Clomipramine,0.5837113857269287,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Clomipramine.,47,Type_47,No
DB00248,Cabergoline,DB08820,Ivacaftor,0.9679818153381348,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Cabergoline.,73,Type_73,Yes
DB00091,Cyclosporine,DB00196,Fluconazole,0.8975912928581238,47,Type_47,The metabolism of Fluconazole can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00939,Meclofenamic acid,DB06725,Lornoxicam,0.9990397095680237,49,Type_49,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Lornoxicam.,49,Type_49,Yes
DB00392,Profenamine,DB09352,Hydroxyamphetamine,0.9842748045921326,76,Type_76,Profenamine may decrease the sedative activities of Hydroxyamphetamine.,76,Type_76,Yes
DB00555,Lamotrigine,DB01035,Procainamide,0.4282199442386627,47,Type_47,The metabolism of Procainamide can be decreased when combined with Lamotrigine.,73,Type_73,No
DB01075,Diphenhydramine,DB01351,Amobarbital,0.7387373447418213,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Amobarbital.,49,Type_49,Yes
DB00636,Clofibrate,DB04855,Dronedarone,0.9731695055961609,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Clofibrate.,47,Type_47,Yes
DB03754,Tromethamine,DB09561,Sodium glycerophosphate,0.9935799837112427,67,Type_67,Tromethamine can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00341,Cetirizine,DB01255,Lisdexamfetamine,0.9572972059249878,76,Type_76,Cetirizine may decrease the sedative activities of Lisdexamfetamine.,76,Type_76,Yes
DB00568,Cinnarizine,DB09120,Zucapsaicin,0.9960137605667114,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Cinnarizine.,47,Type_47,Yes
DB00838,Clocortolone,DB01406,Danazol,0.9976183772087097,74,Type_74,Clocortolone may increase the fluid retaining activities of Danazol.,74,Type_74,Yes
DB00584,Enalapril,DB01351,Amobarbital,0.8491359353065491,60,Type_60,Enalapril may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00735,Naftifine,DB00749,Etodolac,0.9981396198272705,49,Type_49,The risk or severity of adverse effects can be increased when Naftifine is combined with Etodolac.,49,Type_49,Yes
DB01137,Levofloxacin,DB04868,Nilotinib,0.8006836175918579,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB00841,Dobutamine,DB08918,Levomilnacipran,0.9985644221305847,85,Type_85,Dobutamine may increase the tachycardic activities of Levomilnacipran.,85,Type_85,Yes
DB00575,Clonidine,DB04842,Fluspirilene,0.9949586987495422,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Fluspirilene.,49,Type_49,Yes
DB01198,Zopiclone,DB01609,Deferasirox,0.9422678351402283,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Zopiclone.,75,Type_75,Yes
DB00908,Quinidine,DB01157,Trimetrexate,0.44722771644592285,47,Type_47,The metabolism of Trimetrexate can be decreased when combined with Quinidine.,73,Type_73,No
DB04272,Citric acid,DB06605,Apixaban,0.9233182072639465,6,Type_6,Citric acid may increase the anticoagulant activities of Apixaban.,6,Type_6,Yes
DB00189,Ethchlorvynol,DB00391,Sulpiride,0.9994174242019653,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Sulpiride.,49,Type_49,Yes
DB00605,Sulindac,DB01024,Mycophenolic acid,0.9610781073570251,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Mycophenolic acid.,49,Type_49,Yes
DB09065,Cobicistat,DB09095,Difluocortolone,0.918727457523346,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00252,Phenytoin,DB12532,Oxetacaine,0.9930631518363953,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxetacaine.,49,Type_49,Yes
DB09026,Aliskiren,DB09244,Pirlindole,0.9918169379234314,60,Type_60,Aliskiren may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00681,Amphotericin B,DB01410,Ciclesonide,0.9926406741142273,83,Type_83,Amphotericin B may increase the hypokalemic activities of Ciclesonide.,83,Type_83,Yes
DB00875,Flupentixol,DB01224,Quetiapine,0.6572256684303284,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Quetiapine.,49,Type_49,No
DB00222,Glimepiride,DB00335,Atenolol,0.9213380813598633,9,Type_9,Glimepiride may increase the hypoglycemic activities of Atenolol.,9,Type_9,Yes
DB00209,Trospium,DB00332,Ipratropium,0.9684621691703796,49,Type_49,The risk or severity of adverse effects can be increased when Trospium is combined with Ipratropium.,49,Type_49,Yes
DB00990,Exemestane,DB09073,Palbociclib,0.9950227737426758,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Exemestane.,73,Type_73,Yes
DB00502,Haloperidol,DB00986,Glycopyrronium,0.8165769577026367,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Glycopyrronium.,75,Type_75,No
DB00246,Ziprasidone,DB01198,Zopiclone,0.7366315722465515,47,Type_47,The metabolism of Zopiclone can be decreased when combined with Ziprasidone.,73,Type_73,No
DB00564,Carbamazepine,DB08883,Perampanel,0.7822962403297424,16,Type_16,Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,75,Type_75,No
DB00465,Ketorolac,DB00554,Piroxicam,0.9991740584373474,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Piroxicam.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00898,Ethanol,0.4098578095436096,73,Type_73,The serum concentration of Ethanol can be increased when it is combined with Chlorthalidone.,30,Type_30,No
DB01179,Podofilox,DB05812,Abiraterone,0.6961212158203125,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Podofilox.,47,Type_47,No
DB00623,Fluphenazine,DB01071,Mequitazine,0.9810046553611755,82,Type_82,Fluphenazine may increase the arrhythmogenic activities of Mequitazine.,82,Type_82,Yes
DB00687,Fludrocortisone,DB00999,Hydrochlorothiazide,0.9999939203262329,83,Type_83,Fludrocortisone may increase the hypokalemic activities of Hydrochlorothiazide.,83,Type_83,Yes
DB00482,Celecoxib,DB00799,Tazarotene,0.9926291704177856,47,Type_47,The metabolism of Tazarotene can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00461,Nabumetone,DB00779,Nalidixic acid,0.9993388056755066,27,Type_27,Nabumetone may increase the neuroexcitatory activities of Nalidixic acid.,27,Type_27,Yes
DB00633,Dexmedetomidine,DB00802,Alfentanil,0.9844650626182556,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Alfentanil.,49,Type_49,Yes
DB01435,Antipyrine,DB09216,Tolfenamic acid,0.9936119914054871,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Tolfenamic acid.,49,Type_49,Yes
DB00346,Alfuzosin,DB00524,Metolazone,0.9229934215545654,60,Type_60,Alfuzosin may increase the hypotensive activities of Metolazone.,60,Type_60,Yes
DB00196,Fluconazole,DB13874,Enasidenib,0.88475501537323,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00275,Olmesartan,DB00818,Propofol,0.887142539024353,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Propofol.,49,Type_49,Yes
DB00220,Nelfinavir,DB09570,Ixazomib,0.8072762489318848,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00612,Bisoprolol,DB09083,Ivabradine,0.7937121391296387,54,Type_54,Bisoprolol may increase the bradycardic activities of Ivabradine.,54,Type_54,Yes
DB00917,Dinoprostone,DB00945,Acetylsalicylic acid,0.7676183581352234,70,Type_70,The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00263,Sulfisoxazole,DB01131,Proguanil,0.978597104549408,47,Type_47,The metabolism of Proguanil can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00210,Adapalene,DB09093,Chlortetracycline,0.8996208310127258,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Chlortetracycline.,49,Type_49,Yes
DB00235,Milrinone,DB11362,Selexipag,0.5840935111045837,60,Type_60,Milrinone may increase the hypotensive activities of Selexipag.,6,Type_6,No
DB01210,Levobunolol,DB01242,Clomipramine,0.45387041568756104,73,Type_73,The serum concentration of Clomipramine can be increased when it is combined with Levobunolol.,49,Type_49,No
DB00960,Pindolol,DB01355,Hexobarbital,0.8769887685775757,60,Type_60,Pindolol may increase the hypotensive activities of Hexobarbital.,60,Type_60,Yes
DB00402,Eszopiclone,DB00907,Cocaine,0.7659337520599365,49,Type_49,The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cocaine.,49,Type_49,Yes
DB01325,Quinethazone,DB01401,Choline magnesium trisalicylate,0.9994520545005798,70,Type_70,The therapeutic efficacy of Choline magnesium trisalicylate can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB00472,Fluoxetine,DB00489,Sotalol,0.342901349067688,20,Type_20,Fluoxetine may increase the QTc-prolonging activities of Sotalol.,73,Type_73,No
DB00472,Fluoxetine,DB01591,Solifenacin,0.6108606457710266,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Fluoxetine.,20,Type_20,No
DB00337,Pimecrolimus,DB00936,Salicylic acid,0.9882563948631287,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Salicylic acid.,49,Type_49,Yes
DB00613,Amodiaquine,DB01685,Topiroxostat,0.9963686466217041,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Amodiaquine.,47,Type_47,Yes
DB06267,Udenafil,DB09280,Lumacaftor,0.5395439267158508,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Udenafil.,4,Type_4,No
DB00860,Prednisolone,DB08981,Fenbufen,0.9997658133506775,49,Type_49,The risk or severity of adverse effects can be increased when Prednisolone is combined with Fenbufen.,49,Type_49,Yes
DB00795,Sulfasalazine,DB00817,Rosoxacin,0.4726966619491577,27,Type_27,Sulfasalazine may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB01078,Deslanoside,DB08881,Vemurafenib,0.9437804818153381,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Vemurafenib.,58,Type_58,Yes
DB00435,Nitric Oxide,DB09286,Pipamperone,0.9899260997772217,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Pipamperone.,49,Type_49,Yes
DB00376,Trihexyphenidyl,DB01400,Neostigmine,0.9990338087081909,70,Type_70,The therapeutic efficacy of Neostigmine can be decreased when used in combination with Trihexyphenidyl.,70,Type_70,Yes
DB00214,Torasemide,DB00492,Fosinopril,0.90500408411026,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Fosinopril.,49,Type_49,Yes
DB00753,Isoflurane,DB08881,Vemurafenib,0.35262975096702576,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Isoflurane.,75,Type_75,Yes
DB01580,Oxprenolol,DB09072,Sodium oxybate,0.8004473447799683,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Sodium oxybate.,16,Type_16,No
DB01100,Pimozide,DB08918,Levomilnacipran,0.8456137180328369,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Levomilnacipran.,49,Type_49,Yes
DB00678,Losartan,DB09292,Sacubitril,0.9514103531837463,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Sacubitril.,49,Type_49,Yes
DB00390,Digoxin,DB01082,Streptomycin,0.7300542593002319,75,Type_75,The serum concentration of Streptomycin can be decreased when it is combined with Digoxin.,75,Type_75,Yes
DB00277,Theophylline,DB12332,Rucaparib,0.9781129956245422,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00191,Phentermine,DB01390,Sodium bicarbonate,0.9630224108695984,72,Type_72,Phentermine may decrease the excretion rate of Sodium bicarbonate which could result in a higher serum level.,72,Type_72,Yes
DB00952,Naratriptan,DB01608,Periciazine,0.9004254341125488,49,Type_49,The risk or severity of adverse effects can be increased when Naratriptan is combined with Periciazine.,49,Type_49,Yes
DB01036,Tolterodine,DB09074,Olaparib,0.9566068649291992,47,Type_47,The metabolism of Olaparib can be decreased when combined with Tolterodine.,47,Type_47,Yes
DB00182,Amphetamine,DB01132,Pioglitazone,0.8706749081611633,9,Type_9,Amphetamine may increase the hypoglycemic activities of Pioglitazone.,9,Type_9,Yes
DB00734,Risperidone,DB09232,Cilnidipine,0.9203960299491882,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Cilnidipine.,60,Type_60,No
DB01235,Levodopa,DB04868,Nilotinib,0.6861874461174011,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Levodopa.,47,Type_47,Yes
DB09067,Corticorelin ovine triflutate,DB13158,Clobetasone,0.999992847442627,70,Type_70,The therapeutic efficacy of Clobetasone can be decreased when used in combination with Corticorelin ovine triflutate.,70,Type_70,Yes
DB00484,Brimonidine,DB09068,Vortioxetine,0.9568625092506409,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,16,Type_16,Yes
DB00281,Lidocaine,DB01192,Oxymorphone,0.8308923840522766,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Oxymorphone.,49,Type_49,Yes
DB00966,Telmisartan,DB01158,Bretylium,0.7641230821609497,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Bretylium.,49,Type_49,Yes
DB02709,Resveratrol,DB09053,Ibrutinib,0.6416642069816589,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Resveratrol.,49,Type_49,No
DB00454,Meperidine,DB00482,Celecoxib,0.8657355904579163,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Meperidine.,47,Type_47,Yes
DB00625,Efavirenz,DB00898,Ethanol,0.9988077878952026,16,Type_16,Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,49,Type_49,No
DB01124,Tolbutamide,DB09241,Methylene blue,0.9973224997520447,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Methylene blue.,9,Type_9,Yes
DB00590,Doxazosin,DB09245,Toloxatone,0.9885109663009644,60,Type_60,Doxazosin may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00246,Ziprasidone,DB05271,Rotigotine,0.8856635093688965,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Ziprasidone.,32,Type_32,No
DB00598,Labetalol,DB01611,Hydroxychloroquine,0.3955765664577484,73,Type_73,The serum concentration of Hydroxychloroquine can be increased when it is combined with Labetalol.,47,Type_47,No
DB00312,Pentobarbital,DB06145,Spiramycin,0.9759017825126648,4,Type_4,The metabolism of Spiramycin can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00237,Butabarbital,DB00246,Ziprasidone,0.9801856279373169,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Ziprasidone.,49,Type_49,Yes
DB00519,Trandolapril,DB08932,Macitentan,0.9996864795684814,60,Type_60,Trandolapril may increase the hypotensive activities of Macitentan.,60,Type_60,Yes
DB00904,Ondansetron,DB01211,Clarithromycin,0.5963813066482544,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Ondansetron.,20,Type_20,No
DB00903,Etacrynic acid,DB01380,Cortisone acetate,0.9987955093383789,83,Type_83,Etacrynic acid may increase the hypokalemic activities of Cortisone acetate.,83,Type_83,Yes
DB01192,Oxymorphone,DB06290,Simeprevir,0.8756775259971619,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Oxymorphone.,73,Type_73,Yes
DB00334,Olanzapine,DB01255,Lisdexamfetamine,0.9977769255638123,61,Type_61,Olanzapine may decrease the stimulatory activities of Lisdexamfetamine.,61,Type_61,Yes
DB00188,Bortezomib,DB00774,Hydroflumethiazide,0.8730278611183167,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroflumethiazide.,49,Type_49,Yes
DB00696,Ergotamine,DB01174,Phenobarbital,0.9511144757270813,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Ergotamine.,4,Type_4,Yes
DB06603,Panobinostat,DB06772,Cabazitaxel,0.7245016098022461,49,Type_49,The risk or severity of adverse effects can be increased when Panobinostat is combined with Cabazitaxel.,49,Type_49,Yes
DB00569,Fondaparinux,DB09211,Limaprost,0.9939330220222473,49,Type_49,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Limaprost.,49,Type_49,Yes
DB00220,Nelfinavir,DB00648,Mitotane,0.9670458436012268,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Nelfinavir.,75,Type_75,Yes
DB00742,Mannitol,DB01242,Clomipramine,0.6683013439178467,49,Type_49,The risk or severity of adverse effects can be increased when Mannitol is combined with Clomipramine.,49,Type_49,Yes
DB01288,Fenoterol,DB04846,Celiprolol,0.9986868500709534,14,Type_14,Fenoterol may decrease the bronchodilatory activities of Celiprolol.,14,Type_14,Yes
DB00905,Bimatoprost,DB06826,Unoprostone,0.9999998807907104,60,Type_60,Bimatoprost may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB00668,Epinephrine,DB01069,Promethazine,0.8468993902206421,60,Type_60,Epinephrine may increase the hypotensive activities of Promethazine.,5,Type_5,No
DB00246,Ziprasidone,DB00904,Ondansetron,0.725453794002533,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Ondansetron.,47,Type_47,No
DB00343,Diltiazem,DB00393,Nimodipine,0.910849928855896,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Nimodipine.,73,Type_73,No
DB00176,Fluvoxamine,DB00752,Tranylcypromine,0.6232138276100159,47,Type_47,The metabolism of Tranylcypromine can be decreased when combined with Fluvoxamine.,49,Type_49,No
DB00191,Phentermine,DB00805,Minaprine,0.997276246547699,71,Type_71,Phentermine may increase the hypertensive activities of Minaprine.,71,Type_71,Yes
DB00540,Nortriptyline,DB01367,Rasagiline,0.919687032699585,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Rasagiline.,49,Type_49,Yes
DB01263,Posaconazole,DB11574,Elbasvir,0.8713453412055969,47,Type_47,The metabolism of Elbasvir can be decreased when combined with Posaconazole.,47,Type_47,Yes
DB00322,Floxuridine,DB01221,Ketamine,0.9664453268051147,47,Type_47,The metabolism of Ketamine can be decreased when combined with Floxuridine.,47,Type_47,Yes
DB00213,Pantoprazole,DB00514,Dextromethorphan,0.9940246939659119,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00555,Lamotrigine,DB01202,Levetiracetam,0.985896646976471,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Levetiracetam.,49,Type_49,Yes
DB08893,Mirabegron,DB09118,Stiripentol,0.7975255846977234,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Mirabegron.,73,Type_73,Yes
DB00297,Bupivacaine,DB00999,Hydrochlorothiazide,0.6278854608535767,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB01149,Nefazodone,DB01297,Practolol,0.6916013956069946,73,Type_73,The serum concentration of Practolol can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB00325,Nitroprusside,DB04846,Celiprolol,0.9734721183776855,60,Type_60,Nitroprusside may increase the hypotensive activities of Celiprolol.,60,Type_60,Yes
DB00748,Carbinoxamine,DB01621,Pipotiazine,0.9842455983161926,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Pipotiazine.,49,Type_49,Yes
DB00508,Triflupromazine,DB03754,Tromethamine,0.9726675748825073,67,Type_67,Triflupromazine can cause a decrease in the absorption of Tromethamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00582,Voriconazole,DB09119,Eslicarbazepine acetate,0.7758663296699524,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00696,Ergotamine,DB00904,Ondansetron,0.8424602746963501,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Ondansetron.,64,Type_64,No
DB00315,Zolmitriptan,DB01151,Desipramine,0.942834198474884,49,Type_49,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Desipramine.,49,Type_49,Yes
DB00353,Methylergometrine,DB01214,Metipranolol,0.9662045240402222,19,Type_19,Methylergometrine may increase the vasoconstricting activities of Metipranolol.,19,Type_19,Yes
DB00967,Desloratadine,DB01065,Melatonin,0.9949434399604797,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Melatonin.,49,Type_49,Yes
DB00254,Doxycycline,DB01179,Podofilox,0.954882800579071,47,Type_47,The metabolism of Podofilox can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01029,Irbesartan,DB04948,Lofexidine,0.8968074917793274,60,Type_60,Irbesartan may increase the hypotensive activities of Lofexidine.,60,Type_60,Yes
DB08918,Levomilnacipran,DB09080,Olodaterol,0.9490523338317871,85,Type_85,Levomilnacipran may increase the tachycardic activities of Olodaterol.,85,Type_85,Yes
DB00950,Fexofenadine,DB01176,Cyclizine,0.9999953508377075,49,Type_49,The risk or severity of adverse effects can be increased when Fexofenadine is combined with Cyclizine.,49,Type_49,Yes
DB01356,Lithium cation,DB04871,Lorcaserin,0.6409353613853455,49,Type_49,The risk or severity of adverse effects can be increased when Lithium cation is combined with Lorcaserin.,49,Type_49,Yes
DB00656,Trazodone,DB00976,Telithromycin,0.9242432117462158,20,Type_20,Trazodone may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB00201,Caffeine,DB00788,Naproxen,0.6008637547492981,47,Type_47,The metabolism of Naproxen can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00764,Mometasone,DB09269,Phenylacetic acid,0.9072761535644531,70,Type_70,The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Mometasone.,70,Type_70,Yes
DB00476,Duloxetine,DB01029,Irbesartan,0.749370276927948,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Irbesartan.,30,Type_30,Yes
DB00521,Carteolol,DB04846,Celiprolol,0.30004405975341797,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Celiprolol.,60,Type_60,No
DB00922,Levosimendan,DB08941,Isoxsuprine,0.999455988407135,49,Type_49,The risk or severity of adverse effects can be increased when Levosimendan is combined with Isoxsuprine.,49,Type_49,Yes
DB04844,Tetrabenazine,DB06016,Cariprazine,0.516590416431427,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Tetrabenazine.,49,Type_49,No
DB08819,Tafluprost,DB08991,Epirizole,0.9999505281448364,70,Type_70,The therapeutic efficacy of Epirizole can be decreased when used in combination with Tafluprost.,70,Type_70,Yes
DB08820,Ivacaftor,DB08912,Dabrafenib,0.6943831443786621,73,Type_73,The serum concentration of Dabrafenib can be increased when it is combined with Ivacaftor.,75,Type_75,No
DB00239,Oxiconazole,DB00681,Amphotericin B,0.8692669868469238,49,Type_49,The risk or severity of adverse effects can be increased when Oxiconazole is combined with Amphotericin B.,70,Type_70,No
DB09039,Eliglustat,DB09118,Stiripentol,0.9384966492652893,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Eliglustat.,73,Type_73,Yes
DB06710,Methyltestosterone,DB08971,Fluocortolone,0.9909818768501282,74,Type_74,Methyltestosterone may increase the fluid retaining activities of Fluocortolone.,74,Type_74,Yes
DB04572,Thiotepa,DB11613,Velpatasvir,0.907275378704071,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Thiotepa.,47,Type_47,Yes
DB00296,Ropivacaine,DB09204,Arotinolol,0.862520694732666,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Arotinolol.,49,Type_49,Yes
DB01118,Amiodarone,DB01224,Quetiapine,0.489763081073761,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Amiodarone.,73,Type_73,No
DB00652,Pentazocine,DB01621,Pipotiazine,0.9964002370834351,49,Type_49,The risk or severity of adverse effects can be increased when Pentazocine is combined with Pipotiazine.,49,Type_49,Yes
DB00346,Alfuzosin,DB08957,Hexoprenaline,0.9999479055404663,5,Type_5,Alfuzosin may decrease the vasoconstricting activities of Hexoprenaline.,5,Type_5,Yes
DB00246,Ziprasidone,DB09286,Pipamperone,0.7445448637008667,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Pipamperone.,49,Type_49,Yes
DB00203,Sildenafil,DB11737,Icotinib,0.937825083732605,47,Type_47,The metabolism of Icotinib can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00321,Amitriptyline,DB06282,Levocetirizine,0.9820266366004944,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocetirizine.,49,Type_49,Yes
DB00300,Tenofovir disoproxil,DB00976,Telithromycin,0.970110297203064,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00714,Apomorphine,DB04920,Clevidipine,0.9946460723876953,49,Type_49,The risk or severity of adverse effects can be increased when Apomorphine is combined with Clevidipine.,49,Type_49,Yes
DB00195,Betaxolol,DB06148,Mianserin,0.8661275506019592,47,Type_47,The metabolism of Mianserin can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00312,Pentobarbital,DB11614,Rupatadine,0.9647469520568848,4,Type_4,The metabolism of Rupatadine can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00542,Benazepril,DB01236,Sevoflurane,0.9352356195449829,49,Type_49,The risk or severity of adverse effects can be increased when Benazepril is combined with Sevoflurane.,49,Type_49,Yes
DB00745,Modafinil,DB06636,Isavuconazonium,0.8021189570426941,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00861,Diflunisal,DB01077,Etidronic acid,0.9990289211273193,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Etidronic acid.,49,Type_49,Yes
DB00967,Desloratadine,DB01154,Thiamylal,0.9640542268753052,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Thiamylal.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB01023,Felodipine,0.7829359769821167,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Felodipine.,49,Type_49,Yes
DB01241,Gemfibrozil,DB04908,Flibanserin,0.3715948164463043,73,Type_73,The serum concentration of Flibanserin can be increased when it is combined with Gemfibrozil.,73,Type_73,Yes
DB00363,Clozapine,DB00527,Cinchocaine,0.9974601864814758,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Cinchocaine.,49,Type_49,Yes
DB00244,Mesalazine,DB06786,Halcinonide,0.9970274567604065,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Halcinonide.,49,Type_49,Yes
DB00487,Pefloxacin,DB09146,Iron sucrose,0.9614821672439575,75,Type_75,The serum concentration of Iron sucrose can be decreased when it is combined with Pefloxacin.,75,Type_75,Yes
DB01216,Finasteride,DB08933,Luliconazole,0.9640015959739685,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Finasteride.,73,Type_73,Yes
DB01114,Chlorpheniramine,DB01437,Glutethimide,0.999997615814209,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Glutethimide.,49,Type_49,Yes
DB00967,Desloratadine,DB01437,Glutethimide,0.9866307377815247,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Glutethimide.,49,Type_49,Yes
DB00298,Dapiprazole,DB08815,Lurasidone,0.9012562036514282,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Lurasidone.,49,Type_49,Yes
DB01193,Acebutolol,DB06736,Aceclofenac,0.9729838967323303,37,Type_37,Acebutolol may decrease the antihypertensive activities of Aceclofenac.,37,Type_37,Yes
DB00966,Telmisartan,DB09242,Moxonidine,0.921541690826416,60,Type_60,Telmisartan may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00937,Diethylpropion,DB08967,Dimetotiazine,0.9999630451202393,76,Type_76,Diethylpropion may decrease the sedative activities of Dimetotiazine.,76,Type_76,Yes
DB00575,Clonidine,DB00708,Sufentanil,0.9683114290237427,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Sufentanil.,54,Type_54,No
DB00661,Verapamil,DB01143,Amifostine,0.9963172674179077,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Amifostine.,49,Type_49,Yes
DB01173,Orphenadrine,DB05521,Telaprevir,0.7909054160118103,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Orphenadrine.,47,Type_47,Yes
DB00808,Indapamide,DB01064,Isoprenaline,0.9914811849594116,83,Type_83,Indapamide may increase the hypokalemic activities of Isoprenaline.,83,Type_83,Yes
DB00373,Timolol,DB04948,Lofexidine,0.8237234950065613,25,Type_25,Timolol may increase the atrioventricular blocking (AV block) activities of Lofexidine.,25,Type_25,Yes
DB00795,Sulfasalazine,DB09288,Propacetamol,0.9859317541122437,49,Type_49,The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Propacetamol.,49,Type_49,Yes
DB00295,Morphine,DB01337,Pancuronium,0.9996651411056519,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Pancuronium.,49,Type_49,Yes
DB00755,Tretinoin,DB01113,Papaverine,0.9992852807044983,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Papaverine.,49,Type_49,Yes
DB00238,Nevirapine,DB01259,Lapatinib,0.32931938767433167,4,Type_4,The metabolism of Lapatinib can be increased when combined with Nevirapine.,75,Type_75,No
DB01175,Escitalopram,DB11148,Butamben,0.9884506464004517,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Butamben.,49,Type_49,Yes
DB02703,Fusidic acid,DB06772,Cabazitaxel,0.9913811087608337,73,Type_73,The serum concentration of Cabazitaxel can be increased when it is combined with Fusidic acid.,73,Type_73,Yes
DB01466,Ethylmorphine,DB08883,Perampanel,0.9945671558380127,16,Type_16,Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01026,Ketoconazole,DB09555,Dexchlorpheniramine maleate,0.9045862555503845,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00715,Paroxetine,DB06203,Alogliptin,0.9065221548080444,9,Type_9,Paroxetine may increase the hypoglycemic activities of Alogliptin.,47,Type_47,No
DB01174,Phenobarbital,DB09079,Nintedanib,0.9848944544792175,75,Type_75,The serum concentration of Nintedanib can be decreased when it is combined with Phenobarbital.,75,Type_75,Yes
DB00300,Tenofovir disoproxil,DB00619,Imatinib,0.9691924452781677,47,Type_47,The metabolism of Imatinib can be decreased when combined with Tenofovir disoproxil.,47,Type_47,Yes
DB00300,Tenofovir disoproxil,DB00963,Bromfenac,0.9664160013198853,49,Type_49,The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Bromfenac.,49,Type_49,Yes
DB00570,Vinblastine,DB00696,Ergotamine,0.9583746194839478,49,Type_49,The risk or severity of adverse effects can be increased when Vinblastine is combined with Ergotamine.,49,Type_49,Yes
DB00301,Flucloxacillin,DB01032,Probenecid,0.5752658843994141,75,Type_75,The serum concentration of Probenecid can be decreased when it is combined with Flucloxacillin.,73,Type_73,No
DB00328,Indomethacin,DB08912,Dabrafenib,0.8723396062850952,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Indomethacin.,75,Type_75,Yes
DB01167,Itraconazole,DB01224,Quetiapine,0.4924188256263733,73,Type_73,The serum concentration of Quetiapine can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00977,Ethinylestradiol,DB08971,Fluocortolone,0.9958664178848267,73,Type_73,The serum concentration of Fluocortolone can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00575,Clonidine,DB09235,Efonidipine,0.5331714749336243,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Efonidipine.,60,Type_60,No
DB01384,Paramethasone,DB11079,Trolamine salicylate,0.997170627117157,49,Type_49,The risk or severity of adverse effects can be increased when Paramethasone is combined with Trolamine salicylate.,49,Type_49,Yes
DB00870,Suprofen,DB06228,Rivaroxaban,0.9525038599967957,6,Type_6,Suprofen may increase the anticoagulant activities of Rivaroxaban.,6,Type_6,Yes
DB00934,Maprotiline,DB01618,Molindone,0.9988403916358948,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Molindone.,49,Type_49,Yes
DB00413,Pramipexole,DB01612,Amyl Nitrite,0.9957326054573059,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Amyl Nitrite.,49,Type_49,Yes
DB01185,Fluoxymesterone,DB02187,Equilin,1.0,74,Type_74,Fluoxymesterone may increase the fluid retaining activities of Equilin.,74,Type_74,Yes
DB00327,Hydromorphone,DB00771,Clidinium,0.9995656609535217,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clidinium.,49,Type_49,Yes
DB01175,Escitalopram,DB06216,Asenapine,0.5005807280540466,20,Type_20,Escitalopram may increase the QTc-prolonging activities of Asenapine.,49,Type_49,No
DB00312,Pentobarbital,DB00553,Methoxsalen,0.9503872990608215,4,Type_4,The metabolism of Methoxsalen can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01238,Aripiprazole,DB12332,Rucaparib,0.733623743057251,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Aripiprazole.,73,Type_73,Yes
DB00917,Dinoprostone,DB01600,Tiaprofenic acid,0.9551796317100525,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Dinoprostone.,70,Type_70,Yes
DB00327,Hydromorphone,DB00734,Risperidone,0.9701843857765198,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Risperidone.,49,Type_49,Yes
DB00952,Naratriptan,DB06144,Sertindole,0.9971299767494202,49,Type_49,The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertindole.,49,Type_49,Yes
DB00531,Cyclophosphamide,DB01098,Rosuvastatin,0.42997249960899353,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Rosuvastatin.,73,Type_73,No
DB00963,Bromfenac,DB08808,Bupranolol,0.9998829364776611,37,Type_37,Bromfenac may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB00394,Beclomethasone dipropionate,DB09220,Nicorandil,0.9210309386253357,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Nicorandil.,49,Type_49,Yes
DB00398,Sorafenib,DB01175,Escitalopram,0.6322504281997681,47,Type_47,The metabolism of Escitalopram can be decreased when combined with Sorafenib.,20,Type_20,No
DB00230,Pregabalin,DB01164,Calcium chloride,0.9867435693740845,70,Type_70,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Pregabalin.,70,Type_70,Yes
DB00420,Promazine,DB01426,Ajmaline,0.8682348132133484,20,Type_20,Promazine may increase the QTc-prolonging activities of Ajmaline.,47,Type_47,No
DB00727,Nitroglycerin,DB00808,Indapamide,0.9999915361404419,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Indapamide.,49,Type_49,Yes
DB01069,Promethazine,DB06697,Artemether,0.38638678193092346,47,Type_47,The metabolism of Artemether can be decreased when combined with Promethazine.,20,Type_20,No
DB00465,Ketorolac,DB06737,Zaltoprofen,0.9992827773094177,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Zaltoprofen.,49,Type_49,Yes
DB00331,Metformin,DB01357,Mestranol,0.755739152431488,70,Type_70,The therapeutic efficacy of Mestranol can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00357,Aminoglutethimide,DB00390,Digoxin,0.9831499457359314,58,Type_58,Aminoglutethimide may decrease the cardiotoxic activities of Digoxin.,58,Type_58,Yes
DB00220,Nelfinavir,DB00741,Hydrocortisone,0.8234766721725464,47,Type_47,The metabolism of Hydrocortisone can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00934,Maprotiline,DB01209,Dezocine,0.9972012042999268,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Dezocine.,49,Type_49,Yes
DB00215,Citalopram,DB00701,Amprenavir,0.919180154800415,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00483,Gallamine triethiodide,DB01085,Pilocarpine,0.8422971963882446,49,Type_49,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Pilocarpine.,49,Type_49,Yes
DB00434,Cyproheptadine,DB01100,Pimozide,0.9836646914482117,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Pimozide.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00946,Phenprocoumon,0.7640840411186218,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00932,Tipranavir,DB01197,Captopril,0.7256367802619934,75,Type_75,The serum concentration of Captopril can be decreased when it is combined with Tipranavir.,75,Type_75,Yes
DB00104,Octreotide,DB01203,Nadolol,0.9989280104637146,54,Type_54,Octreotide may increase the bradycardic activities of Nadolol.,54,Type_54,Yes
DB00254,Doxycycline,DB00843,Donepezil,0.9662326574325562,47,Type_47,The metabolism of Donepezil can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00184,Nicotine,DB00521,Carteolol,0.5954453945159912,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Carteolol.,49,Type_49,Yes
DB00298,Dapiprazole,DB09128,Brexpiprazole,0.6532245874404907,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Brexpiprazole.,49,Type_49,Yes
DB01014,Balsalazide,DB08984,Etofenamate,0.8879881501197815,57,Type_57,Balsalazide may increase the nephrotoxic activities of Etofenamate.,57,Type_57,Yes
DB00747,Scopolamine,DB00754,Ethotoin,0.7118070721626282,49,Type_49,The risk or severity of adverse effects can be increased when Scopolamine is combined with Ethotoin.,49,Type_49,Yes
DB00549,Zafirlukast,DB09054,Idelalisib,0.8076210618019104,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB01224,Quetiapine,DB01247,Isocarboxazid,0.6386983394622803,49,Type_49,The risk or severity of adverse effects can be increased when Quetiapine is combined with Isocarboxazid.,49,Type_49,Yes
DB00434,Cyproheptadine,DB00653,Magnesium sulfate,0.8083509802818298,16,Type_16,Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.,16,Type_16,Yes
DB01037,Selegiline,DB01324,Polythiazide,0.9483697414398193,60,Type_60,Selegiline may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00270,Isradipine,DB01180,Rescinnamine,0.5104743838310242,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Rescinnamine.,60,Type_60,No
DB00605,Sulindac,DB04574,Estrone sulfate,0.8833611011505127,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Estrone sulfate.,49,Type_49,Yes
DB00247,Methysergide,DB00313,Valproic acid,0.9909159541130066,49,Type_49,The risk or severity of adverse effects can be increased when Methysergide is combined with Valproic acid.,49,Type_49,Yes
DB00794,Primidone,DB00813,Fentanyl,0.8211511969566345,75,Type_75,The serum concentration of Fentanyl can be decreased when it is combined with Primidone.,75,Type_75,Yes
DB00393,Nimodipine,DB01189,Desflurane,0.9990584254264832,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Desflurane.,49,Type_49,Yes
DB00985,Dimenhydrinate,DB01238,Aripiprazole,0.9714439511299133,49,Type_49,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Aripiprazole.,49,Type_49,Yes
DB00673,Aprepitant,DB09330,Osimertinib,0.9736588001251221,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00582,Voriconazole,DB00838,Clocortolone,0.9759230613708496,73,Type_73,The serum concentration of Clocortolone can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00836,Loperamide,DB01167,Itraconazole,0.6496538519859314,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Loperamide.,47,Type_47,Yes
DB00199,Erythromycin,DB00691,Moexipril,0.658748984336853,47,Type_47,The metabolism of Moexipril can be decreased when combined with Erythromycin.,20,Type_20,No
DB00358,Mefloquine,DB00976,Telithromycin,0.8181194067001343,20,Type_20,Mefloquine may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB01158,Bretylium,DB01170,Guanethidine,0.999998927116394,60,Type_60,Bretylium may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB00241,Butalbital,DB00318,Codeine,0.9960330128669739,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Codeine.,49,Type_49,Yes
DB00257,Clotrimazole,DB00938,Salmeterol,0.9607115983963013,47,Type_47,The metabolism of Salmeterol can be decreased when combined with Clotrimazole.,73,Type_73,No
DB00604,Cisapride,DB01167,Itraconazole,0.5051183700561523,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Cisapride.,73,Type_73,Yes
DB00366,Doxylamine,DB00829,Diazepam,0.9999979734420776,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Diazepam.,16,Type_16,Yes
DB00187,Esmolol,DB00310,Chlorthalidone,0.9866743683815002,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Chlorthalidone.,49,Type_49,Yes
DB00559,Bosentan,DB01395,Drospirenone,0.6204864978790283,75,Type_75,The serum concentration of Drospirenone can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00544,Fluorouracil,DB04938,Ospemifene,0.7603625059127808,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Fluorouracil.,73,Type_73,No
DB00903,Etacrynic acid,DB09212,Loxoprofen,0.9999802112579346,29,Type_29,Etacrynic acid may decrease the diuretic activities of Loxoprofen.,29,Type_29,Yes
DB01403,Methotrimeprazine,DB01409,Tiotropium,0.36285606026649475,2,Type_2,Methotrimeprazine may increase the anticholinergic activities of Tiotropium.,47,Type_47,No
DB00976,Telithromycin,DB00997,Doxorubicin,0.7184969782829285,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00169,Cholecalciferol,DB00554,Piroxicam,0.9218324422836304,47,Type_47,The metabolism of Piroxicam can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB00613,Amodiaquine,DB01580,Oxprenolol,0.6814205050468445,47,Type_47,The metabolism of Oxprenolol can be decreased when combined with Amodiaquine.,47,Type_47,Yes
DB00511,Acetyldigitoxin,DB00959,Methylprednisolone,0.9889380931854248,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Methylprednisolone.,58,Type_58,Yes
DB00726,Trimipramine,DB04898,Ximelagatran,0.7149701714515686,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB00571,Propranolol,DB00964,Apraclonidine,0.9766373634338379,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Apraclonidine.,49,Type_49,Yes
DB00540,Nortriptyline,DB00871,Terbutaline,0.9173471927642822,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.,49,Type_49,Yes
DB00540,Nortriptyline,DB09242,Moxonidine,0.6615176200866699,37,Type_37,Nortriptyline may decrease the antihypertensive activities of Moxonidine.,70,Type_70,No
DB00470,Dronabinol,DB00708,Sufentanil,0.9988982677459717,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Sufentanil.,16,Type_16,Yes
DB00820,Tadalafil,DB09242,Moxonidine,0.9693454504013062,10,Type_10,Tadalafil may increase the antihypertensive activities of Moxonidine.,10,Type_10,Yes
DB00240,Alclometasone,DB04552,Niflumic acid,0.9992691874504089,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Niflumic acid.,49,Type_49,Yes
DB00254,Doxycycline,DB01431,Allylestrenol,0.9743214845657349,47,Type_47,The metabolism of Allylestrenol can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB01106,Levocabastine,DB08918,Levomilnacipran,0.9884495735168457,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Levomilnacipran.,49,Type_49,Yes
DB00492,Fosinopril,DB00722,Lisinopril,0.9149982333183289,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Lisinopril.,49,Type_49,Yes
DB00238,Nevirapine,DB04846,Celiprolol,0.4088134467601776,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Nevirapine.,4,Type_4,No
DB04743,Nimesulide,DB12598,Nafamostat,0.9036710858345032,6,Type_6,Nimesulide may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB01069,Promethazine,DB01353,Butobarbital,0.9987488985061646,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Butobarbital.,49,Type_49,Yes
DB00394,Beclomethasone dipropionate,DB04552,Niflumic acid,0.9997439980506897,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Niflumic acid.,49,Type_49,Yes
DB00199,Erythromycin,DB00588,Fluticasone propionate,0.9579179286956787,47,Type_47,The metabolism of Fluticasone propionate can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00374,Treprostinil,DB09063,Ceritinib,0.8771284222602844,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Ceritinib.,73,Type_73,No
DB01154,Thiamylal,DB01367,Rasagiline,0.7713502049446106,49,Type_49,The risk or severity of adverse effects can be increased when Thiamylal is combined with Rasagiline.,60,Type_60,No
DB00273,Topiramate,DB01501,Difenoxin,0.9953978657722473,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Difenoxin.,49,Type_49,Yes
DB00275,Olmesartan,DB04840,Debrisoquine,0.9997654557228088,60,Type_60,Olmesartan may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00399,Zoledronic acid,DB00919,Spectinomycin,0.9999734163284302,24,Type_24,Zoledronic acid may increase the hypocalcemic activities of Spectinomycin.,24,Type_24,Yes
DB00625,Efavirenz,DB01198,Zopiclone,0.7916215658187866,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Zopiclone.,49,Type_49,Yes
DB00679,Thioridazine,DB00892,Oxybuprocaine,0.9991453886032104,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Oxybuprocaine.,49,Type_49,Yes
DB01355,Hexobarbital,DB06292,Dapagliflozin,0.588708758354187,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Dapagliflozin.,60,Type_60,No
DB01189,Desflurane,DB04953,Ezogabine,0.980036735534668,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Ezogabine.,49,Type_49,Yes
DB00674,Galantamine,DB01337,Pancuronium,0.9980295300483704,70,Type_70,The therapeutic efficacy of Pancuronium can be decreased when used in combination with Galantamine.,70,Type_70,Yes
DB00253,Medrysone,DB01609,Deferasirox,0.8224320411682129,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Deferasirox.,49,Type_49,Yes
DB00298,Dapiprazole,DB00690,Flurazepam,0.9941555261611938,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Flurazepam.,49,Type_49,Yes
DB01320,Fosphenytoin,DB06701,Dexmethylphenidate,0.7502337098121643,4,Type_4,The metabolism of Dexmethylphenidate can be increased when combined with Fosphenytoin.,73,Type_73,No
DB01136,Carvedilol,DB08941,Isoxsuprine,0.9950177073478699,49,Type_49,The risk or severity of adverse effects can be increased when Carvedilol is combined with Isoxsuprine.,49,Type_49,Yes
DB00524,Metolazone,DB00657,Mecamylamine,0.9679850935935974,49,Type_49,The risk or severity of adverse effects can be increased when Metolazone is combined with Mecamylamine.,49,Type_49,Yes
DB00976,Telithromycin,DB01268,Sunitinib,0.5348058342933655,20,Type_20,Telithromycin may increase the QTc-prolonging activities of Sunitinib.,47,Type_47,No
DB06237,Avanafil,DB09074,Olaparib,0.8846961259841919,73,Type_73,The serum concentration of Olaparib can be increased when it is combined with Avanafil.,73,Type_73,Yes
DB00482,Celecoxib,DB00582,Voriconazole,0.9908695220947266,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00543,Amoxapine,DB01189,Desflurane,0.8546290397644043,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Desflurane.,49,Type_49,Yes
DB00293,Raltitrexed,DB00390,Digoxin,0.9988753199577332,58,Type_58,Raltitrexed may decrease the cardiotoxic activities of Digoxin.,58,Type_58,Yes
DB00584,Enalapril,DB01626,Pargyline,0.99433833360672,60,Type_60,Enalapril may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB01624,Zuclopenthixol,DB08912,Dabrafenib,0.5749757885932922,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Zuclopenthixol.,20,Type_20,No
DB00296,Ropivacaine,DB09242,Moxonidine,0.8826958537101746,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Moxonidine.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB09075,Edoxaban,0.3296032249927521,75,Type_75,The serum concentration of Edoxaban can be decreased when it is combined with Medroxyprogesterone acetate.,70,Type_70,No
DB00717,Norethisterone,DB04878,Voglibose,0.9980931878089905,70,Type_70,The therapeutic efficacy of Voglibose can be decreased when used in combination with Norethisterone.,70,Type_70,Yes
DB00889,Granisetron,DB01200,Bromocriptine,0.5564089417457581,64,Type_64,Granisetron may increase the serotonergic activities of Bromocriptine.,64,Type_64,Yes
DB08895,Tofacitinib,DB08910,Pomalidomide,0.9434902667999268,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Tofacitinib.,34,Type_34,No
DB00745,Modafinil,DB01259,Lapatinib,0.8371465802192688,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00215,Citalopram,DB11699,Tropisetron,0.9999971389770508,64,Type_64,Citalopram may increase the serotonergic activities of Tropisetron.,64,Type_64,Yes
DB00890,Dienestrol,DB04898,Ximelagatran,0.8944326043128967,75,Type_75,The serum concentration of Ximelagatran can be decreased when it is combined with Dienestrol.,75,Type_75,Yes
DB00206,Reserpine,DB00395,Carisoprodol,0.9943739175796509,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Carisoprodol.,49,Type_49,Yes
DB00545,Pyridostigmine,DB08970,Fluprednidene,0.9998887777328491,49,Type_49,The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Fluprednidene.,49,Type_49,Yes
DB06282,Levocetirizine,DB13323,Trichloroethylene,0.999981164932251,49,Type_49,The risk or severity of adverse effects can be increased when Levocetirizine is combined with Trichloroethylene.,49,Type_49,Yes
DB00491,Miglitol,DB04576,Fleroxacin,0.9966377019882202,9,Type_9,Miglitol may increase the hypoglycemic activities of Fleroxacin.,9,Type_9,Yes
DB01395,Drospirenone,DB05521,Telaprevir,0.7168344259262085,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Drospirenone.,75,Type_75,No
DB00182,Amphetamine,DB01129,Rabeprazole,0.7957947254180908,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Amphetamine.,18,Type_18,No
DB00338,Omeprazole,DB01319,Fosamprenavir,0.8850434422492981,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00596,Ulobetasol,DB00805,Minaprine,0.8615665435791016,49,Type_49,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Minaprine.,49,Type_49,Yes
DB00635,Prednisone,DB03585,Oxyphenbutazone,0.9994575381278992,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Oxyphenbutazone.,49,Type_49,Yes
DB00344,Protriptyline,DB01192,Oxymorphone,0.9357830286026001,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Oxymorphone.,49,Type_49,Yes
DB01268,Sunitinib,DB05521,Telaprevir,0.6096047163009644,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Sunitinib.,47,Type_47,No
DB00889,Granisetron,DB01182,Propafenone,0.970431387424469,20,Type_20,Granisetron may increase the QTc-prolonging activities of Propafenone.,20,Type_20,Yes
DB00794,Primidone,DB01295,Bevantolol,0.6264113783836365,75,Type_75,The serum concentration of Bevantolol can be decreased when it is combined with Primidone.,75,Type_75,Yes
DB00972,Azelastine,DB09009,Articaine,0.5284139513969421,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Articaine.,16,Type_16,No
DB00679,Thioridazine,DB09017,Brotizolam,0.9995416402816772,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Brotizolam.,49,Type_49,Yes
DB00608,Chloroquine,DB08899,Enzalutamide,0.9589502215385437,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Chloroquine.,75,Type_75,Yes
DB00975,Dipyridamole,DB08807,Bopindolol,0.7448149919509888,49,Type_49,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Bopindolol.,54,Type_54,No
DB00338,Omeprazole,DB01424,Aminophenazone,0.9339343905448914,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Omeprazole.,47,Type_47,Yes
DB00296,Ropivacaine,DB04842,Fluspirilene,0.9957733750343323,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fluspirilene.,49,Type_49,Yes
DB00270,Isradipine,DB01165,Ofloxacin,0.9999371767044067,20,Type_20,Isradipine may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00264,Metoprolol,DB04844,Tetrabenazine,0.745774507522583,47,Type_47,The metabolism of Tetrabenazine can be decreased when combined with Metoprolol.,47,Type_47,Yes
DB00228,Enflurane,DB00708,Sufentanil,0.9970921277999878,49,Type_49,The risk or severity of adverse effects can be increased when Enflurane is combined with Sufentanil.,49,Type_49,Yes
DB06707,Levonordefrin,DB09244,Pirlindole,0.4677301347255707,71,Type_71,Levonordefrin may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB00489,Sotalol,DB01154,Thiamylal,0.6689265370368958,60,Type_60,Sotalol may increase the hypotensive activities of Thiamylal.,60,Type_60,Yes
DB00972,Azelastine,DB06781,Difluprednate,0.9965659976005554,49,Type_49,The risk or severity of adverse effects can be increased when Azelastine is combined with Difluprednate.,49,Type_49,Yes
DB00349,Clobazam,DB13872,Lormetazepam,0.9959259033203125,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Lormetazepam.,49,Type_49,Yes
DB00285,Venlafaxine,DB00636,Clofibrate,0.9773941040039062,47,Type_47,The metabolism of Clofibrate can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00960,Pindolol,DB01087,Primaquine,0.4634748697280884,47,Type_47,The metabolism of Primaquine can be decreased when combined with Pindolol.,47,Type_47,Yes
DB00195,Betaxolol,DB00961,Mepivacaine,0.6391381025314331,73,Type_73,The serum concentration of Mepivacaine can be increased when it is combined with Betaxolol.,73,Type_73,Yes
DB00812,Phenylbutazone,DB01410,Ciclesonide,0.9993560910224915,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Ciclesonide.,49,Type_49,Yes
DB00969,Alosetron,DB09272,Eluxadoline,0.9124688506126404,77,Type_77,The serum concentration of the active metabolites of Eluxadoline can be increased when Eluxadoline is used in combination with Alosetron.,39,Type_39,No
DB00224,Indinavir,DB01410,Ciclesonide,0.8992112874984741,47,Type_47,The metabolism of Ciclesonide can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00184,Nicotine,DB00320,Dihydroergotamine,0.8971575498580933,47,Type_47,The metabolism of Dihydroergotamine can be decreased when combined with Nicotine.,47,Type_47,Yes
DB00899,Remifentanil,DB09279,Fimasartan,0.9971914887428284,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Fimasartan.,49,Type_49,Yes
DB01463,Fencamfamin,DB05271,Rotigotine,0.8710522651672363,32,Type_32,Fencamfamin may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00335,Atenolol,DB09244,Pirlindole,0.9424567818641663,60,Type_60,Atenolol may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB00484,Brimonidine,DB01466,Ethylmorphine,0.9861103296279907,16,Type_16,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.,16,Type_16,Yes
DB00780,Phenelzine,DB00850,Perphenazine,0.8532854318618774,49,Type_49,The risk or severity of adverse effects can be increased when Phenelzine is combined with Perphenazine.,49,Type_49,Yes
DB00675,Tamoxifen,DB08893,Mirabegron,0.7475671768188477,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Tamoxifen.,11,Type_11,No
DB01589,Quazepam,DB09017,Brotizolam,0.9999622106552124,49,Type_49,The risk or severity of adverse effects can be increased when Quazepam is combined with Brotizolam.,49,Type_49,Yes
DB00277,Theophylline,DB00779,Nalidixic acid,0.7765663266181946,47,Type_47,The metabolism of Nalidixic acid can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00839,Tolazamide,DB00946,Phenprocoumon,0.9939419627189636,6,Type_6,Tolazamide may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00457,Prazosin,DB00695,Furosemide,0.9988994598388672,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Furosemide.,49,Type_49,Yes
DB01466,Ethylmorphine,DB01624,Zuclopenthixol,0.970252513885498,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Zuclopenthixol.,49,Type_49,Yes
DB00371,Meprobamate,DB00656,Trazodone,0.965853750705719,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Trazodone.,49,Type_49,Yes
DB00333,Methadone,DB00427,Triprolidine,0.9400621652603149,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Triprolidine.,49,Type_49,Yes
DB00104,Octreotide,DB01035,Procainamide,0.8738306164741516,20,Type_20,Octreotide may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00691,Moexipril,DB00872,Conivaptan,0.5046985149383545,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Conivaptan.,49,Type_49,Yes
DB00738,Pentamidine,DB00889,Granisetron,0.9351227283477783,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00573,Fenoprofen,DB09095,Difluocortolone,0.9998681545257568,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Difluocortolone.,49,Type_49,Yes
DB00540,Nortriptyline,DB08918,Levomilnacipran,0.8901337385177612,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levomilnacipran.,49,Type_49,Yes
DB00909,Zonisamide,DB09068,Vortioxetine,0.9992146492004395,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Vortioxetine.,49,Type_49,Yes
DB00656,Trazodone,DB01167,Itraconazole,0.3668556809425354,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Trazodone.,47,Type_47,Yes
DB00594,Amiloride,DB00788,Naproxen,0.9990886449813843,37,Type_37,Amiloride may decrease the antihypertensive activities of Naproxen.,37,Type_37,Yes
DB00477,Chlorpromazine,DB09555,Dexchlorpheniramine maleate,0.9418249726295471,47,Type_47,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00564,Carbamazepine,DB01179,Podofilox,0.8847497701644897,4,Type_4,The metabolism of Podofilox can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00700,Eplerenone,DB09038,Empagliflozin,0.8978559374809265,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Empagliflozin.,49,Type_49,Yes
DB00808,Indapamide,DB06402,Telavancin,1.0,20,Type_20,Indapamide may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00688,Mycophenolate mofetil,DB00774,Hydroflumethiazide,0.9888852834701538,70,Type_70,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Mycophenolate mofetil.,70,Type_70,Yes
DB00402,Eszopiclone,DB09034,Suvorexant,0.9996445178985596,16,Type_16,Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,16,Type_16,Yes
DB00795,Sulfasalazine,DB01155,Gemifloxacin,0.9520264863967896,27,Type_27,Sulfasalazine may increase the neuroexcitatory activities of Gemifloxacin.,27,Type_27,Yes
DB01435,Antipyrine,DB07615,Tranilast,0.9914628863334656,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Tranilast.,49,Type_49,Yes
DB00370,Mirtazapine,DB01035,Procainamide,0.6544633507728577,20,Type_20,Mirtazapine may increase the QTc-prolonging activities of Procainamide.,20,Type_20,Yes
DB00882,Clomifene,DB06616,Bosutinib,0.9725804924964905,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Clomifene.,73,Type_73,Yes
DB00559,Bosentan,DB09242,Moxonidine,0.9938826560974121,60,Type_60,Bosentan may increase the hypotensive activities of Moxonidine.,60,Type_60,Yes
DB00500,Tolmetin,DB00887,Bumetanide,0.999997615814209,29,Type_29,Tolmetin may decrease the diuretic activities of Bumetanide.,29,Type_29,Yes
DB00951,Isoniazid,DB06403,Ambrisentan,0.8904920816421509,47,Type_47,The metabolism of Ambrisentan can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB00477,Chlorpromazine,DB08873,Boceprevir,0.48882219195365906,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00770,Alprostadil,DB03619,Deoxycholic acid,0.9999843835830688,49,Type_49,The risk or severity of adverse effects can be increased when Alprostadil is combined with Deoxycholic acid.,49,Type_49,Yes
DB00619,Imatinib,DB01234,Dexamethasone,0.9439683556556702,47,Type_47,The metabolism of Dexamethasone can be decreased when combined with Imatinib.,75,Type_75,No
DB00334,Olanzapine,DB01106,Levocabastine,0.9995676875114441,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Levocabastine.,49,Type_49,Yes
DB02709,Resveratrol,DB09218,Clonixin,0.9930630326271057,49,Type_49,The risk or severity of adverse effects can be increased when Resveratrol is combined with Clonixin.,49,Type_49,Yes
DB00528,Lercanidipine,DB01188,Ciclopirox,0.9915068745613098,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Ciclopirox.,49,Type_49,Yes
DB06724,Calcium carbonate,DB08826,Deferiprone,0.999974250793457,75,Type_75,The serum concentration of Deferiprone can be decreased when it is combined with Calcium carbonate.,75,Type_75,Yes
DB00635,Prednisone,DB08797,Salicylamide,0.9995092153549194,49,Type_49,The risk or severity of adverse effects can be increased when Prednisone is combined with Salicylamide.,49,Type_49,Yes
DB00370,Mirtazapine,DB01041,Thalidomide,0.9993316531181335,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,16,Type_16,Yes
DB00270,Isradipine,DB06777,Chenodeoxycholic acid,0.9736295342445374,47,Type_47,The metabolism of Chenodeoxycholic acid can be decreased when combined with Isradipine.,47,Type_47,Yes
DB01198,Zopiclone,DB05271,Rotigotine,0.9986741542816162,32,Type_32,Zopiclone may increase the sedative activities of Rotigotine.,32,Type_32,Yes
DB00598,Labetalol,DB00839,Tolazamide,0.992032527923584,9,Type_9,Labetalol may increase the hypoglycemic activities of Tolazamide.,9,Type_9,Yes
DB01100,Pimozide,DB06825,Triptorelin,0.9984732270240784,20,Type_20,Pimozide may increase the QTc-prolonging activities of Triptorelin.,20,Type_20,Yes
DB00915,Amantadine,DB01184,Domperidone,0.9895378351211548,20,Type_20,Amantadine may increase the QTc-prolonging activities of Domperidone.,20,Type_20,Yes
DB00318,Codeine,DB00462,Methscopolamine bromide,0.9996318817138672,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Methscopolamine bromide.,49,Type_49,Yes
DB00498,Phenindione,DB01050,Ibuprofen,0.9987597465515137,6,Type_6,Phenindione may increase the anticoagulant activities of Ibuprofen.,6,Type_6,Yes
DB00549,Zafirlukast,DB01149,Nefazodone,0.9423230886459351,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB01030,Topotecan,DB08864,Rilpivirine,0.9674819111824036,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Topotecan.,73,Type_73,Yes
DB01179,Podofilox,DB09120,Zucapsaicin,0.9937200546264648,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Podofilox.,47,Type_47,Yes
DB00188,Bortezomib,DB01191,Dexfenfluramine,0.9199628829956055,47,Type_47,The metabolism of Dexfenfluramine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00546,Adinazolam,DB08873,Boceprevir,0.886235237121582,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Adinazolam.,47,Type_47,Yes
DB08907,Canagliflozin,DB09049,Naloxegol,0.9917622804641724,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Canagliflozin.,73,Type_73,Yes
DB06770,Benzyl alcohol,DB08880,Teriflunomide,0.3303385078907013,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Benzyl alcohol.,75,Type_75,Yes
DB00426,Famciclovir,DB08881,Vemurafenib,0.626635730266571,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Famciclovir.,75,Type_75,Yes
DB00586,Diclofenac,DB00939,Meclofenamic acid,0.9936273097991943,49,Type_49,The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid.,49,Type_49,Yes
DB00257,Clotrimazole,DB01392,Yohimbine,0.9907110333442688,47,Type_47,The metabolism of Yohimbine can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01253,Ergometrine,DB09204,Arotinolol,0.9772815704345703,19,Type_19,Ergometrine may increase the vasoconstricting activities of Arotinolol.,19,Type_19,Yes
DB00356,Chlorzoxazone,DB09291,Rolapitant,0.9129337668418884,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Chlorzoxazone.,47,Type_47,Yes
DB00266,Dicoumarol,DB00615,Rifabutin,0.816272497177124,4,Type_4,The metabolism of Rifabutin can be increased when combined with Dicoumarol.,4,Type_4,Yes
DB00946,Phenprocoumon,DB01321,Josamycin,0.8537926077842712,73,Type_73,The serum concentration of Josamycin can be increased when it is combined with Phenprocoumon.,73,Type_73,Yes
DB05812,Abiraterone,DB06290,Simeprevir,0.9728277325630188,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB01072,Atazanavir,DB01418,Acenocoumarol,0.6198076009750366,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Atazanavir.,47,Type_47,No
DB00519,Trandolapril,DB00691,Moexipril,0.822721004486084,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Moexipril.,49,Type_49,Yes
DB00866,Alprenolol,DB00907,Cocaine,0.7884214520454407,47,Type_47,The metabolism of Cocaine can be decreased when combined with Alprenolol.,47,Type_47,Yes
DB01615,Aceprometazine,DB06708,Lumefantrine,0.5209636092185974,73,Type_73,The serum concentration of Lumefantrine can be increased when it is combined with Aceprometazine.,73,Type_73,Yes
DB01623,Thiothixene,DB08922,Perospirone,0.9688106775283813,49,Type_49,The risk or severity of adverse effects can be increased when Thiothixene is combined with Perospirone.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB09235,Efonidipine,0.9702020883560181,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Efonidipine.,49,Type_49,Yes
DB00831,Trifluoperazine,DB06144,Sertindole,0.9939038157463074,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Sertindole.,49,Type_49,Yes
DB08910,Pomalidomide,DB09085,Tetracaine,0.9997178912162781,49,Type_49,The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetracaine.,49,Type_49,Yes
DB00744,Zileuton,DB00945,Acetylsalicylic acid,0.7945795059204102,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Acetylsalicylic acid.,49,Type_49,Yes
DB01410,Ciclesonide,DB09281,Magnesium trisilicate,0.9978686571121216,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Ciclesonide.,3,Type_3,Yes
DB00909,Zonisamide,DB01544,Flunitrazepam,0.9964004755020142,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Flunitrazepam.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00361,Vinorelbine,0.8079849481582642,47,Type_47,The metabolism of Vinorelbine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01234,Dexamethasone,DB06335,Saxagliptin,0.8369302749633789,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Dexamethasone.,75,Type_75,No
DB01283,Lumiracoxib,DB04865,Omacetaxine mepesuccinate,0.7821463346481323,49,Type_49,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Omacetaxine mepesuccinate.,49,Type_49,Yes
DB01203,Nadolol,DB09083,Ivabradine,0.7642942667007446,54,Type_54,Nadolol may increase the bradycardic activities of Ivabradine.,54,Type_54,Yes
DB00817,Rosoxacin,DB01399,Salsalate,0.9799776673316956,27,Type_27,Rosoxacin may increase the neuroexcitatory activities of Salsalate.,27,Type_27,Yes
DB00963,Bromfenac,DB01297,Practolol,0.9999473094940186,37,Type_37,Bromfenac may decrease the antihypertensive activities of Practolol.,37,Type_37,Yes
DB00492,Fosinopril,DB01244,Bepridil,0.5040900707244873,49,Type_49,The risk or severity of adverse effects can be increased when Fosinopril is combined with Bepridil.,60,Type_60,No
DB00775,Tirofiban,DB00932,Tipranavir,0.8374307155609131,53,Type_53,Tirofiban may increase the antiplatelet activities of Tipranavir.,53,Type_53,Yes
DB01017,Minocycline,DB01068,Clonazepam,0.9771274924278259,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.,16,Type_16,Yes
DB00564,Carbamazepine,DB00721,Procaine,0.9816809296607971,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procaine.,49,Type_49,Yes
DB00977,Ethinylestradiol,DB01597,Cilastatin,0.5651275515556335,70,Type_70,The therapeutic efficacy of Cilastatin can be decreased when used in combination with Ethinylestradiol.,75,Type_75,No
DB01162,Terazosin,DB01351,Amobarbital,0.9824457168579102,60,Type_60,Terazosin may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB01233,Metoclopramide,DB01601,Lopinavir,0.44864100217819214,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Metoclopramide.,20,Type_20,No
DB00349,Clobazam,DB00918,Almotriptan,0.9175335168838501,47,Type_47,The metabolism of Almotriptan can be decreased when combined with Clobazam.,47,Type_47,Yes
DB01045,Rifampicin,DB08932,Macitentan,0.4968271255493164,75,Type_75,The serum concentration of Macitentan can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB01171,Moclobemide,DB09065,Cobicistat,0.5241795182228088,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Moclobemide.,73,Type_73,No
DB00346,Alfuzosin,DB06695,Dabigatran etexilate,0.84336918592453,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Alfuzosin.,73,Type_73,No
DB00559,Bosentan,DB01067,Glipizide,0.9829097390174866,75,Type_75,The serum concentration of Glipizide can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00461,Nabumetone,DB08971,Fluocortolone,0.9996472597122192,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Fluocortolone.,49,Type_49,Yes
DB00454,Meperidine,DB01545,Ethyl loflazepate,0.9983262419700623,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Ethyl loflazepate.,49,Type_49,Yes
DB01232,Saquinavir,DB06717,Fosaprepitant,0.9208020567893982,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB00497,Oxycodone,DB01580,Oxprenolol,0.9656174778938293,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Oxprenolol.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00904,Ondansetron,0.7611321806907654,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ondansetron.,49,Type_49,Yes
DB00450,Droperidol,DB00455,Loratadine,0.9903832077980042,16,Type_16,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loratadine.,16,Type_16,Yes
DB00472,Fluoxetine,DB08895,Tofacitinib,0.6635543704032898,47,Type_47,The metabolism of Tofacitinib can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB00794,Primidone,DB11560,Lesinurad,0.9902048110961914,4,Type_4,The metabolism of Lesinurad can be increased when combined with Primidone.,4,Type_4,Yes
DB00289,Atomoxetine,DB00869,Dorzolamide,0.9822461605072021,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00906,Tiagabine,DB06148,Mianserin,0.44044074416160583,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Mianserin.,70,Type_70,No
DB01338,Pipecuronium,DB01627,Lincomycin,0.998818576335907,21,Type_21,Pipecuronium may increase the neuromuscular blocking activities of Lincomycin.,21,Type_21,Yes
DB00916,Metronidazole,DB01186,Pergolide,0.88160240650177,49,Type_49,The risk or severity of adverse effects can be increased when Metronidazole is combined with Pergolide.,49,Type_49,Yes
DB00370,Mirtazapine,DB09330,Osimertinib,0.9197389483451843,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Mirtazapine.,73,Type_73,Yes
DB01012,Cinacalcet,DB01244,Bepridil,0.8186510801315308,47,Type_47,The metabolism of Bepridil can be decreased when combined with Cinacalcet.,47,Type_47,Yes
DB00384,Triamterene,DB00872,Conivaptan,0.4581947922706604,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Triamterene.,49,Type_49,No
DB00611,Butorphanol,DB09117,Paraldehyde,0.999417781829834,16,Type_16,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00349,Clobazam,DB08899,Enzalutamide,0.9481393694877625,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Clobazam.,75,Type_75,Yes
DB00263,Sulfisoxazole,DB08875,Cabozantinib,0.9644798636436462,47,Type_47,The metabolism of Cabozantinib can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB01186,Pergolide,DB01217,Anastrozole,0.818787157535553,70,Type_70,The therapeutic efficacy of Anastrozole can be decreased when used in combination with Pergolide.,49,Type_49,No
DB00468,Quinine,DB01253,Ergometrine,0.5037680864334106,49,Type_49,The risk or severity of adverse effects can be increased when Quinine is combined with Ergometrine.,49,Type_49,Yes
DB01229,Paclitaxel,DB06292,Dapagliflozin,0.999826967716217,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Dapagliflozin.,49,Type_49,Yes
DB00808,Indapamide,DB01275,Hydralazine,0.5885074138641357,60,Type_60,Indapamide may increase the hypotensive activities of Hydralazine.,49,Type_49,No
DB00653,Magnesium sulfate,DB09345,Pramocaine,0.9961799383163452,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.,16,Type_16,Yes
DB00344,Protriptyline,DB00455,Loratadine,0.8947792053222656,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Loratadine.,49,Type_49,Yes
DB00540,Nortriptyline,DB00899,Remifentanil,0.97664874792099,49,Type_49,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Remifentanil.,49,Type_49,Yes
DB00237,Butabarbital,DB01624,Zuclopenthixol,0.9984049201011658,49,Type_49,The risk or severity of adverse effects can be increased when Butabarbital is combined with Zuclopenthixol.,49,Type_49,Yes
DB00906,Tiagabine,DB06594,Agomelatine,0.9993160963058472,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Agomelatine.,49,Type_49,Yes
DB00283,Clemastine,DB00869,Dorzolamide,0.9620113372802734,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01117,Atovaquone,DB01615,Aceprometazine,0.9596870541572571,73,Type_73,The serum concentration of Aceprometazine can be increased when it is combined with Atovaquone.,73,Type_73,Yes
DB01088,Iloprost,DB09030,Vorapaxar,0.6786851286888123,6,Type_6,Iloprost may increase the anticoagulant activities of Vorapaxar.,53,Type_53,No
DB00177,Valsartan,DB00206,Reserpine,0.5135493278503418,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Reserpine.,49,Type_49,Yes
DB00395,Carisoprodol,DB01601,Lopinavir,0.933751106262207,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Carisoprodol.,4,Type_4,No
DB01580,Oxprenolol,DB08872,Gabapentin enacarbil,0.9962337613105774,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00949,Felbamate,DB06335,Saxagliptin,0.517951488494873,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Felbamate.,75,Type_75,No
DB00344,Protriptyline,DB09000,Cyamemazine,0.9673312902450562,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyamemazine.,49,Type_49,Yes
DB00396,Progesterone,DB09330,Osimertinib,0.977566659450531,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00817,Rosoxacin,DB09162,Ferric Citrate,0.7783504128456116,75,Type_75,The serum concentration of Ferric Citrate can be decreased when it is combined with Rosoxacin.,75,Type_75,Yes
DB00629,Guanabenz,DB00881,Quinapril,0.9560240507125854,60,Type_60,Guanabenz may increase the hypotensive activities of Quinapril.,60,Type_60,Yes
DB08873,Boceprevir,DB08931,Riociguat,0.6405062675476074,47,Type_47,The metabolism of Riociguat can be decreased when combined with Boceprevir.,73,Type_73,No
DB00622,Nicardipine,DB01137,Levofloxacin,0.9022581577301025,20,Type_20,Nicardipine may increase the QTc-prolonging activities of Levofloxacin.,20,Type_20,Yes
DB00277,Theophylline,DB06717,Fosaprepitant,0.6928647756576538,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Theophylline.,73,Type_73,Yes
DB00563,Methotrexate,DB00814,Meloxicam,0.7350980639457703,73,Type_73,The serum concentration of Meloxicam can be increased when it is combined with Methotrexate.,73,Type_73,Yes
DB00601,Linezolid,DB01253,Ergometrine,0.8262411952018738,49,Type_49,The risk or severity of adverse effects can be increased when Linezolid is combined with Ergometrine.,49,Type_49,Yes
DB00196,Fluconazole,DB01544,Flunitrazepam,0.8585754036903381,47,Type_47,The metabolism of Flunitrazepam can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00404,Alprazolam,DB01072,Atazanavir,0.7303008437156677,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Alprazolam.,73,Type_73,No
DB00962,Zaleplon,DB01227,Levacetylmethadol,0.8645580410957336,49,Type_49,The risk or severity of adverse effects can be increased when Zaleplon is combined with Levacetylmethadol.,49,Type_49,Yes
DB00489,Sotalol,DB00500,Tolmetin,0.9300252199172974,37,Type_37,Sotalol may decrease the antihypertensive activities of Tolmetin.,37,Type_37,Yes
DB00217,Bethanidine,DB01170,Guanethidine,0.9999996423721313,60,Type_60,Bethanidine may increase the hypotensive activities of Guanethidine.,60,Type_60,Yes
DB00552,Pentostatin,DB00864,Tacrolimus,0.7804969549179077,57,Type_57,Pentostatin may increase the nephrotoxic activities of Tacrolimus.,49,Type_49,No
DB00328,Indomethacin,DB01013,Clobetasol propionate,0.9995192289352417,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Clobetasol propionate.,49,Type_49,Yes
DB00363,Clozapine,DB00373,Timolol,0.44169899821281433,47,Type_47,The metabolism of Timolol can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00712,Flurbiprofen,DB00919,Spectinomycin,0.9998501539230347,72,Type_72,Flurbiprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB00812,Phenylbutazone,DB04898,Ximelagatran,0.9141332507133484,6,Type_6,Phenylbutazone may increase the anticoagulant activities of Ximelagatran.,6,Type_6,Yes
DB00989,Rivastigmine,DB04855,Dronedarone,0.8333647847175598,54,Type_54,Rivastigmine may increase the bradycardic activities of Dronedarone.,54,Type_54,Yes
DB00356,Chlorzoxazone,DB00985,Dimenhydrinate,0.9999762773513794,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Dimenhydrinate.,49,Type_49,Yes
DB00491,Miglitol,DB00614,Furazolidone,0.9990806579589844,9,Type_9,Miglitol may increase the hypoglycemic activities of Furazolidone.,9,Type_9,Yes
DB00182,Amphetamine,DB00514,Dextromethorphan,0.41051119565963745,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Dextromethorphan.,64,Type_64,No
DB08797,Salicylamide,DB09075,Edoxaban,0.9932374954223633,6,Type_6,Salicylamide may increase the anticoagulant activities of Edoxaban.,6,Type_6,Yes
DB00240,Alclometasone,DB00615,Rifabutin,0.8704103827476501,4,Type_4,The metabolism of Rifabutin can be increased when combined with Alclometasone.,4,Type_4,Yes
DB01243,Chloroxine,DB06694,Xylometazoline,0.9943587183952332,49,Type_49,The risk or severity of adverse effects can be increased when Chloroxine is combined with Xylometazoline.,49,Type_49,Yes
DB01198,Zopiclone,DB01211,Clarithromycin,0.7873607277870178,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Zopiclone.,73,Type_73,No
DB00653,Magnesium sulfate,DB01188,Ciclopirox,0.8587230443954468,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Ciclopirox.,49,Type_49,Yes
DB01264,Darunavir,DB04878,Voglibose,0.6367464661598206,70,Type_70,The therapeutic efficacy of Voglibose can be decreased when used in combination with Darunavir.,70,Type_70,Yes
DB01259,Lapatinib,DB06212,Tolvaptan,0.9867743253707886,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Lapatinib.,73,Type_73,Yes
DB00248,Cabergoline,DB06712,Nilvadipine,0.8308163285255432,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Nilvadipine.,49,Type_49,Yes
DB00273,Topiramate,DB01545,Ethyl loflazepate,0.997136116027832,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00289,Atomoxetine,DB08932,Macitentan,0.9732998013496399,47,Type_47,The metabolism of Macitentan can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB04898,Ximelagatran,DB09218,Clonixin,0.9758813977241516,6,Type_6,Ximelagatran may increase the anticoagulant activities of Clonixin.,6,Type_6,Yes
DB00246,Ziprasidone,DB00836,Loperamide,0.920463502407074,47,Type_47,The metabolism of Loperamide can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00768,Olopatadine,DB01384,Paramethasone,0.9992231130599976,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Paramethasone.,49,Type_49,Yes
DB08815,Lurasidone,DB09054,Idelalisib,0.7711719274520874,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Lurasidone.,73,Type_73,Yes
DB00334,Olanzapine,DB01142,Doxepin,0.6990565657615662,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Doxepin.,49,Type_49,Yes
DB00972,Azelastine,DB08814,Triflusal,0.6475152373313904,53,Type_53,Azelastine may increase the antiplatelet activities of Triflusal.,6,Type_6,No
DB00285,Venlafaxine,DB01030,Topotecan,0.9904569983482361,73,Type_73,The serum concentration of Topotecan can be increased when it is combined with Venlafaxine.,73,Type_73,Yes
DB00575,Clonidine,DB00611,Butorphanol,0.9958431124687195,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Butorphanol.,49,Type_49,Yes
DB00652,Pentazocine,DB09072,Sodium oxybate,1.0,16,Type_16,Pentazocine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB01399,Salsalate,DB08991,Epirizole,0.9997486472129822,49,Type_49,The risk or severity of adverse effects can be increased when Salsalate is combined with Epirizole.,49,Type_49,Yes
DB01013,Clobetasol propionate,DB09216,Tolfenamic acid,0.9911559820175171,49,Type_49,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Tolfenamic acid.,49,Type_49,Yes
DB00285,Venlafaxine,DB00996,Gabapentin,0.5891904830932617,47,Type_47,The metabolism of Gabapentin can be decreased when combined with Venlafaxine.,49,Type_49,No
DB00178,Ramipril,DB00633,Dexmedetomidine,0.9319840669631958,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Dexmedetomidine.,49,Type_49,Yes
DB00679,Thioridazine,DB01129,Rabeprazole,0.6057441830635071,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Thioridazine.,73,Type_73,No
DB00246,Ziprasidone,DB01580,Oxprenolol,0.5337246656417847,47,Type_47,The metabolism of Oxprenolol can be decreased when combined with Ziprasidone.,49,Type_49,No
DB00363,Clozapine,DB00807,Proparacaine,0.9952741861343384,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Proparacaine.,49,Type_49,Yes
DB00838,Clocortolone,DB01149,Nefazodone,0.8464370965957642,73,Type_73,The serum concentration of Nefazodone can be increased when it is combined with Clocortolone.,73,Type_73,Yes
DB01002,Levobupivacaine,DB06144,Sertindole,0.9634794592857361,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Sertindole.,49,Type_49,Yes
DB00611,Butorphanol,DB00768,Olopatadine,0.937913179397583,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Olopatadine.,49,Type_49,Yes
DB00851,Dacarbazine,DB09198,Lobeglitazone,0.9924106597900391,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Dacarbazine.,47,Type_47,Yes
DB00708,Sufentanil,DB01100,Pimozide,0.9149336218833923,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Pimozide.,49,Type_49,Yes
DB00344,Protriptyline,DB00408,Loxapine,0.9935716390609741,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Loxapine.,49,Type_49,Yes
DB00253,Medrysone,DB08439,Parecoxib,0.9977376461029053,49,Type_49,The risk or severity of adverse effects can be increased when Medrysone is combined with Parecoxib.,49,Type_49,Yes
DB04846,Celiprolol,DB09241,Methylene blue,0.9975233674049377,60,Type_60,Celiprolol may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00959,Methylprednisolone,DB09063,Ceritinib,0.9165931940078735,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Methylprednisolone.,73,Type_73,Yes
DB01351,Amobarbital,DB01463,Fencamfamin,0.9967777132987976,49,Type_49,The risk or severity of adverse effects can be increased when Amobarbital is combined with Fencamfamin.,49,Type_49,Yes
DB01067,Glipizide,DB01254,Dasatinib,0.5328644514083862,73,Type_73,The serum concentration of Dasatinib can be increased when it is combined with Glipizide.,73,Type_73,Yes
DB01390,Sodium bicarbonate,DB01577,Metamfetamine,0.3733574151992798,72,Type_72,Sodium bicarbonate may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,72,Type_72,Yes
DB00608,Chloroquine,DB00919,Spectinomycin,0.9727961421012878,72,Type_72,Chloroquine may decrease the excretion rate of Spectinomycin which could result in a higher serum level.,72,Type_72,Yes
DB00615,Rifabutin,DB06228,Rivaroxaban,0.3602861762046814,4,Type_4,The metabolism of Rivaroxaban can be increased when combined with Rifabutin.,75,Type_75,No
DB00748,Carbinoxamine,DB00754,Ethotoin,0.9992350339889526,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Ethotoin.,49,Type_49,Yes
DB00559,Bosentan,DB08903,Bedaquiline,0.7489088177680969,75,Type_75,The serum concentration of Bedaquiline can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00281,Lidocaine,DB00737,Meclizine,0.9976761937141418,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Meclizine.,49,Type_49,Yes
DB00181,Baclofen,DB09342,Propoxycaine,0.9999949932098389,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Propoxycaine.,49,Type_49,Yes
DB06698,Betahistine,DB09555,Dexchlorpheniramine maleate,0.7640858292579651,70,Type_70,The therapeutic efficacy of Dexchlorpheniramine maleate can be decreased when used in combination with Betahistine.,70,Type_70,Yes
DB01431,Allylestrenol,DB04272,Citric acid,0.9599578380584717,70,Type_70,The therapeutic efficacy of Citric acid can be decreased when used in combination with Allylestrenol.,70,Type_70,Yes
DB00776,Oxcarbazepine,DB09389,Norgestrel,0.8205700516700745,70,Type_70,The therapeutic efficacy of Norgestrel can be decreased when used in combination with Oxcarbazepine.,75,Type_75,No
DB00227,Lovastatin,DB00783,Estradiol,0.7410306334495544,47,Type_47,The metabolism of Estradiol can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00687,Fludrocortisone,DB01024,Mycophenolic acid,0.9898936152458191,49,Type_49,The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Mycophenolic acid.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB09225,Zotepine,0.9983760118484497,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Zotepine.,49,Type_49,Yes
DB00395,Carisoprodol,DB08933,Luliconazole,0.9507508873939514,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Carisoprodol.,73,Type_73,Yes
DB00189,Ethchlorvynol,DB00470,Dronabinol,0.9995798468589783,16,Type_16,Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.,16,Type_16,Yes
DB00854,Levorphanol,DB09290,Ramosetron,0.9999945163726807,39,Type_39,Levorphanol may increase the constipating activities of Ramosetron.,39,Type_39,Yes
DB06739,Seratrodast,DB08439,Parecoxib,0.9566695690155029,49,Type_49,The risk or severity of adverse effects can be increased when Seratrodast is combined with Parecoxib.,49,Type_49,Yes
DB00358,Mefloquine,DB00593,Ethosuximide,0.8175276517868042,70,Type_70,The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Mefloquine.,70,Type_70,Yes
DB00285,Venlafaxine,DB01166,Cilostazol,0.6650923490524292,73,Type_73,The serum concentration of Cilostazol can be increased when it is combined with Venlafaxine.,73,Type_73,Yes
DB00861,Diflunisal,DB01234,Dexamethasone,0.9984317421913147,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Dexamethasone.,49,Type_49,Yes
DB00397,Phenylpropanolamine,DB00610,Metaraminol,0.9993969202041626,49,Type_49,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Metaraminol.,49,Type_49,Yes
DB01069,Promethazine,DB09039,Eliglustat,0.6921139359474182,20,Type_20,Promethazine may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00591,Fluocinolone acetonide,DB00794,Primidone,0.8794750571250916,75,Type_75,The serum concentration of Primidone can be decreased when it is combined with Fluocinolone acetonide.,75,Type_75,Yes
DB01211,Clarithromycin,DB09236,Lacidipine,0.48120108246803284,47,Type_47,The metabolism of Lacidipine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00782,Propantheline,DB00813,Fentanyl,0.9999885559082031,49,Type_49,The risk or severity of adverse effects can be increased when Propantheline is combined with Fentanyl.,49,Type_49,Yes
DB00946,Phenprocoumon,DB05219,Crisaborole,0.9967543482780457,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB01366,Procaterol,DB01577,Metamfetamine,0.9999130964279175,49,Type_49,The risk or severity of adverse effects can be increased when Procaterol is combined with Metamfetamine.,49,Type_49,Yes
DB00908,Quinidine,DB00981,Physostigmine,0.9763240218162537,70,Type_70,The therapeutic efficacy of Physostigmine can be decreased when used in combination with Quinidine.,70,Type_70,Yes
DB00486,Nabilone,DB08883,Perampanel,0.9999988079071045,16,Type_16,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00405,Dexbrompheniramine,DB00748,Carbinoxamine,0.9997984766960144,49,Type_49,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Carbinoxamine.,49,Type_49,Yes
DB00723,Methoxamine,DB01365,Mephentermine,0.9992757439613342,49,Type_49,The risk or severity of adverse effects can be increased when Methoxamine is combined with Mephentermine.,49,Type_49,Yes
DB00312,Pentobarbital,DB00588,Fluticasone propionate,0.9566025137901306,4,Type_4,The metabolism of Fluticasone propionate can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00326,Calcium glucoheptonate,DB06712,Nilvadipine,0.9137539863586426,70,Type_70,The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Calcium glucoheptonate.,70,Type_70,Yes
DB00991,Oxaprozin,DB08991,Epirizole,0.9966681599617004,49,Type_49,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Epirizole.,49,Type_49,Yes
DB00783,Estradiol,DB08439,Parecoxib,0.7362141013145447,81,Type_81,Estradiol may increase the thrombogenic activities of Parecoxib.,81,Type_81,Yes
DB00986,Glycopyrronium,DB01339,Vecuronium,0.9996262788772583,2,Type_2,Glycopyrronium may increase the anticholinergic activities of Vecuronium.,2,Type_2,Yes
DB00312,Pentobarbital,DB04946,Iloperidone,0.8624799251556396,4,Type_4,The metabolism of Iloperidone can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB01028,Methoxyflurane,DB01351,Amobarbital,0.961187481880188,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Amobarbital.,49,Type_49,Yes
DB00221,Isoetharine,DB00458,Imipramine,0.985095202922821,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Imipramine.,49,Type_49,Yes
DB01076,Atorvastatin,DB01206,Lomustine,0.5455420613288879,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Lomustine.,49,Type_49,Yes
DB01197,Captopril,DB06737,Zaltoprofen,0.962526261806488,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Zaltoprofen.,49,Type_49,Yes
DB00802,Alfentanil,DB01356,Lithium cation,0.982340931892395,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Lithium cation.,49,Type_49,Yes
DB00408,Loxapine,DB00949,Felbamate,0.9614362120628357,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Felbamate.,49,Type_49,Yes
DB00834,Mifepristone,DB06788,Histrelin,0.9999901056289673,20,Type_20,Mifepristone may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB01240,Epoprostenol,DB08981,Fenbufen,0.6071428656578064,49,Type_49,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Fenbufen.,70,Type_70,No
DB00317,Gefitinib,DB00857,Terbinafine,0.9288832545280457,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Gefitinib.,47,Type_47,Yes
DB00279,Liothyronine,DB06210,Eltrombopag,0.6545575857162476,75,Type_75,The serum concentration of Eltrombopag can be decreased when it is combined with Liothyronine.,73,Type_73,No
DB06690,Nitrous oxide,DB06770,Benzyl alcohol,0.9999494552612305,49,Type_49,The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Benzyl alcohol.,49,Type_49,Yes
DB00014,Goserelin,DB00710,Ibandronate,0.9972110390663147,20,Type_20,Goserelin may increase the QTc-prolonging activities of Ibandronate.,20,Type_20,Yes
DB00881,Quinapril,DB09288,Propacetamol,0.9631395936012268,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Propacetamol.,49,Type_49,Yes
DB00528,Lercanidipine,DB01229,Paclitaxel,0.9931364059448242,49,Type_49,The risk or severity of adverse effects can be increased when Lercanidipine is combined with Paclitaxel.,49,Type_49,Yes
DB08907,Canagliflozin,DB09235,Efonidipine,0.9785037636756897,49,Type_49,The risk or severity of adverse effects can be increased when Canagliflozin is combined with Efonidipine.,49,Type_49,Yes
DB00396,Progesterone,DB01118,Amiodarone,0.8045768141746521,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Progesterone.,47,Type_47,Yes
DB00653,Magnesium sulfate,DB00738,Pentamidine,0.3408929407596588,75,Type_75,The serum concentration of Pentamidine can be decreased when it is combined with Magnesium sulfate.,49,Type_49,No
DB00300,Tenofovir disoproxil,DB00586,Diclofenac,0.5768324136734009,49,Type_49,The risk or severity of adverse effects can be increased when Tenofovir disoproxil is combined with Diclofenac.,49,Type_49,Yes
DB00822,Disulfiram,DB01263,Posaconazole,0.9008020162582397,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Disulfiram.,47,Type_47,Yes
DB00936,Salicylic acid,DB00996,Gabapentin,0.9138726592063904,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Gabapentin.,49,Type_49,Yes
DB00257,Clotrimazole,DB08860,Pitavastatin,0.5851905345916748,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00337,Pimecrolimus,DB04951,Pirfenidone,0.9895445704460144,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pirfenidone.,49,Type_49,Yes
DB01349,Tasosartan,DB13167,Alclofenac,0.9817318320274353,49,Type_49,The risk or severity of adverse effects can be increased when Tasosartan is combined with Alclofenac.,49,Type_49,Yes
DB01340,Cilazapril,DB06694,Xylometazoline,0.9957732558250427,60,Type_60,Cilazapril may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00232,Methyclothiazide,DB01235,Levodopa,0.968829333782196,30,Type_30,Methyclothiazide may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00937,Diethylpropion,DB09244,Pirlindole,0.9943167567253113,71,Type_71,Diethylpropion may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB01365,Mephentermine,DB01618,Molindone,0.9999914169311523,61,Type_61,Mephentermine may decrease the stimulatory activities of Molindone.,61,Type_61,Yes
DB00909,Zonisamide,DB01167,Itraconazole,0.7776255011558533,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Zonisamide.,47,Type_47,Yes
DB05246,Methsuximide,DB09166,Etizolam,0.9995260238647461,49,Type_49,The risk or severity of adverse effects can be increased when Methsuximide is combined with Etizolam.,49,Type_49,Yes
DB00599,Thiopental,DB00854,Levorphanol,0.9932021498680115,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Levorphanol.,49,Type_49,Yes
DB00615,Rifabutin,DB06237,Avanafil,0.830264151096344,4,Type_4,The metabolism of Avanafil can be increased when combined with Rifabutin.,4,Type_4,Yes
DB01100,Pimozide,DB01551,Dihydrocodeine,0.8955451250076294,49,Type_49,The risk or severity of adverse effects can be increased when Pimozide is combined with Dihydrocodeine.,49,Type_49,Yes
DB00208,Ticlopidine,DB04841,Flunarizine,0.9457393884658813,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00540,Nortriptyline,DB00790,Perindopril,0.6977406144142151,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Nortriptyline.,73,Type_73,Yes
DB00208,Ticlopidine,DB00620,Triamcinolone,0.9327642321586609,47,Type_47,The metabolism of Triamcinolone can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00468,Quinine,DB00876,Eprosartan,0.8169850707054138,60,Type_60,Quinine may increase the hypotensive activities of Eprosartan.,60,Type_60,Yes
DB00296,Ropivacaine,DB08822,Azilsartan medoxomil,0.7416951656341553,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00454,Meperidine,DB04876,Vildagliptin,0.4611264765262604,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Vildagliptin.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB01024,Mycophenolic acid,0.7130361795425415,75,Type_75,The serum concentration of Mycophenolic acid can be decreased when it is combined with Medroxyprogesterone acetate.,75,Type_75,Yes
DB00909,Zonisamide,DB04855,Dronedarone,0.7612892985343933,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Zonisamide.,47,Type_47,Yes
DB00972,Azelastine,DB06282,Levocetirizine,0.9454092979431152,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.,16,Type_16,Yes
DB00679,Thioridazine,DB01189,Desflurane,0.9027585983276367,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Desflurane.,20,Type_20,No
DB00854,Levorphanol,DB01192,Oxymorphone,0.9848029017448425,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Oxymorphone.,49,Type_49,Yes
DB00820,Tadalafil,DB01045,Rifampicin,0.5700609683990479,4,Type_4,The metabolism of Rifampicin can be increased when combined with Tadalafil.,75,Type_75,No
DB00817,Rosoxacin,DB01016,Glyburide,0.9959999322891235,9,Type_9,Rosoxacin may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB01355,Hexobarbital,DB04574,Estrone sulfate,0.33284229040145874,75,Type_75,The serum concentration of Estrone sulfate can be decreased when it is combined with Hexobarbital.,70,Type_70,No
DB00181,Baclofen,DB09117,Paraldehyde,0.9991662502288818,16,Type_16,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00731,Nateglinide,DB09244,Pirlindole,0.9945698380470276,9,Type_9,Nateglinide may increase the hypoglycemic activities of Pirlindole.,9,Type_9,Yes
DB00283,Clemastine,DB00814,Meloxicam,0.9907580614089966,47,Type_47,The metabolism of Meloxicam can be decreased when combined with Clemastine.,47,Type_47,Yes
DB06725,Lornoxicam,DB06739,Seratrodast,0.9882941246032715,49,Type_49,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Seratrodast.,49,Type_49,Yes
DB00323,Tolcapone,DB00771,Clidinium,0.9997442364692688,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Clidinium.,49,Type_49,Yes
DB00373,Timolol,DB06207,Silodosin,0.8937481045722961,30,Type_30,Timolol may increase the orthostatic hypotensive activities of Silodosin.,30,Type_30,Yes
DB00176,Fluvoxamine,DB01106,Levocabastine,0.9994895458221436,49,Type_49,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Levocabastine.,49,Type_49,Yes
DB00216,Eletriptan,DB08918,Levomilnacipran,0.9408977627754211,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Levomilnacipran.,49,Type_49,Yes
DB00381,Amlodipine,DB01169,Arsenic trioxide,0.9852267503738403,49,Type_49,The risk or severity of adverse effects can be increased when Amlodipine is combined with Arsenic trioxide.,49,Type_49,Yes
DB00470,Dronabinol,DB01235,Levodopa,0.9998459815979004,16,Type_16,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Levodopa.,16,Type_16,Yes
DB00883,Isosorbide dinitrate,DB01320,Fosphenytoin,0.8835746049880981,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Isosorbide dinitrate.,4,Type_4,Yes
DB01000,Cyclacillin,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cyclacillin.,70,Type_70,Yes
DB00373,Timolol,DB11362,Selexipag,0.9983335137367249,60,Type_60,Timolol may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00280,Disopyramide,DB00487,Pefloxacin,0.9864605665206909,9,Type_9,Disopyramide may increase the hypoglycemic activities of Pefloxacin.,9,Type_9,Yes
DB00273,Topiramate,DB01083,Orlistat,0.9884628653526306,75,Type_75,The serum concentration of Orlistat can be decreased when it is combined with Topiramate.,75,Type_75,Yes
DB00875,Flupentixol,DB01590,Everolimus,0.9187585115432739,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Flupentixol.,73,Type_73,Yes
DB01097,Leflunomide,DB01384,Paramethasone,0.9272310137748718,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Paramethasone.,49,Type_49,Yes
DB00295,Morphine,DB01106,Levocabastine,0.9992873072624207,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Levocabastine.,49,Type_49,Yes
DB01601,Lopinavir,DB06480,Prucalopride,0.9616541266441345,73,Type_73,The serum concentration of Prucalopride can be increased when it is combined with Lopinavir.,73,Type_73,Yes
DB00631,Clofarabine,DB00808,Indapamide,0.945838987827301,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Indapamide.,49,Type_49,Yes
DB01037,Selegiline,DB09027,Ledipasvir,0.8403450846672058,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Selegiline.,73,Type_73,Yes
DB01394,Colchicine,DB06772,Cabazitaxel,0.6660467982292175,73,Type_73,The serum concentration of Cabazitaxel can be increased when it is combined with Colchicine.,73,Type_73,Yes
DB00476,Duloxetine,DB00945,Acetylsalicylic acid,0.8425596952438354,53,Type_53,Duloxetine may increase the antiplatelet activities of Acetylsalicylic acid.,53,Type_53,Yes
DB01008,Busulfan,DB01141,Micafungin,0.5023419857025146,73,Type_73,The serum concentration of Micafungin can be increased when it is combined with Busulfan.,73,Type_73,Yes
DB00246,Ziprasidone,DB00911,Tinidazole,0.979144811630249,47,Type_47,The metabolism of Tinidazole can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB04861,Nebivolol,DB09227,Barnidipine,0.6980825662612915,49,Type_49,The risk or severity of adverse effects can be increased when Nebivolol is combined with Barnidipine.,49,Type_49,Yes
DB08816,Ticagrelor,DB13874,Enasidenib,0.6131538152694702,47,Type_47,The metabolism of Enasidenib can be decreased when combined with Ticagrelor.,47,Type_47,Yes
DB01242,Clomipramine,DB08882,Linagliptin,0.33895617723464966,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Clomipramine.,73,Type_73,Yes
DB00436,Bendroflumethiazide,DB13783,Acemetacin,0.9797608852386475,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00501,Cimetidine,DB00738,Pentamidine,0.7584338784217834,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB04868,Nilotinib,DB12267,Brigatinib,0.975210428237915,47,Type_47,The metabolism of Brigatinib can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB09212,Loxoprofen,DB09285,Morniflumate,0.999612033367157,49,Type_49,The risk or severity of adverse effects can be increased when Loxoprofen is combined with Morniflumate.,49,Type_49,Yes
DB08860,Pitavastatin,DB12332,Rucaparib,0.6415802836418152,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Pitavastatin.,47,Type_47,No
DB08932,Macitentan,DB09065,Cobicistat,0.7452492713928223,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Macitentan.,73,Type_73,No
DB00549,Zafirlukast,DB01264,Darunavir,0.8397558927536011,47,Type_47,The metabolism of Darunavir can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00227,Lovastatin,DB00496,Darifenacin,0.7844852805137634,47,Type_47,The metabolism of Darifenacin can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00818,Propofol,DB01353,Butobarbital,0.999761164188385,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Butobarbital.,49,Type_49,Yes
DB00731,Nateglinide,DB01151,Desipramine,0.6716986298561096,47,Type_47,The metabolism of Desipramine can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00544,Fluorouracil,DB01015,Sulfamethoxazole,0.9039180278778076,47,Type_47,The metabolism of Sulfamethoxazole can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB01015,Sulfamethoxazole,DB01418,Acenocoumarol,0.4221456050872803,6,Type_6,Sulfamethoxazole may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01263,Posaconazole,DB06772,Cabazitaxel,0.6966620683670044,47,Type_47,The metabolism of Cabazitaxel can be decreased when combined with Posaconazole.,73,Type_73,No
DB00745,Modafinil,DB01232,Saquinavir,0.7614920139312744,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Modafinil.,47,Type_47,Yes
DB00765,Metyrosine,DB00844,Nalbuphine,0.9997878670692444,32,Type_32,Metyrosine may increase the sedative activities of Nalbuphine.,32,Type_32,Yes
DB00537,Ciprofloxacin,DB01267,Paliperidone,0.741759181022644,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB06216,Asenapine,DB06788,Histrelin,0.9999998807907104,20,Type_20,Asenapine may increase the QTc-prolonging activities of Histrelin.,20,Type_20,Yes
DB01137,Levofloxacin,DB01600,Tiaprofenic acid,0.9802111983299255,27,Type_27,Levofloxacin may increase the neuroexcitatory activities of Tiaprofenic acid.,27,Type_27,Yes
DB00568,Cinnarizine,DB11093,Calcium citrate,0.9704657793045044,70,Type_70,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Cinnarizine.,70,Type_70,Yes
DB00611,Butorphanol,DB01551,Dihydrocodeine,0.9965739250183105,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Dihydrocodeine.,49,Type_49,Yes
DB06791,Lanreotide,DB08895,Tofacitinib,0.9985382556915283,54,Type_54,Lanreotide may increase the bradycardic activities of Tofacitinib.,54,Type_54,Yes
DB00436,Bendroflumethiazide,DB05039,Indacaterol,0.9996069073677063,83,Type_83,Bendroflumethiazide may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00628,Clorazepic acid,DB01355,Hexobarbital,0.9930227994918823,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Hexobarbital.,49,Type_49,Yes
DB00210,Adapalene,DB01609,Deferasirox,0.5341753363609314,49,Type_49,The risk or severity of adverse effects can be increased when Adapalene is combined with Deferasirox.,49,Type_49,Yes
DB00404,Alprazolam,DB09072,Sodium oxybate,1.0,16,Type_16,Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00318,Codeine,DB00395,Carisoprodol,0.9885950684547424,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Carisoprodol.,49,Type_49,Yes
DB00555,Lamotrigine,DB09225,Zotepine,0.9997665286064148,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Zotepine.,49,Type_49,Yes
DB01154,Thiamylal,DB01220,Rifaximin,0.49674004316329956,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Thiamylal.,4,Type_4,No
DB01201,Rifapentine,DB01236,Sevoflurane,0.7482926845550537,4,Type_4,The metabolism of Sevoflurane can be increased when combined with Rifapentine.,4,Type_4,Yes
DB00246,Ziprasidone,DB01259,Lapatinib,0.7413297891616821,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Ziprasidone.,20,Type_20,No
DB00150,Tryptophan,DB01114,Chlorpheniramine,0.9208651185035706,64,Type_64,Tryptophan may increase the serotonergic activities of Chlorpheniramine.,64,Type_64,Yes
DB00401,Nisoldipine,DB01340,Cilazapril,0.6355387568473816,49,Type_49,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Cilazapril.,49,Type_49,Yes
DB00949,Felbamate,DB06738,Ketobemidone,0.9515767693519592,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Ketobemidone.,49,Type_49,Yes
DB06412,Oxymetholone,DB08864,Rilpivirine,0.9166123270988464,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Oxymetholone.,73,Type_73,Yes
DB00404,Alprazolam,DB01209,Dezocine,0.9981586337089539,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Dezocine.,49,Type_49,Yes
DB00802,Alfentanil,DB01576,Dextroamphetamine,0.9793987274169922,69,Type_69,Alfentanil may increase the analgesic activities of Dextroamphetamine.,69,Type_69,Yes
DB00234,Reboxetine,DB01590,Everolimus,0.9718273878097534,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Reboxetine.,73,Type_73,Yes
DB08899,Enzalutamide,DB09053,Ibrutinib,0.5680317282676697,75,Type_75,The serum concentration of Ibrutinib can be decreased when it is combined with Enzalutamide.,75,Type_75,Yes
DB01618,Molindone,DB09128,Brexpiprazole,0.7078905701637268,49,Type_49,The risk or severity of adverse effects can be increased when Molindone is combined with Brexpiprazole.,49,Type_49,Yes
DB00884,Risedronic acid,DB01026,Ketoconazole,0.8843767642974854,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Risedronic acid.,49,Type_49,No
DB00864,Tacrolimus,DB01050,Ibuprofen,0.9404029846191406,57,Type_57,Tacrolimus may increase the nephrotoxic activities of Ibuprofen.,57,Type_57,Yes
DB00331,Metformin,DB00780,Phenelzine,0.9987730383872986,9,Type_9,Metformin may increase the hypoglycemic activities of Phenelzine.,9,Type_9,Yes
DB00897,Triazolam,DB11304,Phenoxyethanol,0.9998891353607178,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Phenoxyethanol.,49,Type_49,Yes
DB00476,Duloxetine,DB09291,Rolapitant,0.9768871665000916,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB00343,Diltiazem,DB00836,Loperamide,0.9525160789489746,47,Type_47,The metabolism of Loperamide can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00343,Diltiazem,DB01039,Fenofibrate,0.7315791249275208,47,Type_47,The metabolism of Fenofibrate can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00951,Isoniazid,DB06786,Halcinonide,0.8873037695884705,75,Type_75,The serum concentration of Halcinonide can be decreased when it is combined with Isoniazid.,75,Type_75,Yes
DB01247,Isocarboxazid,DB09209,Pholcodine,1.0,64,Type_64,Isocarboxazid may increase the serotonergic activities of Pholcodine.,64,Type_64,Yes
DB01708,Prasterone,DB08984,Etofenamate,0.9994754195213318,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Etofenamate.,49,Type_49,Yes
DB00243,Ranolazine,DB00869,Dorzolamide,0.7102010846138,47,Type_47,The metabolism of Dorzolamide can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00196,Fluconazole,DB06595,Midostaurin,0.865395724773407,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00419,Miglustat,DB01015,Sulfamethoxazole,0.9997174143791199,9,Type_9,Miglustat may increase the hypoglycemic activities of Sulfamethoxazole.,9,Type_9,Yes
DB00231,Temazepam,DB01351,Amobarbital,0.9821986556053162,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Amobarbital.,49,Type_49,Yes
DB00388,Phenylephrine,DB01247,Isocarboxazid,0.9673293828964233,71,Type_71,Phenylephrine may increase the hypertensive activities of Isocarboxazid.,71,Type_71,Yes
DB09009,Articaine,DB09166,Etizolam,0.9999958276748657,49,Type_49,The risk or severity of adverse effects can be increased when Articaine is combined with Etizolam.,49,Type_49,Yes
DB00370,Mirtazapine,DB09117,Paraldehyde,0.9999961853027344,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB00468,Quinine,DB06207,Silodosin,0.7297441959381104,73,Type_73,The serum concentration of Silodosin can be increased when it is combined with Quinine.,73,Type_73,Yes
DB00741,Hydrocortisone,DB09054,Idelalisib,0.6105456352233887,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Hydrocortisone.,47,Type_47,No
DB01097,Leflunomide,DB08908,Dimethyl fumarate,0.999923586845398,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Dimethyl fumarate.,49,Type_49,Yes
DB01032,Probenecid,DB04743,Nimesulide,0.7965917587280273,73,Type_73,The serum concentration of Nimesulide can be increased when it is combined with Probenecid.,73,Type_73,Yes
DB01180,Rescinnamine,DB01592,Iron,0.9375259280204773,57,Type_57,Rescinnamine may increase the nephrotoxic activities of Iron.,49,Type_49,No
DB00598,Labetalol,DB01246,Alimemazine,0.9798572659492493,60,Type_60,Labetalol may increase the hypotensive activities of Alimemazine.,60,Type_60,Yes
DB00091,Cyclosporine,DB08797,Salicylamide,0.9954361319541931,57,Type_57,Cyclosporine may increase the nephrotoxic activities of Salicylamide.,57,Type_57,Yes
DB00440,Trimethoprim,DB01197,Captopril,0.4758511185646057,68,Type_68,Trimethoprim may increase the hyperkalemic activities of Captopril.,68,Type_68,Yes
DB00898,Ethanol,DB04908,Flibanserin,0.976462185382843,16,Type_16,Ethanol may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,60,Type_60,No
DB00531,Cyclophosphamide,DB09079,Nintedanib,0.9962181448936462,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Nintedanib.,15,Type_15,Yes
DB00502,Haloperidol,DB01259,Lapatinib,0.600604772567749,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Haloperidol.,20,Type_20,No
DB01395,Drospirenone,DB12598,Nafamostat,0.3530716001987457,73,Type_73,The serum concentration of Nafamostat can be increased when it is combined with Drospirenone.,68,Type_68,No
DB00477,Chlorpromazine,DB09274,Artesunate,0.39287006855010986,73,Type_73,The serum concentration of Artesunate can be increased when it is combined with Chlorpromazine.,73,Type_73,Yes
DB00599,Thiopental,DB13025,Tiapride,0.999369204044342,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Tiapride.,49,Type_49,Yes
DB00630,Alendronic acid,DB11126,Calcium gluconate,0.9666060209274292,75,Type_75,The serum concentration of Calcium gluconate can be decreased when it is combined with Alendronic acid.,75,Type_75,Yes
DB00765,Metyrosine,DB01320,Fosphenytoin,0.7355122566223145,16,Type_16,Metyrosine may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.,32,Type_32,No
DB00647,Dextropropoxyphene,DB06690,Nitrous oxide,0.999313235282898,49,Type_49,The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Nitrous oxide.,49,Type_49,Yes
DB00346,Alfuzosin,DB04743,Nimesulide,0.9381538033485413,60,Type_60,Alfuzosin may increase the hypotensive activities of Nimesulide.,60,Type_60,Yes
DB01166,Cilostazol,DB05812,Abiraterone,0.8158155083656311,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB01158,Bretylium,DB09112,Nitrous acid,0.9993802309036255,49,Type_49,The risk or severity of adverse effects can be increased when Bretylium is combined with Nitrous acid.,49,Type_49,Yes
DB00283,Clemastine,DB08873,Boceprevir,0.5397045016288757,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01136,Carvedilol,DB11362,Selexipag,0.9987479448318481,60,Type_60,Carvedilol may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00814,Meloxicam,DB09212,Loxoprofen,0.9985607266426086,49,Type_49,The risk or severity of adverse effects can be increased when Meloxicam is combined with Loxoprofen.,49,Type_49,Yes
DB00468,Quinine,DB06412,Oxymetholone,0.9966480135917664,9,Type_9,Quinine may increase the hypoglycemic activities of Oxymetholone.,9,Type_9,Yes
DB00603,Medroxyprogesterone acetate,DB01045,Rifampicin,0.5112619400024414,4,Type_4,The metabolism of Rifampicin can be increased when combined with Medroxyprogesterone acetate.,4,Type_4,Yes
DB00301,Flucloxacillin,DB00946,Phenprocoumon,0.9618745446205139,12,Type_12,Flucloxacillin may decrease the anticoagulant activities of Phenprocoumon.,12,Type_12,Yes
DB01160,Dinoprost tromethamine,DB06725,Lornoxicam,0.600917398929596,70,Type_70,The therapeutic efficacy of Lornoxicam can be decreased when used in combination with Dinoprost tromethamine.,70,Type_70,Yes
DB00675,Tamoxifen,DB01095,Fluvastatin,0.6922749280929565,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Tamoxifen.,47,Type_47,No
DB00278,Argatroban,DB06736,Aceclofenac,0.9285008907318115,6,Type_6,Argatroban may increase the anticoagulant activities of Aceclofenac.,6,Type_6,Yes
DB01708,Prasterone,DB08881,Vemurafenib,0.8454535007476807,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Prasterone.,75,Type_75,Yes
DB01400,Neostigmine,DB06589,Pazopanib,0.8764621019363403,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Neostigmine.,73,Type_73,Yes
DB00222,Glimepiride,DB00682,Warfarin,0.9722591042518616,6,Type_6,Glimepiride may increase the anticoagulant activities of Warfarin.,6,Type_6,Yes
DB00264,Metoprolol,DB01014,Balsalazide,0.9983134269714355,37,Type_37,Metoprolol may decrease the antihypertensive activities of Balsalazide.,37,Type_37,Yes
DB00723,Methoxamine,DB00830,Phenmetrazine,0.9997149109840393,49,Type_49,The risk or severity of adverse effects can be increased when Methoxamine is combined with Phenmetrazine.,49,Type_49,Yes
DB00331,Metformin,DB00957,Norgestimate,0.9945407509803772,70,Type_70,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Metformin.,70,Type_70,Yes
DB00594,Amiloride,DB00753,Isoflurane,0.9997150301933289,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Isoflurane.,49,Type_49,Yes
DB01219,Dantrolene,DB06716,Fospropofol,0.999987006187439,49,Type_49,The risk or severity of adverse effects can be increased when Dantrolene is combined with Fospropofol.,49,Type_49,Yes
DB00603,Medroxyprogesterone acetate,DB04908,Flibanserin,0.5032739639282227,70,Type_70,The therapeutic efficacy of Flibanserin can be decreased when used in combination with Medroxyprogesterone acetate.,73,Type_73,No
DB06717,Fosaprepitant,DB08906,Fluticasone furoate,0.3753518760204315,4,Type_4,The metabolism of Fluticasone furoate can be increased when combined with Fosaprepitant.,73,Type_73,No
DB00818,Propofol,DB00967,Desloratadine,0.997917115688324,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Desloratadine.,49,Type_49,Yes
DB00660,Metaxalone,DB01267,Paliperidone,0.9994446635246277,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Paliperidone.,49,Type_49,Yes
DB00813,Fentanyl,DB01433,Methadyl acetate,0.9850950241088867,49,Type_49,The risk or severity of adverse effects can be increased when Fentanyl is combined with Methadyl acetate.,49,Type_49,Yes
DB00169,Cholecalciferol,DB01120,Gliclazide,0.834645688533783,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01039,Fenofibrate,DB01251,Gliquidone,0.9933765530586243,9,Type_9,Fenofibrate may increase the hypoglycemic activities of Gliquidone.,9,Type_9,Yes
DB00257,Clotrimazole,DB01236,Sevoflurane,0.8405788540840149,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00349,Clobazam,DB00897,Triazolam,0.5637446045875549,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Triazolam.,49,Type_49,Yes
DB00482,Celecoxib,DB01577,Metamfetamine,0.6057479381561279,76,Type_76,Celecoxib may decrease the sedative activities of Metamfetamine.,47,Type_47,No
DB00385,Valrubicin,DB00469,Tenoxicam,0.9998010993003845,72,Type_72,Valrubicin may decrease the excretion rate of Tenoxicam which could result in a higher serum level.,72,Type_72,Yes
DB00754,Ethotoin,DB08918,Levomilnacipran,0.9911195635795593,49,Type_49,The risk or severity of adverse effects can be increased when Ethotoin is combined with Levomilnacipran.,49,Type_49,Yes
DB00802,Alfentanil,DB01452,Diamorphine,0.9973702430725098,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Diamorphine.,49,Type_49,Yes
DB00390,Digoxin,DB01196,Estramustine,0.9232310056686401,58,Type_58,Digoxin may decrease the cardiotoxic activities of Estramustine.,58,Type_58,Yes
DB00208,Ticlopidine,DB00843,Donepezil,0.9665766954421997,47,Type_47,The metabolism of Donepezil can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB06684,Vilazodone,0.9103339314460754,47,Type_47,The metabolism of Vilazodone can be decreased when combined with Sulfisoxazole.,73,Type_73,No
DB00812,Phenylbutazone,DB08816,Ticagrelor,0.8744285106658936,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Phenylbutazone.,47,Type_47,Yes
DB00091,Cyclosporine,DB00207,Azithromycin,0.7808471918106079,47,Type_47,The metabolism of Azithromycin can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00631,Clofarabine,DB09026,Aliskiren,0.9704252481460571,49,Type_49,The risk or severity of adverse effects can be increased when Clofarabine is combined with Aliskiren.,49,Type_49,Yes
DB00564,Carbamazepine,DB05381,Histamine,0.9763326048851013,4,Type_4,The metabolism of Histamine can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00297,Bupivacaine,DB00363,Clozapine,0.3398738205432892,47,Type_47,The metabolism of Clozapine can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB06210,Eltrombopag,DB08934,Sofosbuvir,0.583223283290863,75,Type_75,The serum concentration of Sofosbuvir can be decreased when it is combined with Eltrombopag.,73,Type_73,No
DB00440,Trimethoprim,DB01028,Methoxyflurane,0.9209599494934082,47,Type_47,The metabolism of Methoxyflurane can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00695,Furosemide,DB01359,Penbutolol,0.9789461493492126,49,Type_49,The risk or severity of adverse effects can be increased when Furosemide is combined with Penbutolol.,49,Type_49,Yes
DB01088,Iloprost,DB08814,Triflusal,0.9792266488075256,53,Type_53,Iloprost may increase the antiplatelet activities of Triflusal.,53,Type_53,Yes
DB00539,Toremifene,DB00726,Trimipramine,0.9146966338157654,20,Type_20,Toremifene may increase the QTc-prolonging activities of Trimipramine.,20,Type_20,Yes
DB00705,Delavirdine,DB09167,Dosulepin,0.760265588760376,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00338,Omeprazole,DB01220,Rifaximin,0.514139711856842,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Omeprazole.,73,Type_73,Yes
DB00246,Ziprasidone,DB00570,Vinblastine,0.8993947505950928,47,Type_47,The metabolism of Vinblastine can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00366,Doxylamine,DB01017,Minocycline,1.0,16,Type_16,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Minocycline.,16,Type_16,Yes
DB00657,Mecamylamine,DB00742,Mannitol,0.970770537853241,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Mannitol.,49,Type_49,Yes
DB00519,Trandolapril,DB00571,Propranolol,0.8297903537750244,49,Type_49,The risk or severity of adverse effects can be increased when Trandolapril is combined with Propranolol.,49,Type_49,Yes
DB00284,Acarbose,DB00592,Piperazine,0.9991889595985413,70,Type_70,The therapeutic efficacy of Piperazine can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB01251,Gliquidone,DB06788,Histrelin,0.998645007610321,70,Type_70,The therapeutic efficacy of Histrelin can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB01173,Orphenadrine,DB08815,Lurasidone,0.9731519818305969,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.,16,Type_16,Yes
DB01324,Polythiazide,DB05039,Indacaterol,0.9999744892120361,83,Type_83,Polythiazide may increase the hypokalemic activities of Indacaterol.,83,Type_83,Yes
DB00287,Travoprost,DB05676,Apremilast,0.9720343947410583,70,Type_70,The therapeutic efficacy of Apremilast can be decreased when used in combination with Travoprost.,70,Type_70,Yes
DB00734,Risperidone,DB08872,Gabapentin enacarbil,0.9998878240585327,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00604,Cisapride,DB01110,Miconazole,0.4459843933582306,47,Type_47,The metabolism of Miconazole can be decreased when combined with Cisapride.,73,Type_73,No
DB00252,Phenytoin,DB00283,Clemastine,0.307015597820282,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Phenytoin.,47,Type_47,No
DB01319,Fosamprenavir,DB01393,Bezafibrate,0.7143865823745728,47,Type_47,The metabolism of Bezafibrate can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB01026,Ketoconazole,DB09275,Bismuth subcitrate potassium,0.9040777087211609,75,Type_75,The serum concentration of Bismuth subcitrate potassium can be decreased when it is combined with Ketoconazole.,75,Type_75,Yes
DB00374,Treprostinil,DB01097,Leflunomide,0.4555668234825134,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Treprostinil.,49,Type_49,No
DB01095,Fluvastatin,DB08899,Enzalutamide,0.9292922019958496,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Fluvastatin.,75,Type_75,Yes
DB04552,Niflumic acid,DB08976,Floctafenine,0.9990782737731934,49,Type_49,The risk or severity of adverse effects can be increased when Niflumic acid is combined with Floctafenine.,49,Type_49,Yes
DB00821,Carprofen,DB13158,Clobetasone,0.9997938275337219,49,Type_49,The risk or severity of adverse effects can be increased when Carprofen is combined with Clobetasone.,49,Type_49,Yes
DB01008,Busulfan,DB01232,Saquinavir,0.7913313508033752,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Busulfan.,47,Type_47,Yes
DB00921,Buprenorphine,DB01622,Thioproperazine,0.7756701111793518,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Thioproperazine.,60,Type_60,No
DB01251,Gliquidone,DB01264,Darunavir,0.5427924990653992,70,Type_70,The therapeutic efficacy of Darunavir can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB01124,Tolbutamide,DB01168,Procarbazine,0.9953038692474365,9,Type_9,Tolbutamide may increase the hypoglycemic activities of Procarbazine.,9,Type_9,Yes
DB01403,Methotrimeprazine,DB01601,Lopinavir,0.44982537627220154,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Methotrimeprazine.,20,Type_20,No
DB06695,Dabigatran etexilate,DB08938,Magaldrate,0.9970921277999878,75,Type_75,The serum concentration of Magaldrate can be decreased when it is combined with Dabigatran etexilate.,75,Type_75,Yes
DB00586,Diclofenac,DB00903,Etacrynic acid,0.9999699592590332,29,Type_29,Diclofenac may decrease the diuretic activities of Etacrynic acid.,29,Type_29,Yes
DB00334,Olanzapine,DB01028,Methoxyflurane,0.9698547124862671,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Methoxyflurane.,49,Type_49,Yes
DB00457,Prazosin,DB02638,Terlipressin,0.9996126294136047,60,Type_60,Prazosin may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB03585,Oxyphenbutazone,DB09138,Technetium Tc-99m medronate,0.9973026514053345,49,Type_49,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Technetium Tc-99m medronate.,49,Type_49,Yes
DB00765,Metyrosine,DB09071,Tasimelteon,0.9969885945320129,32,Type_32,Metyrosine may increase the sedative activities of Tasimelteon.,32,Type_32,Yes
DB06603,Panobinostat,DB08871,Eribulin,0.9973289966583252,20,Type_20,Panobinostat may increase the QTc-prolonging activities of Eribulin.,20,Type_20,Yes
DB00738,Pentamidine,DB01001,Salbutamol,0.9905586242675781,20,Type_20,Pentamidine may increase the QTc-prolonging activities of Salbutamol.,20,Type_20,Yes
DB00421,Spironolactone,DB01002,Levobupivacaine,0.8513055443763733,49,Type_49,The risk or severity of adverse effects can be increased when Spironolactone is combined with Levobupivacaine.,49,Type_49,Yes
DB01068,Clonazepam,DB09048,Netupitant,0.9241779446601868,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Clonazepam.,73,Type_73,Yes
DB01104,Sertraline,DB01218,Halofantrine,0.646844744682312,47,Type_47,The metabolism of Halofantrine can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00374,Treprostinil,DB01165,Ofloxacin,0.9996678829193115,20,Type_20,Treprostinil may increase the QTc-prolonging activities of Ofloxacin.,20,Type_20,Yes
DB00401,Nisoldipine,DB09244,Pirlindole,0.9905298352241516,60,Type_60,Nisoldipine may increase the hypotensive activities of Pirlindole.,60,Type_60,Yes
DB01324,Polythiazide,DB09300,Butylscopolamine,0.9984764456748962,73,Type_73,The serum concentration of Butylscopolamine can be increased when it is combined with Polythiazide.,73,Type_73,Yes
DB01113,Papaverine,DB01144,Diclofenamide,0.9999499320983887,49,Type_49,The risk or severity of adverse effects can be increased when Papaverine is combined with Diclofenamide.,49,Type_49,Yes
DB00327,Hydromorphone,DB09166,Etizolam,0.9975016713142395,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etizolam.,49,Type_49,Yes
DB00363,Clozapine,DB00476,Duloxetine,0.42012280225753784,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Duloxetine.,73,Type_73,No
DB00483,Gallamine triethiodide,DB01035,Procainamide,0.95209801197052,21,Type_21,Gallamine triethiodide may increase the neuromuscular blocking activities of Procainamide.,21,Type_21,Yes
DB00849,Methylphenobarbital,DB00972,Azelastine,0.6276863217353821,16,Type_16,Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,16,Type_16,Yes
DB00681,Amphotericin B,DB01026,Ketoconazole,0.6248626708984375,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Amphotericin B.,70,Type_70,No
DB09073,Palbociclib,DB09118,Stiripentol,0.9905374646186829,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Palbociclib.,73,Type_73,Yes
DB00223,Diflorasone,DB01097,Leflunomide,0.988771378993988,49,Type_49,The risk or severity of adverse effects can be increased when Diflorasone is combined with Leflunomide.,49,Type_49,Yes
DB01222,Budesonide,DB12267,Brigatinib,0.5739136338233948,73,Type_73,The serum concentration of Brigatinib can be increased when it is combined with Budesonide.,75,Type_75,No
DB00434,Cyproheptadine,DB01501,Difenoxin,0.9999343156814575,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Difenoxin.,49,Type_49,Yes
DB00195,Betaxolol,DB01067,Glipizide,0.8982023596763611,9,Type_9,Betaxolol may increase the hypoglycemic activities of Glipizide.,9,Type_9,Yes
DB00933,Mesoridazine,DB01253,Ergometrine,0.9927836656570435,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ergometrine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB06203,Alogliptin,0.9648913145065308,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00905,Bimatoprost,DB08931,Riociguat,0.99994957447052,60,Type_60,Bimatoprost may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00870,Suprofen,DB01240,Epoprostenol,0.47048407793045044,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Epoprostenol.,70,Type_70,No
DB00722,Lisinopril,DB04743,Nimesulide,0.8626662492752075,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Nimesulide.,49,Type_49,Yes
DB01218,Halofantrine,DB01614,Acepromazine,0.5806446671485901,73,Type_73,The serum concentration of Acepromazine can be increased when it is combined with Halofantrine.,73,Type_73,Yes
DB01440,gamma-Hydroxybutyric acid,DB01621,Pipotiazine,0.9998757839202881,49,Type_49,The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Pipotiazine.,49,Type_49,Yes
DB00458,Imipramine,DB06217,Vernakalant,0.990763247013092,47,Type_47,The metabolism of Vernakalant can be decreased when combined with Imipramine.,47,Type_47,Yes
DB00679,Thioridazine,DB01437,Glutethimide,0.9995286464691162,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Glutethimide.,49,Type_49,Yes
DB00457,Prazosin,DB00657,Mecamylamine,0.9708503484725952,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Mecamylamine.,49,Type_49,Yes
DB08987,Etidocaine,DB09117,Paraldehyde,0.999968409538269,16,Type_16,Etidocaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,16,Type_16,Yes
DB01377,Magnesium oxide,DB01576,Dextroamphetamine,0.47418850660324097,75,Type_75,The serum concentration of Dextroamphetamine can be decreased when it is combined with Magnesium oxide.,72,Type_72,No
DB00749,Etodolac,DB08439,Parecoxib,0.9287266135215759,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Parecoxib.,49,Type_49,Yes
DB00929,Misoprostol,DB06737,Zaltoprofen,0.5562024116516113,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Misoprostol.,70,Type_70,Yes
DB00575,Clonidine,DB01219,Dantrolene,0.9845336675643921,49,Type_49,The risk or severity of adverse effects can be increased when Clonidine is combined with Dantrolene.,49,Type_49,Yes
DB00749,Etodolac,DB04743,Nimesulide,0.9629154205322266,49,Type_49,The risk or severity of adverse effects can be increased when Etodolac is combined with Nimesulide.,49,Type_49,Yes
DB00252,Phenytoin,DB08971,Fluocortolone,0.9615705609321594,75,Type_75,The serum concentration of Fluocortolone can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00189,Ethchlorvynol,DB00341,Cetirizine,0.9999970197677612,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Cetirizine.,49,Type_49,Yes
DB01261,Sitagliptin,DB01406,Danazol,0.7458359003067017,70,Type_70,The therapeutic efficacy of Danazol can be decreased when used in combination with Sitagliptin.,70,Type_70,Yes
DB00359,Sulfadiazine,DB01261,Sitagliptin,0.7360913157463074,9,Type_9,Sulfadiazine may increase the hypoglycemic activities of Sitagliptin.,9,Type_9,Yes
DB01069,Promethazine,DB01221,Ketamine,0.9753899574279785,49,Type_49,The risk or severity of adverse effects can be increased when Promethazine is combined with Ketamine.,49,Type_49,Yes
DB00277,Theophylline,DB00978,Lomefloxacin,0.6877108812332153,47,Type_47,The metabolism of Lomefloxacin can be decreased when combined with Theophylline.,47,Type_47,Yes
DB00216,Eletriptan,DB09042,Tedizolid phosphate,0.8308422565460205,64,Type_64,Eletriptan may increase the serotonergic activities of Tedizolid phosphate.,64,Type_64,Yes
DB00179,Masoprocol,DB00955,Netilmicin,0.9999374151229858,72,Type_72,Masoprocol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,72,Type_72,Yes
DB00694,Daunorubicin,DB01232,Saquinavir,0.7686569094657898,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Daunorubicin.,47,Type_47,Yes
DB00677,Isoflurophate,DB01173,Orphenadrine,0.974267303943634,70,Type_70,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Isoflurophate.,70,Type_70,Yes
DB00181,Baclofen,DB00753,Isoflurane,0.9961857199668884,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Isoflurane.,49,Type_49,Yes
DB01466,Ethylmorphine,DB09039,Eliglustat,0.6724277138710022,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Ethylmorphine.,47,Type_47,Yes
DB00277,Theophylline,DB00389,Carbimazole,0.8923617005348206,73,Type_73,The serum concentration of Carbimazole can be increased when it is combined with Theophylline.,73,Type_73,Yes
DB00334,Olanzapine,DB00419,Miglustat,0.998583197593689,70,Type_70,The therapeutic efficacy of Miglustat can be decreased when used in combination with Olanzapine.,70,Type_70,Yes
DB00936,Salicylic acid,DB09295,Talniflumate,0.9999454021453857,49,Type_49,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Talniflumate.,49,Type_49,Yes
DB00289,Atomoxetine,DB00531,Cyclophosphamide,0.45594504475593567,15,Type_15,Atomoxetine may increase the cardiotoxic activities of Cyclophosphamide.,47,Type_47,No
DB00356,Chlorzoxazone,DB00476,Duloxetine,0.863758385181427,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Duloxetine.,47,Type_47,No
DB00876,Eprosartan,DB00903,Etacrynic acid,0.9865229725837708,49,Type_49,The risk or severity of adverse effects can be increased when Eprosartan is combined with Etacrynic acid.,49,Type_49,Yes
DB00195,Betaxolol,DB00714,Apomorphine,0.7129124999046326,25,Type_25,Betaxolol may increase the atrioventricular blocking (AV block) activities of Apomorphine.,25,Type_25,Yes
DB00880,Chlorothiazide,DB00960,Pindolol,0.5849893689155579,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Pindolol.,49,Type_49,Yes
DB00220,Nelfinavir,DB01355,Hexobarbital,0.7312271595001221,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00370,Mirtazapine,DB00405,Dexbrompheniramine,0.9981446266174316,16,Type_16,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.,16,Type_16,Yes
DB00468,Quinine,DB11362,Selexipag,0.7929304838180542,60,Type_60,Quinine may increase the hypotensive activities of Selexipag.,60,Type_60,Yes
DB00169,Cholecalciferol,DB00843,Donepezil,0.8654462695121765,47,Type_47,The metabolism of Donepezil can be decreased when combined with Cholecalciferol.,47,Type_47,Yes
DB01178,Chlormezanone,DB11304,Phenoxyethanol,0.9999994039535522,49,Type_49,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Phenoxyethanol.,49,Type_49,Yes
DB00180,Flunisolide,DB01199,Tubocurarine,0.9998557567596436,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Tubocurarine.,49,Type_49,Yes
DB00318,Codeine,DB01591,Solifenacin,0.9826918244361877,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Solifenacin.,49,Type_49,Yes
DB00469,Tenoxicam,DB00684,Tobramycin,0.9999483823776245,72,Type_72,Tenoxicam may decrease the excretion rate of Tobramycin which could result in a higher serum level.,72,Type_72,Yes
DB00205,Pyrimethamine,DB00936,Salicylic acid,0.9396435618400574,47,Type_47,The metabolism of Salicylic acid can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00821,Carprofen,DB01032,Probenecid,0.8679141402244568,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Carprofen.,73,Type_73,Yes
DB00323,Tolcapone,DB01069,Promethazine,0.996670663356781,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Promethazine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01211,Clarithromycin,0.9498005509376526,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB00737,Meclizine,DB00904,Ondansetron,0.9930229187011719,49,Type_49,The risk or severity of adverse effects can be increased when Meclizine is combined with Ondansetron.,49,Type_49,Yes
DB01390,Sodium bicarbonate,DB09352,Hydroxyamphetamine,0.9203910827636719,72,Type_72,Sodium bicarbonate may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level.,72,Type_72,Yes
DB00091,Cyclosporine,DB01406,Danazol,0.4943027198314667,80,Type_80,Cyclosporine may increase the hepatotoxic activities of Danazol.,80,Type_80,Yes
DB00722,Lisinopril,DB00796,Candesartan cilexetil,0.705075740814209,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Candesartan cilexetil.,49,Type_49,Yes
DB00428,Streptozocin,DB00958,Carboplatin,0.8542587161064148,7,Type_7,Streptozocin may increase the ototoxic activities of Carboplatin.,7,Type_7,Yes
DB01353,Butobarbital,DB08815,Lurasidone,0.9997939467430115,49,Type_49,The risk or severity of adverse effects can be increased when Butobarbital is combined with Lurasidone.,49,Type_49,Yes
DB00805,Minaprine,DB01021,Trichlormethiazide,0.9889334440231323,60,Type_60,Minaprine may increase the hypotensive activities of Trichlormethiazide.,60,Type_60,Yes
DB09166,Etizolam,DB13323,Trichloroethylene,0.9999305009841919,49,Type_49,The risk or severity of adverse effects can be increased when Etizolam is combined with Trichloroethylene.,49,Type_49,Yes
DB00252,Phenytoin,DB06267,Udenafil,0.7464635372161865,4,Type_4,The metabolism of Udenafil can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01023,Felodipine,DB09031,Miltefosine,0.9250373840332031,49,Type_49,The risk or severity of adverse effects can be increased when Felodipine is combined with Miltefosine.,49,Type_49,Yes
DB01088,Iloprost,DB09286,Pipamperone,0.8872305750846863,49,Type_49,The risk or severity of adverse effects can be increased when Iloprost is combined with Pipamperone.,49,Type_49,Yes
DB08875,Cabozantinib,DB09074,Olaparib,0.9090386033058167,47,Type_47,The metabolism of Olaparib can be decreased when combined with Cabozantinib.,47,Type_47,Yes
DB00217,Bethanidine,DB00862,Vardenafil,0.9740586876869202,10,Type_10,Bethanidine may increase the antihypertensive activities of Vardenafil.,10,Type_10,Yes
DB00244,Mesalazine,DB01283,Lumiracoxib,0.8252078890800476,57,Type_57,Mesalazine may increase the nephrotoxic activities of Lumiracoxib.,57,Type_57,Yes
DB00176,Fluvoxamine,DB01120,Gliclazide,0.9367152452468872,47,Type_47,The metabolism of Gliclazide can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00421,Spironolactone,DB01395,Drospirenone,0.7057565450668335,68,Type_68,Spironolactone may increase the hyperkalemic activities of Drospirenone.,68,Type_68,Yes
DB01129,Rabeprazole,DB09570,Ixazomib,0.8073616623878479,47,Type_47,The metabolism of Ixazomib can be decreased when combined with Rabeprazole.,47,Type_47,Yes
DB00391,Sulpiride,DB00423,Methocarbamol,0.9632299542427063,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Methocarbamol.,49,Type_49,Yes
DB00358,Mefloquine,DB01175,Escitalopram,0.3325616419315338,9,Type_9,Mefloquine may increase the hypoglycemic activities of Escitalopram.,20,Type_20,No
DB00679,Thioridazine,DB06708,Lumefantrine,0.28785955905914307,73,Type_73,The serum concentration of Lumefantrine can be increased when it is combined with Thioridazine.,73,Type_73,Yes
DB00392,Profenamine,DB01090,Pentolinium,0.9939088821411133,49,Type_49,The risk or severity of adverse effects can be increased when Profenamine is combined with Pentolinium.,49,Type_49,Yes
DB00399,Zoledronic acid,DB09288,Propacetamol,0.9891259670257568,49,Type_49,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Propacetamol.,49,Type_49,Yes
DB01608,Periciazine,DB06697,Artemether,0.4997798502445221,33,Type_33,The risk or severity of QTc prolongation can be increased when Periciazine is combined with Artemether.,73,Type_73,No
DB00413,Pramipexole,DB01020,Isosorbide mononitrate,0.9520399570465088,49,Type_49,The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide mononitrate.,49,Type_49,Yes
DB00210,Adapalene,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Adapalene.,70,Type_70,Yes
DB00779,Nalidixic acid,DB01223,Aminophylline,0.31815311312675476,70,Type_70,The therapeutic efficacy of Aminophylline can be decreased when used in combination with Nalidixic acid.,47,Type_47,No
DB01173,Orphenadrine,DB04953,Ezogabine,0.9949648976325989,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.,16,Type_16,Yes
DB00502,Haloperidol,DB01218,Halofantrine,0.508554995059967,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Halofantrine.,47,Type_47,No
DB00897,Triazolam,DB00904,Ondansetron,0.9390866160392761,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Ondansetron.,49,Type_49,Yes
DB00277,Theophylline,DB00312,Pentobarbital,0.5026742219924927,4,Type_4,The metabolism of Pentobarbital can be increased when combined with Theophylline.,4,Type_4,Yes
DB00321,Amitriptyline,DB08912,Dabrafenib,0.7791407704353333,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Amitriptyline.,75,Type_75,Yes
DB00537,Ciprofloxacin,DB00582,Voriconazole,0.7547566294670105,20,Type_20,Ciprofloxacin may increase the QTc-prolonging activities of Voriconazole.,20,Type_20,Yes
DB00361,Vinorelbine,DB01092,Ouabain,0.9977297186851501,58,Type_58,Vinorelbine may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00629,Guanabenz,DB00805,Minaprine,0.8693009614944458,71,Type_71,Guanabenz may increase the hypertensive activities of Minaprine.,60,Type_60,No
DB00188,Bortezomib,DB00275,Olmesartan,0.852867603302002,49,Type_49,The risk or severity of adverse effects can be increased when Bortezomib is combined with Olmesartan.,49,Type_49,Yes
DB00408,Loxapine,DB00875,Flupentixol,0.8322117328643799,49,Type_49,The risk or severity of adverse effects can be increased when Loxapine is combined with Flupentixol.,49,Type_49,Yes
DB00949,Felbamate,DB01595,Nitrazepam,0.967776894569397,49,Type_49,The risk or severity of adverse effects can be increased when Felbamate is combined with Nitrazepam.,49,Type_49,Yes
DB00334,Olanzapine,DB01588,Prazepam,0.9829146265983582,49,Type_49,The risk or severity of adverse effects can be increased when Olanzapine is combined with Prazepam.,49,Type_49,Yes
DB00978,Lomefloxacin,DB01092,Ouabain,0.9997323155403137,58,Type_58,Lomefloxacin may decrease the cardiotoxic activities of Ouabain.,58,Type_58,Yes
DB00564,Carbamazepine,DB01129,Rabeprazole,0.8191203474998474,4,Type_4,The metabolism of Rabeprazole can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB01267,Paliperidone,DB08882,Linagliptin,0.7470729351043701,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Paliperidone.,70,Type_70,Yes
DB08828,Vismodegib,DB08865,Crizotinib,0.9499465227127075,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Vismodegib.,47,Type_47,Yes
DB00967,Desloratadine,DB06690,Nitrous oxide,0.9750959277153015,49,Type_49,The risk or severity of adverse effects can be increased when Desloratadine is combined with Nitrous oxide.,49,Type_49,Yes
DB01223,Aminophylline,DB01489,Camazepam,0.9867199063301086,70,Type_70,The therapeutic efficacy of Camazepam can be decreased when used in combination with Aminophylline.,70,Type_70,Yes
DB00238,Nevirapine,DB01380,Cortisone acetate,0.9559157490730286,4,Type_4,The metabolism of Cortisone acetate can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00494,Entacapone,DB09166,Etizolam,0.9984073042869568,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Etizolam.,49,Type_49,Yes
DB00542,Benazepril,DB01351,Amobarbital,0.8065668940544128,60,Type_60,Benazepril may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00193,Tramadol,DB09235,Efonidipine,0.9822155237197876,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Efonidipine.,49,Type_49,Yes
DB00213,Pantoprazole,DB01241,Gemfibrozil,0.988874077796936,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Pantoprazole.,47,Type_47,Yes
DB00465,Ketorolac,DB01410,Ciclesonide,0.9987747073173523,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Ciclesonide.,49,Type_49,Yes
DB00899,Remifentanil,DB01210,Levobunolol,0.6904259920120239,54,Type_54,Remifentanil may increase the bradycardic activities of Levobunolol.,49,Type_49,No
DB00708,Sufentanil,DB00968,Methyldopa,0.9899534583091736,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with Methyldopa.,54,Type_54,No
DB00221,Isoetharine,DB00344,Protriptyline,0.951647937297821,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Protriptyline.,49,Type_49,Yes
DB00283,Clemastine,DB06698,Betahistine,0.5866386890411377,73,Type_73,The serum concentration of Betahistine can be increased when it is combined with Clemastine.,70,Type_70,No
DB00207,Azithromycin,DB06212,Tolvaptan,0.9704486727714539,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00872,Conivaptan,DB01144,Diclofenamide,0.9589778780937195,49,Type_49,The risk or severity of adverse effects can be increased when Conivaptan is combined with Diclofenamide.,49,Type_49,Yes
DB00575,Clonidine,DB09120,Zucapsaicin,0.9673030972480774,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Clonidine.,47,Type_47,Yes
DB00647,Dextropropoxyphene,DB08933,Luliconazole,0.9484352469444275,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Dextropropoxyphene.,73,Type_73,Yes
DB00970,Dactinomycin,DB06772,Cabazitaxel,0.9867193102836609,49,Type_49,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Cabazitaxel.,49,Type_49,Yes
DB01235,Levodopa,DB09204,Arotinolol,0.5143274068832397,73,Type_73,The serum concentration of Arotinolol can be increased when it is combined with Levodopa.,30,Type_30,No
DB00208,Ticlopidine,DB00384,Triamterene,0.6019802689552307,73,Type_73,The serum concentration of Triamterene can be increased when it is combined with Ticlopidine.,47,Type_47,No
DB00324,Fluorometholone,DB00972,Azelastine,0.9706141948699951,49,Type_49,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Azelastine.,49,Type_49,Yes
DB01143,Amifostine,DB09232,Cilnidipine,0.6640279293060303,49,Type_49,The risk or severity of adverse effects can be increased when Amifostine is combined with Cilnidipine.,49,Type_49,Yes
DB00393,Nimodipine,DB09236,Lacidipine,0.9196569919586182,60,Type_60,Nimodipine may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00808,Indapamide,DB01407,Clenbuterol,0.997021496295929,83,Type_83,Indapamide may increase the hypokalemic activities of Clenbuterol.,83,Type_83,Yes
DB00543,Amoxapine,DB01440,gamma-Hydroxybutyric acid,0.9987509250640869,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB04855,Dronedarone,DB06203,Alogliptin,0.5723917484283447,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Dronedarone.,47,Type_47,Yes
DB00839,Tolazamide,DB00999,Hydrochlorothiazide,0.9994751811027527,70,Type_70,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tolazamide.,70,Type_70,Yes
DB00443,Betamethasone,DB01137,Levofloxacin,0.9846085906028748,49,Type_49,The risk or severity of adverse effects can be increased when Betamethasone is combined with Levofloxacin.,49,Type_49,Yes
DB00208,Ticlopidine,DB07615,Tranilast,0.8113706111907959,47,Type_47,The metabolism of Tranilast can be decreased when combined with Ticlopidine.,6,Type_6,No
DB01234,Dexamethasone,DB05676,Apremilast,0.9918899536132812,49,Type_49,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Apremilast.,49,Type_49,Yes
DB00452,Framycetin,DB09320,Procaine benzylpenicillin,0.9617959260940552,75,Type_75,The serum concentration of Procaine benzylpenicillin can be decreased when it is combined with Framycetin.,75,Type_75,Yes
DB00651,Dyphylline,DB01567,Fludiazepam,0.7933734655380249,70,Type_70,The therapeutic efficacy of Fludiazepam can be decreased when used in combination with Dyphylline.,70,Type_70,Yes
DB00175,Pravastatin,DB08874,Fidaxomicin,0.6850261092185974,73,Type_73,The serum concentration of Fidaxomicin can be increased when it is combined with Pravastatin.,49,Type_49,No
DB00829,Diazepam,DB00899,Remifentanil,0.9852441549301147,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Remifentanil.,49,Type_49,Yes
DB00907,Cocaine,DB01166,Cilostazol,0.4663945138454437,47,Type_47,The metabolism of Cilostazol can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00812,Phenylbutazone,DB01275,Hydralazine,0.9804233312606812,37,Type_37,Phenylbutazone may decrease the antihypertensive activities of Hydralazine.,37,Type_37,Yes
DB00524,Metolazone,DB09236,Lacidipine,0.5136885046958923,60,Type_60,Metolazone may increase the hypotensive activities of Lacidipine.,60,Type_60,Yes
DB00254,Doxycycline,DB12332,Rucaparib,0.9167433977127075,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00232,Methyclothiazide,DB01242,Clomipramine,0.9272976517677307,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Clomipramine.,49,Type_49,Yes
DB00091,Cyclosporine,DB00708,Sufentanil,0.8819050192832947,47,Type_47,The metabolism of Sufentanil can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00474,Methohexital,DB01325,Quinethazone,0.8206726312637329,30,Type_30,Methohexital may increase the orthostatic hypotensive activities of Quinethazone.,30,Type_30,Yes
DB00619,Imatinib,DB08899,Enzalutamide,0.9423810839653015,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Imatinib.,75,Type_75,Yes
DB00701,Amprenavir,DB01101,Capecitabine,0.929725706577301,47,Type_47,The metabolism of Capecitabine can be decreased when combined with Amprenavir.,47,Type_47,Yes
DB01133,Tiludronic acid,DB08797,Salicylamide,0.9977548718452454,49,Type_49,The risk or severity of adverse effects can be increased when Tiludronic acid is combined with Salicylamide.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB00854,Levorphanol,0.997376561164856,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Levorphanol.,49,Type_49,Yes
DB00255,Diethylstilbestrol,DB00266,Dicoumarol,0.987468957901001,12,Type_12,Diethylstilbestrol may decrease the anticoagulant activities of Dicoumarol.,12,Type_12,Yes
DB00180,Flunisolide,DB01155,Gemifloxacin,0.9445120096206665,49,Type_49,The risk or severity of adverse effects can be increased when Flunisolide is combined with Gemifloxacin.,49,Type_49,Yes
DB00377,Palonosetron,DB00601,Linezolid,0.999996542930603,64,Type_64,Palonosetron may increase the serotonergic activities of Linezolid.,64,Type_64,Yes
DB06813,Pralatrexate,DB07615,Tranilast,0.643359363079071,73,Type_73,The serum concentration of Tranilast can be increased when it is combined with Pralatrexate.,73,Type_73,Yes
DB00549,Zafirlukast,DB00624,Testosterone,0.8743749260902405,47,Type_47,The metabolism of Testosterone can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB00838,Clocortolone,DB06802,Nepafenac,0.9997132420539856,49,Type_49,The risk or severity of adverse effects can be increased when Clocortolone is combined with Nepafenac.,49,Type_49,Yes
DB00521,Carteolol,DB00706,Tamsulosin,0.6650621294975281,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Tamsulosin.,30,Type_30,No
DB00498,Phenindione,DB00806,Pentoxifylline,0.9990217685699463,6,Type_6,Phenindione may increase the anticoagulant activities of Pentoxifylline.,6,Type_6,Yes
DB00673,Aprepitant,DB13874,Enasidenib,0.9657496809959412,73,Type_73,The serum concentration of Enasidenib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00476,Duloxetine,DB00590,Doxazosin,0.953466534614563,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Doxazosin.,30,Type_30,Yes
DB06196,Icatibant,DB06813,Pralatrexate,0.7887954115867615,73,Type_73,The serum concentration of Pralatrexate can be increased when it is combined with Icatibant.,73,Type_73,Yes
DB00477,Chlorpromazine,DB12161,Deutetrabenazine,0.9245902895927429,47,Type_47,The metabolism of Deutetrabenazine can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB01261,Sitagliptin,DB01348,Spirapril,0.4008106291294098,73,Type_73,The serum concentration of Spirapril can be increased when it is combined with Sitagliptin.,49,Type_49,No
DB00903,Etacrynic acid,DB08976,Floctafenine,0.9999604225158691,29,Type_29,Etacrynic acid may decrease the diuretic activities of Floctafenine.,29,Type_29,Yes
DB06292,Dapagliflozin,DB08899,Enzalutamide,0.9611247181892395,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Dapagliflozin.,75,Type_75,Yes
DB00241,Butalbital,DB01551,Dihydrocodeine,0.9979166388511658,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Dihydrocodeine.,49,Type_49,Yes
DB00238,Nevirapine,DB00762,Irinotecan,0.40001165866851807,47,Type_47,The metabolism of Irinotecan can be decreased when combined with Nevirapine.,75,Type_75,No
DB00850,Perphenazine,DB09072,Sodium oxybate,0.9999980926513672,16,Type_16,Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00298,Dapiprazole,DB00747,Scopolamine,0.9838525056838989,49,Type_49,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Scopolamine.,49,Type_49,Yes
DB00418,Secobarbital,DB00960,Pindolol,0.8728050589561462,60,Type_60,Secobarbital may increase the hypotensive activities of Pindolol.,60,Type_60,Yes
DB00425,Zolpidem,DB08883,Perampanel,0.9999909400939941,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00834,Mifepristone,DB08804,Nandrolone decanoate,0.999049961566925,9,Type_9,Mifepristone may increase the hypoglycemic activities of Nandrolone decanoate.,9,Type_9,Yes
DB00333,Methadone,DB00346,Alfuzosin,0.8914390206336975,20,Type_20,Methadone may increase the QTc-prolonging activities of Alfuzosin.,20,Type_20,Yes
DB00554,Piroxicam,DB01384,Paramethasone,0.9993701577186584,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Paramethasone.,49,Type_49,Yes
DB00549,Zafirlukast,DB06605,Apixaban,0.6876909136772156,47,Type_47,The metabolism of Apixaban can be decreased when combined with Zafirlukast.,47,Type_47,Yes
DB01098,Rosuvastatin,DB08912,Dabrafenib,0.9455246925354004,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Rosuvastatin.,75,Type_75,Yes
DB01092,Ouabain,DB01172,Kanamycin,0.8960792422294617,75,Type_75,The serum concentration of Kanamycin can be decreased when it is combined with Ouabain.,75,Type_75,Yes
DB00227,Lovastatin,DB06335,Saxagliptin,0.45113056898117065,47,Type_47,The metabolism of Saxagliptin can be decreased when combined with Lovastatin.,73,Type_73,No
DB01045,Rifampicin,DB06016,Cariprazine,0.9070775508880615,4,Type_4,The metabolism of Cariprazine can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00712,Flurbiprofen,DB00929,Misoprostol,0.976256251335144,70,Type_70,The therapeutic efficacy of Misoprostol can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB00358,Mefloquine,DB00794,Primidone,0.759393036365509,4,Type_4,The metabolism of Primidone can be increased when combined with Mefloquine.,70,Type_70,No
DB06210,Eltrombopag,DB08884,Gadoxetic acid,0.9999788999557495,73,Type_73,The serum concentration of Gadoxetic acid can be increased when it is combined with Eltrombopag.,73,Type_73,Yes
DB01198,Zopiclone,DB09085,Tetracaine,0.9999986886978149,49,Type_49,The risk or severity of adverse effects can be increased when Zopiclone is combined with Tetracaine.,49,Type_49,Yes
DB00214,Torasemide,DB01168,Procarbazine,0.6887350678443909,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Procarbazine.,60,Type_60,No
DB01149,Nefazodone,DB01590,Everolimus,0.9621922969818115,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB01203,Nadolol,DB01267,Paliperidone,0.862557590007782,25,Type_25,Nadolol may increase the atrioventricular blocking (AV block) activities of Paliperidone.,25,Type_25,Yes
DB00615,Rifabutin,DB01024,Mycophenolic acid,0.7699037790298462,75,Type_75,The serum concentration of Mycophenolic acid can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00035,Desmopressin,DB01600,Tiaprofenic acid,0.8608226180076599,70,Type_70,The therapeutic efficacy of Tiaprofenic acid can be decreased when used in combination with Desmopressin.,49,Type_49,No
DB00589,Lisuride,DB00599,Thiopental,0.9385153651237488,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Thiopental.,49,Type_49,Yes
DB01106,Levocabastine,DB09071,Tasimelteon,0.9999632835388184,49,Type_49,The risk or severity of adverse effects can be increased when Levocabastine is combined with Tasimelteon.,49,Type_49,Yes
DB00542,Benazepril,DB09238,Manidipine,0.970761775970459,60,Type_60,Benazepril may increase the hypotensive activities of Manidipine.,60,Type_60,Yes
DB01248,Docetaxel,DB08910,Pomalidomide,0.5191693305969238,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Pomalidomide.,49,Type_49,Yes
DB00554,Piroxicam,DB00884,Risedronic acid,0.9427496194839478,49,Type_49,The risk or severity of adverse effects can be increased when Piroxicam is combined with Risedronic acid.,49,Type_49,Yes
DB00544,Fluorouracil,DB01154,Thiamylal,0.6648081541061401,47,Type_47,The metabolism of Thiamylal can be decreased when combined with Fluorouracil.,47,Type_47,Yes
DB00250,Dapsone,DB00908,Quinidine,0.7907314896583557,47,Type_47,The metabolism of Quinidine can be decreased when combined with Dapsone.,49,Type_49,No
DB01062,Oxybutynin,DB09065,Cobicistat,0.8585079312324524,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Oxybutynin.,73,Type_73,Yes
DB01656,Roflumilast,DB08877,Ruxolitinib,0.9454992413520813,34,Type_34,Roflumilast may increase the immunosuppressive activities of Ruxolitinib.,34,Type_34,Yes
DB00248,Cabergoline,DB00264,Metoprolol,0.9480299353599548,19,Type_19,Cabergoline may increase the vasoconstricting activities of Metoprolol.,19,Type_19,Yes
DB01248,Docetaxel,DB06589,Pazopanib,0.8761165142059326,49,Type_49,The risk or severity of adverse effects can be increased when Docetaxel is combined with Pazopanib.,49,Type_49,Yes
DB00633,Dexmedetomidine,DB08987,Etidocaine,0.9995691180229187,49,Type_49,The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Etidocaine.,49,Type_49,Yes
DB01577,Metamfetamine,DB08967,Dimetotiazine,0.9998809099197388,76,Type_76,Metamfetamine may decrease the sedative activities of Dimetotiazine.,76,Type_76,Yes
DB04868,Nilotinib,DB06742,Ambroxol,0.9680554270744324,47,Type_47,The metabolism of Ambroxol can be decreased when combined with Nilotinib.,47,Type_47,Yes
DB00215,Citalopram,DB00379,Mexiletine,0.985866367816925,47,Type_47,The metabolism of Mexiletine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00673,Aprepitant,DB04572,Thiotepa,0.8235555291175842,73,Type_73,The serum concentration of Thiotepa can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00820,Tadalafil,DB01029,Irbesartan,0.48305368423461914,10,Type_10,Tadalafil may increase the antihypertensive activities of Irbesartan.,10,Type_10,Yes
DB00484,Brimonidine,DB00678,Losartan,0.6097822189331055,10,Type_10,Brimonidine may increase the antihypertensive activities of Losartan.,10,Type_10,Yes
DB01059,Norfloxacin,DB01390,Sodium bicarbonate,0.8978435397148132,67,Type_67,Norfloxacin can cause a decrease in the absorption of Sodium bicarbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00203,Sildenafil,DB00921,Buprenorphine,0.7022858262062073,47,Type_47,The metabolism of Buprenorphine can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00396,Progesterone,DB08899,Enzalutamide,0.8218206167221069,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Progesterone.,75,Type_75,Yes
DB00983,Formoterol,DB01142,Doxepin,0.6228281259536743,47,Type_47,The metabolism of Doxepin can be decreased when combined with Formoterol.,49,Type_49,No
DB00887,Bumetanide,DB00968,Methyldopa,0.9790604114532471,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Methyldopa.,49,Type_49,Yes
DB00285,Venlafaxine,DB01356,Lithium cation,0.5033257603645325,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Lithium cation.,64,Type_64,No
DB00277,Theophylline,DB01205,Flumazenil,0.6599472761154175,70,Type_70,The therapeutic efficacy of Flumazenil can be decreased when used in combination with Theophylline.,70,Type_70,Yes
DB00738,Pentamidine,DB01016,Glyburide,0.4035312235355377,9,Type_9,Pentamidine may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB01395,Drospirenone,DB09280,Lumacaftor,0.777753472328186,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Drospirenone.,75,Type_75,Yes
DB00968,Methyldopa,DB01420,Testosterone propionate,0.8850980401039124,49,Type_49,The risk or severity of adverse effects can be increased when Methyldopa is combined with Testosterone propionate.,47,Type_47,No
DB01418,Acenocoumarol,DB09324,Sulbactam,0.9779711365699768,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Sulbactam.,6,Type_6,Yes
DB00909,Zonisamide,DB01567,Fludiazepam,0.9990301132202148,49,Type_49,The risk or severity of adverse effects can be increased when Zonisamide is combined with Fludiazepam.,49,Type_49,Yes
DB00176,Fluvoxamine,DB06708,Lumefantrine,0.8115582466125488,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Fluvoxamine.,47,Type_47,Yes
DB00204,Dofetilide,DB09054,Idelalisib,0.8152171969413757,73,Type_73,The serum concentration of Idelalisib can be increased when it is combined with Dofetilide.,73,Type_73,Yes
DB00625,Efavirenz,DB01131,Proguanil,0.8402590155601501,47,Type_47,The metabolism of Proguanil can be decreased when combined with Efavirenz.,75,Type_75,No
DB00682,Warfarin,DB01026,Ketoconazole,0.4404442012310028,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Warfarin.,73,Type_73,No
DB00409,Remoxipride,DB00933,Mesoridazine,0.9980716109275818,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Mesoridazine.,49,Type_49,Yes
DB00283,Clemastine,DB04868,Nilotinib,0.8039809465408325,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00668,Epinephrine,DB00912,Repaglinide,0.9833178520202637,70,Type_70,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Epinephrine.,70,Type_70,Yes
DB00915,Amantadine,DB01601,Lopinavir,0.7439293265342712,20,Type_20,Amantadine may increase the QTc-prolonging activities of Lopinavir.,20,Type_20,Yes
DB01189,Desflurane,DB01351,Amobarbital,0.909986138343811,49,Type_49,The risk or severity of adverse effects can be increased when Desflurane is combined with Amobarbital.,49,Type_49,Yes
DB00599,Thiopental,DB00633,Dexmedetomidine,0.9891343712806702,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Dexmedetomidine.,49,Type_49,Yes
DB00788,Naproxen,DB06781,Difluprednate,0.9997044205665588,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Difluprednate.,49,Type_49,Yes
DB00231,Temazepam,DB06595,Midostaurin,0.9219552278518677,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Temazepam.,47,Type_47,Yes
DB01214,Metipranolol,DB04861,Nebivolol,0.7368694543838501,49,Type_49,The risk or severity of adverse effects can be increased when Metipranolol is combined with Nebivolol.,49,Type_49,Yes
DB00169,Cholecalciferol,DB00215,Citalopram,0.9880785346031189,47,Type_47,The metabolism of Citalopram can be decreased when combined with Cholecalciferol.,73,Type_73,No
DB01209,Dezocine,DB01587,Ketazolam,0.997718334197998,49,Type_49,The risk or severity of adverse effects can be increased when Dezocine is combined with Ketazolam.,49,Type_49,Yes
DB00257,Clotrimazole,DB08868,Fingolimod,0.8134584426879883,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB01041,Thalidomide,DB08872,Gabapentin enacarbil,0.9885520935058594,16,Type_16,Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,16,Type_16,Yes
DB01200,Bromocriptine,DB08804,Nandrolone decanoate,0.773748517036438,9,Type_9,Bromocriptine may increase the hypoglycemic activities of Nandrolone decanoate.,9,Type_9,Yes
DB01283,Lumiracoxib,DB06695,Dabigatran etexilate,0.9780101180076599,6,Type_6,Lumiracoxib may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB08827,Lomitapide,DB08860,Pitavastatin,0.7636383771896362,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Lomitapide.,73,Type_73,Yes
DB01045,Rifampicin,DB09048,Netupitant,0.6114652752876282,75,Type_75,The serum concentration of Netupitant can be decreased when it is combined with Rifampicin.,73,Type_73,No
DB00191,Phentermine,DB01621,Pipotiazine,0.5387254357337952,76,Type_76,Phentermine may decrease the sedative activities of Pipotiazine.,61,Type_61,No
DB00208,Ticlopidine,DB01016,Glyburide,0.9510050415992737,47,Type_47,The metabolism of Glyburide can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01026,Ketoconazole,DB09166,Etizolam,0.7117692828178406,47,Type_47,The metabolism of Etizolam can be decreased when combined with Ketoconazole.,73,Type_73,No
DB02709,Resveratrol,DB09449,"Sodium phosphate, monobasic",0.8905228972434998,57,Type_57,"Resveratrol may increase the nephrotoxic activities of Sodium phosphate, monobasic.",57,Type_57,Yes
DB00295,Morphine,DB00842,Oxazepam,0.9320284128189087,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Oxazepam.,49,Type_49,Yes
DB01176,Cyclizine,DB04896,Milnacipran,0.9952670335769653,49,Type_49,The risk or severity of adverse effects can be increased when Cyclizine is combined with Milnacipran.,49,Type_49,Yes
DB00598,Labetalol,DB04743,Nimesulide,0.9740756750106812,37,Type_37,Labetalol may decrease the antihypertensive activities of Nimesulide.,60,Type_60,No
DB00808,Indapamide,DB00860,Prednisolone,0.9986289739608765,83,Type_83,Indapamide may increase the hypokalemic activities of Prednisolone.,83,Type_83,Yes
DB00960,Pindolol,DB06711,Naphazoline,0.9996716976165771,25,Type_25,Pindolol may increase the atrioventricular blocking (AV block) activities of Naphazoline.,25,Type_25,Yes
DB00760,Meropenem,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Meropenem.,70,Type_70,Yes
DB00433,Prochlorperazine,DB00571,Propranolol,0.7340371608734131,60,Type_60,Prochlorperazine may increase the hypotensive activities of Propranolol.,60,Type_60,Yes
DB00679,Thioridazine,DB08909,Glycerol phenylbutyrate,0.3847324252128601,73,Type_73,The serum concentration of Glycerol phenylbutyrate can be increased when it is combined with Thioridazine.,73,Type_73,Yes
DB12364,Betrixaban,DB13167,Alclofenac,0.999994158744812,16,Type_16,Betrixaban may increase the central nervous system depressant (CNS depressant) activities of Alclofenac.,66,Type_66,No
DB06217,Vernakalant,DB06595,Midostaurin,0.9768312573432922,47,Type_47,The metabolism of Midostaurin can be decreased when combined with Vernakalant.,47,Type_47,Yes
DB00571,Propranolol,DB06717,Fosaprepitant,0.9269870519638062,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB01297,Practolol,0.9961685538291931,54,Type_54,Acetyldigitoxin may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB05676,Apremilast,DB08439,Parecoxib,0.9977774024009705,49,Type_49,The risk or severity of adverse effects can be increased when Apremilast is combined with Parecoxib.,49,Type_49,Yes
DB01595,Nitrazepam,DB08865,Crizotinib,0.877837598323822,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Nitrazepam.,47,Type_47,Yes
DB01229,Paclitaxel,DB09232,Cilnidipine,0.9999710321426392,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Cilnidipine.,49,Type_49,Yes
DB00656,Trazodone,DB00757,Dolasetron,0.894478976726532,20,Type_20,Trazodone may increase the QTc-prolonging activities of Dolasetron.,20,Type_20,Yes
DB00214,Torasemide,DB09082,Vilanterol,0.8067899942398071,83,Type_83,Torasemide may increase the hypokalemic activities of Vilanterol.,83,Type_83,Yes
DB00180,Flunisolide,DB08899,Enzalutamide,0.9931291341781616,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Flunisolide.,75,Type_75,Yes
DB00091,Cyclosporine,DB01229,Paclitaxel,0.49306735396385193,49,Type_49,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Paclitaxel.,47,Type_47,No
DB00749,Etodolac,DB08819,Tafluprost,1.0,70,Type_70,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Etodolac.,70,Type_70,Yes
DB00178,Ramipril,DB00936,Salicylic acid,0.6037863492965698,37,Type_37,Ramipril may decrease the antihypertensive activities of Salicylic acid.,37,Type_37,Yes
DB00543,Amoxapine,DB06594,Agomelatine,0.9970418810844421,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Agomelatine.,49,Type_49,Yes
DB00687,Fludrocortisone,DB08804,Nandrolone decanoate,1.0,74,Type_74,Fludrocortisone may increase the fluid retaining activities of Nandrolone decanoate.,74,Type_74,Yes
DB04938,Ospemifene,DB09120,Zucapsaicin,0.9977096319198608,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Ospemifene.,47,Type_47,Yes
DB00232,Methyclothiazide,DB01119,Diazoxide,0.898520290851593,60,Type_60,Methyclothiazide may increase the hypotensive activities of Diazoxide.,49,Type_49,No
DB00700,Eplerenone,DB00899,Remifentanil,0.9984633922576904,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Remifentanil.,49,Type_49,Yes
DB00680,Moricizine,DB08808,Bupranolol,0.9951192140579224,60,Type_60,Moricizine may increase the hypotensive activities of Bupranolol.,60,Type_60,Yes
DB09414,Dipotassium phosphate,DB13595,Almasilate,0.5454568266868591,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Dipotassium phosphate.,67,Type_67,No
DB00497,Oxycodone,DB01551,Dihydrocodeine,0.9904816746711731,49,Type_49,The risk or severity of adverse effects can be increased when Oxycodone is combined with Dihydrocodeine.,49,Type_49,Yes
DB00465,Ketorolac,DB00864,Tacrolimus,0.9434947371482849,57,Type_57,Ketorolac may increase the nephrotoxic activities of Tacrolimus.,57,Type_57,Yes
DB00353,Methylergometrine,DB01254,Dasatinib,0.537178099155426,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Dasatinib.,49,Type_49,Yes
DB00738,Pentamidine,DB01247,Isocarboxazid,0.5962114334106445,49,Type_49,The risk or severity of adverse effects can be increased when Pentamidine is combined with Isocarboxazid.,9,Type_9,No
DB01380,Cortisone acetate,DB06724,Calcium carbonate,0.9973800778388977,3,Type_3,The bioavailability of Calcium carbonate can be decreased when combined with Cortisone acetate.,3,Type_3,Yes
DB00282,Pamidronic acid,DB06736,Aceclofenac,0.9799174666404724,49,Type_49,The risk or severity of adverse effects can be increased when Pamidronic acid is combined with Aceclofenac.,49,Type_49,Yes
DB00768,Olopatadine,DB06216,Asenapine,0.9172900915145874,49,Type_49,The risk or severity of adverse effects can be increased when Olopatadine is combined with Asenapine.,49,Type_49,Yes
DB00749,Etodolac,DB01177,Idarubicin,0.9966475367546082,72,Type_72,Etodolac may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB00255,Diethylstilbestrol,DB04908,Flibanserin,0.5179530382156372,75,Type_75,The serum concentration of Flibanserin can be decreased when it is combined with Diethylstilbestrol.,73,Type_73,No
DB00273,Topiramate,DB00444,Teniposide,0.8382320404052734,47,Type_47,The metabolism of Teniposide can be decreased when combined with Topiramate.,47,Type_47,Yes
DB00669,Sumatriptan,DB00780,Phenelzine,0.9127474427223206,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Phenelzine.,49,Type_49,Yes
DB00238,Nevirapine,DB00591,Fluocinolone acetonide,0.8802748322486877,75,Type_75,The serum concentration of Fluocinolone acetonide can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB00983,Formoterol,DB01171,Moclobemide,0.6892952919006348,49,Type_49,The risk or severity of adverse effects can be increased when Formoterol is combined with Moclobemide.,47,Type_47,No
DB00816,Orciprenaline,DB00988,Dopamine,0.9967593550682068,49,Type_49,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Dopamine.,49,Type_49,Yes
DB00284,Acarbose,DB00783,Estradiol,0.9970792531967163,70,Type_70,The therapeutic efficacy of Estradiol can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00743,Gadobenic acid,DB01233,Metoclopramide,1.0,20,Type_20,Gadobenic acid may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00209,Trospium,DB01409,Tiotropium,0.7090737819671631,2,Type_2,Trospium may increase the anticholinergic activities of Tiotropium.,2,Type_2,Yes
DB00697,Tizanidine,DB08907,Canagliflozin,0.9355660676956177,49,Type_49,The risk or severity of adverse effects can be increased when Tizanidine is combined with Canagliflozin.,49,Type_49,Yes
DB00227,Lovastatin,DB01062,Oxybutynin,0.6500117182731628,47,Type_47,The metabolism of Oxybutynin can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00320,Dihydroergotamine,DB09000,Cyamemazine,0.8275119662284851,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyamemazine.,49,Type_49,Yes
DB01131,Proguanil,DB06413,Armodafinil,0.9621435403823853,47,Type_47,The metabolism of Armodafinil can be decreased when combined with Proguanil.,47,Type_47,Yes
DB01232,Saquinavir,DB06290,Simeprevir,0.9638588428497314,73,Type_73,The serum concentration of Simeprevir can be increased when it is combined with Saquinavir.,73,Type_73,Yes
DB01320,Fosphenytoin,DB06713,Norelgestromin,0.8554216623306274,70,Type_70,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Fosphenytoin.,70,Type_70,Yes
DB01074,Perhexiline,DB01264,Darunavir,0.743986189365387,47,Type_47,The metabolism of Darunavir can be decreased when combined with Perhexiline.,73,Type_73,No
DB01037,Selegiline,DB01282,Carbetocin,0.964383065700531,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Carbetocin.,49,Type_49,Yes
DB00349,Clobazam,DB01189,Desflurane,0.9885880947113037,49,Type_49,The risk or severity of adverse effects can be increased when Clobazam is combined with Desflurane.,49,Type_49,Yes
DB00243,Ranolazine,DB01211,Clarithromycin,0.748934805393219,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00834,Mifepristone,DB08875,Cabozantinib,0.920689582824707,73,Type_73,The serum concentration of Cabozantinib can be increased when it is combined with Mifepristone.,73,Type_73,Yes
DB00433,Prochlorperazine,DB01577,Metamfetamine,0.9652697443962097,61,Type_61,Prochlorperazine may decrease the stimulatory activities of Metamfetamine.,61,Type_61,Yes
DB00341,Cetirizine,DB01065,Melatonin,0.9999531507492065,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Melatonin.,49,Type_49,Yes
DB00590,Doxazosin,DB08916,Afatinib,0.5833917856216431,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Doxazosin.,73,Type_73,Yes
DB01050,Ibuprofen,DB12364,Betrixaban,0.9990020394325256,66,Type_66,The risk or severity of bleeding can be increased when Ibuprofen is combined with Betrixaban.,66,Type_66,Yes
DB01576,Dextroamphetamine,DB09275,Bismuth subcitrate potassium,0.9828169345855713,72,Type_72,Dextroamphetamine may decrease the excretion rate of Bismuth subcitrate potassium which could result in a higher serum level.,72,Type_72,Yes
DB00956,Hydrocodone,DB01173,Orphenadrine,0.99785977602005,16,Type_16,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,16,Type_16,Yes
DB00869,Dorzolamide,DB01264,Darunavir,0.812224805355072,47,Type_47,The metabolism of Darunavir can be decreased when combined with Dorzolamide.,47,Type_47,Yes
DB00740,Riluzole,DB06210,Eltrombopag,0.3908575773239136,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Riluzole.,73,Type_73,No
DB00423,Methocarbamol,DB00628,Clorazepic acid,0.9992904663085938,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Clorazepic acid.,49,Type_49,Yes
DB06589,Pazopanib,DB08806,Roxatidine acetate,0.727928638458252,75,Type_75,The serum concentration of Roxatidine acetate can be decreased when it is combined with Pazopanib.,67,Type_67,No
DB00361,Vinorelbine,DB01248,Docetaxel,0.9689944386482239,49,Type_49,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Docetaxel.,49,Type_49,Yes
DB06201,Rufinamide,DB11609,Normethadone,0.9999552965164185,49,Type_49,The risk or severity of adverse effects can be increased when Rufinamide is combined with Normethadone.,49,Type_49,Yes
DB01054,Nitrendipine,DB01355,Hexobarbital,0.45373356342315674,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Nitrendipine.,4,Type_4,Yes
DB01319,Fosamprenavir,DB01384,Paramethasone,0.8593546152114868,47,Type_47,The metabolism of Paramethasone can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00472,Fluoxetine,DB11148,Butamben,0.9964338541030884,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Butamben.,49,Type_49,Yes
DB00794,Primidone,DB08822,Azilsartan medoxomil,0.8733746409416199,60,Type_60,Primidone may increase the hypotensive activities of Azilsartan medoxomil.,60,Type_60,Yes
DB00521,Carteolol,DB01115,Nifedipine,0.8278998136520386,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Nifedipine.,60,Type_60,No
DB00841,Dobutamine,DB09273,Doxofylline,0.9783756136894226,49,Type_49,The risk or severity of adverse effects can be increased when Dobutamine is combined with Doxofylline.,49,Type_49,Yes
DB00224,Indinavir,DB00559,Bosentan,0.6363672614097595,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00912,Repaglinide,DB08860,Pitavastatin,0.6556052565574646,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Repaglinide.,73,Type_73,Yes
DB06203,Alogliptin,DB08893,Mirabegron,0.5537663698196411,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Alogliptin.,47,Type_47,Yes
DB00831,Trifluoperazine,DB00962,Zaleplon,0.9908733367919922,49,Type_49,The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zaleplon.,49,Type_49,Yes
DB00349,Clobazam,DB00373,Timolol,0.8832282423973083,47,Type_47,The metabolism of Timolol can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00472,Fluoxetine,DB00950,Fexofenadine,0.7573933601379395,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Fexofenadine.,49,Type_49,Yes
DB00611,Butorphanol,DB01433,Methadyl acetate,0.9979485869407654,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Methadyl acetate.,49,Type_49,Yes
DB00136,Calcitriol,DB08912,Dabrafenib,0.9917987585067749,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Calcitriol.,75,Type_75,Yes
DB01466,Ethylmorphine,DB09338,Mersalyl,0.9991340041160583,49,Type_49,The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Mersalyl.,49,Type_49,Yes
DB00584,Enalapril,DB09027,Ledipasvir,0.8179637789726257,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Enalapril.,73,Type_73,Yes
DB00222,Glimepiride,DB00398,Sorafenib,0.7773197889328003,47,Type_47,The metabolism of Sorafenib can be decreased when combined with Glimepiride.,47,Type_47,Yes
DB00472,Fluoxetine,DB00715,Paroxetine,0.5018700361251831,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Fluoxetine.,20,Type_20,No
DB00772,Malathion,DB01214,Metipranolol,0.9910293817520142,54,Type_54,Malathion may increase the bradycardic activities of Metipranolol.,54,Type_54,Yes
DB00422,Methylphenidate,DB04946,Iloperidone,0.8015099763870239,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Iloperidone.,49,Type_49,Yes
DB01128,Bicalutamide,DB09048,Netupitant,0.9786722660064697,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Bicalutamide.,73,Type_73,Yes
DB00297,Bupivacaine,DB00458,Imipramine,0.44915732741355896,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Imipramine.,47,Type_47,No
DB01068,Clonazepam,DB01104,Sertraline,0.7531463503837585,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Sertraline.,49,Type_49,Yes
DB00569,Fondaparinux,DB00751,Epinastine,0.9335117936134338,6,Type_6,Fondaparinux may increase the anticoagulant activities of Epinastine.,6,Type_6,Yes
DB00396,Progesterone,DB06717,Fosaprepitant,0.8731599450111389,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Progesterone.,73,Type_73,Yes
DB00465,Ketorolac,DB00695,Furosemide,0.9997982382774353,29,Type_29,Ketorolac may decrease the diuretic activities of Furosemide.,29,Type_29,Yes
DB06791,Lanreotide,DB08877,Ruxolitinib,0.6134500503540039,54,Type_54,Lanreotide may increase the bradycardic activities of Ruxolitinib.,54,Type_54,Yes
DB00586,Diclofenac,DB00598,Labetalol,0.9997058510780334,37,Type_37,Diclofenac may decrease the antihypertensive activities of Labetalol.,37,Type_37,Yes
DB04946,Iloperidone,DB08865,Crizotinib,0.5740812420845032,20,Type_20,Iloperidone may increase the QTc-prolonging activities of Crizotinib.,47,Type_47,No
DB00623,Fluphenazine,DB09286,Pipamperone,0.9764565229415894,49,Type_49,The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pipamperone.,49,Type_49,Yes
DB00243,Ranolazine,DB04938,Ospemifene,0.6902191042900085,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Ranolazine.,47,Type_47,Yes
DB00608,Chloroquine,DB06148,Mianserin,0.9677661657333374,47,Type_47,The metabolism of Mianserin can be decreased when combined with Chloroquine.,47,Type_47,Yes
DB00490,Buspirone,DB01173,Orphenadrine,0.5390071272850037,49,Type_49,The risk or severity of adverse effects can be increased when Buspirone is combined with Orphenadrine.,16,Type_16,No
DB00808,Indapamide,DB01609,Deferasirox,0.9657090902328491,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Indapamide.,75,Type_75,Yes
DB00270,Isradipine,DB00444,Teniposide,0.8913158178329468,47,Type_47,The metabolism of Teniposide can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00278,Argatroban,DB00285,Venlafaxine,0.6408407092094421,49,Type_49,The risk or severity of adverse effects can be increased when Argatroban is combined with Venlafaxine.,47,Type_47,No
DB00611,Butorphanol,DB01116,Trimethaphan,0.9960330128669739,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Trimethaphan.,49,Type_49,Yes
DB00223,Diflorasone,DB00681,Amphotericin B,0.9991864562034607,83,Type_83,Diflorasone may increase the hypokalemic activities of Amphotericin B.,83,Type_83,Yes
DB00181,Baclofen,DB00434,Cyproheptadine,0.9954041242599487,49,Type_49,The risk or severity of adverse effects can be increased when Baclofen is combined with Cyproheptadine.,49,Type_49,Yes
DB00468,Quinine,DB00582,Voriconazole,0.582037627696991,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Quinine.,47,Type_47,Yes
DB01340,Cilazapril,DB08916,Afatinib,0.6350024342536926,75,Type_75,The serum concentration of Afatinib can be decreased when it is combined with Cilazapril.,73,Type_73,No
DB01241,Gemfibrozil,DB01559,Clotiazepam,0.8291024565696716,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Gemfibrozil.,47,Type_47,Yes
DB00412,Rosiglitazone,DB09128,Brexpiprazole,0.9478687644004822,70,Type_70,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Rosiglitazone.,70,Type_70,Yes
DB00960,Pindolol,DB01057,Echothiophate,0.994719386100769,54,Type_54,Pindolol may increase the bradycardic activities of Echothiophate.,54,Type_54,Yes
DB00435,Nitric Oxide,DB09112,Nitrous acid,0.9998818635940552,49,Type_49,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nitrous acid.,49,Type_49,Yes
DB00270,Isradipine,DB11613,Velpatasvir,0.9774743914604187,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Isradipine.,47,Type_47,Yes
DB01016,Glyburide,DB01580,Oxprenolol,0.4620914161205292,9,Type_9,Glyburide may increase the hypoglycemic activities of Oxprenolol.,9,Type_9,Yes
DB00312,Pentobarbital,DB00741,Hydrocortisone,0.9656656384468079,4,Type_4,The metabolism of Hydrocortisone can be increased when combined with Pentobarbital.,75,Type_75,No
DB01142,Doxepin,DB08987,Etidocaine,0.9887375831604004,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Etidocaine.,49,Type_49,Yes
DB00584,Enalapril,DB00876,Eprosartan,0.857562243938446,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Eprosartan.,49,Type_49,Yes
DB00735,Naftifine,DB01240,Epoprostenol,0.6469642519950867,70,Type_70,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Naftifine.,70,Type_70,Yes
DB00877,Sirolimus,DB08895,Tofacitinib,0.5517919063568115,34,Type_34,Sirolimus may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB00657,Mecamylamine,DB00664,Sulfametopyrazine,0.6182225346565247,49,Type_49,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Sulfametopyrazine.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB01628,Etoricoxib,0.7886769771575928,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Etoricoxib.,49,Type_49,Yes
DB00641,Simvastatin,DB00898,Ethanol,0.6984252333641052,73,Type_73,The serum concentration of Ethanol can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00434,Cyproheptadine,DB11148,Butamben,0.9996097683906555,49,Type_49,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Butamben.,49,Type_49,Yes
DB00273,Topiramate,DB00356,Chlorzoxazone,0.9792022109031677,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Chlorzoxazone.,49,Type_49,Yes
DB06218,Lacosamide,DB08873,Boceprevir,0.7769509553909302,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Lacosamide.,73,Type_73,No
DB01170,Guanethidine,DB06267,Udenafil,0.67280113697052,10,Type_10,Guanethidine may increase the antihypertensive activities of Udenafil.,10,Type_10,Yes
DB00261,Anagrelide,DB00675,Tamoxifen,0.6871640086174011,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Tamoxifen.,20,Type_20,Yes
DB00214,Torasemide,DB00622,Nicardipine,0.8156676292419434,49,Type_49,The risk or severity of adverse effects can be increased when Torasemide is combined with Nicardipine.,47,Type_47,No
DB00216,Eletriptan,DB00320,Dihydroergotamine,0.7844343781471252,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Dihydroergotamine.,73,Type_73,No
DB00216,Eletriptan,DB01247,Isocarboxazid,0.9525156617164612,49,Type_49,The risk or severity of adverse effects can be increased when Eletriptan is combined with Isocarboxazid.,49,Type_49,Yes
DB01098,Rosuvastatin,DB09477,Enalaprilat,0.8133742213249207,73,Type_73,The serum concentration of Enalaprilat can be increased when it is combined with Rosuvastatin.,73,Type_73,Yes
DB00252,Phenytoin,DB06203,Alogliptin,0.898186445236206,4,Type_4,The metabolism of Alogliptin can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01325,Quinethazone,DB07615,Tranilast,0.8726112842559814,70,Type_70,The therapeutic efficacy of Tranilast can be decreased when used in combination with Quinethazone.,70,Type_70,Yes
DB01002,Levobupivacaine,DB09072,Sodium oxybate,0.9998193383216858,16,Type_16,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,16,Type_16,Yes
DB00035,Desmopressin,DB00321,Amitriptyline,0.9954754710197449,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Amitriptyline.,49,Type_49,Yes
DB01384,Paramethasone,DB09053,Ibrutinib,0.76788729429245,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Paramethasone.,73,Type_73,Yes
DB01104,Sertraline,DB08932,Macitentan,0.8839635252952576,47,Type_47,The metabolism of Macitentan can be decreased when combined with Sertraline.,47,Type_47,Yes
DB00313,Valproic acid,DB00748,Carbinoxamine,0.7150137424468994,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Carbinoxamine.,49,Type_49,Yes
DB00457,Prazosin,DB04920,Clevidipine,0.9668447375297546,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Clevidipine.,49,Type_49,Yes
DB00457,Prazosin,DB00681,Amphotericin B,0.9810108542442322,49,Type_49,The risk or severity of adverse effects can be increased when Prazosin is combined with Amphotericin B.,49,Type_49,Yes
DB01172,Kanamycin,DB08439,Parecoxib,0.9996021389961243,72,Type_72,Kanamycin may decrease the excretion rate of Parecoxib which could result in a higher serum level.,72,Type_72,Yes
DB00474,Methohexital,DB00925,Phenoxybenzamine,0.5360708236694336,4,Type_4,The metabolism of Phenoxybenzamine can be increased when combined with Methohexital.,60,Type_60,No
DB00379,Mexiletine,DB00908,Quinidine,0.9783784747123718,47,Type_47,The metabolism of Quinidine can be decreased when combined with Mexiletine.,47,Type_47,Yes
DB00625,Efavirenz,DB04844,Tetrabenazine,0.7001679539680481,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Tetrabenazine.,49,Type_49,Yes
DB00275,Olmesartan,DB01399,Salsalate,0.9454826712608337,49,Type_49,The risk or severity of adverse effects can be increased when Olmesartan is combined with Salsalate.,49,Type_49,Yes
DB00794,Primidone,DB09291,Rolapitant,0.5175401568412781,4,Type_4,The metabolism of Rolapitant can be increased when combined with Primidone.,75,Type_75,No
DB01377,Magnesium oxide,DB01427,Amrinone,0.4086911380290985,70,Type_70,The therapeutic efficacy of Amrinone can be decreased when used in combination with Magnesium oxide.,49,Type_49,No
DB00818,Propofol,DB00962,Zaleplon,0.9441913962364197,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Zaleplon.,49,Type_49,Yes
DB00502,Haloperidol,DB00619,Imatinib,0.9131271839141846,47,Type_47,The metabolism of Imatinib can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB01295,Bevantolol,DB01397,Magnesium salicylate,0.9918659329414368,37,Type_37,Bevantolol may decrease the antihypertensive activities of Magnesium salicylate.,37,Type_37,Yes
DB00338,Omeprazole,DB00720,Clodronic acid,0.8520817160606384,70,Type_70,The therapeutic efficacy of Clodronic acid can be decreased when used in combination with Omeprazole.,70,Type_70,Yes
DB00461,Nabumetone,DB00586,Diclofenac,0.9878169894218445,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Diclofenac.,49,Type_49,Yes
DB00475,Chlordiazepoxide,DB00750,Prilocaine,0.9999991655349731,49,Type_49,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Prilocaine.,49,Type_49,Yes
DB01082,Streptomycin,DB01397,Magnesium salicylate,0.9980156421661377,72,Type_72,Streptomycin may decrease the excretion rate of Magnesium salicylate which could result in a higher serum level.,72,Type_72,Yes
DB00731,Nateglinide,DB01242,Clomipramine,0.7725085020065308,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Nateglinide.,47,Type_47,Yes
DB00370,Mirtazapine,DB00951,Isoniazid,0.5419631600379944,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Mirtazapine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB01708,Prasterone,0.6332553625106812,47,Type_47,The metabolism of Prasterone can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00496,Darifenacin,DB01149,Nefazodone,0.9587365984916687,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Darifenacin.,47,Type_47,Yes
DB00972,Azelastine,DB08815,Lurasidone,0.9484730958938599,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.,16,Type_16,Yes
DB00808,Indapamide,DB09026,Aliskiren,0.7810319662094116,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Aliskiren.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB11348,Calcium Phosphate,0.9854442477226257,72,Type_72,Trichlormethiazide may decrease the excretion rate of Calcium Phosphate which could result in a higher serum level.,72,Type_72,Yes
DB00501,Cimetidine,DB00956,Hydrocodone,0.9423297643661499,47,Type_47,The metabolism of Hydrocodone can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB01149,Nefazodone,0.7653973698616028,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00335,Atenolol,DB00981,Physostigmine,0.9840244650840759,54,Type_54,Atenolol may increase the bradycardic activities of Physostigmine.,54,Type_54,Yes
DB00373,Timolol,DB00476,Duloxetine,0.38531896471977234,30,Type_30,Timolol may increase the orthostatic hypotensive activities of Duloxetine.,30,Type_30,Yes
DB00238,Nevirapine,DB12332,Rucaparib,0.508948802947998,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Nevirapine.,4,Type_4,No
DB01250,Olsalazine,DB08984,Etofenamate,0.8627079725265503,57,Type_57,Olsalazine may increase the nephrotoxic activities of Etofenamate.,57,Type_57,Yes
DB01200,Bromocriptine,DB09079,Nintedanib,0.9363864064216614,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Bromocriptine.,73,Type_73,Yes
DB00512,Vancomycin,DB00565,Cisatracurium,0.9999994039535522,21,Type_21,Vancomycin may increase the neuromuscular blocking activities of Cisatracurium.,21,Type_21,Yes
DB00182,Amphetamine,DB09068,Vortioxetine,0.5250899195671082,8,Type_8,The therapeutic efficacy of Vortioxetine can be increased when used in combination with Amphetamine.,47,Type_47,No
DB00482,Celecoxib,DB11268,Protocatechualdehyde,0.9963956475257874,6,Type_6,Celecoxib may increase the anticoagulant activities of Protocatechualdehyde.,6,Type_6,Yes
DB00223,Diflorasone,DB01264,Darunavir,0.7428009510040283,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Diflorasone.,73,Type_73,Yes
DB00285,Venlafaxine,DB00617,Paramethadione,0.9679592847824097,47,Type_47,The metabolism of Paramethadione can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00648,Mitotane,DB00820,Tadalafil,0.9829119443893433,75,Type_75,The serum concentration of Tadalafil can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB06636,Isavuconazonium,DB08864,Rilpivirine,0.676548957824707,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Isavuconazonium.,73,Type_73,Yes
DB00404,Alprazolam,DB00996,Gabapentin,0.9975455403327942,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Gabapentin.,49,Type_49,Yes
DB00208,Ticlopidine,DB00584,Enalapril,0.9283963441848755,47,Type_47,The metabolism of Enalapril can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB00440,Trimethoprim,DB09238,Manidipine,0.9290757179260254,47,Type_47,The metabolism of Manidipine can be decreased when combined with Trimethoprim.,47,Type_47,Yes
DB00452,Framycetin,DB00681,Amphotericin B,0.6501851677894592,57,Type_57,Framycetin may increase the nephrotoxic activities of Amphotericin B.,57,Type_57,Yes
DB00677,Isoflurophate,DB01047,Fluocinonide,0.9951500296592712,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurophate is combined with Fluocinonide.,49,Type_49,Yes
DB00543,Amoxapine,DB00813,Fentanyl,0.9900180697441101,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Fentanyl.,49,Type_49,Yes
DB01068,Clonazepam,DB09286,Pipamperone,0.989280641078949,49,Type_49,The risk or severity of adverse effects can be increased when Clonazepam is combined with Pipamperone.,49,Type_49,Yes
DB00924,Cyclobenzaprine,DB06201,Rufinamide,0.9990946054458618,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Rufinamide.,49,Type_49,Yes
DB00346,Alfuzosin,DB09230,Azelnidipine,0.9759962558746338,60,Type_60,Alfuzosin may increase the hypotensive activities of Azelnidipine.,60,Type_60,Yes
DB00424,Hyoscyamine,DB00524,Metolazone,0.9560232758522034,73,Type_73,The serum concentration of Metolazone can be increased when it is combined with Hyoscyamine.,73,Type_73,Yes
DB00246,Ziprasidone,DB00537,Ciprofloxacin,0.6768398284912109,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Ciprofloxacin.,20,Type_20,Yes
DB00264,Metoprolol,DB00412,Rosiglitazone,0.8103939890861511,47,Type_47,The metabolism of Rosiglitazone can be decreased when combined with Metoprolol.,73,Type_73,No
DB00571,Propranolol,DB00922,Levosimendan,0.9165728092193604,49,Type_49,The risk or severity of adverse effects can be increased when Propranolol is combined with Levosimendan.,49,Type_49,Yes
DB00622,Nicardipine,DB00889,Granisetron,0.4983082711696625,20,Type_20,Nicardipine may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00423,Methocarbamol,DB01466,Ethylmorphine,0.9989234805107117,49,Type_49,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ethylmorphine.,49,Type_49,Yes
DB00880,Chlorothiazide,DB00963,Bromfenac,0.9960901141166687,70,Type_70,The therapeutic efficacy of Bromfenac can be decreased when used in combination with Chlorothiazide.,70,Type_70,Yes
DB00611,Butorphanol,DB00986,Glycopyrronium,0.966196596622467,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Glycopyrronium.,49,Type_49,Yes
DB00091,Cyclosporine,DB01628,Etoricoxib,0.7533690333366394,47,Type_47,The metabolism of Etoricoxib can be decreased when combined with Cyclosporine.,57,Type_57,No
DB09241,Methylene blue,DB09245,Toloxatone,0.548369288444519,71,Type_71,Methylene blue may increase the hypertensive activities of Toloxatone.,64,Type_64,No
DB00404,Alprazolam,DB00747,Scopolamine,0.9999548196792603,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Scopolamine.,49,Type_49,Yes
DB01221,Ketamine,DB01614,Acepromazine,0.9997259974479675,49,Type_49,The risk or severity of adverse effects can be increased when Ketamine is combined with Acepromazine.,49,Type_49,Yes
DB00937,Diethylpropion,DB01224,Quetiapine,0.9992511868476868,61,Type_61,Diethylpropion may decrease the stimulatory activities of Quetiapine.,61,Type_61,Yes
DB00498,Phenindione,DB00993,Azathioprine,0.6421602368354797,12,Type_12,Phenindione may decrease the anticoagulant activities of Azathioprine.,12,Type_12,Yes
DB01142,Doxepin,DB06690,Nitrous oxide,0.9688800573348999,49,Type_49,The risk or severity of adverse effects can be increased when Doxepin is combined with Nitrous oxide.,49,Type_49,Yes
DB00221,Isoetharine,DB09241,Methylene blue,0.9777441620826721,49,Type_49,The risk or severity of adverse effects can be increased when Isoetharine is combined with Methylene blue.,49,Type_49,Yes
DB01232,Saquinavir,DB11921,Deflazacort,0.9207192659378052,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00802,Alfentanil,DB01090,Pentolinium,0.9805899858474731,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Pentolinium.,49,Type_49,Yes
DB00476,Duloxetine,DB01588,Prazepam,0.8675343990325928,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Prazepam.,49,Type_49,Yes
DB00641,Simvastatin,DB01054,Nitrendipine,0.3849368989467621,73,Type_73,The serum concentration of Nitrendipine can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00224,Indinavir,DB00715,Paroxetine,0.7854791879653931,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00179,Masoprocol,DB01260,Desonide,0.9999040365219116,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Desonide.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01235,Levodopa,0.9597139358520508,30,Type_30,Chlorthalidone may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00270,Isradipine,DB01226,Mivacurium,0.9998563528060913,21,Type_21,Isradipine may increase the neuromuscular blocking activities of Mivacurium.,21,Type_21,Yes
DB00661,Verapamil,DB01222,Budesonide,0.5950702428817749,34,Type_34,Verapamil may increase the immunosuppressive activities of Budesonide.,73,Type_73,No
DB00182,Amphetamine,DB01193,Acebutolol,0.7934139966964722,60,Type_60,Amphetamine may increase the hypotensive activities of Acebutolol.,49,Type_49,No
DB00327,Hydromorphone,DB00986,Glycopyrronium,0.9864341020584106,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Glycopyrronium.,49,Type_49,Yes
DB00841,Dobutamine,DB09042,Tedizolid phosphate,0.941817045211792,71,Type_71,Dobutamine may increase the hypertensive activities of Tedizolid phosphate.,71,Type_71,Yes
DB00722,Lisinopril,DB01211,Clarithromycin,0.49069783091545105,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Lisinopril.,70,Type_70,No
DB00503,Ritonavir,DB01118,Amiodarone,0.6735321283340454,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Ritonavir.,73,Type_73,No
DB00685,Trovafloxacin,DB13142,Calcium glubionate anhydrous,0.8970804214477539,67,Type_67,Trovafloxacin can cause a decrease in the absorption of Calcium glubionate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00281,Lidocaine,DB00405,Dexbrompheniramine,0.9985480904579163,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Dexbrompheniramine.,49,Type_49,Yes
DB00661,Verapamil,DB00990,Exemestane,0.7648636698722839,47,Type_47,The metabolism of Exemestane can be decreased when combined with Verapamil.,47,Type_47,Yes
DB00721,Procaine,DB01018,Guanfacine,0.9854239821434021,49,Type_49,The risk or severity of adverse effects can be increased when Procaine is combined with Guanfacine.,49,Type_49,Yes
DB00608,Chloroquine,DB09104,Magnesium hydroxide,0.8872707486152649,67,Type_67,Chloroquine can cause a decrease in the absorption of Magnesium hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00245,Benzatropine,DB00338,Omeprazole,0.8152943849563599,47,Type_47,The metabolism of Omeprazole can be decreased when combined with Benzatropine.,47,Type_47,Yes
DB00703,Methazolamide,DB01340,Cilazapril,0.9421411156654358,49,Type_49,The risk or severity of adverse effects can be increased when Methazolamide is combined with Cilazapril.,49,Type_49,Yes
DB00206,Reserpine,DB01068,Clonazepam,0.979023814201355,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Clonazepam.,49,Type_49,Yes
DB00854,Levorphanol,DB01036,Tolterodine,0.9950119256973267,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Tolterodine.,49,Type_49,Yes
DB00481,Raloxifene,DB00661,Verapamil,0.9575120806694031,47,Type_47,The metabolism of Verapamil can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00177,Valsartan,DB00461,Nabumetone,0.8590734004974365,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Nabumetone.,49,Type_49,Yes
DB00899,Remifentanil,DB08987,Etidocaine,0.9998793601989746,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Etidocaine.,49,Type_49,Yes
DB01401,Choline magnesium trisalicylate,DB06826,Unoprostone,0.9999704360961914,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Choline magnesium trisalicylate.,70,Type_70,Yes
DB00420,Promazine,DB13323,Trichloroethylene,0.999554455280304,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Trichloroethylene.,49,Type_49,Yes
DB00193,Tramadol,DB06216,Asenapine,0.6947059631347656,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Asenapine.,49,Type_49,Yes
DB00665,Nilutamide,DB00736,Esomeprazole,0.5829648375511169,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Nilutamide.,47,Type_47,Yes
DB00241,Butalbital,DB06288,Amisulpride,0.9782869219779968,49,Type_49,The risk or severity of adverse effects can be increased when Butalbital is combined with Amisulpride.,49,Type_49,Yes
DB00371,Meprobamate,DB00497,Oxycodone,0.9971503615379333,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Oxycodone.,49,Type_49,Yes
DB05271,Rotigotine,DB09286,Pipamperone,0.9816268682479858,32,Type_32,Rotigotine may increase the sedative activities of Pipamperone.,32,Type_32,Yes
DB00880,Chlorothiazide,DB01197,Captopril,0.6947106719017029,49,Type_49,The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Captopril.,49,Type_49,Yes
DB00455,Loratadine,DB04841,Flunarizine,0.9660508632659912,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Flunarizine.,49,Type_49,Yes
DB00228,Enflurane,DB00484,Brimonidine,0.9859825968742371,16,Type_16,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,16,Type_16,Yes
DB00398,Sorafenib,DB08933,Luliconazole,0.9884505271911621,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Sorafenib.,73,Type_73,Yes
DB06737,Zaltoprofen,DB09288,Propacetamol,0.9978479146957397,49,Type_49,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Propacetamol.,49,Type_49,Yes
DB00972,Azelastine,DB01397,Magnesium salicylate,0.7335168719291687,16,Type_16,Azelastine may increase the central nervous system depressant (CNS depressant) activities of Magnesium salicylate.,49,Type_49,No
DB00763,Methimazole,DB08860,Pitavastatin,0.5452681183815002,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Methimazole.,73,Type_73,Yes
DB00201,Caffeine,DB06212,Tolvaptan,0.8391241431236267,73,Type_73,The serum concentration of Tolvaptan can be increased when it is combined with Caffeine.,73,Type_73,Yes
DB00035,Desmopressin,DB11609,Normethadone,0.9999902248382568,49,Type_49,The risk or severity of adverse effects can be increased when Desmopressin is combined with Normethadone.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01393,Bezafibrate,0.627700924873352,47,Type_47,The metabolism of Bezafibrate can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00899,Remifentanil,DB01247,Isocarboxazid,0.8040297627449036,49,Type_49,The risk or severity of adverse effects can be increased when Remifentanil is combined with Isocarboxazid.,49,Type_49,Yes
DB00559,Bosentan,DB01319,Fosamprenavir,0.7243757843971252,75,Type_75,The serum concentration of Fosamprenavir can be decreased when it is combined with Bosentan.,75,Type_75,Yes
DB00543,Amoxapine,DB00829,Diazepam,0.8561615347862244,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Diazepam.,49,Type_49,Yes
DB00572,Atropine,DB00780,Phenelzine,0.7686219215393066,71,Type_71,Atropine may increase the hypertensive activities of Phenelzine.,71,Type_71,Yes
DB00726,Trimipramine,DB08883,Perampanel,0.9499081969261169,16,Type_16,Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB01072,Atazanavir,DB01466,Ethylmorphine,0.8374611735343933,47,Type_47,The metabolism of Ethylmorphine can be decreased when combined with Atazanavir.,47,Type_47,Yes
DB00611,Butorphanol,DB09049,Naloxegol,0.9961063265800476,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Butorphanol.,49,Type_49,No
DB01297,Practolol,DB06802,Nepafenac,0.9990431666374207,37,Type_37,Practolol may decrease the antihypertensive activities of Nepafenac.,37,Type_37,Yes
DB00906,Tiagabine,DB01219,Dantrolene,0.9985182881355286,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Dantrolene.,49,Type_49,Yes
DB00246,Ziprasidone,DB00270,Isradipine,0.7320464253425598,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Isradipine.,20,Type_20,Yes
DB00238,Nevirapine,DB01418,Acenocoumarol,0.5194495916366577,4,Type_4,The metabolism of Acenocoumarol can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00880,Chlorothiazide,DB01088,Iloprost,0.5557476282119751,60,Type_60,Chlorothiazide may increase the hypotensive activities of Iloprost.,60,Type_60,Yes
DB00091,Cyclosporine,DB00755,Tretinoin,0.6157150864601135,47,Type_47,The metabolism of Tretinoin can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00476,Duloxetine,DB01424,Aminophenazone,0.9520412683486938,47,Type_47,The metabolism of Aminophenazone can be decreased when combined with Duloxetine.,47,Type_47,Yes
DB00196,Fluconazole,DB00759,Tetracycline,0.8506460189819336,47,Type_47,The metabolism of Tetracycline can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00749,Etodolac,DB12598,Nafamostat,0.9276219010353088,6,Type_6,Etodolac may increase the anticoagulant activities of Nafamostat.,6,Type_6,Yes
DB00847,Cysteamine,DB05351,Dexlansoprazole,0.9034205079078674,70,Type_70,The therapeutic efficacy of Dexlansoprazole can be decreased when used in combination with Cysteamine.,70,Type_70,Yes
DB00313,Valproic acid,DB01463,Fencamfamin,0.9874081611633301,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Fencamfamin.,49,Type_49,Yes
DB06207,Silodosin,DB09090,Pinaverium,0.9048519134521484,60,Type_60,Silodosin may increase the hypotensive activities of Pinaverium.,60,Type_60,Yes
DB00496,Darifenacin,DB00956,Hydrocodone,0.5669615864753723,49,Type_49,The risk or severity of adverse effects can be increased when Darifenacin is combined with Hydrocodone.,47,Type_47,No
DB00494,Entacapone,DB01168,Procarbazine,0.9414088129997253,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Procarbazine.,49,Type_49,Yes
DB00499,Flutamide,DB08865,Crizotinib,0.9623847007751465,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Flutamide.,47,Type_47,Yes
DB00518,Albendazole,DB00834,Mifepristone,0.916188657283783,73,Type_73,The serum concentration of Mifepristone can be increased when it is combined with Albendazole.,73,Type_73,Yes
DB00672,Chlorpropamide,DB09049,Naloxegol,0.9338832497596741,73,Type_73,The serum concentration of Naloxegol can be increased when it is combined with Chlorpropamide.,73,Type_73,Yes
DB01092,Ouabain,DB11363,Alectinib,0.9996126294136047,58,Type_58,Ouabain may decrease the cardiotoxic activities of Alectinib.,58,Type_58,Yes
DB00203,Sildenafil,DB00951,Isoniazid,0.7027065753936768,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00278,Argatroban,DB00346,Alfuzosin,0.8080057501792908,60,Type_60,Argatroban may increase the hypotensive activities of Alfuzosin.,73,Type_73,No
DB00673,Aprepitant,DB09262,Imidafenacin,0.9267560243606567,73,Type_73,The serum concentration of Imidafenacin can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00420,Promazine,DB00897,Triazolam,0.8263789415359497,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Triazolam.,49,Type_49,Yes
DB00467,Enoxacin,DB00658,Sevelamer,0.8629570603370667,75,Type_75,The serum concentration of Sevelamer can be decreased when it is combined with Enoxacin.,67,Type_67,No
DB00292,Etomidate,DB11148,Butamben,0.9999587535858154,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Butamben.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB01118,Amiodarone,0.6589944362640381,58,Type_58,Acetyldigitoxin may decrease the cardiotoxic activities of Amiodarone.,73,Type_73,No
DB00933,Mesoridazine,DB01075,Diphenhydramine,0.6049215197563171,49,Type_49,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Diphenhydramine.,47,Type_47,No
DB00925,Phenoxybenzamine,DB01235,Levodopa,0.9873071908950806,30,Type_30,Phenoxybenzamine may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB00482,Celecoxib,DB09280,Lumacaftor,0.6352999210357666,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Celecoxib.,75,Type_75,Yes
DB01016,Glyburide,DB06335,Saxagliptin,0.5493975877761841,9,Type_9,Glyburide may increase the hypoglycemic activities of Saxagliptin.,9,Type_9,Yes
DB01220,Rifaximin,DB08827,Lomitapide,0.7594786286354065,73,Type_73,The serum concentration of Lomitapide can be increased when it is combined with Rifaximin.,73,Type_73,Yes
DB00374,Treprostinil,DB00412,Rosiglitazone,0.5519806742668152,47,Type_47,The metabolism of Rosiglitazone can be decreased when combined with Treprostinil.,49,Type_49,No
DB00425,Zolpidem,DB00877,Sirolimus,0.7858915328979492,47,Type_47,The metabolism of Sirolimus can be decreased when combined with Zolpidem.,73,Type_73,No
DB00608,Chloroquine,DB01578,Metrizamide,0.9841761589050293,72,Type_72,Chloroquine may decrease the excretion rate of Metrizamide which could result in a higher serum level.,72,Type_72,Yes
DB00708,Sufentanil,DB01440,gamma-Hydroxybutyric acid,0.9998646974563599,49,Type_49,The risk or severity of adverse effects can be increased when Sufentanil is combined with gamma-Hydroxybutyric acid.,49,Type_49,Yes
DB01064,Isoprenaline,DB04861,Nebivolol,0.47751563787460327,5,Type_5,Isoprenaline may decrease the vasoconstricting activities of Nebivolol.,14,Type_14,No
DB00323,Tolcapone,DB00753,Isoflurane,0.9857171773910522,49,Type_49,The risk or severity of adverse effects can be increased when Tolcapone is combined with Isoflurane.,49,Type_49,Yes
DB00489,Sotalol,DB09218,Clonixin,0.9266841411590576,37,Type_37,Sotalol may decrease the antihypertensive activities of Clonixin.,37,Type_37,Yes
DB00356,Chlorzoxazone,DB01587,Ketazolam,0.9969103932380676,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ketazolam.,49,Type_49,Yes
DB00903,Etacrynic acid,DB04948,Lofexidine,0.7343178987503052,49,Type_49,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Lofexidine.,49,Type_49,Yes
DB00353,Methylergometrine,DB01136,Carvedilol,0.9680280685424805,19,Type_19,Methylergometrine may increase the vasoconstricting activities of Carvedilol.,19,Type_19,Yes
DB01211,Clarithromycin,DB09026,Aliskiren,0.8527939319610596,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00252,Phenytoin,DB06216,Asenapine,0.4710121154785156,4,Type_4,The metabolism of Asenapine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00921,Buprenorphine,DB01106,Levocabastine,0.9997991919517517,16,Type_16,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.,16,Type_16,Yes
DB00611,Butorphanol,DB01324,Polythiazide,0.9986132383346558,49,Type_49,The risk or severity of adverse effects can be increased when Butorphanol is combined with Polythiazide.,49,Type_49,Yes
DB00327,Hydromorphone,DB08918,Levomilnacipran,0.7935410141944885,64,Type_64,Hydromorphone may increase the serotonergic activities of Levomilnacipran.,64,Type_64,Yes
DB01349,Tasosartan,DB01601,Lopinavir,0.9746115207672119,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Tasosartan.,47,Type_47,Yes
DB00672,Chlorpropamide,DB01072,Atazanavir,0.8670027852058411,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Chlorpropamide.,70,Type_70,No
DB00481,Raloxifene,DB00619,Imatinib,0.9257703423500061,47,Type_47,The metabolism of Imatinib can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00570,Vinblastine,DB09075,Edoxaban,0.9566547274589539,73,Type_73,The serum concentration of Edoxaban can be increased when it is combined with Vinblastine.,73,Type_73,Yes
DB01132,Pioglitazone,DB09065,Cobicistat,0.5651307702064514,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Pioglitazone.,47,Type_47,No
DB00374,Treprostinil,DB01247,Isocarboxazid,0.8209174871444702,60,Type_60,Treprostinil may increase the hypotensive activities of Isocarboxazid.,60,Type_60,Yes
DB00353,Methylergometrine,DB00819,Acetazolamide,0.6941342353820801,49,Type_49,The risk or severity of adverse effects can be increased when Methylergometrine is combined with Acetazolamide.,49,Type_49,Yes
DB00268,Ropinirole,DB00628,Clorazepic acid,0.9715627431869507,32,Type_32,Ropinirole may increase the sedative activities of Clorazepic acid.,32,Type_32,Yes
DB00337,Pimecrolimus,DB05109,Trabectedin,0.7000998258590698,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trabectedin.,49,Type_49,Yes
DB00203,Sildenafil,DB06736,Aceclofenac,0.9783287048339844,47,Type_47,The metabolism of Aceclofenac can be decreased when combined with Sildenafil.,47,Type_47,Yes
DB00594,Amiloride,DB00611,Butorphanol,0.9952697157859802,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Butorphanol.,49,Type_49,Yes
DB00368,Norepinephrine,DB00903,Etacrynic acid,0.9888773560523987,83,Type_83,Norepinephrine may increase the hypokalemic activities of Etacrynic acid.,83,Type_83,Yes
DB00573,Fenoprofen,DB08797,Salicylamide,0.9991722106933594,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Salicylamide.,49,Type_49,Yes
DB01611,Hydroxychloroquine,DB01615,Aceprometazine,0.679306149482727,73,Type_73,The serum concentration of Aceprometazine can be increased when it is combined with Hydroxychloroquine.,73,Type_73,Yes
DB00409,Remoxipride,DB00708,Sufentanil,0.9764739871025085,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Sufentanil.,49,Type_49,Yes
DB00264,Metoprolol,DB00338,Omeprazole,0.8041250109672546,47,Type_47,The metabolism of Omeprazole can be decreased when combined with Metoprolol.,73,Type_73,No
DB00296,Ropivacaine,DB00754,Ethotoin,0.9963462948799133,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ethotoin.,49,Type_49,Yes
DB00748,Carbinoxamine,DB01365,Mephentermine,0.9794984459877014,76,Type_76,Carbinoxamine may decrease the sedative activities of Mephentermine.,76,Type_76,Yes
DB01601,Lopinavir,DB04841,Flunarizine,0.729015588760376,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB00923,Ceforanide,DB09268,Picosulfuric acid,1.0,70,Type_70,The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Ceforanide.,70,Type_70,Yes
DB04572,Thiotepa,DB04841,Flunarizine,0.920012354850769,47,Type_47,The metabolism of Flunarizine can be decreased when combined with Thiotepa.,47,Type_47,Yes
DB01218,Halofantrine,DB06717,Fosaprepitant,0.9350582957267761,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Halofantrine.,73,Type_73,Yes
DB00976,Telithromycin,DB00983,Formoterol,0.5481761693954468,20,Type_20,Telithromycin may increase the QTc-prolonging activities of Formoterol.,20,Type_20,Yes
DB00104,Octreotide,DB00246,Ziprasidone,0.6710746884346008,20,Type_20,Octreotide may increase the QTc-prolonging activities of Ziprasidone.,20,Type_20,Yes
DB00341,Cetirizine,DB08910,Pomalidomide,0.9993091821670532,49,Type_49,The risk or severity of adverse effects can be increased when Cetirizine is combined with Pomalidomide.,49,Type_49,Yes
DB00696,Ergotamine,DB00960,Pindolol,0.5853369235992432,25,Type_25,Ergotamine may increase the atrioventricular blocking (AV block) activities of Pindolol.,25,Type_25,Yes
DB00956,Hydrocodone,DB01626,Pargyline,0.8328507542610168,49,Type_49,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Pargyline.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB00608,Chloroquine,0.9166935682296753,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Chlorzoxazone.,47,Type_47,Yes
DB00494,Entacapone,DB04953,Ezogabine,0.9969556331634521,49,Type_49,The risk or severity of adverse effects can be increased when Entacapone is combined with Ezogabine.,49,Type_49,Yes
DB00349,Clobazam,DB08883,Perampanel,0.97633957862854,16,Type_16,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00498,Phenindione,DB01022,Phylloquinone,0.4450676739215851,12,Type_12,Phenindione may decrease the anticoagulant activities of Phylloquinone.,12,Type_12,Yes
DB01195,Flecainide,DB01267,Paliperidone,0.5661935806274414,20,Type_20,Flecainide may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00347,Trimethadione,DB01263,Posaconazole,0.9418864250183105,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Trimethadione.,47,Type_47,Yes
DB00202,Succinylcholine,DB01408,Bambuterol,0.78328537940979,49,Type_49,The risk or severity of adverse effects can be increased when Succinylcholine is combined with Bambuterol.,8,Type_8,No
DB01601,Lopinavir,DB06739,Seratrodast,0.8390357494354248,47,Type_47,The metabolism of Seratrodast can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB00697,Tizanidine,DB01623,Thiothixene,0.6062489151954651,20,Type_20,Tizanidine may increase the QTc-prolonging activities of Thiothixene.,49,Type_49,No
DB00409,Remoxipride,DB13323,Trichloroethylene,0.9998464584350586,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Trichloroethylene.,49,Type_49,Yes
DB00571,Propranolol,DB01235,Levodopa,0.8378034830093384,30,Type_30,Propranolol may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB04576,Fleroxacin,DB09084,Benzydamine,0.9942816495895386,27,Type_27,Fleroxacin may increase the neuroexcitatory activities of Benzydamine.,27,Type_27,Yes
DB00732,Atracurium besylate,DB00896,Rimexolone,0.9940793514251709,22,Type_22,Atracurium besylate may increase the adverse neuromuscular activities of Rimexolone.,22,Type_22,Yes
DB00677,Isoflurophate,DB01098,Rosuvastatin,0.7360561490058899,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Isoflurophate.,73,Type_73,Yes
DB00425,Zolpidem,DB00735,Naftifine,0.5041711330413818,49,Type_49,The risk or severity of adverse effects can be increased when Zolpidem is combined with Naftifine.,73,Type_73,No
DB00189,Ethchlorvynol,DB00404,Alprazolam,0.9997228980064392,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Alprazolam.,49,Type_49,Yes
DB00502,Haloperidol,DB00622,Nicardipine,0.4691125154495239,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00682,Warfarin,DB01009,Ketoprofen,0.9996820688247681,6,Type_6,Warfarin may increase the anticoagulant activities of Ketoprofen.,6,Type_6,Yes
DB00187,Esmolol,DB00677,Isoflurophate,0.9800804853439331,54,Type_54,Esmolol may increase the bradycardic activities of Isoflurophate.,54,Type_54,Yes
DB06292,Dapagliflozin,DB09065,Cobicistat,0.7194036245346069,47,Type_47,The metabolism of Cobicistat can be decreased when combined with Dapagliflozin.,73,Type_73,No
DB00619,Imatinib,DB01028,Methoxyflurane,0.9657631516456604,47,Type_47,The metabolism of Methoxyflurane can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00502,Haloperidol,DB01563,Chloral hydrate,0.9996833801269531,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Chloral hydrate.,49,Type_49,Yes
DB00425,Zolpidem,DB09031,Miltefosine,0.7683513760566711,73,Type_73,The serum concentration of Miltefosine can be increased when it is combined with Zolpidem.,73,Type_73,Yes
DB00996,Gabapentin,DB01069,Promethazine,0.9930319786071777,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Promethazine.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB01355,Hexobarbital,0.9409266710281372,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Hexobarbital.,49,Type_49,Yes
DB00146,Calcifediol,DB13142,Calcium glubionate anhydrous,0.9751145243644714,49,Type_49,The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium glubionate anhydrous.,49,Type_49,Yes
DB04876,Vildagliptin,DB06287,Temsirolimus,0.8993871212005615,70,Type_70,The therapeutic efficacy of Temsirolimus can be decreased when used in combination with Vildagliptin.,49,Type_49,No
DB00263,Sulfisoxazole,DB00270,Isradipine,0.5808348059654236,20,Type_20,Sulfisoxazole may increase the QTc-prolonging activities of Isradipine.,20,Type_20,Yes
DB01247,Isocarboxazid,DB01367,Rasagiline,0.9169748425483704,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Rasagiline.,49,Type_49,Yes
DB01545,Ethyl loflazepate,DB08910,Pomalidomide,0.9996169805526733,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Pomalidomide.,49,Type_49,Yes
DB00362,Anidulafungin,DB01244,Bepridil,0.9943532943725586,49,Type_49,The risk or severity of adverse effects can be increased when Anidulafungin is combined with Bepridil.,49,Type_49,Yes
DB00502,Haloperidol,DB00736,Esomeprazole,0.9642719030380249,47,Type_47,The metabolism of Esomeprazole can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00613,Amodiaquine,DB00715,Paroxetine,0.9062149524688721,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Amodiaquine.,73,Type_73,No
DB00508,Triflupromazine,DB00754,Ethotoin,0.9934142827987671,49,Type_49,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Ethotoin.,49,Type_49,Yes
DB00231,Temazepam,DB01614,Acepromazine,0.999677300453186,49,Type_49,The risk or severity of adverse effects can be increased when Temazepam is combined with Acepromazine.,49,Type_49,Yes
DB00897,Triazolam,DB08872,Gabapentin enacarbil,0.9998897314071655,49,Type_49,The risk or severity of adverse effects can be increased when Triazolam is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00313,Valproic acid,DB00458,Imipramine,0.37521877884864807,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Imipramine.,73,Type_73,No
DB00643,Mebendazole,DB01590,Everolimus,0.9685433506965637,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Mebendazole.,73,Type_73,Yes
DB00783,Estradiol,DB09095,Difluocortolone,0.9889560341835022,73,Type_73,The serum concentration of Difluocortolone can be increased when it is combined with Estradiol.,73,Type_73,Yes
DB00521,Carteolol,DB02709,Resveratrol,0.9957517385482788,37,Type_37,Carteolol may decrease the antihypertensive activities of Resveratrol.,37,Type_37,Yes
DB00924,Cyclobenzaprine,DB04839,Cyproterone acetate,0.4982227385044098,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Cyclobenzaprine.,75,Type_75,No
DB00404,Alprazolam,DB00543,Amoxapine,0.9778109788894653,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Amoxapine.,49,Type_49,Yes
DB00680,Moricizine,DB06724,Calcium carbonate,0.7485443353652954,67,Type_67,Moricizine can cause a decrease in the absorption of Calcium carbonate resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00283,Clemastine,DB00738,Pentamidine,0.7509602904319763,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB01384,Paramethasone,DB13595,Almasilate,0.9997729659080505,3,Type_3,The bioavailability of Almasilate can be decreased when combined with Paramethasone.,3,Type_3,Yes
DB00318,Codeine,DB01100,Pimozide,0.9096493721008301,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Pimozide.,49,Type_49,Yes
DB00409,Remoxipride,DB04844,Tetrabenazine,0.9813712239265442,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Tetrabenazine.,49,Type_49,Yes
DB00584,Enalapril,DB08912,Dabrafenib,0.9860225915908813,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Enalapril.,75,Type_75,Yes
DB04953,Ezogabine,DB06603,Panobinostat,0.8648999929428101,20,Type_20,Ezogabine may increase the QTc-prolonging activities of Panobinostat.,20,Type_20,Yes
DB06736,Aceclofenac,DB08905,Formestane,0.9996802806854248,49,Type_49,The risk or severity of adverse effects can be increased when Aceclofenac is combined with Formestane.,49,Type_49,Yes
DB00829,Diazepam,DB01202,Levetiracetam,0.9452680945396423,49,Type_49,The risk or severity of adverse effects can be increased when Diazepam is combined with Levetiracetam.,49,Type_49,Yes
DB00620,Triamcinolone,DB07615,Tranilast,0.9958601593971252,49,Type_49,The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tranilast.,49,Type_49,Yes
DB00363,Clozapine,DB09280,Lumacaftor,0.5828903317451477,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Clozapine.,73,Type_73,No
DB00427,Triprolidine,DB00656,Trazodone,0.9845346212387085,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Trazodone.,49,Type_49,Yes
DB00573,Fenoprofen,DB00821,Carprofen,0.9990571141242981,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Carprofen.,49,Type_49,Yes
DB00887,Bumetanide,DB01247,Isocarboxazid,0.5433328747749329,49,Type_49,The risk or severity of adverse effects can be increased when Bumetanide is combined with Isocarboxazid.,49,Type_49,Yes
DB01544,Flunitrazepam,DB06204,Tapentadol,0.9909114241600037,16,Type_16,Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,16,Type_16,Yes
DB00469,Tenoxicam,DB00768,Olopatadine,0.9993247985839844,49,Type_49,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Olopatadine.,49,Type_49,Yes
DB01356,Lithium cation,DB06589,Pazopanib,0.9440051317214966,20,Type_20,Lithium cation may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB00518,Albendazole,DB08916,Afatinib,0.645022451877594,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Albendazole.,73,Type_73,Yes
DB00252,Phenytoin,DB08860,Pitavastatin,0.4003336727619171,75,Type_75,The serum concentration of Pitavastatin can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00784,Mefenamic acid,DB09215,Droxicam,0.9989867806434631,49,Type_49,The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Droxicam.,49,Type_49,Yes
DB00541,Vincristine,DB01186,Pergolide,0.8306965231895447,49,Type_49,The risk or severity of adverse effects can be increased when Vincristine is combined with Pergolide.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00471,Montelukast,0.9937637448310852,47,Type_47,The metabolism of Montelukast can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB05381,Histamine,DB08816,Ticagrelor,0.8331575989723206,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Histamine.,47,Type_47,Yes
DB00263,Sulfisoxazole,DB05219,Crisaborole,0.9993627667427063,47,Type_47,The metabolism of Crisaborole can be decreased when combined with Sulfisoxazole.,47,Type_47,Yes
DB00620,Triamcinolone,DB01149,Nefazodone,0.7840561270713806,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Triamcinolone.,47,Type_47,Yes
DB00322,Floxuridine,DB04938,Ospemifene,0.9421316385269165,47,Type_47,The metabolism of Ospemifene can be decreased when combined with Floxuridine.,73,Type_73,No
DB00764,Mometasone,DB09063,Ceritinib,0.9851190447807312,78,Type_78,Mometasone may increase the hyperglycemic activities of Ceritinib.,78,Type_78,Yes
DB00232,Methyclothiazide,DB00925,Phenoxybenzamine,0.70954430103302,49,Type_49,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Phenoxybenzamine.,49,Type_49,Yes
DB00582,Voriconazole,DB01026,Ketoconazole,0.42639583349227905,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00489,Sotalol,DB09084,Benzydamine,0.9231776595115662,37,Type_37,Sotalol may decrease the antihypertensive activities of Benzydamine.,37,Type_37,Yes
DB00385,Valrubicin,DB09216,Tolfenamic acid,0.9994046688079834,72,Type_72,Valrubicin may decrease the excretion rate of Tolfenamic acid which could result in a higher serum level.,72,Type_72,Yes
DB00603,Medroxyprogesterone acetate,DB00648,Mitotane,0.9851802587509155,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Medroxyprogesterone acetate.,75,Type_75,Yes
DB00284,Acarbose,DB00294,Etonogestrel,0.9969785213470459,70,Type_70,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00916,Metronidazole,DB04946,Iloperidone,0.6316831111907959,20,Type_20,Metronidazole may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB00404,Alprazolam,DB01567,Fludiazepam,0.9995874762535095,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Fludiazepam.,49,Type_49,Yes
DB00239,Oxiconazole,DB00615,Rifabutin,0.7527729272842407,4,Type_4,The metabolism of Rifabutin can be increased when combined with Oxiconazole.,73,Type_73,No
DB01245,Decamethonium,DB01410,Ciclesonide,0.9923298954963684,49,Type_49,The risk or severity of adverse effects can be increased when Decamethonium is combined with Ciclesonide.,49,Type_49,Yes
DB00246,Ziprasidone,DB09071,Tasimelteon,0.7687287330627441,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tasimelteon.,49,Type_49,Yes
DB01002,Levobupivacaine,DB01201,Rifapentine,0.9647761583328247,4,Type_4,The metabolism of Rifapentine can be increased when combined with Levobupivacaine.,4,Type_4,Yes
DB00468,Quinine,DB02638,Terlipressin,0.9916195869445801,60,Type_60,Quinine may increase the hypotensive activities of Terlipressin.,60,Type_60,Yes
DB01151,Desipramine,DB09079,Nintedanib,0.9067360758781433,73,Type_73,The serum concentration of Nintedanib can be increased when it is combined with Desipramine.,73,Type_73,Yes
DB01186,Pergolide,DB13139,Levosalbutamol,0.52006995677948,49,Type_49,The risk or severity of adverse effects can be increased when Pergolide is combined with Levosalbutamol.,49,Type_49,Yes
DB00206,Reserpine,DB01612,Amyl Nitrite,0.9956056475639343,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Amyl Nitrite.,49,Type_49,Yes
DB01392,Yohimbine,DB08808,Bupranolol,0.7488988637924194,37,Type_37,Yohimbine may decrease the antihypertensive activities of Bupranolol.,37,Type_37,Yes
DB00285,Venlafaxine,DB00863,Ranitidine,0.950771689414978,47,Type_47,The metabolism of Ranitidine can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00575,Clonidine,DB08912,Dabrafenib,0.892756998538971,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Clonidine.,75,Type_75,Yes
DB00320,Dihydroergotamine,DB04835,Maraviroc,0.8739739060401917,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB08808,Bupranolol,DB09241,Methylene blue,0.9992663264274597,60,Type_60,Bupranolol may increase the hypotensive activities of Methylene blue.,60,Type_60,Yes
DB00932,Tipranavir,DB01071,Mequitazine,0.3068780303001404,73,Type_73,The serum concentration of Mequitazine can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB00980,Ramelteon,DB01466,Ethylmorphine,0.9934311509132385,49,Type_49,The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethylmorphine.,49,Type_49,Yes
DB01359,Penbutolol,DB08984,Etofenamate,0.9920597076416016,37,Type_37,Penbutolol may decrease the antihypertensive activities of Etofenamate.,37,Type_37,Yes
DB01174,Phenobarbital,DB06145,Spiramycin,0.9120815396308899,4,Type_4,The metabolism of Spiramycin can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB00924,Cyclobenzaprine,DB09085,Tetracaine,0.9992132186889648,49,Type_49,The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Tetracaine.,49,Type_49,Yes
DB00150,Tryptophan,DB00344,Protriptyline,0.9908453822135925,64,Type_64,Tryptophan may increase the serotonergic activities of Protriptyline.,64,Type_64,Yes
DB00908,Quinidine,DB08881,Vemurafenib,0.5477204322814941,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB01656,Roflumilast,DB08899,Enzalutamide,0.8134633302688599,75,Type_75,The serum concentration of Enzalutamide can be decreased when it is combined with Roflumilast.,75,Type_75,Yes
DB00765,Metyrosine,DB06153,Pizotifen,0.9999979734420776,32,Type_32,Metyrosine may increase the sedative activities of Pizotifen.,32,Type_32,Yes
DB01036,Tolterodine,DB04868,Nilotinib,0.6200776100158691,20,Type_20,Tolterodine may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB01016,Glyburide,DB09038,Empagliflozin,0.9860399961471558,9,Type_9,Glyburide may increase the hypoglycemic activities of Empagliflozin.,9,Type_9,Yes
DB01171,Moclobemide,DB04855,Dronedarone,0.8920921087265015,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Moclobemide.,47,Type_47,Yes
DB00734,Risperidone,DB02703,Fusidic acid,0.999119222164154,73,Type_73,The serum concentration of Fusidic acid can be increased when it is combined with Risperidone.,73,Type_73,Yes
DB00136,Calcitriol,DB00253,Medrysone,0.8787454962730408,70,Type_70,The therapeutic efficacy of Medrysone can be decreased when used in combination with Calcitriol.,70,Type_70,Yes
DB00630,Alendronic acid,DB09218,Clonixin,0.9961274266242981,49,Type_49,The risk or severity of adverse effects can be increased when Alendronic acid is combined with Clonixin.,49,Type_49,Yes
DB00418,Secobarbital,DB01340,Cilazapril,0.9038965106010437,60,Type_60,Secobarbital may increase the hypotensive activities of Cilazapril.,60,Type_60,Yes
DB01227,Levacetylmethadol,DB01580,Oxprenolol,0.9581661820411682,49,Type_49,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Oxprenolol.,49,Type_49,Yes
DB00312,Pentobarbital,DB00391,Sulpiride,0.8775361180305481,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Sulpiride.,49,Type_49,Yes
DB01708,Prasterone,DB06802,Nepafenac,0.9994478821754456,49,Type_49,The risk or severity of adverse effects can be increased when Prasterone is combined with Nepafenac.,49,Type_49,Yes
DB06725,Lornoxicam,DB06826,Unoprostone,0.9987897276878357,70,Type_70,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Lornoxicam.,70,Type_70,Yes
DB00615,Rifabutin,DB00708,Sufentanil,0.8453414440155029,4,Type_4,The metabolism of Sufentanil can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00186,Lorazepam,DB00575,Clonidine,0.9819750189781189,49,Type_49,The risk or severity of adverse effects can be increased when Lorazepam is combined with Clonidine.,49,Type_49,Yes
DB01118,Amiodarone,DB01429,Aprindine,0.9919862747192383,47,Type_47,The metabolism of Aprindine can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB00957,Norgestimate,DB01251,Gliquidone,0.9302088022232056,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norgestimate.,70,Type_70,Yes
DB09049,Naloxegol,DB09330,Osimertinib,0.9993070363998413,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Naloxegol.,73,Type_73,Yes
DB00615,Rifabutin,DB06282,Levocetirizine,0.8386629819869995,4,Type_4,The metabolism of Levocetirizine can be increased when combined with Rifabutin.,4,Type_4,Yes
DB00818,Propofol,DB04839,Cyproterone acetate,0.7796728014945984,75,Type_75,The serum concentration of Cyproterone acetate can be decreased when it is combined with Propofol.,75,Type_75,Yes
DB01166,Cilostazol,DB01236,Sevoflurane,0.24486543238162994,49,Type_49,The risk or severity of adverse effects can be increased when Cilostazol is combined with Sevoflurane.,6,Type_6,No
DB00199,Erythromycin,DB00359,Sulfadiazine,0.9887070655822754,47,Type_47,The metabolism of Sulfadiazine can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB01254,Dasatinib,DB06654,Safinamide,0.5515291094779968,73,Type_73,The serum concentration of Safinamide can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB00199,Erythromycin,DB01427,Amrinone,0.8543843626976013,47,Type_47,The metabolism of Amrinone can be decreased when combined with Erythromycin.,47,Type_47,Yes
DB00998,Frovatriptan,DB09330,Osimertinib,0.9198445677757263,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Frovatriptan.,75,Type_75,No
DB00469,Tenoxicam,DB06263,Amrubicin,0.9995951056480408,72,Type_72,Tenoxicam may decrease the excretion rate of Amrubicin which could result in a higher serum level.,72,Type_72,Yes
DB00608,Chloroquine,DB01047,Fluocinonide,0.9980023503303528,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Fluocinonide.,49,Type_49,Yes
DB00254,Doxycycline,DB09320,Procaine benzylpenicillin,0.6215825080871582,70,Type_70,The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Doxycycline.,70,Type_70,Yes
DB00685,Trovafloxacin,DB00738,Pentamidine,0.7733917832374573,9,Type_9,Trovafloxacin may increase the hypoglycemic activities of Pentamidine.,9,Type_9,Yes
DB00705,Delavirdine,DB01394,Colchicine,0.9585211277008057,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Delavirdine.,73,Type_73,Yes
DB00788,Naproxen,DB09288,Propacetamol,0.9963817596435547,49,Type_49,The risk or severity of adverse effects can be increased when Naproxen is combined with Propacetamol.,49,Type_49,Yes
DB00310,Chlorthalidone,DB00876,Eprosartan,0.9642379879951477,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Eprosartan.,49,Type_49,Yes
DB08938,Magaldrate,DB11921,Deflazacort,0.9902302622795105,3,Type_3,The bioavailability of Deflazacort can be decreased when combined with Magaldrate.,3,Type_3,Yes
DB00404,Alprazolam,DB06201,Rufinamide,0.9949695467948914,49,Type_49,The risk or severity of adverse effects can be increased when Alprazolam is combined with Rufinamide.,49,Type_49,Yes
DB00646,Nystatin,DB04743,Nimesulide,0.993147075176239,49,Type_49,The risk or severity of adverse effects can be increased when Nystatin is combined with Nimesulide.,49,Type_49,Yes
DB01093,Dimethyl sulfoxide,DB01095,Fluvastatin,0.6613548994064331,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Dimethyl sulfoxide.,73,Type_73,No
DB00849,Methylphenobarbital,DB11148,Butamben,0.9991113543510437,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butamben.,49,Type_49,Yes
DB00794,Primidone,DB00996,Gabapentin,0.7873315811157227,49,Type_49,The risk or severity of adverse effects can be increased when Primidone is combined with Gabapentin.,49,Type_49,Yes
DB00283,Clemastine,DB01115,Nifedipine,0.9376605749130249,47,Type_47,The metabolism of Nifedipine can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00227,Lovastatin,DB01041,Thalidomide,0.8580801486968994,47,Type_47,The metabolism of Thalidomide can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00688,Mycophenolate mofetil,DB01397,Magnesium salicylate,0.9987121820449829,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Magnesium salicylate.,49,Type_49,Yes
DB00681,Amphotericin B,DB00873,Loteprednol,0.9840459823608398,83,Type_83,Amphotericin B may increase the hypokalemic activities of Loteprednol.,83,Type_83,Yes
DB00451,Levothyroxine,DB00564,Carbamazepine,0.6970403790473938,4,Type_4,The metabolism of Carbamazepine can be increased when combined with Levothyroxine.,75,Type_75,No
DB00476,Duloxetine,DB01233,Metoclopramide,0.7515952587127686,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Metoclopramide.,49,Type_49,Yes
DB00395,Carisoprodol,DB01236,Sevoflurane,0.9538552165031433,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Sevoflurane.,49,Type_49,Yes
DB01609,Deferasirox,DB08820,Ivacaftor,0.9617331624031067,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Deferasirox.,75,Type_75,No
DB00467,Enoxacin,DB01120,Gliclazide,0.9977109432220459,9,Type_9,Enoxacin may increase the hypoglycemic activities of Gliclazide.,9,Type_9,Yes
DB00189,Ethchlorvynol,DB01221,Ketamine,0.9998263716697693,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Ketamine.,49,Type_49,Yes
DB01155,Gemifloxacin,DB09215,Droxicam,0.9970968961715698,27,Type_27,Gemifloxacin may increase the neuroexcitatory activities of Droxicam.,27,Type_27,Yes
DB00349,Clobazam,DB01184,Domperidone,0.9187709093093872,47,Type_47,The metabolism of Domperidone can be decreased when combined with Clobazam.,47,Type_47,Yes
DB06016,Cariprazine,DB09048,Netupitant,0.9446101784706116,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Cariprazine.,73,Type_73,Yes
DB00177,Valsartan,DB00744,Zileuton,0.5831016302108765,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Zileuton.,47,Type_47,No
DB01232,Saquinavir,DB01559,Clotiazepam,0.757815420627594,47,Type_47,The metabolism of Clotiazepam can be decreased when combined with Saquinavir.,47,Type_47,Yes
DB00977,Ethinylestradiol,DB08970,Fluprednidene,0.9955081939697266,73,Type_73,The serum concentration of Fluprednidene can be increased when it is combined with Ethinylestradiol.,73,Type_73,Yes
DB00206,Reserpine,DB00418,Secobarbital,0.6819233894348145,49,Type_49,The risk or severity of adverse effects can be increased when Reserpine is combined with Secobarbital.,49,Type_49,Yes
DB00590,Doxazosin,DB00808,Indapamide,0.6763168573379517,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Indapamide.,49,Type_49,Yes
DB01173,Orphenadrine,DB09017,Brotizolam,0.9796481728553772,16,Type_16,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.,16,Type_16,Yes
DB00296,Ropivacaine,DB01072,Atazanavir,0.8548818230628967,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00635,Prednisone,DB01261,Sitagliptin,0.9327922463417053,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone.,70,Type_70,Yes
DB06589,Pazopanib,DB06663,Pasireotide,0.5364384055137634,20,Type_20,Pazopanib may increase the QTc-prolonging activities of Pasireotide.,20,Type_20,Yes
DB00846,Flurandrenolide,DB05521,Telaprevir,0.9327602982521057,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Flurandrenolide.,75,Type_75,No
DB00278,Argatroban,DB08865,Crizotinib,0.9010685086250305,47,Type_47,The metabolism of Crizotinib can be decreased when combined with Argatroban.,47,Type_47,Yes
DB00166,Lipoic acid,DB00914,Phenformin,0.7308045625686646,9,Type_9,Lipoic acid may increase the hypoglycemic activities of Phenformin.,9,Type_9,Yes
DB00436,Bendroflumethiazide,DB01175,Escitalopram,0.9817312955856323,55,Type_55,Bendroflumethiazide may increase the hyponatremic activities of Escitalopram.,55,Type_55,Yes
DB00622,Nicardipine,DB01091,Butenafine,0.8161895871162415,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Butenafine.,49,Type_49,Yes
DB00178,Ramipril,DB00531,Cyclophosphamide,0.5757814049720764,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Cyclophosphamide.,49,Type_49,Yes
DB00189,Ethchlorvynol,DB00472,Fluoxetine,0.9671646952629089,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Fluoxetine.,49,Type_49,Yes
DB01136,Carvedilol,DB01435,Antipyrine,0.9924151301383972,37,Type_37,Carvedilol may decrease the antihypertensive activities of Antipyrine.,37,Type_37,Yes
DB00297,Bupivacaine,DB00705,Delavirdine,0.790677547454834,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB00599,Thiopental,DB08872,Gabapentin enacarbil,0.9999021291732788,49,Type_49,The risk or severity of adverse effects can be increased when Thiopental is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB01595,Nitrazepam,DB05246,Methsuximide,0.9985707998275757,49,Type_49,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Methsuximide.,49,Type_49,Yes
DB00959,Methylprednisolone,DB09038,Empagliflozin,0.9829968214035034,70,Type_70,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Methylprednisolone.,70,Type_70,Yes
DB01104,Sertraline,DB04871,Lorcaserin,0.8618922829627991,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Sertraline.,49,Type_49,No
DB01233,Metoclopramide,DB01463,Fencamfamin,0.8536015748977661,49,Type_49,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Fencamfamin.,49,Type_49,Yes
DB06697,Artemether,DB09054,Idelalisib,0.7572360634803772,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Artemether.,47,Type_47,Yes
DB01175,Escitalopram,DB06603,Panobinostat,0.8215916752815247,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Escitalopram.,73,Type_73,Yes
DB00722,Lisinopril,DB08439,Parecoxib,0.8933513760566711,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Parecoxib.,49,Type_49,Yes
DB01090,Pentolinium,DB01168,Procarbazine,0.8835716247558594,60,Type_60,Pentolinium may increase the hypotensive activities of Procarbazine.,60,Type_60,Yes
DB00531,Cyclophosphamide,DB01685,Topiroxostat,0.9914736747741699,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Cyclophosphamide.,47,Type_47,Yes
DB00884,Risedronic acid,DB01082,Streptomycin,0.9988595247268677,24,Type_24,Risedronic acid may increase the hypocalcemic activities of Streptomycin.,24,Type_24,Yes
DB01138,Sulfinpyrazone,DB08820,Ivacaftor,0.9839156270027161,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Sulfinpyrazone.,73,Type_73,Yes
DB00189,Ethchlorvynol,DB00490,Buspirone,0.9978592991828918,49,Type_49,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Buspirone.,49,Type_49,Yes
DB04572,Thiotepa,DB09054,Idelalisib,0.8680383563041687,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Thiotepa.,47,Type_47,Yes
DB00184,Nicotine,DB04868,Nilotinib,0.894123911857605,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Nicotine.,47,Type_47,Yes
DB01275,Hydralazine,DB04552,Niflumic acid,0.867158055305481,37,Type_37,Hydralazine may decrease the antihypertensive activities of Niflumic acid.,37,Type_37,Yes
DB00648,Mitotane,DB00736,Esomeprazole,0.9902818202972412,75,Type_75,The serum concentration of Esomeprazole can be decreased when it is combined with Mitotane.,75,Type_75,Yes
DB00328,Indomethacin,DB00749,Etodolac,0.9919556379318237,49,Type_49,The risk or severity of adverse effects can be increased when Indomethacin is combined with Etodolac.,49,Type_49,Yes
DB01037,Selegiline,DB01209,Dezocine,0.9834361672401428,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Dezocine.,49,Type_49,Yes
DB00270,Isradipine,DB02513,Thymol,0.9468132257461548,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Thymol.,49,Type_49,Yes
DB00571,Propranolol,DB00765,Metyrosine,0.9987687468528748,60,Type_60,Propranolol may increase the hypotensive activities of Metyrosine.,60,Type_60,Yes
DB00717,Norethisterone,DB12598,Nafamostat,0.600338876247406,70,Type_70,The therapeutic efficacy of Nafamostat can be decreased when used in combination with Norethisterone.,70,Type_70,Yes
DB00288,Amcinonide,DB01072,Atazanavir,0.8645034432411194,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Amcinonide.,73,Type_73,Yes
DB00238,Nevirapine,DB09297,Paritaprevir,0.8676178455352783,4,Type_4,The metabolism of Paritaprevir can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00866,Alprenolol,DB01009,Ketoprofen,0.9962224960327148,37,Type_37,Alprenolol may decrease the antihypertensive activities of Ketoprofen.,37,Type_37,Yes
DB00371,Meprobamate,DB01567,Fludiazepam,0.9958574175834656,49,Type_49,The risk or severity of adverse effects can be increased when Meprobamate is combined with Fludiazepam.,49,Type_49,Yes
DB00502,Haloperidol,DB13783,Acemetacin,0.4226461350917816,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Haloperidol.,49,Type_49,No
DB00819,Acetazolamide,DB00937,Diethylpropion,0.9584441781044006,72,Type_72,Acetazolamide may decrease the excretion rate of Diethylpropion which could result in a higher serum level.,72,Type_72,Yes
DB00619,Imatinib,DB06654,Safinamide,0.9881083369255066,47,Type_47,The metabolism of Safinamide can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00409,Remoxipride,DB00575,Clonidine,0.9343982338905334,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Clonidine.,49,Type_49,Yes
DB04272,Citric acid,DB09212,Loxoprofen,0.9986585378646851,6,Type_6,Citric acid may increase the anticoagulant activities of Loxoprofen.,6,Type_6,Yes
DB00753,Isoflurane,DB01209,Dezocine,0.9935994148254395,49,Type_49,The risk or severity of adverse effects can be increased when Isoflurane is combined with Dezocine.,49,Type_49,Yes
DB01588,Prazepam,DB06700,Desvenlafaxine,0.9884968996047974,49,Type_49,The risk or severity of adverse effects can be increased when Prazepam is combined with Desvenlafaxine.,49,Type_49,Yes
DB00162,Vitamin A,DB00982,Isotretinoin,0.9895248413085938,70,Type_70,The therapeutic efficacy of Isotretinoin can be decreased when used in combination with Vitamin A.,49,Type_49,No
DB00261,Anagrelide,DB00358,Mefloquine,0.9833903908729553,20,Type_20,Anagrelide may increase the QTc-prolonging activities of Mefloquine.,20,Type_20,Yes
DB06210,Eltrombopag,DB08860,Pitavastatin,0.864799439907074,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Eltrombopag.,73,Type_73,Yes
DB00820,Tadalafil,DB06268,Sitaxentan,0.9780514240264893,10,Type_10,Tadalafil may increase the antihypertensive activities of Sitaxentan.,10,Type_10,Yes
DB00484,Brimonidine,DB00584,Enalapril,0.9362114071846008,10,Type_10,Brimonidine may increase the antihypertensive activities of Enalapril.,10,Type_10,Yes
DB00273,Topiramate,DB00323,Tolcapone,0.9470910429954529,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Tolcapone.,49,Type_49,Yes
DB00605,Sulindac,DB04552,Niflumic acid,0.999096155166626,49,Type_49,The risk or severity of adverse effects can be increased when Sulindac is combined with Niflumic acid.,49,Type_49,Yes
DB00436,Bendroflumethiazide,DB01193,Acebutolol,0.28024205565452576,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Acebutolol.,49,Type_49,Yes
DB00673,Aprepitant,DB08820,Ivacaftor,0.9997130036354065,73,Type_73,The serum concentration of Ivacaftor can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00511,Acetyldigitoxin,DB01021,Trichlormethiazide,0.8493748903274536,49,Type_49,The risk or severity of adverse effects can be increased when Acetyldigitoxin is combined with Trichlormethiazide.,49,Type_49,Yes
DB00854,Levorphanol,DB00897,Triazolam,0.9770562052726746,49,Type_49,The risk or severity of adverse effects can be increased when Levorphanol is combined with Triazolam.,49,Type_49,Yes
DB06402,Telavancin,DB06603,Panobinostat,1.0,20,Type_20,Telavancin may increase the QTc-prolonging activities of Panobinostat.,20,Type_20,Yes
DB00196,Fluconazole,DB00420,Promazine,0.5578927993774414,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Promazine.,47,Type_47,No
DB01155,Gemifloxacin,DB06402,Telavancin,0.9999980926513672,20,Type_20,Gemifloxacin may increase the QTc-prolonging activities of Telavancin.,20,Type_20,Yes
DB00320,Dihydroergotamine,DB01595,Nitrazepam,0.6313059329986572,47,Type_47,The metabolism of Nitrazepam can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00844,Nalbuphine,DB09286,Pipamperone,0.9881646633148193,49,Type_49,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pipamperone.,49,Type_49,Yes
DB01188,Ciclopirox,DB01268,Sunitinib,0.6181290745735168,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Ciclopirox.,47,Type_47,No
DB00770,Alprostadil,DB13167,Alclofenac,0.881041944026947,70,Type_70,The therapeutic efficacy of Alclofenac can be decreased when used in combination with Alprostadil.,70,Type_70,Yes
DB00934,Maprotiline,DB09330,Osimertinib,0.8930662870407104,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Maprotiline.,75,Type_75,No
DB00296,Ropivacaine,DB01029,Irbesartan,0.42598026990890503,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Ropivacaine.,49,Type_49,No
DB06781,Difluprednate,DB09281,Magnesium trisilicate,0.9991907477378845,3,Type_3,The bioavailability of Magnesium trisilicate can be decreased when combined with Difluprednate.,3,Type_3,Yes
DB06154,Pentaerythritol tetranitrate,DB08954,Ifenprodil,0.9999406337738037,6,Type_6,Pentaerythritol tetranitrate may increase the anticoagulant activities of Ifenprodil.,6,Type_6,Yes
DB00628,Clorazepic acid,DB01142,Doxepin,0.993362545967102,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Doxepin.,49,Type_49,Yes
DB01320,Fosphenytoin,DB06594,Agomelatine,0.8522888422012329,49,Type_49,The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Agomelatine.,49,Type_49,Yes
DB00628,Clorazepic acid,DB13872,Lormetazepam,0.9992344379425049,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Lormetazepam.,49,Type_49,Yes
DB01104,Sertraline,DB06176,Romidepsin,0.5386725068092346,47,Type_47,The metabolism of Romidepsin can be decreased when combined with Sertraline.,47,Type_47,Yes
DB06335,Saxagliptin,DB09063,Ceritinib,0.9494365453720093,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Saxagliptin.,73,Type_73,Yes
DB01135,Doxacurium,DB09093,Chlortetracycline,1.0,21,Type_21,Doxacurium may increase the neuromuscular blocking activities of Chlortetracycline.,21,Type_21,Yes
DB00681,Amphotericin B,DB01047,Fluocinonide,0.9843249320983887,83,Type_83,Amphotericin B may increase the hypokalemic activities of Fluocinonide.,83,Type_83,Yes
DB00214,Torasemide,DB01274,Arformoterol,0.9756739139556885,83,Type_83,Torasemide may increase the hypokalemic activities of Arformoterol.,83,Type_83,Yes
DB01054,Nitrendipine,DB09031,Miltefosine,0.8477165699005127,49,Type_49,The risk or severity of adverse effects can be increased when Nitrendipine is combined with Miltefosine.,49,Type_49,Yes
DB00771,Clidinium,DB01353,Butobarbital,0.9999992847442627,49,Type_49,The risk or severity of adverse effects can be increased when Clidinium is combined with Butobarbital.,49,Type_49,Yes
DB00420,Promazine,DB01267,Paliperidone,0.858540415763855,20,Type_20,Promazine may increase the QTc-prolonging activities of Paliperidone.,49,Type_49,No
DB00553,Methoxsalen,DB08873,Boceprevir,0.8548216223716736,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Methoxsalen.,47,Type_47,Yes
DB00349,Clobazam,DB00907,Cocaine,0.8010771870613098,47,Type_47,The metabolism of Cocaine can be decreased when combined with Clobazam.,49,Type_49,No
DB00294,Etonogestrel,DB00686,Pentosan polysulfate,0.9954158067703247,70,Type_70,The therapeutic efficacy of Pentosan polysulfate can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00655,Estrone,DB00764,Mometasone,0.9706873297691345,73,Type_73,The serum concentration of Mometasone can be increased when it is combined with Estrone.,73,Type_73,Yes
DB00298,Dapiprazole,DB01365,Mephentermine,0.9999667406082153,61,Type_61,Dapiprazole may decrease the stimulatory activities of Mephentermine.,61,Type_61,Yes
DB00502,Haloperidol,DB08901,Ponatinib,0.9591553807258606,47,Type_47,The metabolism of Ponatinib can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB01045,Rifampicin,DB06403,Ambrisentan,0.951435387134552,4,Type_4,The metabolism of Ambrisentan can be increased when combined with Rifampicin.,4,Type_4,Yes
DB09093,Chlortetracycline,DB09147,Ferric pyrophosphate,0.8963702321052551,75,Type_75,The serum concentration of Ferric pyrophosphate can be decreased when it is combined with Chlortetracycline.,67,Type_67,No
DB00196,Fluconazole,DB04844,Tetrabenazine,0.9405619502067566,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Tetrabenazine.,20,Type_20,Yes
DB08905,Formestane,DB09218,Clonixin,0.9967965483665466,49,Type_49,The risk or severity of adverse effects can be increased when Formestane is combined with Clonixin.,49,Type_49,Yes
DB01058,Praziquantel,DB09048,Netupitant,0.979935884475708,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Praziquantel.,73,Type_73,Yes
DB00313,Valproic acid,DB06697,Artemether,0.5274508595466614,47,Type_47,The metabolism of Artemether can be decreased when combined with Valproic acid.,47,Type_47,Yes
DB00615,Rifabutin,DB06148,Mianserin,0.38138487935066223,75,Type_75,The serum concentration of Mianserin can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00842,Oxazepam,DB01002,Levobupivacaine,0.9551532864570618,49,Type_49,The risk or severity of adverse effects can be increased when Oxazepam is combined with Levobupivacaine.,49,Type_49,Yes
DB00641,Simvastatin,DB08893,Mirabegron,0.5739218592643738,47,Type_47,The metabolism of Mirabegron can be decreased when combined with Simvastatin.,47,Type_47,Yes
DB00289,Atomoxetine,DB09026,Aliskiren,0.9593580961227417,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB01275,Hydralazine,DB04951,Pirfenidone,0.92264723777771,37,Type_37,Hydralazine may decrease the antihypertensive activities of Pirfenidone.,37,Type_37,Yes
DB09118,Stiripentol,DB12332,Rucaparib,0.7573999166488647,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Stiripentol.,73,Type_73,Yes
DB06738,Ketobemidone,DB11106,Pamabrom,0.9990090131759644,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pamabrom.,49,Type_49,Yes
DB00606,Cyclothiazide,DB01452,Diamorphine,0.9813774228096008,49,Type_49,The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Diamorphine.,49,Type_49,Yes
DB09080,Olodaterol,DB12332,Rucaparib,0.9635698795318604,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Olodaterol.,47,Type_47,Yes
DB00755,Tretinoin,DB00774,Hydroflumethiazide,0.9865230917930603,49,Type_49,The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydroflumethiazide.,49,Type_49,Yes
DB09449,"Sodium phosphate, monobasic",DB11093,Calcium citrate,0.7200733423233032,67,Type_67,"Sodium phosphate, monobasic can cause a decrease in the absorption of Calcium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.",67,Type_67,Yes
DB00900,Didanosine,DB06820,Sulconazole,0.8777802586555481,67,Type_67,Didanosine can cause a decrease in the absorption of Sulconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00653,Magnesium sulfate,DB01028,Methoxyflurane,0.7305892109870911,16,Type_16,Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.,16,Type_16,Yes
DB01067,Glipizide,DB01295,Bevantolol,0.9998260140419006,9,Type_9,Glipizide may increase the hypoglycemic activities of Bevantolol.,9,Type_9,Yes
DB00799,Tazarotene,DB08880,Teriflunomide,0.41513654589653015,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Tazarotene.,47,Type_47,No
DB00960,Pindolol,DB01169,Arsenic trioxide,0.6144071817398071,49,Type_49,The risk or severity of adverse effects can be increased when Pindolol is combined with Arsenic trioxide.,49,Type_49,Yes
DB01103,Quinacrine,DB06636,Isavuconazonium,0.8030722141265869,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Quinacrine.,47,Type_47,Yes
DB00677,Isoflurophate,DB01580,Oxprenolol,0.9565806984901428,54,Type_54,Isoflurophate may increase the bradycardic activities of Oxprenolol.,54,Type_54,Yes
DB01392,Yohimbine,DB09039,Eliglustat,0.9875806570053101,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Yohimbine.,47,Type_47,Yes
DB00391,Sulpiride,DB00555,Lamotrigine,0.9941073656082153,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Lamotrigine.,49,Type_49,Yes
DB00762,Irinotecan,DB01656,Roflumilast,0.9940939545631409,34,Type_34,Irinotecan may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00790,Perindopril,DB00864,Tacrolimus,0.630911111831665,73,Type_73,The serum concentration of Tacrolimus can be increased when it is combined with Perindopril.,47,Type_47,No
DB00177,Valsartan,DB00474,Methohexital,0.737941563129425,60,Type_60,Valsartan may increase the hypotensive activities of Methohexital.,60,Type_60,Yes
DB00458,Imipramine,DB09017,Brotizolam,0.9995129108428955,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Brotizolam.,49,Type_49,Yes
DB00222,Glimepiride,DB00705,Delavirdine,0.6407460570335388,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Glimepiride.,47,Type_47,Yes
DB01078,Deslanoside,DB01262,Decitabine,0.9999927282333374,58,Type_58,Deslanoside may decrease the cardiotoxic activities of Decitabine.,58,Type_58,Yes
DB00715,Paroxetine,DB01614,Acepromazine,0.7910040020942688,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Acepromazine.,49,Type_49,Yes
DB00850,Perphenazine,DB13025,Tiapride,0.9991084933280945,49,Type_49,The risk or severity of adverse effects can be increased when Perphenazine is combined with Tiapride.,49,Type_49,Yes
DB01111,Colistimethate,DB13450,Cisatracurium besylate,1.0,21,Type_21,Colistimethate may increase the neuromuscular blocking activities of Cisatracurium besylate.,21,Type_21,Yes
DB00999,Hydrochlorothiazide,DB01324,Polythiazide,0.8608971834182739,60,Type_60,Hydrochlorothiazide may increase the hypotensive activities of Polythiazide.,60,Type_60,Yes
DB00723,Methoxamine,DB00935,Oxymetazoline,0.9997190833091736,49,Type_49,The risk or severity of adverse effects can be increased when Methoxamine is combined with Oxymetazoline.,49,Type_49,Yes
DB00865,Benzphetamine,DB01193,Acebutolol,0.9774068593978882,25,Type_25,Benzphetamine may increase the atrioventricular blocking (AV block) activities of Acebutolol.,25,Type_25,Yes
DB01072,Atazanavir,DB01251,Gliquidone,0.733617901802063,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Atazanavir.,70,Type_70,Yes
DB00850,Perphenazine,DB00976,Telithromycin,0.6664807796478271,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Perphenazine.,47,Type_47,Yes
DB00452,Framycetin,DB00529,Foscarnet,0.9999924898147583,57,Type_57,Framycetin may increase the nephrotoxic activities of Foscarnet.,57,Type_57,Yes
DB09118,Stiripentol,DB11730,Ribociclib,0.9721316695213318,73,Type_73,The serum concentration of Ribociclib can be increased when it is combined with Stiripentol.,73,Type_73,Yes
DB00967,Desloratadine,DB01255,Lisdexamfetamine,0.999956488609314,76,Type_76,Desloratadine may decrease the sedative activities of Lisdexamfetamine.,76,Type_76,Yes
DB00193,Tramadol,DB09166,Etizolam,0.990050196647644,49,Type_49,The risk or severity of adverse effects can be increased when Tramadol is combined with Etizolam.,49,Type_49,Yes
DB00196,Fluconazole,DB01182,Propafenone,0.5016502141952515,20,Type_20,Fluconazole may increase the QTc-prolonging activities of Propafenone.,73,Type_73,No
DB00645,Dyclonine,DB06594,Agomelatine,0.9999834299087524,49,Type_49,The risk or severity of adverse effects can be increased when Dyclonine is combined with Agomelatine.,49,Type_49,Yes
DB00487,Pefloxacin,DB00573,Fenoprofen,0.9989481568336487,27,Type_27,Pefloxacin may increase the neuroexcitatory activities of Fenoprofen.,27,Type_27,Yes
DB00809,Tropicamide,DB06738,Ketobemidone,0.9999805688858032,49,Type_49,The risk or severity of adverse effects can be increased when Tropicamide is combined with Ketobemidone.,49,Type_49,Yes
DB00266,Dicoumarol,DB00438,Ceftazidime,0.9999265670776367,6,Type_6,Dicoumarol may increase the anticoagulant activities of Ceftazidime.,6,Type_6,Yes
DB00207,Azithromycin,DB00266,Dicoumarol,0.4687022566795349,73,Type_73,The serum concentration of Dicoumarol can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00208,Ticlopidine,DB00582,Voriconazole,0.8030064105987549,47,Type_47,The metabolism of Voriconazole can be decreased when combined with Ticlopidine.,47,Type_47,Yes
DB01095,Fluvastatin,DB01609,Deferasirox,0.7101230025291443,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Fluvastatin.,75,Type_75,Yes
DB00796,Candesartan cilexetil,DB08984,Etofenamate,0.9484767317771912,49,Type_49,The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Etofenamate.,49,Type_49,Yes
DB00727,Nitroglycerin,DB01240,Epoprostenol,0.9659749865531921,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Epoprostenol.,49,Type_49,Yes
DB00266,Dicoumarol,DB00779,Nalidixic acid,0.9784328937530518,6,Type_6,Dicoumarol may increase the anticoagulant activities of Nalidixic acid.,6,Type_6,Yes
DB01065,Melatonin,DB01095,Fluvastatin,0.586080014705658,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Melatonin.,47,Type_47,No
DB00673,Aprepitant,DB04868,Nilotinib,0.8908100128173828,73,Type_73,The serum concentration of Nilotinib can be increased when it is combined with Aprepitant.,73,Type_73,Yes
DB00741,Hydrocortisone,DB06589,Pazopanib,0.8181024193763733,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Hydrocortisone.,73,Type_73,Yes
DB01065,Melatonin,DB13872,Lormetazepam,0.9999858140945435,49,Type_49,The risk or severity of adverse effects can be increased when Melatonin is combined with Lormetazepam.,49,Type_49,Yes
DB00469,Tenoxicam,DB06414,Etravirine,0.9227020144462585,47,Type_47,The metabolism of Etravirine can be decreased when combined with Tenoxicam.,47,Type_47,Yes
DB00872,Conivaptan,DB09477,Enalaprilat,0.5227912664413452,73,Type_73,The serum concentration of Enalaprilat can be increased when it is combined with Conivaptan.,49,Type_49,No
DB00481,Raloxifene,DB09073,Palbociclib,0.9920613765716553,73,Type_73,The serum concentration of Palbociclib can be increased when it is combined with Raloxifene.,73,Type_73,Yes
DB00482,Celecoxib,DB00530,Erlotinib,0.9382631182670593,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB01551,Dihydrocodeine,DB09039,Eliglustat,0.6179237961769104,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Dihydrocodeine.,47,Type_47,Yes
DB01367,Rasagiline,DB01623,Thiothixene,0.9488738775253296,49,Type_49,The risk or severity of adverse effects can be increased when Rasagiline is combined with Thiothixene.,49,Type_49,Yes
DB00425,Zolpidem,DB00477,Chlorpromazine,0.9872357249259949,16,Type_16,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.,16,Type_16,Yes
DB00783,Estradiol,DB01201,Rifapentine,0.8692627549171448,4,Type_4,The metabolism of Rifapentine can be increased when combined with Estradiol.,4,Type_4,Yes
DB00582,Voriconazole,DB01047,Fluocinonide,0.9759657382965088,73,Type_73,The serum concentration of Fluocinonide can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB01026,Ketoconazole,DB01349,Tasosartan,0.9788885712623596,47,Type_47,The metabolism of Tasosartan can be decreased when combined with Ketoconazole.,47,Type_47,Yes
DB00290,Bleomycin,DB01078,Deslanoside,0.9995321035385132,58,Type_58,Bleomycin may decrease the cardiotoxic activities of Deslanoside.,58,Type_58,Yes
DB00727,Nitroglycerin,DB01359,Penbutolol,0.9999709129333496,49,Type_49,The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Penbutolol.,49,Type_49,Yes
DB00610,Metaraminol,DB01193,Acebutolol,0.9484897255897522,49,Type_49,The risk or severity of adverse effects can be increased when Metaraminol is combined with Acebutolol.,49,Type_49,Yes
DB00315,Zolmitriptan,DB08880,Teriflunomide,0.40802034735679626,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Zolmitriptan.,75,Type_75,No
DB00310,Chlorthalidone,DB00584,Enalapril,0.8904623985290527,49,Type_49,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Enalapril.,49,Type_49,Yes
DB00307,Bexarotene,DB01201,Rifapentine,0.8481770157814026,4,Type_4,The metabolism of Rifapentine can be increased when combined with Bexarotene.,4,Type_4,Yes
DB00880,Chlorothiazide,DB01407,Clenbuterol,0.9997722506523132,83,Type_83,Chlorothiazide may increase the hypokalemic activities of Clenbuterol.,83,Type_83,Yes
DB00945,Acetylsalicylic acid,DB09095,Difluocortolone,0.9994519352912903,49,Type_49,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Difluocortolone.,49,Type_49,Yes
DB00774,Hydroflumethiazide,DB00914,Phenformin,0.9989057779312134,70,Type_70,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydroflumethiazide.,70,Type_70,Yes
DB00409,Remoxipride,DB09128,Brexpiprazole,0.9718915820121765,49,Type_49,The risk or severity of adverse effects can be increased when Remoxipride is combined with Brexpiprazole.,49,Type_49,Yes
DB00834,Mifepristone,DB01067,Glipizide,0.5469256043434143,9,Type_9,Mifepristone may increase the hypoglycemic activities of Glipizide.,73,Type_73,No
DB00273,Topiramate,DB00623,Fluphenazine,0.9718524813652039,49,Type_49,The risk or severity of adverse effects can be increased when Topiramate is combined with Fluphenazine.,49,Type_49,Yes
DB06216,Asenapine,DB08912,Dabrafenib,0.8737478852272034,75,Type_75,The serum concentration of Dabrafenib can be decreased when it is combined with Asenapine.,75,Type_75,Yes
DB00964,Apraclonidine,DB01235,Levodopa,0.9993690848350525,30,Type_30,Apraclonidine may increase the orthostatic hypotensive activities of Levodopa.,30,Type_30,Yes
DB01029,Irbesartan,DB09026,Aliskiren,0.6163586974143982,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Aliskiren.,68,Type_68,No
DB00918,Almotriptan,DB09120,Zucapsaicin,0.9923567771911621,47,Type_47,The metabolism of Zucapsaicin can be decreased when combined with Almotriptan.,47,Type_47,Yes
DB00268,Ropinirole,DB01168,Procarbazine,0.7590702772140503,47,Type_47,The metabolism of Procarbazine can be decreased when combined with Ropinirole.,47,Type_47,Yes
DB00468,Quinine,DB00570,Vinblastine,0.8768521547317505,47,Type_47,The metabolism of Vinblastine can be decreased when combined with Quinine.,47,Type_47,Yes
DB01018,Guanfacine,DB01169,Arsenic trioxide,0.8683816194534302,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Arsenic trioxide.,49,Type_49,Yes
DB01046,Lubiprostone,DB06737,Zaltoprofen,0.9998124241828918,70,Type_70,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Lubiprostone.,70,Type_70,Yes
DB00224,Indinavir,DB01319,Fosamprenavir,0.5455986261367798,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00462,Methscopolamine bromide,DB00611,Butorphanol,0.9999516010284424,49,Type_49,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Butorphanol.,49,Type_49,Yes
DB00672,Chlorpropamide,DB01357,Mestranol,0.6136906743049622,70,Type_70,The therapeutic efficacy of Mestranol can be decreased when used in combination with Chlorpropamide.,70,Type_70,Yes
DB00188,Bortezomib,DB01234,Dexamethasone,0.9105167388916016,47,Type_47,The metabolism of Dexamethasone can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00615,Rifabutin,DB09216,Tolfenamic acid,0.7408478260040283,4,Type_4,The metabolism of Tolfenamic acid can be increased when combined with Rifabutin.,75,Type_75,No
DB00932,Tipranavir,DB01177,Idarubicin,0.7074764370918274,47,Type_47,The metabolism of Idarubicin can be decreased when combined with Tipranavir.,47,Type_47,Yes
DB00696,Ergotamine,DB00726,Trimipramine,0.6814244985580444,37,Type_37,Ergotamine may decrease the antihypertensive activities of Trimipramine.,37,Type_37,Yes
DB00482,Celecoxib,DB00946,Phenprocoumon,0.9985685348510742,6,Type_6,Celecoxib may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00238,Nevirapine,DB00687,Fludrocortisone,0.7902877330780029,75,Type_75,The serum concentration of Fludrocortisone can be decreased when it is combined with Nevirapine.,75,Type_75,Yes
DB01009,Ketoprofen,DB06781,Difluprednate,0.9997166991233826,49,Type_49,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Difluprednate.,49,Type_49,Yes
DB00821,Carprofen,DB01177,Idarubicin,0.9994434714317322,72,Type_72,Carprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level.,72,Type_72,Yes
DB00179,Masoprocol,DB06725,Lornoxicam,0.9986282587051392,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Lornoxicam.,49,Type_49,Yes
DB00337,Pimecrolimus,DB01149,Nefazodone,0.7537509202957153,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Pimecrolimus.,47,Type_47,Yes
DB00808,Indapamide,DB05521,Telaprevir,0.8632422089576721,47,Type_47,The metabolism of Telaprevir can be decreased when combined with Indapamide.,47,Type_47,Yes
DB00391,Sulpiride,DB00802,Alfentanil,0.9986879229545593,49,Type_49,The risk or severity of adverse effects can be increased when Sulpiride is combined with Alfentanil.,49,Type_49,Yes
DB00461,Nabumetone,DB01340,Cilazapril,0.9135341048240662,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Cilazapril.,49,Type_49,Yes
DB00661,Verapamil,DB01224,Quetiapine,0.7277093529701233,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Verapamil.,49,Type_49,No
DB00344,Protriptyline,DB00402,Eszopiclone,0.9857499599456787,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Eszopiclone.,49,Type_49,Yes
DB00195,Betaxolol,DB00726,Trimipramine,0.5698612928390503,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00898,Ethanol,DB01289,Glisoxepide,0.40096157789230347,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Glisoxepide.,49,Type_49,Yes
DB00281,Lidocaine,DB06616,Bosutinib,0.8729311227798462,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Lidocaine.,73,Type_73,Yes
DB01551,Dihydrocodeine,DB06690,Nitrous oxide,0.9983812570571899,49,Type_49,The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Nitrous oxide.,49,Type_49,Yes
DB00313,Valproic acid,DB00660,Metaxalone,0.9189096093177795,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Metaxalone.,49,Type_49,Yes
DB00243,Ranolazine,DB05521,Telaprevir,0.6541814804077148,73,Type_73,The serum concentration of Telaprevir can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00481,Raloxifene,DB01263,Posaconazole,0.9564056396484375,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00394,Beclomethasone dipropionate,DB00805,Minaprine,0.8596007227897644,49,Type_49,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Minaprine.,49,Type_49,Yes
DB00934,Maprotiline,DB01106,Levocabastine,0.999984860420227,49,Type_49,The risk or severity of adverse effects can be increased when Maprotiline is combined with Levocabastine.,49,Type_49,Yes
DB00669,Sumatriptan,DB01626,Pargyline,0.5104286670684814,49,Type_49,The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pargyline.,47,Type_47,No
DB00270,Isradipine,DB00602,Ivermectin,0.9906754493713379,47,Type_47,The metabolism of Ivermectin can be decreased when combined with Isradipine.,47,Type_47,Yes
DB01175,Escitalopram,DB06594,Agomelatine,0.9876254200935364,49,Type_49,The risk or severity of adverse effects can be increased when Escitalopram is combined with Agomelatine.,49,Type_49,Yes
DB00334,Olanzapine,DB06702,Fesoterodine,0.9920469522476196,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Olanzapine.,77,Type_77,Yes
DB00584,Enalapril,DB01167,Itraconazole,0.5095895528793335,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Enalapril.,47,Type_47,Yes
DB00468,Quinine,DB06148,Mianserin,0.9207258224487305,47,Type_47,The metabolism of Mianserin can be decreased when combined with Quinine.,47,Type_47,Yes
DB00608,Chloroquine,DB06697,Artemether,0.7375420928001404,47,Type_47,The metabolism of Artemether can be decreased when combined with Chloroquine.,33,Type_33,No
DB00318,Codeine,DB00647,Dextropropoxyphene,0.9916713237762451,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Dextropropoxyphene.,49,Type_49,Yes
DB00433,Prochlorperazine,DB00575,Clonidine,0.927354633808136,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Clonidine.,49,Type_49,Yes
DB00264,Metoprolol,DB01142,Doxepin,0.6807817220687866,73,Type_73,The serum concentration of Doxepin can be increased when it is combined with Metoprolol.,73,Type_73,Yes
DB00255,Diethylstilbestrol,DB00860,Prednisolone,0.8023176193237305,73,Type_73,The serum concentration of Prednisolone can be increased when it is combined with Diethylstilbestrol.,73,Type_73,Yes
DB00608,Chloroquine,DB09091,Tixocortol,0.9948260188102722,49,Type_49,The risk or severity of adverse effects can be increased when Chloroquine is combined with Tixocortol.,49,Type_49,Yes
DB01156,Bupropion,DB01206,Lomustine,0.9520396590232849,47,Type_47,The metabolism of Lomustine can be decreased when combined with Bupropion.,47,Type_47,Yes
DB00179,Masoprocol,DB00710,Ibandronate,0.9278571605682373,49,Type_49,The risk or severity of adverse effects can be increased when Masoprocol is combined with Ibandronate.,49,Type_49,Yes
DB00816,Orciprenaline,DB01162,Terazosin,0.999764621257782,5,Type_5,Orciprenaline may decrease the vasoconstricting activities of Terazosin.,5,Type_5,Yes
DB00812,Phenylbutazone,DB08822,Azilsartan medoxomil,0.9986528158187866,49,Type_49,The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Azilsartan medoxomil.,49,Type_49,Yes
DB00748,Carbinoxamine,DB01545,Ethyl loflazepate,0.9999723434448242,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Ethyl loflazepate.,49,Type_49,Yes
DB00588,Fluticasone propionate,DB00625,Efavirenz,0.6924228072166443,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Efavirenz.,49,Type_49,Yes
DB00481,Raloxifene,DB04868,Nilotinib,0.9092830419540405,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Raloxifene.,47,Type_47,Yes
DB00433,Prochlorperazine,DB00899,Remifentanil,0.9709320068359375,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Remifentanil.,49,Type_49,Yes
DB00573,Fenoprofen,DB09477,Enalaprilat,0.9079107046127319,49,Type_49,The risk or severity of adverse effects can be increased when Fenoprofen is combined with Enalaprilat.,49,Type_49,Yes
DB00530,Erlotinib,DB01396,Digitoxin,0.985375165939331,58,Type_58,Erlotinib may decrease the cardiotoxic activities of Digitoxin.,58,Type_58,Yes
DB00284,Acarbose,DB01325,Quinethazone,0.999943733215332,70,Type_70,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Acarbose.,70,Type_70,Yes
DB00775,Tirofiban,DB06695,Dabigatran etexilate,0.9863983988761902,6,Type_6,Tirofiban may increase the anticoagulant activities of Dabigatran etexilate.,6,Type_6,Yes
DB00728,Rocuronium,DB01035,Procainamide,0.9998518228530884,21,Type_21,Rocuronium may increase the neuromuscular blocking activities of Procainamide.,21,Type_21,Yes
DB00794,Primidone,DB08828,Vismodegib,0.8389654755592346,4,Type_4,The metabolism of Vismodegib can be increased when combined with Primidone.,4,Type_4,Yes
DB00252,Phenytoin,DB09082,Vilanterol,0.8339603543281555,4,Type_4,The metabolism of Vilanterol can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01601,Lopinavir,DB01708,Prasterone,0.9070688486099243,47,Type_47,The metabolism of Prasterone can be decreased when combined with Lopinavir.,47,Type_47,Yes
DB02546,Vorinostat,DB04946,Iloperidone,0.9481808543205261,20,Type_20,Vorinostat may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB01137,Levofloxacin,DB09063,Ceritinib,0.5226469039916992,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Levofloxacin.,20,Type_20,No
DB00935,Oxymetazoline,DB06764,Tetryzoline,0.7826686501502991,49,Type_49,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Tetryzoline.,49,Type_49,Yes
DB00373,Timolol,DB00975,Dipyridamole,0.805791437625885,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Dipyridamole.,54,Type_54,No
DB00908,Quinidine,DB01324,Polythiazide,0.9406698942184448,73,Type_73,The serum concentration of Polythiazide can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB00678,Losartan,DB01264,Darunavir,0.807925820350647,47,Type_47,The metabolism of Darunavir can be decreased when combined with Losartan.,47,Type_47,Yes
DB00608,Chloroquine,DB08933,Luliconazole,0.9520530700683594,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Chloroquine.,73,Type_73,Yes
DB00966,Telmisartan,DB07615,Tranilast,0.8535568118095398,49,Type_49,The risk or severity of adverse effects can be increased when Telmisartan is combined with Tranilast.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB13231,Calcium lactate,0.996208667755127,72,Type_72,Trichlormethiazide may decrease the excretion rate of Calcium lactate which could result in a higher serum level.,72,Type_72,Yes
DB00684,Tobramycin,DB01396,Digitoxin,0.9180843234062195,75,Type_75,The serum concentration of Digitoxin can be decreased when it is combined with Tobramycin.,75,Type_75,Yes
DB00445,Epirubicin,DB08895,Tofacitinib,0.9962896108627319,34,Type_34,Epirubicin may increase the immunosuppressive activities of Tofacitinib.,34,Type_34,Yes
DB01002,Levobupivacaine,DB01612,Amyl Nitrite,0.9462881684303284,49,Type_49,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Amyl Nitrite.,49,Type_49,Yes
DB00712,Flurbiprofen,DB09063,Ceritinib,0.9920094013214111,73,Type_73,The serum concentration of Ceritinib can be increased when it is combined with Flurbiprofen.,73,Type_73,Yes
DB00335,Atenolol,DB00735,Naftifine,0.9763836860656738,37,Type_37,Atenolol may decrease the antihypertensive activities of Naftifine.,37,Type_37,Yes
DB00356,Chlorzoxazone,DB12532,Oxetacaine,0.9999990463256836,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Oxetacaine.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01194,Brinzolamide,0.7089592814445496,47,Type_47,The metabolism of Brinzolamide can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00327,Hydromorphone,DB01151,Desipramine,0.7695468068122864,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Desipramine.,47,Type_47,No
DB00790,Perindopril,DB08907,Canagliflozin,0.7137231230735779,68,Type_68,Perindopril may increase the hyperkalemic activities of Canagliflozin.,68,Type_68,Yes
DB00501,Cimetidine,DB00675,Tamoxifen,0.9178239703178406,47,Type_47,The metabolism of Tamoxifen can be decreased when combined with Cimetidine.,11,Type_11,No
DB00454,Meperidine,DB00462,Methscopolamine bromide,0.999735414981842,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Methscopolamine bromide.,49,Type_49,Yes
DB00678,Losartan,DB01156,Bupropion,0.9829435348510742,47,Type_47,The metabolism of Bupropion can be decreased when combined with Losartan.,47,Type_47,Yes
DB00557,Hydroxyzine,DB08903,Bedaquiline,0.9835996627807617,20,Type_20,Hydroxyzine may increase the QTc-prolonging activities of Bedaquiline.,20,Type_20,Yes
DB00841,Dobutamine,DB01366,Procaterol,0.998279333114624,49,Type_49,The risk or severity of adverse effects can be increased when Dobutamine is combined with Procaterol.,49,Type_49,Yes
DB00474,Methohexital,DB08931,Riociguat,0.46333715319633484,60,Type_60,Methohexital may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00006,Bivalirudin,DB01399,Salsalate,0.9915596842765808,6,Type_6,Bivalirudin may increase the anticoagulant activities of Salsalate.,6,Type_6,Yes
DB00322,Floxuridine,DB06218,Lacosamide,0.9118462800979614,58,Type_58,Floxuridine may decrease the cardiotoxic activities of Lacosamide.,73,Type_73,No
DB00908,Quinidine,DB01001,Salbutamol,0.9659534096717834,20,Type_20,Quinidine may increase the QTc-prolonging activities of Salbutamol.,20,Type_20,Yes
DB00661,Verapamil,DB00714,Apomorphine,0.866284966468811,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Apomorphine.,49,Type_49,Yes
DB00655,Estrone,DB09218,Clonixin,0.9551684260368347,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Clonixin.,49,Type_49,Yes
DB00444,Teniposide,DB00511,Acetyldigitoxin,0.9986640214920044,58,Type_58,Teniposide may decrease the cardiotoxic activities of Acetyldigitoxin.,58,Type_58,Yes
DB01054,Nitrendipine,DB09245,Toloxatone,0.9969550371170044,60,Type_60,Nitrendipine may increase the hypotensive activities of Toloxatone.,60,Type_60,Yes
DB00838,Clocortolone,DB09215,Droxicam,0.9997095465660095,49,Type_49,The risk or severity of adverse effects can be increased when Clocortolone is combined with Droxicam.,49,Type_49,Yes
DB00688,Mycophenolate mofetil,DB01024,Mycophenolic acid,0.947579562664032,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Mycophenolic acid.,49,Type_49,Yes
DB00612,Bisoprolol,DB06196,Icatibant,0.9045283794403076,37,Type_37,Bisoprolol may decrease the antihypertensive activities of Icatibant.,37,Type_37,Yes
DB00344,Protriptyline,DB01407,Clenbuterol,0.839424729347229,49,Type_49,The risk or severity of adverse effects can be increased when Protriptyline is combined with Clenbuterol.,49,Type_49,Yes
DB01021,Trichlormethiazide,DB06694,Xylometazoline,0.9950556755065918,60,Type_60,Trichlormethiazide may increase the hypotensive activities of Xylometazoline.,60,Type_60,Yes
DB00531,Cyclophosphamide,DB00619,Imatinib,0.47798484563827515,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Imatinib.,15,Type_15,Yes
DB08907,Canagliflozin,DB09279,Fimasartan,0.9036975502967834,49,Type_49,The risk or severity of adverse effects can be increased when Canagliflozin is combined with Fimasartan.,68,Type_68,No
DB00465,Ketorolac,DB00946,Phenprocoumon,0.9999643564224243,6,Type_6,Ketorolac may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00337,Pimecrolimus,DB06802,Nepafenac,0.9986276626586914,49,Type_49,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nepafenac.,49,Type_49,Yes
DB01075,Diphenhydramine,DB01466,Ethylmorphine,0.7594692707061768,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Ethylmorphine.,47,Type_47,No
DB00465,Ketorolac,DB00812,Phenylbutazone,0.9992027878761292,49,Type_49,The risk or severity of adverse effects can be increased when Ketorolac is combined with Phenylbutazone.,49,Type_49,Yes
DB00207,Azithromycin,DB00980,Ramelteon,0.7855443954467773,47,Type_47,The metabolism of Ramelteon can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00227,Lovastatin,DB00295,Morphine,0.7713270783424377,47,Type_47,The metabolism of Morphine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00812,Phenylbutazone,DB04272,Citric acid,0.9983338713645935,6,Type_6,Phenylbutazone may increase the anticoagulant activities of Citric acid.,6,Type_6,Yes
DB00502,Haloperidol,DB00530,Erlotinib,0.9052460193634033,47,Type_47,The metabolism of Erlotinib can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00436,Bendroflumethiazide,DB04552,Niflumic acid,0.9796287417411804,70,Type_70,The therapeutic efficacy of Niflumic acid can be decreased when used in combination with Bendroflumethiazide.,70,Type_70,Yes
DB00715,Paroxetine,DB08872,Gabapentin enacarbil,0.9911114573478699,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00955,Netilmicin,DB01024,Mycophenolic acid,0.981223464012146,72,Type_72,Netilmicin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,72,Type_72,Yes
DB00997,Doxorubicin,DB09167,Dosulepin,0.7893528938293457,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Doxorubicin.,47,Type_47,Yes
DB00679,Thioridazine,DB00699,Nicergoline,0.8921369910240173,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Nicergoline.,47,Type_47,No
DB01155,Gemifloxacin,DB09078,Lenvatinib,0.9930468201637268,20,Type_20,Gemifloxacin may increase the QTc-prolonging activities of Lenvatinib.,20,Type_20,Yes
DB00696,Ergotamine,DB06152,Nylidrin,0.9997774958610535,71,Type_71,Ergotamine may increase the hypertensive activities of Nylidrin.,71,Type_71,Yes
DB01050,Ibuprofen,DB02709,Resveratrol,0.998524010181427,49,Type_49,The risk or severity of adverse effects can be increased when Ibuprofen is combined with Resveratrol.,49,Type_49,Yes
DB00762,Irinotecan,DB01118,Amiodarone,0.6678737998008728,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Irinotecan.,73,Type_73,No
DB01097,Leflunomide,DB06781,Difluprednate,0.9984080195426941,49,Type_49,The risk or severity of adverse effects can be increased when Leflunomide is combined with Difluprednate.,49,Type_49,Yes
DB00712,Flurbiprofen,DB11660,Latanoprostene bunod,1.0,70,Type_70,The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Flurbiprofen.,70,Type_70,Yes
DB04908,Flibanserin,DB08883,Perampanel,0.9741480350494385,16,Type_16,Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,16,Type_16,Yes
DB00215,Citalopram,DB01059,Norfloxacin,0.9630923867225647,20,Type_20,Citalopram may increase the QTc-prolonging activities of Norfloxacin.,20,Type_20,Yes
DB00292,Etomidate,DB00623,Fluphenazine,0.9885984659194946,49,Type_49,The risk or severity of adverse effects can be increased when Etomidate is combined with Fluphenazine.,49,Type_49,Yes
DB00790,Perindopril,DB01590,Everolimus,0.7570139169692993,73,Type_73,The serum concentration of Everolimus can be increased when it is combined with Perindopril.,73,Type_73,Yes
DB00543,Amoxapine,DB00946,Phenprocoumon,0.9920966625213623,6,Type_6,Amoxapine may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00750,Prilocaine,DB01018,Guanfacine,0.9923107624053955,49,Type_49,The risk or severity of adverse effects can be increased when Prilocaine is combined with Guanfacine.,49,Type_49,Yes
DB00420,Promazine,DB01233,Metoclopramide,0.6877666115760803,20,Type_20,Promazine may increase the QTc-prolonging activities of Metoclopramide.,20,Type_20,Yes
DB00199,Erythromycin,DB00502,Haloperidol,0.7808631062507629,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Haloperidol.,20,Type_20,Yes
DB00489,Sotalol,DB00537,Ciprofloxacin,0.9076482653617859,20,Type_20,Sotalol may increase the QTc-prolonging activities of Ciprofloxacin.,20,Type_20,Yes
DB00628,Clorazepic acid,DB01189,Desflurane,0.9933081865310669,49,Type_49,The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Desflurane.,49,Type_49,Yes
DB00356,Chlorzoxazone,DB08872,Gabapentin enacarbil,0.9999932050704956,49,Type_49,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Gabapentin enacarbil.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB01171,Moclobemide,0.7415751218795776,47,Type_47,The metabolism of Moclobemide can be decreased when combined with Dihydroergotamine.,49,Type_49,No
DB00996,Gabapentin,DB01355,Hexobarbital,0.8772482872009277,49,Type_49,The risk or severity of adverse effects can be increased when Gabapentin is combined with Hexobarbital.,49,Type_49,Yes
DB00220,Nelfinavir,DB01136,Carvedilol,0.5907788872718811,73,Type_73,The serum concentration of Carvedilol can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00212,Remikiren,DB04840,Debrisoquine,0.9995183944702148,60,Type_60,Remikiren may increase the hypotensive activities of Debrisoquine.,60,Type_60,Yes
DB00220,Nelfinavir,DB00514,Dextromethorphan,0.8914809226989746,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00278,Argatroban,DB09048,Netupitant,0.9170334935188293,73,Type_73,The serum concentration of Netupitant can be increased when it is combined with Argatroban.,73,Type_73,Yes
DB01074,Perhexiline,DB01397,Magnesium salicylate,0.7791720032691956,49,Type_49,The risk or severity of adverse effects can be increased when Perhexiline is combined with Magnesium salicylate.,49,Type_49,Yes
DB01243,Chloroxine,DB06712,Nilvadipine,0.998576283454895,49,Type_49,The risk or severity of adverse effects can be increased when Chloroxine is combined with Nilvadipine.,49,Type_49,Yes
DB00511,Acetyldigitoxin,DB01226,Mivacurium,0.9739654660224915,82,Type_82,Acetyldigitoxin may increase the arrhythmogenic activities of Mivacurium.,82,Type_82,Yes
DB00479,Amikacin,DB00482,Celecoxib,0.9894729256629944,72,Type_72,Amikacin may decrease the excretion rate of Celecoxib which could result in a higher serum level.,72,Type_72,Yes
DB01101,Capecitabine,DB01320,Fosphenytoin,0.34993013739585876,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Capecitabine.,73,Type_73,No
DB00591,Fluocinolone acetonide,DB00805,Minaprine,0.8600441813468933,49,Type_49,The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Minaprine.,49,Type_49,Yes
DB00883,Isosorbide dinitrate,DB01167,Itraconazole,0.49466976523399353,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Isosorbide dinitrate.,47,Type_47,No
DB06738,Ketobemidone,DB06770,Benzyl alcohol,0.9879003763198853,49,Type_49,The risk or severity of adverse effects can be increased when Ketobemidone is combined with Benzyl alcohol.,49,Type_49,Yes
DB00199,Erythromycin,DB06699,Degarelix,0.9998908042907715,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Degarelix.,20,Type_20,Yes
DB00367,Levonorgestrel,DB01045,Rifampicin,0.3863532543182373,4,Type_4,The metabolism of Rifampicin can be increased when combined with Levonorgestrel.,4,Type_4,Yes
DB00321,Amitriptyline,DB12598,Nafamostat,0.3783129155635834,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nafamostat.,73,Type_73,No
DB00257,Clotrimazole,DB09078,Lenvatinib,0.8005109429359436,47,Type_47,The metabolism of Lenvatinib can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00238,Nevirapine,DB05676,Apremilast,0.7294104695320129,4,Type_4,The metabolism of Apremilast can be increased when combined with Nevirapine.,75,Type_75,No
DB00829,Diazepam,DB01104,Sertraline,0.5207654237747192,47,Type_47,The metabolism of Sertraline can be decreased when combined with Diazepam.,47,Type_47,Yes
DB00280,Disopyramide,DB01072,Atazanavir,0.66069495677948,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Atazanavir.,47,Type_47,No
DB00310,Chlorthalidone,DB01407,Clenbuterol,0.9995866417884827,83,Type_83,Chlorthalidone may increase the hypokalemic activities of Clenbuterol.,83,Type_83,Yes
DB00395,Carisoprodol,DB00996,Gabapentin,0.9979378581047058,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin.,49,Type_49,Yes
DB00361,Vinorelbine,DB01403,Methotrimeprazine,0.4763495922088623,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB06237,Avanafil,DB06826,Unoprostone,0.9900369644165039,10,Type_10,Avanafil may increase the antihypertensive activities of Unoprostone.,10,Type_10,Yes
DB00715,Paroxetine,DB00952,Naratriptan,0.9335938692092896,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.,49,Type_49,Yes
DB00208,Ticlopidine,DB00648,Mitotane,0.9470162987709045,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Ticlopidine.,75,Type_75,Yes
DB00359,Sulfadiazine,DB00549,Zafirlukast,0.9866769313812256,47,Type_47,The metabolism of Zafirlukast can be decreased when combined with Sulfadiazine.,47,Type_47,Yes
DB00252,Phenytoin,DB01394,Colchicine,0.5813101530075073,73,Type_73,The serum concentration of Colchicine can be increased when it is combined with Phenytoin.,4,Type_4,No
DB00346,Alfuzosin,DB01174,Phenobarbital,0.6288266181945801,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Alfuzosin.,4,Type_4,Yes
DB01138,Sulfinpyrazone,DB01238,Aripiprazole,0.49019601941108704,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Sulfinpyrazone.,75,Type_75,Yes
DB00351,Megestrol acetate,DB06335,Saxagliptin,0.9220296144485474,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00850,Perphenazine,DB09352,Hydroxyamphetamine,0.9651488065719604,61,Type_61,Perphenazine may decrease the stimulatory activities of Hydroxyamphetamine.,61,Type_61,Yes
DB00734,Risperidone,DB01437,Glutethimide,0.9999310970306396,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Glutethimide.,49,Type_49,Yes
DB09065,Cobicistat,DB09123,Dienogest,0.4046618342399597,73,Type_73,The serum concentration of Dienogest can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB06781,Difluprednate,DB08938,Magaldrate,0.9983615279197693,3,Type_3,The bioavailability of Magaldrate can be decreased when combined with Difluprednate.,3,Type_3,Yes
DB00470,Dronabinol,DB08933,Luliconazole,0.9942551255226135,73,Type_73,The serum concentration of Luliconazole can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB01433,Methadyl acetate,DB01624,Zuclopenthixol,0.9870660901069641,49,Type_49,The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Zuclopenthixol.,49,Type_49,Yes
DB00596,Ulobetasol,DB09063,Ceritinib,0.9850098490715027,78,Type_78,Ulobetasol may increase the hyperglycemic activities of Ceritinib.,78,Type_78,Yes
DB00150,Tryptophan,DB01156,Bupropion,0.9668274521827698,64,Type_64,Tryptophan may increase the serotonergic activities of Bupropion.,64,Type_64,Yes
DB04871,Lorcaserin,DB09118,Stiripentol,0.850805938243866,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Lorcaserin.,73,Type_73,Yes
DB00528,Lercanidipine,DB00648,Mitotane,0.8361281752586365,75,Type_75,The serum concentration of Mitotane can be decreased when it is combined with Lercanidipine.,75,Type_75,Yes
DB01171,Moclobemide,DB09070,Tibolone,0.947672963142395,60,Type_60,Moclobemide may increase the hypotensive activities of Tibolone.,60,Type_60,Yes
DB00608,Chloroquine,DB01195,Flecainide,0.7034116387367249,20,Type_20,Chloroquine may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00598,Labetalol,DB07615,Tranilast,0.9716674089431763,37,Type_37,Labetalol may decrease the antihypertensive activities of Tranilast.,60,Type_60,No
DB09041,Tavaborole,DB09235,Efonidipine,0.9990642666816711,49,Type_49,The risk or severity of adverse effects can be increased when Tavaborole is combined with Efonidipine.,49,Type_49,Yes
DB01159,Halothane,DB06690,Nitrous oxide,0.9996510744094849,49,Type_49,The risk or severity of adverse effects can be increased when Halothane is combined with Nitrous oxide.,49,Type_49,Yes
DB01545,Ethyl loflazepate,DB06690,Nitrous oxide,0.99997878074646,49,Type_49,The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Nitrous oxide.,49,Type_49,Yes
DB00373,Timolol,DB00951,Isoniazid,0.6501118540763855,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Timolol.,47,Type_47,Yes
DB00804,Dicyclomine,DB00940,Methantheline,0.9353922605514526,49,Type_49,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Methantheline.,49,Type_49,Yes
DB00542,Benazepril,DB00696,Ergotamine,0.49585193395614624,73,Type_73,The serum concentration of Ergotamine can be increased when it is combined with Benazepril.,73,Type_73,Yes
DB00696,Ergotamine,DB01085,Pilocarpine,0.5298556685447693,47,Type_47,The metabolism of Pilocarpine can be decreased when combined with Ergotamine.,49,Type_49,No
DB00278,Argatroban,DB09215,Droxicam,0.9944111704826355,6,Type_6,Argatroban may increase the anticoagulant activities of Droxicam.,6,Type_6,Yes
DB00555,Lamotrigine,DB01026,Ketoconazole,0.29072311520576477,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ketoconazole.,49,Type_49,Yes
DB00395,Carisoprodol,DB00949,Felbamate,0.9565815329551697,49,Type_49,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Felbamate.,49,Type_49,Yes
DB01116,Trimethaphan,DB06826,Unoprostone,0.9989238381385803,60,Type_60,Trimethaphan may increase the hypotensive activities of Unoprostone.,60,Type_60,Yes
DB01247,Isocarboxazid,DB01420,Testosterone propionate,0.9124836325645447,49,Type_49,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Testosterone propionate.,49,Type_49,Yes
DB00285,Venlafaxine,DB00645,Dyclonine,0.9540929198265076,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dyclonine.,49,Type_49,Yes
DB00584,Enalapril,DB12598,Nafamostat,0.6935935020446777,49,Type_49,The risk or severity of adverse effects can be increased when Enalapril is combined with Nafamostat.,49,Type_49,Yes
DB00489,Sotalol,DB01400,Neostigmine,0.998464822769165,54,Type_54,Sotalol may increase the bradycardic activities of Neostigmine.,54,Type_54,Yes
DB00872,Conivaptan,DB01396,Digitoxin,0.7786080837249756,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Conivaptan.,73,Type_73,Yes
DB00489,Sotalol,DB05676,Apremilast,0.8955509662628174,37,Type_37,Sotalol may decrease the antihypertensive activities of Apremilast.,37,Type_37,Yes
DB01169,Arsenic trioxide,DB08865,Crizotinib,0.8076087832450867,20,Type_20,Arsenic trioxide may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB00622,Nicardipine,DB00999,Hydrochlorothiazide,0.5512437224388123,49,Type_49,The risk or severity of adverse effects can be increased when Nicardipine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB00310,Chlorthalidone,DB01626,Pargyline,0.9958961009979248,60,Type_60,Chlorthalidone may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB01118,Amiodarone,DB01384,Paramethasone,0.756215512752533,47,Type_47,The metabolism of Paramethasone can be decreased when combined with Amiodarone.,47,Type_47,Yes
DB01045,Rifampicin,DB01128,Bicalutamide,0.7644749879837036,4,Type_4,The metabolism of Bicalutamide can be increased when combined with Rifampicin.,4,Type_4,Yes
DB00717,Norethisterone,DB00997,Doxorubicin,0.5867405533790588,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Norethisterone.,75,Type_75,No
DB01166,Cilostazol,DB08816,Ticagrelor,0.37835779786109924,53,Type_53,Cilostazol may increase the antiplatelet activities of Ticagrelor.,6,Type_6,No
DB00349,Clobazam,DB01623,Thiothixene,0.5085932612419128,47,Type_47,The metabolism of Thiothixene can be decreased when combined with Clobazam.,49,Type_49,No
DB00401,Nisoldipine,DB00857,Terbinafine,0.4906209707260132,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Nisoldipine.,49,Type_49,No
DB01184,Domperidone,DB01685,Topiroxostat,0.9919270277023315,47,Type_47,The metabolism of Topiroxostat can be decreased when combined with Domperidone.,47,Type_47,Yes
DB00276,Amsacrine,DB00608,Chloroquine,0.8127174377441406,47,Type_47,The metabolism of Chloroquine can be decreased when combined with Amsacrine.,47,Type_47,Yes
DB00690,Flurazepam,DB06695,Dabigatran etexilate,0.8980672359466553,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Flurazepam.,77,Type_77,Yes
DB00424,Hyoscyamine,DB00782,Propantheline,0.9968806505203247,49,Type_49,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Propantheline.,49,Type_49,Yes
DB00501,Cimetidine,DB04871,Lorcaserin,0.9870222210884094,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Cimetidine.,47,Type_47,Yes
DB00800,Fenoldopam,DB01351,Amobarbital,0.8432145714759827,60,Type_60,Fenoldopam may increase the hypotensive activities of Amobarbital.,60,Type_60,Yes
DB00571,Propranolol,DB01251,Gliquidone,0.9751773476600647,9,Type_9,Propranolol may increase the hypoglycemic activities of Gliquidone.,9,Type_9,Yes
DB00326,Calcium glucoheptonate,DB01155,Gemifloxacin,0.9082789421081543,67,Type_67,Calcium glucoheptonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00454,Meperidine,DB09342,Propoxycaine,0.935863196849823,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Propoxycaine.,49,Type_49,Yes
DB04576,Fleroxacin,DB13142,Calcium glubionate anhydrous,0.8947086930274963,67,Type_67,Fleroxacin can cause a decrease in the absorption of Calcium glubionate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.,67,Type_67,Yes
DB00270,Isradipine,DB00753,Isoflurane,0.713331401348114,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Isoflurane.,49,Type_49,Yes
DB00748,Carbinoxamine,DB01202,Levetiracetam,0.9991976618766785,49,Type_49,The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Levetiracetam.,49,Type_49,Yes
DB00660,Metaxalone,DB01178,Chlormezanone,0.9999991655349731,49,Type_49,The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlormezanone.,49,Type_49,Yes
DB01016,Glyburide,DB09027,Ledipasvir,0.9197620749473572,73,Type_73,The serum concentration of Ledipasvir can be increased when it is combined with Glyburide.,73,Type_73,Yes
DB00539,Toremifene,DB08893,Mirabegron,0.9694696068763733,20,Type_20,Toremifene may increase the QTc-prolonging activities of Mirabegron.,20,Type_20,Yes
DB00411,Carbamoylcholine,DB01199,Tubocurarine,0.574417233467102,49,Type_49,The risk or severity of adverse effects can be increased when Carbamoylcholine is combined with Tubocurarine.,49,Type_49,Yes
DB00722,Lisinopril,DB01340,Cilazapril,0.830570638179779,49,Type_49,The risk or severity of adverse effects can be increased when Lisinopril is combined with Cilazapril.,49,Type_49,Yes
DB00385,Valrubicin,DB01397,Magnesium salicylate,0.9972266554832458,72,Type_72,Valrubicin may decrease the excretion rate of Magnesium salicylate which could result in a higher serum level.,72,Type_72,Yes
DB00240,Alclometasone,DB01401,Choline magnesium trisalicylate,0.9994674324989319,49,Type_49,The risk or severity of adverse effects can be increased when Alclometasone is combined with Choline magnesium trisalicylate.,49,Type_49,Yes
DB01017,Minocycline,DB01615,Aceprometazine,0.98546302318573,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine.,16,Type_16,Yes
DB00420,Promazine,DB01015,Sulfamethoxazole,0.4753420948982239,20,Type_20,Promazine may increase the QTc-prolonging activities of Sulfamethoxazole.,20,Type_20,Yes
DB00460,Verteporfin,DB04571,Trioxsalen,0.9953585267066956,1,Type_1,Verteporfin may increase the photosensitizing activities of Trioxsalen.,1,Type_1,Yes
DB00460,Verteporfin,DB00553,Methoxsalen,0.6456453800201416,49,Type_49,The risk or severity of adverse effects can be increased when Verteporfin is combined with Methoxsalen.,1,Type_1,No
DB00758,Clopidogrel,DB06441,Cangrelor,0.9172558188438416,26,Type_26,Clopidogrel may decrease the antiplatelet activities of Cangrelor.,26,Type_26,Yes
DB00454,Meperidine,DB01037,Selegiline,0.5453461408615112,41,Type_41,Meperidine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Selegiline.,41,Type_41,Yes
DB00454,Meperidine,DB00805,Minaprine,0.9094392657279968,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Minaprine.,41,Type_41,No
DB00594,Amiloride,DB00864,Tacrolimus,0.4052554965019226,68,Type_68,Amiloride may increase the hyperkalemic activities of Tacrolimus.,42,Type_42,No
DB00289,Atomoxetine,DB09244,Pirlindole,0.9814959168434143,44,Type_44,Atomoxetine may increase the central neurotoxic activities of Pirlindole.,44,Type_44,Yes
DB00289,Atomoxetine,DB01247,Isocarboxazid,0.9794496297836304,44,Type_44,Atomoxetine may increase the central neurotoxic activities of Isocarboxazid.,44,Type_44,Yes
DB00377,Palonosetron,DB06204,Tapentadol,0.7774572372436523,64,Type_64,Palonosetron may increase the serotonergic activities of Tapentadol.,52,Type_52,No
DB00437,Allopurinol,DB00790,Perindopril,0.9937686920166016,86,Type_86,The risk of a hypersensitivity reaction to Perindopril is increased when it is combined with Allopurinol.,86,Type_86,Yes
DB00437,Allopurinol,DB00519,Trandolapril,0.997921884059906,86,Type_86,The risk of a hypersensitivity reaction to Trandolapril is increased when it is combined with Allopurinol.,86,Type_86,Yes
DB00437,Allopurinol,DB00880,Chlorothiazide,0.9900998473167419,86,Type_86,The risk of a hypersensitivity reaction to Chlorothiazide is increased when it is combined with Allopurinol.,86,Type_86,Yes
DB00437,Allopurinol,DB01325,Quinethazone,0.9845825433731079,86,Type_86,The risk of a hypersensitivity reaction to Quinethazone is increased when it is combined with Allopurinol.,86,Type_86,Yes
DB00614,Furazolidone,DB00899,Remifentanil,0.6267969012260437,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Remifentanil.,79,Type_79,No
DB00802,Alfentanil,DB09245,Toloxatone,0.7145742177963257,79,Type_79,Alfentanil may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Toloxatone.,79,Type_79,Yes
DB00614,Furazolidone,DB00708,Sufentanil,0.8655620217323303,79,Type_79,Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Sufentanil.,79,Type_79,Yes
DB00805,Minaprine,DB00813,Fentanyl,0.6458495855331421,79,Type_79,Minaprine may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Fentanyl.,79,Type_79,Yes
